Drug_code,HC_last_status,HC_last_status_date,Drug_identification_number,Brand_name,Number_of_AIS,TC_ATC_Number,TC_ATC,CompoundDPDForm,CompoundRoute,mp_code,mp_formal_name,mp_status,ntp_code,ntp_formal_name,tm_code,tm_formal_name,BC_SCT_route_code,BC_SCT_route_name,BC_SCT_form_code,BC_SCT_form_name,BC_SCT_Unit_of_Presentation_code,BC_SCT_Unit_of_Presentation_name,Flag_Hazardous,Flag_BC_CPP,Flag_Biosimilar
,,,,,,,,,,02480360,AUVI-Q (epinephrine 0.15 mg per 0.15 mL solution for injection syringe) KALEO INC,Inactive,9013250,epinephrine 0.15 mg per 0.15 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
,,,,,,,,,,02480379,AUVI-Q (epinephrine 0.3 mg per 0.3 mL solution for injection syringe) KALEO INC,Inactive,9001299,epinephrine 0.3 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
77936,Cancelled post market,2024-07-31,02293994,NEOCITRAN EXTRA STRENGTH TOTAL COLD,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02293994,NEOCITRAN EXTRA STRENGTH TOTAL COLD (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013259,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
91045,Cancelled post market,2025-09-29,02425815,REFRESH OPTIVE ADVANCED SENSITIVE,3.0,S01XA20,Artificial tears and other indifferent preparations.,Emulsion,Ophthalmic,02425815,REFRESH OPTIVE ADVANCED SENSITIVE (carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013773,carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops,8002223,carboxymethylcellulose and glycerin and polysorbate 80,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
92885,Cancelled post market,2025-04-28,02444062,SYSTANE OINTMENT,3.0,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,02444062,SYSTANE OINTMENT (lanolin 3 % and mineral oil heavy 3 % and white petrolatum 94 % ophthalmic ointment) ALCON CANADA INC,Active,9013695,lanolin 3 % and mineral oil heavy 3 % and white petrolatum 94 % ophthalmic ointment,8002202,lanolin and mineral oil heavy and white petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
97229,Cancelled post market,2022-08-16,02481812,BACITRACIN ZINC OINTMENT USP,1.0,D06AX05,Bacitracin,Ointment,Topical,02481812,"BACITRACIN ZINC OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment) WATER-JEL TECHNOLOGIES, LLC",Active,9013864,bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
15625,Cancelled post market,2025-06-27,01908448,BETOPTIC S,1.0,S01ED02,Betaxolol,Suspension,Ophthalmic,01908448,BETOPTIC S (betaxolol (betaxolol hydrochloride) 0.25 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002631,betaxolol (betaxolol hydrochloride) 0.25 % ophthalmic drops,8001586,betaxolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
19647,Cancelled post market,2025-03-07,02184478,CASODEX,1.0,L02BB03,Bicalutamide,Tablet,Oral,02184478,CASODEX (bicalutamide 50 mg oral tablet) ASTRAZENECA CANADA INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
71470,Cancelled post market,2024-01-31,02247228,STIEPROX SHAMPOO,1.0,D01AE14,Ciclopirox,Shampoo,Topical,02247228,STIEPROX SHAMPOO (ciclopirox olamine 1.5 % shampoo) GLAXOSMITHKLINE INC,Active,9001055,ciclopirox olamine 1.5 % shampoo,8000230,ciclopirox,41695006,Scalp structure,785908001,Shampoo,,,,,
74235,Cancelled post market,2024-09-16,02257130,SENSIPAR,1.0,H05BX01,Cinacalcet,Tablet,Oral,02257130,SENSIPAR (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) AMGEN CANADA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74236,Cancelled post market,2024-09-16,02257149,SENSIPAR,1.0,H05BX01,Cinacalcet,Tablet,Oral,02257149,SENSIPAR (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) AMGEN CANADA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67033,Cancelled post market,2025-11-28,02243158,CLINDOXYL GEL,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02243158,CLINDOXYL GEL (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) GLAXOSMITHKLINE INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,
12944,Cancelled post market,2025-12-16,01934783,ROBAXISAL C 1/4,3.0,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934783,ROBAXISAL C 1/4 (acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9002410,acetylsalicylic acid 325 mg and codeine phosphate 16.2 mg and methocarbamol 400 mg oral tablet,8000861,acetylsalicylic acid and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12946,Cancelled post market,2025-12-15,01934791,ROBAXISAL C 1/2,3.0,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934791,ROBAXISAL C 1/2 (acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9002411,acetylsalicylic acid 325 mg and codeine phosphate 32.4 mg and methocarbamol 400 mg oral tablet,8000861,acetylsalicylic acid and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1931,Cancelled post market,2025-08-14,00287873,SANDOZ COLCHICINE,1.0,M04AC01,Colchicine,Tablet,Oral,00287873,SANDOZ COLCHICINE (colchicine 0.6 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79794,Cancelled post market,2025-12-02,02312433,PRADAXA,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02312433,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001251,dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102517,Cancelled post market,2025-04-17,02536390,DEXLANSOPRAZOLE,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02536390,DEXLANSOPRAZOLE (dexlansoprazole 30 mg gastro-resistant capsule) ALTIUS HEALTHCARE INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
102518,Cancelled post market,2025-04-17,02536404,DEXLANSOPRAZOLE,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02536404,DEXLANSOPRAZOLE (dexlansoprazole 60 mg gastro-resistant capsule) ALTIUS HEALTHCARE INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
197,Cancelled post market,2025-06-11,00013579,GRAVOL IM,1.0,R06AA11,Dimenhydrinate,Solution,Intramuscular,00013579,GRAVOL IM (dimenhydrinate 50 mg per 1 mL solution for injection vial) CHURCH & DWIGHT CANADA CORP,Active,9012705,dimenhydrinate 50 mg per 1 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
81142,Cancelled post market,2025-06-30,02326086,DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,02326086,DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) PRO DOC LIMITEE,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94871,Cancelled post market,2024-12-31,02461218,TIVICAY,1.0,J05AJ03,Dolutegravir,Tablet,Oral,02461218,TIVICAY (dolutegravir (dolutegravir sodium) 10 mg oral tablet) VIIV HEALTHCARE ULC,Active,9006194,dolutegravir (dolutegravir sodium) 10 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94872,Cancelled post market,2024-12-31,02461226,TIVICAY,1.0,J05AJ03,Dolutegravir,Tablet,Oral,02461226,TIVICAY (dolutegravir (dolutegravir sodium) 25 mg oral tablet) VIIV HEALTHCARE ULC,Active,9006195,dolutegravir (dolutegravir sodium) 25 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20083,Cancelled post market,2025-12-08,02216205,TRUSOPT,1.0,S01EC03,Dorzolamide,Solution,Ophthalmic,02216205,TRUSOPT WITH PRESERVATIVE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78681,Cancelled post market,2024-09-25,02301482,CYMBALTA,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02301482,CYMBALTA (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ELI LILLY CANADA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
78682,Cancelled post market,2024-09-25,02301490,CYMBALTA,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02301490,CYMBALTA (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ELI LILLY CANADA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
72003,Cancelled post market,2025-03-31,02247725,FUZEON,1.0,J05AX07,Enfuvirtide,Powder for solution,Subcutaneous,02247725,FUZEON (enfuvirtide 108 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9003820,enfuvirtide 108 mg per vial powder for solution for injection,8001457,enfuvirtide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
75441,Cancelled post market,2024-10-01,02269007,TARCEVA,1.0,L01EB02,Erlotinib,Tablet,Oral,02269007,TARCEVA (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75442,Cancelled post market,2024-10-01,02269015,TARCEVA,1.0,L01EB02,Erlotinib,Tablet,Oral,02269015,TARCEVA (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75443,Cancelled post market,2024-10-01,02269023,TARCEVA,1.0,L01EB02,Erlotinib,Tablet,Oral,02269023,TARCEVA (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92466,Cancelled post market,2026-01-05,02440296,NAT-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02440296,NAT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92467,Cancelled post market,2026-01-05,02440318,NAT-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02440318,NAT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94710,Cancelled post market,2025-06-24,02459779,REPATHA,1.0,C10AX13,Evolocumab,Solution,Subcutaneous,02459779,REPATHA (evolocumab 420 mg per 3.5 mL solution for injection cartridge) AMGEN CANADA INC,Active,9012629,evolocumab 420 mg per 3.5 mL solution for injection cartridge,8001268,evolocumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
97215,Cancelled post market,2025-01-31,02481669,NRA-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02481669,NRA-EZETIMIBE (ezetimibe 10 mg oral tablet) NORA PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9703,Cancelled post market,2024-09-25,00636622,PROZAC CAPSULES 20MG,1.0,N06AB03,Fluoxetine,Capsule,Oral,00636622,PROZAC CAPSULES 20MG (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) ELI LILLY CANADA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13723,Cancelled post market,2024-09-25,02018985,PROZAC CAPSULES 10MG,1.0,N06AB03,Fluoxetine,Capsule,Oral,02018985,PROZAC CAPSULES 10MG (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) ELI LILLY CANADA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72486,Cancelled post market,2025-08-06,02248154,GONAL-F,1.0,G03GA05,Follitropin alfa,Powder for solution,"Subcutaneous,Intramuscular",02248154,"GONAL-F (follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013133,follitropin alfa 75 unit per vial powder for solution for injection with diluent solution syringe,8001475,follitropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81924,Cancelled post market,2024-02-29,02333627,GLUCAGEN HYPOKIT,1.0,H04AA01,Glucagon,"Powder for solution,Kit",Intramuscular,02333627,GLUCAGEN HYPOKIT (glucagon (glucagon hydrochloride) 1 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9012980,glucagon (glucagon hydrochloride) 1 mg per vial powder for solution for injection with diluent solution syringe,8001385,glucagon,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
11918,Cancelled post market,2024-08-12,01931032,ROBITUSSIN MUCUS & PHLEGM,1.0,R05CA03,Guaifenesin,Syrup,Oral,01931032,ROBITUSSIN MUCUS & PHLEGM (guaifenesin 100 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9001847,guaifenesin 100 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,
37334,Cancelled post market,2024-05-14,02223252,PROCTOSEDYL,4.0,C05AA01,Hydrocortisone,Ointment,Rectal,02223252,PROCTOSEDYL (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) APTALIS PHARMA CANADA ULC,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,
84765,Cancelled post market,2025-08-25,02362643,ADVIL COLD & FLU,2.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02362643,ADVIL COLD & FLU (diphenhydramine citrate 38 mg and ibuprofen 200 mg oral tablet) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9004949,diphenhydramine citrate 38 mg and ibuprofen 200 mg oral tablet,8001188,diphenhydramine and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97187,Cancelled post market,2024-10-24,02481383,TEGSEDI,1.0,N07XX15,Inotersen,Solution,Subcutaneous,02481383,"TEGSEDI (inotersen (inotersen sodium) 284 mg per 1.5 mL solution for injection syringe) AKCEA THERAPEUTICS, INC.",Active,9013964,inotersen (inotersen sodium) 284 mg per 1.5 mL solution for injection syringe,8002258,inotersen,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
95819,Cancelled post market,2025-09-09,02469405,PREVYMIS,1.0,J05AX18,Letermovir,Solution,Intravenous,02469405,PREVYMIS 480 MG/24 ML SINGLE-DOSE VIAL (letermovir 480 mg per 24 mL solution for injection vial) MERCK CANADA INC,Active,9012507,letermovir 480 mg per 24 mL solution for injection vial,8001140,letermovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96104,Cancelled post market,2024-07-23,02471833,EQUATE AFTER SUN GEL WITH LIDOCAINE,1.0,D04AB01,Lidocaine,Gel,Topical,02471833,"EQUATE AFTER SUN GEL WITH LIDOCAINE (lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel) FRUIT OF THE EARTH, INC",Active,9014894,lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,
16587,Cancelled post market,2025-11-05,02041448,ATIVAN,1.0,N05BA06,Lorazepam,Tablet,Oral,02041448,ATIVAN (lorazepam 2 mg oral tablet) PFIZER CANADA ULC,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87336,Cancelled post market,2025-08-19,02387786,LATUDA,1.0,N05AE05,Lurasidone,Tablet,Oral,02387786,"LATUDA (lurasidone hydrochloride 120 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
430,Cancelled post market,2025-11-14,00030937,PROVERA 5MG TABLETS,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,00030937,PROVERA 5MG TABLETS (medroxyprogesterone acetate 5 mg oral tablet) PFIZER CANADA ULC,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
7480,Cancelled post market,2025-11-14,00729973,PROVERA 10MG TABLETS,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,00729973,PROVERA 10MG TABLETS (medroxyprogesterone acetate 10 mg oral tablet) PFIZER CANADA ULC,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
13037,Cancelled post market,2025-11-14,00708917,PROVERA 2.5MG TABLETS,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,00708917,PROVERA 2.5MG TABLETS (medroxyprogesterone acetate 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93562,Cancelled post market,2023-12-06,02449781,NUCALA,1.0,R03DX09,Mepolizumab,Powder for solution,Subcutaneous,02449781,NUCALA (mepolizumab 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9005907,mepolizumab 100 mg per vial powder for solution for injection,8001066,mepolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94224,Cancelled post market,2024-12-09,02455439,INVOKAMET,2.0,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455439,INVOKAMET (canagliflozin 150 mg and metformin hydrochloride 500 mg oral tablet) JANSSEN INC,Active,9005986,canagliflozin 150 mg and metformin hydrochloride 500 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81955,Cancelled post market,2025-08-13,02333864,JANUMET,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333864,JANUMET (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69,Cancelled post market,2025-03-06,00050474,METHYLENE BLEU LIQ 2%,1.0,V03AB17,Methylthioninium chloride,Liquid,Oral,00050474,METHYLENE BLEU LIQ 2% (methylene blue 20 mg per mL oral solution) LABORATOIRE ATLAS INC,Active,9013830,methylene blue 20 mg per mL oral solution,8002140,methylene blue,26643006,Oral,385023001,Oral solution,,,,,
12997,Cancelled post market,2024-11-26,01926861,FLAGYL,1.0,G01AF01,Metronidazole,Cream,Vaginal,01926861,FLAGYL (metronidazole 10 % vaginal cream) SANOFI-AVENTIS CANADA INC,Active,9000050,metronidazole 10 % vaginal cream,8000038,metronidazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
72310,Cancelled post market,2025-10-18,02247997,SINGULAIR,1.0,R03DC03,Montelukast,Granules,Oral,02247997,SINGULAIR (montelukast (montelukast sodium) 4 mg per sachet oral granules) ORGANON CANADA INC.,Active,9014703,montelukast (montelukast sodium) 4 mg per sachet oral granules,8000261,montelukast,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
80140,Cancelled post market,2025-11-11,02315890,REFRESH EYE ALLERGY RELIEF,2.0,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,02315890,REFRESH EYE ALLERGY RELIEF (antazoline phosphate 0.51 % and naphazoline hydrochloride 0.051 % ophthalmic drops) ABBVIE CORPORATION,Active,9004514,antazoline phosphate 0.51 % and naphazoline hydrochloride 0.051 % ophthalmic drops,8001886,antazoline and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94576,Cancelled post market,2025-10-31,02458616,NITISINONE TABLETS,1.0,A16AX04,Nitisinone,Tablet,Oral,02458616,NITISINONE TABLETS (nitisinone 2 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006102,nitisinone 2 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94577,Cancelled post market,2025-10-31,02458624,NITISINONE TABLETS,1.0,A16AX04,Nitisinone,Tablet,Oral,02458624,NITISINONE TABLETS (nitisinone 5 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006103,nitisinone 5 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94578,Cancelled post market,2025-10-31,02458632,NITISINONE TABLETS,1.0,A16AX04,Nitisinone,Tablet,Oral,02458632,NITISINONE TABLETS (nitisinone 10 mg oral tablet) CYCLE PHARMACEUTICALS LTD.,Active,9006077,nitisinone 10 mg oral tablet,8001675,nitisinone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
188,Cancelled post market,2024-05-13,00116882,DIOVOL PLUS TABLETS,3.0,A02AF02,Ordinary salt combinations and antiflatulents,Tablet,Oral,00116882,DIOVOL PLUS TABLETS (aluminum magnesium hydroxide carbonate 300 mg and magnesium hydroxide 100 mg and simethicone 25 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9013942,aluminum magnesium hydroxide carbonate 300 mg and magnesium hydroxide 100 mg and simethicone 25 mg oral tablet,8002251,aluminum magnesium hydroxide carbonate and magnesium hydroxide and simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19075,Cancelled post market,2022-11-15,02157624,DIOVOL PLUS ALUMINUM FREE,3.0,A02AF02,Ordinary salt combinations and antiflatulents,Tablet (chewable),Oral,02157624,DIOVOL PLUS ALUMINUM FREE (calcium carbonate 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet) CHURCH & DWIGHT CANADA CORP,Active,9002750,calcium carbonate 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet,8002097,calcium carbonate and magnesium hydroxide and simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
83545,Cancelled post market,2025-07-11,02350238,OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02350238,OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) SANIS HEALTH INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87984,Cancelled post market,2024-11-06,02394693,ROBITUSSIN CHILDREN'S COLD,2.0,R01BA53,"Phenylephrine, combinations",Syrup,Oral,02394693,ROBITUSSIN CHILDREN'S COLD (brompheniramine maleate 2 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9004259,brompheniramine maleate 2 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution,8000922,brompheniramine and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
86284,Cancelled post market,2025-10-31,02377225,MOZOBIL,1.0,L03AX16,Plerixafor,Solution,Subcutaneous,02377225,MOZOBIL (plerixafor 24 mg per 1.2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
46885,Cancelled post market,2024-09-17,01914022,UROCIT-K,1.0,A12BA02,Potassium citrate,Tablet (extended-release),Oral,01914022,UROCIT-K (potassium citrate 5 mEq prolonged-release oral tablet) MISSION PHARMACAL COMPANY,Active,9013988,potassium citrate 5 mEq prolonged-release oral tablet,8001871,potassium citrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
50175,Cancelled post market,2025-09-04,02230897,BILTRICIDE,1.0,P02BA01,Praziquantel,Tablet,Oral,02230897,BILTRICIDE (praziquantel 600 mg oral tablet) BAYER INC,Active,9003085,praziquantel 600 mg oral tablet,8001415,praziquantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87770,Cancelled post market,2025-11-07,02392429,ISENTRESS,1.0,J05AJ01,Raltegravir,Tablet (chewable),Oral,02392429,ISENTRESS (raltegravir (raltegravir potassium) 25 mg chewable tablet) MERCK CANADA INC,Active,9005183,raltegravir (raltegravir potassium) 25 mg chewable tablet,8001224,raltegravir,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
63426,Cancelled post market,2024-08-30,02239926,GLUCONORM 2.0MG,1.0,A10BX02,Repaglinide,Tablet,Oral,02239926,GLUCONORM 2.0MG (repaglinide 2 mg oral tablet) NOVO NORDISK CANADA INC,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97269,Cancelled post market,2025-08-15,02482215,KUVAN,1.0,A16AX07,Sapropterin,Powder,Oral,02482215,KUVAN (sapropterin dihydrochloride 500 mg per sachet powder for oral solution) BIOMARIN INTERNATIONAL LIMITED,Active,9014274,sapropterin dihydrochloride 500 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
97580,Cancelled post market,2025-04-10,02485567,RENVELA,1.0,V03AE02,Sevelamer,Powder for suspension,Oral,02485567,RENVELA (sevelamer carbonate 2.4 g per sachet powder for oral suspension) SANOFI-AVENTIS CANADA INC,Active,9014198,sevelamer carbonate 2.4 g per sachet powder for oral suspension,8001877,sevelamer,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
66943,Cancelled post market,2025-12-22,02243077,HUMATROPE,2.0,H01AC01,Somatropin,"Powder for solution,Liquid","Intramuscular,Subcutaneous",02243077,HUMATROPE (somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013752,somatropin 6 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,
66944,Cancelled post market,2025-12-22,02243078,HUMATROPE,2.0,H01AC01,Somatropin,"Liquid,Powder for solution","Intramuscular,Subcutaneous",02243078,HUMATROPE (somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013739,somatropin 12 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,
66945,Cancelled post market,2025-12-18,02243079,HUMATROPE,2.0,H01AC01,Somatropin,"Powder for solution,Liquid","Subcutaneous,Intramuscular",02243079,HUMATROPE (somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe) ELI LILLY CANADA INC,Active,9013746,somatropin 24 mg per cartridge powder for solution for injection with diluent solution syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,732988008,Cartridge,,,
18639,Cancelled post market,2023-03-22,02048485,NOLVADEX-D TAB 20MG,1.0,L02BA01,Tamoxifen,Tablet,Oral,02048485,NOLVADEX-D TAB 20MG (tamoxifen (tamoxifen citrate) 20 mg oral tablet) ASTRAZENECA CANADA INC,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75550,Cancelled post market,2024-02-15,02270102,FLOMAX CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02270102,FLOMAX CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77934,Cancelled post market,2024-12-31,02293978,PSORIASIN OINTMENT,1.0,D05AA,Tars,Ointment,Topical,02293978,"PSORIASIN OINTMENT (coal tar 2 % cutaneous ointment) ALVA-AMCO PHARMACAL COMPANIES, LLC",Active,9004326,coal tar 2 % cutaneous ointment,8002109,coal tar,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
1275,Cancelled post market,2025-12-18,00029246,DELATESTRYL,1.0,G03BA03,Testosterone,Solution,Intramuscular,00029246,"DELATESTRYL (testosterone enanthate 1000 mg per 5 mL solution for injection ampoule) BAUSCH HEALTH, CANADA INC.",Active,9000013,testosterone enanthate 1000 mg per 5 mL solution for injection ampoule,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
1398,Cancelled post market,2025-07-18,00030783,DEPO-TESTOSTERONE INJ 100MG/ML,1.0,G03BA03,Testosterone,Solution,Intramuscular,00030783,DEPO-TESTOSTERONE INJ 100MG/ML (testosterone cypionate 1000 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9000010,testosterone cypionate 1000 mg per 10 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
75881,Cancelled post market,2025-08-31,02273322,APTIVUS,1.0,J05AE09,Tipranavir,Capsule,Oral,02273322,APTIVUS (tipranavir 250 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004101,tipranavir 250 mg oral capsule,8001239,tipranavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
76057,Cancelled post market,2025-08-18,02275066,TROSEC,1.0,G04BD09,Trospium,Tablet,Oral,02275066,TROSEC (trospium chloride 20 mg oral tablet) SUNOVION PHARMACEUTICALS CANADA INC,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66725,Cancelled post market,2025-09-30,02242893,DIUREX WATER CAPLETS,1.0,C03BD,Xanthine derivatives,Tablet,Oral,02242893,"DIUREX WATER CAPLETS (pamabrom 50 mg oral tablet) ALVA-AMCO PHARMACAL COMPANIES, LLC",Active,9003571,pamabrom 50 mg oral tablet,8002050,pamabrom,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81544,Marketed,2018-06-13,02329727,DRAXIMAGE DTPA,1.0,,,Powder for solution,"Intravenous,Inhalation",,,,,,,,,,,,,,,,
83145,Marketed,2019-04-01,02360845,STANNOUS MAA KIT,1.0,,,"Suspension,Kit",Intravenous,,,,,,,,,,,,,,,,
85949,Marketed,2018-09-17,02374285,RUBY-FILL,1.0,,,Solution,Intravenous,,,,,,,,,,,,,,,,
98097,Marketed,2020-02-14,02490935,CANESORAL COMBI 1 DAY,2.0,,,"Cream,Capsule","Topical,Oral",02490935,CANESORAL COMBI 1 DAY (clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule) BAYER INC,Active,9014252,clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule,8000978,clotrimazole and fluconazole,26643006,Oral,421628006,Cutaneous cream,732937005,Capsule (unit of presentation),,,
98574,Marketed,2022-10-03,02495848,DRAX EXAMETAZIME,1.0,,,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
100572,Marketed,2022-05-13,02516365,ESSENTIAL ENERGY HYDRATING DAY CREAM,4.0,,,Cream,Topical,,,,,,,,,,,,,,,,
103078,Marketed,2024-10-21,02542196,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,,,Solution,Block/infiltration,77701187,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) JUNO PHARMACEUTICALS CORP.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
103078,Marketed,2024-10-21,02542196,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,,,Solution,Block/infiltration,77701188,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) JUNO PHARMACEUTICALS CORP.,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
103079,Marketed,2024-10-21,02542218,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,,,Solution,Block/infiltration,77701189,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) JUNO PHARMACEUTICALS CORP.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
103079,Marketed,2024-10-21,02542218,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,,,Solution,Block/infiltration,77701190,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) JUNO PHARMACEUTICALS CORP.,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
103741,Marketed,2024-12-17,02548550,SITAGLIPTIN,1.0,,,Tablet,Oral,02548550,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SANIS HEALTH INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106054,Marketed,2026-01-21,02557193,LUPIN-TOLVAPTAN,2.0,,,Tablet,Oral,,,,,,,,,,,,,,,,
106055,Marketed,2026-01-21,02557207,LUPIN-TOLVAPTAN,2.0,,,Tablet,Oral,,,,,,,,,,,,,,,,
63900,Marketed,2010-11-25,02240358,ZIAGEN,1.0,J05AF06,Abacavir,Solution,Oral,02240358,ZIAGEN (abacavir (abacavir sulfate) 20 mg per mL oral solution) VIIV HEALTHCARE ULC,Active,9012559,abacavir (abacavir sulfate) 20 mg per mL oral solution,8001162,abacavir,26643006,Oral,385023001,Oral solution,,,1.0,,
88178,Marketed,2016-03-15,02396769,APO-ABACAVIR,1.0,J05AF06,Abacavir,Tablet,Oral,02396769,APO-ABACAVIR (abacavir (abacavir sulfate) 300 mg oral tablet) APOTEX INC,Active,9012561,abacavir (abacavir sulfate) 300 mg oral tablet,8001162,abacavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97160,Marketed,2019-03-25,02480956,MINT-ABACAVIR,1.0,J05AF06,Abacavir,Tablet,Oral,02480956,MINT-ABACAVIR (abacavir (abacavir sulfate) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9012561,abacavir (abacavir sulfate) 300 mg oral tablet,8001162,abacavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76776,Marketed,2006-08-08,02282097,ORENCIA,1.0,L04AA24,Abatacept,Powder for solution,Intravenous,02282097,ORENCIA (abatacept 250 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9004196,abatacept 250 mg per vial powder for solution for injection,8001548,abatacept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88731,Marketed,2013-05-09,02402475,ORENCIA,1.0,L04AA24,Abatacept,Solution,Subcutaneous,02402475,ORENCIA (abatacept 125 mg per 1 mL solution for injection syringe) BRISTOL-MYERS SQUIBB CANADA,Active,9012880,abatacept 125 mg per 1 mL solution for injection syringe,8001548,abatacept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
97723,Marketed,2019-07-03,02487098,VERZENIO,1.0,L01EF03,Abemaciclib,Tablet,Oral,02487098,VERZENIO (abemaciclib 50 mg oral tablet) ELI LILLY CANADA INC,Active,9013997,abemaciclib 50 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97724,Marketed,2019-07-03,02487101,VERZENIO,1.0,L01EF03,Abemaciclib,Tablet,Oral,02487101,VERZENIO (abemaciclib 100 mg oral tablet) ELI LILLY CANADA INC,Active,9013994,abemaciclib 100 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97725,Marketed,2019-07-03,02487128,VERZENIO,1.0,L01EF03,Abemaciclib,Tablet,Oral,02487128,VERZENIO (abemaciclib 150 mg oral tablet) ELI LILLY CANADA INC,Active,9013995,abemaciclib 150 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97726,Marketed,2019-07-03,02487136,VERZENIO,1.0,L01EF03,Abemaciclib,Tablet,Oral,02487136,VERZENIO (abemaciclib 200 mg oral tablet) ELI LILLY CANADA INC,Active,9013996,abemaciclib 200 mg oral tablet,8002268,abemaciclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85626,Marketed,2011-07-28,02371065,ZYTIGA,1.0,L02BX03,Abiraterone,Tablet,Oral,02371065,ZYTIGA (abiraterone acetate 250 mg oral tablet) JANSSEN INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94420,Marketed,2016-09-22,02457113,ZYTIGA,1.0,L02BX03,Abiraterone,Tablet,Oral,02457113,ZYTIGA (abiraterone acetate 500 mg oral tablet) JANSSEN INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96788,Marketed,2021-03-26,02477114,REDDY-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02477114,REDDY-ABIRATERONE (abiraterone acetate 250 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97660,Marketed,2021-01-18,02486393,SANDOZ ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02486393,SANDOZ ABIRATERONE (abiraterone acetate 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98140,Marketed,2021-01-25,02491397,APO-ABIRATERONE FILM COATED TABLETS,1.0,L02BX03,Abiraterone,Tablet,Oral,02491397,APO-ABIRATERONE FILM COATED TABLETS (abiraterone acetate 250 mg oral tablet) APOTEX INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98141,Marketed,2021-01-25,02491400,APO-ABIRATERONE FILM COATED TABLETS,1.0,L02BX03,Abiraterone,Tablet,Oral,02491400,APO-ABIRATERONE FILM COATED TABLETS (abiraterone acetate 500 mg oral tablet) APOTEX INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98260,Marketed,2021-01-11,02492601,PMS-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02492601,PMS-ABIRATERONE (abiraterone acetate 250 mg oral tablet) PHARMASCIENCE INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98417,Marketed,2021-01-18,02494132,NAT-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02494132,NAT-ABIRATERONE (abiraterone acetate 250 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99112,Marketed,2021-01-11,02501503,PMS-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02501503,PMS-ABIRATERONE (abiraterone acetate 500 mg oral tablet) PHARMASCIENCE INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99188,Marketed,2021-02-22,02502305,JAMP ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02502305,JAMP ABIRATERONE (abiraterone acetate 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99344,Marketed,2021-02-03,02503980,MAR-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02503980,MAR-ABIRATERONE (abiraterone acetate 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99345,Marketed,2021-02-03,02503999,MAR-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02503999,MAR-ABIRATERONE (abiraterone acetate 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101082,Marketed,2022-03-28,02521644,SANDOZ ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02521644,SANDOZ ABIRATERONE (abiraterone acetate 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101887,Marketed,2023-01-30,02529629,JAMP ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02529629,JAMP ABIRATERONE (abiraterone acetate 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102226,Marketed,2023-04-28,02533251,REDDY-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02533251,REDDY-ABIRATERONE (abiraterone acetate 500 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102915,Marketed,2025-10-01,02540452,PRZ-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02540452,PRZ-ABIRATERONE (abiraterone acetate 250 mg oral tablet) PHARMARIS CANADA INC,Active,9004897,abiraterone acetate 250 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102916,Marketed,2025-10-01,02540460,PRZ-ABIRATERONE,1.0,L02BX03,Abiraterone,Tablet,Oral,02540460,PRZ-ABIRATERONE (abiraterone acetate 500 mg oral tablet) PHARMARIS CANADA INC,Active,9006043,abiraterone acetate 500 mg oral tablet,8001549,abiraterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101760,Marketed,2022-09-29,02528363,CIBINQO,1.0,D11AH08,Abrocitinib,Tablet,Oral,02528363,CIBINQO (abrocitinib 50 mg oral tablet) PFIZER CANADA ULC,Active,9014772,abrocitinib 50 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101761,Marketed,2022-09-29,02528371,CIBINQO,1.0,D11AH08,Abrocitinib,Tablet,Oral,02528371,CIBINQO (abrocitinib 100 mg oral tablet) PFIZER CANADA ULC,Active,9014770,abrocitinib 100 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101762,Marketed,2022-09-29,02528398,CIBINQO,1.0,D11AH08,Abrocitinib,Tablet,Oral,02528398,CIBINQO (abrocitinib 200 mg oral tablet) PFIZER CANADA ULC,Active,9014771,abrocitinib 200 mg oral tablet,8002440,abrocitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102453,Marketed,2023-05-01,02535696,CALQUENCE,1.0,L01EL02,Acalabrutinib,Tablet,Oral,02535696,CALQUENCE (acalabrutinib (acalabrutinib maleate) 100 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015162,acalabrutinib (acalabrutinib maleate) 100 mg oral tablet,8002299,acalabrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
77863,Marketed,2010-05-28,02293269,CAMPRAL,1.0,N07BB03,Acamprosate,Tablet (delayed-release),Oral,02293269,CAMPRAL (acamprosate calcium 333 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9004319,acamprosate calcium 333 mg gastro-resistant tablet,8001427,acamprosate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
98410,Marketed,2020-02-05,02494078,MAR-ACARBOSE,1.0,A10BF01,Acarbose,Tablet,Oral,02494078,MAR-ACARBOSE (acarbose 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002886,acarbose 50 mg oral tablet,8001316,acarbose,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98411,Marketed,2020-02-05,02494086,MAR-ACARBOSE,1.0,A10BF01,Acarbose,Tablet,Oral,02494086,MAR-ACARBOSE (acarbose 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002885,acarbose 100 mg oral tablet,8001316,acarbose,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17826,Marketed,1995-12-31,02147602,APO-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02147602,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 100 mg oral tablet) APOTEX INC,Active,9000241,acebutolol (acebutolol hydrochloride) 100 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17827,Marketed,1995-12-31,02147610,APO-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02147610,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 200 mg oral tablet) APOTEX INC,Active,9000242,acebutolol (acebutolol hydrochloride) 200 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17828,Marketed,1995-12-31,02147629,APO-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02147629,APO-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 400 mg oral tablet) APOTEX INC,Active,9000552,acebutolol (acebutolol hydrochloride) 400 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42996,Marketed,2011-01-25,02204517,TEVA-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02204517,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000241,acebutolol (acebutolol hydrochloride) 100 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42997,Marketed,2011-01-25,02204525,TEVA-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02204525,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000242,acebutolol (acebutolol hydrochloride) 200 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42998,Marketed,2011-01-25,02204533,TEVA-ACEBUTOLOL,1.0,C07AB04,Acebutolol,Tablet,Oral,02204533,TEVA-ACEBUTOLOL (acebutolol (acebutolol hydrochloride) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000552,acebutolol (acebutolol hydrochloride) 400 mg oral tablet,8000110,acebutolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4733,Marketed,2020-04-08,00544981,APO-ACETAMINOPHEN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00544981,APO-ACETAMINOPHEN (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4734,Marketed,2020-06-17,00545007,APO-ACETAMINOPHEN EXTRA STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00545007,APO-ACETAMINOPHEN EXTRA STRENGTH (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5035,Marketed,2013-10-10,00389218,NOVO-GESIC,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00389218,NOVO-GESIC (acetaminophen 325 mg oral tablet) TEVA CANADA LIMITED,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5184,Marketed,2013-10-10,00482323,NOVO-GESIC FORTE,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00482323,NOVO-GESIC FORTE (acetaminophen 500 mg oral tablet) TEVA CANADA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5254,Marketed,2025-06-27,00559393,TYLENOL REGULAR STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00559393,TYLENOL REGULAR STRENGTH (acetaminophen 325 mg oral tablet) KENVUE CANADA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5255,Marketed,2025-09-25,00559407,TYLENOL EXTRA STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00559407,TYLENOL EXTRA STRENGTH (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5570,Marketed,2002-02-01,00605751,ACETAMINOPHEN TABLETS 325 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00605751,ACETAMINOPHEN TABLETS 325 MG (acetaminophen 325 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5571,Marketed,2002-02-01,00605778,EXTRA STRENGTH ACETAMINOPHEN TABLETS 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00605778,EXTRA STRENGTH ACETAMINOPHEN TABLETS 500 MG (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8387,Marketed,2025-04-17,00723908,TYLENOL EXTRA STRENGTH CAPLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00723908,TYLENOL EXTRA STRENGTH CAPLETS (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8597,Marketed,2025-06-27,00723894,TYLENOL REGULAR STRENGTH CAPLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00723894,TYLENOL REGULAR STRENGTH CAPLETS (acetaminophen 325 mg oral tablet) KENVUE CANADA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9627,Marketed,2024-03-27,00789798,ACETAMINOPHEN TABLETS 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00789798,ACETAMINOPHEN TABLETS 500 MG (acetaminophen 500 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9628,Marketed,2024-01-24,00789801,ACETAMINOPHEN TABLETS 325 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00789801,ACETAMINOPHEN TABLETS 325 MG (acetaminophen 325 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10450,Marketed,2015-08-12,00792691,PDP-ACETAMINOPHEN SOLUTION 160MG/5ML,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Oral,00792691,PDP-ACETAMINOPHEN SOLUTION 160MG/5ML (acetaminophen 160 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002330,acetaminophen 160 mg per 5 mL oral solution,8001044,acetaminophen,26643006,Oral,385023001,Oral solution,,,,,
11794,Marketed,2019-11-20,01905856,ACETAMINOPHEN CHEWABLE TABLETS 80 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,01905856,ACETAMINOPHEN CHEWABLE TABLETS 80 MG (acetaminophen 80 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002512,acetaminophen 80 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
13865,Marketed,2025-09-24,00863270,TYLENOL RAPID RELEASE,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,00863270,TYLENOL RAPID RELEASE (acetaminophen 500 mg oral tablet) KENVUE CANADA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14130,Marketed,2011-04-06,02022214,ACéTAMINOPHèNE COMPRIMé TABLET 325,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02022214,ACÉTAMINOPHÈNE COMPRIMÉ TABLET 325 (acetaminophen 325 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14206,Marketed,2019-11-19,02017458,ACETAMINOPHEN CHEWABLE TABLETS 80 MG FOR CHILDREN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02017458,ACETAMINOPHEN CHEWABLE TABLETS 80 MG FOR CHILDREN (acetaminophen 80 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002512,acetaminophen 80 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
14449,Marketed,2019-11-19,01996169,ACETAMINOPHEN CHEWABLE TABLETS 160 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,01996169,ACETAMINOPHEN CHEWABLE TABLETS 160 MG (acetaminophen 160 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
14450,Marketed,2019-11-20,02017431,ACETAMINOPHEN CHEWABLE TABLETS 160 MG FOR CHILDREN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02017431,ACETAMINOPHEN CHEWABLE TABLETS 160 MG FOR CHILDREN (acetaminophen 160 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
19418,Marketed,2024-01-17,01977415,ACETAMINOPHEN CAPLETS 325 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01977415,ACETAMINOPHEN CAPLETS 325 MG (acetaminophen 325 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19419,Marketed,2023-12-15,01977474,ACETAMINOPHEN CAPLETS 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01977474,ACETAMINOPHEN CAPLETS 500 MG (acetaminophen 500 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
22086,Marketed,2018-08-31,01938088,JAMP ACETAMINOPHEN 325,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01938088,JAMP ACETAMINOPHEN 325 (acetaminophen 325 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
22143,Marketed,2018-09-07,01939122,JAMP ACETAMINOPHEN 500,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,01939122,JAMP ACETAMINOPHEN 500 (acetaminophen 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42135,Marketed,2013-02-02,02027798,PEDIATRIX,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Oral,02027798,PEDIATRIX (acetaminophen 160 mg per 5 mL oral solution) TEVA CANADA LIMITED,Active,9002330,acetaminophen 160 mg per 5 mL oral solution,8001044,acetaminophen,26643006,Oral,385023001,Oral solution,,,,,
42136,Marketed,2013-02-02,02027801,PEDIATRIX DROPS,1.0,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02027801,PEDIATRIX DROPS (acetaminophen 80 mg per mL oral drops) TEVA CANADA LIMITED,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
42341,Marketed,2025-06-16,02046059,INFANTS' TYLENOL,1.0,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02046059,INFANTS' TYLENOL (acetaminophen 80 mg per mL oral drops) KENVUE CANADA INC.,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
42388,Marketed,2025-05-16,02046040,CHILDREN'S TYLENOL,1.0,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02046040,CHILDREN'S TYLENOL (acetaminophen 160 mg per 5 mL oral suspension) KENVUE CANADA INC.,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,
48231,Marketed,2020-04-08,02229873,APO-ACETAMINOPHEN CAPLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02229873,APO-ACETAMINOPHEN CAPLETS (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
48431,Marketed,2020-06-17,02229977,APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02229977,APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49357,Marketed,2013-04-24,02230434,ACET 120,1.0,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230434,ACET 120 (acetaminophen 120 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002400,acetaminophen 120 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
49359,Marketed,2013-03-22,02230435,ACET 160,1.0,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230435,ACET 160 (acetaminophen 160 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002510,acetaminophen 160 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
49360,Marketed,2013-04-30,02230436,ACET 325,1.0,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230436,ACET 325 (acetaminophen 325 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002404,acetaminophen 325 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
49361,Marketed,2013-06-11,02230437,ACET 650,1.0,N02BE01,Acetaminophen (paracetamol),Suppository,Rectal,02230437,ACET 650 (acetaminophen 650 mg suppository) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002407,acetaminophen 650 mg suppository,8001044,acetaminophen,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
60900,Marketed,2019-11-20,02237562,ACETAMINOPHEN 160 MG CHEWABLE TABLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02237562,ACETAMINOPHEN 160 MG CHEWABLE TABLETS (acetaminophen 160 mg chewable tablet) LABORATOIRES TRIANON INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
62325,Marketed,2025-09-26,02238885,TYLENOL ARTHRITIS PAIN 8H,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02238885,TYLENOL ARTHRITIS PAIN 8H (acetaminophen 650 mg prolonged-release oral tablet) KENVUE CANADA INC.,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
64993,Marketed,2025-06-20,02241361,CHILDREN'S TYLENOL CHEWABLES,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02241361,CHILDREN'S TYLENOL CHEWABLES (acetaminophen 160 mg chewable tablet) KENVUE CANADA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
68299,Marketed,2006-12-19,02244331,TAMINOL CAPLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02244331,TAMINOL CAPLETS (acetaminophen 500 mg oral tablet) VIVA PHARMACEUTICAL INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70191,Marketed,2025-06-27,02246060,TYLENOL MUSCLE & BODY,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02246060,TYLENOL MUSCLE & BODY (acetaminophen 650 mg prolonged-release oral tablet) KENVUE CANADA INC.,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
73774,Marketed,2019-07-10,02252805,ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02252805,ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH (acetaminophen 325 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73775,Marketed,2019-07-10,02252813,ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02252813,ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH (acetaminophen 500 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74040,Marketed,2019-03-19,02255251,ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02255251,ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW (acetaminophen 500 mg oral tablet) CELLCHEM PHARMACEUTICALS INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75800,Marketed,2006-08-28,02272482,ACETAMINOPHEN ARTHRITIS PAIN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02272482,ACETAMINOPHEN ARTHRITIS PAIN (acetaminophen 650 mg prolonged-release oral tablet) PERRIGO INTERNATIONAL,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77128,Marketed,2006-10-10,02285797,EXTRA STRENGTH ACETAMINOPHEN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02285797,EXTRA STRENGTH ACETAMINOPHEN (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84722,Marketed,2014-12-01,02362198,ACéTAMINOPHèNE CAPLET 325,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362198,ACÉTAMINOPHÈNE CAPLET 325 (acetaminophen 325 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84724,Marketed,2014-12-01,02362228,ACéTAMINOPHèNE CAPLET 500,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362228,ACÉTAMINOPHÈNE CAPLET 500 (acetaminophen 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84726,Marketed,2011-09-26,02362244,ACETAMINOPHEN TABLETS USP 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362244,ACETAMINOPHEN TABLETS USP 500 MG (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84736,Marketed,2011-06-01,02362341,ACETAMINOPHEN CAPLETS 325 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362341,ACETAMINOPHEN CAPLETS 325 MG (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84737,Marketed,2011-05-26,02362368,ACETAMINOPHEN CAPLETS 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362368,ACETAMINOPHEN CAPLETS 500 MG (acetaminophen 500 mg oral tablet) APOTEX INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84743,Marketed,2011-05-31,02362422,ACETAMINOPHEN TABLETS USP 325 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02362422,ACETAMINOPHEN TABLETS USP 325 MG (acetaminophen 325 mg oral tablet) APOTEX INC,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85632,Marketed,2012-04-16,02371146,ARTHRITIS PAIN RELIEF,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02371146,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) VITA HEALTH PRODUCTS INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
87537,Marketed,2018-08-03,02389908,INFANTS' TYLENOL FEVER & SORE THROAT PAIN,1.0,N02BE01,Acetaminophen (paracetamol),Drops,Oral,02389908,INFANTS' TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 80 mg per mL oral drops) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002337,acetaminophen 80 mg per mL oral drops,8001044,acetaminophen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
87539,Marketed,2018-05-28,02389924,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN,1.0,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02389924,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 160 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,
91942,Marketed,2015-07-06,02435144,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02435144,CHILDREN'S TYLENOL FEVER & SORE THROAT PAIN (acetaminophen 160 mg chewable tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
93341,Marketed,2025-11-14,02447819,JUNIOR STRENGTH CHILDREN'S ACETAMINOPHEN TABLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02447819,JUNIOR STRENGTH CHILDREN'S ACETAMINOPHEN TABLETS (acetaminophen 160 mg chewable tablet) SIGMA LIFE SCIENCES INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
94236,Marketed,2016-08-15,02455560,MUSCLE ACHES AND BODY PAIN RELIEF,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02455560,MUSCLE ACHES AND BODY PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) VITA HEALTH PRODUCTS INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95882,Marketed,2019-03-14,02469928,ACETAMINOPHEN EXTRA STRENGTH LIQUID GELS,1.0,N02BE01,Acetaminophen (paracetamol),Capsule,Oral,02469928,ACETAMINOPHEN EXTRA STRENGTH LIQUID GELS (acetaminophen 500 mg oral capsule) LABORATOIRES TRIANON INC.,Active,9012407,acetaminophen 500 mg oral capsule,8001044,acetaminophen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97378,Marketed,2019-09-13,02483343,ACETAMINOPHEN INJECTION,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02483343,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bag) AVIR PHARMA INC.,Active,9014143,acetaminophen 1000 mg per 100 mL solution for injection bag,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
97700,Marketed,2021-05-23,02486830,CHILDREN'S ACETAMINOPHEN SUSPENSION,1.0,N02BE01,Acetaminophen (paracetamol),Suspension,Oral,02486830,CHILDREN'S ACETAMINOPHEN SUSPENSION (acetaminophen 160 mg per 5 mL oral suspension) JUNO OTC INC,Active,9002402,acetaminophen 160 mg per 5 mL oral suspension,8001044,acetaminophen,26643006,Oral,385024007,Oral suspension,,,,,
97715,Marketed,2020-01-14,02487004,COUGH & COLD RELIEF,3.0,N02BE01,Acetaminophen (paracetamol),Powder for solution,Oral,02487004,COUGH & COLD RELIEF (acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9014236,acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
100663,Marketed,2025-06-10,02517280,CHILDREN'S TYLENOL EASY DISSOLVE,1.0,N02BE01,Acetaminophen (paracetamol),Powder,Oral,02517280,CHILDREN'S TYLENOL EASY DISSOLVE (acetaminophen 160 mg per sachet oral powder) KENVUE CANADA INC.,Active,9014689,acetaminophen 160 mg per sachet oral powder,8001044,acetaminophen,26643006,Oral,385041009,Oral powder,733013000,Sachet (unit of presentation),,,
100858,Marketed,2023-01-13,02519305,ACETAMINOPHEN INJECTION,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02519305,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9014143,acetaminophen 1000 mg per 100 mL solution for injection bag,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
100888,Marketed,2022-09-08,02519631,ARTHRITIS PAIN RELIEF,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02519631,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) GRANULES INDIA LIMITED,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101484,Marketed,2025-06-27,02525844,ACETAMINOPHEN EXTRA STRENGTH TABLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02525844,ACETAMINOPHEN EXTRA STRENGTH TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101709,Marketed,2022-09-14,02527901,ARTHRITIS PAIN RELIEF,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02527901,ARTHRITIS PAIN RELIEF (acetaminophen 650 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101916,Marketed,2025-10-06,02529939,CHILDREN'S TYLENOL DYE-FREE CHEWABLES,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (chewable),Oral,02529939,CHILDREN'S TYLENOL DYE-FREE CHEWABLES (acetaminophen 160 mg chewable tablet) KENVUE CANADA INC.,Active,9002508,acetaminophen 160 mg chewable tablet,8001044,acetaminophen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102061,Marketed,2023-08-26,02531488,VICKS NYQUIL HOT REMEDY,3.0,N02BE01,Acetaminophen (paracetamol),Powder for solution,Oral,02531488,VICKS NYQUIL HOT REMEDY (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) PROCTER & GAMBLE INC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
102375,Marketed,2025-05-12,02534851,MUSCLE & BODY,1.0,N02BE01,Acetaminophen (paracetamol),Tablet (extended-release),Oral,02534851,MUSCLE & BODY (acetaminophen 650 mg prolonged-release oral tablet) GRANULES INDIA LIMITED,Active,9003431,acetaminophen 650 mg prolonged-release oral tablet,8001044,acetaminophen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102456,Marketed,2023-12-15,02535734,ACETAMINOPHEN INJECTION,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535734,ACETAMINOPHEN INJECTION (acetaminophen 100 mg per 10 mL solution for injection ampoule) B. BRAUN MELSUNGEN AG,Active,9014999,acetaminophen 100 mg per 10 mL solution for injection ampoule,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
102457,Marketed,2023-12-15,02535742,ACETAMINOPHEN INJECTION,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535742,ACETAMINOPHEN INJECTION (acetaminophen 500 mg per 50 mL solution for injection bottle) B. BRAUN MELSUNGEN AG,Active,9015000,acetaminophen 500 mg per 50 mL solution for injection bottle,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732986007,Bottle (unit of presentation),,,
102458,Marketed,2024-01-22,02535750,ACETAMINOPHEN INJECTION,1.0,N02BE01,Acetaminophen (paracetamol),Solution,Intravenous,02535750,ACETAMINOPHEN INJECTION (acetaminophen 1000 mg per 100 mL solution for injection bottle) B. BRAUN MELSUNGEN AG,Active,9015011,acetaminophen 1000 mg per 100 mL solution for injection bottle,8001044,acetaminophen,738984000,Parenteral,385219001,Solution for injection,732986007,Bottle (unit of presentation),,,
102713,Marketed,2025-05-12,02538407,ACETAMINOPHEN EXTRA STRENGTH RED TABLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02538407,ACETAMINOPHEN EXTRA STRENGTH RED TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103723,Marketed,2025-04-14,02548356,EXTRA STRENGTH EASY TABS 500 MG,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02548356,EXTRA STRENGTH EASY TABS 500 MG (acetaminophen 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103826,Marketed,2025-05-15,02549417,EXTRA STRENGTH TYLENOL EASY DISSOLVE,1.0,N02BE01,Acetaminophen (paracetamol),Powder,Oral,02549417,EXTRA STRENGTH TYLENOL EASY DISSOLVE (acetaminophen 500 mg per sachet oral powder) KENVUE CANADA INC.,Active,9015212,acetaminophen 500 mg per sachet oral powder,8001044,acetaminophen,26643006,Oral,385041009,Oral powder,733013000,Sachet,,,
103945,Marketed,2025-04-28,02550660,REGULAR STRENGTH ACETAMINOPHEN,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02550660,REGULAR STRENGTH ACETAMINOPHEN (acetaminophen 325 mg oral tablet) LNK INTERNATIONAL INC.,Active,9001583,acetaminophen 325 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104084,Marketed,2025-07-03,02552159,ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS,1.0,N02BE01,Acetaminophen (paracetamol),Tablet,Oral,02552159,ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS (acetaminophen 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9001728,acetaminophen 500 mg oral tablet,8001044,acetaminophen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10188,Marketed,2024-04-15,00843792,NEOCITRAN EXTRA STRENGTH COLD & CONGESTION,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,00843792,NEOCITRAN EXTRA STRENGTH COLD & CONGESTION (acetaminophen 650 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9014184,acetaminophen 650 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8000843,acetaminophen and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
13120,Marketed,2018-10-12,01938371,EXTRA STRENGTH SINUTAB SINUS DAYTIME,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,01938371,EXTRA STRENGTH SINUTAB SINUS DAYTIME (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15805,Marketed,2007-11-15,02047667,MERSYNDOL WITH CODEINE,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02047667,MERSYNDOL WITH CODEINE (acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001927,acetaminophen 325 mg and codeine phosphate 8 mg and doxylamine succinate 5 mg oral tablet,8000828,acetaminophen and codeine and doxylamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17113,Marketed,2018-10-12,01986988,EXTRA STRENGTH SINUTAB SINUS & ALLERGY,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,01986988,EXTRA STRENGTH SINUTAB SINUS & ALLERGY (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17880,Marketed,2010-05-01,02083736,EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02083736,EXTRA STRENGTH COLD MEDICATION DAYTIME RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17887,Marketed,2010-05-01,02039842,EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02039842,EXTRA STRENGTH COLD MEDICATION NIGHTTIME RELIEF (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002727,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
26863,Marketed,2018-10-04,02039982,CHILDREN'S TYLENOL COLD,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02039982,CHILDREN'S TYLENOL COLD (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003128,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,
26864,Marketed,2005-06-18,02039990,CHILDREN'S TYLENOL COLD AND COUGH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02039990,CHILDREN'S TYLENOL COLD AND COUGH (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,
32780,Marketed,2018-12-18,02047349,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02047349,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU REGULAR STRENGTH (acetaminophen 325 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013849,acetaminophen 325 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8002166,acetaminophen and ascorbic acid and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
34150,Marketed,2010-05-01,02159546,EXTRA STRENGTH ALLERGY SINUS MEDICATION,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02159546,EXTRA STRENGTH ALLERGY SINUS MEDICATION (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
37037,Marketed,2018-10-12,02215241,EXTRA STRENGTH SINUTAB SINUS NIGHTTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02215241,EXTRA STRENGTH SINUTAB SINUS NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
37051,Marketed,2024-04-15,02215403,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02215403,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT (acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013636,acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
37105,Marketed,2024-04-02,02217147,NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02217147,NEOCITRAN ULTRA STRENGTH TOTAL FLU NIGHT (acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013846,acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
37150,Marketed,2019-09-03,02218186,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02218186,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
47448,Marketed,2011-04-08,02229538,CHILDREN'S TYLENOL COLD & STUFFY NOSE,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02229538,CHILDREN'S TYLENOL COLD & STUFFY NOSE (acetaminophen 160 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003166,acetaminophen 160 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001338,acetaminophen and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,
61574,Marketed,2018-02-23,02238183,ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02238183,ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet) LABORATOIRES TRIANON INC.,Active,9005112,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet,8001166,acetaminophen and diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62330,Marketed,2018-12-14,02238890,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02238890,HOT LEMON RELIEF FOR SYMPTOMS OF COLD AND FLU EXTRA STRENGTH (acetaminophen 650 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013854,acetaminophen 650 mg per sachet and ascorbic acid 50 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8002166,acetaminophen and ascorbic acid and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
62615,Marketed,2018-10-01,02239159,EXTRA STRENGTH SUDAFED HEAD COLD & SINUS,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02239159,EXTRA STRENGTH SUDAFED HEAD COLD & SINUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65249,Marketed,2024-03-22,02241592,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02241592,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC",Active,9002727,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65250,Marketed,2024-03-22,02241593,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02241593,"BUCKLEY'S COMPLETE EXTRA STRENGTH COUGH, COLD & FLU DAY (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC",Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68230,Marketed,2002-01-09,02244263,COLTALIN COLD & ALLERGY TABLETS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02244263,COLTALIN COLD & ALLERGY TABLETS (acetaminophen 325 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) FORTUNE PHARMACAL CO. LTD.,Active,9002621,acetaminophen 325 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69017,Marketed,2004-06-01,02245016,SINUS MEDICATION,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02245016,SINUS MEDICATION (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003782,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69814,Marketed,2019-09-03,02245710,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02245710,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
70790,Marketed,2024-04-12,02246602,NEOCITRAN COLD & SORE THROAT NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02246602,NEOCITRAN COLD & SORE THROAT NIGHT (acetaminophen 325 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013850,acetaminophen 325 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
71050,Marketed,2018-12-18,02246848,"HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02246848,"HOT LEMON RELIEF FOR SYMPTOMS OF COUGH, COLD AND FLU EXTRA STRENGTH (acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.",Active,9013855,acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
72935,Marketed,2004-03-01,02248580,EXTRA STRENGTH FLU RELIEF DAYTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248580,EXTRA STRENGTH FLU RELIEF DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002728,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73003,Marketed,2004-04-01,02248646,EXTRA STRENGTH HEAD COLD AND SINUS,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248646,EXTRA STRENGTH HEAD COLD AND SINUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73064,Marketed,2004-01-07,02248700,EXTRA STRENGTH FLU RELIEF NIGHTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02248700,EXTRA STRENGTH FLU RELIEF NIGHTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73592,Marketed,2019-10-08,02250993,"BENADRYL ALLERGY, SINUS & PAIN TOTAL",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02250993,"BENADRYL ALLERGY, SINUS & PAIN TOTAL (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73724,Marketed,2019-09-03,02252376,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT",5.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02252376,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004090,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
73935,Marketed,2025-07-11,02254468,TYLENOL ULTRA RELIEF,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02254468,TYLENOL ULTRA RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) KENVUE CANADA INC.,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74181,Marketed,2019-11-01,02256576,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02256576,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74414,Marketed,2014-08-19,02258919,DAYTIME COLD & FLU LIQUID CAPSULES,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02258919,DAYTIME COLD & FLU LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9004003,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74415,Marketed,2017-04-13,02258927,NIGHTTIME COLD & FLU LIQUID CAPSULES,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02258927,NIGHTTIME COLD & FLU LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9004002,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75038,Marketed,2005-06-17,02264870,ULTRA HEADACHE RELIEF,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02264870,ULTRA HEADACHE RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75828,Marketed,2006-12-05,02272784,VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02272784,VICKS DAYQUIL COLD & FLU MULTI-SYMPTOM RELIEF LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004179,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral capsule,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75829,Marketed,2025-04-09,02272792,NYQUIL COLD & FLU LIQUICAPS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02272792,NYQUIL COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg oral capsule) PROCTER & GAMBLE INC,Active,9004180,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg oral capsule,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75895,Marketed,2018-10-09,02273462,BENYLIN EXTRA STRENGTH COLD & SINUS DAY,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02273462,BENYLIN EXTRA STRENGTH COLD & SINUS DAY (acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004190,acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet,8000843,acetaminophen and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75929,Marketed,2006-06-11,02273810,NYQUIL SINUS LIQUICAPS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02273810,NYQUIL SINUS LIQUICAPS (acetaminophen 325 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004169,acetaminophen 325 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule,8000956,acetaminophen and doxylamine and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75930,Marketed,2006-06-11,02273829,DAYQUIL SINUS LIQUICAPS,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02273829,DAYQUIL SINUS LIQUICAPS (acetaminophen 325 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9004170,acetaminophen 325 mg and phenylephrine hydrochloride 5 mg oral capsule,8000843,acetaminophen and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
76086,Marketed,2022-02-24,02275201,MIDOL COMPLETE,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275201,MIDOL COMPLETE (acetaminophen 500 mg and caffeine 60 mg and pyrilamine maleate 15 mg oral tablet) BAYER INC,Active,9004175,acetaminophen 500 mg and caffeine 60 mg and pyrilamine maleate 15 mg oral tablet,8002005,acetaminophen and caffeine and pyrilamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76087,Marketed,2022-03-04,02275228,MIDOL PMS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275228,MIDOL PMS (acetaminophen 500 mg and pamabrom 25 mg and pyrilamine maleate 15 mg oral tablet) BAYER INC,Active,9003388,acetaminophen 500 mg and pamabrom 25 mg and pyrilamine maleate 15 mg oral tablet,8002006,acetaminophen and pamabrom and pyrilamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76167,Marketed,2006-07-24,02275996,EXTRA STRENGTH TYLENOL FLU DAYTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02275996,EXTRA STRENGTH TYLENOL FLU DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004189,acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76168,Marketed,2006-07-24,02276003,EXTRA STRENGTH TYLENOL SINUS DAYTIME,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276003,EXTRA STRENGTH TYLENOL SINUS DAYTIME (acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004190,acetaminophen 500 mg and phenylephrine hydrochloride 5 mg oral tablet,8000843,acetaminophen and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76170,Marketed,2006-07-24,02276038,EXTRA STRENGTH TYLENOL SINUS NIGHTTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276038,EXTRA STRENGTH TYLENOL SINUS NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002622,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76171,Marketed,2006-07-24,02276046,EXTRA STRENGTH TYLENOL FLU NIGHTTIME,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276046,EXTRA STRENGTH TYLENOL FLU NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004188,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001321,acetaminophen and chlorpheniramine and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76185,Marketed,2006-07-24,02276186,EXTRA STRENGTH TYLENOL COLD DAYTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276186,EXTRA STRENGTH TYLENOL COLD DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004189,acetaminophen 500 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76192,Marketed,2006-07-24,02276259,EXTRA STRENGTH TYLENOL COLD NIGHTTIME,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02276259,EXTRA STRENGTH TYLENOL COLD NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004188,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 10 mg and phenylephrine hydrochloride 5 mg oral tablet,8001321,acetaminophen and chlorpheniramine and dextromethorphan and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76469,Marketed,2006-08-31,02279150,CHILDREN'S TYLENOL COLD AND COUGH NIGHTTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02279150,CHILDREN'S TYLENOL COLD AND COUGH NIGHTTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,
76530,Marketed,2024-03-06,02279703,BUCKLEY'S COMPLETE,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02279703,BUCKLEY'S COMPLETE (acetaminophen 325 mg per 5 mL and menthol 20 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9013848,acetaminophen 325 mg per 5 mL and menthol 20 mg per 5 mL oral solution,8000962,acetaminophen and menthol,26643006,Oral,385023001,Oral solution,,,,,
76681,Marketed,2007-04-01,02281147,COLD AND FLU-IN-ONE EXTRA STRENGTH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02281147,COLD AND FLU-IN-ONE EXTRA STRENGTH (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77185,Marketed,2009-05-22,02286394,TOTAL COLD AND FLU,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02286394,TOTAL COLD AND FLU (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77675,Marketed,2024-06-04,02291371,"ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02291371,"ROBITUSSIN TOTAL COUGH, COLD & FLU NIGHTTIME EXTRA STRENGTH (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) HALEON CANADA ULC",Active,9014351,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
78062,Marketed,2016-06-13,02295326,"TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02295326,"TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
78620,Marketed,2009-08-23,02300842,DAYQUIL COLD & FLU,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02300842,DAYQUIL COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9004325,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
78913,Marketed,2008-03-11,02303833,EXTRA STRENGTH ALLERGY TOTAL,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02303833,EXTRA STRENGTH ALLERGY TOTAL (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79084,Marketed,2009-05-22,02305305,NIGHTTIME TOTAL COLD AND FLU,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02305305,NIGHTTIME TOTAL COLD AND FLU (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79088,Marketed,2009-01-22,02305356,COLD & SINUS LIQUID FASTGELS,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02305356,COLD & SINUS LIQUID FASTGELS (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79105,Marketed,2008-09-01,02305496,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02305496,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,
79122,Marketed,2008-09-01,02305666,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02305666,BENYLIN FOR CHILDREN ALL-IN-ONE COLD & FEVER NIGHTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,
79195,Marketed,2018-10-09,02306409,BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02306409,BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002622,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and phenylephrine hydrochloride 5 mg oral tablet,8001323,acetaminophen and chlorpheniramine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79278,Marketed,2024-03-13,02307111,BUCKLEYS COLD & SINUS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02307111,BUCKLEYS COLD & SINUS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004003,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80682,Marketed,2019-11-01,02321432,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02321432,"BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
82084,Marketed,2024-03-22,02335239,BUCKLEY'S COMPLETE NIGHTTIME SOFTGELS,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02335239,BUCKLEY'S COMPLETE NIGHTTIME SOFTGELS (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004002,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82152,Marketed,2024-03-13,02335948,BUCKLEY'S COMPLETE + MUCUS RELIEF,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02335948,BUCKLEY'S COMPLETE + MUCUS RELIEF (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83004,Marketed,2019-01-10,02344548,NIGHT TIME TOTAL EXTRA STRENGTH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02344548,NIGHT TIME TOTAL EXTRA STRENGTH (acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013855,acetaminophen 650 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
83303,Marketed,2011-10-29,02347652,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02347652,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83304,Marketed,2010-08-11,02347660,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02347660,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83343,Marketed,2010-08-11,02348071,EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02348071,EXTRA STRENGTH TYLENOL COLD & SINUS DAYTIME (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83344,Marketed,2010-08-11,02348098,EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02348098,EXTRA STRENGTH TYLENOL COLD & SINUS NIGHTTIME (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002061,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001324,acetaminophen and chlorpheniramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83481,Marketed,2016-06-01,02349523,COLD AND SINUS COMPLETE LIQUID GELS,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02349523,COLD AND SINUS COMPLETE LIQUID GELS (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84236,Marketed,2024-03-07,02357232,BUCKLEY'S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02357232,BUCKLEY'S COMPLETE PLUS EXTRA STRENGTH MUCUS RELIEF (acetaminophen 325 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 20 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9013847,acetaminophen 325 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 20 mg per 5 mL oral solution,8000994,acetaminophen and guaifenesin and menthol,26643006,Oral,385023001,Oral solution,,,,,
85048,Marketed,2011-08-08,02365596,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF NIGHTTIME",5.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365596,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF NIGHTTIME (acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and guaifenesin 200 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004905,acetaminophen 1000 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and guaifenesin 200 mg per 30 mL and pseudoephedrine hydrochloride 60 mg per 30 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
85049,Marketed,2011-08-08,02365618,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF NIGHT,5.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365618,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF NIGHT (acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004090,acetaminophen 500 mg per 15 mL and chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001320,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
85062,Marketed,2011-08-08,02365731,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02365731,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU DAYTIME (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85064,Marketed,2011-08-08,02365766,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02365766,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85065,Marketed,2011-08-08,02365774,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02365774,"EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
85106,Marketed,2011-08-08,02366207,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02366207,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF (acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003812,acetaminophen 500 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL and guaifenesin 100 mg per 15 mL and pseudoephedrine hydrochloride 30 mg per 15 mL syrup,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
85347,Marketed,2012-04-25,02368528,COLD & FLU-IN-ONE,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02368528,COLD & FLU-IN-ONE (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85348,Marketed,2012-08-14,02368536,COLD & FLU,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Capsule,Kit",Oral,02368536,COLD & FLU (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013028,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85382,Marketed,2012-01-13,02368854,SINUS MEDICATION DAYTIME RELIEF,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02368854,SINUS MEDICATION DAYTIME RELIEF (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85947,Marketed,2024-10-08,02374277,VICKS NYQUIL COLD & FLU,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02374277,VICKS NYQUIL COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005174,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,385023001,Oral solution,,,,,
86193,Marketed,2012-08-31,02376474,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02376474,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER (acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9003129,acetaminophen 160 mg per 5 mL and chlorpheniramine maleate 1 mg per 5 mL and dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL oral suspension,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,385024007,Oral suspension,,,,,
86625,Marketed,2012-05-05,02380447,"FLU, COUGH & COLD COMPLETE",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02380447,"FLU, COUGH & COLD COMPLETE (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9003127,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86911,Marketed,2012-08-28,02383357,FLU RELIEF,6.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02383357,FLU RELIEF (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013255,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001327,acetaminophen and dextromethorphan and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86912,Marketed,2012-12-10,02383365,COMPLETE LIQUID CAPSULES,8.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Capsule,Kit",Oral,02383365,COMPLETE LIQUID CAPSULES (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013253,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001329,acetaminophen and dextromethorphan and doxylamine and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86913,Marketed,2012-06-28,02383373,COLD MEDICATION,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02383373,COLD MEDICATION (acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013029,acetaminophen 500 mg and chlorpheniramine maleate 2 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001322,acetaminophen and chlorpheniramine and dextromethorphan and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86935,Marketed,2012-05-05,02383608,SINUS MEDICATION DAY & NIGHT,5.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02383608,SINUS MEDICATION DAY & NIGHT (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012883,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86992,Marketed,2013-07-16,02384175,TOTAL COLD & FLU COMBO,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02384175,TOTAL COLD & FLU COMBO (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87089,Marketed,2014-07-15,02385252,COLD AND SINUS DAYTIME RELIEF,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02385252,COLD AND SINUS DAYTIME RELIEF (acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002333,acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87122,Marketed,2012-10-02,02385619,EXTRA STRENGTH TYLENOL NIGHTTIME,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02385619,EXTRA STRENGTH TYLENOL NIGHTTIME (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9005112,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg oral tablet,8001166,acetaminophen and diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87328,Marketed,2012-07-03,02387697,"FLU, COUGH & COLD COMPLETE DAY AND NIGHT",7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Tablet",Oral,02387697,"FLU, COUGH & COLD COMPLETE DAY AND NIGHT (acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9013254,acetaminophen 500 mg and dextromethorphan hydrobromide 15 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001326,acetaminophen and dextromethorphan and diphenhydramine and guaifenesin and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87406,Marketed,2013-06-24,02388537,COLD AND SINUS RELIEF COMBO,5.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Tablet,Kit",Oral,02388537,COLD AND SINUS RELIEF COMBO (acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012883,acetaminophen 500 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001337,acetaminophen and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88979,Marketed,2024-04-10,02404966,NEOCITRAN ULTRA STRENGTH TOTAL FLU,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02404966,NEOCITRAN ULTRA STRENGTH TOTAL FLU (acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013252,acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet and pseudoephedrine hydrochloride 60 mg per sachet powder for oral solution,8001335,acetaminophen and dextromethorphan and pseudoephedrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
88980,Marketed,2014-07-16,02404974,"NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02404974,"NIGHTTIME FLU, COUGH & COLD COMPLETE RELIEF EXTRA STRENGTH (acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC",Active,9003222,acetaminophen 500 mg and diphenhydramine hydrochloride 25 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001336,acetaminophen and diphenhydramine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89389,Marketed,2024-04-10,02409178,NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02409178,NEOCITRAN EXTRA STRENGTH TOTAL COLD NIGHT (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
89422,Marketed,2014-08-15,02409534,VICKS DAYQUIL COMPLETE COLD & FLU LIQUID,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02409534,VICKS DAYQUIL COMPLETE COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013852,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
89423,Marketed,2014-08-15,02409542,VICKS NYQUIL COMPLETE COLD & FLU,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02409542,VICKS NYQUIL COMPLETE COLD & FLU (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013755,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
89795,Marketed,2024-04-12,02413280,NEOCITRAN TOTAL COLD NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02413280,NEOCITRAN TOTAL COLD NIGHT (acetaminophen 500 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013851,acetaminophen 500 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
90063,Marketed,2014-06-15,02416050,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Suspension,Oral,02416050,"CHILDREN'S TYLENOL COMPLETE COLD, COUGH & FEVER NIGHTTIME (acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC",Active,9004204,acetaminophen 160 mg per 5 mL and dextromethorphan hydrobromide 5 mg per 5 mL and diphenhydramine hydrochloride 6.25 mg per 5 mL oral suspension,8001325,acetaminophen and dextromethorphan and diphenhydramine,26643006,Oral,385024007,Oral suspension,,,,,
90552,Marketed,2018-12-17,02420937,EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02420937,EXTRA STRENGTH TOTAL SYMPTOM RELIEF SUGAR-FREE (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
91244,Marketed,2016-06-01,02427958,COLD & SINUS LIQUID CAPSULES,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Capsule",Oral,02427958,COLD & SINUS LIQUID CAPSULES (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9013028,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91260,Marketed,2015-05-01,02428113,COMPLETE DAYTIME LIQUID CAPSULES,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02428113,COMPLETE DAYTIME LIQUID CAPSULES (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003805,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001333,acetaminophen and dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91779,Marketed,2023-08-19,02433419,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH SOLUTION",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02433419,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH SOLUTION (acetaminophen 650 mg per 20 mL and dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution) RB HEALTH (CANADA) INC.",Active,9014926,acetaminophen 650 mg per 20 mL and dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
91781,Marketed,2021-07-13,02433435,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH",4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02433435,"MUCINEX MULTI-ACTION CONGESTION, COLD & COUGH (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) RB HEALTH (CANADA) INC.",Active,9005568,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91782,Marketed,2021-07-06,02433451,"MUCINEX MULTI-ACTION CONGESTION, COLD & FLU",3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02433451,"MUCINEX MULTI-ACTION CONGESTION, COLD & FLU (acetaminophen 325 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) RB HEALTH (CANADA) INC.",Active,9014416,acetaminophen 325 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001035,acetaminophen and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94410,Marketed,2024-05-01,02456982,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT - APPLE CINNAMON,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02456982,NEOCITRAN EXTRA STRENGTH COLD & SINUS NIGHT - APPLE CINNAMON (acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9013636,acetaminophen 650 mg per sachet and pheniramine maleate 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001883,acetaminophen and pheniramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
96884,Marketed,2026-01-05,02478110,EXTRA STRENGTH TYLENOL COLD & SINUS PLUS,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02478110,EXTRA STRENGTH TYLENOL COLD & SINUS PLUS (acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet) KENVUE CANADA INC.,Active,9003509,acetaminophen 500 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001338,acetaminophen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97240,Marketed,2020-07-20,02481936,DAYQUIL COMPLETE + VICKS VAPOCOOL,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02481936,DAYQUIL COMPLETE + VICKS VAPOCOOL (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet) PROCTER & GAMBLE INC,Active,9005568,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral tablet,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97241,Marketed,2020-07-20,02481928,NYQUIL COMPLETE + VICKS VAPOCOOL,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02481928,NYQUIL COMPLETE + VICKS VAPOCOOL (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral tablet) PROCTER & GAMBLE INC,Active,9005739,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral tablet,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97286,Marketed,2020-07-20,02482401,NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Liquid,Oral,02482401,NYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013755,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
97287,Marketed,2020-07-20,02482428,DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02482428,DAYQUIL COMPLETE + VICKS VAPOCOOL COLD & FLU LIQUID (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9013852,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL oral solution,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
97379,Marketed,2019-07-08,02483351,VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02483351,VICKS NYQUIL COMPLETE COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9013998,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and doxylamine succinate 6.25 mg and phenylephrine hydrochloride 5 mg oral capsule,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97380,Marketed,2019-07-08,02483378,VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02483378,VICKS DAYQUIL COMPLETE COLD & FLU LIQUICAPS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral capsule) PROCTER & GAMBLE INC,Active,9013999,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg and phenylephrine hydrochloride 5 mg oral capsule,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97739,Marketed,2020-01-14,02487233,NIGHTTIME COLD,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02487233,NIGHTTIME COLD (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9013856,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001167,acetaminophen and diphenhydramine and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
97743,Marketed,2020-01-14,02487276,DAYTIME COLD,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02487276,DAYTIME COLD (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) JUNO OTC INC,Active,9013259,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
97838,Marketed,2025-10-31,02488280,COMBOGESIC,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02488280,COMBOGESIC (acetaminophen 325 mg and ibuprofen 97.5 mg oral tablet) AFT PHARMACEUTICALS (CAN) LIMITED,Active,9014417,acetaminophen 325 mg and ibuprofen 97.5 mg oral tablet,8002354,acetaminophen and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98285,Marketed,2021-05-19,02492857,NIGHTTIME COLD & FLU RELIEF,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Oral,02492857,NIGHTTIME COLD & FLU RELIEF (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution) JUNO OTC INC,Active,9005174,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL oral solution,8001328,acetaminophen and dextromethorphan and doxylamine,26643006,Oral,385023001,Oral solution,,,,,
98380,Marketed,2024-03-14,02493802,BUCKLEY'S COLD & SINUS 24 HOUR PACK,7.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Kit,Capsule",Oral,02493802,BUCKLEY'S COLD & SINUS 24 HOUR PACK (acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9014616,acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral tablet with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001331,acetaminophen and dextromethorphan and doxylamine and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98404,Marketed,2024-03-26,02494027,BUCKLEY'S COMPLETE 24 HOUR PACK,8.0,N02BE51,"Acetaminophen, comb excl psycholeptics","Capsule,Kit",Oral,02494027,BUCKLEY'S COMPLETE 24 HOUR PACK (acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9013253,acetaminophen 250 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 100 mg and pseudoephedrine hydrochloride 30 mg oral capsule with acetaminophen 325 mg and dextromethorphan hydrobromide 15 mg and doxylamine succinate 6.25 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001329,acetaminophen and dextromethorphan and doxylamine and guaifenesin and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99301,Marketed,2021-07-19,02503549,NYQUIL COMPLETE,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02503549,NYQUIL COMPLETE (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014574,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and doxylamine succinate 12.5 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8001330,acetaminophen and dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,
99308,Marketed,2021-07-19,02503638,DAYQUIL COMPLETE,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02503638,DAYQUIL COMPLETE (acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014575,acetaminophen 650 mg per 30 mL and dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8001332,acetaminophen and dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,739009002,Syrup,,,,,
99977,Marketed,2021-08-06,02510553,CORICIDIN COLD & FLU LIQUID GELS,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Capsule,Oral,02510553,CORICIDIN COLD & FLU LIQUID GELS (acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg oral capsule) BAYER INC,Active,9014591,acetaminophen 325 mg and dextromethorphan hydrobromide 10 mg and guaifenesin 200 mg oral capsule,8002387,acetaminophen and dextromethorphan and guaifenesin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100854,Marketed,2024-06-19,02519267,ADVIL PLUS ACETAMINOPHEN,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02519267,ADVIL PLUS ACETAMINOPHEN (acetaminophen 250 mg and ibuprofen 125 mg oral tablet) HALEON CANADA ULC,Active,9014710,acetaminophen 250 mg and ibuprofen 125 mg oral tablet,8002354,acetaminophen and ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102063,Marketed,2023-08-26,02531518,VICKS DAYQUIL HOT REMEDY,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02531518,VICKS DAYQUIL HOT REMEDY (acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution) PROCTER & GAMBLE INC,Active,9014236,acetaminophen 500 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet and phenylephrine hydrochloride 10 mg per sachet powder for oral solution,8001334,acetaminophen and dextromethorphan and phenylephrine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
103325,Marketed,2025-07-10,02544687,EXTRA STRENGTH TYLENOL DAYTIME RELIEF,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Tablet,Oral,02544687,EXTRA STRENGTH TYLENOL DAYTIME RELIEF (acetaminophen 500 mg and caffeine 65 mg oral tablet) KENVUE CANADA INC.,Active,9002060,acetaminophen 500 mg and caffeine 65 mg oral tablet,8000837,acetaminophen and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103343,Marketed,2025-05-15,02544806,COMBOGESIC IV,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Solution,Intravenous,02544806,COMBOGESIC IV (acetaminophen 1000 mg per 100 mL and ibuprofen (ibuprofen sodium dihydrate) 300 mg per 100 mL solution for injection vial) AFT PHARMACEUTICALS (CAN) LIMITED,Active,9015211,acetaminophen 1000 mg per 100 mL and ibuprofen (ibuprofen sodium) 300 mg per 100 mL solution for injection vial,8002354,acetaminophen and ibuprofen,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
104039,Marketed,2025-07-07,02551667,NYQUIL COLD & FLU ALCOHOL FREE,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02551667,NYQUIL COLD & FLU ALCOHOL FREE (acetaminophen 650 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9015227,acetaminophen 650 mg per 30 mL and chlorpheniramine maleate 4 mg per 30 mL and dextromethorphan hydrobromide 30 mg per 30 mL syrup,8001319,acetaminophen and chlorpheniramine and dextromethorphan,26643006,Oral,385032004,Oral syrup,,,,,
104148,Marketed,2026-01-15,02552515,NEOCITRAN EXTRA STRENGTH COLD & COUGH,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02552515,NEOCITRAN EXTRA STRENGTH COLD & COUGH (acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015333,acetaminophen 650 mg per sachet and dextromethorphan hydrobromide 20 mg per sachet powder for oral solution,8002570,acetaminophen and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,
104150,Marketed,2026-01-15,02552531,NEOCITRAN EXTRA STRENGTH COLD & COUGH NIGHT,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02552531,NEOCITRAN EXTRA STRENGTH COLD & COUGH NIGHT (acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015334,acetaminophen 650 mg per sachet and diphenhydramine hydrochloride 25 mg per sachet powder for oral solution,8001166,acetaminophen and diphenhydramine,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,
104291,Marketed,2025-08-01,02554011,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH PLUS MUCUS RELIEF,5.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02554011,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH PLUS MUCUS RELIEF (acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and menthol 20 mg per 5 mL syrup) HALEON CANADA ULC,Active,9015241,acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and menthol 20 mg per 5 mL syrup,8002550,acetaminophen and chlorpheniramine and dextromethorphan and guaifenesin and menthol,26643006,Oral,385032004,Oral syrup,,,,,
104302,Marketed,2025-08-01,02554143,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH,4.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Syrup,Oral,02554143,BUCKLEY'S NIGHTTIME COMPLETE EXTRA STRENGTH (acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and menthol 20 mg per 5 mL syrup) HALEON CANADA ULC,Active,9015242,acetaminophen 500 mg per 5 mL and chlorpheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and menthol 20 mg per 5 mL syrup,8002551,acetaminophen and chlorpheniramine and dextromethorphan and menthol,26643006,Oral,385032004,Oral syrup,,,,,
104343,Marketed,2026-01-15,02554593,NEOCITRAN ULTRA STRENGTH FLU & COLD NIGHT,3.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02554593,NEOCITRAN ULTRA STRENGTH FLU & COLD NIGHT (acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015331,acetaminophen 1000 mg per sachet and chlorpheniramine maleate 4 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution,8001319,acetaminophen and chlorpheniramine and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,
104344,Marketed,2026-01-15,02554607,NEOCITRAN ULTRA STRENGTH FLU & COLD,2.0,N02BE51,"Acetaminophen, comb excl psycholeptics",Powder for solution,Oral,02554607,NEOCITRAN ULTRA STRENGTH FLU & COLD (acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution) HALEON CANADA ULC,Active,9015332,acetaminophen 1000 mg per sachet and dextromethorphan hydrobromide 30 mg per sachet powder for oral solution,8002570,acetaminophen and dextromethorphan,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet,,,
4899,Marketed,2011-04-13,00545015,ACETAZOLAMIDE,1.0,S01EC01,Acetazolamide,Tablet,Oral,00545015,ACETAZOLAMIDE (acetazolamide 250 mg oral tablet) AA PHARMA INC,Active,9001928,acetazolamide 250 mg oral tablet,8001428,acetazolamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84336,Marketed,2010-12-03,02358328,"ACETAZOLAMIDE FOR INJECTION, USP",1.0,S01EC01,Acetazolamide,Powder for solution,Intravenous,02358328,"ACETAZOLAMIDE FOR INJECTION, USP (acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection) STERIMAX INC",Active,9004795,acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection,8001428,acetazolamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102665,Marketed,2023-07-26,02537893,ACETAZOLAMIDE FOR INJECTION USP,1.0,S01EC01,Acetazolamide,Powder for solution,Intravenous,02537893,ACETAZOLAMIDE FOR INJECTION USP (acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9004795,acetazolamide (acetazolamide sodium) 500 mg per vial powder for solution for injection,8001428,acetazolamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
31096,Marketed,2011-10-05,02133326,MIOCHOL-E,1.0,S01EB09,Acetylcholine,Powder for solution,Ophthalmic,02133326,MIOCHOL-E (acetylcholine chloride 20 mg per vial powder for solution for intraocular irrigation with diluent solution) BAUSCH & LOMB INC,Active,9013637,acetylcholine chloride 20 mg per vial powder for solution for intraocular irrigation with diluent solution,8001550,acetylcholine,372468001,Intraocular,421857007,Powder for eye solution,733026001,Vial (unit of presentation),,,
66965,Marketed,2022-05-10,02243098,ACETYLCYSTEINE SOLUTION,1.0,R05CB01,Acetylcysteine,Solution,"Oral,Inhalation,Intravenous",77700646,ACETYLCYSTEINE SOLUTION (acetylcysteine 200 mg per mL solution for injection 10 mL vial) SANDOZ CANADA INCORPORATED,Active,9012772,acetylcysteine 200 mg per mL solution for injection 10 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66965,Marketed,2022-05-10,02243098,ACETYLCYSTEINE SOLUTION,1.0,R05CB01,Acetylcysteine,Solution,"Oral,Inhalation,Intravenous",77700647,ACETYLCYSTEINE SOLUTION (acetylcysteine 200 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94721,Marketed,2023-06-13,02459906,ACETYLCYSTEINE SOLUTION USP,1.0,R05CB01,Acetylcysteine,Solution,"Intravenous,Inhalation,Oral",77700650,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 10 mL vial) HIKMA CANADA LIMITED,Active,9012772,acetylcysteine 200 mg per mL solution for injection 10 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94721,Marketed,2023-06-13,02459906,ACETYLCYSTEINE SOLUTION USP,1.0,R05CB01,Acetylcysteine,Solution,"Intravenous,Inhalation,Oral",77700651,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 30 mL vial) HIKMA CANADA LIMITED,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102716,Marketed,2024-03-08,02538431,ACETYLCYSTEINE SOLUTION USP,1.0,R05CB01,Acetylcysteine,Solution,"Intravenous,Inhalation,Oral",02538431,ACETYLCYSTEINE SOLUTION USP (acetylcysteine 200 mg per mL solution for injection 30 mL vial) STERIMAX INC,Active,9012773,acetylcysteine 200 mg per mL solution for injection 30 mL vial,8001429,acetylcysteine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
4272,Marketed,2010-05-01,00530336,ASA 325MG,1.0,N02BA01,Acetylsalicylic acid,Tablet,Oral,00530336,ASA 325MG (acetylsalicylic acid 325 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001640,acetylsalicylic acid 325 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18349,Marketed,2007-07-20,02009013,ASAPHEN,1.0,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02009013,ASAPHEN (acetylsalicylic acid 80 mg chewable tablet) PHARMASCIENCE INC,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
19474,Marketed,2012-11-27,02150328,ASPIRIN REGULAR STRENGTH,1.0,N02BA01,Acetylsalicylic acid,Tablet,Oral,02150328,ASPIRIN REGULAR STRENGTH (acetylsalicylic acid 325 mg oral tablet) BAYER INC,Active,9001640,acetylsalicylic acid 325 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19475,Marketed,1995-12-31,02150336,ASPIRIN EXTRA STRENGTH,1.0,N02BA01,Acetylsalicylic acid,Tablet,Oral,02150336,ASPIRIN EXTRA STRENGTH (acetylsalicylic acid 500 mg oral tablet) BAYER INC,Active,9002736,acetylsalicylic acid 500 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19489,Marketed,2013-08-06,02150417,ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02150417,ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH (acetylsalicylic acid 325 mg gastro-resistant tablet) BAYER INC,Active,9001498,acetylsalicylic acid 325 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
36346,Marketed,1999-12-01,02202352,RIVASA 80MG CROQUABLE - TAB,1.0,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02202352,RIVASA 80MG CROQUABLE - TAB (acetylsalicylic acid 80 mg chewable tablet) LABORATOIRE RIVA INC.,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
36347,Marketed,2008-05-06,02202360,RIVASA FC,1.0,N02BA01,Acetylsalicylic acid,Tablet,Oral,02202360,RIVASA FC (acetylsalicylic acid 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003796,acetylsalicylic acid 80 mg oral tablet,8000795,acetylsalicylic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61080,Marketed,2005-05-02,02237726,ASPIRIN 81MG,1.0,B01AC06,Acetylsalicylic acid,Tablet (enteric-coated),Oral,02237726,ASPIRIN 81MG (acetylsalicylic acid 81 mg gastro-resistant tablet) BAYER INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
61971,Marketed,2018-01-25,02238545,ASAPHEN E.C. 80 MG,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02238545,ASAPHEN E.C. 80 MG (acetylsalicylic acid 80 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
65982,Marketed,2009-07-24,02242281,ENTROPHEN,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02242281,ENTROPHEN (acetylsalicylic acid 81 mg gastro-resistant tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
67917,Marketed,2009-07-24,02243974,ENTROPHEN CHEWABLE,1.0,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02243974,ENTROPHEN CHEWABLE (acetylsalicylic acid 81 mg chewable tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
68992,Marketed,2001-11-30,02244993,ASA 81 MG,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02244993,ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
75453,Marketed,2025-08-07,02269139,JAMP-ASA CHEW,1.0,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02269139,JAMP-ASA CHEW (acetylsalicylic acid 80 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
76929,Marketed,2009-09-21,02283700,PRAXIS ASA EC 81 MG DAILY LOW DOSE,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02283700,PRAXIS ASA EC 81 MG DAILY LOW DOSE (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
76948,Marketed,2020-10-08,02283905,JAMP-ASA EC,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02283905,JAMP-ASA EC (acetylsalicylic acid 80 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
77528,Marketed,2007-05-22,02289970,ASPIRIN 81MG QUICK CHEWS,1.0,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02289970,ASPIRIN 81MG QUICK CHEWS (acetylsalicylic acid 81 mg chewable tablet) BAYER INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
79706,Marketed,2023-03-24,02311496,PRO-AAS EC - 80,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02311496,PRO-AAS EC - 80 (acetylsalicylic acid 80 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
79707,Marketed,2025-09-17,02311518,PRO-AAS - 80 (CROQUABLE),1.0,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02311518,PRO-AAS - 80 (CROQUABLE) (acetylsalicylic acid 80 mg chewable tablet) PRO DOC LIMITEE,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84814,Marketed,2011-06-27,02363127,ENTERIC COATED DAILY LOW DOSE ASA 81 MG,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02363127,ENTERIC COATED DAILY LOW DOSE ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
85732,Marketed,2012-01-12,02372177,ASA 81 MG,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02372177,ASA 81 MG (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87994,Marketed,2013-05-01,02394790,ASA DAILY LOW DOSE,1.0,B01AC06,Acetylsalicylic acid,Tablet (chewable),Oral,02394790,ASA DAILY LOW DOSE (acetylsalicylic acid 81 mg chewable tablet) PHARMASCIENCE INC,Active,9003664,acetylsalicylic acid 81 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
90486,Marketed,2014-03-20,02420279,RIVASA 81 MG EC,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02420279,RIVASA 81 MG EC (acetylsalicylic acid 81 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91170,Marketed,2020-08-13,02427176,SNS-ASA EC,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02427176,SNS-ASA EC (acetylsalicylic acid 80 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91173,Marketed,2015-01-13,02427206,JAMP-ASA 81MG EC,1.0,B01AC06,Acetylsalicylic acid,Tablet (enteric-coated),Oral,02427206,JAMP-ASA 81MG EC (acetylsalicylic acid 81 mg gastro-resistant tablet) VITA HEALTH PRODUCTS INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91435,Marketed,2015-02-11,02429950,M-ASA 80 MG CROQUABLE,1.0,N02BA01,Acetylsalicylic acid,Tablet (chewable),Oral,02429950,M-ASA 80 MG CROQUABLE (acetylsalicylic acid 80 mg chewable tablet) MANTRA PHARMA INC,Active,9002737,acetylsalicylic acid 80 mg chewable tablet,8000795,acetylsalicylic acid,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
91745,Marketed,2015-05-06,02433044,ASA,1.0,B01AC06,Acetylsalicylic acid,Tablet (delayed-release),Oral,02433044,ASA (acetylsalicylic acid 81 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9003295,acetylsalicylic acid 81 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
97547,Marketed,2019-02-01,02485222,RIVASA 80 MG EC,1.0,N02BA01,Acetylsalicylic acid,Tablet (delayed-release),Oral,02485222,RIVASA 80 MG EC (acetylsalicylic acid 80 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9003337,acetylsalicylic acid 80 mg gastro-resistant tablet,8000795,acetylsalicylic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
1233,Marketed,2020-01-21,00226327,FIORINAL,3.0,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,00226327,FIORINAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
5779,Marketed,2017-11-09,00608211,TEVA-TECNAL,3.0,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Tablet,Oral,00608211,TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) TEVA CANADA LIMITED,Active,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
6480,Marketed,2017-11-09,00608238,TEVA-TECNAL,3.0,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,00608238,TEVA-TECNAL (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
23671,Marketed,2015-11-23,01971409,TRIANAL TABLET,3.0,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Tablet,Oral,01971409,TRIANAL TABLET (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
104353,Marketed,2025-05-08,02554690,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE,3.0,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Capsule,Oral,02554690,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule) APOTEX INC,Active,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,8000808,acetylsalicylic acid and butalbital and caffeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
4959,Marketed,2020-12-22,00569771,ZOVIRAX,1.0,D06BB03,Aciclovir,Ointment,Topical,00569771,"ZOVIRAX (acyclovir 5 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
15525,Marketed,2020-12-22,02039524,ZOVIRAX,1.0,D06BB03,Aciclovir,Cream,Topical,02039524,"ZOVIRAX (acyclovir 5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000453,acyclovir 5 % cutaneous cream,8000095,acyclovir,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
96789,Marketed,2019-03-14,02477130,APO-ACYCLOVIR OINTMENT,1.0,D06BB03,Aciclovir,Ointment,Topical,02477130,APO-ACYCLOVIR OINTMENT (acyclovir 5 % cutaneous ointment) APOTEX INC,Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
101144,Marketed,2022-02-25,02522306,TARO-ACYCLOVIR,1.0,D06BB03,Aciclovir,Ointment,Topical,02522306,TARO-ACYCLOVIR (acyclovir 5 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9000174,acyclovir 5 % cutaneous ointment,8000095,acyclovir,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
88879,Marketed,2020-12-30,02404044,XERESE,2.0,D06BB53,"Aciclovir, combinations",Cream,Topical,02404044,"XERESE (acyclovir 5 % and hydrocortisone 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9005293,acyclovir 5 % and hydrocortisone 1 % cutaneous cream,8001003,acyclovir and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
16167,Marketed,2020-03-20,02070863,SORIATANE,1.0,D05BB02,Acitretin,Capsule,Oral,02070863,SORIATANE (acitretin 25 mg oral capsule) ALLERGAN INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
16168,Marketed,2019-12-07,02070847,SORIATANE,1.0,D05BB02,Acitretin,Capsule,Oral,02070847,SORIATANE (acitretin 10 mg oral capsule) ALLERGAN INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95437,Marketed,2018-02-06,02466074,TARO-ACITRETIN,1.0,D05BB02,Acitretin,Capsule,Oral,02466074,TARO-ACITRETIN (acitretin 10 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95438,Marketed,2018-03-26,02466082,TARO-ACITRETIN,1.0,D05BB02,Acitretin,Capsule,Oral,02466082,TARO-ACITRETIN (acitretin 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95745,Marketed,2018-01-24,02468840,MINT-ACITRETIN,1.0,D05BB02,Acitretin,Capsule,Oral,02468840,MINT-ACITRETIN (acitretin 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012776,acitretin 10 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95746,Marketed,2018-01-24,02468859,MINT-ACITRETIN,1.0,D05BB02,Acitretin,Capsule,Oral,02468859,MINT-ACITRETIN (acitretin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012777,acitretin 25 mg oral capsule,8001430,acitretin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
89440,Marketed,2022-09-12,02409720,TUDORZA GENUAIR,1.0,R03BB05,Aclidinium bromide,Powder (metered dose),Inhalation,02409720,TUDORZA GENUAIR (aclidinium bromide 400 mcg per actuation inhalation powder) COVIS PHARMA GMBH,Active,9005324,aclidinium bromide 400 mcg per actuation inhalation powder,8001070,aclidinium,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
43018,Marketed,1997-08-22,02207621,APO-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02207621,APO-ACYCLOVIR (acyclovir 200 mg oral tablet) APOTEX INC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43019,Marketed,1997-08-22,02207648,APO-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02207648,APO-ACYCLOVIR (acyclovir 400 mg oral tablet) APOTEX INC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43020,Marketed,1997-08-22,02207656,APO-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02207656,APO-ACYCLOVIR (acyclovir 800 mg oral tablet) APOTEX INC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60218,Marketed,2015-09-30,02236926,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77700065,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
60218,Marketed,2015-09-30,02236926,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77700066,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66188,Marketed,2009-12-04,02242463,MYLAN-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02242463,MYLAN-ACYCLOVIR (acyclovir 400 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66189,Marketed,2009-12-04,02242464,MYLAN-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02242464,MYLAN-ACYCLOVIR (acyclovir 800 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66607,Marketed,2010-02-12,02242784,MYLAN-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02242784,MYLAN-ACYCLOVIR (acyclovir 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77144,Marketed,2011-01-25,02285959,TEVA-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02285959,TEVA-ACYCLOVIR (acyclovir 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77145,Marketed,2011-01-25,02285967,TEVA-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02285967,TEVA-ACYCLOVIR (acyclovir 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77146,Marketed,2011-01-25,02285975,TEVA-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02285975,TEVA-ACYCLOVIR (acyclovir 800 mg oral tablet) TEVA CANADA LIMITED,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98455,Marketed,2020-10-21,02494558,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77701023,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98455,Marketed,2020-10-21,02494558,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77701024,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) AURO PHARMA INC,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101372,Marketed,2022-07-15,02524708,MINT-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02524708,MINT-ACYCLOVIR (acyclovir 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000500,acyclovir 200 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101373,Marketed,2022-07-15,02524716,MINT-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02524716,MINT-ACYCLOVIR (acyclovir 400 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000501,acyclovir 400 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101374,Marketed,2022-07-15,02524724,MINT-ACYCLOVIR,1.0,J05AB01,Acyclovir,Tablet,Oral,02524724,MINT-ACYCLOVIR (acyclovir 800 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000502,acyclovir 800 mg oral tablet,8000095,acyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102038,Marketed,2024-08-06,02531224,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77701162,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9000800,acyclovir (acyclovir sodium) 500 mg per 10 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102038,Marketed,2024-08-06,02531224,ACYCLOVIR SODIUM INJECTION,1.0,J05AB01,Acyclovir,Solution,Intravenous,77701163,ACYCLOVIR SODIUM INJECTION (acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9000799,acyclovir (acyclovir sodium) 1000 mg per 20 mL solution for injection vial,8000095,acyclovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74379,Marketed,2012-11-23,02258595,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,77701099,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection pen) ABBVIE CORPORATION,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
74379,Marketed,2012-11-23,02258595,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,77701100,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
74379,Marketed,2012-11-23,02258595,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,77701101,HUMIRA (adalimumab 40 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9012597,adalimumab 40 mg per 0.8 mL solution for injection vial,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94543,Marketed,2024-04-23,02458357,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02458357,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection pen) ABBVIE CORPORATION,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94546,Marketed,2024-04-23,02458349,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02458349,HUMIRA (adalimumab 40 mg per 0.4 mL solution for injection syringe) ABBVIE CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94649,Marketed,2021-02-19,02459299,AMGEVITA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02459299,AMGEVITA SINGLE-USE PREFILLED SYRINGE (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
94650,Marketed,2021-02-19,02459302,AMGEVITA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02459302,AMGEVITA SINGLE-USE PREFILLED AUTOINJECTOR (40MG/0.8ML) (adalimumab 40 mg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
94651,Marketed,2021-02-19,02459310,AMGEVITA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02459310,AMGEVITA (adalimumab 20 mg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
96243,Marketed,2021-02-19,02473097,HADLIMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02473097,"HADLIMA (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
96244,Marketed,2021-02-19,02473100,HADLIMA PUSHTOUCH,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02473100,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.8 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
96431,Marketed,2020-08-18,02474263,HUMIRA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02474263,HUMIRA (adalimumab 20 mg per 0.2 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98214,Marketed,2021-02-15,02492156,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02492156,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
98215,Marketed,2021-02-15,02492164,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02492164,HYRIMOZ (adalimumab 40 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99196,Marketed,2024-06-05,02502380,HULIO,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02502380,HULIO (adalimumab 20 mg per 0.4 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99197,Marketed,2024-11-29,02502399,HULIO,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02502399,HULIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99198,Marketed,2024-03-20,02502402,HULIO,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02502402,HULIO (adalimumab 40 mg per 0.8 mL solution for injection pen) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
99222,Marketed,2021-02-16,02502674,IDACIO,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02502674,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection pen) FRESENIUS KABI CANADA LTD,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
99223,Marketed,2021-08-30,02502682,IDACIO,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02502682,IDACIO (adalimumab 40 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99460,Marketed,2021-02-15,02505258,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02505258,HYRIMOZ (adalimumab 20 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
100029,Marketed,2022-02-24,02511045,ABRILADA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02511045,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection pen) PFIZER CANADA ULC,Active,9014442,adalimumab 40 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
100030,Marketed,2022-03-07,02511053,ABRILADA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02511053,ABRILADA (adalimumab 40 mg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014443,adalimumab 40 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
100031,Marketed,2023-03-13,02511061,ABRILADA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02511061,ABRILADA (adalimumab 20 mg per 0.4 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014471,adalimumab 20 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101282,Marketed,2024-06-21,02523760,YUFLYMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02523760,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) CELLTRION INC.,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101284,Marketed,2024-06-21,02523779,YUFLYMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02523779,YUFLYMA (adalimumab 40 mg per 0.4 mL solution for injection pen) CELLTRION INC.,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101299,Marketed,2022-05-19,02523949,SIMLANDI,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02523949,SIMLANDI PREFILLED SYRINGE (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101300,Marketed,2022-04-13,02523957,SIMLANDI,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02523957,SIMLANDI AUTO-INJECTOR (adalimumab 40 mg per 0.4 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101301,Marketed,2022-05-19,02523965,SIMLANDI,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02523965,SIMLANDI (adalimumab 80 mg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102246,Marketed,2023-10-25,02533480,HADLIMA PUSHTOUCH,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02533480,"HADLIMA PUSHTOUCH (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102247,Marketed,2023-10-25,02533472,HADLIMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02533472,"HADLIMA (adalimumab 40 mg per 0.4 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102395,Marketed,2024-06-21,02535076,YUFLYMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02535076,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection syringe) CELLTRION INC.,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102396,Marketed,2024-06-21,02535084,YUFLYMA,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02535084,YUFLYMA (adalimumab 80 mg per 0.8 mL solution for injection pen) CELLTRION INC.,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
103089,Marketed,2024-04-05,02542315,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02542315,HYRIMOZ (adalimumab 20 mg per 0.2 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014352,adalimumab 20 mg per 0.2 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103090,Marketed,2024-04-10,02542323,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02542323,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012596,adalimumab 40 mg per 0.4 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103091,Marketed,2024-04-17,02542331,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02542331,HYRIMOZ (adalimumab 40 mg per 0.4 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9012595,adalimumab 40 mg per 0.4 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103092,Marketed,2024-05-15,02542358,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02542358,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9014690,adalimumab 80 mg per 0.8 mL solution for injection syringe,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103093,Marketed,2024-04-17,02542366,HYRIMOZ,1.0,L04AB04,Adalimumab,Solution,Subcutaneous,02542366,HYRIMOZ (adalimumab 80 mg per 0.8 mL solution for injection pen) SANDOZ CANADA INCORPORATED,Active,9014910,adalimumab 80 mg per 0.8 mL solution for injection pen,8001241,adalimumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
20107,Marketed,1996-12-31,02148749,DIFFERIN,1.0,D10AD03,Adapalene,Gel,Topical,02148749,DIFFERIN (adapalene 0.1 % cutaneous gel) GALDERMA CANADA INC.,Active,9003004,adapalene 0.1 % cutaneous gel,8001242,adapalene,448598008,Cutaneous,385100002,Gel,,,,,
50959,Marketed,1998-01-08,02231592,DIFFERIN,1.0,D10AD03,Adapalene,Cream,Topical,02231592,DIFFERIN (adapalene 0.1 % cutaneous cream) GALDERMA CANADA INC.,Active,9003199,adapalene 0.1 % cutaneous cream,8001242,adapalene,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
75946,Marketed,2007-07-19,02274000,DIFFERIN XP,1.0,D10AD03,Adapalene,Gel,Topical,02274000,DIFFERIN XP (adapalene 0.3 % cutaneous gel) GALDERMA CANADA INC.,Active,9004311,adapalene 0.3 % cutaneous gel,8001242,adapalene,448598008,Cutaneous,385100002,Gel,,,,,
85075,Marketed,2014-06-02,02365871,TACTUPUMP,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02365871,TACTUPUMP (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) GALDERMA CANADA INC.,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
93152,Marketed,2016-01-04,02446235,TACTUPUMP FORTE,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02446235,TACTUPUMP FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) GALDERMA CANADA INC.,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
94404,Marketed,2019-10-01,02456923,TARO-ADAPALENE/BENZOYL PEROXIDE,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02456923,TARO-ADAPALENE/BENZOYL PEROXIDE (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
97906,Marketed,2021-06-21,02489007,SANDOZ ADAPALENE / BENZOYL PEROXIDE,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02489007,SANDOZ ADAPALENE / BENZOYL PEROXIDE (adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel) SANDOZ CANADA INCORPORATED,Active,9004871,adapalene 0.1 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
99442,Marketed,2022-01-24,02505053,TARO-ADAPALENE/BENZOYL PEROXIDE FORTE,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02505053,TARO-ADAPALENE/BENZOYL PEROXIDE FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
100638,Marketed,2022-01-26,02517205,SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE,2.0,D10AD53,"Adapalene, combinations",Gel,Topical,02517205,SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE (adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel) SANDOZ CANADA INCORPORATED,Active,9005841,adapalene 0.3 % and benzoyl peroxide 2.5 % cutaneous gel,8000983,adapalene and benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
75307,Marketed,2015-11-23,02267659,ADENOSINE INJECTION,1.0,C01EB10,Adenosine,Solution,Intravenous,02267659,ADENOSINE INJECTION (adenosine 6 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013265,adenosine 6 mg per 2 mL solution for injection vial,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94452,Marketed,2017-08-17,02457474,ADENOSINE INJECTION,1.0,C01EB10,Adenosine,Solution,Intravenous,02457474,ADENOSINE INJECTION (adenosine 6 mg per 2 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013264,adenosine 6 mg per 2 mL solution for injection syringe,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94453,Marketed,2017-08-17,02457482,ADENOSINE INJECTION,1.0,C01EB10,Adenosine,Solution,Intravenous,02457482,ADENOSINE INJECTION (adenosine 12 mg per 4 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013263,adenosine 12 mg per 4 mL solution for injection syringe,8001885,adenosine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
90026,Marketed,2014-01-17,02415666,GIOTRIF,1.0,L01EB03,Afatinib,Tablet,Oral,02415666,GIOTRIF (afatinib (afatinib dimaleate) 20 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90027,Marketed,2014-01-17,02415674,GIOTRIF,1.0,L01EB03,Afatinib,Tablet,Oral,02415674,GIOTRIF (afatinib (afatinib dimaleate) 30 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90028,Marketed,2014-01-17,02415682,GIOTRIF,1.0,L01EB03,Afatinib,Tablet,Oral,02415682,GIOTRIF (afatinib (afatinib dimaleate) 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100203,Marketed,2024-10-28,02512777,SANDOZ AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02512777,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100204,Marketed,2024-10-28,02512785,SANDOZ AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02512785,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100205,Marketed,2024-10-28,02512793,SANDOZ AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02512793,SANDOZ AFATINIB (afatinib (afatinib dimaleate) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100635,Marketed,2025-01-31,02517019,MAR-AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02517019,MAR-AFATINIB (afatinib (afatinib dimaleate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005402,afatinib (afatinib dimaleate) 20 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100636,Marketed,2025-01-31,02517027,MAR-AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02517027,MAR-AFATINIB (afatinib (afatinib dimaleate) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005403,afatinib (afatinib dimaleate) 30 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100637,Marketed,2025-01-31,02517035,MAR-AFATINIB,1.0,L01EB03,Afatinib,Tablet,Oral,02517035,MAR-AFATINIB (afatinib (afatinib dimaleate) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005404,afatinib (afatinib dimaleate) 40 mg oral tablet,8001551,afatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90055,Marketed,2013-12-23,02415992,EYLEA,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02415992,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection vial) BAYER INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99471,Marketed,2020-11-17,02505355,EYLEA,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02505355,EYLEA (aflibercept 2 mg per 0.05 mL solution for injection syringe) BAYER INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102467,Marketed,2025-07-01,02535858,YESAFILI,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02535858,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
103362,Marketed,2024-09-03,02545004,EYLEA HD,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02545004,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection vial) BAYER INC,Active,9015080,aflibercept 8 mg per 0.07 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103942,Marketed,2025-09-03,02550636,PAVBLU,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02550636,PAVBLU (aflibercept 2 mg per 0.05 mL solution for injection vial) AMGEN CANADA INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
104305,Marketed,2025-07-02,02554178,AFLIVU,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02554178,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection syringe) APOTEX INC,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0
104306,Marketed,2025-07-02,02554194,AFLIVU,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02554194,AFLIVU (aflibercept 2 mg per 0.05 mL solution for injection vial) APOTEX INC,Active,9012884,aflibercept 2 mg per 0.05 mL solution for injection vial,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
104362,Marketed,2025-04-07,02554798,EYLEA HD,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02554798,EYLEA HD (aflibercept 8 mg per 0.07 mL solution for injection syringe) BAYER INC,Active,9015182,aflibercept 8 mg per 0.07 mL solution for injection syringe,8001552,aflibercept,738984000,Injection,385219001,Solution for injection,733020007,Syringe,1.0,,
106151,Marketed,2025-07-01,02558238,YESAFILI,1.0,S01LA05,Aflibercept,Solution,Intravitreal,02558238,YESAFILI (aflibercept 2 mg per 0.05 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014409,aflibercept 2 mg per 0.05 mL solution for injection syringe,8001552,aflibercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,1.0
73392,Marketed,2021-10-13,02249057,REPLAGAL,1.0,A16AB03,Agalsidase alfa,Solution,Intravenous,02249057,REPLAGAL (agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial) TAKEDA CANADA INC,Active,9012885,agalsidase alfa 3.5 mg per 3.5 mL solution for injection vial,8001553,agalsidase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
73340,Marketed,2024-04-08,02248965,FABRAZYME,1.0,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248965,FABRAZYME (agalsidase beta 5 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003938,agalsidase beta 5 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
73341,Marketed,2024-04-08,02248966,FABRAZYME,1.0,A16AB04,Agalsidase beta,Powder for solution,Intravenous,02248966,FABRAZYME (agalsidase beta 35 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003895,agalsidase beta 35 mg per vial powder for solution for injection,8001554,agalsidase beta,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
42926,Marketed,2012-12-04,02189100,PLASBUMIN-5,1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
43384,Marketed,2021-04-28,02223694,"ALBUMIN (HUMAN) 5% SOLUTION, USP",1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
43385,Marketed,2012-09-11,02223708,ALBUMIN (HUMAN) 25% SOLUTION USP,1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
75278,Marketed,2024-10-15,02267357,OCTALBIN 25%,1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
76013,Marketed,2008-01-15,02274655,ALBUREX - 5,1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
76014,Marketed,2007-10-16,02274663,ALBUREX - 25,1.0,B05AA01,Albumin,Solution,Intravenous,,,,,,,,,,,,,,,,
81516,Marketed,2018-08-21,02329417,DRAXIMAGE MAA,1.0,B05AA01,Albumin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
18314,Marketed,2025-07-09,02130181,PROLEUKIN,1.0,L03AC01,Aldesleukin,Powder for solution,Intravenous,02130181,PROLEUKIN (aldesleukin 22000000 unit per vial powder for solution for injection) IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC,Active,9002738,aldesleukin 22000000 unit per vial powder for solution for injection,8001555,aldesleukin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94518,Marketed,2016-10-14,02458136,ALECENSARO,1.0,L01ED03,Alectinib,Capsule,Oral,02458136,ALECENSARO (alectinib (alectinib hydrochloride) 150 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9006051,alectinib (alectinib hydrochloride) 150 mg oral capsule,8001556,alectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77636,Marketed,2024-04-19,02290960,MABCAMPATH,1.0,L04AG06,Alemtuzumab,Solution,Intravenous,02290960,MABCAMPATH (alemtuzumab 30 mg per 1 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012887,alemtuzumab 30 mg per 1 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90290,Marketed,2024-04-19,02418320,LEMTRADA,1.0,L04AG06,Alemtuzumab,Solution,Intravenous,02418320,LEMTRADA (alemtuzumab 12 mg per 1.2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012886,alemtuzumab 12 mg per 1.2 mL solution for injection vial,8001557,alemtuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
69356,Marketed,2022-05-03,02245329,FOSAMAX,1.0,M05BA04,Alendronic acid,Tablet,Oral,02245329,FOSAMAX (alendronic acid (alendronate sodium) 70 mg oral tablet) ORGANON CANADA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73098,Marketed,2005-05-27,02248730,APO-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02248730,APO-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) APOTEX INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74709,Marketed,2010-06-17,02261715,TEVA-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02261715,TEVA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) TEVA CANADA LIMITED,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75626,Marketed,2025-12-09,02270889,RIVA-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02270889,RIVA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76957,Marketed,2006-08-15,02284006,PMS-ALENDRONATE-FC,1.0,M05BA04,Alendronic acid,Tablet,Oral,02284006,PMS-ALENDRONATE-FC (alendronic acid (alendronate sodium) 70 mg oral tablet) PHARMASCIENCE INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77349,Marketed,2016-09-23,02288109,SANDOZ ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02288109,SANDOZ ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78508,Marketed,2022-01-27,02299712,ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02299712,ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78840,Marketed,2024-01-02,02303078,ALENDRONATE-70,1.0,M05BA04,Alendronic acid,Tablet,Oral,02303078,ALENDRONATE-70 (alendronic acid (alendronate sodium) 70 mg oral tablet) PRO DOC LIMITEE,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86732,Marketed,2012-03-20,02381478,ACH-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02381478,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001064,alendronic acid (alendronate sodium) 5 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86733,Marketed,2012-03-20,02381486,ACH-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02381486,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001025,alendronic acid (alendronate sodium) 10 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86734,Marketed,2012-03-20,02381494,ACH-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02381494,ACH-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87407,Marketed,2012-07-26,02388545,AURO-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02388545,AURO-ALENDRONATE (alendronic acid (alendronate sodium) 10 mg oral tablet) AURO PHARMA INC,Active,9001025,alendronic acid (alendronate sodium) 10 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87408,Marketed,2012-07-26,02388553,AURO-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02388553,AURO-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) AURO PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98988,Marketed,2022-07-22,02500175,JAMP ALENDRONATE SODIUM,1.0,M05BA04,Alendronic acid,Tablet,Oral,02500175,JAMP ALENDRONATE SODIUM (alendronic acid (alendronate sodium) 70 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99568,Marketed,2024-04-03,02506327,AG-ALENDRONATE SODIUM,1.0,M05BA04,Alendronic acid,Tablet,Oral,02506327,AG-ALENDRONATE SODIUM (alendronic acid (alendronate sodium) 70 mg oral tablet) ANGITA PHARMA INC.,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101218,Marketed,2022-08-09,02523116,NRA-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02523116,NRA-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) NORA PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101860,Marketed,2025-11-18,02529394,M-ALENDRONATE,1.0,M05BA04,Alendronic acid,Tablet,Oral,02529394,M-ALENDRONATE (alendronic acid (alendronate sodium) 70 mg oral tablet) MANTRA PHARMA INC,Active,9000973,alendronic acid (alendronate sodium) 70 mg oral tablet,8000312,alendronic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76210,Marketed,2022-06-29,02276429,FOSAVANCE,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02276429,FOSAVANCE (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 2800 unit oral tablet) ORGANON CANADA INC.,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80047,Marketed,2022-07-05,02314940,FOSAVANCE,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02314940,FOSAVANCE (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 5600 unit oral tablet) ORGANON CANADA INC.,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94104,Marketed,2016-07-21,02454467,APO-ALENDRONATE/VITAMIN D3,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02454467,APO-ALENDRONATE/VITAMIN D3 (alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet) APOTEX INC,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94105,Marketed,2016-07-21,02454475,APO-ALENDRONATE/VITAMIN D3,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02454475,APO-ALENDRONATE/VITAMIN D3 (alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet) APOTEX INC,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100905,Marketed,2023-06-13,02519828,JAMP ALENDRONATE / VITAMIN D3,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02519828,JAMP ALENDRONATE / VITAMIN D3 (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 2800 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006480,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 2800 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100906,Marketed,2023-03-15,02519836,JAMP ALENDRONATE / VITAMIN D3,2.0,M05BB03,Alendronic acid and cholecalciferol,Tablet,Oral,02519836,JAMP ALENDRONATE / VITAMIN D3 (alendronic acid (alendronate sodium trihydrate) 70 mg and cholecalciferol 5600 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006487,alendronic acid (alendronate sodium) 70 mg and cholecalciferol 5600 unit oral tablet,8000413,alendronic acid and cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43004,Marketed,2012-02-04,02204606,PROLASTIN-C,1.0,B02AB02,Alfa1 antitrypsin,Powder for solution,Intravenous,02204606,PROLASTIN-C (alpha1-proteinase inhibitor human 1000 mg per vial powder for solution for injection with diluent solution) GRIFOLS THERAPEUTICS LLC,Active,9013756,alpha1-proteinase inhibitor human 1000 mg per vial powder for solution for injection with diluent solution,8002214,alpha1-proteinase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101155,Marketed,2024-01-02,02522438,GLASSIA,1.0,B02AB02,Alfa1 antitrypsin,Solution,Intravenous,02522438,GLASSIA (alpha1-proteinase inhibitor human 1000 mg per 50 mL solution for injection vial) TAKEDA CANADA INC,Active,9015001,alpha1-proteinase inhibitor human 1000 mg per 50 mL solution for injection vial,8002214,alpha1-proteinase inhibitor human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
7292,Marketed,2022-01-31,00474517,ONE-ALPHA,1.0,A11CC03,Alfacalcidol,Capsule,Oral,00474517,ONE-ALPHA (alfacalcidol 0.25 mcg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001869,alfacalcidol 0.25 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
7293,Marketed,2022-01-31,00474525,ONE-ALPHA,1.0,A11CC03,Alfacalcidol,Capsule,Oral,00474525,ONE-ALPHA (alfacalcidol 1 mcg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001870,alfacalcidol 1 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
63869,Marketed,2022-01-31,02240329,ONE-ALPHA,1.0,A11CC03,Alfacalcidol,Drops,Oral,02240329,ONE-ALPHA (alfacalcidol 2 mcg per mL oral drops) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003545,alfacalcidol 2 mcg per mL oral drops,8001339,alfacalcidol,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
66245,Marketed,2022-01-31,02242502,ONE-ALPHA,1.0,A11CC03,Alfacalcidol,Solution,Intravenous,77700601,ONE-ALPHA (alfacalcidol 2 mcg per 1 mL solution for injection ampoule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012689,alfacalcidol 2 mcg per 1 mL solution for injection ampoule,8001339,alfacalcidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
66245,Marketed,2022-01-31,02242502,ONE-ALPHA,1.0,A11CC03,Alfacalcidol,Solution,Intravenous,77700602,ONE-ALPHA (alfacalcidol 1 mcg per 0.5 mL solution for injection ampoule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012688,alfacalcidol 1 mcg per 0.5 mL solution for injection ampoule,8001339,alfacalcidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
102231,Marketed,2023-04-24,02533316,SANDOZ ALFACALCIDOL,1.0,A11CC03,Alfacalcidol,Capsule,Oral,02533316,SANDOZ ALFACALCIDOL (alfacalcidol 0.25 mcg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001869,alfacalcidol 0.25 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102232,Marketed,2023-04-24,02533324,SANDOZ ALFACALCIDOL,1.0,A11CC03,Alfacalcidol,Capsule,Oral,02533324,SANDOZ ALFACALCIDOL (alfacalcidol 1 mcg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001870,alfacalcidol 1 mcg oral capsule,8001339,alfacalcidol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
69657,Marketed,2006-03-30,02245565,XATRAL,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02245565,XATRAL (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78993,Marketed,2008-08-28,02304678,SANDOZ ALFUZOSIN,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02304678,SANDOZ ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80137,Marketed,2008-08-20,02315866,APO-ALFUZOSIN,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02315866,APO-ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92777,Marketed,2015-09-02,02443201,AURO-ALFUZOSIN,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02443201,AURO-ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) AURO PHARMA INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93315,Marketed,2015-11-25,02447576,ALFUZOSIN,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02447576,ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100907,Marketed,2022-02-24,02519844,ALFUZOSIN,1.0,G04CA01,Alfuzosin,Tablet (extended-release),Oral,02519844,ALFUZOSIN (alfuzosin hydrochloride 10 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9000974,alfuzosin hydrochloride 10 mg prolonged-release oral tablet,8000313,alfuzosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77041,Marketed,2025-03-04,02284863,MYOZYME,1.0,A16AB07,Alglucosidase alfa,Powder for solution,Intravenous,02284863,MYOZYME (alglucosidase alfa 50 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9004236,alglucosidase alfa 50 mg per vial powder for solution for injection,8001558,alglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
12419,Marketed,2022-10-20,01926306,PANECTYL,1.0,R06AD01,Alimemazine,Tablet,Oral,01926306,PANECTYL (trimeprazine (trimeprazine tartrate) 2.5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001572,trimeprazine (trimeprazine tartrate) 2.5 mg oral tablet,8001541,trimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12651,Marketed,2022-10-20,01926292,PANECTYL,1.0,R06AD01,Alimemazine,Tablet,Oral,01926292,PANECTYL (trimeprazine (trimeprazine tartrate) 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001573,trimeprazine (trimeprazine tartrate) 5 mg oral tablet,8001541,trimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94035,Marketed,2016-05-18,02453819,PRALUENT,1.0,C10AX14,Alirocumab,Solution,Subcutaneous,02453819,PRALUENT (alirocumab 75 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012602,alirocumab 75 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94037,Marketed,2016-04-29,02453835,PRALUENT,1.0,C10AX14,Alirocumab,Solution,Subcutaneous,02453835,PRALUENT (alirocumab 150 mg per 1 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9012600,alirocumab 150 mg per 1 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103666,Marketed,2024-09-16,02547732,PRALUENT,1.0,C10AX14,Alirocumab,Solution,Subcutaneous,02547732,PRALUENT (alirocumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9015086,alirocumab 300 mg per 2 mL solution for injection pen,8001243,alirocumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
96841,Marketed,2021-06-09,02477432,HANZEMA,1.0,D11AH04,Alitretinoin,Capsule,Oral,02477432,HANZEMA (alitretinoin 10 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9004810,alitretinoin 10 mg oral capsule,8001559,alitretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
96842,Marketed,2021-06-09,02477440,HANZEMA,1.0,D11AH04,Alitretinoin,Capsule,Oral,02477440,HANZEMA (alitretinoin 30 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9004790,alitretinoin 30 mg oral capsule,8001559,alitretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
4276,Marketed,2024-09-27,00402818,APO-ALLOPURINOL TABLETS,1.0,M04AA01,Allopurinol,Tablet,Oral,00402818,APO-ALLOPURINOL TABLETS (allopurinol 100 mg oral tablet) APOTEX INC,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4302,Marketed,2024-09-27,00402796,APO-ALLOPURINOL TABLETS,1.0,M04AA01,Allopurinol,Tablet,Oral,00402796,APO-ALLOPURINOL TABLETS (allopurinol 300 mg oral tablet) APOTEX INC,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4303,Marketed,2024-09-27,00479799,APO-ALLOPURINOL TABLETS,1.0,M04AA01,Allopurinol,Tablet,Oral,00479799,APO-ALLOPURINOL TABLETS (allopurinol 200 mg oral tablet) APOTEX INC,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4724,Marketed,2013-11-28,00555681,ALLOPURINOL-100,1.0,M04AA01,Allopurinol,Tablet,Oral,00555681,ALLOPURINOL-100 (allopurinol 100 mg oral tablet) PRO DOC LIMITEE,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4725,Marketed,2013-11-28,00555703,ALLOPURINOL-300,1.0,M04AA01,Allopurinol,Tablet,Oral,00555703,ALLOPURINOL-300 (allopurinol 300 mg oral tablet) PRO DOC LIMITEE,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19183,Marketed,2013-11-28,02130157,ALLOPURINOL-200,1.0,M04AA01,Allopurinol,Tablet,Oral,02130157,ALLOPURINOL-200 (allopurinol 200 mg oral tablet) PRO DOC LIMITEE,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88136,Marketed,2013-04-17,02396327,MAR-ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02396327,MAR-ALLOPURINOL (allopurinol 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88137,Marketed,2013-04-17,02396335,MAR-ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02396335,MAR-ALLOPURINOL (allopurinol 200 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88138,Marketed,2013-04-17,02396343,MAR-ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02396343,MAR-ALLOPURINOL (allopurinol 300 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90624,Marketed,2025-06-05,02421593,JAMP ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02421593,JAMP ALLOPURINOL (allopurinol 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000159,allopurinol 100 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90625,Marketed,2025-03-20,02421607,JAMP ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02421607,JAMP ALLOPURINOL (allopurinol 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000160,allopurinol 200 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90626,Marketed,2025-03-20,02421615,JAMP ALLOPURINOL,1.0,M04AA01,Allopurinol,Tablet,Oral,02421615,JAMP ALLOPURINOL (allopurinol 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000073,allopurinol 300 mg oral tablet,8000046,allopurinol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88339,Marketed,2013-07-22,02398435,MYLAN-ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02398435,MYLAN-ALMOTRIPTAN (almotriptan (almotriptan malate) 6.25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003847,almotriptan (almotriptan malate) 6.25 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88340,Marketed,2013-07-22,02398443,MYLAN-ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02398443,MYLAN-ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89013,Marketed,2013-07-22,02405334,SANDOZ ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02405334,SANDOZ ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90875,Marketed,2014-06-10,02424029,ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02424029,ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91914,Marketed,2014-12-12,02434849,TEVA-ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02434849,TEVA-ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95519,Marketed,2018-03-06,02466821,ALMOTRIPTAN,1.0,N02CC05,Almotriptan,Tablet,Oral,02466821,ALMOTRIPTAN (almotriptan (almotriptan malate) 12.5 mg oral tablet) SANIS HEALTH INC,Active,9003846,almotriptan (almotriptan malate) 12.5 mg oral tablet,8001110,almotriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90182,Marketed,2014-04-30,02417189,NESINA,1.0,A10BH04,Alogliptin,Tablet,Oral,02417189,NESINA (alogliptin (alogliptin benzoate) 6.25 mg oral tablet) TAKEDA CANADA INC,Active,9005509,alogliptin (alogliptin benzoate) 6.25 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90183,Marketed,2014-04-30,02417197,NESINA,1.0,A10BH04,Alogliptin,Tablet,Oral,02417197,NESINA (alogliptin (alogliptin benzoate) 12.5 mg oral tablet) TAKEDA CANADA INC,Active,9005508,alogliptin (alogliptin benzoate) 12.5 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90184,Marketed,2014-05-13,02417200,NESINA,1.0,A10BH04,Alogliptin,Tablet,Oral,02417200,NESINA (alogliptin (alogliptin benzoate) 25 mg oral tablet) TAKEDA CANADA INC,Active,9005521,alogliptin (alogliptin benzoate) 25 mg oral tablet,8001072,alogliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98692,Marketed,2020-06-29,02497069,PIQRAY,1.0,L01EM03,Alpelisib,Tablet,Oral,02497069,PIQRAY (alpelisib 150 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014316,alpelisib 150 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98693,Marketed,2020-06-29,02497077,PIQRAY,1.0,L01EM03,Alpelisib,Tablet,Oral,02497077,PIQRAY (alpelisib 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014317,alpelisib 200 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98694,Marketed,2020-06-29,02497085,PIQRAY,2.0,L01EM03,Alpelisib,"Tablet,Kit",Oral,02497085,PIQRAY (alpelisib 50 mg oral tablet with alpelisib 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014318,alpelisib 50 mg oral tablet with alpelisib 200 mg oral tablet,8002330,alpelisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
4471,Marketed,2023-04-20,00548359,XANAX,1.0,N05BA12,Alprazolam,Tablet,Oral,00548359,XANAX (alprazolam 0.25 mg oral tablet) BGP PHARMA ULC,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4472,Marketed,2023-04-20,00548367,XANAX,1.0,N05BA12,Alprazolam,Tablet,Oral,00548367,XANAX (alprazolam 0.5 mg oral tablet) BGP PHARMA ULC,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10904,Marketed,1990-12-31,00865397,APO-ALPRAZ,1.0,N05BA12,Alprazolam,Tablet,Oral,00865397,APO-ALPRAZ (alprazolam 0.25 mg oral tablet) APOTEX INC,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10905,Marketed,1990-12-31,00865400,APO-ALPRAZ,1.0,N05BA12,Alprazolam,Tablet,Oral,00865400,APO-ALPRAZ (alprazolam 0.5 mg oral tablet) APOTEX INC,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11484,Marketed,2022-03-22,01908189,PRO-ALPRAZOLAM,1.0,N05BA12,Alprazolam,Tablet,Oral,01908189,PRO-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11485,Marketed,2022-03-22,01908170,PRO-ALPRAZOLAM,1.0,N05BA12,Alprazolam,Tablet,Oral,01908170,PRO-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11803,Marketed,2011-05-07,01913484,TEVA-ALPRAZOLAM,1.0,N05BA12,Alprazolam,Tablet,Oral,01913484,TEVA-ALPRAZOLAM (alprazolam 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000161,alprazolam 0.25 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11804,Marketed,2011-05-07,01913492,TEVA-ALPRAZOLAM,1.0,N05BA12,Alprazolam,Tablet,Oral,01913492,TEVA-ALPRAZOLAM (alprazolam 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000162,alprazolam 0.5 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13685,Marketed,2023-04-20,00723770,XANAX,1.0,N05BA12,Alprazolam,Tablet,Oral,00723770,XANAX (alprazolam 1 mg oral tablet) BGP PHARMA ULC,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13686,Marketed,2023-04-20,00813958,XANAX TS,1.0,N05BA12,Alprazolam,Tablet,Oral,00813958,XANAX TS (alprazolam 2 mg oral tablet) BGP PHARMA ULC,Active,9000455,alprazolam 2 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67530,Marketed,2001-04-16,02243611,APO-ALPRAZ,1.0,N05BA12,Alprazolam,Tablet,Oral,02243611,APO-ALPRAZ (alprazolam 1 mg oral tablet) APOTEX INC,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67531,Marketed,2020-10-05,02243612,APO-ALPRAZ TS,1.0,N05BA12,Alprazolam,Tablet,Oral,02243612,APO-ALPRAZ TS (alprazolam 2 mg oral tablet) APOTEX INC,Active,9000455,alprazolam 2 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73070,Marketed,2022-03-22,02248706,PRO-ALPRAZOLAM,1.0,N05BA12,Alprazolam,Tablet,Oral,02248706,PRO-ALPRAZOLAM (alprazolam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000454,alprazolam 1 mg oral tablet,8000088,alprazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4802,Marketed,2006-05-23,00559253,PROSTIN VR STERILE SOLUTION,1.0,C01EA01,Alprostadil,Solution,"Intra-arterial,Intravenous",00559253,PROSTIN VR STERILE SOLUTION (alprostadil 500 mcg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9012778,alprostadil 500 mcg per 1 mL solution for injection ampoule,8001431,alprostadil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
20353,Marketed,2005-11-09,02215756,CAVERJECT STERILE POWDER,1.0,G04BE01,Alprostadil,"Powder for solution,Liquid,Kit",Intracavernosal,02215756,CAVERJECT STERILE POWDER (alprostadil 20 mcg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9012888,alprostadil 20 mcg per vial powder for solution for injection with diluent solution syringe,8001431,alprostadil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
43155,Marketed,2005-11-09,02215187,CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL,1.0,G04BE01,Alprostadil,Powder for solution,Intracavernosal,,,,,,,,,,,,,,,,
20105,Marketed,1996-12-31,02147440,ACTIVASE RT-PA,2.0,B01AD02,Alteplase,"Liquid,Powder for solution",Intravenous,02147440,ACTIVASE RT-PA (alteplase 100 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012889,alteplase 100 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
43443,Marketed,1998-04-12,02225689,ACTIVASE RT-PA,2.0,B01AD02,Alteplase,"Powder for solution,Liquid",Intravenous,02225689,ACTIVASE RT-PA (alteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9012890,alteplase 50 mg per vial powder for solution for injection with diluent solution,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
69976,Marketed,2002-09-26,02245859,CATHFLO,1.0,B01AD02,Alteplase,Powder for solution,Instillation,02245859,CATHFLO (alteplase 2 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9006376,alteplase 2 mg per vial powder for solution for injection,8001561,alteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
13464,Marketed,2017-03-15,01990403,PDP-AMANTADINE HYDROCHLORIDE CAPSULES,1.0,N04BB01,Amantadine,Capsule,Oral,01990403,PDP-AMANTADINE HYDROCHLORIDE CAPSULES (amantadine hydrochloride 100 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002412,amantadine hydrochloride 100 mg oral capsule,8001340,amantadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
14393,Marketed,2018-01-05,02022826,PDP-AMANTADINE HYDROCHLORIDE SYRUP,1.0,N04BB01,Amantadine,Syrup,Oral,02022826,PDP-AMANTADINE HYDROCHLORIDE SYRUP (amantadine hydrochloride 50 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012891,amantadine hydrochloride 50 mg per 5 mL syrup,8001340,amantadine,26643006,Oral,739009002,Syrup,,,,,
102731,Marketed,2023-07-20,02538601,ODAN-AMANTADINE SYRUP,1.0,N04BB01,Amantadine,Syrup,Oral,02538601,ODAN-AMANTADINE SYRUP (amantadine hydrochloride 50 mg per 5 mL syrup) ODAN LABORATORIES LTD,Active,9012891,amantadine hydrochloride 50 mg per 5 mL syrup,8001340,amantadine,26643006,Oral,739009002,Syrup,,,,,
79274,Marketed,2008-06-24,02307065,VOLIBRIS,1.0,C02KX02,Ambrisentan,Tablet,Oral,02307065,VOLIBRIS (ambrisentan 5 mg oral tablet) GLAXOSMITHKLINE INC,Active,9007109,ambrisentan 5 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79275,Marketed,2008-06-24,02307073,VOLIBRIS,1.0,C02KX02,Ambrisentan,Tablet,Oral,02307073,VOLIBRIS (ambrisentan 10 mg oral tablet) GLAXOSMITHKLINE INC,Active,9007108,ambrisentan 10 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96575,Marketed,2018-11-26,02475375,APO-AMBRISENTAN,1.0,C02KX02,Ambrisentan,Tablet,Oral,02475375,APO-AMBRISENTAN (ambrisentan 5 mg oral tablet) APOTEX INC,Active,9007109,ambrisentan 5 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96576,Marketed,2018-11-26,02475383,APO-AMBRISENTAN,1.0,C02KX02,Ambrisentan,Tablet,Oral,02475383,APO-AMBRISENTAN (ambrisentan 10 mg oral tablet) APOTEX INC,Active,9007108,ambrisentan 10 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101593,Marketed,2022-10-07,02526875,SANDOZ AMBRISENTAN TABLETS,1.0,C02KX02,Ambrisentan,Tablet,Oral,02526875,SANDOZ AMBRISENTAN TABLETS (ambrisentan 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9007109,ambrisentan 5 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101594,Marketed,2022-10-07,02526883,SANDOZ AMBRISENTAN TABLETS,1.0,C02KX02,Ambrisentan,Tablet,Oral,02526883,SANDOZ AMBRISENTAN TABLETS (ambrisentan 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9007108,ambrisentan 10 mg oral tablet,8000968,ambrisentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
70909,Marketed,2005-10-24,02246714,TARO-AMCINONIDE,1.0,D07AC11,Amcinonide,Cream,Topical,02246714,TARO-AMCINONIDE (amcinonide 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002930,amcinonide 0.1 % cutaneous cream,8001244,amcinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
73177,Marketed,2020-12-21,02248808,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248808,ADDERALL XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
73178,Marketed,2021-09-23,02248809,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248809,ADDERALL XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
73179,Marketed,2020-12-21,02248810,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248810,ADDERALL XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
73180,Marketed,2020-12-21,02248811,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248811,ADDERALL XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
73181,Marketed,2020-12-21,02248812,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248812,ADDERALL XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
73182,Marketed,2021-09-30,02248813,ADDERALL XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02248813,ADDERALL XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) TAKEDA CANADA INC,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92362,Marketed,2021-10-25,02439239,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439239,TEVA-AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92363,Marketed,2021-10-25,02439247,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439247,TEVA-AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92364,Marketed,2021-10-25,02439255,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439255,TEVA-AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92365,Marketed,2021-10-25,02439263,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439263,TEVA-AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92366,Marketed,2021-10-25,02439271,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439271,TEVA-AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92367,Marketed,2021-10-25,02439298,TEVA-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02439298,TEVA-AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93077,Marketed,2019-04-15,02445492,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445492,APO-AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) APOTEX INC,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93078,Marketed,2019-04-15,02445506,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445506,APO-AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) APOTEX INC,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93079,Marketed,2019-04-15,02445514,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445514,APO-AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) APOTEX INC,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93080,Marketed,2019-04-26,02445522,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445522,APO-AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) APOTEX INC,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93081,Marketed,2019-04-15,02445530,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445530,APO-AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) APOTEX INC,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93082,Marketed,2019-04-15,02445549,APO-AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02445549,APO-AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) APOTEX INC,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94435,Marketed,2016-12-22,02457288,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457288,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013799,amphetamine mixed salts 5 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94436,Marketed,2016-12-22,02457296,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457296,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 10 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013794,amphetamine mixed salts 10 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94437,Marketed,2016-12-22,02457318,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457318,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 15 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013795,amphetamine mixed salts 15 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94438,Marketed,2016-12-22,02457326,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457326,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 20 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013796,amphetamine mixed salts 20 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94439,Marketed,2016-12-22,02457334,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457334,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 25 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013797,amphetamine mixed salts 25 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
94440,Marketed,2016-12-22,02457342,SANDOZ AMPHETAMINE XR,1.0,N06BA01,Amfetamine,Capsule (extended release),Oral,02457342,SANDOZ AMPHETAMINE XR (amphetamine mixed salts 30 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9013798,amphetamine mixed salts 30 mg prolonged-release oral capsule,8002225,amphetamine mixed salts,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
99250,Marketed,2020-10-23,02502984,FIRDAPSE,1.0,N07XX05,Amifampridine,Tablet,Oral,02502984,FIRDAPSE (amifampridine (amifampridine phosphate) 10 mg oral tablet) KYE PHARMACEUTICALS INC.,Active,9014418,amifampridine (amifampridine phosphate) 10 mg oral tablet,8002355,amifampridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99254,Marketed,2023-01-24,02503034,RUZURGI,1.0,N07XX05,Amifampridine,Tablet,Oral,02503034,RUZURGI (amifampridine 10 mg oral tablet) MEDUNIK CANADA,Active,9014419,amifampridine 10 mg oral tablet,8002355,amifampridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66810,Marketed,2005-09-16,02242971,AMIKACIN SULFATE INJECTION USP,1.0,J01GB06,Amikacin,Liquid,"Intramuscular,Intravenous",02242971,AMIKACIN SULFATE INJECTION USP (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97163,Marketed,2019-03-01,02481073,AMIKACIN SULFATE INJECTION USP,1.0,J01GB06,Amikacin,Solution,"Intramuscular,Intravenous",02481073,AMIKACIN SULFATE INJECTION USP (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97689,Marketed,2019-07-31,02486717,AMIKACIN SULFATE INJECTION,1.0,J01GB06,Amikacin,Solution,"Intramuscular,Intravenous",02486717,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101489,Marketed,2023-04-28,02525909,AMIKACIN SULFATE INJECTION,1.0,J01GB06,Amikacin,Solution,"Intravenous,Intramuscular",02525909,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101866,Marketed,2023-10-06,02529459,AMIKACIN SULFATE INJECTION,1.0,J01GB06,Amikacin,Solution,"Intramuscular,Intravenous",02529459,AMIKACIN SULFATE INJECTION (amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012566,amikacin (amikacin sulfate) 500 mg per 2 mL solution for injection vial,8001169,amikacin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
73433,Marketed,2011-04-04,02249510,MIDAMOR,1.0,C03DB01,Amiloride,Tablet,Oral,02249510,MIDAMOR (amiloride hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9007115,amiloride hydrochloride 5 mg oral tablet,8000943,amiloride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11329,Marketed,2013-10-16,00872296,TRAVASOL,15.0,B05BA01,Amino acids,Solution,Intravenous,,,,,,,,,,,,,,,,
43947,Marketed,2015-01-23,02141450,20% PROSOL,17.0,B05BA01,Amino acids,Liquid,Intravenous,,,,,,,,,,,,,,,,
60165,Marketed,2014-12-19,02236875,PRIMENE 10%,20.0,B05BA01,Amino acids,Liquid,Intravenous,,,,,,,,,,,,,,,,
99955,Marketed,2023-01-25,02510324,ESSEPNA,16.0,B05BA01,Amino acids,Solution,Intravenous,,,,,,,,,,,,,,,,
67875,Marketed,2025-07-22,02243933,LEVULAN KERASTICK,1.0,L01XD04,Aminolevulinic acid,Powder for solution,Topical,02243933,"LEVULAN KERASTICK (aminolevulinic acid hydrochloride 20 % cutaneous solution 1.5 mL applicator) SUN PHARMACEUTICAL INDUSTRIES, INC.",Active,9013793,aminolevulinic acid hydrochloride 20 % cutaneous solution 1.5 mL applicator,8001563,aminolevulinic acid,448598008,Cutaneous,385108009,Cutaneous solution,732980001,Applicator (unit of presentation),,,
99429,Marketed,2021-02-22,02504928,GLEOLAN,1.0,L01XD04,Aminolevulinic acid,Powder for solution,Oral,02504928,GLEOLAN (aminolevulinic acid hydrochloride 1.5 g per vial powder for oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9014472,aminolevulinic acid hydrochloride 1.5 g per vial powder for oral solution,8001563,aminolevulinic acid,26643006,Oral,385026009,Powder for oral solution,733026001,Vial (unit of presentation),,,
5705,Marketed,1984-12-31,00582662,AMINOPHYLLINE INJ 25MG/ML,1.0,R03DA05,Aminophylline,Solution,Intravenous,00582662,AMINOPHYLLINE INJ 25MG/ML (aminophylline 250 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012367,aminophylline 250 mg per 10 mL solution for injection vial,8001049,aminophylline,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63322,Marketed,2010-06-02,02239835,TEVA-AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02239835,TEVA-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66036,Marketed,2005-09-16,02242325,AMIODARONE HYDROCHLORIDE FOR INJECTION,1.0,C01BD01,Amiodarone,Solution,Intravenous,77700080,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 150 mg per 3 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000909,amiodarone hydrochloride 150 mg per 3 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66036,Marketed,2005-09-16,02242325,AMIODARONE HYDROCHLORIDE FOR INJECTION,1.0,C01BD01,Amiodarone,Solution,Intravenous,77700081,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 450 mg per 9 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000910,amiodarone hydrochloride 450 mg per 9 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66036,Marketed,2005-09-16,02242325,AMIODARONE HYDROCHLORIDE FOR INJECTION,1.0,C01BD01,Amiodarone,Solution,Intravenous,77700082,AMIODARONE HYDROCHLORIDE FOR INJECTION (amiodarone hydrochloride 900 mg per 18 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000911,amiodarone hydrochloride 900 mg per 18 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66199,Marketed,2000-07-28,02242472,PMS-AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02242472,PMS-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) PHARMASCIENCE INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67777,Marketed,2005-12-02,02243836,SANDOZ AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02243836,SANDOZ AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69271,Marketed,2023-05-25,02245248,"AMIODARONE HYDROCHLORIDE FOR INJECTION, USP",1.0,C01BD01,Amiodarone,Solution,Intravenous,02245248,"AMIODARONE HYDROCHLORIDE FOR INJECTION, USP (amiodarone hydrochloride 150 mg per 3 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000909,amiodarone hydrochloride 150 mg per 3 mL solution for injection vial,8000269,amiodarone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70344,Marketed,2003-09-05,02246194,APO-AMIODARONE TABLETS,1.0,C01BD01,Amiodarone,Tablet,Oral,02246194,APO-AMIODARONE TABLETS (amiodarone hydrochloride 200 mg oral tablet) APOTEX INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71459,Marketed,2024-11-07,02247217,RIVA-AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02247217,RIVA-AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77754,Marketed,2007-04-03,02292173,PMS-AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02292173,PMS-AMIODARONE (amiodarone hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9001194,amiodarone hydrochloride 100 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79532,Marketed,2008-07-04,02309661,PRO-AMIODARONE - 200,1.0,C01BD01,Amiodarone,Tablet,Oral,02309661,PRO-AMIODARONE - 200 (amiodarone hydrochloride 200 mg oral tablet) PRO DOC LIMITEE,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84924,Marketed,2015-10-28,02364336,AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02364336,AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SANIS HEALTH INC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87109,Marketed,2012-06-10,02385465,AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02385465,AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102093,Marketed,2023-04-12,02531844,JAMP AMIODARONE,1.0,C01BD01,Amiodarone,Tablet,Oral,02531844,JAMP AMIODARONE (amiodarone hydrochloride 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000840,amiodarone hydrochloride 200 mg oral tablet,8000269,amiodarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2215,Marketed,2010-09-21,00335088,ELAVIL,1.0,N06AA09,Amitriptyline,Tablet,Oral,00335088,ELAVIL (amitriptyline hydrochloride 50 mg oral tablet) AA PHARMA INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2426,Marketed,2025-10-24,00370991,PRO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00370991,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2427,Marketed,2025-10-24,00371009,PRO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00371009,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) PRO DOC LIMITEE,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3141,Marketed,2025-10-24,00456349,PRO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00456349,PRO-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) PRO DOC LIMITEE,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8199,Marketed,2010-09-21,00754129,ELAVIL,1.0,N06AA09,Amitriptyline,Tablet,Oral,00754129,ELAVIL (amitriptyline hydrochloride 75 mg oral tablet) AA PHARMA INC,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9346,Marketed,1998-12-12,00654515,PMS-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00654515,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) PHARMASCIENCE INC,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9417,Marketed,1998-12-12,00654523,PMS-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00654523,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9418,Marketed,1998-12-12,00654507,PMS-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,00654507,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88797,Marketed,2013-06-12,02403145,APO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02403145,APO-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) APOTEX INC,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88798,Marketed,2013-06-12,02403153,APO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02403153,APO-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) APOTEX INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88799,Marketed,2013-06-12,02403161,APO-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02403161,APO-AMITRIPTYLINE (amitriptyline hydrochloride 75 mg oral tablet) APOTEX INC,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91430,Marketed,2015-04-24,02429861,MAR-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02429861,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91431,Marketed,2015-04-24,02429888,MAR-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02429888,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91432,Marketed,2015-04-24,02429896,MAR-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02429896,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91433,Marketed,2015-04-27,02429918,MAR-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02429918,MAR-AMITRIPTYLINE (amitriptyline hydrochloride 75 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94469,Marketed,2024-06-10,02457679,JAMP-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02457679,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000033,amitriptyline hydrochloride 10 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94471,Marketed,2024-06-10,02457695,JAMP-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02457695,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000056,amitriptyline hydrochloride 25 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94472,Marketed,2024-06-10,02457687,JAMP-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02457687,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000046,amitriptyline hydrochloride 50 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94473,Marketed,2024-06-10,02457660,JAMP-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02457660,JAMP-AMITRIPTYLINE (amitriptyline hydrochloride 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000114,amitriptyline hydrochloride 75 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95683,Marketed,2017-10-18,02468409,PMS-AMITRIPTYLINE,1.0,N06AA09,Amitriptyline,Tablet,Oral,02468409,PMS-AMITRIPTYLINE (amitriptyline hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9012430,amitriptyline hydrochloride 100 mg oral tablet,8000024,amitriptyline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101529,Marketed,2022-04-26,02526182,RYBREVANT,1.0,L01FX18,Amivantamab,Solution,Intravenous,02526182,RYBREVANT (amivantamab 350 mg per 7 mL solution for injection vial) JANSSEN INC,Active,9014711,amivantamab 350 mg per 7 mL solution for injection vial,8002422,amivantamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
12938,Marketed,2023-08-02,00878928,NORVASC,1.0,C08CA01,Amlodipine,Tablet,Oral,00878928,NORVASC (amlodipine (amlodipine besylate) 5 mg oral tablet) BGP PHARMA ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12939,Marketed,2023-08-02,00878936,NORVASC,1.0,C08CA01,Amlodipine,Tablet,Oral,00878936,NORVASC (amlodipine (amlodipine besylate) 10 mg oral tablet) BGP PHARMA ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75765,Marketed,2010-01-15,02272113,MYLAN-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02272113,MYLAN-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75766,Marketed,2010-01-14,02272121,MYLAN-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02272121,MYLAN-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75886,Marketed,2009-07-09,02273373,APO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02273373,APO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) APOTEX INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75887,Marketed,2009-07-09,02273381,APO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02273381,APO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) APOTEX INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76963,Marketed,2009-07-09,02284065,PMS-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02284065,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76964,Marketed,2009-07-09,02284073,PMS-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02284073,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76997,Marketed,2009-07-09,02284383,SANDOZ AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02284383,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76998,Marketed,2009-07-09,02284391,SANDOZ AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02284391,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78046,Marketed,2009-07-15,02295148,PMS-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02295148,PMS-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78283,Marketed,2024-11-08,02297485,TEVA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02297485,TEVA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78284,Marketed,2024-11-08,02297493,TEVA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02297493,TEVA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81213,Marketed,2017-05-29,02326795,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02326795,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81214,Marketed,2017-06-08,02326809,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02326809,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PRO DOC LIMITEE,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81215,Marketed,2017-05-24,02326817,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02326817,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81620,Marketed,2009-08-05,02330474,SANDOZ AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02330474,SANDOZ AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81699,Marketed,2022-09-01,02331284,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02331284,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SANIS HEALTH INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81700,Marketed,2022-09-01,02331292,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02331292,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81717,Marketed,2025-12-17,02331489,RIVA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02331489,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81718,Marketed,2025-12-17,02331497,RIVA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02331497,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81719,Marketed,2025-12-17,02331500,RIVA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02331500,RIVA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84231,Marketed,2021-04-21,02357186,JAMP-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02357186,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84232,Marketed,2025-04-04,02357194,JAMP-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02357194,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84233,Marketed,2021-03-25,02357208,JAMP-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02357208,JAMP-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84766,Marketed,2011-02-16,02362651,MINT-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02362651,MINT-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84767,Marketed,2011-02-16,02362678,MINT-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02362678,MINT-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85416,Marketed,2024-09-27,02369222,AG-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02369222,AG-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85417,Marketed,2021-05-31,02369230,AG-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02369230,AG-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85418,Marketed,2021-05-31,02369249,AG-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02369249,AG-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85684,Marketed,2021-08-06,02371707,MAR-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02371707,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85685,Marketed,2021-08-06,02371715,MAR-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02371715,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85686,Marketed,2021-08-06,02371723,MAR-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02371723,MAR-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87140,Marketed,2016-09-28,02385783,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02385783,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87141,Marketed,2016-09-28,02385791,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02385791,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87142,Marketed,2016-09-28,02385805,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02385805,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87741,Marketed,2013-01-15,02392127,BIO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02392127,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) BIOMED PHARMA,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87742,Marketed,2013-01-15,02392135,BIO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02392135,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) BIOMED PHARMA,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87743,Marketed,2013-01-15,02392143,BIO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02392143,BIO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) BIOMED PHARMA,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88206,Marketed,2013-02-12,02397072,AURO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02397072,AURO-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) AURO PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88207,Marketed,2013-02-12,02397080,AURO-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02397080,AURO-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) AURO PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90417,Marketed,2023-02-22,02419556,ACH-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02419556,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90418,Marketed,2022-09-13,02419564,ACH-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02419564,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90419,Marketed,2022-10-17,02419572,ACH-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02419572,ACH-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91365,Marketed,2021-02-17,02429217,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02429217,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91366,Marketed,2021-02-17,02429225,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02429225,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95637,Marketed,2018-03-07,02468018,M-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02468018,M-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95638,Marketed,2017-12-14,02468026,M-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02468026,M-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) MANTRA PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95639,Marketed,2018-04-03,02468034,M-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02468034,M-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96694,Marketed,2023-12-05,02476452,NRA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02476452,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) NORA PHARMA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96695,Marketed,2023-12-05,02476460,NRA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02476460,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) NORA PHARMA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96696,Marketed,2023-12-05,02476479,NRA-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02476479,NRA-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) NORA PHARMA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96905,Marketed,2023-04-07,02478587,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02478587,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) SANIS HEALTH INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97499,Marketed,2019-08-28,02484706,PDP-AMLODIPINE,1.0,C08CA01,Amlodipine,Solution,Oral,02484706,PDP-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014145,amlodipine (amlodipine besylate) 5 mg per 5 mL oral solution,8000153,amlodipine,26643006,Oral,385023001,Oral solution,,,,,
98084,Marketed,2024-09-30,02490781,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02490781,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ALTAMED PHARMA,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98085,Marketed,2024-10-25,02490803,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02490803,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ALTAMED PHARMA,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98086,Marketed,2024-10-25,02490811,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02490811,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ALTAMED PHARMA,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101162,Marketed,2022-09-21,02522500,PRZ-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02522500,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101163,Marketed,2022-10-03,02522519,PRZ-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02522519,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101164,Marketed,2022-09-21,02522527,PRZ-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02522527,PRZ-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104184,Marketed,2025-09-25,02552868,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02552868,AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9001277,amlodipine (amlodipine besylate) 2.5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104185,Marketed,2025-04-08,02552876,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02552876,AMLODIPINE (amlodipine (amlodipine besylate) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000399,amlodipine (amlodipine besylate) 5 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104186,Marketed,2025-09-25,02552884,AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,02552884,AMLODIPINE (amlodipine (amlodipine besylate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000398,amlodipine (amlodipine besylate) 10 mg oral tablet,8000153,amlodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106010,Marketed,2025-10-29,02556707,NB-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,
106011,Marketed,2025-08-26,02556715,NB-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,
106012,Marketed,2025-08-26,02556723,NB-AMLODIPINE,1.0,C08CA01,Amlodipine,Tablet,Oral,,,,,,,,,,,,,,,,
3263,Marketed,2013-06-03,00406716,NOVAMOXIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,00406716,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3264,Marketed,2013-06-04,00406724,NOVAMOXIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,00406724,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3344,Marketed,2013-06-04,00452130,NOVAMOXIN,1.0,J01CA04,Amoxicillin,Granules for suspension,Oral,00452130,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
5822,Marketed,2019-10-30,00628115,APO-AMOXI,1.0,J01CA04,Amoxicillin,Capsule,Oral,00628115,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) APOTEX INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
5823,Marketed,2019-10-30,00628123,APO-AMOXI,1.0,J01CA04,Amoxicillin,Capsule,Oral,00628123,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) APOTEX INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
5824,Marketed,2020-06-08,00628131,APO-AMOXI,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,00628131,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) APOTEX INC,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
5825,Marketed,2020-06-08,00628158,APO-AMOXI,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,00628158,APO-AMOXI (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) APOTEX INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
6510,Marketed,2020-06-22,00644315,PRO-AMOX-500,1.0,J01CA04,Amoxicillin,Capsule,Oral,00644315,PRO-AMOX-500 (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) PRO DOC LIMITEE,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
6511,Marketed,2020-11-30,00644331,PRO-AMOX-250,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,00644331,PRO-AMOX-250 (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) PRO DOC LIMITEE,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
14506,Marketed,2013-06-04,02036355,NOVAMOXIN,1.0,J01CA04,Amoxicillin,Tablet (chewable),Oral,02036355,NOVAMOXIN (amoxicillin (amoxicillin trihydrate) 250 mg chewable tablet) TEVA CANADA LIMITED,Active,9007157,amoxicillin 250 mg chewable tablet,8000073,amoxicillin,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
16954,Marketed,2013-06-04,01934163,NOVAMOXIN,1.0,J01CA04,Amoxicillin,Granules for suspension,Oral,01934163,NOVAMOXIN SUGAR REDUCED (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
83801,Marketed,2013-10-03,02352753,AMOXICILLIN,1.0,J01CA04,Amoxicillin,Granules for suspension,Oral,02352753,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANIS HEALTH INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
83803,Marketed,2013-10-03,02352788,AMOXICILLIN,1.0,J01CA04,Amoxicillin,Granules for suspension,Oral,02352788,AMOXICILLIN SUGAR-REDUCED (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANIS HEALTH INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
87364,Marketed,2012-07-26,02388073,AURO-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02388073,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) AURO PHARMA INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87365,Marketed,2012-07-26,02388081,AURO-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02388081,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) AURO PHARMA INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88640,Marketed,2020-10-31,02401509,AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02401509,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88644,Marketed,2013-02-14,02401541,AMOXICILLIN,1.0,J01CA04,Amoxicillin,Granules for suspension,Oral,02401541,AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SIVEM PHARMACEUTICALS ULC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
91747,Marketed,2015-12-07,02433060,JAMP-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02433060,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91748,Marketed,2015-12-07,02433079,JAMP-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02433079,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94573,Marketed,2021-10-14,02458586,AURO-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02458586,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
94574,Marketed,2021-10-14,02458594,AURO-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02458594,AURO-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
96865,Marketed,2018-09-06,02477726,AG-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02477726,AG-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) ANGITA PHARMA INC.,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98576,Marketed,2024-04-29,02495864,SANDOZ AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02495864,SANDOZ AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
101436,Marketed,2022-11-03,02525348,AMOXICILLIN CAPSULES BP,1.0,J01CA04,Amoxicillin,Capsule,Oral,02525348,AMOXICILLIN CAPSULES BP (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) SANIS HEALTH INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101437,Marketed,2022-11-03,02525356,AMOXICILLIN CAPSULES BP,1.0,J01CA04,Amoxicillin,Capsule,Oral,02525356,AMOXICILLIN CAPSULES BP (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) SANIS HEALTH INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102111,Marketed,2023-12-22,02532042,PRZ-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02532042,PRZ-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg oral capsule) PHARMARIS CANADA INC,Active,9007158,amoxicillin 250 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102112,Marketed,2023-12-22,02532050,PRZ-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Capsule,Oral,02532050,PRZ-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 500 mg oral capsule) PHARMARIS CANADA INC,Active,9007164,amoxicillin 500 mg oral capsule,8000073,amoxicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102462,Marketed,2023-04-17,02535793,JAMP-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02535793,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9007154,amoxicillin 125 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
102464,Marketed,2023-04-18,02535815,JAMP-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02535815,JAMP-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
102617,Marketed,2024-03-14,02537451,AG-AMOXICILLIN,1.0,J01CA04,Amoxicillin,Powder for suspension,Oral,02537451,AG-AMOXICILLIN (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL oral suspension) ANGITA PHARMA INC.,Active,9007160,amoxicillin 250 mg per 5 mL oral suspension,8000073,amoxicillin,26643006,Oral,385024007,Oral suspension,,,,,
15208,Marketed,2003-02-10,01916882,CLAVULIN 125 F ORAL SUS,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,01916882,CLAVULIN 125 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9000991,amoxicillin 125 mg per 5 mL and clavulanic acid (potassium clavulanate) 31.25 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
15209,Marketed,2003-01-31,01916874,CLAVULIN 250 F ORAL SUS,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,01916874,CLAVULIN 250 F ORAL SUS (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
62268,Marketed,2002-12-17,02238830,CLAVULIN 400,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02238830,CLAVULIN 400 (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
62269,Marketed,2003-01-15,02238831,CLAVULIN 200,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02238831,CLAVULIN 200 (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9006261,amoxicillin 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
67257,Marketed,2020-02-10,02243350,APO-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02243350,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67258,Marketed,2020-02-10,02243351,APO-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02243351,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69723,Marketed,2019-07-03,02245623,APO-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02245623,APO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) APOTEX INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96090,Marketed,2022-03-03,02471671,AURO-AMOXICLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471671,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96091,Marketed,2022-03-03,02471698,AURO-AMOXICLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471698,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96092,Marketed,2022-03-03,02471701,AURO-AMOXICLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02471701,AURO-AMOXICLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) AURO PHARMA INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97300,Marketed,2019-03-01,02482576,SANDOZ AMOXI-CLAV TABLET,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02482576,SANDOZ AMOXI-CLAV TABLET (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97301,Marketed,2019-03-01,02482584,SANDOZ AMOXI-CLAV TABLET,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02482584,SANDOZ AMOXI-CLAV TABLET (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98581,Marketed,2020-07-03,02495910,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495910,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 500 mg per vial and clavulanic acid (potassium clavulanate) 100 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014338,amoxicillin (amoxicillin sodium) 500 mg per vial and clavulanic acid (potassium clavulanate) 100 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98582,Marketed,2020-07-03,02495929,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495929,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 1000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014336,amoxicillin (amoxicillin sodium) 1000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98583,Marketed,2020-07-03,02495937,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02495937,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION (amoxicillin (amoxicillin sodium) 2000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9014337,amoxicillin (amoxicillin sodium) 2000 mg per vial and clavulanic acid (potassium clavulanate) 200 mg per vial powder for solution for injection,8000154,amoxicillin and clavulanic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99763,Marketed,2021-12-24,02508249,JAMP AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508249,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000933,amoxicillin 250 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99764,Marketed,2021-12-24,02508257,JAMP AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508257,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99765,Marketed,2021-12-24,02508265,JAMP AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02508265,JAMP AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99983,Marketed,2022-08-18,02510634,AG-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02510634,AG-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) ANGITA PHARMA INC.,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99984,Marketed,2021-12-31,02510642,AG-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02510642,AG-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) ANGITA PHARMA INC.,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101985,Marketed,2022-11-24,02530694,M-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02530694,M-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) MANTRA PHARMA INC,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
102484,Marketed,2024-02-20,02536021,AMOXICILLIN/CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536021,AMOXICILLIN/CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANIS HEALTH INC,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102485,Marketed,2024-02-20,02536048,AMOXICILLIN/CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536048,AMOXICILLIN/CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) SANIS HEALTH INC,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102526,Marketed,2023-07-10,02536498,PRO-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536498,PRO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) PRO DOC LIMITEE,Active,9000402,amoxicillin 500 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102527,Marketed,2023-07-10,02536501,PRO-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Tablet,Oral,02536501,PRO-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet) PRO DOC LIMITEE,Active,9000823,amoxicillin 875 mg and clavulanic acid (potassium clavulanate) 125 mg oral tablet,8000154,amoxicillin and clavulanic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102817,Marketed,2024-07-22,02539411,JAMP AMOXI CLAV SUSPENSION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539411,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9006261,amoxicillin 200 mg per 5 mL and clavulanic acid (potassium clavulanate) 28.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
102818,Marketed,2024-07-22,02539438,JAMP AMOXI CLAV SUSPENSION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539438,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
102819,Marketed,2024-07-22,02539446,JAMP AMOXI CLAV SUSPENSION,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02539446,JAMP AMOXI CLAV SUSPENSION (amoxicillin (amoxicillin trihydrate) 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9006262,amoxicillin 400 mg per 5 mL and clavulanic acid (potassium clavulanate) 57 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
103081,Marketed,2024-02-01,02542226,M-AMOXI CLAV,2.0,J01CR02,Amoxicillin and beta-lactamase inhibitor,Powder for suspension,Oral,02542226,M-AMOXI CLAV (amoxicillin (amoxicillin trihydrate) 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension) MANTRA PHARMA INC,Active,9000992,amoxicillin 250 mg per 5 mL and clavulanic acid (potassium clavulanate) 62.5 mg per 5 mL oral suspension,8000154,amoxicillin and clavulanic acid,26643006,Oral,385024007,Oral suspension,,,,,
933,Marketed,2020-01-02,00029149,FUNGIZONE,1.0,J02AA01,Amphotericin b,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
65288,Marketed,2012-07-24,02241630,AMBISOME,1.0,J02AA01,Amphotericin b,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
1124,Marketed,2015-07-10,00020885,TEVA-AMPICILLIN,1.0,J01CA01,Ampicillin,Capsule,Oral,00020885,TEVA-AMPICILLIN (ampicillin (ampicillin trihydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9002007,ampicillin 500 mg oral capsule,8001068,ampicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
1125,Marketed,2015-07-10,00020877,TEVA-AMPICILLIN,1.0,J01CA01,Ampicillin,Capsule,Oral,00020877,TEVA-AMPICILLIN (ampicillin (ampicillin trihydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9002005,ampicillin 250 mg oral capsule,8001068,ampicillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
12261,Marketed,2014-05-22,00872644,"AMPICILLIN SODIUM FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",00872644,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
12262,Marketed,2014-05-22,00872652,"AMPICILLIN SODIUM FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",00872652,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
12267,Marketed,2014-05-22,01933345,"AMPICILLIN SODIUM FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",01933345,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
12268,Marketed,2014-05-22,01933353,"AMPICILLIN SODIUM FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",01933353,"AMPICILLIN SODIUM FOR INJECTION, USP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) TEVA CANADA LIMITED",Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37491,Marketed,2019-08-16,02226995,"AMPICILLIN FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,Intravenous,02226995,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37492,Marketed,2019-08-16,02227002,"AMPICILLIN FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02227002,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37493,Marketed,2019-08-16,02227010,"AMPICILLIN FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02227010,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37494,Marketed,2019-08-16,02227029,"AMPICILLIN FOR INJECTION, USP",1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02227029,"AMPICILLIN FOR INJECTION, USP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95004,Marketed,2017-10-20,02462303,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,"Intramuscular,Intravenous",02462303,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002415,ampicillin (ampicillin sodium) 250 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95005,Marketed,2017-10-20,02462311,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02462311,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95006,Marketed,2017-10-20,02462338,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02462338,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95007,Marketed,2017-10-20,02462346,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,Intravenous,02462346,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101968,Marketed,2024-08-02,02530481,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02530481,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002416,ampicillin (ampicillin sodium) 500 mg per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101969,Marketed,2024-08-02,02530503,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,"Intravenous,Intramuscular",02530503,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003279,ampicillin (ampicillin sodium) 1 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101970,Marketed,2024-08-02,02530511,AMPICILLIN SODIUM FOR INJECTION BP,1.0,J01CA01,Ampicillin,Powder for solution,Intravenous,02530511,AMPICILLIN SODIUM FOR INJECTION BP (ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003272,ampicillin (ampicillin sodium) 2 g per vial powder for solution for injection,8001068,ampicillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
76047,Marketed,2006-01-06,02274949,PMS-ANAGRELIDE,1.0,L01XX35,Anagrelide,Capsule,Oral,02274949,PMS-ANAGRELIDE (anagrelide (anagrelide hydrochloride monohydrate) 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9003198,anagrelide (anagrelide hydrochloride) 0.5 mg oral capsule,8001565,anagrelide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
70033,Marketed,2011-06-22,02245913,KINERET,1.0,L04AC03,Anakinra,Solution,Subcutaneous,02245913,KINERET (anakinra 150 mg per mL solution for injection 0.67 mL syringe) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9012892,anakinra 150 mg per mL solution for injection 0.67 mL syringe,8001566,anakinra,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
43395,Marketed,2002-01-25,02224135,ARIMIDEX,1.0,L02BG03,Anastrozole,Tablet,Oral,02224135,ARIMIDEX (anastrozole 1 mg oral tablet) ASTRAZENECA CANADA INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80614,Marketed,2012-10-25,02320738,PMS-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02320738,PMS-ANASTROZOLE (anastrozole 1 mg oral tablet) PHARMASCIENCE INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82412,Marketed,2012-07-26,02338467,SANDOZ ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02338467,SANDOZ ANASTROZOLE (anastrozole 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82471,Marketed,2012-10-25,02339080,JAMP-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02339080,JAMP-ANASTROZOLE (anastrozole 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83640,Marketed,2014-10-23,02351218,ACH-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02351218,ACH-ANASTROZOLE (anastrozole 1 mg oral tablet) ACCORD HEALTHCARE INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85053,Marketed,2012-10-25,02365650,TARO-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02365650,TARO-ANASTROZOLE (anastrozole 1 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85968,Marketed,2012-10-25,02374420,APO-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02374420,APO-ANASTROZOLE (anastrozole 1 mg oral tablet) APOTEX INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86544,Marketed,2012-10-25,02379562,MAR-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02379562,MAR-ANASTROZOLE (anastrozole 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87753,Marketed,2025-12-29,02392259,RIVA-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02392259,RIVA-ANASTROZOLE (anastrozole 1 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87775,Marketed,2013-01-15,02392488,BIO-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02392488,BIO-ANASTROZOLE (anastrozole 1 mg oral tablet) BIOMED PHARMA,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87879,Marketed,2013-11-26,02393573,MINT-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02393573,MINT-ANASTROZOLE (anastrozole 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88004,Marketed,2020-01-21,02394898,TEVA-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02394898,TEVA-ANASTROZOLE (anastrozole 1 mg oral tablet) TEVA CANADA LIMITED,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88072,Marketed,2025-10-30,02395649,PRO-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02395649,PRO-ANASTROZOLE (anastrozole 1 mg oral tablet) PRO DOC LIMITEE,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90247,Marketed,2015-02-03,02417855,NAT-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02417855,NAT-ANASTROZOLE (anastrozole 1 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92706,Marketed,2015-07-22,02442736,ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02442736,ANASTROZOLE (anastrozole 1 mg oral tablet) SANIS HEALTH INC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101913,Marketed,2025-05-29,02529904,ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02529904,ANASTROZOLE (anastrozole 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102307,Marketed,2023-07-27,02534118,AG-ANASTROZOLE,1.0,L02BG03,Anastrozole,Tablet,Oral,02534118,AG-ANASTROZOLE (anastrozole 1 mg oral tablet) ANGITA PHARMA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102927,Marketed,2025-09-29,02540584,JAMP ANASTROZOLE TABLETS,1.0,L02BG03,Anastrozole,Tablet,Oral,02540584,JAMP ANASTROZOLE TABLETS (anastrozole 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104259,Marketed,2025-07-22,02553686,AG-ANASTROZOLE TABLETS,1.0,L02BG03,Anastrozole,Tablet,Oral,02553686,AG-ANASTROZOLE TABLETS (anastrozole 1 mg oral tablet) ANGITA PHARMA INC.,Active,9002909,anastrozole 1 mg oral tablet,8001101,anastrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102725,Marketed,2024-05-27,02538539,ONDEXXYA,1.0,V03AB38,Andexanet alfa,Powder for solution,Intravenous,02538539,ONDEXXYA (andexanet alfa 200 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9015048,andexanet alfa 200 mg per vial powder for solution for injection,8002508,andexanet alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
63884,Marketed,2005-03-31,02240344,SIALOR,1.0,A16AX02,Anethole trithione,Tablet,Oral,02240344,SIALOR (anethole trithione 25 mg oral tablet) PHARMASCIENCE INC,Active,9003505,anethole trithione 25 mg oral tablet,8001567,anethole trithione,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81644,Marketed,2010-01-25,02330695,ERAXIS,1.0,J02AX06,Anidulafungin,Powder for solution,Intravenous,02330695,ERAXIS (anidulafungin 100 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9004633,anidulafungin 100 mg per vial powder for solution for injection,8001170,anidulafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101194,Marketed,2022-03-01,02522845,SAPHNELO,1.0,L04AG11,Anifrolumab,Solution,Intravenous,02522845,SAPHNELO (anifrolumab 300 mg per 2 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014672,anifrolumab 300 mg per 2 mL solution for injection vial,8002411,anifrolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
43218,Marketed,2023-03-24,02217457,STANDARDIZED CAT HAIR AP,1.0,V01AA11,Animals,Solution,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
62882,Marketed,1999-04-19,02239410,ALLERGENIC EXTRACT-STANDARDIZED CAT HAIR,1.0,V01AA11,Animals,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
60637,Marketed,2000-02-18,02237315,PEPTO-BISMOL CHEWABLES,2.0,A02AX,"Antacids, other combinations",Tablet (chewable),Oral,02237315,PEPTO-BISMOL CHEWABLES (bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet) PROCTER & GAMBLE INC,Active,9004592,bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet,8001706,bismuth subsalicylate and calcium carbonate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
87472,Marketed,2013-11-20,02389215,STOMACH RELIEF CHEWABLE TABLETS,2.0,A02AX,"Antacids, other combinations",Tablet (chewable),Oral,02389215,STOMACH RELIEF CHEWABLE TABLETS (bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet) GUARDIAN DRUG COMPANY INC,Active,9004592,bismuth subsalicylate 262 mg and calcium carbonate 350 mg chewable tablet,8001706,bismuth subsalicylate and calcium carbonate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
78787,Marketed,2022-07-11,02302551,WINRHO SDF,1.0,J06BB01,Anti-d (rh) immunoglobulin,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,
78788,Marketed,2022-07-11,02302578,WINRHO SDF,1.0,J06BB01,Anti-d (rh) immunoglobulin,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,
104466,Marketed,2025-06-10,02555948,REBYOTA,1.0,A07FA,Antidiarrheal microorganisms,Suspension,Rectal,02555948,REBYOTA (fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag) FERRING INC,Active,9015235,fecal microbiota 5e10 cfu per mL rectal suspension 150 mL bag,8002548,fecal microbiota,37161004,Rectal,385188006,Rectal suspension,732982009,Bag,,,
76500,Marketed,2023-09-11,02279401,REVATIO,1.0,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02279401,REVATIO (sildenafil (sildenafil citrate) 20 mg oral tablet) BGP PHARMA ULC,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80498,Marketed,2017-11-21,02319500,TEVA-SILDENAFIL R,1.0,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02319500,TEVA-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82711,Marketed,2023-09-11,02341611,REVATIO,1.0,C02KX,Antihypertensives for pulmonary arterial hypertension,Solution,Intravenous,02341611,REVATIO (sildenafil (sildenafil citrate) 10 mg per 12.5 mL solution for injection vial) BGP PHARMA ULC,Active,9001321,sildenafil (sildenafil citrate) 10 mg per 12.5 mL solution for injection vial,8000268,sildenafil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
89674,Marketed,2014-11-14,02412179,PMS-SILDENAFIL R,1.0,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02412179,PMS-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95846,Marketed,2021-02-08,02469669,JAMP-SILDENAFIL R,1.0,C02KX,Antihypertensives for pulmonary arterial hypertension,Tablet,Oral,02469669,JAMP-SILDENAFIL R (sildenafil (sildenafil citrate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001153,sildenafil (sildenafil citrate) 20 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10025,Marketed,2019-08-16,00701785,OPTIMYXIN,2.0,S03AA30,"Antiinfectives, combinations",Drops,"Ophthalmic,Otic",00701785,OPTIMYXIN (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) EURO-PHARM INTERNATIONAL CANADA INC,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,
62611,Marketed,2007-04-16,02239155,POLYSPORIN PLUS PAIN RELIEF EAR DROPS,2.0,S02AA30,"Antiinfectives, combinations",Drops,Otic,02239155,POLYSPORIN PLUS PAIN RELIEF EAR DROPS (lidocaine hydrochloride 50 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL otic drops) JOHNSON & JOHNSON INC,Active,9013889,lidocaine hydrochloride 50 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL otic drops,8002244,lidocaine and polymyxin B,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
62612,Marketed,2007-01-18,02239156,POLYSPORIN EYE AND EAR DROPS STERILE,2.0,S03AA30,"Antiinfectives, combinations",Drops,"Ophthalmic,Otic",02239156,POLYSPORIN EYE AND EAR DROPS STERILE (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) JOHNSON & JOHNSON INC,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,
104107,Marketed,2025-04-09,02552418,SOOTHE ANTIBIOTIC DROPS,2.0,S03AA30,"Antiinfectives, combinations",Drops,"Ophthalmic,Otic",02552418,SOOTHE ANTIBIOTIC DROPS (gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops) BAUSCH & LOMB INC,Active,9013881,gramicidin 0.025 mg per mL and polymyxin B (polymyxin B sulfate) 10000 unit per mL ophthalmic/otic drops,8002242,gramicidin and polymyxin B,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,
100865,Marketed,2021-09-13,02519380,MYINFLA,1.0,M01,Antiinflammatory and antirheumatic products,Tablet (extended-release),Oral,02519380,MYINFLA (colchicine 0.5 mg prolonged-release oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014595,colchicine 0.5 mg prolonged-release oral tablet,8000047,colchicine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
55838,Marketed,2006-08-23,02234470,ATGAM,1.0,L04AA03,Antilymphocyte immunoglobulin (horse),Solution,Intravenous,02234470,ATGAM (anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013762,anti-thymocyte immunoglobulin equine 250 mg per 5 mL solution for injection ampoule,8002217,anti-thymocyte immunoglobulin equine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
103146,Marketed,2024-10-16,02542943,ASPARLAS,1.0,L01,Antineoplastic agents,Solution,Intravenous,02542943,ASPARLAS (calaspargase pegol 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9015107,calaspargase pegol 3750 unit per 5 mL solution for injection vial,8002516,calaspargase pegol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
61169,Marketed,2022-01-28,02237810,ANTITHROMBIN III NF,1.0,B01AB02,Antithrombin,"Kit,Powder for solution",Intravenous,02237810,ANTITHROMBIN III NF (antithrombin III human 900-1100 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014075,antithrombin III human 900-1100 unit per vial powder for solution for injection with diluent solution,8002274,antithrombin III human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
61170,Marketed,2021-04-30,02237811,ANTITHROMBIN III NF,1.0,B01AB02,Antithrombin,"Powder for solution,Kit",Intravenous,02237811,ANTITHROMBIN III NF (antithrombin III human 450-550 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014074,antithrombin III human 450-550 unit per vial powder for solution for injection with diluent solution,8002274,antithrombin III human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
71005,Marketed,2014-05-06,02246805,THYMOGLOBULIN,1.0,L04AA04,Antithymocyte immunoglobulin (rabbit),Powder for solution,Intravenous,02246805,THYMOGLOBULIN (anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013763,anti-thymocyte immunoglobulin rabbit 25 mg per vial powder for solution for injection,8002218,anti-thymocyte immunoglobulin rabbit,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98706,Marketed,2020-09-21,02497220,CABENUVA,2.0,J05AR,"Antivirals for treatment of hiv infections, combinations","Kit,Suspension (extended-release)",Intramuscular,02497220,CABENUVA (cabotegravir 400 mg per 2 mL prolonged-release suspension for injection vial with rilpivirine 600 mg per 2 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9014354,cabotegravir 400 mg per 2 mL prolonged-release suspension for injection vial with rilpivirine 600 mg per 2 mL prolonged-release suspension for injection vial,8002342,cabotegravir and rilpivirine,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
98709,Marketed,2020-09-21,02497247,CABENUVA,2.0,J05AR,"Antivirals for treatment of hiv infections, combinations","Kit,Suspension (extended-release)",Intramuscular,02497247,CABENUVA (cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial with rilpivirine 900 mg per 3 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9014355,cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial with rilpivirine 900 mg per 3 mL prolonged-release suspension for injection vial,8002342,cabotegravir and rilpivirine,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
96913,Marketed,2018-07-27,02478374,ERLEADA,1.0,L02BB05,Apalutamide,Tablet,Oral,02478374,ERLEADA (apalutamide 60 mg oral tablet) JANSSEN INC,Active,9013407,apalutamide 60 mg oral tablet,8002010,apalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102889,Marketed,2023-11-01,02540185,ERLEADA,1.0,L02BB05,Apalutamide,Tablet,Oral,02540185,ERLEADA (apalutamide 240 mg oral tablet) JANSSEN INC,Active,9014937,apalutamide 240 mg oral tablet,8002010,apalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86287,Marketed,2012-02-01,02377233,ELIQUIS,1.0,B01AF02,Apixaban,Tablet,Oral,02377233,ELIQUIS (apixaban 2.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88264,Marketed,2012-12-21,02397714,ELIQUIS,1.0,B01AF02,Apixaban,Tablet,Oral,02397714,ELIQUIS (apixaban 5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97524,Marketed,2023-09-22,02484994,TEVA-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02484994,TEVA-APIXABAN (apixaban 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97527,Marketed,2023-09-22,02485001,TEVA-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02485001,TEVA-APIXABAN (apixaban 5 mg oral tablet) TEVA CANADA LIMITED,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97697,Marketed,2022-11-28,02486806,AURO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02486806,AURO-APIXABAN (apixaban 2.5 mg oral tablet) AURO PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97698,Marketed,2022-11-28,02486814,AURO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02486814,AURO-APIXABAN (apixaban 5 mg oral tablet) AURO PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97756,Marketed,2022-06-20,02487381,APO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02487381,APO-APIXABAN (apixaban 2.5 mg oral tablet) APOTEX INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97757,Marketed,2022-06-20,02487403,APO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02487403,APO-APIXABAN (apixaban 5 mg oral tablet) APOTEX INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97786,Marketed,2022-09-27,02487713,ACH-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02487713,ACH-APIXABAN (apixaban 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97787,Marketed,2022-09-27,02487721,ACH-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02487721,ACH-APIXABAN (apixaban 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97930,Marketed,2022-09-22,02489228,SANDOZ APIXABAN SDZ,1.0,B01AF02,Apixaban,Tablet,Oral,02489228,SANDOZ APIXABAN SDZ (apixaban 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97931,Marketed,2022-09-22,02489236,SANDOZ APIXABAN SDZ,1.0,B01AF02,Apixaban,Tablet,Oral,02489236,SANDOZ APIXABAN SDZ (apixaban 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98239,Marketed,2022-09-21,02492369,MAR-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02492369,MAR-APIXABAN (apixaban 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98240,Marketed,2022-09-21,02492377,MAR-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02492377,MAR-APIXABAN (apixaban 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98281,Marketed,2022-09-21,02492814,NAT-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02492814,NAT-APIXABAN (apixaban 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98282,Marketed,2022-09-21,02492822,NAT-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02492822,NAT-APIXABAN (apixaban 5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98535,Marketed,2023-04-17,02495430,MINT-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02495430,MINT-APIXABAN (apixaban 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98536,Marketed,2022-10-28,02495449,MINT-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02495449,MINT-APIXABAN (apixaban 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99968,Marketed,2022-09-21,02510464,TARO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02510464,TARO-APIXABAN (apixaban 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99969,Marketed,2022-09-21,02510472,TARO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02510472,TARO-APIXABAN (apixaban 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101451,Marketed,2024-06-04,02525518,RIVA APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02525518,RIVA APIXABAN (apixaban 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101452,Marketed,2024-06-04,02525526,RIVA APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02525526,RIVA APIXABAN (apixaban 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101517,Marketed,2022-10-05,02526050,NRA-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02526050,NRA-APIXABAN (apixaban 2.5 mg oral tablet) NORA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101519,Marketed,2022-10-05,02526069,NRA-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02526069,NRA-APIXABAN (apixaban 5 mg oral tablet) NORA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101724,Marketed,2022-09-21,02527979,BIO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02527979,BIO-APIXABAN (apixaban 2.5 mg oral tablet) BIOMED PHARMA,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101725,Marketed,2022-09-21,02527987,BIO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02527987,BIO-APIXABAN (apixaban 5 mg oral tablet) BIOMED PHARMA,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101810,Marketed,2022-09-20,02528924,JAMP APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02528924,JAMP APIXABAN (apixaban 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101811,Marketed,2022-09-20,02528932,JAMP APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02528932,JAMP APIXABAN (apixaban 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101820,Marketed,2022-09-21,02529009,M-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02529009,M-APIXABAN (apixaban 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101821,Marketed,2022-09-21,02529017,M-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02529017,M-APIXABAN (apixaban 5 mg oral tablet) MANTRA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101914,Marketed,2022-10-28,02529912,AG-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02529912,AG-APIXABAN (apixaban 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101915,Marketed,2022-10-28,02529920,AG-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02529920,AG-APIXABAN (apixaban 5 mg oral tablet) ANGITA PHARMA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101986,Marketed,2022-11-01,02530708,APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02530708,APIXABAN (apixaban 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101987,Marketed,2022-11-01,02530716,APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02530716,APIXABAN (apixaban 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101988,Marketed,2022-09-26,02530724,PRO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02530724,PRO-APIXABAN (apixaban 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101990,Marketed,2022-09-26,02530732,PRO-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02530732,PRO-APIXABAN (apixaban 5 mg oral tablet) PRO DOC LIMITEE,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103555,Marketed,2024-04-22,02546884,NRA-APIXABAN TABLETS,1.0,B01AF02,Apixaban,Tablet,Oral,02546884,NRA-APIXABAN TABLETS (apixaban 2.5 mg oral tablet) NORA PHARMA INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103556,Marketed,2024-04-22,02546892,NRA-APIXABAN TABLETS,1.0,B01AF02,Apixaban,Tablet,Oral,02546892,NRA-APIXABAN TABLETS (apixaban 5 mg oral tablet) NORA PHARMA INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103770,Marketed,2024-11-06,02548879,APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02548879,APIXABAN (apixaban 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103771,Marketed,2024-11-06,02548887,APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02548887,APIXABAN (apixaban 5 mg oral tablet) SANIS HEALTH INC,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104255,Marketed,2025-06-05,02553635,NB-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02553635,NB-APIXABAN (apixaban 2.5 mg oral tablet) NB PHARMA INC.,Active,9004980,apixaban 2.5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104256,Marketed,2025-06-05,02553643,NB-APIXABAN,1.0,B01AF02,Apixaban,Tablet,Oral,02553643,NB-APIXABAN (apixaban 5 mg oral tablet) NB PHARMA INC.,Active,9005143,apixaban 5 mg oral tablet,8001147,apixaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12993,Marketed,2023-05-19,00888354,IOPIDINE,1.0,S01EA03,Apraclonidine,Solution,Ophthalmic,00888354,IOPIDINE (apraclonidine (apraclonidine hydrochloride) 1 % ophthalmic drops) ESSENTIAL PHARMA SWITZERLAND GMBH,Active,9002418,apraclonidine (apraclonidine hydrochloride) 1 % ophthalmic drops,8001432,apraclonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18228,Marketed,2023-05-19,02076306,IOPIDINE,1.0,S01EA03,Apraclonidine,Solution,Ophthalmic,02076306,IOPIDINE (apraclonidine (apraclonidine hydrochloride) 0.5 % ophthalmic drops) ESSENTIAL PHARMA SWITZERLAND GMBH,Active,9002740,apraclonidine (apraclonidine hydrochloride) 0.5 % ophthalmic drops,8001432,apraclonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91864,Marketed,2022-01-10,02434318,OTEZLA,3.0,L04AA32,Apremilast,Tablet,Oral,02434318,OTEZLA (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) AMGEN CANADA INC,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91866,Marketed,2021-01-18,02434334,OTEZLA,1.0,L04AA32,Apremilast,Tablet,Oral,02434334,OTEZLA (apremilast 30 mg oral tablet) AMGEN CANADA INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100820,Marketed,2022-11-14,02518910,GLN-APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02518910,GLN-APREMILAST (apremilast 30 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101093,Marketed,2022-11-14,02521733,PMS-APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02521733,PMS-APREMILAST (apremilast 30 mg oral tablet) PHARMASCIENCE INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101314,Marketed,2022-12-07,02524104,AURO-APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02524104,AURO-APREMILAST (apremilast 30 mg oral tablet) AURO PHARMA INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101316,Marketed,2023-04-17,02524120,AURO-APREMILAST,3.0,L04AA32,Apremilast,Tablet,Oral,02524120,AURO-APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) AURO PHARMA INC,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101815,Marketed,2022-11-14,02528959,JAMP APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02528959,JAMP APREMILAST (apremilast 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101816,Marketed,2022-11-14,02528967,JAMP APREMILAST,3.0,L04AA32,Apremilast,Tablet,Oral,02528967,JAMP APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101827,Marketed,2022-11-18,02529084,SANDOZ APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02529084,SANDOZ APREMILAST (apremilast 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101828,Marketed,2024-01-30,02529092,SANDOZ APREMILAST,3.0,L04AA32,Apremilast,Tablet,Oral,02529092,SANDOZ APREMILAST (apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012893,apremilast 10 mg oral tablet with apremilast 20 mg oral tablet with apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102693,Marketed,2023-09-28,02538180,APO-APREMILAST,1.0,L04AA32,Apremilast,Tablet,Oral,02538180,APO-APREMILAST (apremilast 30 mg oral tablet) APOTEX INC,Active,9005619,apremilast 30 mg oral tablet,8001568,apremilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78410,Marketed,2007-09-24,02298791,EMEND,1.0,A04AD12,Aprepitant,Capsule,Oral,02298791,EMEND (aprepitant 80 mg oral capsule) MERCK CANADA INC,Active,9004333,aprepitant 80 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
78411,Marketed,2007-09-24,02298805,EMEND,1.0,A04AD12,Aprepitant,Capsule,Oral,02298805,EMEND (aprepitant 125 mg oral capsule) MERCK CANADA INC,Active,9004332,aprepitant 125 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
78412,Marketed,2007-09-24,02298813,EMEND TRI-PACK,2.0,A04AD12,Aprepitant,"Capsule,Kit",Oral,02298813,EMEND TRI-PACK (aprepitant 80 mg oral capsule with aprepitant 125 mg oral capsule) MERCK CANADA INC,Active,9012894,aprepitant 80 mg oral capsule with aprepitant 125 mg oral capsule,8001433,aprepitant,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103778,Marketed,2025-01-29,02548968,ARGATROBAN,1.0,B01AE03,Argatroban,Solution,Intravenous,02548968,ARGATROBAN (argatroban 50 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9015163,argatroban 50 mg per 50 mL solution for injection vial,8001434,argatroban,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
106451,Marketed,2026-01-07,02561557,ARGATROBAN FOR INJECTION,1.0,B01AE03,Argatroban,Solution,Intravenous,,,,,,,,,,,,,,,,
80782,Marketed,2018-03-19,02322374,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322374,ABILIFY (aripiprazole 2 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80783,Marketed,2018-04-04,02322382,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322382,ABILIFY (aripiprazole 5 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80784,Marketed,2018-07-13,02322390,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322390,ABILIFY (aripiprazole 10 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80785,Marketed,2018-06-05,02322404,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322404,ABILIFY (aripiprazole 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80786,Marketed,2018-11-02,02322412,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322412,ABILIFY (aripiprazole 20 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80790,Marketed,2018-03-19,02322455,ABILIFY,1.0,N05AX12,Aripiprazole,Tablet,Oral,02322455,ABILIFY (aripiprazole 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90545,Marketed,2014-03-27,02420864,ABILIFY MAINTENA,1.0,N05AX12,Aripiprazole,"Powder for suspension, sustained-release,Kit",Intramuscular,02420864,ABILIFY MAINTENA (aripiprazole 300 mg per vial powder for prolonged-release suspension for injection with diluent solution) OTSUKA PHARMACEUTICAL CO LTD,Active,9006493,aripiprazole 300 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000389,aripiprazole,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
90546,Marketed,2014-03-27,02420872,ABILIFY MAINTENA,1.0,N05AX12,Aripiprazole,"Powder for suspension, sustained-release,Kit",Intramuscular,02420872,ABILIFY MAINTENA (aripiprazole 400 mg per vial powder for prolonged-release suspension for injection with diluent solution) OTSUKA PHARMACEUTICAL CO LTD,Active,9006494,aripiprazole 400 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000389,aripiprazole,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
93386,Marketed,2025-11-28,02448173,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448173,AG-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) ANGITA PHARMA INC.,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93387,Marketed,2025-11-28,02448181,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448181,AG-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93388,Marketed,2025-11-28,02448203,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448203,AG-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93389,Marketed,2025-11-28,02448211,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448211,AG-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) ANGITA PHARMA INC.,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93390,Marketed,2025-11-28,02448238,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448238,AG-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93391,Marketed,2025-11-28,02448246,AG-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02448246,AG-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) ANGITA PHARMA INC.,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94732,Marketed,2018-07-10,02460025,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460025,AURO-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) AURO PHARMA INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94733,Marketed,2018-07-10,02460033,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460033,AURO-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) AURO PHARMA INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94734,Marketed,2018-07-10,02460041,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460041,AURO-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) AURO PHARMA INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94735,Marketed,2018-07-10,02460068,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460068,AURO-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) AURO PHARMA INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94736,Marketed,2018-07-10,02460076,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460076,AURO-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) AURO PHARMA INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94737,Marketed,2018-07-10,02460084,AURO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02460084,AURO-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) AURO PHARMA INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95498,Marketed,2018-07-10,02466635,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466635,PMS-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) PHARMASCIENCE INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95499,Marketed,2018-07-10,02466643,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466643,PMS-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) PHARMASCIENCE INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95500,Marketed,2018-07-10,02466651,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466651,PMS-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) PHARMASCIENCE INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95501,Marketed,2018-07-10,02466678,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466678,PMS-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) PHARMASCIENCE INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95503,Marketed,2018-07-10,02466686,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466686,PMS-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) PHARMASCIENCE INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95504,Marketed,2018-07-10,02466694,PMS-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02466694,PMS-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) PHARMASCIENCE INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96019,Marketed,2018-04-10,02471086,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471086,APO-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) APOTEX INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96020,Marketed,2018-04-10,02471094,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471094,APO-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) APOTEX INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96021,Marketed,2018-04-10,02471108,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471108,APO-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) APOTEX INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96022,Marketed,2018-04-10,02471116,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471116,APO-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) APOTEX INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96023,Marketed,2018-04-10,02471124,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471124,APO-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) APOTEX INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96024,Marketed,2018-04-10,02471132,APO-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02471132,APO-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) APOTEX INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96153,Marketed,2024-01-23,02472201,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472201,NRA-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) NORA PHARMA INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96154,Marketed,2024-01-23,02472228,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472228,NRA-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) NORA PHARMA INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96155,Marketed,2024-01-23,02472244,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472244,NRA-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) NORA PHARMA INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96156,Marketed,2024-01-23,02472252,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472252,NRA-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) NORA PHARMA INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96157,Marketed,2024-01-23,02472260,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472260,NRA-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) NORA PHARMA INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96158,Marketed,2024-01-23,02472279,NRA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02472279,NRA-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) NORA PHARMA INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96304,Marketed,2018-07-10,02473658,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473658,SANDOZ ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96305,Marketed,2018-07-10,02473666,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473666,SANDOZ ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96306,Marketed,2018-07-10,02473674,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473674,SANDOZ ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96307,Marketed,2018-07-10,02473682,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473682,SANDOZ ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96308,Marketed,2018-07-10,02473690,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473690,SANDOZ ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96309,Marketed,2018-07-10,02473704,SANDOZ ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02473704,SANDOZ ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96994,Marketed,2018-08-22,02479346,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479346,RIVA-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96995,Marketed,2018-08-22,02479354,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479354,RIVA-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96996,Marketed,2018-08-22,02479362,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479362,RIVA-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96997,Marketed,2018-08-22,02479370,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479370,RIVA-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96998,Marketed,2018-08-22,02479389,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479389,RIVA-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96999,Marketed,2018-08-22,02479397,RIVA-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02479397,RIVA-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97392,Marketed,2020-05-04,02483556,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483556,MINT-ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97393,Marketed,2020-04-14,02483564,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483564,MINT-ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97394,Marketed,2020-04-14,02483572,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483572,MINT-ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97395,Marketed,2020-04-14,02483580,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483580,MINT-ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97396,Marketed,2020-04-14,02483599,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483599,MINT-ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97397,Marketed,2020-04-14,02483602,MINT-ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02483602,MINT-ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97811,Marketed,2019-07-09,02488000,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488000,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) PRO DOC LIMITEE,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97812,Marketed,2019-07-09,02488019,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488019,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) PRO DOC LIMITEE,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97813,Marketed,2019-07-09,02488027,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488027,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) PRO DOC LIMITEE,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97814,Marketed,2019-07-09,02488035,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488035,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) PRO DOC LIMITEE,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97815,Marketed,2019-07-09,02488043,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488043,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) PRO DOC LIMITEE,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97816,Marketed,2019-07-09,02488051,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02488051,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) PRO DOC LIMITEE,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99604,Marketed,2021-04-23,02506688,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506688,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SANIS HEALTH INC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99606,Marketed,2021-04-23,02506718,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506718,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SANIS HEALTH INC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99607,Marketed,2021-04-23,02506726,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506726,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SANIS HEALTH INC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99609,Marketed,2021-04-23,02506734,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506734,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SANIS HEALTH INC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99611,Marketed,2021-04-23,02506750,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506750,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SANIS HEALTH INC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99613,Marketed,2021-04-23,02506785,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02506785,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SANIS HEALTH INC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102326,Marketed,2023-07-20,02534320,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534320,ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102327,Marketed,2023-07-20,02534339,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534339,ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102328,Marketed,2023-07-20,02534347,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534347,ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102329,Marketed,2023-07-20,02534355,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534355,ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102330,Marketed,2023-07-20,02534363,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534363,ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102331,Marketed,2023-07-20,02534371,ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02534371,ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104212,Marketed,2025-11-27,02553163,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553163,JAMP ARIPIPRAZOLE (aripiprazole 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001287,aripiprazole 2 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104213,Marketed,2025-11-27,02553171,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553171,JAMP ARIPIPRAZOLE (aripiprazole 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001289,aripiprazole 5 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104214,Marketed,2025-11-27,02553198,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553198,JAMP ARIPIPRAZOLE (aripiprazole 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001284,aripiprazole 10 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104215,Marketed,2025-11-27,02553201,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553201,JAMP ARIPIPRAZOLE (aripiprazole 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001285,aripiprazole 15 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104216,Marketed,2025-11-27,02553228,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553228,JAMP ARIPIPRAZOLE (aripiprazole 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001286,aripiprazole 20 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104217,Marketed,2025-11-27,02553236,JAMP ARIPIPRAZOLE,1.0,N05AX12,Aripiprazole,Tablet,Oral,02553236,JAMP ARIPIPRAZOLE (aripiprazole 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001288,aripiprazole 30 mg oral tablet,8000389,aripiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104339,Marketed,2025-08-15,02554550,SOLUFY,1.0,N05AX12,Aripiprazole,Solution,Oral,02554550,SOLUFY (aripiprazole 1 mg per mL oral solution) ORIMED PHARMA INC,Active,9015243,aripiprazole 1 mg per mL oral solution,8000389,aripiprazole,26643006,Oral,385023001,Oral solution,,,,,
104340,Marketed,2025-03-20,02554569,ABILIFY ASIMTUFII,1.0,N05AX12,Aripiprazole,Suspension (extended-release),Intramuscular,02554569,ABILIFY ASIMTUFII (aripiprazole 720 mg per 2.4 mL prolonged-release suspension for injection syringe) OTSUKA PHARMACEUTICAL CO LTD,Active,9015183,aripiprazole 720 mg per 2.4 mL prolonged-release suspension for injection syringe,8000389,aripiprazole,738984000,Injection,420873008,Prolonged-release suspension for injection,733020007,Syringe,,,
104341,Marketed,2025-03-20,02554577,ABILIFY ASIMTUFII,1.0,N05AX12,Aripiprazole,Suspension (extended-release),Intramuscular,02554577,ABILIFY ASIMTUFII (aripiprazole 960 mg per 3.2 mL prolonged-release suspension for injection syringe) OTSUKA PHARMACEUTICAL CO LTD,Active,9015184,aripiprazole 960 mg per 3.2 mL prolonged-release suspension for injection syringe,8000389,aripiprazole,738984000,Injection,420873008,Prolonged-release suspension for injection,733020007,Syringe,,,
97753,Marketed,2020-01-31,02487357,ARSENIC TRIOXIDE SOLUTION FOR INJECTION,1.0,L01XX27,Arsenic trioxide,Solution,Intravenous,02487357,ARSENIC TRIOXIDE SOLUTION FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) PHEBRA PTY LTD,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98274,Marketed,2019-12-20,02492768,ARSENIC TRIOXIDE FOR INJECTION,1.0,L01XX27,Arsenic trioxide,Solution,Intravenous,02492768,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100263,Marketed,2022-03-11,02513420,ARSENIC TRIOXIDE FOR INJECTION,1.0,L01XX27,Arsenic trioxide,Solution,Intravenous,02513420,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104322,Marketed,2025-05-27,02554364,ARSENIC TRIOXIDE FOR INJECTION,1.0,L01XX27,Arsenic trioxide,Solution,Intravenous,02554364,ARSENIC TRIOXIDE FOR INJECTION (arsenic trioxide 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014217,arsenic trioxide 10 mg per 10 mL solution for injection vial,8001887,arsenic trioxide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
16508,Marketed,2001-09-20,01988530,ULTRACAINE D-S INJECTION,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,01988530,ULTRACAINE D-S INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.005 mg per mL solution for injection 1.7 mL cartridge) HANSAMED LIMITED,Active,9014080,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
16511,Marketed,2001-05-22,01988557,ULTRACAINE D-S FORTE INJECTION,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,01988557,ULTRACAINE D-S FORTE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.01 mg per mL solution for injection 1.7 mL cartridge) HANSAMED LIMITED,Active,9014081,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine hydrochloride) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
16850,Marketed,1994-12-31,02123398,SEPTANEST SP,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02123398,SEPTANEST SP (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
16851,Marketed,1994-12-31,02123371,SEPTANEST N,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02123371,SEPTANEST N (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) SEPTODONT,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
72840,Marketed,2004-01-29,02248488,"4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML)",2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02248488,"4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014079,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.8 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
72841,Marketed,2004-01-29,02248489,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML)",2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02248489,"4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014077,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
82513,Marketed,2023-05-18,02339536,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02339536,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
82514,Marketed,2023-05-18,02339544,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02339544,ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
84694,Marketed,2023-05-18,02361906,"ORABLOC 1:200,000",2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02361906,"ORABLOC 1:200,000 (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.",Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
84695,Marketed,2023-05-18,02361914,"ORABLOC 1:100,000",2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02361914,"ORABLOC 1:100,000 (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) PIERREL S.P.A.",Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
86711,Marketed,2012-04-13,02381311,POSICAINE N,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02381311,POSICAINE N (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014076,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
86712,Marketed,2012-04-13,02381338,POSICAINE SP,2.0,N01BB58,"Articaine, combinations",Solution,Block/infiltration,02381338,POSICAINE SP (articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014078,articaine hydrochloride 40 mg per mL and epinephrine (epinephrine bitartrate) 0.01 mg per mL solution for injection 1.7 mL cartridge,8001888,articaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
793,Marketed,2023-04-19,00000809,ALCON TEARS 0.5%,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,00000809,ALCON TEARS 0.5% (hypromellose 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9001644,hypromellose 0.5 % ophthalmic drops,8001484,hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
794,Marketed,2023-04-19,00000817,ALCON TEARS 1%,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,00000817,ALCON TEARS 1% (hypromellose 1 % ophthalmic drops) ALCON CANADA INC,Active,9001660,hypromellose 1 % ophthalmic drops,8001484,hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
9820,Marketed,2024-07-09,00210889,REFRESH LACRI-LUBE,2.0,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,00210889,REFRESH LACRI-LUBE (mineral oil heavy 42.5 % and white petrolatum 57.3 % ophthalmic ointment) ABBVIE CORPORATION,Active,9013716,mineral oil heavy 42.5 % and white petrolatum 57.3 % ophthalmic ointment,8002207,mineral oil heavy and white petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
10032,Marketed,2019-09-16,00743445,TEARS NATURALE II,2.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,00743445,TEARS NATURALE II (dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9002182,dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops,8002116,dextran 70 and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
11138,Marketed,2024-05-23,00870153,REFRESH CELLUVISC,1.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,00870153,REFRESH CELLUVISC (carboxymethylcellulose sodium 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9013777,carboxymethylcellulose sodium 1 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
13167,Marketed,2019-10-25,01943308,TEARS NATURALE FREE,2.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,01943308,TEARS NATURALE FREE (dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9002182,dextran 70 0.1 % and hypromellose 0.3 % ophthalmic drops,8002116,dextran 70 and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
15177,Marketed,2003-04-21,02007967,AMO ENDOSOL SOLUTION,6.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Intraocular,,,,,,,,,,,,,,,,
16777,Marketed,2015-05-29,02125706,SOOTHE NIGHT TIME,2.0,S01XA20,Artificial tears and other indifferent preparations.,Ointment,Ophthalmic,02125706,SOOTHE NIGHT TIME (mineral oil heavy 20 % and petrolatum 80 % ophthalmic ointment) BAUSCH & LOMB INC,Active,9013714,mineral oil heavy 20 % and petrolatum 80 % ophthalmic ointment,8002206,mineral oil heavy and petrolatum,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
18791,Marketed,2024-10-16,02138670,REFRESH,1.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02138670,REFRESH (polyvinyl alcohol 1.4 % ophthalmic drops) ABBVIE CORPORATION,Active,9001952,polyvinyl alcohol 1.4 % ophthalmic drops,8002073,polyvinyl alcohol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
27183,Marketed,2025-02-21,02049260,REFRESH PLUS,1.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02049260,REFRESH PLUS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
50289,Marketed,2024-09-17,02231008,REFRESH TEARS,1.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02231008,REFRESH TEARS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
50599,Marketed,2019-10-23,02231289,GENTEAL,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02231289,GENTEAL (hypromellose 3 mg per mL ophthalmic drops) ALCON CANADA INC,Active,9003170,hypromellose 3 mg per mL ophthalmic drops,8001484,hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
65756,Marketed,2021-11-18,02242082,PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS,1.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02242082,PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS (carboxymethylcellulose sodium 0.25 % ophthalmic drops) MEDTECH PRODUCTS INC,Active,9013771,carboxymethylcellulose sodium 0.25 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
66081,Marketed,2015-05-20,02242370,SOOTHE DRY EYES,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02242370,SOOTHE DRY EYES (glycerin 0.3 % and propylene glycol 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013561,glycerin 0.3 % and propylene glycol 1 % ophthalmic drops,8002127,glycerin and propylene glycol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
68637,Marketed,2025-04-11,02244650,REFRESH LIQUIGEL,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02244650,REFRESH LIQUIGEL (carboxymethylcellulose sodium 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9013777,carboxymethylcellulose sodium 1 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
70567,Marketed,2019-10-17,02246397,TEARS NATURALE FORTE,3.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02246397,TEARS NATURALE FORTE (dextran 70 0.1 % and glycerin 0.2 % and hypromellose 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9013544,dextran 70 0.1 % and glycerin 0.2 % and hypromellose 0.3 % ophthalmic drops,8002115,dextran 70 and glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
71788,Marketed,2004-03-24,02247538,MURINE,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02247538,MURINE (polyvinyl alcohol 0.5% and povidone 0.6% ophthalmic drops) PRESTIGE BRANDS INC,Active,9013836,polyvinyl alcohol 0.5% and povidone 0.6% ophthalmic drops,8002074,polyvinyl alcohol and povidone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
73225,Marketed,2021-11-18,02248854,THERATEARS LUBRICANT EYE DROPS,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02248854,THERATEARS LUBRICANT EYE DROPS (carboxymethylcellulose sodium 0.25 % ophthalmic drops) MEDTECH PRODUCTS INC,Active,9013771,carboxymethylcellulose sodium 0.25 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78932,Marketed,2024-10-23,02304015,REFRESH CONTACTS,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02304015,REFRESH CONTACTS (carboxymethylcellulose sodium 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013775,carboxymethylcellulose sodium 0.5 % ophthalmic drops,8002220,carboxymethylcellulose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
80709,Marketed,2022-10-11,02321696,LUBRICANT EYE DROPS/ ARTIFICIAL TEARS,2.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02321696,LUBRICANT EYE DROPS/ ARTIFICIAL TEARS (glycerin 0.3 % and propylene glycol 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013561,glycerin 0.3 % and propylene glycol 1 % ophthalmic drops,8002127,glycerin and propylene glycol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
83970,Marketed,2025-02-05,02354535,ARTIFICIAL TEARS,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02354535,ARTIFICIAL TEARS (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) JUNO OTC INC,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
87535,Marketed,2025-02-04,02389886,DRY EYE TEARS,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02389886,DRY EYE TEARS (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) JUNO OTC INC,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
88404,Marketed,2025-04-25,02399148,REFRESH OPTIVE ADVANCED,3.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02399148,REFRESH OPTIVE ADVANCED (carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9013773,carboxymethylcellulose sodium 0.5 % and glycerin 1 % and polysorbate 80 0.5 % ophthalmic drops,8002223,carboxymethylcellulose and glycerin and polysorbate 80,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91991,Marketed,2025-01-10,02435578,REFRESH OPTIVE FUSION,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02435578,REFRESH OPTIVE FUSION (carboxymethylcellulose sodium 0.5 % and glycerin 0.9 % ophthalmic drops) ABBVIE CORPORATION,Active,9013772,carboxymethylcellulose sodium 0.5 % and glycerin 0.9 % ophthalmic drops,8002222,carboxymethylcellulose and glycerin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
92296,Marketed,2016-06-07,02438585,VISINE FOR DRY EYE TIRED EYE RELIEF,2.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02438585,VISINE FOR DRY EYE TIRED EYE RELIEF (glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9013559,glycerin 0.2 % and hypromellose 0.2 % ophthalmic drops,8002122,glycerin and hypromellose,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
95175,Marketed,2025-07-09,02463652,REFRESH OPTIVE GEL DROPS,2.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02463652,REFRESH OPTIVE GEL DROPS (carboxymethylcellulose sodium 1 % and glycerin 0.9 % ophthalmic drops) ABBVIE CORPORATION,Active,9013776,carboxymethylcellulose sodium 1 % and glycerin 0.9 % ophthalmic drops,8002222,carboxymethylcellulose and glycerin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
95350,Marketed,2018-05-03,02465302,SOOTHE RESTORE,2.0,S01XA20,Artificial tears and other indifferent preparations.,Drops,Ophthalmic,02465302,SOOTHE RESTORE (mineral oil heavy 4.5 % and mineral oil light 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013715,mineral oil heavy 4.5 % and mineral oil light 1 % ophthalmic drops,8002205,mineral oil heavy and mineral oil light,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
104012,Marketed,2024-12-18,02551403,MIEBO,1.0,S01XA20,Artificial tears and other indifferent preparations.,Solution,Ophthalmic,02551403,MIEBO (perfluorohexyloctane 100 % ophthalmic drops) BAUSCH & LOMB INC,Active,9015153,perfluorohexyloctane 100 % ophthalmic drops,8002529,perfluorohexyloctane,54485002,Ophthalmic,385125006,Eye drops solution,,,,,
101756,Marketed,2022-09-01,02528320,SCEMBLIX,1.0,L01EA06,Asciminib,Tablet,Oral,02528320,SCEMBLIX (asciminib (asciminib hydrochloride) 20 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014754,asciminib (asciminib hydrochloride) 20 mg oral tablet,8002433,asciminib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101757,Marketed,2022-09-01,02528339,SCEMBLIX,1.0,L01EA06,Asciminib,Tablet,Oral,02528339,SCEMBLIX (asciminib (asciminib hydrochloride) 40 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014755,asciminib (asciminib hydrochloride) 40 mg oral tablet,8002433,asciminib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
9992,Marketed,2005-10-01,00780634,VITAMIN C,1.0,A11GA01,Ascorbic acid (vit c),Liquid,"Intravenous,Intramuscular",00780634,VITAMIN C (ascorbic acid (sodium ascorbate) 500 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013654,ascorbic acid (sodium ascorbate) 500 mg per 2 mL solution for injection ampoule,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
69229,Marketed,2015-09-15,02245214,VITAMIN C,1.0,A11GA01,Ascorbic acid (vit c),Solution,"Intravenous,Intramuscular,Subcutaneous",02245214,VITAMIN C (ascorbic acid 500 mg per mL solution for injection 50 mL vial) MYLAN PHARMACEUTICALS ULC,Active,9013656,ascorbic acid 500 mg per mL solution for injection 50 mL vial,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84117,Marketed,2019-08-23,02355981,ASCOR L 500,1.0,A11GA01,Ascorbic acid (vit c),Solution,"Intravenous,Subcutaneous,Intramuscular",02355981,ASCOR L 500 (ascorbic acid 500 mg per mL solution for injection 50 mL vial) MCGUFF PHARMACEUTICALS INC,Active,9013656,ascorbic acid 500 mg per mL solution for injection 50 mL vial,8002175,ascorbic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86017,Marketed,2022-04-19,02374803,SAPHRIS,1.0,N05AH05,Asenapine,Tablet,Sublingual,02374803,SAPHRIS (asenapine (asenapine maleate) 5 mg sublingual tablet) ORGANON CANADA INC.,Active,9004958,asenapine (asenapine maleate) 5 mg sublingual tablet,8001435,asenapine,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
86018,Marketed,2022-05-12,02374811,SAPHRIS,1.0,N05AH05,Asenapine,Tablet,Sublingual,02374811,SAPHRIS (asenapine (asenapine maleate) 10 mg sublingual tablet) ORGANON CANADA INC.,Active,9004957,asenapine (asenapine maleate) 10 mg sublingual tablet,8001435,asenapine,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
92969,Marketed,2015-10-20,02444615,STRENSIQ,1.0,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444615,STRENSIQ (asfotase alfa 18 mg per 0.45 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012895,asfotase alfa 18 mg per 0.45 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92970,Marketed,2016-06-07,02444623,STRENSIQ,1.0,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444623,STRENSIQ (asfotase alfa 28 mg per 0.7 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012896,asfotase alfa 28 mg per 0.7 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92971,Marketed,2016-06-01,02444631,STRENSIQ,1.0,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444631,STRENSIQ (asfotase alfa 40 mg per 1 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012897,asfotase alfa 40 mg per 1 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92972,Marketed,2016-02-17,02444658,STRENSIQ,1.0,A16AB13,Asfotase alfa,Solution,Subcutaneous,02444658,STRENSIQ (asfotase alfa 80 mg per 0.8 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012898,asfotase alfa 80 mg per 0.8 mL solution for injection vial,8001569,asfotase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101958,Marketed,2023-05-03,02530406,RYLAZE,1.0,L01XX02,Asparaginase,Solution,Intramuscular,02530406,RYLAZE (crisantaspase 10 mg per 0.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9014854,crisantaspase 10 mg per 0.5 mL solution for injection vial,8002467,crisantaspase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72967,Marketed,2004-01-09,02248611,REYATAZ,1.0,J05AE08,Atazanavir,Capsule,Oral,02248611,REYATAZ (atazanavir (atazanavir sulfate) 200 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77952,Marketed,2007-05-31,02294176,REYATAZ,1.0,J05AE08,Atazanavir,Capsule,Oral,02294176,REYATAZ (atazanavir (atazanavir sulfate) 300 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92854,Marketed,2017-04-18,02443791,TEVA-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02443791,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) TEVA CANADA LIMITED,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92856,Marketed,2017-04-18,02443813,TEVA-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02443813,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) TEVA CANADA LIMITED,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92857,Marketed,2017-04-18,02443821,TEVA-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02443821,TEVA-ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) TEVA CANADA LIMITED,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94389,Marketed,2017-05-03,02456877,MYLAN-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02456877,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94390,Marketed,2017-05-03,02456885,MYLAN-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02456885,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94391,Marketed,2017-05-02,02456893,MYLAN-ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02456893,MYLAN-ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100234,Marketed,2023-01-26,02513102,JAMP ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02513102,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003857,atazanavir (atazanavir sulfate) 150 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100235,Marketed,2023-01-26,02513110,JAMP ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02513110,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 200 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003858,atazanavir (atazanavir sulfate) 200 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100236,Marketed,2023-01-31,02513129,JAMP ATAZANAVIR,1.0,J05AE08,Atazanavir,Capsule,Oral,02513129,JAMP ATAZANAVIR (atazanavir (atazanavir sulfate) 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004300,atazanavir (atazanavir sulfate) 300 mg oral capsule,8001171,atazanavir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9174,Marketed,1988-12-31,00773689,APO-ATENOL TAB 50MG,1.0,C07AB03,Atenolol,Tablet,Oral,00773689,APO-ATENOL TAB 50MG (atenolol 50 mg oral tablet) APOTEX INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9175,Marketed,1988-12-31,00773697,APO-ATENOL TAB 100MG,1.0,C07AB03,Atenolol,Tablet,Oral,00773697,APO-ATENOL TAB 100MG (atenolol 100 mg oral tablet) APOTEX INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9904,Marketed,2025-09-15,00828793,PRO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,00828793,PRO-ATENOLOL (atenolol 100 mg oral tablet) PRO DOC LIMITEE,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9905,Marketed,2025-09-15,00828807,PRO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,00828807,PRO-ATENOLOL (atenolol 50 mg oral tablet) PRO DOC LIMITEE,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17905,Marketed,2022-02-28,02039532,TENORMIN,1.0,C07AB03,Atenolol,Tablet,Oral,02039532,TENORMIN (atenolol 50 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17906,Marketed,2022-02-28,02039540,TENORMIN,1.0,C07AB03,Atenolol,Tablet,Oral,02039540,TENORMIN (atenolol 100 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19691,Marketed,2017-11-22,02171791,TEVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02171791,TEVA-ATENOLOL (atenolol 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19692,Marketed,2017-11-22,02171805,TEVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02171805,TEVA-ATENOLOL (atenolol 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60939,Marketed,1998-03-31,02237600,PMS-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02237600,PMS-ATENOLOL (atenolol 50 mg oral tablet) PHARMASCIENCE INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60940,Marketed,1998-03-31,02237601,PMS-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02237601,PMS-ATENOLOL (atenolol 100 mg oral tablet) PHARMASCIENCE INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61718,Marketed,2024-01-05,02238316,ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02238316,ATENOLOL (atenolol 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61719,Marketed,2024-01-05,02238318,ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02238318,ATENOLOL (atenolol 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65768,Marketed,2000-05-23,02242093,RIVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02242093,RIVA-ATENOLOL (atenolol 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65769,Marketed,2000-05-23,02242094,RIVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02242094,RIVA-ATENOLOL (atenolol 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70768,Marketed,2002-11-28,02246581,PMS-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02246581,PMS-ATENOLOL (atenolol 25 mg oral tablet) PHARMASCIENCE INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75207,Marketed,2010-05-01,02266660,TEVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02266660,TEVA-ATENOLOL (atenolol 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75337,Marketed,2020-01-23,02267985,TARO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02267985,TARO-ATENOLOL (atenolol 50 mg oral tablet) SUN PHARMA CANADA INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75338,Marketed,2020-01-23,02267993,TARO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02267993,TARO-ATENOLOL (atenolol 100 mg oral tablet) SUN PHARMA CANADA INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76301,Marketed,2006-07-12,02277379,RIVA-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02277379,RIVA-ATENOLOL (atenolol 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81205,Marketed,2025-09-15,02326701,PRO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02326701,PRO-ATENOLOL (atenolol 25 mg oral tablet) PRO DOC LIMITEE,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85239,Marketed,2011-06-09,02367556,JAMP-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02367556,JAMP-ATENOLOL (atenolol 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85240,Marketed,2011-06-09,02367564,JAMP-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02367564,JAMP-ATENOLOL (atenolol 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85241,Marketed,2011-06-09,02367572,JAMP-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02367572,JAMP-ATENOLOL (atenolol 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85283,Marketed,2011-06-13,02368013,MINT-ATENOL,1.0,C07AB03,Atenolol,Tablet,Oral,02368013,MINT-ATENOL (atenolol 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85284,Marketed,2011-06-13,02368021,MINT-ATENOL,1.0,C07AB03,Atenolol,Tablet,Oral,02368021,MINT-ATENOL (atenolol 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85285,Marketed,2011-06-13,02368048,MINT-ATENOL,1.0,C07AB03,Atenolol,Tablet,Oral,02368048,MINT-ATENOL (atenolol 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85413,Marketed,2018-07-18,02369192,AG-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02369192,AG-ATENOLOL (atenolol 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85710,Marketed,2012-10-22,02371979,MAR-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02371979,MAR-ATENOLOL (atenolol 25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85711,Marketed,2012-10-22,02371987,MAR-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02371987,MAR-ATENOLOL (atenolol 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85712,Marketed,2012-10-22,02371995,MAR-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02371995,MAR-ATENOLOL (atenolol 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85918,Marketed,2020-01-20,02373963,TARO-ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02373963,TARO-ATENOLOL (atenolol 25 mg oral tablet) SUN PHARMA CANADA INC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95482,Marketed,2017-10-20,02466465,ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02466465,ATENOLOL (atenolol 50 mg oral tablet) SANIS HEALTH INC,Active,9000286,atenolol 50 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95483,Marketed,2017-10-20,02466473,ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02466473,ATENOLOL (atenolol 100 mg oral tablet) SANIS HEALTH INC,Active,9000285,atenolol 100 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103020,Marketed,2024-01-05,02541564,ATENOLOL,1.0,C07AB03,Atenolol,Tablet,Oral,02541564,ATENOLOL (atenolol 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001004,atenolol 25 mg oral tablet,8000121,atenolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73131,Marketed,2020-09-24,02248763,AA-ATENIDONE,2.0,C07CB03,Atenolol and other diuretics,Tablet,Oral,02248763,AA-ATENIDONE (atenolol 50 mg and chlorthalidone 25 mg oral tablet) AA PHARMA INC,Active,9002741,atenolol 50 mg and chlorthalidone 25 mg oral tablet,8000879,atenolol and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73132,Marketed,2020-09-03,02248764,AA-ATENIDONE,2.0,C07CB03,Atenolol and other diuretics,Tablet,Oral,02248764,AA-ATENIDONE (atenolol 100 mg and chlorthalidone 25 mg oral tablet) AA PHARMA INC,Active,9002627,atenolol 100 mg and chlorthalidone 25 mg oral tablet,8000879,atenolol and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95089,Marketed,2017-05-02,02462990,TECENTRIQ,1.0,L01FF05,Atezolizumab,Solution,Intravenous,02462990,TECENTRIQ (atezolizumab 1200 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012899,atezolizumab 1200 mg per 20 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98241,Marketed,2019-10-16,02492393,TECENTRIQ,1.0,L01FF05,Atezolizumab,Solution,Intravenous,02492393,TECENTRIQ (atezolizumab 840 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014159,atezolizumab 840 mg per 14 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103502,Marketed,2024-05-16,02546310,TECENTRIQ SC,1.0,L01FF05,Atezolizumab,Solution,Subcutaneous,02546310,TECENTRIQ SC (atezolizumab 1875 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015043,atezolizumab 1875 mg per 15 mL solution for injection vial,8001570,atezolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102287,Marketed,2023-03-24,02533979,QULIPTA,1.0,N02CD07,Atogepant,Tablet,Oral,02533979,QULIPTA (atogepant 10 mg oral tablet) ABBVIE CORPORATION,Active,9014834,atogepant 10 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102293,Marketed,2023-02-23,02533987,QULIPTA,1.0,N02CD07,Atogepant,Tablet,Oral,02533987,QULIPTA (atogepant 30 mg oral tablet) ABBVIE CORPORATION,Active,9014835,atogepant 30 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102294,Marketed,2023-03-01,02533995,QULIPTA,1.0,N02CD07,Atogepant,Tablet,Oral,02533995,QULIPTA (atogepant 60 mg oral tablet) ABBVIE CORPORATION,Active,9014836,atogepant 60 mg oral tablet,8002461,atogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80008,Marketed,2012-06-01,02314541,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02314541,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) TEVA CANADA LIMITED,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80009,Marketed,2012-06-01,02314568,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02314568,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) TEVA CANADA LIMITED,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80010,Marketed,2012-06-01,02314576,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02314576,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80011,Marketed,2012-06-01,02314584,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02314584,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80012,Marketed,2012-06-01,02314592,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02314592,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) TEVA CANADA LIMITED,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80353,Marketed,2011-03-15,02318024,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318024,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80354,Marketed,2011-03-15,02318032,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318032,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) APOTEX INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80355,Marketed,2011-03-15,02318040,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318040,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80356,Marketed,2011-07-19,02318059,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318059,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) APOTEX INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80357,Marketed,2011-07-19,02318067,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318067,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) APOTEX INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80358,Marketed,2011-07-19,02318075,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318075,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) APOTEX INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80359,Marketed,2011-07-19,02318083,APO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02318083,APO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84752,Marketed,2014-02-28,02362511,TEVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02362511,TEVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) TEVA CANADA LIMITED,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86676,Marketed,2012-06-13,02381028,PMS-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02381028,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) PHARMASCIENCE INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86677,Marketed,2012-06-13,02381036,PMS-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02381036,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) PHARMASCIENCE INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86678,Marketed,2012-06-13,02381044,PMS-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02381044,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) PHARMASCIENCE INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86679,Marketed,2012-06-13,02381052,PMS-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02381052,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) PHARMASCIENCE INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86680,Marketed,2012-06-13,02381060,PMS-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02381060,PMS-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) PHARMASCIENCE INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87200,Marketed,2012-05-30,02386410,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386410,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87201,Marketed,2012-05-30,02386429,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386429,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87202,Marketed,2012-05-30,02386437,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386437,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87203,Marketed,2012-05-30,02386445,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386445,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87204,Marketed,2012-05-30,02386453,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386453,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87205,Marketed,2012-05-30,02386461,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386461,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87206,Marketed,2012-05-30,02386488,SANDOZ ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02386488,SANDOZ ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88191,Marketed,2018-03-20,02396904,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02396904,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) PRO DOC LIMITEE,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88192,Marketed,2017-10-18,02396912,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02396912,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) PRO DOC LIMITEE,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88193,Marketed,2017-10-02,02396920,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02396920,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) PRO DOC LIMITEE,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88194,Marketed,2017-09-07,02396939,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02396939,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) PRO DOC LIMITEE,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88195,Marketed,2017-10-03,02396947,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02396947,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) PRO DOC LIMITEE,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89071,Marketed,2014-04-24,02405962,RIVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02405962,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89072,Marketed,2014-04-24,02405970,RIVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02405970,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89073,Marketed,2014-04-24,02405989,RIVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02405989,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89074,Marketed,2014-04-24,02405997,RIVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02405997,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89075,Marketed,2014-04-24,02406004,RIVA-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02406004,RIVA-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93116,Marketed,2015-10-07,02445883,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02445883,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93118,Marketed,2015-10-07,02445905,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02445905,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93120,Marketed,2015-10-07,02445913,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02445913,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93121,Marketed,2015-10-07,02445948,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02445948,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93122,Marketed,2015-10-07,02445956,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02445956,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95610,Marketed,2018-01-15,02467747,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467747,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) SANIS HEALTH INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95611,Marketed,2018-01-15,02467755,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467755,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) SANIS HEALTH INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95612,Marketed,2018-01-15,02467763,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467763,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) SANIS HEALTH INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95613,Marketed,2018-01-15,02467771,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467771,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) SANIS HEALTH INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95614,Marketed,2018-01-15,02467798,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467798,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) SANIS HEALTH INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95615,Marketed,2018-01-15,02467801,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467801,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) SANIS HEALTH INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95616,Marketed,2018-01-15,02467828,ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02467828,ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) SANIS HEALTH INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96064,Marketed,2019-02-04,02471485,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471485,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) AURO PHARMA INC,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96065,Marketed,2019-02-04,02471493,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471493,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) AURO PHARMA INC,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96066,Marketed,2019-02-04,02471507,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471507,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) AURO PHARMA INC,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96067,Marketed,2019-02-04,02471515,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471515,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) AURO PHARMA INC,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96068,Marketed,2019-02-02,02471523,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471523,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) AURO PHARMA INC,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96069,Marketed,2019-02-04,02471531,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471531,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) AURO PHARMA INC,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96070,Marketed,2019-02-04,02471558,AURO-ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02471558,AURO-ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) AURO PHARMA INC,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99616,Marketed,2023-02-23,02506807,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506807,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001104,atomoxetine (atomoxetine hydrochloride) 10 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99617,Marketed,2023-02-23,02506815,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506815,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001105,atomoxetine (atomoxetine hydrochloride) 18 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99618,Marketed,2023-01-30,02506823,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506823,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001106,atomoxetine (atomoxetine hydrochloride) 25 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99619,Marketed,2023-02-21,02506831,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506831,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001107,atomoxetine (atomoxetine hydrochloride) 40 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99620,Marketed,2023-01-30,02506858,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506858,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001108,atomoxetine (atomoxetine hydrochloride) 60 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99621,Marketed,2023-02-23,02506866,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506866,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001302,atomoxetine (atomoxetine hydrochloride) 80 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99622,Marketed,2023-02-23,02506874,JAMP ATOMOXETINE,1.0,N06BA09,Atomoxetine,Capsule,Oral,02506874,JAMP ATOMOXETINE (atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001303,atomoxetine (atomoxetine hydrochloride) 100 mg oral capsule,8000347,atomoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
49973,Marketed,2023-08-02,02230711,LIPITOR,1.0,C10AA05,Atorvastatin,Tablet,Oral,02230711,LIPITOR (atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49974,Marketed,2023-08-02,02230713,LIPITOR,1.0,C10AA05,Atorvastatin,Tablet,Oral,02230713,LIPITOR (atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49975,Marketed,2023-08-02,02230714,LIPITOR,1.0,C10AA05,Atorvastatin,Tablet,Oral,02230714,LIPITOR (atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66964,Marketed,2023-08-02,02243097,LIPITOR,1.0,C10AA05,Atorvastatin,Tablet,Oral,02243097,LIPITOR (atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78058,Marketed,2010-05-19,02295261,APO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02295261,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78059,Marketed,2010-05-19,02295288,APO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02295288,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78060,Marketed,2010-05-19,02295296,APO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02295296,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78061,Marketed,2010-05-19,02295318,APO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02295318,APO-ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79651,Marketed,2017-06-06,02310899,TEVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02310899,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79652,Marketed,2017-06-06,02310902,TEVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02310902,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79653,Marketed,2017-06-06,02310910,TEVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02310910,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79654,Marketed,2017-06-06,02310929,TEVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02310929,TEVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79921,Marketed,2024-05-03,02313707,TARO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02313707,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79922,Marketed,2024-05-03,02313715,TARO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02313715,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79923,Marketed,2024-05-03,02313723,TARO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02313723,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79925,Marketed,2024-05-03,02313758,TARO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02313758,TARO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81036,Marketed,2010-05-19,02324946,SANDOZ ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02324946,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81037,Marketed,2010-05-19,02324954,SANDOZ ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02324954,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81038,Marketed,2010-05-19,02324962,SANDOZ ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02324962,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81039,Marketed,2010-05-19,02324970,SANDOZ ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02324970,SANDOZ ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83185,Marketed,2010-08-03,02346486,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02346486,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83192,Marketed,2010-08-03,02346494,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02346494,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83193,Marketed,2010-08-03,02346508,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02346508,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) PRO DOC LIMITEE,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83194,Marketed,2010-08-03,02346516,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02346516,ATORVASTATIN (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) PRO DOC LIMITEE,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83405,Marketed,2025-05-29,02348705,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02348705,ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) SANIS HEALTH INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83406,Marketed,2025-04-29,02348713,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02348713,ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) SANIS HEALTH INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83407,Marketed,2025-04-29,02348721,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02348721,ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) SANIS HEALTH INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83408,Marketed,2025-05-29,02348748,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02348748,ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) SANIS HEALTH INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87642,Marketed,2012-09-10,02391058,JAMP-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02391058,JAMP-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87820,Marketed,2014-06-03,02392933,MYLAN-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02392933,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87821,Marketed,2014-06-03,02392941,MYLAN-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02392941,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87822,Marketed,2014-06-03,02392968,MYLAN-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02392968,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87823,Marketed,2014-06-03,02392976,MYLAN-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02392976,MYLAN-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89196,Marketed,2018-04-14,02407256,AURO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02407256,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) AURO PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89197,Marketed,2018-04-14,02407264,AURO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02407264,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) AURO PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89198,Marketed,2018-04-14,02407272,AURO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02407272,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) AURO PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89199,Marketed,2018-04-14,02407280,AURO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02407280,AURO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) AURO PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89596,Marketed,2013-10-23,02411350,ATORVASTATIN-10,1.0,C10AA05,Atorvastatin,Tablet,Oral,02411350,ATORVASTATIN-10 (atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89597,Marketed,2013-10-23,02411369,ATORVASTATIN-20,1.0,C10AA05,Atorvastatin,Tablet,Oral,02411369,ATORVASTATIN-20 (atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89598,Marketed,2013-10-23,02411377,ATORVASTATIN-40,1.0,C10AA05,Atorvastatin,Tablet,Oral,02411377,ATORVASTATIN-40 (atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89599,Marketed,2013-10-23,02411385,ATORVASTATIN-80,1.0,C10AA05,Atorvastatin,Tablet,Oral,02411385,ATORVASTATIN-80 (atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90742,Marketed,2022-11-30,02422751,RIVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02422751,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90743,Marketed,2022-11-30,02422778,RIVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02422778,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90744,Marketed,2022-11-30,02422786,RIVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02422786,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90745,Marketed,2022-11-30,02422794,RIVA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02422794,RIVA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94054,Marketed,2017-05-12,02454017,MAR-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02454017,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94055,Marketed,2017-05-12,02454025,MAR-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02454025,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94056,Marketed,2018-10-05,02454033,MAR-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02454033,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94057,Marketed,2018-10-05,02454041,MAR-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02454041,MAR-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94478,Marketed,2019-10-18,02457741,ACH-ATORVASTATIN CALCIUM,1.0,C10AA05,Atorvastatin,Tablet,Oral,02457741,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94479,Marketed,2019-10-18,02457768,ACH-ATORVASTATIN CALCIUM,1.0,C10AA05,Atorvastatin,Tablet,Oral,02457768,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94480,Marketed,2019-10-18,02457776,ACH-ATORVASTATIN CALCIUM,1.0,C10AA05,Atorvastatin,Tablet,Oral,02457776,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94481,Marketed,2019-10-18,02457784,ACH-ATORVASTATIN CALCIUM,1.0,C10AA05,Atorvastatin,Tablet,Oral,02457784,ACH-ATORVASTATIN CALCIUM (atorvastatin (atorvastatin calcium) 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96027,Marketed,2024-10-10,02471167,M-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02471167,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96028,Marketed,2024-10-01,02471175,M-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02471175,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96029,Marketed,2024-10-21,02471183,M-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02471183,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MANTRA PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96030,Marketed,2024-03-20,02471191,M-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02471191,M-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MANTRA PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96687,Marketed,2024-03-22,02476517,NRA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02476517,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) NORA PHARMA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96688,Marketed,2024-03-22,02476525,NRA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02476525,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) NORA PHARMA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96689,Marketed,2024-03-22,02476533,NRA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02476533,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) NORA PHARMA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96690,Marketed,2024-03-22,02476541,NRA-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02476541,NRA-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) NORA PHARMA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97017,Marketed,2022-11-08,02479508,MINT-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02479508,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97018,Marketed,2022-11-08,02479516,MINT-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02479516,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97019,Marketed,2022-11-08,02479524,MINT-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02479524,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97020,Marketed,2023-12-28,02479532,MINT-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02479532,MINT-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97130,Marketed,2024-04-23,02481189,BIO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02481189,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) BIOMED PHARMA,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97131,Marketed,2024-04-23,02481197,BIO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02481197,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) BIOMED PHARMA,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97132,Marketed,2024-04-23,02481200,BIO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02481200,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) BIOMED PHARMA,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97133,Marketed,2024-04-23,02481219,BIO-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02481219,BIO-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) BIOMED PHARMA,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99363,Marketed,2025-10-17,02504197,JAMP ATORVASTATIN TABLETS,1.0,C10AA05,Atorvastatin,Tablet,Oral,02504197,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99364,Marketed,2025-10-17,02504200,JAMP ATORVASTATIN TABLETS,1.0,C10AA05,Atorvastatin,Tablet,Oral,02504200,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99365,Marketed,2025-10-17,02504219,JAMP ATORVASTATIN TABLETS,1.0,C10AA05,Atorvastatin,Tablet,Oral,02504219,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99367,Marketed,2025-10-17,02504235,JAMP ATORVASTATIN TABLETS,1.0,C10AA05,Atorvastatin,Tablet,Oral,02504235,JAMP ATORVASTATIN TABLETS (atorvastatin (atorvastatin calcium) 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99542,Marketed,2022-02-01,02506076,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02506076,ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99543,Marketed,2022-02-01,02506084,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02506084,ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99544,Marketed,2022-02-01,02506092,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02506092,ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99545,Marketed,2022-02-01,02506106,ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02506106,ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) ANGITA PHARMA INC.,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99662,Marketed,2022-03-18,02507234,PMSC-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02507234,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99663,Marketed,2022-03-18,02507242,PMSC-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02507242,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99664,Marketed,2022-03-18,02507250,PMSC-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02507250,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99665,Marketed,2021-10-01,02507269,PMSC-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02507269,PMSC-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) PHARMASCIENCE INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101074,Marketed,2022-09-19,02521555,PRZ-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02521555,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000703,atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101075,Marketed,2022-09-19,02521563,PRZ-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02521563,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9000704,atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101076,Marketed,2022-09-19,02521571,PRZ-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02521571,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 40 mg oral tablet) PHARMARIS CANADA INC,Active,9000705,atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101077,Marketed,2022-09-19,02521598,PRZ-ATORVASTATIN,1.0,C10AA05,Atorvastatin,Tablet,Oral,02521598,PRZ-ATORVASTATIN (atorvastatin (atorvastatin calcium) 80 mg oral tablet) PHARMARIS CANADA INC,Active,9000947,atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000235,atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75873,Marketed,2023-08-18,02273233,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273233,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75874,Marketed,2023-08-18,02273241,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273241,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75875,Marketed,2023-08-22,02273268,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273268,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75876,Marketed,2023-08-18,02273276,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273276,CADUET (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75877,Marketed,2023-08-18,02273284,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273284,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) BGP PHARMA ULC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75878,Marketed,2023-08-18,02273292,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273292,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) BGP PHARMA ULC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75879,Marketed,2023-08-18,02273306,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273306,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) BGP PHARMA ULC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75880,Marketed,2023-08-18,02273314,CADUET,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02273314,CADUET (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) BGP PHARMA ULC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84775,Marketed,2023-11-28,02362759,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362759,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84776,Marketed,2023-11-28,02362767,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362767,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84777,Marketed,2023-11-28,02362775,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362775,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84778,Marketed,2023-11-28,02362783,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362783,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84779,Marketed,2023-11-28,02362791,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362791,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84780,Marketed,2023-11-28,02362805,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362805,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84781,Marketed,2023-11-28,02362813,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362813,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84782,Marketed,2023-11-28,02362821,MYLAN-AMLODIPINE/ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02362821,MYLAN-AMLODIPINE/ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89588,Marketed,2013-11-15,02411253,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411253,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9004111,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89589,Marketed,2013-11-15,02411261,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411261,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9004112,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89590,Marketed,2013-11-15,02411288,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411288,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9004113,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89591,Marketed,2013-11-15,02411296,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411296,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9004114,amlodipine (amlodipine besylate) 5 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89592,Marketed,2013-11-15,02411318,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411318,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 10 mg oral tablet) APOTEX INC,Active,9004107,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 10 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89593,Marketed,2013-11-15,02411326,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411326,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 20 mg oral tablet) APOTEX INC,Active,9004108,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 20 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89594,Marketed,2013-11-15,02411334,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411334,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 40 mg oral tablet) APOTEX INC,Active,9004109,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 40 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89595,Marketed,2013-11-15,02411342,APO-AMLODIPINE-ATORVASTATIN,2.0,C10BX03,Atorvastatin and amlodipine,Tablet,Oral,02411342,APO-AMLODIPINE-ATORVASTATIN (amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium propylene glycol solvate) 80 mg oral tablet) APOTEX INC,Active,9004110,amlodipine (amlodipine besylate) 10 mg and atorvastatin (atorvastatin calcium) 80 mg oral tablet,8000954,amlodipine and atorvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43212,Marketed,2002-02-25,02217422,MEPRON,1.0,P01AX06,Atovaquone,Suspension,Oral,02217422,MEPRON (atovaquone 750 mg per 5 mL oral suspension) GLAXOSMITHKLINE INC,Active,9002917,atovaquone 750 mg per 5 mL oral suspension,8001436,atovaquone,26643006,Oral,385024007,Oral suspension,,,,,
101772,Marketed,2022-06-30,02528495,GLN-ATOVAQUONE,1.0,P01AX06,Atovaquone,Suspension,Oral,02528495,GLN-ATOVAQUONE (atovaquone 750 mg per 5 mL oral suspension) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9002917,atovaquone 750 mg per 5 mL oral suspension,8001436,atovaquone,26643006,Oral,385024007,Oral suspension,,,,,
254,Marketed,2023-09-11,00035017,ALCON ATROPINE,1.0,S01FA01,Atropine,Solution,Ophthalmic,00035017,ALCON ATROPINE (atropine sulfate 1 % ophthalmic drops) ALCON CANADA INC,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
2390,Marketed,2020-02-25,00328154,ATROPINE SULFATE INJECTION USP,1.0,A03BA01,Atropine,Solution,"Intramuscular,Subcutaneous,Intravenous",00328154,ATROPINE SULFATE INJECTION USP (atropine sulfate 1 mg per 10 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012903,atropine sulfate 1 mg per 10 mL solution for injection syringe,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
3553,Marketed,2005-08-09,00392693,ATROPINE SULFATE INJECTION USP,1.0,A03BA01,Atropine,Solution,"Subcutaneous,Intramuscular,Intravenous",00392693,ATROPINE SULFATE INJECTION USP (atropine sulfate 0.6 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012902,atropine sulfate 0.6 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
3554,Marketed,2005-08-09,00392782,ATROPINE SULFATE INJECTION USP,1.0,A03BA01,Atropine,Solution,"Intramuscular,Intravenous,Subcutaneous",00392782,ATROPINE SULFATE INJECTION USP (atropine sulfate 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012900,atropine sulfate 0.4 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16476,Marketed,2018-09-27,02023695,ATROPINE,1.0,S01FA01,Atropine,Solution,Ophthalmic,02023695,ATROPINE (atropine sulfate 1 % ophthalmic drops) PHARMA STULLN INC.,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18862,Marketed,2022-12-20,02148358,MINIMS ATROPINE SULPHATE,1.0,S01FA01,Atropine,Drops,Ophthalmic,02148358,MINIMS ATROPINE SULPHATE (atropine sulfate 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001601,atropine sulfate 1 % ophthalmic drops,8001571,atropine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91086,Marketed,2021-11-26,02426269,ATROPINE SULFATE INJECTION,1.0,A03BA01,Atropine,Solution,"Subcutaneous,Intravenous,Intramuscular",02426269,ATROPINE SULFATE INJECTION (atropine sulfate 0.5 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012901,atropine sulfate 0.5 mg per 5 mL solution for injection syringe,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91087,Marketed,2021-11-26,02426277,ATROPINE SULFATE INJECTION,1.0,A03BA01,Atropine,Solution,"Intramuscular,Subcutaneous,Intravenous",02426277,ATROPINE SULFATE INJECTION (atropine sulfate 1 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012904,atropine sulfate 1 mg per 5 mL solution for injection syringe,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91662,Marketed,2022-04-22,02432188,ATROPINE INJECTION BP,1.0,A03BA01,Atropine,Solution,"Subcutaneous,Intravenous,Intramuscular",02432188,ATROPINE INJECTION BP (atropine sulfate 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012900,atropine sulfate 0.4 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
91663,Marketed,2022-04-22,02432196,ATROPINE INJECTION BP,1.0,A03BA01,Atropine,Solution,"Intravenous,Intramuscular,Subcutaneous",02432196,ATROPINE INJECTION BP (atropine sulfate 0.6 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012902,atropine sulfate 0.6 mg per 1 mL solution for injection ampoule,8001571,atropine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
15902,Marketed,2010-06-17,01916823,RIDAURA,1.0,M01CB03,Auranofin,Capsule,Oral,01916823,RIDAURA (auranofin 3 mg oral capsule) XEDITON PHARMACEUTICALS INC,Active,9002523,auranofin 3 mg oral capsule,8001573,auranofin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101573,Marketed,2022-11-04,02526662,TAVNEOS,1.0,L04AJ05,Avacopan,Capsule,Oral,02526662,TAVNEOS (avacopan 10 mg oral capsule) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014790,avacopan 10 mg oral capsule,8002446,avacopan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101150,Marketed,2022-02-09,02522365,NEXVIAZYME,1.0,A16AB22,Avalglucosidase alfa,Powder for solution,Intravenous,02522365,NEXVIAZYME (avalglucosidase alfa 100 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9014773,avalglucosidase alfa 100 mg per vial powder for solution for injection,8002441,avalglucosidase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
104048,Marketed,2024-12-02,02551764,AYVAKYT,1.0,L01EX18,Avapritinib,Tablet,Oral,02551764,AYVAKYT (avapritinib 25 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015131,avapritinib 25 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
104049,Marketed,2024-12-02,02551772,AYVAKYT,1.0,L01EX18,Avapritinib,Tablet,Oral,02551772,AYVAKYT (avapritinib 50 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015132,avapritinib 50 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
104050,Marketed,2024-12-02,02551780,AYVAKYT,1.0,L01EX18,Avapritinib,Tablet,Oral,02551780,AYVAKYT (avapritinib 100 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015129,avapritinib 100 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
104051,Marketed,2024-12-02,02551799,AYVAKYT,1.0,L01EX18,Avapritinib,Tablet,Oral,02551799,AYVAKYT (avapritinib 200 mg oral tablet) BLUEPRINT MEDICINES CORPORATION,Active,9015130,avapritinib 200 mg oral tablet,8002523,avapritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
103124,Marketed,2024-01-22,02542706,DOPTELET,1.0,B02BX08,Avatrombopag,Tablet,Oral,02542706,DOPTELET (avatrombopag (avatrombopag maleate) 20 mg oral tablet) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9015002,avatrombopag (avatrombopag maleate) 20 mg oral tablet,8002494,avatrombopag,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
95856,Marketed,2017-12-18,02469723,BAVENCIO,1.0,L01FF04,Avelumab,Solution,Intravenous,02469723,"BAVENCIO (avelumab 200 mg per 10 mL solution for injection vial) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9012470,avelumab 200 mg per 10 mL solution for injection vial,8001141,avelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97587,Marketed,2019-11-27,02485648,YESCARTA,1.0,L01XL03,Axicabtagene ciloleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,
87513,Marketed,2012-08-17,02389630,INLYTA,1.0,L01EK01,Axitinib,Tablet,Oral,02389630,INLYTA (axitinib 1 mg oral tablet) PFIZER CANADA ULC,Active,9005084,axitinib 1 mg oral tablet,8001574,axitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87514,Marketed,2012-08-17,02389649,INLYTA,1.0,L01EK01,Axitinib,Tablet,Oral,02389649,INLYTA (axitinib 5 mg oral tablet) PFIZER CANADA ULC,Active,9005085,axitinib 5 mg oral tablet,8001574,axitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82233,Marketed,2025-02-07,02336707,VIDAZA,1.0,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02336707,VIDAZA (azacitidine 100 mg per vial powder for suspension for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,
95068,Marketed,2017-10-25,02462826,AZACITIDINE FOR INJECTION,1.0,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02462826,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) DR REDDY'S LABORATORIES LTD,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,
99452,Marketed,2024-10-15,02505177,AZACITIDINE FOR INJECTION,1.0,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02505177,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) FRESENIUS KABI CANADA LTD,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,
99702,Marketed,2022-02-24,02507668,AZACITIDINE FOR INJECTION,1.0,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02507668,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) HIKMA CANADA LIMITED,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,
99943,Marketed,2025-01-31,02510197,ONUREG,1.0,L01BC07,Azacitidine,Tablet,Oral,02510197,ONUREG (azacitidine 200 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014482,azacitidine 200 mg oral tablet,8001575,azacitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99944,Marketed,2025-01-31,02510200,ONUREG,1.0,L01BC07,Azacitidine,Tablet,Oral,02510200,ONUREG (azacitidine 300 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014483,azacitidine 300 mg oral tablet,8001575,azacitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101883,Marketed,2023-04-17,02529599,AZACITIDINE FOR INJECTION,1.0,L01BC07,Azacitidine,Powder for suspension,Subcutaneous,02529599,AZACITIDINE FOR INJECTION (azacitidine 100 mg per vial powder for suspension for injection) SANDOZ CANADA INCORPORATED,Active,9004618,azacitidine 100 mg per vial powder for suspension for injection,8001575,azacitidine,738984000,Parenteral,385224003,Powder for suspension for injection,733026001,Vial (unit of presentation),1.0,,
1192,Marketed,2018-01-18,00004596,IMURAN,1.0,L04AX01,Azathioprine,Tablet,Oral,00004596,IMURAN (azathioprine 50 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60109,Marketed,2010-04-23,02236819,TEVA-AZATHIOPRINE,1.0,L04AX01,Azathioprine,Tablet,Oral,02236819,TEVA-AZATHIOPRINE (azathioprine 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66740,Marketed,2000-10-17,02242907,APO-AZATHIOPRINE,1.0,L04AX01,Azathioprine,Tablet,Oral,02242907,APO-AZATHIOPRINE (azathioprine 50 mg oral tablet) APOTEX INC,Active,9000036,azathioprine 50 mg oral tablet,8000027,azathioprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75617,Marketed,2020-04-16,02270811,FINACEA,1.0,D10AX03,Azelaic acid,Gel,Topical,02270811,FINACEA (azelaic acid 15 % cutaneous gel) LEO PHARMA INC,Active,9004742,azelaic acid 15 % cutaneous gel,8001341,azelaic acid,448598008,Cutaneous,385100002,Gel,,,,,
86721,Marketed,2021-07-13,02381389,EDARBI,1.0,C09CA09,Azilsartan medoxomil,Tablet,Oral,02381389,"EDARBI (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005126,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86722,Marketed,2021-07-13,02381397,EDARBI,1.0,C09CA09,Azilsartan medoxomil,Tablet,Oral,02381397,"EDARBI (azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005127,azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103567,Marketed,2025-02-26,02547015,AURO-AZILSARTAN MEDOXOMIL,1.0,C09CA09,Azilsartan medoxomil,Tablet,Oral,02547015,AURO-AZILSARTAN MEDOXOMIL (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet) AURO PHARMA INC,Active,9005126,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103568,Marketed,2025-02-26,02547023,AURO-AZILSARTAN MEDOXOMIL,1.0,C09CA09,Azilsartan medoxomil,Tablet,Oral,02547023,AURO-AZILSARTAN MEDOXOMIL (azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet) AURO PHARMA INC,Active,9005127,azilsartan medoxomil (azilsartan medoxomil potassium) 80 mg oral tablet,8001074,azilsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88267,Marketed,2021-07-13,02397749,EDARBYCLOR,2.0,C09DA09,Azilsartant medoximil and diuretics,Tablet,Oral,02397749,"EDARBYCLOR (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 12.5 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005203,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 12.5 mg oral tablet,8001075,azilsartan and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88269,Marketed,2021-07-13,02397765,EDARBYCLOR,2.0,C09DA09,Azilsartant medoximil and diuretics,Tablet,Oral,02397765,"EDARBYCLOR (azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9005204,azilsartan medoxomil (azilsartan medoxomil potassium) 40 mg and chlorthalidone 25 mg oral tablet,8001075,azilsartan and chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74701,Marketed,2006-01-04,02261634,PMS-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02261634,PMS-AZITHROMYCIN (azithromycin 250 mg oral tablet) PHARMASCIENCE INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74702,Marketed,2006-01-04,02261642,PMS-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02261642,PMS-AZITHROMYCIN (azithromycin 600 mg oral tablet) PHARMASCIENCE INC,Active,9000736,azithromycin 600 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75127,Marketed,2016-03-11,02265826,SANDOZ AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02265826,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75325,Marketed,2017-03-03,02267845,TEVA-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02267845,TEVA-AZITHROMYCIN (azithromycin (azithromycin monohydrate hemiethanolate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76094,Marketed,2024-06-18,02275309,RIVA-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02275309,RIVA-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79623,Marketed,2025-11-18,02310600,PRO-AZITHROMYCINE,1.0,J01FA10,Azithromycin,Tablet,Oral,02310600,PRO-AZITHROMYCINE (azithromycin (azithromycin dihydrate) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81664,Marketed,2017-08-11,02330881,AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02330881,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SANIS HEALTH INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81804,Marketed,2021-10-27,02332388,SANDOZ AZITHROMYCIN,1.0,J01FA10,Azithromycin,Powder for suspension,Oral,02332388,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 100 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9006250,azithromycin 100 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,
81805,Marketed,2021-10-27,02332396,SANDOZ AZITHROMYCIN,1.0,J01FA10,Azithromycin,Powder for suspension,Oral,02332396,SANDOZ AZITHROMYCIN (azithromycin (azithromycin dihydrate) 200 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9006251,azithromycin 200 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,
90013,Marketed,2014-03-06,02415542,APO-AZITHROMYCIN Z,1.0,J01FA10,Azithromycin,Tablet,Oral,02415542,APO-AZITHROMYCIN Z (azithromycin (azithromycin dihydrate) 250 mg oral tablet) APOTEX INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92678,Marketed,2018-01-05,02442434,AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02442434,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93868,Marketed,2016-09-29,02452308,JAMP-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02452308,JAMP-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93870,Marketed,2023-03-31,02452324,MAR-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02452324,MAR-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95383,Marketed,2017-10-25,02465604,"AZITHROMYCIN FOR INJECTION, USP",1.0,J01FA10,Azithromycin,Powder for solution,Intravenous,02465604,"AZITHROMYCIN FOR INJECTION, USP (azithromycin (azithromycin monohydrate) 500 mg per vial powder for solution for injection) AURO PHARMA INC",Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
96991,Marketed,2019-05-07,02479680,NRA-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02479680,NRA-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) NORA PHARMA INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97120,Marketed,2018-09-26,02480700,AG-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02480700,AG-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) ANGITA PHARMA INC.,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97283,Marketed,2019-10-30,02482363,AURO-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Powder for suspension,Oral,02482363,AURO-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 100 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006250,azithromycin 100 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,
97284,Marketed,2019-10-30,02482371,AURO-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Powder for suspension,Oral,02482371,AURO-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 200 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006251,azithromycin 200 mg per 5 mL oral suspension,8000224,azithromycin,26643006,Oral,385024007,Oral suspension,,,,,
97419,Marketed,2019-04-16,02483890,AZITHROMYCIN FOR INJECTION USP,1.0,J01FA10,Azithromycin,Powder for solution,Intravenous,02483890,AZITHROMYCIN FOR INJECTION USP (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99162,Marketed,2021-01-19,02502038,M-AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02502038,M-AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) MANTRA PHARMA INC,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101288,Marketed,2022-05-17,02523825,AZITHROMYCIN FOR INJECTION,1.0,J01FA10,Azithromycin,Powder for solution,Intravenous,02523825,AZITHROMYCIN FOR INJECTION (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101347,Marketed,2023-03-01,02524449,AZITHROMYCIN FOR INJECTION,1.0,J01FA10,Azithromycin,Powder for solution,Intravenous,02524449,AZITHROMYCIN FOR INJECTION (azithromycin (azithromycin dihydrate) 500 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102056,Marketed,2024-10-08,02531429,"AZITHROMYCIN FOR INJECTION, USP",1.0,J01FA10,Azithromycin,Powder for solution,Intravenous,02531429,"AZITHROMYCIN FOR INJECTION, USP (azithromycin (azithromycin monohydrate) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9000862,azithromycin 500 mg per vial powder for solution for injection,8000224,azithromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103468,Marketed,2025-02-26,02545969,AZITHROMYCIN,1.0,J01FA10,Azithromycin,Tablet,Oral,02545969,AZITHROMYCIN (azithromycin (azithromycin dihydrate) 250 mg oral tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000839,azithromycin 250 mg oral tablet,8000224,azithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81558,Marketed,2011-05-18,02329840,CAYSTON,1.0,J01DF01,Aztreonam,Powder for solution,Inhalation,02329840,CAYSTON (aztreonam 75 mg per vial powder for nebulizer solution with diluent solution) GILEAD SCIENCES CANADA INC,Active,9012781,aztreonam 75 mg per vial powder for nebulizer solution with diluent solution,8001172,aztreonam,738984000,Parenteral,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
5863,Marketed,2012-07-19,00584908,BACITIN,1.0,D06AX05,Bacitracin,Ointment,Topical,00584908,BACITIN (bacitracin 500 unit per g cutaneous ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002008,bacitracin 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
69667,Marketed,2003-08-28,02245571,BACIJECT,1.0,J01XX10,Bacitracin,Powder for solution,"Intramuscular,Topical",02245571,BACIJECT (bacitracin 50000 unit per vial powder for solution for injection) STERIMAX INC,Active,9003824,bacitracin 50000 unit per vial powder for solution for injection,8001439,bacitracin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93727,Marketed,2023-10-30,02451026,BACITRACIN OINTMENT,1.0,D06AX05,Bacitracin,Ointment,Topical,02451026,BACITRACIN OINTMENT (bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment) SAFETEC OF AMERICA INC,Active,9013864,bacitracin (bacitracin zinc) 500 unit per g cutaneous ointment,8001439,bacitracin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
15547,Marketed,1994-12-31,02063735,PMS-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02063735,PMS-BACLOFEN (baclofen 10 mg oral tablet) PHARMASCIENCE INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15548,Marketed,1994-12-31,02063743,PMS-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02063743,PMS-BACLOFEN (baclofen 20 mg oral tablet) PHARMASCIENCE INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16532,Marketed,2010-03-24,02088401,MYLAN-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02088401,MYLAN-BACLOFEN (baclofen 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16534,Marketed,2010-01-20,02088398,MYLAN-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02088398,MYLAN-BACLOFEN (baclofen 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17246,Marketed,1994-12-31,02139332,APO-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02139332,APO-BACLOFEN (baclofen 10 mg oral tablet) APOTEX INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17247,Marketed,1994-12-31,02139391,APO-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02139391,APO-BACLOFEN (baclofen 20 mg oral tablet) APOTEX INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20308,Marketed,2025-04-17,02152584,PRO-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02152584,PRO-BACLOFEN (baclofen 10 mg oral tablet) PRO DOC LIMITEE,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20309,Marketed,2025-04-17,02152592,PRO-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02152592,PRO-BACLOFEN (baclofen 20 mg oral tablet) PRO DOC LIMITEE,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65828,Marketed,2003-03-03,02242150,RIVA-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02242150,RIVA-BACLOFEN (baclofen 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65829,Marketed,2003-03-03,02242151,RIVA-BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02242151,RIVA-BACLOFEN (baclofen 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77246,Marketed,2010-02-25,02287021,BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02287021,BACLOFEN (baclofen 10 mg oral tablet) SANIS HEALTH INC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77247,Marketed,2010-02-25,02287048,BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02287048,BACLOFEN (baclofen 20 mg oral tablet) SANIS HEALTH INC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89827,Marketed,2018-01-12,02413620,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,02413620,BACLOFEN INJECTION (baclofen 0.05 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000506,baclofen 0.05 mg per 1 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
89828,Marketed,2018-01-11,02413639,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,02413639,BACLOFEN INJECTION (baclofen 10 mg per 20 mL solution for injection ampoule) STERIMAX INC,Active,9000507,baclofen 10 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
89829,Marketed,2018-01-11,02413647,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,02413647,BACLOFEN INJECTION (baclofen 10 mg per 5 mL solution for injection ampoule) STERIMAX INC,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94414,Marketed,2022-05-19,02457059,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,02457059,BACLOFEN INJECTION (baclofen 0.05 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000506,baclofen 0.05 mg per 1 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94415,Marketed,2023-05-26,02457067,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,02457067,BACLOFEN INJECTION (baclofen 10 mg per 20 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000507,baclofen 10 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94416,Marketed,2023-05-26,02457075,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,77700381,BACLOFEN INJECTION (baclofen 10 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94416,Marketed,2023-05-26,02457075,BACLOFEN INJECTION,1.0,M03BX01,Baclofen,Solution,Intrathecal,77700382,BACLOFEN INJECTION (baclofen 40 mg per 20 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012413,baclofen 40 mg per 20 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
97574,Marketed,2021-07-20,02485508,BACLOFEN INTRATHECAL,1.0,M03BX01,Baclofen,Solution,Intrathecal,02485508,BACLOFEN INTRATHECAL (baclofen 10 mg per 20 mL solution for injection vial) AVIR PHARMA INC.,Active,9014576,baclofen 10 mg per 20 mL solution for injection vial,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97575,Marketed,2021-07-20,02485516,BACLOFEN INTRATHECAL,1.0,M03BX01,Baclofen,Solution,Intrathecal,02485516,BACLOFEN INTRATHECAL (baclofen 40 mg per 20 mL solution for injection vial) AVIR PHARMA INC.,Active,9014577,baclofen 40 mg per 20 mL solution for injection vial,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103303,Marketed,2025-09-12,02544482,JAMP BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02544482,JAMP BACLOFEN (baclofen 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103304,Marketed,2025-09-12,02544490,JAMP BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02544490,JAMP BACLOFEN (baclofen 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103323,Marketed,2024-05-31,02544660,BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02544660,BACLOFEN (baclofen 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000104,baclofen 10 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103324,Marketed,2024-05-31,02544679,BACLOFEN,1.0,M03BX01,Baclofen,Tablet,Oral,02544679,BACLOFEN (baclofen 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000218,baclofen 20 mg oral tablet,8000066,baclofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104229,Marketed,2025-11-10,02553341,BACLOFEN INJECTION USP,1.0,M03BX01,Baclofen,Solution,Intrathecal,02553341,BACLOFEN INJECTION USP (baclofen 10 mg per 5 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000508,baclofen 10 mg per 5 mL solution for injection ampoule,8000066,baclofen,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
98624,Marketed,2025-09-25,02496364,XOFLUZA,1.0,J05AX25,Baloxavir marboxil,Tablet,Oral,02496364,XOFLUZA (baloxavir marboxil 20 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015261,baloxavir marboxil 20 mg oral tablet,8002533,baloxavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
101320,Marketed,2025-03-05,02524163,XOFLUZA,1.0,J05AX25,Baloxavir marboxil,Tablet,Oral,02524163,XOFLUZA (baloxavir marboxil 80 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015175,baloxavir marboxil 80 mg oral tablet,8002533,baloxavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
97056,Marketed,2018-09-27,02480018,OLUMIANT,1.0,L04AF02,Baricitinib,Tablet,Oral,02480018,OLUMIANT (baricitinib 2 mg oral tablet) ELI LILLY CANADA INC,Active,9013408,baricitinib 2 mg oral tablet,8002011,baricitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103336,Marketed,2024-04-09,02544768,OLUMIANT,1.0,L04AF02,Baricitinib,Tablet,Oral,02544768,OLUMIANT (baricitinib 4 mg oral tablet) ELI LILLY CANADA INC,Active,9015032,baricitinib 4 mg oral tablet,8002011,baricitinib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
66643,Marketed,2000-10-23,02242815,SIMULECT,1.0,L04AC02,Basiliximab,Powder for solution,Intravenous,02242815,SIMULECT (basiliximab 20 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003529,basiliximab 20 mg per vial powder for solution for injection,8001576,basiliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19802,Marketed,2013-05-21,02153513,ONCOTICE,1.0,L03AX03,Bcg vaccine,Powder for solution,Intravesical,02153513,ONCOTICE (bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution) MERCK CANADA INC,Active,9014445,bacillus Calmette-Guérin substrain TICE 800000000 unit per vial powder for intravesical solution,8002300,bacillus Calmette-Guérin substrain TICE,372471009,Intravesical,1231578000,Powder for intravesical solution,733026001,Vial (unit of presentation),1.0,,
99797,Marketed,2021-08-30,02508613,VERITY-BCG,1.0,L03AX03,Bcg vaccine,Powder for suspension,Intravesical,02508613,VERITY-BCG (bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension) VERITY PHARMACEUTICALS INC.,Active,9014592,bacillus Calmette-Guérin substrain Russian BCG-I 40 mg per vial powder for intravesical suspension,8002388,bacillus Calmette-Guérin substrain Russian BCG-I,372471009,Intravesical,761907007,Powder for intravesical suspension,733026001,Vial (unit of presentation),1.0,,
28440,Marketed,2020-12-14,02089602,PROPADERM,1.0,D07AC15,Beclometasone,Cream,Topical,02089602,"PROPADERM (beclomethasone dipropionate 0.025 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000793,beclomethasone dipropionate 0.025 % cutaneous cream,8000208,beclomethasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
65700,Marketed,2021-01-01,02242029,QVAR,1.0,R03BA01,Beclometasone,Metered-dose aerosol,Inhalation,02242029,"QVAR (beclomethasone dipropionate 50 mcg per actuation pressurized inhalation) BAUSCH HEALTH, CANADA INC.",Active,9000907,beclomethasone dipropionate 50 mcg per actuation pressurized inhalation,8000208,beclomethasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
65701,Marketed,2021-01-01,02242030,QVAR,1.0,R03BA01,Beclometasone,Metered-dose aerosol,Inhalation,02242030,"QVAR (beclomethasone dipropionate 100 mcg per actuation pressurized inhalation) BAUSCH HEALTH, CANADA INC.",Active,9000906,beclomethasone dipropionate 100 mcg per actuation pressurized inhalation,8000208,beclomethasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
18874,Marketed,2010-06-25,02172712,MYLAN-BECLO AQ,1.0,R01AD01,Beclomethasone,"Suspension,Metered-dose aerosol",Nasal,02172712,MYLAN-BECLO AQ (beclomethasone dipropionate 50 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000553,beclomethasone dipropionate 50 mcg per actuation nasal spray,8000208,beclomethasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
62232,Marketed,1998-10-07,02238796,APO-BECLOMETHASONE NASAL SPRAY,1.0,R01AD01,Beclomethasone,Suspension,Nasal,02238796,APO-BECLOMETHASONE NASAL SPRAY (beclomethasone dipropionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000553,beclomethasone dipropionate 50 mcg per actuation nasal spray,8000208,beclomethasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
106275,Marketed,2025-08-11,02559617,BLENREP,1.0,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559617,BLENREP (belantamab mafodotin 70 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015263,belantamab mafodotin 70 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
106276,Marketed,2025-08-11,02559625,BLENREP,1.0,L01FX15,Belantamab mafodotin,Powder for solution,Intravenous,02559625,BLENREP (belantamab mafodotin 100 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9015262,belantamab mafodotin 100 mg per vial powder for solution for injection,8002552,belantamab mafodotin,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
85508,Marketed,2011-08-24,02370050,BENLYSTA,1.0,L04AG04,Belimumab,Powder for solution,Intravenous,02370050,BENLYSTA (belimumab 120 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004915,belimumab 120 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85509,Marketed,2011-08-24,02370069,BENLYSTA,1.0,L04AG04,Belimumab,Powder for solution,Intravenous,02370069,BENLYSTA (belimumab 400 mg per vial powder for solution for injection) GLAXOSMITHKLINE INC,Active,9004916,belimumab 400 mg per vial powder for solution for injection,8001577,belimumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95946,Marketed,2018-05-14,02470489,BENLYSTA,1.0,L04AG04,Belimumab,Solution,Subcutaneous,02470489,BENLYSTA (belimumab 200 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9012905,belimumab 200 mg per 1 mL solution for injection syringe,8001577,belimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101523,Marketed,2023-03-08,02526115,REZUROCK,1.0,L04AA48,Belumosudil,Tablet,Oral,02526115,REZUROCK (belumosudil (belumosudil mesylate) 200 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9014838,belumosudil (belumosudil mesylate) 200 mg oral tablet,8002462,belumosudil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101808,Marketed,2022-09-01,02528908,WELIREG,1.0,L01XX74,Belzutifan,Tablet,Oral,02528908,WELIREG (belzutifan 40 mg oral tablet) MERCK CANADA INC,Active,9014756,belzutifan 40 mg oral tablet,8002434,belzutifan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75937,Marketed,2012-06-25,02273918,BENAZEPRIL,1.0,C09AA07,Benazepril,Tablet,Oral,02273918,BENAZEPRIL (benazepril hydrochloride 20 mg oral tablet) AA PHARMA INC,Active,9007801,benazepril hydrochloride 20 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77563,Marketed,2012-06-25,02290332,BENAZEPRIL,1.0,C09AA07,Benazepril,Tablet,Oral,02290332,BENAZEPRIL (benazepril hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9007802,benazepril hydrochloride 5 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77564,Marketed,2012-06-25,02290340,BENAZEPRIL,1.0,C09AA07,Benazepril,Tablet,Oral,02290340,BENAZEPRIL (benazepril hydrochloride 10 mg oral tablet) AA PHARMA INC,Active,9007800,benazepril hydrochloride 10 mg oral tablet,8000872,benazepril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87781,Marketed,2018-04-09,02392550,TREANDA,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02392550,TREANDA (bendamustine hydrochloride 25 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
87782,Marketed,2018-04-09,02392569,TREANDA,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02392569,TREANDA (bendamustine hydrochloride 100 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98670,Marketed,2021-03-02,02496852,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02496852,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98671,Marketed,2021-03-02,02496860,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02496860,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98673,Marketed,2021-02-25,02496887,NAT-BENDAMUSTINE,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02496887,NAT-BENDAMUSTINE (bendamustine hydrochloride 25 mg per vial powder for solution for injection) NATCO PHARMA (CANADA) INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98674,Marketed,2021-02-25,02496895,NAT-BENDAMUSTINE,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02496895,NAT-BENDAMUSTINE (bendamustine hydrochloride 100 mg per vial powder for solution for injection) NATCO PHARMA (CANADA) INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
99856,Marketed,2021-03-02,02509253,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02509253,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
99857,Marketed,2021-03-02,02509261,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02509261,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101334,Marketed,2023-01-30,02524309,BENVYON,1.0,L01AA09,Bendamustine,Solution,Intravenous,77701119,BENVYON (bendamustine hydrochloride 100 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9014825,bendamustine hydrochloride 100 mg per 4 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
101334,Marketed,2023-01-30,02524309,BENVYON,1.0,L01AA09,Bendamustine,Solution,Intravenous,77701120,BENVYON (bendamustine hydrochloride 200 mg per 8 mL solution for injection vial) PFIZER CANADA ULC,Active,9014826,bendamustine hydrochloride 200 mg per 8 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
101334,Marketed,2023-01-30,02524309,BENVYON,1.0,L01AA09,Bendamustine,Solution,Intravenous,77701121,BENVYON (bendamustine hydrochloride 25 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9014827,bendamustine hydrochloride 25 mg per 1 mL solution for injection vial,8001578,bendamustine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103059,Marketed,2025-09-08,02541998,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02541998,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 25 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9005104,bendamustine hydrochloride 25 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103060,Marketed,2024-10-08,02542005,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION,1.0,L01AA09,Bendamustine,Powder for solution,Intravenous,02542005,BENDAMUSTINE HYDROCHLORIDE FOR INJECTION (bendamustine hydrochloride 100 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9005103,bendamustine hydrochloride 100 mg per vial powder for solution for injection,8001578,bendamustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
96262,Marketed,2018-03-28,02473232,FASENRA,1.0,R03DX10,Benralizumab,Solution,Subcutaneous,02473232,FASENRA (benralizumab 30 mg per 1 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9012782,benralizumab 30 mg per 1 mL solution for injection syringe,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98601,Marketed,2021-01-13,02496135,FASENRA PEN,1.0,R03DX10,Benralizumab,Solution,Subcutaneous,02496135,FASENRA PEN (benralizumab 30 mg per 1 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014446,benralizumab 30 mg per 1 mL solution for injection pen,8001440,benralizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
62787,Marketed,1999-04-20,02239318,ECOCARE 360,1.0,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,
66672,Marketed,2001-03-01,02242842,DIGISAN E FOAM HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,
70601,Marketed,2003-08-01,02246427,KEYSTONE FOAM HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,
75580,Marketed,2009-09-01,02270420,SOAPOPULAR,1.0,D08AJ01,Benzalkonium,Liquid,Topical,,,,,,,,,,,,,,,,
77627,Marketed,2016-11-30,02290855,X3 CLEAN GERM ATTACK HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
83971,Marketed,2011-12-06,02354543,LORIS 0.13% BZK,1.0,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,
84093,Marketed,2016-08-23,02355736,BENZALKONIUM CHLORIDE ANTISEPTIC TOWELETTE,1.0,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,
85450,Marketed,2014-05-09,02369575,X3 ON-THE-GO ANTISEPTIC SPRAY,1.0,D08AJ01,Benzalkonium,Spray,Topical,,,,,,,,,,,,,,,,
88828,Marketed,2013-07-10,02403471,PURELL SANITIZING WIPES,1.0,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,
89148,Marketed,2014-01-20,02406802,SOFTSOAP ANTIBACTERIAL,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
92173,Marketed,2016-04-01,02437384,PURELL HAND SANITIZING WIPES,1.0,D08AJ01,Benzalkonium,Wipe,Topical,,,,,,,,,,,,,,,,
92527,Marketed,2023-10-24,02440903,TREKSAFE,1.0,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,
92774,Marketed,2015-11-02,02443163,"ALOE-CARE ANTIBACTERIAL LOTION SOAP, BENZALKONIUM CHLORIDE LOTION 0.13% W/W",1.0,D08AJ01,Benzalkonium,Lotion,Topical,,,,,,,,,,,,,,,,
92785,Marketed,2016-04-14,02443252,KLEENEX FOAM HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
94646,Marketed,2017-03-16,02459272,HAND SANITIZER FOAM,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
95295,Marketed,2023-10-18,02464802,DIAL FOAMING ANTIBACTERIAL HAND WASH,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
95297,Marketed,2023-10-17,02464829,DIAL ANTIBACTERIAL HAND SOAP,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
96151,Marketed,2018-06-27,02472236,FUZION AB FOAMING HAND SOAP,1.0,D08AJ01,Benzalkonium,Lotion,Topical (commercial),,,,,,,,,,,,,,,,
96159,Marketed,2019-08-19,02472287,ACCLAIM AB,1.0,D08AJ01,Benzalkonium,Lotion,Topical,,,,,,,,,,,,,,,,
96203,Marketed,2021-09-10,02472724,ENERGY BERRY BAIES ÉNERGISANTES FOAMING HAND SOAP ANTIBACTERIAL,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
96208,Marketed,2021-09-10,02472775,SPRING SHOWERS PLUIES PRINTANIèRES FOAMING HAND SOAP ANTIBACTERIAL,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
97037,Marketed,2020-03-31,02479729,ALCOHOL FREE FOAMING HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
97086,Marketed,2019-11-14,02480336,DYE FREE FRAGRANCE FREE ANTIBACTERIAL FOAMING HAND SOAP,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
97147,Marketed,2019-03-27,02480816,SCOTT ANTIMICROBIAL FOAM SKIN CLEANSER,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
97189,Marketed,2019-02-18,02481456,SCOTT FOAM HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
98983,Marketed,2020-06-15,02500124,FOAM-CARE ULTRA,1.0,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,
99098,Marketed,2021-01-08,02501368,DOVE CARE & PROTECT HAND WASH ANTIBACTERIAL,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
99175,Marketed,2020-07-16,02502178,ANTI-MICROBE M,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
99178,Marketed,2020-08-28,02502208,HAND SANITIZER,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
99238,Marketed,2020-11-04,02502852,FS ANTIMICROBIAL HAND WASH,1.0,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,
99564,Marketed,2022-02-01,02506300,DERMA SOLUTIONS,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
99761,Marketed,2022-02-21,02508222,REFRESH ANTIBAC FOAM,1.0,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,
100018,Marketed,2022-04-20,02510901,SOAPOPULAR ANTIBACTERIAL HAND SOAP,1.0,D08AJ01,Benzalkonium,Solution,Topical (household),,,,,,,,,,,,,,,,
100244,Marketed,2021-03-08,02513226,SANI HANDS FOAM,1.0,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,
102623,Marketed,2024-07-12,02537524,ANTIBACTERIAL FOAMING HAND SOAP,1.0,D08AJ01,Benzalkonium,Solution,Topical (commercial),,,,,,,,,,,,,,,,
102686,Marketed,2023-08-11,02538113,ANTIBACTERIAL HAND WIPES,1.0,D08AJ01,Benzalkonium,Wipe,Topical (household),,,,,,,,,,,,,,,,
103872,Marketed,2025-01-13,02549905,SOFTSOAP ANTIBACTERIAL FOR SENSITIVE SKIN,1.0,D08AJ01,Benzalkonium,Solution,Topical,,,,,,,,,,,,,,,,
103914,Marketed,2024-11-11,02550326,BENZALKONIUM CHLORIDE WIPES,1.0,D08AJ01,Benzalkonium,Wipe,Topical,,,,,,,,,,,,,,,,
77729,Marketed,2014-09-23,02291924,BICILLIN L-A,1.0,J01CE08,Benzathine benzylpenicillin,Suspension,Intramuscular,02291924,BICILLIN L-A (penicillin G benzathine 1200000 unit per 2 mL suspension for injection syringe) PFIZER CANADA ULC,Active,9012685,penicillin G benzathine 1200000 unit per 2 mL suspension for injection syringe,8001221,penicillin G benzathine,738984000,Parenteral,385220007,Suspension for injection,733020007,Syringe (unit of presentation),,,
8060,Marketed,2015-08-13,00706531,PDP-BENZTROPINE,1.0,N04AC01,Benzatropine,Tablet,Oral,00706531,PDP-BENZTROPINE (benztropine mesylate 1 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9000267,benztropine mesylate 1 mg oral tablet,8000067,benztropine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62344,Marketed,1999-07-23,02238903,BENZTROPINE OMEGA,1.0,N04AC01,Benzatropine,Liquid,"Intramuscular,Intravenous",02238903,BENZTROPINE OMEGA (benztropine mesylate 2 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000851,benztropine mesylate 2 mg per 2 mL solution for injection vial,8000067,benztropine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75279,Marketed,2008-06-07,02267365,INO-F-SAN INSTANT HAND SANITIZER,1.0,D08AJ08,Benzethonium chloride,Liquid,Topical,,,,,,,,,,,,,,,,
78942,Marketed,2017-01-05,02304112,WET ONES,1.0,D08AJ08,Benzethonium chloride,Wipe,Topical,,,,,,,,,,,,,,,,
95992,Marketed,2018-03-29,02470853,FINIPIL,1.0,D08AJ08,Benzethonium chloride,Cream,Topical,,,,,,,,,,,,,,,,
99900,Marketed,2024-07-29,02509717,VINDA ANTISEPTIC WIPES,1.0,D08AJ08,Benzethonium chloride,Wipe,Topical (household),,,,,,,,,,,,,,,,
100055,Marketed,2022-06-02,02511339,SALONPAS PAIN RELIEVING CREAM,2.0,D04AB04,Benzocaine,Cream,Topical,02511339,"SALONPAS PAIN RELIEVING CREAM (benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous cream) HISAMITSU AMERICA, INC.",Active,9014797,benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous cream,8002450,benzyl alcohol and lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
100062,Marketed,2022-12-14,02511428,SALONPAS PAIN RELIEVING SOLUTION,2.0,D04AB04,Benzocaine,Solution,Topical,02511428,"SALONPAS PAIN RELIEVING SOLUTION (benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous solution) HISAMITSU AMERICA, INC.",Active,9014798,benzyl alcohol 10 % and lidocaine hydrochloride 4 % cutaneous solution,8002450,benzyl alcohol and lidocaine,448598008,Cutaneous,739006009,Solution,,,,,
11862,Marketed,1991-12-31,01925199,BENZAC W WASH GEL 10%,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,01925199,BENZAC W WASH GEL 10% (benzoyl peroxide 10 % cutaneous gel) GALDERMA CANADA INC.,Active,9002343,benzoyl peroxide 10 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
20299,Marketed,2003-04-23,02162121,BENZAGEL 5 WASH,1.0,D10AE01,Benzoyl peroxide,Solution,Topical,02162121,BENZAGEL 5 WASH (benzoyl peroxide 5 % cutaneous solution) COLUMBIA LABORATORIES CANADA INC,Active,9005256,benzoyl peroxide 5 % cutaneous solution,8000829,benzoyl peroxide,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
34258,Marketed,2003-05-23,02162113,BENZAGEL 5 GEL,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02162113,BENZAGEL 5 GEL (benzoyl peroxide 5 % cutaneous gel) COLUMBIA LABORATORIES CANADA INC,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
59870,Marketed,2000-03-31,02236396,CLEAN & CLEAR PERSA-GEL 5,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02236396,CLEAN & CLEAR PERSA-GEL 5 (benzoyl peroxide 5 % lotion) JOHNSON & JOHNSON INC,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
60085,Marketed,2014-08-07,02236796,DEEP PORE ACNE VANISHING TREATMENT,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02236796,DEEP PORE ACNE VANISHING TREATMENT (benzoyl peroxide 5 % lotion) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
77590,Marketed,2012-10-31,02290561,CLINIQUE ACNE SOLUTIONS ALL-OVER CLEARING TREATMENT,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02290561,CLINIQUE ACNE SOLUTIONS ALL-OVER CLEARING TREATMENT (benzoyl peroxide 2.5 % lotion) CLINIQUE LABORATORIES DIST,Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
80728,Marketed,2009-06-02,02321874,EMERGENCY ACNE VANISHING FACIAL CLEANSER,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02321874,EMERGENCY ACNE VANISHING FACIAL CLEANSER (benzoyl peroxide 5 % lotion) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
82243,Marketed,2011-06-07,02336812,ACNE TREATMENT LOTION,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02336812,ACNE TREATMENT LOTION (benzoyl peroxide 5 % lotion) VIVIER CANADA INCORPORATED,Active,9003009,benzoyl peroxide 5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
84698,Marketed,2011-08-22,02361949,BENZAGEL SPOT-ON ACNE GEL,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02361949,BENZAGEL SPOT-ON ACNE GEL (benzoyl peroxide 2.5 % cutaneous gel) COLUMBIA LABORATORIES CANADA INC,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
87583,Marketed,2022-06-29,02390396,PROACTIV TREAT,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02390396,"PROACTIV TREAT (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
87639,Marketed,2022-09-27,02391015,PROACTIV CLEANSE,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02391015,"PROACTIV CLEANSE (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
87959,Marketed,2022-07-13,02394421,PROACTIV+ SKIN SMOOTHING EXFOLIATOR,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02394421,"PROACTIV+ SKIN SMOOTHING EXFOLIATOR (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
89090,Marketed,2025-09-23,02406179,PROACTIV SOLUTION 3-STEP ACNE ROUTINE,2.0,D10AE01,Benzoyl peroxide,"Kit,Gel",Topical,02406179,"PROACTIV SOLUTION 3-STEP ACNE ROUTINE (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with toner solution) ALCHEMEE, LLC",Active,9014005,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with toner solution,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
89587,Marketed,2022-09-15,02411245,PROACTIV+ PORE TARGETING SOLUTION,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02411245,"PROACTIV+ PORE TARGETING SOLUTION (benzoyl peroxide 2.5 % cutaneous gel) ALCHEMEE, LLC",Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
89660,Marketed,2014-10-24,02412012,BENZOYL PEROXIDE ACNE TREATMENT 5%,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02412012,BENZOYL PEROXIDE ACNE TREATMENT 5% (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
89830,Marketed,2022-09-15,02413655,PROACTIV EMERGENCY BLEMISH RELIEF,1.0,D10AE01,Benzoyl peroxide,Cream,Topical,02413655,"PROACTIV EMERGENCY BLEMISH RELIEF (benzoyl peroxide 5 % cutaneous cream) ALCHEMEE, LLC",Active,9001934,benzoyl peroxide 5 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
89896,Marketed,2015-02-02,02414309,DUAL INTENSIVE ACNE TREATMENT,1.0,D10AE01,Benzoyl peroxide,"Lotion,Gel",Topical,02414309,"DUAL INTENSIVE ACNE TREATMENT (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9014006,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
89901,Marketed,2022-11-25,02414422,PROACTIV+ 3 PIECE SET,2.0,D10AE01,Benzoyl peroxide,"Gel,Kit",Topical,02414422,"PROACTIV+ 3 PIECE SET (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with moisturizer) ALCHEMEE, LLC",Active,9014004,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 2.5 % cutaneous gel with moisturizer,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
91785,Marketed,2015-12-10,02433486,RENEWAL CLEANSER,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02433486,"RENEWAL CLEANSER (benzoyl peroxide 2.5 % lotion) FRUIT OF THE EARTH, INC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
91786,Marketed,2015-12-10,02433494,REPAIRING TREATMENT,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02433494,"REPAIRING TREATMENT (benzoyl peroxide 2.5 % lotion) FRUIT OF THE EARTH, INC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
92488,Marketed,2016-01-18,02440512,STUBBORN ACNE SPOT GEL,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02440512,STUBBORN ACNE SPOT GEL (benzoyl peroxide 5 % cutaneous gel) JOHNSON & JOHNSON INC,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
92524,Marketed,2017-01-30,02440881,STUBBORN ACNE CLEANSER,1.0,D10AE01,Benzoyl peroxide,Paste,Topical,02440881,STUBBORN ACNE CLEANSER (benzoyl peroxide 3.5 % cutaneous paste) JOHNSON & JOHNSON INC,Active,9006122,benzoyl peroxide 3.5 % cutaneous paste,8000829,benzoyl peroxide,448598008,Cutaneous,739002006,Paste,,,,,
92884,Marketed,2015-12-10,02444054,ACTIVE ANTI-ACNE TREATMENT KIT,2.0,D10AE01,Benzoyl peroxide,"Kit,Lotion",Topical,02444054,"ACTIVE ANTI-ACNE TREATMENT KIT (benzoyl peroxide 2.5 % lotion with benzoyl peroxide 2.5 % lotion with toner solution) FRUIT OF THE EARTH, INC",Active,9014009,benzoyl peroxide 2.5 % lotion with benzoyl peroxide 2.5 % lotion with toner solution,8000829,benzoyl peroxide,448598008,Cutaneous,762065001,Cutaneous lotion,,,,,
94496,Marketed,2017-01-30,02457938,STUBBORN ACNE SOLUTION,2.0,D10AE01,Benzoyl peroxide,"Gel,Paste,Kit",Topical,02457938,STUBBORN ACNE SOLUTION (benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 3.5 % cutaneous paste with moisturizer) JOHNSON & JOHNSON INC,Active,9014007,benzoyl peroxide 2.5 % cutaneous gel with benzoyl peroxide 3.5 % cutaneous paste with moisturizer,8000829,benzoyl peroxide,448598008,Cutaneous,385102005,Cutaneous paste,,,,,
95111,Marketed,2019-04-09,02463202,ACNE CLEARING TREATMENT,1.0,D10AE01,Benzoyl peroxide,Lotion,Topical,02463202,"ACNE CLEARING TREATMENT (benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9004306,benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,739000003,Lotion,,,,,
95112,Marketed,2019-04-09,02463210,DAILY ACNE WASH,1.0,D10AE01,Benzoyl peroxide,Cream,Topical,02463210,"DAILY ACNE WASH (benzoyl peroxide 5 % cutaneous cream) RODAN & FIELDS BEAUTY, LLC",Active,9001934,benzoyl peroxide 5 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
95852,Marketed,2019-04-09,02469707,RODAN+FIELDS SPOTLESS,2.0,D10AE01,Benzoyl peroxide,"Kit,Lotion,Cream",Topical,02469707,"RODAN+FIELDS SPOTLESS (benzoyl peroxide 5 % cutaneous cream with benzoyl peroxide 2.5 % lotion) RODAN & FIELDS BEAUTY, LLC",Active,9014010,benzoyl peroxide 5 % cutaneous cream with benzoyl peroxide 2.5 % lotion,8000829,benzoyl peroxide,448598008,Cutaneous,419179001,Kit,,,,,
98034,Marketed,2020-04-03,02490285,BPO5,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02490285,BPO5 (benzoyl peroxide 5 % cutaneous gel) RGR PHARMA LTD.,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
99403,Marketed,2022-01-21,02504634,PANOXYL ACNE WASH,1.0,D10AE01,Benzoyl peroxide,Cream,Topical,02504634,PANOXYL ACNE WASH (benzoyl peroxide 4 % cutaneous cream) CROWN LABORATORIES INC.,Active,9014654,benzoyl peroxide 4 % cutaneous cream,8000829,benzoyl peroxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
99809,Marketed,2022-02-01,02508745,ACNE FOAMING CLEANSER,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02508745,ACNE FOAMING CLEANSER (benzoyl peroxide 4 % cutaneous gel) CERAVE CANADA,Active,9014655,benzoyl peroxide 4 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
99914,Marketed,2025-08-14,02509865,STUBBORN ACNE AM TREATMENT,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02509865,STUBBORN ACNE AM TREATMENT (benzoyl peroxide 2.5 % cutaneous gel) KENVUE CANADA INC.,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
100640,Marketed,2022-11-28,02517043,BPO FACIAL GEL,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02517043,BPO FACIAL GEL (benzoyl peroxide 2.5 % cutaneous gel) ALUMIER EUROPE LTD,Active,9004913,benzoyl peroxide 2.5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
100691,Marketed,2024-06-22,02517515,CLEAR ACTION BENZOYL PEROXIDE ACNE TREATMENT 5%,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02517515,CLEAR ACTION BENZOYL PEROXIDE ACNE TREATMENT 5% (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
102268,Marketed,2024-11-06,02533715,ACNE FOAMING CLEANSER,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02533715,ACNE FOAMING CLEANSER (benzoyl peroxide 4 % cutaneous gel) CRLS,Active,9014655,benzoyl peroxide 4 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
102751,Marketed,2024-11-06,02538822,CLEAR ACTION MEDICATED ACNE GEL,1.0,D10AE01,Benzoyl peroxide,Gel,Topical,02538822,CLEAR ACTION MEDICATED ACNE GEL (benzoyl peroxide 5 % cutaneous gel) CRLS,Active,9002908,benzoyl peroxide 5 % cutaneous gel,8000829,benzoyl peroxide,448598008,Cutaneous,385100002,Gel,,,,,
88701,Marketed,2013-11-15,02402149,ACNE TREATMENT SYSTEM,2.0,D10AE51,"Benzoyl peroxide, combinations","Kit,Liquid,Lotion",Topical,,,,,,,,,,,,,,,,
48059,Marketed,2014-03-27,02229777,PHARIXIA,1.0,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02229777,PHARIXIA (benzydamine hydrochloride 0.15 % gargle/mouthwash) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
63013,Marketed,2018-01-19,02239537,PMS-BENZYDAMINE,1.0,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02239537,PMS-BENZYDAMINE (benzydamine hydrochloride 0.15 % gargle/mouthwash) PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
95103,Marketed,2017-08-11,02463105,ODAN-BENZYDAMINE,1.0,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02463105,ODAN-BENZYDAMINE (benzydamine hydrochloride 0.15 % gargle/mouthwash) ODAN LABORATORIES LTD,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
98444,Marketed,2020-07-13,02494434,PHARIXIA ALCOHOL FREE,1.0,A01AD02,Benzydamine,Mouthwash/gargle,Buccal,02494434,PHARIXIA ALCOHOL FREE (benzydamine hydrochloride 0.15 % gargle/mouthwash) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9012783,benzydamine hydrochloride 0.15 % gargle/mouthwash,8001245,benzydamine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
37244,Marketed,2015-06-26,02220261,"PENICILLIN G SODIUM FOR INJECTION, USP",1.0,J01CE01,Benzylpenicillin,Powder for solution,"Intravenous,Intramuscular",02220261,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 1000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003055,penicillin G (penicillin G sodium) 1000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37245,Marketed,2015-06-26,02220288,"PENICILLIN G SODIUM FOR INJECTION, USP",1.0,J01CE01,Benzylpenicillin,Powder for solution,"Intravenous,Intramuscular",02220288,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 5000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003056,penicillin G (penicillin G sodium) 5000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
37246,Marketed,2015-09-15,02220296,"PENICILLIN G SODIUM FOR INJECTION, USP",1.0,J01CE01,Benzylpenicillin,Powder for solution,"Intravenous,Intramuscular",02220296,"PENICILLIN G SODIUM FOR INJECTION, USP (penicillin G (penicillin G sodium) 10000000 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003054,penicillin G (penicillin G sodium) 10000000 unit per vial powder for solution for injection,8001411,penicillin G,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101674,Marketed,2022-09-06,02527693,ORLADEYO,1.0,B06AC06,Berotralstat,Capsule,Oral,02527693,ORLADEYO (berotralstat (berotralstat hydrochloride) 150 mg oral capsule) BIOCRYST PHARMACEUTICALS INC,Active,9014757,berotralstat (berotralstat hydrochloride) 150 mg oral capsule,8002435,berotralstat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82246,Marketed,2010-01-27,02336847,BESIVANCE,1.0,S01AE08,Besifloxacin,Suspension,Ophthalmic,02336847,BESIVANCE (besifloxacin (besifloxacin hydrochloride) 0.6 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013533,besifloxacin (besifloxacin hydrochloride) 0.6 % ophthalmic drops,8001584,besifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
67819,Marketed,2016-09-07,02243878,SERC,1.0,N07CA01,Betahistine,Tablet,Oral,02243878,SERC (betahistine hydrochloride 16 mg oral tablet) BGP PHARMA ULC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72312,Marketed,2016-06-20,02247998,SERC,1.0,N07CA01,Betahistine,Tablet,Oral,02247998,SERC (betahistine hydrochloride 24 mg oral tablet) BGP PHARMA ULC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76586,Marketed,2014-01-09,02280183,TEVA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02280183,TEVA-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76587,Marketed,2014-01-09,02280191,TEVA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02280191,TEVA-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) TEVA CANADA LIMITED,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76588,Marketed,2014-01-09,02280205,TEVA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02280205,TEVA-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) TEVA CANADA LIMITED,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93496,Marketed,2015-11-30,02449145,AURO-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02449145,AURO-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) AURO PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93497,Marketed,2015-11-30,02449153,AURO-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02449153,AURO-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) AURO PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93498,Marketed,2015-11-30,02449161,AURO-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02449161,AURO-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) AURO PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95480,Marketed,2022-09-28,02466449,BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02466449,BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) SANIS HEALTH INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95481,Marketed,2022-09-28,02466457,BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02466457,BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) SANIS HEALTH INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100892,Marketed,2022-07-27,02519682,M-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02519682,M-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) MANTRA PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100893,Marketed,2022-07-25,02519690,M-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02519690,M-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) MANTRA PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100894,Marketed,2022-07-25,02519704,M-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02519704,M-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) MANTRA PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102687,Marketed,2023-10-20,02538121,MINT-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02538121,MINT-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102688,Marketed,2023-10-20,02538148,MINT-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02538148,MINT-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102689,Marketed,2023-10-31,02538156,MINT-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02538156,MINT-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103354,Marketed,2024-06-05,02544911,NRA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02544911,NRA-BETAHISTINE (betahistine hydrochloride 8 mg oral tablet) NORA PHARMA INC,Active,9001332,betahistine hydrochloride 8 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103355,Marketed,2024-06-05,02544938,NRA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02544938,NRA-BETAHISTINE (betahistine hydrochloride 16 mg oral tablet) NORA PHARMA INC,Active,9000951,betahistine hydrochloride 16 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103356,Marketed,2024-06-05,02544946,NRA-BETAHISTINE,1.0,N07CA01,Betahistine,Tablet,Oral,02544946,NRA-BETAHISTINE (betahistine hydrochloride 24 mg oral tablet) NORA PHARMA INC,Active,9001059,betahistine hydrochloride 24 mg oral tablet,8000302,betahistine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61949,Marketed,2020-01-17,02238526,CYSTADANE,1.0,A16AA06,Betaine,Powder for solution,Oral,02238526,CYSTADANE (betaine 100 % powder for oral solution) RECORDATI RARE DISEASES CANADA INC,Active,9013764,betaine 100 % powder for oral solution,8001585,betaine,26643006,Oral,385026009,Powder for oral solution,,,,,
354,Marketed,2022-08-04,00028096,CELESTONE SOLUSPAN,2.0,H02AB01,Betamethasone,Suspension,"Intramuscular,Intrabursal,Intra-articular,Intradermal",00028096,CELESTONE SOLUSPAN (betamethasone acetate 3 mg per mL and betamethasone (betamethasone sodium phosphate) 3 mg per mL suspension for injection) ORGANON CANADA INC.,Active,9001611,betamethasone acetate 3 mg per mL and betamethasone (betamethasone sodium phosphate) 3 mg per mL suspension for injection,8000794,betamethasone acetate and betamethasone (base),738984000,Parenteral,385220007,Suspension for injection,,,,,
2071,Marketed,2022-06-29,00323071,DIPROSONE,1.0,D07AC01,Betamethasone,Cream,Topical,00323071,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) ORGANON CANADA INC.,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
2272,Marketed,2022-06-16,00344923,DIPROSONE,1.0,D07AC01,Betamethasone,Ointment,Topical,00344923,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) ORGANON CANADA INC.,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
2870,Marketed,2022-09-15,00417246,DIPROSONE,1.0,D07AC01,Betamethasone,Lotion,Topical,00417246,DIPROSONE (betamethasone (betamethasone dipropionate) 0.05 % lotion) ORGANON CANADA INC.,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,
4521,Marketed,2021-04-14,00535427,TEVA-ECTOSONE,1.0,D07AC01,Betamethasone,Cream,Topical,00535427,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000119,betamethasone (betamethasone valerate) 0.05 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
4522,Marketed,2020-07-03,00535435,TEVA-ECTOSONE,1.0,D07AC01,Betamethasone,Cream,Topical,00535435,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.1 % cutaneous cream) TEVA CANADA LIMITED,Active,9000163,betamethasone (betamethasone valerate) 0.1 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
5287,Marketed,2022-05-27,00578436,DIPROSALIC,2.0,D07XC01,Betamethasone,Ointment,Topical,00578436,DIPROSALIC (betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 30 mg per g cutaneous ointment) ORGANON CANADA INC.,Active,9001960,betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 30 mg per g cutaneous ointment,8000831,betamethasone dipropionate and salicylic acid,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
6529,Marketed,2023-08-08,00629367,DIPROLENE,1.0,D07AC01,Betamethasone,Ointment,Topical,00629367,DIPROLENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) ORGANON CANADA INC.,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
6822,Marketed,2018-11-02,00653209,TEVA-ECTOSONE,1.0,D07AC01,Betamethasone,Lotion,Topical,00653209,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000244,betamethasone (betamethasone valerate) 0.05 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,
8972,Marketed,1979-12-31,00716618,BETADERM CRM 0.05%,1.0,D07AC01,Betamethasone,Cream,Topical,00716618,BETADERM CRM 0.05% (betamethasone (betamethasone valerate) 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000119,betamethasone (betamethasone valerate) 0.05 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
8973,Marketed,1988-12-31,00716650,BETADERM ONT 0.1%,1.0,D07AC01,Betamethasone,Ointment,Topical,00716650,BETADERM ONT 0.1% (betamethasone (betamethasone valerate) 0.1 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9001366,betamethasone (betamethasone valerate) 0.1 % cutaneous ointment,8000792,betamethasone valerate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
9268,Marketed,1979-12-31,00716626,BETADERM CRM 0.1%,1.0,D07AC01,Betamethasone,Cream,Topical,00716626,BETADERM CRM 0.1% (betamethasone (betamethasone valerate) 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000163,betamethasone (betamethasone valerate) 0.1 % cutaneous cream,8000792,betamethasone valerate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
9269,Marketed,1979-12-31,00716634,BETADERM LOTION 0.1%,1.0,D07AC01,Betamethasone,Lotion,Topical,00716634,BETADERM LOTION 0.1% (betamethasone (betamethasone valerate) 0.1 % lotion) TARO PHARMACEUTICALS INC,Active,9000121,betamethasone (betamethasone valerate) 0.1 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,
9270,Marketed,1979-12-31,00716642,BETADERM ONT 0.05%,1.0,D07AC01,Betamethasone,Ointment,Topical,00716642,BETADERM ONT 0.05% (betamethasone (betamethasone valerate) 0.05 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9000120,betamethasone (betamethasone valerate) 0.05 % cutaneous ointment,8000792,betamethasone valerate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
10940,Marketed,2017-11-28,00849669,TEVA-TOPILENE,1.0,D07AC01,Betamethasone,Ointment,Topical,00849669,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
10941,Marketed,2017-09-20,00809187,TEVA-TOPISONE,1.0,D07AC01,Betamethasone,Lotion,Topical,00809187,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,
12272,Marketed,1992-12-31,01925350,TARO-SONE,1.0,D07AC01,Betamethasone,Cream,Topical,01925350,TARO-SONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
13690,Marketed,2017-11-28,01927914,TEVA-TOPILENE,1.0,D07AC01,Betamethasone,Lotion,Topical,01927914,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % lotion) TEVA CANADA LIMITED,Active,9000095,betamethasone (betamethasone dipropionate) 0.05 % lotion,8000791,betamethasone dipropionate,448598008,Cutaneous,739000003,Lotion,,,,,
13888,Marketed,2017-09-20,00805009,TEVA-TOPISONE,1.0,D07AC01,Betamethasone,Ointment,Topical,00805009,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000091,betamethasone (betamethasone dipropionate) 0.05 % cutaneous ointment,8000791,betamethasone dipropionate,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
13889,Marketed,2017-09-20,00804991,TEVA-TOPISONE,1.0,D07AC01,Betamethasone,Cream,Topical,00804991,TEVA-TOPISONE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
14445,Marketed,2017-11-28,00849650,TEVA-TOPILENE,1.0,D07AC01,Betamethasone,Cream,Topical,00849650,TEVA-TOPILENE (betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000086,betamethasone (betamethasone dipropionate) 0.05 % cutaneous cream,8000791,betamethasone dipropionate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
19225,Marketed,2018-11-02,00750050,TEVA-ECTOSONE,1.0,D07AC01,Betamethasone,Lotion,Topical,00750050,TEVA-ECTOSONE (betamethasone (betamethasone valerate) 0.1 % lotion) TEVA CANADA LIMITED,Active,9000121,betamethasone (betamethasone valerate) 0.1 % lotion,8000792,betamethasone valerate,448598008,Cutaneous,739000003,Lotion,,,,,
69789,Marketed,2013-02-23,02245688,RATIO-TOPISALIC,2.0,D07XC01,Betamethasone,Lotion,Topical,02245688,RATIO-TOPISALIC (betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 20 mg per g lotion) TEVA CANADA LIMITED,Active,9002009,betamethasone (betamethasone dipropionate) 0.5 mg per g and salicylic acid 20 mg per g lotion,8000831,betamethasone dipropionate and salicylic acid,448598008,Cutaneous,739000003,Lotion,,,,,
91194,Marketed,2020-08-07,02427419,TEVA-BETAMETHASONE/ CALCIPOTRIOL,2.0,D07XC01,Betamethasone,Ointment,Topical,02427419,TEVA-BETAMETHASONE/ CALCIPOTRIOL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment) TEVA CANADA LIMITED,Active,9003670,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
96510,Marketed,2018-10-03,02474883,FUCIBET,2.0,D07CC01,Betamethasone and antibiotics,Cream,Topical,02474883,FUCIBET (betamethasone (betamethasone valerate) 0.1 % and fusidic acid 2 % cutaneous cream) LEO PHARMA INC,Active,9013267,betamethasone (betamethasone valerate) 0.1 % and fusidic acid 2 % cutaneous cream,8001892,betamethasone valerate and fusidic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
12745,Marketed,2025-12-04,01947931,DUVOID,1.0,N07AB02,Bethanechol,Tablet,Oral,01947931,DUVOID (bethanechol chloride 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9002247,bethanechol chloride 25 mg oral tablet,8001587,bethanechol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12746,Marketed,2025-12-04,01947958,DUVOID,1.0,N07AB02,Bethanechol,Tablet,Oral,01947958,DUVOID (bethanechol chloride 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9002246,bethanechol chloride 10 mg oral tablet,8001587,bethanechol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75642,Marketed,2005-11-02,02270994,AVASTIN,1.0,L01FG01,Bevacizumab,Solution,Intravenous,77700679,AVASTIN (bevacizumab 400 mg per 16 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75642,Marketed,2005-11-02,02270994,AVASTIN,1.0,L01FG01,Bevacizumab,Solution,Intravenous,77700680,AVASTIN (bevacizumab 100 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95974,Marketed,2019-08-01,02470748,MVASI,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02470748,MVASI (bevacizumab 100 mg per 4 mL solution for injection vial) AMGEN CANADA INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
95975,Marketed,2019-08-01,02470756,MVASI,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02470756,MVASI (bevacizumab 400 mg per 16 mL solution for injection vial) AMGEN CANADA INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
97952,Marketed,2019-09-25,02489430,ZIRABEV,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02489430,ZIRABEV (bevacizumab 100 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
97953,Marketed,2019-09-25,02489449,ZIRABEV,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02489449,ZIRABEV (bevacizumab 400 mg per 16 mL solution for injection vial) PFIZER CANADA ULC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
100992,Marketed,2021-11-09,02520729,BAMBEVI,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02520729,BAMBEVI (bevacizumab 100 mg per 4 mL solution for injection vial) APOTEX INC,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
100993,Marketed,2021-11-09,02520737,BAMBEVI,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02520737,BAMBEVI (bevacizumab 400 mg per 16 mL solution for injection vial) APOTEX INC,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
101131,Marketed,2025-08-07,02522160,ABEVMY,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02522160,ABEVMY (bevacizumab 400 mg per 16 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
101132,Marketed,2025-08-07,02522179,ABEVMY,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02522179,ABEVMY (bevacizumab 100 mg per 4 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
101187,Marketed,2022-06-27,02522829,AYBINTIO,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02522829,"AYBINTIO (bevacizumab 100 mg per 4 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
101189,Marketed,2022-06-27,02522837,AYBINTIO,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02522837,"AYBINTIO (bevacizumab 400 mg per 16 mL solution for injection vial) SAMSUNG BIOEPIS CO., LTD",Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
102312,Marketed,2024-03-28,02534177,VEGZELMA,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02534177,VEGZELMA (bevacizumab 100 mg per 4 mL solution for injection vial) CELLTRION INC.,Active,9012911,bevacizumab 100 mg per 4 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
102313,Marketed,2024-03-28,02534185,VEGZELMA,1.0,L01FG01,Bevacizumab,Solution,Intravenous,02534185,VEGZELMA (bevacizumab 400 mg per 16 mL solution for injection vial) CELLTRION INC.,Active,9012912,bevacizumab 400 mg per 16 mL solution for injection vial,8001588,bevacizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
16968,Marketed,2020-12-03,02083523,BEZALIP SR,1.0,C10AB02,Bezafibrate,Tablet (extended-release),Oral,02083523,BEZALIP SR (bezafibrate 400 mg prolonged-release oral tablet) ALLERGAN INC,Active,9002620,bezafibrate 400 mg prolonged-release oral tablet,8001246,bezafibrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93984,Marketed,2016-04-06,02453312,JAMP-BEZAFIBRATE SR,1.0,C10AB02,Bezafibrate,Tablet (extended-release),Oral,02453312,JAMP-BEZAFIBRATE SR (bezafibrate 400 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9002620,bezafibrate 400 mg prolonged-release oral tablet,8001246,bezafibrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75561,Marketed,2015-05-06,02270226,TEVA-BICALUTAMIDE,1.0,L02BB03,Bicalutamide,Tablet,Oral,02270226,TEVA-BICALUTAMIDE (bicalutamide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76122,Marketed,2006-02-08,02275589,PMS-BICALUTAMIDE,1.0,L02BB03,Bicalutamide,Tablet,Oral,02275589,PMS-BICALUTAMIDE (bicalutamide 50 mg oral tablet) PHARMASCIENCE INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79663,Marketed,2008-07-09,02311038,PRO-BICALUTAMIDE - 50,1.0,L02BB03,Bicalutamide,Tablet,Oral,02311038,PRO-BICALUTAMIDE - 50 (bicalutamide 50 mg oral tablet) PRO DOC LIMITEE,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
81133,Marketed,2014-08-23,02325985,ACH-BICALUTAMIDE,1.0,L02BB03,Bicalutamide,Tablet,Oral,02325985,ACH-BICALUTAMIDE (bicalutamide 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84234,Marketed,2016-02-01,02357216,JAMP-BICALUTAMIDE,1.0,L02BB03,Bicalutamide,Tablet,Oral,02357216,JAMP-BICALUTAMIDE (bicalutamide 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100844,Marketed,2022-04-28,02519178,BICALUTAMIDE,1.0,L02BB03,Bicalutamide,Tablet,Oral,02519178,BICALUTAMIDE (bicalutamide 50 mg oral tablet) SANIS HEALTH INC,Active,9003010,bicalutamide 50 mg oral tablet,8001589,bicalutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94066,Marketed,2019-05-30,02454130,BLEXTEN,1.0,R06AX29,Bilastine,Tablet,Oral,02454130,BLEXTEN (bilastine 20 mg oral tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100830,Marketed,2022-02-10,02519011,BLEXTEN,1.0,R06AX29,Bilastine,Solution,Oral,02519011,BLEXTEN (bilastine 10 mg per 4 mL oral solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014657,bilastine 10 mg per 4 mL oral solution,8001590,bilastine,26643006,Oral,739006009,Solution,,,,,
100831,Marketed,2022-02-10,02519038,BLEXTEN,1.0,R06AX29,Bilastine,Tablet (orally disintegrating),Oral,02519038,BLEXTEN (bilastine 10 mg orodispersible tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014656,bilastine 10 mg orodispersible tablet,8001590,bilastine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102505,Marketed,2024-10-22,02536269,SANDOZ BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,,,,,,,,,,,,,,,,
103019,Marketed,2024-10-25,02541556,AURO-BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02541556,AURO-BILASTINE (bilastine 20 mg oral tablet) AURO PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103292,Marketed,2024-10-22,02544369,GLN-BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02544369,GLN-BILASTINE (bilastine 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103547,Marketed,2024-10-22,02546795,JAMP BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02546795,JAMP BILASTINE (bilastine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103590,Marketed,2024-10-22,02547279,MAR-BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02547279,MAR-BILASTINE (bilastine 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103730,Marketed,2024-10-24,02548410,M-BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02548410,M-BILASTINE (bilastine 20 mg oral tablet) MANTRA PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104063,Marketed,2024-10-30,02551934,NRA-BILASTINE,1.0,R06AX29,Bilastine,Tablet,Oral,02551934,NRA-BILASTINE (bilastine 20 mg oral tablet) NORA PHARMA INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81041,Marketed,2023-08-04,02324997,LUMIGAN RC,1.0,S01EE03,Bimatoprost,Solution,Ophthalmic,02324997,LUMIGAN RC (bimatoprost 0.01 % ophthalmic drops) ABBVIE CORPORATION,Active,9001276,bimatoprost 0.01 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
83612,Marketed,2024-06-21,02350939,LATISSE,1.0,S01EE03,Bimatoprost,Solution,Topical,02350939,LATISSE (bimatoprost 0.03 % cutaneous solution) ABBVIE CORPORATION,Active,9001325,bimatoprost 0.03 % cutaneous solution,8000315,bimatoprost,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
91352,Marketed,2016-05-13,02429063,VISTITAN,1.0,S01EE03,Bimatoprost,Solution,Ophthalmic,02429063,VISTITAN (bimatoprost 0.03 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000987,bimatoprost 0.03 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102245,Marketed,2023-09-12,02533464,ZIMED PF,1.0,S01EE03,Bimatoprost,Solution,Ophthalmic,02533464,ZIMED PF (bimatoprost 0.03 % ophthalmic drops) AEQUUS PHARMACEUTICALS INC.,Active,9000987,bimatoprost 0.03 % ophthalmic drops,8000315,bimatoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101427,Marketed,2022-03-30,02525267,BIMZELX,1.0,L04AC21,Bimekizumab,Solution,Subcutaneous,02525267,BIMZELX PRE-FILLED SYRINGE (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101428,Marketed,2022-03-30,02525275,BIMZELX,1.0,L04AC21,Bimekizumab,Solution,Subcutaneous,02525275,BIMZELX AUTOINJECTOR (bimekizumab 160 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9014673,bimekizumab 160 mg per 1 mL solution for injection syringe,8002417,bimekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
104253,Marketed,2025-04-07,02553619,BIMZELX,1.0,L04AC21,Bimekizumab,Solution,Subcutaneous,02553619,BIMZELX PREFILLED SYRINGE (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
104254,Marketed,2025-04-07,02553627,BIMZELX,1.0,L04AC21,Bimekizumab,Solution,Subcutaneous,02553627,BIMZELX AUTOINJECTOR (bimekizumab 320 mg per 2 mL solution for injection syringe) UCB CANADA INC,Active,9015185,bimekizumab 320 mg per 2 mL solution for injection syringe,8002417,bimekizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
100232,Marketed,2021-07-05,02513080,MEKTOVI,1.0,L01EE03,Binimetinib,Tablet,Oral,02513080,MEKTOVI (binimetinib 15 mg oral tablet) PFIZER CANADA ULC,Active,9014593,binimetinib 15 mg oral tablet,8002389,binimetinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
1553,Marketed,2020-10-16,00254142,DULCOLAX,1.0,A06AB02,Bisacodyl,Tablet (enteric-coated),Oral,00254142,DULCOLAX (bisacodyl 5 mg gastro-resistant tablet) SANOFI CONSUMER HEALTH INC,Active,9001564,bisacodyl 5 mg gastro-resistant tablet,8000800,bisacodyl,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
1555,Marketed,2020-10-16,00003875,DULCOLAX,1.0,A06AB02,Bisacodyl,Suppository,Rectal,00003875,DULCOLAX (bisacodyl 10 mg suppository) SANOFI CONSUMER HEALTH INC,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
37161,Marketed,2006-04-01,02219190,CARTER'S LITTLE PILLS,1.0,A06AB02,Bisacodyl,Tablet,Oral,02219190,CARTER'S LITTLE PILLS (bisacodyl 5 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61546,Marketed,2024-12-20,02238155,CODULAX TABLETS,1.0,A06AB02,Bisacodyl,Tablet,Oral,02238155,CODULAX TABLETS (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64686,Marketed,2024-09-27,02241091,THE MAGIC BULLET,1.0,A06AB02,Bisacodyl,Suppository,Rectal,02241091,THE MAGIC BULLET (bisacodyl 10 mg suppository) SCI SUPPLY INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
67779,Marketed,2003-04-01,02243838,BISACODYL TABLETS 5MG,1.0,A06AB02,Bisacodyl,Tablet,Oral,02243838,BISACODYL TABLETS 5MG (bisacodyl 5 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70170,Marketed,2014-05-09,02246039,JAMP-BISACODYL,1.0,A06AB02,Bisacodyl,Tablet,Oral,02246039,JAMP-BISACODYL (bisacodyl 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75889,Marketed,2005-12-07,02273411,BISACODYL-ODAN,1.0,A06AB02,Bisacodyl,Tablet (delayed-release),Oral,02273411,BISACODYL-ODAN (bisacodyl 5 mg gastro-resistant tablet) ODAN LABORATORIES LTD,Active,9001564,bisacodyl 5 mg gastro-resistant tablet,8000800,bisacodyl,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
76622,Marketed,2007-12-15,02280566,SILVER BULLET SUPPOSITORY,1.0,A06AB02,Bisacodyl,Suppository,Rectal,02280566,SILVER BULLET SUPPOSITORY (bisacodyl 10 mg suppository) D & C MOBILITY SOLUTIONS INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
84651,Marketed,2014-01-30,02361450,BISACODYL SUPPOSITORY,1.0,A06AB02,Bisacodyl,Suppository,Rectal,02361450,BISACODYL SUPPOSITORY (bisacodyl 10 mg suppository) JAMP PHARMA CORPORATION,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
88276,Marketed,2021-02-17,02397854,DULCOLAX FOR WOMEN,1.0,A06AB02,Bisacodyl,Tablet,Oral,02397854,DULCOLAX FOR WOMEN (bisacodyl 5 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90204,Marketed,2024-12-30,02417413,BISACODYL TABLETS,1.0,A06AB02,Bisacodyl,Tablet,Oral,02417413,BISACODYL TABLETS (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93629,Marketed,2024-12-27,02450232,LAXATIVE FOR WOMEN,1.0,A06AB02,Bisacodyl,Tablet,Oral,02450232,LAXATIVE FOR WOMEN (bisacodyl 5 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97915,Marketed,2020-01-27,02489090,BISACODYL SUPPOSITORY,1.0,A06AB02,Bisacodyl,Suppository,Rectal,02489090,BISACODYL SUPPOSITORY (bisacodyl 10 mg suppository) ANGITA PHARMA INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
98888,Marketed,2022-05-30,02499126,BISACODYL LAXATIVE,1.0,A06AB02,Bisacodyl,Tablet,Oral,02499126,BISACODYL LAXATIVE (bisacodyl 5 mg oral tablet) JUNO OTC INC,Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100967,Marketed,2024-06-03,02520478,AMB-BISACODYL,1.0,A06AB02,Bisacodyl,Suppository,Rectal,02520478,AMB-BISACODYL (bisacodyl 10 mg suppository) AMBICARE PHARMACEUTICALS INC.,Active,9001563,bisacodyl 10 mg suppository,8000800,bisacodyl,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
103975,Marketed,2025-04-01,02550997,"BISACODYL TABLETS, 5 MG",1.0,A06AB02,Bisacodyl,Tablet,Oral,02550997,"BISACODYL TABLETS, 5 MG (bisacodyl 5 mg oral tablet) TIME-CAP LABORATORIES, INC",Active,9002344,bisacodyl 5 mg oral tablet,8000800,bisacodyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81164,Marketed,2010-06-06,02326302,BI-PEGLYTE,6.0,A06AB52,"Bisacodyl, combinations","Kit,Tablet (delayed-release),Powder for solution",Oral,,,,,,,,,,,,,,,,
104160,Marketed,2025-08-01,02552612,JAMPLYTE + BISACODYL,6.0,A06AB52,"Bisacodyl, combinations","Tablet (delayed-release),Powder for solution,Kit",Oral,,,,,,,,,,,,,,,,
42395,Marketed,1998-05-26,02097079,PEPTO-BISMOL,1.0,A07BB,Bismuth preparations,Suspension,Oral,02097079,PEPTO-BISMOL (bismuth subsalicylate 17.5 mg per mL oral suspension) PROCTER & GAMBLE INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
42736,Marketed,1998-05-26,02177994,PEPTO BISMOL CAPLET - 262MG/CAPLET,1.0,A07BB,Bismuth preparations,Tablet,Oral,02177994,PEPTO BISMOL CAPLET - 262MG/CAPLET (bismuth subsalicylate 262 mg oral tablet) PROCTER & GAMBLE INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
47656,Marketed,2015-01-23,02229668,PEPTO-BISMOL EXTRA,1.0,A07BB,Bismuth preparations,Suspension,Oral,02229668,PEPTO-BISMOL EXTRA (bismuth subsalicylate 35 mg per mL oral suspension) PROCTER & GAMBLE INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
79869,Marketed,2021-11-05,02313162,BISMUTH SUBSALICYLATE SUSPENSION,1.0,A07BB,Bismuth preparations,Suspension,Oral,02313162,BISMUTH SUBSALICYLATE SUSPENSION (bismuth subsalicylate 17.5 mg per mL oral suspension) GUARDIAN DRUG COMPANY INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
81194,Marketed,2010-02-01,02326582,BISMUTH SUBSALICYLATE CAPLETS,1.0,A07BB,Bismuth preparations,Tablet,Oral,02326582,BISMUTH SUBSALICYLATE CAPLETS (bismuth subsalicylate 262 mg oral tablet) GUARDIAN DRUG COMPANY INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81398,Marketed,2022-03-03,02328453,EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION,1.0,A07BB,Bismuth preparations,Suspension,Oral,02328453,EXTRA STRENGTH BISMUTH SUBSALICYLATE SUSPENSION (bismuth subsalicylate 35 mg per mL oral suspension) GUARDIAN DRUG COMPANY INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
94421,Marketed,2018-09-28,02457121,BISMUTH CAPLETS,1.0,A07BB,Bismuth preparations,Tablet,Oral,02457121,BISMUTH CAPLETS (bismuth subsalicylate 262 mg oral tablet) JUNO OTC INC,Active,9003011,bismuth subsalicylate 262 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95706,Marketed,2018-07-17,02468646,REGULAR STRENGTH BISMUTH,1.0,A07BB,Bismuth preparations,Suspension,Oral,02468646,REGULAR STRENGTH BISMUTH (bismuth subsalicylate 17.5 mg per mL oral suspension) JUNO OTC INC,Active,9013035,bismuth subsalicylate 17.5 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
96658,Marketed,2020-09-11,02475855,EXTRA STRENGTH BISMUTH,1.0,A07BB,Bismuth preparations,Suspension,Oral,02475855,EXTRA STRENGTH BISMUTH (bismuth subsalicylate 35 mg per mL oral suspension) JUNO OTC INC,Active,9003541,bismuth subsalicylate 35 mg per mL oral suspension,8001705,bismuth subsalicylate,26643006,Oral,385024007,Oral suspension,,,,,
98971,Marketed,2021-03-15,02499991,PEPTO BISMOL LIQUICAPS,1.0,A07BB,Bismuth preparations,Capsule,Oral,02499991,PEPTO BISMOL LIQUICAPS (bismuth subsalicylate 262 mg oral capsule) PROCTER & GAMBLE INC,Active,9014533,bismuth subsalicylate 262 mg oral capsule,8001705,bismuth subsalicylate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101991,Marketed,2023-11-12,02530759,PEPTO-BISMOL EXTRA CAPLET,1.0,A07BB,Bismuth preparations,Tablet,Oral,02530759,PEPTO-BISMOL EXTRA CAPLET (bismuth subsalicylate 524 mg oral tablet) PROCTER & GAMBLE INC,Active,9014960,bismuth subsalicylate 524 mg oral tablet,8001705,bismuth subsalicylate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,
102336,Marketed,2023-03-06,02534436,GASTROVOL LIQUID GELS,1.0,A07BB,Bismuth preparations,Capsule,Oral,02534436,GASTROVOL LIQUID GELS (bismuth subsalicylate 262 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9014533,bismuth subsalicylate 262 mg oral capsule,8001705,bismuth subsalicylate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
71189,Marketed,2025-12-11,02246962,PYLERA,3.0,A02BD08,"Bismuth subcitrate,tetracycline and metronidazole",Capsule,Oral,02246962,PYLERA (bismuth oxide (bismuth subcitrate potassium) 40 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule) LABORATOIRES JUVISE PHARMACEUTICALS,Active,9015293,bismuth oxide (bismuth subcitrate potassium) 40 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule,8002563,bismuth oxide and metronidazole and tetracycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
74136,Marketed,2004-08-10,02256134,APO-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02256134,APO-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) APOTEX INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74140,Marketed,2004-08-10,02256177,APO-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02256177,APO-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) APOTEX INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75288,Marketed,2013-12-17,02267470,TEVA-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02267470,TEVA-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75289,Marketed,2013-12-17,02267489,TEVA-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02267489,TEVA-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79267,Marketed,2008-07-04,02306999,PRO-BISOPROLOL - 5,1.0,C07AB07,Bisoprolol,Tablet,Oral,02306999,PRO-BISOPROLOL - 5 (bisoprolol fumarate 5 mg oral tablet) PRO DOC LIMITEE,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79268,Marketed,2008-07-04,02307006,PRO-BISOPROLOL - 10,1.0,C07AB07,Bisoprolol,Tablet,Oral,02307006,PRO-BISOPROLOL - 10 (bisoprolol fumarate 10 mg oral tablet) PRO DOC LIMITEE,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87691,Marketed,2020-08-27,02391589,BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02391589,BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) SANIS HEALTH INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87692,Marketed,2020-08-27,02391597,BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02391597,BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) SANIS HEALTH INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95384,Marketed,2019-02-05,02465612,MINT-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02465612,MINT-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95385,Marketed,2019-02-05,02465620,MINT-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02465620,MINT-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98405,Marketed,2019-11-27,02494035,SANDOZ BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02494035,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98406,Marketed,2019-11-27,02494043,SANDOZ BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02494043,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98546,Marketed,2024-12-24,02495562,BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02495562,BISOPROLOL TABLETS (bisoprolol fumarate 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98547,Marketed,2024-12-24,02495570,BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02495570,BISOPROLOL TABLETS (bisoprolol fumarate 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100809,Marketed,2022-03-18,02518791,JAMP BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02518791,JAMP BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100810,Marketed,2022-03-18,02518805,JAMP BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02518805,JAMP BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101037,Marketed,2022-03-18,02521156,AG-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02521156,AG-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101038,Marketed,2022-03-18,02521164,AG-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02521164,AG-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103004,Marketed,2025-11-25,02541394,PRZ-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02541394,PRZ-BISOPROLOL (bisoprolol fumarate 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001021,bisoprolol fumarate 5 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103006,Marketed,2025-11-25,02541408,PRZ-BISOPROLOL,1.0,C07AB07,Bisoprolol,Tablet,Oral,02541408,PRZ-BISOPROLOL (bisoprolol fumarate 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001020,bisoprolol fumarate 10 mg oral tablet,8000325,bisoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103278,Marketed,2024-06-11,02544245,SANDOZ BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02544245,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 1.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9015049,bisoprolol fumarate 1.25 mg oral tablet,8000325,bisoprolol,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,
103279,Marketed,2024-06-11,02544253,SANDOZ BISOPROLOL TABLETS,1.0,C07AB07,Bisoprolol,Tablet,Oral,02544253,SANDOZ BISOPROLOL TABLETS (bisoprolol fumarate 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9015050,bisoprolol fumarate 2.5 mg oral tablet,8000325,bisoprolol,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,
70715,Marketed,2016-09-29,02246533,ANGIOMAX,1.0,B01AE06,Bivalirudin,Powder for solution,Intravenous,02246533,ANGIOMAX (bivalirudin 250 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91953,Marketed,2019-04-23,02435268,BIVALIRUDIN FOR INJECTION,1.0,B01AE06,Bivalirudin,Powder for solution,Intravenous,02435268,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99489,Marketed,2021-03-05,02505517,BIVALIRUDIN INJECTION,1.0,B01AE06,Bivalirudin,Solution,Intravenous,02505517,BIVALIRUDIN INJECTION (bivalirudin 250 mg per 50 mL solution for injection vial) AVIR PHARMA INC.,Active,9014474,bivalirudin 250 mg per 50 mL solution for injection vial,8001441,bivalirudin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100065,Marketed,2023-05-01,02511452,BIVALIRUDIN FOR INJECTION,1.0,B01AE06,Bivalirudin,Powder for solution,Intravenous,02511452,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102833,Marketed,2024-09-10,02539586,BIVALIRUDIN FOR INJECTION,1.0,B01AE06,Bivalirudin,Powder for solution,Intravenous,02539586,BIVALIRUDIN FOR INJECTION (bivalirudin 250 mg per vial powder for solution for injection) FORMATIVE PHARMA INC.,Active,9012784,bivalirudin 250 mg per vial powder for solution for injection,8001441,bivalirudin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
43892,Marketed,2017-08-08,02131692,BLEOMYCIN FOR INJECTION USP,1.0,L01DC01,Bleomycin,Powder for solution,"Subcutaneous,Intravenous,Intra-arterial,Intracavitary,Intramuscular",02131692,BLEOMYCIN FOR INJECTION USP (bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003230,bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection,8001591,bleomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
75142,Marketed,2016-08-25,02265982,BLEOMYCIN FOR INJECTION,1.0,L01DC01,Bleomycin,Powder for solution,"Intrapleural,Subcutaneous,Intravenous,Intramuscular",02265982,BLEOMYCIN FOR INJECTION (bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003230,bleomycin (bleomycin sulfate) 15 unit per vial powder for solution for injection,8001591,bleomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
93642,Marketed,2016-03-17,02450283,BLINCYTO,1.0,L01FX07,Blinatumomab,Powder for solution,Intravenous,02450283,BLINCYTO (blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9012913,blinatumomab 38.5 mcg per vial powder for solution for injection with solution stabilizer,8001592,blinatumomab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
75541,Marketed,2012-05-31,02270013,OCTAPLASMA,1.0,B05AX03,Blood plasma,Solution,Intravenous,,,,,,,,,,,,,,,,
10497,Marketed,1990-12-31,00060313,ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML,1.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,00060313,ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML (sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood) BAXTER CORPORATION,Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,
11330,Marketed,2018-09-19,00783668,GLYCEROLYTE 57 SOLUTION,5.0,V07AC,"Blood transfusion, auxiliary products",Solution,0-unassigned,00783668,GLYCEROLYTE 57 SOLUTION (glycerin 57 g per 100 mL and potassium chloride 30 mg per 100 mL and sodium lactate 1.6 g per 100 mL and sodium phosphate dibasic 124.2 mg per 100 mL and sodium phosphate monobasic 51.7 mg per 100 mL anticoagulant and preservative solution for blood) FRESENIUS KABI AG,Active,9013567,glycerin 57 g per 100 mL and potassium chloride 30 mg per 100 mL and sodium lactate 1.6 g per 100 mL and sodium phosphate dibasic 124.2 mg per 100 mL and sodium phosphate monobasic 51.7 mg per 100 mL anticoagulant and preservative solution for blood,8002126,glycerin and potassium chloride and sodium lactate and sodium phosphate dibasic and sodium phosphate monobasic,738984000,Parenteral,739006009,Solution,,,,,
11376,Marketed,2018-03-28,00788139,ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A,3.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,
12168,Marketed,1991-12-31,00783625,12% SODIUM CHLORDIE PROCESSING SOLUTION,1.0,V07AC,"Blood transfusion, auxiliary products",Solution,0-unassigned,,,,,,,,,,,,,,,,
12171,Marketed,1991-12-31,00783641,DEXTROSE 0.2% AND 0.9% SOD CHLOR SOLUTION,2.0,V07AC,"Blood transfusion, auxiliary products",Solution,Irrigation,,,,,,,,,,,,,,,,
86313,Marketed,2024-06-11,02377411,"ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP",1.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,02377411,"ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP (sodium citrate dihydrate 4 g per 100 mL anticoagulant and preservative solution for blood) BAXTER CORPORATION",Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,
87250,Marketed,2013-01-20,02386925,SAG-M,4.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,
92892,Marketed,2016-08-22,02444097,ADDITIVE SOLUTION SODIUM ADENINE GLUCOSE MANNITOL (SAGM),4.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,
92893,Marketed,2016-08-22,02444100,ANTICOAGULANT SOLUTION CITRATE PHOSPHATE DEXTROSE (CPD),4.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,
95858,Marketed,2018-06-20,02469731,ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A,3.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,,,,,,,,,,,,,,,,
98197,Marketed,2021-11-05,02492067,SSP+,7.0,V07AC,"Blood transfusion, auxiliary products",Solution,Intravenous,,,,,,,,,,,,,,,,
98207,Marketed,2022-12-18,02492075,SSP+,7.0,V07AC,"Blood transfusion, auxiliary products",Solution,Intravenous,,,,,,,,,,,,,,,,
101888,Marketed,2023-10-31,02529637,"ANTICOAGULANT SODIUM CITRATE SOLUTION, USP",1.0,V07AC,"Blood transfusion, auxiliary products",Solution,Extracorporeal,02529637,"ANTICOAGULANT SODIUM CITRATE SOLUTION, USP (sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood) FRESENIUS KABI CANADA LTD",Active,9012862,sodium citrate 4 g per 100 mL anticoagulant and preservative solution for blood,8000852,sodium citrate,738984000,Parenteral,739006009,Solution,,,,,
74782,Marketed,2005-02-01,02262452,VELCADE,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02262452,VELCADE (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
90813,Marketed,2015-05-20,02423405,BORTEZOMIB FOR INJECTION,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02423405,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
92278,Marketed,2020-12-30,02438399,ACT BORTEZOMIB,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02438399,ACT BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
93883,Marketed,2017-03-21,02452456,BORTEZOMIB FOR INJECTION,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02452456,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94301,Marketed,2019-03-25,02456176,BORTEZOMIB,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02456176,BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) APOTEX INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95502,Marketed,2018-06-05,02466708,PMS-BORTEZOMIB,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02466708,PMS-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95541,Marketed,2020-06-23,02467003,BORTEZOMIB FOR INJECTION,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02467003,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014320,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
97552,Marketed,2023-03-28,02485257,BORTEZOMIB FOR INJECTION,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02485257,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98328,Marketed,2020-05-19,02493306,BORTEZOMIB FOR INJECTION,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02493306,BORTEZOMIB FOR INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98883,Marketed,2021-04-12,02499061,TARO-BORTEZOMIB,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02499061,TARO-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
99283,Marketed,2022-01-31,02503352,BORTEZOMIB FOR INJECTION SDZ,1.0,L01XG01,Bortezomib,Powder for solution,"Subcutaneous,Intravenous",02503352,BORTEZOMIB FOR INJECTION SDZ (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004006,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100110,Marketed,2022-07-18,02511932,TARO-BORTEZOMIB,1.0,L01XG01,Bortezomib,Powder for solution,"Intravenous,Subcutaneous",02511932,TARO-BORTEZOMIB (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9014320,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per vial powder for solution for injection,8001593,bortezomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103888,Marketed,2025-07-21,02550075,BORTEZOMIB INJECTION,1.0,L01XG01,Bortezomib,Solution,"Intravenous,Subcutaneous",77701191,BORTEZOMIB INJECTION (bortezomib (bortezomib mannitol boronic ester) 2.5 mg per 1 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9015246,bortezomib (bortezomib mannitol boronic ester) 2.5 mg per 1 mL solution for injection vial,8001593,bortezomib,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
103888,Marketed,2025-07-21,02550075,BORTEZOMIB INJECTION,1.0,L01XG01,Bortezomib,Solution,"Intravenous,Subcutaneous",77701192,BORTEZOMIB INJECTION (bortezomib (bortezomib mannitol boronic ester) 3.5 mg per 1.4 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9015247,bortezomib (bortezomib mannitol boronic ester) 3.5 mg per 1.4 mL solution for injection vial,8001593,bortezomib,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
68979,Marketed,2020-02-20,02244981,TRACLEER,1.0,C02KX01,Bosentan,Tablet,Oral,02244981,TRACLEER (bosentan (bosentan monohydrate) 62.5 mg oral tablet) JANSSEN INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
68980,Marketed,2019-10-18,02244982,TRACLEER,1.0,C02KX01,Bosentan,Tablet,Oral,02244982,TRACLEER (bosentan (bosentan monohydrate) 125 mg oral tablet) JANSSEN INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86880,Marketed,2012-06-12,02383012,PMS-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02383012,PMS-BOSENTAN (bosentan (bosentan monohydrate) 62.5 mg oral tablet) PHARMASCIENCE INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86881,Marketed,2012-06-12,02383020,PMS-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02383020,PMS-BOSENTAN (bosentan (bosentan monohydrate) 125 mg oral tablet) PHARMASCIENCE INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95635,Marketed,2020-04-30,02467984,NAT-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02467984,NAT-BOSENTAN (bosentan (bosentan monohydrate) 62.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95636,Marketed,2020-04-30,02467992,NAT-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02467992,NAT-BOSENTAN (bosentan (bosentan monohydrate) 125 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97359,Marketed,2020-05-07,02483130,TARO-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02483130,TARO-BOSENTAN (bosentan (bosentan monohydrate) 62.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9012365,bosentan 62.5 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97360,Marketed,2020-05-07,02483149,TARO-BOSENTAN,1.0,C02KX01,Bosentan,Tablet,Oral,02483149,TARO-BOSENTAN (bosentan (bosentan monohydrate) 125 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9012364,bosentan 125 mg oral tablet,8000929,bosentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90368,Marketed,2014-04-24,02419149,BOSULIF,1.0,L01EA04,Bosutinib,Tablet,Oral,02419149,BOSULIF (bosutinib (bosutinib monohydrate) 100 mg oral tablet) PFIZER CANADA ULC,Active,9005500,bosutinib 100 mg oral tablet,8001594,bosutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90369,Marketed,2014-03-24,02419157,BOSULIF,1.0,L01EA04,Bosutinib,Tablet,Oral,02419157,BOSULIF (bosutinib (bosutinib monohydrate) 500 mg oral tablet) PFIZER CANADA ULC,Active,9005476,bosutinib 500 mg oral tablet,8001594,bosutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
106312,Marketed,2025-09-08,02560038,REDDY-BOSUTINIB,1.0,L01EA04,Bosutinib,Tablet,Oral,,,,,,,,,,,,,,1.0,,
106313,Marketed,2025-09-08,02560046,REDDY-BOSUTINIB,1.0,L01EA04,Bosutinib,Tablet,Oral,,,,,,,,,,,,,,1.0,,
13476,Marketed,2023-11-13,01981501,BOTOX,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,01981501,BOTOX (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
67653,Marketed,2023-12-06,02243721,BOTOX COSMETIC,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02243721,BOTOX COSMETIC (onabotulinumtoxinA 100 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9013891,onabotulinumtoxinA 100 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
80952,Marketed,2021-09-23,02324032,XEOMIN,1.0,M03AX01,Botulinum toxin,Powder for solution,"Intraglandular,Intramuscular",02324032,XEOMIN (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85628,Marketed,2021-07-16,02371081,XEOMIN,1.0,M03AX01,Botulinum toxin,Powder for solution,"Intraglandular,Intramuscular",02371081,XEOMIN (incobotulinumtoxinA 50 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013887,incobotulinumtoxinA 50 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
86922,Marketed,2012-07-05,02383489,XEOMIN COSMETIC,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02383489,XEOMIN COSMETIC (incobotulinumtoxinA 100 unit per vial powder for solution for injection) MERZ PHARMACEUTICALS GMBH,Active,9013886,incobotulinumtoxinA 100 unit per vial powder for solution for injection,8002243,incobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87332,Marketed,2021-12-03,02387735,DYSPORT AESTHETIC,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02387735,DYSPORT AESTHETIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94296,Marketed,2022-04-06,02456117,DYSPORT THERAPEUTIC,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02456117,DYSPORT THERAPEUTIC (abobotulinumtoxinA 500 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013843,abobotulinumtoxinA 500 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94749,Marketed,2022-04-06,02460203,DYSPORT THERAPEUTIC,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02460203,DYSPORT THERAPEUTIC (abobotulinumtoxinA 300 unit per vial powder for solution for injection) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013842,abobotulinumtoxinA 300 unit per vial powder for solution for injection,8002234,abobotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97069,Marketed,2019-10-16,02480158,NUCEIVA,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02480158,NUCEIVA (prabotulinumtoxinA 100 unit per vial powder for solution for injection) EVOLUS INCORPORATED,Active,9014262,prabotulinumtoxinA 100 unit per vial powder for solution for injection,8002321,prabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101740,Marketed,2024-11-08,02528142,LETYBO,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02528142,LETYBO (letibotulinumtoxina 100 unit per vial powder for solution for injection) HUGEL CANADA INC.,Active,9014865,letibotulinumtoxina 100 unit per vial powder for solution for injection,8002469,letibotulinumtoxina,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102069,Marketed,2023-06-20,02531577,BOTOX,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02531577,BOTOX (onabotulinumtoxinA 50 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014874,onabotulinumtoxinA 50 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102070,Marketed,2023-10-11,02531585,BOTOX,1.0,M03AX01,Botulinum toxin,Powder for solution,Intramuscular,02531585,BOTOX (onabotulinumtoxinA 200 unit per vial powder for solution for injection) ABBVIE CORPORATION,Active,9014931,onabotulinumtoxinA 200 unit per vial powder for solution for injection,8002245,onabotulinumtoxinA,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88626,Marketed,2025-10-09,02401347,ADCETRIS,1.0,L01FX05,Brentuximab vedotin,Powder for solution,Intravenous,02401347,ADCETRIS (brentuximab vedotin 50 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9005187,brentuximab vedotin 50 mg per vial powder for solution for injection,8001595,brentuximab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94950,Marketed,2017-04-19,02461749,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461749,REXULTI (brexpiprazole 0.25 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006153,brexpiprazole 0.25 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94951,Marketed,2017-04-19,02461757,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461757,REXULTI (brexpiprazole 0.5 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006154,brexpiprazole 0.5 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94952,Marketed,2017-04-19,02461765,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461765,REXULTI (brexpiprazole 1 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006155,brexpiprazole 1 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94953,Marketed,2017-04-19,02461773,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461773,REXULTI (brexpiprazole 2 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006156,brexpiprazole 2 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94954,Marketed,2017-04-19,02461781,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461781,REXULTI (brexpiprazole 3 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006157,brexpiprazole 3 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94955,Marketed,2017-04-19,02461803,REXULTI,1.0,N05AX16,Brexpiprazole,Tablet,Oral,02461803,REXULTI (brexpiprazole 4 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9006158,brexpiprazole 4 mg oral tablet,8001597,brexpiprazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100600,Marketed,2021-12-16,02516667,TECARTUS,1.0,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,
102173,Marketed,2023-12-15,02532719,TECARTUS,1.0,L01XL06,Brexucabtagene autoleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,
96982,Marketed,2018-08-31,02479206,ALUNBRIG,1.0,L01ED04,Brigatinib,Tablet,Oral,02479206,ALUNBRIG (brigatinib 30 mg oral tablet) TAKEDA CANADA INC,Active,9013411,brigatinib 30 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96983,Marketed,2018-08-31,02479214,ALUNBRIG,1.0,L01ED04,Brigatinib,Tablet,Oral,02479214,ALUNBRIG (brigatinib 90 mg oral tablet) TAKEDA CANADA INC,Active,9013412,brigatinib 90 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96984,Marketed,2018-08-31,02479222,ALUNBRIG,1.0,L01ED04,Brigatinib,Tablet,Oral,02479222,ALUNBRIG (brigatinib 180 mg oral tablet) TAKEDA CANADA INC,Active,9013410,brigatinib 180 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96985,Marketed,2018-08-31,02479230,ALUNBRIG,2.0,L01ED04,Brigatinib,"Kit,Tablet",Oral,02479230,ALUNBRIG (brigatinib 90 mg oral tablet with brigatinib 180 mg oral tablet) TAKEDA CANADA INC,Active,9013413,brigatinib 90 mg oral tablet with brigatinib 180 mg oral tablet,8002014,brigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60166,Marketed,2024-03-27,02236876,ALPHAGAN,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02236876,ALPHAGAN (brimonidine tartrate 0.2 % ophthalmic drops) ABBVIE CORPORATION,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
72483,Marketed,2023-11-28,02248151,ALPHAGAN P,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02248151,ALPHAGAN P (brimonidine tartrate 0.15 % ophthalmic drops) ABBVIE CORPORATION,Active,9003838,brimonidine tartrate 0.15 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78666,Marketed,2021-10-20,02301334,BRIMONIDINE P,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02301334,BRIMONIDINE P (brimonidine tartrate 0.15 % ophthalmic drops) AA PHARMA INC,Active,9003838,brimonidine tartrate 0.15 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
79097,Marketed,2008-02-08,02305429,SANDOZ BRIMONIDINE,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02305429,SANDOZ BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90580,Marketed,2014-03-24,02421208,ONRELTEA,1.0,D11AX21,Brimonidine,Gel,Topical,02421208,ONRELTEA (brimonidine (brimonidine tartrate) 0.33 % cutaneous gel) GALDERMA CANADA INC.,Active,9005477,brimonidine (brimonidine tartrate) 0.33 % cutaneous gel,8001103,brimonidine,448598008,Cutaneous,385100002,Gel,,,,,
93504,Marketed,2026-01-21,02449226,JAMP BRIMONIDINE,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02449226,JAMP BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
99720,Marketed,2021-11-26,02507811,MED-BRIMONIDINE,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02507811,MED-BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100474,Marketed,2021-07-20,02515350,RIVA-BRIMONIDINE,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02515350,RIVA-BRIMONIDINE (brimonidine tartrate 0.2 % ophthalmic drops) LABORATOIRE RIVA INC.,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100476,Marketed,2023-05-31,02515377,BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02515377,BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION (brimonidine tartrate 0.2 % ophthalmic drops) HIKMA CANADA LIMITED,Active,9003188,brimonidine tartrate 0.2 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100706,Marketed,2022-07-05,02517698,LUMIFY,1.0,S01EA05,Brimonidine,Solution,Ophthalmic,02517698,LUMIFY (brimonidine tartrate 0.025 % ophthalmic drops) BAUSCH & LOMB INC,Active,9014731,brimonidine tartrate 0.025 % ophthalmic drops,8001103,brimonidine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
62313,Marketed,2018-03-14,02238873,AZOPT,1.0,S01EC04,Brinzolamide,Suspension,Ophthalmic,02238873,AZOPT (brinzolamide 1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012376,brinzolamide 1 % ophthalmic drops,8001100,brinzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91973,Marketed,2018-04-18,02435411,SIMBRINZA,2.0,S01EC54,"Brinzolamide, combinations",Suspension,Ophthalmic,02435411,SIMBRINZA (brimonidine tartrate 0.2 % and brinzolamide 1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012401,brimonidine tartrate 0.2 % and brinzolamide 1 % ophthalmic drops,8001127,brimonidine and brinzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
93933,Marketed,2016-05-02,02452936,BRIVLERA,1.0,N03AX23,Brivaracetam,Tablet,Oral,02452936,BRIVLERA (brivaracetam 10 mg oral tablet) UCB CANADA INC,Active,9005956,brivaracetam 10 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93934,Marketed,2016-05-02,02452944,BRIVLERA,1.0,N03AX23,Brivaracetam,Tablet,Oral,02452944,BRIVLERA (brivaracetam 25 mg oral tablet) UCB CANADA INC,Active,9005957,brivaracetam 25 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93935,Marketed,2016-05-02,02452952,BRIVLERA,1.0,N03AX23,Brivaracetam,Tablet,Oral,02452952,BRIVLERA (brivaracetam 50 mg oral tablet) UCB CANADA INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93936,Marketed,2016-05-02,02452960,BRIVLERA,1.0,N03AX23,Brivaracetam,Tablet,Oral,02452960,BRIVLERA (brivaracetam 75 mg oral tablet) UCB CANADA INC,Active,9005959,brivaracetam 75 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93937,Marketed,2016-05-02,02452979,BRIVLERA,1.0,N03AX23,Brivaracetam,Tablet,Oral,02452979,BRIVLERA (brivaracetam 100 mg oral tablet) UCB CANADA INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93938,Marketed,2020-04-06,02452987,BRIVLERA,1.0,N03AX23,Brivaracetam,Solution,Oral,02452987,BRIVLERA (brivaracetam 10 mg per mL oral solution) UCB CANADA INC,Active,9014263,brivaracetam 10 mg per mL oral solution,8001598,brivaracetam,26643006,Oral,385023001,Oral solution,,,,,
93939,Marketed,2018-10-10,02452995,BRIVLERA,1.0,N03AX23,Brivaracetam,Solution,Intravenous,02452995,BRIVLERA (brivaracetam 50 mg per 5 mL solution for injection vial) UCB CANADA INC,Active,9013414,brivaracetam 50 mg per 5 mL solution for injection vial,8001598,brivaracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102737,Marketed,2024-09-10,02538679,APO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02538679,APO-BRIVARACETAM (brivaracetam 10 mg oral tablet) APOTEX INC,Active,9005956,brivaracetam 10 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102739,Marketed,2024-09-10,02538687,APO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02538687,APO-BRIVARACETAM (brivaracetam 25 mg oral tablet) APOTEX INC,Active,9005957,brivaracetam 25 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102740,Marketed,2024-09-10,02538695,APO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02538695,APO-BRIVARACETAM (brivaracetam 50 mg oral tablet) APOTEX INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102741,Marketed,2024-09-10,02538709,APO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02538709,APO-BRIVARACETAM (brivaracetam 75 mg oral tablet) APOTEX INC,Active,9005959,brivaracetam 75 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102742,Marketed,2024-09-10,02538717,APO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02538717,APO-BRIVARACETAM (brivaracetam 100 mg oral tablet) APOTEX INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102793,Marketed,2024-09-12,02539292,AURO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02539292,AURO-BRIVARACETAM (brivaracetam 50 mg oral tablet) AURO PHARMA INC,Active,9005958,brivaracetam 50 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102794,Marketed,2024-09-12,02539306,AURO-BRIVARACETAM,1.0,N03AX23,Brivaracetam,Tablet,Oral,02539306,AURO-BRIVARACETAM (brivaracetam 100 mg oral tablet) AURO PHARMA INC,Active,9005955,brivaracetam 100 mg oral tablet,8001598,brivaracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96302,Marketed,2019-06-07,02473623,SILIQ,1.0,L04AC12,Brodalumab,Solution,Subcutaneous,02473623,"SILIQ (brodalumab 210 mg per 1.5 mL solution for injection syringe) BAUSCH HEALTH, CANADA INC.",Active,9013415,brodalumab 210 mg per 1.5 mL solution for injection syringe,8002015,brodalumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98684,Marketed,2020-05-15,02496976,BEOVU,1.0,S01LA06,Brolucizumab,Solution,Intravitreal,02496976,BEOVU (brolucizumab 6 mg per 0.05 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014322,brolucizumab 6 mg per 0.05 mL solution for injection syringe,8002331,brolucizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
19047,Marketed,2022-01-20,02177188,APO-BROMAZEPAM,1.0,N05BA08,Bromazepam,Tablet,Oral,02177188,APO-BROMAZEPAM (bromazepam 6 mg oral tablet) APOTEX INC,Active,9000165,bromazepam 6 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19056,Marketed,2022-01-20,02177161,APO-BROMAZEPAM,1.0,N05BA08,Bromazepam,Tablet,Oral,02177161,APO-BROMAZEPAM (bromazepam 3 mg oral tablet) APOTEX INC,Active,9000164,bromazepam 3 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49693,Marketed,2015-05-29,02230584,TEVA-BROMAZEPAM,1.0,N05BA08,Bromazepam,Tablet,Oral,02230584,TEVA-BROMAZEPAM (bromazepam 3 mg oral tablet) TEVA CANADA LIMITED,Active,9000164,bromazepam 3 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49694,Marketed,2015-05-29,02230585,TEVA-BROMAZEPAM,1.0,N05BA08,Bromazepam,Tablet,Oral,02230585,TEVA-BROMAZEPAM (bromazepam 6 mg oral tablet) TEVA CANADA LIMITED,Active,9000165,bromazepam 6 mg oral tablet,8000090,bromazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92351,Marketed,2015-09-25,02439123,PROLENSA,1.0,S01BC11,Bromfenac,Solution,Ophthalmic,02439123,PROLENSA (bromfenac (bromfenac sodium sesquihydrate) 0.07 % ophthalmic drops) BAUSCH & LOMB INC,Active,9012915,bromfenac (bromfenac sodium) 0.07 % ophthalmic drops,8001599,bromfenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102655,Marketed,2023-06-12,02537788,APO-BROMFENAC,1.0,S01BC11,Bromfenac,Solution,Ophthalmic,02537788,APO-BROMFENAC (bromfenac (bromfenac sodium sesquihydrate) 0.07 % ophthalmic drops) APOTEX INC,Active,9012915,bromfenac (bromfenac sodium) 0.07 % ophthalmic drops,8001599,bromfenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
16195,Marketed,2013-01-13,02087324,BROMOCRIPTINE,1.0,N04BC01,Bromocriptine,Tablet,Oral,02087324,BROMOCRIPTINE (bromocriptine (bromocriptine mesylate) 2.5 mg oral tablet) AA PHARMA INC,Active,9002633,bromocriptine (bromocriptine mesylate) 2.5 mg oral tablet,8001343,bromocriptine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49403,Marketed,2012-10-17,02230454,BROMOCRIPTINE,1.0,N04BC01,Bromocriptine,Capsule,Oral,02230454,BROMOCRIPTINE (bromocriptine (bromocriptine mesylate) 5 mg oral capsule) AA PHARMA INC,Active,9003041,bromocriptine (bromocriptine mesylate) 5 mg oral capsule,8001343,bromocriptine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10666,Marketed,2000-11-07,00851752,PULMICORT TURBUHALER,1.0,R03BA02,Budesonide,Powder (metered dose),Inhalation,00851752,PULMICORT TURBUHALER (budesonide 200 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000344,budesonide 200 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
10667,Marketed,2000-10-13,00852074,PULMICORT TURBUHALER,1.0,R03BA02,Budesonide,Powder (metered dose),Inhalation,00852074,PULMICORT TURBUHALER (budesonide 100 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000342,budesonide 100 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
12182,Marketed,2001-03-23,00851760,PULMICORT TURBUHALER,1.0,R03BA02,Budesonide,Powder (metered dose),Inhalation,00851760,PULMICORT TURBUHALER (budesonide 400 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9000406,budesonide 400 mcg per actuation inhalation powder,8000134,budesonide,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
13190,Marketed,2002-12-15,01978926,PULMICORT NEBUAMP 0.5 MG/ML,1.0,R03BA02,Budesonide,Suspension,Inhalation,01978926,PULMICORT NEBUAMP 0.5 MG/ML (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
13191,Marketed,2000-01-29,01978918,PULMICORT NEBUAMP 0.25 MG/ML,1.0,R03BA02,Budesonide,Suspension,Inhalation,01978918,PULMICORT NEBUAMP 0.25 MG/ML (budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000404,budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
16264,Marketed,2016-07-13,02052431,ENTOCORT ENEMA,1.0,A07EA06,Budesonide,"Tablet,Kit,Enema",Rectal,02052431,ENTOCORT ENEMA (budesonide 2.3 mg tablet for rectal suspension with diluent solution) TILLOTTS PHARMA GMBH,Active,9014852,budesonide 2.3 mg tablet for rectal suspension with diluent solution,8000134,budesonide,37161004,Rectal,385193009,Tablet for rectal suspension,732936001,Tablet (unit of presentation),,,
43511,Marketed,2000-01-29,02229099,PULMICORT NEBUAMP 0.125 MG/ML,1.0,R03BA02,Budesonide,Suspension,Inhalation,02229099,PULMICORT NEBUAMP 0.125 MG/ML (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) ASTRAZENECA CANADA INC,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
43534,Marketed,2016-07-13,02229293,ENTOCORT,1.0,A07EA06,Budesonide,Capsule (sustained-release),Oral,02229293,ENTOCORT (budesonide 3 mg prolonged-release oral capsule) TILLOTTS PHARMA GMBH,Active,9000696,budesonide 3 mg prolonged-release oral capsule,8000134,budesonide,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
49895,Marketed,2010-06-24,02230648,MYLAN-BUDESONIDE AQ,1.0,R01AD05,Budesonide,"Spray, metered dose",Nasal,02230648,MYLAN-BUDESONIDE AQ (budesonide 100 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000699,budesonide 100 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
51375,Marketed,2018-06-09,02231923,RHINOCORT AQUA,1.0,R01AD05,Budesonide,"Spray, metered dose",Nasal,02231923,RHINOCORT AQUA (budesonide 64 mcg per actuation nasal spray) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000746,budesonide 64 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
64595,Marketed,2011-04-21,02241003,MYLAN-BUDESONIDE AQ,1.0,R01AD05,Budesonide,"Spray, metered dose",Nasal,02241003,MYLAN-BUDESONIDE AQ (budesonide 64 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9000746,budesonide 64 mcg per actuation nasal spray,8000134,budesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
94275,Marketed,2016-07-25,02455889,CORTIMENT,1.0,A07EA06,Budesonide,Tablet (delayed and extended release),Oral,02455889,CORTIMENT (budesonide 9 mg modified-release oral tablet) FERRING INC,Active,9001460,budesonide 9 mg modified-release oral tablet,8000134,budesonide,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
95417,Marketed,2017-11-08,02465949,TEVA-BUDESONIDE,1.0,R03BA02,Budesonide,Suspension,Inhalation,02465949,TEVA-BUDESONIDE (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) TEVA CANADA LIMITED,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
95418,Marketed,2017-11-08,02465957,TEVA-BUDESONIDE,1.0,R03BA02,Budesonide,Suspension,Inhalation,02465957,TEVA-BUDESONIDE (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) TEVA CANADA LIMITED,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
98367,Marketed,2021-01-07,02493675,JORVEZA,1.0,A07EA06,Budesonide,Tablet (orally disintegrating),Oral,02493675,JORVEZA (budesonide 1 mg orodispersible tablet) AVIR PHARMA INC.,Active,9014426,budesonide 1 mg orodispersible tablet,8000134,budesonide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
98429,Marketed,2021-06-04,02494264,TARO-BUDESONIDE,1.0,R03BA02,Budesonide,Suspension,Inhalation,02494264,TARO-BUDESONIDE (budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000732,budesonide 0.25 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
98430,Marketed,2021-06-04,02494272,TARO-BUDESONIDE,1.0,R03BA02,Budesonide,Suspension,Inhalation,02494272,TARO-BUDESONIDE (budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000404,budesonide 0.5 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
98431,Marketed,2021-06-04,02494280,TARO-BUDESONIDE,1.0,R03BA02,Budesonide,Suspension,Inhalation,02494280,TARO-BUDESONIDE (budesonide 1 mg per 2 mL nebulizer suspension unit dose vial) TARO PHARMACEUTICALS INC,Active,9000405,budesonide 1 mg per 2 mL nebulizer suspension unit dose vial,8000134,budesonide,738984000,Parenteral,739008005,Suspension,733026001,Vial (unit of presentation),,,
98785,Marketed,2023-09-18,02498057,UCERIS,1.0,A07EA06,Budesonide,Foam,Rectal,02498057,"UCERIS (budesonide 2 mg per actuation rectal foam) BAUSCH HEALTH, CANADA INC.",Active,9014911,budesonide 2 mg per actuation rectal foam,8000134,budesonide,37161004,Rectal,385185009,Rectal foam,732981002,Actuation (unit of presentation),,,
100305,Marketed,2021-10-19,02513854,JORVEZA,1.0,A07EA06,Budesonide,Tablet (orally disintegrating),Oral,02513854,JORVEZA (budesonide 0.5 mg orodispersible tablet) AVIR PHARMA INC.,Active,9014606,budesonide 0.5 mg orodispersible tablet,8000134,budesonide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
106325,Marketed,2025-10-07,02560178,HEPCLUDEX,1.0,J05AX28,Bulevirtide,Powder for solution,Subcutaneous,02560178,HEPCLUDEX (bulevirtide (bulevirtide acetate) 2 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9015264,bulevirtide (bulevirtide acetate) 2 mg per vial powder for solution for injection,8002557,bulevirtide,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
14322,Marketed,2023-04-14,00728276,BURINEX,1.0,C03CA02,Bumetanide,Tablet,Oral,00728276,BURINEX (bumetanide 5 mg oral tablet) KARO PHARMA AB,Active,9008010,bumetanide 5 mg oral tablet,8000873,bumetanide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14334,Marketed,2023-01-10,00728284,BURINEX,1.0,C03CA02,Bumetanide,Tablet,Oral,00728284,BURINEX (bumetanide 1 mg oral tablet) KARO PHARMA AB,Active,9008009,bumetanide 1 mg oral tablet,8000873,bumetanide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16161,Marketed,2018-06-20,01976141,SENSORCAINE,1.0,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700656,SENSORCAINE (bupivacaine hydrochloride 25 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013269,bupivacaine hydrochloride 25 mg per 10 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16161,Marketed,2018-06-20,01976141,SENSORCAINE,1.0,N01BB01,Bupivacaine,Solution,"Epidural,Block/infiltration",77700657,SENSORCAINE (bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9012923,bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
16164,Marketed,2018-06-09,01976168,SENSORCAINE,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700658,SENSORCAINE (bupivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013270,bupivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16164,Marketed,2018-06-09,01976168,SENSORCAINE,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700659,SENSORCAINE (bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9012916,bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65587,Marketed,2019-06-21,02241917,MARCAINE,1.0,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",02241917,MARCAINE (bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9012919,bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79145,Marketed,2019-06-06,02305909,MARCAINE,1.0,N01BB01,Bupivacaine,Solution,Block/infiltration,02305909,MARCAINE (bupivacaine hydrochloride 250 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9012921,bupivacaine hydrochloride 250 mg per 50 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92837,Marketed,2016-05-20,02443686,BUPIVACAINE INJECTION BP,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700696,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012923,bupivacaine hydrochloride 50 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92837,Marketed,2016-05-20,02443686,BUPIVACAINE INJECTION BP,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700697,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 25 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012920,bupivacaine hydrochloride 25 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92838,Marketed,2016-05-20,02443694,BUPIVACAINE INJECTION BP,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700698,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012916,bupivacaine hydrochloride 100 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92838,Marketed,2016-05-20,02443694,BUPIVACAINE INJECTION BP,1.0,N01BB01,Bupivacaine,Solution,"Block/infiltration,Epidural",77700699,BUPIVACAINE INJECTION BP (bupivacaine hydrochloride 50 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012922,bupivacaine hydrochloride 50 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94807,Marketed,2018-03-13,02460645,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,1.0,N01BB01,Bupivacaine,Solution,Intraspinal,02460645,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule) STERIMAX INC,Active,9012918,bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
97900,Marketed,2022-08-15,02488930,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701116,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 75 mg per 10 mL solution for injection vial) BAXTER CORPORATION",Active,9014581,bupivacaine hydrochloride 75 mg per 10 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97900,Marketed,2022-08-15,02488930,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701117,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial) BAXTER CORPORATION",Active,9012919,bupivacaine hydrochloride 150 mg per 20 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97900,Marketed,2022-08-15,02488930,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB01,Bupivacaine,Solution,"Epidural,Retrobulbar",77701118,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP (bupivacaine hydrochloride 225 mg per 30 mL solution for injection vial) BAXTER CORPORATION",Active,9014580,bupivacaine hydrochloride 225 mg per 30 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100171,Marketed,2021-10-02,02512424,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,1.0,N01BB01,Bupivacaine,Solution,Intraspinal,02512424,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014607,bupivacaine hydrochloride 15 mg per 2 mL solution for injection vial,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102546,Marketed,2024-03-19,02536714,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,1.0,N01BB01,Bupivacaine,Solution,Intraspinal,02536714,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule) FORMATIVE PHARMA INC.,Active,9012918,bupivacaine hydrochloride 15 mg per 2 mL solution for injection ampoule,8001600,bupivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16162,Marketed,2018-07-18,01976184,SENSORCAINE WITH EPINEPHRINE,2.0,N01BB51,"Bupivacaine, combinations",Solution,"Block/infiltration,Epidural",01976184,SENSORCAINE WITH EPINEPHRINE (bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014084,bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
16163,Marketed,2018-05-18,01976206,SENSORCAINE WITH EPINEPHRINE,2.0,N01BB51,"Bupivacaine, combinations",Solution,"Block/infiltration,Epidural",01976206,SENSORCAINE WITH EPINEPHRINE (bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014082,bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65585,Marketed,2017-09-07,02241915,MARCAINE E,2.0,N01BB51,"Bupivacaine, combinations",Solution,"Epidural,Block/infiltration",02241915,MARCAINE E (bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014084,bupivacaine hydrochloride 50 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65586,Marketed,2017-09-07,02241916,MARCAINE E,2.0,N01BB51,"Bupivacaine, combinations",Solution,"Block/infiltration,Epidural",02241916,MARCAINE E (bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014082,bupivacaine hydrochloride 100 mg per 20 mL and epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL solution for injection vial,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86769,Marketed,2012-05-07,02381850,"BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION",2.0,N01BB51,"Bupivacaine, combinations",Solution,Block/infiltration,02381850,"BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION (bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC",Active,9014083,bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
96430,Marketed,2019-04-12,02474247,MARCAINE,2.0,N01BB51,"Bupivacaine, combinations",Solution,Block/infiltration,02474247,MARCAINE (bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT INC,Active,9014083,bupivacaine hydrochloride 5 mg per mL and epinephrine (epinephrine bitartrate) 0.005 mg per mL solution for injection 1.8 mL cartridge,8001601,bupivacaine and epinephrine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
82671,Marketed,2010-05-26,02341174,BUTRANS 5,1.0,N02AE01,Buprenorphine,Patch,Transdermal,02341174,BUTRANS 5 (buprenorphine 5 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001317,buprenorphine 5 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
82675,Marketed,2010-05-26,02341212,BUTRANS 10,1.0,N02AE01,Buprenorphine,Patch,Transdermal,02341212,BUTRANS 10 (buprenorphine 10 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001315,buprenorphine 10 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
82676,Marketed,2010-05-26,02341220,BUTRANS 20,1.0,N02AE01,Buprenorphine,Patch,Transdermal,02341220,BUTRANS 20 (buprenorphine 20 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001316,buprenorphine 20 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
93692,Marketed,2016-06-15,02450771,BUTRANS 15,1.0,N02AE01,Buprenorphine,Patch,Transdermal,02450771,BUTRANS 15 (buprenorphine 15 mcg per hour transdermal patch) PURDUE PHARMA,Active,9001459,buprenorphine 15 mcg per hour transdermal patch,8000775,buprenorphine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
97348,Marketed,2020-02-03,02483084,SUBLOCADE,1.0,N07BC01,Buprenorphine,Solution (extended release),Subcutaneous,02483084,SUBLOCADE (buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED,Active,9014238,buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe,8000775,buprenorphine,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,1.0,
97349,Marketed,2020-02-03,02483092,SUBLOCADE,1.0,N07BC01,Buprenorphine,Solution (extended release),Subcutaneous,02483092,SUBLOCADE (buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe) INDIVIOR UK LIMITED,Active,9014239,buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe,8000775,buprenorphine,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,1.0,
78104,Marketed,2016-03-10,02295695,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02295695,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
78105,Marketed,2016-04-01,02295709,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02295709,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
90952,Marketed,2017-11-24,02424851,PMS-BUPRENORPHINE-NALOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02424851,PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) PHARMASCIENCE INC,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
90953,Marketed,2017-11-24,02424878,PMS-BUPRENORPHINE-NALOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02424878,PMS-BUPRENORPHINE-NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) PHARMASCIENCE INC,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
94043,Marketed,2021-03-22,02453908,TEVA-BUPRENORPHINE/NALOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02453908,TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet) TEVA CANADA LIMITED,Active,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
94044,Marketed,2021-03-22,02453916,TEVA-BUPRENORPHINE/NALOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02453916,TEVA-BUPRENORPHINE/NALOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet) TEVA CANADA LIMITED,Active,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
95646,Marketed,2018-02-14,02468085,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02468085,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride dihydrate) 3 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9012472,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
95647,Marketed,2018-02-14,02468093,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations",Tablet,Sublingual,02468093,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride dihydrate) 4 mg sublingual tablet) INDIVIOR UK LIMITED,Active,9012473,buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet,8000372,buprenorphine and naloxone,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
99189,Marketed,2021-01-20,02502313,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations","Film, soluble","Buccal,Sublingual",02502313,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014448,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,
99190,Marketed,2021-06-17,02502321,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations","Film, soluble","Buccal,Sublingual",02502321,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 4 mg and naloxone (naloxone hydrochloride) 1 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014541,buprenorphine (buprenorphine hydrochloride) 4 mg and naloxone (naloxone hydrochloride) 1 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,
99191,Marketed,2021-01-20,02502348,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations","Film, soluble","Buccal,Sublingual",02502348,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014449,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,
99192,Marketed,2021-01-20,02502356,SUBOXONE,2.0,N07BC51,"Buprenorphine, combinations","Film, soluble","Sublingual,Buccal",02502356,SUBOXONE (buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg oromucosal film) INDIVIOR UK LIMITED,Active,9014447,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg oromucosal film,8000372,buprenorphine and naloxone,37839007,Sublingual,420460001,Film,732995004,Film (unit of presentation),,1.0,
61860,Marketed,2021-06-04,02238441,ZYBAN,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02238441,"ZYBAN (bupropion hydrochloride 150 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76058,Marketed,2021-05-14,02275074,ODAN BUPROPION SR,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02275074,ODAN BUPROPION SR (bupropion hydrochloride 100 mg prolonged-release oral tablet) ODAN LABORATORIES LTD,Active,9001158,bupropion hydrochloride 100 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76059,Marketed,2021-05-14,02275082,ODAN BUPROPION SR,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02275082,ODAN BUPROPION SR (bupropion hydrochloride 150 mg prolonged-release oral tablet) ODAN LABORATORIES LTD,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76060,Marketed,2021-06-11,02275090,WELLBUTRIN XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02275090,"WELLBUTRIN XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76061,Marketed,2021-06-11,02275104,WELLBUTRIN XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02275104,"WELLBUTRIN XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92405,Marketed,2020-05-28,02439654,TEVA-BUPROPION XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02439654,TEVA-BUPROPION XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92406,Marketed,2020-05-28,02439662,TEVA-BUPROPION XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02439662,TEVA-BUPROPION XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
96647,Marketed,2021-02-18,02475804,TARO-BUPROPION XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02475804,TARO-BUPROPION XL (bupropion hydrochloride 150 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9000798,bupropion hydrochloride 150 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
96648,Marketed,2021-02-18,02475812,TARO-BUPROPION XL,1.0,N06AX12,Bupropion,Tablet (extended-release),Oral,02475812,TARO-BUPROPION XL (bupropion hydrochloride 300 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001138,bupropion hydrochloride 300 mg prolonged-release oral tablet,8000257,bupropion,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
96230,Marketed,2020-06-02,02472945,CONTRAVE,2.0,A08AA62,Bupropion and naltrexone,Tablet (extended-release),Oral,02472945,"CONTRAVE (bupropion hydrochloride 90 mg and naltrexone hydrochloride 8 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9012691,bupropion hydrochloride 90 mg and naltrexone hydrochloride 8 mg prolonged-release oral tablet,8001345,bupropion and naltrexone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97399,Marketed,2022-11-30,02483629,CRYSVITA,1.0,M05BX05,Burosumab,Solution,Subcutaneous,02483629,"CRYSVITA (burosumab 10 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013944,burosumab 10 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97400,Marketed,2023-03-03,02483637,CRYSVITA,1.0,M05BX05,Burosumab,Solution,Subcutaneous,02483637,"CRYSVITA (burosumab 20 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013945,burosumab 20 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97401,Marketed,2023-04-05,02483645,CRYSVITA,1.0,M05BX05,Burosumab,Solution,Subcutaneous,02483645,"CRYSVITA (burosumab 30 mg per 1 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9013946,burosumab 30 mg per 1 mL solution for injection vial,8002252,burosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
43417,Marketed,2020-06-05,02225166,SUPREFACT,1.0,L02AE01,Buserelin,Solution,Subcutaneous,02225166,SUPREFACT (buserelin (buserelin acetate) 1 mg per mL solution for injection 5.5 mL vial) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9012924,buserelin (buserelin acetate) 1 mg per mL solution for injection 5.5 mL vial,8001602,buserelin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43349,Marketed,2024-10-22,02223163,PRO-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02223163,PRO-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50220,Marketed,1997-05-26,02230942,PMS-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02230942,PMS-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50822,Marketed,2015-06-04,02231492,TEVA-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02231492,TEVA-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93348,Marketed,2016-02-17,02447851,BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02447851,BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98992,Marketed,2020-10-30,02500213,AURO-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02500213,AURO-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99918,Marketed,2021-10-29,02509911,JAMP BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02509911,JAMP BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100833,Marketed,2022-01-26,02519054,MINT-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02519054,MINT-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103936,Marketed,2024-09-24,02550555,AMB-BUSPIRONE,1.0,N05BE01,Buspirone,Tablet,Oral,02550555,AMB-BUSPIRONE (buspirone hydrochloride 10 mg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9003012,buspirone hydrochloride 10 mg oral tablet,8001247,buspirone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
959,Marketed,2018-07-24,00004618,MYLERAN,1.0,L01AB01,Busulfan,Tablet,Oral,00004618,MYLERAN (busulfan 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9001541,busulfan 2 mg oral tablet,8001603,busulfan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95184,Marketed,2017-10-04,02463733,BUSULFAN FOR INJECTION,1.0,L01AB01,Busulfan,Solution,Intravenous,02463733,BUSULFAN FOR INJECTION (busulfan 60 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9012925,busulfan 60 mg per 10 mL solution for injection vial,8001603,busulfan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96833,Marketed,2019-03-29,02477343,PMS-BUSULFAN,1.0,L01AB01,Busulfan,Solution,Intravenous,02477343,PMS-BUSULFAN (busulfan 60 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9012925,busulfan 60 mg per 10 mL solution for injection vial,8001603,busulfan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
66247,Marketed,2015-04-17,02242504,BUTORPHANOL NASAL SPRAY,1.0,N02AF01,Butorphanol,Solution,Nasal,02242504,BUTORPHANOL NASAL SPRAY (butorphanol tartrate 10 mg per mL nasal spray) AA PHARMA INC,Active,9000913,butorphanol tartrate 10 mg per mL nasal spray,8000776,butorphanol,46713006,Nasal,385157007,Nasal spray,,,,1.0,
2481,Marketed,2021-10-28,00363812,BUSCOPAN,1.0,A03BB01,Butylscopolamine,Tablet,Oral,00363812,BUSCOPAN (hyoscine butylbromide 10 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9001758,hyoscine butylbromide 10 mg oral tablet,8001482,hyoscine butylbromide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2483,Marketed,2022-08-16,00363839,BUSCOPAN,1.0,A03BB01,Butylscopolamine,Solution,"Intramuscular,Subcutaneous,Intravenous",00363839,BUSCOPAN (hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule) SANOFI CONSUMER HEALTH INC,Active,9012818,hyoscine butylbromide 20 mg per 1 mL solution for injection ampoule,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
48226,Marketed,2007-05-28,02229868,HYOSCINE BUTYLBROMIDE INJECTION,1.0,A03BB01,Butylscopolamine,Solution,"Intravenous,Intramuscular,Subcutaneous",02229868,HYOSCINE BUTYLBROMIDE INJECTION (hyoscine butylbromide 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012819,hyoscine butylbromide 20 mg per 1 mL solution for injection vial,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99778,Marketed,2024-06-04,02508419,HYOSCINE BUTYLBROMIDE INJECTION BP,1.0,A03BB01,Butylscopolamine,Solution,"Subcutaneous,Intramuscular,Intravenous",02508419,HYOSCINE BUTYLBROMIDE INJECTION BP (hyoscine butylbromide 20 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012819,hyoscine butylbromide 20 mg per 1 mL solution for injection vial,8001482,hyoscine butylbromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100163,Marketed,2021-08-19,02512335,ACCEL-HYOSCINE,1.0,A03BB01,Butylscopolamine,Tablet,Oral,02512335,ACCEL-HYOSCINE (hyoscine butylbromide 10 mg oral tablet) ACCEL PHARMA INC,Active,9001758,hyoscine butylbromide 10 mg oral tablet,8001482,hyoscine butylbromide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83783,Marketed,2014-12-24,02352575,BERINERT 500,1.0,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Intravenous,02352575,BERINERT 500 (C1 esterase inhibitor human 500 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9013841,C1 esterase inhibitor human 500 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92040,Marketed,2015-05-06,02436078,BERINERT 1500,1.0,B06AC01,"C1-inhibitor, plasma derived","Powder for solution,Kit",Intravenous,02436078,BERINERT 1500 (C1 esterase inhibitor human 1500 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9013840,C1 esterase inhibitor human 1500 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95643,Marketed,2020-01-23,02468069,HAEGARDA,1.0,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Subcutaneous,02468069,HAEGARDA (C1 esterase inhibitor human 2000 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014234,C1 esterase inhibitor human 2000 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95644,Marketed,2020-01-23,02468077,HAEGARDA,1.0,B06AC01,"C1-inhibitor, plasma derived","Kit,Powder for solution",Subcutaneous,02468077,HAEGARDA (C1 esterase inhibitor human 3000 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014235,C1 esterase inhibitor human 3000 unit per vial powder for solution for injection with diluent solution,8002233,C1 esterase inhibitor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97765,Marketed,2019-12-18,02487497,CABAZITAXEL FOR INJECTION,1.0,L01CD04,Cabazitaxel,Solution,Intravenous,02487497,CABAZITAXEL FOR INJECTION (cabazitaxel 45 mg per 4.5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014218,cabazitaxel 45 mg per 4.5 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97766,Marketed,2019-12-18,02487500,CABAZITAXEL FOR INJECTION,1.0,L01CD04,Cabazitaxel,Solution,Intravenous,02487500,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 6 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014219,cabazitaxel 60 mg per 6 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98553,Marketed,2020-06-01,02495635,CABAZITAXEL FOR INJECTION,1.0,L01CD04,Cabazitaxel,Solution,Intravenous,02495635,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 1.5 mL solution for injection vial with diluent solution) DR REDDY'S LABORATORIES LTD,Active,9012926,cabazitaxel 60 mg per 1.5 mL solution for injection vial with diluent solution,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104269,Marketed,2025-04-10,02553783,CABAZITAXEL FOR INJECTION,1.0,L01CD04,Cabazitaxel,Solution,Intravenous,02553783,CABAZITAXEL FOR INJECTION (cabazitaxel 45 mg per 4.5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9014218,cabazitaxel 45 mg per 4.5 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104270,Marketed,2025-04-10,02553791,CABAZITAXEL FOR INJECTION,1.0,L01CD04,Cabazitaxel,Solution,Intravenous,02553791,CABAZITAXEL FOR INJECTION (cabazitaxel 60 mg per 6 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9014219,cabazitaxel 60 mg per 6 mL solution for injection vial,8001604,cabazitaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
66198,Marketed,2006-01-05,02242471,DOSTINEX,1.0,G02CB03,Cabergoline,Tablet,Oral,02242471,DOSTINEX (cabergoline 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94276,Marketed,2021-03-01,02455897,APO-CABERGOLINE,1.0,G02CB03,Cabergoline,Tablet,Oral,02455897,APO-CABERGOLINE (cabergoline 0.5 mg oral tablet) APOTEX INC,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103844,Marketed,2025-02-04,02549611,JAMP CABERGOLINE,1.0,G02CB03,Cabergoline,Tablet,Oral,02549611,JAMP CABERGOLINE (cabergoline 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003499,cabergoline 0.5 mg oral tablet,8001346,cabergoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98705,Marketed,2020-09-21,02497204,VOCABRIA,1.0,J05AJ04,Cabotegravir,Tablet,Oral,02497204,VOCABRIA (cabotegravir (cabotegravir sodium) 30 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014353,cabotegravir (cabotegravir sodium) 30 mg oral tablet,8002341,cabotegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103642,Marketed,2024-06-19,02547465,APRETUDE,1.0,J05AJ04,Cabotegravir,Tablet,Oral,02547465,APRETUDE (cabotegravir (cabotegravir sodium) 30 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014353,cabotegravir (cabotegravir sodium) 30 mg oral tablet,8002341,cabotegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103643,Marketed,2024-06-19,02547473,APRETUDE,1.0,J05AJ04,Cabotegravir,Suspension (extended-release),Intramuscular,02547473,APRETUDE (cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial) VIIV HEALTHCARE ULC,Active,9015051,cabotegravir 600 mg per 3 mL prolonged-release suspension for injection vial,8002341,cabotegravir,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
97148,Marketed,2018-10-10,02480824,CABOMETYX,1.0,L01EX07,Cabozantinib,Tablet,Oral,02480824,CABOMETYX (cabozantinib (cabozantinib malate) 20 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013419,cabozantinib (cabozantinib malate) 20 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97149,Marketed,2018-10-10,02480832,CABOMETYX,1.0,L01EX07,Cabozantinib,Tablet,Oral,02480832,CABOMETYX (cabozantinib (cabozantinib malate) 40 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013420,cabozantinib (cabozantinib malate) 40 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97150,Marketed,2018-10-10,02480840,CABOMETYX,1.0,L01EX07,Cabozantinib,Tablet,Oral,02480840,CABOMETYX (cabozantinib (cabozantinib malate) 60 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013421,cabozantinib (cabozantinib malate) 60 mg oral tablet,8002016,cabozantinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98662,Marketed,2020-07-13,02496771,PEYONA,1.0,N06BC01,Caffeine,Solution,"Intravenous,Oral",02496771,PEYONA (caffeine citrate 20 mg per 1 mL solution for injection ampoule) CHIESI FARMACEUTICI S.P.A.,Active,9014339,caffeine citrate 20 mg per 1 mL solution for injection ampoule,8002332,caffeine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
101582,Marketed,2023-07-11,02526751,CAFFEINE CITRATE ORAL SOLUTION USP,1.0,N06BC01,Caffeine,Solution,Oral,02526751,CAFFEINE CITRATE ORAL SOLUTION USP (caffeine citrate 20 mg per mL oral solution) OMEGA LABORATORIES LIMITED,Active,9014888,caffeine citrate 20 mg per mL oral solution,8002332,caffeine,26643006,Oral,739006009,Solution,,,,,
101583,Marketed,2023-07-11,02526778,CAFFEINE CITRATE INJECTION USP,1.0,N06BC01,Caffeine,Solution,Intravenous,02526778,CAFFEINE CITRATE INJECTION USP (caffeine citrate 60 mg per 3 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014889,caffeine citrate 60 mg per 3 mL solution for injection vial,8002332,caffeine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13340,Marketed,1992-12-31,01976133,DOVONEX,1.0,D05AX02,Calcipotriol,Ointment,Topical,01976133,DOVONEX (calcipotriol 50 mcg per g cutaneous ointment) LEO PHARMA INC,Active,9002421,calcipotriol 50 mcg per g cutaneous ointment,8001248,calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
68084,Marketed,2001-11-29,02244126,DOVOBET OINTMENT,2.0,D05AX52,"Calcipotriol, combinations",Ointment,Topical,02244126,DOVOBET OINTMENT (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment) LEO PHARMA INC,Active,9003670,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous ointment,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
80450,Marketed,2012-10-12,02319012,DOVOBET GEL,2.0,D05AX52,"Calcipotriol, combinations",Gel,Topical,02319012,DOVOBET GEL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous gel) LEO PHARMA INC,Active,9012655,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous gel,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,385100002,Gel,,,,,
94445,Marketed,2016-11-11,02457393,ENSTILAR,2.0,D05AX52,"Calcipotriol, combinations","Aerosol, foam",Topical,02457393,ENSTILAR (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous foam) LEO PHARMA INC,Active,9012654,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous foam,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,421166008,Foam,,,,,
101421,Marketed,2022-06-01,02525178,TARO-CALCIPOTRIOL / BETAMETHASONE GEL,2.0,D05AX52,"Calcipotriol, combinations",Gel,Topical,02525178,TARO-CALCIPOTRIOL / BETAMETHASONE GEL (betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol (calcipotriol monohydrate) 50 mcg per g cutaneous gel) TARO PHARMACEUTICALS INC,Active,9012655,betamethasone (betamethasone dipropionate) 0.5 mg per g and calcipotriol 50 mcg per g cutaneous gel,8000927,betamethasone dipropionate and calcipotriol,448598008,Cutaneous,385100002,Gel,,,,,
12837,Marketed,2008-02-13,01926691,CALCIMAR,1.0,H05BA01,Calcitonin (salmon synthetic),Solution,"Subcutaneous,Intramuscular",01926691,CALCIMAR (calcitonin salmon 400 unit per 2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9012927,calcitonin salmon 400 unit per 2 mL solution for injection vial,8001605,calcitonin salmon,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
3429,Marketed,2022-03-14,00481815,ROCALTROL,1.0,A11CC04,Calcitriol,Capsule,Oral,00481815,ROCALTROL (calcitriol 0.5 mcg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3430,Marketed,2022-03-14,00481823,ROCALTROL,1.0,A11CC04,Calcitriol,Capsule,Oral,00481823,ROCALTROL (calcitriol 0.25 mcg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82422,Marketed,2010-04-09,02338572,SILKIS,1.0,D05AX03,Calcitriol,Ointment,Topical,02338572,SILKIS (calcitriol 3 mcg per g cutaneous ointment) GALDERMA CANADA INC.,Active,9001309,calcitriol 3 mcg per g cutaneous ointment,8000075,calcitriol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
88422,Marketed,2015-03-27,02399334,CALCITRIOL INJECTION USP,1.0,A11CC04,Calcitriol,Solution,Intravenous,02399334,CALCITRIOL INJECTION USP (calcitriol 1 mcg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9001033,calcitriol 1 mcg per 1 mL solution for injection ampoule,8000075,calcitriol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
91612,Marketed,2014-10-10,02431637,CALCITRIOL-ODAN,1.0,A11CC04,Calcitriol,Capsule,Oral,02431637,CALCITRIOL-ODAN (calcitriol 0.25 mcg oral capsule) ODAN LABORATORIES LTD,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91613,Marketed,2014-10-10,02431645,CALCITRIOL-ODAN,1.0,A11CC04,Calcitriol,Capsule,Oral,02431645,CALCITRIOL-ODAN (calcitriol 0.5 mcg oral capsule) ODAN LABORATORIES LTD,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97594,Marketed,2019-06-03,02485710,TARO-CALCITRIOL,1.0,A11CC04,Calcitriol,Capsule,Oral,02485710,TARO-CALCITRIOL (calcitriol 0.25 mcg oral capsule) TARO PHARMACEUTICALS INC,Active,9000123,calcitriol 0.25 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97595,Marketed,2019-06-03,02485729,TARO-CALCITRIOL,1.0,A11CC04,Calcitriol,Capsule,Oral,02485729,TARO-CALCITRIOL (calcitriol 0.5 mcg oral capsule) TARO PHARMACEUTICALS INC,Active,9000124,calcitriol 0.5 mcg oral capsule,8000075,calcitriol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
4230,Marketed,2017-09-01,00294748,CALCIUM CHLORIDE INJECTION USP,1.0,B05XA07,Calcium chloride,Solution,Intravenous,00294748,CALCIUM CHLORIDE INJECTION USP (calcium chloride 1000 mg per 10 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013947,calcium chloride 1000 mg per 10 mL solution for injection syringe,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
10770,Marketed,1990-12-31,00821780,CALCIJECT INJ 100MG/ML,1.0,B05XA07,Calcium chloride,Liquid,Intravenous,77701010,CALCIJECT INJ 100MG/ML (calcium chloride 5000 mg per 50 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013037,calcium chloride 5000 mg per 50 mL solution for injection vial,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10770,Marketed,1990-12-31,00821780,CALCIJECT INJ 100MG/ML,1.0,B05XA07,Calcium chloride,Liquid,Intravenous,77701011,CALCIJECT INJ 100MG/ML (calcium chloride 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013948,calcium chloride 1000 mg per 10 mL solution for injection vial,8001710,calcium chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18209,Marketed,2014-05-16,02087316,LEUCOVORIN CALCIUM INJECTION,1.0,V03AF03,Calcium folinate,Solution,"Intramuscular,Intravenous",02087316,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013189,leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
44146,Marketed,2012-03-02,02170493,LEDERLE LEUCOVORIN,1.0,V03AF03,Calcium folinate,Tablet,Oral,02170493,LEDERLE LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) PFIZER CANADA ULC,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
44265,Marketed,2018-04-11,02182998,LEUCOVORIN CALCIUM INJECTION USP,1.0,V03AF03,Calcium folinate,Solution,Intravenous,02182998,LEUCOVORIN CALCIUM INJECTION USP (leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013189,leucovorin (leucovorin calcium) 500 mg per 50 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
44266,Marketed,2019-01-02,02183005,LEUCOVORIN CALCIUM INJECTION USP,1.0,V03AF03,Calcium folinate,Solution,"Intravenous,Intramuscular",02183005,LEUCOVORIN CALCIUM INJECTION USP (leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013188,leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97064,Marketed,2019-09-19,02480042,LEUCOVORIN CALCIUM INJECTION,1.0,V03AF03,Calcium folinate,Solution,"Intramuscular,Intravenous",02480042,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9013188,leucovorin (leucovorin calcium) 50 mg per 5 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98337,Marketed,2019-12-02,02493357,RIVA LEUCOVORIN,1.0,V03AF03,Calcium folinate,Tablet,Oral,02493357,RIVA LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98666,Marketed,2021-01-12,02496828,MINT-LEUCOVORIN,1.0,V03AF03,Calcium folinate,Tablet,Oral,02496828,MINT-LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98680,Marketed,2021-08-17,02496925,LEUCOVORIN CALCIUM INJECTION,1.0,V03AF03,Calcium folinate,Solution,Intravenous,02496925,LEUCOVORIN CALCIUM INJECTION (leucovorin (leucovorin calcium) 1000 mg per 100 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9014700,leucovorin (leucovorin calcium) 1000 mg per 100 mL solution for injection vial,8001833,leucovorin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103709,Marketed,2025-02-14,02548208,JAMP LEUCOVORIN,1.0,V03AF03,Calcium folinate,Tablet,Oral,02548208,JAMP LEUCOVORIN (leucovorin (leucovorin calcium) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002948,leucovorin (leucovorin calcium) 5 mg oral tablet,8001833,leucovorin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18936,Marketed,2015-07-15,02141019,"CALCIUM GLUCONATE INJECTION, USP 10%",1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77700838,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 1000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013902,calcium gluconate 1000 mg per 10 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18936,Marketed,2015-07-15,02141019,"CALCIUM GLUCONATE INJECTION, USP 10%",1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77700839,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 100 mg per mL solution for injection 100 mL vial) FRESENIUS KABI CANADA LTD",Active,9013901,calcium gluconate 100 mg per mL solution for injection 100 mL vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18936,Marketed,2015-07-15,02141019,"CALCIUM GLUCONATE INJECTION, USP 10%",1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77700840,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 5000 mg per 50 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013903,calcium gluconate 5000 mg per 50 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101221,Marketed,2022-06-17,02523140,"CALCIUM GLUCONATE INJECTION, USP 10%",1.0,B05XA19,Calcium gluconate,Solution,Intravenous,02523140,"CALCIUM GLUCONATE INJECTION, USP 10% (calcium gluconate 100 mg per mL solution for injection 500 mL bag) BAXTER CORPORATION",Active,9014732,calcium gluconate 100 mg per mL solution for injection 500 mL bag,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
102734,Marketed,2025-10-06,02538644,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77701193,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION (calcium gluconate 2000 mg per 100 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9015275,calcium gluconate 2000 mg per 100 mL solution for injection bag,8002249,calcium gluconate,738984000,Injection,385219001,Solution for injection,732982009,Bag,,,
102734,Marketed,2025-10-06,02538644,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77701194,2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION (calcium gluconate 1000 mg per 50 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9015274,calcium gluconate 1000 mg per 50 mL solution for injection bag,8002249,calcium gluconate,738984000,Injection,385219001,Solution for injection,732982009,Bag,,,
104384,Marketed,2025-04-17,02555042,CALCIUM GLUCONATE INJECTION USP 10%,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77701175,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 100 mg per mL solution for injection 100 mL vial) STERIMAX INC,Active,9013901,calcium gluconate 100 mg per mL solution for injection 100 mL vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
104384,Marketed,2025-04-17,02555042,CALCIUM GLUCONATE INJECTION USP 10%,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77701176,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 1000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013902,calcium gluconate 1000 mg per 10 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
104384,Marketed,2025-04-17,02555042,CALCIUM GLUCONATE INJECTION USP 10%,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,77701177,CALCIUM GLUCONATE INJECTION USP 10% (calcium gluconate 5000 mg per 50 mL solution for injection vial) STERIMAX INC,Active,9013903,calcium gluconate 5000 mg per 50 mL solution for injection vial,8002249,calcium gluconate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106026,Marketed,2025-10-06,02556871,CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION,1.0,B05XA19,Calcium gluconate,Solution,Intravenous,,,,,,,,,,,,,,,,
91013,Marketed,2014-06-03,02425483,INVOKANA,1.0,A10BK02,Canagliflozin,Tablet,Oral,02425483,INVOKANA (canagliflozin 100 mg oral tablet) JANSSEN INC,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91014,Marketed,2014-05-28,02425491,INVOKANA,1.0,A10BK02,Canagliflozin,Tablet,Oral,02425491,INVOKANA (canagliflozin 300 mg oral tablet) JANSSEN INC,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99959,Marketed,2026-01-02,02510367,AURO-CANAGLIFLOZIN,1.0,A10BK02,Canagliflozin,Tablet,Oral,02510367,AURO-CANAGLIFLOZIN (canagliflozin 100 mg oral tablet) AURO PHARMA INC,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99960,Marketed,2026-01-02,02510375,AURO-CANAGLIFLOZIN,1.0,A10BK02,Canagliflozin,Tablet,Oral,02510375,AURO-CANAGLIFLOZIN (canagliflozin 300 mg oral tablet) AURO PHARMA INC,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103194,Marketed,2026-01-02,02543486,JAMP CANAGLIFLOZIN,1.0,A10BK02,Canagliflozin,Tablet,Oral,02543486,JAMP CANAGLIFLOZIN (canagliflozin 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005536,canagliflozin 100 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103195,Marketed,2026-01-02,02543494,JAMP CANAGLIFLOZIN,1.0,A10BK02,Canagliflozin,Tablet,Oral,02543494,JAMP CANAGLIFLOZIN (canagliflozin 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005527,canagliflozin 300 mg oral tablet,8001126,canagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94767,Marketed,2017-08-22,02460351,ILARIS,1.0,L04AC08,Canakinumab,Solution,Subcutaneous,02460351,ILARIS (canakinumab 150 mg per 1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012928,canakinumab 150 mg per 1 mL solution for injection vial,8001606,canakinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
67964,Marketed,2025-06-10,02244021,ATACAND PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02244021,ATACAND PLUS (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81340,Marketed,2012-09-24,02327902,SANDOZ CANDESARTAN PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02327902,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81858,Marketed,2025-06-19,02332922,ATACAND PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02332922,ATACAND PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81859,Marketed,2025-06-25,02332957,ATACAND PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02332957,ATACAND PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87664,Marketed,2012-09-24,02391295,PMS-CANDESARTAN-HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02391295,PMS-CANDESARTAN-HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87755,Marketed,2012-10-17,02392275,CANDESARTAN-HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02392275,CANDESARTAN-HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87995,Marketed,2024-02-21,02394804,CANDESARTAN/HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02394804,CANDESARTAN/HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SANIS HEALTH INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87997,Marketed,2012-10-18,02394812,CANDESARTAN HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02394812,CANDESARTAN HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88063,Marketed,2013-09-23,02395541,TEVA-CANDESARTAN/HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02395541,TEVA-CANDESARTAN/HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88064,Marketed,2013-06-19,02395568,TEVA-CANDESARTAN/HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02395568,TEVA-CANDESARTAN/HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90530,Marketed,2014-02-12,02420732,SANDOZ CANDESARTAN PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02420732,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90531,Marketed,2014-02-12,02420740,SANDOZ CANDESARTAN PLUS,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02420740,SANDOZ CANDESARTAN PLUS (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90562,Marketed,2015-03-17,02421038,AURO-CANDESARTAN HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02421038,AURO-CANDESARTAN HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) AURO PHARMA INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90563,Marketed,2015-03-17,02421046,AURO-CANDESARTAN HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02421046,AURO-CANDESARTAN HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) AURO PHARMA INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90564,Marketed,2015-03-17,02421054,AURO-CANDESARTAN HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02421054,AURO-CANDESARTAN HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) AURO PHARMA INC,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96264,Marketed,2020-03-23,02473240,JAMP CANDESARTAN-HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02473240,JAMP CANDESARTAN-HCT (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96265,Marketed,2020-03-23,02473259,JAMP CANDESARTAN-HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02473259,JAMP CANDESARTAN-HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96266,Marketed,2020-03-23,02473267,JAMP CANDESARTAN-HCT,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02473267,JAMP CANDESARTAN-HCT (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102039,Marketed,2023-07-20,02531240,NRA-CANDESARTAN HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02531240,NRA-CANDESARTAN HCTZ (candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet) NORA PHARMA INC,Active,9000946,candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102040,Marketed,2023-07-20,02531259,NRA-CANDESARTAN HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02531259,NRA-CANDESARTAN HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) NORA PHARMA INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102041,Marketed,2023-07-20,02531267,NRA-CANDESARTAN HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02531267,NRA-CANDESARTAN HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet) NORA PHARMA INC,Active,9001283,candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102488,Marketed,2024-02-21,02536064,CANDESARTAN/HCTZ,2.0,C09DA06,Candersartan and diuretics,Tablet,Oral,02536064,CANDESARTAN/HCTZ (candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet) SANIS HEALTH INC,Active,9001282,candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet,8000300,candesartan and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62546,Marketed,2025-06-19,02239090,ATACAND,1.0,C09CA06,Candesartan,Tablet,Oral,02239090,ATACAND (candesartan cilexetil 4 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62547,Marketed,2025-06-09,02239091,ATACAND,1.0,C09CA06,Candesartan,Tablet,Oral,02239091,ATACAND (candesartan cilexetil 8 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62548,Marketed,2025-07-07,02239092,ATACAND,1.0,C09CA06,Candesartan,Tablet,Oral,02239092,ATACAND (candesartan cilexetil 16 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79720,Marketed,2025-06-11,02311658,ATACAND,1.0,C09CA06,Candesartan,Tablet,Oral,02311658,ATACAND (candesartan cilexetil 32 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81228,Marketed,2011-04-26,02326957,SANDOZ CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02326957,SANDOZ CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81229,Marketed,2011-04-26,02326965,SANDOZ CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02326965,SANDOZ CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81230,Marketed,2011-04-26,02326973,SANDOZ CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02326973,SANDOZ CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85116,Marketed,2012-06-01,02366312,TEVA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02366312,TEVA-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85118,Marketed,2012-06-01,02366320,TEVA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02366320,TEVA-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) TEVA CANADA LIMITED,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85119,Marketed,2012-06-01,02366339,TEVA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02366339,TEVA-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) TEVA CANADA LIMITED,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86372,Marketed,2012-02-08,02377934,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02377934,CANDESARTAN (candesartan cilexetil 8 mg oral tablet) PRO DOC LIMITEE,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86373,Marketed,2012-02-08,02377942,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02377942,CANDESARTAN (candesartan cilexetil 16 mg oral tablet) PRO DOC LIMITEE,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86515,Marketed,2014-08-15,02379279,ACH-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02379279,ACH-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86516,Marketed,2014-08-15,02379287,ACH-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02379287,ACH-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86517,Marketed,2014-08-15,02379295,ACH-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02379295,ACH-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86646,Marketed,2020-03-04,02380684,TARO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02380684,TARO-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SUN PHARMA CANADA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86647,Marketed,2020-03-04,02380692,TARO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02380692,TARO-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SUN PHARMA CANADA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86648,Marketed,2020-03-04,02380706,TARO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02380706,TARO-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SUN PHARMA CANADA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86649,Marketed,2020-03-04,02380714,TARO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02380714,TARO-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SUN PHARMA CANADA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87208,Marketed,2020-04-20,02386518,JAMP-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02386518,JAMP-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87209,Marketed,2020-04-20,02386526,JAMP-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02386526,JAMP-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87210,Marketed,2020-04-20,02386534,JAMP-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02386534,JAMP-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87423,Marketed,2022-06-21,02388707,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02388707,CANDESARTAN (candesartan cilexetil 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87424,Marketed,2022-06-21,02388715,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02388715,CANDESARTAN (candesartan cilexetil 16 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87654,Marketed,2012-08-06,02391171,PMS-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02391171,PMS-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) PHARMASCIENCE INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87655,Marketed,2012-08-06,02391198,PMS-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02391198,PMS-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) PHARMASCIENCE INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87656,Marketed,2012-08-06,02391201,PMS-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02391201,PMS-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) PHARMASCIENCE INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87657,Marketed,2012-08-06,02391228,PMS-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02391228,PMS-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) PHARMASCIENCE INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90197,Marketed,2014-03-19,02417340,SANDOZ CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02417340,SANDOZ CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90678,Marketed,2014-06-05,02422069,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02422069,CANDESARTAN (candesartan cilexetil 32 mg oral tablet) PRO DOC LIMITEE,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93106,Marketed,2018-06-28,02445786,AURO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02445786,AURO-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) AURO PHARMA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93107,Marketed,2018-06-28,02445794,AURO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02445794,AURO-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) AURO PHARMA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93108,Marketed,2019-02-11,02445808,AURO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02445808,AURO-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) AURO PHARMA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93109,Marketed,2019-02-11,02445816,AURO-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02445816,AURO-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) AURO PHARMA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96769,Marketed,2023-04-14,02476908,MINT-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02476908,MINT-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96770,Marketed,2018-10-19,02476916,MINT-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02476916,MINT-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96771,Marketed,2018-10-19,02476924,MINT-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02476924,MINT-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96772,Marketed,2024-01-11,02476932,MINT-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02476932,MINT-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99045,Marketed,2020-08-12,02500795,AG-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02500795,AG-CANDESARTAN TABLETS (candesartan cilexetil 8 mg oral tablet) ANGITA PHARMA INC.,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99046,Marketed,2020-08-12,02500809,AG-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02500809,AG-CANDESARTAN TABLETS (candesartan cilexetil 16 mg oral tablet) ANGITA PHARMA INC.,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99047,Marketed,2020-08-12,02500817,AG-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02500817,AG-CANDESARTAN TABLETS (candesartan cilexetil 32 mg oral tablet) ANGITA PHARMA INC.,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101606,Marketed,2023-05-03,02527006,NRA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02527006,NRA-CANDESARTAN (candesartan cilexetil 4 mg oral tablet) NORA PHARMA INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101607,Marketed,2022-11-15,02527014,NRA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02527014,NRA-CANDESARTAN (candesartan cilexetil 8 mg oral tablet) NORA PHARMA INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101608,Marketed,2022-11-15,02527022,NRA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02527022,NRA-CANDESARTAN (candesartan cilexetil 16 mg oral tablet) NORA PHARMA INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101609,Marketed,2022-11-15,02527030,NRA-CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02527030,NRA-CANDESARTAN (candesartan cilexetil 32 mg oral tablet) NORA PHARMA INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101749,Marketed,2023-03-16,02528258,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02528258,CANDESARTAN (candesartan cilexetil 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101750,Marketed,2023-03-16,02528266,CANDESARTAN,1.0,C09CA06,Candesartan,Tablet,Oral,02528266,CANDESARTAN (candesartan cilexetil 32 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102993,Marketed,2024-05-21,02541289,APO-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02541289,APO-CANDESARTAN TABLETS (candesartan cilexetil 4 mg oral tablet) APOTEX INC,Active,9001114,candesartan cilexetil 4 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102994,Marketed,2024-05-21,02541297,APO-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02541297,APO-CANDESARTAN TABLETS (candesartan cilexetil 8 mg oral tablet) APOTEX INC,Active,9000831,candesartan cilexetil 8 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102995,Marketed,2024-05-21,02541300,APO-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02541300,APO-CANDESARTAN TABLETS (candesartan cilexetil 16 mg oral tablet) APOTEX INC,Active,9000830,candesartan cilexetil 16 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102996,Marketed,2024-05-21,02541319,APO-CANDESARTAN TABLETS,1.0,C09CA06,Candesartan,Tablet,Oral,02541319,APO-CANDESARTAN TABLETS (candesartan cilexetil 32 mg oral tablet) APOTEX INC,Active,9001253,candesartan cilexetil 32 mg oral tablet,8000266,candesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102353,Marketed,2023-11-30,02534622,KENGREXAL,1.0,B01AC25,Cangrelor,Powder for solution,Intravenous,02534622,KENGREXAL (cangrelor (cangrelor tetrasodium) 50 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9014961,cangrelor (cangrelor tetrasodium) 50 mg per vial powder for solution for injection,8002489,cangrelor,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103157,Marketed,2024-12-10,02543079,EPIDIOLEX,1.0,N03AX24,Cannabidiol,Solution,Oral,,,,,,,,,,,,,,,,
75157,Marketed,2024-12-17,02266121,SATIVEX,2.0,N02BG10,Cannabinoids,Spray,Buccal,02266121,SATIVEX (cannabidiol 2.5 mg per actuation and tetrahydrocannabinol 2.7 mg per actuation oromucosal spray) JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED,Active,9013659,cannabidiol 2.5 mg per actuation and tetrahydrocannabinol 2.7 mg per actuation oromucosal spray,8002180,cannabidiol and tetrahydrocannabinol,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,
90661,Marketed,2014-07-23,02421917,SANDOZ CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02421917,SANDOZ CAPECITABINE (capecitabine 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90662,Marketed,2014-07-23,02421925,SANDOZ CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02421925,SANDOZ CAPECITABINE (capecitabine 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91132,Marketed,2014-09-19,02426757,ACH-CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02426757,ACH-CAPECITABINE (capecitabine 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91133,Marketed,2014-09-19,02426765,ACH-CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02426765,ACH-CAPECITABINE (capecitabine 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94454,Marketed,2017-08-31,02457490,TARO-CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02457490,TARO-CAPECITABINE (capecitabine 150 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94455,Marketed,2017-08-31,02457504,TARO-CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02457504,TARO-CAPECITABINE (capecitabine 500 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99738,Marketed,2021-10-05,02508028,MINT-CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02508028,MINT-CAPECITABINE (capecitabine 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100438,Marketed,2021-10-22,02514982,CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02514982,CAPECITABINE (capecitabine 150 mg oral tablet) SANIS HEALTH INC,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100439,Marketed,2021-10-22,02514990,CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02514990,CAPECITABINE (capecitabine 500 mg oral tablet) SANIS HEALTH INC,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100911,Marketed,2022-06-15,02519879,CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02519879,CAPECITABINE (capecitabine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003303,capecitabine 150 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100912,Marketed,2022-06-16,02519887,CAPECITABINE,1.0,L01BC06,Capecitabine,Tablet,Oral,02519887,CAPECITABINE (capecitabine 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003304,capecitabine 500 mg oral tablet,8001607,capecitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103334,Marketed,2024-04-16,02544733,TRUQAP,1.0,L01EX27,Capivasertib,Tablet,Oral,02544733,TRUQAP (capivasertib 160 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015033,capivasertib 160 mg oral tablet,8002504,capivasertib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
103335,Marketed,2024-04-01,02544741,TRUQAP,1.0,L01EX27,Capivasertib,Tablet,Oral,02544741,TRUQAP (capivasertib 200 mg oral tablet) ASTRAZENECA CANADA INC,Active,9015034,capivasertib 200 mg oral tablet,8002504,capivasertib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
101646,Marketed,2022-09-16,02527391,TABRECTA,1.0,L01EX17,Capmatinib,Tablet,Oral,02527391,TABRECTA (capmatinib (capmatinib hydrochloride) 150 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014774,capmatinib (capmatinib hydrochloride) 150 mg oral tablet,8002442,capmatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101647,Marketed,2022-09-16,02527405,TABRECTA,1.0,L01EX17,Capmatinib,Tablet,Oral,02527405,TABRECTA (capmatinib (capmatinib hydrochloride) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014775,capmatinib (capmatinib hydrochloride) 200 mg oral tablet,8002442,capmatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10900,Marketed,1990-12-31,00893625,APO-CAPTO TAB 100MG,1.0,C09AA01,Captopril,Tablet,Oral,00893625,APO-CAPTO TAB 100MG (captopril 100 mg oral tablet) APOTEX INC,Active,9008155,captopril 100 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10906,Marketed,1990-12-31,00893595,APO-CAPTO TAB 12.5MG,1.0,C09AA01,Captopril,Tablet,Oral,00893595,APO-CAPTO TAB 12.5MG (captopril 12.5 mg oral tablet) APOTEX INC,Active,9008156,captopril 12.5 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10908,Marketed,1990-12-31,00893617,APO-CAPTO TAB 50MG,1.0,C09AA01,Captopril,Tablet,Oral,00893617,APO-CAPTO TAB 50MG (captopril 50 mg oral tablet) APOTEX INC,Active,9008158,captopril 50 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11760,Marketed,2011-07-06,01942964,TEVA-CAPTOPRIL,1.0,C09AA01,Captopril,Tablet,Oral,01942964,TEVA-CAPTOPRIL (captopril 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9008156,captopril 12.5 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11763,Marketed,2011-07-06,01942972,TEVA-CAPTOPRIL,1.0,C09AA01,Captopril,Tablet,Oral,01942972,TEVA-CAPTOPRIL (captopril 25 mg oral tablet) TEVA CANADA LIMITED,Active,9008157,captopril 25 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11764,Marketed,2011-07-06,01942980,TEVA-CAPTOPRIL,1.0,C09AA01,Captopril,Tablet,Oral,01942980,TEVA-CAPTOPRIL (captopril 50 mg oral tablet) TEVA CANADA LIMITED,Active,9008158,captopril 50 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11765,Marketed,2011-07-06,01942999,TEVA-CAPTOPRIL,1.0,C09AA01,Captopril,Tablet,Oral,01942999,TEVA-CAPTOPRIL (captopril 100 mg oral tablet) TEVA CANADA LIMITED,Active,9008155,captopril 100 mg oral tablet,8000847,captopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103233,Marketed,2024-10-28,02543907,NOYADA,1.0,C09AA01,Captopril,Solution,Oral,02543907,NOYADA (captopril 5 mg per 5 mL oral solution) ETHYPHARM INC,Active,9015133,captopril 5 mg per 5 mL oral solution,8000847,captopril,26643006,Oral,385023001,Oral solution,,,,,
103234,Marketed,2024-10-28,02543915,NOYADA,1.0,C09AA01,Captopril,Solution,Oral,02543915,NOYADA (captopril 25 mg per 5 mL oral solution) ETHYPHARM INC,Active,9015108,captopril 25 mg per 5 mL oral solution,8000847,captopril,26643006,Oral,385023001,Oral solution,,,,,
3906,Marketed,1980-12-31,00042544,MIOSTAT OPHTHALMIC LIQ 0.01%,1.0,S01EB02,Carbachol,Solution,Intraocular,00042544,MIOSTAT OPHTHALMIC LIQ 0.01% (carbachol 0.01 % solution for injection 1.5 mL vial) ALCON CANADA INC,Active,9012929,carbachol 0.01 % solution for injection 1.5 mL vial,8001608,carbachol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
777,Marketed,1997-12-15,00010405,TEGRETOL,1.0,N03AF01,Carbamazepine,Tablet,Oral,00010405,TEGRETOL (carbamazepine 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
8373,Marketed,1999-03-10,00773611,TEGRETOL CR,1.0,N03AF01,Carbamazepine,Tablet (extended-release),Oral,00773611,TEGRETOL CR (carbamazepine 200 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000288,carbamazepine 200 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
8374,Marketed,1998-08-18,00755583,TEGRETOL CR,1.0,N03AF01,Carbamazepine,Tablet (extended-release),Oral,00755583,TEGRETOL CR (carbamazepine 400 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000289,carbamazepine 400 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
9242,Marketed,2010-11-26,00782718,TEVA-CARBAMAZEPINE,1.0,N03AF01,Carbamazepine,Tablet,Oral,00782718,TEVA-CARBAMAZEPINE (carbamazepine 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19729,Marketed,1999-06-10,02194333,TEGRETOL SUSPENSION,1.0,N03AF01,Carbamazepine,Suspension,Oral,02194333,TEGRETOL SUSPENSION (carbamazepine 100 mg per 5 mL oral suspension) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000678,carbamazepine 100 mg per 5 mL oral suspension,8000032,carbamazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,
68372,Marketed,2002-04-19,02244403,TARO-CARBAMAZEPINE CHEWABLE TABLETS,1.0,N03AF01,Carbamazepine,Tablet (chewable),Oral,02244403,TARO-CARBAMAZEPINE CHEWABLE TABLETS (carbamazepine 100 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9000219,carbamazepine 100 mg chewable tablet,8000032,carbamazepine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,
68373,Marketed,2002-04-19,02244404,TARO-CARBAMAZEPINE CHEWABLE TABLETS,1.0,N03AF01,Carbamazepine,Tablet (chewable),Oral,02244404,TARO-CARBAMAZEPINE CHEWABLE TABLETS (carbamazepine 200 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9000220,carbamazepine 200 mg chewable tablet,8000032,carbamazepine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,
74720,Marketed,2006-02-02,02261839,SANDOZ-CARBAMAZEPINE CR,1.0,N03AF01,Carbamazepine,Tablet (extended-release),Oral,02261839,SANDOZ-CARBAMAZEPINE CR (carbamazepine 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000288,carbamazepine 200 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
74721,Marketed,2006-02-02,02261847,SANDOZ-CARBAMAZEPINE CR,1.0,N03AF01,Carbamazepine,Tablet (extended-release),Oral,02261847,SANDOZ-CARBAMAZEPINE CR (carbamazepine 400 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000289,carbamazepine 400 mg prolonged-release oral tablet,8000032,carbamazepine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
85224,Marketed,2011-10-07,02367394,TARO-CARBAMAZEPINE,1.0,N03AF01,Carbamazepine,Suspension,Oral,02367394,TARO-CARBAMAZEPINE (carbamazepine 100 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9000678,carbamazepine 100 mg per 5 mL oral suspension,8000032,carbamazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,
102988,Marketed,2024-04-19,02541238,MINT-CARBAMAZEPINE,1.0,N03AF01,Carbamazepine,Tablet,Oral,02541238,MINT-CARBAMAZEPINE (carbamazepine 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000047,carbamazepine 200 mg oral tablet,8000032,carbamazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97932,Marketed,2020-09-14,02489244,CARBETOCIN INJECTION,1.0,H01BB03,Carbetocin,Solution,Intravenous,02489244,CARBETOCIN INJECTION (carbetocin 100 mcg per 1 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9014240,carbetocin 100 mcg per 1 mL solution for injection syringe,8001609,carbetocin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98638,Marketed,2020-08-05,02496526,DURATOCIN,1.0,H01BB03,Carbetocin,Solution,"Intravenous,Intramuscular",02496526,DURATOCIN (carbetocin 100 mcg per 1 mL solution for injection vial) FERRING INC,Active,9012930,carbetocin 100 mcg per 1 mL solution for injection vial,8001609,carbetocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
2902,Marketed,2019-11-27,00037915,DEXTROSE INJECTION USP,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10511,Marketed,2019-03-25,00060348,"5% DEXTROSE INJECTION, USP",1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
13714,Marketed,1998-04-30,01924281,5% DEXTROSE INJECTION USP,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
14251,Marketed,1998-04-30,01924427,10% DEXTROSE INJECTION USP,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
18686,Marketed,2015-01-20,02014874,70% DEXTROSE INJECTION USP,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
59976,Marketed,2019-03-25,00060364,"10% DEXTROSE INJECTION, USP",1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
88832,Marketed,2023-02-03,02403536,5% DEXTROSE INJECTION,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
95694,Marketed,2020-08-18,02468514,DEXTROSE INJECTION USP,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
100647,Marketed,2022-03-30,02517132,DEXTROSE INJECTION,1.0,B05BA03,Carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
5687,Marketed,1911-12-31,00572861,CARBON DIOXIDE 100%,1.0,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,
13884,Marketed,2022-07-29,02014459,CARBON DIOXIDE USP,1.0,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,
19263,Marketed,2020-08-07,02154730,CARBON DIOXIDE U.S.P,1.0,V03AN02,Carbon dioxide,Gas,Inhalation,,,,,,,,,,,,,,,,
17830,Marketed,2013-11-08,02125439,CARBOPLATIN INJECTION,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700662,CARBOPLATIN INJECTION (carboplatin 150 mg per 15 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
17830,Marketed,2013-11-08,02125439,CARBOPLATIN INJECTION,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700663,CARBOPLATIN INJECTION (carboplatin 450 mg per 45 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
17830,Marketed,2013-11-08,02125439,CARBOPLATIN INJECTION,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700664,CARBOPLATIN INJECTION (carboplatin 600 mg per 60 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012934,carboplatin 600 mg per 60 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
17830,Marketed,2013-11-08,02125439,CARBOPLATIN INJECTION,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700665,CARBOPLATIN INJECTION (carboplatin 50 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43846,Marketed,2017-11-11,02126680,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700666,CARBOPLATIN INJECTION BP (carboplatin 450 mg per 45 mL solution for injection vial) PFIZER CANADA ULC,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43846,Marketed,2017-11-11,02126680,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700667,CARBOPLATIN INJECTION BP (carboplatin 150 mg per 15 mL solution for injection vial) PFIZER CANADA ULC,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43846,Marketed,2017-11-11,02126680,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700668,CARBOPLATIN INJECTION BP (carboplatin 600 mg per 60 mL solution for injection vial) PFIZER CANADA ULC,Active,9012934,carboplatin 600 mg per 60 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43846,Marketed,2017-11-11,02126680,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700669,CARBOPLATIN INJECTION BP (carboplatin 50 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80581,Marketed,2015-03-11,02320371,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700687,CARBOPLATIN INJECTION BP (carboplatin 450 mg per 45 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012932,carboplatin 450 mg per 45 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80581,Marketed,2015-03-11,02320371,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700688,CARBOPLATIN INJECTION BP (carboplatin 150 mg per 15 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012931,carboplatin 150 mg per 15 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80581,Marketed,2015-03-11,02320371,CARBOPLATIN INJECTION BP,1.0,L01XA02,Carboplatin,Solution,Intravenous,77700689,CARBOPLATIN INJECTION BP (carboplatin 50 mg per 5 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012933,carboplatin 50 mg per 5 mL solution for injection vial,8001610,carboplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
49287,Marketed,2009-02-03,02230417,HEMABATE,1.0,G02AD04,Carboprost,Solution,Intramuscular,02230417,HEMABATE (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9012935,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection ampoule,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
101962,Marketed,2023-05-16,02530430,"CARBOPROST TROMETHAMINE INJECTION, USP",1.0,G02AD04,Carboprost,Solution,Intramuscular,02530430,"CARBOPROST TROMETHAMINE INJECTION, USP (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102710,Marketed,2024-01-18,02538377,CARBOPROST TROMETHAMINE INJECTION USP,1.0,G02AD04,Carboprost,Solution,Intramuscular,02538377,CARBOPROST TROMETHAMINE INJECTION USP (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103545,Marketed,2025-02-13,02546779,CARBOPROST TROMETHAMINE INJECTION,1.0,G02AD04,Carboprost,Solution,Intramuscular,02546779,CARBOPROST TROMETHAMINE INJECTION (carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9014853,carboprost (carboprost tromethamine) 250 mcg per 1 mL solution for injection vial,8001611,carboprost,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93728,Marketed,2016-02-11,02451034,KYPROLIS,1.0,L01XG02,Carfilzomib,Powder for solution,Intravenous,02451034,KYPROLIS (carfilzomib 60 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9005877,carfilzomib 60 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94724,Marketed,2017-02-13,02459930,KYPROLIS,1.0,L01XG02,Carfilzomib,Powder for solution,Intravenous,02459930,KYPROLIS (carfilzomib 10 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9006128,carfilzomib 10 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94725,Marketed,2017-02-06,02459949,KYPROLIS,1.0,L01XG02,Carfilzomib,Powder for solution,Intravenous,02459949,KYPROLIS (carfilzomib 30 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9006126,carfilzomib 30 mg per vial powder for solution for injection,8001612,carfilzomib,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
92371,Marketed,2020-03-17,02439360,CARBAGLU,1.0,A16AA05,Carglumic acid,Tablet for suspension,Oral,02439360,CARBAGLU (carglumic acid 200 mg dispersible oral tablet) RECORDATI RARE DISEASES,Active,9013806,carglumic acid 200 mg dispersible oral tablet,8001716,carglumic acid,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
101585,Marketed,2024-01-05,02526794,VRAYLAR,1.0,N05AX15,Cariprazine,Capsule,Oral,02526794,VRAYLAR (cariprazine (cariprazine hydrochloride) 1.5 mg oral capsule) ABBVIE CORPORATION,Active,9014712,cariprazine (cariprazine hydrochloride) 1.5 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101586,Marketed,2024-05-14,02526808,VRAYLAR,1.0,N05AX15,Cariprazine,Capsule,Oral,02526808,VRAYLAR (cariprazine (cariprazine hydrochloride) 3 mg oral capsule) ABBVIE CORPORATION,Active,9014713,cariprazine (cariprazine hydrochloride) 3 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101587,Marketed,2024-02-05,02526816,VRAYLAR,1.0,N05AX15,Cariprazine,Capsule,Oral,02526816,VRAYLAR (cariprazine (cariprazine hydrochloride) 4.5 mg oral capsule) ABBVIE CORPORATION,Active,9014714,cariprazine (cariprazine hydrochloride) 4.5 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101588,Marketed,2024-02-08,02526824,VRAYLAR,1.0,N05AX15,Cariprazine,Capsule,Oral,02526824,VRAYLAR (cariprazine (cariprazine hydrochloride) 6 mg oral capsule) ABBVIE CORPORATION,Active,9014715,cariprazine (cariprazine hydrochloride) 6 mg oral capsule,8002425,cariprazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2153,Marketed,2017-09-19,00297763,BICNU,1.0,L01AD01,Carmustine,Powder for solution,Intravenous,00297763,BICNU (carmustine 100 mg per vial powder for solution for injection with diluent solution) MARCAN PHARMACEUTICALS INC,Active,9013038,carmustine 100 mg per vial powder for solution for injection with diluent solution,8001717,carmustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
102096,Marketed,2023-05-18,02531879,CARMUSTINE FOR INJECTION USP,1.0,L01AD01,Carmustine,Powder for solution,Intravenous,02531879,CARMUSTINE FOR INJECTION USP (carmustine 100 mg per vial powder for solution for injection with diluent solution) STERIMAX INC,Active,9013038,carmustine 100 mg per vial powder for solution for injection with diluent solution,8001717,carmustine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
104389,Marketed,2025-04-14,02555093,BICNU,1.0,L01AD01,Carmustine,Solution,Intravenous,77701178,BICNU (carmustine 100 mg per 1 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9015186,carmustine 100 mg per 1 mL solution for injection vial,8001717,carmustine,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
104389,Marketed,2025-04-14,02555093,BICNU,1.0,L01AD01,Carmustine,Solution,Intravenous,77701179,BICNU (carmustine 300 mg per 3 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9015187,carmustine 300 mg per 3 mL solution for injection vial,8001717,carmustine,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
70034,Marketed,2003-08-04,02245914,PMS-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02245914,PMS-CARVEDILOL (carvedilol 3.125 mg oral tablet) PHARMASCIENCE INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70035,Marketed,2003-08-04,02245915,PMS-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02245915,PMS-CARVEDILOL (carvedilol 6.25 mg oral tablet) PHARMASCIENCE INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70036,Marketed,2003-08-04,02245916,PMS-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02245916,PMS-CARVEDILOL (carvedilol 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70037,Marketed,2003-08-04,02245917,PMS-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02245917,PMS-CARVEDILOL (carvedilol 25 mg oral tablet) PHARMASCIENCE INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72243,Marketed,2003-08-06,02247933,APO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02247933,APO-CARVEDILOL (carvedilol 3.125 mg oral tablet) APOTEX INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72245,Marketed,2003-08-06,02247935,APO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02247935,APO-CARVEDILOL (carvedilol 12.5 mg oral tablet) APOTEX INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73120,Marketed,2018-10-24,02248752,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02248752,CARVEDILOL (carvedilol 3.125 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73121,Marketed,2018-07-06,02248753,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02248753,CARVEDILOL (carvedilol 6.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73122,Marketed,2018-07-06,02248754,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02248754,CARVEDILOL (carvedilol 12.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73123,Marketed,2018-07-06,02248755,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02248755,CARVEDILOL (carvedilol 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73718,Marketed,2018-01-09,02252309,TEVA-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02252309,TEVA-CARVEDILOL (carvedilol 3.125 mg oral tablet) TEVA CANADA LIMITED,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73719,Marketed,2018-01-09,02252317,TEVA-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02252317,TEVA-CARVEDILOL (carvedilol 6.25 mg oral tablet) TEVA CANADA LIMITED,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73720,Marketed,2018-01-09,02252325,TEVA-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02252325,TEVA-CARVEDILOL (carvedilol 12.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73721,Marketed,2018-01-09,02252333,TEVA-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02252333,TEVA-CARVEDILOL (carvedilol 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80995,Marketed,2009-06-12,02324504,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02324504,CARVEDILOL (carvedilol 3.125 mg oral tablet) PRO DOC LIMITEE,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80996,Marketed,2009-06-12,02324512,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02324512,CARVEDILOL (carvedilol 6.25 mg oral tablet) PRO DOC LIMITEE,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80997,Marketed,2009-06-12,02324520,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02324520,CARVEDILOL (carvedilol 12.5 mg oral tablet) PRO DOC LIMITEE,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80998,Marketed,2009-06-12,02324539,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02324539,CARVEDILOL (carvedilol 25 mg oral tablet) PRO DOC LIMITEE,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84979,Marketed,2013-10-12,02364913,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02364913,CARVEDILOL (carvedilol 3.125 mg oral tablet) SANIS HEALTH INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84980,Marketed,2013-10-12,02364921,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02364921,CARVEDILOL (carvedilol 6.25 mg oral tablet) SANIS HEALTH INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84981,Marketed,2013-10-12,02364948,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02364948,CARVEDILOL (carvedilol 12.5 mg oral tablet) SANIS HEALTH INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84982,Marketed,2013-10-12,02364956,CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02364956,CARVEDILOL (carvedilol 25 mg oral tablet) SANIS HEALTH INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85386,Marketed,2022-01-12,02368897,JAMP-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02368897,JAMP-CARVEDILOL (carvedilol 3.125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85387,Marketed,2022-01-12,02368900,JAMP-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02368900,JAMP-CARVEDILOL (carvedilol 6.25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85388,Marketed,2022-01-12,02368919,JAMP-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02368919,JAMP-CARVEDILOL (carvedilol 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85389,Marketed,2022-01-12,02368927,JAMP-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02368927,JAMP-CARVEDILOL (carvedilol 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90306,Marketed,2014-02-06,02418495,AURO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02418495,AURO-CARVEDILOL (carvedilol 3.125 mg oral tablet) AURO PHARMA INC,Active,9001047,carvedilol 3.125 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90307,Marketed,2014-02-06,02418509,AURO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02418509,AURO-CARVEDILOL (carvedilol 6.25 mg oral tablet) AURO PHARMA INC,Active,9001048,carvedilol 6.25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90308,Marketed,2014-02-06,02418517,AURO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02418517,AURO-CARVEDILOL (carvedilol 12.5 mg oral tablet) AURO PHARMA INC,Active,9001045,carvedilol 12.5 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90309,Marketed,2014-02-06,02418525,AURO-CARVEDILOL,1.0,C07AG02,Carvedilol,Tablet,Oral,02418525,AURO-CARVEDILOL (carvedilol 25 mg oral tablet) AURO PHARMA INC,Active,9001046,carvedilol 25 mg oral tablet,8000329,carvedilol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68232,Marketed,2006-05-24,02244265,CANCIDAS,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02244265,CANCIDAS (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
68233,Marketed,2006-07-05,02244266,CANCIDAS,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02244266,CANCIDAS (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94846,Marketed,2021-05-25,02460947,CASPOFUNGIN FOR INJECTION,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02460947,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94847,Marketed,2021-05-25,02460955,CASPOFUNGIN FOR INJECTION,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02460955,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97713,Marketed,2020-01-27,02486989,CASPOFUNGIN FOR INJECTION,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02486989,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003635,caspofungin (caspofungin acetate) 50 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97714,Marketed,2020-01-27,02486997,CASPOFUNGIN FOR INJECTION,1.0,J02AX04,Caspofungin,Powder for solution,Intravenous,02486997,CASPOFUNGIN FOR INJECTION (caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003659,caspofungin (caspofungin acetate) 70 mg per vial powder for solution for injection,8001174,caspofungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87544,Marketed,2013-01-30,02389975,TRETTEN,1.0,B02BD11,Catridecacog,Powder for solution,Intravenous,02389975,TRETTEN (catridecacog 2500 unit per vial powder for solution for injection with diluent solution) NOVO NORDISK CANADA INC,Active,9013536,catridecacog 2500 unit per vial powder for solution for injection with diluent solution,8002018,catridecacog,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
56852,Marketed,2012-04-17,02235134,TEVA-CEFADROXIL,1.0,J01DB05,Cefadroxil,Capsule,Oral,02235134,TEVA-CEFADROXIL (cefadroxil (cefadroxil monohydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64363,Marketed,1999-08-31,02240774,APO-CEFADROXIL,1.0,J01DB05,Cefadroxil,Capsule,Oral,02240774,APO-CEFADROXIL (cefadroxil 500 mg oral capsule) APOTEX INC,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103342,Marketed,2024-08-27,02544792,JAMP CEFADROXIL,1.0,J01DB05,Cefadroxil,Capsule,Oral,02544792,JAMP CEFADROXIL (cefadroxil (cefadroxil monohydrate) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003412,cefadroxil 500 mg oral capsule,8001057,cefadroxil,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3945,Marketed,2014-07-12,00342084,TEVA-CEPHALEXIN,1.0,J01DB01,Cefalexin,Capsule,Oral,00342084,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9000126,cephalexin 250 mg oral capsule,8000040,cephalexin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3946,Marketed,2014-07-11,00342114,TEVA-CEPHALEXIN,1.0,J01DB01,Cefalexin,Capsule,Oral,00342114,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9000127,cephalexin 500 mg oral capsule,8000040,cephalexin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
5072,Marketed,2014-07-12,00342092,TEVA-CEPHALEXIN 250,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,00342092,TEVA-CEPHALEXIN 250 (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
5073,Marketed,2014-07-12,00342106,TEVA-CEPHALEXIN 125,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,00342106,TEVA-CEPHALEXIN 125 (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) TEVA CANADA LIMITED,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
5181,Marketed,2014-07-11,00583413,TEVA-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,00583413,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5182,Marketed,2014-07-11,00583421,TEVA-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,00583421,TEVA-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9170,Marketed,1988-12-31,00768715,APO-CEPHALEX,1.0,J01DB01,Cefalexin,Tablet,Oral,00768715,APO-CEPHALEX (cephalexin (cephalexin monohydrate) 500 mg oral tablet) APOTEX INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9171,Marketed,1988-12-31,00768723,APO-CEPHALEX,1.0,J01DB01,Cefalexin,Tablet,Oral,00768723,APO-CEPHALEX (cephalexin (cephalexin monohydrate) 250 mg oral tablet) APOTEX INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95784,Marketed,2018-12-04,02469170,LUPIN-CEPHALEXIN,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02469170,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) LUPIN PHARMA CANADA LIMITED,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
95785,Marketed,2018-12-04,02469189,LUPIN-CEPHALEXIN,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02469189,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) LUPIN PHARMA CANADA LIMITED,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
95956,Marketed,2018-07-30,02470578,AURO-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02470578,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) AURO PHARMA INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95957,Marketed,2018-07-30,02470586,AURO-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02470586,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) AURO PHARMA INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96025,Marketed,2025-09-26,02471140,LUPIN-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02471140,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96026,Marketed,2025-09-26,02471159,LUPIN-CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02471159,LUPIN-CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98468,Marketed,2023-01-26,02494698,JAMP CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02494698,JAMP CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98469,Marketed,2023-01-26,02494701,JAMP CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02494701,JAMP CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98555,Marketed,2020-10-22,02495651,CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02495651,CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98755,Marketed,2020-07-23,02497743,AURO-CEPHALEXIN,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02497743,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
98756,Marketed,2020-07-23,02497751,AURO-CEPHALEXIN,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02497751,AURO-CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
101048,Marketed,2022-05-31,02521253,CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02521253,CEPHALEXIN (cephalexin (cephalexin monohydrate) 250 mg oral tablet) SANIS HEALTH INC,Active,9000096,cephalexin 250 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101049,Marketed,2022-05-31,02521261,CEPHALEXIN,1.0,J01DB01,Cefalexin,Tablet,Oral,02521261,CEPHALEXIN (cephalexin (cephalexin monohydrate) 500 mg oral tablet) SANIS HEALTH INC,Active,9000057,cephalexin 500 mg oral tablet,8000040,cephalexin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101766,Marketed,2023-02-24,02528436,JAMP CEPHALEXIN SUSPENSION,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02528436,JAMP CEPHALEXIN SUSPENSION (cephalexin (cephalexin monohydrate) 125 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000559,cephalexin 125 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
101767,Marketed,2023-02-24,02528444,JAMP CEPHALEXIN SUSPENSION,1.0,J01DB01,Cefalexin,Powder for suspension,Oral,02528444,JAMP CEPHALEXIN SUSPENSION (cephalexin (cephalexin monohydrate) 250 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000560,cephalexin 250 mg per 5 mL oral suspension,8000040,cephalexin,26643006,Oral,385024007,Oral suspension,,,,,
19521,Marketed,2013-04-13,02108119,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02108119,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19532,Marketed,2013-04-13,02108127,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02108127,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19534,Marketed,2013-04-13,02108135,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02108135,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
60453,Marketed,2015-12-30,02237138,"CEFAZOLIN FOR INJECTION, USP",1.0,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02237138,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
60455,Marketed,2016-01-13,02237140,"CEFAZOLIN FOR INJECTION, USP",1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02237140,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79454,Marketed,2008-04-18,02308932,CEFAZOLIN FOR INJECTION USP,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02308932,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79456,Marketed,2008-04-18,02308959,CEFAZOLIN FOR INJECTION USP,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02308959,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79457,Marketed,2008-04-18,02308967,CEFAZOLIN FOR INJECTION USP,1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02308967,CEFAZOLIN FOR INJECTION USP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88577,Marketed,2015-08-21,02401029,"CEFAZOLIN FOR INJECTION, USP",1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02401029,"CEFAZOLIN FOR INJECTION, USP (cefazolin (cefazolin sodium) 100 g per bag powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9013277,cefazolin (cefazolin sodium) 100 g per bag powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag (unit of presentation),,,
92141,Marketed,2025-02-06,02437104,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02437104,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9003323,cefazolin (cefazolin sodium) 500 mg per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92142,Marketed,2023-12-21,02437112,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,"Intravenous,Intramuscular",02437112,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92143,Marketed,2024-02-14,02437120,CEFAZOLIN FOR INJECTION,1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02437120,CEFAZOLIN FOR INJECTION (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95364,Marketed,2023-06-06,02465469,CEFAZOLIN SODIUM FOR INJECTION BP,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02465469,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002758,cefazolin (cefazolin sodium) 1 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95365,Marketed,2023-06-06,02465477,CEFAZOLIN SODIUM FOR INJECTION BP,1.0,J01DB04,Cefazolin,Powder for solution,Intravenous,02465477,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9002757,cefazolin (cefazolin sodium) 10 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98620,Marketed,2025-03-06,02496313,"CEFAZOLIN IN DEXTROSE INJECTION, USP",1.0,J01DB04,Cefazolin,Solution,Intravenous,77701032,"CEFAZOLIN IN DEXTROSE INJECTION, USP (cefazolin (cefazolin sodium) 1000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014450,cefazolin (cefazolin sodium) 1000 mg per 50 mL solution for injection bag,8001175,cefazolin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
98620,Marketed,2025-03-06,02496313,"CEFAZOLIN IN DEXTROSE INJECTION, USP",1.0,J01DB04,Cefazolin,Solution,Intravenous,77701033,"CEFAZOLIN IN DEXTROSE INJECTION, USP (cefazolin (cefazolin sodium) 2000 mg per 100 mL solution for injection bag) BAXTER CORPORATION",Active,9014451,cefazolin (cefazolin sodium) 2000 mg per 100 mL solution for injection bag,8001175,cefazolin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
101381,Marketed,2022-08-05,02524791,CEFAZOLIN SODIUM FOR INJECTION BP,1.0,J01DB04,Cefazolin,Powder for solution,"Intramuscular,Intravenous",02524791,CEFAZOLIN SODIUM FOR INJECTION BP (cefazolin (cefazolin sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9014748,cefazolin (cefazolin sodium) 2 g per vial powder for solution for injection,8001175,cefazolin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95586,Marketed,2018-05-14,02467496,APO-CEFEPIME,1.0,J01DE01,Cefepime,Powder for solution,"Intramuscular,Intravenous",02467496,APO-CEFEPIME (cefepime (cefepime hydrochloride) 1 g per vial powder for solution for injection) APOTEX INC,Active,9012604,cefepime (cefepime hydrochloride) 1 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95587,Marketed,2018-05-14,02467518,APO-CEFEPIME,1.0,J01DE01,Cefepime,Powder for solution,Intravenous,02467518,APO-CEFEPIME (cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection) APOTEX INC,Active,9004526,cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98885,Marketed,2022-05-25,02499096,CEFEPIME FOR INJECTION USP,1.0,J01DE01,Cefepime,Powder for solution,Intravenous,02499096,CEFEPIME FOR INJECTION USP (cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004526,cefepime (cefepime hydrochloride) 2 g per vial powder for solution for injection,8001176,cefepime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
10523,Marketed,2017-07-14,00868965,SUPRAX,1.0,J01DD08,Cefixime,Powder for suspension,Oral,00868965,SUPRAX (cefixime 100 mg per 5 mL oral suspension) ODAN LABORATORIES LTD,Active,9006322,cefixime 100 mg per 5 mL oral suspension,8001443,cefixime,26643006,Oral,385024007,Oral suspension,,,,,
10525,Marketed,2017-07-14,00868981,SUPRAX,1.0,J01DD08,Cefixime,Tablet,Oral,00868981,SUPRAX (cefixime 400 mg oral tablet) ODAN LABORATORIES LTD,Active,9002263,cefixime 400 mg oral tablet,8001443,cefixime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91720,Marketed,2014-10-24,02432773,AURO-CEFIXIME,1.0,J01DD08,Cefixime,Tablet,Oral,02432773,AURO-CEFIXIME (cefixime 400 mg oral tablet) AURO PHARMA INC,Active,9002263,cefixime 400 mg oral tablet,8001443,cefixime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95716,Marketed,2018-01-08,02468689,AURO-CEFIXIME,1.0,J01DD08,Cefixime,Powder for suspension,Oral,02468689,AURO-CEFIXIME (cefixime 100 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006322,cefixime 100 mg per 5 mL oral suspension,8001443,cefixime,26643006,Oral,385024007,Oral suspension,,,,,
91844,Marketed,2015-03-12,02434091,"CEFOTAXIME SODIUM FOR INJECTION, BP",1.0,J01DD01,Cefotaxime,Powder for solution,"Intramuscular,Intravenous",02434091,"CEFOTAXIME SODIUM FOR INJECTION, BP (cefotaxime sodium 1 g per vial powder for solution for injection) STERIMAX INC",Active,9003830,cefotaxime sodium 1 g per vial powder for solution for injection,8001177,cefotaxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91845,Marketed,2015-03-12,02434105,"CEFOTAXIME SODIUM FOR INJECTION, BP",1.0,J01DD01,Cefotaxime,Powder for solution,"Intravenous,Intramuscular",02434105,"CEFOTAXIME SODIUM FOR INJECTION, BP (cefotaxime sodium 2 g per vial powder for solution for injection) STERIMAX INC",Active,9003817,cefotaxime sodium 2 g per vial powder for solution for injection,8001177,cefotaxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19200,Marketed,2013-11-22,02128187,CEFOXITIN FOR INJECTION,1.0,J01DC01,Cefoxitin,Powder for solution,"Intravenous,Intramuscular",02128187,CEFOXITIN FOR INJECTION (cefoxitin (cefoxitin sodium) 1 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002759,cefoxitin (cefoxitin sodium) 1 g per vial powder for solution for injection,8001178,cefoxitin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19201,Marketed,2013-11-22,02128195,CEFOXITIN FOR INJECTION,1.0,J01DC01,Cefoxitin,Powder for solution,"Intramuscular,Intravenous",02128195,CEFOXITIN FOR INJECTION (cefoxitin (cefoxitin sodium) 2 g per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9002760,cefoxitin (cefoxitin sodium) 2 g per vial powder for solution for injection,8001178,cefoxitin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77887,Marketed,2025-06-18,02293528,SPC-CEFPROZIL,1.0,J01DC10,Cefprozil,Tablet,Oral,02293528,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000556,cefprozil 250 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77888,Marketed,2025-06-18,02293536,SPC-CEFPROZIL,1.0,J01DC10,Cefprozil,Tablet,Oral,02293536,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000558,cefprozil 500 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77893,Marketed,2025-10-31,02293579,SPC-CEFPROZIL,1.0,J01DC10,Cefprozil,Powder for suspension,Oral,02293579,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg per 5 mL oral suspension) SUN PHARMA CANADA INC,Active,9006240,cefprozil 250 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,
81489,Marketed,2025-10-31,02329204,SPC-CEFPROZIL,1.0,J01DC10,Cefprozil,Powder for suspension,Oral,02329204,SPC-CEFPROZIL (cefprozil (cefprozil monohydrate) 125 mg per 5 mL oral suspension) SUN PHARMA CANADA INC,Active,9006239,cefprozil 125 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,
83266,Marketed,2019-01-23,02347253,AURO-CEFPROZIL,1.0,J01DC10,Cefprozil,Tablet,Oral,02347253,AURO-CEFPROZIL (cefprozil 500 mg oral tablet) AURO PHARMA INC,Active,9000558,cefprozil 500 mg oral tablet,8000210,cefprozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83267,Marketed,2024-03-01,02347261,AURO-CEFPROZIL,1.0,J01DC10,Cefprozil,Powder for suspension,Oral,02347261,AURO-CEFPROZIL (cefprozil (cefprozil monohydrate) 125 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006239,cefprozil 125 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,
83268,Marketed,2024-03-01,02347288,AURO-CEFPROZIL,1.0,J01DC10,Cefprozil,Powder for suspension,Oral,02347288,AURO-CEFPROZIL (cefprozil (cefprozil monohydrate) 250 mg per 5 mL oral suspension) AURO PHARMA INC,Active,9006240,cefprozil 250 mg per 5 mL oral suspension,8000210,cefprozil,26643006,Oral,385024007,Oral suspension,,,,,
11370,Marketed,2015-11-03,00886971,"CEFTAZIDIME FOR INJECTION, USP",1.0,J01DD02,Ceftazidime,Powder for solution,"Intramuscular,Intravenous",00886971,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002345,ceftazidime 1 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
11371,Marketed,2016-10-04,00886963,"CEFTAZIDIME FOR INJECTION, USP",1.0,J01DD02,Ceftazidime,Powder for solution,Intravenous,00886963,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 6 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002347,ceftazidime 6 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
11372,Marketed,2015-12-04,00886955,"CEFTAZIDIME FOR INJECTION, USP",1.0,J01DD02,Ceftazidime,Powder for solution,Intravenous,00886955,"CEFTAZIDIME FOR INJECTION, USP (ceftazidime 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002346,ceftazidime 2 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92221,Marketed,2015-05-28,02437848,CEFTAZIDIME FOR INJECTION BP,1.0,J01DD02,Ceftazidime,Powder for solution,"Intramuscular,Intravenous",02437848,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002345,ceftazidime 1 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92222,Marketed,2015-05-29,02437856,CEFTAZIDIME FOR INJECTION BP,1.0,J01DD02,Ceftazidime,Powder for solution,Intravenous,02437856,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9002346,ceftazidime 2 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92223,Marketed,2015-06-08,02437864,CEFTAZIDIME FOR INJECTION BP,1.0,J01DD02,Ceftazidime,Powder for solution,Intravenous,02437864,CEFTAZIDIME FOR INJECTION BP (ceftazidime (ceftazidime pentahydrate) 6 g per vial powder for solution for injection) STERIMAX INC,Active,9002347,ceftazidime 6 g per vial powder for solution for injection,8001179,ceftazidime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93212,Marketed,2018-03-20,02446685,ZEVTERA,1.0,J01DI01,Ceftobiprole medocaril,Powder for solution,Intravenous,02446685,ZEVTERA (ceftobiprole (ceftobiprole medocaril sodium) 500 mg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9012785,ceftobiprole (ceftobiprole medocaril sodium) 500 mg per vial powder for solution for injection,8001444,ceftobiprole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93248,Marketed,2016-01-12,02446901,ZERBAXA,2.0,J01DI54,Ceftolozane and beta-lactamase inhibitor,Powder for solution,Intravenous,02446901,ZERBAXA (ceftolozane (ceftolozane sulfate) 1 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) MERCK CANADA INC,Active,9005850,ceftolozane (ceftolozane sulfate) 1 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001347,ceftolozane and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77503,Marketed,2024-08-15,02289695,CEFTRIAXONE FOR INJECTION,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02289695,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77504,Marketed,2024-08-15,02289709,CEFTRIAXONE FOR INJECTION,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02289709,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77762,Marketed,2018-03-15,02292262,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02292262,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004294,ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77763,Marketed,2018-03-15,02292270,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02292270,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77764,Marketed,2018-03-15,02292289,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02292289,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77765,Marketed,2018-03-15,02292297,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02292297,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004264,ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81096,Marketed,2011-04-23,02325594,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02325594,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection) STERIMAX INC,Active,9004294,ceftriaxone (ceftriaxone sodium) 250 mg per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81098,Marketed,2011-03-21,02325616,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intravenous,Intramuscular",02325616,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9004265,ceftriaxone (ceftriaxone sodium) 1 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81099,Marketed,2011-01-31,02325624,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,"Intramuscular,Intravenous",02325624,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9004266,ceftriaxone (ceftriaxone sodium) 2 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81100,Marketed,2011-03-21,02325632,CEFTRIAXONE SODIUM FOR INJECTION BP,1.0,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02325632,CEFTRIAXONE SODIUM FOR INJECTION BP (ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9004264,ceftriaxone (ceftriaxone sodium) 10 g per vial powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89462,Marketed,2015-10-09,02409968,CEFTRIAXONE FOR INJECTION,1.0,J01DD04,Ceftriaxone,Powder for solution,Intravenous,02409968,CEFTRIAXONE FOR INJECTION (ceftriaxone (ceftriaxone sodium) 100 g per bag powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9013278,ceftriaxone (ceftriaxone sodium) 100 g per bag powder for solution for injection,8001180,ceftriaxone,738984000,Parenteral,385223009,Powder for solution for injection,732982009,Bag (unit of presentation),,,
98943,Marketed,2021-03-18,02499711,"CEFTRIAXONE INJECTION, USP",1.0,J01DD04,Ceftriaxone,Solution,Intravenous,02499711,"CEFTRIAXONE INJECTION, USP (ceftriaxone (ceftriaxone sodium) 1000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014484,ceftriaxone (ceftriaxone sodium) 1000 mg per 50 mL solution for injection bag,8001180,ceftriaxone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
98944,Marketed,2021-03-18,02499738,"CEFTRIAXONE INJECTION, USP",1.0,J01DD04,Ceftriaxone,Solution,Intravenous,02499738,"CEFTRIAXONE INJECTION, USP (ceftriaxone (ceftriaxone sodium) 2000 mg per 50 mL solution for injection bag) BAXTER CORPORATION",Active,9014485,ceftriaxone (ceftriaxone sodium) 2000 mg per 50 mL solution for injection bag,8001180,ceftriaxone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
43089,Marketed,2022-10-28,02212307,CEFTIN,1.0,J01DC02,Cefuroxime,Granules for suspension,Oral,02212307,CEFTIN (cefuroxime (cefuroxime axetil) 125 mg per 5 mL oral suspension) SANDOZ CANADA INCORPORATED,Active,9014241,cefuroxime (cefuroxime axetil) 125 mg per 5 mL oral suspension,8001076,cefuroxime,26643006,Oral,385024007,Oral suspension,,,,,
65298,Marketed,2015-07-27,02241638,"CEFUROXIME FOR INJECTION, USP",1.0,J01DC02,Cefuroxime,Powder for solution,Intravenous,02241638,"CEFUROXIME FOR INJECTION, USP (cefuroxime (cefuroxime sodium) 750 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003768,cefuroxime (cefuroxime sodium) 750 mg per vial powder for solution for injection,8001076,cefuroxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
65299,Marketed,2015-07-28,02241639,"CEFUROXIME FOR INJECTION, USP",1.0,J01DC02,Cefuroxime,Powder for solution,Intravenous,02241639,"CEFUROXIME FOR INJECTION, USP (cefuroxime (cefuroxime sodium) 1.5 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003770,cefuroxime (cefuroxime sodium) 1.5 g per vial powder for solution for injection,8001076,cefuroxime,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
68362,Marketed,2001-08-29,02244393,APO-CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02244393,APO-CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) APOTEX INC,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68363,Marketed,2001-08-29,02244394,APO-CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02244394,APO-CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) APOTEX INC,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83030,Marketed,2021-01-11,02344823,AURO-CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02344823,AURO-CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) AURO PHARMA INC,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83031,Marketed,2021-01-11,02344831,AURO-CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02344831,AURO-CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) AURO PHARMA INC,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103583,Marketed,2024-09-27,02547198,JAMP CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02547198,JAMP CEFUROXIME (cefuroxime (cefuroxime axetil) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003346,cefuroxime (cefuroxime axetil) 250 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103584,Marketed,2024-09-27,02547201,JAMP CEFUROXIME,1.0,J01DC02,Cefuroxime,Tablet,Oral,02547201,JAMP CEFUROXIME (cefuroxime (cefuroxime axetil) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003320,cefuroxime (cefuroxime axetil) 500 mg oral tablet,8001076,cefuroxime,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63442,Marketed,2023-09-26,02239941,CELEBREX,1.0,M01AH01,Celecoxib,Capsule,Oral,02239941,CELEBREX (celecoxib 100 mg oral capsule) BGP PHARMA ULC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
63443,Marketed,2023-09-26,02239942,CELEBREX,1.0,M01AH01,Celecoxib,Capsule,Oral,02239942,CELEBREX (celecoxib 200 mg oral capsule) BGP PHARMA ULC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89713,Marketed,2014-11-17,02412497,MINT-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02412497,MINT-CELECOXIB (celecoxib 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89714,Marketed,2014-11-17,02412500,MINT-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02412500,MINT-CELECOXIB (celecoxib 200 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90347,Marketed,2014-11-17,02418932,APO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02418932,APO-CELECOXIB (celecoxib 100 mg oral capsule) APOTEX INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90348,Marketed,2014-11-17,02418940,APO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02418940,APO-CELECOXIB (celecoxib 200 mg oral capsule) APOTEX INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90466,Marketed,2014-11-17,02420058,MAR-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02420058,MAR-CELECOXIB (celecoxib 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90467,Marketed,2014-11-17,02420066,MAR-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02420066,MAR-CELECOXIB (celecoxib 200 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90908,Marketed,2014-11-21,02424371,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02424371,CELECOXIB (celecoxib 100 mg oral capsule) PRO DOC LIMITEE,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90909,Marketed,2014-11-21,02424398,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02424398,CELECOXIB (celecoxib 200 mg oral capsule) PRO DOC LIMITEE,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90922,Marketed,2018-05-18,02424533,JAMP-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02424533,JAMP-CELECOXIB (celecoxib 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90923,Marketed,2018-05-18,02424541,JAMP-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02424541,JAMP-CELECOXIB (celecoxib 200 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91003,Marketed,2014-11-17,02425386,RIVA-CELECOX,1.0,M01AH01,Celecoxib,Capsule,Oral,02425386,RIVA-CELECOX (celecoxib 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91004,Marketed,2014-11-17,02425394,RIVA-CELECOX,1.0,M01AH01,Celecoxib,Capsule,Oral,02425394,RIVA-CELECOX (celecoxib 200 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91097,Marketed,2014-12-05,02426382,BIO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02426382,BIO-CELECOXIB (celecoxib 100 mg oral capsule) BIOMED PHARMA,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91098,Marketed,2014-12-05,02426390,BIO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02426390,BIO-CELECOXIB (celecoxib 200 mg oral capsule) BIOMED PHARMA,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91412,Marketed,2018-07-04,02429675,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02429675,CELECOXIB (celecoxib 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91413,Marketed,2018-07-04,02429683,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02429683,CELECOXIB (celecoxib 200 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92062,Marketed,2021-02-02,02436299,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02436299,CELECOXIB (celecoxib 100 mg oral capsule) SANIS HEALTH INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92063,Marketed,2021-02-02,02436302,CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02436302,CELECOXIB (celecoxib 200 mg oral capsule) SANIS HEALTH INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92190,Marketed,2019-05-13,02437570,AG-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02437570,AG-CELECOXIB (celecoxib 100 mg oral capsule) ANGITA PHARMA INC.,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92191,Marketed,2019-05-13,02437589,AG-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02437589,AG-CELECOXIB (celecoxib 200 mg oral capsule) ANGITA PHARMA INC.,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93095,Marketed,2015-12-02,02445670,AURO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02445670,AURO-CELECOXIB (celecoxib 100 mg oral capsule) AURO PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93096,Marketed,2015-12-02,02445689,AURO-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02445689,AURO-CELECOXIB (celecoxib 200 mg oral capsule) AURO PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97003,Marketed,2019-07-02,02479737,NRA-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02479737,NRA-CELECOXIB (celecoxib 100 mg oral capsule) NORA PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97004,Marketed,2019-07-02,02479745,NRA-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02479745,NRA-CELECOXIB (celecoxib 200 mg oral capsule) NORA PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98538,Marketed,2020-03-24,02495465,M-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02495465,M-CELECOXIB (celecoxib 100 mg oral capsule) MANTRA PHARMA INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98539,Marketed,2020-03-24,02495473,M-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02495473,M-CELECOXIB (celecoxib 200 mg oral capsule) MANTRA PHARMA INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100645,Marketed,2021-11-09,02517116,PMSC-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02517116,PMSC-CELECOXIB (celecoxib 100 mg oral capsule) PHARMASCIENCE INC,Active,9000846,celecoxib 100 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100646,Marketed,2022-04-27,02517124,PMSC-CELECOXIB,1.0,M01AH01,Celecoxib,Capsule,Oral,02517124,PMSC-CELECOXIB (celecoxib 200 mg oral capsule) PHARMASCIENCE INC,Active,9000847,celecoxib 200 mg oral capsule,8000271,celecoxib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97728,Marketed,2025-04-07,02487144,LIBTAYO,1.0,L01FF06,Cemiplimab,Solution,Intravenous,02487144,LIBTAYO (cemiplimab 350 mg per 7 mL solution for injection vial) REGENERON CANADA COMPANY,Active,9013950,cemiplimab 350 mg per 7 mL solution for injection vial,8002253,cemiplimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102735,Marketed,2025-12-19,02538652,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538652,XCOPRI (cenobamate 12.5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014963,cenobamate 12.5 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102736,Marketed,2025-12-19,02538660,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538660,XCOPRI (cenobamate 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014966,cenobamate 25 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102738,Marketed,2025-12-19,02538725,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538725,XCOPRI (cenobamate 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014967,cenobamate 50 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102743,Marketed,2025-12-19,02538733,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538733,XCOPRI (cenobamate 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014962,cenobamate 100 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102744,Marketed,2025-12-19,02538741,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538741,XCOPRI (cenobamate 150 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014964,cenobamate 150 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102745,Marketed,2025-12-19,02538768,XCOPRI,1.0,N03AX25,Cenobamate,Tablet,Oral,02538768,XCOPRI (cenobamate 200 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014965,cenobamate 200 mg oral tablet,8002490,cenobamate,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
102746,Marketed,2025-12-19,02538776,XCOPRI,2.0,N03AX25,Cenobamate,"Tablet,Kit",Oral,02538776,XCOPRI TITRATION PACK 1 (cenobamate 12.5 mg oral tablet with cenobamate 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015213,cenobamate 12.5 mg oral tablet with cenobamate 25 mg oral tablet,8002490,cenobamate,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
102747,Marketed,2025-12-19,02538784,XCOPRI,2.0,N03AX25,Cenobamate,"Kit,Tablet",Oral,02538784,XCOPRI TITRATION PACK 2 (cenobamate 50 mg oral tablet with cenobamate 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015214,cenobamate 50 mg oral tablet with cenobamate 100 mg oral tablet,8002490,cenobamate,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
81334,Marketed,2018-09-04,02327848,NEUROLITE,1.0,V09A,Central nervous system,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
92108,Marketed,2015-04-29,02436779,ZYKADIA,1.0,L01ED02,Ceritinib,Capsule,Oral,02436779,ZYKADIA (ceritinib 150 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005708,ceritinib 150 mg oral capsule,8001613,ceritinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97435,Marketed,2019-03-18,02484013,BRINEURA,1.0,A16AB17,Cerliponase alfa,Solution,Intracerebroventricular,02484013,BRINEURA (cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution) BIOMARIN INTERNATIONAL LIMITED,Active,9013951,cerliponase alfa 150 mg per 5 mL solution for injection vial with flushing solution,8002254,cerliponase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
81737,Marketed,2009-08-31,02331675,CIMZIA,1.0,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02331675,CIMZIA SYRINGE (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
95373,Marketed,2017-08-04,02465574,CIMZIA,1.0,L04AB05,Certolizumab pegol,Solution,Subcutaneous,02465574,CIMZIA AUTOINJECTOR (certolizumab pegol 200 mg per 1 mL solution for injection syringe) UCB CANADA INC,Active,9013041,certolizumab pegol 200 mg per 1 mL solution for injection syringe,8001718,certolizumab pegol,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
43369,Marketed,2007-01-24,02223546,REACTINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02223546,REACTINE (cetirizine hydrochloride 5 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000708,cetirizine hydrochloride 5 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43370,Marketed,2007-01-24,02223554,REACTINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02223554,REACTINE (cetirizine hydrochloride 10 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
46803,Marketed,2007-01-24,01900978,REACTINE 20 MG TABLET,1.0,R06AE07,Cetirizine,Tablet,Oral,01900978,REACTINE 20 MG TABLET (cetirizine hydrochloride 20 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50975,Marketed,1998-10-21,02231603,APO-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02231603,APO-CETIRIZINE (cetirizine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61744,Marketed,2007-01-24,02238337,REACTINE,1.0,R06AE07,Cetirizine,Syrup,Oral,02238337,REACTINE (cetirizine hydrochloride 5 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000877,cetirizine hydrochloride 5 mg per 5 mL syrup,8000237,cetirizine,26643006,Oral,739009002,Syrup,,,,,
63803,Marketed,1999-08-17,02240266,ALLERGY RELIEF,1.0,R06AE07,Cetirizine,Tablet,Oral,02240266,ALLERGY RELIEF (cetirizine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80148,Marketed,2012-09-24,02315955,EXTRA STRENGTH ALLERGY RELIEF,1.0,R06AE07,Cetirizine,Tablet,Oral,02315955,EXTRA STRENGTH ALLERGY RELIEF (cetirizine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80149,Marketed,2008-10-14,02315963,PMS-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02315963,PMS-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84341,Marketed,2014-03-21,02358352,REACTINE FAST MELT JUNIOR,1.0,R06AE07,Cetirizine,Tablet (orally disintegrating),Oral,02358352,REACTINE FAST MELT JUNIOR (cetirizine hydrochloride 10 mg orodispersible tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001412,cetirizine hydrochloride 10 mg orodispersible tablet,8000237,cetirizine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
85288,Marketed,2012-04-01,02368064,REACTINE ALLERGY LIQUID GELS,1.0,R06AE07,Cetirizine,Capsule (immediate release),Oral,02368064,REACTINE ALLERGY LIQUID GELS (cetirizine hydrochloride 10 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001383,cetirizine hydrochloride 10 mg oral capsule,8000237,cetirizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91167,Marketed,2015-10-13,02427141,MAR-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02427141,MAR-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93668,Marketed,2025-07-04,02450526,PRO-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02450526,PRO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) PRO DOC LIMITEE,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93991,Marketed,2016-04-22,02453363,APO-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02453363,APO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) APOTEX INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95446,Marketed,2025-12-15,02466171,JAMP-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02466171,JAMP-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95593,Marketed,2018-03-05,02467577,REACTINE RAPID DISSOLVE,1.0,R06AE07,Cetirizine,Tablet (orally disintegrating),Oral,02467577,REACTINE RAPID DISSOLVE (cetirizine hydrochloride 10 mg orodispersible tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001412,cetirizine hydrochloride 10 mg orodispersible tablet,8000237,cetirizine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97710,Marketed,2020-02-06,02486954,REACTINE ALLERGY,1.0,R06AE07,Cetirizine,Syrup,Oral,02486954,REACTINE ALLERGY (cetirizine hydrochloride 5 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000877,cetirizine hydrochloride 5 mg per 5 mL syrup,8000237,cetirizine,26643006,Oral,739009002,Syrup,,,,,
98634,Marketed,2020-08-20,02496461,NAT-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02496461,NAT-CETIRIZINE (cetirizine hydrochloride 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98635,Marketed,2020-08-19,02496488,NAT-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02496488,NAT-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99929,Marketed,2023-06-19,02510030,BIO-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02510030,BIO-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) BIOMED PHARMA,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100119,Marketed,2021-04-20,02512025,M-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02512025,M-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) MANTRA PHARMA INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100508,Marketed,2025-08-08,02515695,CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02515695,CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) SANIS HEALTH INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100677,Marketed,2022-05-11,02517353,JAMP CETIRIZINE TABLETS,1.0,R06AE07,Cetirizine,Tablet,Oral,02517353,JAMP CETIRIZINE TABLETS (cetirizine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100694,Marketed,2022-06-01,02517566,CETIRIZINE EXTRA STRENGTH,1.0,R06AE07,Cetirizine,Tablet,Oral,02517566,CETIRIZINE EXTRA STRENGTH (cetirizine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000707,cetirizine hydrochloride 10 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101788,Marketed,2023-02-24,02528681,TEVA-CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02528681,TEVA-CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101792,Marketed,2023-04-19,02528738,ALLERGY RELIEF LIQUID GELS,1.0,R06AE07,Cetirizine,Capsule,Oral,02528738,ALLERGY RELIEF LIQUID GELS (cetirizine hydrochloride 10 mg oral capsule) JUNO OTC INC,Active,9001383,cetirizine hydrochloride 10 mg oral capsule,8000237,cetirizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101942,Marketed,2023-04-13,02530236,NRA-CETIRIZINE TABLETS,1.0,R06AE07,Cetirizine,Tablet,Oral,02530236,NRA-CETIRIZINE TABLETS (cetirizine hydrochloride 20 mg oral tablet) NORA PHARMA INC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102306,Marketed,2023-07-20,02534126,CETIRIZINE,1.0,R06AE07,Cetirizine,Tablet,Oral,02534126,CETIRIZINE (cetirizine hydrochloride 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000972,cetirizine hydrochloride 20 mg oral tablet,8000237,cetirizine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10565,Marketed,1990-12-31,00873195,CETRIMIDE TINCTURE 0.5%,1.0,D08AJ02,Cetrimonium,Tincture,Topical,00873195,CETRIMIDE TINCTURE 0.5% (cetrimide 0.5 % cutaneous solution) CANADIAN CUSTOM PACKAGING COMPANY,Active,9014018,cetrimide 0.5 % cutaneous solution,8002270,cetrimide,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
12864,Marketed,1992-12-31,00874426,CETRIMIDE CREAM 0.5%,1.0,D08AJ02,Cetrimonium,Cream,Topical,00874426,CETRIMIDE CREAM 0.5% (cetrimide 0.5 % cutaneous cream) CANADIAN CUSTOM PACKAGING COMPANY,Active,9014017,cetrimide 0.5 % cutaneous cream,8002270,cetrimide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
72060,Marketed,2004-03-03,02247766,CETROTIDE,1.0,H01CC02,Cetrorelix,Powder for solution,Subcutaneous,02247766,"CETROTIDE (cetrorelix (cetrorelix acetate) 0.25 mg per vial powder for solution for injection with diluent solution syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013042,cetrorelix (cetrorelix acetate) 0.25 mg per vial powder for solution for injection with diluent solution syringe,8001719,cetrorelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
75672,Marketed,2010-04-30,02271249,ERBITUX,1.0,L01FE01,Cetuximab,Solution,Intravenous,77700681,"ERBITUX (cetuximab 100 mg per 50 mL solution for injection vial) IMCLONE, LLC",Active,9012936,cetuximab 100 mg per 50 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75672,Marketed,2010-04-30,02271249,ERBITUX,1.0,L01FE01,Cetuximab,Solution,Intravenous,77700682,"ERBITUX (cetuximab 200 mg per 100 mL solution for injection vial) IMCLONE, LLC",Active,9012937,cetuximab 200 mg per 100 mL solution for injection vial,8001614,cetuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5812,Marketed,1984-12-31,00609900,RINCE BOUCHE ANTISEPTIQUE,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,00609900,RINCE BOUCHE ANTISEPTIQUE (cetylpyridinium chloride 0.05 % mouthwash) LABORATOIRE ATLAS INC,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
67489,Marketed,2006-03-22,02243571,ANTISEPTIC ORAL RINSE,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02243571,ANTISEPTIC ORAL RINSE (cetylpyridinium chloride 0.05 % mouthwash) SAGE PRODUCTS LLC,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
75427,Marketed,2010-01-26,02268884,CREST PRO-HEALTH MULTI PROTECTION,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02268884,CREST PRO-HEALTH MULTI PROTECTION (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
92853,Marketed,2025-04-22,02443783,COLGATE TOTAL ACTIVE PREVENTION,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02443783,COLGATE TOTAL ACTIVE PREVENTION (cetylpyridinium chloride 0.07 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
93375,Marketed,2026-01-04,02448068,HELLO CLEAN MINT,1.0,R02AA06,Cetylpyridinium,Mouthwash,Dental,02448068,HELLO CLEAN MINT (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
97708,Marketed,2022-05-11,02486938,THERABREATH HEALTHY GUMS ORAL RINSE,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02486938,THERABREATH HEALTHY GUMS ORAL RINSE (cetylpyridinium chloride 0.05 % mouthwash) CHURCH & DWIGHT CANADA CORP,Active,9013779,cetylpyridinium chloride 0.05 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
98513,Marketed,2026-01-21,02495198,CREST PRO-HEALTH NIGHTLY BACTERIA GUARD,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02495198,CREST PRO-HEALTH NIGHTLY BACTERIA GUARD (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
99377,Marketed,2021-01-04,02504340,CREST PRO-HEALTH BACTERIA GUARD,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02504340,CREST PRO-HEALTH BACTERIA GUARD (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
100089,Marketed,2021-07-05,02511851,CREST PRO-HEALTH GUM & BREATH PURIFY,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02511851,CREST PRO-HEALTH GUM & BREATH PURIFY (cetylpyridinium chloride 0.07 % mouthwash) PROCTER & GAMBLE INC,Active,9005673,cetylpyridinium chloride 0.07 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
101959,Marketed,2025-09-05,02530414,COLGATE TOTAL ACTIVE PREVENTION GUM HEALTH,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02530414,COLGATE TOTAL ACTIVE PREVENTION GUM HEALTH (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
103117,Marketed,2024-07-12,02542617,PERIOGARD PROTECT CETYLPYRIDINIUM CHLORIDE MOUTHWASH,1.0,R02AA06,Cetylpyridinium,Mouthwash,Buccal,02542617,PERIOGARD PROTECT CETYLPYRIDINIUM CHLORIDE MOUTHWASH (cetylpyridinium chloride 0.075 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9014324,cetylpyridinium chloride 0.075 % mouthwash,8001895,cetylpyridinium,26643006,Oral,764788008,Oropharyngeal solution,,,,,
103787,Marketed,2024-10-28,02548984,IXCHIQ,1.0,J07BX07,Chikungunya vaccines,Powder for solution,Intramuscular,,,,,,,,,,,,,,,,
71882,Marketed,2003-08-06,02247621,CHLORAL HYDRATE SYRUP ODAN,1.0,N05CC01,Chloral hydrate,Syrup,Oral,02247621,CHLORAL HYDRATE SYRUP ODAN (chloral hydrate 500 mg per 5 mL syrup) ODAN LABORATORIES LTD,Active,9012567,chloral hydrate 500 mg per 5 mL syrup,8001097,chloral hydrate,26643006,Oral,739009002,Syrup,,,,,
1193,Marketed,2017-11-01,00004626,LEUKERAN,1.0,L01AA02,Chlorambucil,Tablet,Oral,00004626,LEUKERAN (chlorambucil 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012462,chlorambucil 2 mg oral tablet,8001091,chlorambucil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
2789,Marketed,2022-10-20,00312363,CHLOROMYCETIN SUCCINATE INJECTION,1.0,J01BA01,Chloramphenicol,Powder for solution,Intravenous,00312363,CHLOROMYCETIN SUCCINATE INJECTION (chloramphenicol (chloramphenicol sodium succinate) 1 g per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001569,chloramphenicol (chloramphenicol sodium succinate) 1 g per vial powder for solution for injection,8001349,chloramphenicol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
4279,Marketed,2013-05-16,00522996,CHLORDIAZEPOXIDE,1.0,N05BA02,Chlordiazepoxide,Capsule,Oral,00522996,CHLORDIAZEPOXIDE (chlordiazepoxide hydrochloride 25 mg oral capsule) AA PHARMA INC,Active,9001904,chlordiazepoxide hydrochloride 25 mg oral capsule,8001350,chlordiazepoxide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9824,Marketed,1989-12-31,00832030,DEXIDIN 20,1.0,D08AC02,Chlorhexidine,Solution,Topical,00832030,DEXIDIN 20 (chlorhexidine gluconate 20 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9002648,chlorhexidine gluconate 20 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
10668,Marketed,1990-12-31,00832111,DEXIDIN LIQ 4%,1.0,D08AC02,Chlorhexidine,Solution,Topical,00832111,DEXIDIN LIQ 4% (chlorhexidine gluconate 4 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
10669,Marketed,1990-12-31,00832138,DEXIDIN 2 DETERGENT,1.0,D08AC02,Chlorhexidine,Solution,Topical,00832138,DEXIDIN 2 DETERGENT (chlorhexidine gluconate 2 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
10767,Marketed,1997-09-20,00658413,BAXEDIN LIQ 20%,1.0,D08AC02,Chlorhexidine,Solution,Topical,00658413,BAXEDIN LIQ 20% (chlorhexidine gluconate 20 % cutaneous solution) OMEGA LABORATORIES LIMITED,Active,9002648,chlorhexidine gluconate 20 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
13003,Marketed,1991-12-31,01939947,E-Z SCRUB 747 4%,1.0,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),01939947,E-Z SCRUB 747 4% (chlorhexidine gluconate 4 % medicated sponge) BECTON DICKINSON,Active,9003013,chlorhexidine gluconate 4 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,
15801,Marketed,2001-08-28,02046245,PREVORA STAGE 1,1.0,A01AB03,Chlorhexidine,"Solution,Kit",Dental,02046245,PREVORA STAGE 1 (chlorhexidine acetate 10 % dental solution with sealant) CHX TECHNOLOGIES INC,Active,9012938,chlorhexidine acetate 10 % dental solution with sealant,8000809,chlorhexidine,372449004,Dental,385094000,Dental solution,,,,,
17006,Marketed,1992-12-31,00832146,CHLORHEXIDINE GLUCONATE SOLUTION 0.05%,1.0,D08AC02,Chlorhexidine,Solution,Topical,00832146,CHLORHEXIDINE GLUCONATE SOLUTION 0.05% (chlorhexidine gluconate 0.05 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9002430,chlorhexidine gluconate 0.05 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
20216,Marketed,1996-12-31,02209055,ORO-CLENSE,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02209055,ORO-CLENSE (chlorhexidine gluconate 0.12 % mouthwash) GERMIPHENE CORPORATION,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
22030,Marketed,1999-07-21,01936441,BAXEDIN PRE-OP,1.0,D08AC02,Chlorhexidine,Solution,Topical,01936441,BAXEDIN PRE-OP (chlorhexidine gluconate 0.5 % cutaneous solution) OMEGA LABORATORIES LIMITED,Active,9003371,chlorhexidine gluconate 0.5 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
27903,Marketed,2026-01-16,02072955,SOLUPREP LD SPONGE,1.0,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),02072955,SOLUPREP LD SPONGE (chlorhexidine gluconate 0.05 % medicated sponge) SOLVENTUM CANADA LIMITED,Active,9003148,chlorhexidine gluconate 0.05 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,
60786,Marketed,2024-10-31,02237452,PERIDEX ORAL RINSE,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02237452,PERIDEX ORAL RINSE (chlorhexidine gluconate 0.12 % mouthwash) 3M HEALTHCARE CANADA COMPANY LIMITED,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
62430,Marketed,2000-03-28,02238982,DEXIDIN 2 SOLUTION,1.0,D08AC02,Chlorhexidine,Solution,Topical,02238982,DEXIDIN 2 SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
62715,Marketed,1999-02-28,02239252,ENDURE 400 SCRUB-STAT 4,1.0,D08AC02,Chlorhexidine,Solution,Topical,02239252,ENDURE 400 SCRUB-STAT 4 (chlorhexidine gluconate 4 % cutaneous solution) ECOLAB CO,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
63965,Marketed,1999-12-15,02240416,ENDURE 420 CIDA-STAT,1.0,D08AC02,Chlorhexidine,Solution,Topical,02240416,ENDURE 420 CIDA-STAT (chlorhexidine gluconate 2 % cutaneous solution) ECOLAB CO,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
63982,Marketed,2025-09-03,02240433,PMS-CHLORHEXIDINE,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02240433,PMS-CHLORHEXIDINE (chlorhexidine gluconate 0.12 % mouthwash) PHARMASCIENCE INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
69848,Marketed,2006-02-14,02245741,ANTISEPTIC BODY CLEANSER,1.0,D08AC02,Chlorhexidine,Wipe,Topical,02245741,ANTISEPTIC BODY CLEANSER (chlorhexidine gluconate 2 % wipe) SAGE PRODUCTS LLC,Active,9004128,chlorhexidine gluconate 2 % wipe,8000809,chlorhexidine,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,
71177,Marketed,2002-12-04,02246950,STANHEXIDINE AQUEOUS 2% WITH 4% ISOPROPYL ALCOHOL,2.0,D08AC02,Chlorhexidine,Solution,Topical,,,,,,,,,,,,,,,,
75254,Marketed,2025-04-09,02267144,HYGENIPAK 2% CHG FOAMING SKIN CLEANSER,1.0,D08AC02,Chlorhexidine,Solution,"Topical (hospital/hc facilities),Topical (commercial)",02267144,HYGENIPAK 2% CHG FOAMING SKIN CLEANSER (chlorhexidine gluconate 2 % cutaneous solution) SC JOHNSON PROFESSIONAL CA INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
77648,Marketed,2016-01-25,02291096,ORO CLEAR,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02291096,ORO CLEAR (chlorhexidine gluconate 0.12 % mouthwash) GERMIPHENE CORPORATION,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
78057,Marketed,2022-09-23,02295253,CHLORHEXIDINE SOLUTION,1.0,D08AC02,Chlorhexidine,Solution,Topical (commercial),02295253,CHLORHEXIDINE SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) PARTNAR ANIMAL HEALTH INC.,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
78102,Marketed,2022-09-23,02295679,CHLORHEXIDINE 4% ANTISEPTIC HAND WASH,1.0,D08AC02,Chlorhexidine,Solution,Topical (commercial),02295679,CHLORHEXIDINE 4% ANTISEPTIC HAND WASH (chlorhexidine gluconate 4 % cutaneous solution) PARTNAR ANIMAL HEALTH INC.,Active,9001683,chlorhexidine gluconate 4 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
84115,Marketed,2016-10-07,02355965,LORIS 2% CHG WIPE/SERVIETTE,1.0,D08AC02,Chlorhexidine,Wipe,Topical (household),02355965,LORIS 2% CHG WIPE/SERVIETTE (chlorhexidine gluconate 2 % wipe) LERNAPHARM (LORIS) INC.,Active,9004128,chlorhexidine gluconate 2 % wipe,8000809,chlorhexidine,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,
84308,Marketed,2014-07-10,02358018,LORIS 2% CHG SOLUTION,1.0,D08AC02,Chlorhexidine,Solution,Topical (household),02358018,LORIS 2% CHG SOLUTION (chlorhexidine gluconate 2 % cutaneous solution) LERNAPHARM (LORIS) INC.,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
88992,Marketed,2021-10-27,02405091,PERIOGARD ALCOHOL FREE,1.0,A01AB03,Chlorhexidine,Solution,Buccal,02405091,PERIOGARD ALCOHOL FREE (chlorhexidine gluconate 0.12 % mouthwash) COLGATE-PALMOLIVE CANADA INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
89318,Marketed,2025-12-18,02408430,SOLUPREP AQ SPONGE,1.0,D08AC02,Chlorhexidine,Sponge,Topical (hospital/hc facilities),02408430,SOLUPREP AQ SPONGE (chlorhexidine gluconate 2 % medicated sponge) SOLVENTUM CANADA LIMITED,Active,9005433,chlorhexidine gluconate 2 % medicated sponge,8000809,chlorhexidine,448598008,Cutaneous,421288004,Sponge,733014006,Sponge (unit of presentation),,,
91589,Marketed,2025-12-18,02431483,SOLUPREP AQ SWAB,1.0,D08AC02,Chlorhexidine,Swab,Topical (hospital/hc facilities),02431483,SOLUPREP AQ SWAB (chlorhexidine gluconate 2 % swab) SOLVENTUM CANADA LIMITED,Active,9005770,chlorhexidine gluconate 2 % swab,8000809,chlorhexidine,448598008,Cutaneous,420401004,Swab,,,,,
95071,Marketed,2025-06-25,02462842,EURO-CHLORHEXIDINE,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02462842,EURO-CHLORHEXIDINE (chlorhexidine gluconate 0.12 % mouthwash) EURO-PHARM INTERNATIONAL CANADA INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
98313,Marketed,2025-02-23,02493160,PMS-CHLORHEXIDINE WITHOUT ALCOHOL,1.0,A01AB03,Chlorhexidine,Mouthwash,Buccal,02493160,PMS-CHLORHEXIDINE WITHOUT ALCOHOL (chlorhexidine gluconate 0.12 % mouthwash) PHARMASCIENCE INC,Active,9002950,chlorhexidine gluconate 0.12 % mouthwash,8000809,chlorhexidine,26643006,Oral,764788008,Oropharyngeal solution,,,,,
101576,Marketed,2022-12-15,02526697,PURELL ANTIMICROBIAL FOAM HANDWASH 2% CHG,1.0,D08AC02,Chlorhexidine,Solution,Topical (commercial),02526697,PURELL ANTIMICROBIAL FOAM HANDWASH 2% CHG (chlorhexidine gluconate 2 % cutaneous solution) GOJO CANADA INC,Active,9003552,chlorhexidine gluconate 2 % cutaneous solution,8000809,chlorhexidine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
13289,Marketed,2002-10-10,01938991,STANHEXIDINE 2% WITH ISOPROPYL ALCOHOL 4%,2.0,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,
13290,Marketed,2002-10-10,01938983,STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%,2.0,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,
16494,Marketed,2025-12-24,02060019,SOLUPREP QD WIPE,2.0,D08AC52,"Chlorhexidine, combinations",Wipe,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
30398,Marketed,2025-12-18,02119803,SOLUPREP QD SWAB,2.0,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
64263,Marketed,2000-02-02,02240680,DEXIDIN 0.5 SOLUTION,2.0,D08AC52,"Chlorhexidine, combinations",Liquid,Topical,,,,,,,,,,,,,,,,
71113,Marketed,2024-07-05,02246888,AVAGARD CHG,2.0,D08AC52,"Chlorhexidine, combinations",Lotion,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
73640,Marketed,2004-07-07,02251477,BAXEDIN 2% - 70%,2.0,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,
78280,Marketed,2009-02-24,02297442,LORIS - I.V.,2.0,D08AC52,"Chlorhexidine, combinations",Swab,Topical,,,,,,,,,,,,,,,,
86791,Marketed,2025-12-18,02382040,SOLUPREP SWAB,2.0,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
86799,Marketed,2025-12-24,02382113,SOLUPREP APPLICATOR,2.0,D08AC52,"Chlorhexidine, combinations",Solution,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
87132,Marketed,2025-12-05,02385708,SOLUPREP WIPE,2.0,D08AC52,"Chlorhexidine, combinations",Wipe,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
88890,Marketed,2024-07-10,02404125,3M SOLUPREP SPONGE,2.0,D08AC52,"Chlorhexidine, combinations",Sponge,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
97469,Marketed,2019-11-18,02484374,CHLORAPREP,2.0,D08AC52,"Chlorhexidine, combinations",Solution,Topical,,,,,,,,,,,,,,,,
101459,Marketed,2024-12-24,02525585,CHLORAPREP SWABSTICKS,2.0,D08AC52,"Chlorhexidine, combinations",Swab,Topical (hospital/hc facilities),,,,,,,,,,,,,,,,
100609,Marketed,2022-09-14,02516764,LEDAGA,1.0,L01AA05,Chlormethine,Gel,Topical,02516764,LEDAGA (chlormethine (chlormethine hydrochloride) 160 mcg per g cutaneous gel) RECORDATI RARE DISEASES CANADA INC,Active,9014799,chlormethine (chlormethine hydrochloride) 160 mcg per g cutaneous gel,8002451,chlormethine,448598008,Cutaneous,385100002,Gel,,,1.0,,
103981,Marketed,2025-03-04,02551063,CLOROTEKAL,1.0,N01BA04,Chloroprocaine,Solution,Intrathecal,,,,,,,,,,,,,,,,
12639,Marketed,1992-12-31,01977873,GERMICIDAL HAND SOAP LIQ 0.6%,1.0,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,
18208,Marketed,2012-06-23,02131471,VIROBEX-P,1.0,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,
41477,Marketed,2019-02-04,00373435,DETTOL,1.0,D08AE05,Chloroxylenol,Solution,Topical,,,,,,,,,,,,,,,,
66677,Marketed,2001-03-01,02242847,DIGICLEAN E FOAM HAND SOAP,1.0,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,
76258,Marketed,2021-03-29,02276917,QUICK CLEAN,1.0,D08AE05,Chloroxylenol,Gel,Topical,,,,,,,,,,,,,,,,
79962,Marketed,2009-11-10,02314126,PHENREX MVD,1.0,D08AE05,Chloroxylenol,Solution,Topical,,,,,,,,,,,,,,,,
92481,Marketed,2015-08-18,02440458,PURKLENZ,1.0,D08AE05,Chloroxylenol,Liquid,Topical,,,,,,,,,,,,,,,,
93459,Marketed,2017-02-28,02448866,SOFT CARE DEFEND FOAM,1.0,D08AE05,Chloroxylenol,Liquid,Topical (commercial),,,,,,,,,,,,,,,,
93526,Marketed,2017-02-28,02449420,SOFT CARE DEFEND,1.0,D08AE05,Chloroxylenol,Liquid,Topical (commercial),,,,,,,,,,,,,,,,
97106,Marketed,2019-08-02,02480506,APPLAUD AB ANTISEPTIC LOTIONIZED HAND SOAP,1.0,D08AE05,Chloroxylenol,Lotion,Topical (commercial),,,,,,,,,,,,,,,,
579,Marketed,2019-06-13,00021288,TEVA-PHENIRAM,1.0,R06AB04,Chlorpheniramine,Tablet,Oral,00021288,TEVA-PHENIRAM (chlorpheniramine maleate 4 mg oral tablet) TEVA CANADA LIMITED,Active,9001624,chlorpheniramine maleate 4 mg oral tablet,8001353,chlorpheniramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1293,Marketed,2011-03-09,00232807,TEVA-CHLORPROMAZINE,1.0,N05AA01,Chlorpromazine,Tablet,Oral,00232807,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001627,chlorpromazine (chlorpromazine hydrochloride) 50 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1294,Marketed,2011-03-09,00232823,TEVA-CHLORPROMAZINE,1.0,N05AA01,Chlorpromazine,Tablet,Oral,00232823,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001626,chlorpromazine (chlorpromazine hydrochloride) 25 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1295,Marketed,2011-03-09,00232831,TEVA-CHLORPROMAZINE,1.0,N05AA01,Chlorpromazine,Tablet,Oral,00232831,TEVA-CHLORPROMAZINE (chlorpromazine (chlorpromazine hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9001625,chlorpromazine (chlorpromazine hydrochloride) 100 mg oral tablet,8001357,chlorpromazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2467,Marketed,2023-10-12,00360279,APO-CHLORTHALIDONE,1.0,C03BA04,Chlortalidone,Tablet,Oral,00360279,APO-CHLORTHALIDONE (chlorthalidone 50 mg oral tablet) APOTEX INC,Active,9008378,chlorthalidone 50 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101285,Marketed,2022-12-01,02523795,JAMP CHLORTHALIDONE,1.0,C03BA04,Chlortalidone,Tablet,Oral,02523795,JAMP CHLORTHALIDONE (chlorthalidone 12.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014800,chlorthalidone 12.5 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101286,Marketed,2022-12-01,02523809,JAMP CHLORTHALIDONE,1.0,C03BA04,Chlortalidone,Tablet,Oral,02523809,JAMP CHLORTHALIDONE (chlorthalidone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014801,chlorthalidone 25 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101287,Marketed,2022-12-02,02523817,JAMP CHLORTHALIDONE,1.0,C03BA04,Chlortalidone,Tablet,Oral,02523817,JAMP CHLORTHALIDONE (chlorthalidone 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9008378,chlorthalidone 50 mg oral tablet,8000813,chlorthalidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71450,Marketed,2011-08-15,02247208,DUKORAL,5.0,J07AE01,"Cholera, inactivated, whole cell",Suspension,Oral,,,,,,,,,,,,,,,,
102690,Marketed,2024-08-28,02538164,VAXCHORA,1.0,J07AE02,"Cholera, live attenuated",Powder for suspension,Oral,,,,,,,,,,,,,,,,
74742,Marketed,2004-12-20,02262088,OVIDREL,1.0,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02262088,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013812,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection syringe,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
85673,Marketed,2013-05-28,02371588,OVIDREL,1.0,G03GA08,Choriogonadotropin alfa,Solution,Subcutaneous,02371588,"OVIDREL (choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013811,choriogonadotropin alfa 250 mcg per 0.5 mL solution for injection pen,8002227,choriogonadotropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
44257,Marketed,2022-04-06,02182904,PREGNYL,1.0,G03GA01,Chorionic gonadotrophin,"Kit,Powder for solution",Intramuscular,02182904,PREGNYL (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) ORGANON CANADA INC.,Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
71705,Marketed,2015-11-13,02247459,"CHORIONIC GONADOTROPIN FOR INJECTION, USP",1.0,G03GA01,Chorionic gonadotrophin,Powder for solution,"Subcutaneous,Intramuscular",02247459,"CHORIONIC GONADOTROPIN FOR INJECTION, USP (chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution) FRESENIUS KABI CANADA LTD",Active,9013047,chorionic gonadotropin 10000 unit per vial powder for solution for injection with diluent solution,8001723,chorionic gonadotropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
77111,Marketed,2021-09-09,02285606,ALVESCO,1.0,R03BA08,Ciclesonide,"Aerosol, metered dose",Inhalation,02285606,ALVESCO (ciclesonide 100 mcg per actuation pressurized inhalation) COVIS PHARMA GMBH,Active,9001173,ciclesonide 100 mcg per actuation pressurized inhalation,8000367,ciclesonide,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
77112,Marketed,2021-02-10,02285614,ALVESCO,1.0,R03BA08,Ciclesonide,"Aerosol, metered dose",Inhalation,02285614,ALVESCO (ciclesonide 200 mcg per actuation pressurized inhalation) COVIS PHARMA GMBH,Active,9001174,ciclesonide 200 mcg per actuation pressurized inhalation,8000367,ciclesonide,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
78899,Marketed,2022-08-11,02303671,OMNARIS,1.0,R01AD13,Ciclesonide,"Spray, metered dose",Nasal,02303671,OMNARIS (ciclesonide 50 mcg per actuation nasal spray) COVIS PHARMA GMBH,Active,9001244,ciclesonide 50 mcg per actuation nasal spray,8000367,ciclesonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
43306,Marketed,2020-11-27,02221802,LOPROX,1.0,D01AE14,Ciclopirox,Cream,Topical,02221802,"LOPROX (ciclopirox olamine 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000675,ciclopirox olamine 1 % cutaneous cream,8000230,ciclopirox,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
43307,Marketed,2020-11-27,02221810,LOPROX,1.0,D01AE14,Ciclopirox,Lotion,Topical,02221810,"LOPROX (ciclopirox olamine 1 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9000710,ciclopirox olamine 1 % lotion,8000230,ciclopirox,448598008,Cutaneous,739000003,Lotion,,,,,
78435,Marketed,2008-04-18,02298953,APO-CICLOPIROX,1.0,D01AE14,Ciclopirox,Solution,Topical,02298953,APO-CICLOPIROX (ciclopirox 8 % cutaneous solution) APOTEX INC,Active,9001082,ciclopirox 8 % cutaneous solution,8000230,ciclopirox,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
83849,Marketed,2011-10-25,02353288,TARO-CICLOPIROX,1.0,D01AE14,Ciclopirox,Solution,Topical,02353288,TARO-CICLOPIROX (ciclopirox 8 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9001082,ciclopirox 8 % cutaneous solution,8000230,ciclopirox,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
5790,Marketed,1998-07-30,00593257,SANDIMMUNE I.V.,1.0,L04AD01,Ciclosporin,Solution,Intravenous,77700583,SANDIMMUNE I.V. (cyclosporine 250 mg per 5 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012605,cyclosporine 250 mg per 5 mL solution for injection ampoule,8001253,cyclosporine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
5790,Marketed,1998-07-30,00593257,SANDIMMUNE I.V.,1.0,L04AD01,Ciclosporin,Solution,Intravenous,77700584,SANDIMMUNE I.V. (cyclosporine 50 mg per 1 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012606,cyclosporine 50 mg per 1 mL solution for injection ampoule,8001253,cyclosporine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
17799,Marketed,2014-07-12,02150670,NEORAL,1.0,L04AD01,Ciclosporin,Capsule,Oral,02150670,NEORAL (cyclosporine 100 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002770,cyclosporine 100 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
17801,Marketed,2014-07-12,02150697,NEORAL,1.0,L04AD01,Ciclosporin,Solution,Oral,02150697,NEORAL (cyclosporine 100 mg per mL oral solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002771,cyclosporine 100 mg per mL oral solution,8001253,cyclosporine,26643006,Oral,385023001,Oral solution,,,1.0,,
17813,Marketed,2014-07-12,02150689,NEORAL,1.0,L04AD01,Ciclosporin,Capsule,Oral,02150689,NEORAL (cyclosporine 25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002772,cyclosporine 25 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
17814,Marketed,2014-07-12,02150662,NEORAL,1.0,L04AD01,Ciclosporin,Capsule,Oral,02150662,NEORAL (cyclosporine 50 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002773,cyclosporine 50 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
61016,Marketed,1998-10-02,02237671,NEORAL,1.0,L04AD01,Ciclosporin,Capsule,Oral,02237671,NEORAL (cyclosporine 10 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003317,cyclosporine 10 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
66649,Marketed,2006-02-18,02242821,SANDOZ CYCLOSPORINE,1.0,L04AD01,Ciclosporin,Capsule,Oral,02242821,SANDOZ CYCLOSPORINE (cyclosporine 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002770,cyclosporine 100 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
71308,Marketed,2006-02-18,02247073,SANDOZ CYCLOSPORINE,1.0,L04AD01,Ciclosporin,Capsule,Oral,02247073,SANDOZ CYCLOSPORINE (cyclosporine 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002772,cyclosporine 25 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
71309,Marketed,2006-10-18,02247074,SANDOZ CYCLOSPORINE,1.0,L04AD01,Ciclosporin,Capsule,Oral,02247074,SANDOZ CYCLOSPORINE (cyclosporine 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002773,cyclosporine 50 mg oral capsule,8001253,cyclosporine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
84087,Marketed,2024-02-05,02355655,RESTASIS,1.0,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02355655,RESTASIS (cyclosporine 0.05 % ophthalmic drops) ABBVIE CORPORATION,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,
95023,Marketed,2017-12-04,02462486,TEVA-CYCLOSPORINE,1.0,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02462486,TEVA-CYCLOSPORINE (cyclosporine 0.05 % ophthalmic drops) TEVA CANADA LIMITED,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,
96764,Marketed,2023-07-19,02476835,RESTASIS MULTIDOSE,1.0,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02476835,RESTASIS MULTIDOSE (cyclosporine 0.05 % ophthalmic drops) ABBVIE CORPORATION,Active,9004774,cyclosporine 0.05 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,
97446,Marketed,2025-12-08,02484137,VERKAZIA,1.0,S01XA18,Ciclosporin,Emulsion,Ophthalmic,02484137,VERKAZIA (cyclosporine 0.1 % ophthalmic drops) APOTEX INC,Active,9013904,cyclosporine 0.1 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,
100190,Marketed,2022-12-08,02512629,CEQUA,1.0,S01XA18,Ciclosporin,Solution,Ophthalmic,02512629,CEQUA (cyclosporine 0.09 % ophthalmic drops) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014621,cyclosporine 0.09 % ophthalmic drops,8001253,cyclosporine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),1.0,,
96392,Marketed,2018-07-11,02473925,MAR-CIDOFOVIR,1.0,J05AB12,Cidofovir,Solution,Intravenous,02473925,MAR-CIDOFOVIR (cidofovir (cidofovir dihydrate) 375 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013428,cidofovir 375 mg per 5 mL solution for injection vial,8002019,cidofovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
13834,Marketed,2019-08-19,01911481,INHIBACE,1.0,C09AA08,Cilazapril,Tablet,Oral,01911481,INHIBACE (cilazapril (cilazapril monohydrate) 5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76935,Marketed,2010-01-07,02283778,MYLAN-CILAZAPRIL,1.0,C09AA08,Cilazapril,Tablet,Oral,02283778,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 1 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012366,cilazapril 1 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76936,Marketed,2010-01-05,02283786,MYLAN-CILAZAPRIL,1.0,C09AA08,Cilazapril,Tablet,Oral,02283786,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002540,cilazapril 2.5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76937,Marketed,2010-01-07,02283794,MYLAN-CILAZAPRIL,1.0,C09AA08,Cilazapril,Tablet,Oral,02283794,MYLAN-CILAZAPRIL (cilazapril (cilazapril monohydrate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77652,Marketed,2007-02-01,02291142,APO-CILAZAPRIL,1.0,C09AA08,Cilazapril,Tablet,Oral,02291142,APO-CILAZAPRIL (cilazapril (cilazapril monohydrate) 2.5 mg oral tablet) APOTEX INC,Active,9002540,cilazapril 2.5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77653,Marketed,2007-02-01,02291150,APO-CILAZAPRIL,1.0,C09AA08,Cilazapril,Tablet,Oral,02291150,APO-CILAZAPRIL (cilazapril (cilazapril monohydrate) 5 mg oral tablet) APOTEX INC,Active,9002541,cilazapril 5 mg oral tablet,8000874,cilazapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
44252,Marketed,2018-12-12,02181479,INHIBACE PLUS,2.0,C09BA08,Cilazapril and diuretics,Tablet,Oral,02181479,INHIBACE PLUS (cilazapril (cilazapril monohydrate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003374,cilazapril 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000909,cilazapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77051,Marketed,2006-08-23,02284987,APO-CILAZAPRIL/HCTZ,2.0,C09BA08,Cilazapril and diuretics,Tablet,Oral,02284987,APO-CILAZAPRIL/HCTZ (cilazapril (cilazapril monohydrate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet) APOTEX INC,Active,9003374,cilazapril 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000909,cilazapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5195,Marketed,2019-10-04,00584215,CIMETIDINE,1.0,A02BA01,Cimetidine,Tablet,Oral,00584215,CIMETIDINE (cimetidine 200 mg oral tablet) AA PHARMA INC,Active,9001937,cimetidine 200 mg oral tablet,8001359,cimetidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5196,Marketed,2019-10-23,00487872,CIMETIDINE,1.0,A02BA01,Cimetidine,Tablet,Oral,00487872,CIMETIDINE (cimetidine 300 mg oral tablet) AA PHARMA INC,Active,9001938,cimetidine 300 mg oral tablet,8001359,cimetidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91886,Marketed,2016-06-29,02434539,MYLAN-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02434539,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91887,Marketed,2016-12-22,02434547,MYLAN-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02434547,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91888,Marketed,2016-12-22,02434555,MYLAN-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02434555,MYLAN-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92601,Marketed,2016-12-06,02441624,TEVA-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02441624,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92602,Marketed,2016-12-06,02441632,TEVA-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02441632,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) TEVA CANADA LIMITED,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92603,Marketed,2016-12-06,02441640,TEVA-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02441640,TEVA-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) TEVA CANADA LIMITED,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93910,Marketed,2016-05-20,02452693,APO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02452693,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) APOTEX INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93911,Marketed,2016-05-20,02452707,APO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02452707,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) APOTEX INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93912,Marketed,2016-05-20,02452715,APO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02452715,APO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) APOTEX INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96960,Marketed,2019-02-01,02478900,AURO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02478900,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) AURO PHARMA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96962,Marketed,2019-02-01,02478919,AURO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02478919,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) AURO PHARMA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96965,Marketed,2019-02-01,02478943,AURO-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02478943,AURO-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) AURO PHARMA INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97082,Marketed,2018-11-29,02480298,MAR-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02480298,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97083,Marketed,2018-11-29,02480301,MAR-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02480301,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97084,Marketed,2018-11-29,02480328,MAR-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02480328,MAR-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97245,Marketed,2018-12-11,02481987,M-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02481987,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) MANTRA PHARMA INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97246,Marketed,2018-12-11,02481995,M-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02481995,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) MANTRA PHARMA INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97247,Marketed,2018-12-11,02482002,M-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02482002,M-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) MANTRA PHARMA INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98980,Marketed,2025-10-07,02500094,JAMP CINACALCET TABLETS,1.0,H05BX01,Cinacalcet,Tablet,Oral,02500094,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98981,Marketed,2025-10-07,02500108,JAMP CINACALCET TABLETS,1.0,H05BX01,Cinacalcet,Tablet,Oral,02500108,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98982,Marketed,2021-02-15,02500116,JAMP CINACALCET TABLETS,1.0,H05BX01,Cinacalcet,Tablet,Oral,02500116,JAMP CINACALCET TABLETS (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100698,Marketed,2022-12-05,02517604,PMS-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02517604,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) PHARMASCIENCE INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100699,Marketed,2022-12-05,02517612,PMS-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02517612,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet) PHARMASCIENCE INC,Active,9003935,cinacalcet (cinacalcet hydrochloride) 60 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100700,Marketed,2022-12-05,02517620,PMS-CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02517620,PMS-CINACALCET (cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet) PHARMASCIENCE INC,Active,9003936,cinacalcet (cinacalcet hydrochloride) 90 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101391,Marketed,2022-06-22,02524880,CINACALCET,1.0,H05BX01,Cinacalcet,Tablet,Oral,02524880,CINACALCET (cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet) SANIS HEALTH INC,Active,9003934,cinacalcet (cinacalcet hydrochloride) 30 mg oral tablet,8001616,cinacalcet,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106027,Marketed,2025-12-05,02556898,POMBILITI,1.0,A16AB23,Cipaglucosidase alfa,Powder for solution,Intravenous,02556898,POMBILITI (cipaglucosidase alfa 105 mg per vial powder for solution for injection) AMICUS THERAPEUTICS CANADA INC.,Active,9015294,cipaglucosidase alfa 105 mg per vial powder for solution for injection,8002564,cipaglucosidase alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
12953,Marketed,2018-10-15,01945270,CILOXAN,1.0,S03AA07,Ciprofloxacin,Solution,Ophthalmic,01945270,CILOXAN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000408,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops,8000159,ciprofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
42964,Marketed,2018-03-21,02200864,CILOXAN,1.0,S01AE03,Ciprofloxacin,Ointment,Ophthalmic,02200864,CILOXAN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000817,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic ointment,8000159,ciprofloxacin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
60849,Marketed,1998-09-15,02237514,CIPRO ORAL SUSPENSION,1.0,J01MA02,Ciprofloxacin,Suspension,Oral,02237514,CIPRO ORAL SUSPENSION (ciprofloxacin 500 mg per 5 mL oral suspension) BAYER INC,Active,9006258,ciprofloxacin 500 mg per 5 mL oral suspension,8000159,ciprofloxacin,26643006,Oral,385024007,Oral suspension,,,,,
71582,Marketed,2017-10-11,02247339,ACT CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02247339,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71583,Marketed,2017-10-11,02247340,ACT CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02247340,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71584,Marketed,2017-10-11,02247341,ACT CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02247341,ACT CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) TEVA CANADA LIMITED,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72789,Marketed,2004-02-18,02248438,PMS-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02248438,PMS-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) PHARMASCIENCE INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73124,Marketed,2005-12-01,02248756,SANDOZ CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02248756,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73125,Marketed,2005-12-01,02248757,SANDOZ CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02248757,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73126,Marketed,2005-12-01,02248758,SANDOZ CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02248758,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73619,Marketed,2013-07-04,02251248,RIVA-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02251248,RIVA-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78902,Marketed,2020-03-11,02303728,TARO-CIPROFLOX,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02303728,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78903,Marketed,2020-03-11,02303736,TARO-CIPROFLOX,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02303736,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78904,Marketed,2020-03-11,02303744,TARO-CIPROFLOX,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02303744,TARO-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet) SUN PHARMA CANADA INC,Active,9000662,ciprofloxacin (ciprofloxacin hydrochloride) 750 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79003,Marketed,2008-03-27,02304759,CIPROFLOXACIN INTRAVENOUS INFUSION BP,1.0,J01MA02,Ciprofloxacin,Solution,Intravenous,77700551,CIPROFLOXACIN INTRAVENOUS INFUSION BP (ciprofloxacin 400 mg per 200 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9012477,ciprofloxacin 400 mg per 200 mL solution for injection bag,8000159,ciprofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
79003,Marketed,2008-03-27,02304759,CIPROFLOXACIN INTRAVENOUS INFUSION BP,1.0,J01MA02,Ciprofloxacin,Solution,Intravenous,77700552,CIPROFLOXACIN INTRAVENOUS INFUSION BP (ciprofloxacin 200 mg per 100 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9012475,ciprofloxacin 200 mg per 100 mL solution for injection bag,8000159,ciprofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
80332,Marketed,2019-03-13,02317796,PRO-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02317796,PRO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80333,Marketed,2019-03-13,02317818,PRO-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02317818,PRO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) PRO DOC LIMITEE,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86555,Marketed,2012-09-06,02379686,MAR-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02379686,MAR-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86556,Marketed,2012-09-06,02379694,MAR-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02379694,MAR-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86616,Marketed,2012-03-16,02380358,JAMP-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02380358,JAMP-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86617,Marketed,2012-03-16,02380366,JAMP-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02380366,JAMP-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86775,Marketed,2012-06-13,02381907,AURO-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02381907,AURO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) AURO PHARMA INC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86776,Marketed,2012-06-13,02381923,AURO-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02381923,AURO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) AURO PHARMA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87170,Marketed,2014-12-19,02386119,CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02386119,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000660,ciprofloxacin (ciprofloxacin hydrochloride) 250 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87171,Marketed,2014-12-19,02386127,CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02386127,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87272,Marketed,2012-07-03,02387131,SANDOZ CIPROFLOXACIN,1.0,S01AE03,Ciprofloxacin,Solution,Ophthalmic,02387131,SANDOZ CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000408,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % ophthalmic drops,8000159,ciprofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90104,Marketed,2014-01-14,02416433,PMS-CIPROFLOXACIN XL,1.0,J01MA02,Ciprofloxacin,Tablet (immediate and extended release),Oral,02416433,"PMS-CIPROFLOXACIN XL (ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet) PHARMASCIENCE INC",Active,9015330,"ciprofloxacin (ciprofloxacin, ciprofloxacin hydrochloride) 500 mg prolonged-release oral tablet",8000159,ciprofloxacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
90828,Marketed,2020-03-20,02423561,MINT-CIPROFLOX,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02423561,MINT-CIPROFLOX (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93011,Marketed,2016-06-17,02444887,BIO-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02444887,BIO-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) BIOMED PHARMA,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98201,Marketed,2020-12-03,02492008,NRA-CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02492008,NRA-CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) NORA PHARMA INC,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103580,Marketed,2025-02-26,02547147,CIPROFLOXACIN,1.0,J01MA02,Ciprofloxacin,Tablet,Oral,02547147,CIPROFLOXACIN (ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000661,ciprofloxacin (ciprofloxacin hydrochloride) 500 mg oral tablet,8000159,ciprofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89357,Marketed,2024-09-27,02408813,CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE,1.0,M03AC11,Cisatracurium,Solution,Intravenous,02408813,CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE (cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013537,cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial,8002106,cisatracurium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106606,Marketed,2026-01-13,02563266,CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE,1.0,M03AC11,Cisatracurium,Solution,Intravenous,02563266,CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE (cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9013537,cisatracurium (cisatracurium besylate) 20 mg per 10 mL solution for injection vial,8002106,cisatracurium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
43840,Marketed,2017-11-29,02126613,CISPLATIN INJECTION BP,1.0,L01XA01,Cisplatin,Solution,Intravenous,77700718,CISPLATIN INJECTION BP (cisplatin 50 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43840,Marketed,2017-11-29,02126613,CISPLATIN INJECTION BP,1.0,L01XA01,Cisplatin,Solution,Intravenous,77700719,CISPLATIN INJECTION BP (cisplatin 100 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84044,Marketed,2012-04-10,02355183,"CISPLATIN INJECTION, BP",1.0,L01XA01,Cisplatin,Solution,Intravenous,77700749,"CISPLATIN INJECTION, BP (cisplatin 100 mg per 100 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84044,Marketed,2012-04-10,02355183,"CISPLATIN INJECTION, BP",1.0,L01XA01,Cisplatin,Solution,Intravenous,77700750,"CISPLATIN INJECTION, BP (cisplatin 50 mg per 50 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84044,Marketed,2012-04-10,02355183,"CISPLATIN INJECTION, BP",1.0,L01XA01,Cisplatin,Solution,Intravenous,77700751,"CISPLATIN INJECTION, BP (cisplatin 10 mg per 10 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013051,cisplatin 10 mg per 10 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88800,Marketed,2013-08-29,02403188,CISPLATIN INJECTION,1.0,L01XA01,Cisplatin,Solution,Intravenous,77700776,CISPLATIN INJECTION (cisplatin 10 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013051,cisplatin 10 mg per 10 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88800,Marketed,2013-08-29,02403188,CISPLATIN INJECTION,1.0,L01XA01,Cisplatin,Solution,Intravenous,77700777,CISPLATIN INJECTION (cisplatin 100 mg per 100 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88800,Marketed,2013-08-29,02403188,CISPLATIN INJECTION,1.0,L01XA01,Cisplatin,Solution,Intravenous,77700778,CISPLATIN INJECTION (cisplatin 50 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102507,Marketed,2024-02-23,02536285,CISPLATIN INJECTION BP,1.0,L01XA01,Cisplatin,Solution,Intravenous,77701152,CISPLATIN INJECTION BP (cisplatin 50 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013053,cisplatin 50 mg per 50 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102507,Marketed,2024-02-23,02536285,CISPLATIN INJECTION BP,1.0,L01XA01,Cisplatin,Solution,Intravenous,77701153,CISPLATIN INJECTION BP (cisplatin 100 mg per 100 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013052,cisplatin 100 mg per 100 mL solution for injection vial,8001729,cisplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
63077,Marketed,1999-03-08,02239607,CELEXA 20 MG,1.0,N06AB04,Citalopram,Tablet,Oral,02239607,CELEXA 20 MG (citalopram (citalopram hydrobromide) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63078,Marketed,1999-03-08,02239608,CELEXA 40 MG,1.0,N06AB04,Citalopram,Tablet,Oral,02239608,CELEXA 40 MG (citalopram (citalopram hydrobromide) 40 mg oral tablet) LUNDBECK CANADA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70187,Marketed,2004-01-21,02246056,APO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02246056,APO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70188,Marketed,2004-01-21,02246057,APO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02246057,APO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) APOTEX INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72326,Marketed,2004-01-15,02248010,PMS-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02248010,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72327,Marketed,2004-01-15,02248011,PMS-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02248011,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74277,Marketed,2024-11-07,02257513,CITALOPRAM - 20,1.0,N06AB04,Citalopram,Tablet,Oral,02257513,CITALOPRAM - 20 (citalopram (citalopram hydrobromide) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74278,Marketed,2024-11-18,02257521,CITALOPRAM - 40,1.0,N06AB04,Citalopram,Tablet,Oral,02257521,CITALOPRAM - 40 (citalopram (citalopram hydrobromide) 40 mg oral tablet) PRO DOC LIMITEE,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75597,Marketed,2005-09-10,02270609,PMS-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02270609,PMS-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76120,Marketed,2011-11-28,02275562,AURO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02275562,AURO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) AURO PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76121,Marketed,2011-11-28,02275570,AURO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02275570,AURO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) AURO PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77858,Marketed,2010-11-03,02293218,TEVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02293218,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77859,Marketed,2010-11-03,02293226,TEVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02293226,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78149,Marketed,2024-10-16,02296152,CTP 30,1.0,N06AB04,Citalopram,Tablet,Oral,02296152,"CTP 30 (citalopram (citalopram hydrobromide) 30 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9001225,citalopram (citalopram hydrobromide) 30 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78858,Marketed,2008-01-24,02303256,RIVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02303256,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78859,Marketed,2008-01-28,02303264,RIVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02303264,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78860,Marketed,2008-01-28,02303272,RIVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02303272,RIVA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79783,Marketed,2010-11-03,02312336,TEVA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02312336,TEVA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79893,Marketed,2025-08-15,02313405,JAMP-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02313405,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79894,Marketed,2025-08-12,02313413,JAMP-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02313413,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81046,Marketed,2024-08-14,02325047,CITALOPRAM - 10,1.0,N06AB04,Citalopram,Tablet,Oral,02325047,CITALOPRAM - 10 (citalopram (citalopram hydrobromide) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82501,Marketed,2021-09-03,02339390,AG-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02339390,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82502,Marketed,2021-10-13,02339404,AG-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02339404,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83886,Marketed,2016-01-06,02353660,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02353660,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) SANIS HEALTH INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83887,Marketed,2016-01-06,02353679,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02353679,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) SANIS HEALTH INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85511,Marketed,2025-09-12,02370085,JAMP-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02370085,JAMP-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85700,Marketed,2012-09-06,02371871,MAR-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02371871,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85701,Marketed,2012-09-06,02371898,MAR-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02371898,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85702,Marketed,2012-09-06,02371901,MAR-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02371901,MAR-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85994,Marketed,2021-10-14,02374617,AG-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02374617,AG-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87351,Marketed,2024-02-27,02387948,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02387948,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87352,Marketed,2024-02-27,02387956,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02387956,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87353,Marketed,2024-02-27,02387964,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02387964,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89374,Marketed,2023-09-08,02409003,NATCO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02409003,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91414,Marketed,2015-10-14,02429691,MINT-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02429691,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91415,Marketed,2015-10-14,02429705,MINT-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02429705,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91416,Marketed,2015-10-14,02429713,MINT-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02429713,MINT-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91495,Marketed,2020-03-06,02430517,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02430517,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91496,Marketed,2020-03-06,02430541,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02430541,CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91497,Marketed,2020-03-06,02430568,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02430568,CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92865,Marketed,2023-09-18,02443880,NATCO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02443880,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92866,Marketed,2023-09-15,02443899,NATCO-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02443899,NATCO-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93099,Marketed,2015-10-14,02445719,CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02445719,CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) SANIS HEALTH INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95617,Marketed,2023-11-13,02467836,M-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02467836,M-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95618,Marketed,2023-11-13,02467844,M-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02467844,M-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) MANTRA PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96828,Marketed,2025-11-21,02477637,NRA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02477637,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NORA PHARMA INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96829,Marketed,2025-11-21,02477645,NRA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02477645,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NORA PHARMA INC,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96830,Marketed,2025-11-21,02477653,NRA-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02477653,NRA-CITALOPRAM (citalopram (citalopram hydrobromide) 40 mg oral tablet) NORA PHARMA INC,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100286,Marketed,2025-08-19,02513684,AG-CITALOPRAM TABLETS,1.0,N06AB04,Citalopram,Tablet,Oral,02513684,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100287,Marketed,2025-07-22,02513692,AG-CITALOPRAM TABLETS,1.0,N06AB04,Citalopram,Tablet,Oral,02513692,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000835,citalopram (citalopram hydrobromide) 40 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102119,Marketed,2023-11-13,02532123,M-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02532123,M-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103156,Marketed,2024-01-30,02543060,AG-CITALOPRAM TABLETS,1.0,N06AB04,Citalopram,Tablet,Oral,02543060,AG-CITALOPRAM TABLETS (citalopram (citalopram hydrobromide) 30 mg oral tablet) ANGITA PHARMA INC.,Active,9001225,citalopram (citalopram hydrobromide) 30 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104472,Marketed,2025-07-16,02555999,NB-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02555999,NB-CITALOPRAM (citalopram (citalopram hydrobromide) 10 mg oral tablet) NB PHARMA INC.,Active,9001126,citalopram (citalopram hydrobromide) 10 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104473,Marketed,2025-07-16,02556006,NB-CITALOPRAM,1.0,N06AB04,Citalopram,Tablet,Oral,02556006,NB-CITALOPRAM (citalopram (citalopram hydrobromide) 20 mg oral tablet) NB PHARMA INC.,Active,9000834,citalopram (citalopram hydrobromide) 20 mg oral tablet,8000267,citalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80536,Marketed,2016-08-22,02319918,CLADRIBINE INJECTION,1.0,L01BB04,Cladribine,Solution,Intravenous,02319918,CLADRIBINE INJECTION (cladribine 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013055,cladribine 10 mg per 10 mL solution for injection vial,8001730,cladribine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95915,Marketed,2017-11-30,02470179,MAVENCLAD,1.0,L04AA40,Cladribine,Tablet,Oral,02470179,"MAVENCLAD (cladribine 10 mg oral tablet) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013054,cladribine 10 mg oral tablet,8001730,cladribine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98457,Marketed,2020-08-19,02494574,CLADRIBINE INJECTION,1.0,L01BB04,Cladribine,Solution,Intravenous,02494574,CLADRIBINE INJECTION (cladribine 10 mg per 10 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC,Active,9013055,cladribine 10 mg per 10 mL solution for injection vial,8001730,cladribine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104223,Marketed,2025-12-22,02553295,APO-CLADRIBINE,1.0,L04AA40,Cladribine,Tablet,Oral,02553295,APO-CLADRIBINE (cladribine 10 mg oral tablet) APOTEX INC,Active,9013054,cladribine 10 mg oral tablet,8001730,cladribine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
12779,Marketed,2016-08-30,01984853,BIAXIN BID,1.0,J01FA09,Clarithromycin,Tablet,Oral,01984853,BIAXIN BID (clarithromycin 250 mg oral tablet) BGP PHARMA ULC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17240,Marketed,2016-05-20,02126710,BIAXIN BID,1.0,J01FA09,Clarithromycin,Tablet,Oral,02126710,BIAXIN BID (clarithromycin 500 mg oral tablet) BGP PHARMA ULC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18066,Marketed,2016-04-08,02146908,BIAXIN,1.0,J01FA09,Clarithromycin,Granules for suspension,Oral,02146908,BIAXIN (clarithromycin 125 mg per 5 mL oral suspension) BGP PHARMA ULC,Active,9006241,clarithromycin 125 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,
68628,Marketed,2016-04-26,02244641,BIAXIN,1.0,J01FA09,Clarithromycin,Granules for suspension,Oral,02244641,BIAXIN (clarithromycin 250 mg per 5 mL oral suspension) BGP PHARMA ULC,Active,9006277,clarithromycin 250 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,
75196,Marketed,2008-06-06,02266539,SANDOZ CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02266539,SANDOZ CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75197,Marketed,2008-06-06,02266547,SANDOZ CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02266547,SANDOZ CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76021,Marketed,2007-07-26,02274744,APO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02274744,APO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) APOTEX INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76022,Marketed,2007-07-26,02274752,APO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02274752,APO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) APOTEX INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80993,Marketed,2025-12-23,02324482,PRO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02324482,PRO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) PRO DOC LIMITEE,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80994,Marketed,2025-12-23,02324490,PRO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02324490,PRO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) PRO DOC LIMITEE,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84648,Marketed,2024-05-28,02361426,TARO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02361426,TARO-CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SUN PHARMA CANADA INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84649,Marketed,2024-03-22,02361434,TARO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02361434,TARO-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SUN PHARMA CANADA INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87587,Marketed,2017-07-31,02390450,TARO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Powder for suspension,Oral,02390450,TARO-CLARITHROMYCIN (clarithromycin 250 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9006277,clarithromycin 250 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,
87588,Marketed,2017-07-31,02390442,TARO-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Powder for suspension,Oral,02390442,TARO-CLARITHROMYCIN (clarithromycin 125 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9006241,clarithromycin 125 mg per 5 mL oral suspension,8000160,clarithromycin,26643006,Oral,385024007,Oral suspension,,,,,
88801,Marketed,2024-10-03,02403196,TEVA-CLARITHROMYCIN XL,1.0,J01FA09,Clarithromycin,Tablet (extended-release),Oral,02403196,TEVA-CLARITHROMYCIN XL (clarithromycin 500 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000985,clarithromycin 500 mg prolonged-release oral tablet,8000160,clarithromycin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89802,Marketed,2021-07-15,02413345,APO-CLARITHROMYCIN XL,1.0,J01FA09,Clarithromycin,Tablet (extended-release),Oral,02413345,APO-CLARITHROMYCIN XL (clarithromycin 500 mg prolonged-release oral tablet) APOTEX INC,Active,9000985,clarithromycin 500 mg prolonged-release oral tablet,8000160,clarithromycin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92681,Marketed,2015-07-22,02442469,CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02442469,CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92683,Marketed,2015-07-22,02442485,CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02442485,CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95443,Marketed,2021-07-28,02466120,CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02466120,CLARITHROMYCIN (clarithromycin 250 mg oral tablet) SANIS HEALTH INC,Active,9000409,clarithromycin 250 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95444,Marketed,2021-07-28,02466139,CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02466139,CLARITHROMYCIN (clarithromycin 500 mg oral tablet) SANIS HEALTH INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96050,Marketed,2018-03-07,02471396,M-CLARITHROMYCIN,1.0,J01FA09,Clarithromycin,Tablet,Oral,02471396,M-CLARITHROMYCIN (clarithromycin 500 mg oral tablet) MANTRA PHARMA INC,Active,9000509,clarithromycin 500 mg oral tablet,8000160,clarithromycin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102757,Marketed,2023-09-08,02538881,WINLEVI,1.0,D10AX06,Clascoterone,Cream,Topical,02538881,WINLEVI (clascoterone 1 % cutaneous cream) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014912,clascoterone 1 % cutaneous cream,8002477,clascoterone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
85108,Marketed,2023-08-04,02366223,CLEVIPREX,1.0,C08CA16,Clevidipine,Emulsion,Intravenous,77701130,CLEVIPREX (clevidipine 25 mg per 50 mL emulsion for injection vial) CHIESI FARMACEUTICI S.P.A.,Active,9014928,clevidipine 25 mg per 50 mL emulsion for injection vial,8002478,clevidipine,738984000,Parenteral,385221006,Emulsion for injection,733026001,Vial (unit of presentation),1.0,,
85108,Marketed,2023-08-04,02366223,CLEVIPREX,1.0,C08CA16,Clevidipine,Emulsion,Intravenous,77701131,CLEVIPREX (clevidipine 50 mg per 100 mL emulsion for injection vial) CHIESI FARMACEUTICI S.P.A.,Active,9014929,clevidipine 50 mg per 100 mL emulsion for injection vial,8002478,clevidipine,738984000,Parenteral,385221006,Emulsion for injection,733026001,Vial (unit of presentation),1.0,,
728,Marketed,2019-06-11,00115630,LIBRAX,2.0,A03CA02,Clidinium and psycholeptics,Capsule,Oral,00115630,"LIBRAX (chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001584,chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule,8001351,chlordiazepoxide and clidinium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
1225,Marketed,2004-12-16,00225851,DALACIN C FLAVOURED GRANULES,1.0,J01FF01,Clindamycin,Granules for solution,Oral,00225851,DALACIN C FLAVOURED GRANULES (clindamycin (clindamycin palmitate hydrochloride) 75 mg per 5 mL oral solution) PFIZER CANADA ULC,Active,9013056,clindamycin (clindamycin palmitate hydrochloride) 75 mg per 5 mL oral solution,8000036,clindamycin,26643006,Oral,385023001,Oral solution,,,,,
1620,Marketed,2006-07-11,00260436,DALACIN C PHOSPHATE,1.0,J01FF01,Clindamycin,Solution,"Intramuscular,Intravenous",77700238,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000064,clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1620,Marketed,2006-07-11,00260436,DALACIN C PHOSPHATE,1.0,J01FF01,Clindamycin,Solution,"Intramuscular,Intravenous",77700239,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9000065,clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1620,Marketed,2006-07-11,00260436,DALACIN C PHOSPHATE,1.0,J01FF01,Clindamycin,Solution,"Intramuscular,Intravenous",77700240,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial) PFIZER CANADA ULC,Active,9006264,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1620,Marketed,2006-07-11,00260436,DALACIN C PHOSPHATE,1.0,J01FF01,Clindamycin,Solution,"Intramuscular,Intravenous",77700241,DALACIN C PHOSPHATE (clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial) PFIZER CANADA ULC,Active,9000067,clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
15942,Marketed,2003-10-14,02060604,DALACIN VAGINAL CREAM,1.0,G01AA10,Clindamycin,Cream,Vaginal,02060604,DALACIN VAGINAL CREAM (clindamycin (clindamycin phosphate) 20 mg per g vaginal cream) PFIZER CANADA ULC,Active,9000510,clindamycin (clindamycin phosphate) 20 mg per g vaginal cream,8000036,clindamycin,16857009,Vaginal,385165005,Vaginal cream,,,,,
49605,Marketed,2005-08-26,02230535,CLINDAMYCIN INJECTION USP,1.0,J01FF01,Clindamycin,Solution,Intravenous,77700235,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000064,clindamycin (clindamycin phosphate) 300 mg per 2 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49605,Marketed,2005-08-26,02230535,CLINDAMYCIN INJECTION USP,1.0,J01FF01,Clindamycin,Solution,Intravenous,77700236,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000065,clindamycin (clindamycin phosphate) 600 mg per 4 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49605,Marketed,2005-08-26,02230535,CLINDAMYCIN INJECTION USP,1.0,J01FF01,Clindamycin,Solution,Intravenous,77700237,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000067,clindamycin (clindamycin phosphate) 900 mg per 6 mL solution for injection vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49612,Marketed,2005-08-26,02230540,CLINDAMYCIN INJECTION USP,1.0,J01FF01,Clindamycin,Liquid,"Intramuscular,Intravenous",77700233,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 120 mL vial) SANDOZ CANADA INCORPORATED,Active,9006263,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 120 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49612,Marketed,2005-08-26,02230540,CLINDAMYCIN INJECTION USP,1.0,J01FF01,Clindamycin,Liquid,"Intramuscular,Intravenous",77700234,CLINDAMYCIN INJECTION USP (clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial) SANDOZ CANADA INCORPORATED,Active,9006264,clindamycin (clindamycin phosphate) 150 mg per mL solution for injection 60 mL vial,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65371,Marketed,2011-01-24,02241709,TEVA-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02241709,TEVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) TEVA CANADA LIMITED,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65372,Marketed,2011-01-24,02241710,TEVA-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02241710,TEVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75233,Marketed,2005-10-03,02266938,TARO-CLINDAMYCIN,1.0,D10AF01,Clindamycin,Solution,Topical,02266938,TARO-CLINDAMYCIN (clindamycin (clindamycin phosphate) 1 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9000377,clindamycin (clindamycin phosphate) 1 % cutaneous solution,8000036,clindamycin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
88532,Marketed,2022-02-11,02400529,CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02400529,CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) SANIS HEALTH INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88533,Marketed,2022-02-11,02400537,CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02400537,CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) SANIS HEALTH INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89326,Marketed,2013-12-05,02408511,CLINDAMYCIN IV INFUSION,1.0,J01FF01,Clindamycin,Solution,Intravenous,02408511,CLINDAMYCIN IV INFUSION (clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9001409,clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
89327,Marketed,2013-12-05,02408538,CLINDAMYCIN IV INFUSION,1.0,J01FF01,Clindamycin,Solution,Intravenous,02408538,CLINDAMYCIN IV INFUSION (clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag) SANDOZ CANADA INCORPORATED,Active,9001410,clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
92122,Marketed,2015-03-02,02436906,AURO-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02436906,AURO-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) AURO PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92123,Marketed,2015-03-02,02436914,AURO-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02436914,AURO-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) AURO PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95045,Marketed,2021-12-22,02462656,MED-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02462656,MED-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95046,Marketed,2021-12-22,02462664,MED-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02462664,MED-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95691,Marketed,2017-10-13,02468484,RIVA-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02468484,RIVA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97049,Marketed,2019-05-28,02479923,M-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02479923,M-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) MANTRA PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97050,Marketed,2019-05-28,02479931,M-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02479931,M-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) MANTRA PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97408,Marketed,2019-09-27,02483734,JAMP CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02483734,JAMP CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97409,Marketed,2019-09-27,02483742,JAMP CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02483742,JAMP CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97571,Marketed,2019-11-26,02485478,CLINDAMYCIN INJECTION IN 5% DEXTROSE,1.0,J01FF01,Clindamycin,Solution,Intravenous,02485478,CLINDAMYCIN INJECTION IN 5% DEXTROSE (clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9001409,clindamycin (clindamycin phosphate) 600 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
97572,Marketed,2019-12-03,02485486,CLINDAMYCIN INJECTION IN 5% DEXTROSE,1.0,J01FF01,Clindamycin,Solution,Intravenous,02485486,CLINDAMYCIN INJECTION IN 5% DEXTROSE (clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9001410,clindamycin (clindamycin phosphate) 900 mg per 50 mL solution for injection bag,8000036,clindamycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
98373,Marketed,2020-07-06,02493748,NRA-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02493748,NRA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 150 mg oral capsule) NORA PHARMA INC,Active,9000048,clindamycin (clindamycin hydrochloride) 150 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98374,Marketed,2020-07-06,02493756,NRA-CLINDAMYCIN,1.0,J01FF01,Clindamycin,Capsule,Oral,02493756,NRA-CLINDAMYCIN (clindamycin (clindamycin hydrochloride) 300 mg oral capsule) NORA PHARMA INC,Active,9000562,clindamycin (clindamycin hydrochloride) 300 mg oral capsule,8000036,clindamycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72824,Marketed,2021-03-29,02248472,BENZACLIN,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02248472,"BENZACLIN (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,
84468,Marketed,2019-10-18,02359685,BIACNA TOPICAL GEL,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02359685,"BIACNA TOPICAL GEL (clindamycin phosphate 1.2 % and tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004872,clindamycin phosphate 1.2 % and tretinoin 0.025 % cutaneous gel,8000984,clindamycin and tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
86863,Marketed,2013-08-20,02382822,CLINDOXYL ADV GEL,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02382822,CLINDOXYL ADV GEL (benzoyl peroxide 3 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) GLAXOSMITHKLINE INC,Active,9005309,benzoyl peroxide 3 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,
92456,Marketed,2015-08-05,02440180,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02440180,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,
95265,Marketed,2017-07-24,02464519,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,2.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02464519,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT (benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel) TARO PHARMACEUTICALS INC,Active,9003644,benzoyl peroxide 5 % and clindamycin (clindamycin phosphate) 1 % cutaneous gel,8000924,benzoyl peroxide and clindamycin,448598008,Cutaneous,385100002,Gel,,,,,
103924,Marketed,2024-10-07,02550423,CABTREO,3.0,D10AF51,"Clindamycin, combinations",Gel,Topical,02550423,"CABTREO (adapalene 0.15 % and benzoyl peroxide 3.1 % and clindamycin phosphate 1.2 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9015085,adapalene 0.15 % and benzoyl peroxide 3.1 % and clindamycin phosphate 1.2 % cutaneous gel,8002515,adapalene and benzoyl peroxide and clindamycin,448598008,Cutaneous,421949005,Conventional release cutaneous gel,,,,,
61740,Marketed,2017-01-10,02238334,TEVA-CLOBAZAM,1.0,N05BA09,Clobazam,Tablet,Oral,02238334,TEVA-CLOBAZAM (clobazam 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000711,clobazam 10 mg oral tablet,8000238,clobazam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
68625,Marketed,2001-11-28,02244638,APO-CLOBAZAM,1.0,N05BA09,Clobazam,Tablet,Oral,02244638,APO-CLOBAZAM (clobazam 10 mg oral tablet) APOTEX INC,Active,9000711,clobazam 10 mg oral tablet,8000238,clobazam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
13437,Marketed,2017-12-19,01910272,TEVA-CLOBETASOL,1.0,D07AD01,Clobetasol,Cream,Topical,01910272,TEVA-CLOBETASOL (clobetasol propionate 0.05 % cutaneous cream) TEVA CANADA LIMITED,Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
13438,Marketed,2017-12-19,01910299,TEVA-CLOBETASOL,1.0,D07AD01,Clobetasol,Lotion,Topical,01910299,TEVA-CLOBETASOL (clobetasol propionate 0.05 % lotion) TEVA CANADA LIMITED,Active,9000412,clobetasol propionate 0.05 % lotion,8000161,clobetasol,448598008,Cutaneous,739000003,Lotion,,,,,
13439,Marketed,2017-12-19,01910280,TEVA-CLOBETASOL,1.0,D07AD01,Clobetasol,Ointment,Topical,01910280,TEVA-CLOBETASOL (clobetasol propionate 0.05 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
14381,Marketed,2010-07-21,02024187,MYLAN-CLOBETASOL CREAM,1.0,D07AD01,Clobetasol,Cream,Topical,02024187,MYLAN-CLOBETASOL CREAM (clobetasol propionate 0.05 % cutaneous cream) MYLAN PHARMACEUTICALS ULC,Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
14382,Marketed,2010-08-31,02026767,MYLAN-CLOBETASOL OINTMENT,1.0,D07AD01,Clobetasol,Ointment,Topical,02026767,MYLAN-CLOBETASOL OINTMENT (clobetasol propionate 0.05 % cutaneous ointment) MYLAN PHARMACEUTICALS ULC,Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
36952,Marketed,2004-03-29,02213265,DERMOVATE CREAM,1.0,D07AD01,Clobetasol,Cream,Topical,02213265,"DERMOVATE CREAM (clobetasol propionate 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
36953,Marketed,2004-04-06,02213273,DERMOVATE OINTMENT,1.0,D07AD01,Clobetasol,Ointment,Topical,02213273,"DERMOVATE OINTMENT (clobetasol propionate 0.05 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
36954,Marketed,2004-04-23,02213281,DERMOVATE SCALP APPLICATION,1.0,D07AD01,Clobetasol,Solution,Topical,02213281,"DERMOVATE SCALP APPLICATION (clobetasol propionate 0.05 % cutaneous solution) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000945,clobetasol propionate 0.05 % cutaneous solution,8000161,clobetasol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
43175,Marketed,2010-03-02,02216213,MYLAN-CLOBETASOL SCALP APPLICATION,1.0,D07AD01,Clobetasol,Lotion,Topical,02216213,MYLAN-CLOBETASOL SCALP APPLICATION (clobetasol propionate 0.05 % lotion) MYLAN PHARMACEUTICALS ULC,Active,9000412,clobetasol propionate 0.05 % lotion,8000161,clobetasol,448598008,Cutaneous,739000003,Lotion,,,,,
69609,Marketed,2005-10-03,02245522,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",1.0,D07AD01,Clobetasol,Solution,Topical,02245522,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% (clobetasol propionate 0.05 % cutaneous solution) TARO PHARMACEUTICALS INC",Active,9000945,clobetasol propionate 0.05 % cutaneous solution,8000161,clobetasol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
69610,Marketed,2005-10-03,02245523,"TARO-CLOBETASOL CREAM USP, 0.05%",1.0,D07AD01,Clobetasol,Cream,Topical,02245523,"TARO-CLOBETASOL CREAM USP, 0.05% (clobetasol propionate 0.05 % cutaneous cream) TARO PHARMACEUTICALS INC",Active,9000410,clobetasol propionate 0.05 % cutaneous cream,8000161,clobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
69611,Marketed,2005-10-03,02245524,"TARO-CLOBETASOL OINTMENT USP, 0.05%",1.0,D07AD01,Clobetasol,Ointment,Topical,02245524,"TARO-CLOBETASOL OINTMENT USP, 0.05% (clobetasol propionate 0.05 % cutaneous ointment) TARO PHARMACEUTICALS INC",Active,9000411,clobetasol propionate 0.05 % cutaneous ointment,8000161,clobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
74161,Marketed,2004-12-15,02256371,CLOBEX SHAMPOO,1.0,D07AD01,Clobetasol,Shampoo,Topical,02256371,CLOBEX SHAMPOO (clobetasol propionate 0.05 % shampoo) GALDERMA CANADA INC.,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,
78510,Marketed,2007-12-19,02299739,CLOBEX SPRAY,1.0,D07AD01,Clobetasol,Spray,Topical,02299739,CLOBEX SPRAY (clobetasol propionate 0.05 % cutaneous spray) GALDERMA CANADA INC.,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,
97970,Marketed,2019-08-26,02489619,TARO-CLOBETASOL SPRAY,1.0,D07AD01,Clobetasol,Spray,Topical,02489619,TARO-CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) TARO PHARMACEUTICALS INC,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,
98076,Marketed,2019-09-26,02490706,ODAN CLOBETASOL SPRAY,1.0,D07AD01,Clobetasol,Spray,Topical,02490706,ODAN CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) ODAN LABORATORIES LTD,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,
98498,Marketed,2020-04-23,02495023,SANDOZ CLOBETASOL,1.0,D07AD01,Clobetasol,Spray,Topical,02495023,SANDOZ CLOBETASOL (clobetasol propionate 0.05 % cutaneous spray) SANDOZ CANADA INCORPORATED,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,
99554,Marketed,2020-12-22,02506203,TARO-CLOBETASOL SHAMPOO,1.0,D07AD01,Clobetasol,Shampoo,Topical,02506203,TARO-CLOBETASOL SHAMPOO (clobetasol propionate 0.05 % shampoo) TARO PHARMACEUTICALS INC,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,
100870,Marketed,2022-01-10,02519437,REDDY-CLOBETASOL SHAMPOO,1.0,D07AD01,Clobetasol,Shampoo,Topical,02519437,REDDY-CLOBETASOL SHAMPOO (clobetasol propionate 0.05 % shampoo) DR. REDDY'S LABORATORIES CANADA INC.,Active,9001098,clobetasol propionate 0.05 % shampoo,8000161,clobetasol,41695006,Scalp structure,785908001,Shampoo,,,,,
102357,Marketed,2024-03-28,02534665,JAMP CLOBETASOL SPRAY,1.0,D07AD01,Clobetasol,Spray,Topical,02534665,JAMP CLOBETASOL SPRAY (clobetasol propionate 0.05 % cutaneous spray) JAMP PHARMA CORPORATION,Active,9006600,clobetasol propionate 0.05 % cutaneous spray,8000161,clobetasol,448598008,Cutaneous,421720008,Spray,,,,,
37001,Marketed,2025-11-03,02214415,SPECTRO ECZEMACARE MEDICATED CREAM,1.0,D07AB01,Clobetasone,Cream,Topical,02214415,SPECTRO ECZEMACARE MEDICATED CREAM (clobetasone butyrate 0.05 % cutaneous cream) HALEON CANADA ULC,Active,9003424,clobetasone butyrate 0.05 % cutaneous cream,8001617,clobetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
69944,Marketed,2025-11-07,02245828,CLASTEON,1.0,M05BA02,Clodronic acid,Capsule,Oral,02245828,CLASTEON (clodronate disodium 400 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9003906,clodronate disodium 400 mg oral capsule,8001360,clodronate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81614,Marketed,2014-04-08,02330407,CLOLAR,1.0,L01BB06,Clofarabine,Solution,Intravenous,02330407,CLOLAR (clofarabine 20 mg per 20 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013057,clofarabine 20 mg per 20 mL solution for injection vial,8001732,clofarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
13907,Marketed,2022-11-24,01966294,ULONE,1.0,R05DB10,Clofedanol,Syrup,Oral,01966294,ULONE (clofedanol hydrochloride 25 mg per 5 mL syrup) BAUSCH & LOMB INC,Active,9001588,clofedanol hydrochloride 25 mg per 5 mL syrup,8001618,clofedanol,26643006,Oral,739009002,Syrup,,,,,
2039,Marketed,2021-03-12,00324019,ANAFRANIL,1.0,N06AA04,Clomipramine,Tablet,Oral,00324019,ANAFRANIL (clomipramine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001698,clomipramine hydrochloride 25 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2164,Marketed,2021-03-12,00330566,ANAFRANIL,1.0,N06AA04,Clomipramine,Tablet,Oral,00330566,ANAFRANIL (clomipramine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001731,clomipramine hydrochloride 10 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4382,Marketed,2021-03-12,00402591,ANAFRANIL,1.0,N06AA04,Clomipramine,Tablet,Oral,00402591,ANAFRANIL (clomipramine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001906,clomipramine hydrochloride 50 mg oral tablet,8001250,clomipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98731,Marketed,2020-05-07,02497506,TARO-CLOMIPRAMINE,1.0,N06AA04,Clomipramine,Capsule,Oral,02497506,TARO-CLOMIPRAMINE (clomipramine hydrochloride 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014305,clomipramine hydrochloride 25 mg oral capsule,8001250,clomipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98733,Marketed,2020-05-07,02497514,TARO-CLOMIPRAMINE,1.0,N06AA04,Clomipramine,Capsule,Oral,02497514,TARO-CLOMIPRAMINE (clomipramine hydrochloride 50 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014306,clomipramine hydrochloride 50 mg oral capsule,8001250,clomipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2568,Marketed,2023-01-31,00382825,RIVOTRIL,1.0,N03AE01,Clonazepam,Tablet,Oral,00382825,RIVOTRIL (clonazepam 0.5 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
2569,Marketed,2023-01-31,00382841,RIVOTRIL,1.0,N03AE01,Clonazepam,Tablet,Oral,00382841,RIVOTRIL (clonazepam 2 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
14587,Marketed,1993-12-31,02048728,PMS-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02048728,PMS-CLONAZEPAM (clonazepam 1 mg oral tablet) PHARMASCIENCE INC,Active,9000459,clonazepam 1 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
14589,Marketed,1993-12-31,02048736,PMS-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02048736,PMS-CLONAZEPAM (clonazepam 2 mg oral tablet) PHARMASCIENCE INC,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19048,Marketed,2021-06-11,02177897,APO-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02177897,APO-CLONAZEPAM (clonazepam 2 mg oral tablet) APOTEX INC,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19063,Marketed,2021-06-11,02177889,APO-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02177889,APO-CLONAZEPAM (clonazepam 0.5 mg oral tablet) APOTEX INC,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19221,Marketed,1995-12-31,02179660,PMS-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02179660,PMS-CLONAZEPAM (clonazepam 0.25 mg oral tablet) PHARMASCIENCE INC,Active,9000563,clonazepam 0.25 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19628,Marketed,1996-12-31,02207818,PMS-CLONAZEPAM-R,1.0,N03AE01,Clonazepam,Tablet,Oral,02207818,PMS-CLONAZEPAM-R (clonazepam 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79715,Marketed,2014-07-26,02311593,PRO-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02311593,PRO-CLONAZEPAM (clonazepam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000097,clonazepam 0.5 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79716,Marketed,2008-07-09,02311607,PRO-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02311607,PRO-CLONAZEPAM (clonazepam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000459,clonazepam 1 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79718,Marketed,2008-07-09,02311615,PRO-CLONAZEPAM,1.0,N03AE01,Clonazepam,Tablet,Oral,02311615,PRO-CLONAZEPAM (clonazepam 2 mg oral tablet) PRO DOC LIMITEE,Active,9000098,clonazepam 2 mg oral tablet,8000061,clonazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
14713,Marketed,2014-01-17,02046148,TEVA-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02046148,TEVA-CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) TEVA CANADA LIMITED,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14715,Marketed,2014-01-17,02046121,TEVA-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02046121,TEVA-CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) TEVA CANADA LIMITED,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78947,Marketed,2014-01-17,02304163,TEVA-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02304163,TEVA-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) TEVA CANADA LIMITED,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94992,Marketed,2017-06-23,02462192,MINT-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02462192,MINT-CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94993,Marketed,2017-06-23,02462206,MINT-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02462206,MINT-CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100518,Marketed,2022-02-02,02515784,SANDOZ CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02515784,SANDOZ CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100519,Marketed,2022-02-02,02515792,SANDOZ CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02515792,SANDOZ CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100559,Marketed,2022-02-02,02516217,SANDOZ CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02516217,SANDOZ CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101324,Marketed,2022-04-11,02524198,MAR-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02524198,MAR-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101745,Marketed,2023-03-07,02528207,JAMP CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02528207,JAMP CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102362,Marketed,2023-05-10,02534738,MINT-CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02534738,MINT-CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102721,Marketed,2024-02-02,02538490,CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02538490,CLONIDINE (clonidine hydrochloride 0.1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000346,clonidine hydrochloride 0.1 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102722,Marketed,2024-02-02,02538504,CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02538504,CLONIDINE (clonidine hydrochloride 0.2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000347,clonidine hydrochloride 0.2 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102879,Marketed,2024-02-02,02540061,CLONIDINE,1.0,C02AC01,Clonidine,Tablet,Oral,02540061,CLONIDINE (clonidine hydrochloride 0.025 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001081,clonidine hydrochloride 0.025 mg oral tablet,8000135,clonidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62114,Marketed,2007-04-10,02238682,PLAVIX,1.0,B01AC04,Clopidogrel,Tablet,Oral,02238682,PLAVIX (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73770,Marketed,2011-12-19,02252767,APO-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02252767,APO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) APOTEX INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77854,Marketed,2011-12-14,02293161,TEVA-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02293161,TEVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) TEVA CANADA LIMITED,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83336,Marketed,2011-12-14,02348004,PMS-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02348004,PMS-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) PHARMASCIENCE INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86568,Marketed,2020-06-26,02379813,TARO-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02379813,TARO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SUN PHARMA CANADA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87143,Marketed,2012-06-11,02385813,CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02385813,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87363,Marketed,2013-01-02,02388065,TEVA-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02388065,TEVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 300 mg oral tablet) TEVA CANADA LIMITED,Active,9001290,clopidogrel (clopidogrel bisulfate) 300 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87405,Marketed,2019-05-30,02388529,RIVA-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02388529,RIVA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87998,Marketed,2012-11-22,02394820,CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02394820,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) PRO DOC LIMITEE,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88354,Marketed,2013-01-21,02398591,APO-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02398591,APO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 300 mg oral tablet) APOTEX INC,Active,9001290,clopidogrel (clopidogrel bisulfate) 300 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88535,Marketed,2021-05-14,02400553,CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02400553,CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) SANIS HEALTH INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89366,Marketed,2023-03-29,02408910,MINT-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02408910,MINT-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90014,Marketed,2014-01-15,02415550,JAMP-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02415550,JAMP-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90094,Marketed,2014-02-06,02416387,AURO-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02416387,AURO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) AURO PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90695,Marketed,2023-06-14,02422255,MAR-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02422255,MAR-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91644,Marketed,2022-02-10,02431971,AG-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02431971,AG-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) ANGITA PHARMA INC.,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93012,Marketed,2023-08-02,02444895,BIO-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02444895,BIO-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) BIOMED PHARMA,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97237,Marketed,2020-03-05,02482037,NRA-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02482037,NRA-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) NORA PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99186,Marketed,2020-11-03,02502283,M-CLOPIDOGREL,1.0,B01AC04,Clopidogrel,Tablet,Oral,02502283,M-CLOPIDOGREL (clopidogrel (clopidogrel bisulfate) 75 mg oral tablet) MANTRA PHARMA INC,Active,9000818,clopidogrel (clopidogrel bisulfate) 75 mg oral tablet,8000263,clopidogrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10899,Marketed,2013-04-10,00860697,CLORAZEPATE,1.0,N05BA05,Clorazepate potassium,Capsule,Oral,00860697,CLORAZEPATE (clorazepate dipotassium 15 mg oral capsule) AA PHARMA INC,Active,9002269,clorazepate dipotassium 15 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10902,Marketed,2013-04-10,00860689,CLORAZEPATE,1.0,N05BA05,Clorazepate potassium,Capsule,Oral,00860689,CLORAZEPATE (clorazepate dipotassium 3.75 mg oral capsule) AA PHARMA INC,Active,9002270,clorazepate dipotassium 3.75 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10903,Marketed,2013-05-16,00860700,CLORAZEPATE,1.0,N05BA05,Clorazepate potassium,Capsule,Oral,00860700,CLORAZEPATE (clorazepate dipotassium 7.5 mg oral capsule) AA PHARMA INC,Active,9002271,clorazepate dipotassium 7.5 mg oral capsule,8001361,clorazepate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9926,Marketed,2020-02-21,00812366,CLOTRIMADERM VAGINAL 6,1.0,G01AF02,Clotrimazole,Cream,Vaginal,00812366,CLOTRIMADERM VAGINAL 6 (clotrimazole 1 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
9927,Marketed,2020-02-21,00812374,CLOTRIMADERM VAGINAL 3,1.0,G01AF02,Clotrimazole,Cream,Vaginal,00812374,CLOTRIMADERM VAGINAL 3 (clotrimazole 2 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
11893,Marketed,2022-07-05,00812382,CLOTRIMADERM TOPICAL,1.0,D01AC01,Clotrimazole,Cream,Topical,00812382,CLOTRIMADERM TOPICAL (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
19479,Marketed,2008-09-09,02150840,CANESTEN COMFORTAB 3,1.0,G01AF02,Clotrimazole,Vaginal tablet,Vaginal,02150840,CANESTEN COMFORTAB 3 (clotrimazole 200 mg vaginal tablet) BAYER INC,Active,9000564,clotrimazole 200 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,
19480,Marketed,2008-09-09,02150859,CANESTEN COMFORTAB 1,1.0,G01AF02,Clotrimazole,Vaginal tablet,Vaginal,02150859,CANESTEN COMFORTAB 1 (clotrimazole 500 mg vaginal tablet) BAYER INC,Active,9000565,clotrimazole 500 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,
19483,Marketed,2018-11-09,02150891,CANESTEN 6 DAY INTERNAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02150891,CANESTEN 6 DAY INTERNAL CREAM (clotrimazole 1 % vaginal cream) BAYER INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
19484,Marketed,2018-11-09,02150905,CANESTEN 3 DAY INTERNAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02150905,CANESTEN 3 DAY INTERNAL CREAM (clotrimazole 2 % vaginal cream) BAYER INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
19487,Marketed,1995-12-31,02150867,CANESTEN 1% TOPICAL CREAM,1.0,D01AC01,Clotrimazole,Cream,Topical,02150867,CANESTEN 1% TOPICAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
44016,Marketed,2020-05-01,02150883,CANESTEN 1 DAY INTERNAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02150883,CANESTEN 1 DAY INTERNAL CREAM (clotrimazole 10 % vaginal cream) BAYER INC,Active,9000729,clotrimazole 10 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
47168,Marketed,2020-10-16,02229378,CLOTRIMAZOLE VAGINAL 6,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02229378,CLOTRIMAZOLE VAGINAL 6 (clotrimazole 1 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000311,clotrimazole 1 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
47180,Marketed,2020-10-16,02229379,CLOTRIMAZOLE VAGINAL 3,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02229379,CLOTRIMAZOLE VAGINAL 3 (clotrimazole 2 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9000312,clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
47181,Marketed,2022-10-07,02229380,CLOTRIMAZOLE TOPICAL,1.0,D01AC01,Clotrimazole,Cream,Topical,02229380,CLOTRIMAZOLE TOPICAL (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
49563,Marketed,2018-11-09,02230509,CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS,2.0,G01AF02,Clotrimazole,"Kit,Cream","Topical,Vaginal",02230509,CANESTEN COMBI 1 DAY INTERNAL + EXTERNAL CREAMS (clotrimazole 1 % cutaneous cream with clotrimazole 10 % vaginal cream) BAYER INC,Active,9006468,clotrimazole 1 % cutaneous cream with clotrimazole 10 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
62905,Marketed,2020-02-14,02239432,CANESTEN EXTERNAL ANTIFUNGAL CREAM,1.0,D01AC01,Clotrimazole,Cream,Topical,02239432,CANESTEN EXTERNAL ANTIFUNGAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
74951,Marketed,2023-02-16,02264099,CANESTEN COMBI 3 DAY,2.0,G01AF02,Clotrimazole,"Cream,Vaginal tablet,Kit","Vaginal,Topical",02264099,CANESTEN COMBI 3 DAY (clotrimazole 1 % cutaneous cream with clotrimazole 200 mg vaginal tablet) BAYER INC,Active,9006482,clotrimazole 1 % cutaneous cream with clotrimazole 200 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385178005,Vaginal tablet,733021006,System,,,
74952,Marketed,2023-02-21,02264102,CANESTEN COMBI 1 DAY,2.0,G01AF02,Clotrimazole,"Vaginal tablet,Cream,Kit","Vaginal,Topical",02264102,CANESTEN COMBI 1 DAY (clotrimazole 1 % cutaneous cream with clotrimazole 500 mg vaginal tablet) BAYER INC,Active,9006481,clotrimazole 1 % cutaneous cream with clotrimazole 500 mg vaginal tablet,8000773,clotrimazole,16857009,Vaginal,385178005,Vaginal tablet,733021006,System,,,
79727,Marketed,2010-03-10,02311720,CANESTEN EXTERNAL CREAM,1.0,G01AF02,Clotrimazole,Cream,"Topical,Vaginal",02311720,CANESTEN EXTERNAL CREAM (clotrimazole 1 % cutaneous cream) BAYER INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
95015,Marketed,2020-10-16,02462397,CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Topical,02462397,CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM (clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000290,clotrimazole 1 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
98096,Marketed,2020-02-14,02490927,CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Topical,02490927,CANESTEN EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM (clotrimazole 2 % cutaneous cream) BAYER INC,Active,9014251,clotrimazole 2 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
99284,Marketed,2021-06-19,02503360,CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM,1.0,G01AF02,Clotrimazole,Cream,Vaginal,02503360,CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM (clotrimazole 2 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9014251,clotrimazole 2 % cutaneous cream,8000773,clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
100712,Marketed,2022-05-03,02517760,EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI,2.0,G01AF02,Clotrimazole,"Cream,Capsule","Topical,Oral",02517760,EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE COMBI (clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9014252,clotrimazole 2 % cutaneous cream with fluconazole 150 mg oral capsule,8000978,clotrimazole and fluconazole,26643006,Oral,421628006,Cutaneous cream,732937005,Capsule (unit of presentation),1.0,,
103588,Marketed,2025-02-03,02547252,CANESTEN SOFT CAPSULE 1,1.0,G01AF02,Clotrimazole,Vaginal capsule,Vaginal,02547252,CANESTEN SOFT CAPSULE 1 (clotrimazole 500 mg vaginal capsule) BAYER INC,Active,9015165,clotrimazole 500 mg vaginal capsule,8000773,clotrimazole,16857009,Vaginal,385175008,Vaginal capsule,732937005,Capsule,,,
103589,Marketed,2025-02-03,02547260,CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM,2.0,G01AF02,Clotrimazole,"Cream,Kit,Vaginal capsule","Vaginal,Topical",02547260,CANESTEN COMBI 1 DAY SOFT CAPSULE + EXTRA STRENGTH EXTERNAL CREAM (clotrimazole 500 mg vaginal capsule with clotrimazole 2 % vaginal cream) BAYER INC,Active,9015166,clotrimazole 500 mg vaginal capsule with clotrimazole 2 % vaginal cream,8000773,clotrimazole,16857009,Vaginal,385175008,Vaginal capsule,733021006,System,,,
2233,Marketed,2016-09-29,00337765,TEVA-CLOXACILLIN,1.0,J01CF02,Cloxacillin,Capsule,Oral,00337765,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 250 mg oral capsule) TEVA CANADA LIMITED,Active,9001732,cloxacillin (cloxacillin sodium) 250 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2234,Marketed,2016-09-29,00337773,TEVA-CLOXACILLIN,1.0,J01CF02,Cloxacillin,Capsule,Oral,00337773,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 500 mg oral capsule) TEVA CANADA LIMITED,Active,9001733,cloxacillin (cloxacillin sodium) 500 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3794,Marketed,2016-09-29,00337757,TEVA-CLOXACILLIN,1.0,J01CF02,Cloxacillin,Granules for solution,Oral,00337757,TEVA-CLOXACILLIN (cloxacillin (cloxacillin sodium) 125 mg per 5 mL oral solution) TEVA CANADA LIMITED,Active,9013058,cloxacillin (cloxacillin sodium) 125 mg per 5 mL oral solution,8001362,cloxacillin,26643006,Oral,385023001,Oral solution,,,,,
85225,Marketed,2011-09-14,02367408,CLOXACILLIN FOR INJECTION,1.0,J01CF02,Cloxacillin,Powder for solution,"Intramuscular,Intravenous",02367408,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9004924,cloxacillin (cloxacillin sodium) 500 mg per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85226,Marketed,2011-07-28,02367416,CLOXACILLIN FOR INJECTION,1.0,J01CF02,Cloxacillin,Powder for solution,Intravenous,02367416,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9012696,cloxacillin (cloxacillin sodium) 1 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85227,Marketed,2011-07-28,02367424,CLOXACILLIN FOR INJECTION,1.0,J01CF02,Cloxacillin,Powder for solution,Intravenous,02367424,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 2 g per vial powder for solution for injection) STERIMAX INC,Active,9012698,cloxacillin (cloxacillin sodium) 2 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88492,Marketed,2013-04-03,02400081,CLOXACILLIN FOR INJECTION,1.0,J01CF02,Cloxacillin,Powder for solution,Intravenous,02400081,CLOXACILLIN FOR INJECTION (cloxacillin (cloxacillin sodium) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9005216,cloxacillin (cloxacillin sodium) 10 g per vial powder for solution for injection,8001362,cloxacillin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99993,Marketed,2022-02-17,02510731,JAMP CLOXACILLIN,1.0,J01CF02,Cloxacillin,Capsule,Oral,02510731,JAMP CLOXACILLIN (cloxacillin (cloxacillin sodium) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001732,cloxacillin (cloxacillin sodium) 250 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99994,Marketed,2022-02-17,02510758,JAMP CLOXACILLIN,1.0,J01CF02,Cloxacillin,Capsule,Oral,02510758,JAMP CLOXACILLIN (cloxacillin (cloxacillin sodium) 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001733,cloxacillin (cloxacillin sodium) 500 mg oral capsule,8001362,cloxacillin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
11421,Marketed,2016-04-08,00894745,CLOZARIL,1.0,N05AH02,Clozapine,Tablet,Oral,00894745,CLOZARIL (clozapine 100 mg oral tablet) HLS THERAPEUTICS INC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11422,Marketed,2016-04-08,00894737,CLOZARIL,1.0,N05AH02,Clozapine,Tablet,Oral,00894737,CLOZARIL (clozapine 25 mg oral tablet) HLS THERAPEUTICS INC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71485,Marketed,2010-02-09,02247243,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02247243,GEN-CLOZAPINE (clozapine 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71486,Marketed,2009-10-15,02247244,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02247244,GEN-CLOZAPINE (clozapine 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72354,Marketed,2016-11-21,02248034,AA-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02248034,AA-CLOZAPINE (clozapine 25 mg oral tablet) AA PHARMA INC,Active,9000379,clozapine 25 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72355,Marketed,2016-11-21,02248035,AA-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02248035,AA-CLOZAPINE (clozapine 100 mg oral tablet) AA PHARMA INC,Active,9000378,clozapine 100 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79038,Marketed,2010-11-22,02305003,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02305003,GEN-CLOZAPINE (clozapine 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79039,Marketed,2010-11-24,02305011,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02305011,GEN-CLOZAPINE (clozapine 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94589,Marketed,2017-02-27,02458748,AA-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02458748,AA-CLOZAPINE (clozapine 50 mg oral tablet) AA PHARMA INC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94590,Marketed,2017-02-27,02458756,AA-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet,Oral,02458756,AA-CLOZAPINE (clozapine 200 mg oral tablet) AA PHARMA INC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98072,Marketed,2019-12-18,02490668,CLOZARIL,1.0,N05AH02,Clozapine,Tablet,Oral,02490668,CLOZARIL (clozapine 50 mg oral tablet) HLS THERAPEUTICS INC,Active,9001239,clozapine 50 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98073,Marketed,2019-12-18,02490676,CLOZARIL,1.0,N05AH02,Clozapine,Tablet,Oral,02490676,CLOZARIL (clozapine 200 mg oral tablet) HLS THERAPEUTICS INC,Active,9001238,clozapine 200 mg oral tablet,8000147,clozapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104347,Marketed,2025-05-29,02554631,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554631,GEN-CLOZAPINE (clozapine 12.5 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015216,clozapine 12.5 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,
104348,Marketed,2025-05-29,02554658,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554658,GEN-CLOZAPINE (clozapine 25 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015218,clozapine 25 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,
104349,Marketed,2025-05-29,02554666,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554666,GEN-CLOZAPINE (clozapine 50 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015219,clozapine 50 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,
104350,Marketed,2025-05-29,02554674,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554674,GEN-CLOZAPINE (clozapine 100 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015215,clozapine 100 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,
104351,Marketed,2025-05-29,02554682,GEN-CLOZAPINE,1.0,N05AH02,Clozapine,Tablet (orally disintegrating),Oral,02554682,GEN-CLOZAPINE (clozapine 200 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9015217,clozapine 200 mg orodispersible tablet,8000147,clozapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet,,,
43011,Marketed,2021-11-05,02206021,IMMUNINE VH,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02206021,IMMUNINE VH (coagulation factor IX human 480-720 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014089,coagulation factor IX human 480-720 unit per vial powder for solution for injection with diluent solution,8002277,coagulation factor IX human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77916,Marketed,2012-07-31,02293773,BENEFIX,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293773,BENEFIX (nonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014122,nonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77917,Marketed,2012-09-11,02293781,BENEFIX,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293781,BENEFIX (nonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014119,nonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77918,Marketed,2012-05-03,02293803,BENEFIX,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02293803,BENEFIX (nonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014120,nonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87824,Marketed,2013-02-12,02392984,BENEFIX,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02392984,BENEFIX (nonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9014121,nonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002283,nonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90757,Marketed,2022-05-13,02422913,ALPROLIX,1.0,B02BD04,Coagulation factor ix,"Powder for solution,Kit",Intravenous,02422913,ALPROLIX (eftrenonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014169,eftrenonacog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90758,Marketed,2021-09-22,02422921,ALPROLIX,1.0,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422921,ALPROLIX (eftrenonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014166,eftrenonacog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90759,Marketed,2021-09-22,02422948,ALPROLIX,1.0,B02BD04,Coagulation factor ix,"Powder for solution,Kit",Intravenous,02422948,ALPROLIX (eftrenonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014167,eftrenonacog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90760,Marketed,2021-10-22,02422956,ALPROLIX,1.0,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02422956,ALPROLIX (eftrenonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014168,eftrenonacog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002301,eftrenonacog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91641,Marketed,2021-09-28,02431947,RIXUBIS,1.0,B02BD04,Coagulation factor ix,"Powder for solution,Kit",Intravenous,02431947,RIXUBIS (nonacog gamma 1000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9013587,nonacog gamma 1000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91642,Marketed,2021-10-22,02431955,RIXUBIS,1.0,B02BD04,Coagulation factor ix,"Powder for solution,Kit",Intravenous,02431955,RIXUBIS (nonacog gamma 2000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9013588,nonacog gamma 2000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91643,Marketed,2021-09-28,02431963,RIXUBIS,1.0,B02BD04,Coagulation factor ix,"Kit,Powder for solution",Intravenous,02431963,RIXUBIS (nonacog gamma 3000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014126,nonacog gamma 3000 unit per vial powder for solution for injection with diluent solution,8002149,nonacog gamma,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95917,Marketed,2018-03-23,02470187,REBINYN,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470187,REBINYN (nonacog beta pegol 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014125,nonacog beta pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95924,Marketed,2018-03-23,02470268,REBINYN,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470268,REBINYN (nonacog beta pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014123,nonacog beta pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95925,Marketed,2018-03-23,02470276,REBINYN,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02470276,REBINYN (nonacog beta pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014124,nonacog beta pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102197,Marketed,2024-02-13,02532964,REBINYN,1.0,B02BD04,Coagulation factor ix,Powder for solution,Intravenous,02532964,REBINYN (nonacog beta pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9015018,nonacog beta pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002284,nonacog beta pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,
78001,Marketed,2008-07-08,02294664,OCTAPLEX,6.0,B02BD01,"Coagulation factor ix, ii, vii and x in comb","Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,
84428,Marketed,2011-07-28,02359251,BERIPLEX P/N 500,6.0,B02BD01,"Coagulation factor ix, ii, vii and x in comb",Powder for solution,Intravenous,,,,,,,,,,,,,,,,
89540,Marketed,2013-11-21,02410826,BERIPLEX P/N 1000,6.0,B02BD01,"Coagulation factor ix, ii, vii and x in comb",Powder for solution,Intravenous,,,,,,,,,,,,,,,,
91926,Marketed,2015-08-11,02434970,OCTAPLEX,6.0,B02BD01,"Coagulation factor ix, ii, vii and x in comb","Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,
90174,Marketed,2015-05-05,02417103,NIASTASE RT,1.0,B02BD08,Coagulation factor viia,"Kit,Powder for solution",Intravenous,02417103,NIASTASE RT (eptacog alfa (activated) 1 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013548,eptacog alfa (activated) 1 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90175,Marketed,2015-05-05,02417111,NIASTASE RT,1.0,B02BD08,Coagulation factor viia,"Kit,Powder for solution",Intravenous,02417111,NIASTASE RT (eptacog alfa (activated) 2 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013549,eptacog alfa (activated) 2 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90176,Marketed,2015-05-05,02417138,NIASTASE RT,1.0,B02BD08,Coagulation factor viia,"Kit,Powder for solution",Intravenous,02417138,NIASTASE RT (eptacog alfa (activated) 5 mg per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013550,eptacog alfa (activated) 5 mg per vial powder for solution for injection with diluent solution syringe,8002119,eptacog alfa (activated),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79508,Marketed,2012-02-17,02309483,XYNTHA,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02309483,XYNTHA (moroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013583,moroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79509,Marketed,2012-07-09,02309491,XYNTHA,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02309491,XYNTHA (moroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013585,moroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85926,Marketed,2019-09-27,02374064,XYNTHA SOLOFUSE,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374064,XYNTHA SOLOFUSE (moroctocog alfa 500 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014224,moroctocog alfa 500 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
85927,Marketed,2012-04-13,02374072,XYNTHA SOLOFUSE,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374072,XYNTHA SOLOFUSE (moroctocog alfa 1000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013581,moroctocog alfa 1000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
85928,Marketed,2012-05-08,02374080,XYNTHA SOLOFUSE,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374080,XYNTHA SOLOFUSE (moroctocog alfa 2000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013582,moroctocog alfa 2000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
85929,Marketed,2012-05-08,02374099,XYNTHA SOLOFUSE,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02374099,XYNTHA SOLOFUSE (moroctocog alfa 3000 unit powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013584,moroctocog alfa 3000 unit powder for solution for injection with diluent solution per syringe,8002147,moroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
91477,Marketed,2022-05-20,02430290,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430290,ELOCTATE (efmoroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014102,efmoroctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91479,Marketed,2021-09-13,02430304,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02430304,ELOCTATE (efmoroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014104,efmoroctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91480,Marketed,2021-09-10,02430312,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02430312,ELOCTATE (efmoroctocog alfa 750 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014105,efmoroctocog alfa 750 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91481,Marketed,2021-11-03,02430320,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02430320,ELOCTATE (efmoroctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014099,efmoroctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91482,Marketed,2021-11-10,02430339,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02430339,ELOCTATE (efmoroctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014100,efmoroctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91483,Marketed,2021-10-29,02430347,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02430347,ELOCTATE (efmoroctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014101,efmoroctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91484,Marketed,2022-01-13,02430355,ELOCTATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02430355,ELOCTATE (efmoroctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9014103,efmoroctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002280,efmoroctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91946,Marketed,2018-03-23,02435187,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02435187,ZONOVATE (turoctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013623,turoctocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91947,Marketed,2018-03-23,02435195,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435195,ZONOVATE (turoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013625,turoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91948,Marketed,2018-03-23,02435209,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02435209,ZONOVATE (turoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013620,turoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91949,Marketed,2018-03-23,02435217,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02435217,ZONOVATE (turoctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013621,turoctocog alfa 1500 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91950,Marketed,2018-03-23,02435225,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02435225,ZONOVATE (turoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013622,turoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91951,Marketed,2018-03-23,02435233,ZONOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02435233,ZONOVATE (turoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9013624,turoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002165,turoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93300,Marketed,2021-06-08,02447401,OBIZUR,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02447401,OBIZUR (susoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) TAKEDA CANADA INC,Active,9014141,susoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002288,susoctocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93366,Marketed,2025-12-11,02447967,ALTUVIIIO,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02447967,ALTUVIIIO (efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015298,efanesoctocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
93381,Marketed,2025-12-09,02448122,ALTUVIIIO,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448122,ALTUVIIIO (efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015300,efanesoctocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
93382,Marketed,2025-12-09,02448130,ALTUVIIIO,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448130,ALTUVIIIO (efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015297,efanesoctocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
93383,Marketed,2025-12-19,02448149,ALTUVIIIO,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448149,ALTUVIIIO (efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015337,efanesoctocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
93384,Marketed,2025-12-09,02448157,ALTUVIIIO,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02448157,ALTUVIIIO (efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe) SANOFI-AVENTIS CANADA INC,Active,9015299,efanesoctocog alfa 4000 unit per vial powder for solution for injection with diluent solution syringe,8002565,efanesoctocog alfa,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
93773,Marketed,2016-07-20,02451441,KOVALTRY,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451441,KOVALTRY (octocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014133,octocog alfa 250 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93774,Marketed,2016-07-06,02451468,KOVALTRY,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02451468,KOVALTRY (octocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014137,octocog alfa 500 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93775,Marketed,2016-07-06,02451476,KOVALTRY,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451476,KOVALTRY (octocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014128,octocog alfa 1000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93776,Marketed,2016-07-15,02451484,KOVALTRY,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451484,KOVALTRY (octocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014131,octocog alfa 2000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93777,Marketed,2016-08-18,02451492,KOVALTRY,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02451492,KOVALTRY (octocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014135,octocog alfa 3000 unit per vial powder for solution for injection with diluent solution syringe,8002285,octocog alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94622,Marketed,2021-08-13,02459078,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02459078,ADYNOVATE (rurioctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014230,rurioctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97224,Marketed,2020-04-08,02481766,JIVI,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481766,JIVI (damoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014288,damoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97225,Marketed,2020-03-11,02481774,JIVI,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481774,JIVI (damoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014286,damoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97226,Marketed,2020-03-11,02481782,JIVI,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481782,JIVI (damoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014287,damoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97227,Marketed,2020-01-27,02481790,JIVI,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02481790,JIVI (damoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) BAYER INC,Active,9014253,damoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002319,damoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98013,Marketed,2022-03-10,02490064,ESPEROCT,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490064,ESPEROCT (turoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014687,turoctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98014,Marketed,2022-03-10,02490072,ESPEROCT,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490072,ESPEROCT (turoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014685,turoctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98016,Marketed,2022-03-10,02490099,ESPEROCT,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490099,ESPEROCT (turoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014686,turoctocog alfa pegol 2000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98017,Marketed,2022-09-15,02490102,ESPEROCT,1.0,B02BD02,Coagulation factor viii,Powder for solution,Intravenous,02490102,ESPEROCT (turoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe) NOVO NORDISK CANADA INC,Active,9014769,turoctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution syringe,8002415,turoctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98830,Marketed,2021-07-16,02498537,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02498537,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 250 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014231,rurioctocog alfa pegol 250 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98831,Marketed,2021-08-13,02498545,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02498545,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014232,rurioctocog alfa pegol 500 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98834,Marketed,2021-08-13,02498588,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02498588,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014229,rurioctocog alfa pegol 1000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98835,Marketed,2021-08-27,02498596,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Kit,Powder for solution",Intravenous,02498596,ADYNOVATE (2 ML DILUENT) - SINGLE USE VIAL (rurioctocog alfa pegol 1500 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014612,rurioctocog alfa pegol 1500 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98837,Marketed,2021-02-23,02498626,ADYNOVATE,1.0,B02BD02,Coagulation factor viii,"Powder for solution,Kit",Intravenous,02498626,ADYNOVATE (rurioctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014389,rurioctocog alfa pegol 3000 unit per vial powder for solution for injection with diluent solution,8002314,rurioctocog alfa pegol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90329,Marketed,2014-04-03,02418738,CORIFACT 250,1.0,B02BD07,Coagulation factor xiii,Powder for solution,Intravenous,02418738,CORIFACT 250 (coagulation factor XIII human 250 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014096,coagulation factor XIII human 250 unit per vial powder for solution for injection with diluent solution,8002279,coagulation factor XIII human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90330,Marketed,2014-04-03,02418746,CORIFACT 1250,1.0,B02BD07,Coagulation factor xiii,Powder for solution,Intravenous,02418746,CORIFACT 1250 (coagulation factor XIII human 1250 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014095,coagulation factor XIII human 1250 unit per vial powder for solution for injection with diluent solution,8002279,coagulation factor XIII human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93872,Marketed,2016-04-06,02452340,COTELLIC,1.0,L01EE02,Cobimetinib,Tablet,Oral,02452340,COTELLIC (cobimetinib (cobimetinib fumarate) 20 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9005928,cobimetinib (cobimetinib fumarate) 20 mg oral tablet,8001619,cobimetinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
872,Marketed,2020-10-21,00176192,FIORINAL-C 1/4,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00176192,FIORINAL-C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
873,Marketed,2018-12-10,00176206,FIORINAL-C 1/2,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00176206,FIORINAL-C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
6419,Marketed,2017-11-20,00608181,TEVA-TECNAL C 1/2,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00608181,TEVA-TECNAL C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) TEVA CANADA LIMITED,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
6479,Marketed,2017-11-20,00608203,TEVA-TECNAL C 1/4,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,00608203,TEVA-TECNAL C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) TEVA CANADA LIMITED,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
104345,Marketed,2025-05-08,02554615,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,02554615,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule) APOTEX INC,Active,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
104346,Marketed,2025-05-08,02554623,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2,4.0,N02AA79,"Codein, combinations with psycholeptics",Capsule,Oral,02554623,APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2 (acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule) APOTEX INC,Active,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,8000805,acetylsalicylic acid and butalbital and caffeine and codeine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
943,Marketed,1986-12-18,00050024,CODEINE PHOSPHATE SYRUP,1.0,R05DA04,Codeine,Syrup,Oral,00050024,CODEINE PHOSPHATE SYRUP (codeine phosphate 25 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9006207,codeine phosphate 25 mg per 5 mL syrup,8000069,codeine,26643006,Oral,739009002,Syrup,,,,1.0,
2982,Marketed,1978-12-31,00380571,LINCTUS CODEINE BLANC,1.0,R05DA04,Codeine,Solution,Oral,00380571,LINCTUS CODEINE BLANC (codeine phosphate 10 mg per 5 mL oral solution) LABORATOIRE ATLAS INC,Active,9006199,codeine phosphate 10 mg per 5 mL oral solution,8000069,codeine,26643006,Oral,385023001,Oral solution,,,,1.0,
6415,Marketed,2017-11-17,00593435,TEVA-CODEINE,1.0,R05DA04,Codeine,Tablet,Oral,00593435,TEVA-CODEINE (codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000181,codeine phosphate 15 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
6416,Marketed,2017-11-17,00593451,TEVA-CODEINE,1.0,R05DA04,Codeine,Tablet,Oral,00593451,TEVA-CODEINE (codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000182,codeine phosphate 30 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
16474,Marketed,2015-10-14,02009757,CODEINE 30,1.0,R05DA04,Codeine,Tablet,Oral,02009757,CODEINE 30 (codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000182,codeine phosphate 30 mg oral tablet,8000069,codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
19049,Marketed,1995-12-31,02163799,CODEINE CONTIN 200MG CONTROLLED RELEASE TAB,1.0,R05DA04,Codeine,Tablet (extended-release),Oral,02163799,"CODEINE CONTIN 200MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 200 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000568,"codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
19050,Marketed,1995-12-31,02163748,CODEINE CONTIN 100MG CONTROLLED RELEASE TAB,1.0,R05DA04,Codeine,Tablet (extended-release),Oral,02163748,"CODEINE CONTIN 100MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 100 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000566,"codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
19051,Marketed,1995-12-31,02163780,CODEINE CONTIN 150MG CONTROLLED RELEASE TAB,1.0,R05DA04,Codeine,Tablet (extended-release),Oral,02163780,"CODEINE CONTIN 150MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 150 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000567,"codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
49057,Marketed,1997-03-13,02230302,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,1.0,R05DA04,Codeine,Tablet (extended-release),Oral,02230302,"CODEINE CONTIN 50MG CONTROLLED RELEASE TAB (codeine (codeine monohydrate, codeine sulfate trihydrate) 50 mg prolonged-release oral tablet) PURDUE PHARMA",Active,9000709,"codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet",8000069,codeine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
5780,Marketed,2017-06-08,00608882,TEVA-EMTEC-30,2.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00608882,TEVA-EMTEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000194,acetaminophen 300 mg and codeine phosphate 30 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6346,Marketed,2018-10-19,00653276,TEVA-LENOLTEC NO. 3,3.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653276,TEVA-LENOLTEC NO. 3 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000032,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 30 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6763,Marketed,2019-07-04,00653233,TEVA-LENOLTEC NO. 1,3.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653233,TEVA-LENOLTEC NO. 1 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6764,Marketed,2018-10-19,00653241,TEVA-LENOLTEC NO. 2,3.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00653241,TEVA-LENOLTEC NO. 2 (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000031,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 15 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6824,Marketed,2018-10-05,00621463,TEVA-LENOLTEC NO. 4,2.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00621463,TEVA-LENOLTEC NO. 4 (acetaminophen 300 mg and codeine phosphate 60 mg oral tablet) TEVA CANADA LIMITED,Active,9000103,acetaminophen 300 mg and codeine phosphate 60 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
9626,Marketed,2015-10-14,00789828,TRIATEC-30,2.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,00789828,TRIATEC-30 (acetaminophen 300 mg and codeine phosphate 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000194,acetaminophen 300 mg and codeine phosphate 30 mg oral tablet,8000065,acetaminophen and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11384,Marketed,1991-12-31,00816027,PMS-ACETAMINOPHEN WITH CODEINE ELIXIR,2.0,N02AJ06,Codeine and paracetamol,Elixir,Oral,00816027,PMS-ACETAMINOPHEN WITH CODEINE ELIXIR (acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9000371,acetaminophen 160 mg per 5 mL and codeine phosphate 8 mg per 5 mL oral solution,8000065,acetaminophen and codeine,26643006,Oral,385023001,Oral solution,,,,,
31568,Marketed,2014-01-17,02143933,ACETAMINOPHEN WITH CODEINE - CAPLET,3.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,02143933,ACETAMINOPHEN WITH CODEINE - CAPLET (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) TEVA CANADA LIMITED,Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
33917,Marketed,2019-11-25,02154234,"ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS",3.0,N02AJ06,Codeine and paracetamol,Tablet,Oral,02154234,"ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) LABORATOIRE RIVA INC.",Active,9000243,acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet,8000023,acetaminophen and caffeine and codeine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12942,Marketed,2024-11-19,01934767,ROBAXACET-8,3.0,N02AA59,"Codeine, combinations excl. psycholeptics",Tablet,Oral,01934767,ROBAXACET-8 (acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9002403,acetaminophen 325 mg and codeine phosphate 8 mg and methocarbamol 400 mg oral tablet,8000859,acetaminophen and codeine and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5069,Marketed,1982-12-31,00572349,COLCHICINE TAB 0.6MG,1.0,M04AC01,Colchicine,Tablet,Oral,00572349,COLCHICINE TAB 0.6MG (colchicine 0.6 mg oral tablet) ODAN LABORATORIES LTD,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85904,Marketed,2011-10-07,02373823,JAMP-COLCHICINE,1.0,M04AC01,Colchicine,Tablet,Oral,02373823,JAMP-COLCHICINE (colchicine 0.6 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88705,Marketed,2013-02-27,02402181,PMS-COLCHICINE,1.0,M04AC01,Colchicine,Tablet,Oral,02402181,PMS-COLCHICINE (colchicine 0.6 mg oral tablet) PHARMASCIENCE INC,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94355,Marketed,2019-10-10,02456559,EURO-COLCHICINE,1.0,M04AC01,Colchicine,Tablet,Oral,02456559,EURO-COLCHICINE (colchicine 0.6 mg oral tablet) EURO-PHARM INTERNATIONAL CANADA INC,Active,9000074,colchicine 0.6 mg oral tablet,8000047,colchicine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
12345,Marketed,2022-03-02,00821772,D-TABS,1.0,A11CC05,Colecalciferol,Tablet,Oral,00821772,D-TABS (cholecalciferol 10000 unit oral tablet) LABORATOIRE RIVA INC.,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73813,Marketed,2020-09-24,02253178,SANDOZ D 10 000,1.0,A11CC05,Colecalciferol,Capsule,Oral,02253178,SANDOZ D 10 000 (cholecalciferol 10000 unit oral capsule) SANDOZ CANADA INCORPORATED,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85666,Marketed,2018-07-05,02371502,EURO-D 50000 IU,1.0,A11CC05,Colecalciferol,Capsule,Oral,02371502,EURO-D 50000 IU (cholecalciferol 50000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC,Active,9006491,cholecalciferol 50000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90259,Marketed,2014-01-16,02417995,VITAMINE D 10 000,1.0,A11CC05,Colecalciferol,Tablet,Oral,02417995,VITAMINE D 10 000 (cholecalciferol 10000 unit oral tablet) PRO DOC LIMITEE,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92661,Marketed,2017-10-16,02442256,LUXA-D,1.0,A11CC05,Colecalciferol,Capsule,Oral,02442256,LUXA-D (cholecalciferol 2000 unit oral capsule) ORIMED PHARMA INC,Active,9006496,cholecalciferol 2000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93491,Marketed,2015-11-20,02449099,JAMP-VITAMIN D,1.0,A11CC05,Colecalciferol,Capsule,Oral,02449099,JAMP-VITAMIN D (cholecalciferol 10000 unit oral capsule) JAMP PHARMA CORPORATION,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93493,Marketed,2016-06-23,02449110,JAMP-VITAMIN D,1.0,A11CC05,Colecalciferol,Capsule,Oral,02449110,JAMP-VITAMIN D (cholecalciferol 50000 unit oral capsule) JAMP PHARMA CORPORATION,Active,9006491,cholecalciferol 50000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95272,Marketed,2017-08-16,02464594,EURO D 10 000,1.0,A11CC05,Colecalciferol,Capsule,Oral,02464594,EURO D 10 000 (cholecalciferol 10000 unit oral capsule) EURO-PHARM INTERNATIONAL CANADA INC,Active,9006479,cholecalciferol 10000 unit oral capsule,8000172,cholecalciferol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98866,Marketed,2025-08-28,02498944,AG-VITAMINE D TABLETS,1.0,A11CC05,Colecalciferol,Tablet,Oral,02498944,AG-VITAMINE D TABLETS (cholecalciferol 10000 unit oral tablet) ANGITA PHARMA INC.,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103554,Marketed,2024-04-30,02546876,VITAMIN D3,1.0,A11CC05,Colecalciferol,Tablet,Oral,02546876,VITAMIN D3 (cholecalciferol 10000 unit oral tablet) JAMP PHARMA CORPORATION,Active,9006461,cholecalciferol 10000 unit oral tablet,8000172,cholecalciferol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85917,Marketed,2020-12-09,02373955,LODALIS,1.0,C10AC04,Colesevelam,Tablet,Oral,02373955,"LODALIS (colesevelam hydrochloride 625 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9004983,colesevelam hydrochloride 625 mg oral tablet,8001251,colesevelam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91692,Marketed,2020-12-09,02432463,LODALIS,1.0,C10AC04,Colesevelam,Powder for suspension,Oral,02432463,"LODALIS (colesevelam hydrochloride 3.75 g per sachet powder for oral suspension) BAUSCH HEALTH, CANADA INC.",Active,9013782,colesevelam hydrochloride 3.75 g per sachet powder for oral suspension,8001251,colesevelam,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
98409,Marketed,2020-07-23,02494051,APO-COLESEVELAM,1.0,C10AC04,Colesevelam,Tablet,Oral,02494051,APO-COLESEVELAM (colesevelam hydrochloride 625 mg oral tablet) APOTEX INC,Active,9004983,colesevelam hydrochloride 625 mg oral tablet,8001251,colesevelam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18627,Marketed,2006-07-18,02132680,COLESTID TABLETS,1.0,C10AC02,Colestipol,Tablet,Oral,02132680,COLESTID TABLETS (colestipol hydrochloride 1 g oral tablet) PFIZER CANADA ULC,Active,9002769,colestipol hydrochloride 1 g oral tablet,8001252,colestipol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14332,Marketed,2017-02-17,00890960,OLESTYR,1.0,C10AC01,Colestyramine,Powder for suspension,Oral,00890960,OLESTYR LIGHT POWDER SUGAR FREE (cholestyramine 4 g per sachet powder for oral suspension) PHARMASCIENCE INC,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
19757,Marketed,2017-10-18,02210320,OLESTYR,1.0,C10AC01,Colestyramine,Powder for suspension,Oral,02210320,OLESTYR REGULAR POWDER (cholestyramine 4 g per sachet powder for oral suspension) PHARMASCIENCE INC,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
94242,Marketed,2016-12-23,02455609,CHOLESTYRAMINE-ODAN,1.0,C10AC01,Colestyramine,Powder for suspension,Oral,02455609,CHOLESTYRAMINE-ODAN (cholestyramine 4 g per sachet powder for oral suspension) ODAN LABORATORIES LTD,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
96937,Marketed,2020-02-10,02478595,JAMP-CHOLESTYRAMINE,1.0,C10AC01,Colestyramine,Powder for suspension,Oral,02478595,JAMP-CHOLESTYRAMINE SUGAR FREE (cholestyramine 4 g per sachet powder for oral suspension) JAMP PHARMA CORPORATION,Active,9013781,cholestyramine 4 g per sachet powder for oral suspension,8001311,cholestyramine,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
5524,Marketed,2024-07-25,00476420,COLY-MYCIN M,1.0,J01XB01,Colistin,Powder for solution,"Intravenous,Intramuscular",00476420,COLY-MYCIN M (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
68839,Marketed,2002-04-15,02244849,COLISTIMETHATE FOR INJECTION U.S.P.,1.0,J01XB01,Colistin,Powder for solution,"Intramuscular,Intravenous",02244849,COLISTIMETHATE FOR INJECTION U.S.P. (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) STERIMAX INC,Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88833,Marketed,2024-12-17,02403544,"COLISTIMETHATE FOR INJECTION, USP",1.0,J01XB01,Colistin,Powder for solution,"Intramuscular,Intravenous",02403544,"COLISTIMETHATE FOR INJECTION, USP (colistin (colistimethate sodium) 150 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9001712,colistin (colistimethate sodium) 150 mg per vial powder for solution for injection,8001181,colistin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103531,Marketed,2024-06-10,02546639,COLISTIMETHATE FOR INJECTION USP,1.0,J01XB01,Colistin,Powder for solution,"Intravenous,Intramuscular",,,,,,,,,,,,,,,,
13890,Marketed,1993-12-31,02014440,"OXYGEN USP, HELIUM USP, MEDICAL GAS MIXTURE",2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
13894,Marketed,1993-12-31,02014378,"OXYGEN USP, NITROGEN NF, MEDICAL GAS MIXTURE",2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
13910,Marketed,1993-12-31,02014432,"CARBON DIOXIDE USP, OXYGEN USP MEDICAL G.M.",2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
19100,Marketed,2020-08-06,02182238,CO-NE-O2-N2 MIXTURE,4.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
19101,Marketed,2020-08-06,02154773,CO-HE-O2-N2 MIXTURE,4.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
19290,Marketed,2022-02-21,02154846,HELIUM / OXYGEN MIXTURE,2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
19293,Marketed,2020-08-07,02154749,CARBOGEN,2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
90106,Marketed,2025-04-17,02416468,HELIOX 70/30,2.0,V03AN20,Combination,Gas,Inhalation,,,,,,,,,,,,,,,,
2148,Marketed,2020-06-26,00299561,CREO-RECTAL ADULTES/ADULTS,3.0,R05CA10,Combinations,Suppository,Rectal,00299561,CREO-RECTAL ADULTES/ADULTS (camphor 5 mg and diphenylpyraline hydrochloride 1.5 mg and guaiacol carbonate 600 mg suppository) LABORATOIRES CONFAB INC,Active,9001505,camphor 5 mg and diphenylpyraline hydrochloride 1.5 mg and guaiacol carbonate 600 mg suppository,8002178,camphor and diphenylpyraline and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
2150,Marketed,2020-06-26,00299596,CREO-RECTAL ENFANTS/CHILDREN,3.0,R05CA10,Combinations,Suppository,Rectal,00299596,CREO-RECTAL ENFANTS/CHILDREN (camphor 2 mg and diphenylpyraline hydrochloride 0.5 mg and guaiacol carbonate 200 mg suppository) LABORATOIRES CONFAB INC,Active,9001504,camphor 2 mg and diphenylpyraline hydrochloride 0.5 mg and guaiacol carbonate 200 mg suppository,8002178,camphor and diphenylpyraline and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
2787,Marketed,2022-07-19,00319724,DEMO-CINEOL ENFANTS/CHILDREN,4.0,R05CA10,Combinations,Suppository,Rectal,00319724,DEMO-CINEOL ENFANTS/CHILDREN (camphor 20 mg and eucalyptol 185 mg and guaiacol 90 mg and guaiacol carbonate 100 mg suppository) LABORATOIRES CONFAB INC,Active,9001777,camphor 20 mg and eucalyptol 185 mg and guaiacol 90 mg and guaiacol carbonate 100 mg suppository,8002179,camphor and eucalyptol and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
3823,Marketed,2019-09-10,00498807,SORBITOL MANNITOL IRRIGATION,2.0,B05CX10,Combinations,Solution,Irrigation,00498807,SORBITOL MANNITOL IRRIGATION (mannitol 5.4 mg per mL and sorbitol 27 mg per mL irrigation solution 3000 mL bag) ICU MEDICAL CANADA INC,Active,9013705,mannitol 5.4 mg per mL and sorbitol 27 mg per mL irrigation solution 3000 mL bag,8002139,mannitol and sorbitol,372471009,Intravesical,785898006,Solution for irrigation,732982009,Bag (unit of presentation),,,
6645,Marketed,2022-07-19,00319716,DEMO-CINEOL ADULTES/ADULTS,4.0,R05CA10,Combinations,Suppository,Rectal,00319716,DEMO-CINEOL ADULTES/ADULTS (camphor 40 mg and eucalyptol 370 mg and guaiacol 180 mg and guaiacol carbonate 200 mg suppository) LABORATOIRES CONFAB INC,Active,9002063,camphor 40 mg and eucalyptol 370 mg and guaiacol 180 mg and guaiacol carbonate 200 mg suppository,8002179,camphor and eucalyptol and guaiacol,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
8601,Marketed,2019-12-23,00758566,LACTATED RINGER'S IRRIGATION,4.0,B05CB10,Combinations,Solution,Irrigation,,,,,,,,,,,,,,,,
9829,Marketed,1989-12-31,00799963,CYSTOSOL W 3% HEXITOLS,2.0,B05CX10,Combinations,Liquid,Irrigation,00799963,CYSTOSOL W 3% HEXITOLS (mannitol 5 mg per mL and sorbitol 25 mg per mL irrigation solution 3000 mL bag) BAXTER CORPORATION,Active,9013922,mannitol 5 mg per mL and sorbitol 25 mg per mL irrigation solution 3000 mL bag,8002139,mannitol and sorbitol,372471009,Intravesical,785898006,Solution for irrigation,732982009,Bag (unit of presentation),,,
9830,Marketed,1989-12-31,00799971,LACTATED RINGER'S IRRIGATION SOL,4.0,B05CB10,Combinations,Liquid,Irrigation,,,,,,,,,,,,,,,,
10939,Marketed,1990-12-31,00800007,TIS-U-SOL SOLUTION,5.0,B05CB10,Combinations,Liquid,Irrigation,,,,,,,,,,,,,,,,
12504,Marketed,2019-04-18,01944746,BENYLIN FOR CHILDREN COUGH & COLD,2.0,R05DA20,Combinations,Syrup,Oral,01944746,BENYLIN FOR CHILDREN COUGH & COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
14075,Marketed,2013-11-01,02014076,CLINIMIX E,19.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
14076,Marketed,2013-11-01,02013967,CLINIMIX E,19.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
14077,Marketed,2013-11-02,02013886,CLINIMIX,15.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
14551,Marketed,2024-05-15,02044013,ROBITUSSIN CHILDREN'S COUGH AND COLD,2.0,R05DA20,Combinations,Syrup,Oral,02044013,ROBITUSSIN CHILDREN'S COUGH AND COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
18550,Marketed,2013-11-02,02013940,CLINIMIX,15.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
19143,Marketed,2013-11-02,02046709,CLINIMIX,15.0,B05BA10,Combinations,Liquid,Intravenous,,,,,,,,,,,,,,,,
19610,Marketed,2013-11-02,02013932,CLINIMIX,15.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
20291,Marketed,2013-11-01,02142384,CLINIMIX E,20.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
20329,Marketed,2018-03-05,02169126,TEVA-COTRIDIN,3.0,R05DA20,Combinations,Syrup,Oral,02169126,TEVA-COTRIDIN (codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001575,codeine phosphate 10 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup,8002113,codeine and pseudoephedrine and triprolidine,26643006,Oral,739009002,Syrup,,,,,
26564,Marketed,1996-09-19,02028867,CETACAINE LIQUID,3.0,N01BB20,Combinations,Liquid,Topical,02028867,CETACAINE LIQUID (benzocaine 14 % and butamben 2 % and tetracaine hydrochloride 2 % oromucosal solution) CETYLITE INDUSTRIES INC.,Active,9013800,benzocaine 14 % and butamben 2 % and tetracaine hydrochloride 2 % oromucosal solution,8002012,benzocaine and butamben and tetracaine,372473007,Oromucosal,385070000,Oromucosal solution,,,,,
49687,Marketed,2002-11-06,02230578,TWINRIX,2.0,J07BC20,Combinations,Suspension,Intramuscular,,,,,,,,,,,,,,,,
50030,Marketed,1997-03-26,02230769,DALMACOL,5.0,R05DA20,Combinations,Syrup,Oral,02230769,DALMACOL (alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup) LABORATOIRE RIVA INC.,Active,9006201,alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup,8000779,alcohol anhydrous and doxylamine and etafedrine and hydrocodone and sodium citrate,26643006,Oral,739009002,Syrup,,,,1.0,
60885,Marketed,2002-10-21,02237548,TWINRIX JUNIOR,2.0,J07BC20,Combinations,Suspension,Intramuscular,,,,,,,,,,,,,,,,
75882,Marketed,2024-12-05,02273330,NYQUIL KIDS COUGH & COLD,2.0,R05DA20,Combinations,Syrup,Oral,02273330,NYQUIL KIDS COUGH & COLD (chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL oral solution) PROCTER & GAMBLE INC,Active,9013810,chlorpheniramine maleate 2 mg per 15 mL and dextromethorphan hydrobromide 15 mg per 15 mL oral solution,8001354,chlorpheniramine and dextromethorphan,26643006,Oral,385023001,Oral solution,,,,,
79504,Marketed,2025-11-14,02309440,COLDASIDE COUGH & COLD,2.0,R05DA20,Combinations,Tablet,Oral,02309440,COLDASIDE COUGH & COLD (chlorpheniramine maleate 4 mg and dextromethorphan hydrobromide 30 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9003861,chlorpheniramine maleate 4 mg and dextromethorphan hydrobromide 30 mg oral tablet,8001354,chlorpheniramine and dextromethorphan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81134,Marketed,2010-02-11,02325993,ORAQIX,2.0,N01BB20,Combinations,Gel,Topical,02325993,ORAQIX (lidocaine 2.5 % and prilocaine 2.5 % cutaneous gel) DENTSPLY CANADA LIMITED,Active,9004644,lidocaine 2.5 % and prilocaine 2.5 % cutaneous gel,8001841,lidocaine and prilocaine,448598008,Cutaneous,385100002,Gel,,,,,
81147,Marketed,2016-02-15,02326132,TISSEEL,4.0,B02BC30,Combinations,Kit,Topical,,,,,,,,,,,,,,,,
81150,Marketed,2016-12-13,02326167,ARTISS,4.0,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,
81151,Marketed,2016-04-22,02326175,TISSEEL,4.0,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,
83774,Marketed,2011-02-28,02352494,PERIOLIMEL 2.5% E,25.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
83779,Marketed,2011-01-19,02352532,OLIMEL 5.7% E,25.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
83780,Marketed,2019-09-19,02352540,OLIMEL 5.7%,20.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
87985,Marketed,2024-05-10,02394707,ROBITUSSIN CHILDREN'S COUGH & COLD BEDTIME,3.0,R05DA20,Combinations,Syrup,Oral,02394707,ROBITUSSIN CHILDREN'S COUGH & COLD BEDTIME (brompheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution) HALEON CANADA ULC,Active,9004258,brompheniramine maleate 2 mg per 5 mL and dextromethorphan hydrobromide 10 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL oral solution,8001344,brompheniramine and dextromethorphan and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
92505,Marketed,2015-09-15,02440687,SMOFKABIVEN ELECTROLYTE FREE,21.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
92506,Marketed,2015-09-15,02440695,SMOFKABIVEN,27.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
94308,Marketed,2017-02-14,02456206,SMOFKABIVEN PERIPHERAL,27.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
95965,Marketed,2021-10-21,02470640,PERGOVERIS,2.0,G03GA30,Combinations,Solution,Subcutaneous,02470640,"PERGOVERIS (follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014622,follitropin alfa 300 unit per 0.48 mL and lutropin alfa 150 unit per 0.48 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
95966,Marketed,2021-10-29,02470659,PERGOVERIS,2.0,G03GA30,Combinations,Solution,Subcutaneous,02470659,"PERGOVERIS (follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014623,follitropin alfa 450 unit per 0.72 mL and lutropin alfa 225 unit per 0.72 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
95967,Marketed,2021-10-29,02470667,PERGOVERIS,2.0,G03GA30,Combinations,Solution,Subcutaneous,02470667,"PERGOVERIS (follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014624,follitropin alfa 900 unit per 1.44 mL and lutropin alfa 450 unit per 1.44 mL solution for injection pen,8001782,follitropin alfa and lutropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
96873,Marketed,2021-07-26,02477947,OLIMEL 7.6%,20.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
96874,Marketed,2018-10-25,02477955,OLIMEL 7.6% E,25.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
97569,Marketed,2024-05-16,02485443,ROBITUSSIN HONEY COUGH & COLD NIGHTTIME,2.0,R05DA20,Combinations,Syrup,Oral,02485443,ROBITUSSIN HONEY COUGH & COLD NIGHTTIME (dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014146,dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup,8001369,dextromethorphan and doxylamine,26643006,Oral,739009002,Syrup,,,,,
98816,Marketed,2021-10-01,02498413,CLINIMIX E,20.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
98819,Marketed,2020-12-01,02498421,CLINIMIX E,20.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
98820,Marketed,2022-04-01,02498448,CLINIMIX,16.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
98821,Marketed,2023-04-26,02498456,CLINIMIX,16.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
98822,Marketed,2020-11-19,02498464,CLINIMIX,16.0,B05BA10,Combinations,Solution,Intravenous,,,,,,,,,,,,,,,,
99138,Marketed,2021-07-09,02501775,SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE,21.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
99142,Marketed,2021-05-05,02501813,SMOFKABIVEN EXTRA NITROGEN,27.0,B05BA10,Combinations,Emulsion,Intravenous,,,,,,,,,,,,,,,,
99307,Marketed,2021-07-19,02503611,NYQUIL COUGH DM + CONGESTION,3.0,R05DA20,Combinations,Syrup,Oral,02503611,NYQUIL COUGH DM + CONGESTION (dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9014903,dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup,8002380,dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,
100339,Marketed,2023-04-10,02514222,VISTASEAL,2.0,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,
100342,Marketed,2022-02-16,02514257,VISTASEAL,2.0,B02BC30,Combinations,Solution,Topical,,,,,,,,,,,,,,,,
100961,Marketed,2023-07-31,02520419,NYQUIL KIDS,3.0,R05DA20,Combinations,Syrup,Oral,02520419,NYQUIL KIDS (dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9014903,dextromethorphan hydrobromide 10 mg per 15 mL and doxylamine succinate 6.25 mg per 15 mL and phenylephrine hydrochloride 5 mg per 15 mL syrup,8002380,dextromethorphan and doxylamine and phenylephrine,26643006,Oral,739009002,Syrup,,,,,
101204,Marketed,2024-08-20,02522969,JACK & JILL BEDTIME HONEY COUGH & COLD,2.0,R05DA20,Combinations,Syrup,Oral,02522969,JACK & JILL BEDTIME HONEY COUGH & COLD (dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014146,dextromethorphan hydrobromide 7.5 mg per 5 mL and doxylamine succinate 3.125 mg per 5 mL syrup,8001369,dextromethorphan and doxylamine,26643006,Oral,739009002,Syrup,,,,,
102260,Marketed,2024-08-13,02533626,JACK & JILL MULTI-SYMPTOM COLD & COUGH,2.0,R05DA20,Combinations,Syrup,Oral,02533626,JACK & JILL MULTI-SYMPTOM COLD & COUGH (dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002454,dextromethorphan hydrobromide 7.5 mg per 5 mL and pseudoephedrine hydrochloride 15 mg per 5 mL syrup,8001373,dextromethorphan and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
8398,Marketed,1987-12-31,00621366,BIODERM OINTMENT,2.0,D06AX30,Combinations of antibiotics,Ointment,Topical,00621366,BIODERM OINTMENT (bacitracin 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) ODAN LABORATORIES LTD,Active,9013866,bacitracin 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
20134,Marketed,1996-12-31,02181908,POLYDERM OINTMENT USP,2.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02181908,POLYDERM OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
48982,Marketed,2002-06-10,02230251,ANTIBIOTIC OINTMENT USP,2.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02230251,ANTIBIOTIC OINTMENT USP (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
50105,Marketed,2025-08-26,02230844,POLYSPORIN ANTIBIOTIC CREAM,2.0,D06AX30,Combinations of antibiotics,Cream,Topical,02230844,POLYSPORIN ANTIBIOTIC CREAM (gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013885,gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002242,gramicidin and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
60209,Marketed,2019-02-19,02236917,OZONOL ANTIBIOTICS PLUS,3.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02236917,OZONOL ANTIBIOTICS PLUS (bacitracin 500 unit per g and lidocaine hydrochloride 40 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) EXZELL PHARMA INC,Active,9013865,bacitracin 500 unit per g and lidocaine hydrochloride 40 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002238,bacitracin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
60248,Marketed,2006-02-07,02236954,BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC,2.0,D06AX30,Combinations of antibiotics,"Ointment,Pad",Topical,02236954,BAND-AID BRAND ADHESIVE BANDAGES PLUS ANTIBIOTIC (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g dressing) JOHNSON & JOHNSON INC,Active,9013899,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g dressing,8002239,bacitracin and polymyxin B,448598008,Cutaneous,700478009,Dressing,732993006,Dressing (unit of presentation),,,
60545,Marketed,2025-08-26,02237226,POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT,3.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02237226,POLYSPORIN TRIPLE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013860,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002237,bacitracin and gramicidin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
60546,Marketed,2025-08-26,02237227,POLYSPORIN ANTIBIOTIC OINTMENT,2.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02237227,POLYSPORIN ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013862,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002239,bacitracin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
62658,Marketed,2025-08-27,02239201,POLYSPORIN PLUS PAIN RELIEF,3.0,D06AX30,Combinations of antibiotics,Cream,Topical,02239201,POLYSPORIN PLUS PAIN RELIEF (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
64139,Marketed,2025-08-26,02240568,POLYSPORIN COMPLETE,4.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02240568,POLYSPORIN COMPLETE (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) KENVUE CANADA INC.,Active,9013859,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002236,bacitracin and gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
70888,Marketed,2003-01-20,02246693,TRIPLE ANTIBIOTIC OINTMENT,3.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02246693,TRIPLE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013860,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002237,bacitracin and gramicidin and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
72525,Marketed,2025-08-26,02248189,POLYSPORIN FOR KIDS,3.0,D06AX30,Combinations of antibiotics,Cream,Topical,02248189,POLYSPORIN FOR KIDS (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) KENVUE CANADA INC.,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
78974,Marketed,2009-07-30,02304457,ANTIBIOTIC PLUS PAIN RELIEF CREAM,3.0,D06AX30,Combinations of antibiotics,Cream,Topical,02304457,ANTIBIOTIC PLUS PAIN RELIEF CREAM (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
78975,Marketed,2009-01-23,02304465,COMPLETE ANTIBIOTIC OINTMENT,4.0,D06AX30,Combinations of antibiotics,Ointment,Topical,02304465,COMPLETE ANTIBIOTIC OINTMENT (bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9013859,bacitracin (bacitracin zinc) 500 unit per g and gramicidin 0.25 mg per g and lidocaine 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous ointment,8002236,bacitracin and gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
80057,Marketed,2009-07-30,02315033,ANTIBIOTIC CREAM FOR KIDS,3.0,D06AX30,Combinations of antibiotics,Cream,Topical,02315033,ANTIBIOTIC CREAM FOR KIDS (gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013884,gramicidin 0.25 mg per g and lidocaine hydrochloride 50 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002241,gramicidin and lidocaine and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
80317,Marketed,2010-10-26,02317656,ORIGINAL ANTIBIOTIC CREAM,2.0,D06AX30,Combinations of antibiotics,Cream,Topical,02317656,ORIGINAL ANTIBIOTIC CREAM (gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9013885,gramicidin 0.25 mg per g and polymyxin B (polymyxin B sulfate) 10000 unit per g cutaneous cream,8002242,gramicidin and polymyxin B,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
62695,Marketed,2012-08-02,02239234,SANDOZ POLYTRIMETHOPRIM,2.0,S01AA30,Combinations of different antibiotics,Solution,Ophthalmic,02239234,SANDOZ POLYTRIMETHOPRIM (polymyxin B (polymyxin B sulfate) 10000 unit per mL and trimethoprim (trimethoprim sulfate) 1 mg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9013894,polymyxin B (polymyxin B sulfate) 10000 unit per mL and trimethoprim (trimethoprim sulfate) 1 mg per mL ophthalmic drops,8002247,polymyxin B and trimethoprim,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
84489,Marketed,2021-06-03,02359928,STERISPORIN,2.0,S01AA30,Combinations of different antibiotics,Ointment,Ophthalmic,02359928,STERISPORIN (bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g ophthalmic ointment) STERI-MED PHARMA INC.,Active,9013863,bacitracin (bacitracin zinc) 500 unit per g and polymyxin B (polymyxin B sulfate) 10000 unit per g ophthalmic ointment,8002239,bacitracin and polymyxin B,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
5535,Marketed,2017-08-16,00590215,TPN ELECTROLYTES,5.0,B05XA30,Combinations of electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
18554,Marketed,1995-12-31,02035472,DORMER 211 FACE CREAM SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
42376,Marketed,2013-06-18,02093006,MARCELLE/ OIL FREE MULTI-DéFENSE LOTION SPF 15 FPS/ FLUIDE MULTI-DéFENSE SANS HUILE,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
42377,Marketed,2013-06-06,02093014,MARCELLE/MULTI-DEFENSE CREAM/CRèME MULTI-DéFENSE/SPF 15 FPS,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
42607,Marketed,2014-02-13,02157292,BLISTEX DCT,5.0,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,
64883,Marketed,2021-01-07,02241273,REVERSA CRèME ANTI-RIDES CONTOUR DES YEUX FPS 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
65907,Marketed,2002-06-01,02242226,DORMER 211 SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
67232,Marketed,2001-06-19,02243329,CETAPHIL DAILY FACIAL MOISTURIZER SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
68850,Marketed,2002-09-01,02244858,REVERSA UV CREME VISAGE ET COU FPS 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
75697,Marketed,2013-06-22,02271508,CLINIQUE FOR MEN SPF 21 MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
76603,Marketed,2007-03-01,02280353,OMBRELLE CREAM SPF 60,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
79215,Marketed,2018-08-23,02306441,FLAWLESS EFFECT LIQUID FOUNDATION BROAD SPECTRUM SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
79420,Marketed,2008-09-11,02308576,DEEP MOISTURE RENEWAL WITH SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
80045,Marketed,2022-05-04,02314924,ELTAMD SKINCARE UV SPORT SPF 50,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
80135,Marketed,2009-01-21,02315831,CETAPHIL DAILY FACIAL MOISTURIZER   (SPF 50),5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
80199,Marketed,2009-03-25,02316498,CLINIQUE SPF 50 FACE CREAM,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
80776,Marketed,2022-04-22,02322307,ELTAMD SKINCARE UV DAILY SPF 40,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
81175,Marketed,2012-09-24,02326426,PREVAGE ANTI-AGING MOISTURE LOTION SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
83908,Marketed,2011-01-19,02353873,ANEW PLATINUM DAY CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
83966,Marketed,2018-04-23,02354497,PHOTODERM SPF/FPS 50+ LAIT,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
83967,Marketed,2018-04-23,02354500,PHOTODERM SPF/FPS 40 SPRAY,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
84055,Marketed,2010-10-18,02355302,PREVAGE ANTI-AGING EYE CREAM SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
85102,Marketed,2012-09-24,02366169,PREVAGE ANTI-AGING MOISTURE CREAM SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
85281,Marketed,2012-03-01,02367998,CLINIQUE EVEN BETTER MAKEUP SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
85335,Marketed,2012-01-23,02368382,RAPID WRINKLE REPAIR MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
85341,Marketed,2011-07-26,02368455,FOUNDATION PRIMER PLUS SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
85343,Marketed,2011-06-30,02368463,LIP CONDITIONER SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
85558,Marketed,2012-03-01,02370425,CLINIQUE REDNESS SOLUTIONS MAKEUP SPF 15 WITH PROBIOTIC TECHNOLOGY,3.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
85697,Marketed,2012-01-16,02371847,CERAMIDE PREMIERE INTENSE MOISTURE AND RENEWAL ACTIVATION CREAM SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
85940,Marketed,2012-02-15,02374196,SPF 45 SPORT CLEAR CONTINUOUS SPRAY,5.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
85941,Marketed,2023-10-18,02374218,SPORT CLEAR SPRAY SUNSCREEN,5.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
85986,Marketed,2019-07-22,02374536,CETAPHIL PRO DERMACONTROL OIL CONTROL MOISTURIZER,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
86119,Marketed,2017-05-01,02375788,SPF 30 SPRAY-ON ALCOHOL-FREE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
86192,Marketed,2022-01-12,02376466,OLAY REGENERIST ENHANCING UVA/UVB LOTION WITH SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
86761,Marketed,2021-05-08,02381753,MOISTURE THERAPY LIP BALM SPF 25,2.0,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,
86786,Marketed,2021-05-08,02381990,DOUBLE-DUTY FACE MOISTURIZER SPF 20,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
86907,Marketed,2012-09-01,02383314,PHELITYL DAY LOTION SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
87051,Marketed,2012-10-01,02384825,CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 VERY DRY TO DRY,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
87052,Marketed,2012-10-01,02384833,CLINIQUE REPAIRWEAR UPLIFTING FIRMING CREAM SPF 15 DRY COMBINATION TO COMBINATION OILY,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
87316,Marketed,2015-01-12,02387557,TRIPLE AGE REPAIR MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
87370,Marketed,2016-01-25,02388154,SUNSCREEN OIL SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
87518,Marketed,2012-09-01,02389681,FIRMARINE DAY CREAM SPF 30 CRèME DE JOUR SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
87816,Marketed,2013-02-11,02392895,ELIZABETH ARDEN NOURISHING LIP BALM SPF 20,2.0,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,
88402,Marketed,2013-04-29,02399113,ANTI-AGING COMPLEX EMULSION BROAD SPECTRUM SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
88679,Marketed,2022-04-13,02401916,BARE SKIN FEEL UV LOTION,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
88698,Marketed,2013-05-20,02402114,CLINIQUE MOISTURE SURGE CC CREAM HYDRATING COLOUR CORRECTOR SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
88702,Marketed,2014-12-18,02402157,SPF 60 ANTHELIOS XL LOTION,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
88834,Marketed,2013-06-05,02403552,PREVENTAGE FIRMING DEFENSE CRèME NORMAL/DRY BROAD SPECTRUM SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
88835,Marketed,2013-06-17,02403560,PREVENTAGE FIRMING DEFENSE CRèME NORMAL/OILY BROAD SPECTRUM SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
88967,Marketed,2013-08-28,02404842,ANTI-AGING COMPLEX EYE TREATMENT BROAD SPECTRUM SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89158,Marketed,2013-07-18,02406926,MARCELLE/CC/CREAM/CRèME COMPLETE CORRECTION/CORRECTION COMPLèTE/SPF 35 FPS,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
89171,Marketed,2016-04-19,02407051,RODAN+FIELDS ESSENTIALS LIP SHIELD,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
89192,Marketed,2014-04-24,02407205,ESSENTIAL-C DAY MOISTURE BROAD SPECTRUM SPF 30 PA+++,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89463,Marketed,2014-09-01,02409976,LA MER THE SPF 50 UV PROTECTING FLUID,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89471,Marketed,2014-01-06,02410044,FPS 30 SOIN COMPLET,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89473,Marketed,2014-01-06,02410060,FPS 60 SOIN COMPLET,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89557,Marketed,2018-03-23,02410923,CERAVE,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89908,Marketed,2014-02-16,02414430,MARY KAY CC CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
89965,Marketed,2015-01-12,02415038,M.A.C PREP + PRIME FACE PROTECT LOTION SPF 50,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
89994,Marketed,2019-12-03,02415321,SPF 30 FPS SUNSCREEN LOTION LOTION ÉCRAN SOLAIRE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
90154,Marketed,2014-03-25,02416921,SUNSCREEN STICK SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
90618,Marketed,2017-05-01,02421542,BROAD SPECTRUM SPF FPS 50,5.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
90920,Marketed,2025-08-15,02424517,TOTAL EFFECTS 7 IN ONE FEATHERWEIGHT MOISTURIZER WITH SPF,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
90992,Marketed,2015-02-01,02425289,HAUTE EXIGENCE JOUR SPF 20 MULTI-INTENSIVE,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
91075,Marketed,2014-09-02,02426145,CC CREAM BROAD SPECTRUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
91470,Marketed,2016-01-04,02430215,BANANA BOAT KIDS SUNSCREEN LOTION SPF/FPS 60,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
91549,Marketed,2015-12-14,02431041,DRY OIL SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
91576,Marketed,2022-04-22,02431343,UV DAILY TINTED,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
91585,Marketed,2024-05-02,02431432,ANEW ULTIMATE MULTI-PERFORMANCE DAY CREAM CRèME DE JOUR BROAD SPECTRUM SPF25 À LARGE SPECTRE FPS 25,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
91586,Marketed,2022-08-02,02431440,Q10 POWER TM/MC ANTI-WRINKLE FIRMING DAY CREAM,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
91835,Marketed,2017-06-02,02434016,TEINT LUMIèRE,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
91939,Marketed,2015-05-11,02435101,REVERSA CREME FPS30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
91979,Marketed,2015-03-27,02435489,SPF FPS 40 LOTION,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92015,Marketed,2015-07-18,02435802,REVERSA CRèME RADIANCE FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
92153,Marketed,2015-04-07,02437236,HIGH PROTECTION LOTION SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92160,Marketed,2015-04-07,02437309,HIGH PROTECTION SPRAY SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92171,Marketed,2015-09-15,02437376,M.A.C. STUDIO WATERWEIGHT SPF 30 FOUNDATION,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
92215,Marketed,2022-07-14,02437775,VIVIER SHEER SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92260,Marketed,2015-06-15,02438232,RENERGIE LIFT MULTI-ACTION SPF 15 FIRMING MOISTURIZING CREAM ALL SKIN TYPES,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
92515,Marketed,2019-06-17,02440792,DENTEC LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92523,Marketed,2016-01-18,02440873,ABSOLUTELY AGELESS DAILY MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92717,Marketed,2025-08-22,02442779,UVA/UVB MOISTURIZING CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
92910,Marketed,2025-06-13,02444208,AGE DEFYING ANTI-WRINKLE LOTION WITH SPF,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
92912,Marketed,2016-05-01,02444216,ORIGINS PLANTSCRIPTION SPF 25 POWER ANTI-AGING CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
93187,Marketed,2016-02-15,02446529,UV 50 ECRAN MULTI-PROTECTION SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
93191,Marketed,2016-03-01,02446545,EMULSION SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
93192,Marketed,2020-06-19,02446553,KIDS SPRAY,5.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
93254,Marketed,2024-06-03,02446979,MULTI-ACTION CREAM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
93309,Marketed,2016-03-17,02447509,LIFE BRAND SPORT SUNSCREEN BROAD SPECTRUM SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
93310,Marketed,2016-04-20,02447517,SUNSCREEN FACE LOTION,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93311,Marketed,2016-03-08,02447525,SUNSCREEN CONTINUOUS SPRAY NO PUMPING NEEDED,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
93312,Marketed,2016-03-16,02447533,KIDS SUNSCREEN CONTINUOUS SPRAY,5.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
93321,Marketed,2016-02-11,02447630,SPORT SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93322,Marketed,2016-03-07,02447649,SUNSCREEN CONTINUOUS SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
93336,Marketed,2016-02-22,02447770,SPF 30 SPORT ENDURANCE,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93346,Marketed,2016-10-19,02447843,SPF 60 SPORT ENDURANCE,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93442,Marketed,2021-04-23,02448718,ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93545,Marketed,2016-07-14,02449617,SPF 50+ FPS ULTRA LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
93546,Marketed,2017-01-17,02449625,SPF 50+ FPS ULTRA,5.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
93921,Marketed,2021-01-20,02452804,COPPERTONE LOTION SUNSCREEN SPF 30 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94010,Marketed,2020-07-14,02453541,NO7 PROTECT & PERFECT INTENSE ADVANCED DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94131,Marketed,2019-12-11,02454602,HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
94316,Marketed,2017-02-15,02456273,UV 50 ECRAN TEINTé MULTI-PROTECTION SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
94463,Marketed,2017-06-15,02457571,ORIGINS GINZING SPF 40 ENERGY-BOOSTING TINTED MOISTURIZER,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94656,Marketed,2022-04-29,02459353,ULTRA-LIGHT REFRESHING UV LOTION,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94759,Marketed,2020-04-27,02460300,NO7 LIFT & LUMINATE TRIPLE ACTION DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94764,Marketed,2017-03-28,02460327,TIMELESS ILLUMINATING MAKEUP BROAD SPECTRUM SPF 30,2.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
94837,Marketed,2025-06-17,02460882,AGE DEFYING CLASSIC LOTION WITH SPF,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94854,Marketed,2020-11-13,02461048,COMPLETE* DRY TOUCH SUNSCREEN/ÉCRAN SOLAIRE,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94857,Marketed,2022-03-04,02461072,COMPLETE* DRY TOUCH,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94867,Marketed,2025-08-26,02461188,COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94870,Marketed,2025-06-04,02461196,COMPLETE HYDRATING CREAM WITH SPF,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94873,Marketed,2025-06-13,02461242,COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 15 SENSITIVE,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94874,Marketed,2025-08-21,02461234,COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94877,Marketed,2025-08-01,02461269,COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM 15 FOR COMBINATION/OILY SKIN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
94970,Marketed,2017-09-08,02461943,FUTURE SOLUTION LX TOTAL PROTECTIVE CREAM E,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94981,Marketed,2017-06-05,02462079,MARCELLE REVIVAL+ SKIN RENEWAL ANTI-AGING DAY CREAM SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
94986,Marketed,2018-06-01,02462125,SPF 50 BROAD SPECTRUM KIDS,5.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
94990,Marketed,2018-06-01,02462176,SPF/FPS 50 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN,5.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
94991,Marketed,2018-06-01,02462184,SPF/FPS 30 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
95201,Marketed,2018-01-01,02463911,OLAY LUMINOUS WHIP,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95202,Marketed,2026-01-30,02463938,WHIP REGENERIST,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95203,Marketed,2018-01-01,02463946,OLAY TOTAL EFFECTS WHIP,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95248,Marketed,2019-09-01,02464322,SPF 50+ KIDS (80 MINUTES) WATER RESISTANT,5.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
95288,Marketed,2019-02-07,02464748,MARCELLE SHEER TINT MOISTURIZER HYDRATANT TEINTé TRANSLUCIDE SPF 30 FPS,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95318,Marketed,2017-12-10,02464977,BANANA BOAT KIDS TEAR-FREE SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
95414,Marketed,2019-09-01,02465884,COMPLETE SENSITIVE ADVANCED [80 MINUTES] WATER/SWEAT RESISTANT LOTION SPF 60,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
95472,Marketed,2018-05-11,02466376,ANTI-SHINE ANTHELIOS XL DRY TOUCH GEL-CREAM,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95476,Marketed,2022-05-11,02466406,ANTI-SHINE DRY TOUCH UV LOTION,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
95486,Marketed,2018-03-19,02466511,BOBBI BROWN PRIMER PLUS PROTECTION SPF 50,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
95491,Marketed,2021-02-22,02466570,NOURISHING DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95492,Marketed,2021-02-22,02466589,REFRESHING DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95508,Marketed,2018-10-01,02466724,REVITALIFT ANTI-WRINKLE + FIRMING DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95550,Marketed,2023-02-14,02467100,COPPERTONE SUNSCREEN STICK SPF 50 WATER BABIES,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
95734,Marketed,2018-04-09,02468808,HYDRATANT DéFENSE FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
95951,Marketed,2018-09-24,02470527,MATRIX SUPPORT WITH SUNSCREEN BROAD SPECTRUM SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
96009,Marketed,2019-02-01,02470993,SPF 60 KIDS WET'N PROTECT,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96099,Marketed,2018-03-07,02471795,TANNING OIL HUILE BRONZANTE 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,
96113,Marketed,2021-09-08,02471906,REGULAR LIP BALM,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
96176,Marketed,2021-09-28,02472449,BERRY LIP BALM,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
96178,Marketed,2021-09-28,02472465,MINT LIP BALM,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
96253,Marketed,2018-04-21,02473178,REVERSA URBAN PROTECTION HYDRATING CARE SPF 30 SOIN HYDRATANT PROTECTION URBAINE FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
96549,Marketed,2020-04-24,02475189,COMPLETE MOISTURE,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
96579,Marketed,2019-10-03,02475405,BANANA BOAT ULTRA SPORT SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96580,Marketed,2021-01-30,02475413,COPPERTONE LOTION SUNSCREEN SPF 50 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96704,Marketed,2019-05-29,02476118,FACE & NECK MULTI ACTION VISAGE ET COU MULTI ACTION DAY CREAM / CRèME DE JOUR SPF 30 / FPS 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
96825,Marketed,2019-04-30,02477297,LAIT SOLAIRE CORPS LOTION PROTECTRICE CORPS FPS 30,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96827,Marketed,2019-04-30,02477319,SOIN SOLAIRE VISAGE CRèME PROTECTRICE VISAGE FPS 50 PLUS,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
96858,Marketed,2019-10-03,02477521,BANANA BOAT ULTRA SPORT SUNSCREEN LOTION SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96859,Marketed,2019-10-11,02477548,BANANA BOAT ULTRA SPORT CLEAR SUNSCREEN SPRAY SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
96860,Marketed,2019-10-15,02477556,BANANA BOAT ULTRA SPORT CLEAR SUNSCREEN SPRAY SPF 50 PLUS,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
96901,Marketed,2021-01-30,02478250,COPPERTONE SPRAY SUNSCREEN SPF 30 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
96902,Marketed,2020-04-09,02478269,COPPERTONE LOTION SUNSCREEN SPF 50 KIDS,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96904,Marketed,2021-04-02,02478285,COPPERTONE SPRAY SUNSCREEN SPF 30 SUN GUARD,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
96970,Marketed,2020-04-02,02478986,PREMIUM SUNSCREEN FACE LOTION SUN BUM FACE 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96971,Marketed,2019-04-08,02478994,PREMIUM SUNSCREEN LOTION SUN BUM 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96972,Marketed,2019-04-08,02479001,PREMIUM SUNSCREEN LOTION SUN BUM 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
96973,Marketed,2019-01-04,02479028,BENEFIANCE WRINKLE SMOOTHING DAY CREAM,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
97178,Marketed,2018-12-17,02481294,EXTRA-FIRMING JOUR FPS/SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
97242,Marketed,2024-09-23,02481944,ULTRA-LIGHT MOISTURIZING LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97249,Marketed,2019-12-23,02482010,SHEER HYDRATION SUNSCREEN BROAD SPECTRUM SPF 40,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97264,Marketed,2022-07-21,02482177,OLAY REGENERIST SPF 30 REGENERIST MICRO-SCULPTING CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97289,Marketed,2020-07-09,02482444,MAKEUP SETTING SPRAY PULVéRISATION POUR FIXER LE MAQUILLAGE,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
97377,Marketed,2019-04-08,02483335,PREMIUM SUNSCREEN SPRAY SUN BUM 30,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
97407,Marketed,2019-04-08,02483726,PREMIUM SUNSCREEN SPRAY SUN BUM 50,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
97412,Marketed,2019-03-19,02483777,FACIAL FUEL,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97422,Marketed,2019-07-28,02483866,OIL AND PORE CONTROL MATTIFIER BROAD SPECTRUM SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97460,Marketed,2025-07-31,02484285,HYDRO BOOST GEL CREAM SPF 25,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
97662,Marketed,2025-08-14,02486407,ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97667,Marketed,2025-10-22,02486474,ULTRA SHEER BODY MIST SUNSCREEN SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
97685,Marketed,2019-07-18,02486687,PRISMA PROTECT SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97785,Marketed,2021-01-30,02487705,COPPERTONE SPRAY SUNSCREEN SPF 50 KIDS,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
97790,Marketed,2025-10-14,02487764,FACE SUNSCREEN SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97794,Marketed,2025-08-14,02487780,DRY-TOUCH SUNSCREEN SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97795,Marketed,2021-01-30,02487799,COPPERTONE LOTION SUNSCREEN SPF 50 WATERBABIES,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97800,Marketed,2025-09-12,02487845,CLEAR FACE SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97804,Marketed,2019-11-01,02487926,ULTRA-RICH HYDRATION,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
97805,Marketed,2020-04-09,02487934,COPPERTONE SPRAY SUNSCREEN SPF 50 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
97806,Marketed,2025-10-22,02487942,ULTRA SHEER BODY MIST SUNSCREEN SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
97823,Marketed,2020-04-09,02488124,COPPERTONE LOTION SUNSCREEN SPF 30 GLOW,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97839,Marketed,2019-08-07,02488299,IOPE AIR CUSHION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97856,Marketed,2020-10-07,02488477,SENSITIVE SKIN SUNSCREEN CONTINUOUS SPRAY SPF 50 PLUS,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
97857,Marketed,2019-11-11,02488485,SPORT SUNSCREEN LOTION SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97876,Marketed,2020-02-27,02488663,KIDS SUNSCREEN CONTINUOUS SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
97890,Marketed,2019-11-11,02488825,KIDS SUNSCREEN STICK SPF 50+,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
97917,Marketed,2020-05-29,02489112,SUN ULTIMATE FACE CREAM / CRèME VISAGE,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
97925,Marketed,2020-02-01,02489155,OMBRELLE KIDS LOTION WET'N PROTECT,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
97966,Marketed,2020-02-19,02489589,FACE ANTI-SHINE CREAM,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98009,Marketed,2020-04-15,02490021,ULTRA FLUIDE VISAGE,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98040,Marketed,2021-02-03,02490358,COPPERTONE CLEAR BLUE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
98043,Marketed,2020-06-04,02490382,KIDS SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98045,Marketed,2021-04-14,02490404,ULTRA FLUIDE CORPS,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98050,Marketed,2020-11-09,02490455,MATTE DEFENSE SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98055,Marketed,2020-03-15,02490501,AGE PERFECT ROSY TONE DAY CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98090,Marketed,2019-11-04,02490862,SPORT SUNSCREEN CONTINUOUS SPRAY SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98103,Marketed,2020-04-02,02491001,RODAN + FIELDS ESSENTIALS FACE + BODY SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98104,Marketed,2020-01-14,02491028,SENSITIVE SKIN SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98105,Marketed,2020-02-19,02491036,SPORT SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98108,Marketed,2020-03-21,02491052,SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98116,Marketed,2020-02-15,02491141,REVITALIFT TRIPLE POWER LZR DAY LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98139,Marketed,2024-07-08,02491389,SPORT 30 PUMP SPRAY GEL SUNSCREEN ÉCRAN SOLAIRE GEL EN VAPORISATEUR,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
98155,Marketed,2019-11-01,02491567,SPORT 50 CONTINUOUS SPRAY SUNSCREEN ECRAN SOLAIRE EN VAPORISATEUR,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98178,Marketed,2020-03-10,02491761,RODAN + FIELDS UNBLEMISH INVISIBLE MATTE DEFENSE,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
98206,Marketed,2020-02-17,02492059,MOISTURE SURGE SHEERTINT HYDRATOR SPF 25,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98230,Marketed,2019-11-01,02492261,SPORT 30 CONTINUOUS SPRAY SUNSCREEN ÉCRAN SOLAIRE EN VAPORISATEUR,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98246,Marketed,2020-06-10,02492458,TOLERIANE SENSITIVE CRèME UV,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98279,Marketed,2020-01-01,02492792,OLAY SENSITIVE,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98283,Marketed,2020-09-16,02492830,RODAN + FIELDS REDEFINE TRIPLE DEFENSE LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98284,Marketed,2020-09-16,02492849,RODAN + FIELDS REDEFINE TRIPLE DEFENSE CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98294,Marketed,2019-12-15,02492962,RéNERGIE LIFT MULTI-ACTION ULTRA SPF30,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98295,Marketed,2020-03-01,02492970,SUPERDEFENSE CITY BLOCK DAILY ENERGY + FACE PROTECTOR SPF 50,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98305,Marketed,2022-05-06,02493063,SUNTHERA3 SPF 30 LIPBALM,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
98306,Marketed,2021-02-11,02493071,SUNTHERA3 SPF 30 CONTINUOUS SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98307,Marketed,2020-05-01,02493098,OLAY REGENERIST WHIP SUN PROTECTION FACTOR 40,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98308,Marketed,2021-04-16,02493101,SUNTHERA3 SPF 50+ SUN PROTECTION LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98342,Marketed,2021-05-06,02493403,SUNTHERA3 SPF 30 SUN PROTECTION LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98343,Marketed,2021-08-06,02493411,SUNTHERA3 SPF 50+ CONTINUOUS SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98344,Marketed,2021-05-01,02493438,SUNTHERA3 SPORT SPF 50+ CONTINUOUS SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98377,Marketed,2020-02-27,02493772,SUNSCREEN CONTINUOUS SPRAY SPF 30 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98412,Marketed,2020-02-27,02494094,SUNSCREEN CONTINUOUS SPRAY SPF 50 KIDS,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98413,Marketed,2020-02-27,02494108,SUNSCREEN CONTINUOUS SPRAY SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98422,Marketed,2021-03-02,02494183,SUNTHERA3 KIDS SPF 50+ CONTINUOUS SPRAY SUNSCREEN BROAD SPECTRUM UVA/UVB PROTECTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98423,Marketed,2023-05-03,02494191,SUNTHERA3 SPORT SPF 50+ SUN PROTECTION LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98424,Marketed,2021-12-10,02494205,ÉMULSION HYDRATANTE VISAGE FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
98425,Marketed,2022-01-20,02494213,SUNTHERA3 KIDS SPF 50+ SUN PROTECTION LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98446,Marketed,2020-05-15,02494450,CRèME SOLAIRE VISAGE TOUCHER SEC FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98447,Marketed,2020-05-15,02494469,LAIT SOLAIRE CORPS FPS 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98448,Marketed,2020-05-15,02494477,CRèME SOLAIRE VISAGE TOUCHER SEC FPS 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98460,Marketed,2020-02-11,02494604,FUTURIST HYDRA RESCUE MOISTURIZING MAKEUP FOND DE TEINT HYDRATANT SPF/FPS 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98465,Marketed,2020-05-15,02494655,CRèME SOLAIRE CORPS FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98476,Marketed,2020-06-01,02494787,HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN LOTION SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98477,Marketed,2020-08-26,02494795,HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN LOTION SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98480,Marketed,2020-02-27,02494825,SUNSCREEN LOTION 30 SPF/FPS SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98481,Marketed,2020-02-27,02494833,KIDS SUNSCREEN LOTION 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98492,Marketed,2024-05-09,02494949,PLAY EVERYDAY LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98493,Marketed,2020-12-15,02494965,SPF 50 FACE CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98494,Marketed,2023-01-12,02494973,SUNSCREEN LOTION 50 SPF/FPS SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98499,Marketed,2021-01-31,02495031,HAWAIIAN TROPIC ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRAY SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
98511,Marketed,2020-02-27,02495163,SUNSCREEN LOTION 30 SPF FPS,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98512,Marketed,2020-02-27,02495171,SUNSCREEN LOTION 50 SPF FPS,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98514,Marketed,2020-02-27,02495201,SUNSCREEN CONTINUOUS SPRAY SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98515,Marketed,2020-02-27,02495228,SUNSCREEN CONTINUOUS SPRAY SPF 50 SPORT,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
98540,Marketed,2023-09-30,02495481,UNSEEN SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98558,Marketed,2021-07-20,02495694,ULTRA FACIAL CREAM/CRèME SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98611,Marketed,2025-07-31,02496240,NEUTROGENA CLEAR FACE SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98618,Marketed,2022-04-22,02496291,ELTAMD SKINCARE UV CLEAR,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98644,Marketed,2025-05-29,02496585,HYDRO BOOST WATER GEL LOTION SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98664,Marketed,2025-09-05,02496798,PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98665,Marketed,2025-08-27,02496801,PROTECT + HYDRATE MOISTURIZING SUNSCREEN SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98672,Marketed,2020-12-11,02496879,ULTRA SUN PROTECTOR CREAM CRèME SOLAIRE ULTRA PROTECTION 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98678,Marketed,2020-09-01,02496909,HEALTHY GLOW ALL-IN-ONE TINTED MOISTURIZER BROAD SPECTRUM SPF 25,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98691,Marketed,2020-12-11,02497050,ULTRA SUN PROTECTOR LOTION LAIT SOLAIRE ULTRA PROTECTION 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98695,Marketed,2021-05-16,02497093,STOKODERM SUNSCREEN PURE,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
98696,Marketed,2021-03-25,02497123,LIFE BRAND SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98716,Marketed,2025-09-05,02497336,PROTECT + HYDRATE FACE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98717,Marketed,2020-10-30,02497344,INSTANT BRONZER INSTANTANé 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
98752,Marketed,2021-04-20,02497727,LIFE BRAND KIDS SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98759,Marketed,2021-03-19,02497794,LIFE BRAND SUNSCREEN LOTION SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98761,Marketed,2021-04-15,02497816,LIFE BRAND SUNSCREEN FACE LOTION SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98788,Marketed,2021-03-09,02498081,RODAN + FIELDS REVERSE BRIGHTENING DEFENSE FLUID LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
98882,Marketed,2021-03-03,02499053,LIFE BRAND SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+,5.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99028,Marketed,2021-03-11,02500612,SUNSCREEN FACE STICK / ÉCRAN SOLAIRE BâTON,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
99070,Marketed,2020-10-30,02501058,INSTANT BRONZER INSTANTANé 30 CONTINUOUS SPRAY SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99071,Marketed,2020-10-30,02501066,INSTANT BRONZER INSTANTANé 15 CONTINUOUS SPRAY SUNSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99101,Marketed,2021-04-12,02501384,CLEAR SUNSCREEN STICK 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
99103,Marketed,2020-10-13,02501406,SUNSCREEN LIP BALM,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
99165,Marketed,2020-10-30,02502054,INSTANT BRONZER INSTANTANé 30 SPRAY GEL SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
99166,Marketed,2020-10-30,02502062,INSTANT BRONZER INSTANTANé 4 SPRAY GEL SUNSCREEN,2.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
99209,Marketed,2025-05-16,02502526,ULTRA SHEER BODY MIST SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
99210,Marketed,2025-07-31,02502534,ULTRA SHEER DRY-TOUCH SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99211,Marketed,2025-07-31,02502542,ULTRA SHEER FACE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99248,Marketed,2021-04-14,02502968,ARTISTRY SKIN NUTRITION BALANCING MATTE DAY LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99249,Marketed,2021-04-16,02502976,ARTISTRY SKIN NUTRITION HYDRATING DAY LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99261,Marketed,2023-03-13,02503107,GLOWSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99426,Marketed,2021-12-10,02504871,LOTION SOLAIRE CORPS FPS 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99466,Marketed,2021-01-25,02505290,BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99467,Marketed,2021-01-25,02505304,BANANA BOAT DAILY PROTECT SUNSCREEN LOTION SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99531,Marketed,2021-01-25,02505959,BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
99532,Marketed,2021-01-25,02505967,BANANA BOAT DAILY PROTECT SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
99541,Marketed,2020-12-11,02506068,SCALP MIST,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
99683,Marketed,2022-04-08,02507439,SENSITIVE EXPERT+ FACE,5.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
99684,Marketed,2022-04-08,02507447,SENSITIVE EXPERT+ SUNSCREEN,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99705,Marketed,2021-03-10,02507692,NIVEA MEN SENSITIVE,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
99854,Marketed,2023-02-01,02509237,ULTRA LIGHT ADVANCED LOTION,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99932,Marketed,2024-07-15,02510065,COOLA CLEAR SUNSCREEN SPRAY TROPICAL COCONUT SCENT,3.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99933,Marketed,2022-04-22,02510073,ELTAMD SKINCARE UV CLEAR TINTED,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
99934,Marketed,2024-07-12,02510081,COOLA CLEAR SUNSCREEN SPRAY FRAGRANCE FREE,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99956,Marketed,2024-07-12,02510332,COOLA CLEAR SUNSCREEN SPRAY PINA COLADA SCENT,3.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
99963,Marketed,2021-09-22,02510405,ARTISTRY SKIN NUTRITION RENEWING REACTIVATION DAY CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
99964,Marketed,2021-09-22,02510413,ARTISTRY SKIN NUTRITION RENEWING REACTIVATION DAY LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100000,Marketed,2021-03-31,02510804,COOLA CLASSIC FACE SPF 50 SUNSCREEN LOTION FRAGRANCE-FREE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100001,Marketed,2021-03-31,02510812,COOLA CLASSIC FACE SPF 50 SUNSCREEN LOTION WHITE TEA SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100165,Marketed,2021-09-22,02512351,OLAY REGENERIST SPF 30 HYDRATING COLLAGEN PEPTIDE 24,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100167,Marketed,2021-09-22,02512386,OLAY REGENERIST SPF 30 HYDRATING RETINOL 24 + PEPTIDES,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100276,Marketed,2025-08-15,02513560,TOTAL EFFECTS 7 IN ONE MOISTURIZER WITH SPF BROAD SPECTRUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100283,Marketed,2021-03-24,02513641,RODAN+FIELDS REVERSE KIT,4.0,D02BA30,Combinations of protectives against uv-radiation,"Kit,Lotion",Topical,,,,,,,,,,,,,,,,
100284,Marketed,2021-03-24,02513668,RODAN + FIELDS UNBLEMISH KIT,5.0,D02BA30,Combinations of protectives against uv-radiation,"Kit,Gel,Lotion",Topical,,,,,,,,,,,,,,,,
100299,Marketed,2025-08-08,02513765,TOTAL EFFECTS 7 IN ONE MOISTURIZER WITH SPF BROAD SPECTRUM SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100303,Marketed,2021-03-24,02513838,RODAN+FIELDS REDEFINE,3.0,D02BA30,Combinations of protectives against uv-radiation,"Cream,Kit",Topical,,,,,,,,,,,,,,,,
100325,Marketed,2022-07-28,02514079,COLOR CONTROL OIL-FREE MOISTURIZER BROAD SPECTRUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
100356,Marketed,2025-06-04,02514419,7 IN ONE TONE CORRECTING CC CREAM WITH SPF ,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
100520,Marketed,2022-04-13,02515806,ULTRA-LIGHT UV LOTION,6.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100574,Marketed,2022-03-14,02516403,PHOTO REGUL CREAM / CRèME UNIFYING PROTECTIVE FACE CARE / SOIN PROTECTEUR VISAGE UNIFICATEUR SPF 25 / FPS 25,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
100649,Marketed,2022-02-10,02517159,AQUAGEL DEFENSE 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
100653,Marketed,2021-12-11,02517191,FACE MIST,4.0,D02BA30,Combinations of protectives against uv-radiation,Solution,Topical,,,,,,,,,,,,,,,,
100737,Marketed,2022-04-13,02518031,FPS 60 LOTION UV ULTRA-LéGèRE,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100759,Marketed,2022-05-09,02518279,SUPER-C SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100770,Marketed,2025-05-16,02518384,ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
100877,Marketed,2023-01-01,02519526,HAWAIIAN SUNSCREEN SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
100880,Marketed,2022-04-08,02519550,URBAN ENVIRONMENT OIL-FREE,4.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
100922,Marketed,2022-12-12,02519992,LIFT & FIRM Y-ZONE CRèME JOUR HAUTE FERMETé FPS 20,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101061,Marketed,2022-03-21,02521415,COOLA DAILY PROTECTION SPF 50 REFRESHING WATER CREAM SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101062,Marketed,2024-07-19,02521423,COOLA HYDRATING SUNSCREEN LOTION PINA COLADA SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101081,Marketed,2022-07-21,02521636,URBAN ENVIRONMENT FRESH - MOISTURE,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101084,Marketed,2022-03-21,02521660,COOLA CLASSIC FACE SPF 30 SUNSCREEN LOTION CUCUMBER SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101115,Marketed,2024-07-19,02521989,COOLA CLEAR SUNSCREEN SPRAY GUAVA MANGO SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,"Spray, bag-on-valve",Topical,,,,,,,,,,,,,,,,
101118,Marketed,2024-07-19,02522012,COOLA HYDRATING SUNSCREEN LOTION GUAVA MANGO SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101152,Marketed,2022-03-21,02522381,COOLA DAILY PROTECTION SPF 30 SUN SILK DROPS SUNSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Solution,Topical,,,,,,,,,,,,,,,,
101180,Marketed,2024-02-13,02522691,OLAY HYALURONIC HYDRATING FACIAL MOISTURIZER WITH SPF,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101202,Marketed,2022-06-02,02522942,AQUA-FLUID,5.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
101226,Marketed,2023-01-15,02523183,SUPER FLUID UV DEFENSE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101233,Marketed,2023-02-09,02523213,PREMIUM SUNSCREEN LOTION WITH INSTANT BRONZER BROAD SPECTRUM SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101235,Marketed,2022-04-25,02523248,COOLA LIPLUX ORIGINAL,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
101257,Marketed,2022-04-15,02523477,COOLA DEW GOOD ILLUMINATING SERUM SUNSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101258,Marketed,2022-03-21,02523485,COOLA CLASSIC SUNSCREEN STICK SPF 30 TROPICAL COCONUT SCENT,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
101357,Marketed,2023-02-09,02524554,GLOW 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101388,Marketed,2023-03-10,02524872,CLé DE PEAU BEAUTé SOIN PROTECTEUR POUR LES LèVRES PROTECTIVE LIP TREATMENT 25,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
101405,Marketed,2023-04-15,02525062,FACE DAILY UV ANTI-AGING MOISTURIZER,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101410,Marketed,2023-04-15,02525089,FACE DAILY UV ANTI-DRY MOISTURIZER,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101422,Marketed,2023-02-13,02525216,CRèME UV PROTECTRICE PROTECTIVE UV CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101442,Marketed,2023-01-16,02525402,BLUE LIZARD AUSTRALIAN SUNSCREEN 50 SPF KIDS,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101444,Marketed,2023-01-16,02525429,BLUE LIZARD AUSTRALIAN SUNSCREEN 50 SPF SPORT,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101464,Marketed,2025-03-03,02525631,MOISTURIZING SUNSCREEN LOTION FOR FACE AND BODY,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101467,Marketed,2025-07-10,02525720,KIDS MOISTURIZING SUNSCREEN LOTION FOR FACE AND BODY,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101511,Marketed,2025-09-11,02525984,AVEENO POSITIVELY RADIANT DAILY MOISTURIZER SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101512,Marketed,2025-09-10,02525992,AVEENO POSITIVELY RADIANT DAILY MOISTURIZER SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101534,Marketed,2024-01-24,02526239,UV+AGE DAILY,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101569,Marketed,2023-01-10,02526611,BANANA BOAT SIMPLY PROTECT KIDS KIDS SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101571,Marketed,2023-01-10,02526646,BANANA BOAT SIMPLY PROTECT BABY BABY SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101589,Marketed,2024-01-30,02526859,EUCERIN COMPLETE HYDRATION LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101590,Marketed,2024-01-30,02526832,EUCERIN AGE DEFENSE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101591,Marketed,2024-04-01,02526840,EUCERIN ANTI-SHINE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101592,Marketed,2024-01-30,02526867,EUCERIN COMPLETE HYDRATION SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101632,Marketed,2023-02-20,02527251,COPPERTONE LOTION SUNSCREEN SPF 50 COMPLETE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101633,Marketed,2023-02-20,02527278,COPPERTONE LOTION SUNSCREEN SPF 30 COMPLETE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101635,Marketed,2023-02-20,02527294,COPPERTONE SPRAY SUNSCREEN SPF 30 COMPLETE,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101637,Marketed,2023-02-20,02527316,COPPERTONE SPRAY SUNSCREEN SPF 50 COMPLETE,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101661,Marketed,2024-05-08,02527545,ULTRA-HYDRATING UV LOTION,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101663,Marketed,2023-01-10,02527561,BANANA BOAT DRY BALANCE CLEAR SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101665,Marketed,2023-01-10,02527596,BANANA BOAT SIMPLY PROTECT SPORT SPORT SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
101694,Marketed,2024-04-10,02527766,ANTHELIOS DERMO-KIDS 50+,7.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101699,Marketed,2023-05-01,02527812,ANTHELIOS AGE CORRECT,6.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101708,Marketed,2025-03-01,02527898,FACIAL MOISTURIZING LOTION SPF 30,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101729,Marketed,2023-04-06,02528029,ADAPTASUN SEA AND TROPICS PROTECTIVE BODY LOTION SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101832,Marketed,2023-09-04,02529130,FLUID SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101850,Marketed,2023-03-08,02529289,URBAN ENVIRONMENT VITA-CLEAR,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101857,Marketed,2023-03-24,02529351,YOUR SKIN BUT BETTER CC+,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
101858,Marketed,2025-08-22,02529378,INVISIBLE DAILY DEFENSE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101859,Marketed,2025-09-17,02529386,INVISIBLE DAILY DEFENSE BODY MIST SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
101877,Marketed,2023-01-15,02529521,DAILY DOSE HYDRATING-CERAMIDE BOOST,4.0,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,
101901,Marketed,2024-10-10,02529777,HYDRATING LIP PROTECTANT STICK SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
101940,Marketed,2023-04-06,02530201,ISA KNOX ANEW SOLAIRE 50 SPF / FPS ACTIVE FACE & BODY,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101941,Marketed,2024-06-13,02530228,ISA KNOX ANEW SOLAIRE 50 SPF / FPS EVERYDAY FACE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
101976,Marketed,2023-05-01,02530597,EVEN BETTER BRIGHTENING MOISTURIZER,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102027,Marketed,2023-07-28,02531119,VITAMIN ENRICHED SKIN TINT SPF 15,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102074,Marketed,2023-05-15,02531623,UNSEEN SUNSCREEN BODY,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102088,Marketed,2023-05-15,02531771,LIP SCREEN SHINE,4.0,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,
102152,Marketed,2023-05-01,02532492,MOISTURE SURGE SPF 28 SHEER HYDRATOR,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102153,Marketed,2023-04-24,02532506,SKIN FIRMING RETINOL MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102227,Marketed,2023-08-16,02533278,DAYTIME DEFENDER SUNSCREEN BROAD SPECTRUM SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102230,Marketed,2024-01-19,02533308,FUTURIST SKINTINT SERUM,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102240,Marketed,2023-04-14,02533405,PREMIUM BEAUTY BALM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102241,Marketed,2023-11-01,02533413,HAWAIIAN TROPIC SUNSCREEN OIL SPRAY,2.0,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,
102242,Marketed,2023-04-14,02533421,BB PREMIUM BEAUTY BALM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102407,Marketed,2024-05-26,02535203,CLEAR SUNSCREEN FACE STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
102461,Marketed,2026-01-05,02535785,DEGIL SUN 30 SPF FPS,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102478,Marketed,2023-12-01,02535955,SHEER TOUCH LEAVES SKIN RADIANT SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102479,Marketed,2023-12-01,02535963,SHEER TOUCH LEAVES SKIN RADIANT SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102480,Marketed,2023-12-01,02535971,SHEER TOUCH LEAVES SKIN RADIANT SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102565,Marketed,2024-02-14,02536927,DAILY SHEER BROAD-SPECTRUM SUNSCREEN SPF 50 WATER/SWEAT RESISTANT (40 MINUTES),4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102587,Marketed,2024-04-01,02537141,EVERY. SINGLE. FACE. WATERY LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102605,Marketed,2023-10-11,02537338,KIDS 50 CLEAR SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102625,Marketed,2023-12-01,02537540,BANANA BOAT KIDS SUNSCREEN LOTION ROLL-ON,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102626,Marketed,2023-12-01,02537559,BANANA BOAT KIDS SUNSCREEN SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
102660,Marketed,2024-05-15,02537826,COOLA CLASSIC FACE MIST SUNSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
102677,Marketed,2023-12-01,02538016,BANANA BOAT DAILY PROTECT FACE SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102697,Marketed,2024-06-19,02538229,DYNAMIC SKIN RECOVERY,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102703,Marketed,2024-05-09,02538296,GLOW SCREEN DAWN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102704,Marketed,2024-04-04,02538318,GLOW SCREEN GOLDEN HOUR,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102705,Marketed,2024-04-01,02538326,GLOW SCREEN SUNSET,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102720,Marketed,2024-05-01,02538482,WEIGHTLESS SKIN FOUNDATION SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102723,Marketed,2025-09-10,02538512,KIDS SUNSCREEN STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
102724,Marketed,2025-08-19,02538520,INVISIBLE DAILY DEFENSE FACE SERUM SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102727,Marketed,2024-01-01,02538547,BIORé UV AQUA RICH WEIGHTLESS MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102729,Marketed,2024-01-08,02538571,BIORé UV AQUA RICH WEIGHTLESS MOISTURIZER HYDRATANT LéGER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102730,Marketed,2024-07-01,02538598,REVITALIZING SUPREME+ YOUTH POWER CREME,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102752,Marketed,2023-12-01,02538830,SILK HYDRATION WEIGHTLESS SUNSCREEN SPRAY SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
102753,Marketed,2023-12-01,02538849,SILK HYDRATION WEIGHTLESS SUNSCREEN SPRAY SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
102760,Marketed,2025-06-04,02538938,ANTHELIOS 50+,7.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102762,Marketed,2023-12-01,02538946,SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION SPF 50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102766,Marketed,2024-07-02,02538997,YOUTH-EXTENDING DAILY HYDRATING FLUID,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102775,Marketed,2023-12-01,02539098,SILK HYDRATION FACE SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102777,Marketed,2024-04-19,02539128,ULTRA SUN PROTECTOR SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
102783,Marketed,2024-06-12,02539187,ULTRA SUN PROTECTOR LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102787,Marketed,2023-12-01,02539225,SILK HYDRATION WEIGHTLESS SUNSCREEN LOTION SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102797,Marketed,2023-12-01,02539349,SILK HYDRATION SERUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102798,Marketed,2023-12-01,02539330,SILK HYDRATION FACE SERUM SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102815,Marketed,2024-07-01,02539381,SUN SOLEIL,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
102816,Marketed,2025-01-01,02539403,SOOTHING CARE SPF 15,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
102832,Marketed,2024-04-01,02539578,GLOW STICK,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
102863,Marketed,2023-08-14,02539918,BROAD SPECTRUM SPF45,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102864,Marketed,2023-08-14,02539926,UNIVERSAL TINTED MOISTURIZER SPF46,2.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102880,Marketed,2024-02-01,02540088,SMART SPF 30 WRINKLE CORRECTING CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102887,Marketed,2024-07-30,02540169,REVITALIFT ANTI-WRINKLE + FIRMING,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102922,Marketed,2024-04-05,02540525,SUPREME HYDRATING FACIAL SCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
102923,Marketed,2024-04-16,02540533,EXTREME HYDRATING BODY + HAND SCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102930,Marketed,2023-10-10,02540614,INVISIBLE SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
102987,Marketed,2023-12-01,02541211,BANANA BOAT KIDS SUNSCREEN LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
102990,Marketed,2024-12-28,02541254,BRIGHT REVEAL SPF50+,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103010,Marketed,2025-08-26,02541459,COMPLETE + FACIAL MOISTURIZER WITH SPF BROAD SPECTRUM SPF 40,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103067,Marketed,2025-02-10,02542072,ÉMULSION UV PROTECTRICE POUR LE CORPS PROTECTIVE UV EMULSION FOR BODY,4.0,D02BA30,Combinations of protectives against uv-radiation,Emulsion,Topical,,,,,,,,,,,,,,,,
103097,Marketed,2024-04-30,02542404,WATERMELON GLOW DEW BALM,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103105,Marketed,2024-03-11,02542498,FIVE STAR LIP PROTECTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103132,Marketed,2024-09-17,02542781,UNSEEN SUNSCREEN LIP PROTECTOR,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103145,Marketed,2024-03-25,02542927,CC+ NATURAL MATTE,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103151,Marketed,2026-01-10,02543001,CABANACLEAR WATER GEL LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103164,Marketed,2024-08-01,02543141,NOURISHING DAY CREAM CRèME DE JOUR NOURRISSANTE SPF 15 FPS 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103169,Marketed,2024-04-01,02543206,BEYOND SCREEN UV SERUM,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103181,Marketed,2024-08-01,02543346,EVERY SUN DAY SUN FLUID,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103183,Marketed,2024-04-10,02543362,HELLO SUNSHINE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103191,Marketed,2026-01-05,02543443,DEGIL SUN 50 SPF FPS,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103200,Marketed,2024-08-01,02543540,REFRESHING DAY CREAM CRèME DE JOUR RAFRAîCHISSANTE SPF 15 FPS 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103226,Marketed,2024-06-01,02543834,DAILYSCREEN HYDRATING DAILY CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103232,Marketed,2024-09-10,02543893,TIMEWISE REPAIR VOLU-FIRM DAY CREAM SUNSCREEN BROAD SPECTRUM SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103242,Marketed,2024-06-04,02544008,FAVE FLUID SPF50+ ULTRALIGHT SCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103320,Marketed,2024-05-01,02544636,DAYWEAR MULTI-PROTECTION 24H-MOISTURE CREME,2.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103352,Marketed,2024-05-01,02544881,RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103389,Marketed,2025-05-09,02545098,HUEGUARD INVISIBLE SUNSCREEN STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103410,Marketed,2024-07-25,02545322,SMART TONE BROAD-SPECTRUM SUNSCREEN SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103417,Marketed,2024-07-07,02545403,LANEIGE HYDRO UV DEFENSE EX,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103419,Marketed,2024-06-04,02545438,SHEEN HYDRATING LIP BALM SPF 50,3.0,D02BA30,Combinations of protectives against uv-radiation,Ointment,Topical,,,,,,,,,,,,,,,,
103431,Marketed,2024-08-12,02545551,MULTI-VITA CLEAR COAT BROAD SPECTRUM SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103456,Marketed,2024-05-07,02545829,RODAN + FIELDS PLUMPING LIP OIL,2.0,D02BA30,Combinations of protectives against uv-radiation,Oil,Topical,,,,,,,,,,,,,,,,
103519,Marketed,2025-02-26,02546507,OLAY GLOW + PROTECT SPF STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103521,Marketed,2025-09-11,02546523,ULTRA GENTLE DAILY FACIAL MOISTURIZER SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103548,Marketed,2026-01-27,02546809,COLLAGEN PEPTIDE SPF MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103565,Marketed,2024-08-05,02546981,QUEEN SCREEN LUMINISING SKINSCREEN,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103566,Marketed,2024-11-07,02547007,FOUNDATION PRIMER SUNSCREEN BROAD SPECTRUM SPF 15,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
103596,Marketed,2025-12-16,02547325,FUTURE SOLUTION LX UNIVERSAL DEFENSE,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103645,Marketed,2025-03-11,02547503,PROTEC(TINT),3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103649,Marketed,2025-06-03,02547554,COOLA DAILY PROTECTION REFRESHING WATER PLUMPING GEL SERUM,4.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
103713,Marketed,2025-01-01,02548240,ISLAND SPORT FACE SWEAT RESISTANT SUNSCREEN SPRITZ SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103715,Marketed,2025-04-02,02548267,UNSEEN SUNSCREEN STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
103719,Marketed,2025-01-01,02548291,ISLAND SPORT SWEAT RESISTANT SUNSCREEN SPRITZ SPF 30,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103720,Marketed,2024-08-27,02548313,BELIF SPF/FPS 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
103769,Marketed,2025-09-11,02548860,SPORT ACTIVE DEFENSE SUNSCREEN SPF 70,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
103777,Marketed,2025-09-11,02548941,KIDS SUNSCREEN SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Aerosol,Topical,,,,,,,,,,,,,,,,
103804,Marketed,2025-11-03,02549174,COOLA HYDRATING SUNSCREEN LOTION TROPICAL COCONUT SCENT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103805,Marketed,2025-11-03,02549182,COOLA HYDRATING SUNSCREEN LOTION FRAGRANCE FREE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103832,Marketed,2025-05-15,02549484,C5 SHEER MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103875,Marketed,2025-02-25,02549948,SUNSCREEN BROAD SPECTRUM SPF 50,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103876,Marketed,2025-07-10,02549956,HYDRATING SUNSCREEN MILK,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103927,Marketed,2025-08-01,02550466,PRISMA PROTECT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103940,Marketed,2025-01-08,02550601,ROC DEEP WRINKLE DAILY MOISTURIZER SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
103965,Marketed,2024-12-06,02550873,BANANA BOAT ULTRA SPORT SMARTMIST SUNSCREEN SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
103968,Marketed,2025-03-06,02550911,COOLA DEW GOOD ILLUMINATING BODY MELT SUNSCREEN LOTION,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104011,Marketed,2025-04-03,02551381,ULTRA PROTECTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
104022,Marketed,2025-02-03,02551489,UV BRIGHTENING DAILY CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104040,Marketed,2025-04-09,02551675,CLEAR DAILY SOOTHING UV DEFENSE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104064,Marketed,2025-04-28,02551942,WATERMELON GLOW DEWY DEFENSE,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104080,Marketed,2025-04-09,02552116,SUNTOUCHABLE WHOA GLOW SPF 30 SUNSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104097,Marketed,2025-09-11,02552299,SPORT FACE ACTIVE DEFENSE,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104102,Marketed,2025-06-09,02552345,PREEN SCREEN REAPPLICATION MIST SKINSCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
104106,Marketed,2025-01-31,02552396,YOUR SKIN BUT BETTER CC+ NUDE GLOW,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104161,Marketed,2025-03-03,02552647,LAIT FAMILLE - VISAGE & CORPS,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104163,Marketed,2025-03-03,02552663,LAIT VISAGE & CORPS,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104166,Marketed,2025-04-30,02552701,SUPER BRIGHTENING SPF 50 ACTIVE MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104176,Marketed,2025-03-10,02552795,COPPERTONE SUNSCREEN LOTION SPORT FACE SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104177,Marketed,2025-04-30,02552809,SUPER WRINKLE-FIGHTING SPF 50 ACTIVE MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104188,Marketed,2025-04-28,02552922,SPRAY VISAGE & CORPS,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104210,Marketed,2025-06-11,02553147,LIGHT DAY SUNSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104227,Marketed,2025-06-24,02553325,EVERY SUN DAY ULTRA-SHEER PRIMING SUNSCREEN STICK,4.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
104228,Marketed,2025-05-21,02553333,BROAD SPECTRUM SPF 30 HOLY HYDRATION! FACE CREAM,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104243,Marketed,2025-04-30,02553503,SUPER MATTIFYING OIL & PORE CONTROL SPF 50 ACTIVE MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104263,Marketed,2025-07-01,02553732,DRAMATICALLY DIFFERENT MOISTURIZING LOTION+ SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104292,Marketed,2026-01-28,02554038,UNSEEN SUNSCREEN SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104298,Marketed,2025-05-01,02554100,WATER DRENCH SHEER TINT,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104354,Marketed,2025-05-29,02554712,SUPER CRèME WITH SPF BROAD SPECTRUM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104376,Marketed,2025-07-14,02554941,ULTRA SUN PROTECTOR CREAM,3.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104394,Marketed,2025-07-03,02555158,BIORé UV AQUA RICH GLOWY MOISTURIZER,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104418,Marketed,2025-05-30,02555417,AVON BEYOND GLOW 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
104419,Marketed,2025-05-30,02555425,AVON BEYOND GLOW 50,5.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104440,Marketed,2025-11-14,02555662,AUSTRALIAN GOLD ULTIMATE HYDRATION 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
104500,Marketed,2025-05-15,02556308,OLAY TOTAL EFFECTS ADVANCED,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106008,Marketed,2025-08-25,02556685,PEPPERMINT,2.0,D02BA30,Combinations of protectives against uv-radiation,Stick,Topical,,,,,,,,,,,,,,,,
106072,Marketed,2025-12-30,02557398,FACE SPF 50+ SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106074,Marketed,2025-09-17,02557428,SUPRA SCREEN,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106079,Marketed,2026-01-12,02557479,FACIAL MOISTURIZING LOTION SPF 50,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106088,Marketed,2025-12-30,02557576,SPF 50+ SUNSCREEN LOTION,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106136,Marketed,2026-01-14,02558076,ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 100,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106186,Marketed,2025-09-18,02558629,YOUTHSCREEN,3.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106288,Marketed,2025-12-01,02559757,BANANA BOAT KIDS SMARTMIST SUNSCREEN SPRAY,4.0,D02BA30,Combinations of protectives against uv-radiation,Spray,Topical,,,,,,,,,,,,,,,,
106310,Marketed,2025-12-08,02560003,MULTI-DEFENSE REPLENISHING LOTION SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Lotion,Topical,,,,,,,,,,,,,,,,
106314,Marketed,2025-12-09,02560054,MULTI-DEFENSE REPLENISHING CREAM SPF 45,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
106419,Marketed,2026-01-05,02561204,AGE CONTROL SUPREME SUBLIME ADVANCED CRèME DE JOUR FPS 30 DAY CREAM SPF 30,4.0,D02BA30,Combinations of protectives against uv-radiation,Cream,Topical,,,,,,,,,,,,,,,,
106531,Marketed,2026-01-02,02562421,ULTRA HYDRATING SUNSCREEN,6.0,D02BA30,Combinations of protectives against uv-radiation,Gel,Topical,,,,,,,,,,,,,,,,
15704,Marketed,2012-06-19,02043440,PREMARIN VAGINAL CREAM,1.0,G03CA57,Conjugated estrogens,Cream,Vaginal,02043440,PREMARIN VAGINAL CREAM (conjugated estrogens 0.625 mg per g vaginal cream) PFIZER CANADA ULC,Active,9000511,conjugated estrogens 0.625 mg per g vaginal cream,8000021,conjugated estrogens,16857009,Vaginal,385165005,Vaginal cream,,,1.0,,
16736,Marketed,2014-01-29,02043386,PREMARIN INTRAVENOUS,1.0,G03CA57,Conjugated estrogens,Powder for solution,"Intramuscular,Intravenous",02043386,PREMARIN INTRAVENOUS (conjugated estrogens 25 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9000512,conjugated estrogens 25 mg per vial powder for solution for injection,8000021,conjugated estrogens,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
89930,Marketed,2014-10-03,02414678,PREMARIN,1.0,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414678,PREMARIN (conjugated estrogens 0.3 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001431,conjugated estrogens 0.3 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
89931,Marketed,2014-10-03,02414686,PREMARIN,1.0,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414686,PREMARIN (conjugated estrogens 0.625 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001432,conjugated estrogens 0.625 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
89932,Marketed,2014-10-03,02414694,PREMARIN,1.0,G03CA57,Conjugated estrogens,Tablet (extended-release),Oral,02414694,PREMARIN (conjugated estrogens 1.25 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001433,conjugated estrogens 1.25 mg prolonged-release oral tablet,8000021,conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
91723,Marketed,2023-06-09,02432854,DUAVIVE,2.0,G03CC07,Conjugated estrogens and bazedoxifene,Tablet (immediate and extended release),Oral,02432854,DUAVIVE (bazedoxifene (bazedoxifene acetate) 20 mg and conjugated estrogens 0.45 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9015292,bazedoxifene (bazedoxifene acetate) 20 mg and conjugated estrogens 0.45 mg prolonged-release oral tablet,8001889,bazedoxifene and conjugated estrogens,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
90012,Marketed,2018-04-20,02415534,DUREZOL,1.0,S01BA,"Corticosteroids, plain",Emulsion,Ophthalmic,02415534,DUREZOL (difluprednate 0.05 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012791,difluprednate 0.05 % ophthalmic drops,8001452,difluprednate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
1802,Marketed,2019-06-17,00280437,CORTISONE ACETATE,1.0,H02AB10,Cortisone,Tablet,Oral,00280437,"CORTISONE ACETATE (cortisone acetate 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001700,cortisone acetate 25 mg oral tablet,8001446,cortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103049,Marketed,2024-09-13,02541882,COUGH & CHEST CONGESTION REGULAR STRENGTH,2.0,R05FB02,Cough suppressants and expectorants,Syrup,Oral,02541882,COUGH & CHEST CONGESTION REGULAR STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) CRLS,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
103050,Marketed,2024-12-20,02541890,COUGH & CHEST CONGESTION EXTRA STRENGTH,2.0,R05FB02,Cough suppressants and expectorants,Syrup,Oral,02541890,COUGH & CHEST CONGESTION EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
102992,Marketed,2024-09-17,02541270,SPIKEVAX,1.0,J07BN01,"Covid-19, rna-based vaccine",Dispersion,Intramuscular,02541270,"SPIKEVAX (SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 0.1 mg per mL dispersion for injection 2.5 mL vial) MODERNA BIOPHARMA CANADA CORPORATION",Active,9015112,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 0.1 mg per mL dispersion for injection 2.5 mL vial",8002519,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA",738984000,Parenteral,1230185002,Dispersion,733026001,Vial (unit of presentation),,,
103044,Marketed,2024-09-30,02541823,COMIRNATY,1.0,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701144,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 0.3 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015118,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 0.3 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
103044,Marketed,2024-09-30,02541823,COMIRNATY,1.0,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701145,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 1.8 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015119,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection 1.8 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
103046,Marketed,2025-09-03,02541858,COMIRNATY,1.0,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701146,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 0.3 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015116,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 0.3 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
103046,Marketed,2025-09-03,02541858,COMIRNATY,1.0,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,77701147,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 1.8 mL vial) BIONTECH MANUFACTURING GMBH",Active,9015117,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 10 mcg per 0.3 mL suspension for injection 1.8 mL vial",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
104073,Marketed,2025-09-03,02552035,COMIRNATY,1.0,J07BN01,"Covid-19, rna-based vaccine",Suspension,Intramuscular,02552035,"COMIRNATY (SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection syringe) BIONTECH MANUFACTURING GMBH",Active,9015270,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker 30 mcg per 0.3 mL suspension for injection syringe",8002518,"SARSCoV2 S-protein mRNA, 5'[m27,3'-oGppp(m12'-O)ApG], 3'polyA+linker",738984000,Injection,385220007,Suspension for injection,733020007,Syringe,,,
106107,Marketed,2025-08-25,02557770,SPIKEVAX,1.0,J07BN01,"Covid-19, rna-based vaccine",Dispersion,Intramuscular,02557770,"SPIKEVAX (SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 50 mcg per 0.5 mL dispersion for injection syringe) MODERNA BIOPHARMA CANADA CORPORATION",Active,9015258,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA 50 mcg per 0.5 mL dispersion for injection syringe",8002519,"SARSCoV2 S-protein mRNA, 5'(m7G-5'-ppp-5'-Gm), 3'polyA",738984000,Injection,1230185002,Dispersion for injection,733020007,Syringe,,,
96774,Marketed,2018-08-29,02476991,EUCRISA,1.0,D11AH06,Crisaborole,Ointment,Topical,02476991,EUCRISA (crisaborole 2 % cutaneous ointment) PFIZER CANADA ULC,Active,9013673,crisaborole 2 % cutaneous ointment,8002186,crisaborole,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
86999,Marketed,2012-05-10,02384256,XALKORI,1.0,L01ED01,Crizotinib,Capsule,Oral,02384256,XALKORI (crizotinib 200 mg oral capsule) PFIZER CANADA ULC,Active,9005038,crizotinib 200 mg oral capsule,8001620,crizotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87000,Marketed,2012-05-10,02384264,XALKORI,1.0,L01ED01,Crizotinib,Capsule,Oral,02384264,XALKORI (crizotinib 250 mg oral capsule) PFIZER CANADA ULC,Active,9005039,crizotinib 250 mg oral capsule,8001620,crizotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
4114,Marketed,2025-03-05,00500895,NALCROM,1.0,A07EB01,Cromoglicic acid,Capsule,Oral,00500895,NALCROM (cromolyn sodium 100 mg oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9001907,cromolyn sodium 100 mg oral capsule,8001077,cromolyn,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13857,Marketed,2012-08-21,02009277,CROMOLYN EYE DROPS,1.0,S01GX01,Cromoglicic acid,Solution,Ophthalmic,02009277,CROMOLYN EYE DROPS (cromolyn sodium 2 % ophthalmic drops) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002548,cromolyn sodium 2 % ophthalmic drops,8001077,cromolyn,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
104492,Marketed,2025-11-10,02558262,PIASKY,1.0,L04AJ07,Crovalimab,Solution,"Subcutaneous,Intravenous",02558262,PIASKY (crovalimab 340 mg per 2 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9015276,crovalimab 340 mg per 2 mL solution for injection vial,8002559,crovalimab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
4432,Marketed,2005-07-20,00521515,VITAMIN B12,1.0,B03BA01,Cyanocobalamin,Solution,"Intramuscular,Subcutaneous",77700959,VITAMIN B12 (cyanocobalamin 30000 mcg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013677,cyanocobalamin 30000 mcg per 30 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
4432,Marketed,2005-07-20,00521515,VITAMIN B12,1.0,B03BA01,Cyanocobalamin,Solution,"Intramuscular,Subcutaneous",77700960,VITAMIN B12 (cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013675,cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
4432,Marketed,2005-07-20,00521515,VITAMIN B12,1.0,B03BA01,Cyanocobalamin,Solution,"Intramuscular,Subcutaneous",77700961,VITAMIN B12 (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13324,Marketed,2019-02-14,01987003,CYANOCOBALAMIN INJECTION USP,1.0,B03BA01,Cyanocobalamin,Solution,"Intramuscular,Subcutaneous",77700964,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) STERIMAX INC,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13324,Marketed,2019-02-14,01987003,CYANOCOBALAMIN INJECTION USP,1.0,B03BA01,Cyanocobalamin,Solution,"Intramuscular,Subcutaneous",77700965,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 30000 mcg per 30 mL solution for injection vial) STERIMAX INC,Active,9013677,cyanocobalamin 30000 mcg per 30 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95136,Marketed,2022-04-20,02463393,CYANOCOBALAMIN INJECTION USP,1.0,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",02463393,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013675,cyanocobalamin 1000 mcg per 1 mL solution for injection ampoule,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
95368,Marketed,2023-03-24,02465507,CYANOCOBALAMIN INJECTION USP,1.0,B03BA01,Cyanocobalamin,Solution,"Subcutaneous,Intramuscular",02465507,CYANOCOBALAMIN INJECTION USP (cyanocobalamin 10000 mcg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013676,cyanocobalamin 10000 mcg per 10 mL solution for injection vial,8002187,cyanocobalamin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
15912,Marketed,2016-12-22,02080052,TEVA-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02080052,TEVA-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18806,Marketed,2021-06-18,02177145,APO-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02177145,APO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19827,Marketed,1996-12-31,02212048,PMS-CYCLOBENZAPRINE - TAB 10MG,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02212048,PMS-CYCLOBENZAPRINE - TAB 10MG (cyclobenzaprine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43292,Marketed,2025-05-01,02220644,PRO-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02220644,PRO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) PRO DOC LIMITEE,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65753,Marketed,2018-10-05,02242079,RIVA-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02242079,RIVA-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77249,Marketed,2016-08-24,02287064,CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02287064,CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83419,Marketed,2011-06-15,02348853,AURO-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02348853,AURO-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84222,Marketed,2019-01-02,02357127,JAMP-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02357127,JAMP-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90926,Marketed,2014-10-01,02424584,CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02424584,CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97566,Marketed,2020-12-22,02485419,AG-CYCLOBENZAPRINE,1.0,M03BX08,Cyclobenzaprine,Tablet,Oral,02485419,AG-CYCLOBENZAPRINE (cyclobenzaprine hydrochloride 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000513,cyclobenzaprine hydrochloride 10 mg oral tablet,8000196,cyclobenzaprine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1530,Marketed,2018-12-04,00252506,CYCLOGYL,1.0,S01FA04,Cyclopentolate,Drops,Ophthalmic,00252506,CYCLOGYL (cyclopentolate hydrochloride 1 % ophthalmic drops) ALCON CANADA INC,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
5997,Marketed,2021-05-11,00626627,ODAN-CYCLOPENTOLATE,1.0,S01FA04,Cyclopentolate,Solution,Ophthalmic,00626627,ODAN-CYCLOPENTOLATE (cyclopentolate hydrochloride 1 % ophthalmic drops) ODAN LABORATORIES LTD,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18742,Marketed,2023-01-18,02148382,MINIMS CYCLOPENTOLATE HYDROCHLORIDE,1.0,S01FA04,Cyclopentolate,Solution,Ophthalmic,02148382,MINIMS CYCLOPENTOLATE HYDROCHLORIDE (cyclopentolate hydrochloride 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001684,cyclopentolate hydrochloride 1 % ophthalmic drops,8001622,cyclopentolate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
65460,Marketed,2003-10-03,02241795,PROCYTOX TAB 25MG,1.0,L01AA01,Cyclophosphamide,Tablet,Oral,02241795,PROCYTOX TAB 25MG (cyclophosphamide 25 mg oral tablet) BAXTER CORPORATION,Active,9003518,cyclophosphamide 25 mg oral tablet,8001736,cyclophosphamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65461,Marketed,2003-09-09,02241796,PROCYTOX TAB 50MG,1.0,L01AA01,Cyclophosphamide,Tablet,Oral,02241796,PROCYTOX TAB 50MG (cyclophosphamide 50 mg oral tablet) BAXTER CORPORATION,Active,9003514,cyclophosphamide 50 mg oral tablet,8001736,cyclophosphamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65462,Marketed,2003-08-11,02241797,PROCYTOX,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241797,PROCYTOX (cyclophosphamide 200 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003542,cyclophosphamide 200 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
65463,Marketed,2003-07-28,02241798,PROCYTOX,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241798,PROCYTOX (cyclophosphamide 500 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003530,cyclophosphamide 500 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
65464,Marketed,2003-11-18,02241799,PROCYTOX,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241799,PROCYTOX (cyclophosphamide 1000 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
65465,Marketed,2003-11-03,02241800,PROCYTOX,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02241800,PROCYTOX (cyclophosphamide 2000 mg per vial powder for solution for injection) BAXTER CORPORATION,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103541,Marketed,2025-06-06,02546736,CYCLOPHOSPHAMIDE FOR INJECTION USP,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02546736,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 1000 mg per vial powder for solution for injection) ANDONE PHARMACEUTICAL INC,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103542,Marketed,2025-06-06,02546744,CYCLOPHOSPHAMIDE FOR INJECTION USP,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02546744,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 2000 mg per vial powder for solution for injection) ANDONE PHARMACEUTICAL INC,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103661,Marketed,2024-09-27,02547686,CYCLOPHOSPHAMIDE FOR INJECTION USP,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02547686,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 1000 mg per vial powder for solution for injection) STERIMAX INC,Active,9003840,cyclophosphamide 1000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103662,Marketed,2024-09-27,02547694,CYCLOPHOSPHAMIDE FOR INJECTION USP,1.0,L01AA01,Cyclophosphamide,Powder for solution,Intravenous,02547694,CYCLOPHOSPHAMIDE FOR INJECTION USP (cyclophosphamide 2000 mg per vial powder for solution for injection) STERIMAX INC,Active,9003836,cyclophosphamide 2000 mg per vial powder for solution for injection,8001736,cyclophosphamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
81790,Marketed,2021-04-15,02332248,JAMP-CYPROHEPTADINE,1.0,R06AX02,Cyproheptadine,Tablet,Oral,02332248,JAMP-CYPROHEPTADINE (cyproheptadine hydrochloride 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002941,cyproheptadine hydrochloride 4 mg oral tablet,8001365,cyproheptadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95509,Marketed,2023-11-03,02466732,EURO-CYPROHEPTADINE 2MG/5ML,1.0,R06AX02,Cyproheptadine,Syrup,Oral,02466732,EURO-CYPROHEPTADINE 2MG/5ML (cyproheptadine hydrochloride 2 mg per 5 mL syrup) EURO-PHARM INTERNATIONAL CANADA INC,Active,9003804,cyproheptadine hydrochloride 2 mg per 5 mL syrup,8001365,cyproheptadine,26643006,Oral,739009002,Syrup,,,,,
102209,Marketed,2023-05-26,02533065,MAR-CYPROHEPTADINE,1.0,R06AX02,Cyproheptadine,Tablet,Oral,02533065,MAR-CYPROHEPTADINE (cyproheptadine hydrochloride 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002941,cyproheptadine hydrochloride 4 mg oral tablet,8001365,cyproheptadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7394,Marketed,2025-05-08,00704431,ANDROCUR,1.0,G03HA01,Cyproterone,Tablet,Oral,00704431,ANDROCUR (cyproterone acetate 50 mg oral tablet) AMDIPHARM LIMITED,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
70015,Marketed,2011-03-22,02245898,CYPROTERONE,1.0,G03HA01,Cyproterone,Tablet,Oral,02245898,CYPROTERONE (cyproterone acetate 50 mg oral tablet) AA PHARMA INC,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87616,Marketed,2012-10-02,02390760,MED-CYPROTERONE,1.0,G03HA01,Cyproterone,Tablet,Oral,02390760,MED-CYPROTERONE (cyproterone acetate 50 mg oral tablet) GENERIC MEDICAL PARTNERS INC,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88085,Marketed,2012-11-28,02395797,RIVA-CYPROTERONE,1.0,G03HA01,Cyproterone,Tablet,Oral,02395797,RIVA-CYPROTERONE (cyproterone acetate 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002103,cyproterone acetate 50 mg oral tablet,8000841,cyproterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
53444,Marketed,2007-12-17,02233542,DIANE-35,2.0,G03HB01,Cyproterone and estrogen,Tablet,Oral,02233542,DIANE-35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) BAYER INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77558,Marketed,2024-11-20,02290308,CYESTRA-35,2.0,G03HB01,Cyproterone and estrogen,Tablet,Oral,02290308,CYESTRA-35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) ENDO OPERATIONS LTD.,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79517,Marketed,2018-03-08,02309556,TEVA-CYPROTERONE / ETHINYL ESTRADIOL,2.0,G03HB01,Cyproterone and estrogen,Tablet,Oral,02309556,TEVA-CYPROTERONE/ETHINYL ESTRADIOL (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) TEVA CANADA LIMITED,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90968,Marketed,2020-08-05,02425017,TARO-CYPROTERONE/ETHINYL ESTRADIOL,2.0,G03HB01,Cyproterone and estrogen,Tablet,Oral,02425017,TARO-CYPROTERONE/ETHINYL ESTRADIOL (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) SUN PHARMA CANADA INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92104,Marketed,2018-05-04,02436736,CLéO -35,2.0,G03HB01,Cyproterone and estrogen,Tablet,Oral,02436736,CLÉO -35 (cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet) ALTIUS HEALTHCARE INC,Active,9008629,cyproterone acetate 2 mg and ethinyl estradiol 35 mcg oral tablet,8000256,cyproterone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
43843,Marketed,2017-09-12,02126656,CYTARABINE INJECTION,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",77700720,CYTARABINE INJECTION (cytarabine 100 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9013061,cytarabine 100 mg per 1 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43843,Marketed,2017-09-12,02126656,CYTARABINE INJECTION,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",77700721,CYTARABINE INJECTION (cytarabine 1000 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013063,cytarabine 1000 mg per 10 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
43843,Marketed,2017-09-12,02126656,CYTARABINE INJECTION,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",77700722,CYTARABINE INJECTION (cytarabine 2000 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89145,Marketed,2017-02-16,02406772,PMS-CYTARABINE,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",77700781,PMS-CYTARABINE (cytarabine 2000 mg per 20 mL solution for injection vial) PHARMASCIENCE INC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89145,Marketed,2017-02-16,02406772,PMS-CYTARABINE,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",77700782,PMS-CYTARABINE (cytarabine 1000 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9013063,cytarabine 1000 mg per 10 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100469,Marketed,2022-04-21,02515296,CYTARABINE INJECTION,1.0,L01BC01,Cytarabine,Solution,"Intravenous,Subcutaneous,Intrathecal",02515296,CYTARABINE INJECTION (cytarabine 2000 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9013064,cytarabine 2000 mg per 20 mL solution for injection vial,8001737,cytarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100489,Marketed,2021-07-06,02515490,VYXEOS,2.0,L01XY01,Cytarabine and daunorubicin,Powder,Intravenous,,,,,,,,,,,,,,1.0,,
51418,Marketed,2022-06-27,02231962,CYTOGAM,1.0,J06BB09,Cytomegalovirus immunoglobulin,Solution,Intravenous,,,,,,,,,,,,,,,,
79795,Marketed,2008-07-03,02312441,PRADAXA,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02312441,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001250,dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84384,Marketed,2013-03-28,02358808,PRADAXA,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02358808,PRADAXA (dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001327,dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95754,Marketed,2019-08-14,02468891,APO-DABIGATRAN,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02468891,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule) APOTEX INC,Active,9001251,dabigatran etexilate (dabigatran etexilate mesilate) 75 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95755,Marketed,2022-10-05,02468905,APO-DABIGATRAN,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02468905,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule) APOTEX INC,Active,9001250,dabigatran etexilate (dabigatran etexilate mesilate) 110 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95756,Marketed,2019-02-04,02468913,APO-DABIGATRAN,1.0,B01AE07,Dabigatran etexilate,Capsule,Oral,02468913,APO-DABIGATRAN (dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule) APOTEX INC,Active,9001327,dabigatran etexilate (dabigatran etexilate mesilate) 150 mg oral capsule,8000378,dabigatran,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89429,Marketed,2016-09-27,02409607,TAFINLAR,1.0,L01EC02,Dabrafenib,Capsule,Oral,02409607,TAFINLAR (dabrafenib (dabrafenib mesylate) 50 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005313,dabrafenib (dabrafenib mesylate) 50 mg oral capsule,8001623,dabrafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
89430,Marketed,2016-05-04,02409615,TAFINLAR,1.0,L01EC02,Dabrafenib,Capsule,Oral,02409615,TAFINLAR (dabrafenib (dabrafenib mesylate) 75 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005314,dabrafenib (dabrafenib mesylate) 75 mg oral capsule,8001623,dabrafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102878,Marketed,2023-11-30,02540053,TAFINLAR,1.0,L01EC02,Dabrafenib,Tablet for suspension,Oral,02540053,TAFINLAR (dabrafenib (dabrafenib mesylate) 10 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014972,dabrafenib (dabrafenib mesylate) 10 mg dispersible oral tablet,8001623,dabrafenib,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,
65081,Marketed,2017-05-31,02241445,DACARBAZINE FOR INJECTION BP,1.0,L01AX04,Dacarbazine,Powder for solution,Intravenous,02241445,DACARBAZINE FOR INJECTION BP (dacarbazine 600 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012787,dacarbazine 600 mg per vial powder for solution for injection,8001447,dacarbazine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
250,Marketed,2019-12-01,00213071,COSMEGEN,1.0,L01DA01,Dactinomycin,Powder for solution,Intravenous,00213071,COSMEGEN (dactinomycin 0.5 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9001593,dactinomycin 0.5 mg per vial powder for solution for injection,8001738,dactinomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
97107,Marketed,2021-05-28,02480522,XYDALBA,1.0,J01XA04,Dalbavancin,Powder for solution,Intravenous,02480522,XYDALBA (dalbavancin (dalbavancin hydrochloride) 500 mg per vial powder for solution for injection) ENDO OPERATIONS LTD.,Active,9014534,dalbavancin (dalbavancin hydrochloride) 500 mg per vial powder for solution for injection,8002369,dalbavancin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
18306,Marketed,2005-05-03,02132648,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02132648,FRAGMIN (dalteparin sodium 5000 unit per 0.2 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012615,dalteparin sodium 5000 unit per 0.2 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
18307,Marketed,2005-07-12,02132621,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02132621,FRAGMIN (dalteparin sodium 2500 unit per 0.2 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012612,dalteparin sodium 2500 unit per 0.2 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50478,Marketed,2005-05-20,02231171,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02231171,FRAGMIN (dalteparin sodium 25000 unit per mL solution for injection 3.8 mL vial) PFIZER CANADA ULC,Active,9012613,dalteparin sodium 25000 unit per mL solution for injection 3.8 mL vial,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
83790,Marketed,2011-02-01,02352648,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352648,FRAGMIN (dalteparin sodium 7500 unit per 0.3 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012616,dalteparin sodium 7500 unit per 0.3 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
83791,Marketed,2011-02-01,02352656,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Subcutaneous,Intravenous",02352656,FRAGMIN (dalteparin sodium 10000 unit per 0.4 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012607,dalteparin sodium 10000 unit per 0.4 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
83792,Marketed,2011-02-01,02352664,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352664,FRAGMIN (dalteparin sodium 12500 unit per 0.5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012609,dalteparin sodium 12500 unit per 0.5 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
83793,Marketed,2011-02-01,02352672,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352672,FRAGMIN (dalteparin sodium 15000 unit per 0.6 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012610,dalteparin sodium 15000 unit per 0.6 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
83794,Marketed,2011-02-01,02352680,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02352680,FRAGMIN (dalteparin sodium 18000 unit per 0.72 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012611,dalteparin sodium 18000 unit per 0.72 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91522,Marketed,2015-03-25,02430789,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02430789,FRAGMIN (dalteparin sodium 3500 unit per 0.28 mL solution for injection syringe) PFIZER CANADA ULC,Active,9012614,dalteparin sodium 3500 unit per 0.28 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98458,Marketed,2020-06-08,02494582,FRAGMIN,1.0,B01AB04,Dalteparin,Solution,"Intravenous,Subcutaneous",02494582,FRAGMIN (dalteparin sodium 16500 unit per 0.66 mL solution for injection syringe) PFIZER CANADA ULC,Active,9014340,dalteparin sodium 16500 unit per 0.66 mL solution for injection syringe,8001254,dalteparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
18868,Marketed,2018-11-06,02129043,ORGARAN,1.0,B01AB09,Danaparoid,Solution,"Intravenous,Subcutaneous",02129043,ORGARAN (danaparoid sodium 750 unit per 0.6 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9012617,danaparoid sodium 750 unit per 0.6 mL solution for injection ampoule,8001255,danaparoid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
14747,Marketed,2009-02-06,02018160,CYCLOMEN,1.0,G03XA01,Danazol,Capsule,Oral,02018160,CYCLOMEN (danazol 200 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9001685,danazol 200 mg oral capsule,8001624,danazol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
15163,Marketed,2008-08-06,02018152,CYCLOMEN,1.0,G03XA01,Danazol,Capsule,Oral,02018152,CYCLOMEN (danazol 100 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9001753,danazol 100 mg oral capsule,8001624,danazol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103882,Marketed,2024-11-07,02550040,VOYDEYA,1.0,L04AJ09,Danicopan,Tablet,Oral,02550040,VOYDEYA 150 MG DOSE (danicopan 50 mg oral tablet with danicopan 100 mg oral tablet) ALEXION PHARMA GMBH,Active,9015146,danicopan 50 mg oral tablet with danicopan 100 mg oral tablet,8002524,danicopan,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
103886,Marketed,2024-11-07,02550059,VOYDEYA,1.0,L04AJ09,Danicopan,Tablet,Oral,02550059,VOYDEYA 200 MG DOSE (danicopan 100 mg oral tablet) ALEXION PHARMA GMBH,Active,9015145,danicopan 100 mg oral tablet,8002524,danicopan,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
14017,Marketed,2026-01-16,01997572,DANTRIUM INTRAVENOUS,1.0,M03CA01,Dantrolene,Powder for solution,Intravenous,01997572,DANTRIUM INTRAVENOUS (dantrolene sodium 20 mg per vial powder for solution for injection) KNIGHT THERAPEUTICS INC.,Active,9012788,dantrolene sodium 20 mg per vial powder for solution for injection,8001448,dantrolene,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
14019,Marketed,2026-01-27,01997602,DANTRIUM CAPSULES,1.0,M03CA01,Dantrolene,Capsule,Oral,01997602,DANTRIUM CAPSULES (dantrolene sodium 25 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012789,dantrolene sodium 25 mg oral capsule,8001448,dantrolene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101921,Marketed,2023-03-29,02529998,"DANTROLENE SODIUM FOR INJECTION, USP",1.0,M03CA01,Dantrolene,Powder for solution,Intravenous,02529998,"DANTROLENE SODIUM FOR INJECTION, USP (dantrolene sodium 20 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012788,dantrolene sodium 20 mg per vial powder for solution for injection,8001448,dantrolene,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91977,Marketed,2015-01-16,02435462,FORXIGA,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02435462,FORXIGA (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012664,dapagliflozin (dapagliflozin propanediol) 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91978,Marketed,2015-01-16,02435470,FORXIGA,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02435470,FORXIGA (dapagliflozin (dapagliflozin propanediol monohydrate) 10 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012661,dapagliflozin (dapagliflozin propanediol) 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100803,Marketed,2023-05-17,02518732,SANDOZ DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02518732,SANDOZ DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100804,Marketed,2023-05-17,02518740,SANDOZ DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02518740,SANDOZ DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100909,Marketed,2023-05-23,02519852,GLN-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02519852,GLN-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100910,Marketed,2023-05-23,02519860,GLN-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02519860,GLN-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101624,Marketed,2023-05-16,02527189,APO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02527189,APO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) APOTEX INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101625,Marketed,2023-05-16,02527197,APO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02527197,APO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) APOTEX INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101817,Marketed,2023-06-06,02528975,RIVA-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02528975,RIVA-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101818,Marketed,2023-06-06,02528983,RIVA-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02528983,RIVA-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102050,Marketed,2023-05-15,02531364,JAMP DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531364,JAMP DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102051,Marketed,2023-05-15,02531372,JAMP DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531372,JAMP DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102054,Marketed,2023-05-16,02531402,AURO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531402,AURO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) AURO PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102055,Marketed,2023-05-16,02531410,AURO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531410,AURO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) AURO PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102067,Marketed,2023-05-15,02531550,PMS-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531550,PMS-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) PHARMASCIENCE INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102068,Marketed,2023-05-15,02531569,PMS-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02531569,PMS-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) PHARMASCIENCE INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102206,Marketed,2023-05-15,02533049,AG-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02533049,AG-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) ANGITA PHARMA INC.,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102207,Marketed,2023-05-15,02533057,AG-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02533057,AG-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) ANGITA PHARMA INC.,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102415,Marketed,2023-05-17,02535297,M-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02535297,M-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) MANTRA PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102416,Marketed,2023-05-17,02535300,M-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02535300,M-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) MANTRA PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102636,Marketed,2023-05-29,02537656,PRO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02537656,PRO-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) PRO DOC LIMITEE,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102637,Marketed,2023-05-29,02537664,PRO-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02537664,PRO-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) PRO DOC LIMITEE,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102706,Marketed,2023-08-01,02538334,NRA-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02538334,NRA-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) NORA PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102707,Marketed,2023-08-01,02538342,NRA-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02538342,NRA-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) NORA PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103167,Marketed,2026-01-05,02543184,ACCEL-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02543184,ACCEL-DAPAGLIFLOZIN (dapagliflozin 5 mg oral tablet) ACCEL PHARMA INC,Active,9014863,dapagliflozin 5 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103168,Marketed,2026-01-05,02543192,ACCEL-DAPAGLIFLOZIN,1.0,A10BK01,Dapagliflozin,Tablet,Oral,02543192,ACCEL-DAPAGLIFLOZIN (dapagliflozin 10 mg oral tablet) ACCEL PHARMA INC,Active,9014860,dapagliflozin 10 mg oral tablet,8001256,dapagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76674,Marketed,2020-06-04,02281074,ACZONE,1.0,D10AX05,Dapsone,Gel,Topical,02281074,"ACZONE (dapsone 5 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004944,dapsone 5 % cutaneous gel,8001183,dapsone,448598008,Cutaneous,385100002,Gel,,,,,
97168,Marketed,2018-11-13,02481227,MAR-DAPSONE,1.0,J04BA02,Dapsone,Tablet,Oral,02481227,MAR-DAPSONE (dapsone 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002656,dapsone 100 mg oral tablet,8001183,dapsone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95367,Marketed,2018-01-17,02465493,CUBICIN RF,1.0,J01XX09,Daptomycin,Powder for solution,Intravenous,02465493,CUBICIN RF (daptomycin 500 mg per vial powder for solution for injection) CUBIST PHARMACEUTICALS LLC,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98052,Marketed,2020-11-19,02490463,DAPTOMYCIN FOR INJECTION,1.0,J01XX09,Daptomycin,Powder for solution,Intravenous,02490463,DAPTOMYCIN FOR INJECTION (daptomycin 500 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98087,Marketed,2020-10-27,02490838,DAPTOMYCIN FOR INJECTION,1.0,J01XX09,Daptomycin,Powder for solution,Intravenous,02490838,DAPTOMYCIN FOR INJECTION (daptomycin 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004358,daptomycin 500 mg per vial powder for solution for injection,8001184,daptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94282,Marketed,2016-07-12,02455951,DARZALEX,1.0,L01FC01,Daratumumab,Solution,Intravenous,02455951,DARZALEX (daratumumab 100 mg per 5 mL solution for injection vial) JANSSEN INC,Active,9013066,daratumumab 100 mg per 5 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94283,Marketed,2016-07-12,02455978,DARZALEX,1.0,L01FC01,Daratumumab,Solution,Intravenous,02455978,DARZALEX (daratumumab 400 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9013067,daratumumab 400 mg per 20 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99226,Marketed,2020-08-12,02502712,DARZALEX SC,1.0,L01FC01,Daratumumab,Solution,Subcutaneous,02502712,DARZALEX SC (daratumumab 1800 mg per 15 mL solution for injection vial) JANSSEN INC,Active,9014341,daratumumab 1800 mg per 15 mL solution for injection vial,8001739,daratumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87706,Marketed,2013-12-11,02391740,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391740,ARANESP (darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012949,darbepoetin alfa 40 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87707,Marketed,2014-05-07,02391759,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391759,ARANESP (darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012950,darbepoetin alfa 50 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87708,Marketed,2014-01-27,02391767,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391767,ARANESP (darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012953,darbepoetin alfa 80 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87709,Marketed,2014-03-26,02391775,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391775,ARANESP (darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012942,darbepoetin alfa 100 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87710,Marketed,2014-02-10,02391783,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391783,ARANESP (darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe) AMGEN CANADA INC,Active,9012943,darbepoetin alfa 130 mcg per 0.65 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87711,Marketed,2014-04-21,02391791,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02391791,ARANESP (darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012944,darbepoetin alfa 150 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87712,Marketed,2014-05-05,02391805,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391805,ARANESP (darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012946,darbepoetin alfa 200 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87714,Marketed,2013-11-04,02391821,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02391821,ARANESP (darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9012948,darbepoetin alfa 300 mcg per 0.6 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87760,Marketed,2013-08-16,02392313,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392313,ARANESP (darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe) AMGEN CANADA INC,Active,9012941,darbepoetin alfa 10 mcg per 0.4 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87761,Marketed,2014-03-12,02392321,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392321,ARANESP (darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9012945,darbepoetin alfa 20 mcg per 0.5 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87762,Marketed,2014-03-03,02392348,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392348,ARANESP (darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012947,darbepoetin alfa 30 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87763,Marketed,2014-04-03,02392356,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Intravenous,Subcutaneous",02392356,ARANESP (darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe) AMGEN CANADA INC,Active,9012952,darbepoetin alfa 60 mcg per 0.3 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87764,Marketed,2014-02-24,02392364,ARANESP,1.0,B03XA02,Darbepoetin alfa,Solution,"Subcutaneous,Intravenous",02392364,ARANESP (darbepoetin alfa 500 mcg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012951,darbepoetin alfa 500 mcg per 1 mL solution for injection syringe,8001625,darbepoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102616,Marketed,2023-07-12,02537443,QUVIVIQ,1.0,N05CJ03,Daridorexant,Tablet,Oral,02537443,QUVIVIQ (daridorexant (daridorexant hydrochloride) 50 mg oral tablet) IDORSIA PHARMACEUTICALS LTD,Active,9014890,daridorexant (daridorexant hydrochloride) 50 mg oral tablet,8002471,daridorexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75871,Marketed,2019-04-02,02273217,ENABLEX,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02273217,ENABLEX (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75872,Marketed,2019-04-02,02273225,ENABLEX,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02273225,ENABLEX (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93889,Marketed,2021-07-28,02452529,APO-DARIFENACIN,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02452529,APO-DARIFENACIN (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) APOTEX INC,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93890,Marketed,2021-07-28,02452510,APO-DARIFENACIN,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02452510,APO-DARIFENACIN (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) APOTEX INC,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98186,Marketed,2021-12-24,02491869,JAMP DARIFENACIN,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02491869,JAMP DARIFENACIN (darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9004148,darifenacin (darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98187,Marketed,2021-12-24,02491877,JAMP DARIFENACIN,1.0,G04BD10,Darifenacin,Tablet (extended-release),Oral,02491877,JAMP DARIFENACIN (darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9004147,darifenacin (darifenacin hydrobromide) 15 mg prolonged-release oral tablet,8001114,darifenacin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98622,Marketed,2020-03-24,02496348,NUBEQA,1.0,L02BB06,Darolutamide,Tablet,Oral,02496348,NUBEQA (darolutamide 300 mg oral tablet) BAYER INC,Active,9014289,darolutamide 300 mg oral tablet,8002324,darolutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97636,Marketed,2020-03-18,02486121,AURO-DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02486121,AURO-DARUNAVIR (darunavir (darunavir propylene glycolate) 600 mg oral tablet) AURO PHARMA INC,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97637,Marketed,2020-03-18,02486148,AURO-DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02486148,AURO-DARUNAVIR (darunavir (darunavir propylene glycolate) 800 mg oral tablet) AURO PHARMA INC,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97741,Marketed,2020-02-14,02487241,APO-DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02487241,APO-DARUNAVIR (darunavir 600 mg oral tablet) APOTEX INC,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97742,Marketed,2020-02-14,02487268,APO-DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02487268,APO-DARUNAVIR (darunavir 800 mg oral tablet) APOTEX INC,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101054,Marketed,2022-04-25,02521342,DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02521342,DARUNAVIR (darunavir 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004524,darunavir 600 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101055,Marketed,2022-04-25,02521350,DARUNAVIR,1.0,J05AE10,Darunavir,Tablet,Oral,02521350,DARUNAVIR (darunavir 800 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005128,darunavir 800 mg oral tablet,8001185,darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91108,Marketed,2014-08-28,02426501,PREZCOBIX,2.0,J05AR14,Darunavir and cobicistat,Tablet,Oral,02426501,PREZCOBIX (cobicistat 150 mg and darunavir (darunavir ethanolate) 800 mg oral tablet) JANSSEN INC,Active,9005578,cobicistat 150 mg and darunavir 800 mg oral tablet,8001312,cobicistat and darunavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77850,Marketed,2007-04-13,02293129,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02293129,SPRYCEL (dasatinib (dasatinib monohydrate) 20 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77851,Marketed,2007-04-13,02293137,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02293137,SPRYCEL (dasatinib (dasatinib monohydrate) 50 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77852,Marketed,2007-04-13,02293145,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02293145,SPRYCEL (dasatinib (dasatinib monohydrate) 70 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80564,Marketed,2009-05-04,02320193,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02320193,SPRYCEL (dasatinib (dasatinib monohydrate) 100 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84581,Marketed,2011-09-02,02360810,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02360810,SPRYCEL (dasatinib (dasatinib monohydrate) 80 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84582,Marketed,2011-03-29,02360829,SPRYCEL,1.0,L01EA02,Dasatinib,Tablet,Oral,02360829,SPRYCEL (dasatinib (dasatinib monohydrate) 140 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95971,Marketed,2020-01-06,02470705,APO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02470705,APO-DASATINIB (dasatinib 20 mg oral tablet) APOTEX INC,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95972,Marketed,2020-01-06,02470713,APO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02470713,APO-DASATINIB (dasatinib 50 mg oral tablet) APOTEX INC,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95973,Marketed,2020-01-06,02470721,APO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02470721,APO-DASATINIB (dasatinib 100 mg oral tablet) APOTEX INC,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96907,Marketed,2021-05-05,02478307,TEVA-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02478307,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96908,Marketed,2021-05-05,02478315,TEVA-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02478315,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96909,Marketed,2021-05-05,02478323,TEVA-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02478323,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 70 mg oral tablet) TEVA CANADA LIMITED,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96910,Marketed,2021-05-05,02478331,TEVA-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02478331,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96911,Marketed,2021-05-05,02478358,TEVA-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02478358,TEVA-DASATINIB (dasatinib (dasatinib monohydrate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97193,Marketed,2020-01-06,02481499,APO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02481499,APO-DASATINIB (dasatinib 70 mg oral tablet) APOTEX INC,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97194,Marketed,2020-01-06,02481502,APO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02481502,APO-DASATINIB (dasatinib 80 mg oral tablet) APOTEX INC,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98902,Marketed,2021-03-04,02499282,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499282,TARO-DASATINIB (dasatinib 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98904,Marketed,2021-03-04,02499304,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499304,TARO-DASATINIB (dasatinib 50 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98905,Marketed,2021-03-04,02499312,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499312,TARO-DASATINIB (dasatinib 70 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98906,Marketed,2021-03-04,02499320,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499320,TARO-DASATINIB (dasatinib 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98907,Marketed,2021-03-04,02499339,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499339,TARO-DASATINIB (dasatinib 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98908,Marketed,2021-03-04,02499347,TARO-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02499347,TARO-DASATINIB (dasatinib 140 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100414,Marketed,2021-09-16,02514737,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514737,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 20 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013070,dasatinib 20 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100415,Marketed,2021-09-16,02514745,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514745,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013071,dasatinib 50 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100416,Marketed,2021-09-16,02514753,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514753,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 70 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013072,dasatinib 70 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100417,Marketed,2021-09-16,02514761,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514761,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 80 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013073,dasatinib 80 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100418,Marketed,2021-09-16,02514788,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514788,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 100 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013068,dasatinib 100 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100419,Marketed,2021-09-16,02514796,REDDY-DASATINIB,1.0,L01EA02,Dasatinib,Tablet,Oral,02514796,REDDY-DASATINIB (dasatinib (dasatinib (s)-propylene glycol) 140 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013069,dasatinib 140 mg oral tablet,8001740,dasatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
13226,Marketed,2022-10-14,01926683,CERUBIDINE,1.0,L01DB02,Daunorubicin,Powder for solution,Intravenous,01926683,CERUBIDINE (daunorubicin (daunorubicin hydrochloride) 20 mg per vial powder for solution for injection) SEARCHLIGHT PHARMA INC,Active,9001671,daunorubicin (daunorubicin hydrochloride) 20 mg per vial powder for solution for injection,8001741,daunorubicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
102786,Marketed,2024-01-31,02539209,DAUNORUBICIN HYDROCHLORIDE INJECTION,1.0,L01DB02,Daunorubicin,Solution,Intravenous,02539209,DAUNORUBICIN HYDROCHLORIDE INJECTION (daunorubicin (daunorubicin hydrochloride) 20 mg per 4 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9015013,daunorubicin (daunorubicin hydrochloride) 20 mg per 4 mL solution for injection vial,8001741,daunorubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97510,Marketed,2021-03-24,02484811,DEMYLOCAN,1.0,L01BC08,Decitabine,Powder,Intravenous,02484811,DEMYLOCAN (decitabine 50 mg per vial powder for solution for injection) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014535,decitabine 50 mg per vial powder for solution for injection,8002370,decitabine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
99121,Marketed,2025-06-04,02501600,INQOVI,2.0,L01BC58,"Decitabine, combinations",Tablet,Oral,02501600,"INQOVI (cedazuridine 100 mg and decitabine 35 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9014398,cedazuridine 100 mg and decitabine 35 mg oral tablet,8002348,cedazuridine and decitabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77283,Marketed,2006-11-10,02287420,EXJADE,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02287420,EXJADE (deferasirox 125 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
77284,Marketed,2006-11-10,02287439,EXJADE,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02287439,EXJADE (deferasirox 250 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
77285,Marketed,2006-11-10,02287447,EXJADE,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02287447,EXJADE (deferasirox 500 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
93864,Marketed,2016-03-24,02452219,JADENU,1.0,V03AC03,Deferasirox,Tablet,Oral,02452219,JADENU (deferasirox 90 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93865,Marketed,2016-03-24,02452227,JADENU,1.0,V03AC03,Deferasirox,Tablet,Oral,02452227,JADENU (deferasirox 180 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93866,Marketed,2016-03-24,02452235,JADENU,1.0,V03AC03,Deferasirox,Tablet,Oral,02452235,JADENU (deferasirox 360 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94918,Marketed,2017-06-26,02461544,APO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02461544,APO-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) APOTEX INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
94919,Marketed,2017-06-29,02461552,APO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02461552,APO-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) APOTEX INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
94920,Marketed,2017-06-26,02461560,APO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02461560,APO-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) APOTEX INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95161,Marketed,2017-06-26,02463520,TARO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02463520,TARO-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95162,Marketed,2017-06-26,02463539,TARO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02463539,TARO-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95163,Marketed,2017-06-30,02463547,TARO-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02463547,TARO-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) TARO PHARMACEUTICALS INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95259,Marketed,2017-07-04,02464454,SANDOZ DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02464454,SANDOZ DEFERASIROX (deferasirox 125 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95260,Marketed,2017-07-04,02464462,SANDOZ DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02464462,SANDOZ DEFERASIROX (deferasirox 250 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
95261,Marketed,2017-07-04,02464470,SANDOZ DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02464470,SANDOZ DEFERASIROX (deferasirox 500 mg dispersible oral tablet) SANDOZ CANADA INCORPORATED,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
96437,Marketed,2018-04-25,02474328,PMS-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02474328,PMS-DEFERASIROX (deferasirox 125 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004226,deferasirox 125 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
96438,Marketed,2018-04-25,02474336,PMS-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02474336,PMS-DEFERASIROX (deferasirox 250 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004227,deferasirox 250 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
96439,Marketed,2018-04-25,02474344,PMS-DEFERASIROX,1.0,V03AC03,Deferasirox,Tablet for suspension,Oral,02474344,PMS-DEFERASIROX (deferasirox 500 mg dispersible oral tablet) PHARMASCIENCE INC,Active,9004228,deferasirox 500 mg dispersible oral tablet,8001626,deferasirox,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
97553,Marketed,2019-05-29,02485265,APO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02485265,APO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) APOTEX INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97554,Marketed,2019-05-29,02485273,APO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02485273,APO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) APOTEX INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97555,Marketed,2019-05-29,02485281,APO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02485281,APO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) APOTEX INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97996,Marketed,2021-04-19,02489899,SANDOZ DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02489899,SANDOZ DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97997,Marketed,2021-04-19,02489902,SANDOZ DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02489902,SANDOZ DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97998,Marketed,2021-04-19,02489910,SANDOZ DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02489910,SANDOZ DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99672,Marketed,2021-03-04,02507315,TARO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02507315,TARO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99673,Marketed,2021-03-04,02507323,TARO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02507323,TARO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99674,Marketed,2021-03-04,02507331,TARO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02507331,TARO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101695,Marketed,2024-08-14,02527774,AURO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02527774,AURO-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) AURO PHARMA INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101696,Marketed,2024-08-14,02527782,AURO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02527782,AURO-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) AURO PHARMA INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101697,Marketed,2024-08-14,02527790,AURO-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02527790,AURO-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) AURO PHARMA INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101753,Marketed,2022-08-31,02528290,PMS-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02528290,PMS-DEFERASIROX (TYPE J) (deferasirox 90 mg oral tablet) PHARMASCIENCE INC,Active,9005917,deferasirox 90 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101754,Marketed,2022-09-30,02528304,PMS-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02528304,PMS-DEFERASIROX (TYPE J) (deferasirox 180 mg oral tablet) PHARMASCIENCE INC,Active,9005915,deferasirox 180 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101755,Marketed,2022-08-31,02528312,PMS-DEFERASIROX (TYPE J),1.0,V03AC03,Deferasirox,Tablet,Oral,02528312,PMS-DEFERASIROX (TYPE J) (deferasirox 360 mg oral tablet) PHARMASCIENCE INC,Active,9005916,deferasirox 360 mg oral tablet,8001626,deferasirox,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92086,Marketed,2020-03-12,02436523,FERRIPROX,1.0,V03AC02,Deferiprone,Solution,Oral,02436523,FERRIPROX (deferiprone 500 mg per 5 mL oral solution) CHIESI CANADA CORP.,Active,9013813,deferiprone 500 mg per 5 mL oral solution,8001627,deferiprone,26643006,Oral,385023001,Oral solution,,,1.0,,
92087,Marketed,2020-03-12,02436531,FERRIPROX,1.0,V03AC02,Deferiprone,Tablet,Oral,02436531,FERRIPROX (deferiprone 500 mg oral tablet) CHIESI CANADA CORP.,Active,9005913,deferiprone 500 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92088,Marketed,2020-03-12,02436558,FERRIPROX,1.0,V03AC02,Deferiprone,Tablet,Oral,02436558,FERRIPROX (deferiprone 1000 mg oral tablet) CHIESI CANADA CORP.,Active,9005707,deferiprone 1000 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102533,Marketed,2023-06-05,02536579,FERRIPROX MR,1.0,V03AC02,Deferiprone,Tablet (extended-release),Oral,02536579,FERRIPROX MR (deferiprone 1000 mg prolonged-release oral tablet) CHIESI CANADA CORP.,Active,9014864,deferiprone 1000 mg prolonged-release oral tablet,8001627,deferiprone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
104207,Marketed,2025-03-03,02553112,TARO-DEFERIPRONE,1.0,V03AC02,Deferiprone,Tablet,Oral,02553112,TARO-DEFERIPRONE (deferiprone 1000 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005707,deferiprone 1000 mg oral tablet,8001627,deferiprone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
13546,Marketed,1999-05-10,01981242,DESFERAL 500MG,1.0,V03AC01,Deferoxamine,Powder for solution,"Intramuscular,Subcutaneous,Intravenous,Intraperitoneal",01981242,DESFERAL 500MG (deferoxamine mesylate 500 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002445,deferoxamine mesylate 500 mg per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
65257,Marketed,2017-07-12,02241600,DEFEROXAMINE MESYLATE FOR INJECTION,1.0,V03AC01,Deferoxamine,Powder for solution,"Subcutaneous,Intraperitoneal,Intravenous,Intramuscular",02241600,DEFEROXAMINE MESYLATE FOR INJECTION (deferoxamine mesylate 500 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9002445,deferoxamine mesylate 500 mg per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
71256,Marketed,2018-08-08,02247022,DEFEROXAMINE MESYLATE FOR INJECTION,1.0,V03AC01,Deferoxamine,Powder for solution,"Intravenous,Intramuscular,Intraperitoneal,Subcutaneous",02247022,DEFEROXAMINE MESYLATE FOR INJECTION (deferoxamine mesylate 2 g per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003634,deferoxamine mesylate 2 g per vial powder for solution for injection,8001742,deferoxamine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95424,Marketed,2017-09-06,02465981,DEFITELIO,1.0,B01AX01,Defibrotide,Solution,Intravenous,02465981,DEFITELIO (defibrotide 200 mg per 2.5 mL solution for injection vial) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9012482,defibrotide 200 mg per 2.5 mL solution for injection vial,8001133,defibrotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
82263,Marketed,2009-11-24,02337029,FIRMAGON,1.0,L02BX02,Degarelix,Powder for solution,Subcutaneous,02337029,FIRMAGON (degarelix (degarelix acetate) 80 mg per vial powder for solution for injection with diluent solution syringe) FERRING INC,Active,9013075,degarelix (degarelix acetate) 80 mg per vial powder for solution for injection with diluent solution syringe,8001743,degarelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
82264,Marketed,2009-11-24,02337037,FIRMAGON,1.0,L02BX02,Degarelix,Powder for solution,Subcutaneous,02337037,FIRMAGON (degarelix (degarelix acetate) 120 mg per vial powder for solution for injection with diluent solution syringe) FERRING INC,Active,9013074,degarelix (degarelix acetate) 120 mg per vial powder for solution for injection with diluent solution syringe,8001743,degarelix,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
106374,Marketed,2025-08-28,02560704,ANZUPGO,1.0,D11AH11,Delgocitinib,Cream,Topical,02560704,ANZUPGO (delgocitinib 20 mg per g cutaneous cream) LEO PHARMA INC,Active,9015252,delgocitinib 20 mg per g cutaneous cream,8002554,delgocitinib,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
82897,Marketed,2010-08-12,02343541,PROLIA,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02343541,PROLIA (denosumab 60 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
85304,Marketed,2011-06-06,02368153,XGEVA,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02368153,XGEVA (denosumab 120 mg per 1.7 mL solution for injection vial) AMGEN CANADA INC,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103418,Marketed,2024-07-25,02545411,JUBBONTI,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02545411,JUBBONTI (denosumab 60 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103450,Marketed,2024-06-26,02545764,WYOST,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02545764,WYOST (denosumab 120 mg per 1.7 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
106391,Marketed,2025-10-30,02560895,OSENVELT,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02560895,OSENVELT (denosumab 120 mg per 1.7 mL solution for injection vial) CELLTRION INC.,Active,9013076,denosumab 120 mg per 1.7 mL solution for injection vial,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
106393,Marketed,2025-10-30,02560917,STOBOCLO,1.0,M05BX04,Denosumab,Solution,Subcutaneous,02560917,STOBOCLO (denosumab 60 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012955,denosumab 60 mg per 1 mL solution for injection syringe,8001628,denosumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
92869,Marketed,2024-03-05,02443910,BELKYRA,1.0,D11AX24,Deoxycholic acid,Solution,Subcutaneous,02443910,BELKYRA (deoxycholic acid 20 mg per 2 mL solution for injection vial) ABBVIE CORPORATION,Active,9012956,deoxycholic acid 20 mg per 2 mL solution for injection vial,8001629,deoxycholic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
28979,Marketed,2024-09-05,02100207,DEQUADIN,1.0,R02AA02,Dequalinium,Lozenge,Oral,02100207,DEQUADIN (dequalinium chloride 0.25 mg lozenge) PHARMASCIENCE INC,Active,9003076,dequalinium chloride 0.25 mg lozenge,8001630,dequalinium,26643006,Oral,385087003,Lozenge,733000006,Lozenge,,,
100757,Marketed,2022-05-17,02518252,VABLYS,1.0,G01AC05,Dequalinium,Vaginal tablet,Vaginal,02518252,VABLYS (dequalinium chloride 10 mg vaginal tablet) DUCHESNAY INC,Active,9014716,dequalinium chloride 10 mg vaginal tablet,8001630,dequalinium,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),,,
101172,Marketed,2023-10-11,02522616,DEQUADIN ORAL SPRAY,1.0,R02AA02,Dequalinium,Solution,Buccal,02522616,DEQUADIN ORAL SPRAY (dequalinium chloride 0.5 % oromucosal spray) PHARMASCIENCE INC,Active,9014791,dequalinium chloride 0.5 % oromucosal spray,8001630,dequalinium,372473007,Oromucosal,385073003,Oromucosal spray,,,,,
43455,Marketed,2000-08-01,02227428,SUPRANE,1.0,N01AB07,Desflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
20014,Marketed,2022-12-16,02216248,DESIPRAMINE,1.0,N06AA01,Desipramine,Tablet,Oral,02216248,DESIPRAMINE (desipramine hydrochloride 10 mg oral tablet) AA PHARMA INC,Active,9014804,desipramine hydrochloride 10 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20015,Marketed,2022-12-16,02216256,DESIPRAMINE,1.0,N06AA01,Desipramine,Tablet,Oral,02216256,DESIPRAMINE (desipramine hydrochloride 25 mg oral tablet) AA PHARMA INC,Active,9014806,desipramine hydrochloride 25 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20021,Marketed,2022-12-16,02216280,DESIPRAMINE,1.0,N06AA01,Desipramine,Tablet,Oral,02216280,DESIPRAMINE (desipramine hydrochloride 100 mg oral tablet) AA PHARMA INC,Active,9014805,desipramine hydrochloride 100 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20022,Marketed,2022-12-16,02216272,DESIPRAMINE,1.0,N06AA01,Desipramine,Tablet,Oral,02216272,DESIPRAMINE (desipramine hydrochloride 75 mg oral tablet) AA PHARMA INC,Active,9014808,desipramine hydrochloride 75 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20023,Marketed,2022-12-16,02216264,DESIPRAMINE,1.0,N06AA01,Desipramine,Tablet,Oral,02216264,DESIPRAMINE (desipramine hydrochloride 50 mg oral tablet) AA PHARMA INC,Active,9014807,desipramine hydrochloride 50 mg oral tablet,8001449,desipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67861,Marketed,2017-02-03,02243919,AERIUS,1.0,R06AX27,Desloratadine,Tablet,Oral,02243919,AERIUS (desloratadine 5 mg oral tablet) BAYER INC,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71435,Marketed,2017-05-25,02247193,AERIUS KIDS,1.0,R06AX27,Desloratadine,Syrup,Oral,02247193,AERIUS KIDS (desloratadine 0.5 mg per mL syrup) BAYER INC,Active,9004028,desloratadine 0.5 mg per mL syrup,8001366,desloratadine,26643006,Oral,739009002,Syrup,,,,,
78346,Marketed,2012-12-15,02298155,DESLORATADINE ALLERGY CONTROL,1.0,R06AX27,Desloratadine,Tablet,Oral,02298155,DESLORATADINE ALLERGY CONTROL (desloratadine 5 mg oral tablet) PHARMASCIENCE INC,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103474,Marketed,2024-11-29,02546019,DESLORATADINE,1.0,R06AX27,Desloratadine,Tablet,Oral,02546019,DESLORATADINE (desloratadine 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003690,desloratadine 5 mg oral tablet,8001366,desloratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13867,Marketed,1993-12-31,00873993,DDAVP INJ 4MCG/ML,1.0,H01BA02,Desmopressin,Liquid,"Subcutaneous,Intravenous,Intramuscular",00873993,DDAVP INJ 4MCG/ML (desmopressin acetate 4 mcg per 1 mL solution for injection ampoule) FERRING INC,Active,9012790,desmopressin acetate 4 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
18289,Marketed,1995-12-31,02024179,OCTOSTIM LIQ INJ. 15MCG/ML,1.0,H01BA02,Desmopressin,Solution,"Subcutaneous,Intravenous",02024179,OCTOSTIM LIQ INJ. 15MCG/ML (desmopressin acetate 15 mcg per 1 mL solution for injection ampoule) FERRING INC,Active,9012700,desmopressin acetate 15 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
66190,Marketed,2011-03-10,02242465,DESMOPRESSIN SPRAY,1.0,H01BA02,Desmopressin,"Spray, metered dose",Nasal,02242465,DESMOPRESSIN SPRAY (desmopressin acetate 10 mcg per actuation nasal spray) AA PHARMA INC,Active,9002181,desmopressin acetate 10 mcg per actuation nasal spray,8001259,desmopressin,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
76960,Marketed,2022-04-07,02284030,APO-DESMOPRESSIN,1.0,H01BA02,Desmopressin,Tablet,Oral,02284030,APO-DESMOPRESSIN (desmopressin acetate 0.1 mg oral tablet) APOTEX INC,Active,9002781,desmopressin acetate 0.1 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76961,Marketed,2022-04-07,02284049,APO-DESMOPRESSIN,1.0,H01BA02,Desmopressin,Tablet,Oral,02284049,APO-DESMOPRESSIN (desmopressin acetate 0.2 mg oral tablet) APOTEX INC,Active,9002782,desmopressin acetate 0.2 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77052,Marketed,2006-11-02,02284995,DDAVP MELT,1.0,H01BA02,Desmopressin,Tablet (orally disintegrating),Sublingual,02284995,DDAVP MELT (desmopressin (desmopressin acetate) 60 mcg sublingual tablet) FERRING INC,Active,9014737,desmopressin (desmopressin acetate) 60 mcg sublingual tablet,8001259,desmopressin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
77053,Marketed,2006-11-02,02285002,DDAVP MELT,1.0,H01BA02,Desmopressin,Tablet (orally disintegrating),Sublingual,02285002,DDAVP MELT (desmopressin (desmopressin acetate) 120 mcg sublingual tablet) FERRING INC,Active,9014733,desmopressin (desmopressin acetate) 120 mcg sublingual tablet,8001259,desmopressin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
78965,Marketed,2008-01-23,02304368,PMS-DESMOPRESSIN,1.0,H01BA02,Desmopressin,Tablet,Oral,02304368,PMS-DESMOPRESSIN (desmopressin acetate (desmopressin acetate trihydrate) 0.1 mg oral tablet) PHARMASCIENCE INC,Active,9002781,desmopressin acetate 0.1 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78966,Marketed,2021-11-25,02304376,PMS-DESMOPRESSIN,1.0,H01BA02,Desmopressin,Tablet,Oral,02304376,PMS-DESMOPRESSIN (desmopressin acetate (desmopressin acetate trihydrate) 0.2 mg oral tablet) PHARMASCIENCE INC,Active,9002782,desmopressin acetate 0.2 mg oral tablet,8001259,desmopressin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100269,Marketed,2021-10-13,02513579,BIPAZEN,1.0,H01BA02,Desmopressin,Solution,"Intravenous,Subcutaneous,Intramuscular",02513579,BIPAZEN (desmopressin acetate 4 mcg per 1 mL solution for injection ampoule) KVR PHARMACEUTICALS INC.,Active,9012790,desmopressin acetate 4 mcg per 1 mL solution for injection ampoule,8001259,desmopressin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
14354,Marketed,2022-05-19,02042487,MARVELON 21,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02042487,MARVELON 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) ORGANON CANADA INC.,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
14355,Marketed,2022-06-17,02042479,MARVELON 28,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02042479,MARVELON 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) ORGANON CANADA INC.,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74243,Marketed,2019-05-13,02257238,LINESSA 28,6.0,G03AB05,Desogestrel and estrogen,Tablet,Oral,02257238,LINESSA 28 (desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet with lactose oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9008749,desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75841,Marketed,2019-02-15,02272903,LINESSA 21,6.0,G03AB05,Desogestrel and estrogen,Tablet,Oral,02272903,LINESSA 21 (desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9008750,desogestrel 100 mcg and estradiol 25 mcg oral tablet with desogestrel 125 mcg and estradiol 25 mcg oral tablet with desogestrel 150 mcg and ethinyl estradiol 25 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80270,Marketed,2015-05-28,02317192,APRI 21,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02317192,APRI 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) TEVA CANADA LIMITED,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80272,Marketed,2015-05-28,02317206,APRI 28,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02317206,APRI 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88154,Marketed,2016-09-19,02396491,FREYA 21,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02396491,FREYA 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88165,Marketed,2016-09-19,02396610,FREYA 28,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02396610,FREYA 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89490,Marketed,2014-01-07,02410249,MIRVALA 21,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02410249,MIRVALA 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) APOTEX INC,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89491,Marketed,2014-01-07,02410257,MIRVALA 28,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02410257,MIRVALA 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104524,Marketed,2025-08-18,02556553,MILEY 21,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02556553,MILEY 21 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9008751,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104525,Marketed,2025-08-18,02556561,MILEY 28,2.0,G03AA09,Desogestrel and estrogen,Tablet,Oral,02556561,MILEY 28 (desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) AMBICARE PHARMACEUTICALS INC.,Active,9008752,desogestrel 150 mcg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000179,desogestrel and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
43536,Marketed,2015-09-25,02229315,PDP-DESONIDE,1.0,D07AB08,Desonide,Cream,Topical,02229315,PDP-DESONIDE (desonide 0.05 % cutaneous cream) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002961,desonide 0.05 % cutaneous cream,8001260,desonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
43537,Marketed,2014-08-06,02229323,PDP-DESONIDE,1.0,D07AB08,Desonide,Ointment,Topical,02229323,PDP-DESONIDE (desonide 0.05 % cutaneous ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003043,desonide 0.05 % cutaneous ointment,8001260,desonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
43314,Marketed,2019-06-26,02221896,TOPICORT,1.0,D07AC03,Desoximetasone,Cream,Topical,02221896,"TOPICORT (desoximetasone 0.25 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003069,desoximetasone 0.25 % cutaneous cream,8001261,desoximetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
43315,Marketed,2020-10-19,02221918,TOPICORT,1.0,D07AC03,Desoximetasone,Cream,Topical,02221918,"TOPICORT (desoximetasone 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9002955,desoximetasone 0.05 % cutaneous cream,8001261,desoximetasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
43316,Marketed,2020-10-19,02221926,TOPICORT,1.0,D07AC03,Desoximetasone,Gel,Topical,02221926,"TOPICORT (desoximetasone 0.05 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002979,desoximetasone 0.05 % cutaneous gel,8001261,desoximetasone,448598008,Cutaneous,385100002,Gel,,,,,
43317,Marketed,2020-10-19,02221934,TOPICORT,1.0,D07AC03,Desoximetasone,Ointment,Topical,02221934,"TOPICORT (desoximetasone 0.25 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9003070,desoximetasone 0.25 % cutaneous ointment,8001261,desoximetasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
80650,Marketed,2014-12-06,02321092,PRISTIQ,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02321092,PRISTIQ (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80651,Marketed,2014-12-06,02321106,PRISTIQ,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02321106,PRISTIQ (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
94528,Marketed,2022-02-14,02458217,TEVA-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02458217,TEVA-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
94529,Marketed,2022-02-14,02458225,TEVA-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02458225,TEVA-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95539,Marketed,2017-10-20,02466988,APO-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02466988,APO-DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) APOTEX INC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95540,Marketed,2017-10-20,02466996,APO-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02466996,APO-DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) APOTEX INC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98506,Marketed,2022-02-14,02495139,JAMP DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02495139,JAMP DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98510,Marketed,2022-02-14,02495147,JAMP DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02495147,JAMP DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101462,Marketed,2024-08-12,02525615,AG-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02525615,AG-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101463,Marketed,2023-05-12,02525623,AG-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02525623,AG-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102121,Marketed,2024-02-12,02532158,TARO-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02532158,TARO-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001271,desvenlafaxine (desvenlafaxine succinate) 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102122,Marketed,2024-02-12,02532166,TARO-DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02532166,TARO-DESVENLAFAXINE (desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001272,desvenlafaxine (desvenlafaxine succinate) 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102398,Marketed,2023-05-25,02535106,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02535106,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102399,Marketed,2023-05-25,02535114,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02535114,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102714,Marketed,2024-05-30,02538415,SANDOZ DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02538415,SANDOZ DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102715,Marketed,2024-05-30,02538423,SANDOZ DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02538423,SANDOZ DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103213,Marketed,2024-04-12,02543672,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02543672,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103214,Marketed,2024-04-12,02543680,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02543680,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
104377,Marketed,2025-05-13,02554968,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02554968,DESVENLAFAXINE (desvenlafaxine 50 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9012484,desvenlafaxine 50 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
104378,Marketed,2025-05-13,02554976,DESVENLAFAXINE,1.0,N06AX23,Desvenlafaxine,Tablet (extended-release),Oral,02554976,DESVENLAFAXINE (desvenlafaxine 100 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9012483,desvenlafaxine 100 mg prolonged-release oral tablet,8000385,desvenlafaxine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102205,Marketed,2023-02-14,02533030,SOTYKTU,1.0,L04AF07,Deucravacitinib,Tablet,Oral,02533030,SOTYKTU (deucravacitinib 6 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9014839,deucravacitinib 6 mg oral tablet,8002463,deucravacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2620,Marketed,2018-02-22,00042560,MAXIDEX,1.0,S01BA01,Dexamethasone,Suspension,Ophthalmic,00042560,MAXIDEX (dexamethasone 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000099,dexamethasone 0.1 % ophthalmic drops,8000028,dexamethasone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
4591,Marketed,2018-01-19,00042579,MAXIDEX,1.0,S01BA01,Dexamethasone,Ointment,Ophthalmic,00042579,MAXIDEX (dexamethasone 0.1 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000037,dexamethasone 0.1 % ophthalmic ointment,8000028,dexamethasone (base),54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
6593,Marketed,2005-09-01,00664227,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML,1.0,H02AB02,Dexamethasone,Solution,"Intramuscular,Intrasynovial,Intravenous",00664227,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML (dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000315,dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
12208,Marketed,2005-09-01,00874582,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP,1.0,H02AB02,Dexamethasone,Liquid,"Intrasynovial,Intravenous,Intramuscular",00874582,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP (dexamethasone (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006551,dexamethasone (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000028,dexamethasone (base),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
12967,Marketed,1992-12-31,01946897,PMS-DEXAMETHASONE ELIXIR,1.0,H02AB02,Dexamethasone,Elixir,Oral,01946897,PMS-DEXAMETHASONE ELIXIR (dexamethasone 0.5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9001097,dexamethasone 0.5 mg per 5 mL oral solution,8000028,dexamethasone (base),26643006,Oral,385023001,Oral solution,,,,,
13255,Marketed,2015-07-31,01977547,"DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP",1.0,H02AB02,Dexamethasone,Solution,"Intra-articular,Intravenous,Intramuscular",01977547,"DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP (dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial) STERIMAX INC",Active,9000315,dexamethasone phosphate (dexamethasone sodium phosphate) 20 mg per 5 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
16262,Marketed,2019-03-28,02023865,DEXAMETHASONE,1.0,S03BA01,Dexamethasone,Solution,"Ophthalmic,Otic",02023865,DEXAMETHASONE (dexamethasone sodium phosphate 0.1 % ophthalmic/otic drops) PHARMA STULLN INC.,Active,9006235,dexamethasone sodium phosphate 0.1 % ophthalmic/otic drops,8000137,dexamethasone sodium phosphate,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,
23194,Marketed,2023-10-11,01964070,PMS-DEXAMETHASONE,1.0,H02AB02,Dexamethasone,Tablet,Oral,01964070,PMS-DEXAMETHASONE (dexamethasone 4 mg oral tablet) PHARMASCIENCE INC,Active,9000651,dexamethasone 4 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
23261,Marketed,2023-10-11,01964976,PMS-DEXAMETHASONE,1.0,H02AB02,Dexamethasone,Tablet,Oral,01964976,PMS-DEXAMETHASONE (dexamethasone 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000648,dexamethasone 0.5 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
36480,Marketed,1999-08-19,02204266,DEXAMETHASONE-OMEGA,1.0,H02AB02,Dexamethasone,Liquid,"Intravenous,Intralesional,Intramuscular,Soft tissue injection,Intra-articular",02204266,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006265,dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
36481,Marketed,1999-08-19,02204274,DEXAMETHASONE-OMEGA,1.0,H02AB02,Dexamethasone,Liquid,"Intravenous,Intramuscular",77700242,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 100 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000352,dexamethasone phosphate (dexamethasone sodium phosphate) 100 mg per 10 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
36481,Marketed,1999-08-19,02204274,DEXAMETHASONE-OMEGA,1.0,H02AB02,Dexamethasone,Liquid,"Intravenous,Intramuscular",77700243,DEXAMETHASONE-OMEGA (dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006266,dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
73487,Marketed,2004-03-08,02250055,APO-DEXAMETHASONE,1.0,H02AB02,Dexamethasone,Tablet,Oral,02250055,APO-DEXAMETHASONE (dexamethasone 4 mg oral tablet) APOTEX INC,Active,9000651,dexamethasone 4 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74650,Marketed,2004-11-17,02261081,APO-DEXAMETHASONE,1.0,H02AB02,Dexamethasone,Tablet,Oral,02261081,APO-DEXAMETHASONE (dexamethasone 0.5 mg oral tablet) APOTEX INC,Active,9000648,dexamethasone 0.5 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76497,Marketed,2006-06-08,02279363,PMS-DEXAMETHASONE,1.0,H02AB02,Dexamethasone,Tablet,Oral,02279363,PMS-DEXAMETHASONE (dexamethasone 2 mg oral tablet) PHARMASCIENCE INC,Active,9001152,dexamethasone 2 mg oral tablet,8000028,dexamethasone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84844,Marketed,2024-03-11,02363445,OZURDEX,1.0,S01BA01,Dexamethasone,Implant,Intravitreal,02363445,OZURDEX (dexamethasone 0.7 mg intravitreal implant) ABBVIE CORPORATION,Active,9001348,dexamethasone 0.7 mg intravitreal implant,8000028,dexamethasone (base),418401004,Intravitreal,385286003,Implant,732996003,Implant (unit of presentation),,,
87333,Marketed,2013-05-08,02387743,DEXAMETHASONE OMEGA UNIDOSE,1.0,H02AB02,Dexamethasone,Solution,"Intrasynovial,Intramuscular,Intravenous",02387743,DEXAMETHASONE OMEGA UNIDOSE (dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9006266,dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg per 1 mL solution for injection vial,8000114,dexamethasone phosphate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101779,Marketed,2022-11-25,02528584,ODAN-DEXAMETHASONE ELIXIR,1.0,H02AB02,Dexamethasone,Elixir,Oral,02528584,ODAN-DEXAMETHASONE ELIXIR (dexamethasone 0.5 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9001097,dexamethasone 0.5 mg per 5 mL oral solution,8000028,dexamethasone (base),26643006,Oral,385023001,Oral solution,,,,,
259,Marketed,2018-06-01,00042676,MAXITROL,3.0,S01CA01,Dexamethasone and antiinfectives,Suspension,Ophthalmic,00042676,MAXITROL (dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per mL and polymyxin B (polymyxin B sulfate) 6000 unit per mL ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013869,dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per mL and polymyxin B (polymyxin B sulfate) 6000 unit per mL ophthalmic drops,8002240,dexamethasone (base) and neomycin and polymyxin B,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
2423,Marketed,2019-03-18,00358177,MAXITROL,3.0,S01CA01,Dexamethasone and antiinfectives,Ointment,Ophthalmic,00358177,MAXITROL (dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per g and polymyxin B (polymyxin B sulfate) 6000 unit per g ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013868,dexamethasone 0.1 % and neomycin (neomycin sulfate) 3.5 mg per g and polymyxin B (polymyxin B sulfate) 6000 unit per g ophthalmic ointment,8002240,dexamethasone (base) and neomycin and polymyxin B,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
10971,Marketed,2018-04-26,00778915,TOBRADEX,2.0,S01CA01,Dexamethasone and antiinfectives,Ointment,Ophthalmic,00778915,TOBRADEX (dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002274,dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic ointment,8000848,dexamethasone (base) and tobramycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
11068,Marketed,2018-05-10,00778907,TOBRADEX,2.0,S01CA01,Dexamethasone and antiinfectives,Suspension,Ophthalmic,00778907,TOBRADEX (dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002273,dexamethasone 0.1 % and tobramycin 0.3 % ophthalmic drops,8000848,dexamethasone (base) and tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
37363,Marketed,2024-07-30,02224623,SOFRACORT,3.0,S03CA01,Dexamethasone and antiinfectives,Drops,"Ophthalmic,Otic",02224623,SOFRACORT (dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg per mL and framycetin sulfate 5 mg per mL and gramicidin 0.05 mg per mL ophthalmic/otic drops) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9006374,dexamethasone (dexamethasone sodium metasulphobenzoate) 0.5 mg per mL and framycetin sulfate 5 mg per mL and gramicidin 0.05 mg per mL ophthalmic/otic drops,8000932,dexamethasone (base) and framycetin and gramicidin,255204007,Multiple (ophthalmic or otic),420636007,Ear or eye drops,732994000,Drop (unit of presentation),,,
73758,Marketed,2018-06-11,02252716,CIPRODEX,2.0,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02252716,CIPRODEX (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
97239,Marketed,2020-11-23,02481901,TARO-CIPROFLOXACIN/DEXAMETHASONE,2.0,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02481901,TARO-CIPROFLOXACIN/DEXAMETHASONE (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) TARO PHARMACEUTICALS INC,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
99623,Marketed,2021-01-26,02506882,SANDOZ CIPROFLOXACIN / DEXAMETHASONE,2.0,S02CA06,Dexamethasone and antiinfectives,Suspension,Otic,02506882,SANDOZ CIPROFLOXACIN / DEXAMETHASONE (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops) SANDOZ CANADA INCORPORATED,Active,9001079,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and dexamethasone 0.1 % otic drops,8000338,ciprofloxacin and dexamethasone (base),10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
103219,Marketed,2025-08-21,02543745,LEVODEXA,2.0,S01CA01,Dexamethasone and antiinfectives,Solution,Ophthalmic,02543745,LEVODEXA (dexamethasone (dexamethasone sodium phosphate) 0.1 % and levofloxacin (levofloxacin hemihydrate) 0.5 % ophthalmic drops) XEDITON PHARMACEUTICALS INC,Active,9015253,dexamethasone (dexamethasone sodium phosphate) 0.1 % and levofloxacin 0.5 % ophthalmic drops,8002555,dexamethasone (base) and levofloxacin,54485002,Ophthalmic,385125006,Eye drops solution,,,,,
15210,Marketed,2024-11-06,01924567,DEXEDRINE SPANSULE,1.0,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,01924567,DEXEDRINE SPANSULE (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) ENDO OPERATIONS LTD.,Active,9000415,dextroamphetamine sulfate 15 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
15211,Marketed,2024-11-06,01924559,DEXEDRINE SPANSULE,1.0,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,01924559,DEXEDRINE SPANSULE (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) ENDO OPERATIONS LTD.,Active,9000414,dextroamphetamine sulfate 10 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
15225,Marketed,2024-11-06,01924516,DEXEDRINE,1.0,N06BA02,Dexamfetamine,Tablet,Oral,01924516,DEXEDRINE (dextroamphetamine sulfate 5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9000416,dextroamphetamine sulfate 5 mg oral tablet,8000162,dextroamphetamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92781,Marketed,2018-10-31,02443236,DEXTROAMPHETAMINE,1.0,N06BA02,Dexamfetamine,Tablet,Oral,02443236,DEXTROAMPHETAMINE (dextroamphetamine sulfate 5 mg oral tablet) AA PHARMA INC,Active,9000416,dextroamphetamine sulfate 5 mg oral tablet,8000162,dextroamphetamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93401,Marketed,2025-08-13,02448319,TEVA-DEXTROAMPHETAMINE SR,1.0,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,02448319,TEVA-DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 10 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000414,dextroamphetamine sulfate 10 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93402,Marketed,2025-08-13,02448327,TEVA-DEXTROAMPHETAMINE SR,1.0,N06BA02,Dexamfetamine,Capsule (sustained-release),Oral,02448327,TEVA-DEXTROAMPHETAMINE SR (dextroamphetamine sulfate 15 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000415,dextroamphetamine sulfate 15 mg prolonged-release oral capsule,8000162,dextroamphetamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
84014,Marketed,2017-01-13,02354950,DEXILANT,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02354950,DEXILANT (dexlansoprazole 30 mg gastro-resistant capsule) TAKEDA CANADA INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
84015,Marketed,2017-01-13,02354969,DEXILANT,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02354969,DEXILANT (dexlansoprazole 60 mg gastro-resistant capsule) TAKEDA CANADA INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
101819,Marketed,2024-02-26,02528991,APO-DEXLANSOPRAZOLE,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Oral,Nasogastric",02528991,APO-DEXLANSOPRAZOLE (dexlansoprazole 30 mg gastro-resistant capsule) APOTEX INC,Active,9001319,dexlansoprazole 30 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
101822,Marketed,2024-02-26,02529025,APO-DEXLANSOPRAZOLE,1.0,A02BC06,Dexlansoprazole,Capsule (delayed release),"Nasogastric,Oral",02529025,APO-DEXLANSOPRAZOLE (dexlansoprazole 60 mg gastro-resistant capsule) APOTEX INC,Active,9001320,dexlansoprazole 60 mg gastro-resistant capsule,8000394,dexlansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92145,Marketed,2019-03-04,02437147,PRECEDEX,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77700571,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9012487,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92145,Marketed,2019-03-04,02437147,PRECEDEX,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77700572,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 80 mcg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9012488,dexmedetomidine (dexmedetomidine hydrochloride) 80 mcg per 20 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92145,Marketed,2019-03-04,02437147,PRECEDEX,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77700573,PRECEDEX (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9012486,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95254,Marketed,2019-10-10,02464381,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02464381,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) AURO PHARMA INC,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95633,Marketed,2021-03-01,02467976,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP",1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02467976,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.",Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96831,Marketed,2019-03-29,02477327,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02477327,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97754,Marketed,2020-09-30,02487365,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02487365,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9012486,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97755,Marketed,2020-09-30,02487373,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02487373,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9012487,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100316,Marketed,2024-06-05,02513978,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP",1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02513978,"DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) BAXTER CORPORATION",Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
101806,Marketed,2024-10-07,02528886,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,02528886,DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012485,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 2 mL solution for injection vial,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102581,Marketed,2023-11-03,02537109,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77701141,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 1000 mcg per 250 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014973,dexmedetomidine (dexmedetomidine hydrochloride) 1000 mcg per 250 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,
102581,Marketed,2023-11-03,02537109,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77701142,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014974,dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg per 50 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,
102581,Marketed,2023-11-03,02537109,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,1.0,N05CM18,Dexmedetomidine,Solution,Intravenous,77701143,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION (dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014975,dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg per 100 mL solution for injection bag,8001118,dexmedetomidine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,
18480,Marketed,2009-02-03,02153432,ZINECARD,1.0,V03AF02,Dexrazoxane,Powder for solution,Intravenous,02153432,ZINECARD (dexrazoxane 250 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9002784,dexrazoxane 250 mg per vial powder for solution for injection,8001745,dexrazoxane,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
103261,Marketed,2025-06-21,02544083,DEXRAZOXANE FOR INJECTION,1.0,V03AF02,Dexrazoxane,Powder for solution,Intravenous,02544083,DEXRAZOXANE FOR INJECTION (dexrazoxane 250 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9002784,dexrazoxane 250 mg per vial powder for solution for injection,8001745,dexrazoxane,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
1743,Marketed,2017-09-21,00224227,LMD 10% IN 0.9% SODIUM CHLORIDE,2.0,B05AA55,"Dextran,combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
1744,Marketed,2017-09-20,00224235,LMD 10% IN DEXTROSE 5%,2.0,B05AA55,"Dextran,combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
4590,Marketed,1981-12-31,00522791,BRONCHOPHAN FORTE DM SYR,1.0,R05DA09,Dextromethorphan,Syrup,Oral,00522791,BRONCHOPHAN FORTE DM SYR (dextromethorphan hydrobromide 15 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
11847,Marketed,2013-01-11,01928791,KOFFEX DM (SUCROSE FREE),1.0,R05DA09,Dextromethorphan,Syrup,Oral,01928791,KOFFEX DM (SUCROSE FREE) (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
11848,Marketed,2013-01-11,01928783,KOFFEX DM,1.0,R05DA09,Dextromethorphan,Syrup,Oral,01928783,KOFFEX DM (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
12411,Marketed,2026-01-28,01944738,BENYLIN EXTRA STRENGTH DRY COUGH,1.0,R05DA09,Dextromethorphan,Syrup,Oral,01944738,BENYLIN EXTRA STRENGTH DRY COUGH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
12788,Marketed,2013-01-09,01928775,BALMINIL DM (3MG/ML SUCROSE FREE),1.0,R05DA09,Dextromethorphan,Syrup,Oral,01928775,BALMINIL DM (3MG/ML SUCROSE FREE) (dextromethorphan hydrobromide 15 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
37038,Marketed,2019-11-15,02215268,BENYLIN FOR CHILDREN DRY COUGH,1.0,R05DA09,Dextromethorphan,Solution,Oral,02215268,BENYLIN FOR CHILDREN DRY COUGH (dextromethorphan hydrobromide 7.5 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9013870,dextromethorphan hydrobromide 7.5 mg per 5 mL oral solution,8001368,dextromethorphan,26643006,Oral,385023001,Oral solution,,,,,
73742,Marketed,2024-06-14,02252554,ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX,1.0,R05DA09,Dextromethorphan,Capsule,Oral,02252554,ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX (dextromethorphan hydrobromide 15 mg oral capsule) HALEON CANADA ULC,Active,9004070,dextromethorphan hydrobromide 15 mg oral capsule,8001368,dextromethorphan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100054,Marketed,2024-03-06,02511320,BUCKLEY'S DRY COUGH EXTRA STRENGTH,1.0,R05DA09,Dextromethorphan,Solution,Oral,02511320,BUCKLEY'S DRY COUGH EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) HALEON CANADA ULC,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
102364,Marketed,2024-06-03,02534754,DRY COUGH RELIEF EXTRA STRENGTH,1.0,R05DA09,Dextromethorphan,Syrup,Oral,02534754,DRY COUGH RELIEF EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL syrup) CRLS,Active,9001832,dextromethorphan hydrobromide 15 mg per 5 mL syrup,8001368,dextromethorphan,26643006,Oral,739009002,Syrup,,,,,
103815,Marketed,2025-07-07,02549360,DAYQUIL KIDS HONEY,1.0,R05DA09,Dextromethorphan,Syrup,Oral,02549360,DAYQUIL KIDS HONEY (dextromethorphan hydrobromide 10 mg per 15 mL syrup) PROCTER & GAMBLE INC,Active,9015233,dextromethorphan hydrobromide 10 mg per 15 mL syrup,8001368,dextromethorphan,26643006,Oral,385032004,Oral syrup,,,,,
81407,Marketed,2018-10-30,02328550,TECHNELITE,1.0,V09,Diagnostic radiopharmaceuticals,Solution,"Oral,Instillation,Intravenous",,,,,,,,,,,,,,,,
101402,Marketed,2022-06-16,02524996,DIACETYLMORPHINE HYDROCHLORIDE,1.0,N07BC06,Diamorphine,Powder for solution,"Intramuscular,Intravenous",02524996,DIACETYLMORPHINE HYDROCHLORIDE (diamorphine hydrochloride 200 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9014809,diamorphine hydrochloride 200 mg per vial powder for solution for injection,8002454,diamorphine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,1.0,
101403,Marketed,2022-04-11,02525003,DIACETYLMORPHINE HYDROCHLORIDE,1.0,N07BC06,Diamorphine,Powder for solution,"Intravenous,Intramuscular",02525003,DIACETYLMORPHINE HYDROCHLORIDE (diamorphine hydrochloride 5000 mg per vial powder for solution for injection) PHARMASCIENCE INC,Active,9014810,diamorphine hydrochloride 5000 mg per vial powder for solution for injection,8002454,diamorphine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,1.0,
37570,Marketed,1997-04-22,02228564,GASTROGRAFIN,2.0,V08AA01,Diatrizoic acid,Solution,"Oral,Rectal",,,,,,,,,,,,,,,,
2657,Marketed,2019-06-13,00362158,DIAZEPAM,1.0,N05BA01,Diazepam,Tablet,Oral,00362158,DIAZEPAM (diazepam 5 mg oral tablet) AA PHARMA INC,Active,9000075,diazepam 5 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3178,Marketed,2024-11-01,00013285,VALIUM,1.0,N05BA01,Diazepam,Tablet,Oral,00013285,VALIUM (diazepam 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000075,diazepam 5 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3290,Marketed,2019-08-27,00405329,DIAZEPAM,1.0,N05BA01,Diazepam,Tablet,Oral,00405329,DIAZEPAM (diazepam 2 mg oral tablet) AA PHARMA INC,Active,9000128,diazepam 2 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3291,Marketed,2020-05-07,00405337,DIAZEPAM,1.0,N05BA01,Diazepam,Tablet,Oral,00405337,DIAZEPAM (diazepam 10 mg oral tablet) AA PHARMA INC,Active,9000108,diazepam 10 mg oral tablet,8000048,diazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3721,Marketed,2005-09-19,00399728,DIAZEPAM INJECTION USP,1.0,N05BA01,Diazepam,Solution,"Intramuscular,Intravenous",00399728,DIAZEPAM INJECTION USP (diazepam 10 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9001477,diazepam 10 mg per 2 mL solution for injection ampoule,8000048,diazepam,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
61553,Marketed,2021-08-18,02238162,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,77700067,"DIASTAT (diazepam 2.5 mg per 0.5 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000881,diazepam 2.5 mg per 0.5 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
61553,Marketed,2021-08-18,02238162,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,77700068,"DIASTAT (diazepam 5 mg per 1 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9000882,diazepam 5 mg per 1 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
61553,Marketed,2021-08-18,02238162,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,77700069,"DIASTAT (diazepam 7.5 mg per 1.5 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000883,diazepam 7.5 mg per 1.5 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
61553,Marketed,2021-08-18,02238162,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,77700071,"DIASTAT (diazepam 20 mg per 4 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Inactive,9000880,diazepam 20 mg per 4 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
100835,Marketed,2022-04-21,02519070,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,02519070,"DIASTAT (diazepam 10 mg per 2 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9014676,diazepam 10 mg per 2 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
100836,Marketed,2022-04-21,02519089,DIASTAT,1.0,N05BA01,Diazepam,Gel,Rectal,02519089,"DIASTAT (diazepam 15 mg per 3 mL rectal gel tube) BAUSCH HEALTH, CANADA INC.",Active,9000879,diazepam 15 mg per 3 mL rectal gel tube,8000048,diazepam,37161004,Rectal,385100002,Gel,,,,,
6269,Marketed,2012-10-19,00503347,PROGLYCEM,1.0,V03AH01,Diazoxide,Capsule,Oral,00503347,PROGLYCEM (diazoxide 100 mg oral capsule) MERCK CANADA INC,Active,9002046,diazoxide 100 mg oral capsule,8001631,diazoxide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86098,Marketed,2013-03-07,02375567,ANTIBACTERIAL THROAT LOZENGES,2.0,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02375567,ANTIBACTERIAL THROAT LOZENGES (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) QUIMICA CANADA LIMITED,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
86869,Marketed,2019-02-01,02382881,CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE,3.0,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02382881,CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and levomenthol 8 mg lozenge) RB HEALTH (CANADA) INC.,Active,9013761,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and levomenthol 8 mg lozenge,8002216,amylmetacresol and dichlorobenzyl alcohol and levomenthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
86872,Marketed,2019-02-12,02382938,CEPACOL SENSATIONS,2.0,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02382938,CEPACOL SENSATIONS (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) RB HEALTH (CANADA) INC.,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
87415,Marketed,2019-02-11,02388642,CEPACOL SENSATIONS SORE THROAT & COUGH,3.0,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02388642,CEPACOL SENSATIONS SORE THROAT & COUGH (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and menthol 8 mg lozenge) RB HEALTH (CANADA) INC.,Active,9005063,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg and menthol 8 mg lozenge,8002094,amylmetacresol and dichlorobenzyl alcohol and menthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
88981,Marketed,2019-02-01,02404982,CEPACOL CHILDREN'S FRUITY STRAWBERRY,2.0,R02AA03,Dichlorobenzyl alcohol,Lozenge,Oral,02404982,CEPACOL CHILDREN'S FRUITY STRAWBERRY (amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge) RB HEALTH (CANADA) INC.,Active,9005064,amylmetacresol 0.6 mg and dichlorobenzyl alcohol 1.2 mg lozenge,8002093,amylmetacresol and dichlorobenzyl alcohol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
6379,Marketed,1998-08-27,00590827,VOLTAREN SR,1.0,M01AB05,Diclofenac,Tablet (extended-release),Oral,00590827,VOLTAREN SR (diclofenac sodium 100 mg prolonged-release oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000221,diclofenac sodium 100 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
6461,Marketed,2000-06-16,00632724,VOLTAREN,1.0,M01AB05,Diclofenac,Suppository,Rectal,00632724,VOLTAREN (diclofenac sodium 50 mg suppository) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000223,diclofenac sodium 50 mg suppository,8000082,diclofenac,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
9889,Marketed,2010-10-09,00808547,TEVA-DICLOFENAC EC,1.0,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00808547,TEVA-DICLOFENAC EC (diclofenac sodium 50 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
10036,Marketed,1989-12-31,00839175,APO-DICLO,1.0,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00839175,APO-DICLO (diclofenac sodium 25 mg gastro-resistant tablet) APOTEX INC,Active,9000316,diclofenac sodium 25 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
10037,Marketed,1989-12-31,00839183,APO-DICLO,1.0,M01AB05,Diclofenac,Tablet (enteric-coated),Oral,00839183,APO-DICLO (diclofenac sodium 50 mg gastro-resistant tablet) APOTEX INC,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
10772,Marketed,2026-01-15,00870978,PRO-DICLOFENAC,1.0,M01AB05,Diclofenac,Tablet (delayed-release),Oral,00870978,PRO-DICLOFENAC (diclofenac sodium 50 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
11969,Marketed,2018-01-17,01940414,VOLTAREN OPHTHA,1.0,S01BC03,Diclofenac,Solution,Ophthalmic,01940414,VOLTAREN OPHTHA (diclofenac sodium 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
13805,Marketed,1998-08-27,00881635,VOLTAREN RAPIDE,1.0,M01AB05,Diclofenac,Tablet,Oral,00881635,VOLTAREN RAPIDE (diclofenac potassium 50 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16471,Marketed,1994-12-31,02091194,APO-DICLO SR,1.0,M01AB05,Diclofenac,Tablet (extended-release),Oral,02091194,APO-DICLO SR (diclofenac sodium 100 mg prolonged-release oral tablet) APOTEX INC,Active,9000221,diclofenac sodium 100 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
18239,Marketed,2010-10-09,02158582,TEVA-DICLOFENAC SR,1.0,M01AB05,Diclofenac,Tablet (extended-release),Oral,02158582,TEVA-DICLOFENAC SR (diclofenac sodium 75 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000317,diclofenac sodium 75 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
19125,Marketed,2019-12-23,02162814,APO-DICLO SR,1.0,M01AB05,Diclofenac,Tablet (extended-release),Oral,02162814,APO-DICLO SR (diclofenac sodium 75 mg prolonged-release oral tablet) APOTEX INC,Active,9000317,diclofenac sodium 75 mg prolonged-release oral tablet,8000082,diclofenac,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
62824,Marketed,2010-10-09,02239355,TEVA-DICLOFENAC-K,1.0,M01AB05,Diclofenac,Tablet,Oral,02239355,TEVA-DICLOFENAC-K (diclofenac potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71508,Marketed,2025-11-21,02247265,PENNSAID,1.0,M02AA15,Diclofenac,Solution,Topical,02247265,PENNSAID (diclofenac sodium 1.5 % cutaneous solution) KNIGHT THERAPEUTICS INC.,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
74714,Marketed,2006-02-02,02261774,SANDOZ DICLOFENAC RAPIDE,1.0,M01AB05,Diclofenac,Tablet,Oral,02261774,SANDOZ DICLOFENAC RAPIDE (diclofenac potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000461,diclofenac potassium 50 mg oral tablet,8000082,diclofenac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74727,Marketed,2008-10-01,02261928,SANDOZ-DICLOFENAC,1.0,M01AB05,Diclofenac,Suppository,Rectal,02261928,SANDOZ-DICLOFENAC (diclofenac sodium 50 mg suppository) SANDOZ CANADA INCORPORATED,Active,9000223,diclofenac sodium 50 mg suppository,8000082,diclofenac,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
78791,Marketed,2008-05-12,02302616,PMS-DICLOFENAC,1.0,M01AB05,Diclofenac,Tablet (delayed-release),Oral,02302616,PMS-DICLOFENAC (diclofenac sodium 25 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000316,diclofenac sodium 25 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78792,Marketed,2008-05-12,02302624,PMS-DICLOFENAC,1.0,M01AB05,Diclofenac,Tablet (delayed-release),Oral,02302624,PMS-DICLOFENAC (diclofenac sodium 50 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000146,diclofenac sodium 50 mg gastro-resistant tablet,8000082,diclofenac,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
82423,Marketed,2025-01-29,02338580,VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH,1.0,M02AA15,Diclofenac,Gel,Topical,02338580,VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,
86754,Marketed,2019-08-08,02381680,CAMBIA,1.0,M01AB05,Diclofenac,Powder for solution,Oral,02381680,CAMBIA (diclofenac potassium 50 mg per sachet powder for oral solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9001385,diclofenac potassium 50 mg per sachet powder for oral solution,8000082,diclofenac,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
87843,Marketed,2024-09-26,02393190,VOLTAREN EMULGEL EXTRA STRENGTH,1.0,M02AA15,Diclofenac,Gel,Topical,02393190,VOLTAREN EMULGEL EXTRA STRENGTH (diclofenac diethylamine 2.32 % cutaneous gel) HALEON CANADA ULC,Active,9001434,diclofenac diethylamine 2.32 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,
90557,Marketed,2014-03-31,02420988,TARO-DICLOFENAC,1.0,M02AA15,Diclofenac,Solution,Topical,02420988,TARO-DICLOFENAC (diclofenac sodium 1.5 % cutaneous solution) TARO PHARMACEUTICALS INC,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
94156,Marketed,2016-09-29,02454807,SANDOZ DICLOFENAC OPHTHA,1.0,S01BC03,Diclofenac,Solution,Ophthalmic,02454807,SANDOZ DICLOFENAC OPHTHA (diclofenac sodium 0.1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
95324,Marketed,2025-01-29,02465035,VOLTAREN EMULGEL BACK & MUSCLE PAIN,1.0,M02AA15,Diclofenac,Gel,Topical,02465035,VOLTAREN EMULGEL BACK & MUSCLE PAIN (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,
95325,Marketed,2024-09-26,02465043,VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH,1.0,M02AA15,Diclofenac,Gel,Topical,02465043,VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH (diclofenac diethylamine 2.32 % cutaneous gel) HALEON CANADA ULC,Active,9001434,diclofenac diethylamine 2.32 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,
96140,Marketed,2018-07-25,02472309,JAMP DICLOFENAC TOPICAL SOLUTION,1.0,M02AA15,Diclofenac,Solution,Topical,02472309,JAMP DICLOFENAC TOPICAL SOLUTION (diclofenac sodium 1.5 % cutaneous solution) JAMP PHARMA CORPORATION,Active,9001019,diclofenac sodium 1.5 % cutaneous solution,8000082,diclofenac,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
96535,Marketed,2019-03-29,02475065,DICLOFENAC,1.0,S01BC03,Diclofenac,Solution,Ophthalmic,02475065,DICLOFENAC (diclofenac sodium 0.1 % ophthalmic drops) PHARMA STULLN INC.,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102344,Marketed,2024-02-09,02534525,JAMP DICLOFENAC,1.0,S01BC03,Diclofenac,Solution,Ophthalmic,02534525,JAMP DICLOFENAC (diclofenac sodium 0.1 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000380,diclofenac sodium 0.1 % ophthalmic drops,8000082,diclofenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
104363,Marketed,2025-09-03,02554801,VOLTAREN EMULGEL ACTIVE,1.0,M02AA15,Diclofenac,Gel,Topical,02554801,VOLTAREN EMULGEL ACTIVE (diclofenac diethylamine 1.16 % cutaneous gel) HALEON CANADA ULC,Active,9001255,diclofenac diethylamine 1.16 % cutaneous gel,8000082,diclofenac,448598008,Cutaneous,385100002,Gel,,,,,
13636,Marketed,2005-11-21,01917056,ARTHROTEC 50,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,01917056,ARTHROTEC 50 (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) PFIZER CANADA ULC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
48191,Marketed,2006-01-12,02229837,ARTHROTEC 75,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02229837,ARTHROTEC 75 (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) PFIZER CANADA ULC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
82718,Marketed,2014-07-22,02341689,GD-DICLOFENAC/MISOPROSTOL 50,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02341689,GD-DICLOFENAC/MISOPROSTOL 50 (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
82719,Marketed,2014-07-22,02341697,GD-DICLOFENAC/MISOPROSTOL 75,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02341697,GD-DICLOFENAC/MISOPROSTOL 75 (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
89812,Marketed,2018-12-11,02413469,PMS-DICLOFENAC-MISOPROSTOL,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02413469,PMS-DICLOFENAC-MISOPROSTOL (diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001399,diclofenac sodium 50 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
89813,Marketed,2018-12-11,02413477,PMS-DICLOFENAC-MISOPROSTOL,2.0,M01AB55,"Diclofenac, combinations",Tablet (delayed-release),Oral,02413477,PMS-DICLOFENAC-MISOPROSTOL (diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001400,diclofenac sodium 75 mg and misoprostol 200 mcg gastro-resistant tablet,8000180,diclofenac and misoprostol,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
4710,Marketed,2022-06-10,00557102,RIVA-DICYCLOMINE,1.0,A03AA07,Dicycloverine,Capsule,Oral,00557102,RIVA-DICYCLOMINE (dicyclomine hydrochloride 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001714,dicyclomine hydrochloride 10 mg oral capsule,8001374,dicyclomine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85095,Marketed,2011-08-08,02366088,JAMP-DICYCLOMINE HCL,1.0,A03AA07,Dicycloverine,Tablet,Oral,02366088,JAMP-DICYCLOMINE HCL (dicyclomine hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002799,dicyclomine hydrochloride 20 mg oral tablet,8001374,dicyclomine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87694,Marketed,2012-10-23,02391619,JAMP-DICYCLOMINE HCL,1.0,A03AA07,Dicycloverine,Tablet,Oral,02391619,JAMP-DICYCLOMINE HCL (dicyclomine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002798,dicyclomine hydrochloride 10 mg oral tablet,8001374,dicyclomine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86025,Marketed,2011-10-25,02374900,VISANNE,1.0,G03DB08,Dienogest,Tablet,Oral,02374900,VISANNE (dienogest 2 mg oral tablet) BAYER INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98304,Marketed,2020-04-14,02493055,ASPEN-DIENOGEST,1.0,G03DB08,Dienogest,Tablet,Oral,02493055,ASPEN-DIENOGEST (dienogest 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98796,Marketed,2020-12-10,02498189,JAMP DIENOGEST,1.0,G03DB08,Dienogest,Tablet,Oral,02498189,JAMP DIENOGEST (dienogest 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103207,Marketed,2024-04-23,02543613,M-DIENOGEST,1.0,G03DB08,Dienogest,Tablet,Oral,02543613,M-DIENOGEST (dienogest 2 mg oral tablet) MANTRA PHARMA INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104041,Marketed,2025-06-30,02551683,MAR-DIENOGEST,1.0,G03DB08,Dienogest,Tablet,Oral,02551683,MAR-DIENOGEST (dienogest 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004945,dienogest 2 mg oral tablet,8001450,dienogest,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101892,Marketed,2023-02-06,02529688,KORSUVA,1.0,V03AX04,Difelikefalin,Solution,Intravenous,02529688,KORSUVA (difelikefalin (difelikefalin acetate) 50 mcg per 1 mL solution for injection vial) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014828,difelikefalin (difelikefalin acetate) 50 mcg per 1 mL solution for injection vial,8002460,difelikefalin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84609,Marketed,2011-11-04,02361043,DIGIFAB,1.0,V03AB24,Digitalis antitoxin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
15757,Marketed,2005-10-06,02048264,DIGOXIN INJECTION C.S.D.,1.0,C01AA05,Digoxin,Liquid,"Intramuscular,Intravenous",02048264,DIGOXIN INJECTION C.S.D. (digoxin 0.5 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000517,digoxin 0.5 mg per 2 mL solution for injection ampoule,8000198,digoxin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
66031,Marketed,2023-10-06,02242320,PMS-DIGOXIN,1.0,C01AA05,Digoxin,Solution,Oral,02242320,PMS-DIGOXIN (digoxin 0.05 mg per mL oral solution) PHARMASCIENCE INC,Active,9000941,digoxin 0.05 mg per mL oral solution,8000198,digoxin,26643006,Oral,385023001,Oral solution,,,,,
82129,Marketed,2023-07-05,02335700,PMS-DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02335700,PMS-DIGOXIN (digoxin 0.0625 mg oral tablet) PHARMASCIENCE INC,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82130,Marketed,2023-07-10,02335719,PMS-DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02335719,PMS-DIGOXIN (digoxin 0.125 mg oral tablet) PHARMASCIENCE INC,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98827,Marketed,2026-01-16,02498502,JAMP DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02498502,JAMP DIGOXIN (digoxin 0.0625 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98828,Marketed,2026-01-20,02498510,JAMP DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02498510,JAMP DIGOXIN (digoxin 0.125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104325,Marketed,2025-07-22,02554399,AURO-DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02554399,AURO-DIGOXIN (digoxin 0.0625 mg oral tablet) AURO PHARMA INC,Active,9001155,digoxin 0.0625 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104326,Marketed,2025-07-22,02554402,AURO-DIGOXIN,1.0,C01AA05,Digoxin,Tablet,Oral,02554402,AURO-DIGOXIN (digoxin 0.125 mg oral tablet) AURO PHARMA INC,Active,9001156,digoxin 0.125 mg oral tablet,8000198,digoxin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
415,Marketed,2004-07-30,00027243,"DIHYDROERGOTAMINE (DHE), 1MG/ML",1.0,N02CA01,Dihydroergotamine,Liquid,"Intravenous,Subcutaneous,Intramuscular",00027243,"DIHYDROERGOTAMINE (DHE), 1MG/ML (dihydroergotamine mesylate 1 mg per 1 mL solution for injection ampoule) STERIMAX INC",Active,9012957,dihydroergotamine mesylate 1 mg per 1 mL solution for injection ampoule,8001632,dihydroergotamine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
43498,Marketed,2004-11-01,02228947,MIGRANAL NASAL SPRAY 4MG/ML,1.0,N02CA01,Dihydroergotamine,Liquid,Nasal,02228947,MIGRANAL NASAL SPRAY 4MG/ML (dihydroergotamine mesylate 0.5 mg per actuation nasal spray) STERIMAX INC,Active,9013547,dihydroergotamine mesylate 0.5 mg per actuation nasal spray,8001632,dihydroergotamine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),1.0,,
9172,Marketed,2020-10-28,00771376,AA-DILTIAZ,1.0,C08DB01,Diltiazem,Tablet,Oral,00771376,AA-DILTIAZ (diltiazem hydrochloride 30 mg oral tablet) AA PHARMA INC,Active,9000291,diltiazem hydrochloride 30 mg oral tablet,8000122,diltiazem,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9173,Marketed,2020-06-22,00771384,AA-DILTIAZ,1.0,C08DB01,Diltiazem,Tablet,Oral,00771384,AA-DILTIAZ (diltiazem hydrochloride 60 mg oral tablet) AA PHARMA INC,Active,9000292,diltiazem hydrochloride 60 mg oral tablet,8000122,diltiazem,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
47431,Marketed,1997-01-31,02229526,APO-DILTIAZ CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02229526,APO-DILTIAZ CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) APOTEX INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50278,Marketed,2019-01-09,02230997,APO-DILTIAZ CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230997,APO-DILTIAZ CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) APOTEX INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50279,Marketed,1997-03-27,02230998,APO-DILTIAZ CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230998,APO-DILTIAZ CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) APOTEX INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50280,Marketed,1997-03-27,02230999,APO-DILTIAZ CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02230999,APO-DILTIAZ CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) APOTEX INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50458,Marketed,2021-06-04,02231150,TIAZAC,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02231150,"TIAZAC (diltiazem hydrochloride 120 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50459,Marketed,2021-06-04,02231151,TIAZAC,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02231151,"TIAZAC (diltiazem hydrochloride 180 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50460,Marketed,2021-06-04,02231152,TIAZAC,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02231152,"TIAZAC (diltiazem hydrochloride 240 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50461,Marketed,2021-06-04,02231154,TIAZAC,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02231154,"TIAZAC (diltiazem hydrochloride 300 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
50462,Marketed,2021-06-04,02231155,TIAZAC,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02231155,"TIAZAC (diltiazem hydrochloride 360 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
66289,Marketed,2024-10-07,02242538,TEVA-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242538,TEVA-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
66290,Marketed,2024-10-07,02242539,TEVA-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242539,TEVA-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
66291,Marketed,2024-10-07,02242540,TEVA-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242540,TEVA-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
66292,Marketed,2024-10-07,02242541,TEVA-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02242541,TEVA-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
68717,Marketed,2005-09-15,02244728,DILTIAZEM HYDROCHLORIDE INJECTION,1.0,C08DB01,Diltiazem,Solution,Intravenous,77700086,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 25 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000720,diltiazem hydrochloride 25 mg per 5 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68717,Marketed,2005-09-15,02244728,DILTIAZEM HYDROCHLORIDE INJECTION,1.0,C08DB01,Diltiazem,Solution,Intravenous,77700087,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000721,diltiazem hydrochloride 50 mg per 10 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74195,Marketed,2021-06-04,02256738,TIAZAC XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256738,"TIAZAC XC (diltiazem hydrochloride 120 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001083,diltiazem hydrochloride 120 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
74196,Marketed,2021-06-04,02256746,TIAZAC XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256746,"TIAZAC XC (diltiazem hydrochloride 180 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001084,diltiazem hydrochloride 180 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
74197,Marketed,2021-06-04,02256754,TIAZAC XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256754,"TIAZAC XC (diltiazem hydrochloride 240 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001085,diltiazem hydrochloride 240 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
74198,Marketed,2021-06-04,02256762,TIAZAC XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256762,"TIAZAC XC (diltiazem hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001086,diltiazem hydrochloride 300 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
74199,Marketed,2021-06-04,02256770,TIAZAC XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02256770,"TIAZAC XC (diltiazem hydrochloride 360 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001087,diltiazem hydrochloride 360 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75715,Marketed,2021-09-09,02271605,TEVA-DILTIAZEM HCL ER,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02271605,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 120 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
75716,Marketed,2021-09-09,02271613,TEVA-DILTIAZEM HCL ER,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02271613,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 180 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
75717,Marketed,2021-09-09,02271621,TEVA-DILTIAZEM HCL ER,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02271621,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 240 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
75718,Marketed,2021-09-09,02271648,TEVA-DILTIAZEM HCL ER,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02271648,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 300 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
75719,Marketed,2021-09-09,02271656,TEVA-DILTIAZEM HCL ER,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02271656,"TEVA-DILTIAZEM HCL ER (diltiazem hydrochloride 360 mg prolonged-release oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85560,Marketed,2024-10-23,02370441,TEVA-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02370441,TEVA-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85564,Marketed,2024-10-23,02370492,TEVA-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02370492,TEVA-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85565,Marketed,2024-10-23,02370506,TEVA-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02370506,TEVA-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85566,Marketed,2024-10-23,02370514,TEVA-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02370514,TEVA-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85567,Marketed,2024-10-23,02370522,TEVA-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02370522,TEVA-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
88523,Marketed,2022-04-20,02400421,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400421,DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
88524,Marketed,2022-04-20,02400448,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400448,DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
88525,Marketed,2022-04-20,02400456,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400456,DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
88526,Marketed,2022-04-20,02400464,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02400464,DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
91375,Marketed,2022-06-27,02429322,TEVA-DILTIAZEM XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429322,TEVA-DILTIAZEM XC (diltiazem hydrochloride 180 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001084,diltiazem hydrochloride 180 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91376,Marketed,2022-06-27,02429330,TEVA-DILTIAZEM XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429330,TEVA-DILTIAZEM XC (diltiazem hydrochloride 240 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001085,diltiazem hydrochloride 240 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91377,Marketed,2022-06-27,02429349,TEVA-DILTIAZEM XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429349,TEVA-DILTIAZEM XC (diltiazem hydrochloride 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001086,diltiazem hydrochloride 300 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91378,Marketed,2022-06-27,02429357,TEVA-DILTIAZEM XC,1.0,C08DB01,Diltiazem,Tablet (extended-release),Oral,02429357,TEVA-DILTIAZEM XC (diltiazem hydrochloride 360 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001087,diltiazem hydrochloride 360 mg prolonged-release oral tablet,8000122,diltiazem,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93126,Marketed,2024-05-09,02445999,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02445999,DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93127,Marketed,2024-05-09,02446006,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02446006,DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93128,Marketed,2024-05-09,02446014,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02446014,DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93129,Marketed,2024-05-09,02446022,DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02446022,DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
95355,Marketed,2018-05-28,02465353,MAR-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02465353,MAR-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
95356,Marketed,2018-05-28,02465361,MAR-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02465361,MAR-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
95357,Marketed,2018-05-28,02465388,MAR-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02465388,MAR-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
95358,Marketed,2018-05-22,02465396,MAR-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02465396,MAR-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
95359,Marketed,2018-05-22,02465418,MAR-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02465418,MAR-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97439,Marketed,2020-03-30,02484064,MAR-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484064,MAR-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97440,Marketed,2020-03-30,02484072,MAR-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484072,MAR-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97441,Marketed,2020-03-30,02484080,MAR-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484080,MAR-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97442,Marketed,2020-03-30,02484099,MAR-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02484099,MAR-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98529,Marketed,2021-07-03,02495376,JAMP DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02495376,JAMP DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98530,Marketed,2021-07-03,02495384,JAMP DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02495384,JAMP DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98531,Marketed,2021-07-03,02495392,JAMP DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02495392,JAMP DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98532,Marketed,2021-07-03,02495406,JAMP DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02495406,JAMP DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98533,Marketed,2021-07-03,02495414,JAMP DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02495414,JAMP DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100327,Marketed,2021-10-07,02514095,DILTIAZEM HYDROCHLORIDE INJECTION,1.0,C08DB01,Diltiazem,Solution,Intravenous,77701097,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 50 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000721,diltiazem hydrochloride 50 mg per 10 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100327,Marketed,2021-10-07,02514095,DILTIAZEM HYDROCHLORIDE INJECTION,1.0,C08DB01,Diltiazem,Solution,Intravenous,77701098,DILTIAZEM HYDROCHLORIDE INJECTION (diltiazem hydrochloride 25 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000720,diltiazem hydrochloride 25 mg per 5 mL solution for injection vial,8000122,diltiazem,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100545,Marketed,2021-10-15,02516101,DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02516101,DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100546,Marketed,2021-10-15,02516128,DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02516128,DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100547,Marketed,2021-10-15,02516136,DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02516136,DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100548,Marketed,2021-10-15,02516144,DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02516144,DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100549,Marketed,2021-10-15,02516152,DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02516152,DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101730,Marketed,2022-12-16,02528037,JAMP DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528037,JAMP DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101731,Marketed,2022-12-16,02528045,JAMP DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528045,JAMP DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101732,Marketed,2022-12-16,02528053,JAMP DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528053,JAMP DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101733,Marketed,2022-12-16,02528061,JAMP DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02528061,JAMP DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102963,Marketed,2023-10-04,02540924,PRO-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540924,PRO-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102964,Marketed,2023-10-04,02540932,PRO-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540932,PRO-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102965,Marketed,2023-10-04,02540940,PRO-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540940,PRO-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102966,Marketed,2023-10-05,02540959,PRO-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02540959,PRO-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103480,Marketed,2024-08-26,02546086,M-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546086,M-DILTIAZEM CD (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103481,Marketed,2024-08-26,02546094,M-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546094,M-DILTIAZEM CD (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103482,Marketed,2024-08-26,02546108,M-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546108,M-DILTIAZEM CD (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103483,Marketed,2024-08-26,02546116,M-DILTIAZEM CD,1.0,C08DB01,Diltiazem,Capsule (controlled-delivery),Oral,02546116,M-DILTIAZEM CD (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103512,Marketed,2024-08-23,02546434,M-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02546434,M-DILTIAZEM T (diltiazem hydrochloride 120 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000569,diltiazem hydrochloride 120 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103513,Marketed,2024-08-23,02546442,M-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02546442,M-DILTIAZEM T (diltiazem hydrochloride 180 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000570,diltiazem hydrochloride 180 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103514,Marketed,2024-08-23,02546450,M-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02546450,M-DILTIAZEM T (diltiazem hydrochloride 240 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000571,diltiazem hydrochloride 240 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103515,Marketed,2024-08-23,02546469,M-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02546469,M-DILTIAZEM T (diltiazem hydrochloride 300 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000572,diltiazem hydrochloride 300 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103516,Marketed,2024-08-23,02546477,M-DILTIAZEM T,1.0,C08DB01,Diltiazem,Capsule (extended release),Oral,02546477,M-DILTIAZEM T (diltiazem hydrochloride 360 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000728,diltiazem hydrochloride 360 mg prolonged-release oral capsule,8000122,diltiazem,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
193,Marketed,2021-01-04,00013609,GRAVOL SUPPOSITORIES,1.0,R06AA11,Dimenhydrinate,Suppository,Rectal,00013609,GRAVOL SUPPOSITORIES (dimenhydrinate 100 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9001511,dimenhydrinate 100 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
1256,Marketed,2021-05-18,00230197,KIDS GRAVOL LIQUID,1.0,R06AA11,Dimenhydrinate,Syrup,Oral,00230197,KIDS GRAVOL LIQUID (dimenhydrinate 15 mg per 5 mL syrup) CHURCH & DWIGHT CANADA CORP,Active,9001512,dimenhydrinate 15 mg per 5 mL syrup,8001375,dimenhydrinate,26643006,Oral,739009002,Syrup,,,,,
2890,Marketed,2022-01-30,00392545,CONFAB DIMENHYDRINATE 100 MG,1.0,R06AA11,Dimenhydrinate,Suppository,Rectal,00392545,CONFAB DIMENHYDRINATE 100 MG (dimenhydrinate 100 mg suppository) LABORATOIRES CONFAB INC,Active,9001511,dimenhydrinate 100 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
2891,Marketed,2022-01-30,00392553,CONFAB DIMENHYDRINATE 50 MG,1.0,R06AA11,Dimenhydrinate,Suppository,Rectal,00392553,CONFAB DIMENHYDRINATE 50 MG (dimenhydrinate 50 mg suppository) LABORATOIRES CONFAB INC,Active,9001715,dimenhydrinate 50 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
3397,Marketed,2023-03-22,00392537,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",77700589,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Inactive,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
3397,Marketed,2023-03-22,00392537,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",77700590,DIMENHYDRINATE INJECTION USP (dimenhydrinate 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012704,dimenhydrinate 50 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
3595,Marketed,2005-08-08,00392731,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,Intravenous,77700591,DIMENHYDRINATE INJECTION USP (dimenhydrinate 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012702,dimenhydrinate 10 mg per 1 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
3595,Marketed,2005-08-08,00392731,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,Intravenous,77700592,DIMENHYDRINATE INJECTION USP (dimenhydrinate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012701,dimenhydrinate 10 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
3944,Marketed,2021-03-22,00013803,GRAVOL TABLETS,1.0,R06AA11,Dimenhydrinate,Tablet,Oral,00013803,GRAVOL TABLETS (dimenhydrinate 50 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5572,Marketed,2010-05-01,00605786,TRAVEL TABS 50 MG,1.0,R06AA11,Dimenhydrinate,Tablet,Oral,00605786,TRAVEL TABS 50 MG (dimenhydrinate 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9585,Marketed,2021-06-01,00783595,KIDS GRAVOL SUPPOSITORIES,1.0,R06AA11,Dimenhydrinate,Suppository,Rectal,00783595,KIDS GRAVOL SUPPOSITORIES (dimenhydrinate 25 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9002187,dimenhydrinate 25 mg suppository,8001375,dimenhydrinate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
65184,Marketed,2010-05-01,02241532,ANTI-NAUSEANT,1.0,R06AA11,Dimenhydrinate,Tablet,Oral,02241532,ANTI-NAUSEANT (dimenhydrinate 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69468,Marketed,2020-08-25,02245416,JAMP-DIMENHYDRINATE,1.0,R06AA11,Dimenhydrinate,Tablet,Oral,02245416,JAMP-DIMENHYDRINATE (dimenhydrinate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69984,Marketed,2021-05-04,02245867,GRAVOL LIQUID GELS,1.0,R06AA11,Dimenhydrinate,Capsule,Oral,02245867,GRAVOL LIQUID GELS (dimenhydrinate 50 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9003754,dimenhydrinate 50 mg oral capsule,8001375,dimenhydrinate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73930,Marketed,2012-11-14,02254409,GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS,1.0,R06AA11,Dimenhydrinate,Tablet (combined release),Oral,02254409,GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS (dimenhydrinate 100 mg prolonged-release oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9015295,dimenhydrinate 100 mg prolonged-release oral tablet,8001375,dimenhydrinate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
86986,Marketed,2021-06-08,02384116,KIDS GRAVOL CHEWABLES,1.0,R06AA11,Dimenhydrinate,Tablet (chewable),Oral,02384116,KIDS GRAVOL CHEWABLES (dimenhydrinate 15 mg chewable tablet) CHURCH & DWIGHT CANADA CORP,Active,9002661,dimenhydrinate 15 mg chewable tablet,8001375,dimenhydrinate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86988,Marketed,2021-06-18,02384132,GRAVOL CHEWABLES,1.0,R06AA11,Dimenhydrinate,Tablet (chewable),Oral,02384132,GRAVOL CHEWABLES (dimenhydrinate 50 mg chewable tablet) CHURCH & DWIGHT CANADA CORP,Active,9001840,dimenhydrinate 50 mg chewable tablet,8001375,dimenhydrinate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
91339,Marketed,2022-04-22,02428954,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,"Intramuscular,Intravenous",77700626,DIMENHYDRINATE INJECTION USP (dimenhydrinate 50 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012704,dimenhydrinate 50 mg per 1 mL solution for injection ampoule,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
91952,Marketed,2022-04-22,02435241,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,"Intramuscular,Intravenous",02435241,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98056,Marketed,2020-02-24,02490528,GAVISCON NAUSEA,1.0,R06AA11,Dimenhydrinate,Tablet,Oral,02490528,GAVISCON NAUSEA (dimenhydrinate 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001628,dimenhydrinate 50 mg oral tablet,8001375,dimenhydrinate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98298,Marketed,2020-08-04,02493004,ANTI-NAUSEANT LIQUID GELS,1.0,R06AA11,Dimenhydrinate,Capsule,Oral,02493004,ANTI-NAUSEANT LIQUID GELS (dimenhydrinate 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003754,dimenhydrinate 50 mg oral capsule,8001375,dimenhydrinate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102529,Marketed,2024-08-27,02536536,DIMENHYDRINATE INJECTION USP,1.0,R06AA11,Dimenhydrinate,Solution,"Intravenous,Intramuscular",02536536,DIMENHYDRINATE INJECTION USP (dimenhydrinate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012703,dimenhydrinate 250 mg per 5 mL solution for injection vial,8001375,dimenhydrinate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88926,Marketed,2013-04-12,02404508,TECFIDERA,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02404508,TECFIDERA (dimethyl fumarate 120 mg gastro-resistant capsule) BIOGEN CANADA INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
90480,Marketed,2014-02-04,02420201,TECFIDERA,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02420201,TECFIDERA (dimethyl fumarate 240 mg gastro-resistant capsule) BIOGEN CANADA INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98478,Marketed,2021-10-19,02494809,GLN-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02494809,GLN-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98479,Marketed,2021-10-21,02494817,GLN-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02494817,GLN-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98689,Marketed,2021-10-04,02497026,PMS-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02497026,PMS-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98690,Marketed,2021-10-04,02497034,PMS-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02497034,PMS-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99224,Marketed,2021-10-04,02502690,MAR-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02502690,MAR-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99225,Marketed,2021-10-04,02502704,MAR-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02502704,MAR-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99514,Marketed,2021-10-04,02505762,APO-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02505762,APO-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) APOTEX INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99515,Marketed,2021-10-04,02505770,APO-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02505770,APO-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) APOTEX INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
100300,Marketed,2021-10-04,02513781,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02513781,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES (dimethyl fumarate 120 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
100301,Marketed,2021-10-04,02513803,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02513803,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES (dimethyl fumarate 240 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
100540,Marketed,2021-10-04,02516047,JAMP DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02516047,JAMP DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
100541,Marketed,2021-10-04,02516055,JAMP DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02516055,JAMP DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
102941,Marketed,2024-06-07,02540746,AURO-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02540746,AURO-DIMETHYL FUMARATE (dimethyl fumarate 120 mg gastro-resistant capsule) AURO PHARMA INC,Active,9005220,dimethyl fumarate 120 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
102942,Marketed,2024-06-07,02540754,AURO-DIMETHYL FUMARATE,1.0,L04AX07,Dimethyl fumarate,Capsule (delayed release),Oral,02540754,AURO-DIMETHYL FUMARATE (dimethyl fumarate 240 mg gastro-resistant capsule) AURO PHARMA INC,Active,9005422,dimethyl fumarate 240 mg gastro-resistant capsule,8001904,dimethyl fumarate,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
3769,Marketed,2018-10-31,00493392,RIMSO-50,1.0,G04BX13,Dimethyl sulfoxide,Solution,Intravesical,00493392,RIMSO-50 (dimethyl sulfoxide 50 % intravesical solution 50 mL vial) MYLAN PHARMACEUTICALS ULC,Active,9014164,dimethyl sulfoxide 50 % intravesical solution 50 mL vial,8002118,dimethyl sulfoxide,738984000,Parenteral,385242008,Intravesical solution,733026001,Vial (unit of presentation),,,
85900,Marketed,2012-01-06,02373785,NYDA,1.0,P03AX05,Dimeticone,Solution,Topical,02373785,NYDA (dimethicone 50 % cutaneous solution) G POHL-BOSKAMP GMBH & CO KG,Active,9004965,dimethicone 50 % cutaneous solution,8001633,dimethicone,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
2684,Marketed,2006-07-04,00400688,PROSTIN E2 TABLETS,1.0,G02AD02,Dinoprostone,Tablet,Oral,00400688,PROSTIN E2 TABLETS (dinoprostone 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9001783,dinoprostone 0.5 mg oral tablet,8001635,dinoprostone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10492,Marketed,2006-06-19,00860786,PREPIDIL GEL,1.0,G02AD02,Dinoprostone,Gel,Intracervical,00860786,PREPIDIL GEL (dinoprostone 0.5 mg per 2.5 mL endocervical gel syringe) PFIZER CANADA ULC,Active,9013433,dinoprostone 0.5 mg per 2.5 mL endocervical gel syringe,8001635,dinoprostone,372450004,Endocervical,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,
11830,Marketed,2006-06-12,01919679,PROSTIN E2 VAGINAL GEL,1.0,G02AD02,Dinoprostone,Gel,Vaginal,01919679,PROSTIN E2 VAGINAL GEL (dinoprostone 1 mg per 3 g vaginal gel syringe) PFIZER CANADA ULC,Active,9013434,dinoprostone 1 mg per 3 g vaginal gel syringe,8001635,dinoprostone,16857009,Vaginal,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,
11831,Marketed,2006-05-15,01919687,PROSTIN E2 VAGINAL GEL,1.0,G02AD02,Dinoprostone,Gel,Vaginal,01919687,PROSTIN E2 VAGINAL GEL (dinoprostone 2 mg per 3 g vaginal gel syringe) PFIZER CANADA ULC,Active,9013435,dinoprostone 2 mg per 3 g vaginal gel syringe,8001635,dinoprostone,16857009,Vaginal,385100002,Gel,733020007,Syringe (unit of presentation),1.0,,
50327,Marketed,1997-06-17,02231047,CERVIDIL,1.0,G02AD02,Dinoprostone,Insert,Vaginal,02231047,CERVIDIL (dinoprostone 0.3 mg per hour vaginal delivery system) FERRING INC,Active,9014165,dinoprostone 0.3 mg per hour vaginal delivery system,8001635,dinoprostone,16857009,Vaginal,420873008,Prolonged-release suspension for injection,733021006,System,1.0,,
97347,Marketed,2019-05-01,02483076,UNITUXIN,1.0,L01FX06,Dinutuximab beta,Solution,Intravenous,02483076,UNITUXIN (dinutuximab 17.5 mg per 5 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013956,dinutuximab 17.5 mg per 5 mL solution for injection vial,8002256,dinutuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
3775,Marketed,2019-11-01,00489867,DORMIPHEN EXTRA-FORT CAPSULE,1.0,R06AA02,Diphenhydramine,Capsule,Oral,00489867,DORMIPHEN EXTRA-FORT CAPSULE (diphenhydramine hydrochloride 50 mg oral capsule) LABORATOIRE LALCO INC.,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
5187,Marketed,2012-06-06,00583332,EXTRA STRENGTH NYTOL TAB 50MG,1.0,R06AA02,Diphenhydramine,Tablet,Oral,00583332,EXTRA STRENGTH NYTOL TAB 50MG (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5430,Marketed,2005-08-12,00596612,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP,1.0,R06AA02,Diphenhydramine,Liquid,"Intravenous,Intramuscular",00596612,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10874,Marketed,2016-10-18,00757683,PDP-DIPHENHYDRAMINE,1.0,R06AA02,Diphenhydramine,Capsule,Oral,00757683,PDP-DIPHENHYDRAMINE (diphenhydramine hydrochloride 25 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10875,Marketed,2020-11-20,00757691,PDP-DIPHENHYDRAMINE EXTRA STRENGTH/ EXTRA FORT,1.0,R06AA02,Diphenhydramine,Capsule,Oral,00757691,PDP-DIPHENHYDRAMINE EXTRA STRENGTH/ EXTRA FORT (diphenhydramine hydrochloride 50 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
11762,Marketed,2012-06-06,01934414,NYTOL EXTRA STRENGTH SLEEP AID CAPLET 50MG,1.0,R06AA02,Diphenhydramine,Tablet,Oral,01934414,NYTOL EXTRA STRENGTH SLEEP AID CAPLET 50MG (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12743,Marketed,2025-10-21,01946986,UNISOM,1.0,R06AA02,Diphenhydramine,Tablet,Oral,01946986,UNISOM (diphenhydramine hydrochloride 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13782,Marketed,2020-01-31,02017849,BENADRYL ALLERGY,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02017849,BENADRYL ALLERGY (diphenhydramine hydrochloride 25 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15516,Marketed,2020-01-31,02019736,BENADRYL ALLERGY LIQUID,1.0,R06AA02,Diphenhydramine,Solution,Oral,02019736,BENADRYL ALLERGY LIQUID (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
15880,Marketed,2020-01-06,02019698,CHILDREN'S BENADRYL ALLERGY LIQUID,1.0,R06AA02,Diphenhydramine,Solution,Oral,02019698,CHILDREN'S BENADRYL ALLERGY LIQUID (diphenhydramine hydrochloride 6.25 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003730,diphenhydramine hydrochloride 6.25 mg per 5 mL syrup,8001187,diphenhydramine,26643006,Oral,739009002,Syrup,,,,,
17781,Marketed,2013-04-11,02097575,ALLERNIX EXTRA STRENGTH,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02097575,ALLERNIX EXTRA STRENGTH (diphenhydramine hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17794,Marketed,2013-04-11,02097583,ALLERNIX,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02097583,ALLERNIX (diphenhydramine hydrochloride 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
31477,Marketed,1999-07-26,02141728,ALLERGY FORMULA CAPLETS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02141728,ALLERGY FORMULA CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) PERRIGO INTERNATIONAL,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
37198,Marketed,1997-10-28,02219336,DIPHENIST,1.0,R06AA02,Diphenhydramine,Liquid,"Intramuscular,Intravenous",02219336,DIPHENIST (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
41558,Marketed,2013-04-11,00538493,CALAMINE LOTION WITH ANTIHISTAMINE,2.0,D04AA32,Diphenhydramine,Suspension,Topical,00538493,CALAMINE LOTION WITH ANTIHISTAMINE (calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension) TEVA CANADA LIMITED,Active,9001899,calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension,8001707,calamine and diphenhydramine,448598008,Cutaneous,739008005,Suspension,,,,,
47391,Marketed,2009-08-10,02229492,ALLERGY FORMULA,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02229492,ALLERGY FORMULA (diphenhydramine hydrochloride 25 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
48413,Marketed,2012-05-23,02229959,SLEEP-EZE EXTRA STRENGTH CAPLETS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02229959,SLEEP-EZE EXTRA STRENGTH CAPLETS (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
48414,Marketed,2012-05-24,02229960,SLEEP-EZE REGULAR STRENGTH CAPLETS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02229960,SLEEP-EZE REGULAR STRENGTH CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49476,Marketed,2009-12-15,02230485,SLEEP AID,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02230485,SLEEP AID (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60487,Marketed,2012-06-06,02237169,EXTRA STRENGTH NYTOL QUICKGELS,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02237169,EXTRA STRENGTH NYTOL QUICKGELS (diphenhydramine hydrochloride 50 mg oral capsule) MEDTECH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
61146,Marketed,2019-11-01,02237789,DORMIPHEN EXTRA-FORT COMPRIME,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02237789,DORMIPHEN EXTRA-FORT COMPRIME (diphenhydramine hydrochloride 50 mg oral tablet) LABORATOIRE LALCO INC.,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62073,Marketed,2012-05-24,02238644,SLEEP-EZE EXTRA STRENGTH GELCAPS,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02238644,SLEEP-EZE EXTRA STRENGTH GELCAPS (diphenhydramine hydrochloride 50 mg oral capsule) MEDTECH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
62481,Marketed,2002-02-14,02239029,NADRYL 25MG,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02239029,NADRYL 25MG (diphenhydramine hydrochloride 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62594,Marketed,2019-11-07,02239138,EXTRA STRENGTH BENADRYL ALLERGY NIGHTTIME,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02239138,EXTRA STRENGTH BENADRYL ALLERGY NIGHTTIME (diphenhydramine hydrochloride 50 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65100,Marketed,2000-10-13,02241462,LOTION CALAMINE AVEC ANTIHISTAMINIQUE,2.0,D04AA32,Diphenhydramine,Suspension,Topical,02241462,LOTION CALAMINE AVEC ANTIHISTAMINIQUE (calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension) LABORATOIRE ATLAS INC,Active,9001899,calamine 8 % and diphenhydramine hydrochloride 1 % cutaneous suspension,8001707,calamine and diphenhydramine,448598008,Cutaneous,739008005,Suspension,,,,,
68166,Marketed,2009-12-15,02244203,SLEEP AID LIQUID FASTGELS,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02244203,SLEEP AID LIQUID FASTGELS (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
71812,Marketed,2007-12-20,02247560,ANTI-ITCH CREAM,1.0,D04AA32,Diphenhydramine,Cream,Topical,02247560,ANTI-ITCH CREAM (diphenhydramine hydrochloride 2 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002568,diphenhydramine hydrochloride 2 % cutaneous cream,8001187,diphenhydramine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
73230,Marketed,2026-01-28,02248858,BENYLIN FOR CHILDREN COUGH NIGHT,1.0,R06AA02,Diphenhydramine,Solution,Oral,02248858,BENYLIN FOR CHILDREN COUGH NIGHT (diphenhydramine hydrochloride 6.25 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003730,diphenhydramine hydrochloride 6.25 mg per 5 mL syrup,8001187,diphenhydramine,26643006,Oral,739009002,Syrup,,,,,
73231,Marketed,2012-08-31,02248859,BENYLIN SLEEP TIME,1.0,R06AA02,Diphenhydramine,Liquid,Oral,02248859,BENYLIN SLEEP TIME (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
74279,Marketed,2020-12-02,02257548,JAMP DIPHENHYDRAMINE 25 MG,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02257548,JAMP DIPHENHYDRAMINE 25 MG (diphenhydramine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74280,Marketed,2021-11-01,02257556,JAMP DIPHENHYDRAMINE 50 MG,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02257556,JAMP DIPHENHYDRAMINE 50 MG (diphenhydramine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76653,Marketed,2011-06-30,02280868,BENADRYL BUG BITE RELIEF,2.0,D04AA32,Diphenhydramine,Liquid,Topical,02280868,BENADRYL BUG BITE RELIEF (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9013818,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
78380,Marketed,2009-01-30,02298503,DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP,1.0,R06AA02,Diphenhydramine,Elixir,Oral,02298503,DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
78954,Marketed,2008-05-05,02304252,BENADRYL ALLERGY LIQUIGELS,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02304252,BENADRYL ALLERGY LIQUIGELS (diphenhydramine hydrochloride 25 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79190,Marketed,2008-07-11,02306352,ALLERGY FORMULA LIQUID CAPSULES,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02306352,ALLERGY FORMULA LIQUID CAPSULES (diphenhydramine hydrochloride 25 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80667,Marketed,2009-11-05,02321270,EXTRA STRENGTH ALLERGY FORMULA LIQUID CAPSULES,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02321270,EXTRA STRENGTH ALLERGY FORMULA LIQUID CAPSULES (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83395,Marketed,2010-08-03,02348608,SLEEP-EZE,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02348608,SLEEP-EZE (diphenhydramine hydrochloride 25 mg oral tablet) PRESTIGE BRANDS INC,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85056,Marketed,2018-10-16,02365685,REGULAR STRENGTH SLEEP AID,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02365685,REGULAR STRENGTH SLEEP AID (diphenhydramine hydrochloride 25 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85449,Marketed,2024-12-13,02369567,"DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP",1.0,R06AA02,Diphenhydramine,Solution,"Intravenous,Intramuscular",02369567,"DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP (diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012686,diphenhydramine hydrochloride 50 mg per 1 mL solution for injection vial,8001187,diphenhydramine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86902,Marketed,2013-02-12,02383268,ZZZQUIL,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02383268,ZZZQUIL (diphenhydramine hydrochloride 25 mg oral capsule) PROCTER & GAMBLE INC,Active,9002296,diphenhydramine hydrochloride 25 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89394,Marketed,2020-01-10,02409224,EXTRA STRENGTH DORMEX CAPSULES,1.0,R06AA02,Diphenhydramine,Capsule,Oral,02409224,EXTRA STRENGTH DORMEX CAPSULES (diphenhydramine hydrochloride 50 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001882,diphenhydramine hydrochloride 50 mg oral capsule,8001187,diphenhydramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89397,Marketed,2019-01-07,02409259,EXTRA STRENGTH DORMEX CAPLETS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02409259,EXTRA STRENGTH DORMEX CAPLETS (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90439,Marketed,2014-08-15,02419769,ZZZQUIL LIQUID,1.0,R06AA02,Diphenhydramine,Liquid,Oral,02419769,ZZZQUIL LIQUID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
91657,Marketed,2015-03-30,02432129,SLEEP-EZE EZE-LIQUID,1.0,R06AA02,Diphenhydramine,Solution,Oral,02432129,SLEEP-EZE EZE-LIQUID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) MEDTECH PRODUCTS INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
95281,Marketed,2018-06-14,02464683,NIGHTTIME SLEEP AID,1.0,R06AA02,Diphenhydramine,Solution,Oral,02464683,NIGHTTIME SLEEP AID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) JUNO OTC INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
95330,Marketed,2018-09-10,02465108,ALLERGY FORMULA,1.0,R06AA02,Diphenhydramine,Solution,Oral,02465108,ALLERGY FORMULA (diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution) JUNO OTC INC,Active,9002356,diphenhydramine hydrochloride 12.5 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
95910,Marketed,2018-03-26,02470144,EXTRA STRENGTH BENADRYL ALLERGY,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02470144,EXTRA STRENGTH BENADRYL ALLERGY (diphenhydramine hydrochloride 50 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96508,Marketed,2018-12-03,02474867,SLEEP-EZE EZE-FREE,1.0,R06AA02,Diphenhydramine,Solution,Oral,02474867,SLEEP-EZE EZE-FREE (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) MEDTECH PRODUCTS INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
96880,Marketed,2025-08-15,02478072,CHILDREN'S BENADRYL BUG BITE RELIEF,2.0,D04AA32,Diphenhydramine,Solution,Topical,02478072,CHILDREN'S BENADRYL BUG BITE RELIEF (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution) KENVUE CANADA INC.,Active,9013818,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous solution,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
96896,Marketed,2020-04-24,02478242,CHILDREN'S CLEAR ALLERGY FORMULA,1.0,R06AA02,Diphenhydramine,Solution,Oral,02478242,CHILDREN'S CLEAR ALLERGY FORMULA (diphenhydramine hydrochloride 6.25 mg per 5 mL oral solution) JUNO OTC INC,Active,9014315,diphenhydramine hydrochloride 6.25 mg per 5 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
96950,Marketed,2018-12-03,02478757,SLEEP-EZE EXTRA STRENGTH MINIS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02478757,SLEEP-EZE EXTRA STRENGTH MINIS (diphenhydramine hydrochloride 50 mg oral tablet) MEDTECH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97036,Marketed,2024-12-24,02479710,ALLERGY FORMULA CAPLETS,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02479710,ALLERGY FORMULA CAPLETS (diphenhydramine hydrochloride 25 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9001841,diphenhydramine hydrochloride 25 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97511,Marketed,2025-06-19,02484838,BENADRYL ITCH STOPPING CREAM,2.0,D04AA32,Diphenhydramine,Cream,Topical,02484838,BENADRYL ITCH STOPPING CREAM (diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous cream) KENVUE CANADA INC.,Active,9014242,diphenhydramine hydrochloride 2 % and zinc acetate 0.1 % cutaneous cream,8001754,diphenhydramine and zinc acetate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
98098,Marketed,2021-01-06,02490943,ALLERGY FORMULA EXTRA STRENGTH,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02490943,ALLERGY FORMULA EXTRA STRENGTH (diphenhydramine hydrochloride 50 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98867,Marketed,2022-05-23,02498952,SLEEP AID,1.0,R06AA02,Diphenhydramine,Tablet,Oral,02498952,SLEEP AID (diphenhydramine hydrochloride 50 mg oral tablet) JUNO OTC INC,Active,9001939,diphenhydramine hydrochloride 50 mg oral tablet,8001187,diphenhydramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99502,Marketed,2022-05-26,02505649,CHILDREN'S ALLERGY FORMULA RAPID MELTS,1.0,R06AA02,Diphenhydramine,Tablet (orally disintegrating),Oral,02505649,CHILDREN'S ALLERGY FORMULA RAPID MELTS (diphenhydramine hydrochloride 12.5 mg orodispersible tablet) JUNO OTC INC,Active,9014717,diphenhydramine hydrochloride 12.5 mg orodispersible tablet,8001187,diphenhydramine,372473007,Oromucosal,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
103206,Marketed,2025-07-01,02543591,ZZZQUIL SLEEP AID,1.0,R06AA02,Diphenhydramine,Solution,Oral,02543591,ZZZQUIL SLEEP AID (diphenhydramine hydrochloride 50 mg per 30 mL oral solution) PROCTER & GAMBLE INC,Active,9005685,diphenhydramine hydrochloride 50 mg per 30 mL oral solution,8001187,diphenhydramine,26643006,Oral,385023001,Oral solution,,,,,
50217,Marketed,2024-03-25,02230939,BUCKLEY'S NIGHTTIME COUGH & CONGESTION,2.0,R06AA52,"Diphenhydramine, combinations",Syrup,Oral,02230939,BUCKLEY'S NIGHTTIME COUGH & CONGESTION (diphenhydramine hydrochloride 12.5 mg per 5 mL and menthol 22 mg per 5 mL syrup) HALEON CANADA ULC,Active,9003110,diphenhydramine hydrochloride 12.5 mg per 5 mL and menthol 22 mg per 5 mL syrup,8001753,diphenhydramine and menthol,26643006,Oral,739009002,Syrup,,,,,
937,Marketed,2006-01-23,00036323,LOMOTIL,2.0,A07DA01,Diphenoxylate,Tablet,Oral,00036323,LOMOTIL (atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9001574,atropine sulfate 0.025 mg and diphenoxylate hydrochloride 2.5 mg oral tablet,8001572,atropine and diphenoxylate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102369,Marketed,2024-05-06,02534797,PENTACEL,11.0,J07CA06,Dipht-hemoph influen b-pertuss-polio-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,
73878,Marketed,2008-12-04,02253852,INFANRIX HEXA,11.0,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,
79806,Marketed,2010-10-22,02312557,BOOSTRIX-POLIO,8.0,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,
83726,Marketed,2011-03-11,02352044,ADACEL-POLIO,9.0,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,
102368,Marketed,2024-05-06,02534789,QUADRACEL,9.0,J07CA02,Diphtheria-pertussis-poliomyelitis-tetanus,Suspension,Intramuscular,,,,,,,,,,,,,,,,
6720,Marketed,2024-02-08,00637734,PERSANTINE,1.0,B01AC07,Dipyridamole,Solution,Intravenous,00637734,PERSANTINE (dipyridamole 50 mg per 10 mL solution for injection vial) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9012618,dipyridamole 50 mg per 10 mL solution for injection vial,8001262,dipyridamole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68448,Marketed,2015-09-11,02244475,"DIPYRIDAMOLE INJECTION, USP",1.0,B01AC07,Dipyridamole,Liquid,Intravenous,02244475,"DIPYRIDAMOLE INJECTION, USP (dipyridamole 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012618,dipyridamole 50 mg per 10 mL solution for injection vial,8001262,dipyridamole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
37379,Marketed,2021-01-04,02224801,RYTHMODAN,1.0,C01BA03,Disopyramide,Capsule,Oral,02224801,RYTHMODAN (disopyramide 100 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003828,disopyramide 100 mg oral capsule,8001376,disopyramide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65680,Marketed,2005-10-06,02242010,DOBUTAMINE INJECTION USP,1.0,C01CA07,Dobutamine,Liquid,Intravenous,02242010,DOBUTAMINE INJECTION USP (dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012960,dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial,8001636,dobutamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95055,Marketed,2024-07-12,02462729,DOBUTAMINE INJECTION USP,1.0,C01CA07,Dobutamine,Solution,Intravenous,02462729,DOBUTAMINE INJECTION USP (dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9012960,dobutamine (dobutamine hydrochloride) 250 mg per 20 mL solution for injection vial,8001636,dobutamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84699,Marketed,2017-06-16,02361957,DOCETAXEL INJECTION USP,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700752,DOCETAXEL INJECTION USP (docetaxel 80 mg per 8 mL solution for injection vial) PFIZER CANADA ULC,Active,9013083,docetaxel 80 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84699,Marketed,2017-06-16,02361957,DOCETAXEL INJECTION USP,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700753,DOCETAXEL INJECTION USP (docetaxel 160 mg per 16 mL solution for injection vial) PFIZER CANADA ULC,Active,9013077,docetaxel 160 mg per 16 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84699,Marketed,2017-06-16,02361957,DOCETAXEL INJECTION USP,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700754,DOCETAXEL INJECTION USP (docetaxel 20 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013080,docetaxel 20 mg per 2 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92370,Marketed,2016-06-02,02439336,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700813,DOCETAXEL INJECTION (docetaxel 160 mg per 16 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013077,docetaxel 160 mg per 16 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92370,Marketed,2016-06-02,02439336,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700814,DOCETAXEL INJECTION (docetaxel 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013080,docetaxel 20 mg per 2 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92370,Marketed,2016-06-02,02439336,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700815,DOCETAXEL INJECTION (docetaxel 80 mg per 8 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013083,docetaxel 80 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94508,Marketed,2017-10-17,02458020,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700816,DOCETAXEL INJECTION (docetaxel 20 mg per 1 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013079,docetaxel 20 mg per 1 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94508,Marketed,2017-10-17,02458020,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700817,DOCETAXEL INJECTION (docetaxel 160 mg per 8 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013078,docetaxel 160 mg per 8 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94508,Marketed,2017-10-17,02458020,DOCETAXEL INJECTION,1.0,L01CD02,Docetaxel,Solution,Intravenous,77700818,DOCETAXEL INJECTION (docetaxel 80 mg per 4 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013082,docetaxel 80 mg per 4 mL solution for injection vial,8001755,docetaxel,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
6258,Marketed,1985-12-31,00514888,SELAX CAP 100MG,1.0,A06AA02,Docusate sodium,Capsule,Oral,00514888,SELAX CAP 100MG (docusate sodium 100 mg oral capsule) ODAN LABORATORIES LTD,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
7365,Marketed,1986-12-31,00703494,PMS-DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,00703494,PMS-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
8974,Marketed,2010-12-18,00716731,TARO-DOCUSATE,1.0,A06AA02,Docusate sodium,Capsule,Oral,00716731,TARO-DOCUSATE (docusate sodium 100 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
11520,Marketed,2013-06-11,00870226,RATIO-DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Syrup,Oral,00870226,RATIO-DOCUSATE SODIUM (docusate sodium 20 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,
14487,Marketed,1993-12-31,01994344,SOFLAX CAPSULES 100MG,1.0,A06AA02,Docusate sodium,Capsule,Oral,01994344,SOFLAX CAPSULES 100MG (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
28280,Marketed,2024-11-29,02086018,COLACE SYRUP,1.0,A06AA02,Docusate sodium,Syrup,Oral,02086018,COLACE SYRUP (docusate sodium 20 mg per 5 mL syrup) PHARMASCIENCE INC,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,
28453,Marketed,2024-11-19,02090163,COLACE,1.0,A06AA02,Docusate sodium,Solution,Oral,02090163,COLACE (docusate sodium 10 mg per mL oral solution) PHARMASCIENCE INC,Active,9014938,docusate sodium 10 mg per mL oral solution,8001045,docusate,26643006,Oral,739006009,Solution,,,,,
29540,Marketed,2024-12-24,02106256,COLACE CAPSULES,1.0,A06AA02,Docusate sodium,Capsule,Oral,02106256,COLACE CAPSULES (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
52463,Marketed,1998-08-07,02232969,STOOL SOFTENER,1.0,A06AA02,Docusate sodium,Capsule,Oral,02232969,STOOL SOFTENER (docusate sodium 100 mg oral capsule) PERRIGO INTERNATIONAL,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
61679,Marketed,1998-09-02,02238283,SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML,1.0,A06AA02,Docusate sodium,Syrup,Oral,02238283,SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML (docusate sodium 20 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9002359,docusate sodium 20 mg per 5 mL syrup,8001045,docusate,26643006,Oral,739009002,Syrup,,,,,
70070,Marketed,2016-04-04,02245946,JAMP-DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,02245946,JAMP-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
71630,Marketed,2018-05-23,02247385,SANDOZ DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,02247385,SANDOZ DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
76671,Marketed,2012-09-05,02281031,STOOL SOFTENER,1.0,A06AA02,Docusate sodium,Capsule,Oral,02281031,STOOL SOFTENER (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84243,Marketed,2011-01-10,02357305,STOOL SOFTENER,1.0,A06AA02,Docusate sodium,Capsule,Oral,02357305,STOOL SOFTENER (docusate sodium 100 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91138,Marketed,2014-07-16,02426838,DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,02426838,DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) SANIS HEALTH INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92166,Marketed,2019-09-24,02437317,M-DOCUSATE SODIUM 100 MG,1.0,A06AA02,Docusate sodium,Capsule,Oral,02437317,M-DOCUSATE SODIUM 100 MG (docusate sodium 100 mg oral capsule) MANTRA PHARMA INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97454,Marketed,2024-12-12,02484226,COLACE CLEAR,1.0,A06AA02,Docusate sodium,Capsule,Oral,02484226,COLACE CLEAR (docusate sodium 100 mg oral capsule) PHARMASCIENCE INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101967,Marketed,2025-05-08,02530538,NRA-DOCUSATE SODIUM,1.0,A06AA02,Docusate sodium,Capsule,Oral,02530538,NRA-DOCUSATE SODIUM (docusate sodium 100 mg oral capsule) NORA PHARMA INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102519,Marketed,2023-09-30,02536412,STOOL SOFTENER CLEAR,1.0,A06AA02,Docusate sodium,Capsule,Oral,02536412,STOOL SOFTENER CLEAR (docusate sodium 100 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9002047,docusate sodium 100 mg oral capsule,8001045,docusate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101558,Marketed,2022-09-21,02526492,ENEMEEZ,1.0,A06AG10,"Docusate sodium, incl combinations",Enema,Rectal,02526492,"ENEMEEZ (docusate sodium 283 mg per 5 mL rectal liquid) QUEST PRODUCTS, LLC",Active,9014777,docusate sodium 283 mg per 5 mL rectal liquid,8001045,docusate,37161004,Rectal,420699003,Liquid,,,,,
89957,Marketed,2013-11-08,02414945,TIVICAY,1.0,J05AJ03,Dolutegravir,Tablet,Oral,02414945,TIVICAY (dolutegravir (dolutegravir sodium) 50 mg oral tablet) VIIV HEALTHCARE ULC,Active,9005361,dolutegravir (dolutegravir sodium) 50 mg oral tablet,8001191,dolutegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100071,Marketed,2022-01-31,02511517,TIVICAY,1.0,J05AJ03,Dolutegravir,Tablet for suspension,Oral,02511517,TIVICAY (dolutegravir (dolutegravir sodium) 5 mg dispersible oral tablet) VIIV HEALTHCARE ULC,Active,9014658,dolutegravir (dolutegravir sodium) 5 mg dispersible oral tablet,8001191,dolutegravir,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),,,
96645,Marketed,2018-06-04,02475774,JULUCA,2.0,J05AR21,Dolutegravir and rilpivirine,Tablet,Oral,02475774,JULUCA (dolutegravir (dolutegravir sodium) 50 mg and rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet) VIIV HEALTHCARE ULC,Active,9012706,dolutegravir (dolutegravir sodium) 50 mg and rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet,8001377,dolutegravir and rilpivirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13180,Marketed,2018-04-12,01912070,TEVA-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,01912070,TEVA-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43813,Marketed,2015-03-07,02103613,APO-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02103613,APO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) APOTEX INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60147,Marketed,2025-09-23,02236857,PRO-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02236857,PRO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61748,Marketed,2018-10-04,02238341,DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02238341,DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75346,Marketed,2021-11-30,02268078,TARO-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02268078,TARO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83565,Marketed,2013-05-10,02350440,DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02350440,DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85414,Marketed,2017-09-19,02369206,JAMP-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02369206,JAMP-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88864,Marketed,2014-01-02,02403870,MAR-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02403870,MAR-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93024,Marketed,2016-04-26,02445034,BIO-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02445034,BIO-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) BIOMED PHARMA,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95069,Marketed,2022-08-30,02462834,PRZ-DOMPERIDONE,1.0,A03FA03,Domperidone,Tablet,Oral,02462834,PRZ-DOMPERIDONE (domperidone (domperidone maleate) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000463,domperidone (domperidone maleate) 10 mg oral tablet,8000181,domperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51491,Marketed,1997-08-20,02232043,ARICEPT,1.0,N06DA02,Donepezil,Tablet,Oral,02232043,ARICEPT (donepezil hydrochloride 5 mg oral tablet) PFIZER CANADA ULC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51492,Marketed,1997-08-20,02232044,ARICEPT,1.0,N06DA02,Donepezil,Tablet,Oral,02232044,ARICEPT (donepezil hydrochloride 10 mg oral tablet) PFIZER CANADA ULC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80779,Marketed,2013-12-27,02322331,PMS-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02322331,PMS-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80780,Marketed,2013-12-27,02322358,PMS-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02322358,PMS-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81417,Marketed,2013-12-27,02328666,SANDOZ DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02328666,SANDOZ DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81419,Marketed,2013-12-27,02328682,SANDOZ DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02328682,SANDOZ DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82618,Marketed,2013-12-27,02340607,TEVA-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02340607,TEVA-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82619,Marketed,2013-12-27,02340615,TEVA-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02340615,TEVA-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84728,Marketed,2013-12-27,02362260,APO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02362260,APO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) APOTEX INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84729,Marketed,2014-12-27,02362279,APO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02362279,APO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) APOTEX INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86735,Marketed,2020-03-10,02381508,TARO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02381508,TARO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86736,Marketed,2020-03-10,02381516,TARO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02381516,TARO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88536,Marketed,2013-12-27,02400561,AURO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02400561,AURO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) AURO PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88537,Marketed,2013-12-27,02400588,AURO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02400588,AURO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) AURO PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88696,Marketed,2014-01-06,02402092,MAR-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02402092,MAR-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88697,Marketed,2014-01-06,02402106,MAR-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02402106,MAR-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88749,Marketed,2022-12-12,02402645,ACH-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02402645,ACH-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88750,Marketed,2023-08-04,02402653,ACH-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02402653,ACH-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89334,Marketed,2019-06-11,02408600,MINT-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02408600,MINT-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89335,Marketed,2019-06-11,02408619,MINT-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02408619,MINT-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89756,Marketed,2013-12-27,02412853,BIO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02412853,BIO-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) BIOMED PHARMA,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89757,Marketed,2013-12-27,02412861,BIO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02412861,BIO-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) BIOMED PHARMA,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90097,Marketed,2025-10-02,02416417,PRO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02416417,PRO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg oral tablet) PRO DOC LIMITEE,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90098,Marketed,2025-10-02,02416425,PRO-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02416425,PRO-DONEPEZIL (donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90157,Marketed,2014-09-26,02416948,JAMP-DONEPEZIL TABLETS,1.0,N06DA02,Donepezil,Tablet,Oral,02416948,JAMP-DONEPEZIL TABLETS (donepezil hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90158,Marketed,2014-09-26,02416956,JAMP-DONEPEZIL TABLETS,1.0,N06DA02,Donepezil,Tablet,Oral,02416956,JAMP-DONEPEZIL TABLETS (donepezil hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90516,Marketed,2025-07-08,02420597,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02420597,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90517,Marketed,2025-07-08,02420600,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02420600,DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91139,Marketed,2025-07-31,02426846,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02426846,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) SANIS HEALTH INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91140,Marketed,2025-06-27,02426854,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02426854,DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91711,Marketed,2021-05-10,02432684,AG-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02432684,AG-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91712,Marketed,2021-05-10,02432692,AG-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02432692,AG-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95583,Marketed,2017-12-14,02467453,M-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02467453,M-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95584,Marketed,2017-12-14,02467461,M-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02467461,M-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) MANTRA PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96563,Marketed,2018-05-16,02475278,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02475278,DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96564,Marketed,2018-05-16,02475286,DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02475286,DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102424,Marketed,2023-10-16,02535386,NRA-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02535386,NRA-DONEPEZIL (donepezil hydrochloride 5 mg oral tablet) NORA PHARMA INC,Active,9000744,donepezil hydrochloride 5 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102425,Marketed,2023-10-16,02535394,NRA-DONEPEZIL,1.0,N06DA02,Donepezil,Tablet,Oral,02535394,NRA-DONEPEZIL (donepezil hydrochloride 10 mg oral tablet) NORA PHARMA INC,Active,9000743,donepezil hydrochloride 10 mg oral tablet,8000246,donepezil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11624,Marketed,1990-12-31,00761834,DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP,2.0,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,
11625,Marketed,1990-12-31,00761826,DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP,2.0,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,
12256,Marketed,1992-12-31,00761850,DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP,2.0,C01CA04,Dopamine,Solution,Intravenous,,,,,,,,,,,,,,,,
97199,Marketed,2018-11-14,02481545,PIFELTRO,1.0,J05AG06,Doravirine,Tablet,Oral,02481545,PIFELTRO (doravirine 100 mg oral tablet) MERCK CANADA INC,Active,9013682,doravirine 100 mg oral tablet,8002188,doravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15483,Marketed,1998-06-23,02046733,PULMOZYME,1.0,R05CB13,Dornase alfa (desoxyribonuclease),Solution,Inhalation,02046733,PULMOZYME (dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial) HOFFMANN-LA ROCHE LIMITED,Active,9013957,dornase alfa 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8001637,dornase alfa,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
80181,Marketed,2012-02-04,02316307,SANDOZ DORZOLAMIDE,1.0,S01EC03,Dorzolamide,Solution,Ophthalmic,02316307,SANDOZ DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94429,Marketed,2023-05-26,02457210,MED-DORZOLAMIDE,1.0,S01EC03,Dorzolamide,Solution,Ophthalmic,02457210,MED-DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101151,Marketed,2023-09-28,02522373,DORZOLAMIDE,1.0,S01EC03,Dorzolamide,Solution,Ophthalmic,02522373,DORZOLAMIDE (dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003026,dorzolamide (dorzolamide hydrochloride) 2 % ophthalmic drops,8000899,dorzolamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101252,Marketed,2022-02-22,02523434,JEMPERLI,1.0,L01FF07,Dostarlimab,Solution,Intravenous,02523434,JEMPERLI (dostarlimab 500 mg per 10 mL solution for injection vial) GLAXOSMITHKLINE INC,Active,9014677,dostarlimab 500 mg per 10 mL solution for injection vial,8002413,dostarlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
64159,Marketed,1999-07-22,02240588,APO-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02240588,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) APOTEX INC,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64160,Marketed,1999-07-22,02240589,APO-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02240589,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) APOTEX INC,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64161,Marketed,1999-07-22,02240590,APO-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02240590,APO-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) APOTEX INC,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66535,Marketed,2014-02-07,02242728,TEVA-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02242728,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66536,Marketed,2014-02-07,02242729,TEVA-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02242729,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66537,Marketed,2014-02-07,02242730,TEVA-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02242730,TEVA-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98001,Marketed,2020-05-06,02489937,JAMP-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02489937,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000418,doxazosin (doxazosin mesylate) 1 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98002,Marketed,2020-05-06,02489945,JAMP-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02489945,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000419,doxazosin (doxazosin mesylate) 2 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98003,Marketed,2020-05-06,02489953,JAMP-DOXAZOSIN,1.0,C02CA04,Doxazosin,Tablet,Oral,02489953,JAMP-DOXAZOSIN (doxazosin (doxazosin mesylate) 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000420,doxazosin (doxazosin mesylate) 4 mg oral tablet,8000163,doxazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
944,Marketed,2017-12-29,00024325,SINEQUAN,1.0,N06AA12,Doxepin,Capsule,Oral,00024325,SINEQUAN (doxepin (doxepin hydrochloride) 10 mg oral capsule) AA PHARMA INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
945,Marketed,2018-02-01,00024333,SINEQUAN,1.0,N06AA12,Doxepin,Capsule,Oral,00024333,SINEQUAN (doxepin (doxepin hydrochloride) 25 mg oral capsule) AA PHARMA INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
946,Marketed,2018-03-13,00024341,SINEQUAN,1.0,N06AA12,Doxepin,Capsule,Oral,00024341,SINEQUAN (doxepin (doxepin hydrochloride) 50 mg oral capsule) AA PHARMA INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2049,Marketed,2018-11-12,00326925,SINEQUAN,1.0,N06AA12,Doxepin,Capsule,Oral,00326925,SINEQUAN (doxepin (doxepin hydrochloride) 100 mg oral capsule) AA PHARMA INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2780,Marketed,2018-11-12,00400750,SINEQUAN,1.0,N06AA12,Doxepin,Capsule,Oral,00400750,SINEQUAN (doxepin (doxepin hydrochloride) 75 mg oral capsule) AA PHARMA INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15104,Marketed,2025-11-13,02050048,APO-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02050048,APO-DOXEPIN (doxepin (doxepin hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15106,Marketed,2025-11-13,02050005,APO-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02050005,APO-DOXEPIN (doxepin (doxepin hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15107,Marketed,2025-11-13,02050013,APO-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02050013,APO-DOXEPIN (doxepin (doxepin hydrochloride) 50 mg oral capsule) APOTEX INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15108,Marketed,2025-11-13,02050021,APO-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02050021,APO-DOXEPIN (doxepin (doxepin hydrochloride) 75 mg oral capsule) APOTEX INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15118,Marketed,2026-01-09,02049996,APO-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02049996,APO-DOXEPIN (doxepin (doxepin hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88319,Marketed,2026-01-22,02398257,SILENOR,1.0,N06AA12,Doxepin,Tablet,Oral,02398257,SILENOR (doxepin (doxepin hydrochloride) 3 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005151,doxepin (doxepin hydrochloride) 3 mg oral tablet,8001263,doxepin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88320,Marketed,2026-01-22,02398265,SILENOR,1.0,N06AA12,Doxepin,Tablet,Oral,02398265,SILENOR (doxepin (doxepin hydrochloride) 6 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005152,doxepin (doxepin hydrochloride) 6 mg oral tablet,8001263,doxepin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106227,Marketed,2025-08-06,02559080,MAR-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02559080,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001657,doxepin (doxepin hydrochloride) 10 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106228,Marketed,2025-08-06,02559099,MAR-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02559099,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001658,doxepin (doxepin hydrochloride) 25 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106229,Marketed,2025-08-06,02559102,MAR-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02559102,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001659,doxepin (doxepin hydrochloride) 50 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106230,Marketed,2025-08-06,02559110,MAR-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02559110,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 75 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002459,doxepin (doxepin hydrochloride) 75 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106231,Marketed,2025-08-06,02559129,MAR-DOXEPIN,1.0,N06AA12,Doxepin,Capsule,Oral,02559129,MAR-DOXEPIN (doxepin (doxepin hydrochloride) 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002457,doxepin (doxepin hydrochloride) 100 mg oral capsule,8001263,doxepin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
42944,Marketed,2018-06-08,02194465,DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP,1.0,L01DB01,Doxorubicin,Powder for solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,
42945,Marketed,2018-06-08,02194473,DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP,1.0,L01DB01,Doxorubicin,Powder for solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,
61804,Marketed,2022-03-04,02238389,CAELYX,1.0,L01DB01,Doxorubicin,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,
86785,Marketed,2019-05-27,02381982,"DOXORUBICIN INJECTION, BP",1.0,L01DB01,Doxorubicin,Solution,"Intravesical,Intravenous",,,,,,,,,,,,,,1.0,,
89399,Marketed,2014-02-27,02409275,DOXORUBICIN HYDROCHLORIDE INJECTION,1.0,L01DB01,Doxorubicin,Solution,"Intravenous,Intravesical",,,,,,,,,,,,,,1.0,,
89506,Marketed,2014-05-21,02410397,DOXORUBICIN,1.0,L01DB01,Doxorubicin,Solution,"Intravenous,Intravesical",,,,,,,,,,,,,,1.0,,
98300,Marketed,2020-05-19,02493020,TARO-DOXORUBICIN LIPOSOMAL,1.0,L01DB01,Doxorubicin,Suspension,Intravenous,,,,,,,,,,,,,,1.0,,
7627,Marketed,1987-12-31,00740713,APO-DOXY CAP 100MG,1.0,J01AA02,Doxycycline,Capsule,Oral,00740713,APO-DOXY CAP 100MG (doxycycline (doxycycline hyclate) 100 mg oral capsule) APOTEX INC,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10024,Marketed,1989-12-31,00860751,DOXYCIN TAB 100MG,1.0,J01AA02,Doxycycline,Tablet,Oral,00860751,DOXYCIN TAB 100MG (doxycycline (doxycycline hyclate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10117,Marketed,2014-02-07,00725250,TEVA-DOXYCYCLINE,1.0,J01AA02,Doxycycline,Capsule,Oral,00725250,TEVA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10383,Marketed,1990-12-31,00874256,APO-DOXY TABS 100MG,1.0,J01AA02,Doxycycline,Tablet,Oral,00874256,APO-DOXY TABS 100MG (doxycycline (doxycycline hyclate) 100 mg oral tablet) APOTEX INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10897,Marketed,1990-12-31,00887064,DOXYTAB,1.0,J01AA02,Doxycycline,Tablet,Oral,00887064,DOXYTAB (doxycycline (doxycycline hyclate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18421,Marketed,2014-02-07,02158574,TEVA-DOXYCYCLINE,1.0,J01AA02,Doxycycline,Tablet,Oral,02158574,TEVA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71343,Marketed,2025-12-01,02247104,PMS-DOXYCYCLINE,1.0,A01AB22,Doxycycline,Capsule,Oral,02247104,PMS-DOXYCYCLINE (doxycycline (doxycycline hyclate) 20 mg oral capsule) PHARMASCIENCE INC,Active,9001050,doxycycline (doxycycline hyclate) 20 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83642,Marketed,2015-03-25,02351234,DOXYCYCLINE CAPSULES,1.0,J01AA02,Doxycycline,Capsule,Oral,02351234,DOXYCYCLINE CAPSULES (doxycycline (doxycycline hyclate) 100 mg oral capsule) SANIS HEALTH INC,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83643,Marketed,2015-03-25,02351242,DOXYCYCLINE TABLETS,1.0,J01AA02,Doxycycline,Tablet,Oral,02351242,DOXYCYCLINE TABLETS (doxycycline (doxycycline hyclate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86128,Marketed,2012-11-29,02375885,APPRILON,1.0,J01AA02,Doxycycline,Capsule (immediate and delayed release),Oral,02375885,APPRILON (doxycycline (doxycycline monohydrate) 40 mg modified-release oral capsule) GALDERMA CANADA INC.,Active,9001394,doxycycline 40 mg modified-release oral capsule,8000117,doxycycline,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,
100192,Marketed,2021-09-01,02512645,APO-DOXYCYCLINE MR,1.0,J01AA02,Doxycycline,Capsule (immediate and delayed release),Oral,02512645,APO-DOXYCYCLINE MR (doxycycline (doxycycline monohydrate) 40 mg modified-release oral capsule) APOTEX INC,Active,9001394,doxycycline 40 mg modified-release oral capsule,8000117,doxycycline,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,
101777,Marketed,2024-05-03,02528568,JAMP DOXYCYCLINE,1.0,A01AB22,Doxycycline,Capsule,Oral,02528568,JAMP DOXYCYCLINE (doxycycline (doxycycline hyclate) 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001050,doxycycline (doxycycline hyclate) 20 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101814,Marketed,2024-05-03,02528940,JAMP DOXYCYCLINE CAPSULES,1.0,J01AA02,Doxycycline,Capsule,Oral,02528940,JAMP DOXYCYCLINE CAPSULES (doxycycline (doxycycline hyclate) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000268,doxycycline (doxycycline hyclate) 100 mg oral capsule,8000117,doxycycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102504,Marketed,2023-09-01,02536250,PRZ-DOXYCYCLINE,1.0,J01AA02,Doxycycline,Tablet,Oral,02536250,PRZ-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) PHARMARIS CANADA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103193,Marketed,2024-06-05,02543478,M-DOXYCYCLINE,1.0,J01AA02,Doxycycline,Tablet,Oral,02543478,M-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) MANTRA PHARMA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106175,Marketed,2025-12-12,02558505,NRA-DOXYCYCLINE,1.0,J01AA02,Doxycycline,Tablet,Oral,02558505,NRA-DOXYCYCLINE (doxycycline (doxycycline hyclate) 100 mg oral tablet) NORA PHARMA INC,Active,9000318,doxycycline (doxycycline hyclate) 100 mg oral tablet,8000117,doxycycline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106441,Marketed,2025-11-24,02561441,DOXYCYCLINE FOR INJECTION USP,1.0,J01AA02,Doxycycline,Powder for solution,Intravenous,02561441,DOXYCYCLINE FOR INJECTION USP (doxycycline (doxycycline hyclate) 100 mg per vial powder for solution for injection) STERIMAX INC,Active,9015277,doxycycline (doxycycline hyclate) 100 mg per vial powder for solution for injection,8000117,doxycycline,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
5509,Marketed,1983-12-31,00609129,DICLECTIN,2.0,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,00609129,DICLECTIN (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) DUCHESNAY INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
89091,Marketed,2017-07-10,02406187,PMS-DOXYLAMINE-PYRIDOXINE,2.0,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02406187,PMS-DOXYLAMINE-PYRIDOXINE (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
89791,Marketed,2017-08-11,02413248,APO-DOXYLAMINE/B6,2.0,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02413248,APO-DOXYLAMINE/B6 (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) APOTEX INC,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
104153,Marketed,2025-04-17,02552574,ALOG-DOXYLAMINE/PYRIDOXINE,2.0,R06AA59,"Doxylamine, combinations",Tablet (delayed-release),Oral,02552574,ALOG-DOXYLAMINE/PYRIDOXINE (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet) ANALOG PHARMA CANADA INC.,Active,9001975,doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg gastro-resistant tablet,8001905,doxylamine and pyridoxine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
81672,Marketed,2009-09-28,02330989,MULTAQ,1.0,C01BD07,Dronedarone,Tablet,Oral,02330989,MULTAQ (dronedarone (dronedarone hydrochloride) 400 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9004593,dronedarone (dronedarone hydrochloride) 400 mg oral tablet,8001638,dronedarone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101192,Marketed,2022-04-20,02522802,SLYND,1.0,G03AC10,Drospirenone,Tablet,Oral,02522802,SLYND (drospirenone 4 mg oral tablet) DUCHESNAY INC,Active,9014678,drospirenone 4 mg oral tablet,8002419,drospirenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100241,Marketed,2021-06-15,02513218,NEXTSTELLIS,2.0,G03AA18,Drospirenone and estetrol,Tablet,Oral,02513218,NEXTSTELLIS (drospirenone 3 mg and estetrol monohydrate 15 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9014542,drospirenone 3 mg and estetrol 15 mg oral tablet,8002372,drospirenone and estetrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74710,Marketed,2007-12-13,02261723,YASMIN 21,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02261723,YASMIN 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) BAYER INC,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74711,Marketed,2007-11-28,02261731,YASMIN 28,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02261731,YASMIN 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75422,Marketed,2008-10-20,02268825,ANGELIQ,2.0,G03FA17,Drospirenone and estrogen,Tablet,Oral,02268825,ANGELIQ (drospirenone 1 mg and estradiol 1 mg oral tablet) BAYER INC,Active,9004467,drospirenone 1 mg and estradiol 1 mg oral tablet,8000970,drospirenone and estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80656,Marketed,2009-01-06,02321157,YAZ,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02321157,YAZ (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87302,Marketed,2013-03-01,02387433,YAZ PLUS,4.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02387433,YAZ PLUS (drospirenone 3 mg and ethinyl estradiol 20 mcg and levomefolate calcium 451 mcg oral tablet with levomefolate calcium 451 mcg oral tablet) BAYER INC,Active,9006607,drospirenone 3 mg and ethinyl estradiol 20 mcg and levomefolate calcium 451 mcg oral tablet with levomefolate calcium 451 mcg oral tablet,8002190,drospirenone and ethinyl estradiol and levomefolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89544,Marketed,2020-09-01,02410788,ZAMINE 21,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02410788,ZAMINE 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) APOTEX INC,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89545,Marketed,2020-09-01,02410796,ZAMINE 28,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02410796,ZAMINE 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89999,Marketed,2020-09-01,02415380,MYA,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02415380,MYA (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90606,Marketed,2021-10-22,02421437,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02421437,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006564,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90607,Marketed,2021-10-22,02421445,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02421445,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 (drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006565,drospirenone 3 mg and ethinyl estradiol 30 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94980,Marketed,2021-09-07,02462060,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP,2.0,G03AA12,Drospirenone and estrogen,Tablet,Oral,02462060,DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP (drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9006572,drospirenone 3 mg and ethinyl estradiol 20 mcg oral tablet with lactose oral tablet,8000345,drospirenone and ethinyl estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93430,Marketed,2016-01-08,02448599,TRULICITY,1.0,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448599,TRULICITY (dulaglutide 0.75 mg per 0.5 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013089,dulaglutide 0.75 mg per 0.5 mL solution for injection syringe,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
93431,Marketed,2015-11-24,02448602,TRULICITY,1.0,A10BJ05,Dulaglutide,Solution,Subcutaneous,02448602,TRULICITY (dulaglutide 1.5 mg per 0.5 mL solution for injection pen) ELI LILLY CANADA INC,Active,9013090,dulaglutide 1.5 mg per 0.5 mL solution for injection pen,8001639,dulaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
91389,Marketed,2016-05-02,02429446,PMS-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02429446,PMS-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
91391,Marketed,2016-05-02,02429454,PMS-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02429454,PMS-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92097,Marketed,2016-05-02,02436647,AURO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02436647,AURO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) AURO PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92098,Marketed,2016-05-02,02436655,AURO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02436655,AURO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) AURO PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92335,Marketed,2016-05-02,02438984,MINT-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02438984,MINT-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MINT PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92336,Marketed,2016-05-02,02438992,MINT-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02438992,MINT-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MINT PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92433,Marketed,2016-05-02,02439948,SANDOZ DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02439948,SANDOZ DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92434,Marketed,2016-05-02,02439956,SANDOZ DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02439956,SANDOZ DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92479,Marketed,2016-05-03,02440423,APO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02440423,APO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) APOTEX INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
92480,Marketed,2016-05-03,02440431,APO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02440431,APO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) APOTEX INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93136,Marketed,2019-05-14,02446081,MAR-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02446081,MAR-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93137,Marketed,2019-05-14,02446103,MAR-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02446103,MAR-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MARCAN PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93831,Marketed,2016-05-03,02451913,JAMP-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02451913,JAMP-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93832,Marketed,2016-05-03,02451921,JAMP-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02451921,JAMP-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93902,Marketed,2025-10-10,02452650,PRO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02452650,PRO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93903,Marketed,2025-10-10,02452669,PRO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02452669,PRO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94019,Marketed,2016-05-05,02453630,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02453630,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94020,Marketed,2016-05-05,02453649,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02453649,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94374,Marketed,2020-04-24,02456753,TEVA-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02456753,TEVA-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94375,Marketed,2020-04-24,02456761,TEVA-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02456761,TEVA-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94427,Marketed,2025-10-15,02457199,TARO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02457199,TARO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) TARO PHARMACEUTICALS INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94428,Marketed,2025-10-15,02457202,TARO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02457202,TARO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) TARO PHARMACEUTICALS INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
96254,Marketed,2019-06-27,02473208,M-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02473208,M-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) MANTRA PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
96255,Marketed,2019-06-27,02473216,M-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02473216,M-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) MANTRA PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
96567,Marketed,2018-07-19,02475308,AG-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02475308,AG-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ANGITA PHARMA INC.,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
96568,Marketed,2018-07-19,02475316,AG-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02475316,AG-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ANGITA PHARMA INC.,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
97213,Marketed,2023-10-05,02481952,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02481952,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ALTAMED PHARMA,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
97214,Marketed,2023-09-20,02481960,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02481960,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ALTAMED PHARMA,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
97243,Marketed,2019-03-06,02482126,NRA-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02482126,NRA-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) NORA PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
97244,Marketed,2019-03-06,02482134,NRA-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02482134,NRA-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) NORA PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98503,Marketed,2020-04-06,02495082,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02495082,DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
98504,Marketed,2020-04-06,02495090,DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02495090,DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99712,Marketed,2023-02-17,02507722,BIO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02507722,BIO-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) BIOMED PHARMA,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99716,Marketed,2023-02-17,02507765,BIO-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02507765,BIO-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) BIOMED PHARMA,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
100179,Marketed,2023-11-17,02512505,JAMP DULOXETINE CAPSULES,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02512505,JAMP DULOXETINE CAPSULES (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) JAMP PHARMA CORPORATION,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
101196,Marketed,2022-04-04,02522861,ACCEL-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02522861,ACCEL-DULOXETINE (duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule) ACCEL PHARMA INC,Active,9001234,duloxetine (duloxetine hydrochloride) 30 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
101197,Marketed,2022-04-04,02522888,ACCEL-DULOXETINE,1.0,N06AX21,Duloxetine,Capsule (delayed release),Oral,02522888,ACCEL-DULOXETINE (duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule) ACCEL PHARMA INC,Active,9001235,duloxetine (duloxetine hydrochloride) 60 mg gastro-resistant capsule,8000375,duloxetine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
95935,Marketed,2018-02-06,02470365,DUPIXENT,1.0,D11AH05,Dupilumab,Solution,Subcutaneous,02470365,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012489,dupilumab 300 mg per 2 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98251,Marketed,2019-11-29,02492504,DUPIXENT,1.0,D11AH05,Dupilumab,Solution,Subcutaneous,02492504,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9014202,dupilumab 200 mg per 1.14 mL solution for injection syringe,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
99930,Marketed,2021-05-27,02510049,DUPIXENT,1.0,D11AH05,Dupilumab,Solution,Subcutaneous,02510049,DUPIXENT (dupilumab 300 mg per 2 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014543,dupilumab 300 mg per 2 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101328,Marketed,2022-06-23,02524252,DUPIXENT,1.0,D11AH05,Dupilumab,Solution,Subcutaneous,02524252,DUPIXENT (dupilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9014738,dupilumab 200 mg per 1.14 mL solution for injection pen,8001148,dupilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
95736,Marketed,2017-11-20,02468816,IMFINZI,1.0,L01FF03,Durvalumab,Solution,Intravenous,77700574,IMFINZI (durvalumab 120 mg per 2.4 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012490,durvalumab 120 mg per 2.4 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95736,Marketed,2017-11-20,02468816,IMFINZI,1.0,L01FF03,Durvalumab,Solution,Intravenous,77700575,IMFINZI (durvalumab 500 mg per 10 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9012491,durvalumab 500 mg per 10 mL solution for injection vial,8001138,durvalumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
72107,Marketed,2003-11-14,02247813,AVODART,1.0,G04CB02,Dutasteride,Capsule,Oral,02247813,AVODART (dutasteride 0.5 mg oral capsule) GLAXOSMITHKLINE INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88899,Marketed,2014-07-18,02404206,APO-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02404206,APO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) APOTEX INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
89301,Marketed,2014-07-16,02408287,TEVA-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02408287,TEVA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) TEVA CANADA LIMITED,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90086,Marketed,2014-10-10,02416298,MED-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02416298,MED-DUTASTERIDE (dutasteride 0.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90637,Marketed,2019-04-10,02421712,DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02421712,DUTASTERIDE (dutasteride 0.5 mg oral capsule) PRO DOC LIMITEE,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90912,Marketed,2024-06-17,02424444,SANDOZ DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02424444,SANDOZ DUTASTERIDE (dutasteride 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91226,Marketed,2014-09-18,02427753,RIVA-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02427753,RIVA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91334,Marketed,2014-09-19,02428873,MINT-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02428873,MINT-DUTASTERIDE (dutasteride 0.5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91345,Marketed,2025-10-23,02429012,DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02429012,DUTASTERIDE (dutasteride 0.5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92760,Marketed,2025-08-13,02443058,DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02443058,DUTASTERIDE (dutasteride 0.5 mg oral capsule) SANIS HEALTH INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95804,Marketed,2018-06-04,02469308,AURO-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02469308,AURO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) AURO PHARMA INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97515,Marketed,2019-11-07,02484870,JAMP DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02484870,JAMP DUTASTERIDE (dutasteride 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97590,Marketed,2025-08-19,02485672,AG-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02485672,AG-DUTASTERIDE (dutasteride 0.5 mg oral capsule) ANGITA PHARMA INC.,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98062,Marketed,2024-01-02,02490587,NRA-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02490587,NRA-DUTASTERIDE (dutasteride 0.5 mg oral capsule) NORA PHARMA INC,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103240,Marketed,2024-07-22,02543990,PRO-DUTASTERIDE,1.0,G04CB02,Dutasteride,Capsule,Oral,02543990,PRO-DUTASTERIDE (dutasteride 0.5 mg oral capsule) PRO DOC LIMITEE,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103488,Marketed,2025-03-17,02546167,JAMP DUTASTERIDE CAPSULES,1.0,G04CB02,Dutasteride,Capsule,Oral,02546167,JAMP DUTASTERIDE CAPSULES (dutasteride 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001054,dutasteride 0.5 mg oral capsule,8000330,dutasteride,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
80774,Marketed,2013-09-16,02322285,SOLIRIS,1.0,L04AJ01,Eculizumab,Solution,Intravenous,02322285,SOLIRIS (eculizumab 300 mg per 30 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9012965,eculizumab 300 mg per 30 mL solution for injection vial,8001641,eculizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102163,Marketed,2023-02-09,02532611,RADICAVA,1.0,N07XX14,Edaravone,Suspension,Oral,02532611,RADICAVA (edaravone 105 mg per 5 mL oral suspension) MITSUBISHI TANABE PHARMA CORPORATION,Active,9014830,edaravone 105 mg per 5 mL oral suspension,8002305,edaravone,26643006,Oral,385024007,Oral suspension,,,1.0,,
94579,Marketed,2017-04-25,02458640,LIXIANA,1.0,B01AF03,Edoxaban,Tablet,Oral,02458640,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) SERVIER CANADA INC,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94580,Marketed,2017-04-25,02458659,LIXIANA,1.0,B01AF03,Edoxaban,Tablet,Oral,02458659,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) SERVIER CANADA INC,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94581,Marketed,2017-04-25,02458667,LIXIANA,1.0,B01AF03,Edoxaban,Tablet,Oral,02458667,LIXIANA (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) SERVIER CANADA INC,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104235,Marketed,2025-05-06,02553414,SANDOZ EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02553414,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104236,Marketed,2025-05-06,02553422,SANDOZ EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02553422,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104237,Marketed,2025-05-06,02553430,SANDOZ EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02553430,SANDOZ EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104307,Marketed,2025-05-05,02554208,TEVA-EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02554208,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 15 mg oral tablet) TEVA CANADA LIMITED,Active,9006163,edoxaban (edoxaban tosylate) 15 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104308,Marketed,2025-05-05,02554216,TEVA-EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02554216,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104309,Marketed,2025-05-05,02554224,TEVA-EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02554224,TEVA-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) TEVA CANADA LIMITED,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106033,Marketed,2025-07-17,02556960,PRO-EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02556960,PRO-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) PRO DOC LIMITEE,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106034,Marketed,2025-07-17,02556979,PRO-EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02556979,PRO-EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) PRO DOC LIMITEE,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106062,Marketed,2025-05-16,02557282,JAMP EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02557282,JAMP EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006164,edoxaban (edoxaban tosylate) 30 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106063,Marketed,2025-05-16,02557290,JAMP EDOXABAN,1.0,B01AF03,Edoxaban,Tablet,Oral,02557290,JAMP EDOXABAN (edoxaban (edoxaban tosylate monohydrate) 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9006165,edoxaban (edoxaban tosylate) 60 mg oral tablet,8001759,edoxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86737,Marketed,2013-07-30,02381524,MYLAN-EFAVIRENZ,1.0,J05AG03,Efavirenz,Tablet,Oral,02381524,MYLAN-EFAVIRENZ (efavirenz 600 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87524,Marketed,2013-07-30,02389762,TEVA-EFAVIRENZ,1.0,J05AG03,Efavirenz,Tablet,Oral,02389762,TEVA-EFAVIRENZ (efavirenz 600 mg oral tablet) TEVA CANADA LIMITED,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90299,Marketed,2014-03-03,02418428,AURO-EFAVIRENZ,1.0,J05AG03,Efavirenz,Tablet,Oral,02418428,AURO-EFAVIRENZ (efavirenz 600 mg oral tablet) AURO PHARMA INC,Active,9003764,efavirenz 600 mg oral tablet,8001192,efavirenz,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103023,Marketed,2023-11-06,02541599,VYVGART,1.0,L04AA58,Efgartigimod alfa,Solution,Intravenous,02541599,VYVGART (efgartigimod alfa 400 mg per 20 mL solution for injection vial) ARGENX BV,Active,9014976,efgartigimod alfa 400 mg per 20 mL solution for injection vial,8002491,efgartigimod alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106549,Marketed,2026-01-20,02562634,VYVGART SC,1.0,L04AA58,Efgartigimod alfa,Solution,Subcutaneous,,,,,,,,,,,,,,,,
89805,Marketed,2020-01-21,02413388,JUBLIA,1.0,D01AC19,Efinaconazole,Solution,Topical,02413388,"JUBLIA (efinaconazole 10 % cutaneous solution) BAUSCH HEALTH, CANADA INC.",Active,9005554,efinaconazole 10 % cutaneous solution,8001264,efinaconazole,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
67778,Marketed,2015-12-04,02243837,VANIQA,1.0,D11AX16,Eflornithine,Cream,Topical,02243837,VANIQA (eflornithine hydrochloride 13.9 % cutaneous cream) CIPHER PHARMACEUTICALS INC,Active,9004095,eflornithine hydrochloride 13.9 % cutaneous cream,8001642,eflornithine,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,
106038,Marketed,2025-05-20,02557010,IQIRVO,1.0,A05AX06,Elafibranor,Tablet,Oral,02557010,IQIRVO (elafibranor 80 mg oral tablet) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9015202,elafibranor 80 mg oral tablet,8002543,elafibranor,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
97182,Marketed,2018-10-30,02481332,ORILISSA,1.0,H01CC03,Elagolix,Tablet,Oral,02481332,ORILISSA (elagolix (elagolix sodium) 150 mg oral tablet) ABBVIE CORPORATION,Active,9013436,elagolix (elagolix sodium) 150 mg oral tablet,8002021,elagolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97183,Marketed,2019-05-24,02481340,ORILISSA,1.0,H01CC03,Elagolix,Tablet,Oral,02481340,ORILISSA (elagolix (elagolix sodium) 200 mg oral tablet) ABBVIE CORPORATION,Active,9013905,elagolix (elagolix sodium) 200 mg oral tablet,8002021,elagolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
1628,Marketed,1957-12-31,00061085,"LACTATED RINGER'S INJECTION, USP",4.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
1745,Marketed,2019-12-19,00039470,LACTATED RINGER'S INJECTION,4.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
9826,Marketed,2013-01-29,00786209,(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP,2.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
9827,Marketed,2013-01-21,00786217,(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP,2.0,B05BB01,Electrolytes,Liquid,Intravenous,,,,,,,,,,,,,,,,
12186,Marketed,1998-09-03,01931636,LACTATED RINGER'S INJECTION USP,4.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
12741,Marketed,1998-06-17,01931628,ISOLYTE S (MULTI-ELECTROLYTE INJECTION),5.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
21757,Marketed,1998-06-17,01931679,ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION),7.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
67329,Marketed,2001-05-31,02243421,POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION,4.0,B05BB01,Electrolytes,Liquid,Intravenous,,,,,,,,,,,,,,,,
75479,Marketed,2008-03-31,02269414,POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP,2.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
82495,Marketed,2010-12-23,02339358,PLASMA-LYTE A INJECTION,5.0,B05BB01,Electrolytes,Solution,Intravenous,,,,,,,,,,,,,,,,
16226,Marketed,2006-07-19,02091100,MICRO PLUS 6  (PEDIATRIC),6.0,B05XA31,Electrolytes in comb with other drugs,Liquid,Intravenous,,,,,,,,,,,,,,,,
19923,Marketed,2024-05-03,02091135,MICRO +4 REGULAR STRENGTH,4.0,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,
98749,Marketed,2020-12-01,02497697,ADDNUTRIV,9.0,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,
99695,Marketed,2021-06-18,02507587,MICRO+6 CONCENTRATE,6.0,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,
102495,Marketed,2024-06-25,02536145,MICRO+ TE PEDIATRIC,5.0,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,
104175,Marketed,2025-05-30,02552787,MICRO+6 REGULAR,6.0,B05XA31,Electrolytes in comb with other drugs,Solution,Intravenous,,,,,,,,,,,,,,,,
1673,Marketed,1973-12-31,00061131,"LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP",5.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
1750,Marketed,2020-09-15,00038903,5% DEXTROSE AND 0.45% SODIUM CHLORIDE,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
3132,Marketed,2013-01-21,00438014,(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
3133,Marketed,2013-01-21,00438022,(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10041,Marketed,2013-01-21,00438049,(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10042,Marketed,2013-01-21,00438030,(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10044,Marketed,2013-01-21,00437999,(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10045,Marketed,2013-01-20,00438006,(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10438,Marketed,1990-12-31,00060704,DEXTROSE 5% AND 0.2% SOD CHLORIDE INJ,2.0,B05BB02,Electrolytes with carbohydrates,Liquid,Intravenous,,,,,,,,,,,,,,,,
10439,Marketed,1990-12-31,00060739,DEXTROSE 5% AND 0.45% SOD CHLORIDE INJ,2.0,B05BB02,Electrolytes with carbohydrates,Liquid,Intravenous,,,,,,,,,,,,,,,,
10440,Marketed,1990-12-31,00060747,DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ,2.0,B05BB02,Electrolytes with carbohydrates,Liquid,Intravenous,,,,,,,,,,,,,,,,
10441,Marketed,1990-12-31,00060755,DEXTROSE 10% AND 0.9% SOD CHLORIDE INJ,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10515,Marketed,1990-12-31,00060712,DEXTROSE 3.3% AND 0.3% SOD CHLORIDE INJ,2.0,B05BB02,Electrolytes with carbohydrates,Liquid,Intravenous,,,,,,,,,,,,,,,,
10866,Marketed,2013-01-21,00786292,(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
10867,Marketed,1990-12-31,00786306,POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
13033,Marketed,1998-05-01,01927531,5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
13288,Marketed,1998-05-01,01924435,5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP,2.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
21753,Marketed,1998-10-01,01931598,0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP,3.0,B05BB02,Electrolytes with carbohydrates,Solution,Intravenous,,,,,,,,,,,,,,,,
74152,Marketed,2023-08-30,02256290,RELPAX,1.0,N02CC06,Eletriptan,Tablet,Oral,02256290,RELPAX (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) BGP PHARMA ULC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74153,Marketed,2023-08-30,02256304,RELPAX,1.0,N02CC06,Eletriptan,Tablet,Oral,02256304,RELPAX (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) BGP PHARMA ULC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82774,Marketed,2023-12-05,02342235,MYLAN-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02342235,MYLAN-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82775,Marketed,2023-12-05,02342243,MYLAN-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02342243,MYLAN-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86796,Marketed,2013-12-20,02382091,TEVA-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02382091,TEVA-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86797,Marketed,2013-12-20,02382105,TEVA-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02382105,TEVA-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97013,Marketed,2019-02-01,02479451,AURO-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02479451,AURO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) AURO PHARMA INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97014,Marketed,2019-02-01,02479478,AURO-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02479478,AURO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) AURO PHARMA INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98004,Marketed,2026-01-22,02489961,PRO-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02489961,PRO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) PRO DOC LIMITEE,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98005,Marketed,2026-01-22,02489988,PRO-ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02489988,PRO-ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) PRO DOC LIMITEE,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100048,Marketed,2021-07-22,02511266,ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02511266,ELETRIPTAN (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) SANIS HEALTH INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100049,Marketed,2021-07-22,02511274,ELETRIPTAN,1.0,N02CC06,Eletriptan,Tablet,Oral,02511274,ELETRIPTAN (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) SANIS HEALTH INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100735,Marketed,2022-06-01,02518015,APO-ELETRIPTAN TABLETS,1.0,N02CC06,Eletriptan,Tablet,Oral,02518015,APO-ELETRIPTAN TABLETS (eletriptan (eletriptan hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9003961,eletriptan (eletriptan hydrobromide) 20 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100736,Marketed,2022-06-01,02518023,APO-ELETRIPTAN TABLETS,1.0,N02CC06,Eletriptan,Tablet,Oral,02518023,APO-ELETRIPTAN TABLETS (eletriptan (eletriptan hydrobromide) 40 mg oral tablet) APOTEX INC,Active,9003962,eletriptan (eletriptan hydrobromide) 40 mg oral tablet,8001112,eletriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95117,Marketed,2024-10-14,02463261,CERDELGA,1.0,A16AX10,Eliglustat,Capsule,Oral,02463261,CERDELGA (eliglustat (eliglustat tartrate) 84 mg oral capsule) SANOFI-AVENTIS CANADA INC,Active,9012796,eliglustat (eliglustat tartrate) 84 mg oral capsule,8001454,eliglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91171,Marketed,2014-08-27,02427184,VIMIZIM,1.0,A16AB12,Elosulfase alfa,Solution,Intravenous,02427184,VIMIZIM (elosulfase alfa 5 mg per 5 mL solution for injection vial) BIOMARIN INTERNATIONAL LIMITED,Active,9013091,elosulfase alfa 5 mg per 5 mL solution for injection vial,8001760,elosulfase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103201,Marketed,2024-01-23,02543559,ELREXFIO,1.0,L01FX32,Elranatamab,Solution,Subcutaneous,02543559,ELREXFIO (elranatamab 44 mg per 1.1 mL solution for injection vial) PFIZER CANADA ULC,Active,9015024,elranatamab 44 mg per 1.1 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103202,Marketed,2024-01-23,02543567,ELREXFIO,1.0,L01FX32,Elranatamab,Solution,Subcutaneous,02543567,ELREXFIO (elranatamab 76 mg per 1.9 mL solution for injection vial) PFIZER CANADA ULC,Active,9015025,elranatamab 76 mg per 1.9 mL solution for injection vial,8002498,elranatamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84687,Marketed,2016-03-24,02361825,REVOLADE,1.0,B02BX05,Eltrombopag,Tablet,Oral,02361825,REVOLADE (eltrombopag (eltrombopag olamine) 25 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004860,eltrombopag (eltrombopag olamine) 25 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84688,Marketed,2016-02-16,02361833,REVOLADE,1.0,B02BX05,Eltrombopag,Tablet,Oral,02361833,REVOLADE (eltrombopag (eltrombopag olamine) 50 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004855,eltrombopag (eltrombopag olamine) 50 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99608,Marketed,2023-05-23,02506742,APO-ELTROMBOPAG,1.0,B02BX05,Eltrombopag,Tablet,Oral,02506742,APO-ELTROMBOPAG (eltrombopag (eltrombopag olamine) 25 mg oral tablet) APOTEX INC,Active,9004860,eltrombopag (eltrombopag olamine) 25 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99610,Marketed,2023-05-23,02506769,APO-ELTROMBOPAG,1.0,B02BX05,Eltrombopag,Tablet,Oral,02506769,APO-ELTROMBOPAG (eltrombopag (eltrombopag olamine) 50 mg oral tablet) APOTEX INC,Active,9004855,eltrombopag (eltrombopag olamine) 50 mg oral tablet,8001906,eltrombopag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94840,Marketed,2025-06-09,02460890,VIBERZI,1.0,A07DA06,Eluxadoline,Tablet,Oral,02460890,VIBERZI (eluxadoline 75 mg oral tablet) ABBVIE CORPORATION,Active,9006161,eluxadoline 75 mg oral tablet,8001761,eluxadoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94841,Marketed,2025-03-03,02460904,VIBERZI,1.0,A07DA06,Eluxadoline,Tablet,Oral,02460904,VIBERZI (eluxadoline 100 mg oral tablet) ABBVIE CORPORATION,Active,9006160,eluxadoline 100 mg oral tablet,8001761,eluxadoline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97030,Marketed,2018-10-19,02479621,HEMLIBRA,1.0,B02BX06,Emicizumab,Solution,Subcutaneous,02479621,HEMLIBRA (emicizumab 30 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014256,emicizumab 30 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97031,Marketed,2018-10-19,02479648,HEMLIBRA,1.0,B02BX06,Emicizumab,Solution,Subcutaneous,02479648,HEMLIBRA (emicizumab 60 mg per 0.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014257,emicizumab 60 mg per 0.4 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97032,Marketed,2019-02-21,02479656,HEMLIBRA,1.0,B02BX06,Emicizumab,Solution,Subcutaneous,02479656,HEMLIBRA (emicizumab 105 mg per 0.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014254,emicizumab 105 mg per 0.7 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97033,Marketed,2018-11-27,02479664,HEMLIBRA,1.0,B02BX06,Emicizumab,Solution,Subcutaneous,02479664,HEMLIBRA (emicizumab 150 mg per 1 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014255,emicizumab 150 mg per 1 mL solution for injection vial,8002320,emicizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92871,Marketed,2015-08-11,02443937,JARDIANCE,1.0,A10BK03,Empagliflozin,Tablet,Oral,02443937,JARDIANCE (empagliflozin 10 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005754,empagliflozin 10 mg oral tablet,8001455,empagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92872,Marketed,2015-08-11,02443945,JARDIANCE,1.0,A10BK03,Empagliflozin,Tablet,Oral,02443945,JARDIANCE (empagliflozin 25 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005755,empagliflozin 25 mg oral tablet,8001455,empagliflozin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94099,Marketed,2016-06-03,02454416,DESCOVY,2.0,J05AR17,Emtricitabine and tenofovir alafenamide,Tablet,Oral,02454416,DESCOVY (emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005979,emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001197,emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94100,Marketed,2016-06-03,02454424,DESCOVY,2.0,J05AR17,Emtricitabine and tenofovir alafenamide,Tablet,Oral,02454424,DESCOVY (emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005980,emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001197,emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96935,Marketed,2018-08-08,02478579,BIKTARVY,3.0,J05AR20,"Emtricitabine, tenofovir alafenamide and bictegravir",Tablet,Oral,02478579,BIKTARVY (bictegravir (bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9013409,bictegravir (bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8002013,bictegravir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94909,Marketed,2017-03-20,02461463,ODEFSEY,3.0,J05AR19,"Emtricitabine, tenofovir alafenamide and rilpivirine",Tablet,Oral,02461463,ODEFSEY (emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006139,emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001195,emtricitabine and rilpivirine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96312,Marketed,2018-04-25,02473720,SYMTUZA,4.0,J05AR22,"Emtricitabine, tenofovir alafenamide, darunavir and cobicistat",Tablet,Oral,02473720,SYMTUZA (cobicistat 150 mg and darunavir (darunavir ethanolate) 800 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) JANSSEN INC,Active,9012699,cobicistat 150 mg and darunavir 800 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001363,cobicistat and darunavir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93532,Marketed,2016-02-03,02449498,GENVOYA,4.0,J05AR18,"Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",Tablet,Oral,02449498,GENVOYA (cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005870,cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (tenofovir alafenamide hemifumarate) 10 mg oral tablet,8001313,cobicistat and elvitegravir and emtricitabine and tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87876,Marketed,2017-07-26,02393549,TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR,3.0,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02393549,TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94902,Marketed,2017-07-31,02461412,MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,3.0,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02461412,MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95665,Marketed,2018-09-04,02468247,APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR,3.0,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02468247,APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96916,Marketed,2020-03-18,02478404,AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR,3.0,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02478404,AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100873,Marketed,2022-12-14,02519461,JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,3.0,J05AR06,"Emtricitabine, tenofovir disoproxil and efavirenz",Tablet,Oral,02519461,JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004343,efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001193,efavirenz and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85932,Marketed,2014-10-04,02374129,COMPLERA,3.0,J05AR08,"Emtricitabine, tenofovir disoproxil and rilpivirine",Tablet,Oral,02374129,COMPLERA (emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9004942,emtricitabine 200 mg and rilpivirine (rilpivirine hydrochloride) 25 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001196,emtricitabine and rilpivirine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88208,Marketed,2012-12-20,02397137,STRIBILD,4.0,J05AR09,"Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",Tablet,Oral,02397137,STRIBILD (cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005142,cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001314,cobicistat and elvitegravir and emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8102,Marketed,2022-04-07,00670901,VASOTEC,1.0,C09AA02,Enalapril,Tablet,Oral,00670901,VASOTEC (enalapril maleate 10 mg oral tablet) ORGANON CANADA INC.,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8103,Marketed,2022-06-17,00670928,VASOTEC,1.0,C09AA02,Enalapril,Tablet,Oral,00670928,VASOTEC (enalapril maleate 20 mg oral tablet) ORGANON CANADA INC.,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8111,Marketed,2022-04-11,00708879,VASOTEC,1.0,C09AA02,Enalapril,Tablet,Oral,00708879,VASOTEC (enalapril maleate 5 mg oral tablet) ORGANON CANADA INC.,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14385,Marketed,1993-12-31,02020025,APO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02020025,APO-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) APOTEX INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14386,Marketed,1993-12-31,02019884,APO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02019884,APO-ENALAPRIL (enalapril maleate 5 mg oral tablet) APOTEX INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14387,Marketed,1993-12-31,02019892,APO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02019892,APO-ENALAPRIL (enalapril maleate 10 mg oral tablet) APOTEX INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14388,Marketed,1993-12-31,02019906,APO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02019906,APO-ENALAPRIL (enalapril maleate 20 mg oral tablet) APOTEX INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77724,Marketed,2017-08-18,02291878,ACT ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02291878,ACT ENALAPRIL (enalapril maleate 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77725,Marketed,2017-08-18,02291886,ACT ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02291886,ACT ENALAPRIL (enalapril maleate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77726,Marketed,2017-08-18,02291894,ACT ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02291894,ACT ENALAPRIL (enalapril maleate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77727,Marketed,2017-08-18,02291908,ACT ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02291908,ACT ENALAPRIL (enalapril maleate 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78528,Marketed,2007-10-17,02299933,SANDOZ ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02299933,SANDOZ ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78529,Marketed,2007-10-17,02299941,SANDOZ ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02299941,SANDOZ ENALAPRIL (enalapril maleate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78530,Marketed,2007-10-17,02299968,SANDOZ ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02299968,SANDOZ ENALAPRIL (enalapril maleate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78531,Marketed,2007-10-17,02299976,SANDOZ ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02299976,SANDOZ ENALAPRIL (enalapril maleate 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79698,Marketed,2008-07-04,02311402,PRO-ENALAPRIL - 2.5,1.0,C09AA02,Enalapril,Tablet,Oral,02311402,PRO-ENALAPRIL - 2.5 (enalapril maleate 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79699,Marketed,2008-07-04,02311410,PRO-ENALAPRIL - 5,1.0,C09AA02,Enalapril,Tablet,Oral,02311410,PRO-ENALAPRIL - 5 (enalapril maleate 5 mg oral tablet) PRO DOC LIMITEE,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79700,Marketed,2008-07-04,02311429,PRO-ENALAPRIL - 10,1.0,C09AA02,Enalapril,Tablet,Oral,02311429,PRO-ENALAPRIL - 10 (enalapril maleate 10 mg oral tablet) PRO DOC LIMITEE,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79701,Marketed,2008-07-04,02311437,PRO-ENALAPRIL - 20,1.0,C09AA02,Enalapril,Tablet,Oral,02311437,PRO-ENALAPRIL - 20 (enalapril maleate 20 mg oral tablet) PRO DOC LIMITEE,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83747,Marketed,2022-02-15,02352230,TARO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02352230,TARO-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83748,Marketed,2022-02-15,02352249,TARO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02352249,TARO-ENALAPRIL (enalapril maleate 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83749,Marketed,2022-02-15,02352257,TARO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02352257,TARO-ENALAPRIL (enalapril maleate 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83750,Marketed,2022-02-15,02352265,TARO-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02352265,TARO-ENALAPRIL (enalapril maleate 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87402,Marketed,2024-05-22,02388499,ENALAPRILAT INJECTION USP,1.0,C09AA02,Enalapril,Solution,Intravenous,77700621,ENALAPRILAT INJECTION USP (enalaprilat 1.25 mg per 1 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9005100,enalaprilat 1.25 mg per 1 mL solution for injection vial,8001378,enalaprilat,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87402,Marketed,2024-05-22,02388499,ENALAPRILAT INJECTION USP,1.0,C09AA02,Enalapril,Solution,Intravenous,77700622,ENALAPRILAT INJECTION USP (enalaprilat 2.5 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9002460,enalaprilat 2.5 mg per 2 mL solution for injection vial,8001378,enalaprilat,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88543,Marketed,2022-01-07,02400650,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02400650,ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SANIS HEALTH INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88544,Marketed,2022-01-07,02400669,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02400669,ENALAPRIL (enalapril maleate 5 mg oral tablet) SANIS HEALTH INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88545,Marketed,2022-01-07,02400677,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02400677,ENALAPRIL (enalapril maleate 10 mg oral tablet) SANIS HEALTH INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88546,Marketed,2022-01-07,02400685,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02400685,ENALAPRIL (enalapril maleate 20 mg oral tablet) SANIS HEALTH INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92748,Marketed,2018-10-04,02442957,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02442957,ENALAPRIL (enalapril maleate 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92749,Marketed,2018-10-04,02442965,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02442965,ENALAPRIL (enalapril maleate 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92750,Marketed,2018-10-04,02442973,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02442973,ENALAPRIL (enalapril maleate 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92751,Marketed,2018-10-04,02442981,ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02442981,ENALAPRIL (enalapril maleate 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92998,Marketed,2019-03-20,02444771,MAR-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02444771,MAR-ENALAPRIL (enalapril maleate 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92999,Marketed,2019-03-20,02444798,MAR-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02444798,MAR-ENALAPRIL (enalapril maleate 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94669,Marketed,2019-03-20,02459450,MAR-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02459450,MAR-ENALAPRIL (enalapril maleate 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94670,Marketed,2019-03-20,02459469,MAR-ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02459469,MAR-ENALAPRIL (enalapril maleate 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96497,Marketed,2019-02-25,02474786,JAMP ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02474786,JAMP ENALAPRIL (enalapril maleate 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000466,enalapril maleate 2.5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96498,Marketed,2019-02-25,02474794,JAMP ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02474794,JAMP ENALAPRIL (enalapril maleate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000467,enalapril maleate 5 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96499,Marketed,2019-02-25,02474808,JAMP ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02474808,JAMP ENALAPRIL (enalapril maleate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000464,enalapril maleate 10 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96500,Marketed,2019-02-25,02474816,JAMP ENALAPRIL,1.0,C09AA02,Enalapril,Tablet,Oral,02474816,JAMP ENALAPRIL (enalapril maleate 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000465,enalapril maleate 20 mg oral tablet,8000118,enalapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10913,Marketed,2022-02-01,00657298,VASERETIC,2.0,C09BA02,Enalapril and diuretics,Tablet,Oral,00657298,VASERETIC (enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet) ORGANON CANADA INC.,Active,9004832,enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83816,Marketed,2017-12-28,02352923,ENALAPRIL MALEATE/HCTZ,2.0,C09BA02,Enalapril and diuretics,Tablet,Oral,02352923,ENALAPRIL MALEATE/HCTZ (enalapril maleate 5 mg and hydrochlorothiazide 12.5 mg oral tablet) AA PHARMA INC,Active,9004833,enalapril maleate 5 mg and hydrochlorothiazide 12.5 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83817,Marketed,2017-12-28,02352931,ENALAPRIL MALEATE/HCTZ,2.0,C09BA02,Enalapril and diuretics,Tablet,Oral,02352931,ENALAPRIL MALEATE/HCTZ (enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet) AA PHARMA INC,Active,9004832,enalapril maleate 10 mg and hydrochlorothiazide 25 mg oral tablet,8000849,enalapril and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81890,Marketed,2013-10-09,02333279,IXIARO,1.0,J07BA02,"Encephalitis, japanese, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,
100233,Marketed,2021-07-05,02513099,BRAFTOVI,1.0,L01EC03,Encorafenib,Capsule,Oral,02513099,BRAFTOVI (encorafenib 75 mg oral capsule) PFIZER CANADA ULC,Active,9014597,encorafenib 75 mg oral capsule,8002390,encorafenib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101108,Marketed,2025-09-19,02521903,PADCEV,1.0,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521903,PADCEV (enfortumab vedotin 20 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014639,enfortumab vedotin 20 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101109,Marketed,2025-09-19,02521911,PADCEV,1.0,L01FX13,Enfortumab vedotin,Powder for solution,Intravenous,02521911,PADCEV (enfortumab vedotin 30 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014819,enfortumab vedotin 30 mg per vial powder for solution for injection,8002402,enfortumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
14049,Marketed,2012-02-04,02012472,LOVENOX,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02012472,LOVENOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
59932,Marketed,2007-02-22,02236564,LOVENOX WITH PRESERVATIVE 300MG/3ML,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02236564,LOVENOX WITH PRESERVATIVE 300MG/3ML (enoxaparin sodium 100 mg per mL solution for injection 3 mL vial) SANOFI-AVENTIS CANADA INC,Active,9012620,enoxaparin sodium 100 mg per mL solution for injection 3 mL vial,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
60174,Marketed,2012-02-04,02236883,LOVENOX,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02236883,LOVENOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
66484,Marketed,2012-02-04,02242692,LOVENOX HP,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02242692,LOVENOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
86422,Marketed,2012-11-13,02378426,LOVENOX,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02378426,LOVENOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
86423,Marketed,2012-09-11,02378434,LOVENOX,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02378434,LOVENOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
86424,Marketed,2012-09-21,02378442,LOVENOX,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02378442,LOVENOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
86426,Marketed,2012-12-07,02378469,LOVENOX HP,1.0,B01AB05,Enoxaparin,Solution,Subcutaneous,02378469,LOVENOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
99582,Marketed,2021-06-25,02506459,NOROMBY,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506459,NOROMBY (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99583,Marketed,2021-06-25,02506467,NOROMBY,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506467,NOROMBY (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99584,Marketed,2021-06-25,02506475,NOROMBY,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506475,NOROMBY (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99585,Marketed,2021-06-25,02506483,NOROMBY,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506483,NOROMBY (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99586,Marketed,2021-06-25,02506491,NOROMBY,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506491,NOROMBY (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99587,Marketed,2021-06-25,02506505,NOROMBY HP,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02506505,NOROMBY HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99588,Marketed,2021-06-25,02506513,NOROMBY HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02506513,NOROMBY HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) JUNO PHARMACEUTICALS CORP.,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99688,Marketed,2021-06-09,02507501,INCLUNOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507501,INCLUNOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99689,Marketed,2021-05-04,02507528,INCLUNOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507528,INCLUNOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99690,Marketed,2021-05-04,02507536,INCLUNOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507536,INCLUNOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99691,Marketed,2021-05-04,02507544,INCLUNOX,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02507544,INCLUNOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99692,Marketed,2021-05-04,02507552,INCLUNOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507552,INCLUNOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99693,Marketed,2021-05-04,02507560,INCLUNOX HP,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507560,INCLUNOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99694,Marketed,2021-05-04,02507579,INCLUNOX HP,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02507579,INCLUNOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99839,Marketed,2021-04-09,02509075,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509075,"REDESCA (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99840,Marketed,2021-04-09,02509083,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509083,"REDESCA (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99841,Marketed,2021-04-09,02509091,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509091,"REDESCA (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99842,Marketed,2021-04-09,02509105,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509105,"REDESCA (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99843,Marketed,2021-04-09,02509113,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509113,"REDESCA (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99844,Marketed,2021-04-09,02509121,REDESCA,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509121,"REDESCA (enoxaparin sodium 300 mg per 3 mL solution for injection vial) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9014487,enoxaparin sodium 300 mg per 3 mL solution for injection vial,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
99845,Marketed,2021-04-09,02509148,REDESCA HP,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02509148,"REDESCA HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99846,Marketed,2021-04-09,02509156,REDESCA HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02509156,"REDESCA HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.",Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102130,Marketed,2023-03-09,02532247,ELONOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532247,ELONOX (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102131,Marketed,2023-03-09,02532255,ELONOX,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532255,ELONOX (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102132,Marketed,2023-03-09,02532263,ELONOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532263,ELONOX (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102133,Marketed,2023-03-09,02532271,ELONOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532271,ELONOX (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102134,Marketed,2023-03-09,02532298,ELONOX,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02532298,ELONOX (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102135,Marketed,2023-03-09,02532301,ELONOX HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532301,ELONOX HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102136,Marketed,2023-03-17,02532328,ELONOX HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02532328,ELONOX HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102870,Marketed,2024-10-15,02539977,AXBERI,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02539977,AXBERI (enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe) BAXTER CORPORATION,Active,9012623,enoxaparin sodium 30 mg per 0.3 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102871,Marketed,2024-10-15,02539985,AXBERI,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02539985,AXBERI (enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe) BAXTER CORPORATION,Active,9012624,enoxaparin sodium 40 mg per 0.4 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102873,Marketed,2024-10-01,02540002,AXBERI,1.0,B01AB05,Enoxaparin,Solution,"Intravenous,Subcutaneous",02540002,AXBERI (enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe) BAXTER CORPORATION,Active,9012625,enoxaparin sodium 60 mg per 0.6 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102874,Marketed,2024-10-01,02540010,AXBERI,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540010,AXBERI (enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe) BAXTER CORPORATION,Active,9012626,enoxaparin sodium 80 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102875,Marketed,2024-10-01,02540029,AXBERI HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540029,AXBERI HP (enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe) BAXTER CORPORATION,Active,9012621,enoxaparin sodium 120 mg per 0.8 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102876,Marketed,2024-10-15,02540037,AXBERI HP,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540037,AXBERI HP (enoxaparin sodium 150 mg per 1 mL solution for injection syringe) BAXTER CORPORATION,Active,9012622,enoxaparin sodium 150 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
102877,Marketed,2024-10-15,02540045,AXBERI,1.0,B01AB05,Enoxaparin,Solution,"Subcutaneous,Intravenous",02540045,AXBERI (enoxaparin sodium 100 mg per 1 mL solution for injection syringe) BAXTER CORPORATION,Active,9012619,enoxaparin sodium 100 mg per 1 mL solution for injection syringe,8001379,enoxaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
86097,Marketed,2012-03-29,02375559,TEVA-ENTACAPONE,1.0,N04BX02,Entacapone,Tablet,Oral,02375559,TEVA-ENTACAPONE (entacapone 200 mg oral tablet) TEVA CANADA LIMITED,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86585,Marketed,2012-03-30,02380005,SANDOZ ENTACAPONE,1.0,N04BX02,Entacapone,Tablet,Oral,02380005,SANDOZ ENTACAPONE (entacapone 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102475,Marketed,2024-02-21,02535939,MINT-ENTACAPONE,1.0,N04BX02,Entacapone,Tablet,Oral,02535939,MINT-ENTACAPONE (entacapone 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003617,entacapone 200 mg oral tablet,8001458,entacapone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76788,Marketed,2006-09-12,02282224,BARACLUDE,1.0,J05AF10,Entecavir,Tablet,Oral,02282224,BARACLUDE (entecavir 0.5 mg oral tablet) BRISTOL-MYERS SQUIBB CANADA,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88196,Marketed,2013-01-18,02396955,APO-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02396955,APO-ENTECAVIR (entecavir 0.5 mg oral tablet) APOTEX INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91502,Marketed,2014-09-09,02430576,PMS-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02430576,PMS-ENTECAVIR (entecavir 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91503,Marketed,2018-09-02,02430584,PMS-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02430584,PMS-ENTECAVIR (entecavir 1 mg oral tablet) PHARMASCIENCE INC,Active,9005584,entecavir 1 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93451,Marketed,2015-12-01,02448777,AURO-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02448777,AURO-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) AURO PHARMA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94033,Marketed,2020-12-01,02453797,ENTECAVIR TABLETS,1.0,J05AF10,Entecavir,Tablet,Oral,02453797,ENTECAVIR TABLETS (entecavir (entecavir monohydrate) 0.5 mg oral tablet) STRIDES PHARMA CANADA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95562,Marketed,2019-02-21,02467232,JAMP ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02467232,JAMP ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97047,Marketed,2020-03-11,02479907,ACCEL-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02479907,ACCEL-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) ACCEL PHARMA INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97614,Marketed,2020-01-06,02485907,MINT-ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02485907,MINT-ENTECAVIR (entecavir (entecavir monohydrate) 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101620,Marketed,2022-10-20,02527154,ENTECAVIR,1.0,J05AF10,Entecavir,Tablet,Oral,02527154,ENTECAVIR (entecavir 0.5 mg oral tablet) SANIS HEALTH INC,Active,9004212,entecavir 0.5 mg oral tablet,8001199,entecavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98496,Marketed,2020-03-10,02495007,ROZLYTREK,1.0,L01EX14,Entrectinib,Capsule,Oral,02495007,ROZLYTREK (entrectinib 100 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9014295,entrectinib 100 mg oral capsule,8002325,entrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98497,Marketed,2020-03-04,02495015,ROZLYTREK,1.0,L01EX14,Entrectinib,Capsule,Oral,02495015,ROZLYTREK (entrectinib 200 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9014296,entrectinib 200 mg oral capsule,8002325,entrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
89203,Marketed,2013-06-07,02407329,XTANDI,1.0,L02BB04,Enzalutamide,Capsule,Oral,02407329,XTANDI (enzalutamide 40 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9005262,enzalutamide 40 mg oral capsule,8001644,enzalutamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103087,Marketed,2023-12-18,02542293,EPKINLY,1.0,L01FX27,Epcoritamab,Solution,Subcutaneous,02542293,EPKINLY (epcoritamab 4 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015004,epcoritamab 4 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103088,Marketed,2023-12-18,02542307,EPKINLY,1.0,L01FX27,Epcoritamab,Solution,Subcutaneous,02542307,EPKINLY (epcoritamab 48 mg per 0.8 mL solution for injection vial) ABBVIE CORPORATION,Active,9015003,epcoritamab 48 mg per 0.8 mL solution for injection vial,8002492,epcoritamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
11096,Marketed,2005-08-12,00876534,EPHEDRINE SULFATE INJECTION USP,1.0,C01CA26,Ephedrine,Solution,"Intramuscular,Subcutaneous,Intravenous",00876534,EPHEDRINE SULFATE INJECTION USP (ephedrine sulfate 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012368,ephedrine sulfate 50 mg per 1 mL solution for injection ampoule,8001078,ephedrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
940,Marketed,2023-05-24,00155357,ADRENALIN,1.0,C01CA24,Epinephrine,Solution,"Ophthalmic,Intravenous,Subcutaneous,Intracardiac,Intraspinal,Intramuscular",77700211,ADRENALIN (epinephrine (epinephrine hydrochloride) 1 mg per 1 mL solution for injection ampoule) SEARCHLIGHT PHARMA INC,Active,9000003,epinephrine (epinephrine hydrochloride) 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
940,Marketed,2023-05-24,00155357,ADRENALIN,1.0,C01CA24,Epinephrine,Solution,"Ophthalmic,Intravenous,Subcutaneous,Intracardiac,Intraspinal,Intramuscular",77700212,ADRENALIN (epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9015026,epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vial,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1508,Marketed,2022-10-06,00155365,ADRENALIN TOPICAL SOLUTION,1.0,B02BC09,Epinephrine,Solution,Topical,00155365,ADRENALIN TOPICAL SOLUTION (epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solution) SEARCHLIGHT PHARMA INC,Active,9014635,epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solution,8000003,epinephrine,448598008,Cutaneous,739006009,Solution,,,,,
3883,Marketed,2013-03-22,00509558,EPIPEN,1.0,C01CA24,Epinephrine,Solution,Intramuscular,00509558,EPIPEN (epinephrine 0.3 mg per 0.3 mL solution for injection syringe) MYLAN SPECIALTY LP,Active,9001299,epinephrine 0.3 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
5970,Marketed,2013-01-30,00578657,EPIPEN JR,1.0,C01CA24,Epinephrine,Solution,Intramuscular,00578657,EPIPEN JR (epinephrine 0.15 mg per 0.3 mL solution for injection syringe) MYLAN SPECIALTY LP,Active,9001298,epinephrine 0.15 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
8352,Marketed,2018-03-16,00710814,EPINEPHRINE INJECTION USP,1.0,C01CA24,Epinephrine,Solution,"Intracardiac,Intravenous",00710814,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 10 mL solution for injection syringe) PFIZER CANADA ULC,Active,9000272,epinephrine 1 mg per 10 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
9164,Marketed,2018-03-16,00721891,EPINEPHRINE INJECTION USP,1.0,C01CA24,Epinephrine,Solution,"Intramuscular,Intracardiac,Subcutaneous,Intratracheal,Intravenous",00721891,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9000294,epinephrine 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92016,Marketed,2023-06-27,02435810,EPINEPHRINE INJECTION USP,1.0,C01CA24,Epinephrine,Solution,"Intramuscular,Intratracheal,Intravenous,Subcutaneous",02435810,EPINEPHRINE INJECTION USP (epinephrine 1 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9000294,epinephrine 1 mg per 1 mL solution for injection ampoule,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94557,Marketed,2020-10-08,02458446,EMERADE,1.0,C01CA24,Epinephrine,Solution,Intramuscular,02458446,"EMERADE (epinephrine (epinephrine bitartrate) 0.3 mg per 0.3 mL solution for injection syringe) BAUSCH HEALTH, CANADA INC.",Active,9014377,epinephrine (epinephrine bitartrate) 0.3 mg per 0.3 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94558,Marketed,2020-10-08,02458454,EMERADE,1.0,C01CA24,Epinephrine,Solution,Intramuscular,02458454,"EMERADE (epinephrine (epinephrine bitartrate) 0.5 mg per 0.5 mL solution for injection syringe) BAUSCH HEALTH, CANADA INC.",Active,9014378,epinephrine (epinephrine bitartrate) 0.5 mg per 0.5 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101036,Marketed,2022-05-18,02521148,EPINEPHRINE INJECTION,1.0,C01CA24,Epinephrine,Solution,Intravenous,02521148,EPINEPHRINE INJECTION (epinephrine (epinephrine bitartrate) 1 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014720,epinephrine (epinephrine bitartrate) 1 mg per 10 mL solution for injection syringe,8000003,epinephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
80958,Marketed,2013-11-22,02324091,EPIRUBICIN FOR INJECTION,1.0,L01DB03,Epirubicin,Solution,Intravenous,77700744,EPIRUBICIN FOR INJECTION (epirubicin hydrochloride 10 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013092,epirubicin hydrochloride 10 mg per 5 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80958,Marketed,2013-11-22,02324091,EPIRUBICIN FOR INJECTION,1.0,L01DB03,Epirubicin,Solution,Intravenous,77700745,EPIRUBICIN FOR INJECTION (epirubicin hydrochloride 150 mg per 75 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013094,epirubicin hydrochloride 150 mg per 75 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80958,Marketed,2013-11-22,02324091,EPIRUBICIN FOR INJECTION,1.0,L01DB03,Epirubicin,Solution,Intravenous,77700746,EPIRUBICIN FOR INJECTION (epirubicin hydrochloride 50 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013097,epirubicin hydrochloride 50 mg per 25 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80958,Marketed,2013-11-22,02324091,EPIRUBICIN FOR INJECTION,1.0,L01DB03,Epirubicin,Solution,Intravenous,77700747,EPIRUBICIN FOR INJECTION (epirubicin hydrochloride 2 mg per mL solution for injection 100 mL vial) TEVA CANADA LIMITED,Active,9013095,epirubicin hydrochloride 2 mg per mL solution for injection 100 mL vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80958,Marketed,2013-11-22,02324091,EPIRUBICIN FOR INJECTION,1.0,L01DB03,Epirubicin,Solution,Intravenous,77700748,EPIRUBICIN FOR INJECTION (epirubicin hydrochloride 20 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013096,epirubicin hydrochloride 20 mg per 10 mL solution for injection vial,8001764,epirubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
80855,Marketed,2023-07-07,02323052,INSPRA,1.0,C03DA04,Eplerenone,Tablet,Oral,02323052,INSPRA (eplerenone 25 mg oral tablet) BGP PHARMA ULC,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80856,Marketed,2023-07-07,02323060,INSPRA,1.0,C03DA04,Eplerenone,Tablet,Oral,02323060,INSPRA (eplerenone 50 mg oral tablet) BGP PHARMA ULC,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96055,Marketed,2018-04-09,02471442,MINT-EPLERENONE,1.0,C03DA04,Eplerenone,Tablet,Oral,02471442,MINT-EPLERENONE (eplerenone 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96056,Marketed,2018-04-09,02471450,MINT-EPLERENONE,1.0,C03DA04,Eplerenone,Tablet,Oral,02471450,MINT-EPLERENONE (eplerenone 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103185,Marketed,2024-06-18,02543389,JAMP EPLERENONE,1.0,C03DA04,Eplerenone,Tablet,Oral,02543389,JAMP EPLERENONE (eplerenone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9009287,eplerenone 25 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103186,Marketed,2024-06-18,02543397,JAMP EPLERENONE,1.0,C03DA04,Eplerenone,Tablet,Oral,02543397,JAMP EPLERENONE (eplerenone 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9009288,eplerenone 50 mg oral tablet,8000973,eplerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103775,Marketed,2024-10-07,02548909,WAINUA,1.0,N07XX21,Eplontersen,Solution,Subcutaneous,02548909,WAINUA (eplontersen (eplontersen sodium) 45 mg per 0.8 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9015110,eplontersen (eplontersen sodium) 45 mg per 0.8 mL solution for injection syringe,8002517,eplontersen,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50121,Marketed,2003-02-25,02230845,FLOLAN,1.0,B01AC09,Epoprostenol,Powder for solution,Intravenous,02230845,FLOLAN (epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection with diluent solution) GLAXOSMITHKLINE INC,Active,9013283,epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection with diluent solution,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
50122,Marketed,2003-02-19,02230848,FLOLAN,1.0,B01AC09,Epoprostenol,Powder for solution,Intravenous,02230848,FLOLAN (epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection with diluent solution) GLAXOSMITHKLINE INC,Active,9013284,epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection with diluent solution,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88240,Marketed,2020-11-05,02397447,CARIPUL,1.0,B01AC09,Epoprostenol,Powder for solution,Intravenous,02397447,CARIPUL (epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9003122,epoprostenol (epoprostenol sodium) 0.5 mg per vial powder for solution for injection,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88241,Marketed,2020-05-26,02397455,CARIPUL,1.0,B01AC09,Epoprostenol,Powder for solution,Intravenous,02397455,CARIPUL (epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection) JANSSEN INC,Active,9003123,epoprostenol (epoprostenol sodium) 1.5 mg per vial powder for solution for injection,8001766,epoprostenol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102949,Marketed,2024-05-16,02540819,EPTIFIBATIDE INJECTION,1.0,B01AC16,Eptifibatide,Solution,Intravenous,02540819,EPTIFIBATIDE INJECTION (eptifibatide 75 mg per 100 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013109,eptifibatide 75 mg per 100 mL solution for injection vial,8001767,eptifibatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102950,Marketed,2024-05-16,02540827,EPTIFIBATIDE INJECTION,1.0,B01AC16,Eptifibatide,Solution,Intravenous,02540827,EPTIFIBATIDE INJECTION (eptifibatide 20 mg per 10 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013285,eptifibatide 20 mg per 10 mL solution for injection vial,8001767,eptifibatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100002,Marketed,2022-08-17,02510839,VYEPTI,1.0,N02CD05,Eptinezumab,Solution,Intravenous,02510839,VYEPTI (eptinezumab 100 mg per 1 mL solution for injection vial) LUNDBECK CANADA INC,Active,9014760,eptinezumab 100 mg per 1 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103084,Marketed,2024-07-01,02542269,VYEPTI,1.0,N02CD05,Eptinezumab,Solution,Intravenous,02542269,VYEPTI (eptinezumab 300 mg per 3 mL solution for injection vial) LUNDBECK CANADA INC,Active,9015062,eptinezumab 300 mg per 3 mL solution for injection vial,8002431,eptinezumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98320,Marketed,2019-12-09,02493217,BALVERSA,1.0,L01EN01,Erdafitinib,Tablet,Oral,02493217,BALVERSA (erdafitinib 3 mg oral tablet) JANSSEN INC,Active,9014204,erdafitinib 3 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98321,Marketed,2019-12-09,02493225,BALVERSA,1.0,L01EN01,Erdafitinib,Tablet,Oral,02493225,BALVERSA (erdafitinib 4 mg oral tablet) JANSSEN INC,Active,9014205,erdafitinib 4 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98322,Marketed,2019-12-09,02493233,BALVERSA,1.0,L01EN01,Erdafitinib,Tablet,Oral,02493233,BALVERSA (erdafitinib 5 mg oral tablet) JANSSEN INC,Active,9014206,erdafitinib 5 mg oral tablet,8002307,erdafitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97029,Marketed,2018-12-04,02479613,AIMOVIG,1.0,N02CD01,Erenumab,Solution,Subcutaneous,02479613,AIMOVIG (erenumab 70 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013683,erenumab 70 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
97746,Marketed,2019-05-22,02487306,AIMOVIG,1.0,N02CD01,Erenumab,Solution,Subcutaneous,02487306,AIMOVIG (erenumab 140 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014025,erenumab 140 mg per 1 mL solution for injection syringe,8002191,erenumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
92564,Marketed,2023-06-29,02441241,ERGONOVINE MALEATE INJECTION USP,1.0,G02AB03,Ergometrine,Solution,"Intramuscular,Intravenous",02441241,ERGONOVINE MALEATE INJECTION USP (ergonovine maleate 0.25 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013111,ergonovine maleate 0.25 mg per 1 mL solution for injection ampoule,8001769,ergonovine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
86314,Marketed,2012-03-19,02377438,HALAVEN,1.0,L01XX41,Eribulin,Solution,Intravenous,02377438,HALAVEN (eribulin mesylate 1 mg per 2 mL solution for injection vial) EISAI LIMITED,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102778,Marketed,2024-01-08,02539136,NAT-ERIBULIN,1.0,L01XX41,Eribulin,Solution,Intravenous,02539136,NAT-ERIBULIN (eribulin mesylate 1 mg per 2 mL solution for injection vial) NATCO PHARMA (CANADA) INC,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103467,Marketed,2025-07-11,02545950,ERIBULIN MESYLATE INJECTION,1.0,L01XX41,Eribulin,Solution,Intravenous,02545950,ERIBULIN MESYLATE INJECTION (eribulin mesylate 1 mg per 2 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9013112,eribulin mesylate 1 mg per 2 mL solution for injection vial,8001645,eribulin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
86351,Marketed,2014-12-08,02377691,TEVA-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02377691,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86352,Marketed,2014-12-08,02377705,TEVA-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02377705,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86353,Marketed,2014-12-08,02377713,TEVA-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02377713,TEVA-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) TEVA CANADA LIMITED,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94097,Marketed,2016-07-28,02454394,PMS-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02454394,PMS-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) PHARMASCIENCE INC,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94960,Marketed,2017-08-22,02461862,APO-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02461862,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) APOTEX INC,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94961,Marketed,2017-08-22,02461870,APO-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02461870,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) APOTEX INC,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94962,Marketed,2017-08-22,02461889,APO-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02461889,APO-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) APOTEX INC,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97427,Marketed,2019-05-08,02483912,NAT-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02483912,NAT-ERLOTINIB (erlotinib (erlotinib hydrochloride) 25 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004246,erlotinib (erlotinib hydrochloride) 25 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97428,Marketed,2019-05-08,02483920,NAT-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02483920,NAT-ERLOTINIB (erlotinib (erlotinib hydrochloride) 100 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004067,erlotinib (erlotinib hydrochloride) 100 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97429,Marketed,2019-05-08,02483939,NAT-ERLOTINIB,1.0,L01EB02,Erlotinib,Tablet,Oral,02483939,NAT-ERLOTINIB (erlotinib (erlotinib hydrochloride) 150 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004068,erlotinib (erlotinib hydrochloride) 150 mg oral tablet,8001646,erlotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
71683,Marketed,2006-07-06,02247437,INVANZ,1.0,J01DH03,Ertapenem,Powder for solution,"Intravenous,Intramuscular",02247437,INVANZ (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) MERCK CANADA INC,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98083,Marketed,2021-01-05,02490773,ERTAPENEM FOR INJECTION,1.0,J01DH03,Ertapenem,Powder for solution,"Intravenous,Intramuscular",02490773,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98213,Marketed,2021-10-08,02492148,ERTAPENEM FOR INJECTION,1.0,J01DH03,Ertapenem,Powder for solution,"Intravenous,Intramuscular",02492148,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98600,Marketed,2021-06-07,02496127,ERTAPENEM FOR INJECTION,1.0,J01DH03,Ertapenem,Powder for solution,"Intravenous,Intramuscular",02496127,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
100038,Marketed,2021-01-27,02511150,ERTAPENEM FOR INJECTION,1.0,J01DH03,Ertapenem,Powder for solution,"Intravenous,Intramuscular",02511150,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102591,Marketed,2024-07-23,02537176,ERTAPENEM FOR INJECTION,1.0,J01DH03,Ertapenem,Powder for solution,"Intramuscular,Intravenous",02537176,ERTAPENEM FOR INJECTION (ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003822,ertapenem (ertapenem sodium) 1 g per vial powder for solution for injection,8001200,ertapenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
9396,Marketed,2009-05-04,00682268,ERYTHROCIN I.V.,1.0,J01FA01,Erythromycin,Powder for solution,Intravenous,00682268,ERYTHROCIN I.V. (erythromycin (erythromycin lactobionate) 500 mg per vial powder for solution for injection) AMDIPHARM LIMITED,Active,9000296,erythromycin (erythromycin lactobionate) 500 mg per vial powder for solution for injection,8000037,erythromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
9397,Marketed,2009-05-12,00682276,ERYTHROCIN I.V.,1.0,J01FA01,Erythromycin,Powder for solution,Intravenous,00682276,ERYTHROCIN I.V. (erythromycin (erythromycin lactobionate) 1 g per vial powder for solution for injection) AMDIPHARM LIMITED,Active,9000295,erythromycin (erythromycin lactobionate) 1 g per vial powder for solution for injection,8000037,erythromycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
11423,Marketed,2015-06-09,01912755,PDP-ERYTHROMYCIN,1.0,S01AA17,Erythromycin,Ointment,Ophthalmic,01912755,PDP-ERYTHROMYCIN (erythromycin 5 mg per g ophthalmic ointment) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
31467,Marketed,2023-07-20,02141574,ERYTHROMYCIN,1.0,S01AA17,Erythromycin,Ointment,Ophthalmic,02141574,ERYTHROMYCIN (erythromycin 5 mg per g ophthalmic ointment) PHARMA STULLN INC.,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
81202,Marketed,2022-04-07,02326663,ERYTHROMYCIN OPHTHALMIC OINTMENT USP,1.0,S01AA17,Erythromycin,Ointment,Ophthalmic,02326663,ERYTHROMYCIN OPHTHALMIC OINTMENT USP (erythromycin 5 mg per g ophthalmic ointment) STERI-MED PHARMA INC.,Active,9000381,erythromycin 5 mg per g ophthalmic ointment,8000037,erythromycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
43428,Marketed,2020-10-01,02225271,BENZAMYCIN,2.0,D10AF52,"Erythromycin, combinations",Gel,Topical,02225271,"BENZAMYCIN (benzoyl peroxide 5 % and erythromycin 3 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9012907,benzoyl peroxide 5 % and erythromycin 3 % cutaneous gel,8000897,benzoyl peroxide and erythromycin,448598008,Cutaneous,385100002,Gel,,,,,
50949,Marketed,1997-09-19,02231583,EPREX STERILE SOLUTION 1000IU/0.5ML,1.0,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02231583,EPREX STERILE SOLUTION 1000IU/0.5ML (epoetin alfa 1000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013098,epoetin alfa 1000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50950,Marketed,1997-09-19,02231584,EPREX STERILE SOLUTION 2000IU/0.5ML,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231584,EPREX STERILE SOLUTION 2000IU/0.5ML (epoetin alfa 2000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013100,epoetin alfa 2000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50951,Marketed,1997-09-19,02231585,EPREX STERILE SOLUTION 3000IU/0.3ML,1.0,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02231585,EPREX STERILE SOLUTION 3000IU/0.3ML (epoetin alfa 3000 unit per 0.3 mL solution for injection syringe) JANSSEN INC,Active,9013102,epoetin alfa 3000 unit per 0.3 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50952,Marketed,1997-09-19,02231586,EPREX STERILE SOLUTION 4000IU/0.4ML,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02231586,EPREX STERILE SOLUTION 4000IU/0.4ML (epoetin alfa 4000 unit per 0.4 mL solution for injection syringe) JANSSEN INC,Active,9013104,epoetin alfa 4000 unit per 0.4 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50953,Marketed,1997-09-19,02231587,EPREX STERILE SOLUTION 10000IU/1.0ML,1.0,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02231587,EPREX STERILE SOLUTION 10000IU/1.0ML (epoetin alfa 10000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013099,epoetin alfa 10000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
64311,Marketed,1999-12-21,02240722,EPREX STERILE SOLUTION 40000IU/ML,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02240722,EPREX STERILE SOLUTION 40000IU/ML (epoetin alfa 40000 unit per 1 mL solution for injection syringe) JANSSEN INC,Active,9013105,epoetin alfa 40000 unit per 1 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
67133,Marketed,2005-08-24,02243239,EPREX STERILE SOLUTION,1.0,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02243239,EPREX STERILE SOLUTION (epoetin alfa 20000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013101,epoetin alfa 20000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
67308,Marketed,2002-07-01,02243400,EPREX STERILE SOLUTION 5000IU/0.5ML,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243400,EPREX STERILE SOLUTION 5000IU/0.5ML (epoetin alfa 5000 unit per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013106,epoetin alfa 5000 unit per 0.5 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
67309,Marketed,2001-02-20,02243401,EPREX STERILE SOLUTION 6000 IU/0.6 ML,1.0,B03XA01,Erythropoietin,Solution,"Intravenous,Subcutaneous",02243401,EPREX STERILE SOLUTION 6000 IU/0.6 ML (epoetin alfa 6000 unit per 0.6 mL solution for injection syringe) JANSSEN INC,Active,9013107,epoetin alfa 6000 unit per 0.6 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
67311,Marketed,2001-02-20,02243403,EPREX STERILE SOLUTION 8000 IU/0.8 ML,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02243403,EPREX STERILE SOLUTION 8000 IU/0.8 ML (epoetin alfa 8000 unit per 0.8 mL solution for injection syringe) JANSSEN INC,Active,9013108,epoetin alfa 8000 unit per 0.8 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
77409,Marketed,2007-11-19,02288680,EPREX STERILE SOLUTION,1.0,B03XA01,Erythropoietin,Solution,"Subcutaneous,Intravenous",02288680,EPREX STERILE SOLUTION (epoetin alfa 30000 unit per 0.75 mL solution for injection syringe) JANSSEN INC,Active,9013103,epoetin alfa 30000 unit per 0.75 mL solution for injection syringe,8001765,epoetin alfa,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
74862,Marketed,2005-02-14,02263238,CIPRALEX  -10MG,1.0,N06AB10,Escitalopram,Tablet,Oral,02263238,CIPRALEX  -10MG (escitalopram (escitalopram oxalate) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74864,Marketed,2005-02-14,02263254,CIPRALEX  -20MG,1.0,N06AB10,Escitalopram,Tablet,Oral,02263254,CIPRALEX  -20MG (escitalopram (escitalopram oxalate) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78034,Marketed,2014-09-10,02295016,APO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02295016,APO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) APOTEX INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78035,Marketed,2014-09-10,02295024,APO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02295024,APO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) APOTEX INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79506,Marketed,2014-09-10,02309467,MYLAN-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02309467,MYLAN-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79507,Marketed,2014-09-10,02309475,MYLAN-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02309475,MYLAN-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80368,Marketed,2014-09-10,02318180,TEVA-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02318180,TEVA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80371,Marketed,2014-09-10,02318202,TEVA-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02318202,TEVA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84901,Marketed,2014-09-10,02364077,SANDOZ ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02364077,SANDOZ ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84902,Marketed,2014-09-10,02364085,SANDOZ ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02364085,SANDOZ ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87111,Marketed,2022-09-06,02385481,TARO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02385481,TARO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87112,Marketed,2022-09-06,02385503,TARO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02385503,TARO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88231,Marketed,2014-09-10,02397358,AURO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02397358,AURO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) AURO PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88233,Marketed,2014-09-10,02397374,AURO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02397374,AURO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) AURO PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89210,Marketed,2015-03-19,02407418,MINT-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02407418,MINT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89212,Marketed,2015-03-19,02407434,MINT-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02407434,MINT-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90820,Marketed,2014-09-10,02423480,MAR-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02423480,MAR-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90822,Marketed,2014-09-10,02423502,MAR-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02423502,MAR-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90910,Marketed,2014-09-15,02424401,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02424401,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90911,Marketed,2014-09-15,02424428,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02424428,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) PRO DOC LIMITEE,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91347,Marketed,2018-11-01,02429039,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02429039,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91348,Marketed,2018-11-01,02429047,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02429047,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91422,Marketed,2023-04-26,02429780,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02429780,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91423,Marketed,2023-04-26,02429799,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02429799,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91451,Marketed,2014-09-18,02430118,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02430118,ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) SANIS HEALTH INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91453,Marketed,2014-09-18,02430126,ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02430126,ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) SANIS HEALTH INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91896,Marketed,2016-06-10,02434652,ACH-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02434652,ACH-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91897,Marketed,2016-06-10,02434660,ACH-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02434660,ACH-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94081,Marketed,2020-05-01,02454297,ACT ESCITALOPRAM ODT,1.0,N06AB10,Escitalopram,Tablet (orally disintegrating),Oral,02454297,ACT ESCITALOPRAM ODT (escitalopram 10 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9001389,escitalopram 10 mg orodispersible tablet,8000346,escitalopram,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
94082,Marketed,2020-05-01,02454300,ACT ESCITALOPRAM ODT,1.0,N06AB10,Escitalopram,Tablet (orally disintegrating),Oral,02454300,ACT ESCITALOPRAM ODT (escitalopram 20 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9001390,escitalopram 20 mg orodispersible tablet,8000346,escitalopram,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
95793,Marketed,2021-08-10,02469243,PMS-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02469243,PMS-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95794,Marketed,2021-08-10,02469251,PMS-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02469251,PMS-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96051,Marketed,2021-03-19,02471418,M-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02471418,M-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96052,Marketed,2021-03-19,02471426,M-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02471426,M-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) MANTRA PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96678,Marketed,2024-03-08,02476851,NRA-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02476851,NRA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NORA PHARMA INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96679,Marketed,2024-03-08,02476878,NRA-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02476878,NRA-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NORA PHARMA INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96819,Marketed,2018-09-06,02477742,AG-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02477742,AG-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96821,Marketed,2018-09-06,02477769,AG-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02477769,AG-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97143,Marketed,2019-06-19,02481154,BIO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02481154,BIO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) BIOMED PHARMA,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97145,Marketed,2019-06-19,02481170,BIO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02481170,BIO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) BIOMED PHARMA,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99822,Marketed,2023-12-22,02508893,JAMP ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02508893,JAMP ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99823,Marketed,2023-12-24,02508907,JAMP ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02508907,JAMP ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100019,Marketed,2025-04-16,02510944,AG-ESCITALOPRAM TABLETS,1.0,N06AB10,Escitalopram,Tablet,Oral,02510944,AG-ESCITALOPRAM TABLETS (escitalopram (escitalopram oxalate) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100020,Marketed,2025-04-16,02510952,AG-ESCITALOPRAM TABLETS,1.0,N06AB10,Escitalopram,Tablet,Oral,02510952,AG-ESCITALOPRAM TABLETS (escitalopram (escitalopram oxalate) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100193,Marketed,2021-06-25,02512653,KYE-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02512653,KYE-ESCITALOPRAM (escitalopram (escitalopram oxalate) 15 mg oral tablet) KYE PHARMACEUTICALS INC.,Active,9014545,escitalopram (escitalopram oxalate) 15 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104373,Marketed,2025-08-29,02554909,NATCO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02554909,NATCO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001102,escitalopram (escitalopram oxalate) 10 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104375,Marketed,2025-08-29,02554933,NATCO-ESCITALOPRAM,1.0,N06AB10,Escitalopram,Tablet,Oral,02554933,NATCO-ESCITALOPRAM (escitalopram (escitalopram oxalate) 20 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001103,escitalopram (escitalopram oxalate) 20 mg oral tablet,8000346,escitalopram,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98903,Marketed,2020-06-11,02499290,SPRAVATO,1.0,N06AX27,Esketamine,Solution,Nasal,02499290,SPRAVATO (esketamine (esketamine hydrochloride) 28 mg per 2 actuation nasal spray) JANSSEN INC,Active,9014326,esketamine (esketamine hydrochloride) 28 mg per 2 actuation nasal spray,8002333,esketamine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
91141,Marketed,2024-05-30,02426862,APTIOM,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02426862,"APTIOM (eslicarbazepine acetate 200 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91142,Marketed,2024-04-12,02426870,APTIOM,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02426870,"APTIOM (eslicarbazepine acetate 400 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91143,Marketed,2024-05-15,02426889,APTIOM,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02426889,"APTIOM (eslicarbazepine acetate 600 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91145,Marketed,2024-02-07,02426897,APTIOM,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02426897,"APTIOM (eslicarbazepine acetate 800 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101648,Marketed,2025-05-08,02527421,AURO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02527421,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 200 mg oral tablet) AURO PHARMA INC,Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101649,Marketed,2025-05-08,02527448,AURO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02527448,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 400 mg oral tablet) AURO PHARMA INC,Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101650,Marketed,2025-05-08,02527456,AURO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02527456,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 600 mg oral tablet) AURO PHARMA INC,Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101651,Marketed,2025-05-08,02527464,AURO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02527464,AURO-ESLICARBAZEPINE (eslicarbazepine acetate 800 mg oral tablet) AURO PHARMA INC,Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102669,Marketed,2025-05-06,02537931,APO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02537931,APO-ESLICARBAZEPINE (eslicarbazepine acetate 200 mg oral tablet) APOTEX INC,Active,9005561,eslicarbazepine acetate 200 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102670,Marketed,2025-05-06,02537958,APO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02537958,APO-ESLICARBAZEPINE (eslicarbazepine acetate 400 mg oral tablet) APOTEX INC,Active,9005562,eslicarbazepine acetate 400 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102671,Marketed,2025-05-06,02537966,APO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02537966,APO-ESLICARBAZEPINE (eslicarbazepine acetate 600 mg oral tablet) APOTEX INC,Active,9005563,eslicarbazepine acetate 600 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102672,Marketed,2025-05-06,02537974,APO-ESLICARBAZEPINE,1.0,N03AF04,Eslicarbazepine,Tablet,Oral,02537974,APO-ESLICARBAZEPINE (eslicarbazepine acetate 800 mg oral tablet) APOTEX INC,Active,9005564,eslicarbazepine acetate 800 mg oral tablet,8001462,eslicarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42910,Marketed,2000-08-01,02188880,BREVIBLOC INJECTION 10MG/ML,1.0,C07AB09,Esmolol,Solution,Intravenous,02188880,BREVIBLOC INJECTION 10MG/ML (esmolol hydrochloride 100 mg per 10 mL solution for injection vial) BAXTER CORPORATION,Active,9009341,esmolol hydrochloride 100 mg per 10 mL solution for injection vial,8000895,esmolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79483,Marketed,2008-09-12,02309238,BREVIBLOC PREMIXED INJECTION,1.0,C07AB09,Esmolol,Solution,Intravenous,02309238,BREVIBLOC PREMIXED INJECTION (esmolol hydrochloride 10 mg per mL solution for injection 250 mL bag) BAXTER CORPORATION,Active,9009340,esmolol hydrochloride 10 mg per mL solution for injection 250 mL bag,8000895,esmolol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
68498,Marketed,2001-08-20,02244521,NEXIUM - 20MG,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02244521,NEXIUM - 20MG (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant tablet) ASTRAZENECA CANADA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
68499,Marketed,2001-08-20,02244522,NEXIUM - 40MG,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02244522,NEXIUM - 40MG (esomeprazole (esomeprazole magnesium trihydrate) 40 mg gastro-resistant tablet) ASTRAZENECA CANADA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78581,Marketed,2008-01-02,02300524,NEXIUM,1.0,A02BC05,Esomeprazole,"Granules for suspension, delayed release",Oral,02300524,NEXIUM (esomeprazole (esomeprazole magnesium trihydrate) 10 mg per sachet gastro-resistant granules for oral suspension) ASTRAZENECA CANADA INC,Active,9001231,esomeprazole (esomeprazole magnesium) 10 mg per sachet gastro-resistant granules for oral suspension,8000303,esomeprazole,26643006,Oral,385029002,Granules for oral suspension,733013000,Sachet (unit of presentation),,,
82472,Marketed,2021-09-20,02339099,APO-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02339099,APO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) APOTEX INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
82473,Marketed,2021-09-20,02339102,APO-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02339102,APO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) APOTEX INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87999,Marketed,2021-09-20,02394839,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02394839,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
88000,Marketed,2021-08-27,02394847,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02394847,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90860,Marketed,2019-09-11,02423855,TEVA-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423855,TEVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90861,Marketed,2019-09-11,02423863,TEVA-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423863,TEVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90870,Marketed,2022-03-07,02423979,TARO-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423979,TARO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90871,Marketed,2022-03-07,02423987,TARO-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02423987,TARO-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91561,Marketed,2021-07-23,02431173,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02431173,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92684,Marketed,2022-01-12,02442493,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02442493,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92685,Marketed,2022-01-12,02442507,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02442507,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92986,Marketed,2025-06-11,02444712,NEXIUM 24HR,1.0,A02BC05,Esomeprazole,Capsule (delayed release),Oral,02444712,NEXIUM 24HR (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant capsule) HALEON CANADA ULC,Active,9001461,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant capsule,8000303,esomeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
94844,Marketed,2018-09-25,02460920,SANDOZ ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02460920,SANDOZ ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
94845,Marketed,2018-09-25,02460939,SANDOZ ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02460939,SANDOZ ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
97006,Marketed,2020-04-20,02479419,MYL-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02479419,MYL-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium trihydrate) 20 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
97007,Marketed,2020-04-20,02479427,MYL-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02479427,MYL-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium trihydrate) 40 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
100932,Marketed,2022-03-16,02520109,M-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520109,M-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
100933,Marketed,2022-03-16,02520117,M-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520117,M-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
100989,Marketed,2022-06-27,02520699,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520699,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
100990,Marketed,2022-06-28,02520702,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02520702,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
101769,Marketed,2023-03-06,02528479,PMSC-ESOMEPRAZOLE DR,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02528479,PMSC-ESOMEPRAZOLE DR (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
101770,Marketed,2023-03-06,02528487,PMSC-ESOMEPRAZOLE DR,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02528487,PMSC-ESOMEPRAZOLE DR (esomeprazole (esomeprazole magnesium dihydrate) 40 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
102419,Marketed,2024-03-20,02535335,ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02535335,ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium dihydrate) 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
106098,Marketed,2025-12-16,02557673,RIVA-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02557673,RIVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000952,esomeprazole (esomeprazole magnesium) 20 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
106099,Marketed,2025-11-28,02557681,RIVA-ESOMEPRAZOLE,1.0,A02BC05,Esomeprazole,Tablet (delayed-release),Oral,02557681,RIVA-ESOMEPRAZOLE (esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000953,esomeprazole (esomeprazole magnesium) 40 mg gastro-resistant tablet,8000303,esomeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
18640,Marketed,2006-04-13,02168898,ESTRING,1.0,G03CA03,Estradiol,Ring (slow-release),Vaginal,02168898,ESTRING (estradiol 7.5 mcg per 24 hour vaginal delivery system) PFIZER CANADA ULC,Active,9009358,estradiol 7.5 mcg per 24 hour vaginal delivery system,8000213,estradiol,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,
50849,Marketed,2008-08-15,02231509,CLIMARA 50,1.0,G03CA03,Estradiol,Patch,Transdermal,02231509,CLIMARA 50 (estradiol (estradiol hemihydrate) 50 mcg per 24 hour transdermal patch) BAYER INC,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
62136,Marketed,2022-03-24,02238704,ESTROGEL,1.0,G03CA03,Estradiol,Gel,Transdermal,02238704,ESTROGEL (estradiol (estradiol hemihydrate) 0.06 % transdermal gel) ORGANON CANADA INC.,Active,9009349,estradiol 0.06 % transdermal gel,8000213,estradiol,45890007,Transdermal,385100002,Gel,,,1.0,,
67942,Marketed,2022-12-06,02243999,ESTRADOT 37.5,1.0,G03CA03,Estradiol,Patch,Transdermal,02243999,ESTRADOT 37.5 (estradiol 37.5 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009360,estradiol 37.5 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
67943,Marketed,2022-12-07,02244000,ESTRADOT 50,1.0,G03CA03,Estradiol,Patch,Transdermal,02244000,ESTRADOT 50 (estradiol 50 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
67944,Marketed,2022-12-06,02244001,ESTRADOT 75,1.0,G03CA03,Estradiol,Patch,Transdermal,02244001,ESTRADOT 75 (estradiol 75 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
67945,Marketed,2022-12-06,02244002,ESTRADOT 100,1.0,G03CA03,Estradiol,Patch,Transdermal,02244002,ESTRADOT 100 (estradiol 100 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009356,estradiol 100 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
69776,Marketed,2022-12-06,02245676,ESTRADOT 25,1.0,G03CA03,Estradiol,Patch,Transdermal,02245676,ESTRADOT 25 (estradiol 25 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009359,estradiol 25 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
71196,Marketed,2006-01-12,02246967,SANDOZ ESTRADIOL DERM 50,1.0,G03CA03,Estradiol,Patch,Transdermal,02246967,SANDOZ ESTRADIOL DERM 50 (estradiol (estradiol hemihydrate) 50 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009364,estradiol 50 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
71197,Marketed,2006-01-12,02246968,SANDOZ ESTRADIOL DERM 75,1.0,G03CA03,Estradiol,Patch,Transdermal,02246968,SANDOZ ESTRADIOL DERM 75 (estradiol (estradiol hemihydrate) 75 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
71198,Marketed,2006-01-12,02246969,SANDOZ ESTRADIOL DERM 100,1.0,G03CA03,Estradiol,Patch,Transdermal,02246969,SANDOZ ESTRADIOL DERM 100 (estradiol (estradiol hemihydrate) 100 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9009356,estradiol 100 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
71749,Marketed,2008-07-30,02247499,CLIMARA 25,1.0,G03CA03,Estradiol,Patch,Transdermal,02247499,CLIMARA 25 (estradiol (estradiol hemihydrate) 25 mcg per 24 hour transdermal patch) BAYER INC,Active,9009359,estradiol 25 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
71750,Marketed,2008-06-25,02247500,CLIMARA 75,1.0,G03CA03,Estradiol,Patch,Transdermal,02247500,CLIMARA 75 (estradiol (estradiol hemihydrate) 75 mcg per 24 hour transdermal patch) BAYER INC,Active,9009365,estradiol 75 mcg per 24 hour transdermal patch,8000213,estradiol,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
81084,Marketed,2010-09-22,02325462,VAGIFEM 10,1.0,G03CA03,Estradiol,Vaginal tablet,Vaginal,02325462,VAGIFEM 10 (estradiol (estradiol hemihydrate) 10 mcg vaginal tablet) NOVO NORDISK CANADA INC,Active,9009355,estradiol 10 mcg vaginal tablet,8000213,estradiol,16857009,Vaginal,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
90950,Marketed,2019-08-26,02424835,DIVIGEL,1.0,G03CA03,Estradiol,Gel,Transdermal,02424835,DIVIGEL 0.5MG PACK (estradiol 0.1 % transdermal gel 0.5 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012569,estradiol 0.1 % transdermal gel 0.5 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
90951,Marketed,2019-08-26,02424843,DIVIGEL,1.0,G03CA03,Estradiol,Gel,Transdermal,02424843,DIVIGEL 1MG PACK (estradiol 0.1 % transdermal gel 1 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012570,estradiol 0.1 % transdermal gel 1 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
90959,Marketed,2018-11-29,02424924,DIVIGEL,1.0,G03CA03,Estradiol,Gel,Transdermal,02424924,DIVIGEL 0.25 MG PACK (estradiol 0.1 % transdermal gel 0.25 mg sachet) SEARCHLIGHT PHARMA INC,Active,9012568,estradiol 0.1 % transdermal gel 0.25 mg sachet,8000213,estradiol,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
93486,Marketed,2016-02-29,02449048,LUPIN-ESTRADIOL,1.0,G03CA03,Estradiol,Tablet,Oral,02449048,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 0.5 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009352,estradiol 0.5 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93487,Marketed,2016-02-29,02449056,LUPIN-ESTRADIOL,1.0,G03CA03,Estradiol,Tablet,Oral,02449056,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 1 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009354,estradiol 1 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93488,Marketed,2016-02-29,02449064,LUPIN-ESTRADIOL,1.0,G03CA03,Estradiol,Tablet,Oral,02449064,LUPIN-ESTRADIOL (estradiol (estradiol hemihydrate) 2 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009357,estradiol 2 mg oral tablet,8000213,estradiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99313,Marketed,2023-11-14,02503689,IMVEXXY,1.0,G03CA03,Estradiol,Insert,Vaginal,02503689,IMVEXXY (estradiol (estradiol hemihydrate) 4 mcg vaginal capsule) KNIGHT THERAPEUTICS INC.,Active,9014940,estradiol 4 mcg vaginal capsule,8000213,estradiol,16857009,Vaginal,385175008,Vaginal capule,732937005,Capsule (unit of presentation),1.0,,
99314,Marketed,2023-11-14,02503697,IMVEXXY,1.0,G03CA03,Estradiol,Insert,Vaginal,02503697,IMVEXXY (estradiol (estradiol hemihydrate) 10 mcg vaginal capsule) KNIGHT THERAPEUTICS INC.,Active,9014939,estradiol 10 mcg vaginal capsule,8000213,estradiol,16857009,Vaginal,385175008,Vaginal capule,732937005,Capsule (unit of presentation),1.0,,
7645,Marketed,2016-08-18,00727369,ESTRAGYN VAGINAL CREAM,1.0,G03CA07,Estrone,Cream,Vaginal,00727369,ESTRAGYN VAGINAL CREAM (estrone 0.1 % vaginal cream) SEARCHLIGHT PHARMA INC,Active,9002106,estrone 0.1 % vaginal cream,8001647,estrone,16857009,Vaginal,385165005,Vaginal cream,,,1.0,,
93974,Marketed,2026-01-20,02453207,LUNESTA,1.0,N05CF04,Eszopiclone,Tablet,Oral,02453207,"LUNESTA (eszopiclone 1 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93975,Marketed,2026-01-20,02453215,LUNESTA,1.0,N05CF04,Eszopiclone,Tablet,Oral,02453215,LUNESTA (eszopiclone 2 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93976,Marketed,2026-01-22,02453223,LUNESTA,1.0,N05CF04,Eszopiclone,Tablet,Oral,02453223,LUNESTA (eszopiclone 3 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103828,Marketed,2024-09-03,02549433,MAR-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02549433,MAR-ESZOPICLONE (eszopiclone 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103829,Marketed,2024-09-03,02549441,MAR-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02549441,MAR-ESZOPICLONE (eszopiclone 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103830,Marketed,2024-09-03,02549468,MAR-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02549468,MAR-ESZOPICLONE (eszopiclone 3 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103992,Marketed,2024-12-10,02551187,M-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02551187,M-ESZOPICLONE (eszopiclone 1 mg oral tablet) MANTRA PHARMA INC,Active,9014379,eszopiclone 1 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103993,Marketed,2024-12-10,02551195,M-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02551195,M-ESZOPICLONE (eszopiclone 2 mg oral tablet) MANTRA PHARMA INC,Active,9014380,eszopiclone 2 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103994,Marketed,2024-12-10,02551209,M-ESZOPICLONE,1.0,N05CF04,Eszopiclone,Tablet,Oral,02551209,M-ESZOPICLONE (eszopiclone 3 mg oral tablet) MANTRA PHARMA INC,Active,9014381,eszopiclone 3 mg oral tablet,8002347,eszopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74372,Marketed,2020-12-22,02258528,EDECRIN,1.0,C03CC01,Etacrynic acid,Tablet,Oral,02258528,"EDECRIN (ethacrynic acid 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9009371,ethacrynic acid 25 mg oral tablet,8000804,ethacrynic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95012,Marketed,2024-02-29,02462362,ETHACRYNATE SODIUM,1.0,C03CC01,Etacrynic acid,Powder for solution,Intravenous,02462362,ETHACRYNATE SODIUM (ethacrynic acid (ethacrynate sodium) 50 mg per vial powder for solution for injection) STERIMAX INC,Active,9009370,ethacrynic acid (ethacrynate sodium) 50 mg per vial powder for solution for injection,8000804,ethacrynic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
76019,Marketed,2005-12-21,02274728,ENBREL,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02274728,ENBREL (etanercept 50 mg per 1 mL solution for injection syringe) IMMUNEX CORPORATION,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94214,Marketed,2016-09-23,02455323,BRENZYS,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02455323,"BRENZYS PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
94215,Marketed,2016-09-13,02455331,BRENZYS,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02455331,"BRENZYS PRE-FILLED AUTO-INJECTOR (etanercept 50 mg per 1 mL solution for injection syringe) SAMSUNG BIOEPIS CO., LTD",Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
95072,Marketed,2017-08-04,02462850,ERELZI,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02462850,ERELZI SENSOREADY PEN. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
95073,Marketed,2017-08-04,02462869,ERELZI,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02462869,ERELZI PREFILLED SYRINGE WITH NEEDLE GUARD. SINGLE USE. (etanercept 50 mg per 1 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
95074,Marketed,2017-12-08,02462877,ERELZI,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02462877,ERELZI (etanercept 25 mg per 0.5 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013113,etanercept 25 mg per 0.5 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101948,Marketed,2024-04-05,02530295,RYMTI,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02530295,RYMTI 1 ML SINGLE-USE PRE-FILLED SYRINGE (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101949,Marketed,2024-04-05,02530309,RYMTI,1.0,L04AB01,Etanercept,Solution,Subcutaneous,02530309,RYMTI 1 ML SINGLE-USE PRE-FILLED AUTO-INJECTOR PEN (etanercept 50 mg per 1 mL solution for injection syringe) LUPIN PHARMA CANADA LIMITED,Active,9012968,etanercept 50 mg per 1 mL solution for injection syringe,8001266,etanercept,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
1471,Marketed,2019-07-10,00247960,ETIBI,1.0,J04AK02,Ethambutol,Tablet,Oral,00247960,"ETIBI (ethambutol hydrochloride 100 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001686,ethambutol hydrochloride 100 mg oral tablet,8001201,ethambutol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1472,Marketed,2019-07-10,00247979,ETIBI,1.0,J04AK02,Ethambutol,Tablet,Oral,00247979,"ETIBI (ethambutol hydrochloride 400 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001687,ethambutol hydrochloride 400 mg oral tablet,8001201,ethambutol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
731,Marketed,2022-10-11,00023485,ZARONTIN SYRUP,1.0,N03AD01,Ethosuximide,Syrup,Oral,00023485,ZARONTIN SYRUP (ethosuximide 250 mg per 5 mL syrup) SEARCHLIGHT PHARMA INC,Active,9001605,ethosuximide 250 mg per 5 mL syrup,8001463,ethosuximide,26643006,Oral,739009002,Syrup,,,,,
771,Marketed,2022-10-11,00022799,ZARONTIN,1.0,N03AD01,Ethosuximide,Capsule,Oral,00022799,ZARONTIN (ethosuximide 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103451,Marketed,2024-06-19,02545772,MAR-ETHOSUXIMIDE,1.0,N03AD01,Ethosuximide,Capsule,Oral,02545772,MAR-ETHOSUXIMIDE (ethosuximide 250 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103582,Marketed,2024-06-25,02547171,ODAN-ETHOSUXIMIDE,1.0,N03AD01,Ethosuximide,Capsule,Oral,02547171,ODAN-ETHOSUXIMIDE (ethosuximide 250 mg oral capsule) ODAN LABORATORIES LTD,Active,9001576,ethosuximide 250 mg oral capsule,8001463,ethosuximide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2570,Marketed,2017-07-13,00386685,LIPIODOL ULTRA FLUID,1.0,V08AD01,Ethyl esters of iodised fatty acids,Liquid,"Intracavitary,Parenteral (unspecified)",,,,,,,,,,,,,,,,
98840,Marketed,2020-09-14,02498650,TOMVI,1.0,N01AX07,Etomidate,Solution,Intravenous,77701030,TOMVI (etomidate 40 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9014428,etomidate 40 mg per 20 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98840,Marketed,2020-09-14,02498650,TOMVI,1.0,N01AX07,Etomidate,Solution,Intravenous,77701031,TOMVI (etomidate 20 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014427,etomidate 20 mg per 10 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101447,Marketed,2022-05-20,02525453,ETOMIDATE INJECTION USP,1.0,N01AX07,Etomidate,Solution,Intravenous,77701111,ETOMIDATE INJECTION USP (etomidate 40 mg per 20 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014428,etomidate 40 mg per 20 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101447,Marketed,2022-05-20,02525453,ETOMIDATE INJECTION USP,1.0,N01AX07,Etomidate,Solution,Intravenous,77701112,ETOMIDATE INJECTION USP (etomidate 22 mg per 11 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014721,etomidate 22 mg per 11 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102621,Marketed,2024-07-03,02537508,"ETOMIDATE INJECTION, USP",1.0,N01AX07,Etomidate,Solution,Intravenous,77701160,"ETOMIDATE INJECTION, USP (etomidate 20 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014427,etomidate 20 mg per 10 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102621,Marketed,2024-07-03,02537508,"ETOMIDATE INJECTION, USP",1.0,N01AX07,Etomidate,Solution,Intravenous,77701161,"ETOMIDATE INJECTION, USP (etomidate 40 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014428,etomidate 40 mg per 20 mL solution for injection vial,8002356,etomidate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98924,Marketed,2022-09-08,02499509,NEXPLANON,1.0,G03AC08,Etonogestrel,Implant,Subcutaneous,02499509,NEXPLANON (etonogestrel 68 mg implant) ORGANON CANADA INC.,Active,9014360,etonogestrel 68 mg implant,8002344,etonogestrel,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,
5963,Marketed,2020-01-02,00616192,VEPESID,1.0,L01CB01,Etoposide,Capsule,Oral,00616192,VEPESID (etoposide 50 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002019,etoposide 50 mg oral capsule,8001772,etoposide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
16507,Marketed,2014-04-12,02080036,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77700713,ETOPOSIDE INJECTION (etoposide 100 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013114,etoposide 100 mg per 5 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
16507,Marketed,2014-04-12,02080036,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77700714,ETOPOSIDE INJECTION (etoposide 1000 mg per 50 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013115,etoposide 1000 mg per 50 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
16507,Marketed,2014-04-12,02080036,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77700715,ETOPOSIDE INJECTION (etoposide 500 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013118,etoposide 500 mg per 25 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
16507,Marketed,2014-04-12,02080036,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77700716,ETOPOSIDE INJECTION (etoposide 200 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013116,etoposide 200 mg per 10 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
16507,Marketed,2014-04-12,02080036,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77700717,ETOPOSIDE INJECTION (etoposide 400 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013117,etoposide 400 mg per 20 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104164,Marketed,2025-06-20,02552671,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77701184,ETOPOSIDE INJECTION (etoposide 100 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013114,etoposide 100 mg per 5 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104164,Marketed,2025-06-20,02552671,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77701185,ETOPOSIDE INJECTION (etoposide 200 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013116,etoposide 200 mg per 10 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104164,Marketed,2025-06-20,02552671,ETOPOSIDE INJECTION,1.0,L01CB01,Etoposide,Solution,Intravenous,77701186,ETOPOSIDE INJECTION (etoposide 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013117,etoposide 400 mg per 20 mL solution for injection vial,8001772,etoposide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103353,Marketed,2024-04-18,02544903,VELSIPITY,1.0,L04AE05,Etrasimod,Tablet,Oral,02544903,VELSIPITY (etrasimod (etrasimod L-arginine) 2 mg oral tablet) PFIZER CANADA ULC,Active,9015035,etrasimod (etrasimod L-arginine) 2 mg oral tablet,8002505,etrasimod,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,
79246,Marketed,2008-03-27,02306778,INTELENCE,1.0,J05AG04,Etravirine,Tablet,Oral,02306778,INTELENCE (etravirine 100 mg oral tablet) JANSSEN INC,Active,9004386,etravirine 100 mg oral tablet,8001202,etravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86137,Marketed,2011-12-12,02375931,INTELENCE,1.0,J05AG04,Etravirine,Tablet,Oral,02375931,INTELENCE (etravirine 200 mg oral tablet) JANSSEN INC,Active,9004954,etravirine 200 mg oral tablet,8001202,etravirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82511,Marketed,2010-03-15,02339501,AFINITOR,1.0,L04AH02,Everolimus,Tablet,Oral,02339501,AFINITOR (everolimus 5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82512,Marketed,2010-01-19,02339528,AFINITOR,1.0,L04AH02,Everolimus,Tablet,Oral,02339528,AFINITOR (everolimus 10 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85419,Marketed,2011-08-05,02369257,AFINITOR,1.0,L04AH02,Everolimus,Tablet,Oral,02369257,AFINITOR (everolimus 2.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91028,Marketed,2014-11-28,02425645,AFINITOR DISPERZ,1.0,L04AH02,Everolimus,Tablet for suspension,Oral,02425645,AFINITOR DISPERZ (everolimus 2 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005615,everolimus 2 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,
91029,Marketed,2014-11-28,02425653,AFINITOR DISPERZ,1.0,L04AH02,Everolimus,Tablet for suspension,Oral,02425653,AFINITOR DISPERZ (everolimus 3 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005616,everolimus 3 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,
91030,Marketed,2014-11-28,02425661,AFINITOR DISPERZ,1.0,L04AH02,Everolimus,Tablet for suspension,Oral,02425661,AFINITOR DISPERZ (everolimus 5 mg dispersible oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005617,everolimus 5 mg dispersible oral tablet,8001650,everolimus,26643006,Oral,421366001,Dispersible oral tablet,732936001,Tablet (unit of presentation),1.0,,
95113,Marketed,2019-12-06,02463229,TEVA-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02463229,TEVA-EVEROLIMUS (everolimus 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95114,Marketed,2019-12-06,02463237,TEVA-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02463237,TEVA-EVEROLIMUS (everolimus 5 mg oral tablet) TEVA CANADA LIMITED,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95116,Marketed,2019-12-06,02463253,TEVA-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02463253,TEVA-EVEROLIMUS (everolimus 10 mg oral tablet) TEVA CANADA LIMITED,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98290,Marketed,2020-09-17,02492911,SANDOZ EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02492911,SANDOZ EVEROLIMUS (everolimus 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98291,Marketed,2020-09-17,02492938,SANDOZ EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02492938,SANDOZ EVEROLIMUS (everolimus 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98292,Marketed,2020-09-17,02492946,SANDOZ EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02492946,SANDOZ EVEROLIMUS (everolimus 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99407,Marketed,2021-09-08,02504677,PMS-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02504677,PMS-EVEROLIMUS (everolimus 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99408,Marketed,2021-09-08,02504685,PMS-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02504685,PMS-EVEROLIMUS (everolimus 5 mg oral tablet) PHARMASCIENCE INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99409,Marketed,2021-09-08,02504693,PMS-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02504693,PMS-EVEROLIMUS (everolimus 10 mg oral tablet) PHARMASCIENCE INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101930,Marketed,2023-04-05,02530090,NAT-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02530090,NAT-EVEROLIMUS (everolimus 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101931,Marketed,2023-04-05,02530104,NAT-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02530104,NAT-EVEROLIMUS (everolimus 5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101933,Marketed,2023-04-05,02530120,NAT-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02530120,NAT-EVEROLIMUS (everolimus 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102144,Marketed,2024-08-27,02532409,REDDY-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02532409,REDDY-EVEROLIMUS (everolimus 2.5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004904,everolimus 2.5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102145,Marketed,2024-08-27,02532417,REDDY-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02532417,REDDY-EVEROLIMUS (everolimus 5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004667,everolimus 5 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102147,Marketed,2024-08-27,02532433,REDDY-EVEROLIMUS,1.0,L04AH02,Everolimus,Tablet,Oral,02532433,REDDY-EVEROLIMUS (everolimus 10 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9004628,everolimus 10 mg oral tablet,8001650,everolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103038,Marketed,2023-11-21,02541769,EVKEEZA,1.0,C10AX17,Evinacumab,Solution,Intravenous,77701139,EVKEEZA (evinacumab 345 mg per 2.3 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014942,evinacumab 345 mg per 2.3 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103038,Marketed,2023-11-21,02541769,EVKEEZA,1.0,C10AX17,Evinacumab,Solution,Intravenous,77701140,EVKEEZA (evinacumab 1200 mg per 8 mL solution for injection vial) ULTRAGENYX PHARMACEUTICAL INC,Active,9014941,evinacumab 1200 mg per 8 mL solution for injection vial,8002486,evinacumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93132,Marketed,2015-09-28,02446057,REPATHA,1.0,C10AX13,Evolocumab,Solution,Subcutaneous,02446057,REPATHA (evolocumab 140 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9012628,evolocumab 140 mg per 1 mL solution for injection syringe,8001268,evolocumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
66502,Marketed,2004-11-16,02242705,AROMASIN,1.0,L02BG06,Exemestane,Tablet,Oral,02242705,AROMASIN (exemestane 25 mg oral tablet) PFIZER CANADA ULC,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87564,Marketed,2020-01-31,02390183,ACT EXEMESTANE,1.0,L02BG06,Exemestane,Tablet,Oral,02390183,ACT EXEMESTANE (exemestane 25 mg oral tablet) TEVA CANADA LIMITED,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89256,Marketed,2013-12-02,02407841,MED-EXEMESTANE,1.0,L02BG06,Exemestane,Tablet,Oral,02407841,MED-EXEMESTANE (exemestane 25 mg oral tablet) GENERIC MEDICAL PARTNERS INC,Active,9003510,exemestane 25 mg oral tablet,8001109,exemestane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
71771,Marketed,2022-04-22,02247521,EZETROL,1.0,C10AX09,Ezetimibe,Tablet,Oral,02247521,EZETROL (ezetimibe 10 mg oral tablet) ORGANON CANADA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83931,Marketed,2014-09-15,02354101,TEVA-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02354101,TEVA-EZETIMIBE (ezetimibe 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90096,Marketed,2014-09-15,02416409,PMS-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02416409,PMS-EZETIMIBE (ezetimibe 10 mg oral tablet) PHARMASCIENCE INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90134,Marketed,2014-09-15,02416778,SANDOZ EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02416778,SANDOZ EZETIMIBE (ezetimibe 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90416,Marketed,2024-08-19,02419548,TARO-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02419548,TARO-EZETIMIBE (ezetimibe 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90723,Marketed,2018-04-19,02422549,EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02422549,EZETIMIBE (ezetimibe 10 mg oral tablet) PRO DOC LIMITEE,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90733,Marketed,2014-09-15,02422662,MAR-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02422662,MAR-EZETIMIBE (ezetimibe 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90797,Marketed,2014-09-15,02423235,JAMP-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02423235,JAMP-EZETIMIBE (ezetimibe 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90798,Marketed,2014-09-15,02423243,MINT-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02423243,MINT-EZETIMIBE (ezetimibe 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90986,Marketed,2014-10-08,02425211,BIO-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02425211,BIO-EZETIMIBE (ezetimibe 10 mg oral tablet) BIOMED PHARMA,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91025,Marketed,2014-09-17,02425610,ACH-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02425610,ACH-EZETIMIBE (ezetimibe 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91410,Marketed,2017-03-07,02429659,EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02429659,EZETIMIBE (ezetimibe 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91572,Marketed,2022-08-04,02431300,EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02431300,EZETIMIBE (ezetimibe 10 mg oral tablet) SANIS HEALTH INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94824,Marketed,2024-06-17,02460750,GLN-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02460750,GLN-EZETIMIBE (ezetimibe 10 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95581,Marketed,2017-12-14,02467437,M-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02467437,M-EZETIMIBE (ezetimibe 10 mg oral tablet) MANTRA PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95800,Marketed,2018-04-25,02469286,AURO-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02469286,AURO-EZETIMIBE (ezetimibe 10 mg oral tablet) AURO PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96664,Marketed,2018-07-20,02475898,AG-EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02475898,AG-EZETIMIBE (ezetimibe 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96932,Marketed,2024-06-11,02478544,EZETIMIBE,1.0,C10AX09,Ezetimibe,Tablet,Oral,02478544,EZETIMIBE (ezetimibe 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102520,Marketed,2024-01-11,02536420,NRA-EZETIMIBE TABLETS,1.0,C10AX09,Ezetimibe,Tablet,Oral,02536420,NRA-EZETIMIBE TABLETS (ezetimibe 10 mg oral tablet) NORA PHARMA INC,Active,9001031,ezetimibe 10 mg oral tablet,8000326,ezetimibe,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42981,Marketed,2021-07-29,02202581,FEIBA NF,1.0,B02BD03,Factor viii inhibitor bypassing activity,"Kit,Powder for solution",Intravenous,02202581,FEIBA NF (anti-inhibitor coagulant complex 700-1300 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014374,anti-inhibitor coagulant complex 700-1300 unit per vial powder for solution for injection with diluent solution,8002169,anti-inhibitor coagulant complex,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
83912,Marketed,2021-07-29,02353903,FEIBA NF,1.0,B02BD03,Factor viii inhibitor bypassing activity,"Kit,Powder for solution",Intravenous,02353903,FEIBA NF (anti-inhibitor coagulant complex 1750-3250 unit per vial powder for solution for injection with diluent solution) TAKEDA CANADA INC,Active,9014373,anti-inhibitor coagulant complex 1750-3250 unit per vial powder for solution for injection with diluent solution,8002169,anti-inhibitor coagulant complex,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
18768,Marketed,2025-02-13,02177102,FAMVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02177102,FAMVIR (famciclovir 500 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002808,famciclovir 500 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43513,Marketed,2025-02-13,02229110,FAMVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02229110,FAMVIR (famciclovir 125 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002928,famciclovir 125 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43514,Marketed,2025-02-13,02229129,FAMVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02229129,FAMVIR (famciclovir 250 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9002929,famciclovir 250 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77739,Marketed,2007-02-22,02292025,APO-FAMCICLOVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02292025,APO-FAMCICLOVIR (famciclovir 125 mg oral tablet) APOTEX INC,Active,9002928,famciclovir 125 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77741,Marketed,2007-02-22,02292041,APO-FAMCICLOVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02292041,APO-FAMCICLOVIR (famciclovir 250 mg oral tablet) APOTEX INC,Active,9002929,famciclovir 250 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77742,Marketed,2007-02-22,02292068,APO-FAMCICLOVIR,1.0,J05AB09,Famciclovir,Tablet,Oral,02292068,APO-FAMCICLOVIR (famciclovir 500 mg oral tablet) APOTEX INC,Active,9002808,famciclovir 500 mg oral tablet,8001203,famciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13654,Marketed,2014-04-03,02022133,TEVA-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02022133,TEVA-FAMOTIDINE (famotidine 20 mg oral tablet) TEVA CANADA LIMITED,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13655,Marketed,2014-04-03,02022141,TEVA-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02022141,TEVA-FAMOTIDINE (famotidine 40 mg oral tablet) TEVA CANADA LIMITED,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42879,Marketed,2025-11-28,02185938,PEPCID AC,1.0,A02BA03,Famotidine,Tablet,Oral,02185938,PEPCID AC (famotidine 10 mg oral tablet) KENVUE CANADA INC.,Active,9002889,famotidine 10 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72016,Marketed,2003-10-30,02247735,FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE),1.0,A02BA03,Famotidine,Solution,Intravenous,02247735,FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) (famotidine 20 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012708,famotidine 20 mg per 2 mL solution for injection vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72026,Marketed,2003-10-31,02247745,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL)",1.0,A02BA03,Famotidine,Solution,Intravenous,77700609,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL) (famotidine 40 mg per 4 mL solution for injection vial) OMEGA LABORATORIES LIMITED",Active,9012709,famotidine 40 mg per 4 mL solution for injection vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72026,Marketed,2003-10-31,02247745,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL)",1.0,A02BA03,Famotidine,Solution,Intravenous,77700610,"FAMOTIDINE OMEGA  -(WITH PRESERVATIVE,BENZYL ALCOHOL) (famotidine 10 mg per mL solution for injection 20 mL vial) OMEGA LABORATORIES LIMITED",Active,9012707,famotidine 10 mg per mL solution for injection 20 mL vial,8001380,famotidine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75884,Marketed,2025-11-28,02273357,MAXIMUM STRENGTH PEPCID AC,1.0,A02BA03,Famotidine,Tablet,Oral,02273357,MAXIMUM STRENGTH PEPCID AC (famotidine 20 mg oral tablet) KENVUE CANADA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83631,Marketed,2024-10-24,02351102,FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02351102,FAMOTIDINE (famotidine 20 mg oral tablet) SANIS HEALTH INC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83632,Marketed,2024-10-24,02351110,FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02351110,FAMOTIDINE (famotidine 40 mg oral tablet) SANIS HEALTH INC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99714,Marketed,2021-09-21,02507749,JAMP FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02507749,JAMP FAMOTIDINE (famotidine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99715,Marketed,2021-09-17,02507757,JAMP FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02507757,JAMP FAMOTIDINE (famotidine 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99923,Marketed,2021-09-21,02509970,AG-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02509970,AG-FAMOTIDINE (famotidine 20 mg oral tablet) ANGITA PHARMA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99924,Marketed,2021-09-21,02509989,AG-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02509989,AG-FAMOTIDINE (famotidine 40 mg oral tablet) ANGITA PHARMA INC.,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102708,Marketed,2025-01-27,02538350,ACID CONTROLLER MAXIMUM STRENGTH,1.0,A02BA03,Famotidine,Tablet,Oral,02538350,ACID CONTROLLER MAXIMUM STRENGTH (famotidine 20 mg oral tablet) ANGITA PHARMA INC.,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102732,Marketed,2024-04-30,02538628,MINT-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02538628,MINT-FAMOTIDINE (famotidine 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102733,Marketed,2024-04-30,02538636,MINT-FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02538636,MINT-FAMOTIDINE (famotidine 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103798,Marketed,2024-11-13,02549107,FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02549107,FAMOTIDINE (famotidine 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002571,famotidine 20 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103799,Marketed,2024-11-13,02549115,FAMOTIDINE,1.0,A02BA03,Famotidine,Tablet,Oral,02549115,FAMOTIDINE (famotidine 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002572,famotidine 40 mg oral tablet,8001380,famotidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66915,Marketed,2025-12-18,02243053,PEPCID COMPLETE,3.0,A02BA53,"Famotidine, combinations",Tablet (chewable),Oral,02243053,PEPCID COMPLETE (calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet) KENVUE CANADA INC.,Active,9003599,calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet,8002096,calcium carbonate and famotidine and magnesium hydroxide,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86577,Marketed,2025-11-03,02379910,FAMPYRA,1.0,N07XX07,Fampridine,Tablet (extended-release),Oral,02379910,FAMPYRA (fampridine 10 mg prolonged-release oral tablet) MERZ THERAPEUTICS GMBH,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97285,Marketed,2020-11-24,02482398,TARO-FAMPRIDINE,1.0,N07XX07,Fampridine,Tablet (extended-release),Oral,02482398,TARO-FAMPRIDINE (fampridine 10 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98608,Marketed,2021-04-12,02496216,PMS-FAMPRIDINE,1.0,N07XX07,Fampridine,Tablet (extended-release),Oral,02496216,PMS-FAMPRIDINE (fampridine 10 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9004991,fampridine 10 mg prolonged-release oral tablet,8001651,fampridine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101666,Marketed,2022-07-18,02527618,VABYSMO,1.0,S01LA09,Faricimab,Solution,Intravitreal,02527618,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014739,faricimab 6 mg per 0.05 mL solution for injection vial,8002427,faricimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
104289,Marketed,2025-06-30,02554003,VABYSMO,1.0,S01LA09,Faricimab,Solution,Intravitreal,02554003,VABYSMO (faricimab 6 mg per 0.05 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9015234,faricimab 6 mg per 0.05 mL solution for injection syringe,8002427,faricimab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
18647,Marketed,2015-10-19,02065673,INTRALIPID 20%,1.0,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,
82981,Marketed,2012-03-28,02344327,CLINOLEIC 20%,2.0,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,
88197,Marketed,2016-02-09,02396963,SMOFLIPID 20%,4.0,B05BA02,Fat emulsions,Emulsion,Intravenous,,,,,,,,,,,,,,,,
95449,Marketed,2019-11-28,02466198,TEVA-FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02466198,TEVA-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) TEVA CANADA LIMITED,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96300,Marketed,2019-05-16,02473607,MAR-FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02473607,MAR-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98091,Marketed,2020-02-25,02490870,JAMP FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02490870,JAMP FEBUXOSTAT (febuxostat 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102225,Marketed,2023-05-15,02533243,AURO-FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02533243,AURO-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) AURO PHARMA INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102857,Marketed,2023-12-07,02539837,FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02539837,FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) SANIS HEALTH INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103827,Marketed,2025-04-25,02549425,M-FEBUXOSTAT,1.0,M04AA03,Febuxostat,Tablet,Oral,02549425,M-FEBUXOSTAT (febuxostat (febuxostat hemihydrate) 80 mg oral tablet) MANTRA PHARMA INC,Active,9004776,febuxostat 80 mg oral tablet,8001652,febuxostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99202,Marketed,2025-02-03,02502445,INREBIC,1.0,L01EJ02,Fedratinib,Capsule,Oral,02502445,INREBIC (fedratinib (fedratinib hydrochloride) 100 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014546,fedratinib (fedratinib hydrochloride) 100 mg oral capsule,8002374,fedratinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
12458,Marketed,2024-08-07,00851779,PLENDIL,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,00851779,PLENDIL (felodipine 5 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
12459,Marketed,2024-08-07,00851787,PLENDIL,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,00851787,PLENDIL (felodipine 10 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
15574,Marketed,2024-08-07,02057778,PLENDIL,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02057778,PLENDIL (felodipine 2.5 mg prolonged-release oral tablet) GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Active,9000518,felodipine 2.5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76593,Marketed,2006-08-15,02280264,SANDOZ FELODIPINE,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02280264,SANDOZ FELODIPINE (felodipine 5 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
76594,Marketed,2006-08-15,02280272,SANDOZ FELODIPINE,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02280272,SANDOZ FELODIPINE (felodipine 10 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93875,Marketed,2016-04-22,02452367,APO-FELODIPINE,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02452367,APO-FELODIPINE (felodipine 2.5 mg prolonged-release oral tablet) APOTEX INC,Active,9000518,felodipine 2.5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93876,Marketed,2016-04-22,02452375,APO-FELODIPINE,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02452375,APO-FELODIPINE (felodipine 5 mg prolonged-release oral tablet) APOTEX INC,Active,9000423,felodipine 5 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93877,Marketed,2016-04-22,02452383,APO-FELODIPINE,1.0,C08CA02,Felodipine,Tablet (extended-release),Oral,02452383,APO-FELODIPINE (felodipine 10 mg prolonged-release oral tablet) APOTEX INC,Active,9000422,felodipine 10 mg prolonged-release oral tablet,8000165,felodipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
63352,Marketed,2020-01-21,02239864,AA-FENO-MICRO,1.0,C10AB05,Fenofibrate,Capsule,Oral,02239864,AA-FENO-MICRO (fenofibrate 200 mg oral capsule) AA PHARMA INC,Active,9000841,fenofibrate 200 mg oral capsule,8000225,fenofibrate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65259,Marketed,2016-03-08,02241602,LIPIDIL SUPRA,1.0,C10AB05,Fenofibrate,Tablet,Oral,02241602,LIPIDIL SUPRA (fenofibrate 160 mg oral tablet) BGP PHARMA ULC,Active,9000886,fenofibrate 160 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67060,Marketed,2019-11-15,02243180,AA-FENO-MICRO,1.0,C10AB05,Fenofibrate,Capsule,Oral,02243180,AA-FENO-MICRO (fenofibrate 67 mg oral capsule) AA PHARMA INC,Active,9000931,fenofibrate 67 mg oral capsule,8000225,fenofibrate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
71082,Marketed,2021-09-24,02246859,AA-FENO-SUPER,1.0,C10AB05,Fenofibrate,Tablet,Oral,02246859,AA-FENO-SUPER (fenofibrate 100 mg oral tablet) AA PHARMA INC,Active,9001142,fenofibrate 100 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71083,Marketed,2021-09-24,02246860,AA-FENO-SUPER,1.0,C10AB05,Fenofibrate,Tablet,Oral,02246860,AA-FENO-SUPER (fenofibrate 160 mg oral tablet) AA PHARMA INC,Active,9000886,fenofibrate 160 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75447,Marketed,2016-04-12,02269074,LIPIDIL EZ,1.0,C10AB05,Fenofibrate,Tablet,Oral,02269074,LIPIDIL EZ (fenofibrate 48 mg oral tablet) BGP PHARMA ULC,Active,9001123,fenofibrate 48 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75448,Marketed,2015-04-01,02269082,LIPIDIL EZ,1.0,C10AB05,Fenofibrate,Tablet,Oral,02269082,LIPIDIL EZ (fenofibrate 145 mg oral tablet) BGP PHARMA ULC,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87610,Marketed,2012-12-12,02390698,SANDOZ FENOFIBRATE E,1.0,C10AB05,Fenofibrate,Tablet,Oral,02390698,SANDOZ FENOFIBRATE E (fenofibrate 48 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001123,fenofibrate 48 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87611,Marketed,2012-08-24,02390701,SANDOZ FENOFIBRATE E,1.0,C10AB05,Fenofibrate,Tablet,Oral,02390701,SANDOZ FENOFIBRATE E (fenofibrate 145 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94139,Marketed,2025-11-07,02454696,SPC-FENOFIBRATE E,1.0,C10AB05,Fenofibrate,Tablet,Oral,02454696,SPC-FENOFIBRATE E (fenofibrate 145 mg oral tablet) SUN PHARMA CANADA INC,Active,9001122,fenofibrate 145 mg oral tablet,8000225,fenofibrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63983,Marketed,2005-08-26,02240434,FENTANYL CITRATE INJECTION USP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77700447,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
63983,Marketed,2005-08-26,02240434,FENTANYL CITRATE INJECTION USP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77700448,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
63983,Marketed,2005-08-26,02240434,FENTANYL CITRATE INJECTION USP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77700449,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000324,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
63983,Marketed,2005-08-26,02240434,FENTANYL CITRATE INJECTION USP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77700450,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
63983,Marketed,2005-08-26,02240434,FENTANYL CITRATE INJECTION USP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",77700451,FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
76857,Marketed,2012-12-21,02282941,TEVA-FENTANYL,1.0,N02AB03,Fentanyl,Patch,Transdermal,02282941,TEVA-FENTANYL (fentanyl 25 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001162,fentanyl 25 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
76858,Marketed,2012-12-21,02282968,TEVA-FENTANYL,1.0,N02AB03,Fentanyl,Patch,Transdermal,02282968,TEVA-FENTANYL (fentanyl 50 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001163,fentanyl 50 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
76859,Marketed,2012-12-21,02282976,TEVA-FENTANYL,1.0,N02AB03,Fentanyl,Patch,Transdermal,02282976,TEVA-FENTANYL (fentanyl 75 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001164,fentanyl 75 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
76860,Marketed,2012-12-21,02282984,TEVA-FENTANYL,1.0,N02AB03,Fentanyl,Patch,Transdermal,02282984,TEVA-FENTANYL (fentanyl 100 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001161,fentanyl 100 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
79746,Marketed,2012-12-21,02311925,TEVA-FENTANYL,1.0,N02AB03,Fentanyl,Patch,Transdermal,02311925,TEVA-FENTANYL (fentanyl 12 mcg per hour transdermal patch) TEVA CANADA LIMITED,Active,9001249,fentanyl 12 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81243,Marketed,2010-11-01,02327112,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327112,SANDOZ FENTANYL PATCH (fentanyl 12 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001249,fentanyl 12 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81244,Marketed,2010-11-01,02327120,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327120,SANDOZ FENTANYL PATCH (fentanyl 25 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001162,fentanyl 25 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81245,Marketed,2010-11-01,02327139,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327139,SANDOZ FENTANYL PATCH (fentanyl 37 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001326,fentanyl 37 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81246,Marketed,2010-11-01,02327147,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327147,SANDOZ FENTANYL PATCH (fentanyl 50 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001163,fentanyl 50 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81247,Marketed,2010-11-01,02327155,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327155,SANDOZ FENTANYL PATCH (fentanyl 75 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001164,fentanyl 75 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
81248,Marketed,2010-11-01,02327163,SANDOZ FENTANYL PATCH,1.0,N02AB03,Fentanyl,Patch,Transdermal,02327163,SANDOZ FENTANYL PATCH (fentanyl 100 mcg per hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9001161,fentanyl 100 mcg per hour transdermal patch,8000127,fentanyl,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,1.0,
86987,Marketed,2021-01-19,02384124,FENTANYL CITRATE INJECTION SDZ,1.0,N01AH01,Fentanyl,Solution,"Epidural,Intramuscular,Intravenous",77700486,FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
86987,Marketed,2021-01-19,02384124,FENTANYL CITRATE INJECTION SDZ,1.0,N01AH01,Fentanyl,Solution,"Epidural,Intramuscular,Intravenous",77700487,FENTANYL CITRATE INJECTION SDZ (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
89270,Marketed,2014-05-14,02408007,FENTORA,1.0,N02AB03,Fentanyl,Tablet (effervescent),"Sublingual,Buccal",02408007,FENTORA (fentanyl (fentanyl citrate) 100 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001424,fentanyl (fentanyl citrate) 100 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
89271,Marketed,2014-05-14,02408015,FENTORA,1.0,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408015,FENTORA (fentanyl (fentanyl citrate) 200 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001425,fentanyl (fentanyl citrate) 200 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
89272,Marketed,2014-05-14,02408023,FENTORA,1.0,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408023,FENTORA (fentanyl (fentanyl citrate) 400 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001426,fentanyl (fentanyl citrate) 400 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
89273,Marketed,2014-05-14,02408031,FENTORA,1.0,N02AB03,Fentanyl,Tablet (effervescent),"Buccal,Sublingual",02408031,FENTORA (fentanyl (fentanyl citrate) 600 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001427,fentanyl (fentanyl citrate) 600 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
89274,Marketed,2014-05-14,02408058,FENTORA,1.0,N02AB03,Fentanyl,Tablet (effervescent),"Sublingual,Buccal",02408058,FENTORA (fentanyl (fentanyl citrate) 800 mcg buccal tablet) TEVA CANADA LIMITED,Active,9001428,fentanyl (fentanyl citrate) 800 mcg buccal tablet,8000127,fentanyl,54471007,Buccal,385055001,Tablet,732936001,Tablet (unit of presentation),,1.0,
98602,Marketed,2020-09-09,02496143,FENTANYL INJECTION BP,1.0,N01AH01,Fentanyl,Solution,"Epidural,Intravenous,Intramuscular",02496143,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) STERIMAX INC,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
98603,Marketed,2020-04-23,02496151,FENTANYL INJECTION BP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",02496151,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) STERIMAX INC,Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98604,Marketed,2020-04-23,02496178,FENTANYL INJECTION BP,1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Intravenous,Epidural",02496178,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) STERIMAX INC,Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98605,Marketed,2020-04-23,02496186,FENTANYL INJECTION BP,1.0,N01AH01,Fentanyl,Solution,"Intravenous,Epidural,Intramuscular",02496186,FENTANYL INJECTION BP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99116,Marketed,2021-06-18,02501554,"FENTANYL CITRATE INJECTION, USP",1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77701082,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014567,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99116,Marketed,2021-06-18,02501554,"FENTANYL CITRATE INJECTION, USP",1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77701083,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99116,Marketed,2021-06-18,02501554,"FENTANYL CITRATE INJECTION, USP",1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77701084,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 50 mcg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014568,fentanyl (fentanyl citrate) 50 mcg per 1 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99116,Marketed,2021-06-18,02501554,"FENTANYL CITRATE INJECTION, USP",1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77701085,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99116,Marketed,2021-06-18,02501554,"FENTANYL CITRATE INJECTION, USP",1.0,N01AH01,Fentanyl,Solution,"Intramuscular,Epidural,Intravenous",77701086,"FENTANYL CITRATE INJECTION, USP (fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99638,Marketed,2022-06-06,02506963,FENTANYL CITRATE INJECTION,1.0,N01AH01,Fentanyl,Solution,"Epidural,Intravenous,Intramuscular",77701109,FENTANYL CITRATE INJECTION (fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
99638,Marketed,2022-06-06,02506963,FENTANYL CITRATE INJECTION,1.0,N01AH01,Fentanyl,Solution,"Epidural,Intravenous,Intramuscular",77701110,FENTANYL CITRATE INJECTION (fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,8000127,fentanyl,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
103946,Marketed,2025-02-28,02550679,ACCRUFER,1.0,B03AB10,Ferric maltol,Capsule,Oral,02550679,ACCRUFER (iron (ferric maltol) 30 mg oral capsule) KYE PHARMACEUTICALS INC.,Active,9015177,iron (ferric maltol) 30 mg oral capsule,8002534,ferric maltol,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
86587,Marketed,2012-04-19,02380021,TOVIAZ,1.0,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02380021,TOVIAZ (fesoterodine fumarate 4 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9005022,fesoterodine fumarate 4 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
86588,Marketed,2012-04-19,02380048,TOVIAZ,1.0,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02380048,TOVIAZ (fesoterodine fumarate 8 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9005023,fesoterodine fumarate 8 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101095,Marketed,2022-05-02,02521768,SANDOZ FESOTERODINE FUMARATE,1.0,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02521768,SANDOZ FESOTERODINE FUMARATE (fesoterodine fumarate 4 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005022,fesoterodine fumarate 4 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101096,Marketed,2022-05-02,02521776,SANDOZ FESOTERODINE FUMARATE,1.0,G04BD11,Fesoterodine,Tablet (extended-release),Oral,02521776,SANDOZ FESOTERODINE FUMARATE (fesoterodine fumarate 8 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9005023,fesoterodine fumarate 8 mg prolonged-release oral tablet,8001123,fesoterodine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
50779,Marketed,2019-11-15,02231462,ALLEGRA 12 HOUR,1.0,R06AX26,Fexofenadine,Tablet,Oral,02231462,ALLEGRA 12 HOUR (fexofenadine hydrochloride 60 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003118,fexofenadine hydrochloride 60 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66647,Marketed,2019-11-15,02242819,ALLEGRA 24 HOUR,1.0,R06AX26,Fexofenadine,Tablet,Oral,02242819,ALLEGRA 24 HOUR (fexofenadine hydrochloride 120 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003554,fexofenadine hydrochloride 120 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101047,Marketed,2023-01-19,02521245,ALLEGRA HIVES,1.0,R06AX26,Fexofenadine,Tablet,Oral,02521245,ALLEGRA HIVES (fexofenadine hydrochloride 60 mg oral tablet) SANOFI CONSUMER HEALTH INC,Active,9003118,fexofenadine hydrochloride 60 mg oral tablet,8001466,fexofenadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104252,Marketed,2025-03-11,02553600,VEOZAH,1.0,G02CX06,Fezolinetant,Tablet,Oral,02553600,VEOZAH (fezolinetant 45 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9015176,fezolinetant 45 mg oral tablet,8002535,fezolinetant,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
87858,Marketed,2013-01-31,02393352,RIASTAP,1.0,B02BB01,"Fibrinogen, human",Powder for solution,Intravenous,02393352,RIASTAP (fibrinogen human 1 g per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014111,fibrinogen human 1 g per vial powder for solution for injection with diluent solution,8002281,fibrinogen human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95274,Marketed,2018-08-08,02464616,FIBRYGA,1.0,B02BB01,"Fibrinogen, human",Powder for solution,Intravenous,02464616,FIBRYGA (fibrinogen human 1 g per vial powder for solution for injection) OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H,Active,9014110,fibrinogen human 1 g per vial powder for solution for injection,8002281,fibrinogen human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87275,Marketed,2016-09-20,02387174,DIFICID,1.0,A07AA12,Fidaxomicin,Tablet,Oral,02387174,DIFICID (fidaxomicin 200 mg oral tablet) MERCK CANADA INC,Active,9005056,fidaxomicin 200 mg oral tablet,8001773,fidaxomicin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12474,Marketed,2002-06-20,01968017,NEUPOGEN,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",77700711,NEUPOGEN (filgrastim 480 mcg per 1.6 mL solution for injection vial) AMGEN CANADA INC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
12474,Marketed,2002-06-20,01968017,NEUPOGEN,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",77700712,NEUPOGEN (filgrastim 300 mcg per 1 mL solution for injection vial) AMGEN CANADA INC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90471,Marketed,2016-01-28,02420104,NEUPOGEN,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02420104,NEUPOGEN (filgrastim 300 mcg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
90472,Marketed,2016-02-02,02420112,NEUPOGEN,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02420112,NEUPOGEN (filgrastim 480 mcg per 0.8 mL solution for injection syringe) AMGEN CANADA INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
92587,Marketed,2016-03-17,02441489,GRASTOFIL,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02441489,GRASTOFIL (filgrastim 300 mcg per 0.5 mL solution for injection syringe) APOTEX INC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
94117,Marketed,2016-11-28,02454548,GRASTOFIL,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02454548,GRASTOFIL (filgrastim 480 mcg per 0.8 mL solution for injection syringe) APOTEX INC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
97581,Marketed,2020-05-11,02485575,NIVESTYM,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485575,NIVESTYM (filgrastim 300 mcg per 0.5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
97582,Marketed,2020-05-11,02485583,NIVESTYM,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02485583,NIVESTYM (filgrastim 480 mcg per 0.8 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
97583,Marketed,2020-06-10,02485591,NIVESTYM,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485591,NIVESTYM (filgrastim 300 mcg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9013120,filgrastim 300 mcg per 1 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
97588,Marketed,2020-06-10,02485656,NIVESTYM,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02485656,NIVESTYM (filgrastim 480 mcg per 1.6 mL solution for injection vial) PFIZER CANADA ULC,Active,9013122,filgrastim 480 mcg per 1.6 mL solution for injection vial,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
101023,Marketed,2024-01-24,02520990,NYPOZI,1.0,L03AA02,Filgrastim,Solution,"Subcutaneous,Intravenous",02520990,"NYPOZI (filgrastim 300 mcg per 0.5 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101024,Marketed,2024-01-24,02521008,NYPOZI,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02521008,"NYPOZI (filgrastim 480 mcg per 0.8 mL solution for injection syringe) TANVEX BIOPHARMA USA, INC.",Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104522,Marketed,2025-09-16,02556537,FILRA,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02556537,FILRA (filgrastim 300 mcg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013119,filgrastim 300 mcg per 0.5 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
104523,Marketed,2025-09-16,02556545,FILRA,1.0,L03AA02,Filgrastim,Solution,"Intravenous,Subcutaneous",02556545,FILRA (filgrastim 480 mcg per 0.8 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013121,filgrastim 480 mcg per 0.8 mL solution for injection syringe,8001774,filgrastim (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
13370,Marketed,2022-07-19,02010909,PROSCAR,1.0,G04CB01,Finasteride,Tablet,Oral,02010909,PROSCAR (finasteride 5 mg oral tablet) ORGANON CANADA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
61606,Marketed,2022-05-11,02238213,PROPECIA,1.0,D11AX10,Finasteride,Tablet,Oral,02238213,PROPECIA (finasteride 1 mg oral tablet) ORGANON CANADA INC.,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79578,Marketed,2010-03-17,02310112,PMS-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02310112,PMS-FINASTERIDE (finasteride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80561,Marketed,2010-05-13,02320169,PMS-FINASTERIDE,1.0,D11AX10,Finasteride,Tablet,Oral,02320169,PMS-FINASTERIDE (finasteride 1 mg oral tablet) PHARMASCIENCE INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80802,Marketed,2020-10-20,02322579,SANDOZ FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02322579,SANDOZ FINASTERIDE (finasteride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82509,Marketed,2010-05-12,02339471,SANDOZ FINASTERIDE A,1.0,D11AX10,Finasteride,Tablet,Oral,02339471,SANDOZ FINASTERIDE A (finasteride 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83386,Marketed,2011-08-12,02348500,TEVA-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02348500,TEVA-FINASTERIDE (finasteride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83549,Marketed,2019-08-27,02350270,FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02350270,FINASTERIDE (finasteride 5 mg oral tablet) PRO DOC LIMITEE,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84031,Marketed,2014-11-13,02355043,ACH-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02355043,ACH-FINASTERIDE (finasteride 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84235,Marketed,2014-10-11,02357224,JAMP-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02357224,JAMP-FINASTERIDE (finasteride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85961,Marketed,2021-02-03,02374404,AG-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02374404,AG-FINASTERIDE (finasteride 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87534,Marketed,2012-07-25,02389878,MINT-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02389878,MINT-FINASTERIDE (finasteride 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89058,Marketed,2013-05-30,02405814,AURO-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02405814,AURO-FINASTERIDE (finasteride 5 mg oral tablet) AURO PHARMA INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91262,Marketed,2014-11-12,02428148,AURO-FINASTERIDE 1MG,1.0,D11AX10,Finasteride,Tablet,Oral,02428148,AURO-FINASTERIDE 1MG (finasteride 1 mg oral tablet) AURO PHARMA INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93028,Marketed,2015-10-14,02445077,FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02445077,FINASTERIDE (finasteride 5 mg oral tablet) SANIS HEALTH INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93029,Marketed,2015-10-14,02445085,FINASTERIDE,1.0,D11AX10,Finasteride,Tablet,Oral,02445085,FINASTERIDE (finasteride 1 mg oral tablet) SANIS HEALTH INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93313,Marketed,2015-11-25,02447541,FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02447541,FINASTERIDE (finasteride 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93314,Marketed,2015-11-25,02447568,FINASTERIDE,1.0,D11AX10,Finasteride,Tablet,Oral,02447568,FINASTERIDE (finasteride 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94182,Marketed,2024-06-27,02455013,RIVA-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02455013,RIVA-FINASTERIDE (finasteride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101160,Marketed,2022-10-07,02522489,M-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02522489,M-FINASTERIDE (finasteride 5 mg oral tablet) MANTRA PHARMA INC,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101704,Marketed,2023-04-18,02527847,BIO-FINASTERIDE,1.0,G04CB01,Finasteride,Tablet,Oral,02527847,BIO-FINASTERIDE (finasteride 5 mg oral tablet) BIOMED PHARMA,Active,9000424,finasteride 5 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102614,Marketed,2024-05-15,02537427,MINT-FINASTERIDE,1.0,D11AX10,Finasteride,Tablet,Oral,02537427,MINT-FINASTERIDE (finasteride 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000803,finasteride 1 mg oral tablet,8000166,finasteride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102100,Marketed,2022-11-22,02531917,KERENDIA,1.0,C03DA05,Finerenone,Tablet,Oral,02531917,KERENDIA (finerenone 10 mg oral tablet) BAYER INC,Active,9014792,finerenone 10 mg oral tablet,8002447,finerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102101,Marketed,2022-11-22,02531925,KERENDIA,1.0,C03DA05,Finerenone,Tablet,Oral,02531925,KERENDIA (finerenone 20 mg oral tablet) BAYER INC,Active,9014793,finerenone 20 mg oral tablet,8002447,finerenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85038,Marketed,2011-03-28,02365480,GILENYA,1.0,L04AE01,Fingolimod,Capsule,Oral,02365480,GILENYA (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95841,Marketed,2019-10-24,02469618,TARO-FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02469618,TARO-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95854,Marketed,2019-09-25,02469715,MYLAN-FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02469715,MYLAN-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95865,Marketed,2019-08-30,02469782,PMS-FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02469782,PMS-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
96603,Marketed,2019-12-11,02475669,ACH-FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02475669,ACH-FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97297,Marketed,2019-01-03,02482533,GILENYA,1.0,L04AE01,Fingolimod,Capsule,Oral,02482533,GILENYA (fingolimod (fingolimod hydrochloride) 0.25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013686,fingolimod (fingolimod hydrochloride) 0.25 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97303,Marketed,2019-10-31,02482606,SANDOZ FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02482606,SANDOZ FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97793,Marketed,2019-10-31,02487772,JAMP FINGOLIMOD,1.0,L04AE01,Fingolimod,Capsule,Oral,02487772,JAMP FINGOLIMOD (fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004852,fingolimod (fingolimod hydrochloride) 0.5 mg oral capsule,8001775,fingolimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
76117,Marketed,2017-12-15,02275538,APO-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02275538,APO-FLECAINIDE (flecainide acetate 50 mg oral tablet) APOTEX INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76118,Marketed,2017-12-15,02275546,APO-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02275546,APO-FLECAINIDE (flecainide acetate 100 mg oral tablet) APOTEX INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94726,Marketed,2017-02-27,02459957,AURO-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02459957,AURO-FLECAINIDE (flecainide acetate 50 mg oral tablet) AURO PHARMA INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94727,Marketed,2017-02-27,02459965,AURO-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02459965,AURO-FLECAINIDE (flecainide acetate 100 mg oral tablet) AURO PHARMA INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98370,Marketed,2020-10-27,02493705,JAMP FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02493705,JAMP FLECAINIDE (flecainide acetate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98371,Marketed,2020-11-13,02493713,JAMP FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02493713,JAMP FLECAINIDE (flecainide acetate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100542,Marketed,2023-06-08,02516063,AG-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02516063,AG-FLECAINIDE (flecainide acetate 50 mg oral tablet) ANGITA PHARMA INC.,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100543,Marketed,2023-06-08,02516071,AG-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02516071,AG-FLECAINIDE (flecainide acetate 100 mg oral tablet) ANGITA PHARMA INC.,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101927,Marketed,2023-04-13,02530066,NRA-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02530066,NRA-FLECAINIDE (flecainide acetate 50 mg oral tablet) NORA PHARMA INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101928,Marketed,2023-04-13,02530074,NRA-FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02530074,NRA-FLECAINIDE (flecainide acetate 100 mg oral tablet) NORA PHARMA INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102370,Marketed,2023-10-24,02534800,FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02534800,FLECAINIDE (flecainide acetate 50 mg oral tablet) SANIS HEALTH INC,Active,9002141,flecainide acetate 50 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102371,Marketed,2023-10-24,02534819,FLECAINIDE,1.0,C01BC04,Flecainide,Tablet,Oral,02534819,FLECAINIDE (flecainide acetate 100 mg oral tablet) SANIS HEALTH INC,Active,9001620,flecainide acetate 100 mg oral tablet,8001381,flecainide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96294,Marketed,2025-11-25,02473550,ADDYI,1.0,G02CX02,Flibanserin,Tablet,Oral,02473550,ADDYI (flibanserin 100 mg oral tablet) SPROUT PHARMACEUTICALS INC,Active,9013687,flibanserin 100 mg oral tablet,8002196,flibanserin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94968,Marketed,2018-08-13,02461927,NEURACEQ,1.0,V09AX06,Florbetaben 18f,Solution,Intravenous,,,,,,,,,,,,,,,,
10954,Marketed,1990-12-31,00891835,DIFLUCAN,1.0,J02AC01,Fluconazole,Solution,Intravenous,00891835,DIFLUCAN (fluconazole 200 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9012554,fluconazole 200 mg per 100 mL solution for injection vial,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
17789,Marketed,2019-07-25,02141442,DIFLUCAN ONE,1.0,J02AC01,Fluconazole,Capsule,Oral,02141442,DIFLUCAN ONE (fluconazole 150 mg oral capsule) PFIZER CANADA ULC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
18010,Marketed,1995-12-31,02024152,DIFLUCAN,1.0,J02AC01,Fluconazole,Powder for solution,Oral,02024152,DIFLUCAN (fluconazole 50 mg per 5 mL oral solution) PFIZER CANADA ULC,Active,9014361,fluconazole 50 mg per 5 mL oral solution,8000850,fluconazole,26643006,Oral,385023001,Oral solution,,,1.0,,
60693,Marketed,2024-08-29,02237370,APO-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02237370,APO-FLUCONAZOLE (fluconazole 50 mg oral tablet) APOTEX INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60694,Marketed,2024-08-29,02237371,APO-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02237371,APO-FLUCONAZOLE (fluconazole 100 mg oral tablet) APOTEX INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65565,Marketed,2011-03-02,02241895,APO-FLUCONAZOLE-150,1.0,J02AC01,Fluconazole,Capsule,Oral,02241895,APO-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) APOTEX INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
69316,Marketed,2010-04-16,02245292,MYLAN-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02245292,MYLAN-FLUCONAZOLE (fluconazole 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
69317,Marketed,2009-12-17,02245293,MYLAN-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02245293,MYLAN-FLUCONAZOLE (fluconazole 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
69743,Marketed,2002-06-05,02245643,PMS-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02245643,PMS-FLUCONAZOLE (fluconazole 50 mg oral tablet) PHARMASCIENCE INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
69744,Marketed,2002-06-05,02245644,PMS-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02245644,PMS-FLUCONAZOLE (fluconazole 100 mg oral tablet) PHARMASCIENCE INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74071,Marketed,2014-11-01,02255510,RIVA-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Capsule,Oral,02255510,RIVA-FLUCONAZOLE (fluconazole 150 mg oral capsule) LABORATOIRE RIVA INC.,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
74685,Marketed,2017-02-10,02261472,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP,1.0,J02AC01,Fluconazole,Solution,Intravenous,77700274,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP (fluconazole 200 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9006593,fluconazole 200 mg per 100 mL solution for injection bag,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,
74685,Marketed,2017-02-10,02261472,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP,1.0,J02AC01,Fluconazole,Solution,Intravenous,77700275,FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP (fluconazole 400 mg per 200 mL solution for injection bag) BAXTER CORPORATION,Active,9006594,fluconazole 400 mg per 200 mL solution for injection bag,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),1.0,,
76691,Marketed,2020-04-16,02281260,ACT FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02281260,ACT FLUCONAZOLE (fluconazole 50 mg oral tablet) TEVA CANADA LIMITED,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76692,Marketed,2020-04-16,02281279,ACT FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02281279,ACT FLUCONAZOLE (fluconazole 100 mg oral tablet) TEVA CANADA LIMITED,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79630,Marketed,2008-07-08,02310686,PRO-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02310686,PRO-FLUCONAZOLE (fluconazole 100 mg oral tablet) PRO DOC LIMITEE,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79724,Marketed,2010-03-10,02311690,CANESORAL,1.0,J02AC01,Fluconazole,Capsule,Oral,02311690,CANESORAL (fluconazole 150 mg oral capsule) BAYER INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
83738,Marketed,2011-03-25,02352133,FLUCONAZOLE 150,1.0,J02AC01,Fluconazole,Capsule,Oral,02352133,FLUCONAZOLE 150 (fluconazole 150 mg oral capsule) APOTEX INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
86844,Marketed,2012-10-25,02382628,MONICURE COMBO,2.0,J02AC01,Fluconazole,"Cream,Capsule,Kit","Topical,Oral",02382628,"MONICURE COMBO (fluconazole 150 mg oral capsule with miconazole nitrate 2 % cutaneous cream) INSIGHT PHARMACEUTICALS, LLC",Active,9012806,fluconazole 150 mg oral capsule with miconazole nitrate 2 % cutaneous cream,8001382,fluconazole and miconazole,255204007,Multiple (oral and cutaneous),420692007,Oral capsule,732937005,Capsule,1.0,,
87397,Marketed,2012-10-18,02388448,FLUCONAZOLE INJECTION SDZ,1.0,J02AC01,Fluconazole,Solution,Intravenous,02388448,FLUCONAZOLE INJECTION SDZ (fluconazole 200 mg per 100 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012554,fluconazole 200 mg per 100 mL solution for injection vial,8000850,fluconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91325,Marketed,2016-12-14,02428792,MAR-FLUCONAZOLE-150,1.0,J02AC01,Fluconazole,Capsule,Oral,02428792,MAR-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91671,Marketed,2015-01-08,02432471,JAMP-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Capsule,Oral,02432471,JAMP-FLUCONAZOLE (fluconazole 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91806,Marketed,2025-01-17,02433702,NRA-FLUCONAZOLE-150,1.0,J02AC01,Fluconazole,Capsule,Oral,02433702,NRA-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) NORA PHARMA INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93803,Marketed,2021-02-11,02451727,CLOTRIMAZOLE-FLUCONAZOLE COMBI,2.0,J02AC01,Fluconazole,"Cream,Kit,Capsule","Topical,Oral",02451727,CLOTRIMAZOLE-FLUCONAZOLE COMBI (clotrimazole 1 % cutaneous cream with fluconazole 150 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9012660,clotrimazole 1 % cutaneous cream with fluconazole 150 mg oral capsule,8000978,clotrimazole and fluconazole,255204007,Multiple (oral and cutaneous),420692007,Oral capsule,732937005,Capsule,1.0,,
94989,Marketed,2019-09-20,02462168,BIO-FLUCONAZOLE,1.0,J02AC01,Fluconazole,Capsule,Oral,02462168,BIO-FLUCONAZOLE (fluconazole 150 mg oral capsule) BIOMED PHARMA,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100680,Marketed,2022-01-14,02517396,FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02517396,FLUCONAZOLE (fluconazole 50 mg oral tablet) SANIS HEALTH INC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100681,Marketed,2022-01-14,02517418,FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02517418,FLUCONAZOLE (fluconazole 100 mg oral tablet) SANIS HEALTH INC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101044,Marketed,2022-05-12,02521229,FLUCONAZOLE-150,1.0,J02AC01,Fluconazole,Capsule,Oral,02521229,FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) SANIS HEALTH INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102377,Marketed,2023-10-24,02534886,FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02534886,FLUCONAZOLE (fluconazole 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002304,fluconazole 50 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102378,Marketed,2023-10-24,02534894,FLUCONAZOLE,1.0,J02AC01,Fluconazole,Tablet,Oral,02534894,FLUCONAZOLE (fluconazole 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9002302,fluconazole 100 mg oral tablet,8000850,fluconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103678,Marketed,2025-03-11,02547864,JAMP FLUCONAZOLE 150 MG,1.0,J02AC01,Fluconazole,Capsule,Oral,02547864,JAMP FLUCONAZOLE 150 MG (fluconazole 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
104234,Marketed,2025-08-22,02553406,M-FLUCONAZOLE-150,1.0,J02AC01,Fluconazole,Capsule,Oral,02553406,M-FLUCONAZOLE-150 (fluconazole 150 mg oral capsule) MANTRA PHARMA INC,Active,9002809,fluconazole 150 mg oral capsule,8000850,fluconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
70384,Marketed,2014-02-28,02246226,FLUDARA,1.0,L01BB05,Fludarabine,Tablet,Oral,02246226,FLUDARA (fludarabine phosphate 10 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003755,fludarabine phosphate 10 mg oral tablet,8001776,fludarabine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76943,Marketed,2014-02-08,02283859,FLUDARABINE PHOSPHATE FOR INJECTION,1.0,L01BB05,Fludarabine,Solution,Intravenous,02283859,FLUDARABINE PHOSPHATE FOR INJECTION (fludarabine phosphate 50 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013123,fludarabine phosphate 50 mg per 2 mL solution for injection vial,8001776,fludarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92295,Marketed,2022-08-25,02438577,"FLUDARABINE PHOSPHATE INJECTION, USP",1.0,L01BB05,Fludarabine,Solution,Intravenous,02438577,"FLUDARABINE PHOSPHATE INJECTION, USP (fludarabine phosphate 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC",Active,9013123,fludarabine phosphate 50 mg per 2 mL solution for injection vial,8001776,fludarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
81315,Marketed,2024-02-12,02327740,FLUGLUCOSCAN,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
81437,Marketed,2018-08-03,02328739,18F-FLUDEOXYGLUCOSE (18F-FDG),1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
88689,Marketed,2018-08-13,02402017,NAF PLUS,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
89749,Marketed,2025-04-25,02412837,FLUDEOXYGLUCOSE (18F) INJECTION,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
91763,Marketed,2018-09-28,02433230,FLUDEOXYGLUCOSE (18F) INJECTION,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
92276,Marketed,2019-07-26,02438380,ATLANTISCAN,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
94822,Marketed,2019-10-16,02460734,[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
95011,Marketed,2018-10-17,02462354,FLUDEOXYGLUCOSE (F-18),1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
95083,Marketed,2020-02-04,02462958,CYCLODX,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
95555,Marketed,2021-10-20,02467151,FLUDEOXYGLUCOSE [F-18] FDG INJECTION,1.0,V09IX04,Fludeoxyglucose (18f),Solution,Intravenous,,,,,,,,,,,,,,,,
19460,Marketed,2024-12-31,02086026,FLORINEF,1.0,H02AA02,Fludrocortisone,Tablet,Oral,02086026,FLORINEF (fludrocortisone acetate 0.1 mg oral tablet) ENDO OPERATIONS LTD.,Active,9012630,fludrocortisone acetate 0.1 mg oral tablet,8001269,fludrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104092,Marketed,2025-05-20,02552248,JAMP FLUDROCORTISONE,1.0,H02AA02,Fludrocortisone,Tablet,Oral,02552248,JAMP FLUDROCORTISONE (fludrocortisone acetate 0.1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012630,fludrocortisone acetate 0.1 mg oral tablet,8001269,fludrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73439,Marketed,2005-09-15,02249561,FLUMAZENIL INJECTION,1.0,V03AB25,Flumazenil,Solution,Intravenous,02249561,FLUMAZENIL INJECTION (flumazenil 0.5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013124,flumazenil 0.5 mg per 5 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75176,Marketed,2025-05-08,02266342,"FLUMAZENIL INJECTION, USP",1.0,V03AB25,Flumazenil,Solution,Intravenous,77700738,"FLUMAZENIL INJECTION, USP (flumazenil 0.5 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013124,flumazenil 0.5 mg per 5 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75176,Marketed,2025-05-08,02266342,"FLUMAZENIL INJECTION, USP",1.0,V03AB25,Flumazenil,Solution,Intravenous,77700739,"FLUMAZENIL INJECTION, USP (flumazenil 1 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013125,flumazenil 1 mg per 10 mL solution for injection vial,8001777,flumazenil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
631,Marketed,2025-12-19,00074462,LOCACORTEN VIOFORM,2.0,D07CB05,Flumetasone and antibiotics,Cream,Topical,00074462,LOCACORTEN VIOFORM (clioquinol 3 % and flumethasone pivalate 0.02 % cutaneous cream) KNIGHT THERAPEUTICS INC.,Active,9001633,clioquinol 3 % and flumethasone pivalate 0.02 % cutaneous cream,8001899,clioquinol and flumethasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
868,Marketed,2025-12-23,00074454,LOCACORTEN VIOFORM EARDROPS,2.0,S02CA02,Flumetasone and antiinfectives,Drops,Otic,00074454,LOCACORTEN VIOFORM EARDROPS (clioquinol 1 % and flumethasone pivalate 0.02 % otic drops) KNIGHT THERAPEUTICS INC.,Active,9001643,clioquinol 1 % and flumethasone pivalate 0.02 % otic drops,8001899,clioquinol and flumethasone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
70217,Marketed,2011-12-01,02246082,FLUNARIZINE,1.0,N07CA03,Flunarizine,Capsule,Oral,02246082,FLUNARIZINE (flunarizine (flunarizine hydrochloride) 5 mg oral capsule) AA PHARMA INC,Active,9003743,flunarizine (flunarizine hydrochloride) 5 mg oral capsule,8001468,flunarizine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13875,Marketed,1991-12-31,00873292,DERMA SMOOTHE/FS LIQ 0.01%,1.0,D07AC04,Fluocinolone acetonide,Emulsion,Topical,00873292,DERMA SMOOTHE/FS LIQ 0.01% (fluocinolone acetonide 0.01 % cutaneous emulsion) HILL DERMACEUTICALS INC,Active,9013291,fluocinolone acetonide 0.01 % cutaneous emulsion,8001778,fluocinolone,448598008,Cutaneous,738998008,Emulsion,,,,,
78584,Marketed,2008-01-09,02300559,DERMOTIC OIL EAR DROPS,1.0,S02BA08,Fluocinolone acetonide,Solution,Otic,02300559,DERMOTIC OIL EAR DROPS (fluocinolone acetonide 0.01 % otic drops) HILL DERMACEUTICALS INC,Active,9004368,fluocinolone acetonide 0.01 % otic drops,8001778,fluocinolone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
94696,Marketed,2023-01-25,02459655,OTIXAL,2.0,S02CA05,Fluocinolone acetonide and antiinfectives,Solution,Otic,02459655,OTIXAL (ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and fluocinolone acetonide 0.025 % otic drops) MEDEXUS PHARMACEUTICALS INC.,Active,9006171,ciprofloxacin (ciprofloxacin hydrochloride) 0.3 % and fluocinolone acetonide 0.025 % otic drops,8001728,ciprofloxacin and fluocinolone,10547007,Otic,385136004,Otic drops,732994000,Drop (unit of presentation),,,
5439,Marketed,2004-04-06,00598933,TIAMOL CREAM 0.05%,1.0,D07AC08,Fluocinonide,Cream,Topical,00598933,"TIAMOL CREAM 0.05% (fluocinonide 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9001977,fluocinonide 0.05 % cutaneous cream,8001270,fluocinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
9276,Marketed,2023-12-06,00716863,LYDERM,1.0,D07AC08,Fluocinonide,Cream,Topical,00716863,"LYDERM (fluocinonide 0.05 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9001977,fluocinonide 0.05 % cutaneous cream,8001270,fluocinonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
60294,Marketed,2023-12-07,02236996,LYDERM,1.0,D07AC08,Fluocinonide,Ointment,Topical,02236996,"LYDERM (fluocinonide 0.05 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9002813,fluocinonide 0.05 % cutaneous ointment,8001270,fluocinonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
60295,Marketed,2023-12-07,02236997,LYDERM,1.0,D07AC08,Fluocinonide,Gel,Topical,02236997,"LYDERM (fluocinonide 0.05 % cutaneous gel) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9002812,fluocinonide 0.05 % cutaneous gel,8001270,fluocinonide,448598008,Cutaneous,385100002,Gel,,,,,
18747,Marketed,2022-12-28,02148390,MINIMS FLUORESCEIN SODIUM,1.0,S01JA01,Fluorescein,Drops,Ophthalmic,02148390,MINIMS FLUORESCEIN SODIUM (fluorescein sodium 2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002815,fluorescein sodium 2 % ophthalmic drops,8001469,fluorescein,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
19197,Marketed,1995-12-31,02160773,DIOFLUOR STRIPS,1.0,S01JA01,Fluorescein,Strip,Ophthalmic,02160773,DIOFLUOR STRIPS (fluorescein sodium 1 mg ophthalmic strip) DIOPTIC PHARMACEUTICALS INC,Active,9002668,fluorescein sodium 1 mg ophthalmic strip,8001469,fluorescein,54485002,Ophthalmic,758679000,Strip,733018009,Strip,,,
1470,Marketed,2024-03-28,00247855,FML,1.0,S01BA07,Fluorometholone,Suspension,Ophthalmic,00247855,FML (fluorometholone 0.1 % ophthalmic drops) ABBVIE CORPORATION,Active,9001688,fluorometholone 0.1 % ophthalmic drops,8001470,fluorometholone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
42778,Marketed,2012-07-24,00432814,SANDOZ FLUOROMETHOLONE,1.0,S01BA07,Fluorometholone,Suspension,Ophthalmic,00432814,SANDOZ FLUOROMETHOLONE (fluorometholone 0.1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001688,fluorometholone 0.1 % ophthalmic drops,8001470,fluorometholone (base),54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
2138,Marketed,2021-06-10,00330582,EFUDEX,1.0,L01BC02,Fluorouracil,Cream,Topical,00330582,"EFUDEX (fluorouracil 5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9001736,fluorouracil 5 % cutaneous cream,8001779,fluorouracil,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,
10015,Marketed,2009-03-06,00012882,FLUOROURACIL INJECTION,1.0,L01BC02,Fluorouracil,Solution,Intravenous,77700962,FLUOROURACIL INJECTION (fluorouracil 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013557,fluorouracil 500 mg per 10 mL solution for injection vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
10015,Marketed,2009-03-06,00012882,FLUOROURACIL INJECTION,1.0,L01BC02,Fluorouracil,Solution,Intravenous,77700963,FLUOROURACIL INJECTION (fluorouracil 50 mg per mL solution for injection 100 mL vial) SANDOZ CANADA INCORPORATED,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89810,Marketed,2017-06-15,02413450,FLUOROURACIL INJECTION USP,1.0,L01BC02,Fluorouracil,Solution,Intravenous,02413450,FLUOROURACIL INJECTION USP (fluorouracil 50 mg per mL solution for injection 100 mL vial) ACCORD HEALTHCARE INC,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96316,Marketed,2021-12-02,02473763,FLUOROURACIL INJECTION,1.0,L01BC02,Fluorouracil,Solution,Intravenous,02473763,FLUOROURACIL INJECTION (fluorouracil 500 mg per 10 mL solution for injection vial) BIOLYSE PHARMA CORPORATION,Active,9013557,fluorouracil 500 mg per 10 mL solution for injection vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96320,Marketed,2019-06-06,02473771,FLUOROURACIL INJECTION,1.0,L01BC02,Fluorouracil,Solution,Intravenous,02473771,FLUOROURACIL INJECTION (fluorouracil 50 mg per mL solution for injection 100 mL vial) BIOLYSE PHARMA CORPORATION,Active,9013556,fluorouracil 50 mg per mL solution for injection 100 mL vial,8001779,fluorouracil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97559,Marketed,2019-06-25,02485346,TOLAK,1.0,L01BC02,Fluorouracil,Cream,Topical,02485346,TOLAK (fluorouracil (fluorouracil sodium) 4 % cutaneous cream) HILL DERMACEUTICALS INC,Active,9013962,fluorouracil (fluorouracil sodium) 4 % cutaneous cream,8001779,fluorouracil,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,
91338,Marketed,2016-02-19,02428946,ACTIKERALL,2.0,L01BC52,"Fluorouracil, combinations",Solution,Topical,02428946,ACTIKERALL (fluorouracil 0.5 % and salicylic acid 10 % cutaneous solution) CIPHER PHARMACEUTICALS INC,Active,9005885,fluorouracil 0.5 % and salicylic acid 10 % cutaneous solution,8001780,fluorouracil and salicylic acid,448598008,Cutaneous,385108009,Cutaneous solution,,,1.0,,
19064,Marketed,2001-12-22,02177587,PMS-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02177587,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) PHARMASCIENCE INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19074,Marketed,2001-12-22,02177579,PMS-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02177579,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) PHARMASCIENCE INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19895,Marketed,2010-10-09,02216590,TEVA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02216590,TEVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) TEVA CANADA LIMITED,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19916,Marketed,2010-10-09,02216582,TEVA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02216582,TEVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) TEVA CANADA LIMITED,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19961,Marketed,2022-01-20,02216361,APO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02216361,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) APOTEX INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19962,Marketed,2022-01-20,02216353,APO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02216353,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) APOTEX INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
50635,Marketed,2022-01-20,02231328,APO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Solution,Oral,02231328,APO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) APOTEX INC,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,
77154,Marketed,2017-01-27,02286068,FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02286068,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) SANIS HEALTH INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77155,Marketed,2015-10-08,02286076,FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02286076,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) SANIS HEALTH INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79103,Marketed,2010-10-22,02305461,RIVA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02305461,RIVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79104,Marketed,2009-09-21,02305488,RIVA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02305488,RIVA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80053,Marketed,2025-11-28,02314991,PRO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02314991,PRO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) PRO DOC LIMITEE,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80054,Marketed,2008-10-15,02315009,PRO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02315009,PRO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) PRO DOC LIMITEE,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85969,Marketed,2023-02-15,02374447,FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02374447,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85980,Marketed,2023-02-15,02374455,FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02374455,FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86635,Marketed,2020-11-12,02380560,MINT-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02380560,MINT-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86636,Marketed,2020-11-12,02380579,MINT-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02380579,MINT-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86901,Marketed,2019-09-04,02383241,ACH-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02383241,ACH-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87125,Marketed,2012-07-24,02385627,AURO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02385627,AURO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) AURO PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87126,Marketed,2012-07-24,02385635,AURO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02385635,AURO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) AURO PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87199,Marketed,2021-10-22,02386402,JAMP-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02386402,JAMP-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87817,Marketed,2025-03-21,02392909,MAR-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02392909,MAR-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87818,Marketed,2025-03-21,02392917,MAR-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02392917,MAR-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87867,Marketed,2019-09-04,02393441,ACH-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02393441,ACH-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88677,Marketed,2021-10-22,02401894,JAMP-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02401894,JAMP-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93411,Marketed,2024-12-05,02448424,BIO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02448424,BIO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) BIOMED PHARMA,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93412,Marketed,2024-12-05,02448432,BIO-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02448432,BIO-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) BIOMED PHARMA,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94657,Marketed,2017-01-24,02459361,ODAN-FLUOXETINE,1.0,N06AB03,Fluoxetine,Solution,Oral,02459361,ODAN-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,
95277,Marketed,2018-02-21,02464640,PMS-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02464640,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 40 mg oral capsule) PHARMASCIENCE INC,Active,9012453,fluoxetine (fluoxetine hydrochloride) 40 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95278,Marketed,2018-08-01,02464659,PMS-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02464659,PMS-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 60 mg oral capsule) PHARMASCIENCE INC,Active,9012971,fluoxetine (fluoxetine hydrochloride) 60 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99331,Marketed,2024-10-23,02503875,NRA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02503875,NRA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) NORA PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99332,Marketed,2024-10-23,02503883,NRA-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02503883,NRA-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) NORA PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101864,Marketed,2024-10-17,02529432,M-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02529432,M-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule) MANTRA PHARMA INC,Active,9000469,fluoxetine (fluoxetine hydrochloride) 10 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101865,Marketed,2024-10-17,02529440,M-FLUOXETINE,1.0,N06AB03,Fluoxetine,Capsule,Oral,02529440,M-FLUOXETINE (fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule) MANTRA PHARMA INC,Active,9000325,fluoxetine (fluoxetine hydrochloride) 20 mg oral capsule,8000128,fluoxetine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103543,Marketed,2025-04-28,02546752,JAMP FLUOXETINE SOLUTION,1.0,N06AB03,Fluoxetine,Solution,Oral,02546752,JAMP FLUOXETINE SOLUTION (fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9000733,fluoxetine (fluoxetine hydrochloride) 20 mg per 5 mL oral solution,8000128,fluoxetine,26643006,Oral,385023001,Oral solution,,,,,
18737,Marketed,1995-12-31,02156040,FLUANXOL DEPOT 10%- LIQ IM 100MG/ML,1.0,N05AF01,Flupentixol,Solution,Intramuscular,02156040,FLUANXOL DEPOT 10%- LIQ IM 100MG/ML (flupentixol decanoate 100 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9013126,flupentixol decanoate 100 mg per 1 mL solution for injection ampoule,8001472,flupentixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
18739,Marketed,1995-12-31,02156008,FLUANXOL 0.5MG - TAB,1.0,N05AF01,Flupentixol,Tablet,Oral,02156008,FLUANXOL 0.5MG - TAB (flupentixol (flupentixol dihydrochloride) 0.5 mg oral tablet) LUNDBECK CANADA INC,Active,9002818,flupentixol (flupentixol dihydrochloride) 0.5 mg oral tablet,8001472,flupentixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18740,Marketed,1995-12-31,02156016,FLUANXOL 3MG - TAB,1.0,N05AF01,Flupentixol,Tablet,Oral,02156016,FLUANXOL 3MG - TAB (flupentixol (flupentixol dihydrochloride) 3 mg oral tablet) LUNDBECK CANADA INC,Active,9002819,flupentixol (flupentixol dihydrochloride) 3 mg oral tablet,8001472,flupentixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18800,Marketed,1995-12-31,02156032,FLUANXOL DEPOT 2% -LIQ IM 20MG/ML,1.0,N05AF01,Flupentixol,Solution,Intramuscular,02156032,FLUANXOL DEPOT 2% -LIQ IM 20MG/ML (flupentixol decanoate 20 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9013127,flupentixol decanoate 20 mg per 1 mL solution for injection ampoule,8001472,flupentixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
2858,Marketed,2012-07-10,00405345,FLUPHENAZINE,1.0,N05AB02,Fluphenazine,Tablet,Oral,00405345,FLUPHENAZINE (fluphenazine hydrochloride 1 mg oral tablet) AA PHARMA INC,Active,9001785,fluphenazine hydrochloride 1 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2860,Marketed,2014-03-12,00405361,FLUPHENAZINE,1.0,N05AB02,Fluphenazine,Tablet,Oral,00405361,FLUPHENAZINE (fluphenazine hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9001788,fluphenazine hydrochloride 5 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2861,Marketed,2012-07-10,00410632,FLUPHENAZINE,1.0,N05AB02,Fluphenazine,Tablet,Oral,00410632,FLUPHENAZINE (fluphenazine hydrochloride 2 mg oral tablet) AA PHARMA INC,Active,9001787,fluphenazine hydrochloride 2 mg oral tablet,8001473,fluphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4728,Marketed,2015-12-17,00521698,FLURAZEPAM,1.0,N05CD01,Flurazepam,Capsule,Oral,00521698,FLURAZEPAM (flurazepam hydrochloride 15 mg oral capsule) AA PHARMA INC,Active,9000168,flurazepam hydrochloride 15 mg oral capsule,8000091,flurazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
4729,Marketed,2015-05-06,00521701,FLURAZEPAM,1.0,N05CD01,Flurazepam,Capsule,Oral,00521701,FLURAZEPAM (flurazepam hydrochloride 30 mg oral capsule) AA PHARMA INC,Active,9000169,flurazepam hydrochloride 30 mg oral capsule,8000091,flurazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
11465,Marketed,2019-08-13,01912038,FLURBIPROFEN,1.0,M01AE09,Flurbiprofen,Tablet,Oral,01912038,FLURBIPROFEN (flurbiprofen 100 mg oral tablet) AA PHARMA INC,Active,9002362,flurbiprofen 100 mg oral tablet,8001474,flurbiprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11466,Marketed,2019-06-07,01912046,FLURBIPROFEN,1.0,M01AE09,Flurbiprofen,Tablet,Oral,01912046,FLURBIPROFEN (flurbiprofen 50 mg oral tablet) AA PHARMA INC,Active,9002363,flurbiprofen 50 mg oral tablet,8001474,flurbiprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61987,Marketed,2020-05-25,02238560,FLUTAMIDE,1.0,L02BB01,Flutamide,Tablet,Oral,02238560,FLUTAMIDE (flutamide 250 mg oral tablet) AA PHARMA INC,Active,9003045,flutamide 250 mg oral tablet,8001654,flutamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60565,Marketed,2003-12-22,02237245,FLOVENT DISKUS,1.0,R03BA05,Fluticasone,Powder,Inhalation,02237245,FLOVENT DISKUS (fluticasone propionate 100 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000794,fluticasone propionate 100 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
60566,Marketed,2003-01-06,02237246,FLOVENT DISKUS,1.0,R03BA05,Fluticasone,Powder,Inhalation,02237246,FLOVENT DISKUS (fluticasone propionate 250 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000795,fluticasone propionate 250 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
60567,Marketed,2002-12-19,02237247,FLOVENT DISKUS,1.0,R03BA05,Fluticasone,Powder,Inhalation,02237247,FLOVENT DISKUS (fluticasone propionate 500 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9000796,fluticasone propionate 500 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
68258,Marketed,2001-12-20,02244291,FLOVENT HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244291,FLOVENT HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
68259,Marketed,2001-12-20,02244292,FLOVENT HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244292,FLOVENT HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
68260,Marketed,2001-12-20,02244293,FLOVENT HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02244293,FLOVENT HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
72648,Marketed,2024-07-24,02248307,FLONASE ALLERGY RELIEF,1.0,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02248307,FLONASE ALLERGY RELIEF (fluticasone propionate 50 mcg per actuation nasal spray) HALEON CANADA ULC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
78009,Marketed,2007-07-05,02294745,APO-FLUTICASONE,1.0,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02294745,APO-FLUTICASONE (fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
94027,Marketed,2017-09-28,02453738,TEVA-FLUTICASONE,1.0,R01AD08,Fluticasone,Metered-dose pump,Nasal,02453738,TEVA-FLUTICASONE (fluticasone propionate 50 mcg per actuation nasal spray) TEVA CANADA LIMITED,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
94795,Marketed,2017-07-19,02460513,24HR NASAL ALLERGY RELIEF,1.0,R01AD08,Fluticasone,"Spray, metered dose",Nasal,02460513,24HR NASAL ALLERGY RELIEF (fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9000452,fluticasone propionate 50 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
95621,Marketed,2020-09-30,02467895,AERMONY RESPICLICK,1.0,R03BA05,Fluticasone,Powder (metered dose),Inhalation,02467895,AERMONY RESPICLICK (fluticasone propionate 55 mcg per actuation inhalation powder) TEVA CANADA LIMITED,Active,9014384,fluticasone propionate 55 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
95625,Marketed,2020-09-30,02467909,AERMONY RESPICLICK,1.0,R03BA05,Fluticasone,Powder (metered dose),Inhalation,02467909,AERMONY RESPICLICK (fluticasone propionate 113 mcg per actuation inhalation powder) TEVA CANADA LIMITED,Active,9014382,fluticasone propionate 113 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
95626,Marketed,2020-09-30,02467917,AERMONY RESPICLICK,1.0,R03BA05,Fluticasone,Powder (metered dose),Inhalation,02467917,AERMONY RESPICLICK (fluticasone propionate 232 mcg per actuation inhalation powder) TEVA CANADA LIMITED,Active,9014383,fluticasone propionate 232 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
99262,Marketed,2022-08-31,02503115,PMS-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02503115,PMS-FLUTICASONE HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
99263,Marketed,2022-04-18,02503123,PMS-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02503123,PMS-FLUTICASONE HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
99264,Marketed,2021-01-21,02503131,PMS-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Oral,Inhalation",02503131,PMS-FLUTICASONE HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) PHARMASCIENCE INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
100023,Marketed,2021-04-26,02510987,APO-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Inhalation,Oral",02510987,APO-FLUTICASONE HFA (fluticasone propionate 250 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000968,fluticasone propionate 250 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
101564,Marketed,2022-11-22,02526557,APO-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,Metered-dose aerosol,"Oral,Inhalation",02526557,APO-FLUTICASONE HFA (fluticasone propionate 125 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000967,fluticasone propionate 125 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
101764,Marketed,2025-02-27,02528428,APO-FLUTICASONE HFA,1.0,R03BA05,Fluticasone,"Aerosol, metered dose","Oral,Inhalation",02528428,APO-FLUTICASONE HFA (fluticasone propionate 50 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000969,fluticasone propionate 50 mcg per actuation pressurized inhalation,8000173,fluticasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
78388,Marketed,2007-10-22,02298589,AVAMYS,1.0,R01AD12,Fluticasone furoate,"Spray, metered dose",Nasal,02298589,AVAMYS (fluticasone furoate 27.5 mcg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9001222,fluticasone furoate 27.5 mcg per actuation nasal spray,8000173,fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
93200,Marketed,2016-01-26,02446561,ARNUITY ELLIPTA,1.0,R03BA09,Fluticasone furoate,Powder,"Oral,Inhalation",02446561,ARNUITY ELLIPTA (fluticasone furoate 100 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9001454,fluticasone furoate 100 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
93201,Marketed,2015-12-14,02446588,ARNUITY ELLIPTA,1.0,R03BA09,Fluticasone furoate,Powder,"Inhalation,Oral",02446588,ARNUITY ELLIPTA (fluticasone furoate 200 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9001452,fluticasone furoate 200 mcg per actuation inhalation powder,8000173,fluticasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
91729,Marketed,2018-07-31,02432889,DYMISTA,2.0,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02432889,DYMISTA (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) BGP PHARMA ULC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
101952,Marketed,2023-08-16,02530341,MYLAN-AZELASTINE/FLUTICASONE,2.0,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02530341,MYLAN-AZELASTINE/FLUTICASONE (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) MYLAN PHARMACEUTICALS ULC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
102955,Marketed,2023-10-31,02540886,APO-AZELASTINE/FLUTICASONE,2.0,R01AD58,"Fluticasone, combinations","Spray, metered dose",Nasal,02540886,APO-AZELASTINE/FLUTICASONE (azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray) APOTEX INC,Active,9005686,azelastine hydrochloride 137 mcg per actuation and fluticasone propionate 50 mcg per actuation nasal spray,8001438,azelastine and fluticasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
78461,Marketed,2012-12-11,02299224,TEVA-FLUVASTATIN,1.0,C10AA04,Fluvastatin,Capsule,Oral,02299224,TEVA-FLUVASTATIN (fluvastatin (fluvastatin sodium) 20 mg oral capsule) TEVA CANADA LIMITED,Active,9002671,fluvastatin (fluvastatin sodium) 20 mg oral capsule,8001271,fluvastatin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
78462,Marketed,2012-12-11,02299232,TEVA-FLUVASTATIN,1.0,C10AA04,Fluvastatin,Capsule,Oral,02299232,TEVA-FLUVASTATIN (fluvastatin (fluvastatin sodium) 40 mg oral capsule) TEVA CANADA LIMITED,Active,9002672,fluvastatin (fluvastatin sodium) 40 mg oral capsule,8001271,fluvastatin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
11751,Marketed,2016-08-26,01919369,LUVOX,1.0,N06AB08,Fluvoxamine,Tablet,Oral,01919369,LUVOX (fluvoxamine maleate 100 mg oral tablet) BGP PHARMA ULC,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11752,Marketed,2017-01-09,01919342,LUVOX,1.0,N06AB08,Fluvoxamine,Tablet,Oral,01919342,LUVOX (fluvoxamine maleate 50 mg oral tablet) BGP PHARMA ULC,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50637,Marketed,2022-09-22,02231329,APO-FLUVOXAMINE,1.0,N06AB08,Fluvoxamine,Tablet,Oral,02231329,APO-FLUVOXAMINE (fluvoxamine maleate 50 mg oral tablet) APOTEX INC,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50638,Marketed,2022-09-22,02231330,APO-FLUVOXAMINE,1.0,N06AB08,Fluvoxamine,Tablet,Oral,02231330,APO-FLUVOXAMINE (fluvoxamine maleate 100 mg oral tablet) APOTEX INC,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74072,Marketed,2024-02-16,02255529,TEVA-FLUVOXAMINE,1.0,N06AB08,Fluvoxamine,Tablet,Oral,02255529,TEVA-FLUVOXAMINE (fluvoxamine maleate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9002365,fluvoxamine maleate 50 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74073,Marketed,2024-02-16,02255537,TEVA-FLUVOXAMINE,1.0,N06AB08,Fluvoxamine,Tablet,Oral,02255537,TEVA-FLUVOXAMINE (fluvoxamine maleate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9002364,fluvoxamine maleate 100 mg oral tablet,8001272,fluvoxamine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3002,Marketed,2019-01-15,00426849,FOLIC ACID,1.0,B03BB01,Folic acid,Tablet,Oral,00426849,FOLIC ACID (folic acid 5 mg oral tablet) AA PHARMA INC,Active,9000109,folic acid 5 mg oral tablet,8000055,folic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
31358,Marketed,2022-01-14,02139480,"FOLIC ACID INJECTION, USP",1.0,B03BB01,Folic acid,Solution,"Intravenous,Intramuscular,Subcutaneous",02139480,"FOLIC ACID INJECTION, USP (folic acid (sodium folate) 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9006567,folic acid (sodium folate) 50 mg per 10 mL solution for injection vial,8000055,folic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
85094,Marketed,2024-02-07,02366061,JAMP-FOLIC ACID,1.0,B03BB01,Folic acid,Tablet,Oral,02366061,JAMP-FOLIC ACID (folic acid 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000109,folic acid 5 mg oral tablet,8000055,folic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75576,Marketed,2005-09-06,02270382,GONAL-F PEN,1.0,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270382,"GONAL-F PEN (follitropin alfa 900 unit per 1.5 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013134,follitropin alfa 900 unit per 1.5 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
75577,Marketed,2005-09-06,02270390,GONAL-F PEN,1.0,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270390,"GONAL-F PEN (follitropin alfa 450 unit per 0.75 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013131,follitropin alfa 450 unit per 0.75 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
75578,Marketed,2005-09-06,02270404,GONAL-F PEN,1.0,G03GA05,Follitropin alfa,Solution,Subcutaneous,02270404,"GONAL-F PEN (follitropin alfa 300 unit per 0.5 mL solution for injection pen) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013130,follitropin alfa 300 unit per 0.5 mL solution for injection pen,8001475,follitropin alfa,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
67891,Marketed,2022-08-10,02243948,PUREGON,1.0,G03GA06,Follitropin beta,Solution,Subcutaneous,,,,,,,,,,,,,,,,
97762,Marketed,2019-11-01,02487462,REKOVELLE,1.0,G03GA10,Follitropin delta,Solution,Subcutaneous,02487462,REKOVELLE (follitropin delta 12 mcg per 0.36 mL solution for injection pen) FERRING INC,Active,9014190,follitropin delta 12 mcg per 0.36 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
97763,Marketed,2019-11-01,02487470,REKOVELLE,1.0,G03GA10,Follitropin delta,Solution,Subcutaneous,02487470,REKOVELLE (follitropin delta 36 mcg per 1.08 mL solution for injection pen) FERRING INC,Active,9014191,follitropin delta 36 mcg per 1.08 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
97764,Marketed,2019-11-01,02487489,REKOVELLE,1.0,G03GA10,Follitropin delta,Solution,Subcutaneous,02487489,REKOVELLE (follitropin delta 72 mcg per 2.16 mL solution for injection pen) FERRING INC,Active,9014192,follitropin delta 72 mcg per 2.16 mL solution for injection pen,8001477,follitropin delta,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
66820,Marketed,2024-06-06,02242980,ANTIZOL,1.0,V03AB34,Fomepizole,Liquid,Intravenous,02242980,ANTIZOL (fomepizole 1.5 g per 1.5 mL solution for injection vial) ENDO OPERATIONS LTD.,Active,9013292,fomepizole 1.5 g per 1.5 mL solution for injection vial,8001907,fomepizole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92000,Marketed,2015-09-22,02435667,FOMEPIZOLE FOR INJECTION,1.0,V03AB34,Fomepizole,Solution,Intravenous,02435667,FOMEPIZOLE FOR INJECTION (fomepizole 1.5 g per 1.5 mL solution for injection vial) STERIMAX INC,Active,9013292,fomepizole 1.5 g per 1.5 mL solution for injection vial,8001907,fomepizole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
69618,Marketed,2018-07-10,02245531,ARIXTRA,1.0,B01AX05,Fondaparinux,Solution,"Intravenous,Subcutaneous",02245531,ARIXTRA (fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe) ASPEN PHARMACARE CANADA INC.,Active,9013137,fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
74328,Marketed,2018-07-17,02258056,ARIXTRA,1.0,B01AX05,Fondaparinux,Solution,Subcutaneous,02258056,ARIXTRA (fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe) ASPEN PHARMACARE CANADA INC.,Active,9013138,fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
89154,Marketed,2014-03-21,02406853,FONDAPARINUX SODIUM INJECTION,1.0,B01AX05,Fondaparinux,Solution,"Subcutaneous,Intravenous",02406853,FONDAPARINUX SODIUM INJECTION (fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe) DR REDDY'S LABORATORIES LTD,Active,9013137,fondaparinux sodium 2.5 mg per 0.5 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
89156,Marketed,2014-03-21,02406896,FONDAPARINUX SODIUM INJECTION,1.0,B01AX05,Fondaparinux,Solution,Subcutaneous,02406896,FONDAPARINUX SODIUM INJECTION (fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe) DR REDDY'S LABORATORIES LTD,Active,9013138,fondaparinux sodium 7.5 mg per 0.6 mL solution for injection syringe,8001655,fondaparinux,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
60542,Marketed,2016-06-01,02237224,OXEZE TURBUHALER,1.0,R03AC13,Formoterol,Powder,Inhalation,02237224,OXEZE TURBUHALER (formoterol fumarate dihydrate 12 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012379,formoterol fumarate 12 mcg per actuation inhalation powder,8000902,formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
60543,Marketed,2016-06-01,02237225,OXEZE TURBUHALER,1.0,R03AC13,Formoterol,Powder,Inhalation,02237225,OXEZE TURBUHALER (formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012460,formoterol fumarate 6 mcg per actuation inhalation powder,8000902,formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
92396,Marketed,2022-09-15,02439530,DUAKLIR GENUAIR,2.0,R03AL05,Formoterol and aclidinium bromide,Powder (metered dose),Inhalation,02439530,DUAKLIR GENUAIR (aclidinium bromide 400 mcg per actuation and formoterol fumarate dihydrate 12 mcg per actuation inhalation powder) COVIS PHARMA GMBH,Active,9005740,aclidinium bromide 400 mcg per actuation and formoterol fumarate 12 mcg per actuation inhalation powder,8001071,aclidinium and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
69428,Marketed,2002-02-08,02245385,SYMBICORT 100 TURBUHALER,2.0,R03AK07,Formoterol and budesonide,Powder,Inhalation,02245385,SYMBICORT 100 TURBUHALER (budesonide 100 mcg per actuation and formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012377,budesonide 100 mcg per actuation and formoterol fumarate 6 mcg per actuation inhalation powder,8000930,budesonide and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
69429,Marketed,2002-02-08,02245386,SYMBICORT 200 TURBUHALER,2.0,R03AK07,Formoterol and budesonide,Powder,Inhalation,02245386,SYMBICORT 200 TURBUHALER (budesonide 200 mcg per actuation and formoterol fumarate dihydrate 6 mcg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9012378,budesonide 200 mcg per actuation and formoterol fumarate 6 mcg per actuation inhalation powder,8000930,budesonide and formoterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
84680,Marketed,2022-02-22,02361752,ZENHALE,2.0,R03AK09,Formoterol and mometasone,"Aerosol, metered dose",Inhalation,02361752,ZENHALE (formoterol fumarate dihydrate 5 mcg per actuation and mometasone furoate 100 mcg per actuation pressurized inhalation) ORGANON CANADA INC.,Active,9012380,formoterol fumarate 5 mcg per actuation and mometasone furoate 100 mcg per actuation pressurized inhalation,8000982,formoterol and mometasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
84681,Marketed,2022-04-05,02361760,ZENHALE,2.0,R03AK09,Formoterol and mometasone,"Aerosol, metered dose",Inhalation,02361760,ZENHALE (formoterol fumarate dihydrate 5 mcg per actuation and mometasone furoate 200 mcg per actuation pressurized inhalation) ORGANON CANADA INC.,Active,9012381,formoterol fumarate 5 mcg per actuation and mometasone furoate 200 mcg per actuation pressurized inhalation,8000982,formoterol and mometasone,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
100738,Marketed,2024-01-05,02518058,BREZTRI AEROSPHERE,3.0,R03AL11,"Formoterol, glycopyrronium bromide and budesonide","Aerosol, metered dose",Inhalation,02518058,BREZTRI AEROSPHERE (budesonide 160 mcg per actuation and formoterol fumarate dihydrate 5 mcg per actuation and glycopyrronium (glycopyrronium bromide) 7.2 mcg per actuation pressurized inhalation) ASTRAZENECA CANADA INC,Active,9014844,budesonide 160 mcg per actuation and formoterol fumarate 5 mcg per actuation and glycopyrronium (glycopyrronium bromide) 7.2 mcg per actuation pressurized inhalation,8002401,budesonide and formoterol and glycopyrronium,447694001,Respiratory tract,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
99528,Marketed,2021-03-30,02505924,VOCARVI,1.0,J05AD01,Foscarnet,Solution,Intravenous,02505924,VOCARVI (foscarnet sodium 6000 mg per 250 mL solution for injection bag) STERIMAX INC,Active,9014794,foscarnet sodium 6000 mg per 250 mL solution for injection bag,8002448,foscarnet,738984000,Parenteral,385219001,solution for injection,732982009,Bag (unit of presentation),1.0,,
63874,Marketed,2024-08-20,02240335,MONUROL,1.0,J01XX01,Fosfomycin,Powder for solution,Oral,02240335,MONUROL (fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution) ENDO OPERATIONS LTD.,Active,9013558,fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution,8001657,fosfomycin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
96331,Marketed,2018-08-02,02473801,JAMP-FOSFOMYCIN,1.0,J01XX01,Fosfomycin,Powder for solution,Oral,02473801,JAMP-FOSFOMYCIN (fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution) JAMP PHARMA CORPORATION,Active,9013558,fosfomycin (fosfomycin tromethamine) 3 g per sachet powder for oral solution,8001657,fosfomycin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
97819,Marketed,2020-02-12,02488086,IVOZFO,1.0,J01XX01,Fosfomycin,Powder for solution,Intravenous,02488086,IVOZFO (fosfomycin (fosfomycin sodium) 4 g per vial powder for solution for injection) VERITY PHARMACEUTICALS INC.,Active,9014260,fosfomycin (fosfomycin sodium) 4 g per vial powder for solution for injection,8001657,fosfomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
72096,Marketed,2010-05-01,02247802,TEVA-FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02247802,TEVA-FOSINOPRIL (fosinopril sodium 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72097,Marketed,2010-05-01,02247803,TEVA-FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02247803,TEVA-FOSINOPRIL (fosinopril sodium 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75144,Marketed,2005-04-27,02266008,APO-FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02266008,APO-FOSINOPRIL (fosinopril sodium 10 mg oral tablet) APOTEX INC,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75145,Marketed,2005-04-27,02266016,APO-FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02266016,APO-FOSINOPRIL (fosinopril sodium 20 mg oral tablet) APOTEX INC,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94662,Marketed,2017-04-11,02459388,FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02459388,FOSINOPRIL (fosinopril sodium 10 mg oral tablet) SANIS HEALTH INC,Active,9001057,fosinopril sodium 10 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94663,Marketed,2017-04-11,02459396,FOSINOPRIL,1.0,C09AA09,Fosinopril,Tablet,Oral,02459396,FOSINOPRIL (fosinopril sodium 20 mg oral tablet) SANIS HEALTH INC,Active,9001058,fosinopril sodium 20 mg oral tablet,8000332,fosinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102649,Marketed,2024-02-05,02537702,VYALEV,2.0,N04BA07,Foslevodopa and decarboxylase inhibitor,Solution,Subcutaneous,,,,,,,,,,,,,,,,
50269,Marketed,2022-10-07,02230988,CEREBYX,1.0,N03AB05,Fosphenytoin,Solution,"Intramuscular,Intravenous",77700642,CEREBYX (fosphenytoin sodium 750 mg per 10 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9012814,fosphenytoin sodium 750 mg per 10 mL solution for injection vial,8001478,fosphenytoin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
50269,Marketed,2022-10-07,02230988,CEREBYX,1.0,N03AB05,Fosphenytoin,Solution,"Intramuscular,Intravenous",77700643,CEREBYX (fosphenytoin sodium 150 mg per 2 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9012813,fosphenytoin sodium 150 mg per 2 mL solution for injection vial,8001478,fosphenytoin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99741,Marketed,2022-08-15,02508052,TAVALISSE,1.0,B02BX09,Fostamatinib,Tablet,Oral,02508052,TAVALISSE (fostamatinib (fostamatinib disodium) 100 mg oral tablet) MEDISON PHARMA CANADA INC.,Active,9014438,fostamatinib (fostamatinib disodium) 100 mg oral tablet,8002362,fostamatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99742,Marketed,2022-07-04,02508060,TAVALISSE,1.0,B02BX09,Fostamatinib,Tablet,Oral,02508060,TAVALISSE (fostamatinib (fostamatinib disodium) 150 mg oral tablet) MEDISON PHARMA CANADA INC.,Active,9014439,fostamatinib (fostamatinib disodium) 150 mg oral tablet,8002362,fostamatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101006,Marketed,2022-04-26,02520869,RUKOBIA,1.0,J05AX29,Fostemsavir,Tablet (extended-release),Oral,02520869,RUKOBIA (fostemsavir (fostemsavir tromethamine) 600 mg prolonged-release oral tablet) VIIV HEALTHCARE ULC,Active,9014693,fostemsavir (fostemsavir tromethamine) 600 mg prolonged-release oral tablet,8002423,fostemsavir,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
98765,Marketed,2020-08-04,02497859,AJOVY,1.0,N02CD03,Fremanezumab,Solution,Subcutaneous,02497859,AJOVY SINGLE DOSE PREFILLED SYRINGE (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
99876,Marketed,2021-04-01,02509474,AJOVY,1.0,N02CD03,Fremanezumab,Solution,Subcutaneous,02509474,AJOVY SINGLE-DOSE PREFILLED AUTOINJECTOR (fremanezumab 225 mg per 1.5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9014362,fremanezumab 225 mg per 1.5 mL solution for injection syringe,8002337,fremanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
74230,Marketed,2024-06-04,02257084,FROVA,1.0,N02CC07,Frovatriptan,Tablet,Oral,02257084,FROVA (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90043,Marketed,2024-08-09,02415844,TEVA-FROVATRIPTAN,1.0,N02CC07,Frovatriptan,Tablet,Oral,02415844,TEVA-FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91106,Marketed,2020-06-23,02426471,APO-FROVATRIPTAN,1.0,N02CC07,Frovatriptan,Tablet,Oral,02426471,APO-FROVATRIPTAN (frovatriptan (frovatriptan succinate monohydrate) 2.5 mg oral tablet) APOTEX INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98700,Marketed,2021-01-19,02497131,JAMP FROVATRIPTAN,1.0,N02CC07,Frovatriptan,Tablet,Oral,02497131,JAMP FROVATRIPTAN (frovatriptan (frovatriptan succinate monohydrate) 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99896,Marketed,2022-06-10,02509687,MINT-FROVATRIPTAN,1.0,N02CC07,Frovatriptan,Tablet,Oral,02509687,MINT-FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102432,Marketed,2023-12-27,02535475,FROVATRIPTAN,1.0,N02CC07,Frovatriptan,Tablet,Oral,02535475,FROVATRIPTAN (frovatriptan (frovatriptan succinate) 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004362,frovatriptan (frovatriptan succinate) 2.5 mg oral tablet,8001384,frovatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104019,Marketed,2024-10-30,02551454,FRUZAQLA,1.0,L01EK04,Fruquintinib,Capsule,Oral,02551454,FRUZAQLA (fruquintinib 1 mg oral capsule) TAKEDA CANADA INC,Active,9015136,fruquintinib 1 mg oral capsule,8002525,fruquintinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,
104020,Marketed,2024-10-30,02551462,FRUZAQLA,1.0,L01EK04,Fruquintinib,Capsule,Oral,02551462,FRUZAQLA (fruquintinib 5 mg oral capsule) TAKEDA CANADA INC,Active,9015137,fruquintinib 5 mg oral capsule,8002525,fruquintinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,
72981,Marketed,2004-06-14,02248624,FASLODEX,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02248624,FASLODEX (fulvestrant 250 mg per 5 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94743,Marketed,2019-01-15,02460130,TEVA-FULVESTRANT INJECTION,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02460130,TEVA-FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
97398,Marketed,2019-02-01,02483610,FULVESTRANT INJECTION,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02483610,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101980,Marketed,2024-09-12,02530635,FULVESTRANT INJECTABLE,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02530635,FULVESTRANT INJECTABLE (fulvestrant 250 mg per 5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102508,Marketed,2023-12-18,02536293,FULVESTRANT INJECTION,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02536293,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) FORMATIVE PHARMA INC.,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
106218,Marketed,2025-09-30,02558971,FULVESTRANT INJECTION,1.0,L02BA03,Fulvestrant,Solution,Intramuscular,02558971,FULVESTRANT INJECTION (fulvestrant 250 mg per 5 mL solution for injection syringe) STERIMAX INC,Active,9013139,fulvestrant 250 mg per 5 mL solution for injection syringe,8001783,fulvestrant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
2333,Marketed,2012-07-11,00337730,TEVA-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00337730,TEVA-FUROSEMIDE (furosemide 20 mg oral tablet) TEVA CANADA LIMITED,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2447,Marketed,2012-07-11,00337749,TEVA-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00337749,TEVA-FUROSEMIDE (furosemide 40 mg oral tablet) TEVA CANADA LIMITED,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2472,Marketed,1976-12-31,00362166,APO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00362166,APO-FUROSEMIDE (furosemide 40 mg oral tablet) APOTEX INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2798,Marketed,1977-12-31,00396788,APO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00396788,APO-FUROSEMIDE (furosemide 20 mg oral tablet) APOTEX INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2851,Marketed,2022-01-10,00397792,PRO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00397792,PRO-FUROSEMIDE (furosemide 40 mg oral tablet) PRO DOC LIMITEE,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3809,Marketed,2022-01-10,00496723,PRO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00496723,PRO-FUROSEMIDE (furosemide 20 mg oral tablet) PRO DOC LIMITEE,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4431,Marketed,2005-10-25,00527033,FUROSEMIDE INJ USP,1.0,C03CA01,Furosemide,Liquid,"Intravenous,Intramuscular",77700284,FUROSEMIDE INJ USP (furosemide 20 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
4431,Marketed,2005-10-25,00527033,FUROSEMIDE INJ USP,1.0,C03CA01,Furosemide,Liquid,"Intravenous,Intramuscular",77700285,FUROSEMIDE INJ USP (furosemide 40 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009621,furosemide 40 mg per 4 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
6827,Marketed,1986-12-31,00707570,APO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00707570,APO-FUROSEMIDE (furosemide 80 mg oral tablet) APOTEX INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9240,Marketed,2012-07-11,00765953,TEVA-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00765953,TEVA-FUROSEMIDE (furosemide 80 mg oral tablet) TEVA CANADA LIMITED,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19189,Marketed,2022-01-10,00667080,PRO-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,00667080,PRO-FUROSEMIDE (furosemide 80 mg oral tablet) PRO DOC LIMITEE,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
37372,Marketed,2008-03-20,02224720,LASIX ORAL SOLUTION,1.0,C03CA01,Furosemide,Solution,Oral,02224720,LASIX ORAL SOLUTION (furosemide 10 mg per mL oral solution) SANOFI-AVENTIS CANADA INC,Active,9009613,furosemide 10 mg per mL oral solution,8000057,furosemide,26643006,Oral,385023001,Oral solution,,,,,
37375,Marketed,2008-05-07,02224755,LASIX SPECIAL,1.0,C03CA01,Furosemide,Tablet,Oral,02224755,LASIX SPECIAL (furosemide 500 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9009624,furosemide 500 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83669,Marketed,2015-03-25,02351420,FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02351420,FUROSEMIDE (furosemide 20 mg oral tablet) SANIS HEALTH INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83670,Marketed,2015-03-25,02351439,FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02351439,FUROSEMIDE (furosemide 40 mg oral tablet) SANIS HEALTH INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83671,Marketed,2015-03-25,02351447,FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02351447,FUROSEMIDE (furosemide 80 mg oral tablet) SANIS HEALTH INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86837,Marketed,2012-07-26,02382539,FUROSEMIDE INJECTION SDZ,1.0,C03CA01,Furosemide,Solution,"Intravenous,Intramuscular",77700278,FUROSEMIDE INJECTION SDZ (furosemide 20 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
86837,Marketed,2012-07-26,02382539,FUROSEMIDE INJECTION SDZ,1.0,C03CA01,Furosemide,Solution,"Intravenous,Intramuscular",77700279,FUROSEMIDE INJECTION SDZ (furosemide 40 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9009621,furosemide 40 mg per 4 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
86984,Marketed,2022-04-29,02384094,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",02384094,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9009615,furosemide 20 mg per 2 mL solution for injection ampoule,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94899,Marketed,2017-07-31,02461404,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700522,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94899,Marketed,2017-07-31,02461404,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77700523,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) STERIMAX INC,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95511,Marketed,2018-07-30,02466759,MINT-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02466759,MINT-FUROSEMIDE (furosemide 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009614,furosemide 20 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95512,Marketed,2018-07-30,02466767,MINT-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02466767,MINT-FUROSEMIDE (furosemide 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009619,furosemide 40 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95513,Marketed,2018-07-30,02466775,MINT-FUROSEMIDE,1.0,C03CA01,Furosemide,Tablet,Oral,02466775,MINT-FUROSEMIDE (furosemide 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9009625,furosemide 80 mg oral tablet,8000057,furosemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97109,Marketed,2021-05-10,02480530,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701073,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97109,Marketed,2021-05-10,02480530,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701074,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101655,Marketed,2023-04-04,02527499,FUROSEMIDE SPECIAL INJECTION,1.0,C03CA01,Furosemide,Solution,Intravenous,02527499,FUROSEMIDE SPECIAL INJECTION (furosemide 250 mg per 25 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009618,furosemide 250 mg per 25 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101656,Marketed,2024-01-23,02527502,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701148,FUROSEMIDE INJECTION USP (furosemide 20 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009617,furosemide 20 mg per 2 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101656,Marketed,2024-01-23,02527502,FUROSEMIDE INJECTION USP,1.0,C03CA01,Furosemide,Solution,"Intramuscular,Intravenous",77701149,FUROSEMIDE INJECTION USP (furosemide 40 mg per 4 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9009623,furosemide 40 mg per 4 mL solution for injection vial,8000057,furosemide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5637,Marketed,1984-12-31,00586668,FUCIDIN CREAM 2%,1.0,D06AX01,Fusidic acid,Cream,Topical,00586668,FUCIDIN CREAM 2% (fusidic acid 2 % cutaneous cream) LEO PHARMA INC,Active,9000199,fusidic acid 2 % cutaneous cream,8000104,fusidic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
5638,Marketed,1984-12-31,00586676,FUCIDIN OINTMENT 2%,1.0,D06AX01,Fusidic acid,Ointment,Topical,00586676,FUCIDIN OINTMENT 2% (fusidate sodium 2 % cutaneous ointment) LEO PHARMA INC,Active,9002020,fusidate sodium 2 % cutaneous ointment,8000104,fusidic acid,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
67803,Marketed,2014-10-10,02243862,FUCITHALMIC,1.0,S01AA13,Fusidic acid,Drops,Ophthalmic,02243862,FUCITHALMIC WITH PRESERVATIVE (fusidic acid 1 % ophthalmic drops) AMDIPHARM LIMITED,Active,9000949,fusidic acid 1 % ophthalmic drops,8000104,fusidic acid,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101735,Marketed,2024-05-22,02528096,TARO-FUSIDIC ACID,1.0,D06AX01,Fusidic acid,Cream,Topical,,,,,,,,,,,,,,,,
15944,Marketed,2023-05-05,02084260,NEURONTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02084260,NEURONTIN (gabapentin 100 mg oral capsule) BGP PHARMA ULC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15945,Marketed,2023-05-05,02084279,NEURONTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02084279,NEURONTIN (gabapentin 300 mg oral capsule) BGP PHARMA ULC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
16210,Marketed,2023-05-05,02084287,NEURONTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02084287,NEURONTIN (gabapentin 400 mg oral capsule) BGP PHARMA ULC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
63199,Marketed,2023-05-05,02239717,NEURONTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02239717,NEURONTIN (gabapentin 600 mg oral tablet) BGP PHARMA ULC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63200,Marketed,2023-05-05,02239718,NEURONTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02239718,NEURONTIN (gabapentin 800 mg oral tablet) BGP PHARMA ULC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67356,Marketed,2001-02-23,02243446,PMS-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02243446,PMS-GABAPENTIN (gabapentin 100 mg oral capsule) PHARMASCIENCE INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
67357,Marketed,2001-02-23,02243447,PMS-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02243447,PMS-GABAPENTIN (gabapentin 300 mg oral capsule) PHARMASCIENCE INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
67358,Marketed,2001-02-23,02243448,PMS-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02243448,PMS-GABAPENTIN (gabapentin 400 mg oral capsule) PHARMASCIENCE INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68271,Marketed,2001-08-27,02244304,APO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244304,APO-GABAPENTIN (gabapentin 100 mg oral capsule) APOTEX INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68273,Marketed,2001-08-27,02244305,APO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244305,APO-GABAPENTIN (gabapentin 300 mg oral capsule) APOTEX INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68274,Marketed,2001-08-27,02244306,APO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244306,APO-GABAPENTIN (gabapentin 400 mg oral capsule) APOTEX INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68490,Marketed,2010-04-21,02244513,TEVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244513,TEVA-GABAPENTIN (gabapentin 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68491,Marketed,2010-04-21,02244514,TEVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244514,TEVA-GABAPENTIN (gabapentin 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68492,Marketed,2010-04-21,02244515,TEVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02244515,TEVA-GABAPENTIN (gabapentin 400 mg oral capsule) TEVA CANADA LIMITED,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
70477,Marketed,2018-04-13,02246314,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02246314,GABAPENTIN (gabapentin 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
70478,Marketed,2018-04-13,02246315,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02246315,GABAPENTIN (gabapentin 300 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
70479,Marketed,2018-04-13,02246316,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02246316,GABAPENTIN (gabapentin 400 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
71589,Marketed,2010-04-21,02247346,TEVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02247346,TEVA-GABAPENTIN (gabapentin 800 mg oral tablet) TEVA CANADA LIMITED,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72809,Marketed,2010-04-21,02248457,TEVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02248457,TEVA-GABAPENTIN (gabapentin 600 mg oral tablet) TEVA CANADA LIMITED,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73612,Marketed,2026-01-22,02251167,RIVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02251167,RIVA-GABAPENTIN (gabapentin 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73613,Marketed,2026-01-22,02251175,RIVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02251175,RIVA-GABAPENTIN (gabapentin 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73614,Marketed,2026-01-22,02251183,RIVA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02251183,RIVA-GABAPENTIN (gabapentin 400 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77872,Marketed,2020-07-15,02293358,APO-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02293358,APO-GABAPENTIN (gabapentin 600 mg oral tablet) APOTEX INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77873,Marketed,2020-08-04,02293366,APO-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02293366,APO-GABAPENTIN (gabapentin 800 mg oral tablet) APOTEX INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79608,Marketed,2008-10-27,02310449,PRO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02310449,PRO-GABAPENTIN (gabapentin 100 mg oral capsule) PRO DOC LIMITEE,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79609,Marketed,2008-10-27,02310457,PRO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02310457,PRO-GABAPENTIN (gabapentin 300 mg oral capsule) PRO DOC LIMITEE,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79610,Marketed,2008-10-27,02310465,PRO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02310465,PRO-GABAPENTIN (gabapentin 400 mg oral capsule) PRO DOC LIMITEE,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79611,Marketed,2020-08-07,02310473,PRO-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02310473,PRO-GABAPENTIN (gabapentin 600 mg oral tablet) PRO DOC LIMITEE,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79612,Marketed,2020-08-07,02310481,PRO-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02310481,PRO-GABAPENTIN (gabapentin 800 mg oral tablet) PRO DOC LIMITEE,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80660,Marketed,2011-06-15,02321203,AURO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02321203,AURO-GABAPENTIN (gabapentin 100 mg oral capsule) AURO PHARMA INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80661,Marketed,2011-06-15,02321211,AURO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02321211,AURO-GABAPENTIN (gabapentin 300 mg oral capsule) AURO PHARMA INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80662,Marketed,2011-06-15,02321238,AURO-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02321238,AURO-GABAPENTIN (gabapentin 400 mg oral capsule) AURO PHARMA INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83846,Marketed,2013-10-10,02353245,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02353245,GABAPENTIN (gabapentin 100 mg oral capsule) SANIS HEALTH INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83847,Marketed,2013-10-10,02353253,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02353253,GABAPENTIN (gabapentin 300 mg oral capsule) SANIS HEALTH INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83848,Marketed,2013-10-10,02353261,GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02353261,GABAPENTIN (gabapentin 400 mg oral capsule) SANIS HEALTH INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84654,Marketed,2014-02-21,02361469,JAMP-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02361469,JAMP-GABAPENTIN (gabapentin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84656,Marketed,2014-02-21,02361485,JAMP-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02361485,JAMP-GABAPENTIN (gabapentin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84657,Marketed,2014-02-21,02361493,JAMP-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02361493,JAMP-GABAPENTIN (gabapentin 400 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87375,Marketed,2019-05-02,02388200,GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02388200,GABAPENTIN (gabapentin 600 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87376,Marketed,2019-03-22,02388219,GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02388219,GABAPENTIN (gabapentin 800 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87778,Marketed,2025-11-18,02392526,ACH-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02392526,ACH-GABAPENTIN (gabapentin 600 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87779,Marketed,2025-11-18,02392534,ACH-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02392534,ACH-GABAPENTIN (gabapentin 800 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89363,Marketed,2023-08-25,02408880,MINT-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02408880,MINT-GABAPENTIN (gabapentin 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89364,Marketed,2023-08-25,02408899,MINT-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02408899,MINT-GABAPENTIN (gabapentin 300 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89365,Marketed,2023-08-25,02408902,MINT-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02408902,MINT-GABAPENTIN (gabapentin 400 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89563,Marketed,2019-09-27,02410990,GLN-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02410990,GLN-GABAPENTIN (gabapentin 600 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89564,Marketed,2019-05-29,02411008,GLN-GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02411008,GLN-GABAPENTIN (gabapentin 800 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90145,Marketed,2025-11-18,02416840,ACH-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02416840,ACH-GABAPENTIN (gabapentin 100 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90146,Marketed,2025-11-18,02416859,ACH-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02416859,ACH-GABAPENTIN (gabapentin 300 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90147,Marketed,2025-11-18,02416867,ACH-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02416867,ACH-GABAPENTIN (gabapentin 400 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91281,Marketed,2019-01-29,02428334,AURO-GABAPENTIN TABLETS,1.0,N02BF01,Gabapentin,Tablet,Oral,02428334,AURO-GABAPENTIN TABLETS (gabapentin 600 mg oral tablet) AURO PHARMA INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91282,Marketed,2019-01-29,02428342,AURO-GABAPENTIN TABLETS,1.0,N02BF01,Gabapentin,Tablet,Oral,02428342,AURO-GABAPENTIN TABLETS (gabapentin 800 mg oral tablet) AURO PHARMA INC,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91570,Marketed,2020-08-06,02431289,GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02431289,GABAPENTIN (gabapentin 600 mg oral tablet) SANIS HEALTH INC,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91652,Marketed,2023-05-19,02432072,GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02432072,GABAPENTIN (gabapentin 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000891,gabapentin 600 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91653,Marketed,2023-05-19,02432080,GABAPENTIN,1.0,N02BF01,Gabapentin,Tablet,Oral,02432080,GABAPENTIN (gabapentin 800 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000892,gabapentin 800 mg oral tablet,8000200,gabapentin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102411,Marketed,2024-03-07,02535246,JAMP GABAPENTIN CAPSULES,1.0,N02BF01,Gabapentin,Capsule,Oral,02535246,JAMP GABAPENTIN CAPSULES (gabapentin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102412,Marketed,2024-03-07,02535254,JAMP GABAPENTIN CAPSULES,1.0,N02BF01,Gabapentin,Capsule,Oral,02535254,JAMP GABAPENTIN CAPSULES (gabapentin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102413,Marketed,2024-03-07,02535262,JAMP GABAPENTIN CAPSULES,1.0,N02BF01,Gabapentin,Capsule,Oral,02535262,JAMP GABAPENTIN CAPSULES (gabapentin 400 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103883,Marketed,2025-06-02,02550016,NRA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02550016,NRA-GABAPENTIN (gabapentin 100 mg oral capsule) NORA PHARMA INC,Active,9000519,gabapentin 100 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103884,Marketed,2025-06-02,02550024,NRA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02550024,NRA-GABAPENTIN (gabapentin 300 mg oral capsule) NORA PHARMA INC,Active,9000520,gabapentin 300 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103885,Marketed,2025-06-02,02550032,NRA-GABAPENTIN,1.0,N02BF01,Gabapentin,Capsule,Oral,02550032,NRA-GABAPENTIN (gabapentin 400 mg oral capsule) NORA PHARMA INC,Active,9000521,gabapentin 400 mg oral capsule,8000200,gabapentin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72643,Marketed,2004-10-28,02248302,MULTIHANCE,1.0,V08CA08,Gadobenic acid,Solution,Intravenous,,,,,,,,,,,,,,,,
64684,Marketed,2008-02-05,02241089,GADOVIST 1.0,1.0,V08CA09,Gadobutrol,Solution,Intravenous,,,,,,,,,,,,,,,,
104258,Marketed,2025-04-07,02553678,PIXXOSCAN,1.0,V08CA09,Gadobutrol,Solution,Intravenous,,,,,,,,,,,,,,,,
44188,Marketed,2006-10-19,02172771,OMNISCAN,1.0,V08CA03,Gadodiamide,Solution,Intravenous,,,,,,,,,,,,,,,,
13384,Marketed,2008-04-10,01989987,MAGNEVIST,1.0,V08CA01,Gadopentetic acid,Solution,Intravenous,,,,,,,,,,,,,,,,
94652,Marketed,2017-09-22,02459329,DOTAREM,1.0,V08CA02,Gadoteric acid,Solution,Intravenous,,,,,,,,,,,,,,,,
43507,Marketed,1998-09-08,02229056,PROHANCE,1.0,V08CA04,Gadoteridol,Solution,Intravenous,,,,,,,,,,,,,,,,
82625,Marketed,2010-02-04,02340666,PRIMOVIST,1.0,V08CA10,Gadoxetic acid,Solution,Intravenous,,,,,,,,,,,,,,,,
80244,Marketed,2020-07-20,02316943,PAT-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02316943,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) JANSSEN INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
80245,Marketed,2020-04-07,02316951,PAT-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02316951,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) JANSSEN INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
80246,Marketed,2020-07-29,02316978,PAT-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02316978,PAT-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) JANSSEN INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82505,Marketed,2011-11-13,02339439,MYLAN-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02339439,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82506,Marketed,2011-11-13,02339447,MYLAN-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02339447,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82507,Marketed,2011-11-13,02339455,MYLAN-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02339455,MYLAN-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
90981,Marketed,2014-06-12,02425157,AURO-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02425157,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
90982,Marketed,2014-06-12,02425165,AURO-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02425165,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
90983,Marketed,2014-06-12,02425173,AURO-GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02425173,AURO-GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92757,Marketed,2016-01-11,02443015,GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02443015,GALANTAMINE ER (galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001330,galantamine (galantamine hydrobromide) 8 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92758,Marketed,2016-01-11,02443023,GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02443023,GALANTAMINE ER (galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001328,galantamine (galantamine hydrobromide) 16 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92759,Marketed,2016-01-11,02443031,GALANTAMINE ER,1.0,N06DA04,Galantamine,Capsule (extended release),Oral,02443031,GALANTAMINE ER (galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9001329,galantamine (galantamine hydrobromide) 24 mg prolonged-release oral capsule,8000396,galantamine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98107,Marketed,2019-10-07,02491060,EMGALITY,1.0,N02CD02,Galcanezumab,Solution,Subcutaneous,02491060,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014194,galcanezumab 120 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98110,Marketed,2019-10-02,02491087,EMGALITY,1.0,N02CD02,Galcanezumab,Solution,Subcutaneous,02491087,EMGALITY (galcanezumab 120 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014193,galcanezumab 120 mg per 1 mL solution for injection pen,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
99448,Marketed,2021-01-11,02505134,EMGALITY,1.0,N02CD02,Galcanezumab,Solution,Subcutaneous,02505134,EMGALITY (galcanezumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014454,galcanezumab 100 mg per 1 mL solution for injection syringe,8002302,galcanezumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102092,Marketed,2023-04-03,02531836,ILLUCCIX,1.0,V09IX14,Gallium (68ga) gozetotide,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
102582,Marketed,2024-02-28,02537117,LOCAMETZ,1.0,V09IX14,Gallium (68ga) gozetotide,"Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,
81328,Marketed,2019-07-22,02327813,GALLIUM (GA67) CITRATE INJECTION,1.0,V09HX01,Gallium 67 ga citrate,Solution,Intravenous,,,,,,,,,,,,,,,,
89735,Marketed,2014-01-01,02412683,NAGLAZYME,1.0,A16AB08,Galsufase,Solution,Intravenous,02412683,NAGLAZYME (galsulfase 5 mg per 5 mL solution for injection vial) BIOMARIN PHARMACEUTICAL INC.,Active,9013140,galsulfase 5 mg per 5 mL solution for injection vial,8001784,galsulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19553,Marketed,2019-08-09,02162695,CYTOVENE,1.0,J05AB06,Ganciclovir,Powder for solution,Intravenous,02162695,CYTOVENE (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
88956,Marketed,2025-11-14,02404761,"GANCICLOVIR FOR INJECTION, USP",1.0,J05AB06,Ganciclovir,Powder for solution,Intravenous,02404761,"GANCICLOVIR FOR INJECTION, USP (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
96577,Marketed,2021-07-19,02475391,GANCICLOVIR FOR INJECTION USP,1.0,J05AB06,Ganciclovir,Powder for solution,Intravenous,02475391,GANCICLOVIR FOR INJECTION USP (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101971,Marketed,2023-09-26,02530546,EYEZIRGAN,1.0,S01AD09,Ganciclovir,Gel,Ophthalmic,,,,,,,,,,,,,,1.0,,
102588,Marketed,2023-10-04,02537168,GANCICLOVIR FOR INJECTION,1.0,J05AB06,Ganciclovir,Powder for solution,Intravenous,02537168,GANCICLOVIR FOR INJECTION (ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection) FORMATIVE PHARMA INC.,Active,9002820,ganciclovir (ganciclovir sodium) 500 mg per vial powder for solution for injection,8001205,ganciclovir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
69741,Marketed,2022-05-17,02245641,ORGALUTRAN,1.0,H01CC01,Ganirelix,Solution,Subcutaneous,02245641,ORGALUTRAN (ganirelix (ganirelix acetate) 250 mcg per 0.5 mL solution for injection syringe) ORGANON CANADA INC.,Active,9013294,ganirelix (ganirelix acetate) 250 mcg per 0.5 mL solution for injection syringe,8001785,ganirelix,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
106290,Marketed,2025-10-24,02559773,ANDEMBRY,1.0,B06AC07,Garadacimab,Solution,Subcutaneous,,,,,,,,,,,,,,,,
74247,Marketed,2023-12-06,02257270,ZYMAR,1.0,S01AE06,Gatifloxacin,Solution,Ophthalmic,02257270,ZYMAR (gatifloxacin 0.3 % ophthalmic drops) ABBVIE CORPORATION,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
81256,Marketed,2019-11-15,02327260,APO-GATIFLOXACIN,1.0,S01AE06,Gatifloxacin,Solution,Ophthalmic,02327260,APO-GATIFLOXACIN (gatifloxacin (gatifloxacin hemihydrate) 0.3 % ophthalmic drops) APOTEX INC,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102224,Marketed,2024-12-05,02533235,JAMP GATIFLOXACIN,1.0,S01AE06,Gatifloxacin,Solution,Ophthalmic,02533235,JAMP GATIFLOXACIN (gatifloxacin 0.3 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003959,gatifloxacin 0.3 % ophthalmic drops,8001479,gatifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
73040,Marketed,2003-12-17,02248676,IRESSA,1.0,L01EB01,Gefitinib,Tablet,Oral,02248676,IRESSA (gefitinib 250 mg oral tablet) ASTRAZENECA CANADA INC,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95642,Marketed,2017-10-18,02468050,APO-GEFITINIB,1.0,L01EB01,Gefitinib,Tablet,Oral,02468050,APO-GEFITINIB (gefitinib 250 mg oral tablet) APOTEX INC,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97788,Marketed,2019-06-26,02487748,SANDOZ GEFITINIB,1.0,L01EB01,Gefitinib,Tablet,Oral,02487748,SANDOZ GEFITINIB (gefitinib 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98180,Marketed,2019-11-13,02491796,NAT-GEFITINIB,1.0,L01EB01,Gefitinib,Tablet,Oral,02491796,NAT-GEFITINIB (gefitinib 250 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99033,Marketed,2020-12-23,02500663,JAMP GEFITINIB,1.0,L01EB01,Gefitinib,Tablet,Oral,02500663,JAMP GEFITINIB (gefitinib 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003851,gefitinib 250 mg oral tablet,8001786,gefitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88767,Marketed,2017-08-31,02402831,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700773,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 5.3 mL vial) PFIZER CANADA ULC,Active,9013143,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 5.3 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88767,Marketed,2017-08-31,02402831,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700774,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 26.3 mL vial) PFIZER CANADA ULC,Active,9013141,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 26.3 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88767,Marketed,2017-08-31,02402831,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700775,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 52.6 mL vial) PFIZER CANADA ULC,Active,9013144,gemcitabine (gemcitabine hydrochloride) 38 mg per mL solution for injection 52.6 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89685,Marketed,2013-09-24,02412292,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700795,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 5 mL vial) SANDOZ CANADA INCORPORATED,Active,9013146,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 5 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89685,Marketed,2013-09-24,02412292,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700796,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9013147,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 50 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89685,Marketed,2013-09-24,02412292,GEMCITABINE INJECTION,1.0,L01BC05,Gemcitabine,Solution,Intravenous,77700797,GEMCITABINE INJECTION (gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 25 mL vial) SANDOZ CANADA INCORPORATED,Active,9013145,gemcitabine (gemcitabine hydrochloride) 40 mg per mL solution for injection 25 mL vial,8001787,gemcitabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
17230,Marketed,2015-07-14,02142074,TEVA-GEMFIBROZIL,1.0,C10AB04,Gemfibrozil,Tablet,Oral,02142074,TEVA-GEMFIBROZIL (gemfibrozil 600 mg oral tablet) TEVA CANADA LIMITED,Active,9002574,gemfibrozil 600 mg oral tablet,8001658,gemfibrozil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98440,Marketed,2020-03-11,02494388,MYLOTARG,1.0,L01FX02,Gemtuzumab ozogamicin,Powder for solution,Intravenous,02494388,MYLOTARG (gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014298,gemtuzumab ozogamicin 4.5 mg per vial powder for solution for injection,8002326,gemtuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
18242,Marketed,1995-12-31,02082136,GENTAMICIN(E),1.0,J01GB03,Gentamicin,Solution,Intravenous,02082136,GENTAMICIN(E) (gentamicin (gentamicin sulfate) 100 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9012571,gentamicin (gentamicin sulfate) 100 mg per 100 mL solution for injection bag,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
18243,Marketed,1995-12-31,02082152,GENTAMICIN(E),1.0,J01GB03,Gentamicin,Solution,Intravenous,02082152,GENTAMICIN(E) (gentamicin (gentamicin sulfate) 80 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9012575,gentamicin (gentamicin sulfate) 80 mg per 50 mL solution for injection bag,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
66434,Marketed,2005-08-18,02242652,GENTAMICIN INJECTION USP,1.0,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02242652,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012574,gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection vial,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75394,Marketed,2005-08-29,02268531,GENTAMICIN INJECTION USP,1.0,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02268531,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012572,gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection vial,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94412,Marketed,2024-01-11,02457008,GENTAMICIN INJECTION USP,1.0,J01GB03,Gentamicin,Solution,"Intravenous,Intramuscular",02457008,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012573,gentamicin (gentamicin sulfate) 80 mg per 2 mL solution for injection ampoule,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
95943,Marketed,2024-01-11,02470462,GENTAMICIN INJECTION USP,1.0,J01GB03,Gentamicin,Solution,"Intramuscular,Intravenous",02470462,GENTAMICIN INJECTION USP (gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013906,gentamicin (gentamicin sulfate) 20 mg per 2 mL solution for injection ampoule,8001206,gentamicin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
98500,Marketed,2020-02-03,02495058,XOSPATA,1.0,L01EX13,Gilteritinib,Tablet,Oral,02495058,XOSPATA (gilteritinib (gilteritinib fumarate) 40 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9014243,gilteritinib (gilteritinib fumarate) 40 mg oral tablet,8002317,gilteritinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99566,Marketed,2020-12-01,02506343,GIVLAARI,1.0,A16AX16,Givosiran,Solution,Subcutaneous,02506343,GIVLAARI (givosiran (givosiran sodium) 189 mg per 1 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014547,givosiran (givosiran sodium) 189 mg per 1 mL solution for injection vial,8002375,givosiran,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98824,Marketed,2020-08-10,02498472,DAURISMO,1.0,L01XJ03,Glasdegib,Tablet,Oral,02498472,DAURISMO (glasdegib (glasdegib maleate) 25 mg oral tablet) PFIZER CANADA ULC,Active,9014364,glasdegib (glasdegib maleate) 25 mg oral tablet,8002345,glasdegib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98825,Marketed,2020-08-10,02498480,DAURISMO,1.0,L01XJ03,Glasdegib,Tablet,Oral,02498480,DAURISMO (glasdegib (glasdegib maleate) 100 mg oral tablet) PFIZER CANADA ULC,Active,9014363,glasdegib (glasdegib maleate) 100 mg oral tablet,8002345,glasdegib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
69719,Marketed,2016-01-28,02245619,COPAXONE,1.0,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02245619,COPAXONE (glatiramer acetate 20 mg per 1 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94398,Marketed,2016-08-26,02456915,COPAXONE,1.0,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02456915,COPAXONE (glatiramer acetate 40 mg per 1 mL solution for injection syringe) TEVA CANADA LIMITED,Active,9013296,glatiramer acetate 40 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94809,Marketed,2017-08-21,02460661,GLATECT,1.0,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02460661,GLATECT (glatiramer acetate 20 mg per 1 mL solution for injection syringe) PHARMASCIENCE INC,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103009,Marketed,2024-04-11,02541440,GLATIRAMER ACETATE INJECTION,1.0,L03AX13,Glatiramer acetate,Solution,Subcutaneous,02541440,GLATIRAMER ACETATE INJECTION (glatiramer acetate 20 mg per 1 mL solution for injection syringe) MYLAN PHARMACEUTICALS ULC,Active,9013295,glatiramer acetate 20 mg per 1 mL solution for injection syringe,8001788,glatiramer,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
95591,Marketed,2017-09-13,02467550,MAVIRET,2.0,J05AP57,Glecaprevir and pibrentasvir,Tablet,Oral,02467550,MAVIRET (glecaprevir 100 mg and pibrentasvir 40 mg oral tablet) ABBVIE CORPORATION,Active,9012419,glecaprevir 100 mg and pibrentasvir 40 mg oral tablet,8001136,glecaprevir and pibrentasvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101158,Marketed,2022-04-22,02522470,MAVIRET,2.0,J05AP57,Glecaprevir and pibrentasvir,Granules,Oral,02522470,MAVIRET (glecaprevir 50 mg per sachet and pibrentasvir 20 mg per sachet oral granules) ABBVIE CORPORATION,Active,9014694,glecaprevir 50 mg per sachet and pibrentasvir 20 mg per sachet oral granules,8001136,glecaprevir and pibrentasvir,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
11727,Marketed,1991-12-31,01913662,APO GLYBURIDE TAB 5MG,1.0,A10BB01,Glibenclamide,Tablet,Oral,01913662,APO GLYBURIDE TAB 5MG (glyburide 5 mg oral tablet) APOTEX INC,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11728,Marketed,1991-12-31,01913654,APO GLYBURIDE TAB 2.5MG,1.0,A10BB01,Glibenclamide,Tablet,Oral,01913654,APO GLYBURIDE TAB 2.5MG (glyburide 2.5 mg oral tablet) APOTEX INC,Active,9000383,glyburide 2.5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11780,Marketed,2010-10-09,01913670,TEVA-GLYBURIDE,1.0,A10BB01,Glibenclamide,Tablet,Oral,01913670,TEVA-GLYBURIDE (glyburide 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000383,glyburide 2.5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11781,Marketed,2010-10-09,01913689,TEVA-GLYBURIDE,1.0,A10BB01,Glibenclamide,Tablet,Oral,01913689,TEVA-GLYBURIDE (glyburide 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83567,Marketed,2017-03-01,02350467,GLYBURIDE,1.0,A10BB01,Glibenclamide,Tablet,Oral,02350467,GLYBURIDE (glyburide 5 mg oral tablet) SANIS HEALTH INC,Active,9000250,glyburide 5 mg oral tablet,8000115,glyburide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61497,Marketed,2014-02-11,02238103,TEVA-GLICLAZIDE,1.0,A10BB09,Gliclazide,Tablet,Oral,02238103,TEVA-GLICLAZIDE (gliclazide 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66827,Marketed,2001-04-04,02242987,DIAMICRON MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02242987,DIAMICRON MR (gliclazide 30 mg prolonged-release oral tablet) SERVIER CANADA INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
69269,Marketed,2002-07-02,02245247,APO-GLICLAZIDE,1.0,A10BB09,Gliclazide,Tablet,Oral,02245247,APO-GLICLAZIDE (gliclazide 80 mg oral tablet) APOTEX INC,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77250,Marketed,2014-06-10,02287072,GLICLAZIDE,1.0,A10BB09,Gliclazide,Tablet,Oral,02287072,GLICLAZIDE (gliclazide 80 mg oral tablet) SANIS HEALTH INC,Active,9000357,gliclazide 80 mg oral tablet,8000139,gliclazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78313,Marketed,2014-12-12,02297795,APO-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02297795,APO-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) APOTEX INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
84157,Marketed,2010-12-09,02356422,DIAMICRON MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02356422,DIAMICRON MR (gliclazide 60 mg prolonged-release oral tablet) SERVIER CANADA INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89182,Marketed,2015-04-14,02407124,APO-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02407124,APO-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) APOTEX INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90799,Marketed,2014-06-02,02423286,MINT-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02423286,MINT-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90800,Marketed,2025-04-16,02423294,MINT-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02423294,MINT-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91420,Marketed,2024-10-04,02429764,JAMP GLICLAZIDE-MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02429764,JAMP GLICLAZIDE-MR (gliclazide 30 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91421,Marketed,2024-10-04,02429772,JAMP GLICLAZIDE-MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02429772,JAMP GLICLAZIDE-MR (gliclazide 60 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92302,Marketed,2015-08-07,02438658,MYLAN-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02438658,MYLAN-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92369,Marketed,2021-02-22,02439328,TARO-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02439328,TARO-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
94883,Marketed,2017-06-02,02461323,SANDOZ GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02461323,SANDOZ GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
94884,Marketed,2017-06-02,02461331,SANDOZ GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02461331,SANDOZ GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95168,Marketed,2021-02-22,02463571,TARO-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02463571,TARO-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) SUN PHARMA CANADA INC,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97374,Marketed,2025-02-03,02483300,AG-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02483300,AG-GLICLAZIDE MR (gliclazide 30 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9000938,gliclazide 30 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97375,Marketed,2025-02-03,02483319,AG-GLICLAZIDE MR,1.0,A10BB09,Gliclazide,Tablet (extended-release),Oral,02483319,AG-GLICLAZIDE MR (gliclazide 60 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001331,gliclazide 60 mg prolonged-release oral tablet,8000139,gliclazide,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75494,Marketed,2006-01-28,02269589,SANDOZ GLIMEPIRIDE,1.0,A10BB12,Glimepiride,Tablet,Oral,02269589,SANDOZ GLIMEPIRIDE (glimepiride 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003702,glimepiride 1 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75495,Marketed,2006-01-28,02269597,SANDOZ GLIMEPIRIDE,1.0,A10BB12,Glimepiride,Tablet,Oral,02269597,SANDOZ GLIMEPIRIDE (glimepiride 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003703,glimepiride 2 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75497,Marketed,2006-01-28,02269619,SANDOZ GLIMEPIRIDE,1.0,A10BB12,Glimepiride,Tablet,Oral,02269619,SANDOZ GLIMEPIRIDE (glimepiride 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003704,glimepiride 4 mg oral tablet,8001480,glimepiride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102531,Marketed,2023-07-05,02536552,COLUMVI,1.0,L01FX28,Glofitamab,Solution,Intravenous,02536552,COLUMVI (glofitamab 2.5 mg per 2.5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014893,glofitamab 2.5 mg per 2.5 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102532,Marketed,2023-07-05,02536560,COLUMVI,1.0,L01FX28,Glofitamab,Solution,Intravenous,02536560,COLUMVI (glofitamab 10 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014892,glofitamab 10 mg per 10 mL solution for injection vial,8002472,glofitamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98243,Marketed,2024-09-23,02492415,BAQSIMI,1.0,H04AA01,Glucagon,Powder,Nasal,02492415,"BAQSIMI (glucagon 3 mg per actuation nasal powder) AMPHASTAR PHARMACEUTICALS, INC.",Active,9014207,glucagon 3 mg per actuation nasal powder,8001385,glucagon,46713006,Nasal,385156003,Nasal powder,732981002,Actuation (unit of presentation),,,
14183,Marketed,1977-12-31,02020939,SCLERODEX,2.0,C05BB56,"Glucose, combinations",Liquid,Intravenous,,,,,,,,,,,,,,,,
93983,Marketed,2016-11-03,02453304,RAVICTI,1.0,A16AX09,Glycerol phenylbutyrate,Liquid,Oral,02453304,RAVICTI (glycerol phenylbutyrate 1.1 g per mL oral liquid) HORIZON THERAPEUTICS IRELAND DAC,Active,9006061,glycerol phenylbutyrate 1.1 g per mL oral liquid,8001915,phenylbutyric acid,26643006,Oral,420699003,Liquid,,,,,
1253,Marketed,2023-08-03,00037621,NITROSTAT,1.0,C01DA02,Glyceryl trinitrate,Tablet,Sublingual,00037621,NITROSTAT (nitroglycerin 0.6 mg sublingual tablet) BGP PHARMA ULC,Active,9010878,nitroglycerin 0.6 mg sublingual tablet,8000044,nitroglycerin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
1254,Marketed,2023-08-03,00037613,NITROSTAT,1.0,C01DA02,Glyceryl trinitrate,Tablet,Sublingual,00037613,NITROSTAT (nitroglycerin 0.3 mg sublingual tablet) BGP PHARMA ULC,Active,9010874,nitroglycerin 0.3 mg sublingual tablet,8000044,nitroglycerin,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
10706,Marketed,2025-10-17,00778869,NITROJECT,1.0,C01DA02,Glyceryl trinitrate,Solution,Intravenous,00778869,NITROJECT (nitroglycerin 50 mg per 10 mL solution for injection vial) JUNO PHARMA CANADA INC.,Active,9000302,nitroglycerin 50 mg per 10 mL solution for injection vial,8000044,nitroglycerin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
11225,Marketed,2018-07-12,01911902,NITRO-DUR 0.4,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911902,NITRO-DUR 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) USPHARMA LTD,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
11226,Marketed,2018-07-12,01911929,NITRO-DUR 0.6,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911929,NITRO-DUR 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) USPHARMA LTD,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
11227,Marketed,2018-07-12,01911910,NITRO-DUR 0.2,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,01911910,NITRO-DUR 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) USPHARMA LTD,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
14742,Marketed,2018-07-12,02011271,NITRO-DUR 0.8,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02011271,NITRO-DUR 0.8 (nitroglycerin 0.8 mg per hour transdermal patch) USPHARMA LTD,Active,9010879,nitroglycerin 0.8 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
18085,Marketed,1995-12-31,02145316,NITROGLYCERIN IN 5% DEXTROSE INJ.-400MCG/ML,2.0,C01DA02,Glyceryl trinitrate,Solution,Intravenous,,,,,,,,,,,,,,,,
18086,Marketed,1995-12-31,02145308,NITROGLYCERIN IN 5% DEXTROSE INJ.-200MCG/ML,2.0,C01DA02,Glyceryl trinitrate,Solution,Intravenous,,,,,,,,,,,,,,,,
49993,Marketed,2024-08-21,02230732,TRINIPATCH 0.2,1.0,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230732,TRINIPATCH 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) ENDO OPERATIONS LTD.,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
49995,Marketed,2024-08-21,02230733,TRINIPATCH 0.4,1.0,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230733,TRINIPATCH 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) ENDO OPERATIONS LTD.,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
49996,Marketed,2024-08-21,02230734,TRINIPATCH 0.6,1.0,C01DA02,Glyceryl trinitrate,Patch,Transdermal,02230734,TRINIPATCH 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) ENDO OPERATIONS LTD.,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
50758,Marketed,2008-02-25,02231441,NITROLINGUAL PUMPSPRAY,1.0,C01DA02,Glyceryl trinitrate,Metered-dose pump,Sublingual,02231441,NITROLINGUAL PUMPSPRAY (nitroglycerin 0.4 mg per actuation sublingual spray) SANOFI-AVENTIS CANADA INC,Active,9010875,nitroglycerin 0.4 mg per actuation sublingual spray,8000044,nitroglycerin,37839007,Sublingual,421720008,Spray,732981002,Actuation (unit of presentation),,,
62447,Marketed,2011-02-26,02238998,RHO-NITRO PUMPSPRAY,1.0,C01DA02,Glyceryl trinitrate,Metered-dose pump,Sublingual,02238998,RHO-NITRO PUMPSPRAY (nitroglycerin 0.4 mg per actuation sublingual spray) SANDOZ CANADA INCORPORATED,Active,9010875,nitroglycerin 0.4 mg per actuation sublingual spray,8000044,nitroglycerin,37839007,Sublingual,421720008,Spray,732981002,Actuation (unit of presentation),,,
89213,Marketed,2013-06-04,02407442,MYLAN-NITRO PATCH 0.2,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407442,MYLAN-NITRO PATCH 0.2 (nitroglycerin 0.2 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010873,nitroglycerin 0.2 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
89214,Marketed,2013-06-04,02407450,MYLAN-NITRO PATCH 0.4,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407450,MYLAN-NITRO PATCH 0.4 (nitroglycerin 0.4 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010876,nitroglycerin 0.4 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
89215,Marketed,2013-06-04,02407469,MYLAN-NITRO PATCH 0.6,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407469,MYLAN-NITRO PATCH 0.6 (nitroglycerin 0.6 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010877,nitroglycerin 0.6 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
89216,Marketed,2013-06-04,02407477,MYLAN-NITRO PATCH 0.8,1.0,C01DA02,Glyceryl trinitrate,Patch (extended release),Transdermal,02407477,MYLAN-NITRO PATCH 0.8 (nitroglycerin 0.8 mg per hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9010879,nitroglycerin 0.8 mg per hour transdermal patch,8000044,nitroglycerin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
3865,Marketed,2020-02-10,00498793,GLYCINE IRRIGATION USP,1.0,B05CX03,Glycine,Solution,Irrigation,,,,,,,,,,,,,,,,
9828,Marketed,1989-12-31,00799955,GLYCINE 1.5% IRRIGATION USP SOL,1.0,B05CX03,Glycine,Liquid,Irrigation,,,,,,,,,,,,,,,,
14577,Marketed,2005-09-21,02039508,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",77700654,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
14577,Marketed,2005-09-21,02039508,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",77700655,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86865,Marketed,2012-07-13,02382849,GLYCOPYRROLATE INJECTION MULTIDOSE,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02382849,GLYCOPYRROLATE INJECTION MULTIDOSE (glycopyrrolate 4 mg per 20 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86866,Marketed,2012-06-29,02382857,GLYCOPYRROLATE INJECTION,1.0,A03AB02,Glycopyrronium,Liquid,"Intramuscular,Intravenous",77700694,GLYCOPYRROLATE INJECTION (glycopyrrolate 0.2 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012982,glycopyrrolate 0.2 mg per 1 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86866,Marketed,2012-06-29,02382857,GLYCOPYRROLATE INJECTION,1.0,A03AB02,Glycopyrronium,Liquid,"Intramuscular,Intravenous",77700695,GLYCOPYRROLATE INJECTION (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95811,Marketed,2022-11-01,02469332,CUVPOSA,1.0,A03AB02,Glycopyrronium,Solution,Oral,02469332,CUVPOSA (glycopyrrolate 1 mg per 5 mL oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9012984,glycopyrrolate 1 mg per 5 mL oral solution,8001082,glycopyrronium,26643006,Oral,385023001,Oral solution,,,,,
96360,Marketed,2021-05-26,02473879,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intramuscular,Intravenous",02473879,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.2 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9012982,glycopyrrolate 0.2 mg per 1 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96361,Marketed,2021-05-26,02473895,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02473895,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96362,Marketed,2021-05-26,02473887,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02473887,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100293,Marketed,2022-04-01,02513749,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02513749,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 0.4 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012983,glycopyrrolate 0.4 mg per 2 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102141,Marketed,2024-01-18,02532379,GLYCOPYRROLATE INJECTION USP,1.0,A03AB02,Glycopyrronium,Solution,"Intravenous,Intramuscular",02532379,GLYCOPYRROLATE INJECTION USP (glycopyrrolate 4 mg per 20 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012985,glycopyrrolate 4 mg per 20 mL solution for injection vial,8001082,glycopyrronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88007,Marketed,2013-01-14,02394936,SEEBRI BREEZHALER,1.0,R03BB06,Glycopyrronium bromide,Capsule,Inhalation,02394936,SEEBRI BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005156,glycopyrronium (glycopyrronium bromide) 50 mcg inhalation powder capsule,8001082,glycopyrronium,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,
81020,Marketed,2013-09-20,02324776,SIMPONI,1.0,L04AB06,Golimumab,Solution,Subcutaneous,02324776,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
81021,Marketed,2013-09-20,02324784,SIMPONI,1.0,L04AB06,Golimumab,Solution,Subcutaneous,02324784,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 50 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013152,golimumab 50 mg per 0.5 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
89785,Marketed,2013-10-03,02413175,SIMPONI,1.0,L04AB06,Golimumab,Solution,Subcutaneous,02413175,SIMPONI SINGLE-USE PRE-FILLED SYRINGE (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
89786,Marketed,2013-10-03,02413183,SIMPONI,1.0,L04AB06,Golimumab,Solution,Subcutaneous,02413183,SIMPONI SINGLE-USE AUTOINJECTOR (golimumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013151,golimumab 100 mg per 1 mL solution for injection syringe,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
90217,Marketed,2013-12-12,02417472,SIMPONI I.V.,1.0,L04AB06,Golimumab,Solution,Intravenous,02417472,SIMPONI I.V. (golimumab 50 mg per 4 mL solution for injection vial) JANSSEN INC,Active,9013153,golimumab 50 mg per 4 mL solution for injection vial,8001790,golimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
16216,Marketed,2018-02-28,02049325,ZOLADEX,1.0,L02AE03,Goserelin,Implant,Subcutaneous,02049325,ZOLADEX (goserelin (goserelin acetate) 3.6 mg implant) TERSERA THERAPEUTICS LLC,Active,9002677,goserelin (goserelin acetate) 3.6 mg implant,8001792,goserelin,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,
43433,Marketed,2018-02-28,02225905,ZOLADEX LA,1.0,L02AE03,Goserelin,Implant,Subcutaneous,02225905,ZOLADEX LA (goserelin (goserelin acetate) 10.8 mg implant) TERSERA THERAPEUTICS LLC,Active,9002907,goserelin (goserelin acetate) 10.8 mg implant,8001792,goserelin,34206005,Subcutaneous,385286003,Implant,732996003,Implant (unit of presentation),1.0,,
79450,Marketed,2016-09-16,02308894,APO-GRANISETRON,1.0,A04AA02,Granisetron,Tablet,Oral,02308894,APO-GRANISETRON (granisetron (granisetron hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9004515,granisetron (granisetron hydrochloride) 1 mg oral tablet,8001116,granisetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80824,Marketed,2009-05-14,02322765,GRANISETRON HYDROCHLORIDE INJECTION,1.0,A04AA02,Granisetron,Liquid,Intravenous,77700553,GRANISETRON HYDROCHLORIDE INJECTION (granisetron (granisetron hydrochloride) 4 mg per 4 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012496,granisetron (granisetron hydrochloride) 4 mg per 4 mL solution for injection vial,8001116,granisetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
80824,Marketed,2009-05-14,02322765,GRANISETRON HYDROCHLORIDE INJECTION,1.0,A04AA02,Granisetron,Liquid,Intravenous,77700554,GRANISETRON HYDROCHLORIDE INJECTION (granisetron (granisetron hydrochloride) 1 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012494,granisetron (granisetron hydrochloride) 1 mg per 1 mL solution for injection vial,8001116,granisetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
93873,Marketed,2016-03-01,02452359,NAT-GRANISETRON,1.0,A04AA02,Granisetron,Tablet,Oral,02452359,NAT-GRANISETRON (granisetron (granisetron hydrochloride) 1 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004515,granisetron (granisetron hydrochloride) 1 mg oral tablet,8001116,granisetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61900,Marketed,2023-06-22,02238480,STANDARDIZED GRASS POLLEN - KENTUCKY BLUEGRASS (100000 BAU/ML),1.0,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
61905,Marketed,2024-03-25,02238485,STANDARDIZED GRASS POLLEN - ORCHARD GRASS (100000 BAU/ML),1.0,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
61909,Marketed,2023-09-25,02238489,"STANDARDIZED GRASS POLLEN - REDTOP (100,000 BAU/ML)",1.0,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
61913,Marketed,2023-09-20,02238493,"STANDARDIZED GRASS POLLEN - SWEET VERNAL GRASS (100,000 BAU/ML)",1.0,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,
61918,Marketed,2024-02-23,02238497,STANDARDIZED GRASS POLLEN - TIMOTHY (100000 BAU/ML),1.0,V01AA02,Grass pollen,Solution,"Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,
61922,Marketed,2023-03-24,02238501,STANDARDIZED GRASS POLLEN - PERENNIAL RYEGRASS (100000 BAU/ML),1.0,V01AA02,Grass pollen,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
66453,Marketed,2000-10-30,02242664,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - TIMOTHY,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
66455,Marketed,2019-04-03,02242666,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - KENTUCKY BLUE/JUNE,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
66457,Marketed,2019-08-28,02242668,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - SWEET VERNAL,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
66459,Marketed,2000-10-30,02242670,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - RED TOP,1.0,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,
66461,Marketed,2019-04-03,02242672,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - MEADOW FESCUE,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
66463,Marketed,2000-10-31,02242674,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - ORCHARD,1.0,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,
66465,Marketed,2019-04-03,02242676,ALLERGENIC EXTRACT - STANDARDIZED GRASS POLLEN - PERENNIAL RYE,1.0,V01AA02,Grass pollen,Liquid,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,
66518,Marketed,2001-04-01,02242713,ALLERGY CANADA ALLERGEN EXTRACT - ALUM PRECIPITATED,1.0,V01AA02,Grass pollen,Liquid,Subcutaneous,,,,,,,,,,,,,,,,
81083,Marketed,2009-07-30,02325454,ALLERGENIC EXTRACT - STANDARDIZED JUNE GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Intradermal,Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,
81085,Marketed,2009-07-30,02325470,ALLERGENIC EXTRACT - STANDARDIZED TIMOTHY GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,
81086,Marketed,2009-07-30,02325489,ALLERGENIC EXTRACT - STANDARDIZED ORCHARD GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
81087,Marketed,2009-07-30,02325497,ALLERGENIC EXTRACT - STANDARDIZED REDTOP GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,
81088,Marketed,2009-07-30,02325500,ALLERGENIC EXTRACT - STANDARDIZED PERENNNIAL RYE GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Percutaneous,Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
81089,Marketed,2009-07-30,02325519,ALLERGENIC EXTRACT - STANDARDIZED SWEET VERNAL GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Intradermal,Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
81090,Marketed,2009-07-30,02325527,ALLERGENIC EXTRACT - STANDARDIZED MEADOW FESCUE GRASS POLLEN,1.0,V01AA02,Grass pollen,Liquid,"Intradermal,Percutaneous,Subcutaneous",,,,,,,,,,,,,,,,
81092,Marketed,2009-07-30,02325543,ALLERGENIC EXTRACT - MIXTURE OF 5 STANDARDIZED GRASS POLLEN,5.0,V01AA02,Grass pollen,Liquid,"Percutaneous,Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
86772,Marketed,2015-05-22,02381885,ORALAIR,1.0,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,
86773,Marketed,2015-05-22,02381893,ORALAIR,1.0,V01AA02,Grass pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,
90288,Marketed,2017-11-06,02418304,GRASTEK,1.0,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,
90842,Marketed,2017-11-06,02423723,RAGWITEK,1.0,V01AA02,Grass pollen,Tablet (orally disintegrating),Sublingual,,,,,,,,,,,,,,,,
91016,Marketed,2019-04-17,02425513,ALLERGENIC EXTRACTS - 7 GRASS MIX,7.0,V01AA02,Grass pollen,Liquid,Subcutaneous,,,,,,,,,,,,,,,,
93285,Marketed,2015-11-10,02447304,"ALLERGENIC EXTRACTS, K-O-R-T GRASS MIXTURE",4.0,V01AA02,Grass pollen,Solution,"Intracutaneous,Subcutaneous",,,,,,,,,,,,,,,,
19044,Marketed,2024-05-23,02142783,ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM,1.0,R05CA03,Guaifenesin,Syrup,Oral,02142783,ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM (guaifenesin 200 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002826,guaifenesin 200 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,
30557,Marketed,2005-10-06,02121999,BRONCHOPHAN EXPECTORANT (SANS SUCROSE),1.0,R05CA03,Guaifenesin,Syrup,Oral,02121999,BRONCHOPHAN EXPECTORANT (SANS SUCROSE) (guaifenesin 100 mg per 5 mL syrup) LABORATOIRE ATLAS INC,Active,9001847,guaifenesin 100 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,
41989,Marketed,2013-01-04,00609951,BALMINIL EXPECTORANT (SUCROSE FREE),1.0,R05CA03,Guaifenesin,Syrup,Oral,00609951,BALMINIL EXPECTORANT (SUCROSE FREE) (guaifenesin 100 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9001847,guaifenesin 100 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,
75089,Marketed,2019-09-03,02265427,BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD,2.0,R05CA03,Guaifenesin,Syrup,Oral,02265427,BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
77454,Marketed,2024-03-05,02289164,BUCKLEY'S CHEST CONGESTION,2.0,R05CA03,Guaifenesin,Syrup,Oral,02289164,BUCKLEY'S CHEST CONGESTION (guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup) HALEON CANADA ULC,Active,9004322,guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
80636,Marketed,2011-07-27,02320940,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM,2.0,R05CA03,Guaifenesin,Syrup,Oral,02320940,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
83190,Marketed,2024-03-13,02346451,BUCKLEY'S MUCUS & PHLEGM,2.0,R05CA03,Guaifenesin,Syrup,Oral,02346451,BUCKLEY'S MUCUS & PHLEGM (guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup) HALEON CANADA ULC,Active,9004322,guaifenesin 100 mg per 5 mL and menthol 10 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
91903,Marketed,2018-12-10,02434725,MUCINEX CHEST CONGESTION,1.0,R05CA03,Guaifenesin,Tablet (immediate and extended release),Oral,02434725,MUCINEX CHEST CONGESTION (guaifenesin 600 mg prolonged-release oral tablet) RB HEALTH (CANADA) INC.,Active,9015302,guaifenesin 600 mg prolonged-release oral tablet,8000821,guaifenesin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
97024,Marketed,2019-07-02,02479869,BENYLIN EXTRA STRENGTH SORE THROAT & COUGH,2.0,R05CA03,Guaifenesin,Syrup,Oral,02479869,BENYLIN EXTRA STRENGTH SORE THROAT & COUGH (guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004092,guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8000953,guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
102365,Marketed,2024-12-30,02534762,MUCUS & PHLEGM RELIEF EXTRA STRENGTH,1.0,R05CA03,Guaifenesin,Syrup,Oral,02534762,MUCUS & PHLEGM RELIEF EXTRA STRENGTH (guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9002826,guaifenesin 200 mg per 5 mL syrup,8000821,guaifenesin,26643006,Oral,739009002,Syrup,,,,,
89383,Marketed,2021-08-24,02409100,INTUNIV XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409100,INTUNIV XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89384,Marketed,2021-07-29,02409119,INTUNIV XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409119,INTUNIV XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89385,Marketed,2021-09-01,02409127,INTUNIV XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409127,INTUNIV XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89386,Marketed,2021-07-26,02409135,INTUNIV XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02409135,INTUNIV XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) TAKEDA CANADA INC,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101263,Marketed,2022-01-27,02523558,JAMP GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523558,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101264,Marketed,2022-01-26,02523566,JAMP GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523566,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101265,Marketed,2022-01-27,02523574,JAMP GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523574,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101266,Marketed,2022-01-27,02523582,JAMP GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523582,JAMP GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101278,Marketed,2022-01-31,02523728,APO-GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523728,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet) APOTEX INC,Active,9005296,guanfacine (guanfacine hydrochloride) 1 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101279,Marketed,2022-01-31,02523736,APO-GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523736,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet) APOTEX INC,Active,9005297,guanfacine (guanfacine hydrochloride) 2 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101280,Marketed,2022-01-31,02523744,APO-GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523744,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet) APOTEX INC,Active,9005298,guanfacine (guanfacine hydrochloride) 3 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101281,Marketed,2022-01-31,02523752,APO-GUANFACINE XR,1.0,C02AC02,Guanfacine,Tablet (extended-release),Oral,02523752,APO-GUANFACINE XR (guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet) APOTEX INC,Active,9005299,guanfacine (guanfacine hydrochloride) 4 mg prolonged-release oral tablet,8001273,guanfacine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95860,Marketed,2017-11-27,02469758,TREMFYA,1.0,L04AC16,Guselkumab,Solution,Subcutaneous,02469758,TREMFYA (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
97748,Marketed,2019-05-20,02487314,TREMFYA ONE-PRESS,1.0,L04AC16,Guselkumab,Solution,Subcutaneous,02487314,TREMFYA ONE-PRESS (guselkumab 100 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9012497,guselkumab 100 mg per 1 mL solution for injection syringe,8001142,guselkumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
106233,Marketed,2025-08-15,02559145,TREMFYA,1.0,L04AC16,Guselkumab,Solution,Subcutaneous,02559145,TREMFYA (guselkumab 200 mg per 2 mL solution for injection pen) JANSSEN INC,Active,9015256,guselkumab 200 mg per 2 mL solution for injection pen,8001142,guselkumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,
106234,Marketed,2025-08-15,02559153,TREMFYA I.V.,1.0,L04AC16,Guselkumab,Solution,Intravenous,02559153,TREMFYA I.V. (guselkumab 200 mg per 20 mL solution for injection vial) JANSSEN INC,Active,9015255,guselkumab 200 mg per 20 mL solution for injection vial,8001142,guselkumab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
5859,Marketed,2016-09-12,00363650,TEVA-HALOPERIDOL,1.0,N05AD01,Haloperidol,Tablet,Oral,00363650,TEVA-HALOPERIDOL (haloperidol 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000200,haloperidol 5 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7128,Marketed,2016-09-12,00363685,TEVA-HALOPERIDOL,1.0,N05AD01,Haloperidol,Tablet,Oral,00363685,TEVA-HALOPERIDOL (haloperidol 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000149,haloperidol 0.5 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7129,Marketed,2016-09-12,00363677,TEVA-HALOPERIDOL,1.0,N05AD01,Haloperidol,Tablet,Oral,00363677,TEVA-HALOPERIDOL (haloperidol 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000150,haloperidol 1 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7130,Marketed,2016-09-12,00363669,TEVA-HALOPERIDOL,1.0,N05AD01,Haloperidol,Tablet,Oral,00363669,TEVA-HALOPERIDOL (haloperidol 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000252,haloperidol 2 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7131,Marketed,2016-09-12,00713449,TEVA-HALOPERIDOL,1.0,N05AD01,Haloperidol,Tablet,Oral,00713449,TEVA-HALOPERIDOL (haloperidol 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000251,haloperidol 10 mg oral tablet,8000084,haloperidol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10026,Marketed,2005-09-15,00808652,HALOPERIDOL INJ 5MG/ML USP,1.0,N05AD01,Haloperidol,Liquid,Intramuscular,00808652,HALOPERIDOL INJ 5MG/ML USP (haloperidol 5 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000326,haloperidol 5 mg per 1 mL solution for injection ampoule,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16902,Marketed,2005-08-26,02130300,HALOPERIDOL LA,1.0,N05AD01,Haloperidol,Liquid,Intramuscular,77700024,HALOPERIDOL LA (haloperidol (haloperidol decanoate) 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000522,haloperidol (haloperidol decanoate) 100 mg per 1 mL solution for injection ampoule,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
16902,Marketed,2005-08-26,02130300,HALOPERIDOL LA,1.0,N05AD01,Haloperidol,Liquid,Intramuscular,77700025,HALOPERIDOL LA (haloperidol (haloperidol decanoate) 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000524,haloperidol (haloperidol decanoate) 500 mg per 5 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
85088,Marketed,2011-09-19,02366010,HALOPERIDOL INJECTION,1.0,N05AD01,Haloperidol,Solution,Intramuscular,02366010,HALOPERIDOL INJECTION (haloperidol 5 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9001362,haloperidol 5 mg per 1 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
89112,Marketed,2016-01-21,02406411,"HALOPERIDOL INJECTION, USP",1.0,N05AD01,Haloperidol,Solution,Intramuscular,77700123,"HALOPERIDOL INJECTION, USP (haloperidol 5 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9001362,haloperidol 5 mg per 1 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
89112,Marketed,2016-01-21,02406411,"HALOPERIDOL INJECTION, USP",1.0,N05AD01,Haloperidol,Solution,Intramuscular,77700124,"HALOPERIDOL INJECTION, USP (haloperidol 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9001435,haloperidol 50 mg per 10 mL solution for injection vial,8000084,haloperidol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5688,Marketed,1911-12-31,00572888,HELIUM 100%,1.0,V03AN03,Helium,Gas,Inhalation,,,,,,,,,,,,,,,,
13883,Marketed,2022-05-04,02014475,HELIUM USP,1.0,V03AN03,Helium,Gas,Inhalation,,,,,,,,,,,,,,,,
96951,Marketed,2018-12-05,02478765,PANHEMATIN,1.0,B06AB01,Hematin,Powder for solution,Intravenous,02478765,PANHEMATIN (hemin 268 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9013688,hemin 268 mg per vial powder for solution for injection,8002197,hemin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
6775,Marketed,2024-05-07,00691623,BICARBONATE CONCENTRATE D17000,1.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
9852,Marketed,2024-05-08,00860565,ACID CONCENTRATE D12201,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
10009,Marketed,2024-04-12,00799823,DIANEAL PD101 CAPD SOLUTION WITH 2.5% DEXTROSE,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10143,Marketed,2024-04-12,00799807,DIANEAL PD101 CAPD SOLUTION WITH 4.25% DEXTROSE,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10144,Marketed,2024-04-12,00799815,DIANEAL PD101 CAPD SOLUTION WITH 1.5% DEXTROSE,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10512,Marketed,2024-04-12,00799793,DIANEAL PD101 CAPD SOLUTION WITH 0.5% DEXTROSE,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10820,Marketed,2024-05-06,00890197,ACID CONCENTRATE D12207,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
10863,Marketed,2024-04-12,00865095,DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10864,Marketed,2024-04-12,00865109,DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
10865,Marketed,2024-04-12,00865117,DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
13833,Marketed,2024-05-06,01905740,K+ 45,1.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
18200,Marketed,2024-05-13,02158159,ACID CONCENTRATE D12264,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
18202,Marketed,2024-05-08,02158221,ACID CONCENTRATE D12262,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
18268,Marketed,2024-05-08,02158329,ACID CONCENTRATE D12248,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
18310,Marketed,2024-04-26,02161060,CALCIUM-45 0.25-4.5,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
18321,Marketed,2024-04-29,02160986,CALCIUM-45 0.5-4.5,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
20040,Marketed,2024-05-08,02217244,ACID CONCENTRATE D12236,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20041,Marketed,2024-05-09,02217643,ACID CONCENTRATE D12290,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20044,Marketed,2024-05-09,02217554,ACID CONCENTRATE D12293,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20046,Marketed,2024-05-10,02217635,ACID CONCENTRATE D12302,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20111,Marketed,2024-05-08,02217597,ACID CONCENTRATE D12300,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20112,Marketed,2024-04-26,02219301,MAGNESIUM-45 0.5-4.5,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
20114,Marketed,2024-05-09,02218879,ACID CONCENTRATE D12275,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20115,Marketed,2024-05-08,02217260,ACID CONCENTRATE D12299,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20116,Marketed,2024-05-09,02217252,ACID CONCENTRATE D12286,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20118,Marketed,2024-05-10,02217600,ACID CONCENTRATE D12305,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20119,Marketed,2024-05-06,02217619,ACID CONCENTRATE D12294,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
20121,Marketed,2024-05-09,02217279,ACID CONCENTRATE D12291,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
34878,Marketed,2024-05-09,02178125,ACID CONCENTRATE D12272,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
34881,Marketed,2024-05-09,02178168,ACID CONCENTRATE D12316,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
36836,Marketed,2024-05-06,02210835,ACID CONCENTRATE 2182,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
62965,Marketed,2024-05-06,02239491,ACID CONCENTRATE 2156,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
66962,Marketed,2024-04-18,02243095,PRISMASOL 0,5.0,B05ZA,"Hemodialytics, concentrates",Solution,"Intravenous,Haemodialysis",,,,,,,,,,,,,,,,
71993,Marketed,2024-05-23,02247721,PHYSIONEAL 40 GLUCOSE 1.36%,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
71997,Marketed,2024-05-23,02247722,PHYSIONEAL 40 GLUCOSE 2.27%,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
71998,Marketed,2024-05-27,02247723,PHYSIONEAL 40 GLUCOSE 3.86%,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
73309,Marketed,2005-07-04,02248934,BICARBONATE CONCENTRATE B38,1.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73901,Marketed,2023-07-14,02254085,ACID CONCENTRATE A1230,5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73916,Marketed,2023-07-14,02254247,ACID CONCENTRATE A1227,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73917,Marketed,2023-07-14,02254255,ACID CONCENTRATE A1226,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73919,Marketed,2023-07-14,02254298,ACID CONCENTRATE A1225,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73921,Marketed,2023-07-14,02254301,ACID CONCENTRATE A1224,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73922,Marketed,2023-07-17,02254328,ACID CONCENTRATE A1223,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73923,Marketed,2023-07-17,02254336,ACID CONCENTRATE A1222,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
73924,Marketed,2023-07-14,02254344,ACID CONCENTRATE A1221,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
74786,Marketed,2023-07-14,02262479,ACID CONCENTRATE A1261,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
74787,Marketed,2023-07-17,02262487,ACID CONCENTRATE A1262,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
74791,Marketed,2023-07-14,02262525,ACID CONCENTRATE A1266,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
75411,Marketed,2023-07-17,02268728,ACID CONCENTRATE A1294,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
75808,Marketed,2023-07-14,02272563,ACID CONCENTRATE A1275,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
75810,Marketed,2023-07-14,02272598,ACID CONCENTRATE A1277,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
75812,Marketed,2023-07-14,02272628,ACID CONCENTRATE A1279,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
76040,Marketed,2024-04-18,02274876,PRISM0CAL,4.0,B05ZA,"Hemodialytics, concentrates",Solution,"Haemodialysis,Intravenous",,,,,,,,,,,,,,,,
76310,Marketed,2024-04-29,02277476,PRISMASOL 4,7.0,B05ZA,"Hemodialytics, concentrates",Solution,"Haemodialysis,Intravenous",,,,,,,,,,,,,,,,
81095,Marketed,2022-02-01,02325586,BIBAG,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
81113,Marketed,2010-01-23,02325772,HEMACART,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
81227,Marketed,2020-08-19,02326949,NATURALYTE H-229,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81238,Marketed,2020-11-11,02327066,NATURALYTE H-616,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81262,Marketed,2020-08-26,02327309,NATURALYTE H-401,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81265,Marketed,2020-08-17,02327333,NATURALYTE H-332,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81270,Marketed,2021-02-12,02327384,NATURALYTE H-260,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81272,Marketed,2020-09-04,02327406,NATURALYTE H-226,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81275,Marketed,2020-09-04,02327422,NATURALYTE H-402,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81279,Marketed,2020-08-27,02327465,NATURALYTE H-225,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81282,Marketed,2020-08-14,02327503,NATURALYTE H-330,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81283,Marketed,2020-10-13,02327511,NATURALYTE H-410,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81284,Marketed,2020-09-18,02327538,NATURALYTE H-408,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81574,Marketed,2020-11-05,02329980,NATURALYTE H-208,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81577,Marketed,2020-08-20,02330016,NATURALYTE H-623,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81578,Marketed,2020-10-28,02330024,NATURALYTE H-201,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81579,Marketed,2020-08-12,02330032,NATURALYTE H-624,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81592,Marketed,2021-10-06,02330164,NATURALYTE H-608,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81593,Marketed,2020-10-21,02330172,NATURALYTE H-200,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81598,Marketed,2020-08-18,02330229,NATURALYTE H-320,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
81601,Marketed,2020-08-13,02330253,NATURALYTE H-232,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
84860,Marketed,2013-12-20,02363615,NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301),6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
84861,Marketed,2013-11-13,02363631,NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304),6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
84863,Marketed,2013-07-05,02363666,NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302),6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
85372,Marketed,2024-05-23,02368730,PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
85373,Marketed,2024-05-23,02368749,PHYSIONEAL 40 GLUCOSE 3.86% CLEAR-FLEX,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
85374,Marketed,2024-05-23,02368757,PHYSIONEAL 40 GLUCOSE 2.27% CLEAR-FLEX,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
87315,Marketed,2013-03-26,02387549,CALCIUM CHLORIDE FOR HAEMODIALYSIS,1.0,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,
88829,Marketed,2024-04-29,02403498,BICART,1.0,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,
88830,Marketed,2024-04-29,02403501,BICART,1.0,B05ZA,"Hemodialytics, concentrates",Powder,Haemodialysis,,,,,,,,,,,,,,,,
89853,Marketed,2021-01-15,02413892,HEMOSATE ULTRA HS1125,7.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89855,Marketed,2021-01-15,02413906,HEMOSATE ULTRA HS2125,7.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89856,Marketed,2021-01-15,02413914,HEMOSATE ULTRA HS3125,7.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89857,Marketed,2021-01-15,02413922,HEMOSATE ULTRA HS4125,7.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89944,Marketed,2024-05-06,02414813,SELECTBAG ONE (AX 125 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89945,Marketed,2024-05-06,02414821,SELECTBAG ONE (AX 150 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89948,Marketed,2024-05-06,02414856,SELECTBAG ONE (AX 225 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
89953,Marketed,2024-05-06,02414902,SELECTBAG ONE (AX 325 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
90007,Marketed,2024-05-06,02415461,SELECTBAG ONE (AX 250 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
90008,Marketed,2024-05-13,02415488,SELECTBAG ONE (AX 450 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
90009,Marketed,2024-05-10,02415496,SELECTBAG ONE (AX 2525 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
90011,Marketed,2024-05-08,02415526,SELECTBAG ONE (AX 350 G),5.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
90988,Marketed,2024-05-08,02425246,BICART SELECT COMBI-PAK,2.0,B05ZA,"Hemodialytics, concentrates","Kit,Powder for solution",Haemodialysis,,,,,,,,,,,,,,,,
92024,Marketed,2023-07-14,02435918,ACID CONCENTRATE A1296,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92029,Marketed,2023-07-14,02435950,ACID CONCENTRATE A1298,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92030,Marketed,2023-07-14,02435969,ACID CONCENTRATE A1297,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92790,Marketed,2016-09-15,02443279,NXSTAGE PUREFLOW SOLUTION RFP-204-CAN,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92791,Marketed,2016-09-15,02443287,NXSTAGE PUREFLOW SOLUTION RFP-207-CAN,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92792,Marketed,2016-09-15,02443295,NXSTAGE PUREFLOW SOLUTION RFP-209-CAN,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
97789,Marketed,2022-04-26,02487756,BIBAG,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
101744,Marketed,2023-02-16,02528193,MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15,1.0,B05ZA,"Hemodialytics, concentrates",Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
102272,Marketed,2023-01-16,02533758,ACID CONCENTRATE A1243,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102273,Marketed,2023-08-16,02533766,ACID CONCENTRATE A1255,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102274,Marketed,2023-01-10,02533774,ACID CONCENTRATE A1228,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102276,Marketed,2023-02-07,02533782,ACID CONCENTRATE A1241,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102278,Marketed,2023-02-22,02533820,ACID CONCENTRATE A1246,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102279,Marketed,2023-01-20,02533812,ACID CONCENTRATE A1245,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102280,Marketed,2023-08-27,02533839,ACID CONCENTRATE A1252,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102281,Marketed,2023-02-09,02533847,ACID CONCENTRATE A1242,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102282,Marketed,2023-01-23,02533871,ACID CONCENTRATE A1263,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102283,Marketed,2023-08-24,02533855,ACID CONCENTRATE A1231,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102284,Marketed,2023-08-27,02533863,ACID CONCENTRATE A1265,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
102286,Marketed,2023-01-23,02533898,ACID CONCENTRATE A1267,6.0,B05ZA,"Hemodialytics, concentrates",Solution,Haemodialysis,,,,,,,,,,,,,,,,
92609,Marketed,2024-04-19,02441691,PRISM0CAL B22K0/0,3.0,B05ZB,Hemofiltrates,Solution,"Haemodialysis,Intravenous",,,,,,,,,,,,,,,,
98660,Marketed,2024-05-06,02496755,REGIOCIT,2.0,B05ZB,Hemofiltrates,Solution,Extracorporeal,,,,,,,,,,,,,,,,
13140,Marketed,2006-07-14,01959034,ACT-HIB,2.0,J07AG01,"Hemophilus influenzae b, purified antig. conjugated","Kit,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,
8042,Marketed,1984-12-31,00727520,HEPARIN LEO 100UNIT/ML,1.0,B01AB01,Heparin,Solution,Extracorporeal,00727520,HEPARIN LEO 100UNIT/ML (heparin sodium 100 unit per mL lock flush solution 10 mL vial) LEO PHARMA INC,Active,9015303,heparin sodium 100 unit per mL lock flush solution 10 mL vial,8001274,heparin,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
10526,Marketed,1987-12-31,00453811,HEPARIN LEO INJ 1000UNIT/ML,1.0,B01AB01,Heparin,Liquid,"Subcutaneous,Intravenous",00453811,HEPARIN LEO INJ 1000UNIT/ML (heparin sodium 10000 unit per 10 mL solution for injection vial) LEO PHARMA INC,Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
17227,Marketed,2017-06-13,01990748,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION,1.0,B01AB01,Heparin,Solution,Intravenous,77700660,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION (heparin sodium 2000 unit per 1000 mL solution for injection bag) PFIZER CANADA ULC,Active,9012992,heparin sodium 2000 unit per 1000 mL solution for injection bag,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
17227,Marketed,2017-06-13,01990748,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION,1.0,B01AB01,Heparin,Solution,Intravenous,77700661,HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION (heparin sodium 1000 unit per 500 mL solution for injection bag) PFIZER CANADA ULC,Active,9012987,heparin sodium 1000 unit per 500 mL solution for injection bag,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
74973,Marketed,2015-09-09,02264307,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700674,"HEPARIN SODIUM INJECTION, USP (heparin sodium 50000 unit per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012997,heparin sodium 50000 unit per 5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74973,Marketed,2015-09-09,02264307,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700675,"HEPARIN SODIUM INJECTION, USP (heparin sodium 10000 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012989,heparin sodium 10000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74976,Marketed,2015-10-08,02264315,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",77700676,"HEPARIN SODIUM INJECTION, USP (heparin sodium 10000 unit per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74976,Marketed,2015-10-08,02264315,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",77700677,"HEPARIN SODIUM INJECTION, USP (heparin sodium 1000 unit per mL solution for injection 30 mL vial) FRESENIUS KABI CANADA LTD",Active,9012988,heparin sodium 1000 unit per mL solution for injection 30 mL vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74976,Marketed,2015-10-08,02264315,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",77700678,"HEPARIN SODIUM INJECTION, USP (heparin sodium 1000 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012986,heparin sodium 1000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78841,Marketed,2008-05-19,02303086,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE),1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700683,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE) (heparin sodium 10000 unit per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012990,heparin sodium 10000 unit per 10 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78841,Marketed,2008-05-19,02303086,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE),1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",77700684,HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE) (heparin sodium 1000 unit per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012988,heparin sodium 1000 unit per mL solution for injection 30 mL vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86817,Marketed,2013-03-01,02382326,HEPARIN SODIUM INJECTION USP,1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",02382326,HEPARIN SODIUM INJECTION USP (heparin sodium 10000 unit per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9012989,heparin sodium 10000 unit per 1 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87773,Marketed,2015-08-31,02392453,"HEPARIN SODIUM INJECTION, USP",1.0,B01AB01,Heparin,Solution,"Subcutaneous,Intravenous",02392453,"HEPARIN SODIUM INJECTION, USP (heparin sodium 5000 unit per 0.5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012996,heparin sodium 5000 unit per 0.5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94407,Marketed,2016-11-17,02456958,HEPARIN SODIUM INJECTION USP,1.0,B01AB01,Heparin,Solution,Subcutaneous,02456958,HEPARIN SODIUM INJECTION USP (heparin sodium 5000 unit per 0.5 mL solution for injection syringe) STERINOVA INC.,Active,9012995,heparin sodium 5000 unit per 0.5 mL solution for injection syringe,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103735,Marketed,2024-09-26,02548488,HEPARIN SODIUM INJECTION USP,1.0,B01AB01,Heparin,Solution,"Intravenous,Subcutaneous",02548488,HEPARIN SODIUM INJECTION USP (heparin sodium 5000 unit per 0.5 mL solution for injection vial) STERIMAX INC,Active,9012996,heparin sodium 5000 unit per 0.5 mL solution for injection vial,8001274,heparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10521,Marketed,1990-12-31,00828750,HEPARIN SOD AND 0.9% SOD CHLORIDE INJ,2.0,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
16794,Marketed,1998-09-03,01935941,"HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML",4.0,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
36794,Marketed,1998-06-17,02209713,HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ,2.0,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
36795,Marketed,1998-06-17,02209721,HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ,2.0,B01AB51,"Heparin, combinations",Solution,Intravenous,,,,,,,,,,,,,,,,
20256,Marketed,2002-09-23,02187078,HAVRIX 1440,1.0,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,
47865,Marketed,2007-10-23,02229702,VAQTA,1.0,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,
50339,Marketed,2002-08-22,02231056,HAVRIX 720 JUNIOR,1.0,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,
61149,Marketed,2006-08-14,02237792,AVAXIM,1.0,J07BC02,"Hepatitis a, inactivated, whole virus",Suspension,Intramuscular,,,,,,,,,,,,,,,,
77637,Marketed,2022-11-10,02290979,HEPAGAM B,1.0,J06BB04,Hepatitis b immunoglobulin,Solution,"Intravenous,Intramuscular",,,,,,,,,,,,,,,,
100923,Marketed,2023-02-21,02520001,HYPERHEP B,1.0,J06BB04,Hepatitis b immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,
100934,Marketed,2022-08-16,02520125,HYPERHEP B,1.0,J06BB04,Hepatitis b immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,
67606,Marketed,2006-02-07,02243676,RECOMBIVAX HB,1.0,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
70103,Marketed,2006-04-10,02245977,RECOMBIVAX HB,1.0,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
97717,Marketed,2019-10-07,02487020,ENGERIX-B,1.0,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
97718,Marketed,2019-11-15,02487039,ENGERIX-B,1.0,J07BC01,"Hepatitis b, purified antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
11321,Marketed,2020-11-16,00895466,BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG,1.0,R02AA12,Hexylresorcinol,Lozenge,Oral,00895466,BRADOSOL LOZENGES EXTRA STRENGTH 3.5MG (hexylresorcinol 3.5 mg lozenge) COLUMBIA LABORATORIES CANADA INC,Active,9014400,hexylresorcinol 3.5 mg lozenge,8001795,hexylresorcinol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
67829,Marketed,2019-02-04,02243888,STREPSILS ANAESTHETIC FORMULA,1.0,R02AA12,Hexylresorcinol,Lozenge,Oral,02243888,STREPSILS ANAESTHETIC FORMULA (hexylresorcinol 2.4 mg lozenge) RB HEALTH (CANADA) INC.,Active,9002371,hexylresorcinol 2.4 mg lozenge,8001795,hexylresorcinol,26643006,Oral,385087003,Lozenge,733000006,Lozenge,,,
74940,Marketed,2019-02-04,02263998,STREPSILS EXTRA BLACK CHERRY,2.0,R02AA12,Hexylresorcinol,Lozenge,Oral,02263998,STREPSILS EXTRA BLACK CHERRY (hexylresorcinol 2.4 mg and levomenthol 4 mg lozenge) RB HEALTH (CANADA) INC.,Active,9013568,hexylresorcinol 2.4 mg and levomenthol 4 mg lozenge,8002129,hexylresorcinol and levomenthol,26643006,Oral,385087003,Lozenge,733000006,Lozenge (unit of presentation),,,
37350,Marketed,2023-03-24,02223945,"ALLERGENIC EXTRACT STANDARDIZED MITE DP (30,000 AU/ML)",1.0,V01AA03,House dust mites,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
37352,Marketed,2023-03-24,02223961,"ALLERGENIC EXTRACT STANDARDIZED MITE DF (30,000 AU/ML)",1.0,V01AA03,House dust mites,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
37354,Marketed,2025-12-04,02223996,"ALLERGENIC EXTRACT MIXTURE OF STANDARDIZED MITES (5,000 AU/ML)",2.0,V01AA03,House dust mites,Solution,"Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
43205,Marketed,2004-08-26,02217082,"ALLERGENIC EXTRACT, STANDARDARDIZED MITE, D. FARINAE",1.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Percutaneous,Intradermal",,,,,,,,,,,,,,,,
43207,Marketed,2004-08-26,02217104,"ALLERGENIC EXTRACT, STANDARDIZED MITE, D.PTERONYSSINUS",1.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,
50628,Marketed,1999-03-15,02231321,ALLERGENIC EXTRACT - STANDARDIZED MITE DERMATOPHAGOIDES FARINAE,1.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
50631,Marketed,1999-03-15,02231324,ALLERGENIC EXTRACT - STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS,1.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
50632,Marketed,2002-08-20,02231325,ALLERGENIC EXTRACT - STANDARDIZED MITE MIX,2.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Intracutaneous",,,,,,,,,,,,,,,,
75630,Marketed,2006-02-28,02270919,"ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED",2.0,V01AA03,House dust mites,Liquid,"Subcutaneous,Intradermal,Percutaneous",,,,,,,,,,,,,,,,
95174,Marketed,2017-11-06,02463644,ACARIZAX,2.0,V01AA03,House dust mites,Tablet,Sublingual,,,,,,,,,,,,,,,,
76872,Marketed,2006-09-19,02283093,MENOPUR,1.0,G03GA02,Human menopausal gonadotrophin,Powder for solution,Subcutaneous,02283093,MENOPUR (menotropins 75 unit per vial powder for solution for injection with diluent solution) FERRING INC,Active,9013224,menotropins 75 unit per vial powder for solution for injection with diluent solution,8001847,menotropins,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
11047,Marketed,2017-10-02,00441619,APO-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,00441619,APO-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11626,Marketed,2017-10-02,00441627,APO-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,00441627,APO-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11627,Marketed,2017-10-02,00441635,APO-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,00441635,APO-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94490,Marketed,2017-08-28,02457865,JAMP-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02457865,JAMP-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94491,Marketed,2017-08-28,02457873,JAMP-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02457873,JAMP-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94492,Marketed,2017-08-28,02457881,JAMP-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02457881,JAMP-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95730,Marketed,2018-04-13,02468778,MINT-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02468778,MINT-HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95731,Marketed,2018-02-16,02468786,MINT-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02468786,MINT-HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95732,Marketed,2018-02-16,02468794,MINT-HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02468794,MINT-HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100550,Marketed,2023-07-26,02516160,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP",1.0,C02DB02,Hydralazine,Solution,Intravenous,02516160,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP (hydralazine hydrochloride 20 mg per 1 mL solution for injection vial) AURO PHARMA INC",Active,9012384,hydralazine hydrochloride 20 mg per 1 mL solution for injection vial,8000851,hydralazine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102648,Marketed,2024-10-07,02537699,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP",1.0,C02DB02,Hydralazine,Solution,Intravenous,02537699,"HYDRALAZINE HYDROCHLORIDE INJECTION, USP (hydralazine hydrochloride 20 mg per 1 mL solution for injection vial) EUGIA PHARMA INC.",Active,9012384,hydralazine hydrochloride 20 mg per 1 mL solution for injection vial,8000851,hydralazine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102854,Marketed,2024-02-29,02539802,HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02539802,HYDRALAZINE (hydralazine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9002309,hydralazine hydrochloride 10 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102855,Marketed,2024-02-29,02539810,HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02539810,HYDRALAZINE (hydralazine hydrochloride 25 mg oral tablet) SANIS HEALTH INC,Active,9002373,hydralazine hydrochloride 25 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102856,Marketed,2024-02-29,02539829,HYDRALAZINE,1.0,C02DB02,Hydralazine,Tablet,Oral,02539829,HYDRALAZINE (hydralazine hydrochloride 50 mg oral tablet) SANIS HEALTH INC,Active,9002374,hydralazine hydrochloride 50 mg oral tablet,8000851,hydralazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
778,Marketed,2011-02-17,00021474,TEVA-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,00021474,TEVA-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
812,Marketed,2011-02-17,00021482,TEVA-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,00021482,TEVA-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4280,Marketed,2020-10-15,00312800,APO-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,00312800,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) APOTEX INC,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4281,Marketed,2020-10-15,00326844,APO-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,00326844,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) APOTEX INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71631,Marketed,2014-05-26,02247386,PMS-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02247386,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) PHARMASCIENCE INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71632,Marketed,2013-10-18,02247387,PMS-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02247387,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 50 mg oral tablet) PHARMASCIENCE INC,Active,9000044,hydrochlorothiazide 50 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75953,Marketed,2013-11-20,02274086,PMS-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02274086,PMS-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) PHARMASCIENCE INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81335,Marketed,2020-10-19,02327856,APO-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02327856,APO-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) APOTEX INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84556,Marketed,2020-05-01,02360594,HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02360594,HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) SANIS HEALTH INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91057,Marketed,2018-08-30,02425947,MINT-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02425947,MINT-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 12.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001134,hydrochlorothiazide 12.5 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91079,Marketed,2018-08-30,02426196,MINT-HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02426196,MINT-HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97711,Marketed,2019-08-14,02486962,HYDROCHLOROTHIAZIDE,1.0,C03AA03,Hydrochlorothiazide,Tablet,Oral,02486962,HYDROCHLOROTHIAZIDE (hydrochlorothiazide 25 mg oral tablet) PRO DOC LIMITEE,Active,9000043,hydrochlorothiazide 25 mg oral tablet,8000031,hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4523,Marketed,2011-05-07,00532657,TEVA-TRIAMTERENE/HCTZ,2.0,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00532657,TEVA-TRIAMTERENE/HCTZ (hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000172,hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet,8000092,hydrochlorothiazide and triamterene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5672,Marketed,1984-12-31,00441775,APO TRIAZIDE,2.0,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00441775,APO TRIAZIDE (hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet) APOTEX INC,Active,9000172,hydrochlorothiazide 25 mg and triamterene 50 mg oral tablet,8000092,hydrochlorothiazide and triamterene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5858,Marketed,2011-06-29,00613231,TEVA-SPIRONOLACTONE/HCTZ,2.0,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00613231,TEVA-SPIRONOLACTONE/HCTZ (hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet) TEVA CANADA LIMITED,Active,9009869,hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet,8000802,hydrochlorothiazide and spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
6892,Marketed,2011-06-29,00657182,TEVA-SPIRONOLACTONE/HCTZ,2.0,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00657182,TEVA-SPIRONOLACTONE/HCTZ (hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet) TEVA CANADA LIMITED,Active,9009877,hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet,8000802,hydrochlorothiazide and spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10494,Marketed,2019-10-30,00784400,AA-AMILZIDE,2.0,C03EA01,Hydrochlorothiazide and potassium-sparing agents,Tablet,Oral,00784400,AA-AMILZIDE (amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet) AA PHARMA INC,Active,9007114,amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet,8000844,amiloride and hydrochlorothiazide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80973,Marketed,2016-07-08,02324253,PDP-HYDROCODONE,1.0,R05DA03,Hydrocodone,Syrup,Oral,02324253,PDP-HYDROCODONE (hydrocodone bitartrate 5 mg per 5 mL syrup) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9009884,hydrocodone bitartrate 5 mg per 5 mL syrup,8000777,hydrocodone,26643006,Oral,739009002,Syrup,,,,1.0,
432,Marketed,2005-06-21,00030910,CORTEF,1.0,H02AB09,Hydrocortisone,Tablet,Oral,00030910,CORTEF (hydrocortisone 10 mg oral tablet) PFIZER CANADA ULC,Active,9000011,hydrocortisone 10 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
433,Marketed,2005-05-27,00030929,CORTEF,1.0,H02AB09,Hydrocortisone,Tablet,Oral,00030929,CORTEF (hydrocortisone 20 mg oral tablet) PFIZER CANADA ULC,Active,9000012,hydrocortisone 20 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2219,Marketed,2009-02-03,00030600,SOLU-CORTEF,1.0,H02AB09,Hydrocortisone,Powder for solution,"Intravenous,Intramuscular",00030600,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 100 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012632,hydrocortisone (hydrocortisone sodium succinate) 100 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
2220,Marketed,2009-02-03,00030619,SOLU-CORTEF,1.0,H02AB09,Hydrocortisone,Powder for solution,"Intravenous,Intramuscular",00030619,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012633,hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
2221,Marketed,2009-02-03,00030627,SOLU-CORTEF,1.0,H02AB09,Hydrocortisone,Powder for solution,"Intravenous,Intramuscular",00030627,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012634,hydrocortisone (hydrocortisone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
2222,Marketed,2009-02-03,00030635,SOLU-CORTEF,1.0,H02AB09,Hydrocortisone,Powder for solution,"Intravenous,Intramuscular",00030635,SOLU-CORTEF (hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9012631,hydrocortisone (hydrocortisone sodium succinate) 1 g powder for solution for injection with diluent solution per vial,8000008,hydrocortisone,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
4389,Marketed,2017-03-03,00505773,ANUSOL-HC OINTMENT,2.0,C05AA01,Hydrocortisone,Ointment,Rectal,00505773,ANUSOL-HC OINTMENT (hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment) CHURCH & DWIGHT CANADA CORP,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,
4630,Marketed,2017-03-03,00476285,ANUSOL-HC SUPPOSITORIES,2.0,C05AA01,Hydrocortisone,Suppository,Rectal,00476285,ANUSOL-HC SUPPOSITORIES (hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9001737,hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
10052,Marketed,1989-12-31,00770957,PRAMOX HC CREAM,2.0,D07XA01,Hydrocortisone,Cream,Topical,00770957,PRAMOX HC CREAM (hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % cutaneous cream) DERMTEK PHARMA INC,Active,9013963,hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % cutaneous cream,8001797,hydrocortisone and pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
15948,Marketed,1994-12-31,01954210,PRAMOX HC LOTION,2.0,D07XA01,Hydrocortisone,Lotion,Topical,01954210,PRAMOX HC LOTION (hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % lotion) DERMTEK PHARMA INC,Active,9002681,hydrocortisone (hydrocortisone acetate) 1 % and pramoxine hydrochloride 1 % lotion,8001797,hydrocortisone and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,
18240,Marketed,1995-12-31,02128446,ANODAN-HC OINTMENT,2.0,C05AA01,Hydrocortisone,Ointment,"Topical,Rectal",02128446,ANODAN-HC OINTMENT (hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,
37454,Marketed,2018-01-22,02226383,TEVA-PROCTOSONE,4.0,C05AA01,Hydrocortisone,Ointment,Rectal,02226383,TEVA-PROCTOSONE (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) TEVA CANADA LIMITED,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,
55837,Marketed,1998-01-23,02234466,PROCTODAN-HC OINTMENT,3.0,C05AA01,Hydrocortisone,Ointment,"Rectal,Topical",02234466,PROCTODAN-HC OINTMENT (hydrocortisone acetate 0.5 % and pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9001910,hydrocortisone acetate 0.5 % and pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment,8001798,hydrocortisone and pramoxine and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,
59873,Marketed,1998-08-13,02236399,ANODAN-HC 10MG SUPPOSITORIES,2.0,C05AA01,Hydrocortisone,Suppository,Rectal,02236399,ANODAN-HC 10MG SUPPOSITORIES (hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository) ODAN LABORATORIES LTD,Active,9001737,hydrocortisone acetate 10 mg and zinc sulfate 10 mg suppository,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
64442,Marketed,2000-03-23,02240851,PROCTODAN-HC SUPPOSITORIES,3.0,C05AA01,Hydrocortisone,Suppository,Rectal,02240851,PROCTODAN-HC SUPPOSITORIES (hydrocortisone acetate 10 mg and pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository) ODAN LABORATORIES LTD,Active,9001809,hydrocortisone acetate 10 mg and pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository,8001798,hydrocortisone and pramoxine and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
66824,Marketed,2004-03-30,02242984,HYDROVAL CREAM 0.2%,1.0,D07AA02,Hydrocortisone,Cream,Topical,02242984,"HYDROVAL CREAM 0.2% (hydrocortisone valerate 0.2 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000926,hydrocortisone valerate 0.2 % cutaneous cream,8000008,hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
66825,Marketed,2004-04-06,02242985,HYDROVAL OINTMENT 0.2%,1.0,D07AA02,Hydrocortisone,Ointment,Topical,02242985,"HYDROVAL OINTMENT 0.2% (hydrocortisone valerate 0.2 % cutaneous ointment) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000927,hydrocortisone valerate 0.2 % cutaneous ointment,8000008,hydrocortisone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
71565,Marketed,2003-08-06,02247322,PROCTOL OINTMENT,4.0,C05AA01,Hydrocortisone,Ointment,Rectal,02247322,PROCTOL OINTMENT (dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment) ODAN LABORATORIES LTD,Active,9006369,dibucaine hydrochloride 0.5 % and esculin 1 % and framycetin sulfate 1 % and hydrocortisone 0.5 % rectal ointment,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385184008,Rectal ointment,,,,,
72190,Marketed,2004-03-15,02247882,PROCTOL SUPPOSITORIES,4.0,C05AA01,Hydrocortisone,Suppository,Rectal,02247882,PROCTOL SUPPOSITORIES (dibucaine hydrochloride 5 mg and esculin 10 mg and framycetin sulfate 10 mg and hydrocortisone 5 mg suppository) ODAN LABORATORIES LTD,Active,9003053,dibucaine hydrochloride 5 mg and esculin 10 mg and framycetin sulfate 10 mg and hydrocortisone 5 mg suppository,8000898,dibucaine and esculin and framycetin and hydrocortisone,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
87281,Marketed,2012-07-23,02387239,JAMPZINC-HC,2.0,C05AA01,Hydrocortisone,Ointment,"Rectal,Topical",02387239,JAMPZINC-HC (hydrocortisone acetate 0.5 % and zinc sulfate monohydrate 0.5 % rectal ointment) JAMP PHARMA CORPORATION,Active,9001911,hydrocortisone acetate 0.5 % and zinc sulfate 0.5 % rectal ointment,8000812,hydrocortisone and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,
95822,Marketed,2019-06-04,02469421,SANDOZ HYDROCORTISONE,1.0,D07AA02,Hydrocortisone,Cream,Topical,02469421,SANDOZ HYDROCORTISONE (hydrocortisone 2.5 % cutaneous cream) SANDOZ CANADA INCORPORATED,Active,9000187,hydrocortisone 2.5 % cutaneous cream,8000008,hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
101351,Marketed,2022-11-22,02524465,AURO-HYDROCORTISONE,1.0,H02AB09,Hydrocortisone,Tablet,Oral,02524465,AURO-HYDROCORTISONE (hydrocortisone 10 mg oral tablet) AURO PHARMA INC,Active,9000011,hydrocortisone 10 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101352,Marketed,2022-11-22,02524473,AURO-HYDROCORTISONE,1.0,H02AB09,Hydrocortisone,Tablet,Oral,02524473,AURO-HYDROCORTISONE (hydrocortisone 20 mg oral tablet) AURO PHARMA INC,Active,9000012,hydrocortisone 20 mg oral tablet,8000008,hydrocortisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
810,Marketed,2025-09-24,00074500,VIOFORM HYDROCORTISONE,2.0,D07CA01,Hydrocortisone and antibiotics,Cream,Topical,00074500,VIOFORM HYDROCORTISONE (clioquinol 3 % and hydrocortisone 1 % cutaneous cream) KNIGHT THERAPEUTICS INC.,Active,9001554,clioquinol 3 % and hydrocortisone 1 % cutaneous cream,8000798,clioquinol and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
62005,Marketed,1998-11-11,02238578,FUCIDIN H,2.0,D07CA01,Hydrocortisone and antibiotics,Cream,Topical,02238578,FUCIDIN H (fusidic acid 2 % and hydrocortisone acetate 1 % cutaneous cream) LEO PHARMA INC,Active,9003329,fusidic acid 2 % and hydrocortisone acetate 1 % cutaneous cream,8000908,fusidic acid and hydrocortisone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
5939,Marketed,2009-01-21,00125083,DILAUDID,1.0,N02AA03,Hydromorphone,Tablet,Oral,00125083,DILAUDID (hydromorphone hydrochloride 2 mg oral tablet) PURDUE PHARMA,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
5940,Marketed,2008-12-29,00125121,DILAUDID,1.0,N02AA03,Hydromorphone,Tablet,Oral,00125121,DILAUDID (hydromorphone hydrochloride 4 mg oral tablet) PURDUE PHARMA,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
6889,Marketed,2008-12-12,00705438,DILAUDID,1.0,N02AA03,Hydromorphone,Tablet,Oral,00705438,DILAUDID (hydromorphone hydrochloride 1 mg oral tablet) PURDUE PHARMA,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
9509,Marketed,2008-12-29,00786543,DILAUDID,1.0,N02AA03,Hydromorphone,Tablet,Oral,00786543,DILAUDID (hydromorphone hydrochloride 8 mg oral tablet) PURDUE PHARMA,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
11363,Marketed,1991-12-31,00885428,PMS-HYDROMORPHONE TAB 8MG,1.0,N02AA03,Hydromorphone,Tablet,Oral,00885428,PMS-HYDROMORPHONE TAB 8MG (hydromorphone hydrochloride 8 mg oral tablet) PHARMASCIENCE INC,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
11413,Marketed,1991-12-31,00885444,PMS-HYDROMORPHONE TAB 1MG,1.0,N02AA03,Hydromorphone,Tablet,Oral,00885444,PMS-HYDROMORPHONE TAB 1MG (hydromorphone hydrochloride 1 mg oral tablet) PHARMASCIENCE INC,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
11425,Marketed,1991-12-31,00885401,PMS-HYDROMORPHONE TAB 4MG,1.0,N02AA03,Hydromorphone,Tablet,Oral,00885401,PMS-HYDROMORPHONE TAB 4MG (hydromorphone hydrochloride 4 mg oral tablet) PHARMASCIENCE INC,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
11428,Marketed,1991-12-31,00885436,PMS-HYDROMORPHONE TAB 2MG,1.0,N02AA03,Hydromorphone,Tablet,Oral,00885436,PMS-HYDROMORPHONE TAB 2MG (hydromorphone hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
11870,Marketed,1991-12-31,01916386,PMS HYDROMORPHONE SIROP 1MG/ML,1.0,N02AA03,Hydromorphone,Syrup,Oral,01916386,PMS HYDROMORPHONE SIROP 1MG/ML (hydromorphone hydrochloride 1 mg per mL syrup) PHARMASCIENCE INC,Active,9000384,hydromorphone hydrochloride 1 mg per mL syrup,8000106,hydromorphone,26643006,Oral,739009002,Syrup,,,,1.0,
18315,Marketed,2005-10-08,02145901,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,1.0,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",02145901,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
18323,Marketed,2005-08-26,02145928,HYDROMORPHONE HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700290,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000579,hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18323,Marketed,2005-08-26,02145928,HYDROMORPHONE HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700291,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18323,Marketed,2005-08-26,02145928,HYDROMORPHONE HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700292,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18323,Marketed,2005-08-26,02145928,HYDROMORPHONE HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700293,HYDROMORPHONE HP 10 (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18324,Marketed,2005-08-26,02146126,HYDROMORPHONE HP 50,1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700297,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000582,hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18324,Marketed,2005-08-26,02146126,HYDROMORPHONE HP 50,1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700298,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000584,hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18324,Marketed,2005-08-26,02146126,HYDROMORPHONE HP 50,1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700299,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18324,Marketed,2005-08-26,02146126,HYDROMORPHONE HP 50,1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77700300,HYDROMORPHONE HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18325,Marketed,2005-08-26,02145936,HYDROMORPHONE HP 20,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700294,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9012635,hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18325,Marketed,2005-08-26,02145936,HYDROMORPHONE HP 20,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700295,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006243,hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18325,Marketed,2005-08-26,02145936,HYDROMORPHONE HP 20,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intravenous,Intramuscular",77700296,HYDROMORPHONE HP 20 (hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006244,hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
18556,Marketed,1995-12-31,02125323,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125323,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG (hydromorphone hydrochloride 3 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000583,hydromorphone hydrochloride 3 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
18558,Marketed,1995-12-31,02125331,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125331,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG (hydromorphone hydrochloride 6 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000586,hydromorphone hydrochloride 6 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
20171,Marketed,1996-12-31,02125366,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125366,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG (hydromorphone hydrochloride 12 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000679,hydromorphone hydrochloride 12 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
20172,Marketed,1996-12-31,02125382,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125382,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG (hydromorphone hydrochloride 24 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000680,hydromorphone hydrochloride 24 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
43838,Marketed,1998-02-16,02125390,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02125390,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG (hydromorphone hydrochloride 30 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000781,hydromorphone hydrochloride 30 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
67480,Marketed,2001-07-03,02243562,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02243562,HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG (hydromorphone hydrochloride 18 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9000948,hydromorphone hydrochloride 18 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
84452,Marketed,2011-04-14,02359502,HYDROMORPH CONTIN,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02359502,HYDROMORPH CONTIN (hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9001340,hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
84453,Marketed,2011-04-14,02359510,HYDROMORPH CONTIN,1.0,N02AA03,Hydromorphone,Capsule (sustained-release),Oral,02359510,HYDROMORPH CONTIN (hydromorphone hydrochloride 9 mg prolonged-release oral capsule) PURDUE PHARMA,Active,9001341,hydromorphone hydrochloride 9 mg prolonged-release oral capsule,8000106,hydromorphone,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
84905,Marketed,2012-12-18,02364115,APO-HYDROMORPHONE,1.0,N02AA03,Hydromorphone,Tablet,Oral,02364115,APO-HYDROMORPHONE (hydromorphone hydrochloride 1 mg oral tablet) APOTEX INC,Active,9000253,hydromorphone hydrochloride 1 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
84906,Marketed,2012-12-18,02364123,APO-HYDROMORPHONE,1.0,N02AA03,Hydromorphone,Tablet,Oral,02364123,APO-HYDROMORPHONE (hydromorphone hydrochloride 2 mg oral tablet) APOTEX INC,Active,9000202,hydromorphone hydrochloride 2 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
84907,Marketed,2012-12-18,02364131,APO-HYDROMORPHONE,1.0,N02AA03,Hydromorphone,Tablet,Oral,02364131,APO-HYDROMORPHONE (hydromorphone hydrochloride 4 mg oral tablet) APOTEX INC,Active,9000204,hydromorphone hydrochloride 4 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
84908,Marketed,2012-12-18,02364158,APO-HYDROMORPHONE,1.0,N02AA03,Hydromorphone,Tablet,Oral,02364158,APO-HYDROMORPHONE (hydromorphone hydrochloride 8 mg oral tablet) APOTEX INC,Active,9000328,hydromorphone hydrochloride 8 mg oral tablet,8000106,hydromorphone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
94803,Marketed,2017-02-06,02460602,HYDROMORPHONE HYDROCHLORIDE INJECTION,1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",02460602,HYDROMORPHONE HYDROCHLORIDE INJECTION (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
94804,Marketed,2017-02-06,02460610,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",77700301,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule) STERIMAX INC,Active,9001473,hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
94804,Marketed,2017-02-06,02460610,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",77700302,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 (hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9001474,hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
95689,Marketed,2018-06-20,02468468,HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",02468468,HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE (hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9000966,hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
95820,Marketed,2018-08-21,02469413,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",77700957,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial) STERIMAX INC,Active,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
95820,Marketed,2018-08-21,02469413,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50,1.0,N02AA03,Hydromorphone,Solution,"Subcutaneous,Intramuscular,Intravenous",77700958,HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 (hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
97577,Marketed,2019-09-18,02485532,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,1.0,N02AA03,Hydromorphone,Solution,Intravenous,02485532,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag) STERINOVA INC.,Active,9014172,hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,
97578,Marketed,2019-08-28,02485540,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,1.0,N02AA03,Hydromorphone,Solution,Intravenous,02485540,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014173,hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,
98169,Marketed,2020-11-10,02491680,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77701025,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98169,Marketed,2020-11-10,02491680,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77701026,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98169,Marketed,2020-11-10,02491680,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Subcutaneous,Intramuscular",77701027,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98170,Marketed,2020-11-10,02491699,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",1.0,N02AA03,Hydromorphone,Solution,"Intravenous,Intramuscular,Subcutaneous",02491699,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014412,hydromorphone hydrochloride 2 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
100362,Marketed,2022-08-24,02514435,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,1.0,N02AA03,Hydromorphone,Solution,"Intramuscular,Subcutaneous,Intravenous",02514435,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 1 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014761,hydromorphone hydrochloride 1 mg per 1 mL solution for injection vial,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
101889,Marketed,2023-02-22,02529645,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,1.0,N02AA03,Hydromorphone,Solution,"Intramuscular,Intravenous,Subcutaneous",02529645,HYDROMORPHONE HYDROCHLORIDE INJECTION USP (hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,8000106,hydromorphone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
98171,Marketed,2022-09-29,02491702,ERFA HYDROQUINONE,1.0,D11AX11,Hydroquinone,Gel,Topical,02491702,ERFA HYDROQUINONE (hydroquinone 4 % cutaneous gel) SEARCHLIGHT PHARMA INC,Active,9003775,hydroquinone 4 % cutaneous gel,8001661,hydroquinone,448598008,Cutaneous,385100002,Gel,,,,,
86078,Marketed,2016-07-22,02375370,CYANOKIT,1.0,V03AB33,Hydroxocobalamin,Powder for solution,Intravenous,02375370,CYANOKIT (hydroxocobalamin 5 g per vial powder for solution for injection) SERB S.A.,Active,9005116,hydroxocobalamin 5 g per vial powder for solution for injection,8001799,hydroxocobalamin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
75367,Marketed,2018-01-03,02268272,XYREM,1.0,N07XX04,Hydroxybutyric acid,Solution,Oral,02268272,XYREM (sodium oxybate 500 mg per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9004321,sodium oxybate 500 mg per mL oral solution,8002542,sodium oxybate,26643006,Oral,385023001,Oral solution,,,,,
102698,Marketed,2023-10-04,02538237,XYWAV,4.0,N07XX04,Hydroxybutyric acid,Solution,Oral,02538237,XYWAV (calcium oxybate 0.234 g per mL and magnesium oxybate 0.096 g per mL and potassium oxybate 0.13 g per mL and sodium oxybate 0.04 g per mL oral solution) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9015164,calcium oxybate 0.234 g per mL and magnesium oxybate 0.096 g per mL and potassium oxybate 0.13 g per mL and sodium oxybate 0.04 g per mL oral solution,8002536,calcium oxybate and magnesium oxybate and potassium oxybate and sodium oxybate,26643006,Oral,385023001,Oral solution,,,,,
3453,Marketed,2022-11-18,00465283,HYDREA,1.0,L01XX05,Hydroxycarbamide,Capsule,Oral,00465283,HYDREA (hydroxyurea 500 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
66754,Marketed,2010-01-29,02242920,MYLAN-HYDROXYUREA,1.0,L01XX05,Hydroxycarbamide,Capsule,Oral,02242920,MYLAN-HYDROXYUREA (hydroxyurea 500 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
72247,Marketed,2017-12-12,02247937,APO-HYDROXYUREA,1.0,L01XX05,Hydroxycarbamide,Capsule,Oral,02247937,APO-HYDROXYUREA (hydroxyurea 500 mg oral capsule) APOTEX INC,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101945,Marketed,2023-05-01,02530260,RIVA-HYDROXYUREA,1.0,L01XX05,Hydroxycarbamide,Capsule,Oral,02530260,RIVA-HYDROXYUREA (hydroxyurea 500 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001850,hydroxyurea 500 mg oral capsule,8001662,hydroxyurea,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
14735,Marketed,2007-09-26,02017709,PLAQUENIL,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02017709,PLAQUENIL (hydroxychloroquine sulfate 200 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70886,Marketed,2002-12-13,02246691,APO-HYDROXYQUINE,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02246691,APO-HYDROXYQUINE (hydroxychloroquine sulfate 200 mg oral tablet) APOTEX INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90966,Marketed,2014-06-10,02424991,MINT-HYDROXYCHLOROQUINE,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02424991,MINT-HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98143,Marketed,2020-02-06,02491427,JAMP HYDROXYCHLOROQUINE SULFATE,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02491427,JAMP HYDROXYCHLOROQUINE SULFATE (hydroxychloroquine sulfate 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100105,Marketed,2021-09-14,02511886,NRA-HYDROXYCHLOROQUINE,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02511886,NRA-HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) NORA PHARMA INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100862,Marketed,2022-04-18,02519348,HYDROXYCHLOROQUINE,1.0,P01BA02,Hydroxychloroquine,Tablet,Oral,02519348,HYDROXYCHLOROQUINE (hydroxychloroquine sulfate 200 mg oral tablet) SANIS HEALTH INC,Active,9000018,hydroxychloroquine sulfate 200 mg oral tablet,8000012,hydroxychloroquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76364,Marketed,2015-04-18,02278057,VOLUVEN,1.0,B05AA07,Hydroxyethylstarch,Solution,Intravenous,,,,,,,,,,,,,,,,
84242,Marketed,2015-11-26,02357291,VOLULYTE,1.0,B05AA07,Hydroxyethylstarch,Solution,Intravenous,,,,,,,,,,,,,,,,
316,Marketed,2022-10-14,00024694,ATARAX,1.0,N05BB01,Hydroxyzine,Syrup,Oral,00024694,ATARAX (hydroxyzine hydrochloride 10 mg per 5 mL syrup) SEARCHLIGHT PHARMA INC,Active,9000014,hydroxyzine hydrochloride 10 mg per 5 mL syrup,8000009,hydroxyzine,26643006,Oral,739009002,Syrup,,,,,
7391,Marketed,2019-01-24,00646016,HYDROXYZINE,1.0,N05BB01,Hydroxyzine,Capsule,Oral,00646016,HYDROXYZINE (hydroxyzine hydrochloride 50 mg oral capsule) AA PHARMA INC,Active,9000256,hydroxyzine hydrochloride 50 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
7392,Marketed,2019-03-28,00646024,HYDROXYZINE,1.0,N05BB01,Hydroxyzine,Capsule,Oral,00646024,HYDROXYZINE (hydroxyzine hydrochloride 25 mg oral capsule) AA PHARMA INC,Active,9000255,hydroxyzine hydrochloride 25 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
7393,Marketed,2019-02-14,00646059,HYDROXYZINE,1.0,N05BB01,Hydroxyzine,Capsule,Oral,00646059,HYDROXYZINE (hydroxyzine hydrochloride 10 mg oral capsule) AA PHARMA INC,Active,9000254,hydroxyzine hydrochloride 10 mg oral capsule,8000009,hydroxyzine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
8118,Marketed,2005-09-21,00742813,HYDROXYZINE HYDROCHLORIDE INJECTION USP,1.0,N05BB01,Hydroxyzine,Liquid,Intramuscular,00742813,HYDROXYZINE HYDROCHLORIDE INJECTION USP (hydroxyzine hydrochloride 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000274,hydroxyzine hydrochloride 50 mg per 1 mL solution for injection vial,8000009,hydroxyzine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
74647,Marketed,2021-04-12,02261057,"BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM",5.0,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
74648,Marketed,2021-05-17,02261065,"BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM",5.0,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
74649,Marketed,2021-04-08,02261073,"BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM",5.0,B05DB,Hypertonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
91874,Marketed,2014-11-19,02434407,IMBRUVICA,1.0,L01EL01,Ibrutinib,Capsule,Oral,02434407,IMBRUVICA (ibrutinib 140 mg oral capsule) JANSSEN INC,Active,9005610,ibrutinib 140 mg oral capsule,8001800,ibrutinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102892,Marketed,2023-11-13,02540215,IMBRUVICA,1.0,L01EL01,Ibrutinib,Suspension,Oral,02540215,IMBRUVICA (ibrutinib 70 mg per mL oral suspension) JANSSEN INC,Active,9014943,ibrutinib 70 mg per mL oral suspension,8001800,ibrutinib,26643006,Oral,385024007,Oral suspension,,,,,
5432,Marketed,2020-11-05,00506052,APO-IBUPROFEN,1.0,M01AE01,Ibuprofen,Tablet,Oral,00506052,APO-IBUPROFEN (ibuprofen 400 mg oral tablet) APOTEX INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5433,Marketed,2021-01-06,00441651,APO-IBUPROFEN,1.0,M01AE01,Ibuprofen,Tablet,Oral,00441651,APO-IBUPROFEN (ibuprofen 300 mg oral tablet) APOTEX INC,Active,9000189,ibuprofen 300 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5917,Marketed,2020-12-28,00585114,APO-IBUPROFEN TAB 600MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,00585114,APO-IBUPROFEN TAB 600MG (ibuprofen 600 mg oral tablet) APOTEX INC,Active,9000207,ibuprofen 600 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10294,Marketed,2020-11-05,00441643,APO-IBUPROFEN,1.0,M01AE01,Ibuprofen,Tablet,Oral,00441643,APO-IBUPROFEN (ibuprofen 200 mg oral tablet) APOTEX INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13452,Marketed,2025-05-22,01933531,ADVIL CAPLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,01933531,ADVIL CAPLETS (ibuprofen 200 mg oral tablet) HALEON CANADA ULC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13625,Marketed,2025-05-22,01933558,ADVIL TABLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,01933558,ADVIL TABLETS (ibuprofen 200 mg oral tablet) HALEON CANADA ULC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19585,Marketed,2013-02-15,02186934,MOTRIN 200MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02186934,MOTRIN 200MG (ibuprofen 200 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51742,Marketed,2025-08-21,02232297,CHILDREN'S ADVIL,1.0,M01AE01,Ibuprofen,Suspension,Oral,02232297,CHILDREN'S ADVIL (ibuprofen 100 mg per 5 mL oral suspension) HALEON CANADA ULC,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,
62054,Marketed,2019-10-18,02238626,INFANTS' MOTRIN,1.0,M01AE01,Ibuprofen,Drops,Oral,02238626,INFANTS' MOTRIN (ibuprofen 40 mg per mL oral drops) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9012636,ibuprofen 40 mg per mL oral drops,8000043,ibuprofen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
65432,Marketed,2025-04-28,02241769,ADVIL LIQUI-GELS,1.0,M01AE01,Ibuprofen,Capsule,Oral,02241769,ADVIL LIQUI-GELS (ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
66076,Marketed,2019-10-18,02242365,CHILDREN'S MOTRIN,1.0,M01AE01,Ibuprofen,Suspension,Oral,02242365,CHILDREN'S MOTRIN (ibuprofen 100 mg per 5 mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,
66270,Marketed,2025-08-21,02242522,ADVIL PEDIATRIC DROPS,1.0,M01AE01,Ibuprofen,Drops,Oral,02242522,ADVIL PEDIATRIC DROPS (ibuprofen 40 mg per mL oral drops) HALEON CANADA ULC,Active,9012636,ibuprofen 40 mg per mL oral drops,8000043,ibuprofen,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
66413,Marketed,2013-02-15,02242632,MOTRIN 300MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02242632,MOTRIN 300MG (ibuprofen 300 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000189,ibuprofen 300 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66438,Marketed,2013-02-15,02242658,MOTRIN 400MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02242658,MOTRIN 400MG (ibuprofen 400 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68562,Marketed,2025-05-22,02244577,ADVIL EXTRA STRENGTH CAPLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,02244577,ADVIL EXTRA STRENGTH CAPLETS (ibuprofen 400 mg oral tablet) HALEON CANADA ULC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70575,Marketed,2025-08-21,02246403,JUNIOR STRENGTH ADVIL,1.0,M01AE01,Ibuprofen,Tablet (chewable),Oral,02246403,JUNIOR STRENGTH ADVIL (ibuprofen 100 mg chewable tablet) HALEON CANADA ULC,Active,9001018,ibuprofen 100 mg chewable tablet,8000043,ibuprofen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
72567,Marketed,2025-04-28,02248231,ADVIL EXTRA STRENGTH LIQUI-GELS,1.0,M01AE01,Ibuprofen,Capsule,Oral,02248231,ADVIL EXTRA STRENGTH LIQUI-GELS (ibuprofen 400 mg oral capsule) HALEON CANADA ULC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74314,Marketed,2022-12-16,02257912,IBUPROFEN 200 MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02257912,IBUPROFEN 200 MG (ibuprofen 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75835,Marketed,2021-12-01,02272849,IBUPROFEN TABLETS 200 MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02272849,IBUPROFEN TABLETS 200 MG (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75836,Marketed,2006-04-07,02272857,IBUPROFEN CAPLETS 200 MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02272857,IBUPROFEN CAPLETS 200 MG (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76585,Marketed,2007-08-30,02280175,CHILDREN'S IBUPROFEN SUSPENSION,1.0,M01AE01,Ibuprofen,Suspension,Oral,02280175,CHILDREN'S IBUPROFEN SUSPENSION (ibuprofen 100 mg per 5 mL oral suspension) PERRIGO INTERNATIONAL,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,
78292,Marketed,2020-05-19,02297582,MOTRIN LIQUID GELS 200MG,1.0,M01AE01,Ibuprofen,Capsule,Oral,02297582,MOTRIN LIQUID GELS 200MG (ibuprofen 200 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80029,Marketed,2020-10-16,02314754,IBUPROFEN TABLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,02314754,IBUPROFEN TABLETS (ibuprofen 200 mg oral tablet) PHARMASCIENCE INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80030,Marketed,2020-10-16,02314762,IBUPROFEN CAPLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,02314762,IBUPROFEN CAPLETS (ibuprofen 200 mg oral tablet) PHARMASCIENCE INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80031,Marketed,2012-01-04,02314770,EXTRA STRENGTH IBUPROFEN,1.0,M01AE01,Ibuprofen,Tablet,Oral,02314770,EXTRA STRENGTH IBUPROFEN (ibuprofen 400 mg oral tablet) PHARMASCIENCE INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80286,Marketed,2022-12-16,02317338,IBUPROFEN 400 MG,1.0,M01AE01,Ibuprofen,Tablet,Oral,02317338,IBUPROFEN 400 MG (ibuprofen 400 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81395,Marketed,2025-08-21,02328429,JUNIOR STRENGTH ADVIL FEVER FROM COLDS OR FLU,1.0,M01AE01,Ibuprofen,Tablet (chewable),Oral,02328429,JUNIOR STRENGTH ADVIL FEVER FROM COLDS OR FLU (ibuprofen 100 mg chewable tablet) HALEON CANADA ULC,Active,9001018,ibuprofen 100 mg chewable tablet,8000043,ibuprofen,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
81396,Marketed,2025-08-21,02328437,CHILDREN'S ADVIL FEVER FROM COLDS OR FLU,1.0,M01AE01,Ibuprofen,Suspension,Oral,02328437,CHILDREN'S ADVIL FEVER FROM COLDS OR FLU (ibuprofen 100 mg per 5 mL oral suspension) HALEON CANADA ULC,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,
84091,Marketed,2025-05-22,02355701,ADVIL MUSCLE AND JOINT,1.0,M01AE01,Ibuprofen,Tablet,Oral,02355701,ADVIL MUSCLE AND JOINT (ibuprofen 400 mg oral tablet) HALEON CANADA ULC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84240,Marketed,2011-03-31,02357275,IBUPROFEN LIQUID CAPSULES,1.0,M01AE01,Ibuprofen,Capsule,Oral,02357275,IBUPROFEN LIQUID CAPSULES (ibuprofen 200 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84241,Marketed,2011-06-10,02357283,EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES,1.0,M01AE01,Ibuprofen,Capsule,Oral,02357283,EXTRA STRENGTH IBUPROFEN LIQUID CAPSULES (ibuprofen 400 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85290,Marketed,2017-01-26,02368080,IBUPROFEN CAPLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,02368080,IBUPROFEN CAPLETS (ibuprofen 200 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85291,Marketed,2011-08-05,02368099,IBUPROFEN EXTRA STRENGTH CAPLETS,1.0,M01AE01,Ibuprofen,Tablet,Oral,02368099,IBUPROFEN EXTRA STRENGTH CAPLETS (ibuprofen 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85942,Marketed,2016-11-10,02374226,MUSCLE & JOINT,1.0,M01AE01,Ibuprofen,Tablet,Oral,02374226,MUSCLE & JOINT (ibuprofen 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86208,Marketed,2016-09-15,02376598,IBUPROFEN LIQUID GEL CAPSULES,1.0,M01AE01,Ibuprofen,Capsule,Oral,02376598,IBUPROFEN LIQUID GEL CAPSULES (ibuprofen 200 mg oral capsule) APOTEX INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86209,Marketed,2012-07-15,02376601,EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES,1.0,M01AE01,Ibuprofen,Capsule,Oral,02376601,EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES (ibuprofen 400 mg oral capsule) APOTEX INC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86271,Marketed,2012-09-12,02377101,IBUPROFEN MUSCLE AND JOINT,1.0,M01AE01,Ibuprofen,Tablet,Oral,02377101,IBUPROFEN MUSCLE AND JOINT (ibuprofen 400 mg oral tablet) PHARMASCIENCE INC,Active,9000190,ibuprofen 400 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86413,Marketed,2020-05-19,02378310,MOTRIN LIQUID GELS 400 MG,1.0,M01AE01,Ibuprofen,Capsule,Oral,02378310,MOTRIN LIQUID GELS 400 MG (ibuprofen 400 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90021,Marketed,2025-04-28,02415623,ADVIL ARTHRITIS PAIN,1.0,M01AE01,Ibuprofen,Capsule,Oral,02415623,ADVIL ARTHRITIS PAIN (ibuprofen 400 mg oral capsule) HALEON CANADA ULC,Active,9001080,ibuprofen 400 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92408,Marketed,2021-02-17,02439689,IBUPROFEN,1.0,M01AE01,Ibuprofen,Tablet,Oral,02439689,IBUPROFEN (ibuprofen 200 mg oral tablet) APOTEX INC,Active,9000059,ibuprofen 200 mg oral tablet,8000043,ibuprofen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92825,Marketed,2025-05-22,02443562,ADVIL 12 HOUR,1.0,M01AE01,Ibuprofen,Tablet (extended-release),Oral,02443562,ADVIL 12 HOUR (ibuprofen 600 mg prolonged-release oral tablet) HALEON CANADA ULC,Active,9001462,ibuprofen 600 mg prolonged-release oral tablet,8000043,ibuprofen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97565,Marketed,2024-08-23,02485400,ADVIL MINI-GELS,1.0,M01AE01,Ibuprofen,Capsule,Oral,02485400,ADVIL MINI-GELS (ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98438,Marketed,2021-03-22,02494353,IBUPROFEN LIQUID GELS,1.0,M01AE01,Ibuprofen,Capsule,Oral,02494353,IBUPROFEN LIQUID GELS (ibuprofen 200 mg oral capsule) PHARMASCIENCE INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103444,Marketed,2025-06-16,02545691,IBUPROFEN MINI LIQUID CAPSULES,1.0,M01AE01,Ibuprofen,Capsule,Oral,02545691,IBUPROFEN MINI LIQUID CAPSULES (ibuprofen 200 mg oral capsule) JUNO OTC INC,Active,9000921,ibuprofen 200 mg oral capsule,8000043,ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104264,Marketed,2025-12-30,02553724,JAMP IBUPROFEN SUSPENSION,1.0,M01AE01,Ibuprofen,Suspension,Oral,02553724,JAMP IBUPROFEN SUSPENSION (ibuprofen 100 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9000757,ibuprofen 100 mg per 5 mL oral suspension,8000043,ibuprofen,26643006,Oral,385024007,Oral suspension,,,,,
14492,Marketed,2025-09-26,02036312,ADVIL COLD AND SINUS,2.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02036312,ADVIL COLD AND SINUS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65897,Marketed,2007-01-24,02242217,SUDAFED SINUS ADVANCE,2.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02242217,SUDAFED SINUS ADVANCE (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73002,Marketed,2025-05-16,02248645,ADVIL COLD & SINUS PLUS,3.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02248645,ADVIL COLD & SINUS PLUS (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73565,Marketed,2025-09-26,02250705,ADVIL COLD & SINUS LIQUI-GELS,2.0,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02250705,ADVIL COLD & SINUS LIQUI-GELS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral capsule) HALEON CANADA ULC,Active,9004057,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral capsule,8001387,ibuprofen and pseudoephedrine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75302,Marketed,2025-09-26,02267616,ADVIL COLD AND SINUS DAYTIME,2.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02267616,ADVIL COLD AND SINUS DAYTIME (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75304,Marketed,2025-05-16,02267632,ADVIL COLD AND SINUS NIGHTTIME,3.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02267632,ADVIL COLD AND SINUS NIGHTTIME (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) HALEON CANADA ULC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83757,Marketed,2011-10-14,02352281,COLD + SINUS,2.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02352281,COLD + SINUS (ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002580,ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001387,ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84104,Marketed,2025-08-28,02355841,ADVIL NIGHTTIME,2.0,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02355841,ADVIL NIGHTTIME (diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9004807,diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule,8001188,diphenhydramine and ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84427,Marketed,2011-04-19,02359243,COLD + SINUS PLUS,3.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02359243,COLD + SINUS PLUS (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003926,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87360,Marketed,2014-05-23,02388030,COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME,5.0,M01AE51,"Ibuprofen, combinations","Kit,Tablet",Oral,02388030,COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9012940,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88459,Marketed,2021-07-21,02399733,ADVIL COLD & SINUS CONVENIENCE PACK,5.0,M01AE51,"Ibuprofen, combinations","Kit,Tablet",Oral,02399733,ADVIL COLD & SINUS CONVENIENCE PACK (chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet ) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9012940,chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet with ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88592,Marketed,2025-08-05,02401193,ADVIL FLU,2.0,M01AE51,"Ibuprofen, combinations",Capsule,Oral,02401193,ADVIL FLU (diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule) HALEON CANADA ULC,Active,9004807,diphenhydramine hydrochloride 25 mg and ibuprofen 200 mg oral capsule,8001188,diphenhydramine and ibuprofen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96076,Marketed,2025-05-16,02471604,"ADVIL COLD, SINUS & FLU EXTRA STRENGTH",3.0,M01AE51,"Ibuprofen, combinations",Tablet,Oral,02471604,"ADVIL COLD, SINUS & FLU EXTRA STRENGTH (chlorpheniramine maleate 4 mg and ibuprofen 400 mg and pseudoephedrine hydrochloride 60 mg oral tablet) HALEON CANADA ULC",Active,9013044,chlorpheniramine maleate 4 mg and ibuprofen 400 mg and pseudoephedrine hydrochloride 60 mg oral tablet,8001355,chlorpheniramine and ibuprofen and pseudoephedrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66196,Marketed,2017-10-03,02242470,CORVERT,1.0,C01BD05,Ibutilide,Solution,Intravenous,02242470,CORVERT (ibutilide fumarate 1 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012576,ibutilide fumarate 1 mg per 10 mL solution for injection vial,8001108,ibutilide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
91034,Marketed,2021-07-21,02425696,FIRAZYR,1.0,B06AC02,Icatibant,Solution,Subcutaneous,02425696,FIRAZYR (icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe) TAKEDA CANADA INC,Active,9013298,icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe,8001801,icatibant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
103650,Marketed,2024-10-04,02547562,ICATIBANT INJECTION,1.0,B06AC02,Icatibant,Solution,Subcutaneous,02547562,ICATIBANT INJECTION (icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013298,icatibant (icatibant acetate) 30 mg per 3 mL solution for injection syringe,8001801,icatibant,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
89467,Marketed,2014-11-04,02410028,IDARUBICIN,1.0,L01DB06,Idarubicin,Solution,Intravenous,77700786,IDARUBICIN (idarubicin hydrochloride 20 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013156,idarubicin hydrochloride 20 mg per 20 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89467,Marketed,2014-11-04,02410028,IDARUBICIN,1.0,L01DB06,Idarubicin,Solution,Intravenous,77700787,IDARUBICIN (idarubicin hydrochloride 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013155,idarubicin hydrochloride 10 mg per 10 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89467,Marketed,2014-11-04,02410028,IDARUBICIN,1.0,L01DB06,Idarubicin,Solution,Intravenous,77700788,IDARUBICIN (idarubicin hydrochloride 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013157,idarubicin hydrochloride 5 mg per 5 mL solution for injection vial,8001802,idarubicin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94091,Marketed,2016-05-24,02454343,PRAXBIND,1.0,V03AB37,Idarucizimab,Solution,Intravenous,02454343,PRAXBIND (idarucizumab 2500 mg per 50 mL solution for injection vial) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9013158,idarucizumab 2500 mg per 50 mL solution for injection vial,8001803,idarucizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92318,Marketed,2015-04-21,02438798,ZYDELIG,1.0,L01EM01,Idelalisib,Tablet,Oral,02438798,ZYDELIG (idelalisib 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005701,idelalisib 100 mg oral tablet,8001804,idelalisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92319,Marketed,2015-04-21,02438801,ZYDELIG,1.0,L01EM01,Idelalisib,Tablet,Oral,02438801,ZYDELIG (idelalisib 150 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005702,idelalisib 150 mg oral tablet,8001804,idelalisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78165,Marketed,2021-02-11,02296314,ELAPRASE,1.0,A16AB09,Idursulfase,Solution,Intravenous,02296314,ELAPRASE (idursulfase 6 mg per 3 mL solution for injection vial) TAKEDA CANADA INC,Active,9013159,idursulfase 6 mg per 3 mL solution for injection vial,8001805,idursulfase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
64988,Marketed,2003-09-09,02241356,IFEX,1.0,L01AA06,Ifosfamide,Powder for solution,Intravenous,02241356,IFEX (ifosfamide 3 g per vial powder for solution for injection) BAXTER CORPORATION,Active,9003555,ifosfamide 3 g per vial powder for solution for injection,8001806,ifosfamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
64989,Marketed,2003-09-09,02241357,IFEX,1.0,L01AA06,Ifosfamide,Powder for solution,Intravenous,02241357,IFEX (ifosfamide 1 g per vial powder for solution for injection) BAXTER CORPORATION,Active,9003576,ifosfamide 1 g per vial powder for solution for injection,8001806,ifosfamide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
73824,Marketed,2005-04-05,02253275,GLEEVEC,1.0,L01EA01,Imatinib,Tablet,Oral,02253275,GLEEVEC (imatinib (imatinib mesylate) 100 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73825,Marketed,2004-10-25,02253283,GLEEVEC,1.0,L01EA01,Imatinib,Tablet,Oral,02253283,GLEEVEC (imatinib (imatinib mesylate) 400 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84058,Marketed,2013-04-19,02355337,APO-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02355337,APO-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) APOTEX INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84059,Marketed,2013-04-19,02355345,APO-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02355345,APO-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) APOTEX INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88225,Marketed,2017-08-11,02397285,NAT-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02397285,NAT-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88226,Marketed,2017-08-11,02397293,NAT-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02397293,NAT-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88465,Marketed,2013-04-02,02399806,TEVA-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02399806,TEVA-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88466,Marketed,2013-05-22,02399814,TEVA-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02399814,TEVA-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98101,Marketed,2020-11-24,02490986,ACH-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02490986,ACH-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98102,Marketed,2020-11-24,02490994,ACH-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02490994,ACH-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98235,Marketed,2020-06-19,02492334,MINT-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02492334,MINT-IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98236,Marketed,2020-06-19,02492342,MINT-IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02492342,MINT-IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99400,Marketed,2021-04-07,02504596,IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02504596,IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) SANIS HEALTH INC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99401,Marketed,2021-04-07,02504618,IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02504618,IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) SANIS HEALTH INC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101043,Marketed,2024-04-29,02521202,IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02521202,IMATINIB (imatinib (imatinib mesylate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004037,imatinib (imatinib mesylate) 100 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101045,Marketed,2024-04-29,02521210,IMATINIB,1.0,L01EA01,Imatinib,Tablet,Oral,02521210,IMATINIB (imatinib (imatinib mesylate) 400 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003965,imatinib (imatinib mesylate) 400 mg oral tablet,8001807,imatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10748,Marketed,2022-03-10,00611174,LOTRIDERM,2.0,D01AC20,Imidazoles/triazoles in combination with corticosteroids,Cream,Topical,00611174,LOTRIDERM (betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream) ORGANON CANADA INC.,Active,9002245,betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream,8000846,betamethasone dipropionate and clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
98629,Marketed,2020-04-06,02496410,TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE,2.0,D01AC20,Imidazoles/triazoles in combination with corticosteroids,Cream,Topical,02496410,TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE (betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9002245,betamethasone (betamethasone dipropionate) 0.05 % and clotrimazole 1 % cutaneous cream,8000846,betamethasone dipropionate and clotrimazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
65414,Marketed,2025-03-06,02241751,CEREZYME,1.0,A16AB02,Imiglucerase,Powder for solution,Intravenous,02241751,CEREZYME (imiglucerase 400 unit per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9003496,imiglucerase 400 unit per vial powder for solution for injection,8001808,imiglucerase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
83696,Marketed,2021-05-31,02351706,TARO-IMIPENEM-CILASTATIN,2.0,J01DH51,Imipenem and cilastatin,Powder for solution,Intravenous,02351706,TARO-IMIPENEM-CILASTATIN (cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002101,cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection,8001358,cilastatin and imipenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84340,Marketed,2010-12-21,02358344,IMIPENEM AND CILASTATIN FOR INJECTION USP,2.0,J01DH51,Imipenem and cilastatin,Powder for solution,Intravenous,02358344,IMIPENEM AND CILASTATIN FOR INJECTION USP (cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002101,cilastatin (cilastatin sodium) 500 mg per vial and imipenem 500 mg per vial powder for solution for injection,8001358,cilastatin and imipenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
2211,Marketed,2026-01-20,00312797,APO-IMIPRAMINE TABLETS,1.0,N06AA02,Imipramine,Tablet,Oral,00312797,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001673,imipramine hydrochloride 25 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2212,Marketed,2026-01-20,00326852,APO-IMIPRAMINE TABLETS,1.0,N06AA02,Imipramine,Tablet,Oral,00326852,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001674,imipramine hydrochloride 50 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2444,Marketed,2026-01-20,00360201,APO-IMIPRAMINE TABLETS,1.0,N06AA02,Imipramine,Tablet,Oral,00360201,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001672,imipramine hydrochloride 10 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10008,Marketed,2026-01-20,00644579,APO-IMIPRAMINE TABLETS,1.0,N06AA02,Imipramine,Tablet,Oral,00644579,APO-IMIPRAMINE TABLETS (imipramine hydrochloride 75 mg oral tablet) APOTEX INC,Active,9002199,imipramine hydrochloride 75 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103504,Marketed,2024-11-29,02546337,JAMP IMIPRAMINE,1.0,N06AA02,Imipramine,Tablet,Oral,02546337,JAMP IMIPRAMINE (imipramine hydrochloride 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001672,imipramine hydrochloride 10 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103505,Marketed,2024-11-29,02546345,JAMP IMIPRAMINE,1.0,N06AA02,Imipramine,Tablet,Oral,02546345,JAMP IMIPRAMINE (imipramine hydrochloride 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001673,imipramine hydrochloride 25 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103506,Marketed,2024-11-29,02546353,JAMP IMIPRAMINE,1.0,N06AA02,Imipramine,Tablet,Oral,02546353,JAMP IMIPRAMINE (imipramine hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001674,imipramine hydrochloride 50 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103507,Marketed,2024-11-29,02546361,JAMP IMIPRAMINE,1.0,N06AA02,Imipramine,Tablet,Oral,02546361,JAMP IMIPRAMINE (imipramine hydrochloride 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002199,imipramine hydrochloride 75 mg oral tablet,8001388,imipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62979,Marketed,2019-06-18,02239505,ALDARA P,1.0,D06BB10,Imiquimod,Cream,Topical,77701004,"ALDARA P (imiquimod 5 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013910,imiquimod 5 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,
62979,Marketed,2019-06-18,02239505,ALDARA P,1.0,D06BB10,Imiquimod,Cream,Topical,77701005,"ALDARA P (imiquimod 5 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013909,imiquimod 5 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,
82603,Marketed,2020-10-30,02340445,ZYCLARA,1.0,D06BB10,Imiquimod,Cream,Topical,77701006,"ZYCLARA (imiquimod 3.75 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013907,imiquimod 3.75 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,
82603,Marketed,2020-10-30,02340445,ZYCLARA,1.0,D06BB10,Imiquimod,Cream,Topical,77701007,"ZYCLARA (imiquimod 3.75 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013908,imiquimod 3.75 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,
85046,Marketed,2019-07-02,02365561,VYLOMA,1.0,D06BB10,Imiquimod,Cream,Topical,77701008,"VYLOMA (imiquimod 3.75 % cutaneous cream sachet) BAUSCH HEALTH, CANADA INC.",Active,9013908,imiquimod 3.75 % cutaneous cream sachet,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,733013000,Sachet (unit of presentation),,,
85046,Marketed,2019-07-02,02365561,VYLOMA,1.0,D06BB10,Imiquimod,Cream,Topical,77701009,"VYLOMA (imiquimod 3.75 % cutaneous cream pump) BAUSCH HEALTH, CANADA INC.",Active,9013907,imiquimod 3.75 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,
97338,Marketed,2019-01-23,02482983,TARO-IMIQUIMOD PUMP,1.0,D06BB10,Imiquimod,Cream,Topical,02482983,TARO-IMIQUIMOD PUMP (imiquimod 5 % cutaneous cream pump) TARO PHARMACEUTICALS INC,Active,9013909,imiquimod 5 % cutaneous cream pump,8001809,imiquimod,448598008,Cutaneous,421628006,Cutaneous cream,732981002,Actuation (unit of presentation),,,
94943,Marketed,2021-12-03,02461692,CUVITRU,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
95095,Marketed,2017-09-21,02463059,HIZENTRA,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
95096,Marketed,2017-09-21,02463067,HIZENTRA,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
97678,Marketed,2020-03-27,02486598,GAMASTAN,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Intramuscular,,,,,,,,,,,,,,,,
98804,Marketed,2021-05-13,02498251,HIZENTRA,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
101339,Marketed,2023-11-07,02524368,HYQVIA,2.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
101340,Marketed,2023-11-07,02524376,HYQVIA,2.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
101341,Marketed,2023-11-07,02524384,HYQVIA,2.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
101342,Marketed,2023-11-07,02524392,HYQVIA,2.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
101343,Marketed,2023-11-07,02524406,HYQVIA,2.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
102422,Marketed,2024-02-15,02535424,HIZENTRA,1.0,J06BA01,"Immunoglobulins, normal human, for extravasc. adm",Solution,Subcutaneous,,,,,,,,,,,,,,,,
50794,Marketed,2022-02-09,02231470,GAMMAGARD S/D,1.0,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.","Powder for solution,Solution,Kit",Intravenous,,,,,,,,,,,,,,,,
72002,Marketed,2012-09-11,02247724,GAMUNEX,1.0,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,"Subcutaneous,Intravenous",,,,,,,,,,,,,,,,
76352,Marketed,2012-10-09,02277921,IGIVNEX,1.0,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,"Intravenous,Subcutaneous",,,,,,,,,,,,,,,,
76503,Marketed,2021-12-06,02279444,GAMMAGARD LIQUID,1.0,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,Intravenous,,,,,,,,,,,,,,,,
78988,Marketed,2009-01-08,02304619,PRIVIGEN,1.0,J06BA02,"Immunoglobulins, normal human, for intravasc. adm.",Solution,Intravenous,,,,,,,,,,,,,,,,
100766,Marketed,2022-09-26,02518376,LEQVIO,1.0,C10AX16,Inclisiran,Solution,Subcutaneous,02518376,LEQVIO (inclisiran (inclisiran sodium) 284 mg per 1.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014795,inclisiran (inclisiran sodium) 284 mg per 1.5 mL solution for injection syringe,8002444,inclisiran,738984000,Parenteral,385219001,solution for injection,733020007,Syringe (unit of presentation),,,
90285,Marketed,2014-03-05,02418282,ULTIBRO BREEZHALER,2.0,R03AL04,Indacaterol and glycopyrronium bromide,Capsule,Inhalation,02418282,ULTIBRO BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol maleate) 110 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005460,glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol maleate) 110 mcg inhalation powder capsule,8001083,glycopyrronium and indacaterol,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,
98847,Marketed,2020-08-19,02498685,ATECTURA BREEZHALER,2.0,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498685,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 80 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014347,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 80 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,
98848,Marketed,2020-08-19,02498693,ATECTURA BREEZHALER,2.0,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498693,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 320 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014346,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 320 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,
98849,Marketed,2020-08-19,02498707,ATECTURA BREEZHALER,2.0,R03AK14,Indacaterol and mometasone,Capsule,Inhalation,02498707,ATECTURA BREEZHALER (indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014345,indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule,8002339,indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,
99087,Marketed,2020-11-05,02501244,ENERZAIR BREEZHALER,3.0,R03AL12,"Indacaterol, glycopyrronium bromide and mometasone",Capsule,Inhalation,02501244,ENERZAIR BREEZHALER (glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014399,glycopyrronium (glycopyrronium bromide) 50 mcg and indacaterol (indacaterol acetate) 150 mcg and mometasone furoate 160 mcg inhalation powder capsule,8002349,glycopyrronium and indacaterol and mometasone,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,
18065,Marketed,2009-11-16,02153483,MYLAN-INDAPAMIDE,1.0,C03BA11,Indapamide,Tablet,Oral,02153483,MYLAN-INDAPAMIDE (indapamide 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000177,indapamide 2.5 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43381,Marketed,2002-01-22,02223678,APO-INDAPAMIDE 2.5MG TABLETS,1.0,C03BA11,Indapamide,Tablet,Oral,02223678,APO-INDAPAMIDE 2.5MG TABLETS (indapamide 2.5 mg oral tablet) APOTEX INC,Active,9000177,indapamide 2.5 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63577,Marketed,2009-11-13,02240067,MYLAN-INDAPAMIDE,1.0,C03BA11,Indapamide,Tablet,Oral,02240067,MYLAN-INDAPAMIDE (indapamide 1.25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000587,indapamide 1.25 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69270,Marketed,2002-11-08,02245246,APO-INDAPAMIDE 1.25 MG TABLETS,1.0,C03BA11,Indapamide,Tablet,Oral,02245246,APO-INDAPAMIDE 1.25 MG TABLETS (indapamide 1.25 mg oral tablet) APOTEX INC,Active,9000587,indapamide 1.25 mg oral tablet,8000097,indapamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81467,Marketed,2019-02-26,02329026,INDIUM (111IN) OXINE SOLUTION,1.0,V09HB,Indium 111 in compounds,Solution,Intravenous,,,,,,,,,,,,,,,,
81479,Marketed,2019-02-26,02329093,INDIUM DTPA IN 111,1.0,V09AX01,Indium 111 in pentetic acid,Solution,Intrathecal,,,,,,,,,,,,,,,,
81497,Marketed,2019-10-06,02329271,OCTREOSCAN,2.0,V09IB01,Indium 111 in pentetreotide,"Powder for solution,Kit,Solution",Intravenous,,,,,,,,,,,,,,,,
97402,Marketed,2023-11-08,02483653,SPY AGENT GREEN,1.0,V04CX01,Indocyanine green,Powder for solution,"Intravenous,Interstitial,Intradermal",,,,,,,,,,,,,,,,
97403,Marketed,2023-11-09,02483661,SPY AGENT GREEN KIT FOR SPY ELITE,1.0,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
97404,Marketed,2023-11-09,02483688,SPY AGENT GREEN KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT,1.0,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
97405,Marketed,2023-11-09,02483696,SPY AGENT GREEN LYMPHATICS KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT,1.0,V04CX01,Indocyanine green,"Kit,Powder for solution",Interstitial,,,,,,,,,,,,,,,,
97602,Marketed,2019-06-11,02485796,"INDOCYANINE GREEN FOR INJECTION, USP",1.0,V04CX01,Indocyanine green,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
98842,Marketed,2023-11-09,02498677,SPY AGENT GREEN KIT FOR SPY-PHI,1.0,V04CX01,Indocyanine green,"Powder for solution,Kit","Interstitial,Intravenous,Intradermal",,,,,,,,,,,,,,,,
101703,Marketed,2023-11-09,02527839,SPY AGENT GREEN KIT FOR ADVANCED IMAGING MODALITY (AIM) AND PINPOINT,1.0,V04CX01,Indocyanine green,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
4129,Marketed,2015-07-15,00337420,TEVA-INDOMETHACIN,1.0,M01AB01,Indometacin,Capsule,Oral,00337420,TEVA-INDOMETHACIN (indomethacin 25 mg oral capsule) TEVA CANADA LIMITED,Active,9000151,indomethacin 25 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
4130,Marketed,2015-07-14,00337439,TEVA-INDOMETHACIN,1.0,M01AB01,Indometacin,Capsule,Oral,00337439,TEVA-INDOMETHACIN (indomethacin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
51232,Marketed,2023-08-23,02231799,ODAN-INDOMETHACIN,1.0,M01AB01,Indometacin,Suppository,Rectal,02231799,ODAN-INDOMETHACIN (indomethacin 50 mg suppository) ODAN LABORATORIES LTD,Active,9000758,indomethacin 50 mg suppository,8000085,indomethacin,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
51233,Marketed,2025-05-01,02231800,ODAN-INDOMETHACIN,1.0,M01AB01,Indometacin,Suppository,Rectal,02231800,ODAN-INDOMETHACIN (indomethacin 100 mg suppository) ODAN LABORATORIES LTD,Active,9000470,indomethacin 100 mg suppository,8000085,indomethacin,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
94917,Marketed,2017-04-03,02461536,MINT-INDOMETHACIN,1.0,M01AB01,Indometacin,Capsule,Oral,02461536,MINT-INDOMETHACIN (indomethacin 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94956,Marketed,2017-04-03,02461811,MINT-INDOMETHACIN,1.0,M01AB01,Indometacin,Capsule,Oral,02461811,MINT-INDOMETHACIN (indomethacin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000151,indomethacin 25 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98897,Marketed,2021-07-08,02499223,AURO-INDOMETHACIN,1.0,M01AB01,Indometacin,Capsule,Oral,02499223,AURO-INDOMETHACIN (indomethacin 50 mg oral capsule) AURO PHARMA INC,Active,9000152,indomethacin 50 mg oral capsule,8000085,indomethacin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103236,Marketed,2025-03-31,02543931,UPLIZNA,1.0,L04AG10,Inebilizumab,Solution,Intravenous,02543931,UPLIZNA (inebilizumab 100 mg per 10 mL solution for injection vial) AMGEN CANADA INC,Active,9015096,inebilizumab 100 mg per 10 mL solution for injection vial,8002513,inebilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
67959,Marketed,2011-11-22,02244016,REMICADE,1.0,L04AB02,Infliximab,Powder for solution,Intravenous,02244016,REMICADE (infliximab 100 mg per vial powder for solution for injection) JANSSEN INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90410,Marketed,2025-03-12,02419475,REMDANTRY,1.0,L04AB02,Infliximab,Powder for solution,Intravenous,02419475,REMDANTRY (infliximab 100 mg per vial powder for solution for injection) CELLTRION INC.,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0
95936,Marketed,2018-03-22,02470373,RENFLEXIS,1.0,L04AB02,Infliximab,Powder for solution,Intravenous,02470373,"RENFLEXIS (infliximab 100 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0
98681,Marketed,2020-06-01,02496933,AVSOLA,1.0,L04AB02,Infliximab,Powder for solution,Intravenous,02496933,AVSOLA (infliximab 100 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0
100077,Marketed,2024-06-28,02511584,REMSIMA SC,1.0,L04AB02,Infliximab,"Solution,Kit",Subcutaneous,02511584,REMSIMA SC (infliximab 120 mg per 1 mL solution for injection pen) CELLTRION INC.,Active,9014548,infliximab 120 mg per 1 mL solution for injection pen,8001275,infliximab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
101230,Marketed,2025-04-01,02523191,IXIFI,1.0,L04AB02,Infliximab,Powder for solution,Intravenous,02523191,IXIFI (infliximab 100 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003611,infliximab 100 mg per vial powder for solution for injection,8001275,infliximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,1.0
84739,Marketed,2017-09-08,02362384,FLUAD,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
85059,Marketed,2025-09-10,02365707,FLUZONE,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
85079,Marketed,2025-09-10,02365936,FLUZONE,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
88676,Marketed,2025-03-21,02401886,AREPANRIX H5N1,1.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Emulsion,Intramuscular,,,,,,,,,,,,,,,,
90522,Marketed,2017-09-15,02420643,FLUZONE QUADRIVALENT,4.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
90524,Marketed,2025-09-08,02420686,FLUVIRAL,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
91717,Marketed,2017-02-10,02432730,FLUZONE QUADRIVALENT,4.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
93092,Marketed,2025-09-10,02445646,FLUZONE HIGH-DOSE,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
97512,Marketed,2019-10-17,02484854,INFLUVAC TETRA,4.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,
99020,Marketed,2021-09-17,02500523,FLUZONE HIGH-DOSE QUADRIVALENT,4.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
104261,Marketed,2025-09-10,02553708,FLUCELVAX,3.0,J07BB02,"Influenza, inactivated, split virus or surface antigen",Suspension,Intramuscular,,,,,,,,,,,,,,,,
75489,Marketed,2025-09-15,02269562,INFLUVAC,3.0,J07BB01,"Influenza, inactivated, whole virus",Suspension,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,
83789,Marketed,2025-09-25,02352621,FLUMIST,3.0,J07BB03,"Influenza, live attenuated",Spray,Nasal,,,,,,,,,,,,,,,,
64296,Marketed,2013-05-07,02240713,IMUNOVIR,1.0,J05AX05,Inosine pranobex,Tablet,Oral,02240713,IMUNOVIR (inosine pranobex 500 mg oral tablet) KORA HEALTHCARE,Active,9003452,inosine pranobex 500 mg oral tablet,8001207,inosine pranobex,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96383,Marketed,2018-05-03,02473909,BESPONSA,1.0,L01FB01,Inotuzumab ozogamicin,Powder for solution,Intravenous,02473909,BESPONSA (inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012820,inotuzumab ozogamicin 0.9 mg per vial powder for solution for injection,8001485,inotuzumab ozogamicin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
43270,Marketed,2019-02-04,02220075,HYMENOPTERA VENOM PRODUCT - HONEY BEE VENOM (550 MCG),1.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
43271,Marketed,2024-03-25,02220083,HYMENOPTERA VENOM PRODUCTS-YELLOW HORNET VENOM PROTEIN (550 MCG),1.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
43272,Marketed,2018-11-19,02220091,HYMENOPTERA VENOM PRODUCT-WASP VENOM PROTEIN (550 MCG),1.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
43273,Marketed,2018-09-24,02220105,HYMENOPTERA VENOM PRODUCT-WHITE-FACED HORNET VENOM PROTEIN (550 MCG),1.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
43274,Marketed,2013-01-04,02220113,HYMENOPTERA VENOM PRODUCT - YELLOW JACKET VENOM PROTEIN (550 MCG),1.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
43302,Marketed,2017-02-22,02221314,HYMENOPTERA VENOM PRODUCT-MIXED VESPID VENOM PROTEIN (1650 MCG),3.0,V01AA07,Insects,Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
5325,Marketed,1997-12-11,00586714,HUMULIN R,1.0,A10AB01,Insulin (human),Solution,"Intravenous,Intramuscular,Subcutaneous",77700632,HUMULIN R (insulin human 100 unit per mL solution for injection 3 mL vial) ELI LILLY CANADA INC,Active,9012826,insulin human 100 unit per mL solution for injection 3 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5325,Marketed,1997-12-11,00586714,HUMULIN R,1.0,A10AB01,Insulin (human),Solution,"Intravenous,Intramuscular,Subcutaneous",77700633,HUMULIN R (insulin human 100 unit per mL solution for injection 10 mL vial) ELI LILLY CANADA INC,Active,9012716,insulin human 100 unit per mL solution for injection 10 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5326,Marketed,1997-12-11,00587737,HUMULIN N,1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,77701034,HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC,Active,9000471,insulin isophane human 100 unit per mL suspension for injection 10 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
5326,Marketed,1997-12-11,00587737,HUMULIN N,1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,77701035,HUMULIN N (insulin isophane human 100 unit per mL suspension for injection 3 mL vial) ELI LILLY CANADA INC,Active,9014488,insulin isophane human 100 unit per mL suspension for injection 3 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
9788,Marketed,1997-12-11,00795879,HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ),2.0,A10AD01,Insulin (human),Suspension,Subcutaneous,00795879,HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial) ELI LILLY CANADA INC,Active,9012719,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
12568,Marketed,1997-12-11,01959212,HUMULIN 30/70 CARTRIDGE,2.0,A10AD01,Insulin (human),Suspension,Subcutaneous,01959212,HUMULIN 30/70 CARTRIDGE (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012720,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
12569,Marketed,1997-12-11,01959220,HUMULIN R CARTRIDGE,1.0,A10AB01,Insulin (human),Solution,"Subcutaneous,Intramuscular,Intravenous",01959220,HUMULIN R CARTRIDGE (insulin human 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012717,insulin human 100 unit per mL solution for injection 3 mL cartridge,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
12570,Marketed,2010-09-20,01959239,HUMULIN N (CARTRIDGE),1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,01959239,HUMULIN N (CARTRIDGE) (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9000426,insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
14260,Marketed,2011-01-08,02024233,NOVOLIN GE TORONTO,1.0,A10AB01,Insulin (human),Solution,"Intravenous,Intramuscular,Subcutaneous",02024233,NOVOLIN GE TORONTO (insulin human 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9012716,insulin human 100 unit per mL solution for injection 10 mL vial,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
14261,Marketed,2011-01-08,02024225,NOVOLIN GE NPH,1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,02024225,NOVOLIN GE NPH (insulin isophane human 100 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000471,insulin isophane human 100 unit per mL suspension for injection 10 mL vial,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
14265,Marketed,2011-01-08,02025248,NOVOLIN GE 30/70 PENFILL,2.0,A10AD01,Insulin (human),Suspension,Subcutaneous,02025248,NOVOLIN GE 30/70 PENFILL (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9012720,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 3 mL cartridge,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
14266,Marketed,2011-01-08,02024268,NOVOLIN GE NPH PENFILL,1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,02024268,NOVOLIN GE NPH PENFILL (insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000426,insulin isophane human 100 unit per mL suspension for injection 3 mL cartridge,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
14269,Marketed,2011-01-08,02024217,NOVOLIN GE 30/70,2.0,A10AD01,Insulin (human),Suspension,Subcutaneous,02024217,NOVOLIN GE 30/70 (insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9012719,insulin human 30 unit per mL and insulin isophane human 70 unit per mL suspension for injection 10 mL vial,8001392,insulin human and insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
14459,Marketed,2011-01-08,02024284,NOVOLIN GE TORONTO PENFILL,1.0,A10AB01,Insulin (human),Solution,"Intramuscular,Intravenous,Subcutaneous",02024284,NOVOLIN GE TORONTO PENFILL (insulin human 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9012717,insulin human 100 unit per mL solution for injection 3 mL cartridge,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
88825,Marketed,2013-09-13,02403447,HUMULIN N (KWIKPEN),1.0,A10AC01,Insulin (human),Suspension,Subcutaneous,02403447,HUMULIN N (KWIKPEN) (insulin isophane human 100 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001407,insulin isophane human 100 unit per mL suspension for injection 3 mL pen,8000168,insulin isophane human,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,
89971,Marketed,2014-03-03,02415089,HUMULIN R (KWIKPEN),1.0,A10AB01,Insulin (human),Solution,"Intramuscular,Subcutaneous",02415089,HUMULIN R (KWIKPEN) (insulin human 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012718,insulin human 100 unit per mL solution for injection 3 mL pen,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
95524,Marketed,2017-10-20,02466864,ENTUZITY KWIKPEN,1.0,A10AD01,Insulin (human),Solution,Subcutaneous,02466864,ENTUZITY KWIKPEN (insulin human 500 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012723,insulin human 500 unit per mL solution for injection 3 mL pen,8001391,insulin human,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101884,Marketed,2023-07-28,02529602,MYXREDLIN,1.0,A10AB01,Insulin (human),Solution,Intravenous,,,,,,,,,,,,,,,,1.0
76152,Marketed,2006-04-01,02275864,HYPURIN NPH INSULIN ISOPHANE PORK,1.0,A10AC03,Insulin (pork),Suspension,"Subcutaneous,Intramuscular",02275864,HYPURIN NPH INSULIN ISOPHANE PORK (insulin isophane pork 100 unit per mL suspension for injection 10 mL vial) WOCKHARDT UK LIMITED,Active,9012724,insulin isophane pork 100 unit per mL suspension for injection 10 mL vial,8001393,insulin isophane pork,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
76153,Marketed,2006-04-01,02275872,HYPURIN REGULAR INSULIN PORK,1.0,A10AB03,Insulin (pork),Solution,"Intramuscular,Intravenous,Subcutaneous",02275872,HYPURIN REGULAR INSULIN PORK (insulin pork 100 unit per mL solution for injection 10 mL vial) WOCKHARDT UK LIMITED,Active,9012729,insulin pork 100 unit per mL solution for injection 10 mL vial,8001281,insulin pork,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68321,Marketed,2001-10-31,02244353,NOVORAPID,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02244353,NOVORAPID 3ML PENFILL CARTRIDGE (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
69441,Marketed,2002-06-12,02245397,NOVORAPID,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02245397,NOVORAPID (insulin aspart 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
75090,Marketed,2005-09-12,02265435,NOVOMIX 30,2.0,A10AD05,Insulin aspart,Suspension,Subcutaneous,02265435,NOVOMIX 30 (insulin aspart 30 unit per mL and insulin aspart protamine 70 unit per mL suspension for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9013160,insulin aspart 30 unit per mL and insulin aspart protamine 70 unit per mL suspension for injection 3 mL cartridge,8000950,insulin aspart and insulin aspart protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
94775,Marketed,2017-03-03,02460408,FIASP,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02460408,FIASP (insulin aspart 100 unit per mL solution for injection 10 mL vial) NOVO NORDISK CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94776,Marketed,2017-03-03,02460416,FIASP,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02460416,FIASP (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
94777,Marketed,2017-03-03,02460424,FIASP,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02460424,FIASP (insulin aspart 100 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
99592,Marketed,2021-03-30,02506564,TRURAPI,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02506564,TRURAPI (insulin aspart 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9000962,insulin aspart 100 unit per mL solution for injection 3 mL cartridge,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
99593,Marketed,2021-03-30,02506572,TRURAPI,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02506572,TRURAPI (insulin aspart 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
101021,Marketed,2024-04-04,02520974,KIRSTY,1.0,A10AB05,Insulin aspart,Solution,Subcutaneous,02520974,KIRSTY (insulin aspart 100 unit per mL solution for injection 3 mL pen) BIOCON SDN.BHD,Active,9001476,insulin aspart 100 unit per mL solution for injection 3 mL pen,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
101847,Marketed,2022-11-03,02529254,TRURAPI,1.0,A10AB05,Insulin aspart,Solution,"Intravenous,Subcutaneous",02529254,TRURAPI (insulin aspart 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000990,insulin aspart 100 unit per mL solution for injection 10 mL vial,8000307,insulin aspart,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
95622,Marketed,2023-01-30,02467860,TRESIBA,1.0,A10AE06,Insulin degludec,Solution,Subcutaneous,02467860,TRESIBA (insulin degludec 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9014831,insulin degludec 100 unit per mL solution for injection 3 mL cartridge,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge,,,
95623,Marketed,2017-09-15,02467879,TRESIBA,1.0,A10AE06,Insulin degludec,Solution,Subcutaneous,02467879,TRESIBA (insulin degludec 100 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012499,insulin degludec 100 unit per mL solution for injection 3 mL pen,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
95624,Marketed,2017-09-15,02467887,TRESIBA,1.0,A10AE06,Insulin degludec,Solution,Subcutaneous,02467887,TRESIBA (insulin degludec 200 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012500,insulin degludec 200 unit per mL solution for injection 3 mL pen,8001137,insulin degludec,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
96506,Marketed,2018-06-06,02474875,XULTOPHY,2.0,A10AE56,Insulin degludec and liraglutide,Solution,Subcutaneous,02474875,XULTOPHY (insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9012822,insulin degludec 100 unit per mL and liraglutide 3.6 mg per mL solution for injection 3 mL pen,8001389,insulin degludec and liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
75736,Marketed,2005-11-14,02271842,LEVEMIR PENFILL,1.0,A10AE05,Insulin detemir,Solution,Subcutaneous,02271842,LEVEMIR PENFILL (insulin detemir 100 unit per mL solution for injection 3 mL cartridge) NOVO NORDISK CANADA INC,Active,9001131,insulin detemir 100 unit per mL solution for injection 3 mL cartridge,8000353,insulin detemir,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
69790,Marketed,2007-10-23,02245689,LANTUS,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02245689,LANTUS (insulin glargine 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000994,insulin glargine 100 unit per mL solution for injection 10 mL vial,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
73683,Marketed,2006-05-04,02251930,LANTUS,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02251930,LANTUS (insulin glargine 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9001143,insulin glargine 100 unit per mL solution for injection 3 mL cartridge,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
77967,Marketed,2007-09-24,02294338,LANTUS,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02294338,LANTUS (insulin glargine 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
92621,Marketed,2015-07-15,02441829,TOUJEO SOLOSTAR,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02441829,TOUJEO SOLOSTAR (insulin glargine 300 unit per mL solution for injection 1.5 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001447,insulin glargine 300 unit per mL solution for injection 1.5 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
93005,Marketed,2015-12-18,02444844,BASAGLAR,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02444844,BASAGLAR (insulin glargine 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9001143,insulin glargine 100 unit per mL solution for injection 3 mL cartridge,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
94916,Marketed,2017-08-18,02461528,BASAGLAR,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02461528,BASAGLAR KWIKPEN - 80 UNITS PER INJECTION DELIVERY (insulin glargine 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
98339,Marketed,2020-02-04,02493373,TOUJEO DOUBLESTAR,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02493373,TOUJEO DOUBLESTAR (insulin glargine 300 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9014245,insulin glargine 300 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101554,Marketed,2024-07-12,02526441,SEMGLEE,1.0,A10AE04,Insulin glargine,Solution,Subcutaneous,02526441,SEMGLEE (insulin glargine 100 unit per mL solution for injection 3 mL pen) BIOCON SDN.BHD,Active,9001210,insulin glargine 100 unit per mL solution for injection 3 mL pen,8000317,insulin glargine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
96906,Marketed,2018-09-12,02478293,SOLIQUA,2.0,A10AE54,Insulin glargine and lixisenatide,Solution,Subcutaneous,02478293,SOLIQUA (insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9013299,insulin glargine 100 unit per mL and lixisenatide 33 mcg per mL solution for injection 3 mL pen,8001811,insulin glargine and lixisenatide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
76506,Marketed,2008-09-22,02279460,APIDRA,1.0,A10AB06,Insulin glulisine,Solution,Subcutaneous,02279460,APIDRA (insulin glulisine 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9012823,insulin glulisine 100 unit per mL solution for injection 10 mL vial,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
76507,Marketed,2009-10-01,02279479,APIDRA,1.0,A10AB06,Insulin glulisine,Solution,Subcutaneous,02279479,APIDRA (insulin glulisine 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9012824,insulin glulisine 100 unit per mL solution for injection 3 mL cartridge,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
77968,Marketed,2008-09-22,02294346,APIDRA,1.0,A10AB06,Insulin glulisine,Solution,Subcutaneous,02294346,APIDRA (insulin glulisine 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9012825,insulin glulisine 100 unit per mL solution for injection 3 mL pen,8001390,insulin glulisine,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103492,Marketed,2024-06-13,02546205,AWIQLI,1.0,A10AE07,Insulin icodec,Solution,Subcutaneous,02546205,AWIQLI (insulin icodec 700 unit per mL solution for injection 1 mL pen) NOVO NORDISK CANADA INC,Active,9015054,insulin icodec 700 unit per mL solution for injection 1 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103493,Marketed,2024-06-13,02546213,AWIQLI,1.0,A10AE07,Insulin icodec,Solution,Subcutaneous,02546213,AWIQLI (insulin icodec 700 unit per mL solution for injection 1.5 mL pen) NOVO NORDISK CANADA INC,Active,9015053,insulin icodec 700 unit per mL solution for injection 1.5 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103494,Marketed,2024-06-13,02546221,AWIQLI,1.0,A10AE07,Insulin icodec,Solution,Subcutaneous,02546221,AWIQLI (insulin icodec 700 unit per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9015055,insulin icodec 700 unit per mL solution for injection 3 mL pen,8002509,insulin icodec,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
47871,Marketed,1997-09-17,02229704,HUMALOG,1.0,A10AB04,Insulin lispro,Solution,"Intramuscular,Intravenous,Subcutaneous",02229704,HUMALOG (insulin lispro 100 unit per mL solution for injection 10 mL vial) ELI LILLY CANADA INC,Active,9000671,insulin lispro 100 unit per mL solution for injection 10 mL vial,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
47872,Marketed,1998-05-25,02229705,HUMALOG (CARTRIDGE),1.0,A10AB04,Insulin lispro,Solution,"Subcutaneous,Intravenous,Intramuscular",02229705,HUMALOG (CARTRIDGE) (insulin lispro 100 unit per mL solution for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9000673,insulin lispro 100 unit per mL solution for injection 3 mL cartridge,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
63832,Marketed,1999-07-05,02240294,HUMALOG MIX 25 (CARTRIDGE),2.0,A10AD04,Insulin lispro,Suspension,Subcutaneous,02240294,HUMALOG MIX 25 (CARTRIDGE) (insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012725,insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL cartridge,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
63835,Marketed,2013-03-08,02240297,HUMALOG MIX 50 (CARTRIDGE),2.0,A10AD04,Insulin lispro,Suspension,Subcutaneous,02240297,HUMALOG MIX 50 (CARTRIDGE) (insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL cartridge) ELI LILLY CANADA INC,Active,9012727,insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL cartridge,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,732988008,Cartridge (unit of presentation),,,
88822,Marketed,2013-08-14,02403412,HUMALOG (KWIKPEN),1.0,A10AB04,Insulin lispro,Solution,"Intramuscular,Intravenous,Subcutaneous",02403412,HUMALOG (KWIKPEN) (insulin lispro 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
88823,Marketed,2013-09-30,02403420,HUMALOG MIX 25 (KWIKPEN),2.0,A10AD04,Insulin lispro,Suspension,Subcutaneous,02403420,HUMALOG MIX 25 (KWIKPEN) (insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012726,insulin lispro 25 unit per mL and insulin lispro protamine 75 unit per mL suspension for injection 3 mL pen,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,
88824,Marketed,2014-01-23,02403439,HUMALOG MIX 50 (KWIKPEN),2.0,A10AD04,Insulin lispro,Suspension,Subcutaneous,02403439,HUMALOG MIX 50 (KWIKPEN) (insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL pen) ELI LILLY CANADA INC,Active,9012728,insulin lispro 50 unit per mL and insulin lispro protamine 50 unit per mL suspension for injection 3 mL pen,8001394,insulin lispro and insulin lispro protamine,738984000,Parenteral,385220007,Suspension for injection,733006000,Pen (unit of presentation),,,
92402,Marketed,2015-09-14,02439611,HUMALOG 200 UNITS/ML KWIKPEN,1.0,A10AB04,Insulin lispro,Solution,Subcutaneous,02439611,HUMALOG 200 UNITS/ML KWIKPEN (insulin lispro 200 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001449,insulin lispro 200 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
95877,Marketed,2019-11-22,02469898,ADMELOG,1.0,A10AB04,Insulin lispro,Solution,Subcutaneous,02469898,ADMELOG (insulin lispro 100 unit per mL solution for injection 3 mL cartridge) SANOFI-AVENTIS CANADA INC,Active,9000673,insulin lispro 100 unit per mL solution for injection 3 mL cartridge,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
95880,Marketed,2019-11-22,02469871,ADMELOG SOLOSTAR,1.0,A10AB04,Insulin lispro,Solution,Subcutaneous,02469871,ADMELOG SOLOSTAR (insulin lispro 100 unit per mL solution for injection 3 mL pen) SANOFI-AVENTIS CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,1.0
95881,Marketed,2019-11-22,02469901,ADMELOG,1.0,A10AB04,Insulin lispro,Solution,Subcutaneous,02469901,ADMELOG (insulin lispro 100 unit per mL solution for injection 10 mL vial) SANOFI-AVENTIS CANADA INC,Active,9000671,insulin lispro 100 unit per mL solution for injection 10 mL vial,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
95912,Marketed,2018-04-06,02470152,HUMALOG,1.0,A10AB04,Insulin lispro,Solution,Subcutaneous,02470152,HUMALOG JUNIOR KWIKPEN (insulin lispro 100 unit per mL solution for injection 3 mL pen) ELI LILLY CANADA INC,Active,9001406,insulin lispro 100 unit per mL solution for injection 3 mL pen,8000787,insulin lispro,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
60641,Marketed,1998-02-23,02237319,REBIF,1.0,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237319,"REBIF (interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013167,interferon beta-1a 22 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
60642,Marketed,1998-02-24,02237320,REBIF,1.0,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02237320,"REBIF (interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013168,interferon beta-1a 44 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
75459,Marketed,2005-12-02,02269201,AVONEX,1.0,L03AB07,Interferon beta-1a,Solution,Intramuscular,02269201,AVONEX (interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9013912,interferon beta-1a 30 mcg per 0.5 mL solution for injection syringe,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
80376,Marketed,2009-05-14,02318253,REBIF,1.0,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318253,"REBIF (interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013169,interferon beta-1a 66 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
80377,Marketed,2009-05-14,02318261,REBIF,1.0,L03AB07,Interferon beta-1a,Solution,Subcutaneous,02318261,"REBIF (interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013166,interferon beta-1a 132 mcg per 1.5 mL solution for injection cartridge,8001814,interferon beta-1a (conventional),738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
19241,Marketed,2008-01-29,02169649,BETASERON,1.0,L03AB08,Interferon beta-1b,Powder for solution,Subcutaneous,02169649,BETASERON (interferon beta-1b 0.3 mg per vial powder for solution for injection) BAYER INC,Active,9002829,interferon beta-1b 0.3 mg per vial powder for solution for injection,8001815,interferon beta-1b,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87259,Marketed,2019-02-26,02387034,ADREVIEW,1.0,V09IX01,Iobenguane (123 i),Solution,Intravenous,,,,,,,,,,,,,,,,
95962,Marketed,2018-11-15,02470624,DATSCAN,1.0,V09AB03,Iodine ioflupane 123 i,Solution,Intravenous,,,,,,,,,,,,,,,,
18685,Marketed,2021-09-08,02145766,VISIPAQUE 270,1.0,V08AB09,Iodixanol,Solution,"Intravenous,Intra-arterial",,,,,,,,,,,,,,,,
18694,Marketed,2021-09-02,02145774,VISIPAQUE 320,1.0,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,
104285,Marketed,2025-05-29,02553953,IODIXANOL INJECTION 270,1.0,V08AB09,Iodixanol,Solution,"Intravenous,Intra-arterial",,,,,,,,,,,,,,,,
104286,Marketed,2025-05-29,02553961,IODIXANOL INJECTION 320,1.0,V08AB09,Iodixanol,Solution,"Intra-arterial,Intravenous",,,,,,,,,,,,,,,,
44185,Marketed,2023-12-29,02172739,OMNIPAQUE 240,1.0,V08AB02,Iohexol,Solution,"Oral,Rectal,Subarachnoidal,Intravascular,Intra-articular",,,,,,,,,,,,,,,,
44186,Marketed,2024-01-03,02172747,OMNIPAQUE 300,1.0,V08AB02,Iohexol,Solution,"Intravascular,Intra-articular,Oral,Subarachnoidal,Rectal",,,,,,,,,,,,,,,,
44187,Marketed,2023-12-29,02172755,OMNIPAQUE 350,1.0,V08AB02,Iohexol,Solution,"Oral,Intravascular",,,,,,,,,,,,,,,,
43504,Marketed,1998-01-08,02229013,ISOVUE 200 INJECTION,1.0,V08AB04,Iopamidol,Solution,"Subarachnoidal,Intravascular",,,,,,,,,,,,,,,,
43505,Marketed,1998-01-08,02229021,ISOVUE 300 INJECTION,1.0,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,
43506,Marketed,1998-01-08,02229048,ISOVUE 370 INJECTION,1.0,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,
65799,Marketed,2001-07-30,02242121,ISOVUE MULTIPACK-370,1.0,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,
65800,Marketed,2001-07-30,02242122,ISOVUE MULTIPACK-300,1.0,V08AB04,Iopamidol,Liquid,Intravascular,,,,,,,,,,,,,,,,
16179,Marketed,2007-04-19,02078600,ULTRAVIST 300,1.0,V08AB05,Iopromide,Solution,Intravascular,,,,,,,,,,,,,,,,
16180,Marketed,2007-04-18,02078619,ULTRAVIST 370,1.0,V08AB05,Iopromide,Solution,Intravascular,,,,,,,,,,,,,,,,
11328,Marketed,2021-11-30,01900854,OPTIRAY 320,1.0,V08AB07,Ioversol,Solution,Intravascular,,,,,,,,,,,,,,,,
43604,Marketed,2021-11-30,02035626,OPTIRAY 320 (ULTRAJECT),1.0,V08AB07,Ioversol,Solution,Intravascular,,,,,,,,,,,,,,,,
86525,Marketed,2012-03-08,02379384,YERVOY,1.0,L01FX04,Ipilimumab,Solution,Intravenous,77700763,YERVOY (ipilimumab 200 mg per 40 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013172,ipilimumab 200 mg per 40 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86525,Marketed,2012-03-08,02379384,YERVOY,1.0,L01FX04,Ipilimumab,Solution,Intravenous,77700764,YERVOY (ipilimumab 50 mg per 10 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013173,ipilimumab 50 mg per 10 mL solution for injection vial,8001816,ipilimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
16947,Marketed,2024-03-28,02126222,AA-IPRAVENT,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,02126222,AA-IPRAVENT (ipratropium bromide 250 mcg per mL nebulizer solution 20 mL bottle) AA PHARMA INC,Active,9000527,ipratropium bromide 250 mcg per mL nebulizer solution 20 mL bottle,8000202,ipratropium,738984000,Parenteral,385198000,Solution for nebuliser,,,,,
43176,Marketed,2012-07-12,02216221,TEVA-IPRATROPIUM STERINEBS,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,77700374,TEVA-IPRATROPIUM STERINEBS (ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000754,ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
43176,Marketed,2012-07-12,02216221,TEVA-IPRATROPIUM STERINEBS,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,77700375,TEVA-IPRATROPIUM STERINEBS (ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000756,ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
50442,Marketed,2001-06-08,02231135,PMS-IPRATROPIUM,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,02231135,PMS-IPRATROPIUM (ipratropium bromide 250 mcg per 2 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000755,ipratropium bromide 250 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
50551,Marketed,1997-10-29,02231244,PMS-IPRATROPIUM,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,02231244,PMS-IPRATROPIUM (ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000754,ipratropium bromide 250 mcg per 1 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
50552,Marketed,1997-10-29,02231245,PMS-IPRATROPIUM,1.0,R03BB01,Ipratropium bromide,Solution,Inhalation,02231245,PMS-IPRATROPIUM (ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000756,ipratropium bromide 500 mcg per 2 mL nebulizer solution unit dose vial,8000202,ipratropium,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
63098,Marketed,1999-04-15,02239627,PMS-IPRATROPIUM,1.0,R03BB01,Ipratropium bromide,Solution,Nasal,02239627,PMS-IPRATROPIUM (ipratropium bromide 21 mcg per actuation nasal spray) PHARMASCIENCE INC,Active,9000588,ipratropium bromide 21 mcg per actuation nasal spray,8000202,ipratropium,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
70219,Marketed,2014-05-28,02246084,IPRAVENT,1.0,R01AX03,Ipratropium bromide,Solution,Nasal,02246084,IPRAVENT (ipratropium bromide 42 mcg per actuation nasal spray) AA PHARMA INC,Active,9000640,ipratropium bromide 42 mcg per actuation nasal spray,8000202,ipratropium,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
71950,Marketed,2004-03-24,02247686,ATROVENT HFA,1.0,R03BB01,Ipratropium bromide,Metered-dose aerosol,Inhalation,02247686,ATROVENT HFA (ipratropium bromide 20 mcg per actuation pressurized inhalation) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001074,ipratropium bromide 20 mcg per actuation pressurized inhalation,8000202,ipratropium,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
103113,Marketed,2024-08-15,02542587,JAMP IPRATROPIUM HFA,1.0,R03BB01,Ipratropium bromide,Metered-dose aerosol,Inhalation,02542587,JAMP IPRATROPIUM HFA (ipratropium bromide 20 mcg per actuation pressurized inhalation) JAMP PHARMA CORPORATION,Active,9001074,ipratropium bromide 20 mcg per actuation pressurized inhalation,8000202,ipratropium,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
104318,Marketed,2025-03-28,02554313,FABHALTA,1.0,L04AJ08,Iptacopan,Capsule,Oral,02554313,FABHALTA (iptacopan (iptacopan hydrochloride) 200 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015190,iptacopan (iptacopan hydrochloride) 200 mg oral capsule,8002538,iptacopan,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,
61289,Marketed,2007-05-14,02237924,AVAPRO,1.0,C09CA04,Irbesartan,Tablet,Oral,02237924,AVAPRO (irbesartan 150 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61290,Marketed,2007-05-03,02237925,AVAPRO,1.0,C09CA04,Irbesartan,Tablet,Oral,02237925,AVAPRO (irbesartan 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80190,Marketed,2018-06-11,02316390,TEVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02316390,TEVA-IRBESARTAN (irbesartan 75 mg oral tablet) TEVA CANADA LIMITED,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80191,Marketed,2018-06-11,02316404,TEVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02316404,TEVA-IRBESARTAN (irbesartan 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80192,Marketed,2018-06-11,02316412,TEVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02316412,TEVA-IRBESARTAN (irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80257,Marketed,2011-03-24,02317060,PMS-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02317060,PMS-IRBESARTAN (irbesartan 75 mg oral tablet) PHARMASCIENCE INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80258,Marketed,2011-03-24,02317079,PMS-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02317079,PMS-IRBESARTAN (irbesartan 150 mg oral tablet) PHARMASCIENCE INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80259,Marketed,2011-03-24,02317087,PMS-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02317087,PMS-IRBESARTAN (irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81399,Marketed,2011-03-21,02328461,SANDOZ IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02328461,SANDOZ IRBESARTAN (irbesartan 75 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81400,Marketed,2011-03-21,02328488,SANDOZ IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02328488,SANDOZ IRBESARTAN (irbesartan 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81401,Marketed,2011-03-21,02328496,SANDOZ IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02328496,SANDOZ IRBESARTAN (irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85004,Marketed,2011-05-27,02365197,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02365197,IRBESARTAN (irbesartan 75 mg oral tablet) PRO DOC LIMITEE,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85005,Marketed,2011-05-27,02365200,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02365200,IRBESARTAN (irbesartan 150 mg oral tablet) PRO DOC LIMITEE,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85006,Marketed,2011-05-27,02365219,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02365219,IRBESARTAN (irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85748,Marketed,2025-11-25,02372347,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02372347,IRBESARTAN (irbesartan 75 mg oral tablet) SANIS HEALTH INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85751,Marketed,2024-07-04,02372371,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02372371,IRBESARTAN (irbesartan 150 mg oral tablet) SANIS HEALTH INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85752,Marketed,2025-11-25,02372398,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02372398,IRBESARTAN (irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87092,Marketed,2012-06-10,02385287,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02385287,IRBESARTAN (irbesartan 75 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87093,Marketed,2012-06-10,02385295,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02385295,IRBESARTAN (irbesartan 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87094,Marketed,2012-06-10,02385309,IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02385309,IRBESARTAN (irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89149,Marketed,2020-03-03,02406810,TARO-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02406810,TARO-IRBESARTAN (irbesartan 75 mg oral tablet) SUN PHARMA CANADA INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89150,Marketed,2020-03-03,02406829,TARO-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02406829,TARO-IRBESARTAN (irbesartan 150 mg oral tablet) SUN PHARMA CANADA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89151,Marketed,2020-03-03,02406837,TARO-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02406837,TARO-IRBESARTAN (irbesartan 300 mg oral tablet) SUN PHARMA CANADA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90771,Marketed,2021-05-17,02422980,MINT-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02422980,MINT-IRBESARTAN (irbesartan 75 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90772,Marketed,2021-04-28,02422999,MINT-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02422999,MINT-IRBESARTAN (irbesartan 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90773,Marketed,2021-04-28,02423006,MINT-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02423006,MINT-IRBESARTAN (irbesartan 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101375,Marketed,2023-06-08,02524732,RIVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524732,RIVA-IRBESARTAN (irbesartan 75 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101376,Marketed,2023-06-08,02524740,RIVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524740,RIVA-IRBESARTAN (irbesartan 150 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101377,Marketed,2023-06-08,02524759,RIVA-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524759,RIVA-IRBESARTAN (irbesartan 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101383,Marketed,2022-07-25,02524813,M-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524813,M-IRBESARTAN (irbesartan 75 mg oral tablet) MANTRA PHARMA INC,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101384,Marketed,2022-07-25,02524821,M-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524821,M-IRBESARTAN (irbesartan 150 mg oral tablet) MANTRA PHARMA INC,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101385,Marketed,2022-07-25,02524848,M-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02524848,M-IRBESARTAN (irbesartan 300 mg oral tablet) MANTRA PHARMA INC,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103401,Marketed,2025-02-04,02545225,JAMP IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02545225,JAMP IRBESARTAN (irbesartan 75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103402,Marketed,2025-02-04,02545233,JAMP IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02545233,JAMP IRBESARTAN (irbesartan 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103403,Marketed,2025-02-04,02545241,JAMP IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02545241,JAMP IRBESARTAN (irbesartan 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103710,Marketed,2025-03-12,02548216,AG-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02548216,AG-IRBESARTAN (irbesartan 75 mg oral tablet) ANGITA PHARMA INC.,Active,9000802,irbesartan 75 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103711,Marketed,2025-02-15,02548224,AG-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02548224,AG-IRBESARTAN (irbesartan 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000805,irbesartan 150 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103712,Marketed,2025-02-14,02548232,AG-IRBESARTAN,1.0,C09CA04,Irbesartan,Tablet,Oral,02548232,AG-IRBESARTAN (irbesartan 300 mg oral tablet) ANGITA PHARMA INC.,Active,9000806,irbesartan 300 mg oral tablet,8000259,irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65483,Marketed,2007-06-11,02241818,AVALIDE,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02241818,AVALIDE (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65484,Marketed,2007-05-14,02241819,AVALIDE,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02241819,AVALIDE (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81403,Marketed,2011-03-24,02328518,PMS-IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328518,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) PHARMASCIENCE INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81404,Marketed,2011-03-24,02328526,PMS-IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328526,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81405,Marketed,2011-03-24,02328534,PMS-IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02328534,PMS-IRBESARTAN-HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) PHARMASCIENCE INC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81624,Marketed,2018-06-13,02330512,TEVA-IRBESARTAN HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330512,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81625,Marketed,2018-06-13,02330520,TEVA-IRBESARTAN HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330520,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81626,Marketed,2018-06-13,02330539,TEVA-IRBESARTAN HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02330539,TEVA-IRBESARTAN HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) TEVA CANADA LIMITED,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82301,Marketed,2011-03-21,02337428,SANDOZ IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337428,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82302,Marketed,2011-03-21,02337436,SANDOZ IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337436,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82303,Marketed,2011-03-21,02337444,SANDOZ IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02337444,SANDOZ IRBESARTAN HCT (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85001,Marketed,2018-05-08,02365162,IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365162,IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) PRO DOC LIMITEE,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85002,Marketed,2018-05-04,02365170,IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365170,IRBESARTAN-HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85003,Marketed,2018-05-04,02365189,IRBESARTAN-HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02365189,IRBESARTAN-HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) PRO DOC LIMITEE,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85799,Marketed,2026-01-21,02372886,IRBESARTAN/HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372886,IRBESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SANIS HEALTH INC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85800,Marketed,2026-01-21,02372894,IRBESARTAN/HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372894,IRBESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85801,Marketed,2026-01-21,02372908,IRBESARTAN/HCTZ,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02372908,IRBESARTAN/HCTZ (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SANIS HEALTH INC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87095,Marketed,2012-06-10,02385317,IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385317,IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000887,hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87096,Marketed,2012-06-12,02385325,IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385325,IRBESARTAN HCT (hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000888,hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87097,Marketed,2012-06-10,02385333,IRBESARTAN HCT,2.0,C09DA04,Irbesartan and diuretics,Tablet,Oral,02385333,IRBESARTAN HCT (hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001339,hydrochlorothiazide 25 mg and irbesartan 300 mg oral tablet,8000284,hydrochlorothiazide and irbesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74343,Marketed,2018-03-13,02258218,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700865,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 40 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
74343,Marketed,2018-03-13,02258218,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700866,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
74343,Marketed,2018-03-13,02258218,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700867,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) PFIZER CANADA ULC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
79791,Marketed,2014-04-30,02312409,IRINOTECAN FOR INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700872,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 40 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
79791,Marketed,2014-04-30,02312409,IRINOTECAN FOR INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700873,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
79791,Marketed,2014-04-30,02312409,IRINOTECAN FOR INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700874,IRINOTECAN FOR INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84269,Marketed,2019-01-15,02357585,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700879,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 500 mg per 25 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84269,Marketed,2019-01-15,02357585,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700880,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 40 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
84269,Marketed,2019-01-15,02357585,IRINOTECAN HYDROCHLORIDE INJECTION USP,1.0,L01CE02,Irinotecan,Solution,Intravenous,77700881,IRINOTECAN HYDROCHLORIDE INJECTION USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 100 mg per 5 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93881,Marketed,2024-05-22,02452421,"IRINOTECAN HYDROCHLORIDE INJECTION, USP",1.0,L01CE02,Irinotecan,Solution,Intravenous,77701154,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 40 mg per 2 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012671,irinotecan hydrochloride 40 mg per 2 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93881,Marketed,2024-05-22,02452421,"IRINOTECAN HYDROCHLORIDE INJECTION, USP",1.0,L01CE02,Irinotecan,Solution,Intravenous,77701155,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 100 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93881,Marketed,2024-05-22,02452421,"IRINOTECAN HYDROCHLORIDE INJECTION, USP",1.0,L01CE02,Irinotecan,Solution,Intravenous,77701156,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 300 mg per 15 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012670,irinotecan hydrochloride 300 mg per 15 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93881,Marketed,2024-05-22,02452421,"IRINOTECAN HYDROCHLORIDE INJECTION, USP",1.0,L01CE02,Irinotecan,Solution,Intravenous,77701157,"IRINOTECAN HYDROCHLORIDE INJECTION, USP (irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 500 mg per 25 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95553,Marketed,2024-07-18,02467135,ONIVYDE,1.0,L01CE02,Irinotecan,Suspension,Intravenous,02467135,ONIVYDE (irinotecan (irinotecan sucrose octasulfate liposomal) 43 mg per 10 mL suspension for injection vial) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014222,irinotecan (irinotecan sucrose octasulfate liposomal) 43 mg per 10 mL suspension for injection vial,8002199,irinotecan (liposomal),738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),1.0,,
99090,Marketed,2022-05-19,02501279,IRINOTECAN HYDROCHLORIDE INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,02501279,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) AURO PHARMA INC,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99092,Marketed,2022-05-19,02501295,IRINOTECAN HYDROCHLORIDE INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,02501295,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) AURO PHARMA INC,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
101797,Marketed,2024-02-28,02528789,IRINOTECAN HYDROCHLORIDE INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,02528789,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 500 mg per 25 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012672,irinotecan hydrochloride 500 mg per 25 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
101799,Marketed,2024-08-12,02528800,IRINOTECAN HYDROCHLORIDE INJECTION,1.0,L01CE02,Irinotecan,Solution,Intravenous,02528800,IRINOTECAN HYDROCHLORIDE INJECTION (irinotecan hydrochloride 100 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012669,irinotecan hydrochloride 100 mg per 5 mL solution for injection vial,8002198,irinotecan (conventional),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102454,Marketed,2023-11-03,02535718,PREGNANCY MULTIVITAMIN,17.0,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,
102618,Marketed,2023-12-04,02537478,PREGNANCY MULTIVITAMIN FOLIC 5,17.0,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,
104157,Marketed,2025-02-06,02552620,PREGVIT,17.0,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,
104158,Marketed,2025-03-31,02552639,PREGVIT FOLIC 5,17.0,B03AE04,"Iron, multivitamins and minerals",Tablet,Oral,,,,,,,,,,,,,,,,
67236,Marketed,2010-02-26,02243333,FERRLECIT,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02243333,FERRLECIT (iron (sodium ferric gluconate complex) 62.5 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013823,iron (sodium ferric gluconate complex) 62.5 mg per 5 mL solution for injection vial,8002232,sodium ferric gluconate complex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
67648,Marketed,2019-06-19,02243716,VENOFER,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02243716,"VENOFER (iron (iron sucrose) 100 mg per 5 mL solution for injection vial) AMERICAN REGENT, INC",Active,9013439,iron (iron sucrose) 100 mg per 5 mL solution for injection vial,8002230,iron sucrose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96866,Marketed,2022-01-14,02477777,MONOFERRIC,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700987,MONOFERRIC (iron (ferric derisomaltose) 1000 mg per 10 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013691,iron (ferric derisomaltose) 1000 mg per 10 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96866,Marketed,2022-01-14,02477777,MONOFERRIC,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700988,MONOFERRIC (iron (ferric derisomaltose) 500 mg per 5 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013692,iron (ferric derisomaltose) 500 mg per 5 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96866,Marketed,2022-01-14,02477777,MONOFERRIC,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,77700989,MONOFERRIC (iron (ferric derisomaltose) 100 mg per 1 mL solution for injection vial) PHARMACOSMOS A/S,Active,9013690,iron (ferric derisomaltose) 100 mg per 1 mL solution for injection vial,8002229,ferric derisomaltose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99244,Marketed,2021-01-12,02502917,PMS-IRON SUCROSE,1.0,B03AC,"Iron, parenteral preparations",Solution,Intravenous,02502917,PMS-IRON SUCROSE (iron (iron sucrose) 100 mg per 5 mL solution for injection vial) PHARMASCIENCE INC,Active,9013439,iron (iron sucrose) 100 mg per 5 mL solution for injection vial,8002230,iron sucrose,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103479,Marketed,2024-11-07,02546078,FERINJECT,1.0,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701170,FERINJECT (iron (ferric carboxymaltose) 100 mg per 2 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015168,iron (ferric carboxymaltose) 100 mg per 2 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Injection,1230185002,Dispersion for injection,733026001,Vial,,,
103479,Marketed,2024-11-07,02546078,FERINJECT,1.0,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701171,FERINJECT (iron (ferric carboxymaltose) 500 mg per 10 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015169,iron (ferric carboxymaltose) 500 mg per 10 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Injection,1230185002,Dispersion for injection,733026001,Vial,,,
103479,Marketed,2024-11-07,02546078,FERINJECT,1.0,B03AC,"Iron, parenteral preparations",Dispersion,Intravenous,77701172,FERINJECT (iron (ferric carboxymaltose) 1000 mg per 20 mL dispersion for injection vial) VIFOR (INTERNATIONAL) INC.,Active,9015167,iron (ferric carboxymaltose) 1000 mg per 20 mL dispersion for injection vial,8002527,ferric carboxymaltose,738984000,Injection,1230185002,Dispersion for injection,733026001,Vial,,,
98801,Marketed,2020-07-03,02498235,SARCLISA,1.0,L01FC02,Isatuximab,Solution,Intravenous,02498235,SARCLISA (isatuximab 100 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014327,isatuximab 100 mg per 5 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98802,Marketed,2020-07-03,02498243,SARCLISA,1.0,L01FC02,Isatuximab,Solution,Intravenous,02498243,SARCLISA (isatuximab 500 mg per 25 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9014328,isatuximab 500 mg per 25 mL solution for injection vial,8002334,isatuximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97432,Marketed,2019-05-02,02483971,CRESEMBA,1.0,J02AC05,Isavuconazole,Capsule,Oral,02483971,CRESEMBA (isavuconazole (isavuconazonium sulfate) 100 mg oral capsule) AVIR PHARMA INC.,Active,9013965,isavuconazole (isavuconazonium sulfate) 100 mg oral capsule,8002259,isavuconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97433,Marketed,2019-05-31,02483998,CRESEMBA,1.0,J02AC05,Isavuconazole,Powder for solution,Intravenous,02483998,CRESEMBA (isavuconazole (isavuconazonium sulfate) 200 mg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9013966,isavuconazole (isavuconazonium sulfate) 200 mg per vial powder for solution for injection,8002259,isavuconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
104221,Marketed,2025-05-12,02553279,CRESEMBA,1.0,J02AC05,Isavuconazole,Capsule,Oral,02553279,CRESEMBA (isavuconazole (isavuconazonium sulfate) 40 mg oral capsule) AVIR PHARMA INC.,Active,9015203,isavuconazole (isavuconazonium sulfate) 40 mg oral capsule,8002259,isavuconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
20160,Marketed,2000-01-01,02188856,FORANE,1.0,N01AB06,Isoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
51381,Marketed,2015-09-25,02231929,ISOFLURANE USP,1.0,N01AB06,Isoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
5718,Marketed,2015-01-16,00577790,PDP-ISONIAZID,1.0,J04AC01,Isoniazid,Tablet,Oral,00577790,PDP-ISONIAZID (isoniazid 100 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001689,isoniazid 100 mg oral tablet,8001395,isoniazid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5719,Marketed,2015-01-20,00577804,PDP-ISONIAZID,1.0,J04AC01,Isoniazid,Tablet,Oral,00577804,PDP-ISONIAZID (isoniazid 300 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001690,isoniazid 300 mg oral tablet,8001395,isoniazid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5720,Marketed,2015-05-04,00577812,PDP-ISONIAZID,1.0,J04AC01,Isoniazid,Solution,Oral,00577812,PDP-ISONIAZID (isoniazid 50 mg per 5 mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002027,isoniazid 50 mg per 5 mL oral solution,8001395,isoniazid,26643006,Oral,385023001,Oral solution,,,,,
11642,Marketed,2005-10-05,00897639,ISOPROTERENOL HYDROCHLORIDE INJECTION USP,1.0,C01CA02,Isoprenaline,Solution,"Intravenous,Subcutaneous,Intramuscular",77700709,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013175,isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
11642,Marketed,2005-10-05,00897639,ISOPROTERENOL HYDROCHLORIDE INJECTION USP,1.0,C01CA02,Isoprenaline,Solution,"Intravenous,Subcutaneous,Intramuscular",77700710,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013174,isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection ampoule,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
99218,Marketed,2020-12-11,02502615,ISOPROTERENOL HYDROCHLORIDE INJECTION USP,1.0,C01CA02,Isoprenaline,Solution,"Intramuscular,Intravenous,Subcutaneous",02502615,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9014455,isoproterenol hydrochloride 0.2 mg per 1 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99219,Marketed,2021-01-06,02502623,ISOPROTERENOL HYDROCHLORIDE INJECTION USP,1.0,C01CA02,Isoprenaline,Solution,"Intravenous,Intramuscular,Subcutaneous",02502623,ISOPROTERENOL HYDROCHLORIDE INJECTION USP (isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013175,isoproterenol hydrochloride 1 mg per 5 mL solution for injection vial,8001820,isoproterenol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
4730,Marketed,2011-08-17,00441686,ISDN,1.0,C01DA08,Isosorbide dinitrate,Tablet,Oral,00441686,ISDN (isosorbide dinitrate 10 mg oral tablet) AA PHARMA INC,Active,9001942,isosorbide dinitrate 10 mg oral tablet,8000830,isosorbide dinitrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4731,Marketed,2011-05-10,00441694,ISDN,1.0,C01DA08,Isosorbide dinitrate,Tablet,Oral,00441694,ISDN (isosorbide dinitrate 30 mg oral tablet) AA PHARMA INC,Active,9001943,isosorbide dinitrate 30 mg oral tablet,8000830,isosorbide dinitrate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16804,Marketed,2022-12-15,02126559,IMDUR,1.0,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02126559,IMDUR (isosorbide mononitrate 60 mg prolonged-release oral tablet) JUNO PHARMACEUTICALS CORP.,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75834,Marketed,2006-03-03,02272830,APO-ISMN,1.0,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02272830,APO-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) APOTEX INC,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78661,Marketed,2007-11-08,02301288,PMS-ISMN,1.0,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02301288,PMS-ISMN (isosorbide mononitrate 60 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
79692,Marketed,2008-07-04,02311321,PRO-ISMN - 60,1.0,C01DA14,Isosorbide mononitrate,Tablet (extended-release),Oral,02311321,PRO-ISMN - 60 (isosorbide mononitrate 60 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000528,isosorbide mononitrate 60 mg prolonged-release oral tablet,8000203,isosorbide mononitrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
64397,Marketed,2024-04-12,02240806,EXTRANEAL,5.0,B05DA,Isotonic solutions,Solution,Haemodialysis (intraperitoneal),,,,,,,,,,,,,,,,
5128,Marketed,2025-09-10,00582344,ACCUTANE,1.0,D10BA01,Isotretinoin,Capsule,Oral,00582344,ACCUTANE (isotretinoin 10 mg oral capsule) CHEPLAPHARM SCHWEIZ GMBH,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
5129,Marketed,2025-09-05,00582352,ACCUTANE,1.0,D10BA01,Isotretinoin,Capsule,Oral,00582352,ACCUTANE (isotretinoin 40 mg oral capsule) CHEPLAPHARM SCHWEIZ GMBH,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
74319,Marketed,2010-03-01,02257955,CLARUS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02257955,CLARUS (isotretinoin 10 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
74320,Marketed,2010-03-01,02257963,CLARUS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02257963,CLARUS (isotretinoin 40 mg oral capsule) MYLAN PHARMACEUTICALS ULC,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88198,Marketed,2013-05-07,02396971,EPURIS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02396971,EPURIS (isotretinoin 10 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001985,isotretinoin 10 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88199,Marketed,2013-05-07,02396998,EPURIS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02396998,EPURIS (isotretinoin 20 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9005240,isotretinoin 20 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88200,Marketed,2013-05-07,02397005,EPURIS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02397005,EPURIS (isotretinoin 30 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9005241,isotretinoin 30 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88201,Marketed,2013-05-07,02397013,EPURIS,1.0,D10BA01,Isotretinoin,Capsule,Oral,02397013,EPURIS (isotretinoin 40 mg oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001986,isotretinoin 40 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102771,Marketed,2023-09-26,02539047,ABSORICA LD,1.0,D10BA01,Isotretinoin,Capsule,Oral,02539047,ABSORICA LD (isotretinoin 8 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014917,isotretinoin 8 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102772,Marketed,2023-09-26,02539055,ABSORICA LD,1.0,D10BA01,Isotretinoin,Capsule,Oral,02539055,ABSORICA LD (isotretinoin 16 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014914,isotretinoin 16 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102773,Marketed,2023-09-26,02539063,ABSORICA LD,1.0,D10BA01,Isotretinoin,Capsule,Oral,02539063,ABSORICA LD (isotretinoin 24 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014915,isotretinoin 24 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102774,Marketed,2023-09-26,02539071,ABSORICA LD,1.0,D10BA01,Isotretinoin,Capsule,Oral,02539071,ABSORICA LD (isotretinoin 32 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014916,isotretinoin 32 mg oral capsule,8001283,isotretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
14518,Marketed,2002-06-20,02047454,SPORANOX,1.0,J02AC02,Itraconazole,Capsule,Oral,02047454,SPORANOX (itraconazole 100 mg oral capsule) JANSSEN INC,Active,9002587,itraconazole 100 mg oral capsule,8001208,itraconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95031,Marketed,2017-05-18,02462559,MINT-ITRACONAZOLE,1.0,J02AC02,Itraconazole,Capsule,Oral,02462559,MINT-ITRACONAZOLE (itraconazole 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9002587,itraconazole 100 mg oral capsule,8001208,itraconazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97463,Marketed,2019-07-31,02484315,JAMP ITRACONAZOLE ORAL SOLUTION,1.0,J02AC02,Itraconazole,Solution,Oral,02484315,JAMP ITRACONAZOLE ORAL SOLUTION (itraconazole 10 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9003125,itraconazole 10 mg per mL oral solution,8001208,itraconazole,26643006,Oral,385023001,Oral solution,,,,,
98587,Marketed,2020-07-08,02495988,ODAN ITRACONAZOLE,1.0,J02AC02,Itraconazole,Solution,Oral,02495988,ODAN ITRACONAZOLE (itraconazole 10 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9003125,itraconazole 10 mg per mL oral solution,8001208,itraconazole,26643006,Oral,385023001,Oral solution,,,,,
94728,Marketed,2017-03-17,02459973,LANCORA,1.0,C01EB17,Ivabradine,Tablet,Oral,02459973,LANCORA (ivabradine (ivabradine hydrochloride) 5 mg oral tablet) SERVIER CANADA INC,Active,9006137,ivabradine (ivabradine hydrochloride) 5 mg oral tablet,8001821,ivabradine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94729,Marketed,2017-03-17,02459981,LANCORA,1.0,C01EB17,Ivabradine,Tablet,Oral,02459981,LANCORA (ivabradine (ivabradine hydrochloride) 7.5 mg oral tablet) SERVIER CANADA INC,Active,9006138,ivabradine (ivabradine hydrochloride) 7.5 mg oral tablet,8001821,ivabradine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88237,Marketed,2012-11-27,02397412,KALYDECO,1.0,R07AX02,Ivacaftor,Tablet,Oral,02397412,KALYDECO (ivacaftor 150 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9005135,ivacaftor 150 mg oral tablet,8001663,ivacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92696,Marketed,2015-09-14,02442612,KALYDECO,1.0,R07AX02,Ivacaftor,Granules,Oral,02442612,KALYDECO (ivacaftor 50 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014698,ivacaftor 50 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
92697,Marketed,2015-09-14,02442620,KALYDECO,1.0,R07AX02,Ivacaftor,Granules,Oral,02442620,KALYDECO (ivacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014699,ivacaftor 75 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
100863,Marketed,2021-09-01,02519364,KALYDECO,1.0,R07AX02,Ivacaftor,Granules,Oral,02519364,KALYDECO (ivacaftor 25 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014697,ivacaftor 25 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
103192,Marketed,2023-12-07,02543451,KALYDECO,1.0,R07AX02,Ivacaftor,Granules,Oral,02543451,KALYDECO (ivacaftor 13.4 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9015063,ivacaftor 13.4 mg per sachet oral granules,8001663,ivacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
93762,Marketed,2016-01-27,02451379,ORKAMBI,2.0,R07AX30,Ivacaftor and lumacaftor,Tablet,Oral,02451379,ORKAMBI (ivacaftor 125 mg and lumacaftor 200 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9005865,ivacaftor 125 mg and lumacaftor 200 mg oral tablet,8001664,ivacaftor and lumacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95094,Marketed,2017-05-03,02463040,ORKAMBI,2.0,R07AX30,Ivacaftor and lumacaftor,Tablet,Oral,02463040,ORKAMBI (ivacaftor 125 mg and lumacaftor 100 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9006170,ivacaftor 125 mg and lumacaftor 100 mg oral tablet,8001664,ivacaftor and lumacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97420,Marketed,2018-12-14,02483831,ORKAMBI,2.0,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02483831,ORKAMBI (ivacaftor 125 mg per sachet and lumacaftor 100 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014695,ivacaftor 125 mg per sachet and lumacaftor 100 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
97421,Marketed,2018-12-14,02483858,ORKAMBI,2.0,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02483858,ORKAMBI (ivacaftor 188 mg per sachet and lumacaftor 150 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014696,ivacaftor 188 mg per sachet and lumacaftor 150 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
102579,Marketed,2023-04-14,02537087,ORKAMBI,2.0,R07AX30,Ivacaftor and lumacaftor,Granules,Oral,02537087,ORKAMBI (ivacaftor 94 mg per sachet and lumacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014846,ivacaftor 94 mg per sachet and lumacaftor 75 mg per sachet oral granules,8001664,ivacaftor and lumacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
96881,Marketed,2018-06-28,02478080,SYMDEKO,3.0,R07AX31,Ivacaftor and tezacaftor,Tablet,Oral,02478080,SYMDEKO (ivacaftor 150 mg oral tablet with ivacaftor 150 mg and tezacaftor 100 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9013441,ivacaftor 150 mg oral tablet with ivacaftor 150 mg and tezacaftor 100 mg oral tablet,8002027,ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100648,Marketed,2021-06-22,02517140,TRIKAFTA,4.0,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Tablet,Oral,02517140,TRIKAFTA (elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet with ivacaftor 150 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014544,elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet with ivacaftor 150 mg oral tablet,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101574,Marketed,2022-04-22,02526670,TRIKAFTA,4.0,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Tablet,Oral,02526670,TRIKAFTA (elexacaftor 50 mg and ivacaftor 37.5 mg and tezacaftor 25 mg oral tablet with ivacaftor 75 mg oral tablet) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014692,elexacaftor 50 mg and ivacaftor 37.5 mg and tezacaftor 25 mg oral tablet with ivacaftor 75 mg oral tablet,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103085,Marketed,2023-10-27,02542277,TRIKAFTA,4.0,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Granules,Oral,02542277,TRIKAFTA (elexacaftor 100 mg per sachet and ivacaftor 75 mg per sachet and tezacaftor 50 mg per sachet oral granules with ivacaftor 75 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014977,elexacaftor 100 mg per sachet and ivacaftor 75 mg per sachet and tezacaftor 50 mg per sachet oral granules with ivacaftor 75 mg per sachet oral granules,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
103086,Marketed,2023-10-27,02542285,TRIKAFTA,4.0,R07AX32,"Ivacaftor, tezacaftor and elexacaftor",Granules,Oral,02542285,TRIKAFTA (elexacaftor 80 mg per sachet and ivacaftor 60 mg per sachet and tezacaftor 40 mg per sachet oral granules with ivacaftor 59.5 mg per sachet oral granules) VERTEX PHARMACEUTICALS (CANADA) INCORPORATED,Active,9014978,elexacaftor 80 mg per sachet and ivacaftor 60 mg per sachet and tezacaftor 40 mg per sachet oral granules with ivacaftor 59.5 mg per sachet oral granules,8002373,elexacaftor and ivacaftor and tezacaftor,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
92470,Marketed,2015-05-25,02440342,ROSIVER,1.0,D11AX22,Ivermectin,Cream,Topical,02440342,ROSIVER (ivermectin 1 % cutaneous cream) GALDERMA CANADA INC.,Active,9005722,ivermectin 1 % cutaneous cream,8001486,ivermectin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
97110,Marketed,2018-11-06,02480557,STROMECTOL,1.0,P02CF01,Ivermectin,Tablet,Oral,02480557,STROMECTOL (ivermectin 3 mg oral tablet) MERCK CANADA INC,Active,9013442,ivermectin 3 mg oral tablet,8001486,ivermectin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103879,Marketed,2024-10-28,02549980,TIBSOVO,1.0,L01XM02,Ivosidenib,Tablet (immediate release),Oral,02549980,TIBSOVO (ivosidenib 250 mg oral tablet) SERVIER CANADA INC,Active,9015121,ivosidenib 250 mg oral tablet,8002520,ivosidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
94382,Marketed,2016-09-21,02456796,NINLARO,1.0,L01XG03,Ixazomib,Capsule,Oral,02456796,NINLARO (ixazomib (ixazomib citrate) 2.3 mg oral capsule) TAKEDA CANADA INC,Active,9006040,ixazomib (ixazomib citrate) 2.3 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94383,Marketed,2016-09-21,02456818,NINLARO,1.0,L01XG03,Ixazomib,Capsule,Oral,02456818,NINLARO (ixazomib (ixazomib citrate) 3 mg oral capsule) TAKEDA CANADA INC,Active,9006041,ixazomib (ixazomib citrate) 3 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94384,Marketed,2016-09-21,02456826,NINLARO,1.0,L01XG03,Ixazomib,Capsule,Oral,02456826,NINLARO (ixazomib (ixazomib citrate) 4 mg oral capsule) TAKEDA CANADA INC,Active,9006042,ixazomib (ixazomib citrate) 4 mg oral capsule,8001822,ixazomib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94193,Marketed,2023-03-20,02455102,TALTZ,1.0,L04AC13,Ixekizumab,Solution,Subcutaneous,02455102,TALTZ AUTOINJECTOR (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94194,Marketed,2023-04-12,02455110,TALTZ,1.0,L04AC13,Ixekizumab,Solution,Subcutaneous,02455110,TALTZ SYRINGE (ixekizumab 80 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9013176,ixekizumab 80 mg per 1 mL solution for injection syringe,8001823,ixekizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
1214,Marketed,2023-10-16,00224391,KETALAR,1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",00224391,KETALAR (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1215,Marketed,2024-02-12,00224405,KETALAR,1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",00224405,KETALAR (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) SEARCHLIGHT PHARMA INC,Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70995,Marketed,2005-09-21,02246795,KETAMINE HYDROCHLORIDE INJECTION USP,1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",77700929,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013444,ketamine (ketamine hydrochloride) 20 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70995,Marketed,2005-09-21,02246795,KETAMINE HYDROCHLORIDE INJECTION USP,1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",77700930,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70996,Marketed,2005-09-21,02246796,KETAMINE HYDROCHLORIDE INJECTION USP,1.0,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700931,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013443,ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70996,Marketed,2005-09-21,02246796,KETAMINE HYDROCHLORIDE INJECTION USP,1.0,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",77700932,KETAMINE HYDROCHLORIDE INJECTION USP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102449,Marketed,2023-11-14,02535645,"KETAMINE INJECTION, BP",1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",77701132,"KETAMINE INJECTION, BP (ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial) STERIMAX INC",Active,9013443,ketamine (ketamine hydrochloride) 100 mg per 2 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102449,Marketed,2023-11-14,02535645,"KETAMINE INJECTION, BP",1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",77701133,"KETAMINE INJECTION, BP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) STERIMAX INC",Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103925,Marketed,2025-12-03,02550431,"KETAMINE HYDROCHLORIDE INJECTION, USP",1.0,N01AX03,Ketamine,Solution,"Intramuscular,Intravenous",02550431,"KETAMINE HYDROCHLORIDE INJECTION, USP (ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013445,ketamine (ketamine hydrochloride) 200 mg per 20 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103926,Marketed,2025-12-03,02550458,"KETAMINE HYDROCHLORIDE INJECTION, USP",1.0,N01AX03,Ketamine,Solution,"Intravenous,Intramuscular",02550458,"KETAMINE HYDROCHLORIDE INJECTION, USP (ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013446,ketamine (ketamine hydrochloride) 500 mg per 10 mL solution for injection vial,8002028,ketamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
44259,Marketed,2019-03-18,02182920,NIZORAL,1.0,D01AC08,Ketoconazole,Shampoo,Topical,02182920,"NIZORAL (ketoconazole 2 % shampoo) KRAMER LABORATORIES, INC",Active,9002234,ketoconazole 2 % shampoo,8001209,ketoconazole,41695006,Scalp structure,785908001,Shampoo,,,,,
50343,Marketed,2014-03-29,02231061,TEVA-KETOCONAZOLE,1.0,J02AB02,Ketoconazole,Tablet,Oral,02231061,TEVA-KETOCONAZOLE (ketoconazole 200 mg oral tablet) TEVA CANADA LIMITED,Active,9003213,ketoconazole 200 mg oral tablet,8001209,ketoconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60554,Marketed,2021-11-08,02237235,APO-KETOCONAZOLE,1.0,J02AB02,Ketoconazole,Tablet,Oral,02237235,APO-KETOCONAZOLE (ketoconazole 200 mg oral tablet) APOTEX INC,Active,9003213,ketoconazole 200 mg oral tablet,8001209,ketoconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69762,Marketed,2004-03-19,02245662,KETODERM CREAM 2%,1.0,D01AC08,Ketoconazole,Cream,Topical,02245662,"KETODERM CREAM 2% (ketoconazole 2 % cutaneous cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9003719,ketoconazole 2 % cutaneous cream,8001209,ketoconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
10134,Marketed,2012-01-03,00842664,KETOPROFEN-E,1.0,M01AE03,Ketoprofen,Tablet (enteric-coated),Oral,00842664,KETOPROFEN-E (ketoprofen 100 mg gastro-resistant tablet) AA PHARMA INC,Active,9002201,ketoprofen 100 mg gastro-resistant tablet,8001824,ketoprofen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
10135,Marketed,2011-02-17,00790435,KETOPROFEN-E,1.0,M01AE03,Ketoprofen,Tablet (enteric-coated),Oral,00790435,KETOPROFEN-E (ketoprofen 50 mg gastro-resistant tablet) AA PHARMA INC,Active,9002202,ketoprofen 50 mg gastro-resistant tablet,8001824,ketoprofen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
19115,Marketed,2011-06-01,02172577,KETOPROFEN SR,1.0,M01AE03,Ketoprofen,Tablet (extended-release),Oral,02172577,KETOPROFEN SR (ketoprofen 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002832,ketoprofen 200 mg prolonged-release oral tablet,8001824,ketoprofen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
13121,Marketed,2023-10-05,01968300,ACULAR,1.0,S01BC05,Ketorolac,Solution,Ophthalmic,01968300,ACULAR (ketorolac tromethamine 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9000427,ketorolac tromethamine 0.5 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
19348,Marketed,2018-07-30,02162660,TORADOL,1.0,M01AB15,Ketorolac,Tablet,Oral,02162660,TORADOL (ketorolac tromethamine 10 mg oral tablet) AA PHARMA INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43510,Marketed,2017-12-11,02229080,APO-KETOROLAC,1.0,M01AB15,Ketorolac,Tablet,Oral,02229080,APO-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) APOTEX INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
44090,Marketed,2015-11-16,02162644,TORADOL IM,1.0,M01AB15,Ketorolac,Solution,Intramuscular,02162644,TORADOL IM (ketorolac tromethamine 10 mg per 1 mL solution for injection ampoule) ATNAHS PHARMA UK LIMITED,Active,9000663,ketorolac tromethamine 10 mg per 1 mL solution for injection ampoule,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
63447,Marketed,2005-09-21,02239944,KETOROLAC TROMETHAMINE INJECTION USP,1.0,M01AB15,Ketorolac,Solution,Intramuscular,02239944,KETOROLAC TROMETHAMINE INJECTION USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68945,Marketed,2015-08-27,02244947,"KETOROLAC TROMETHAMINE INJECTION, USP",1.0,M01AB15,Ketorolac,Liquid,Intramuscular,77700088,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68945,Marketed,2015-08-27,02244947,"KETOROLAC TROMETHAMINE INJECTION, USP",1.0,M01AB15,Ketorolac,Liquid,Intramuscular,77700089,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 60 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9000986,ketorolac tromethamine 60 mg per 2 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
69937,Marketed,2014-08-19,02245821,KETOROLAC,1.0,S01BC05,Ketorolac,Solution,Ophthalmic,02245821,KETOROLAC (ketorolac tromethamine 0.5 % ophthalmic drops) AA PHARMA INC,Active,9000427,ketorolac tromethamine 0.5 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
85428,Marketed,2024-06-04,02369362,ACUVAIL,1.0,S01BC05,Ketorolac,Solution,Ophthalmic,02369362,ACUVAIL (ketorolac tromethamine 0.45 % ophthalmic drops) ABBVIE CORPORATION,Active,9001373,ketorolac tromethamine 0.45 % ophthalmic drops,8000169,ketorolac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
87600,Marketed,2019-01-07,02390582,KETOROLAC TROMETHAMINE INJECTION USP,1.0,M01AB15,Ketorolac,Solution,Intramuscular,02390582,KETOROLAC TROMETHAMINE INJECTION USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92801,Marketed,2021-07-27,02443376,"KETOROLAC TROMETHAMINE INJECTION, USP",1.0,M01AB15,Ketorolac,Solution,Intramuscular,02443376,"KETOROLAC TROMETHAMINE INJECTION, USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.",Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94908,Marketed,2019-06-28,02461455,MINT-KETOROLAC,1.0,M01AB15,Ketorolac,Tablet,Oral,02461455,MINT-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95332,Marketed,2017-08-16,02465124,MAR-KETOROLAC,1.0,M01AB15,Ketorolac,Tablet,Oral,02465124,MAR-KETOROLAC (ketorolac tromethamine 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100012,Marketed,2023-04-18,02510855,JAMP KETOROLAC,1.0,M01AB15,Ketorolac,Tablet,Oral,02510855,JAMP KETOROLAC (ketorolac tromethamine 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000590,ketorolac tromethamine 10 mg oral tablet,8000169,ketorolac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101242,Marketed,2024-01-29,02523310,KETOROLAC TROMETHAMINE INJECTION USP,1.0,M01AB15,Ketorolac,Solution,Intramuscular,02523310,KETOROLAC TROMETHAMINE INJECTION USP (ketorolac tromethamine 30 mg per 1 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9000848,ketorolac tromethamine 30 mg per 1 mL solution for injection vial,8000169,ketorolac,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10832,Marketed,2010-11-02,00577308,ZADITEN,1.0,R06AX17,Ketotifen,Tablet,Oral,00577308,ZADITEN (ketotifen (ketotifen fumarate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9002311,ketotifen (ketotifen fumarate) 1 mg oral tablet,8001396,ketotifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66035,Marketed,2012-08-10,02242324,ZADITOR,1.0,S01GX08,Ketotifen,Solution,Ophthalmic,02242324,ZADITOR (ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops) LABORATOIRES THEA,Active,9003504,ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops,8001396,ketotifen,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
103126,Marketed,2025-02-21,02542722,JAMP KETOTIFEN OPHTHALMIC,1.0,S01GX08,Ketotifen,Solution,Ophthalmic,02542722,JAMP KETOTIFEN OPHTHALMIC (ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003504,ketotifen (ketotifen fumarate) 0.25 mg per mL ophthalmic drops,8001396,ketotifen,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
29542,Marketed,2025-12-29,02106272,TRANDATE,1.0,C07AG01,Labetalol,Tablet,Oral,02106272,TRANDATE (labetalol hydrochloride 100 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
29543,Marketed,2025-12-29,02106280,TRANDATE,1.0,C07AG01,Labetalol,Tablet,Oral,02106280,TRANDATE (labetalol hydrochloride 200 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51066,Marketed,2005-09-21,02231689,LABETALOL HYDROCHLORIDE INJECTION USP,1.0,C07AG01,Labetalol,Solution,Intravenous,02231689,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
67456,Marketed,2020-07-14,02243538,APO-LABETALOL,1.0,C07AG01,Labetalol,Tablet,Oral,02243538,APO-LABETALOL (labetalol hydrochloride 100 mg oral tablet) APOTEX INC,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67457,Marketed,2020-07-14,02243539,APO-LABETALOL,1.0,C07AG01,Labetalol,Tablet,Oral,02243539,APO-LABETALOL (labetalol hydrochloride 200 mg oral tablet) APOTEX INC,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87077,Marketed,2021-05-26,02385120,LABETALOL HYDROCHLORIDE INJECTION USP,1.0,C07AG01,Labetalol,Solution,Intravenous,02385120,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) STERIMAX INC,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87646,Marketed,2017-08-01,02391090,LABETALOL HYDROCHLORIDE INJECTION USP,1.0,C07AG01,Labetalol,Solution,Intravenous,02391090,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94413,Marketed,2018-06-02,02457040,LABETALOL HYDROCHLORIDE INJECTION,1.0,C07AG01,Labetalol,Solution,Intravenous,77700628,LABETALOL HYDROCHLORIDE INJECTION (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94413,Marketed,2018-06-02,02457040,LABETALOL HYDROCHLORIDE INJECTION,1.0,C07AG01,Labetalol,Solution,Intravenous,77700629,LABETALOL HYDROCHLORIDE INJECTION (labetalol hydrochloride 200 mg per 40 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9010188,labetalol hydrochloride 200 mg per 40 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97949,Marketed,2019-09-04,02489406,RIVA-LABETALOL,1.0,C07AG01,Labetalol,Tablet,Oral,02489406,RIVA-LABETALOL (labetalol hydrochloride 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9010185,labetalol hydrochloride 100 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97950,Marketed,2019-09-04,02489414,RIVA-LABETALOL,1.0,C07AG01,Labetalol,Tablet,Oral,02489414,RIVA-LABETALOL (labetalol hydrochloride 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9010187,labetalol hydrochloride 200 mg oral tablet,8000894,labetalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103015,Marketed,2024-05-24,02541505,LABETALOL HYDROCHLORIDE INJECTION USP,1.0,C07AG01,Labetalol,Solution,Intravenous,02541505,LABETALOL HYDROCHLORIDE INJECTION USP (labetalol hydrochloride 100 mg per 20 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9010186,labetalol hydrochloride 100 mg per 20 mL solution for injection vial,8000894,labetalol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84272,Marketed,2010-10-21,02357615,VIMPAT,1.0,N03AX18,Lacosamide,Tablet,Oral,02357615,VIMPAT (lacosamide 50 mg oral tablet) UCB CANADA INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84273,Marketed,2010-10-21,02357623,VIMPAT,1.0,N03AX18,Lacosamide,Tablet,Oral,02357623,VIMPAT (lacosamide 100 mg oral tablet) UCB CANADA INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84274,Marketed,2010-10-21,02357631,VIMPAT,1.0,N03AX18,Lacosamide,Tablet,Oral,02357631,VIMPAT (lacosamide 150 mg oral tablet) UCB CANADA INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84275,Marketed,2010-10-21,02357658,VIMPAT,1.0,N03AX18,Lacosamide,Tablet,Oral,02357658,VIMPAT (lacosamide 200 mg oral tablet) UCB CANADA INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84276,Marketed,2011-09-20,02357666,VIMPAT,1.0,N03AX18,Lacosamide,Solution,Intravenous,02357666,VIMPAT (lacosamide 200 mg per 20 mL solution for injection vial) UCB CANADA INC,Active,9013302,lacosamide 200 mg per 20 mL solution for injection vial,8001825,lacosamide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96224,Marketed,2018-10-01,02472902,TEVA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02472902,TEVA-LACOSAMIDE (lacosamide 50 mg oral tablet) TEVA CANADA LIMITED,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96225,Marketed,2018-10-01,02472910,TEVA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02472910,TEVA-LACOSAMIDE (lacosamide 100 mg oral tablet) TEVA CANADA LIMITED,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96226,Marketed,2018-10-01,02472929,TEVA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02472929,TEVA-LACOSAMIDE (lacosamide 150 mg oral tablet) TEVA CANADA LIMITED,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96228,Marketed,2018-10-01,02472937,TEVA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02472937,TEVA-LACOSAMIDE (lacosamide 200 mg oral tablet) TEVA CANADA LIMITED,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96485,Marketed,2018-10-01,02474670,SANDOZ LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02474670,SANDOZ LACOSAMIDE (lacosamide 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96486,Marketed,2018-10-01,02474689,SANDOZ LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02474689,SANDOZ LACOSAMIDE (lacosamide 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96487,Marketed,2018-10-01,02474697,SANDOZ LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02474697,SANDOZ LACOSAMIDE (lacosamide 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96488,Marketed,2018-10-01,02474700,SANDOZ LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02474700,SANDOZ LACOSAMIDE (lacosamide 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96571,Marketed,2018-10-01,02475332,AURO-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02475332,AURO-LACOSAMIDE (lacosamide 50 mg oral tablet) AURO PHARMA INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96572,Marketed,2018-10-01,02475340,AURO-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02475340,AURO-LACOSAMIDE (lacosamide 100 mg oral tablet) AURO PHARMA INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96573,Marketed,2018-10-01,02475359,AURO-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02475359,AURO-LACOSAMIDE (lacosamide 150 mg oral tablet) AURO PHARMA INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96574,Marketed,2018-10-01,02475367,AURO-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02475367,AURO-LACOSAMIDE (lacosamide 200 mg oral tablet) AURO PHARMA INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96892,Marketed,2018-10-01,02478196,PHARMA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02478196,PHARMA-LACOSAMIDE (lacosamide 50 mg oral tablet) PHARMASCIENCE INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96893,Marketed,2018-10-01,02478218,PHARMA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02478218,PHARMA-LACOSAMIDE (lacosamide 100 mg oral tablet) PHARMASCIENCE INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96894,Marketed,2018-10-01,02478226,PHARMA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02478226,PHARMA-LACOSAMIDE (lacosamide 150 mg oral tablet) PHARMASCIENCE INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96895,Marketed,2018-10-01,02478234,PHARMA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02478234,PHARMA-LACOSAMIDE (lacosamide 200 mg oral tablet) PHARMASCIENCE INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97796,Marketed,2025-11-17,02487802,ZDS-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02487802,ZDS-LACOSAMIDE (lacosamide 50 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97797,Marketed,2025-11-17,02487810,ZDS-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02487810,ZDS-LACOSAMIDE (lacosamide 100 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97798,Marketed,2025-11-17,02487829,ZDS-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02487829,ZDS-LACOSAMIDE (lacosamide 150 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97799,Marketed,2025-11-17,02487837,ZDS-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02487837,ZDS-LACOSAMIDE (lacosamide 200 mg oral tablet) ZYDUS PHARMACEUTICALS (CANADA) INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97848,Marketed,2020-03-06,02488388,JAMP-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02488388,JAMP-LACOSAMIDE (lacosamide 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97849,Marketed,2020-03-06,02488396,JAMP-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02488396,JAMP-LACOSAMIDE (lacosamide 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97850,Marketed,2020-03-06,02488418,JAMP-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02488418,JAMP-LACOSAMIDE (lacosamide 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97851,Marketed,2020-03-07,02488426,JAMP-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02488426,JAMP-LACOSAMIDE (lacosamide 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97936,Marketed,2021-04-27,02489287,ACH-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02489287,ACH-LACOSAMIDE (lacosamide 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97937,Marketed,2021-04-27,02489295,ACH-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02489295,ACH-LACOSAMIDE (lacosamide 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97938,Marketed,2021-04-27,02489309,ACH-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02489309,ACH-LACOSAMIDE (lacosamide 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97939,Marketed,2021-04-27,02489317,ACH-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02489317,ACH-LACOSAMIDE (lacosamide 200 mg oral tablet) ACCORD HEALTHCARE INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98058,Marketed,2019-11-25,02490544,MINT-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02490544,MINT-LACOSAMIDE (lacosamide 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98059,Marketed,2019-11-25,02490552,MINT-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02490552,MINT-LACOSAMIDE (lacosamide 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98060,Marketed,2019-11-25,02490560,MINT-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02490560,MINT-LACOSAMIDE (lacosamide 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98061,Marketed,2019-11-25,02490579,MINT-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02490579,MINT-LACOSAMIDE (lacosamide 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98929,Marketed,2021-02-18,02499568,NRA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02499568,NRA-LACOSAMIDE (lacosamide 50 mg oral tablet) NORA PHARMA INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98930,Marketed,2021-02-18,02499576,NRA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02499576,NRA-LACOSAMIDE (lacosamide 100 mg oral tablet) NORA PHARMA INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98931,Marketed,2021-02-18,02499584,NRA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02499584,NRA-LACOSAMIDE (lacosamide 150 mg oral tablet) NORA PHARMA INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98932,Marketed,2021-02-18,02499592,NRA-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02499592,NRA-LACOSAMIDE (lacosamide 200 mg oral tablet) NORA PHARMA INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99152,Marketed,2021-12-24,02501910,AG-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02501910,AG-LACOSAMIDE (lacosamide 50 mg oral tablet) ANGITA PHARMA INC.,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99154,Marketed,2021-12-24,02501937,AG-LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02501937,AG-LACOSAMIDE (lacosamide 150 mg oral tablet) ANGITA PHARMA INC.,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100212,Marketed,2024-11-26,02512874,LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02512874,LACOSAMIDE (lacosamide 50 mg oral tablet) SANIS HEALTH INC,Active,9004783,lacosamide 50 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100213,Marketed,2024-11-26,02512882,LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02512882,LACOSAMIDE (lacosamide 100 mg oral tablet) SANIS HEALTH INC,Active,9004780,lacosamide 100 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100214,Marketed,2024-11-26,02512890,LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02512890,LACOSAMIDE (lacosamide 150 mg oral tablet) SANIS HEALTH INC,Active,9004781,lacosamide 150 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100215,Marketed,2024-11-26,02512904,LACOSAMIDE,1.0,N03AX18,Lacosamide,Tablet,Oral,02512904,LACOSAMIDE (lacosamide 200 mg oral tablet) SANIS HEALTH INC,Active,9004782,lacosamide 200 mg oral tablet,8001825,lacosamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12699,Marketed,2013-07-11,00854409,RATIO-LACTULOSE,1.0,A06AD11,Lactulose,Solution,Oral,00854409,RATIO-LACTULOSE (lactulose 667 mg per mL oral solution) TEVA CANADA LIMITED,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
71628,Marketed,2016-06-22,02247383,PHARMA-LACTULOSE,1.0,A06AD11,Lactulose,Solution,Oral,02247383,PHARMA-LACTULOSE (lactulose 667 mg per mL oral solution) PHARMASCIENCE INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
78124,Marketed,2008-08-21,02295881,JAMP-LACTULOSE,1.0,A06AD11,Lactulose,Solution,Oral,02295881,JAMP-LACTULOSE (lactulose 667 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
81724,Marketed,2014-02-22,02331551,TEVA-LACTULOSE,1.0,A06AD11,Lactulose,Solution,Oral,02331551,TEVA-LACTULOSE (lactulose 667 mg per mL oral solution) TEVA CANADA LIMITED,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
89682,Marketed,2023-06-19,02412268,LACTULOSE,1.0,A06AD11,Lactulose,Solution,Oral,02412268,LACTULOSE (lactulose 667 mg per mL oral solution) SANIS HEALTH INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
95818,Marketed,2018-04-02,02469391,PMS-LACTULOSE-PHARMA,1.0,A06AD11,Lactulose,Solution,Oral,02469391,PMS-LACTULOSE-PHARMA (lactulose 667 mg per mL oral solution) PHARMASCIENCE INC,Active,9010195,lactulose 667 mg per mL oral solution,8000840,lactulose,26643006,Oral,385023001,Oral solution,,,,,
19614,Marketed,2013-11-15,02192683,3TC,1.0,J05AF05,Lamivudine,Tablet,Oral,02192683,3TC (lamivudine 150 mg oral tablet) VIIV HEALTHCARE ULC,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19615,Marketed,2014-01-31,02192691,3TC,1.0,J05AF05,Lamivudine,Solution,Oral,02192691,3TC (lamivudine 10 mg per mL oral solution) VIIV HEALTHCARE ULC,Active,9002834,lamivudine 10 mg per mL oral solution,8001210,lamivudine,26643006,Oral,385023001,Oral solution,,,,,
72120,Marketed,2013-11-28,02247825,3TC,1.0,J05AF05,Lamivudine,Tablet,Oral,02247825,3TC (lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85400,Marketed,2012-05-18,02369052,APO-LAMIVUDINE,1.0,J05AF05,Lamivudine,Tablet,Oral,02369052,APO-LAMIVUDINE (lamivudine 150 mg oral tablet) APOTEX INC,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85401,Marketed,2012-05-18,02369060,APO-LAMIVUDINE,1.0,J05AF05,Lamivudine,Tablet,Oral,02369060,APO-LAMIVUDINE (lamivudine 300 mg oral tablet) APOTEX INC,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87847,Marketed,2016-01-22,02393239,APO-LAMIVUDINE HBV,1.0,J05AF05,Lamivudine,Tablet,Oral,02393239,APO-LAMIVUDINE HBV (lamivudine 100 mg oral tablet) APOTEX INC,Active,9003336,lamivudine 100 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99652,Marketed,2021-03-16,02507110,JAMP LAMIVUDINE,1.0,J05AF05,Lamivudine,Tablet,Oral,02507110,JAMP LAMIVUDINE (lamivudine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002835,lamivudine 150 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99653,Marketed,2021-03-16,02507129,JAMP LAMIVUDINE,1.0,J05AF05,Lamivudine,Tablet,Oral,02507129,JAMP LAMIVUDINE (lamivudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003827,lamivudine 300 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100175,Marketed,2021-08-16,02512467,JAMP LAMIVUDINE HBV,1.0,J05AF05,Lamivudine,Tablet,Oral,02512467,JAMP LAMIVUDINE HBV (lamivudine 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003336,lamivudine 100 mg oral tablet,8001210,lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88441,Marketed,2020-11-03,02399539,APO-ABACAVIR-LAMIVUDINE,2.0,J05AR02,Lamivudine and abacavir,Tablet,Oral,02399539,APO-ABACAVIR-LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) APOTEX INC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90124,Marketed,2016-03-14,02416662,TEVA-ABACAVIR/LAMIVUDINE,2.0,J05AR02,Lamivudine and abacavir,Tablet,Oral,02416662,TEVA-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) TEVA CANADA LIMITED,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93683,Marketed,2016-03-29,02450682,MYLAN-ABACAVIR/LAMIVUDINE,2.0,J05AR02,Lamivudine and abacavir,Tablet,Oral,02450682,MYLAN-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94109,Marketed,2016-08-31,02454513,AURO-ABACAVIR/LAMIVUDINE,2.0,J05AR02,Lamivudine and abacavir,Tablet,Oral,02454513,AURO-ABACAVIR/LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) AURO PHARMA INC,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98745,Marketed,2022-02-22,02497654,JAMP ABACAVIR / LAMIVUDINE,2.0,J05AR02,Lamivudine and abacavir,Tablet,Oral,02497654,JAMP ABACAVIR / LAMIVUDINE (abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9012563,abacavir (abacavir sulfate) 600 mg and lamivudine 300 mg oral tablet,8001164,abacavir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98173,Marketed,2019-09-09,02491753,DOVATO,2.0,J05AR25,Lamivudine and dolutegravir,Tablet,Oral,02491753,DOVATO (dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9014147,dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet,8002291,dolutegravir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91536,Marketed,2014-10-22,02430932,TRIUMEQ,3.0,J05AR13,"Lamivudine, abacavir and dolutegravir",Tablet,Oral,02430932,TRIUMEQ (abacavir (abacavir sulfate) 600 mg and dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9012562,abacavir (abacavir sulfate) 600 mg and dolutegravir (dolutegravir sodium) 50 mg and lamivudine 300 mg oral tablet,8001163,abacavir and dolutegravir and lamivudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97302,Marketed,2018-12-10,02482592,DELSTRIGO,3.0,J05AR24,"Lamivudine, tenofovir disoproxil and doravirine",Tablet,Oral,02482592,DELSTRIGO (doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MERCK CANADA INC,Active,9013681,doravirine 100 mg and lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8002189,doravirine and lamivudine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17160,Marketed,2002-03-07,02142112,LAMICTAL,1.0,N03AX09,Lamotrigine,Tablet,Oral,02142112,LAMICTAL (lamotrigine 150 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17201,Marketed,2002-05-22,02142104,LAMICTAL,1.0,N03AX09,Lamotrigine,Tablet,Oral,02142104,LAMICTAL (lamotrigine 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17203,Marketed,2002-06-14,02142082,LAMICTAL,1.0,N03AX09,Lamotrigine,Tablet,Oral,02142082,LAMICTAL (lamotrigine 25 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63629,Marketed,2002-09-05,02240115,LAMICTAL,1.0,N03AX09,Lamotrigine,Tablet,Oral,02240115,LAMICTAL (lamotrigine 5 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000853,lamotrigine 5 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67741,Marketed,2001-09-13,02243803,LAMICTAL,1.0,N03AX09,Lamotrigine,Tablet,Oral,02243803,LAMICTAL (lamotrigine 2 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000961,lamotrigine 2 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69223,Marketed,2002-03-18,02245208,APO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02245208,APO-LAMOTRIGINE (lamotrigine 25 mg oral tablet) APOTEX INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69224,Marketed,2017-08-04,02245209,APO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02245209,APO-LAMOTRIGINE (lamotrigine 100 mg oral tablet) APOTEX INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69225,Marketed,2002-03-18,02245210,APO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02245210,APO-LAMOTRIGINE (lamotrigine 150 mg oral tablet) APOTEX INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75095,Marketed,2009-10-22,02265494,MYLAN-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02265494,MYLAN-LAMOTRIGINE (lamotrigine 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75096,Marketed,2009-10-21,02265508,MYLAN-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02265508,MYLAN-LAMOTRIGINE (lamotrigine 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75097,Marketed,2009-10-26,02265516,MYLAN-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02265516,MYLAN-LAMOTRIGINE (lamotrigine 150 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78826,Marketed,2008-03-07,02302969,LAMOTRIGINE-25,1.0,N03AX09,Lamotrigine,Tablet,Oral,02302969,LAMOTRIGINE-25 (lamotrigine 25 mg oral tablet) PRO DOC LIMITEE,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78830,Marketed,2008-03-08,02302985,LAMOTRIGINE-100,1.0,N03AX09,Lamotrigine,Tablet,Oral,02302985,LAMOTRIGINE-100 (lamotrigine 100 mg oral tablet) PRO DOC LIMITEE,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78831,Marketed,2008-03-07,02302993,LAMOTRIGINE-150,1.0,N03AX09,Lamotrigine,Tablet,Oral,02302993,LAMOTRIGINE-150 (lamotrigine 150 mg oral tablet) PRO DOC LIMITEE,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82850,Marketed,2010-02-16,02343010,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02343010,LAMOTRIGINE (lamotrigine 25 mg oral tablet) SANIS HEALTH INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82851,Marketed,2010-02-16,02343029,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02343029,LAMOTRIGINE (lamotrigine 100 mg oral tablet) SANIS HEALTH INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82852,Marketed,2010-02-16,02343037,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02343037,LAMOTRIGINE (lamotrigine 150 mg oral tablet) SANIS HEALTH INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86718,Marketed,2012-06-13,02381354,AURO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02381354,AURO-LAMOTRIGINE (lamotrigine 25 mg oral tablet) AURO PHARMA INC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86719,Marketed,2012-06-13,02381362,AURO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02381362,AURO-LAMOTRIGINE (lamotrigine 100 mg oral tablet) AURO PHARMA INC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86720,Marketed,2012-06-13,02381370,AURO-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02381370,AURO-LAMOTRIGINE (lamotrigine 150 mg oral tablet) AURO PHARMA INC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91268,Marketed,2014-10-08,02428202,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02428202,LAMOTRIGINE (lamotrigine 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91269,Marketed,2014-10-08,02428210,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02428210,LAMOTRIGINE (lamotrigine 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91270,Marketed,2014-10-08,02428229,LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02428229,LAMOTRIGINE (lamotrigine 150 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103127,Marketed,2024-06-21,02542730,JAMP LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02542730,JAMP LAMOTRIGINE (lamotrigine 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103128,Marketed,2024-06-21,02542749,JAMP LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02542749,JAMP LAMOTRIGINE (lamotrigine 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103129,Marketed,2024-06-21,02542757,JAMP LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02542757,JAMP LAMOTRIGINE (lamotrigine 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103216,Marketed,2024-06-26,02543710,AG-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02543710,AG-LAMOTRIGINE (lamotrigine 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000593,lamotrigine 25 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103217,Marketed,2024-06-26,02543729,AG-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02543729,AG-LAMOTRIGINE (lamotrigine 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000591,lamotrigine 100 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103218,Marketed,2024-06-26,02543737,AG-LAMOTRIGINE,1.0,N03AX09,Lamotrigine,Tablet,Oral,02543737,AG-LAMOTRIGINE (lamotrigine 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000592,lamotrigine 150 mg oral tablet,8000214,lamotrigine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97159,Marketed,2022-01-12,02480948,TAKHZYRO,1.0,B06AC05,Lanadelumab,Solution,Subcutaneous,02480948,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection vial) TAKEDA CANADA INC,Active,9013447,lanadelumab 300 mg per 2 mL solution for injection vial,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99498,Marketed,2022-02-28,02505614,TAKHZYRO,1.0,B06AC05,Lanadelumab,Solution,Subcutaneous,02505614,TAKHZYRO (lanadelumab 300 mg per 2 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014456,lanadelumab 300 mg per 2 mL solution for injection syringe,8002029,lanadelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103179,Marketed,2024-08-11,02543338,SIBBORAN,1.0,C07AB14,Landiolol,Powder for solution,Intravenous,02543338,SIBBORAN (landiolol hydrochloride 300 mg per vial powder for solution for injection) TRIMEDIC THERAPEUTICS INC.,Active,9015072,landiolol hydrochloride 300 mg per vial powder for solution for injection,8002512,landiolol,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial,,,
76900,Marketed,2022-02-16,02283395,SOMATULINE AUTOGEL,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283395,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013968,lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
76901,Marketed,2022-02-16,02283409,SOMATULINE AUTOGEL,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283409,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013969,lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
76902,Marketed,2021-12-15,02283417,SOMATULINE AUTOGEL,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02283417,SOMATULINE AUTOGEL (lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9013967,lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
104459,Marketed,2025-06-06,02555867,MYTOLAC,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555867,MYTOLAC (lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013968,lanreotide (lanreotide acetate) 60 mg per 0.2 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
104460,Marketed,2025-06-06,02555875,MYTOLAC,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555875,MYTOLAC (lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013969,lanreotide (lanreotide acetate) 90 mg per 0.3 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
104461,Marketed,2025-06-06,02555883,MYTOLAC,1.0,H01CB03,Lanreotide,Solution (extended release),Subcutaneous,02555883,MYTOLAC (lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe) ADVANZ PHARMA CANADA INC.,Active,9013967,lanreotide (lanreotide acetate) 120 mg per 0.5 mL prolonged-release solution for injection syringe,8001826,lanreotide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),,,
18515,Marketed,2008-10-10,02165503,PREVACID,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02165503,PREVACID (lansoprazole 15 mg gastro-resistant capsule) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
18516,Marketed,2008-10-10,02165511,PREVACID,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02165511,PREVACID (lansoprazole 30 mg gastro-resistant capsule) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
73429,Marketed,2008-10-10,02249464,PREVACID FASTAB,1.0,A02BC03,Lansoprazole,Tablet (delayed-release),Oral,02249464,PREVACID FASTAB (lansoprazole 15 mg gastro-resistant tablet) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9001181,lansoprazole 15 mg gastro-resistant tablet,8000215,lansoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
73430,Marketed,2008-10-10,02249472,PREVACID FASTAB,1.0,A02BC03,Lansoprazole,Tablet (delayed-release),Oral,02249472,PREVACID FASTAB (lansoprazole 30 mg gastro-resistant tablet) TAKEDA PHARMACEUTICALS AMERICA INC,Active,9001133,lansoprazole 30 mg gastro-resistant tablet,8000215,lansoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
76617,Marketed,2011-04-22,02280515,TEVA-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02280515,TEVA-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
76618,Marketed,2011-04-22,02280523,TEVA-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02280523,TEVA-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) TEVA CANADA LIMITED,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
77919,Marketed,2009-06-03,02293811,APO-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02293811,APO-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) APOTEX INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
77920,Marketed,2009-06-03,02293838,APO-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02293838,APO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) APOTEX INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
83904,Marketed,2010-06-18,02353830,MYLAN-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02353830,MYLAN-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) MYLAN PHARMACEUTICALS ULC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
83905,Marketed,2010-06-18,02353849,MYLAN-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02353849,MYLAN-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) MYLAN PHARMACEUTICALS ULC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
84278,Marketed,2020-11-23,02357682,LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02357682,LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
84279,Marketed,2020-11-23,02357690,LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02357690,LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
85113,Marketed,2025-12-08,02366282,PRO-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02366282,PRO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
87127,Marketed,2012-07-03,02385643,SANDOZ LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385643,SANDOZ LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
87128,Marketed,2012-07-03,02385651,SANDOZ LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385651,SANDOZ LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
87138,Marketed,2024-06-07,02385767,LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02385767,LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
88746,Marketed,2021-04-16,02402610,TARO-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02402610,TARO-LANSOPRAZOLE (lansoprazole 15 mg gastro-resistant capsule) SUN PHARMA CANADA INC,Active,9000594,lansoprazole 15 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
88747,Marketed,2021-04-16,02402629,TARO-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02402629,TARO-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SUN PHARMA CANADA INC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
89503,Marketed,2024-06-07,02410389,LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02410389,LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
90747,Marketed,2015-04-15,02422816,RIVA-LANSOPRAZOLE,1.0,A02BC03,Lansoprazole,Capsule (delayed release),Oral,02422816,RIVA-LANSOPRAZOLE (lansoprazole 30 mg gastro-resistant capsule) LABORATOIRE RIVA INC.,Active,9000595,lansoprazole 30 mg gastro-resistant capsule,8000215,lansoprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
95983,Marketed,2022-10-04,02470780,AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN,3.0,A02BD07,"Lansoprazole, amoxicillin and clarithromycin","Kit,Capsule,Capsule (delayed release),Tablet",Oral,02470780,AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN (amoxicillin 500 mg oral capsule with clarithromycin 500 mg oral tablet with lansoprazole 30 mg gastro-resistant capsule) AA PHARMA INC,Active,9012653,amoxicillin 500 mg oral capsule with clarithromycin 500 mg oral tablet with lansoprazole 30 mg gastro-resistant capsule,8000907,amoxicillin and clarithromycin and lansoprazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
98843,Marketed,2020-07-21,02498731,NAT-LANTHANUM,1.0,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498731,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 250 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013181,lanthanum (lanthanum carbonate) 250 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98844,Marketed,2020-07-21,02498758,NAT-LANTHANUM,1.0,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498758,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 500 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013182,lanthanum (lanthanum carbonate) 500 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98845,Marketed,2020-07-21,02498766,NAT-LANTHANUM,1.0,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498766,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 750 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013183,lanthanum (lanthanum carbonate) 750 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98846,Marketed,2020-07-21,02498774,NAT-LANTHANUM,1.0,V03AE03,Lanthanum carbonate,Tablet (chewable),Oral,02498774,NAT-LANTHANUM (lanthanum (lanthanum carbonate dihydrate) 1000 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9013180,lanthanum (lanthanum carbonate) 1000 mg chewable tablet,8001827,lanthanum,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
81179,Marketed,2016-04-19,02326442,TYKERB,1.0,L01EH01,Lapatinib,Tablet,Oral,02326442,TYKERB (lapatinib (lapatinib ditosylate) 250 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013184,lapatinib (lapatinib ditosylate) 250 mg oral tablet,8001828,lapatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73940,Marketed,2024-04-26,02254506,ALDURAZYME,1.0,A16AB05,Laronidase,Solution,Intravenous,02254506,ALDURAZYME (laronidase 2.9 mg per 5 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9013185,laronidase 2.9 mg per 5 mL solution for injection vial,8001829,laronidase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98037,Marketed,2020-11-13,02490315,VITRAKVI,1.0,L01EX12,Larotrectinib,Capsule,Oral,02490315,VITRAKVI (larotrectinib (larotrectinib sulfate) 25 mg oral capsule) BAYER INC,Active,9014404,larotrectinib (larotrectinib sulfate) 25 mg oral capsule,8002297,larotrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98038,Marketed,2020-11-13,02490323,VITRAKVI,1.0,L01EX12,Larotrectinib,Capsule,Oral,02490323,VITRAKVI (larotrectinib (larotrectinib sulfate) 100 mg oral capsule) BAYER INC,Active,9014403,larotrectinib (larotrectinib sulfate) 100 mg oral capsule,8002297,larotrectinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98039,Marketed,2019-09-04,02490331,VITRAKVI,1.0,L01EX12,Larotrectinib,Solution,Oral,02490331,VITRAKVI (larotrectinib (larotrectinib sulfate) 20 mg per mL oral solution) BAYER INC,Active,9014155,larotrectinib (larotrectinib sulfate) 20 mg per mL oral solution,8002297,larotrectinib,26643006,Oral,385023001,Oral solution,,,1.0,,
50823,Marketed,2023-07-31,02231493,XALATAN,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02231493,XALATAN (latanoprost 50 mcg per mL ophthalmic drops) BGP PHARMA ULC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
73994,Marketed,2019-01-31,02254786,TEVA-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02254786,TEVA-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) TEVA CANADA LIMITED,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78185,Marketed,2018-07-03,02296527,APO-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02296527,APO-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) APOTEX INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
82663,Marketed,2015-05-28,02341085,RIVA-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02341085,RIVA-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) LABORATOIRE RIVA INC.,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
85213,Marketed,2011-12-06,02367335,SANDOZ LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02367335,SANDOZ LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
85817,Marketed,2023-11-16,02373041,MYLAN-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02373041,MYLAN-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) MYLAN PHARMACEUTICALS ULC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91148,Marketed,2015-01-09,02426935,MED-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02426935,MED-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
93988,Marketed,2023-10-13,02453355,JAMP LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02453355,JAMP LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94312,Marketed,2018-01-03,02456230,MONOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02456230,MONOPROST (latanoprost 50 mcg per mL ophthalmic drops) LABORATOIRES THEA,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100250,Marketed,2021-11-10,02513285,M-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02513285,M-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102373,Marketed,2024-08-16,02534835,AG-LATANOPROST,1.0,S01EE01,Latanoprost,Solution,Ophthalmic,02534835,AG-LATANOPROST (latanoprost 50 mcg per mL ophthalmic drops) ANGITA PHARMA INC.,Active,9000737,latanoprost 50 mcg per mL ophthalmic drops,8000244,latanoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
97453,Marketed,2019-05-17,02484218,VYZULTA,1.0,S01EE06,Latanoprostene bunod,Solution,Ophthalmic,02484218,VYZULTA (latanoprostene bunod 0.024 % ophthalmic drops) BAUSCH & LOMB INC,Active,9013970,latanoprostene bunod 0.024 % ophthalmic drops,8002260,latanoprostene bunod,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
104468,Marketed,2025-04-28,02555964,LAZCLUZE,1.0,L01EB09,Lazertinib,Tablet,Oral,02555964,LAZCLUZE (lazertinib (lazertinib mesylate) 80 mg oral tablet) JANSSEN INC,Active,9015205,lazertinib (lazertinib mesylate) 80 mg oral tablet,8002544,lazertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
104469,Marketed,2025-04-28,02555972,LAZCLUZE,1.0,L01EB09,Lazertinib,Tablet,Oral,02555972,LAZCLUZE (lazertinib (lazertinib mesylate) 240 mg oral tablet) JANSSEN INC,Active,9015204,lazertinib (lazertinib mesylate) 240 mg oral tablet,8002544,lazertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
103800,Marketed,2024-09-19,02549123,EBGLYSS,1.0,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549123,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015097,lebrikizumab 250 mg per 2 mL solution for injection pen,8002514,lebrikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103801,Marketed,2024-11-26,02549131,EBGLYSS,1.0,D11AH10,Lebrikizumab,Solution,Subcutaneous,02549131,EBGLYSS (lebrikizumab 250 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015138,lebrikizumab 250 mg per 2 mL solution for injection syringe,8002514,lebrikizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
106527,Marketed,2025-12-16,02562383,LEQEMBI,1.0,N06DX04,Lecanemab,Solution,Intravenous,77701197,LEQEMBI (lecanemab 200 mg per 2 mL solution for injection vial) EISAI LIMITED,Active,9015304,lecanemab 200 mg per 2 mL solution for injection vial,8002566,lecanemab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
106527,Marketed,2025-12-16,02562383,LEQEMBI,1.0,N06DX04,Lecanemab,Solution,Intravenous,77701198,LEQEMBI (lecanemab 500 mg per 5 mL solution for injection vial) EISAI LIMITED,Active,9015305,lecanemab 500 mg per 5 mL solution for injection vial,8002566,lecanemab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
65558,Marketed,2008-11-03,02241888,ARAVA,1.0,L04AK01,Leflunomide,Tablet,Oral,02241888,ARAVA (leflunomide 10 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65559,Marketed,2008-10-10,02241889,ARAVA,1.0,L04AK01,Leflunomide,Tablet,Oral,02241889,ARAVA (leflunomide 20 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74173,Marketed,2004-09-14,02256495,APO-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02256495,APO-LEFLUNOMIDE (leflunomide 10 mg oral tablet) APOTEX INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74174,Marketed,2004-09-14,02256509,APO-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02256509,APO-LEFLUNOMIDE (leflunomide 20 mg oral tablet) APOTEX INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74665,Marketed,2014-02-14,02261251,TEVA-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02261251,TEVA-LEFLUNOMIDE (leflunomide 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74666,Marketed,2014-02-14,02261278,TEVA-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02261278,TEVA-LEFLUNOMIDE (leflunomide 20 mg oral tablet) TEVA CANADA LIMITED,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76953,Marketed,2006-08-15,02283964,SANDOZ LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02283964,SANDOZ LEFLUNOMIDE (leflunomide 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76954,Marketed,2006-08-15,02283972,SANDOZ LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02283972,SANDOZ LEFLUNOMIDE (leflunomide 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83692,Marketed,2014-07-12,02351668,LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02351668,LEFLUNOMIDE (leflunomide 10 mg oral tablet) SANIS HEALTH INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83693,Marketed,2014-07-12,02351676,LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02351676,LEFLUNOMIDE (leflunomide 20 mg oral tablet) SANIS HEALTH INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90041,Marketed,2025-11-27,02415828,PRO-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02415828,PRO-LEFLUNOMIDE (leflunomide 10 mg oral tablet) PRO DOC LIMITEE,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90042,Marketed,2025-11-27,02415836,PRO-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02415836,PRO-LEFLUNOMIDE (leflunomide 20 mg oral tablet) PRO DOC LIMITEE,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96957,Marketed,2019-09-19,02478862,ACCEL-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02478862,ACCEL-LEFLUNOMIDE (leflunomide 10 mg oral tablet) ACCEL PHARMA INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96958,Marketed,2019-09-19,02478870,ACCEL-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02478870,ACCEL-LEFLUNOMIDE (leflunomide 20 mg oral tablet) ACCEL PHARMA INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103203,Marketed,2024-06-03,02543575,LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02543575,LEFLUNOMIDE (leflunomide 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103204,Marketed,2024-06-03,02543583,LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02543583,LEFLUNOMIDE (leflunomide 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104061,Marketed,2024-12-04,02551918,MAR-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02551918,MAR-LEFLUNOMIDE (leflunomide 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003479,leflunomide 10 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104062,Marketed,2024-12-04,02551926,MAR-LEFLUNOMIDE,1.0,L04AK01,Leflunomide,Tablet,Oral,02551926,MAR-LEFLUNOMIDE (leflunomide 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003480,leflunomide 20 mg oral tablet,8001830,leflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99675,Marketed,2020-11-06,02507366,DAYVIGO,1.0,N05CJ02,Lemborexant,Tablet,Oral,02507366,DAYVIGO (lemborexant 5 mg oral tablet) EISAI LIMITED,Active,9014458,lemborexant 5 mg oral tablet,8002363,lemborexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99676,Marketed,2020-11-06,02507374,DAYVIGO,1.0,N05CJ02,Lemborexant,Tablet,Oral,02507374,DAYVIGO (lemborexant 10 mg oral tablet) EISAI LIMITED,Active,9014457,lemborexant 10 mg oral tablet,8002363,lemborexant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102149,Marketed,2023-03-15,02532468,SUNLENCA,1.0,J05AX31,Lenacapavir,Tablet,Oral,02532468,SUNLENCA (lenacapavir (lenacapavir sodium) 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9014847,lenacapavir (lenacapavir sodium) 300 mg oral tablet,8002465,lenacapavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102150,Marketed,2023-03-15,02532476,SUNLENCA,1.0,J05AX31,Lenacapavir,Solution,Subcutaneous,02532476,SUNLENCA (lenacapavir (lenacapavir sodium) 463.5 mg per 1.5 mL solution for injection vial) GILEAD SCIENCES CANADA INC,Active,9014848,lenacapavir (lenacapavir sodium) 463.5 mg per 1.5 mL solution for injection vial,8002465,lenacapavir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79016,Marketed,2025-01-31,02304899,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02304899,REVLIMID (lenalidomide 5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
79017,Marketed,2025-01-31,02304902,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02304902,REVLIMID (lenalidomide 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
80322,Marketed,2025-02-03,02317699,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02317699,REVLIMID (lenalidomide 15 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
80324,Marketed,2025-01-31,02317710,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02317710,REVLIMID (lenalidomide 25 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92497,Marketed,2025-02-05,02440601,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02440601,REVLIMID (lenalidomide 20 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94664,Marketed,2024-11-22,02459418,REVLIMID,1.0,L04AX04,Lenalidomide,Capsule,Oral,02459418,REVLIMID (lenalidomide 2.5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97342,Marketed,2021-09-01,02483017,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02483017,REDDY-LENALIDOMIDE (lenalidomide 5 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97343,Marketed,2021-09-01,02483025,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02483025,REDDY-LENALIDOMIDE (lenalidomide 10 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97344,Marketed,2021-09-01,02483033,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02483033,REDDY-LENALIDOMIDE (lenalidomide 15 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97345,Marketed,2021-09-01,02483041,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02483041,REDDY-LENALIDOMIDE (lenalidomide 20 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97346,Marketed,2021-09-01,02483068,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02483068,REDDY-LENALIDOMIDE (lenalidomide 25 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97500,Marketed,2021-09-01,02484714,REDDY-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02484714,REDDY-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98383,Marketed,2021-09-01,02493837,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493837,NAT-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98384,Marketed,2021-09-01,02493845,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493845,NAT-LENALIDOMIDE (lenalidomide 5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98386,Marketed,2021-09-01,02493861,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493861,NAT-LENALIDOMIDE (lenalidomide 10 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98387,Marketed,2021-09-01,02493888,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493888,NAT-LENALIDOMIDE (lenalidomide 15 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98388,Marketed,2021-09-01,02493896,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493896,NAT-LENALIDOMIDE (lenalidomide 20 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98389,Marketed,2021-09-01,02493918,NAT-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02493918,NAT-LENALIDOMIDE (lenalidomide 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99548,Marketed,2022-02-02,02506130,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506130,JAMP LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99549,Marketed,2022-02-02,02506149,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506149,JAMP LENALIDOMIDE (lenalidomide 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99550,Marketed,2022-02-02,02506157,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506157,JAMP LENALIDOMIDE (lenalidomide 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99551,Marketed,2022-02-02,02506165,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506165,JAMP LENALIDOMIDE (lenalidomide 15 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99552,Marketed,2022-02-02,02506173,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506173,JAMP LENALIDOMIDE (lenalidomide 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99553,Marketed,2022-02-02,02506181,JAMP LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02506181,JAMP LENALIDOMIDE (lenalidomide 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99724,Marketed,2022-06-13,02507862,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507862,TARO-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99725,Marketed,2022-06-13,02507870,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507870,TARO-LENALIDOMIDE (lenalidomide 5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99726,Marketed,2022-06-13,02507889,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507889,TARO-LENALIDOMIDE (lenalidomide 10 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99727,Marketed,2022-06-13,02507897,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507897,TARO-LENALIDOMIDE (lenalidomide 15 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99728,Marketed,2022-06-13,02507900,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507900,TARO-LENALIDOMIDE (lenalidomide 20 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99729,Marketed,2022-06-13,02507919,TARO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507919,TARO-LENALIDOMIDE (lenalidomide 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99730,Marketed,2021-09-01,02507927,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507927,APO-LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) APOTEX INC,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99731,Marketed,2021-09-01,02507935,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507935,APO-LENALIDOMIDE (lenalidomide 5 mg oral capsule) APOTEX INC,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99732,Marketed,2021-09-01,02507943,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507943,APO-LENALIDOMIDE (lenalidomide 10 mg oral capsule) APOTEX INC,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99733,Marketed,2021-09-01,02507951,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507951,APO-LENALIDOMIDE (lenalidomide 15 mg oral capsule) APOTEX INC,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99734,Marketed,2021-09-01,02507978,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507978,APO-LENALIDOMIDE (lenalidomide 20 mg oral capsule) APOTEX INC,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99735,Marketed,2021-09-01,02507986,APO-LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02507986,APO-LENALIDOMIDE (lenalidomide 25 mg oral capsule) APOTEX INC,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100787,Marketed,2021-09-07,02518562,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518562,SANDOZ LENALIDOMIDE (lenalidomide 2.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9006081,lenalidomide 2.5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100788,Marketed,2021-09-07,02518570,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518570,SANDOZ LENALIDOMIDE (lenalidomide 5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004378,lenalidomide 5 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100789,Marketed,2021-09-07,02518589,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518589,SANDOZ LENALIDOMIDE (lenalidomide 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004377,lenalidomide 10 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100790,Marketed,2021-09-07,02518597,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518597,SANDOZ LENALIDOMIDE (lenalidomide 15 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004465,lenalidomide 15 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100791,Marketed,2021-09-07,02518600,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518600,SANDOZ LENALIDOMIDE (lenalidomide 20 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005785,lenalidomide 20 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100792,Marketed,2021-09-07,02518619,SANDOZ LENALIDOMIDE,1.0,L04AX04,Lenalidomide,Capsule,Oral,02518619,SANDOZ LENALIDOMIDE (lenalidomide 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004466,lenalidomide 25 mg oral capsule,8001831,lenalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93643,Marketed,2016-03-31,02450291,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02450291,LENVIMA (lenvatinib (lenvatinib mesylate) 24 mg oral capsule) EISAI LIMITED,Active,9005922,lenvatinib (lenvatinib mesylate) 24 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93644,Marketed,2016-03-31,02450305,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02450305,LENVIMA (lenvatinib (lenvatinib mesylate) 20 mg oral capsule) EISAI LIMITED,Active,9005921,lenvatinib (lenvatinib mesylate) 20 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93645,Marketed,2016-03-31,02450313,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02450313,LENVIMA (lenvatinib (lenvatinib mesylate) 14 mg oral capsule) EISAI LIMITED,Active,9005920,lenvatinib (lenvatinib mesylate) 14 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93646,Marketed,2016-03-31,02450321,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02450321,LENVIMA (lenvatinib (lenvatinib mesylate) 10 mg oral capsule) EISAI LIMITED,Active,9005919,lenvatinib (lenvatinib mesylate) 10 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95663,Marketed,2018-05-08,02468220,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02468220,LENVIMA (lenvatinib (lenvatinib mesylate) 8 mg oral capsule) EISAI LIMITED,Active,9013187,lenvatinib (lenvatinib mesylate) 8 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95664,Marketed,2018-05-08,02468239,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02468239,LENVIMA (lenvatinib (lenvatinib mesylate) 18 mg oral capsule) EISAI LIMITED,Active,9013186,lenvatinib (lenvatinib mesylate) 18 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97438,Marketed,2019-10-21,02484056,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02484056,LENVIMA (lenvatinib (lenvatinib mesylate) 4 mg oral capsule) EISAI LIMITED,Active,9014177,lenvatinib (lenvatinib mesylate) 4 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97445,Marketed,2019-10-21,02484129,LENVIMA,1.0,L01EX08,Lenvatinib,Capsule,Oral,02484129,LENVIMA (lenvatinib (lenvatinib mesylate) 12 mg oral capsule) EISAI LIMITED,Active,9014176,lenvatinib (lenvatinib mesylate) 12 mg oral capsule,8001832,lenvatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
95815,Marketed,2017-12-20,02469367,PREVYMIS,1.0,J05AX18,Letermovir,Solution,Intravenous,02469367,PREVYMIS 240 MG/12 ML SINGLE-DOSE VIAL (letermovir 240 mg per 12 mL solution for injection vial) MERCK CANADA INC,Active,9012506,letermovir 240 mg per 12 mL solution for injection vial,8001140,letermovir,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
50695,Marketed,1997-09-02,02231384,FEMARA,1.0,L02BG04,Letrozole,Tablet,Oral,02231384,FEMARA (letrozole 2.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79471,Marketed,2010-04-28,02309114,PMS-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02309114,PMS-LETROZOLE (letrozole 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82411,Marketed,2014-05-03,02338459,ACH-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02338459,ACH-LETROZOLE (letrozole 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
82909,Marketed,2013-07-08,02343657,TEVA-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02343657,TEVA-LETROZOLE (letrozole 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83029,Marketed,2010-04-27,02344815,SANDOZ LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02344815,SANDOZ LETROZOLE (letrozole 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84356,Marketed,2020-11-24,02358514,APO-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02358514,APO-LETROZOLE (letrozole 2.5 mg oral tablet) APOTEX INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85813,Marketed,2022-05-16,02373009,JAMP-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02373009,JAMP-LETROZOLE (letrozole 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85857,Marketed,2022-02-09,02373424,MAR-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02373424,MAR-LETROZOLE (letrozole 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85979,Marketed,2022-05-16,02374439,AG-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02374439,AG-LETROZOLE (letrozole 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87776,Marketed,2024-11-20,02392496,BIO-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02392496,BIO-LETROZOLE (letrozole 2.5 mg oral tablet) BIOMED PHARMA,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88359,Marketed,2024-07-03,02398656,RIVA-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02398656,RIVA-LETROZOLE (letrozole 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88690,Marketed,2013-02-14,02402025,LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02402025,LETROZOLE (letrozole 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90623,Marketed,2015-02-03,02421585,NAT-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02421585,NAT-LETROZOLE (letrozole 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99746,Marketed,2021-07-20,02508109,MINT-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02508109,MINT-LETROZOLE (letrozole 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100968,Marketed,2022-03-25,02520486,NRA-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02520486,NRA-LETROZOLE (letrozole 2.5 mg oral tablet) NORA PHARMA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101329,Marketed,2022-07-18,02524244,LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02524244,LETROZOLE (letrozole 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103052,Marketed,2024-08-20,02541912,JAMP LETROZOLE TABLETS,1.0,L02BG04,Letrozole,Tablet,Oral,02541912,JAMP LETROZOLE TABLETS (letrozole 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103188,Marketed,2024-08-20,02543419,AG-LETROZOLE TABLETS,1.0,L02BG04,Letrozole,Tablet,Oral,02543419,AG-LETROZOLE TABLETS (letrozole 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103878,Marketed,2025-04-25,02549972,M-LETROZOLE,1.0,L02BG04,Letrozole,Tablet,Oral,02549972,M-LETROZOLE (letrozole 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9003147,letrozole 2.5 mg oral tablet,8001102,letrozole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10318,Marketed,2013-12-11,00836273,LUPRON DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,00836273,LUPRON DEPOT (leuprolide acetate 7.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013311,leuprolide acetate 7.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
13443,Marketed,2013-12-01,00884502,LUPRON DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,00884502,LUPRON DEPOT (leuprolide acetate 3.75 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013306,leuprolide acetate 3.75 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
48922,Marketed,2013-12-09,02230248,LUPRON DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02230248,LUPRON DEPOT (leuprolide acetate 22.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013305,leuprolide acetate 22.5 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
63320,Marketed,2013-12-17,02239833,LUPRON DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02239833,LUPRON DEPOT (leuprolide acetate 30 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013308,leuprolide acetate 30 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
63321,Marketed,2013-11-04,02239834,LUPRON DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Intramuscular,02239834,LUPRON DEPOT (leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection with diluent solution per syringe) ABBVIE CORPORATION,Active,9013303,leuprolide acetate 11.25 mg powder for prolonged-release suspension for injection with diluent solution per syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
72576,Marketed,2022-05-30,02248239,ELIGARD,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248239,ELIGARD (leuprolide acetate 7.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013310,leuprolide acetate 7.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,
72577,Marketed,2022-03-25,02248240,ELIGARD,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248240,ELIGARD (leuprolide acetate 22.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013304,leuprolide acetate 22.5 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,
73384,Marketed,2022-04-08,02248999,ELIGARD,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02248999,ELIGARD (leuprolide acetate 30 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013307,leuprolide acetate 30 mg per syringe powder for prolonged-release solution for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,1231833006,Prolonged-release solution for injection,733020007,Syringe (unit of presentation),1.0,,
75428,Marketed,2022-04-22,02268892,ELIGARD,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release",Subcutaneous,02268892,ELIGARD (leuprolide acetate 45 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) TOLMAR INTERNATIONAL LTD.,Active,9013309,leuprolide acetate 45 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe (unit of presentation),1.0,,
91439,Marketed,2019-10-08,02429977,ZEULIDE DEPOT,1.0,L02AE02,Leuprorelin,"Kit,Powder for suspension, sustained-release",Intramuscular,02429977,ZEULIDE DEPOT (leuprolide acetate 3.75 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) VERITY PHARMACEUTICALS INC.,Active,9014179,leuprolide acetate 3.75 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
95052,Marketed,2019-10-08,02462699,ZEULIDE DEPOT,1.0,L02AE02,Leuprorelin,"Powder for suspension, sustained-release,Kit",Intramuscular,02462699,ZEULIDE DEPOT (leuprolide acetate 22.5 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) VERITY PHARMACEUTICALS INC.,Active,9014178,leuprolide acetate 22.5 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8001834,leuprolide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
71262,Marketed,2010-09-10,02247027,KEPPRA,1.0,N03AX14,Levetiracetam,Tablet,Oral,02247027,KEPPRA (levetiracetam 250 mg oral tablet) UCB CANADA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71263,Marketed,2010-09-13,02247028,KEPPRA,1.0,N03AX14,Levetiracetam,Tablet,Oral,02247028,KEPPRA (levetiracetam 500 mg oral tablet) UCB CANADA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71264,Marketed,2011-06-02,02247029,KEPPRA,1.0,N03AX14,Levetiracetam,Tablet,Oral,02247029,KEPPRA (levetiracetam 750 mg oral tablet) UCB CANADA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75964,Marketed,2020-12-17,02274183,TEVA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02274183,TEVA-LEVETIRACETAM (levetiracetam 250 mg oral tablet) TEVA CANADA LIMITED,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75965,Marketed,2020-12-17,02274191,TEVA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02274191,TEVA-LEVETIRACETAM (levetiracetam 500 mg oral tablet) TEVA CANADA LIMITED,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75966,Marketed,2020-12-17,02274205,TEVA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02274205,TEVA-LEVETIRACETAM (levetiracetam 750 mg oral tablet) TEVA CANADA LIMITED,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77141,Marketed,2006-10-20,02285924,APO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02285924,APO-LEVETIRACETAM (levetiracetam 250 mg oral tablet) APOTEX INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77142,Marketed,2006-10-20,02285932,APO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02285932,APO-LEVETIRACETAM (levetiracetam 500 mg oral tablet) APOTEX INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77143,Marketed,2006-10-20,02285940,APO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02285940,APO-LEVETIRACETAM (levetiracetam 750 mg oral tablet) APOTEX INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78145,Marketed,2021-09-30,02296101,PMS-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02296101,PMS-LEVETIRACETAM (levetiracetam 250 mg oral tablet) PHARMASCIENCE INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78146,Marketed,2021-09-30,02296128,PMS-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02296128,PMS-LEVETIRACETAM (levetiracetam 500 mg oral tablet) PHARMASCIENCE INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78147,Marketed,2021-09-30,02296136,PMS-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02296136,PMS-LEVETIRACETAM (levetiracetam 750 mg oral tablet) PHARMASCIENCE INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79695,Marketed,2020-02-11,02311372,PRO-LEVETIRACETAM - 250,1.0,N03AX14,Levetiracetam,Tablet,Oral,02311372,PRO-LEVETIRACETAM - 250 (levetiracetam 250 mg oral tablet) PRO DOC LIMITEE,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79696,Marketed,2009-06-16,02311380,PRO-LEVETIRACETAM - 500,1.0,N03AX14,Levetiracetam,Tablet,Oral,02311380,PRO-LEVETIRACETAM - 500 (levetiracetam 500 mg oral tablet) PRO DOC LIMITEE,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79697,Marketed,2009-10-08,02311399,PRO-LEVETIRACETAM - 750,1.0,N03AX14,Levetiracetam,Tablet,Oral,02311399,PRO-LEVETIRACETAM - 750 (levetiracetam 750 mg oral tablet) PRO DOC LIMITEE,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83854,Marketed,2023-07-04,02353342,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02353342,LEVETIRACETAM (levetiracetam 250 mg oral tablet) SANIS HEALTH INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83855,Marketed,2023-07-04,02353350,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02353350,LEVETIRACETAM (levetiracetam 500 mg oral tablet) SANIS HEALTH INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83856,Marketed,2023-07-04,02353369,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02353369,LEVETIRACETAM (levetiracetam 750 mg oral tablet) SANIS HEALTH INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86064,Marketed,2012-02-14,02375249,AURO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02375249,AURO-LEVETIRACETAM (levetiracetam 250 mg oral tablet) AURO PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86065,Marketed,2012-03-15,02375257,AURO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02375257,AURO-LEVETIRACETAM (levetiracetam 500 mg oral tablet) AURO PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86066,Marketed,2012-02-14,02375265,AURO-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02375265,AURO-LEVETIRACETAM (levetiracetam 750 mg oral tablet) AURO PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88462,Marketed,2023-04-14,02399776,ACH-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02399776,ACH-LEVETIRACETAM (levetiracetam 250 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88463,Marketed,2023-03-29,02399784,ACH-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02399784,ACH-LEVETIRACETAM (levetiracetam 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88464,Marketed,2023-03-31,02399792,ACH-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02399792,ACH-LEVETIRACETAM (levetiracetam 750 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92674,Marketed,2021-06-28,02442388,MINT-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442388,MINT-LEVETIRACETAM (levetiracetam 250 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92675,Marketed,2021-06-28,02442396,MINT-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442396,MINT-LEVETIRACETAM (levetiracetam 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92676,Marketed,2021-06-28,02442418,MINT-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442418,MINT-LEVETIRACETAM (levetiracetam 750 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92688,Marketed,2018-04-13,02442531,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442531,LEVETIRACETAM (levetiracetam 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92689,Marketed,2018-04-13,02442558,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442558,LEVETIRACETAM (levetiracetam 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92690,Marketed,2018-04-13,02442566,LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02442566,LEVETIRACETAM (levetiracetam 750 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94973,Marketed,2017-08-04,02461986,SANDOZ LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02461986,SANDOZ LEVETIRACETAM (levetiracetam 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94974,Marketed,2017-08-04,02461994,SANDOZ LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02461994,SANDOZ LEVETIRACETAM (levetiracetam 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94975,Marketed,2017-08-04,02462001,SANDOZ LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02462001,SANDOZ LEVETIRACETAM (levetiracetam 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94976,Marketed,2018-06-01,02462028,SANDOZ LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02462028,SANDOZ LEVETIRACETAM (levetiracetam 1000 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012827,levetiracetam 1000 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97544,Marketed,2022-03-02,02485192,AG-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02485192,AG-LEVETIRACETAM (levetiracetam 250 mg oral tablet) ANGITA PHARMA INC.,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97545,Marketed,2022-03-02,02485206,AG-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02485206,AG-LEVETIRACETAM (levetiracetam 500 mg oral tablet) ANGITA PHARMA INC.,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97546,Marketed,2022-03-02,02485214,AG-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02485214,AG-LEVETIRACETAM (levetiracetam 750 mg oral tablet) ANGITA PHARMA INC.,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98048,Marketed,2019-10-30,02490439,PDP-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Solution,Intravenous,02490439,PDP-LEVETIRACETAM (levetiracetam 500 mg per 5 mL solution for injection vial) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98049,Marketed,2020-05-01,02490447,PDP-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Solution,Oral,02490447,PDP-LEVETIRACETAM (levetiracetam 100 mg per mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,
98894,Marketed,2021-02-17,02499193,NRA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02499193,NRA-LEVETIRACETAM (levetiracetam 250 mg oral tablet) NORA PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98895,Marketed,2021-02-17,02499207,NRA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02499207,NRA-LEVETIRACETAM (levetiracetam 500 mg oral tablet) NORA PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98896,Marketed,2021-02-17,02499215,NRA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02499215,NRA-LEVETIRACETAM (levetiracetam 750 mg oral tablet) NORA PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99397,Marketed,2022-06-10,02504553,JAMP LEVETIRACETAM TABLETS,1.0,N03AX14,Levetiracetam,Tablet,Oral,02504553,JAMP LEVETIRACETAM TABLETS (levetiracetam 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99398,Marketed,2022-06-10,02504561,JAMP LEVETIRACETAM TABLETS,1.0,N03AX14,Levetiracetam,Tablet,Oral,02504561,JAMP LEVETIRACETAM TABLETS (levetiracetam 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99399,Marketed,2022-06-10,02504588,JAMP LEVETIRACETAM TABLETS,1.0,N03AX14,Levetiracetam,Tablet,Oral,02504588,JAMP LEVETIRACETAM TABLETS (levetiracetam 750 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100470,Marketed,2025-12-22,02515318,PHARMA-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Solution,Oral,02515318,PHARMA-LEVETIRACETAM (levetiracetam 100 mg per mL oral solution) PHARMASCIENCE INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,
101358,Marketed,2022-08-23,02524562,M-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02524562,M-LEVETIRACETAM (levetiracetam 250 mg oral tablet) MANTRA PHARMA INC,Active,9001035,levetiracetam 250 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101359,Marketed,2022-08-23,02524570,M-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02524570,M-LEVETIRACETAM (levetiracetam 500 mg oral tablet) MANTRA PHARMA INC,Active,9001036,levetiracetam 500 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101360,Marketed,2022-08-23,02524589,M-LEVETIRACETAM,1.0,N03AX14,Levetiracetam,Tablet,Oral,02524589,M-LEVETIRACETAM (levetiracetam 750 mg oral tablet) MANTRA PHARMA INC,Active,9001037,levetiracetam 750 mg oral tablet,8000328,levetiracetam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101643,Marketed,2022-08-05,02527375,LEVETIRACETAM INJECTION USP,1.0,N03AX14,Levetiracetam,Solution,Intravenous,02527375,LEVETIRACETAM INJECTION USP (levetiracetam 500 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103901,Marketed,2025-05-05,02550172,LEVETIRACETAM INJECTION USP,1.0,N03AX14,Levetiracetam,Solution,Intravenous,02550172,LEVETIRACETAM INJECTION USP (levetiracetam 500 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9014195,levetiracetam 500 mg per 5 mL solution for injection vial,8000328,levetiracetam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106166,Marketed,2025-08-14,02558416,MINT-LEVETIRACETAM SOLUTION,1.0,N03AX14,Levetiracetam,Solution,Oral,02558416,MINT-LEVETIRACETAM SOLUTION (levetiracetam 100 mg per mL oral solution) MINT PHARMACEUTICALS INC,Active,9014311,levetiracetam 100 mg per mL oral solution,8000328,levetiracetam,26643006,Oral,385023001,Oral solution,,,,,
18903,Marketed,2018-05-07,02144344,CARNITOR,1.0,A16AA01,Levocarnitine,Solution,Intravenous,02144344,"CARNITOR (levocarnitine 1000 mg per 5 mL solution for injection vial) LEADIANT BIOSCIENCES, INC",Active,9013572,levocarnitine 1000 mg per 5 mL solution for injection vial,8002134,levocarnitine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18931,Marketed,2019-01-28,02144328,CARNITOR,1.0,A16AA01,Levocarnitine,Tablet,Oral,02144328,"CARNITOR (levocarnitine 330 mg oral tablet) LEADIANT BIOSCIENCES, INC",Active,9002839,levocarnitine 330 mg oral tablet,8002134,levocarnitine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19094,Marketed,2018-08-02,02144336,CARNITOR,1.0,A16AA01,Levocarnitine,Solution,Oral,02144336,"CARNITOR (levocarnitine 100 mg per mL oral solution) LEADIANT BIOSCIENCES, INC",Active,9006634,levocarnitine 100 mg per mL oral solution,8002134,levocarnitine,26643006,Oral,385023001,Oral solution,,,,,
98210,Marketed,2019-11-18,02492105,ODAN LEVOCARNITINE,1.0,A16AA01,Levocarnitine,Solution,Oral,02492105,ODAN LEVOCARNITINE (levocarnitine 100 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9006634,levocarnitine 100 mg per mL oral solution,8002134,levocarnitine,26643006,Oral,385023001,Oral solution,,,,,
2723,Marketed,1977-12-31,00386464,PROLOPA CAP 100-25,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00386464,PROLOPA CAP 100-25 (benserazide (benserazide hydrochloride) 25 mg and levodopa 100 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001775,benserazide (benserazide hydrochloride) 25 mg and levodopa 100 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2724,Marketed,1977-12-31,00386472,PROLOPA CAP 200-50,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00386472,PROLOPA CAP 200-50 (benserazide (benserazide hydrochloride) 50 mg and levodopa 200 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001776,benserazide (benserazide hydrochloride) 50 mg and levodopa 200 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
4459,Marketed,1981-12-31,00522597,PROLOPA CAP 50-12.5,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Capsule,Oral,00522597,PROLOPA CAP 50-12.5 (benserazide (benserazide hydrochloride) 12.5 mg and levodopa 50 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9001898,benserazide (benserazide hydrochloride) 12.5 mg and levodopa 50 mg oral capsule,8001342,benserazide and levodopa,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
20189,Marketed,2024-08-27,02195933,APO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195933,APO-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) APOTEX INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20190,Marketed,2024-08-27,02195968,APO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195968,APO-LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) APOTEX INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20239,Marketed,2024-08-27,02195941,APO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02195941,APO-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) APOTEX INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68471,Marketed,2011-12-13,02244495,TEVA-LEVOCARBIDOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02244495,TEVA-LEVOCARBIDOPA (carbidopa 25 mg and levodopa 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68472,Marketed,2011-12-13,02244496,TEVA-LEVOCARBIDOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02244496,TEVA-LEVOCARBIDOPA (carbidopa 25 mg and levodopa 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69226,Marketed,2020-06-12,02245211,AA-LEVOCARB CR,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet (extended-release),Oral,02245211,AA-LEVOCARB CR (carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000376,carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet,8000054,carbidopa and levodopa,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75839,Marketed,2020-05-26,02272873,AA-LEVOCARB CR,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet (extended-release),Oral,02272873,AA-LEVOCARB CR (carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000458,carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet,8000054,carbidopa and levodopa,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77753,Marketed,2013-07-17,02292165,DUODOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Gel,Intraintestinal (upper),02292165,DUODOPA (carbidopa (carbidopa monohydrate) 5 mg per mL and levodopa 20 mg per mL intestinal gel) ABBVIE CORPORATION,Active,9001258,carbidopa 5 mg per mL and levodopa 20 mg per mL intestinal gel,8000054,carbidopa and levodopa,5.8731E+13,Intestinal ,385100002,Gel,,,,,
94498,Marketed,2026-01-12,02457954,MINT-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02457954,MINT-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94499,Marketed,2024-09-20,02457962,MINT-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02457962,MINT-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102071,Marketed,2023-04-28,02531593,AURO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531593,AURO-LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) AURO PHARMA INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102072,Marketed,2023-04-14,02531607,AURO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531607,AURO-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) AURO PHARMA INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102073,Marketed,2023-04-14,02531615,AURO-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02531615,AURO-LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) AURO PHARMA INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103509,Marketed,2024-12-13,02546396,JAMP LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546396,JAMP LEVOCARB (carbidopa 10 mg and levodopa 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103510,Marketed,2024-12-13,02546418,JAMP LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546418,JAMP LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103511,Marketed,2024-12-13,02546426,JAMP LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02546426,JAMP LEVOCARB (carbidopa 25 mg and levodopa 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103853,Marketed,2025-03-05,02549719,PMS-LEVODOPA-CARBIDOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549719,PMS-LEVODOPA-CARBIDOPA (carbidopa 10 mg and levodopa 100 mg oral tablet) PHARMASCIENCE INC,Active,9000125,carbidopa 10 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103854,Marketed,2025-03-05,02549727,PMS-LEVODOPA-CARBIDOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549727,PMS-LEVODOPA-CARBIDOPA (carbidopa 25 mg and levodopa 100 mg oral tablet) PHARMASCIENCE INC,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103855,Marketed,2025-03-05,02549735,PMS-LEVODOPA-CARBIDOPA,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02549735,PMS-LEVODOPA-CARBIDOPA (carbidopa 25 mg and levodopa 250 mg oral tablet) PHARMASCIENCE INC,Active,9000087,carbidopa 25 mg and levodopa 250 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104009,Marketed,2024-12-17,02551365,AG-LEVOCARB,2.0,N04BA02,Levodopa and decarboxylase inhibitor,Tablet,Oral,02551365,AG-LEVOCARB (carbidopa 25 mg and levodopa 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000144,carbidopa 25 mg and levodopa 100 mg oral tablet,8000054,carbidopa and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79150,Marketed,2020-07-24,02305933,STALEVO,3.0,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305933,STALEVO (carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004414,carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79151,Marketed,2020-07-24,02305941,STALEVO,3.0,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305941,STALEVO (carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004415,carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79152,Marketed,2020-07-24,02305968,STALEVO,3.0,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02305968,STALEVO (carbidopa 37.5 mg and entacapone 200 mg and levodopa 150 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004416,carbidopa 37.5 mg and entacapone 200 mg and levodopa 150 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82347,Marketed,2020-07-24,02337827,STALEVO,3.0,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02337827,STALEVO (carbidopa 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004629,carbidopa 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82348,Marketed,2020-07-24,02337835,STALEVO,3.0,N04BA03,"Levodopa,decarboxylase inhibitor, and comt inhibitor",Tablet,Oral,02337835,STALEVO (carbidopa 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004630,carbidopa 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet,8000967,carbidopa and entacapone and levodopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77026,Marketed,2009-06-24,02284707,APO-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02284707,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) APOTEX INC,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77027,Marketed,2009-06-24,02284715,APO-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02284715,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) APOTEX INC,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78395,Marketed,2009-06-24,02298635,SANDOZ LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02298635,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78396,Marketed,2009-06-24,02298643,SANDOZ LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02298643,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78397,Marketed,2009-06-24,02298651,SANDOZ LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02298651,SANDOZ LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80046,Marketed,2017-08-31,02314932,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77700578,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 250 mg per 50 mL solution for injection bag) PFIZER CANADA ULC,Active,9012556,levofloxacin 250 mg per 50 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
80046,Marketed,2017-08-31,02314932,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77700579,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 750 mg per 150 mL solution for injection bag) PFIZER CANADA ULC,Active,9012558,levofloxacin 750 mg per 150 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
80046,Marketed,2017-08-31,02314932,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77700580,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 500 mg per 100 mL solution for injection bag) PFIZER CANADA ULC,Active,9012557,levofloxacin 500 mg per 100 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
80096,Marketed,2025-10-16,02315424,TEVA-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02315424,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80097,Marketed,2025-10-16,02315432,TEVA-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02315432,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80098,Marketed,2025-10-16,02315440,TEVA-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02315440,TEVA-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) TEVA CANADA LIMITED,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81129,Marketed,2009-06-24,02325942,APO-LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02325942,APO-LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) APOTEX INC,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90046,Marketed,2016-10-04,02415879,LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02415879,LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) PRO DOC LIMITEE,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92667,Marketed,2017-05-01,02442302,QUINSAIR,1.0,J01MA12,Levofloxacin,Solution,Inhalation,02442302,QUINSAIR (levofloxacin (levofloxacin hemihydrate) 240 mg per 2.4 mL nebulizer solution unit dose vial) HORIZON THERAPEUTICS IRELAND DAC,Active,9012508,levofloxacin 240 mg per 2.4 mL nebulizer solution unit dose vial,8000947,levofloxacin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
99781,Marketed,2024-07-19,02508443,JAMP LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02508443,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003981,levofloxacin 250 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99782,Marketed,2024-07-19,02508451,JAMP LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02508451,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003982,levofloxacin 500 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99783,Marketed,2024-07-22,02508478,JAMP LEVOFLOXACIN,1.0,J01MA12,Levofloxacin,Tablet,Oral,02508478,JAMP LEVOFLOXACIN (levofloxacin (levofloxacin hemihydrate) 750 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004560,levofloxacin 750 mg oral tablet,8000947,levofloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102578,Marketed,2023-10-23,02537079,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77701134,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 500 mg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012557,levofloxacin 500 mg per 100 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
102578,Marketed,2023-10-23,02537079,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77701135,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 750 mg per 150 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012558,levofloxacin 750 mg per 150 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
102578,Marketed,2023-10-23,02537079,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,1.0,J01MA12,Levofloxacin,Solution,Intravenous,77701136,LEVOFLOXACIN IN 5% DEXTROSE INJECTION (levofloxacin 250 mg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9012556,levofloxacin 250 mg per 50 mL solution for injection bag,8000947,levofloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
13163,Marketed,2023-12-19,01927698,NOZINAN,1.0,N05AA02,Levomepromazine,Solution,"Intramuscular,Intravenous",01927698,NOZINAN (methotrimeprazine (methotrimeprazine hydrochloride) 25 mg per 1 mL solution for injection ampoule) NEURAXPHARM ARZNEIMITTEL GMBH,Active,9012518,methotrimeprazine (methotrimeprazine hydrochloride) 25 mg per 1 mL solution for injection ampoule,8001143,methotrimeprazine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
61820,Marketed,2013-06-24,02238403,METHOPRAZINE,1.0,N05AA02,Levomepromazine,Tablet,Oral,02238403,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 2 mg oral tablet) AA PHARMA INC,Active,9003267,methotrimeprazine (methotrimeprazine maleate) 2 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61821,Marketed,2013-06-27,02238404,METHOPRAZINE,1.0,N05AA02,Levomepromazine,Tablet,Oral,02238404,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 5 mg oral tablet) AA PHARMA INC,Active,9002725,methotrimeprazine (methotrimeprazine maleate) 5 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61822,Marketed,2014-04-14,02238405,METHOPRAZINE,1.0,N05AA02,Levomepromazine,Tablet,Oral,02238405,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 25 mg oral tablet) AA PHARMA INC,Active,9003032,methotrimeprazine (methotrimeprazine maleate) 25 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61823,Marketed,2014-04-23,02238406,METHOPRAZINE,1.0,N05AA02,Levomepromazine,Tablet,Oral,02238406,METHOPRAZINE (methotrimeprazine (methotrimeprazine maleate) 50 mg oral tablet) AA PHARMA INC,Active,9003171,methotrimeprazine (methotrimeprazine maleate) 50 mg oral tablet,8001143,methotrimeprazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92533,Marketed,2023-10-11,02440970,FETZIMA,1.0,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440970,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 20 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005811,levomilnacipran (levomilnacipran hydrochloride) 20 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92534,Marketed,2023-10-10,02440989,FETZIMA,1.0,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440989,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 40 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005812,levomilnacipran (levomilnacipran hydrochloride) 40 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92535,Marketed,2023-10-10,02440997,FETZIMA,1.0,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02440997,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 80 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005949,levomilnacipran (levomilnacipran hydrochloride) 80 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
92536,Marketed,2024-03-04,02441004,FETZIMA,1.0,N06AX28,Levomilnacipran,Capsule (extended release),Oral,02441004,FETZIMA (levomilnacipran (levomilnacipran hydrochloride) 120 mg prolonged-release oral capsule) ABBVIE CORPORATION,Active,9005948,levomilnacipran (levomilnacipran hydrochloride) 120 mg prolonged-release oral capsule,8001836,levomilnacipran,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
77922,Marketed,2018-10-11,02293854,PLAN B,1.0,G03AD01,Levonorgestrel,Tablet,Oral,02293854,"PLAN B (levonorgestrel 1.5 mg oral tablet) FOUNDATION CONSUMER HEALTHCARE, LLC",Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90967,Marketed,2016-06-29,02425009,CONTINGENCY ONE,1.0,G03AD01,Levonorgestrel,Tablet,Oral,02425009,CONTINGENCY ONE (levonorgestrel 1.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91790,Marketed,2016-06-07,02433532,BACKUP PLAN ONESTEP,1.0,G03AD01,Levonorgestrel,Tablet,Oral,02433532,BACKUP PLAN ONESTEP (levonorgestrel 1.5 mg oral tablet) APOTEX INC,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103734,Marketed,2025-06-10,02548461,MYSTEP,1.0,G03AD01,Levonorgestrel,Tablet,Oral,02548461,MYSTEP (levonorgestrel 1.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005743,levonorgestrel 1.5 mg oral tablet,8000915,levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
8123,Marketed,2008-05-21,00707503,TRIQUILAR 28,6.0,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,00707503,TRIQUILAR 28 (ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with lactose oral tablet) BAYER INC,Active,9009387,ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
8124,Marketed,2008-07-03,00707600,TRIQUILAR 21,6.0,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,00707600,TRIQUILAR 21 (ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet) BAYER INC,Active,9009386,ethinyl estradiol 30 mcg and levonorgestrel 50 mcg oral tablet with ethinyl estradiol 40 mcg and levonorgestrel 750 mcg oral tablet with ethinyl estradiol 30 mcg and levonorgestrel 125 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18754,Marketed,2011-12-05,02042320,MIN-OVRAL 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02042320,MIN-OVRAL 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) PFIZER CANADA ULC,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18755,Marketed,2011-11-25,02042339,MIN-OVRAL 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02042339,MIN-OVRAL 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60269,Marketed,2012-04-10,02236974,ALESSE 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02236974,ALESSE 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) PFIZER CANADA ULC,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60270,Marketed,2012-03-16,02236975,ALESSE 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02236975,ALESSE 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78129,Marketed,2015-05-28,02295946,PORTIA 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02295946,PORTIA 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) TEVA CANADA LIMITED,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78130,Marketed,2015-05-28,02295954,PORTIA 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02295954,PORTIA 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78201,Marketed,2022-09-26,02296659,SEASONALE,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02296659,SEASONALE (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78383,Marketed,2015-05-20,02298538,AVIANE 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02298538,AVIANE 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) TEVA CANADA LIMITED,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78384,Marketed,2015-05-20,02298546,AVIANE 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02298546,AVIANE 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) TEVA CANADA LIMITED,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83160,Marketed,2022-06-21,02346176,SEASONIQUE,3.0,G03AB03,Levonorgestrel and estrogen,Tablet,Oral,02346176,SEASONIQUE (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with ethinyl estradiol 10 mcg oral tablet) TEVA CANADA LIMITED,Active,9013289,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with ethinyl estradiol 10 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87265,Marketed,2013-08-27,02387085,OVIMA 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387085,OVIMA 21 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet) APOTEX INC,Active,9009383,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87266,Marketed,2013-08-27,02387093,OVIMA 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387093,OVIMA 28 (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87345,Marketed,2012-11-19,02387875,ALYSENA 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387875,ALYSENA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) APOTEX INC,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87346,Marketed,2012-11-19,02387883,ALYSENA 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02387883,ALYSENA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88378,Marketed,2016-09-01,02398869,INDAYO,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02398869,INDAYO (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9009385,ethinyl estradiol 30 mcg and levonorgestrel 150 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90899,Marketed,2023-11-10,02424282,LAYLAA 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02424282,LAYLAA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90900,Marketed,2023-11-10,02424290,LAYLAA 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02424290,LAYLAA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102123,Marketed,2023-06-09,02532174,AUDRINA 21,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02532174,AUDRINA 21 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet) JAMP PHARMA CORPORATION,Active,9009376,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102124,Marketed,2023-06-08,02532182,AUDRINA 28,2.0,G03AA07,Levonorgestrel and estrogen,Tablet,Oral,02532182,AUDRINA 28 (ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet) JAMP PHARMA CORPORATION,Active,9009377,ethinyl estradiol 20 mcg and levonorgestrel 100 mcg oral tablet with lactose oral tablet,8000119,ethinyl estradiol and levonorgestrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19587,Marketed,2016-03-10,02172070,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172070,SYNTHROID (levothyroxine sodium 50 mcg oral tablet) BGP PHARMA ULC,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19588,Marketed,2016-03-18,02172062,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172062,SYNTHROID (levothyroxine sodium 25 mcg oral tablet) BGP PHARMA ULC,Active,9000686,levothyroxine sodium 25 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19589,Marketed,2016-03-18,02171228,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02171228,SYNTHROID (levothyroxine sodium 112 mcg oral tablet) BGP PHARMA ULC,Active,9000682,levothyroxine sodium 112 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19594,Marketed,2016-03-18,02172119,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172119,SYNTHROID (levothyroxine sodium 125 mcg oral tablet) BGP PHARMA ULC,Active,9000683,levothyroxine sodium 125 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19595,Marketed,2016-03-10,02172089,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172089,SYNTHROID (levothyroxine sodium 75 mcg oral tablet) BGP PHARMA ULC,Active,9000688,levothyroxine sodium 75 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19596,Marketed,2016-08-19,02172151,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172151,SYNTHROID (levothyroxine sodium 300 mcg oral tablet) BGP PHARMA ULC,Active,9000687,levothyroxine sodium 300 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19597,Marketed,2016-03-10,02172143,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172143,SYNTHROID (levothyroxine sodium 200 mcg oral tablet) BGP PHARMA ULC,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19598,Marketed,2016-03-10,02172127,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172127,SYNTHROID (levothyroxine sodium 150 mcg oral tablet) BGP PHARMA ULC,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19599,Marketed,2016-04-20,02172097,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172097,SYNTHROID (levothyroxine sodium 88 mcg oral tablet) BGP PHARMA ULC,Active,9000689,levothyroxine sodium 88 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19600,Marketed,2016-03-17,02172135,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172135,SYNTHROID (levothyroxine sodium 175 mcg oral tablet) BGP PHARMA ULC,Active,9000684,levothyroxine sodium 175 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19601,Marketed,2016-03-17,02172100,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02172100,SYNTHROID (levothyroxine sodium 100 mcg oral tablet) BGP PHARMA ULC,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
36945,Marketed,2018-03-15,02213192,ELTROXIN,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02213192,ELTROXIN (levothyroxine sodium 50 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
36946,Marketed,2018-04-06,02213206,ELTROXIN,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02213206,ELTROXIN (levothyroxine sodium 100 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
36947,Marketed,2018-04-06,02213214,ELTROXIN,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02213214,ELTROXIN (levothyroxine sodium 150 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
36948,Marketed,2017-10-26,02213222,ELTROXIN,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02213222,ELTROXIN (levothyroxine sodium 200 mcg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
53868,Marketed,2016-03-10,02233852,SYNTHROID,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02233852,SYNTHROID (levothyroxine sodium 137 mcg oral tablet) BGP PHARMA ULC,Active,9001052,levothyroxine sodium 137 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70072,Marketed,2016-01-21,02245948,LEVOTHYROXINE SODIUM FOR INJECTION,1.0,H03AA01,Levothyroxine sodium,Powder for solution,"Intravenous,Intramuscular",02245948,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 500 mcg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9000997,levothyroxine sodium 500 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94948,Marketed,2019-11-15,02461714,LEVOTHYROXINE SODIUM FOR INJECTION,1.0,H03AA01,Levothyroxine sodium,Powder for solution,"Intramuscular,Intravenous",02461714,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 200 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9014196,levothyroxine sodium 200 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94949,Marketed,2018-09-26,02461722,LEVOTHYROXINE SODIUM FOR INJECTION,1.0,H03AA01,Levothyroxine sodium,Powder for solution,"Intravenous,Intramuscular",02461722,LEVOTHYROXINE SODIUM FOR INJECTION (levothyroxine sodium 500 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9000997,levothyroxine sodium 500 mcg per vial powder for solution for injection,8000001,levothyroxine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98962,Marketed,2022-06-10,02499916,LEVOTHYROXINE SODIUM INJECTION,1.0,H03AA01,Levothyroxine sodium,Solution,"Intravenous,Intramuscular",02499916,LEVOTHYROXINE SODIUM INJECTION (levothyroxine sodium 200 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9014740,levothyroxine sodium 200 mcg per 5 mL solution for injection vial,8000001,levothyroxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98963,Marketed,2022-06-10,02499924,LEVOTHYROXINE SODIUM INJECTION,1.0,H03AA01,Levothyroxine sodium,Solution,"Intramuscular,Intravenous",02499924,LEVOTHYROXINE SODIUM INJECTION (levothyroxine sodium 500 mcg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9014741,levothyroxine sodium 500 mcg per 5 mL solution for injection vial,8000001,levothyroxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102359,Marketed,2025-03-17,02534681,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02534681,APO-LEVOTHYROXINE (levothyroxine sodium 100 mcg oral tablet) APOTEX INC,Active,9000681,levothyroxine sodium 100 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102360,Marketed,2025-03-17,02534703,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02534703,APO-LEVOTHYROXINE (levothyroxine sodium 300 mcg oral tablet) APOTEX INC,Active,9000687,levothyroxine sodium 300 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103949,Marketed,2025-03-17,02550709,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550709,APO-LEVOTHYROXINE (levothyroxine sodium 25 mcg oral tablet) APOTEX INC,Active,9000686,levothyroxine sodium 25 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103950,Marketed,2025-03-17,02550717,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550717,APO-LEVOTHYROXINE (levothyroxine sodium 50 mcg oral tablet) APOTEX INC,Active,9000002,levothyroxine sodium 50 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103951,Marketed,2025-03-07,02550725,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550725,APO-LEVOTHYROXINE (levothyroxine sodium 75 mcg oral tablet) APOTEX INC,Active,9000688,levothyroxine sodium 75 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103952,Marketed,2025-03-17,02550733,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550733,APO-LEVOTHYROXINE (levothyroxine sodium 88 mcg oral tablet) APOTEX INC,Active,9000689,levothyroxine sodium 88 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103953,Marketed,2025-03-17,02550741,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550741,APO-LEVOTHYROXINE (levothyroxine sodium 112 mcg oral tablet) APOTEX INC,Active,9000682,levothyroxine sodium 112 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103954,Marketed,2025-03-17,02550768,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550768,APO-LEVOTHYROXINE (levothyroxine sodium 125 mcg oral tablet) APOTEX INC,Active,9000683,levothyroxine sodium 125 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103955,Marketed,2025-03-17,02550776,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550776,APO-LEVOTHYROXINE (levothyroxine sodium 137 mcg oral tablet) APOTEX INC,Active,9001052,levothyroxine sodium 137 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103956,Marketed,2025-03-17,02550784,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550784,APO-LEVOTHYROXINE (levothyroxine sodium 150 mcg oral tablet) APOTEX INC,Active,9000078,levothyroxine sodium 150 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103957,Marketed,2025-03-17,02550792,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550792,APO-LEVOTHYROXINE (levothyroxine sodium 175 mcg oral tablet) APOTEX INC,Active,9000684,levothyroxine sodium 175 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103958,Marketed,2025-03-17,02550806,APO-LEVOTHYROXINE,1.0,H03AA01,Levothyroxine sodium,Tablet,Oral,02550806,APO-LEVOTHYROXINE (levothyroxine sodium 200 mcg oral tablet) APOTEX INC,Active,9000685,levothyroxine sodium 200 mcg oral tablet,8000001,levothyroxine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
211,Marketed,2018-08-21,00001961,XYLOCAINE OINTMENT 5%,1.0,D04AB01,Lidocaine,Ointment,Topical,00001961,XYLOCAINE OINTMENT 5% (lidocaine 5 % cutaneous ointment) ASPEN PHARMACARE CANADA INC.,Active,9001544,lidocaine 5 % cutaneous ointment,8001837,lidocaine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
212,Marketed,2018-06-27,00001694,XYLOCAINE JELLY 2%,1.0,N01BB02,Lidocaine,Gel,Topical,00001694,XYLOCAINE JELLY 2% (lidocaine hydrochloride 2 % mucosal gel 30 mL tube) ASPEN PHARMACARE CANADA INC.,Active,9013973,lidocaine hydrochloride 2 % mucosal gel 30 mL tube,8001837,lidocaine,404815008,Mucosal,385100002,Gel,,,,,
585,Marketed,2018-06-06,00001732,XYLOCAINE 1%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700700,XYLOCAINE 1% (lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013210,lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
585,Marketed,2018-06-06,00001732,XYLOCAINE 1%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700701,XYLOCAINE 1% (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
585,Marketed,2018-06-06,00001732,XYLOCAINE 1%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700702,XYLOCAINE 1% (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
587,Marketed,2018-07-16,00036641,XYLOCAINE 2%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700703,XYLOCAINE 2% (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
587,Marketed,2018-07-16,00036641,XYLOCAINE 2%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700704,XYLOCAINE 2% (lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013215,lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
587,Marketed,2018-07-16,00036641,XYLOCAINE 2%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700705,XYLOCAINE 2% (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
2935,Marketed,2018-07-18,00385484,XYLOCAINE JELLY 2%,1.0,N01BB02,Lidocaine,Gel,Topical,00385484,XYLOCAINE JELLY 2% (lidocaine hydrochloride 2 % mucosal gel 10 mL syringe) ASPEN PHARMACARE CANADA INC.,Active,9013971,lidocaine hydrochloride 2 % mucosal gel 10 mL syringe,8001837,lidocaine,404815008,Mucosal,385100002,Gel,733020007,Syringe (unit of presentation),,,
4478,Marketed,2018-10-09,00001937,XYLOCARD,1.0,C01BB01,Lidocaine,Solution,Intravenous,00001937,XYLOCARD (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
8351,Marketed,2018-11-09,00436208,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,C01BB01,Lidocaine,Solution,Intravenous,00436208,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013915,lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
10519,Marketed,2019-12-20,00828602,0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION,2.0,C01BB01,Lidocaine,Solution,Intravenous,,,,,,,,,,,,,,,,
12266,Marketed,2023-07-07,01923986,SOLARCAINE FIRST AID LIDOCAINE SPRAY,1.0,D04AB01,Lidocaine,Aerosol,Topical,01923986,SOLARCAINE FIRST AID LIDOCAINE SPRAY (lidocaine 0.5 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9002314,lidocaine 0.5 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,421720008,Spray,,,,,
12645,Marketed,2019-07-02,00884154,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700825,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
12645,Marketed,2019-07-02,00884154,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700826,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
12645,Marketed,2019-07-02,00884154,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700827,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013210,lidocaine hydrochloride 20 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
12645,Marketed,2019-07-02,00884154,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700828,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
14240,Marketed,2021-02-12,02003767,XYLOCAINE SPRAY,1.0,N01BB02,Lidocaine,"Spray, metered dose",Topical,02003767,XYLOCAINE SPRAY (lidocaine 10 mg per actuation nasal/oromucosal spray) ASPEN PHARMACARE CANADA INC.,Active,9014459,lidocaine 10 mg per actuation nasal/oromucosal spray,8001837,lidocaine,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,
16823,Marketed,1994-12-31,01968823,LIDODAN VISCOUS 2%,1.0,N01BB02,Lidocaine,Solution,Buccal,01968823,LIDODAN VISCOUS 2% (lidocaine hydrochloride 2 % oromucosal/laryngopharyngeal solution) ODAN LABORATORIES LTD,Active,9013917,lidocaine hydrochloride 2 % oromucosal/laryngopharyngeal solution,8001837,lidocaine,255204007,Multiple (oromucosal or laryngopharyngeal),385070000,Oromucosal solution,,,,,
17236,Marketed,1994-12-31,02083795,LIDODAN OINTMENT 5%,1.0,D04AB01,Lidocaine,Ointment,Topical,02083795,LIDODAN OINTMENT 5% (lidocaine 5 % cutaneous ointment) ODAN LABORATORIES LTD,Active,9001544,lidocaine 5 % cutaneous ointment,8001837,lidocaine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
18012,Marketed,2019-07-02,01901982,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700831,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18012,Marketed,2019-07-02,01901982,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700832,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18012,Marketed,2019-07-02,01901982,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700833,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013312,lidocaine hydrochloride 100 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18012,Marketed,2019-07-02,01901982,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700834,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
18012,Marketed,2019-07-02,01901982,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700835,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013215,lidocaine hydrochloride 40 mg per 2 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
19488,Marketed,2016-02-15,02150379,BACTINE FIRST AID SPRAY,2.0,D04AB01,Lidocaine,Spray,Topical,02150379,BACTINE FIRST AID SPRAY (benzalkonium chloride 0.13 % and lidocaine hydrochloride 2.5 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9002745,benzalkonium chloride 0.13 % and lidocaine hydrochloride 2.5 % cutaneous spray,8001002,benzalkonium and lidocaine,448598008,Cutaneous,421720008,Spray,,,,,
31563,Marketed,2002-03-27,02143879,LIDODAN JELLY 2%,1.0,D04AB01,Lidocaine,Jelly,Topical,02143879,LIDODAN JELLY 2% (lidocaine hydrochloride 2 % cutaneous gel) ODAN LABORATORIES LTD,Active,9002691,lidocaine hydrochloride 2 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,
46020,Marketed,2009-01-27,01901532,STUD 100,1.0,D04AB01,Lidocaine,"Spray, metered dose",Topical,01901532,STUD 100 (lidocaine 9.6 % cutaneous spray) POUND INTERNATIONAL LTD.,Active,9003119,lidocaine 9.6 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,421720008,Spray,,,,,
50454,Marketed,1998-07-22,02231147,LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY,1.0,N01BB02,Lidocaine,"Spray, metered dose",Topical,02231147,LIDODAN ENDOTRACHEAL NON-AEROSOL SPRAY (lidocaine (lidocaine hydrochloride) 10 mg per actuation endotracheopulmonary instillation) ODAN LABORATORIES LTD,Active,9013913,lidocaine (lidocaine hydrochloride) 10 mg per actuation endotracheopulmonary instillation,8001837,lidocaine,372452007,Endotracheopulmonary,385247002,Solution for endotracheopulmonary instillation,732981002,Actuation (unit of presentation),,,
68513,Marketed,2004-12-22,02244533,MAXILENE 4,1.0,D04AB01,Lidocaine,Cream,Topical,02244533,MAXILENE 4 (lidocaine 4 % cutaneous cream) RGR PHARMA LTD.,Active,9003801,lidocaine 4 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
70063,Marketed,2005-01-06,02245939,MAXILENE 5,1.0,D04AB01,Lidocaine,Cream,Topical,02245939,MAXILENE 5 (lidocaine 5 % cutaneous cream) RGR PHARMA LTD.,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
78773,Marketed,2018-09-10,02302411,XYLOCAINE 1%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700740,XYLOCAINE 1% (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78773,Marketed,2018-09-10,02302411,XYLOCAINE 1%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700741,XYLOCAINE 1% (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78774,Marketed,2018-08-21,02302438,XYLOCAINE 2%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700742,XYLOCAINE 2% (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78774,Marketed,2018-08-21,02302438,XYLOCAINE 2%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700743,XYLOCAINE 2% (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79467,Marketed,2018-01-16,02309076,TPR20,2.0,D04AB01,Lidocaine,Cream,Topical,02309076,TPR20 (lidocaine hydrochloride 5 % and menthol 1 % cutaneous cream) HUMN PHARMACEUTICALS INC,Active,9004544,lidocaine hydrochloride 5 % and menthol 1 % cutaneous cream,8001838,lidocaine and menthol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
83969,Marketed,2015-08-18,02354527,DR. NUMB,1.0,D04AB01,Lidocaine,Cream,Topical,02354527,DR. NUMB (lidocaine 5 % cutaneous cream) SHINPHARMA INC,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
85604,Marketed,2020-09-28,02370840,CATHEJELL,1.0,N01BB02,Lidocaine,Gel,Topical,02370840,CATHEJELL (lidocaine hydrochloride 2 % mucosal gel 12.5 g syringe) PHARMAZEUTISCHE FABRIK MONTAVIT GES M.B.H.,Active,9013972,lidocaine hydrochloride 2 % mucosal gel 12.5 g syringe,8001837,lidocaine,404815008,Mucosal,385100002,Gel,733020007,Syringe (unit of presentation),,,
85810,Marketed,2018-05-24,02372983,XYLOCAINE 0.5%,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02372983,XYLOCAINE 0.5% (lidocaine hydrochloride 100 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013206,lidocaine hydrochloride 100 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90413,Marketed,2014-02-20,02419505,LIDODAN 4% TOPICAL SOLUTION,1.0,D04AB01,Lidocaine,Solution,Topical,02419505,LIDODAN 4% TOPICAL SOLUTION (lidocaine hydrochloride 4 % cutaneous solution) ODAN LABORATORIES LTD,Active,9005434,lidocaine hydrochloride 4 % cutaneous solution,8001837,lidocaine,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
90668,Marketed,2023-07-31,02421984,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700798,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013219,lidocaine hydrochloride 50 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90668,Marketed,2023-07-31,02421984,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700799,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
90668,Marketed,2023-07-31,02421984,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700800,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013205,lidocaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
90670,Marketed,2023-03-16,02422018,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700801,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 500 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013220,lidocaine hydrochloride 500 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90670,Marketed,2023-03-16,02422018,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700802,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90671,Marketed,2023-08-14,02421992,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700803,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013207,lidocaine hydrochloride 100 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
90671,Marketed,2023-08-14,02421992,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700804,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9013213,lidocaine hydrochloride 200 mg per 10 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
90672,Marketed,2023-04-17,02422026,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700805,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013208,lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90672,Marketed,2023-04-17,02422026,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,77700806,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
93551,Marketed,2016-05-20,02449684,ZENSA,1.0,D04AB01,Lidocaine,Cream,Topical,02449684,ZENSA (lidocaine 5 % cutaneous cream) ALERA SKIN CARE PRODUCTS INC.,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
95020,Marketed,2021-06-09,02462443,LIDOCAINE INJECTION BP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02462443,LIDOCAINE INJECTION BP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95021,Marketed,2021-06-09,02462451,LIDOCAINE INJECTION BP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02462451,LIDOCAINE INJECTION BP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) AURO PHARMA INC,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95780,Marketed,2018-05-28,02469146,JELIDO,1.0,N01BB02,Lidocaine,Gel,Topical,,,,,,,,,,,,,,,,
97557,Marketed,2019-05-21,02485311,LIDOCAINE,1.0,D04AB01,Lidocaine,Gel,Topical,02485311,LIDOCAINE (lidocaine 4 % cutaneous gel) THE MENTHOLATUM COMPANY OF CANADA LTD,Active,9013914,lidocaine 4 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,
98886,Marketed,2021-02-17,02499118,AFTER SUN GEL,1.0,D04AB01,Lidocaine,Gel,Topical,02499118,"AFTER SUN GEL (lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel) FRUIT OF THE EARTH, INC",Active,9014894,lidocaine (lidocaine hydrochloride) 0.8 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,
99031,Marketed,2023-05-15,02500647,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02500647,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014866,lidocaine hydrochloride 100 mg per 10 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
99032,Marketed,2023-05-15,02500655,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02500655,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 200 mg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9014867,lidocaine hydrochloride 200 mg per 10 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
100915,Marketed,2022-01-27,02519917,ALOCANE,1.0,D04AB01,Lidocaine,Gel,Topical,02519917,"ALOCANE (lidocaine hydrochloride 4 % cutaneous gel) QUEST PRODUCTS, LLC",Active,9014659,lidocaine hydrochloride 4 % cutaneous gel,8001837,lidocaine,448598008,Cutaneous,385100002,Gel,,,,,
101141,Marketed,2023-04-19,02522268,LIDOCAINE HYDROCHLORIDE INJECTION,1.0,C01BB01,Lidocaine,Solution,Intravenous,02522268,LIDOCAINE HYDROCHLORIDE INJECTION (lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9013915,lidocaine hydrochloride 100 mg per 5 mL solution for injection syringe,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101485,Marketed,2023-05-01,02525860,NUMBSKIN,1.0,D04AB01,Lidocaine,Cream,Topical,02525860,NUMBSKIN (lidocaine 5 % cutaneous cream) SHINPHARMA INC,Active,9003802,lidocaine 5 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
101961,Marketed,2022-09-10,02530422,THE SOLUTION ANORECTAL SPRAY TEMPORARY PAIN RELIEF,2.0,D04AB01,Lidocaine,Spray,Topical,02530422,THE SOLUTION ANORECTAL SPRAY TEMPORARY PAIN RELIEF (epinephrine (epinephrine hydrochloride) 0.01 % and lidocaine hydrochloride 5 % cutaneous spray) SCALP TECH INC.,Active,9014759,epinephrine (epinephrine hydrochloride) 0.01 % and lidocaine hydrochloride 5 % cutaneous spray,8001762,epinephrine and lidocaine,448598008,Cutaneous,421720008,Spray,,,,,
101963,Marketed,2024-10-07,02530449,LIDOCAINE INJECTION BP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02530449,LIDOCAINE INJECTION BP (lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013214,lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101964,Marketed,2024-10-07,02530457,LIDOCAINE INJECTION BP,1.0,N01BB02,Lidocaine,Solution,Block/infiltration,02530457,LIDOCAINE INJECTION BP (lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013216,lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102372,Marketed,2026-01-23,02534827,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,"Block/infiltration,Epidural",77701150,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule) FORMATIVE PHARMA INC.,Active,9013218,lidocaine hydrochloride 50 mg per 5 mL solution for injection ampoule,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
102372,Marketed,2026-01-23,02534827,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,"Block/infiltration,Epidural",77701151,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 50 mg per 5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9013219,lidocaine hydrochloride 50 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103135,Marketed,2024-06-17,02542838,SOLARCAINE BURN PAIN RELIEF,1.0,D04AB01,Lidocaine,"Spray, bag-on-valve",Topical,02542838,SOLARCAINE BURN PAIN RELIEF (lidocaine hydrochloride 4 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9015056,lidocaine hydrochloride 4 % cutaneous spray,8001837,lidocaine,448598008,Cutaneous,385105007,Cutaneous spray,,,,,
103677,Marketed,2026-01-23,02547856,LIDOCAINE HYDROCHLORIDE INJECTION USP,1.0,N01BB02,Lidocaine,Solution,"Block/infiltration,Epidural",02547856,LIDOCAINE HYDROCHLORIDE INJECTION USP (lidocaine hydrochloride 100 mg per 5 mL solution for injection vial) FORMATIVE PHARMA INC.,Active,9013312,lidocaine hydrochloride 100 mg per 5 mL solution for injection vial,8001837,lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103697,Marketed,2025-06-09,02548070,PRECISE PAIN RELIEF CREAM,1.0,D04AB01,Lidocaine,Cream,Topical,02548070,PRECISE PAIN RELIEF CREAM (lidocaine 4 % cutaneous cream) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003801,lidocaine 4 % cutaneous cream,8001837,lidocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
589,Marketed,2018-12-14,00001791,XYLOCAINE 1% W EPINEPHRINE 1:100000,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00001791,XYLOCAINE 1% W EPINEPHRINE 1:100000 (epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013874,epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
590,Marketed,2018-07-16,00001805,XYLOCAINE 1% W EPINEPHRINE 1:200000,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00001805,XYLOCAINE 1% W EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9014106,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 200 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
635,Marketed,1964-12-31,00151874,OCTOCAINE HCL 2% EPINEPHRINE 1:50000,2.0,N01BB52,"Lidocaine, combinations",Solution,Subcutaneous,00151874,OCTOCAINE HCL 2% EPINEPHRINE 1:50000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
636,Marketed,1964-12-31,00151866,OCTOCAINE HCL 2% EPINEPHRINE 1:100000,2.0,N01BB52,"Lidocaine, combinations",Solution,Subcutaneous,00151866,OCTOCAINE HCL 2% EPINEPHRINE 1:100000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
1830,Marketed,2018-06-06,00284106,XYLOCAINE 2% W EPINEPHRINE 1:200000,2.0,N01BB52,"Lidocaine, combinations",Solution,Epidural,00284106,XYLOCAINE 2% W EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013873,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
2506,Marketed,1976-12-31,00375799,LIGNOSPAN FORTE,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00375799,LIGNOSPAN FORTE (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
2541,Marketed,1976-12-31,00375780,LIGNOSPAN STANDARD,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,00375780,LIGNOSPAN STANDARD (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
12648,Marketed,2019-04-08,01901915,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,01901915,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9014109,epinephrine 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
37164,Marketed,1997-03-26,02218607,XYLONOR,2.0,N01BB52,"Lidocaine, combinations","Spray, metered dose",Buccal,02218607,XYLONOR (cetrimide 0.1 mg per actuation and lidocaine 10 mg per actuation oromucosal spray) SEPTODONT,Active,9014015,cetrimide 0.1 mg per actuation and lidocaine 10 mg per actuation oromucosal spray,8002103,cetrimide and lidocaine,372473007,Oromucosal,421720008,Spray,732981002,Actuation (unit of presentation),,,
78032,Marketed,2013-07-04,02294990,INSTILLAGEL,2.0,N01BB52,"Lidocaine, combinations",Gel,Urethral,77700933,INSTILLAGEL (chlorhexidine gluconate 0.05 % and lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % urethral gel 6 mL syringe) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014188,chlorhexidine gluconate 0.05 % and lidocaine hydrochloride 2 % urethral gel 6 mL syringe,8001720,chlorhexidine and lidocaine,90028008,Urethral,385100002,Gel,733020007,Syringe (unit of presentation),,,
78032,Marketed,2013-07-04,02294990,INSTILLAGEL,2.0,N01BB52,"Lidocaine, combinations",Gel,Urethral,77700934,INSTILLAGEL (chlorhexidine gluconate 0.05 % and lidocaine hydrochloride (lidocaine hydrochloride monohydrate) 2 % urethral gel 11 mL syringe) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9014187,chlorhexidine gluconate 0.05 % and lidocaine hydrochloride 2 % urethral gel 11 mL syringe,8001720,chlorhexidine and lidocaine,90028008,Urethral,385100002,Gel,733020007,Syringe (unit of presentation),,,
81732,Marketed,2009-10-19,02331640,"XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000",2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02331640,"XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
83052,Marketed,2010-07-29,02345072,"XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000",2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02345072,"XYLOCAINE DENTAL LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:50,000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
85829,Marketed,2018-08-21,02373130,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02373130,XYLOCAINE 2% WITH EPINEPHRINE 1:200000 (epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013873,epinephrine (epinephrine bitartrate) 0.1 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88297,Marketed,2021-11-25,02398028,PLIAGLIS,2.0,N01BB52,"Lidocaine, combinations",Cream,Topical,02398028,PLIAGLIS (lidocaine 7 % and tetracaine 7 % cutaneous cream) SCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.,Active,9005786,lidocaine 7 % and tetracaine 7 % cutaneous cream,8001911,lidocaine and tetracaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
92056,Marketed,2023-09-22,02436221,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,77701000,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013875,epinephrine (epinephrine bitartrate) 0.2 mg per 20 mL and lidocaine hydrochloride 400 mg per 20 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92056,Marketed,2023-09-22,02436221,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,77701001,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP (epinephrine (epinephrine bitartrate) 0.5 mg per 50 mL and lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013876,epinephrine (epinephrine bitartrate) 0.5 mg per 50 mL and lidocaine hydrochloride 1000 mg per 50 mL solution for injection vial,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96290,Marketed,2019-04-29,02473518,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000",2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02473518,"LIDOCAINE 2% AND EPINEPHRINE 1:100,000 (epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT",Active,9013871,epinephrine (epinephrine bitartrate) 0.01 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
96291,Marketed,2019-05-10,02473526,"LIDOCAINE 2% AND EPINEPHRINE 1:50,000",2.0,N01BB52,"Lidocaine, combinations",Solution,Block/infiltration,02473526,"LIDOCAINE 2% AND EPINEPHRINE 1:50,000 (epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT",Active,9013872,epinephrine (epinephrine bitartrate) 0.02 mg per mL and lidocaine hydrochloride 20 mg per mL solution for injection 1.8 mL cartridge,8001762,epinephrine and lidocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
96012,Marketed,2024-08-20,02471027,XIIDRA,1.0,S01XA25,Lifitegrast,Solution,Ophthalmic,02471027,XIIDRA (lifitegrast 5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9012509,lifitegrast 5 % ophthalmic drops,8001149,lifitegrast,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90180,Marketed,2023-12-11,02417162,CONSTELLA,1.0,A06AX04,Linaclotide,Capsule,Oral,02417162,CONSTELLA (linaclotide 145 mcg oral capsule) ABBVIE CORPORATION,Active,9005503,linaclotide 145 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90181,Marketed,2023-12-15,02417170,CONSTELLA,1.0,A06AX04,Linaclotide,Capsule,Oral,02417170,CONSTELLA (linaclotide 290 mcg oral capsule) ABBVIE CORPORATION,Active,9005625,linaclotide 290 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95831,Marketed,2024-08-01,02469510,CONSTELLA,1.0,A06AX04,Linaclotide,Capsule,Oral,02469510,CONSTELLA (linaclotide 72 mcg oral capsule) ABBVIE CORPORATION,Active,9012577,linaclotide 72 mcg oral capsule,8001125,linaclotide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
85612,Marketed,2011-09-13,02370921,TRAJENTA,1.0,A10BH05,Linagliptin,Tablet,Oral,02370921,TRAJENTA (linagliptin 5 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004923,linagliptin 5 mg oral tablet,8001397,linagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67615,Marketed,2006-02-07,02243685,ZYVOXAM,1.0,J01XX08,Linezolid,Solution,Intravenous,02243685,ZYVOXAM (linezolid 600 mg per 300 mL solution for injection bag) PFIZER CANADA ULC,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
67616,Marketed,2010-08-04,02243686,ZYVOXAM,1.0,J01XX08,Linezolid,Powder for suspension,Oral,02243686,ZYVOXAM (linezolid 100 mg per 5 mL oral suspension) PFIZER CANADA ULC,Active,9013784,linezolid 100 mg per 5 mL oral suspension,8001489,linezolid,26643006,Oral,385024007,Oral suspension,,,,,
90735,Marketed,2014-08-25,02422689,SANDOZ LINEZOLID,1.0,J01XX08,Linezolid,Tablet,Oral,02422689,SANDOZ LINEZOLID (linezolid 600 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91113,Marketed,2019-10-31,02426552,APO-LINEZOLID,1.0,J01XX08,Linezolid,Tablet,Oral,02426552,APO-LINEZOLID (linezolid 600 mg oral tablet) APOTEX INC,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91526,Marketed,2015-06-12,02430827,LINEZOLID INJECTION,1.0,J01XX08,Linezolid,Solution,Intravenous,02430827,LINEZOLID INJECTION (linezolid 600 mg per 300 mL solution for injection bag) FRESENIUS KABI CANADA LTD,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
97176,Marketed,2019-12-30,02481278,LINEZOLID INJECTION,1.0,J01XX08,Linezolid,Solution,Intravenous,02481278,LINEZOLID INJECTION (linezolid 600 mg per 300 mL solution for injection bag) JAMP PHARMA CORPORATION,Active,9012829,linezolid 600 mg per 300 mL solution for injection bag,8001489,linezolid,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
100955,Marketed,2022-10-31,02520354,JAMP LINEZOLID,1.0,J01XX08,Linezolid,Tablet,Oral,02520354,JAMP LINEZOLID (linezolid 600 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003587,linezolid 600 mg oral tablet,8001489,linezolid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15908,Marketed,2013-03-20,01919466,CYTOMEL,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,01919466,CYTOMEL (liothyronine (liothyronine sodium) 25 mcg oral tablet) PFIZER CANADA ULC,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15909,Marketed,2013-03-20,01919458,CYTOMEL,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,01919458,CYTOMEL (liothyronine (liothyronine sodium) 5 mcg oral tablet) PFIZER CANADA ULC,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98436,Marketed,2020-07-10,02494337,TEVA-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02494337,TEVA-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) TEVA CANADA LIMITED,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98437,Marketed,2020-07-10,02494345,TEVA-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02494345,TEVA-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) TEVA CANADA LIMITED,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103880,Marketed,2025-09-18,02549999,AURO-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02549999,AURO-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) AURO PHARMA INC,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103881,Marketed,2025-09-18,02550008,AURO-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02550008,AURO-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) AURO PHARMA INC,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106427,Marketed,2026-01-15,02561298,ZDS-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02561298,ZDS-LIOTHYRONINE (liothyronine (liothyronine sodium) 5 mcg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9002592,liothyronine (liothyronine sodium) 5 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106428,Marketed,2026-01-15,02561301,ZDS-LIOTHYRONINE,1.0,H03AA02,Liothyronine sodium,Tablet,Oral,02561301,ZDS-LIOTHYRONINE (liothyronine (liothyronine sodium) 25 mcg oral tablet) ZYDUS LIFESCIENCES LIMITED,Active,9002591,liothyronine (liothyronine sodium) 25 mcg oral tablet,8001665,liothyronine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
721,Marketed,2018-04-02,00107875,FLEET ENEMA MINERAL OIL,1.0,A06AA01,Liquid paraffin,Enema,Rectal,00107875,FLEET ENEMA MINERAL OIL (mineral oil heavy 100 % rectal liquid) C B FLEET COMPANY INC,Active,9013713,mineral oil heavy 100 % rectal liquid,8002204,mineral oil heavy,37161004,Rectal,420699003,Liquid,,,,,
5792,Marketed,2004-11-22,00608734,LANSOYL GEL 78%,1.0,A06AA01,Liquid paraffin,Gel,Oral,00608734,LANSOYL GEL 78% (mineral oil heavy 78 % oral gel) AURIUM PHARMA INC.,Active,9013718,mineral oil heavy 78 % oral gel,8002204,mineral oil heavy,26643006,Oral,385100002,Gel,,,,,
11629,Marketed,1991-12-31,01935348,MINERAL OIL (HEAVY),1.0,A06AA01,Liquid paraffin,Liquid,Oral,01935348,MINERAL OIL (HEAVY) (mineral oil heavy 100 % oral liquid) RW CONSUMER PRODUCTS LTD,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,
20312,Marketed,2004-11-22,02186926,LANSOYL SUGAR FREE - JELLY - 78%,1.0,A06AA01,Liquid paraffin,Gel,Oral,02186926,LANSOYL SUGAR FREE - JELLY - 78% (mineral oil heavy 78 % oral gel) AURIUM PHARMA INC.,Active,9013718,mineral oil heavy 78 % oral gel,8002204,mineral oil heavy,26643006,Oral,385100002,Gel,,,,,
41536,Marketed,2013-05-15,00485802,MINERAL OIL,1.0,A06AA01,Liquid paraffin,Liquid,Oral,00485802,MINERAL OIL (mineral oil heavy 100 % oral liquid) TEVA CANADA LIMITED,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,
41698,Marketed,1998-04-08,00704172,HUILE MINERALE LOURDE LIQ 100% USP,1.0,A06AA01,Liquid paraffin,Liquid,Oral,00704172,HUILE MINERALE LOURDE LIQ 100% USP (mineral oil heavy 100 % oral liquid) LABORATOIRE ATLAS INC,Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,
86767,Marketed,2019-02-06,02381834,MINERAL OIL USP,1.0,A06AA01,Liquid paraffin,Solution,Oral,02381834,"MINERAL OIL USP (mineral oil heavy 100 % oral liquid) VI-JON, LLC",Active,9013712,mineral oil heavy 100 % oral liquid,8002204,mineral oil heavy,26643006,Oral,420699003,Liquid,,,,,
83627,Marketed,2010-05-27,02351064,VICTOZA,1.0,A10BJ02,Liraglutide,Solution,Subcutaneous,02351064,VICTOZA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
92226,Marketed,2015-05-27,02437899,SAXENDA,1.0,A10BJ02,Liraglutide,Solution,Subcutaneous,02437899,SAXENDA (liraglutide 6 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9013000,liraglutide 6 mg per mL solution for injection 3 mL pen,8001119,liraglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
80843,Marketed,2021-04-19,02322951,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02322951,VYVANSE (lisdexamfetamine dimesylate 30 mg oral capsule) TAKEDA CANADA INC,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
80844,Marketed,2021-05-31,02322978,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02322978,VYVANSE (lisdexamfetamine dimesylate 50 mg oral capsule) TAKEDA CANADA INC,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83254,Marketed,2021-04-14,02347156,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02347156,VYVANSE (lisdexamfetamine dimesylate 20 mg oral capsule) TAKEDA CANADA INC,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83255,Marketed,2021-03-30,02347164,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02347164,VYVANSE (lisdexamfetamine dimesylate 40 mg oral capsule) TAKEDA CANADA INC,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83256,Marketed,2021-06-24,02347172,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02347172,VYVANSE (lisdexamfetamine dimesylate 60 mg oral capsule) TAKEDA CANADA INC,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92401,Marketed,2021-06-18,02439603,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02439603,VYVANSE (lisdexamfetamine dimesylate 10 mg oral capsule) TAKEDA CANADA INC,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94514,Marketed,2021-07-26,02458071,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02458071,VYVANSE (lisdexamfetamine dimesylate 70 mg oral capsule) TAKEDA CANADA INC,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98028,Marketed,2021-12-09,02490226,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490226,VYVANSE (lisdexamfetamine dimesylate 10 mg chewable tablet) TAKEDA CANADA INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98029,Marketed,2021-06-01,02490234,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490234,VYVANSE (lisdexamfetamine dimesylate 20 mg chewable tablet) TAKEDA CANADA INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98030,Marketed,2021-11-02,02490242,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490242,VYVANSE (lisdexamfetamine dimesylate 30 mg chewable tablet) TAKEDA CANADA INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98031,Marketed,2021-12-10,02490250,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490250,VYVANSE (lisdexamfetamine dimesylate 40 mg chewable tablet) TAKEDA CANADA INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98032,Marketed,2021-12-15,02490269,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490269,VYVANSE (lisdexamfetamine dimesylate 50 mg chewable tablet) TAKEDA CANADA INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
98033,Marketed,2021-12-15,02490277,VYVANSE,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02490277,VYVANSE (lisdexamfetamine dimesylate 60 mg chewable tablet) TAKEDA CANADA INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102234,Marketed,2024-06-04,02533340,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533340,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 10 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102235,Marketed,2024-06-04,02533359,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533359,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 20 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102236,Marketed,2024-06-04,02533367,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533367,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 30 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102237,Marketed,2024-06-04,02533375,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533375,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 40 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102238,Marketed,2024-06-04,02533383,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533383,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 50 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102239,Marketed,2024-06-04,02533391,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02533391,TARO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 60 mg chewable tablet) TARO PHARMACEUTICALS INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102335,Marketed,2025-05-23,02534444,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534444,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 10 mg chewable tablet) APOTEX INC,Active,9014113,lisdexamfetamine dimesylate 10 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102337,Marketed,2025-05-23,02534452,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534452,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 20 mg chewable tablet) APOTEX INC,Active,9014114,lisdexamfetamine dimesylate 20 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102338,Marketed,2025-05-23,02534460,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534460,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 30 mg chewable tablet) APOTEX INC,Active,9014115,lisdexamfetamine dimesylate 30 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102339,Marketed,2025-05-23,02534479,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534479,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 40 mg chewable tablet) APOTEX INC,Active,9014116,lisdexamfetamine dimesylate 40 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102340,Marketed,2025-05-23,02534487,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534487,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 50 mg chewable tablet) APOTEX INC,Active,9014117,lisdexamfetamine dimesylate 50 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102341,Marketed,2025-05-23,02534495,APO-LISDEXAMFETAMINE CHEWABLE TABLETS,1.0,N06BA12,Lisdexamfetamine,Tablet (chewable),Oral,02534495,APO-LISDEXAMFETAMINE CHEWABLE TABLETS (lisdexamfetamine dimesylate 60 mg chewable tablet) APOTEX INC,Active,9014118,lisdexamfetamine dimesylate 60 mg chewable tablet,8000387,lisdexamfetamine,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102400,Marketed,2025-07-17,02535122,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535122,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102401,Marketed,2025-07-17,02535130,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535130,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102402,Marketed,2025-07-17,02535149,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535149,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102403,Marketed,2025-07-17,02535157,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535157,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102404,Marketed,2025-07-17,02535165,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535165,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102405,Marketed,2025-07-17,02535173,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535173,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102406,Marketed,2025-07-17,02535181,JAMP LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02535181,JAMP LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103460,Marketed,2024-06-03,02545861,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545861,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) TEVA CANADA LIMITED,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103461,Marketed,2024-06-03,02545888,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545888,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) TEVA CANADA LIMITED,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103462,Marketed,2024-06-03,02545896,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545896,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) TEVA CANADA LIMITED,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103463,Marketed,2024-06-03,02545918,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545918,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) TEVA CANADA LIMITED,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103464,Marketed,2024-06-03,02545926,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545926,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) TEVA CANADA LIMITED,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103465,Marketed,2024-06-03,02545934,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545934,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) TEVA CANADA LIMITED,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103466,Marketed,2024-06-03,02545942,TEVA-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02545942,TEVA-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) TEVA CANADA LIMITED,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103495,Marketed,2024-06-04,02546248,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546248,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 10 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103496,Marketed,2024-06-04,02546256,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546256,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 20 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103497,Marketed,2024-09-23,02546264,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546264,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 30 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103498,Marketed,2024-06-04,02546272,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546272,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 40 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103499,Marketed,2024-06-04,02546280,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546280,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103500,Marketed,2024-06-04,02546299,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546299,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 60 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103501,Marketed,2024-06-04,02546302,SANDOZ LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546302,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 70 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103532,Marketed,2025-02-18,02546647,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546647,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 10 mg oral capsule) APOTEX INC,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103533,Marketed,2025-02-18,02546655,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546655,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 20 mg oral capsule) APOTEX INC,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103534,Marketed,2025-02-18,02546663,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546663,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 30 mg oral capsule) APOTEX INC,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103535,Marketed,2025-02-18,02546671,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546671,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 40 mg oral capsule) APOTEX INC,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103536,Marketed,2025-02-18,02546698,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546698,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 50 mg oral capsule) APOTEX INC,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103537,Marketed,2025-02-18,02546701,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546701,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 60 mg oral capsule) APOTEX INC,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103538,Marketed,2025-02-18,02546728,APO-LISDEXAMFETAMINE CAPSULES,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02546728,APO-LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 70 mg oral capsule) APOTEX INC,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103569,Marketed,2024-12-10,02547031,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547031,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 10 mg oral capsule) PRO DOC LIMITEE,Active,9001446,lisdexamfetamine dimesylate 10 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103570,Marketed,2024-12-10,02547058,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547058,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 20 mg oral capsule) PRO DOC LIMITEE,Active,9001310,lisdexamfetamine dimesylate 20 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103571,Marketed,2024-12-10,02547066,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547066,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 30 mg oral capsule) PRO DOC LIMITEE,Active,9001278,lisdexamfetamine dimesylate 30 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103572,Marketed,2024-12-10,02547074,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547074,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 40 mg oral capsule) PRO DOC LIMITEE,Active,9001311,lisdexamfetamine dimesylate 40 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103573,Marketed,2024-12-10,02547082,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547082,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 50 mg oral capsule) PRO DOC LIMITEE,Active,9001279,lisdexamfetamine dimesylate 50 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103574,Marketed,2024-12-10,02547090,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547090,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 60 mg oral capsule) PRO DOC LIMITEE,Active,9001312,lisdexamfetamine dimesylate 60 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103575,Marketed,2024-12-10,02547104,PRO-LISDEXAMFETAMINE,1.0,N06BA12,Lisdexamfetamine,Capsule,Oral,02547104,PRO-LISDEXAMFETAMINE (lisdexamfetamine dimesylate 70 mg oral capsule) PRO DOC LIMITEE,Active,9001472,lisdexamfetamine dimesylate 70 mg oral capsule,8000387,lisdexamfetamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
17123,Marketed,2022-02-28,02049384,ZESTRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02049384,ZESTRIL (lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17126,Marketed,2022-02-28,02049333,ZESTRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02049333,ZESTRIL (lisinopril 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17215,Marketed,2022-02-28,02049376,ZESTRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02049376,ZESTRIL (lisinopril 10 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43221,Marketed,2001-10-06,02217481,APO-LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02217481,APO-LISINOPRIL (lisinopril 5 mg oral tablet) APOTEX INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77062,Marketed,2010-12-09,02285118,TEVA-LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02285118,TEVA-LISINOPRIL (TYPE Z) (lisinopril 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77063,Marketed,2010-12-09,02285126,TEVA-LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02285126,TEVA-LISINOPRIL (TYPE Z) (lisinopril 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77064,Marketed,2010-12-09,02285134,TEVA-LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02285134,TEVA-LISINOPRIL (TYPE Z) (lisinopril 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87181,Marketed,2012-06-11,02386232,LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02386232,LISINOPRIL (lisinopril 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87182,Marketed,2012-06-11,02386240,LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02386240,LISINOPRIL (lisinopril 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87183,Marketed,2012-06-11,02386259,LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02386259,LISINOPRIL (lisinopril 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87963,Marketed,2013-02-12,02394472,AURO-LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02394472,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 5 mg oral tablet) AURO PHARMA INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87964,Marketed,2013-02-12,02394480,AURO-LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02394480,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 10 mg oral tablet) AURO PHARMA INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87965,Marketed,2013-02-12,02394499,AURO-LISINOPRIL,1.0,C09AA03,Lisinopril,Tablet,Oral,02394499,AURO-LISINOPRIL (lisinopril (lisinopril dihydrate) 20 mg oral tablet) AURO PHARMA INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101418,Marketed,2025-03-17,02525186,LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02525186,LISINOPRIL (TYPE Z) (lisinopril 5 mg oral tablet) SANIS HEALTH INC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101419,Marketed,2025-03-17,02525194,LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02525194,LISINOPRIL (TYPE Z) (lisinopril 10 mg oral tablet) SANIS HEALTH INC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101420,Marketed,2025-03-17,02525208,LISINOPRIL (TYPE Z),1.0,C09AA03,Lisinopril,Tablet,Oral,02525208,LISINOPRIL (TYPE Z) (lisinopril 20 mg oral tablet) SANIS HEALTH INC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104333,Marketed,2025-12-29,02554488,LISINOPRIL TABLETS,1.0,C09AA03,Lisinopril,Tablet,Oral,02554488,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000529,lisinopril 5 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104334,Marketed,2025-12-29,02554496,LISINOPRIL TABLETS,1.0,C09AA03,Lisinopril,Tablet,Oral,02554496,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000358,lisinopril 10 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104335,Marketed,2025-12-29,02554518,LISINOPRIL TABLETS,1.0,C09AA03,Lisinopril,Tablet,Oral,02554518,LISINOPRIL TABLETS (lisinopril (lisinopril dihydrate) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000359,lisinopril 20 mg oral tablet,8000140,lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16636,Marketed,2022-02-28,02103729,ZESTORETIC,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02103729,ZESTORETIC (hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16903,Marketed,2022-02-28,02045737,ZESTORETIC,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02045737,ZESTORETIC (hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17903,Marketed,2021-07-21,02045729,ZESTORETIC,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02045729,ZESTORETIC (hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78710,Marketed,2010-12-09,02301768,TEVA-LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301768,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78711,Marketed,2010-12-09,02301776,TEVA-LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301776,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78712,Marketed,2010-12-09,02301784,TEVA-LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02301784,TEVA-LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78769,Marketed,2007-11-21,02302365,SANDOZ LISINOPRIL HCT,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302365,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78770,Marketed,2007-11-21,02302373,SANDOZ LISINOPRIL HCT,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302373,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78771,Marketed,2007-11-21,02302381,SANDOZ LISINOPRIL HCT,2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02302381,SANDOZ LISINOPRIL HCT (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84793,Marketed,2014-12-12,02362945,LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362945,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000525,hydrochlorothiazide 12.5 mg and lisinopril 10 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84794,Marketed,2014-12-12,02362953,LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362953,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 12.5 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000526,hydrochlorothiazide 12.5 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84795,Marketed,2014-12-12,02362961,LISINOPRIL/HCTZ (TYPE Z),2.0,C09BA03,Lisinopril and diuretics,Tablet,Oral,02362961,LISINOPRIL/HCTZ (TYPE Z) (hydrochlorothiazide 25 mg and lisinopril (lisinopril dihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000577,hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet,8000201,hydrochlorothiazide and lisinopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101618,Marketed,2024-11-19,02527138,BREYANZI,1.0,L01XL08,Lisocabtagene maraleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,
1327,Marketed,2019-06-03,00236683,CARBOLITH,1.0,N05AN01,Lithium,Capsule,Oral,00236683,"CARBOLITH (lithium carbonate 300 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000054,lithium carbonate 300 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3192,Marketed,2022-09-22,00406775,LITHANE,1.0,N05AN01,Lithium,Capsule,Oral,00406775,LITHANE (lithium carbonate 300 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000054,lithium carbonate 300 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3414,Marketed,2019-06-03,00461733,CARBOLITH,1.0,N05AN01,Lithium,Capsule,Oral,00461733,"CARBOLITH (lithium carbonate 150 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13429,Marketed,2019-06-03,02011239,CARBOLITH,1.0,N05AN01,Lithium,Capsule,Oral,02011239,"CARBOLITH (lithium carbonate 600 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000428,lithium carbonate 600 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13626,Marketed,2022-09-23,02013231,LITHANE,1.0,N05AN01,Lithium,Capsule,Oral,02013231,LITHANE (lithium carbonate 150 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19894,Marketed,1996-12-31,02216132,PMS-LITHIUM CARBONATE - CAP 150MG,1.0,N05AN01,Lithium,Capsule,Oral,02216132,PMS-LITHIUM CARBONATE - CAP 150MG (lithium carbonate 150 mg oral capsule) PHARMASCIENCE INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
66667,Marketed,2001-02-12,02242837,APO-LITHIUM CARBONATE,1.0,N05AN01,Lithium,Capsule,Oral,02242837,APO-LITHIUM CARBONATE (lithium carbonate 150 mg oral capsule) APOTEX INC,Active,9000130,lithium carbonate 150 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
66668,Marketed,2001-02-12,02242838,APO-LITHIUM CARBONATE,1.0,N05AN01,Lithium,Capsule,Oral,02242838,APO-LITHIUM CARBONATE (lithium carbonate 300 mg oral capsule) APOTEX INC,Active,9000054,lithium carbonate 300 mg oral capsule,8000041,lithium carbonate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75210,Marketed,2011-01-14,02266695,LITHMAX,1.0,N05AN01,Lithium,Tablet (extended-release),Oral,02266695,LITHMAX (lithium carbonate 300 mg prolonged-release oral tablet) AA PHARMA INC,Active,9001110,lithium carbonate 300 mg prolonged-release oral tablet,8000041,lithium carbonate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
13591,Marketed,2018-03-16,00893560,ALOMIDE,1.0,S01GX05,Lodoxamide,Solution,Ophthalmic,00893560,ALOMIDE (lodoxamide (lodoxamide tromethamine) 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012830,lodoxamide (lodoxamide tromethamine) 0.1 % ophthalmic drops,8001490,lodoxamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90495,Marketed,2024-03-18,02420341,JUXTAPID,1.0,C10AX12,Lomitapide,Capsule,Oral,02420341,JUXTAPID (lomitapide (lomitapide mesylate) 5 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005518,lomitapide (lomitapide mesylate) 5 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90496,Marketed,2024-02-23,02420376,JUXTAPID,1.0,C10AX12,Lomitapide,Capsule,Oral,02420376,JUXTAPID (lomitapide (lomitapide mesylate) 10 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005516,lomitapide (lomitapide mesylate) 10 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90498,Marketed,2024-02-23,02420384,JUXTAPID,1.0,C10AX12,Lomitapide,Capsule,Oral,02420384,JUXTAPID (lomitapide (lomitapide mesylate) 20 mg oral capsule) CHIESI FARMACEUTICI S.P.A.,Active,9005517,lomitapide (lomitapide mesylate) 20 mg oral capsule,8001315,lomitapide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
2530,Marketed,2009-12-14,00360422,CEENU,1.0,L01AD02,Lomustine,Capsule,Oral,00360422,CEENU (lomustine 40 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9001763,lomustine 40 mg oral capsule,8001842,lomustine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
2531,Marketed,2010-02-18,00360430,CEENU,1.0,L01AD02,Lomustine,Capsule,Oral,00360430,CEENU (lomustine 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9001762,lomustine 10 mg oral capsule,8001842,lomustine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
14567,Marketed,1993-12-31,02016095,PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML,1.0,A07DA03,Loperamide,Solution,Oral,02016095,PMS-LOPERAMIDE HYDROCHLORIDE SOLUTION.2MG/ML (loperamide hydrochloride 0.2 mg per mL oral solution) PHARMASCIENCE INC,Active,9002593,loperamide hydrochloride 0.2 mg per mL oral solution,8001213,loperamide,26643006,Oral,385023001,Oral solution,,,,,
18071,Marketed,2016-12-23,02132591,TEVA-LOPERAMIDE,1.0,A07DA03,Loperamide,Tablet,Oral,02132591,TEVA-LOPERAMIDE (loperamide hydrochloride 2 mg oral tablet) TEVA CANADA LIMITED,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43419,Marketed,2014-05-26,02225182,LOPERAMIDE-2,1.0,A07DA03,Loperamide,Tablet,Oral,02225182,LOPERAMIDE-2 (loperamide hydrochloride 2 mg oral tablet) PRO DOC LIMITEE,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43486,Marketed,1996-09-12,02228351,PMS-LOPERAMIDE - CAPLET 2MG,1.0,A07DA03,Loperamide,Tablet,Oral,02228351,PMS-LOPERAMIDE - CAPLET 2MG (loperamide hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49614,Marketed,1998-06-11,02230542,IMODIUM QUICK DISSOLVE,1.0,A07DA03,Loperamide,Tablet (orally disintegrating),Oral,02230542,IMODIUM QUICK DISSOLVE (loperamide hydrochloride 2 mg orodispersible tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9013221,loperamide hydrochloride 2 mg orodispersible tablet,8001213,loperamide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
61604,Marketed,1998-08-27,02238211,RIVA-LOPERAMIDE,1.0,A07DA03,Loperamide,Tablet,Oral,02238211,RIVA-LOPERAMIDE (loperamide hydrochloride 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73379,Marketed,2004-06-11,02248994,DIARRHEA RELIEF,1.0,A07DA03,Loperamide,Tablet,Oral,02248994,DIARRHEA RELIEF (loperamide hydrochloride 2 mg oral tablet) PHARMASCIENCE INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74169,Marketed,2004-12-19,02256452,DIARRHEA RELIEF,1.0,A07DA03,Loperamide,Tablet,Oral,02256452,DIARRHEA RELIEF (loperamide hydrochloride 2 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002841,loperamide hydrochloride 2 mg oral tablet,8001213,loperamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77716,Marketed,2011-05-06,02291800,IMODIUM CALMING LIQUID,1.0,A07DA03,Loperamide,Solution,Oral,02291800,IMODIUM CALMING LIQUID (loperamide hydrochloride 2 mg per 15 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004307,loperamide hydrochloride 2 mg per 15 mL oral solution,8001213,loperamide,26643006,Oral,385023001,Oral solution,,,,,
86147,Marketed,2013-07-02,02376016,IMODIUM LIQUI-GELS,1.0,A07DA03,Loperamide,Capsule,Oral,02376016,IMODIUM LIQUI-GELS (loperamide hydrochloride 2 mg oral capsule) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98925,Marketed,2022-05-30,02499517,DIARRHEA RELIEF FAST DISSOLVE,1.0,A07DA03,Loperamide,Tablet (orally disintegrating),Oral,02499517,DIARRHEA RELIEF FAST DISSOLVE (loperamide hydrochloride 2 mg orodispersible tablet) JUNO OTC INC,Active,9013221,loperamide hydrochloride 2 mg orodispersible tablet,8001213,loperamide,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
103360,Marketed,2025-03-14,02544989,JAMP LOPERAMIDE,1.0,A07DA03,Loperamide,Capsule,Oral,02544989,JAMP LOPERAMIDE (loperamide hydrochloride 2 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104101,Marketed,2025-08-19,02552337,DIARRHEA RELIEF LIQUID GELS,1.0,A07DA03,Loperamide,Capsule,Oral,02552337,DIARRHEA RELIEF LIQUID GELS (loperamide hydrochloride 2 mg oral capsule) LABORATOIRE RIVA INC.,Active,9005282,loperamide hydrochloride 2 mg oral capsule,8001213,loperamide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
69200,Marketed,2025-11-28,02245185,IMODIUM COMPLETE,2.0,A07DA53,"Loperamide, combinations",Tablet,Oral,02245185,IMODIUM COMPLETE (loperamide hydrochloride 2 mg and simethicone 125 mg oral tablet) KENVUE CANADA INC.,Active,9003731,loperamide hydrochloride 2 mg and simethicone 125 mg oral tablet,8002135,loperamide and simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67570,Marketed,2014-06-09,02243644,KALETRA,2.0,J05AR10,Lopinavir and ritonavir,Solution,Oral,02243644,KALETRA (lopinavir 400 mg per 5 mL and ritonavir 100 mg per 5 mL oral solution) ABBVIE CORPORATION,Active,9013451,lopinavir 400 mg per 5 mL and ritonavir 100 mg per 5 mL oral solution,8001491,lopinavir and ritonavir,26643006,Oral,385023001,Oral solution,,,,,
77104,Marketed,2015-01-14,02285533,KALETRA,2.0,J05AR10,Lopinavir and ritonavir,Tablet,Oral,02285533,KALETRA (lopinavir 200 mg and ritonavir 50 mg oral tablet) ABBVIE CORPORATION,Active,9004211,lopinavir 200 mg and ritonavir 50 mg oral tablet,8001491,lopinavir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79781,Marketed,2014-11-25,02312301,KALETRA,2.0,J05AR10,Lopinavir and ritonavir,Tablet,Oral,02312301,KALETRA (lopinavir 100 mg and ritonavir 25 mg oral tablet) ABBVIE CORPORATION,Active,9004452,lopinavir 100 mg and ritonavir 25 mg oral tablet,8001491,lopinavir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10533,Marketed,2020-02-27,00782696,CLARITIN ALLERGY,1.0,R06AX13,Loratadine,Tablet,Oral,00782696,CLARITIN ALLERGY (loratadine 10 mg oral tablet) BAYER INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61088,Marketed,2014-12-19,02237734,CLARITIN RAPID DISSOLVE,1.0,R06AX13,Loratadine,Tablet (orally disintegrating),Oral,02237734,CLARITIN RAPID DISSOLVE (loratadine 10 mg orodispersible tablet) BAYER INC,Active,9003251,loratadine 10 mg orodispersible tablet,8001492,loratadine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
65175,Marketed,2017-03-01,02241523,CLARITIN KIDS,1.0,R06AX13,Loratadine,Syrup,Oral,02241523,CLARITIN KIDS (loratadine 5 mg per 5 mL syrup) BAYER INC,Active,9013453,loratadine 5 mg per 5 mL syrup,8001492,loratadine,26643006,Oral,739009002,Syrup,,,,,
67821,Marketed,2010-10-09,02243880,APO-LORATADINE,1.0,R06AX13,Loratadine,Tablet,Oral,02243880,APO-LORATADINE (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76583,Marketed,2010-09-24,02280159,24 HOUR ALLERGY REMEDY,1.0,R06AX13,Loratadine,Tablet,Oral,02280159,24 HOUR ALLERGY REMEDY (loratadine 10 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85127,Marketed,2013-04-18,02366444,LORATADINE,1.0,R06AX13,Loratadine,Tablet,Oral,02366444,LORATADINE (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86145,Marketed,2024-02-01,02375990,ALLERGY REMEDY,1.0,R06AX13,Loratadine,Tablet,Oral,02375990,ALLERGY REMEDY (loratadine 10 mg oral tablet) APOTEX INC,Active,9002125,loratadine 10 mg oral tablet,8001492,loratadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86538,Marketed,2012-09-07,02379481,LORATADINE SOFT GEL CAPSULES,1.0,R06AX13,Loratadine,Capsule,Oral,02379481,LORATADINE SOFT GEL CAPSULES (loratadine 10 mg oral capsule) APOTEX INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87582,Marketed,2013-10-31,02390388,ALLERTIN,1.0,R06AX13,Loratadine,Capsule,Oral,02390388,ALLERTIN (loratadine 10 mg oral capsule) APOTEX INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88925,Marketed,2016-05-31,02404494,CLARITIN LIQUID CAPSULES,1.0,R06AX13,Loratadine,Capsule,Oral,02404494,CLARITIN LIQUID CAPSULES (loratadine 10 mg oral capsule) BAYER INC,Active,9005099,loratadine 10 mg oral capsule,8001492,loratadine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99811,Marketed,2021-09-20,02508761,CLARITIN KIDS RAPID DISSOLVE,1.0,R06AX13,Loratadine,Tablet (orally disintegrating),Oral,02508761,CLARITIN KIDS RAPID DISSOLVE (loratadine 5 mg orodispersible tablet) BAYER INC,Active,9014609,loratadine 5 mg orodispersible tablet,8001492,loratadine,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),,,
6135,Marketed,2014-01-11,00637742,TEVA-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00637742,TEVA-LORAZEPAM (lorazepam 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6136,Marketed,2014-01-11,00637750,TEVA-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00637750,TEVA-LORAZEPAM (lorazepam 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6295,Marketed,1985-12-31,00655740,APO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655740,APO-LORAZEPAM (lorazepam 0.5 mg oral tablet) APOTEX INC,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6296,Marketed,1985-12-31,00655759,APO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655759,APO-LORAZEPAM (lorazepam 1 mg oral tablet) APOTEX INC,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6297,Marketed,1985-12-31,00655767,APO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655767,APO-LORAZEPAM (lorazepam 2 mg oral tablet) APOTEX INC,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6656,Marketed,2022-03-22,00655643,PRO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655643,PRO-LORAZEPAM (lorazepam 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6657,Marketed,2022-03-22,00655651,PRO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655651,PRO-LORAZEPAM (lorazepam 1 mg oral tablet) PRO DOC LIMITEE,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6658,Marketed,2022-03-22,00655678,PRO-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00655678,PRO-LORAZEPAM (lorazepam 2 mg oral tablet) PRO DOC LIMITEE,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7314,Marketed,2014-01-11,00711101,TEVA-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00711101,TEVA-LORAZEPAM (lorazepam 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9349,Marketed,1988-12-31,00728187,PMS-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00728187,PMS-LORAZEPAM (lorazepam 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000224,lorazepam 0.5 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9423,Marketed,1988-12-31,00728195,PMS-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00728195,PMS-LORAZEPAM (lorazepam 1 mg oral tablet) PHARMASCIENCE INC,Active,9000225,lorazepam 1 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9424,Marketed,1988-12-31,00728209,PMS-LORAZEPAM,1.0,N05BA06,Lorazepam,Tablet,Oral,00728209,PMS-LORAZEPAM (lorazepam 2 mg oral tablet) PHARMASCIENCE INC,Active,9000226,lorazepam 2 mg oral tablet,8000109,lorazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16118,Marketed,2025-12-01,02041464,ATIVAN,1.0,N05BA06,Lorazepam,Tablet,Sublingual,02041464,ATIVAN (lorazepam 1 mg sublingual tablet) PFIZER CANADA ULC,Active,9000531,lorazepam 1 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
17817,Marketed,2025-12-01,02041456,ATIVAN,1.0,N05BA06,Lorazepam,Tablet,Sublingual,02041456,ATIVAN (lorazepam 0.5 mg sublingual tablet) PFIZER CANADA ULC,Active,9000596,lorazepam 0.5 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
67176,Marketed,2005-09-21,02243278,LORAZEPAM INJECTION USP,1.0,N05BA06,Lorazepam,Solution,"Intravenous,Intramuscular",02243278,LORAZEPAM INJECTION USP (lorazepam 4 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000942,lorazepam 4 mg per 1 mL solution for injection vial,8000109,lorazepam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
89541,Marketed,2018-01-15,02410745,LORAZEPAM SUBLINGUAL,1.0,N05BA06,Lorazepam,Tablet,Sublingual,02410745,LORAZEPAM SUBLINGUAL (lorazepam 0.5 mg sublingual tablet) AA PHARMA INC,Active,9000596,lorazepam 0.5 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
89542,Marketed,2018-01-15,02410753,LORAZEPAM SUBLINGUAL,1.0,N05BA06,Lorazepam,Tablet,Sublingual,02410753,LORAZEPAM SUBLINGUAL (lorazepam 1 mg sublingual tablet) AA PHARMA INC,Active,9000531,lorazepam 1 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
89543,Marketed,2018-01-15,02410761,LORAZEPAM SUBLINGUAL,1.0,N05BA06,Lorazepam,Tablet,Sublingual,02410761,LORAZEPAM SUBLINGUAL (lorazepam 2 mg sublingual tablet) AA PHARMA INC,Active,9000532,lorazepam 2 mg sublingual tablet,8000109,lorazepam,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
103972,Marketed,2026-01-20,02550962,"LORAZEPAM INJECTION, USP",1.0,N05BA06,Lorazepam,Solution,"Intravenous,Intramuscular",,,,,,,,,,,,,,,,
97619,Marketed,2019-04-22,02485966,LORBRENA,1.0,L01ED05,Lorlatinib,Tablet,Oral,02485966,LORBRENA (lorlatinib 25 mg oral tablet) PFIZER CANADA ULC,Active,9013975,lorlatinib 25 mg oral tablet,8002261,lorlatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97620,Marketed,2019-04-22,02485974,LORBRENA,1.0,L01ED05,Lorlatinib,Tablet,Oral,02485974,LORBRENA (lorlatinib 100 mg oral tablet) PFIZER CANADA ULC,Active,9013974,lorlatinib 100 mg oral tablet,8002261,lorlatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19167,Marketed,2022-02-21,02182815,COZAAR,1.0,C09CA01,Losartan,Tablet,Oral,02182815,COZAAR (losartan potassium 25 mg oral tablet) ORGANON CANADA INC.,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19168,Marketed,2022-01-05,02182874,COZAAR,1.0,C09CA01,Losartan,Tablet,Oral,02182874,COZAAR (losartan potassium 50 mg oral tablet) ORGANON CANADA INC.,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
44255,Marketed,2022-01-07,02182882,COZAAR,1.0,C09CA01,Losartan,Tablet,Oral,02182882,COZAAR (losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79542,Marketed,2020-12-16,02309750,PMS-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02309750,PMS-LOSARTAN (losartan potassium 25 mg oral tablet) PHARMASCIENCE INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79543,Marketed,2020-11-05,02309769,PMS-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02309769,PMS-LOSARTAN (losartan potassium 50 mg oral tablet) PHARMASCIENCE INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79544,Marketed,2012-01-25,02309777,PMS-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02309777,PMS-LOSARTAN (losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79886,Marketed,2012-01-25,02313332,SANDOZ LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02313332,SANDOZ LOSARTAN (losartan potassium 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79887,Marketed,2012-01-25,02313340,SANDOZ LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02313340,SANDOZ LOSARTAN (losartan potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79888,Marketed,2012-01-25,02313359,SANDOZ LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02313359,SANDOZ LOSARTAN (losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84304,Marketed,2012-01-25,02357968,TEVA-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02357968,TEVA-LOSARTAN (losartan potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84305,Marketed,2012-01-25,02357976,TEVA-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02357976,TEVA-LOSARTAN (losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86659,Marketed,2012-02-28,02380838,TEVA-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02380838,TEVA-LOSARTAN (losartan potassium 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87431,Marketed,2025-06-12,02388790,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388790,LOSARTAN (losartan potassium 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87432,Marketed,2025-06-12,02388804,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388804,LOSARTAN (losartan potassium 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87433,Marketed,2025-06-12,02388812,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388812,LOSARTAN (losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87441,Marketed,2012-07-20,02388863,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388863,LOSARTAN (losartan potassium 25 mg oral tablet) SANIS HEALTH INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87442,Marketed,2012-07-20,02388871,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388871,LOSARTAN (losartan potassium 50 mg oral tablet) SANIS HEALTH INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87443,Marketed,2012-07-20,02388898,LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02388898,LOSARTAN (losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88375,Marketed,2016-06-01,02398834,JAMP-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02398834,JAMP-LOSARTAN (losartan potassium 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88376,Marketed,2016-06-01,02398842,JAMP-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02398842,JAMP-LOSARTAN (losartan potassium 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88377,Marketed,2016-06-01,02398850,JAMP-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02398850,JAMP-LOSARTAN (losartan potassium 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88814,Marketed,2013-03-26,02403323,AURO-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02403323,AURO-LOSARTAN (losartan potassium 25 mg oral tablet) AURO PHARMA INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88815,Marketed,2013-03-26,02403331,AURO-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02403331,AURO-LOSARTAN (losartan potassium 50 mg oral tablet) AURO PHARMA INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88816,Marketed,2013-03-26,02403358,AURO-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02403358,AURO-LOSARTAN (losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89050,Marketed,2024-03-22,02405733,MINT-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02405733,MINT-LOSARTAN (losartan potassium 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000597,losartan potassium 25 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89051,Marketed,2024-03-22,02405741,MINT-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02405741,MINT-LOSARTAN (losartan potassium 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000598,losartan potassium 50 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89052,Marketed,2024-03-22,02405768,MINT-LOSARTAN,1.0,C09CA01,Losartan,Tablet,Oral,02405768,MINT-LOSARTAN (losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000775,losartan potassium 100 mg oral tablet,8000216,losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
48580,Marketed,2022-03-03,02230047,HYZAAR,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02230047,HYZAAR (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) ORGANON CANADA INC.,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64599,Marketed,2022-04-01,02241007,HYZAAR DS,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02241007,HYZAAR DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78318,Marketed,2022-04-05,02297841,HYZAAR,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02297841,HYZAAR (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) ORGANON CANADA INC.,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79890,Marketed,2012-01-25,02313375,SANDOZ LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02313375,SANDOZ LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79891,Marketed,2012-01-25,02313383,SANDOZ LOSARTAN HCT DS,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02313383,SANDOZ LOSARTAN HCT DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84332,Marketed,2012-04-16,02358263,TEVA-LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02358263,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84745,Marketed,2012-01-25,02362449,SANDOZ LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02362449,SANDOZ LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86273,Marketed,2012-01-25,02377144,TEVA-LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02377144,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86274,Marketed,2012-01-25,02377152,TEVA-LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02377152,TEVA-LOSARTAN/HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87449,Marketed,2025-10-07,02388960,LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02388960,LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87450,Marketed,2025-10-07,02388979,LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02388979,LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87451,Marketed,2025-10-07,02388987,LOSARTAN HCT DS,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02388987,LOSARTAN HCT DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87515,Marketed,2024-06-14,02389657,MINT-LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02389657,MINT-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87516,Marketed,2024-06-14,02389665,MINT-LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02389665,MINT-LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87517,Marketed,2024-06-14,02389673,MINT-LOSARTAN/HCTZ DS,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02389673,MINT-LOSARTAN/HCTZ DS (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87750,Marketed,2012-09-04,02392224,PMS-LOSARTAN-HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02392224,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) PHARMASCIENCE INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87751,Marketed,2012-09-04,02392232,PMS-LOSARTAN-HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02392232,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87752,Marketed,2012-09-04,02392240,PMS-LOSARTAN-HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02392240,PMS-LOSARTAN-HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) PHARMASCIENCE INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90835,Marketed,2014-04-29,02423642,AURO-LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02423642,AURO-LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) AURO PHARMA INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90836,Marketed,2014-04-29,02423650,AURO-LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02423650,AURO-LOSARTAN HCT (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90837,Marketed,2014-04-29,02423669,AURO-LOSARTAN HCT,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02423669,AURO-LOSARTAN HCT (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) AURO PHARMA INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91215,Marketed,2014-07-25,02427648,LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02427648,LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet) SANIS HEALTH INC,Active,9000672,hydrochlorothiazide 12.5 mg and losartan potassium 50 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91216,Marketed,2020-08-25,02427656,LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02427656,LOSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9001208,hydrochlorothiazide 12.5 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91217,Marketed,2014-07-25,02427664,LOSARTAN/HCTZ,2.0,C09DA01,Losartan and diuretics,Tablet,Oral,02427664,LOSARTAN/HCTZ (hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet) SANIS HEALTH INC,Active,9000878,hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet,8000229,hydrochlorothiazide and losartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80634,Marketed,2009-06-24,02320924,ALREX,1.0,S01BA14,Loteprednol,Suspension,Ophthalmic,02320924,ALREX (loteprednol etabonate 0.2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9004561,loteprednol etabonate 0.2 % ophthalmic drops,8001285,loteprednol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
80652,Marketed,2009-06-24,02321114,LOTEMAX,1.0,S01BA14,Loteprednol,Suspension,Ophthalmic,02321114,LOTEMAX (loteprednol etabonate 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9004562,loteprednol etabonate 0.5 % ophthalmic drops,8001285,loteprednol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90664,Marketed,2014-10-29,02421941,LOTEMAX OINTMENT,1.0,S01BA14,Loteprednol,Ointment,Ophthalmic,02421941,LOTEMAX OINTMENT (loteprednol etabonate 0.5 % ophthalmic ointment) BAUSCH & LOMB INC,Active,9005607,loteprednol etabonate 0.5 % ophthalmic ointment,8001285,loteprednol,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
92020,Marketed,2015-06-25,02435853,LOTEMAX GEL,1.0,S01BA14,Loteprednol,Gel,Ophthalmic,02435853,LOTEMAX GEL (loteprednol etabonate 0.5 % ophthalmic gel) BAUSCH & LOMB INC,Active,9005735,loteprednol etabonate 0.5 % ophthalmic gel,8001285,loteprednol,54485002,Ophthalmic,385100002,Gel,,,,,
43279,Marketed,2021-06-15,02220172,LOVASTATIN,1.0,C10AA02,Lovastatin,Tablet,Oral,02220172,LOVASTATIN (lovastatin 20 mg oral tablet) AA PHARMA INC,Active,9003074,lovastatin 20 mg oral tablet,8001286,lovastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43280,Marketed,2021-06-15,02220180,LOVASTATIN,1.0,C10AA02,Lovastatin,Tablet,Oral,02220180,LOVASTATIN (lovastatin 40 mg oral tablet) AA PHARMA INC,Active,9003075,lovastatin 40 mg oral tablet,8001286,lovastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
34560,Marketed,2005-10-06,02169991,LOXAPAC IM,1.0,N05AH01,Loxapine,Solution,Intramuscular,02169991,LOXAPAC IM (loxapine (loxapine hydrochloride) 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013004,loxapine (loxapine hydrochloride) 50 mg per 1 mL solution for injection ampoule,8001666,loxapine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
50116,Marketed,2013-09-20,02230838,XYLAC,1.0,N05AH01,Loxapine,Tablet,Oral,02230838,XYLAC (loxapine (loxapine succinate) 10 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003239,loxapine (loxapine succinate) 10 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50117,Marketed,2013-11-11,02230839,XYLAC,1.0,N05AH01,Loxapine,Tablet,Oral,02230839,XYLAC (loxapine (loxapine succinate) 25 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003116,loxapine (loxapine succinate) 25 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66699,Marketed,2014-04-14,02242868,XYLAC,1.0,N05AH01,Loxapine,Tablet,Oral,02242868,XYLAC (loxapine (loxapine succinate) 2.5 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9003526,loxapine (loxapine succinate) 2.5 mg oral tablet,8001666,loxapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101476,Marketed,2022-05-05,02525755,OXLUMO,1.0,A16AX18,Lumasiran,Solution,Subcutaneous,02525755,OXLUMO (lumasiran (lumasiran sodium) 94.5 mg per 0.5 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014722,lumasiran (lumasiran sodium) 94.5 mg per 0.5 mL solution for injection vial,8002424,lumasiran,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87334,Marketed,2025-09-08,02387751,LATUDA,1.0,N05AE05,Lurasidone,Tablet,Oral,02387751,"LATUDA (lurasidone hydrochloride 40 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87335,Marketed,2024-01-19,02387778,LATUDA,1.0,N05AE05,Lurasidone,Tablet,Oral,02387778,"LATUDA (lurasidone hydrochloride 80 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89804,Marketed,2024-01-19,02413361,LATUDA,1.0,N05AE05,Lurasidone,Tablet,Oral,02413361,"LATUDA (lurasidone hydrochloride 60 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90675,Marketed,2024-01-19,02422050,LATUDA,1.0,N05AE05,Lurasidone,Tablet,Oral,02422050,"LATUDA (lurasidone hydrochloride 20 mg oral tablet) SUMITOMO PHARMA CANADA, INC.",Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99391,Marketed,2022-05-02,02504499,TARO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02504499,TARO-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99392,Marketed,2022-05-02,02504502,TARO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02504502,TARO-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99393,Marketed,2022-05-02,02504510,TARO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02504510,TARO-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99394,Marketed,2022-05-02,02504529,TARO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02504529,TARO-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99395,Marketed,2022-05-02,02504537,TARO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02504537,TARO-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99523,Marketed,2022-05-02,02505878,PMS-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02505878,PMS-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99524,Marketed,2022-05-02,02505886,PMS-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02505886,PMS-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) PHARMASCIENCE INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99525,Marketed,2022-05-02,02505894,PMS-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02505894,PMS-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) PHARMASCIENCE INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99526,Marketed,2022-05-02,02505908,PMS-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02505908,PMS-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) PHARMASCIENCE INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99527,Marketed,2022-05-02,02505916,PMS-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02505916,PMS-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) PHARMASCIENCE INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100317,Marketed,2023-10-30,02513986,AURO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02513986,AURO-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) AURO PHARMA INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100318,Marketed,2023-10-30,02513994,AURO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02513994,AURO-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) AURO PHARMA INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100319,Marketed,2023-10-30,02514001,AURO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02514001,AURO-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) AURO PHARMA INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100320,Marketed,2023-10-30,02514028,AURO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02514028,AURO-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) AURO PHARMA INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100321,Marketed,2023-10-30,02514036,AURO-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02514036,AURO-LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) AURO PHARMA INC,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100577,Marketed,2022-05-02,02516438,JAMP LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02516438,JAMP LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100578,Marketed,2022-05-02,02516446,JAMP LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02516446,JAMP LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100579,Marketed,2022-05-02,02516454,JAMP LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02516454,JAMP LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100580,Marketed,2022-05-02,02516462,JAMP LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02516462,JAMP LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100581,Marketed,2022-09-02,02516470,JAMP LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02516470,JAMP LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101030,Marketed,2022-04-07,02521075,SANDOZ LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02521075,SANDOZ LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101032,Marketed,2022-04-07,02521091,SANDOZ LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02521091,SANDOZ LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101033,Marketed,2022-04-07,02521105,SANDOZ LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02521105,SANDOZ LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101034,Marketed,2022-04-07,02521113,SANDOZ LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02521113,SANDOZ LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101035,Marketed,2023-06-01,02521121,SANDOZ LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02521121,SANDOZ LURASIDONE (lurasidone hydrochloride 120 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005097,lurasidone hydrochloride 120 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101145,Marketed,2024-09-23,02522314,NRA-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02522314,NRA-LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) NORA PHARMA INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101146,Marketed,2024-09-23,02522322,NRA-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02522322,NRA-LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) NORA PHARMA INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101147,Marketed,2024-09-23,02522330,NRA-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02522330,NRA-LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) NORA PHARMA INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101148,Marketed,2024-09-23,02522349,NRA-LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02522349,NRA-LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) NORA PHARMA INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103744,Marketed,2024-12-17,02548585,LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02548585,LURASIDONE (lurasidone hydrochloride 20 mg oral tablet) SANIS HEALTH INC,Active,9005491,lurasidone hydrochloride 20 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103745,Marketed,2024-12-17,02548593,LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02548593,LURASIDONE (lurasidone hydrochloride 40 mg oral tablet) SANIS HEALTH INC,Active,9005098,lurasidone hydrochloride 40 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103746,Marketed,2024-12-17,02548607,LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02548607,LURASIDONE (lurasidone hydrochloride 60 mg oral tablet) SANIS HEALTH INC,Active,9005467,lurasidone hydrochloride 60 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103747,Marketed,2024-12-17,02548615,LURASIDONE,1.0,N05AE05,Lurasidone,Tablet,Oral,02548615,LURASIDONE (lurasidone hydrochloride 80 mg oral tablet) SANIS HEALTH INC,Active,9005096,lurasidone hydrochloride 80 mg oral tablet,8001287,lurasidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101003,Marketed,2021-12-06,02520834,ZEPZELCA,1.0,L01XX69,Lurbinectedin,Powder,Intravenous,02520834,ZEPZELCA (lurbinectedin 4 mg per vial powder for solution for injection) JAZZ PHARMACEUTICALS IRELAND LIMITED,Active,9014641,lurbinectedin 4 mg per vial powder for solution for injection,8002403,lurbinectedin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
99492,Marketed,2025-02-24,02505541,REBLOZYL,1.0,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505541,REBLOZYL (luspatercept 25 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014549,luspatercept 25 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99493,Marketed,2025-02-19,02505568,REBLOZYL,1.0,B03XA06,Luspatercept,Powder for solution,Subcutaneous,02505568,REBLOZYL (luspatercept 75 mg per vial powder for solution for injection) BRISTOL-MYERS SQUIBB CANADA,Active,9014550,luspatercept 75 mg per vial powder for solution for injection,8002376,luspatercept,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97485,Marketed,2024-02-28,02484552,LUTATHERA,1.0,V10XX04,Lutetium (177lu) oxodotreotide,Solution,Intravenous,,,,,,,,,,,,,,,,
101939,Marketed,2024-09-02,02530198,PLUVICTO,1.0,V10XX05,Lutetium (177lu) vipivotide tetraxetan,Solution,Intravenous,,,,,,,,,,,,,,,,
75446,Marketed,2005-06-28,02269066,LUVERIS,1.0,G03GA07,Lutropin alfa,Powder for solution,Subcutaneous,02269066,"LUVERIS (lutropin alfa 75 unit per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013222,lutropin alfa 75 unit per vial powder for solution for injection with diluent solution,8001843,lutropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90029,Marketed,2019-09-09,02415690,OPSUMIT,1.0,C02KX04,Macitentan,Tablet,Oral,02415690,OPSUMIT (macitentan 10 mg oral tablet) JANSSEN INC,Active,9005397,macitentan 10 mg oral tablet,8001494,macitentan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101031,Marketed,2021-11-25,02521083,OPSYNVI,2.0,C02KX54,Macitentan and tadalafil,Tablet,Oral,02521083,OPSYNVI (macitentan 10 mg and tadalafil 40 mg oral tablet) JANSSEN INC,Active,9014625,macitentan 10 mg and tadalafil 40 mg oral tablet,8002396,macitentan and tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80321,Marketed,2008-12-10,02317680,LAX-A-DAY,1.0,A06AD15,Macrogol,Powder for solution,Oral,02317680,LAX-A-DAY (polyethylene glycol 3350 100 % powder for oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
80366,Marketed,2017-01-12,02318164,RESTORALAX,1.0,A06AD15,Macrogol,Powder for solution,Oral,02318164,RESTORALAX (polyethylene glycol 3350 100 % powder for oral solution) BAYER INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
81040,Marketed,2011-06-28,02324989,CLEARLAX,1.0,A06AD15,Macrogol,Powder for solution,Oral,02324989,CLEARLAX (polyethylene glycol 3350 100 % powder for oral solution) PERRIGO INTERNATIONAL,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
83209,Marketed,2023-01-04,02346672,RELAXA,1.0,A06AD15,Macrogol,Powder for solution,Oral,02346672,RELAXA (polyethylene glycol 3350 100 % powder for oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
84310,Marketed,2012-03-28,02358034,PEG 3350,1.0,A06AD15,Macrogol,Powder for solution,Oral,02358034,PEG 3350 (polyethylene glycol 3350 100 % powder for oral solution) MEDISCA PHARMACEUTIQUE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
85934,Marketed,2015-10-04,02374137,EMOLAX,1.0,A06AD15,Macrogol,Powder for solution,Oral,02374137,EMOLAX (polyethylene glycol 3350 100 % powder for oral solution) JAMP PHARMA CORPORATION,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
93607,Marketed,2025-06-19,02450070,COLAXOR,1.0,A06AD15,Macrogol,Powder for solution,Oral,02450070,COLAXOR (polyethylene glycol 3350 100 % powder for oral solution) MANTRA PHARMA INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
93973,Marketed,2016-08-30,02453193,LAX-A-DAY PHARMA,1.0,A06AD15,Macrogol,Powder for solution,Oral,02453193,LAX-A-DAY PHARMA (polyethylene glycol 3350 100 % powder for oral solution) PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
94758,Marketed,2017-08-20,02460297,COMFILAX,1.0,A06AD15,Macrogol,Powder for solution,Oral,02460297,COMFILAX (polyethylene glycol 3350 100 % powder for oral solution) CELLCHEM PHARMACEUTICALS INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
96245,Marketed,2019-04-26,02473119,HYDRALAX,1.0,A06AD15,Macrogol,Powder for solution,Oral,02473119,HYDRALAX (polyethylene glycol 3350 100 % powder for oral solution) JUNO OTC INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
100998,Marketed,2023-01-30,02520796,PEG 3350,1.0,A06AD15,Macrogol,Powder for solution,Oral,02520796,PEG 3350 (polyethylene glycol 3350 100 % powder for oral solution) ANGITA PHARMA INC.,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
103776,Marketed,2025-12-16,02548933,LAXATIVE,1.0,A06AD15,Macrogol,Powder for solution,Oral,02548933,LAXATIVE (polyethylene glycol 3350 100 % powder for oral solution) PHARMASCIENCE INC,Active,9004589,polyethylene glycol 3350 100 % powder for oral solution,8002072,polyethylene glycol 3350,26643006,Oral,385026009,Powder for oral solution,,,,,
6616,Marketed,2013-04-01,00677442,COLYTE,5.0,A06AD65,"Macrogol, combinations",Powder for solution,"Oral,Nasogastric",,,,,,,,,,,,,,,,
84451,Marketed,2020-08-13,02359499,MOVIPREP,6.0,A06AD65,"Macrogol, combinations",Powder for solution,Oral,,,,,,,,,,,,,,,,
86414,Marketed,2025-06-17,02378329,JAMPLYTE,5.0,A06AD65,"Macrogol, combinations",Powder,Oral,,,,,,,,,,,,,,,,
3088,Marketed,1978-12-31,00392618,MAGNESIUM SULFATE INJECTION USP,1.0,B05XA05,Magnesium sulphate,Liquid,"Intravenous,Intramuscular",00392618,MAGNESIUM SULFATE INJECTION USP (magnesium sulfate 2000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013455,magnesium sulfate 2000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19701,Marketed,2022-12-14,02139499,"MAGNESIUM SULFATE INJECTION, USP",1.0,B05XA05,Magnesium sulphate,Solution,"Intravenous,Intramuscular",77700916,"MAGNESIUM SULFATE INJECTION, USP (magnesium sulfate 500 mg per mL solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9013456,magnesium sulfate 500 mg per mL solution for injection 50 mL vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19701,Marketed,2022-12-14,02139499,"MAGNESIUM SULFATE INJECTION, USP",1.0,B05XA05,Magnesium sulphate,Solution,"Intravenous,Intramuscular",77700917,"MAGNESIUM SULFATE INJECTION, USP (magnesium sulfate 5000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013457,magnesium sulfate 5000 mg per 10 mL solution for injection vial,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100227,Marketed,2021-10-01,02513161,"MAGNESIUM SULFATE INJECTION, BP 49.3%",1.0,B05XA05,Magnesium sulphate,Solution,Intravenous,02513161,"MAGNESIUM SULFATE INJECTION, BP 49.3% (magnesium sulfate 493 mg per mL solution for injection 500 mL bag) BAXTER CORPORATION",Active,9014610,magnesium sulfate 493 mg per mL solution for injection 500 mL bag,8001845,magnesium sulfate,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
103075,Marketed,2024-11-18,02542153,MAGNESIUM SULFATE IN WATER FOR INJECTION,1.0,B05XA05,Magnesium sulphate,Solution,Intravenous,77701168,MAGNESIUM SULFATE IN WATER FOR INJECTION (magnesium sulfate 2000 mg per 50 mL solution for injection bag) BAXTER CORPORATION,Active,9015139,magnesium sulfate 2000 mg per 50 mL solution for injection bag,8001845,magnesium sulfate,738984000,Injection,385219001,Solution for injection,732982009,Bag,,,
103075,Marketed,2024-11-18,02542153,MAGNESIUM SULFATE IN WATER FOR INJECTION,1.0,B05XA05,Magnesium sulphate,Solution,Intravenous,77701169,MAGNESIUM SULFATE IN WATER FOR INJECTION (magnesium sulfate 4000 mg per 100 mL solution for injection bag) BAXTER CORPORATION,Active,9015140,magnesium sulfate 4000 mg per 100 mL solution for injection bag,8001845,magnesium sulfate,738984000,Injection,385219001,Solution for injection,732982009,Bag,,,
1181,Marketed,2017-11-10,00038024,MANNITOL INJECTION USP,1.0,B05BC01,Mannitol,Solution,Intravenous,00038024,MANNITOL INJECTION USP (mannitol 25 % solution for injection 50 mL vial) PFIZER CANADA ULC,Active,9013921,mannitol 25 % solution for injection 50 mL vial,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1740,Marketed,2020-03-05,00038016,MANNITOL INJECTION USP,1.0,B05BC01,Mannitol,Solution,Intravenous,00038016,MANNITOL INJECTION USP (mannitol 20 % solution for injection 500 mL bag) ICU MEDICAL CANADA INC,Active,9013920,mannitol 20 % solution for injection 500 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
10516,Marketed,2020-05-21,00060437,OSMITROL INJECTION 20%,1.0,B05BC01,Mannitol,Solution,Intravenous,00060437,OSMITROL INJECTION 20% (mannitol 20 % solution for injection 500 mL bag) BAXTER CORPORATION,Active,9013920,mannitol 20 % solution for injection 500 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
10517,Marketed,2020-05-21,00060410,OSMITROL INJECTION 10%,1.0,B05BC01,Mannitol,Solution,Intravenous,00060410,OSMITROL INJECTION 10% (mannitol 10 % solution for injection 1000 mL bag) BAXTER CORPORATION,Active,9013919,mannitol 10 % solution for injection 1000 mL bag,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
67055,Marketed,2022-10-19,02243176,"MANNITOL INJECTION, USP",1.0,B05BC01,Mannitol,Solution,Intravenous,02243176,"MANNITOL INJECTION, USP (mannitol 25 % solution for injection 50 mL vial) FRESENIUS KABI CANADA LTD",Active,9013921,mannitol 25 % solution for injection 50 mL vial,8002138,mannitol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102861,Marketed,2023-08-11,02539888,LIVMARLI,1.0,A05AX04,Maraliximab chloride,Solution,Oral,02539888,"LIVMARLI (maralixibat (maralixibat chloride) 9.5 mg per mL oral solution) MIRUM PHARMACEUTICALS, INC.",Active,9014905,maralixibat (maralixibat chloride) 9.5 mg per mL oral solution,8002476,maralixibat,26643006,Oral,385023001,Oral solution,,,,,
78519,Marketed,2014-08-30,02299844,CELSENTRI,1.0,J05AX09,Maraviroc,Tablet,Oral,02299844,CELSENTRI (maraviroc 150 mg oral tablet) VIIV HEALTHCARE ULC,Active,9004335,maraviroc 150 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78520,Marketed,2014-08-30,02299852,CELSENTRI,1.0,J05AX09,Maraviroc,Tablet,Oral,02299852,CELSENTRI (maraviroc 300 mg oral tablet) VIIV HEALTHCARE ULC,Active,9004336,maraviroc 300 mg oral tablet,8001214,maraviroc,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101989,Marketed,2022-10-25,02530740,LIVTENCITY,1.0,J05AX10,Maribavir,Tablet,Oral,02530740,LIVTENCITY (maribavir 200 mg oral tablet) TAKEDA CANADA INC,Active,9014796,maribavir 200 mg oral tablet,8002449,maribavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
102157,Marketed,2023-01-09,02532549,CAMZYOS,1.0,C01EB24,Mavacamten,Capsule,Oral,02532549,CAMZYOS (mavacamten 2.5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014821,mavacamten 2.5 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102158,Marketed,2023-01-09,02532557,CAMZYOS,1.0,C01EB24,Mavacamten,Capsule,Oral,02532557,CAMZYOS (mavacamten 5 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014822,mavacamten 5 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102159,Marketed,2023-06-13,02532565,CAMZYOS,1.0,C01EB24,Mavacamten,Capsule,Oral,02532565,CAMZYOS (mavacamten 10 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014868,mavacamten 10 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102160,Marketed,2023-08-08,02532573,CAMZYOS,1.0,C01EB24,Mavacamten,Capsule,Oral,02532573,CAMZYOS (mavacamten 15 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014906,mavacamten 15 mg oral capsule,8002458,mavacamten,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
3569,Marketed,2024-12-03,00466085,M-M-R II,3.0,J07BD52,"Measles, combin. with mumps and rubella, live attenuated",Powder for solution,"Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,
62666,Marketed,2002-12-19,02239208,PRIORIX,4.0,J07BD52,"Measles, combin. with mumps and rubella, live attenuated","Kit,Powder for solution","Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,
78322,Marketed,2008-06-04,02297884,PRIORIX-TETRA,4.0,J07BD54,"Measles, combinations with mumps, rubella and varicella, live attenuated",Powder for solution,"Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,
88411,Marketed,2014-05-09,02399229,PROQUAD,4.0,J07BD54,"Measles, combinations with mumps, rubella and varicella, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
4743,Marketed,2001-11-08,00556734,VERMOX,1.0,P02CA01,Mebendazole,Tablet,Oral,00556734,VERMOX (mebendazole 100 mg oral tablet) JANSSEN INC,Active,9001946,mebendazole 100 mg oral tablet,8001398,mebendazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99902,Marketed,2021-03-01,02509733,INCRELEX,1.0,H01AC03,Mecasermin,Solution,Subcutaneous,02509733,INCRELEX (mecasermin 40 mg per 4 mL solution for injection vial) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014475,mecasermin 40 mg per 4 mL solution for injection vial,8002368,mecasermin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
5684,Marketed,1911-12-31,00572837,MEDICAL AIR 100%,1.0,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,
13896,Marketed,1993-12-31,02014343,"CARBON DIOXIDE, COMPRESSED AIR MEDICAL G.MIX.",2.0,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,
19291,Marketed,2020-08-06,02154781,MEDICAL AIR U.S.P.,2.0,V03AN05,Medical air,Gas,Inhalation,,,,,,,,,,,,,,,,
5686,Marketed,1911-12-31,00572853,OXYGEN CARBON DIOXIDE MIXTURE,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
5689,Marketed,1911-12-31,00572896,HELIUM OXYGEN MIXTURE,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
8185,Marketed,1997-05-02,00588075,LUNG DIFFUSION TEST MIX NO NE CO,4.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
11058,Marketed,1997-05-02,00882755,CARBON DIOXIDE 7.1% W OXYGEN,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
11060,Marketed,2024-07-02,00882771,CARBON DIOXIDE 23.1% W OXYGEN,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
13885,Marketed,2022-03-08,02014483,MEDICAL AIR USP,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
13920,Marketed,1993-12-31,02014424,"CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.",4.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
46353,Marketed,1997-05-02,01906801,HELIUM-OXYGEN MIX GAS,2.0,V03AN,Medical gases,Gas,Inhalation,,,,,,,,,,,,,,,,
6317,Marketed,1997-10-17,00637955,CHARAC-50,1.0,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,
7267,Marketed,1997-10-17,00649236,CHARACTOL-50,1.0,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,
16533,Marketed,1997-10-17,02056429,CHARAC-25,1.0,A07BA01,Medicinal charcoal,Suspension,Oral,,,,,,,,,,,,,,,,
22917,Marketed,2018-05-14,00789674,ACTIVATED CHARCOAL 260MG,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
59931,Marketed,1998-10-07,02236563,ACTIVATED CHARCOAL,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
88060,Marketed,2026-01-06,02395517,WAMPOLE ACTIVATED CHARCOAL,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
90525,Marketed,2019-02-01,02420694,ACTIVATED CHARCOAL,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
90843,Marketed,2016-01-15,02423715,CHARCO CAPS,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
99412,Marketed,2021-03-31,02504723,ACTIVATED CHARCOAL CAPSULES,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
102646,Marketed,2023-11-15,02537680,ACTIVATED CHARCOAL CAPSULES,1.0,A07BA01,Medicinal charcoal,Capsule,Oral,,,,,,,,,,,,,,,,
43299,Marketed,2011-01-19,02221284,TEVA-MEDROXYPROGESTERONE,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02221284,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
43300,Marketed,2011-01-19,02221292,TEVA-MEDROXYPROGESTERONE,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02221292,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
43301,Marketed,2011-01-19,02221306,TEVA-MEDROXYPROGESTERONE,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02221306,TEVA-MEDROXYPROGESTERONE (medroxyprogesterone acetate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
68715,Marketed,2024-11-15,02244726,AA-MEDROXY,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02244726,AA-MEDROXY (medroxyprogesterone acetate 2.5 mg oral tablet) AA PHARMA INC,Active,9000429,medroxyprogesterone acetate 2.5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
68716,Marketed,2024-12-16,02244727,AA-MEDROXY,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02244727,AA-MEDROXY (medroxyprogesterone acetate 5 mg oral tablet) AA PHARMA INC,Active,9000027,medroxyprogesterone acetate 5 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
75305,Marketed,2024-12-16,02267640,AA-MEDROXY,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02267640,AA-MEDROXY (medroxyprogesterone acetate 100 mg oral tablet) AA PHARMA INC,Active,9001124,medroxyprogesterone acetate 100 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76294,Marketed,2024-11-15,02277298,AA-MEDROXY,1.0,G03DA02,Medroxyprogesterone,Tablet,Oral,02277298,AA-MEDROXY (medroxyprogesterone acetate 10 mg oral tablet) AA PHARMA INC,Active,9000275,medroxyprogesterone acetate 10 mg oral tablet,8000018,medroxyprogesterone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101256,Marketed,2022-04-25,02523493,DEPO-PROVERA,1.0,G03AC06,Medroxyprogesterone,Suspension,Intramuscular,02523493,DEPO-PROVERA (medroxyprogesterone acetate 150 mg per 1 mL suspension for injection syringe) PFIZER CANADA ULC,Active,9014702,medroxyprogesterone acetate 150 mg per 1 mL suspension for injection syringe,8000018,medroxyprogesterone,738984000,Parenteral,385220007,Suspension for injection,733020007,Syringe (unit of presentation),1.0,,
47338,Marketed,2024-09-03,02229452,MEFENAMIC,1.0,M01AG01,Mefenamic acid,Capsule,Oral,02229452,MEFENAMIC (mefenamic acid 250 mg oral capsule) AA PHARMA INC,Active,9001621,mefenamic acid 250 mg oral capsule,8001495,mefenamic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68334,Marketed,2011-05-31,02244366,MEFLOQUINE,1.0,P01BC02,Mefloquine,Tablet,Oral,02244366,MEFLOQUINE (mefloquine (mefloquine hydrochloride) 250 mg oral tablet) AA PHARMA INC,Active,9003737,mefloquine (mefloquine hydrochloride) 250 mg oral tablet,8001399,mefloquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20026,Marketed,2021-09-23,02195925,MEGESTROL,1.0,L02AB01,Megestrol,Tablet,Oral,02195925,MEGESTROL (megestrol acetate 160 mg oral tablet) AA PHARMA INC,Active,9002845,megestrol acetate 160 mg oral tablet,8001496,megestrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
20029,Marketed,2021-09-23,02195917,MEGESTROL,1.0,L02AB01,Megestrol,Tablet,Oral,02195917,MEGESTROL (megestrol acetate 40 mg oral tablet) AA PHARMA INC,Active,9002846,megestrol acetate 40 mg oral tablet,8001496,megestrol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72606,Marketed,2003-11-07,02248267,PMS-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02248267,PMS-MELOXICAM (meloxicam 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72607,Marketed,2003-11-07,02248268,PMS-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02248268,PMS-MELOXICAM (meloxicam 15 mg oral tablet) PHARMASCIENCE INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73355,Marketed,2004-02-13,02248973,APO-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02248973,APO-MELOXICAM (meloxicam 7.5 mg oral tablet) APOTEX INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73356,Marketed,2004-02-13,02248974,APO-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02248974,APO-MELOXICAM (meloxicam 15 mg oral tablet) APOTEX INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74353,Marketed,2010-07-19,02258315,TEVA-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02258315,TEVA-MELOXICAM (meloxicam 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74354,Marketed,2010-07-19,02258323,TEVA-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02258323,TEVA-MELOXICAM (meloxicam 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83836,Marketed,2021-12-17,02353148,MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02353148,MELOXICAM (meloxicam 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83837,Marketed,2021-12-17,02353156,MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02353156,MELOXICAM (meloxicam 15 mg oral tablet) SANIS HEALTH INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87627,Marketed,2012-10-19,02390884,AURO-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02390884,AURO-MELOXICAM (meloxicam 7.5 mg oral tablet) AURO PHARMA INC,Active,9000920,meloxicam 7.5 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87628,Marketed,2012-10-18,02390892,AURO-MELOXICAM,1.0,M01AC06,Meloxicam,Tablet,Oral,02390892,AURO-MELOXICAM (meloxicam 15 mg oral tablet) AURO PHARMA INC,Active,9000919,meloxicam 15 mg oral tablet,8000290,meloxicam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1195,Marketed,2018-04-26,00004715,ALKERAN,1.0,L01AA03,Melphalan,Tablet,Oral,00004715,ALKERAN (melphalan 2 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012831,melphalan 2 mg oral tablet,8001497,melphalan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18786,Marketed,2017-06-19,02087286,ALKERAN,2.0,L01AA03,Melphalan,"Powder for solution,Solution,Kit","Intravenous,Intra-arterial",02087286,ALKERAN (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) ASPEN PHARMACARE CANADA INC.,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
96274,Marketed,2018-06-18,02473348,MELPHALAN FOR INJECTION,2.0,L01AA03,Melphalan,"Kit,Powder for solution,Solution","Intravenous,Intra-arterial",02473348,MELPHALAN FOR INJECTION (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) MARCAN PHARMACEUTICALS INC,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
97057,Marketed,2021-01-25,02480026,TARO-MELPHALAN,2.0,L01AA03,Melphalan,"Kit,Powder for solution","Intravenous,Intra-arterial",02480026,TARO-MELPHALAN (melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution) TARO PHARMACEUTICALS INC,Active,9013005,melphalan (melphalan hydrochloride) 50 mg per vial powder for solution for injection with diluent solution,8001497,melphalan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
74607,Marketed,2004-12-16,02260638,EBIXA,1.0,N06DX01,Memantine,Tablet,Oral,02260638,EBIXA (memantine hydrochloride 10 mg oral tablet) LUNDBECK CANADA INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80653,Marketed,2009-11-04,02321130,PMS-MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02321130,PMS-MEMANTINE (memantine hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80955,Marketed,2020-04-06,02324067,ACT MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02324067,ACT MEMANTINE (memantine hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83428,Marketed,2010-06-14,02348950,RIVA-MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02348950,RIVA-MEMANTINE (memantine hydrochloride 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85130,Marketed,2020-05-25,02366487,APO-MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02366487,APO-MEMANTINE (memantine hydrochloride 10 mg oral tablet) APOTEX INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86095,Marketed,2014-07-17,02375532,SANDOZ MEMANTINE FCT,1.0,N06DX01,Memantine,Tablet,Oral,02375532,SANDOZ MEMANTINE FCT (memantine hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86864,Marketed,2015-03-02,02382830,PMS-MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02382830,PMS-MEMANTINE (memantine hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9005670,memantine hydrochloride 5 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92762,Marketed,2017-06-14,02443082,MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02443082,MEMANTINE (memantine hydrochloride 10 mg oral tablet) SANIS HEALTH INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93131,Marketed,2018-06-08,02446049,MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02446049,MEMANTINE (memantine hydrochloride 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102097,Marketed,2025-02-11,02531887,MINT-MEMANTINE,1.0,N06DX01,Memantine,Tablet,Oral,02531887,MINT-MEMANTINE (memantine hydrochloride 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003989,memantine hydrochloride 10 mg oral tablet,8001288,memantine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95723,Marketed,2018-01-31,02468751,TRUMENBA,2.0,J07AH,Meningococcal vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,
90167,Marketed,2016-09-08,02417030,BEXSERO,4.0,J07AH09,"Meningococcus b, multicomponent vaccine",Suspension,Intramuscular,,,,,,,,,,,,,,,,
69061,Marketed,2015-12-03,02245057,NEISVAC-C,2.0,J07AH07,"Meningococcus c, purified polysaccharides antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,
88773,Marketed,2017-05-17,02402904,NIMENRIX,5.0,J07AH04,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen","Kit,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,
76550,Marketed,2006-10-20,02279924,MENACTRA,4.0,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,
83276,Marketed,2017-03-27,02347393,MENVEO,5.0,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated","Powder for solution,Solution",Intramuscular,,,,,,,,,,,,,,,,
99657,Marketed,2025-04-01,02507161,MENQUADFI,5.0,J07AH08,"Meningococcus, a, c, y, w-135, tetraval. purified polysacc. antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,
2743,Marketed,1977-12-31,00364304,ISOCAINE HCL INJ 3%,1.0,N01BB03,Mepivacaine,Solution,Block/infiltration,00364304,ISOCAINE HCL INJ 3% (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
3804,Marketed,1980-12-31,00479934,SCANDONEST 3% PLAIN INJ,1.0,N01BB03,Mepivacaine,Solution,Block/infiltration,00479934,SCANDONEST 3% PLAIN INJ (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
65669,Marketed,2017-08-02,02241999,CARBOCAINE 1%,1.0,N01BB03,Mepivacaine,Solution,"Intracaudal,Epidural",02241999,CARBOCAINE 1% 30ML SINGLE USE VIAL (mepivacaine hydrochloride 300 mg per 30 mL solution for injection vial) PFIZER CANADA ULC,Active,9014041,mepivacaine hydrochloride 300 mg per 30 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65670,Marketed,2017-08-02,02242000,CARBOCAINE 1%,1.0,N01BB03,Mepivacaine,Solution,Block/infiltration,02242000,CARBOCAINE 1% (mepivacaine hydrochloride 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9014042,mepivacaine hydrochloride 500 mg per 50 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65671,Marketed,2017-08-02,02242001,CARBOCAINE 2%,1.0,N01BB03,Mepivacaine,Solution,"Epidural,Intracaudal",02242001,CARBOCAINE 2% (mepivacaine hydrochloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013225,mepivacaine hydrochloride 400 mg per 20 mL solution for injection vial,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
81649,Marketed,2009-10-19,02330733,3% POLOCAINE DENTAL,1.0,N01BB03,Mepivacaine,Liquid,Block/infiltration,02330733,3% POLOCAINE DENTAL (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
96420,Marketed,2019-05-07,02474174,CARBOCAINE 3%,1.0,N01BB03,Mepivacaine,Solution,Block/infiltration,02474174,CARBOCAINE 3% (mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge) SEPTODONT,Active,9014040,mepivacaine hydrochloride 30 mg per mL solution for injection 1.8 mL cartridge,8001849,mepivacaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
98296,Marketed,2019-12-10,02492989,NUCALA,1.0,R03DX09,Mepolizumab,Solution,Subcutaneous,02492989,NUCALA PRE-FILLED AUTOINJECTOR (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98297,Marketed,2019-12-10,02492997,NUCALA,1.0,R03DX09,Mepolizumab,Solution,Subcutaneous,02492997,NUCALA PRE-FILLED SYRINGE (mepolizumab 100 mg per 1 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014223,mepolizumab 100 mg per 1 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101998,Marketed,2023-02-13,02530821,NUCALA,1.0,R03DX09,Mepolizumab,Solution,Subcutaneous,02530821,NUCALA (mepolizumab 40 mg per 0.4 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9014833,mepolizumab 40 mg per 0.4 mL solution for injection syringe,8001066,mepolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
95283,Marketed,2025-04-17,02464705,PROCYSBI,1.0,A16AA04,Mercaptamine,Capsule (delayed release),Oral,02464705,PROCYSBI (cysteamine (cysteamine bitartrate) 25 mg gastro-resistant capsule) AMGEN CANADA INC,Active,9012428,cysteamine (cysteamine bitartrate) 25 mg gastro-resistant capsule,8001131,cysteamine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
95284,Marketed,2025-04-17,02464713,PROCYSBI,1.0,A16AA04,Mercaptamine,Capsule (delayed release),Oral,02464713,PROCYSBI (cysteamine (cysteamine bitartrate) 75 mg gastro-resistant capsule) AMGEN CANADA INC,Active,9012429,cysteamine (cysteamine bitartrate) 75 mg gastro-resistant capsule,8001131,cysteamine,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
97584,Marketed,2019-05-15,02485605,CYSTADROPS,1.0,S01XA21,Mercaptamine,Solution,Ophthalmic,02485605,CYSTADROPS (cysteamine (cysteamine hydrochloride) 0.37 % ophthalmic drops) RECORDATI RARE DISEASES CANADA INC,Active,9013952,cysteamine (cysteamine hydrochloride) 0.37 % ophthalmic drops,8001131,cysteamine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
960,Marketed,2014-03-19,00004723,PURINETHOL,1.0,L01BB02,Mercaptopurine,Tablet,Oral,00004723,PURINETHOL (mercaptopurine 50 mg oral tablet) TEVA CANADA LIMITED,Active,9001549,mercaptopurine 50 mg oral tablet,8001850,mercaptopurine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89989,Marketed,2013-11-27,02415275,MERCAPTOPURINE TABLETS USP,1.0,L01BB02,Mercaptopurine,Tablet,Oral,02415275,MERCAPTOPURINE TABLETS USP (mercaptopurine 50 mg oral tablet) STERIMAX INC,Active,9001549,mercaptopurine 50 mg oral tablet,8001850,mercaptopurine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86463,Marketed,2012-01-26,02378787,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02378787,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
86467,Marketed,2012-01-26,02378795,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02378795,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89983,Marketed,2021-03-25,02415216,"MEROPENEM FOR INJECTION, USP",1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02415216,"MEROPENEM FOR INJECTION, USP (meropenem 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89984,Marketed,2021-03-25,02415224,"MEROPENEM FOR INJECTION, USP",1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02415224,"MEROPENEM FOR INJECTION, USP (meropenem 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90612,Marketed,2021-06-11,02421518,TARO-MEROPENEM,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02421518,TARO-MEROPENEM (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
90613,Marketed,2021-06-11,02421526,TARO-MEROPENEM,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02421526,TARO-MEROPENEM (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) SUN PHARMA CANADA INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95075,Marketed,2017-10-20,02462885,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02462885,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95076,Marketed,2017-10-20,02462893,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02462893,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) AURO PHARMA INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98335,Marketed,2021-05-25,02493330,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02493330,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98336,Marketed,2021-02-22,02493349,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02493349,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101800,Marketed,2024-08-19,02528819,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02528819,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002957,meropenem 500 mg per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101801,Marketed,2024-08-19,02528827,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02528827,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102515,Marketed,2024-03-26,02536374,MEROPENEM FOR INJECTION,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02536374,MEROPENEM FOR INJECTION (meropenem (meropenem trihydrate) 1 g per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9002962,meropenem 1 g per vial powder for solution for injection,8001215,meropenem,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103285,Marketed,2025-03-25,02544334,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02544334,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP (meropenem 500 mg powder for solution for injection with diluent solution per bag) B. BRAUN MEDICAL INC,Active,9015192,meropenem 500 mg powder for solution for injection with diluent solution per bag,8001215,meropenem,738984000,Injection,385223009,Powder for solution for injection,732982009,Bag,,,
103286,Marketed,2025-03-25,02544342,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP,1.0,J01DH02,Meropenem,Powder for solution,Intravenous,02544342,MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP (meropenem 1 g powder for solution for injection with diluent solution per bag) B. BRAUN MEDICAL INC,Active,9015191,meropenem 1 g powder for solution for injection with diluent solution per bag,8001215,meropenem,738984000,Injection,385223009,Powder for solution for injection,732982009,Bag,,,
104303,Marketed,2025-06-30,02554151,VABOMERE,2.0,J01DH52,Meropenem and vaborbactam,Powder for solution,Intravenous,02554151,VABOMERE (meropenem (meropenem trihydrate) 1 g per vial and vaborbactam 1 g per vial powder for solution for injection) XEDITON PHARMACEUTICALS INC,Active,9015236,meropenem 1 g per vial and vaborbactam 1 g per vial powder for solution for injection,8002549,meropenem and vaborbactam,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
16855,Marketed,1999-04-01,02099683,PENTASA,1.0,A07EC02,Mesalazine,Tablet (extended-release),Oral,02099683,PENTASA (mesalazine 500 mg prolonged-release oral tablet) FERRING INC,Active,9010500,mesalazine 500 mg prolonged-release oral tablet,8000183,mesalazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
18212,Marketed,2024-07-10,02112760,SALOFALK,1.0,A07EC02,Mesalazine,Suppository,Rectal,02112760,SALOFALK (mesalazine 500 mg suppository) ABBVIE CORPORATION,Active,9010501,mesalazine 500 mg suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
18214,Marketed,2024-01-23,02112787,SALOFALK,1.0,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02112787,SALOFALK (mesalazine 500 mg gastro-resistant tablet) ABBVIE CORPORATION,Active,9010499,mesalazine 500 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
18493,Marketed,1999-11-09,02153564,PENTASA,1.0,A07EC02,Mesalazine,Suppository,Rectal,02153564,PENTASA (mesalazine 1 g suppository) FERRING INC,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
18494,Marketed,1999-11-08,02153556,PENTASA,1.0,A07EC02,Mesalazine,Suspension,Rectal,02153556,PENTASA (mesalazine 4 g per 100 mL rectal suspension) FERRING INC,Active,9010496,mesalazine 4 g per 100 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,
18496,Marketed,1999-11-09,02153521,PENTASA,1.0,A07EC02,Mesalazine,Suspension,Rectal,02153521,PENTASA (mesalazine 1 g per 100 mL rectal suspension) FERRING INC,Active,9010491,mesalazine 1 g per 100 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,
18509,Marketed,2024-06-12,02112809,SALOFALK,1.0,A07EC02,Mesalazine,Suspension,Rectal,02112809,SALOFALK (mesalazine 4 g per 60 mL rectal suspension) ABBVIE CORPORATION,Active,9010497,mesalazine 4 g per 60 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,
18510,Marketed,2024-07-16,02112795,SALOFALK,1.0,A07EC02,Mesalazine,Suspension,Rectal,02112795,SALOFALK (mesalazine 2 g per 60 mL rectal suspension) ABBVIE CORPORATION,Active,9010495,mesalazine 2 g per 60 mL rectal suspension,8000183,mesalazine,37161004,Rectal,739008005,Suspension,,,,,
19524,Marketed,2015-05-12,02171929,TEVA-5 ASA,1.0,A07EC02,Mesalazine,Tablet (enteric-coated),Oral,02171929,TEVA-5 ASA (mesalazine 400 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9010498,mesalazine 400 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
65824,Marketed,2024-03-28,02242146,SALOFALK,1.0,A07EC02,Mesalazine,Suppository,Rectal,02242146,SALOFALK (mesalazine 1 g suppository) ABBVIE CORPORATION,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
78289,Marketed,2021-11-22,02297558,MEZAVANT,1.0,A07EC02,Mesalazine,Tablet (delayed and extended release),Oral,02297558,MEZAVANT (mesalazine 1.2 g modified-release oral tablet) TAKEDA CANADA INC,Active,9010494,mesalazine 1.2 g modified-release oral tablet,8000183,mesalazine,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
88434,Marketed,2013-03-12,02399466,PENTASA,1.0,A07EC02,Mesalazine,Tablet (extended-release),Oral,02399466,PENTASA (mesalazine 1 g prolonged-release oral tablet) FERRING INC,Active,9010492,mesalazine 1 g prolonged-release oral tablet,8000183,mesalazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95399,Marketed,2022-09-28,02465752,OCTASA,1.0,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02465752,OCTASA (mesalazine 800 mg gastro-resistant tablet) TILLOTTS PHARMA AG,Active,9010502,mesalazine 800 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
96402,Marketed,2018-07-13,02474018,MEZERA,1.0,A07EC02,Mesalazine,Suppository,Rectal,02474018,MEZERA (mesalazine 1 g suppository) AVIR PHARMA INC.,Active,9010493,mesalazine 1 g suppository,8000183,mesalazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
96403,Marketed,2018-07-13,02474026,MEZERA,1.0,A07EC02,Mesalazine,Foam,Rectal,02474026,MEZERA (mesalazine 1 g per actuation rectal foam) AVIR PHARMA INC.,Active,9012832,mesalazine 1 g per actuation rectal foam,8000183,mesalazine,37161004,Rectal,421166008,Foam,732981002,Actuation (unit of presentation),,,
101350,Marketed,2022-10-05,02524481,MEZERA,1.0,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02524481,MEZERA (mesalazine 500 mg gastro-resistant tablet) AVIR PHARMA INC.,Active,9010499,mesalazine 500 mg gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
101886,Marketed,2023-03-02,02529610,OCTASA,1.0,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02529610,OCTASA (mesalazine 1.6 g gastro-resistant tablet) TILLOTTS PHARMA AG,Active,9014840,mesalazine 1.6 g gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
103363,Marketed,2024-07-26,02545012,MEZERA,1.0,A07EC02,Mesalazine,Tablet (delayed-release),Oral,02545012,MEZERA (mesalazine 1 g gastro-resistant tablet) AVIR PHARMA INC.,Active,9015073,mesalazine 1 g gastro-resistant tablet,8000183,mesalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
65047,Marketed,2004-01-16,02241411,UROMITEXAN,1.0,V03AF01,Mesna,Solution,"Oral,Intravenous",77700723,UROMITEXAN (mesna 1000 mg per 10 mL solution for injection ampoule) BAXTER CORPORATION,Active,9013227,mesna 1000 mg per 10 mL solution for injection ampoule,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
65047,Marketed,2004-01-16,02241411,UROMITEXAN,1.0,V03AF01,Mesna,Solution,"Oral,Intravenous",77700724,UROMITEXAN (mesna 400 mg per 4 mL solution for injection ampoule) BAXTER CORPORATION,Active,9013229,mesna 400 mg per 4 mL solution for injection ampoule,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
68929,Marketed,2016-05-09,02244931,MESNA FOR INJECTION,1.0,V03AF01,Mesna,Solution,Intravenous,02244931,MESNA FOR INJECTION (mesna 1000 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013228,mesna 1000 mg per 10 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
85696,Marketed,2012-04-13,02371839,UROMITEXAN,1.0,V03AF01,Mesna,Solution,Intravenous,77700758,UROMITEXAN (mesna 1000 mg per 10 mL solution for injection vial) BAXTER CORPORATION,Active,9013228,mesna 1000 mg per 10 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
85696,Marketed,2012-04-13,02371839,UROMITEXAN,1.0,V03AF01,Mesna,Solution,Intravenous,77700759,UROMITEXAN (mesna 5000 mg per 50 mL solution for injection vial) BAXTER CORPORATION,Active,9013230,mesna 5000 mg per 50 mL solution for injection vial,8001851,mesna,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
17104,Marketed,2007-10-09,02099233,GLUCOPHAGE,1.0,A10BA02,Metformin,Tablet,Oral,02099233,GLUCOPHAGE (metformin hydrochloride 500 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18835,Marketed,2008-01-29,02162849,GLUCOPHAGE,1.0,A10BA02,Metformin,Tablet,Oral,02162849,GLUCOPHAGE (metformin hydrochloride 850 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62536,Marketed,2022-11-15,02239081,RIVA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02239081,RIVA-METFORMIN (metformin hydrochloride 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66606,Marketed,2022-11-15,02242783,RIVA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02242783,RIVA-METFORMIN (metformin hydrochloride 850 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71020,Marketed,2006-01-12,02246820,SANDOZ METFORMIN FC,1.0,A10BA02,Metformin,Tablet,Oral,02246820,SANDOZ METFORMIN FC (metformin hydrochloride 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71021,Marketed,2006-01-12,02246821,SANDOZ METFORMIN FC,1.0,A10BA02,Metformin,Tablet,Oral,02246821,SANDOZ METFORMIN FC (metformin hydrochloride 850 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74296,Marketed,2023-06-15,02257726,TEVA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02257726,TEVA-METFORMIN (metformin hydrochloride 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74297,Marketed,2023-06-15,02257734,TEVA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02257734,TEVA-METFORMIN (metformin hydrochloride 850 mg oral tablet) TEVA CANADA LIMITED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75387,Marketed,2020-12-22,02268493,GLUMETZA,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02268493,"GLUMETZA (metformin hydrochloride 500 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78575,Marketed,2020-12-22,02300451,GLUMETZA,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02300451,"GLUMETZA (metformin hydrochloride 1000 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
79043,Marketed,2023-06-30,02305062,APO-METFORMIN ER,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02305062,APO-METFORMIN ER (metformin hydrochloride 500 mg prolonged-release oral tablet) APOTEX INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80042,Marketed,2025-07-24,02314894,PRO-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02314894,PRO-METFORMIN (metformin hydrochloride 850 mg oral tablet) PRO DOC LIMITEE,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80043,Marketed,2025-07-08,02314908,PRO-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02314908,PRO-METFORMIN (metformin hydrochloride 500 mg oral tablet) PRO DOC LIMITEE,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83857,Marketed,2019-05-30,02353377,METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02353377,METFORMIN (metformin hydrochloride 500 mg oral tablet) SANIS HEALTH INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83858,Marketed,2019-05-30,02353385,METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02353385,METFORMIN (metformin hydrochloride 850 mg oral tablet) SANIS HEALTH INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86441,Marketed,2023-06-26,02378620,MAR-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02378620,MAR-METFORMIN (metformin hydrochloride 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86442,Marketed,2023-06-26,02378639,MAR-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02378639,MAR-METFORMIN (metformin hydrochloride 850 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86602,Marketed,2019-09-24,02380196,JAMP METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02380196,JAMP METFORMIN (metformin hydrochloride 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86603,Marketed,2019-09-24,02380218,JAMP METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02380218,JAMP METFORMIN (metformin hydrochloride 850 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87098,Marketed,2012-06-10,02385341,METFORMIN FC,1.0,A10BA02,Metformin,Tablet,Oral,02385341,METFORMIN FC (metformin hydrochloride 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87099,Marketed,2012-06-10,02385368,METFORMIN FC,1.0,A10BA02,Metformin,Tablet,Oral,02385368,METFORMIN FC (metformin hydrochloride 850 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87428,Marketed,2023-11-16,02388766,MINT-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02388766,MINT-METFORMIN (metformin hydrochloride 500 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87429,Marketed,2023-11-16,02388774,MINT-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02388774,MINT-METFORMIN (metformin hydrochloride 850 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92264,Marketed,2017-02-22,02438275,AURO-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02438275,AURO-METFORMIN (metformin hydrochloride 500 mg oral tablet) AURO PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92265,Marketed,2017-02-22,02438283,AURO-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02438283,AURO-METFORMIN (metformin hydrochloride 850 mg oral tablet) AURO PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94808,Marketed,2017-10-02,02460653,APO-METFORMIN ER,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02460653,APO-METFORMIN ER (metformin hydrochloride 1000 mg prolonged-release oral tablet) APOTEX INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98443,Marketed,2023-01-04,02494418,AG-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02494418,AG-METFORMIN (metformin hydrochloride 500 mg oral tablet) ANGITA PHARMA INC.,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98445,Marketed,2023-01-04,02494442,AG-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02494442,AG-METFORMIN (metformin hydrochloride 850 mg oral tablet) ANGITA PHARMA INC.,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100366,Marketed,2022-02-04,02514486,METFORMIN TABLETS,1.0,A10BA02,Metformin,Tablet,Oral,02514486,METFORMIN TABLETS (metformin hydrochloride 500 mg oral tablet) GRANULES INDIA LIMITED,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100367,Marketed,2022-02-04,02514494,METFORMIN TABLETS,1.0,A10BA02,Metformin,Tablet,Oral,02514494,METFORMIN TABLETS (metformin hydrochloride 850 mg oral tablet) GRANULES INDIA LIMITED,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100951,Marketed,2022-02-04,02520303,PMSC-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02520303,PMSC-METFORMIN (metformin hydrochloride 500 mg oral tablet) PHARMASCIENCE INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100952,Marketed,2022-02-04,02520311,PMSC-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02520311,PMSC-METFORMIN (metformin hydrochloride 850 mg oral tablet) PHARMASCIENCE INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102098,Marketed,2023-04-14,02531895,PRZ-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02531895,PRZ-METFORMIN (metformin hydrochloride 500 mg oral tablet) PHARMARIS CANADA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102099,Marketed,2023-04-14,02531909,PRZ-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02531909,PRZ-METFORMIN (metformin hydrochloride 850 mg oral tablet) PHARMARIS CANADA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102358,Marketed,2023-05-23,02534673,PRZ-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02534673,PRZ-METFORMIN (metformin hydrochloride 1000 mg oral tablet) PHARMARIS CANADA INC,Active,9014870,metformin hydrochloride 1000 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102521,Marketed,2023-08-03,02536439,NRA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02536439,NRA-METFORMIN (metformin hydrochloride 500 mg oral tablet) NORA PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102522,Marketed,2023-08-03,02536447,NRA-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02536447,NRA-METFORMIN (metformin hydrochloride 850 mg oral tablet) NORA PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103593,Marketed,2024-10-02,02547309,MINT-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02547309,MINT-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103594,Marketed,2024-10-31,02547317,MINT-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02547317,MINT-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103669,Marketed,2024-11-14,02547767,M-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02547767,M-METFORMIN (metformin hydrochloride 500 mg oral tablet) MANTRA PHARMA INC,Active,9000473,metformin hydrochloride 500 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103670,Marketed,2024-11-14,02547775,M-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02547775,M-METFORMIN (metformin hydrochloride 850 mg oral tablet) MANTRA PHARMA INC,Active,9000609,metformin hydrochloride 850 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103716,Marketed,2024-11-14,02548275,M-METFORMIN,1.0,A10BA02,Metformin,Tablet,Oral,02548275,M-METFORMIN (metformin hydrochloride 1000 mg oral tablet) MANTRA PHARMA INC,Active,9014870,metformin hydrochloride 1000 mg oral tablet,8000184,metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103931,Marketed,2024-10-21,02550504,MAR-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02550504,MAR-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103932,Marketed,2024-10-02,02550512,MAR-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02550512,MAR-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
104056,Marketed,2025-09-23,02551845,M-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02551845,M-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
104057,Marketed,2025-09-23,02551853,M-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02551853,M-METFORMIN XR (metformin hydrochloride 1000 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
104072,Marketed,2025-10-15,02552027,TARO-METFORMIN XR,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02552027,TARO-METFORMIN XR (metformin hydrochloride 500 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
106200,Marketed,2026-01-08,02558785,METFORMIN ER,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02558785,METFORMIN ER (metformin hydrochloride 500 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001130,metformin hydrochloride 500 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
106201,Marketed,2025-12-29,02558793,METFORMIN ER,1.0,A10BA02,Metformin,Tablet (extended-release),Oral,02558793,METFORMIN ER (metformin hydrochloride 1000 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001233,metformin hydrochloride 1000 mg prolonged-release oral tablet,8000184,metformin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90185,Marketed,2014-04-30,02417219,KAZANO,2.0,A10BD13,Metformin and alogliptin,Tablet,Oral,02417219,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet) TAKEDA CANADA INC,Active,9005506,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90186,Marketed,2014-04-30,02417227,KAZANO,2.0,A10BD13,Metformin and alogliptin,Tablet,Oral,02417227,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet) TAKEDA CANADA INC,Active,9005507,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90187,Marketed,2014-04-30,02417235,KAZANO,2.0,A10BD13,Metformin and alogliptin,Tablet,Oral,02417235,KAZANO (alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 1000 mg oral tablet) TAKEDA CANADA INC,Active,9005505,alogliptin (alogliptin benzoate) 12.5 mg and metformin hydrochloride 1000 mg oral tablet,8001073,alogliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94221,Marketed,2016-06-28,02455404,INVOKAMET,2.0,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455404,INVOKAMET (canagliflozin 50 mg and metformin hydrochloride 500 mg oral tablet) JANSSEN INC,Active,9005989,canagliflozin 50 mg and metformin hydrochloride 500 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94223,Marketed,2016-06-28,02455420,INVOKAMET,2.0,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455420,INVOKAMET (canagliflozin 50 mg and metformin hydrochloride 1000 mg oral tablet) JANSSEN INC,Active,9005988,canagliflozin 50 mg and metformin hydrochloride 1000 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94226,Marketed,2016-06-28,02455455,INVOKAMET,2.0,A10BD16,Metformin and canagliflozin,Tablet,Oral,02455455,INVOKAMET (canagliflozin 150 mg and metformin hydrochloride 1000 mg oral tablet) JANSSEN INC,Active,9005985,canagliflozin 150 mg and metformin hydrochloride 1000 mg oral tablet,8001016,canagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93580,Marketed,2016-02-08,02449935,XIGDUO,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02449935,XIGDUO (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg and metformin hydrochloride 850 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012663,dapagliflozin (dapagliflozin propanediol) 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93581,Marketed,2016-02-08,02449943,XIGDUO,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02449943,XIGDUO (dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg and metformin hydrochloride 1000 mg oral tablet) ASTRAZENECA CANADA INC,Active,9012662,dapagliflozin (dapagliflozin propanediol) 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102210,Marketed,2023-05-16,02533073,AURO-DAPAGLIFLOZIN / METFORMIN,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02533073,AURO-DAPAGLIFLOZIN / METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) AURO PHARMA INC,Active,9014862,dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102211,Marketed,2023-05-16,02533081,AURO-DAPAGLIFLOZIN / METFORMIN,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02533081,AURO-DAPAGLIFLOZIN / METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) AURO PHARMA INC,Active,9014861,dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102496,Marketed,2023-12-14,02536153,APO-DAPAGLIFLOZIN-METFORMIN,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02536153,APO-DAPAGLIFLOZIN-METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) APOTEX INC,Active,9014862,dapagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102497,Marketed,2023-12-01,02536161,APO-DAPAGLIFLOZIN-METFORMIN,2.0,A10BD15,Metformin and dapagliflozin,Tablet,Oral,02536161,APO-DAPAGLIFLOZIN-METFORMIN (dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) APOTEX INC,Active,9014861,dapagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001257,dapagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94357,Marketed,2016-08-03,02456575,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456575,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006022,empagliflozin 5 mg and metformin hydrochloride 500 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94358,Marketed,2016-08-03,02456583,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456583,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006023,empagliflozin 5 mg and metformin hydrochloride 850 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94359,Marketed,2016-08-03,02456591,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456591,SYNJARDY (empagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006021,empagliflozin 5 mg and metformin hydrochloride 1000 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94360,Marketed,2016-08-03,02456605,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456605,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006019,empagliflozin 12.5 mg and metformin hydrochloride 500 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94361,Marketed,2016-08-03,02456613,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456613,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006020,empagliflozin 12.5 mg and metformin hydrochloride 850 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94362,Marketed,2016-08-03,02456621,SYNJARDY,2.0,A10BD20,Metformin and empagliflozin,Tablet,Oral,02456621,SYNJARDY (empagliflozin 12.5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9006018,empagliflozin 12.5 mg and metformin hydrochloride 1000 mg oral tablet,8001018,empagliflozin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88807,Marketed,2013-04-17,02403250,JENTADUETO,2.0,A10BD11,Metformin and linagliptin,Tablet,Oral,02403250,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005222,linagliptin 2.5 mg and metformin hydrochloride 500 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88808,Marketed,2013-04-17,02403269,JENTADUETO,2.0,A10BD11,Metformin and linagliptin,Tablet,Oral,02403269,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 850 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005223,linagliptin 2.5 mg and metformin hydrochloride 850 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88809,Marketed,2013-04-17,02403277,JENTADUETO,2.0,A10BD11,Metformin and linagliptin,Tablet,Oral,02403277,JENTADUETO (linagliptin 2.5 mg and metformin hydrochloride 1000 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005221,linagliptin 2.5 mg and metformin hydrochloride 1000 mg oral tablet,8001000,linagliptin and metformin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87467,Marketed,2014-11-19,02389169,KOMBOGLYZE,2.0,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389169,KOMBOGLYZE (metformin hydrochloride 500 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005228,metformin hydrochloride 500 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87468,Marketed,2014-11-27,02389177,KOMBOGLYZE,2.0,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389177,KOMBOGLYZE (metformin hydrochloride 850 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005229,metformin hydrochloride 850 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87469,Marketed,2014-11-08,02389185,KOMBOGLYZE,2.0,A10BD10,Metformin and saxagliptin,Tablet,Oral,02389185,KOMBOGLYZE (metformin hydrochloride 1000 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005227,metformin hydrochloride 1000 mg and saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8001001,metformin and saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81954,Marketed,2009-10-08,02333856,JANUMET,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333856,JANUMET (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81956,Marketed,2009-10-08,02333872,JANUMET,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02333872,JANUMET (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90139,Marketed,2015-01-13,02416786,JANUMET XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416786,JANUMET XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90140,Marketed,2014-01-15,02416794,JANUMET XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416794,JANUMET XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90141,Marketed,2015-01-13,02416808,JANUMET XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02416808,JANUMET XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) MERCK CANADA INC,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99341,Marketed,2023-01-10,02503956,SANDOZ SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503956,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99342,Marketed,2023-01-05,02503964,SANDOZ SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503964,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99343,Marketed,2023-01-05,02503972,SANDOZ SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02503972,SANDOZ SITAGLIPTIN-METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99561,Marketed,2022-11-07,02506270,APO-SITAGLIPTIN/METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506270,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) APOTEX INC,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99562,Marketed,2022-11-07,02506289,APO-SITAGLIPTIN/METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506289,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) APOTEX INC,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99563,Marketed,2022-11-07,02506297,APO-SITAGLIPTIN/METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02506297,APO-SITAGLIPTIN/METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) APOTEX INC,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99871,Marketed,2022-11-07,02509415,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509415,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99872,Marketed,2022-11-07,02509423,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509423,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99873,Marketed,2022-11-07,02509431,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02509431,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100969,Marketed,2024-09-24,02520494,TEVA-SITAGLIPTIN MALATE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520494,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100970,Marketed,2024-09-24,02520508,TEVA-SITAGLIPTIN MALATE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520508,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100971,Marketed,2024-09-24,02520516,TEVA-SITAGLIPTIN MALATE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02520516,TEVA-SITAGLIPTIN MALATE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101829,Marketed,2023-03-22,02529106,SANDOZ SITAGLIPTIN-METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529106,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001438,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101830,Marketed,2023-03-22,02529114,SANDOZ SITAGLIPTIN-METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529114,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001411,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101831,Marketed,2023-03-22,02529122,SANDOZ SITAGLIPTIN-METFORMIN XR,2.0,A10BD07,Metformin and sitagliptin,Tablet (extended-release),Oral,02529122,SANDOZ SITAGLIPTIN-METFORMIN XR (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001437,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 100 mg prolonged-release oral tablet,8000390,metformin and sitagliptin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101839,Marketed,2023-02-06,02529157,SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529157,SITAGLIPTIN-METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101840,Marketed,2023-02-06,02529165,SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529165,SITAGLIPTIN-METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101841,Marketed,2023-02-06,02529173,SITAGLIPTIN-METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02529173,SITAGLIPTIN-METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102317,Marketed,2023-02-01,02534223,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534223,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014871,metformin hydrochloride 500 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102318,Marketed,2023-02-01,02534231,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534231,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014872,metformin hydrochloride 850 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102319,Marketed,2023-02-01,02534258,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02534258,PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014869,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin malate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102882,Marketed,2023-10-05,02540118,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540118,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001292,metformin hydrochloride 500 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102883,Marketed,2023-10-05,02540126,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540126,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001293,metformin hydrochloride 850 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102884,Marketed,2023-10-05,02540134,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02540134,REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001291,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103673,Marketed,2025-07-22,02547805,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547805,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
103674,Marketed,2025-07-22,02547813,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547813,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
103675,Marketed,2025-07-22,02547821,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02547821,AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
104488,Marketed,2025-07-10,02556189,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556189,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
104489,Marketed,2025-07-11,02556197,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556197,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
104490,Marketed,2025-07-04,02556200,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02556200,JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
106101,Marketed,2025-07-22,02557711,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557711,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015238,metformin hydrochloride 500 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
106102,Marketed,2025-07-22,02557738,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557738,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015239,metformin hydrochloride 850 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
106103,Marketed,2025-07-22,02557746,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN,2.0,A10BD07,Metformin and sitagliptin,Tablet,Oral,02557746,AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9015237,metformin hydrochloride 1000 mg and sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000390,metformin and sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
65010,Marketed,2025-03-18,02241377,METADOL,1.0,N07BC02,Methadone,Solution,Oral,02241377,METADOL (methadone hydrochloride 10 mg per mL oral solution) ENDO OPERATIONS LTD.,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
68257,Marketed,2025-04-15,02244290,METADOL-D,1.0,N07BC02,Methadone,Solution,Oral,02244290,METADOL-D (methadone hydrochloride 10 mg per mL oral solution) ENDO OPERATIONS LTD.,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
71619,Marketed,2025-04-15,02247374,METADOL-D,1.0,N07BC02,Methadone,Solution,Oral,02247374,METADOL-D (methadone hydrochloride 1 mg per mL oral solution) ENDO OPERATIONS LTD.,Active,9001034,methadone hydrochloride 1 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
71958,Marketed,2025-03-18,02247694,METADOL,1.0,N07BC02,Methadone,Solution,Oral,02247694,METADOL (methadone hydrochloride 1 mg per mL oral solution) ENDO OPERATIONS LTD.,Active,9001034,methadone hydrochloride 1 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
71959,Marketed,2025-03-18,02247698,METADOL,1.0,N07BC02,Methadone,Tablet,Oral,02247698,METADOL (methadone hydrochloride 1 mg oral tablet) ENDO OPERATIONS LTD.,Active,9001042,methadone hydrochloride 1 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
71963,Marketed,2025-03-18,02247699,METADOL,1.0,N07BC02,Methadone,Tablet,Oral,02247699,METADOL (methadone hydrochloride 5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9001044,methadone hydrochloride 5 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
71964,Marketed,2025-03-18,02247700,METADOL,1.0,N07BC02,Methadone,Tablet,Oral,02247700,METADOL (methadone hydrochloride 10 mg oral tablet) ENDO OPERATIONS LTD.,Active,9001041,methadone hydrochloride 10 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
71965,Marketed,2025-03-18,02247701,METADOL,1.0,N07BC02,Methadone,Tablet,Oral,02247701,METADOL (methadone hydrochloride 25 mg oral tablet) ENDO OPERATIONS LTD.,Active,9001043,methadone hydrochloride 25 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
87974,Marketed,2013-01-03,02394596,METHADOSE,1.0,N07BC02,Methadone,Solution,Oral,02394596,METHADOSE (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
87975,Marketed,2013-01-03,02394618,METHADOSE,1.0,N07BC02,Methadone,Solution,Oral,02394618,"METHADOSE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) MALLINCKRODT CANADA ULC",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
98568,Marketed,2020-10-30,02495783,JAMP METHADONE ORAL CONCENTRATE,1.0,N07BC02,Methadone,Solution,Oral,02495783,JAMP METHADONE ORAL CONCENTRATE (methadone hydrochloride 10 mg per mL oral solution) JAMP PHARMA CORPORATION,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
98577,Marketed,2020-06-17,02495872,ODAN-METHADONE,1.0,N07BC02,Methadone,Solution,Oral,02495872,ODAN-METHADONE (methadone hydrochloride 10 mg per mL oral solution) ODAN LABORATORIES LTD,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
98578,Marketed,2020-06-17,02495880,ODAN-METHADONE,1.0,N07BC02,Methadone,Solution,Oral,02495880,"ODAN-METHADONE DYE FREE, SUGAR FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) ODAN LABORATORIES LTD",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
102261,Marketed,2024-03-08,02533642,APO-METHADONE,1.0,N07BC02,Methadone,Tablet,Oral,02533642,APO-METHADONE (methadone hydrochloride 1 mg oral tablet) APOTEX INC,Active,9001042,methadone hydrochloride 1 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
102262,Marketed,2024-03-08,02533650,APO-METHADONE,1.0,N07BC02,Methadone,Tablet,Oral,02533650,APO-METHADONE (methadone hydrochloride 5 mg oral tablet) APOTEX INC,Active,9001044,methadone hydrochloride 5 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
102263,Marketed,2024-03-08,02533669,APO-METHADONE,1.0,N07BC02,Methadone,Tablet,Oral,02533669,APO-METHADONE (methadone hydrochloride 10 mg oral tablet) APOTEX INC,Active,9001041,methadone hydrochloride 10 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
102264,Marketed,2024-03-08,02533677,APO-METHADONE,1.0,N07BC02,Methadone,Tablet,Oral,02533677,APO-METHADONE (methadone hydrochloride 25 mg oral tablet) APOTEX INC,Active,9001043,methadone hydrochloride 25 mg oral tablet,8000285,methadone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
104168,Marketed,2025-02-14,02552728,PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE,1.0,N07BC02,Methadone,Solution,Oral,02552728,"PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE DYE-FREE, SUGAR-FREE, UNFLAVORED (methadone hydrochloride 10 mg per mL oral solution) PHARMASCIENCE INC",Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
104169,Marketed,2025-02-14,02552736,PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE,1.0,N07BC02,Methadone,Solution,Oral,02552736,PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE CHERRY FLAVORED (methadone hydrochloride 10 mg per mL oral solution) PHARMASCIENCE INC,Active,9001395,methadone hydrochloride 10 mg per mL oral solution,8000285,methadone,26643006,Oral,385023001,Oral solution,,,,1.0,
69999,Marketed,2011-05-10,02245882,METHAZOLAMIDE,1.0,S01EC05,Methazolamide,Tablet,Oral,02245882,METHAZOLAMIDE (methazolamide 50 mg oral tablet) AA PHARMA INC,Active,9003738,methazolamide 50 mg oral tablet,8001853,methazolamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13624,Marketed,2024-11-19,01932187,ROBAXIN 750,1.0,M03BA03,Methocarbamol,Tablet,Oral,01932187,ROBAXIN 750 (methocarbamol 750 mg oral tablet) HALEON CANADA ULC,Active,9002595,methocarbamol 750 mg oral tablet,8001854,methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14509,Marketed,2024-09-24,02026805,ROBAXACET,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02026805,ROBAXACET (acetaminophen 325 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9002511,acetaminophen 325 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50062,Marketed,2001-10-17,02230790,MUSCLE & BACK PAIN RELIEF CAPLETS,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02230790,MUSCLE & BACK PAIN RELIEF CAPLETS (acetaminophen 325 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9002511,acetaminophen 325 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50227,Marketed,2024-10-09,02230949,ROBAXISAL EXTRA STRENGTH,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02230949,ROBAXISAL EXTRA STRENGTH (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50484,Marketed,2024-12-02,02231176,ROBAXACET EXTRA STRENGTH,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02231176,ROBAXACET EXTRA STRENGTH (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) HALEON CANADA ULC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62597,Marketed,2002-01-23,02239141,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02239141,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71388,Marketed,2025-08-28,02247147,ROBAX PLATINUM,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02247147,ROBAX PLATINUM (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) HALEON CANADA ULC,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73710,Marketed,2005-05-01,02252228,EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02252228,EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77584,Marketed,2009-07-10,02290510,EXTRA STRENGTH TYLENOL BACK PAIN,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02290510,EXTRA STRENGTH TYLENOL BACK PAIN (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84247,Marketed,2011-03-30,02357356,EXTRA STRENGTH TYLENOL BODY PAIN NIGHT,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02357356,EXTRA STRENGTH TYLENOL BODY PAIN NIGHT (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86317,Marketed,2014-04-01,02377462,ANALGESIC AND MUSCLE RELAXANT,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02377462,ANALGESIC AND MUSCLE RELAXANT (ibuprofen 400 mg and methocarbamol 500 mg oral tablet) PHARMASCIENCE INC,Active,9005006,ibuprofen 400 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90351,Marketed,2019-06-10,02418967,MOTRIN PLATINUM MUSCLE & BODY,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02418967,MOTRIN PLATINUM MUSCLE & BODY (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90673,Marketed,2014-06-17,02422042,MUSCLE AND BACK PAIN PLATINUM RELIEF,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02422042,MUSCLE AND BACK PAIN PLATINUM RELIEF (ibuprofen 200 mg and methocarbamol 500 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003811,ibuprofen 200 mg and methocarbamol 500 mg oral tablet,8000936,ibuprofen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91119,Marketed,2014-09-04,02426625,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02426625,EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA (acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003112,acetylsalicylic acid 500 mg and methocarbamol 400 mg oral tablet,8000901,acetylsalicylic acid and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93755,Marketed,2018-04-03,02451298,MUSCLE AND BACK PAIN RELIEF,2.0,M03BA53,"Methocarbamol, combinations excl psycholeptics",Tablet,Oral,02451298,MUSCLE AND BACK PAIN RELIEF (acetaminophen 500 mg and methocarbamol 400 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003111,acetaminophen 500 mg and methocarbamol 400 mg oral tablet,8000869,acetaminophen and methocarbamol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19681,Marketed,2017-08-31,02099705,METHOTREXATE SODIUM INJECTION,1.0,L01BA01,Methotrexate,Solution,"Intra-arterial,Intravenous,Intrathecal,Intracerebroventricular,Intramuscular",77700329,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
19681,Marketed,2017-08-31,02099705,METHOTREXATE SODIUM INJECTION,1.0,L01BA01,Methotrexate,Solution,"Intra-arterial,Intravenous,Intrathecal,Intracerebroventricular,Intramuscular",77700330,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
19681,Marketed,2017-08-31,02099705,METHOTREXATE SODIUM INJECTION,1.0,L01BA01,Methotrexate,Solution,"Intra-arterial,Intravenous,Intrathecal,Intracerebroventricular,Intramuscular",77700331,METHOTREXATE SODIUM INJECTION (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
42842,Marketed,2017-08-17,02182750,"METHOTREXATE TABLETS, USP",1.0,L01BA01,Methotrexate,Tablet,Oral,02182750,"METHOTREXATE TABLETS, USP (methotrexate 10 mg oral tablet) PFIZER CANADA ULC",Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42844,Marketed,2018-08-23,02182777,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular,Intra-arterial",77701012,METHOTREXATE INJECTION USP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
42844,Marketed,2018-08-23,02182777,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular,Intra-arterial",77701013,METHOTREXATE INJECTION USP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44161,Marketed,2018-10-04,02170698,PMS-METHOTREXATE,1.0,L01BA01,Methotrexate,Tablet,Oral,02170698,PMS-METHOTREXATE (methotrexate 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
44261,Marketed,2017-06-06,02182947,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,"Intra-arterial,Intramuscular,Intravenous,Intrathecal,Intracerebroventricular",02182947,METHOTREXATE INJECTION USP (methotrexate (methotrexate sodium) 20 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000738,methotrexate (methotrexate sodium) 20 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44262,Marketed,2017-06-06,02182955,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,"Intrathecal,Intravenous,Intracerebroventricular,Intra-arterial,Intramuscular",02182955,METHOTREXATE INJECTION USP SINGLE USE VIALS. PRESERVATIVE-FREE (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44263,Marketed,2021-07-22,02182963,APO-METHOTREXATE,1.0,L01BA01,Methotrexate,Tablet,Oral,02182963,APO-METHOTREXATE (methotrexate 2.5 mg oral tablet) APOTEX INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
44264,Marketed,2018-04-23,02182971,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,Intravenous,77701014,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 2500 mg per 100 mL solution for injection vial) PFIZER CANADA ULC,Active,9014050,methotrexate (methotrexate sodium) 2500 mg per 100 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44264,Marketed,2018-04-23,02182971,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,Intravenous,77701015,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) PFIZER CANADA ULC,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44264,Marketed,2018-04-23,02182971,METHOTREXATE INJECTION USP,1.0,L01BA01,Methotrexate,Solution,Intravenous,77701016,METHOTREXATE INJECTION USP PRESERVATIVE-FREE (PHARMACY BULK VIAL) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
81253,Marketed,2019-08-26,02327236,METHOTREXATE INJECTION BP,1.0,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous,Intra-arterial,Intrathecal,Intracerebroventricular",77700324,METHOTREXATE INJECTION BP (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
90687,Marketed,2024-09-12,02422166,"METHOTREXATE INJECTION, BP",1.0,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous",02422166,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013828,methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
90688,Marketed,2024-09-12,02422174,"METHOTREXATE INJECTION, BP",1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular",02422174,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013825,methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
90689,Marketed,2024-09-12,02422182,"METHOTREXATE INJECTION, BP",1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intramuscular",02422182,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013826,methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
90690,Marketed,2024-09-12,02422190,"METHOTREXATE INJECTION, BP",1.0,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous",02422190,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013827,methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
90691,Marketed,2024-09-12,02422204,"METHOTREXATE INJECTION, BP",1.0,L01BA01,Methotrexate,Solution,"Intramuscular,Intravenous",02422204,"METHOTREXATE INJECTION, BP (methotrexate (methotrexate sodium) 25 mg per 1 mL solution for injection syringe) PHARMASCIENCE INC",Active,9013231,methotrexate (methotrexate sodium) 25 mg per 1 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94144,Marketed,2019-09-16,02454750,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454750,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94145,Marketed,2016-12-02,02454769,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454769,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94146,Marketed,2016-12-02,02454777,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454777,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94161,Marketed,2019-09-16,02454831,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454831,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94162,Marketed,2018-11-30,02454858,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454858,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94163,Marketed,2016-12-02,02454866,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454866,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
94164,Marketed,2016-12-02,02454874,METOJECT SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02454874,METOJECT SUBCUTANEOUS (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) MEDEXUS PHARMACEUTICALS INC.,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
95252,Marketed,2020-10-22,02464365,METHOTREXATE INJECTION BP,1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701021,METHOTREXATE INJECTION BP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000612,methotrexate (methotrexate sodium) 50 mg per 2 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95252,Marketed,2020-10-22,02464365,METHOTREXATE INJECTION BP,1.0,L01BA01,Methotrexate,Solution,"Intravenous,Intra-arterial,Intramuscular",77701022,METHOTREXATE INJECTION BP WITH PRESERVATIVE (MULTIDOSE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96492,Marketed,2019-04-23,02474735,METHOTREXATE INJECTION BP,1.0,L01BA01,Methotrexate,Solution,Intravenous,02474735,METHOTREXATE INJECTION BP WITHOUT PRESERVATIVE (20 ML SINGLE-USE VIALS) (methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000611,methotrexate (methotrexate sodium) 500 mg per 20 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96511,Marketed,2019-04-23,02474891,METHOTREXATE INJECTION BP,1.0,L01BA01,Methotrexate,Solution,Intravenous,02474891,METHOTREXATE INJECTION BP (methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9000610,methotrexate (methotrexate sodium) 1000 mg per 40 mL solution for injection vial,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98130,Marketed,2025-10-20,02491281,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491281,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98131,Marketed,2025-10-20,02491303,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491303,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98132,Marketed,2020-06-02,02491311,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491311,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98133,Marketed,2020-02-28,02491338,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491338,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98134,Marketed,2020-02-28,02491346,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491346,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98135,Marketed,2020-02-28,02491354,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491354,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
98136,Marketed,2020-02-28,02491362,METHOTREXATE SUBCUTANEOUS,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02491362,METHOTREXATE SUBCUTANEOUS (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
99838,Marketed,2021-10-21,02509067,ACH-METHOTREXATE,1.0,L01BA01,Methotrexate,Tablet,Oral,02509067,ACH-METHOTREXATE (methotrexate 2.5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101306,Marketed,2023-02-02,02524023,AURO-METHOTREXATE,1.0,L04AX03,Methotrexate,Tablet,Oral,02524023,AURO-METHOTREXATE (methotrexate 2.5 mg oral tablet) AURO PHARMA INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101993,Marketed,2025-07-02,02530775,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530775,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101994,Marketed,2025-07-02,02530783,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530783,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101995,Marketed,2025-07-02,02530791,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530791,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101996,Marketed,2025-07-02,02530805,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530805,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101999,Marketed,2025-07-02,02530813,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530813,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102001,Marketed,2025-07-02,02530848,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530848,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102002,Marketed,2025-07-02,02530856,METHOFILL SELF-DOSE INJECTOR,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02530856,METHOFILL SELF-DOSE INJECTOR (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) ACCORD HEALTHCARE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102380,Marketed,2024-04-24,02534916,M-METHOTREXATE,1.0,L01BA01,Methotrexate,Tablet,Oral,02534916,M-METHOTREXATE (methotrexate 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9000870,methotrexate 2.5 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102835,Marketed,2024-03-14,02539608,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539608,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe) PHARMASCIENCE INC,Active,9014180,methotrexate (methotrexate sodium) 10 mg per 0.2 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102836,Marketed,2024-03-14,02539616,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539616,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe) PHARMASCIENCE INC,Active,9014181,methotrexate (methotrexate sodium) 12.5 mg per 0.25 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102837,Marketed,2024-03-14,02539624,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539624,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe) PHARMASCIENCE INC,Active,9013923,methotrexate (methotrexate sodium) 15 mg per 0.3 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102838,Marketed,2024-03-14,02539632,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539632,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012579,methotrexate (methotrexate sodium) 17.5 mg per 0.35 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102839,Marketed,2024-03-14,02539640,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539640,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012580,methotrexate (methotrexate sodium) 20 mg per 0.4 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102840,Marketed,2024-03-14,02539659,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539659,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012581,methotrexate (methotrexate sodium) 22.5 mg per 0.45 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
102841,Marketed,2024-03-14,02539667,PMS-METHOTREXATE INJECTION,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02539667,PMS-METHOTREXATE INJECTION (methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe) PHARMASCIENCE INC,Active,9012582,methotrexate (methotrexate sodium) 25 mg per 0.5 mL solution for injection syringe,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
103522,Marketed,2024-08-01,02546531,NORDIMET,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02546531,NORDIMET (methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015078,methotrexate (methotrexate sodium) 7.5 mg per 0.3 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
103523,Marketed,2024-08-01,02546558,NORDIMET,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02546558,NORDIMET (methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015074,methotrexate (methotrexate sodium) 10 mg per 0.4 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
103525,Marketed,2024-08-01,02546574,NORDIMET,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02546574,NORDIMET (methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015075,methotrexate (methotrexate sodium) 15 mg per 0.6 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
103527,Marketed,2024-08-01,02546590,NORDIMET,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02546590,NORDIMET (methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection pen) NORDIC GROUP B.V.,Active,9015076,methotrexate (methotrexate sodium) 20 mg per 0.8 mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
103529,Marketed,2024-08-01,02546612,NORDIMET,1.0,L04AX03,Methotrexate,Solution,Subcutaneous,02546612,NORDIMET (methotrexate (methotrexate sodium) 25 mg per mL solution for injection pen) NORDIC GROUP B.V.,Active,9015077,methotrexate (methotrexate sodium) 25 mg per mL solution for injection pen,8000217,methotrexate,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
104265,Marketed,2025-06-10,02553740,JAMP METHOTREXATE TABLETS,1.0,L01BA01,Methotrexate,Tablet,Oral,02553740,JAMP METHOTREXATE TABLETS (methotrexate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
106487,Marketed,2025-11-28,02561956,PMS-METHOTREXATE TABLETS,1.0,L01BA01,Methotrexate,Tablet,Oral,02561956,PMS-METHOTREXATE TABLETS (methotrexate 10 mg oral tablet) PHARMASCIENCE INC,Active,9001077,methotrexate 10 mg oral tablet,8000217,methotrexate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89096,Marketed,2013-12-09,02406233,UVADEX,1.0,D05BA02,"Methoxalen, systemic",Solution,Extracorporeal,02406233,UVADEX (methoxsalen 200 mcg per 10 mL solution for blood fraction modification vial) THERAKOS LLC,Active,9015308,methoxsalen 200 mcg per 10 mL solution for blood fraction modification vial,8001855,methoxsalen,,,1008211000202107,Conventional release solution for blood fraction modification (dose form),733026001,Vial,1.0,,
96490,Marketed,2022-10-22,02474719,PENTHROX,1.0,N02BG09,Methoxyflurane,Solution,Inhalation,,,,,,,,,,,,,,,,
96491,Marketed,2022-10-22,02474727,PENTHROX,1.0,N02BG09,Methoxyflurane,"Kit,Solution",Inhalation,,,,,,,,,,,,,,,,
80876,Marketed,2009-06-16,02323273,METVIX,1.0,L01XD03,Methyl aminolevulinate,Cream,Topical,02323273,METVIX (methyl aminolevulinate (methyl aminolevulinate hydrochloride) 168 mg per g cutaneous cream) GALDERMA CANADA INC.,Active,9004556,methyl aminolevulinate (methyl aminolevulinate hydrochloride) 168 mg per g cutaneous cream,8001563,aminolevulinic acid,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
2470,Marketed,2011-04-04,00360252,METHYLDOPA,1.0,C02AB02,Methyldopa (racemic),Tablet,Oral,00360252,METHYLDOPA (methyldopa 125 mg oral tablet) AA PHARMA INC,Active,9001866,methyldopa 125 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2471,Marketed,2011-04-04,00360260,METHYLDOPA,1.0,C02AB02,Methyldopa (racemic),Tablet,Oral,00360260,METHYLDOPA (methyldopa 250 mg oral tablet) AA PHARMA INC,Active,9001764,methyldopa 250 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2909,Marketed,2011-05-10,00426830,METHYLDOPA,1.0,C02AB02,Methyldopa (racemic),Tablet,Oral,00426830,METHYLDOPA (methyldopa 500 mg oral tablet) AA PHARMA INC,Active,9001813,methyldopa 500 mg oral tablet,8001145,methyldopa,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79388,Marketed,2021-01-18,02308215,RELISTOR,1.0,A06AH01,Methylnaltrexone bromide,Solution,Subcutaneous,02308215,RELISTOR (methylnaltrexone bromide 12 mg per 0.6 mL solution for injection vial) SALIX PHARMACEUTICALS INC,Active,9013233,methylnaltrexone bromide 12 mg per 0.6 mL solution for injection vial,8001857,methylnaltrexone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10398,Marketed,1998-12-15,00584991,PMS-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,00584991,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000015,methylphenidate hydrochloride 10 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10399,Marketed,1998-12-15,00585009,PMS-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,00585009,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000023,methylphenidate hydrochloride 20 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
55866,Marketed,1997-10-24,02234749,PMS-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,02234749,PMS-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000753,methylphenidate hydrochloride 5 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72012,Marketed,2003-07-23,02247732,CONCERTA,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247732,CONCERTA (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) JANSSEN INC,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
72013,Marketed,2003-07-23,02247733,CONCERTA,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247733,CONCERTA (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) JANSSEN INC,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
72014,Marketed,2003-07-23,02247734,CONCERTA,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02247734,CONCERTA (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) JANSSEN INC,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
73416,Marketed,2004-11-02,02249324,APO-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,02249324,APO-METHYLPHENIDATE (methylphenidate hydrochloride 10 mg oral tablet) APOTEX INC,Active,9000015,methylphenidate hydrochloride 10 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73417,Marketed,2004-11-02,02249332,APO-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,02249332,APO-METHYLPHENIDATE (methylphenidate hydrochloride 20 mg oral tablet) APOTEX INC,Active,9000023,methylphenidate hydrochloride 20 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73505,Marketed,2005-01-06,02250241,CONCERTA,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02250241,CONCERTA (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) JANSSEN INC,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75209,Marketed,2025-11-07,02266687,AA-METHYLPHENIDATE SR,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02266687,AA-METHYLPHENIDATE SR (methylphenidate hydrochloride 20 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000208,methylphenidate hydrochloride 20 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75941,Marketed,2006-02-01,02273950,APO-METHYLPHENIDATE,1.0,N06BA04,Methylphenidate,Tablet,Oral,02273950,APO-METHYLPHENIDATE (methylphenidate hydrochloride 5 mg oral tablet) APOTEX INC,Active,9000753,methylphenidate hydrochloride 5 mg oral tablet,8000010,methylphenidate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76279,Marketed,2020-09-03,02277131,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277131,BIPHENTIN (methylphenidate hydrochloride 15 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001166,methylphenidate hydrochloride 15 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76280,Marketed,2020-09-03,02277158,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277158,BIPHENTIN (methylphenidate hydrochloride 20 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001167,methylphenidate hydrochloride 20 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76281,Marketed,2020-09-08,02277166,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277166,BIPHENTIN (methylphenidate hydrochloride 10 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001165,methylphenidate hydrochloride 10 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76282,Marketed,2020-09-08,02277174,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277174,BIPHENTIN (methylphenidate hydrochloride 30 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001168,methylphenidate hydrochloride 30 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76283,Marketed,2020-09-08,02277182,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277182,BIPHENTIN (methylphenidate hydrochloride 40 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001169,methylphenidate hydrochloride 40 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76284,Marketed,2020-09-03,02277190,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277190,BIPHENTIN (methylphenidate hydrochloride 50 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001170,methylphenidate hydrochloride 50 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76285,Marketed,2020-09-03,02277204,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277204,BIPHENTIN (methylphenidate hydrochloride 60 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001171,methylphenidate hydrochloride 60 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76286,Marketed,2020-09-03,02277212,BIPHENTIN,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02277212,BIPHENTIN (methylphenidate hydrochloride 80 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9001189,methylphenidate hydrochloride 80 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
81611,Marketed,2016-07-22,02330377,APO-METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02330377,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) APOTEX INC,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92630,Marketed,2020-03-03,02441934,ACT METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441934,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92631,Marketed,2020-03-03,02441942,ACT METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441942,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92632,Marketed,2020-03-03,02441950,ACT METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441950,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92633,Marketed,2020-03-03,02441969,ACT METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02441969,ACT METHYLPHENIDATE ER (methylphenidate hydrochloride 54 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001040,methylphenidate hydrochloride 54 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93914,Marketed,2016-07-22,02452731,APO-METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452731,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 18 mg prolonged-release oral tablet) APOTEX INC,Active,9001038,methylphenidate hydrochloride 18 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93915,Marketed,2016-07-22,02452758,APO-METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452758,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 27 mg prolonged-release oral tablet) APOTEX INC,Active,9001100,methylphenidate hydrochloride 27 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93916,Marketed,2016-07-22,02452766,APO-METHYLPHENIDATE ER,1.0,N06BA04,Methylphenidate,Tablet (extended-release),Oral,02452766,APO-METHYLPHENIDATE ER (methylphenidate hydrochloride 36 mg prolonged-release oral tablet) APOTEX INC,Active,9001039,methylphenidate hydrochloride 36 mg prolonged-release oral tablet,8000010,methylphenidate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
95927,Marketed,2020-09-08,02470292,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470292,FOQUEST (methylphenidate hydrochloride 25 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015311,methylphenidate hydrochloride 25 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95928,Marketed,2020-09-08,02470306,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470306,FOQUEST (methylphenidate hydrochloride 35 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015312,methylphenidate hydrochloride 35 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95929,Marketed,2020-09-08,02470314,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470314,FOQUEST (methylphenidate hydrochloride 45 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015314,methylphenidate hydrochloride 45 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95930,Marketed,2020-09-08,02470322,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470322,FOQUEST (methylphenidate hydrochloride 55 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015315,methylphenidate hydrochloride 55 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95931,Marketed,2020-09-08,02470330,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470330,FOQUEST (methylphenidate hydrochloride 70 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015317,methylphenidate hydrochloride 70 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95932,Marketed,2020-09-10,02470349,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470349,FOQUEST (methylphenidate hydrochloride 85 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015319,methylphenidate hydrochloride 85 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
95933,Marketed,2020-09-03,02470357,FOQUEST,1.0,N06BA04,Methylphenidate,Capsule (controlled release),Oral,02470357,FOQUEST (methylphenidate hydrochloride 100 mg prolonged-release oral capsule) ELVIUM LIFE SCIENCES,Active,9015309,methylphenidate hydrochloride 100 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
102567,Marketed,2023-10-30,02536943,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536943,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 10 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001165,methylphenidate hydrochloride 10 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102568,Marketed,2023-10-30,02536951,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536951,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 15 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001166,methylphenidate hydrochloride 15 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102569,Marketed,2023-10-30,02536978,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536978,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 20 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001167,methylphenidate hydrochloride 20 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102570,Marketed,2023-10-30,02536986,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536986,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 30 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001168,methylphenidate hydrochloride 30 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102571,Marketed,2023-10-30,02536994,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02536994,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 40 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001169,methylphenidate hydrochloride 40 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102572,Marketed,2023-10-30,02537001,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537001,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 50 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001170,methylphenidate hydrochloride 50 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102573,Marketed,2023-10-30,02537028,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537028,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 60 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001171,methylphenidate hydrochloride 60 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
102574,Marketed,2023-10-30,02537036,PMS-METHYLPHENIDATE CR,1.0,N06BA04,Methylphenidate,Capsule (extended release),Oral,02537036,PMS-METHYLPHENIDATE CR (methylphenidate hydrochloride 80 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9001189,methylphenidate hydrochloride 80 mg prolonged-release oral capsule,8000010,methylphenidate,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103024,Marketed,2024-06-24,02541602,QUILLIVANT ER CHEWABLE TABLETS,1.0,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541602,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 20 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015064,methylphenidate hydrochloride 20 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
103025,Marketed,2024-06-24,02541610,QUILLIVANT ER CHEWABLE TABLETS,1.0,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541610,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 30 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015065,methylphenidate hydrochloride 30 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
103026,Marketed,2024-06-24,02541629,QUILLIVANT ER CHEWABLE TABLETS,1.0,N06BA04,Methylphenidate,"Tablet (chewable, extended-release)",Oral,02541629,QUILLIVANT ER CHEWABLE TABLETS (methylphenidate hydrochloride 40 mg prolonged-release chewable tablet) KYE PHARMACEUTICALS INC.,Active,9015066,methylphenidate hydrochloride 40 mg prolonged-release chewable tablet,8000010,methylphenidate,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
103027,Marketed,2024-08-19,02541637,QUILLIVANT ER ORAL SUSPENSION,1.0,N06BA04,Methylphenidate,Powder (extended release),Oral,02541637,QUILLIVANT ER ORAL SUSPENSION (methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension) KYE PHARMACEUTICALS INC.,Active,9015083,methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension,8000010,methylphenidate,26643006,Oral,422353003,Prolonged-release oral suspension,,,,,
104199,Marketed,2025-11-06,02553023,JORNAY PM,1.0,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553023,JORNAY PM (methylphenidate hydrochloride 100 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012448,methylphenidate hydrochloride 100 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule (unit of presentation),,,
104200,Marketed,2025-11-06,02553031,JORNAY PM,1.0,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553031,JORNAY PM (methylphenidate hydrochloride 80 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015318,methylphenidate hydrochloride 80 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,
104201,Marketed,2025-11-06,02553058,JORNAY PM,1.0,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553058,JORNAY PM (methylphenidate hydrochloride 60 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015316,methylphenidate hydrochloride 60 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,
104202,Marketed,2025-11-06,02553066,JORNAY PM,1.0,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553066,JORNAY PM (methylphenidate hydrochloride 40 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015313,methylphenidate hydrochloride 40 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,
104203,Marketed,2025-11-06,02553074,JORNAY PM,1.0,N06BA04,Methylphenidate,Capsule (delayed and extended release),Oral,02553074,JORNAY PM (methylphenidate hydrochloride 20 mg modified-release oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015310,methylphenidate hydrochloride 20 mg modified-release oral capsule,8000010,methylphenidate,26643006,Oral,385054002,Modified-release oral capsule,732937005,Capsule,,,
789,Marketed,2004-03-16,00030767,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intrasynovial,Intra-articular,Intralesional,Intramuscular",00030767,DEPO-MEDROL (methylprednisolone acetate 80 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012840,methylprednisolone acetate 80 mg per 1 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
1130,Marketed,2009-02-03,00036137,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,Powder for solution,"Intravenous,Intramuscular",00036137,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 1 g per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013008,methylprednisolone (methylprednisolone sodium succinate) 1 g per vial powder for solution for injection with diluent solution,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
1132,Marketed,2009-02-03,00030678,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,Powder for solution,"Intravenous,Intramuscular",00030678,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 500 mg per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013012,methylprednisolone (methylprednisolone sodium succinate) 500 mg per vial powder for solution for injection with diluent solution,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
1134,Marketed,2004-01-08,00030759,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intramuscular,Intrasynovial,Intralesional,Intra-articular",00030759,DEPO-MEDROL (methylprednisolone acetate 40 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012838,methylprednisolone acetate 40 mg per 1 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
1396,Marketed,2009-02-03,00036129,MEDROL,1.0,H02AB04,Methylprednisolone,Tablet,Oral,00036129,MEDROL (methylprednisolone 16 mg oral tablet) PFIZER CANADA ULC,Active,9001639,methylprednisolone 16 mg oral tablet,8001667,methylprednisolone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1397,Marketed,2006-01-10,00030988,MEDROL,1.0,H02AB04,Methylprednisolone,Tablet,Oral,00030988,MEDROL (methylprednisolone 4 mg oral tablet) PFIZER CANADA ULC,Active,9001578,methylprednisolone 4 mg oral tablet,8001667,methylprednisolone (base),26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16275,Marketed,2009-02-03,01934333,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intra-articular,Intralesional,Intramuscular,Intrasynovial",77700634,DEPO-MEDROL (methylprednisolone acetate 200 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012837,methylprednisolone acetate 200 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
16275,Marketed,2009-02-03,01934333,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intra-articular,Intralesional,Intramuscular,Intrasynovial",77700635,DEPO-MEDROL (methylprednisolone acetate 80 mg per 2 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012841,methylprednisolone acetate 80 mg per 2 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
16276,Marketed,2009-02-03,01934341,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intramuscular,Intrasynovial,Intralesional,Intra-articular",01934341,DEPO-MEDROL (methylprednisolone acetate 400 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012839,methylprednisolone acetate 400 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
18988,Marketed,2006-05-03,01934325,DEPO-MEDROL,1.0,H02AB04,Methylprednisolone,Suspension,"Intrasynovial,Intra-articular,Intramuscular,Intralesional",01934325,DEPO-MEDROL (methylprednisolone acetate 100 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9012836,methylprednisolone acetate 100 mg per 5 mL suspension for injection vial,8001291,methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
85277,Marketed,2012-01-11,02367947,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,"Kit,Powder for solution","Intramuscular,Intravenous",02367947,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 40 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013011,methylprednisolone (methylprednisolone sodium succinate) 40 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85278,Marketed,2012-01-18,02367955,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,"Kit,Powder for solution","Intravenous,Intramuscular",02367955,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 125 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013010,methylprednisolone (methylprednisolone sodium succinate) 125 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85279,Marketed,2012-01-18,02367963,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,"Kit,Powder for solution","Intravenous,Intramuscular",02367963,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013013,methylprednisolone (methylprednisolone sodium succinate) 500 mg powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85280,Marketed,2012-02-07,02367971,SOLU-MEDROL,1.0,H02AB04,Methylprednisolone,"Kit,Powder for solution","Intravenous,Intramuscular",02367971,SOLU-MEDROL (methylprednisolone (methylprednisolone sodium succinate) 1 g powder for solution for injection with diluent solution per vial) PFIZER CANADA ULC,Active,9013009,methylprednisolone (methylprednisolone sodium succinate) 1 g powder for solution for injection with diluent solution per vial,8001667,methylprednisolone (base),738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
1619,Marketed,2022-05-20,00260428,DEPO-MEDROL WITH LIDOCAINE,2.0,H02BX01,"Methylprednisolone, combinations",Suspension,"Periarticular,Intrasynovial,Intrabursal,Intra-articular",77700706,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 50 mg per 5 mL and methylprednisolone acetate 200 mg per 5 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013217,lidocaine hydrochloride 50 mg per 5 mL and methylprednisolone acetate 200 mg per 5 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
1619,Marketed,2022-05-20,00260428,DEPO-MEDROL WITH LIDOCAINE,2.0,H02BX01,"Methylprednisolone, combinations",Suspension,"Periarticular,Intrasynovial,Intrabursal,Intra-articular",77700707,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 10 mg per 1 mL and methylprednisolone acetate 40 mg per 1 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013202,lidocaine hydrochloride 10 mg per 1 mL and methylprednisolone acetate 40 mg per 1 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
1619,Marketed,2022-05-20,00260428,DEPO-MEDROL WITH LIDOCAINE,2.0,H02BX01,"Methylprednisolone, combinations",Suspension,"Periarticular,Intrasynovial,Intrabursal,Intra-articular",77700708,DEPO-MEDROL WITH LIDOCAINE (lidocaine hydrochloride 20 mg per 2 mL and methylprednisolone acetate 80 mg per 2 mL suspension for injection vial) PFIZER CANADA ULC,Active,9013209,lidocaine hydrochloride 20 mg per 2 mL and methylprednisolone acetate 80 mg per 2 mL suspension for injection vial,8001839,lidocaine and methylprednisolone acetate,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
68,Marketed,1951-12-31,00050466,METHYLENE BLEU LIQ 1%,1.0,V04CG05,Methylthionine,Liquid,Oral,00050466,METHYLENE BLEU LIQ 1% (methylene blue 10 mg per mL oral solution) LABORATOIRE ATLAS INC,Active,9013829,methylene blue 10 mg per mL oral solution,8002140,methylene blue,26643006,Oral,385023001,Oral solution,,,,,
50032,Marketed,2001-03-11,02230770,METHYLENE BLUE INJECTION USP,1.0,V03AB17,Methylthioninium chloride,Liquid,Intravenous,77700969,METHYLENE BLUE INJECTION USP (methylene blue 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013577,methylene blue 10 mg per 1 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
50032,Marketed,2001-03-11,02230770,METHYLENE BLUE INJECTION USP,1.0,V03AB17,Methylthioninium chloride,Liquid,Intravenous,77700970,METHYLENE BLUE INJECTION USP (methylene blue 50 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013579,methylene blue 50 mg per 5 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97817,Marketed,2020-09-22,02487993,METHYLENE BLUE INJECTION,1.0,V03AB17,Methylthioninium chloride,Solution,Intravenous,02487993,METHYLENE BLUE INJECTION (methylene blue 50 mg per 5 mL solution for injection vial) PHEBRA PTY LTD,Active,9013579,methylene blue 50 mg per 5 mL solution for injection vial,8002140,methylene blue,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19409,Marketed,2005-09-21,02185431,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700199,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19409,Marketed,2005-09-21,02185431,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700200,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19409,Marketed,2005-09-21,02185431,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Liquid,"Intramuscular,Intravenous",77700201,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49332,Marketed,2021-10-29,02230431,PMS-METOCLOPRAMIDE TABLETS,1.0,A03FA01,Metoclopramide,Tablet,Oral,02230431,PMS-METOCLOPRAMIDE TABLETS (metoclopramide hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49340,Marketed,2021-10-29,02230433,PMS-METOCLOPRAMIDE ORAL SOLUTION,1.0,A03FA01,Metoclopramide,Solution,Oral,02230433,PMS-METOCLOPRAMIDE ORAL SOLUTION (metoclopramide hydrochloride 5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9006556,metoclopramide hydrochloride 5 mg per 5 mL oral solution,8000130,metoclopramide,26643006,Oral,385023001,Oral solution,,,,,
67481,Marketed,2024-04-12,02243563,METOCLOPRAMIDE INJECTION USP,1.0,A03FA01,Metoclopramide,Solution,"Intravenous,Intramuscular",77700202,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
67481,Marketed,2024-04-12,02243563,METOCLOPRAMIDE INJECTION USP,1.0,A03FA01,Metoclopramide,Solution,"Intravenous,Intramuscular",77700203,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
67481,Marketed,2024-04-12,02243563,METOCLOPRAMIDE INJECTION USP,1.0,A03FA01,Metoclopramide,Solution,"Intravenous,Intramuscular",77700204,METOCLOPRAMIDE INJECTION USP (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99999,Marketed,2021-07-23,02510790,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701092,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial) PHARMASCIENCE INC,Active,9000615,metoclopramide hydrochloride 50 mg per 10 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99999,Marketed,2021-07-23,02510790,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701093,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) PHARMASCIENCE INC,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99999,Marketed,2021-07-23,02510790,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",77701094,PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial) PHARMASCIENCE INC,Active,9000614,metoclopramide hydrochloride 150 mg per 30 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100715,Marketed,2021-07-29,02517795,MAR-METOCLOPRAMIDE,1.0,A03FA01,Metoclopramide,Tablet,Oral,02517795,MAR-METOCLOPRAMIDE (metoclopramide hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102085,Marketed,2024-06-04,02531747,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Solution,"Intravenous,Intramuscular",02531747,METOCLOPRAMIDE HYDROCHLORIDE INJECTION (metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial) BAXTER CORPORATION,Active,9000613,metoclopramide hydrochloride 10 mg per 2 mL solution for injection vial,8000130,metoclopramide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102611,Marketed,2024-02-08,02537397,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,1.0,A03FA01,Metoclopramide,Solution,"Intramuscular,Intravenous",,,,,,,,,,,,,,,,
103759,Marketed,2025-04-30,02548747,PRZ-METOCLOPRAMIDE,1.0,A03FA01,Metoclopramide,Tablet,Oral,02548747,PRZ-METOCLOPRAMIDE (metoclopramide hydrochloride 5 mg oral tablet) PHARMARIS CANADA INC,Active,9000330,metoclopramide hydrochloride 5 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103760,Marketed,2025-04-29,02548755,PRZ-METOCLOPRAMIDE,1.0,A03FA01,Metoclopramide,Tablet,Oral,02548755,PRZ-METOCLOPRAMIDE (metoclopramide hydrochloride 10 mg oral tablet) PHARMARIS CANADA INC,Active,9000329,metoclopramide hydrochloride 10 mg oral tablet,8000130,metoclopramide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13126,Marketed,2008-01-21,00888400,ZAROXOLYN,1.0,C03BA08,Metolazone,Tablet,Oral,00888400,ZAROXOLYN (metolazone 2.5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001718,metolazone 2.5 mg oral tablet,8001400,metolazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5818,Marketed,1984-12-31,00618632,APO-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00618632,APO-METOPROLOL (metoprolol tartrate 50 mg oral tablet) APOTEX INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5819,Marketed,1984-12-31,00618640,APO-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00618640,APO-METOPROLOL (metoprolol tartrate 100 mg oral tablet) APOTEX INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6512,Marketed,2025-06-27,00648019,PRO-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,00648019,PRO-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) PRO DOC LIMITEE,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6513,Marketed,2025-06-27,00648027,PRO-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,00648027,PRO-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) PRO DOC LIMITEE,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6611,Marketed,2011-01-25,00648035,TEVA-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00648035,TEVA-METOPROLOL FILM COATED (metoprolol tartrate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6612,Marketed,2011-01-25,00648043,TEVA-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00648043,TEVA-METOPROLOL FILM COATED (metoprolol tartrate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8602,Marketed,1988-12-31,00751170,APO-METOPROLOL (TYPE L),1.0,C07AB02,Metoprolol,Tablet,Oral,00751170,APO-METOPROLOL (TYPE L) (metoprolol tartrate 100 mg oral tablet) APOTEX INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8603,Marketed,1988-12-31,00749354,APO-METOPROLOL (TYPE L),1.0,C07AB02,Metoprolol,Tablet,Oral,00749354,APO-METOPROLOL (TYPE L) (metoprolol tartrate 50 mg oral tablet) APOTEX INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9886,Marketed,2011-01-25,00842648,TEVA-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00842648,TEVA-METOPROLOL UNCOATED (metoprolol tartrate 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9887,Marketed,2011-01-25,00842656,TEVA-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,00842656,TEVA-METOPROLOL UNCOATED (metoprolol tartrate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50067,Marketed,1998-04-16,02230803,PMS-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02230803,PMS-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) PHARMASCIENCE INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50068,Marketed,1998-04-16,02230804,PMS-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02230804,PMS-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) PHARMASCIENCE INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70136,Marketed,2002-10-08,02246010,APO-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,02246010,APO-METOPROLOL (metoprolol tartrate 25 mg oral tablet) APOTEX INC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73226,Marketed,2004-03-19,02248855,PMS-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02248855,PMS-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) PHARMASCIENCE INC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74725,Marketed,2012-02-15,02261898,TEVA-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,02261898,TEVA-METOPROLOL (metoprolol tartrate 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75326,Marketed,2005-10-05,02267853,METOPROLOL TARTRATE INJECTION USP,1.0,C07AB02,Metoprolol,Solution,Intravenous,02267853,METOPROLOL TARTRATE INJECTION USP (metoprolol tartrate 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9001120,metoprolol tartrate 5 mg per 5 mL solution for injection vial,8000063,metoprolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
77067,Marketed,2022-10-13,02285169,AA-METOPROLOL SR,1.0,C07AB02,Metoprolol,Tablet (extended-release),Oral,02285169,AA-METOPROLOL SR (metoprolol tartrate 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9000227,metoprolol tartrate 100 mg prolonged-release oral tablet,8000063,metoprolol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78208,Marketed,2025-06-27,02296713,PRO-METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,02296713,PRO-METOPROLOL (metoprolol tartrate 25 mg oral tablet) PRO DOC LIMITEE,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80085,Marketed,2008-09-10,02315300,RIVA-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02315300,RIVA-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80086,Marketed,2008-09-10,02315319,RIVA-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02315319,RIVA-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80087,Marketed,2008-09-10,02315327,RIVA-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02315327,RIVA-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83560,Marketed,2014-05-24,02350394,METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,02350394,METOPROLOL (metoprolol tartrate 50 mg oral tablet) SANIS HEALTH INC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83561,Marketed,2014-05-24,02350408,METOPROLOL,1.0,C07AB02,Metoprolol,Tablet,Oral,02350408,METOPROLOL (metoprolol tartrate 100 mg oral tablet) SANIS HEALTH INC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84194,Marketed,2018-05-04,02356813,JAMP-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02356813,JAMP-METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84195,Marketed,2018-05-04,02356821,JAMP-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02356821,JAMP-METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84196,Marketed,2018-05-04,02356848,JAMP-METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02356848,JAMP-METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92647,Marketed,2021-09-17,02442116,METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02442116,METOPROLOL-L (metoprolol tartrate 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001001,metoprolol tartrate 25 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92648,Marketed,2021-09-13,02442124,METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02442124,METOPROLOL-L (metoprolol tartrate 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000101,metoprolol tartrate 50 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92649,Marketed,2021-09-13,02442132,METOPROLOL-L,1.0,C07AB02,Metoprolol,Tablet,Oral,02442132,METOPROLOL-L (metoprolol tartrate 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000100,metoprolol tartrate 100 mg oral tablet,8000063,metoprolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96432,Marketed,2021-07-27,02474271,METOPROLOL TARTRATE INJECTION USP,1.0,C07AB02,Metoprolol,Solution,Intravenous,02474271,METOPROLOL TARTRATE INJECTION USP (metoprolol tartrate 5 mg per 5 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9001120,metoprolol tartrate 5 mg per 5 mL solution for injection vial,8000063,metoprolol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103314,Marketed,2024-10-25,02544555,MYALEPTA,1.0,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544555,MYALEPTA (metreleptin 3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015122,metreleptin 3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103315,Marketed,2024-10-25,02544563,MYALEPTA,1.0,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544563,MYALEPTA (metreleptin 5.8 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015123,metreleptin 5.8 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103316,Marketed,2024-08-02,02544571,MYALEPTA,1.0,A16AA07,Metreleptin,Powder for solution,Subcutaneous,02544571,MYALEPTA (metreleptin 11.3 mg per vial powder for solution for injection) CHIESI FARMACEUTICI S.P.A.,Active,9015067,metreleptin 11.3 mg per vial powder for solution for injection,8002511,metreleptin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
4902,Marketed,2024-05-22,00545066,APO-METRONIDAZOLE TABLETS,1.0,P01AB01,Metronidazole,Tablet,Oral,00545066,APO-METRONIDAZOLE TABLETS (metronidazole 250 mg oral tablet) APOTEX INC,Active,9000055,metronidazole 250 mg oral tablet,8000038,metronidazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9910,Marketed,2021-04-29,00783137,PMS-METRONIDAZOLE,1.0,J01XD01,Metronidazole,Capsule,Oral,00783137,PMS-METRONIDAZOLE (metronidazole 500 mg oral capsule) PHARMASCIENCE INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
10871,Marketed,2019-09-03,00870420,"METRONIDAZOLE INJECTION, USP",1.0,J01XD01,Metronidazole,Solution,Intravenous,77700015,"METRONIDAZOLE INJECTION, USP (metronidazole 500 mg per 100 mL solution for injection bag) BAXTER CORPORATION",Active,9000279,metronidazole 500 mg per 100 mL solution for injection bag,8000038,metronidazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
10871,Marketed,2019-09-03,00870420,"METRONIDAZOLE INJECTION, USP",1.0,J01XD01,Metronidazole,Solution,Intravenous,77700016,"METRONIDAZOLE INJECTION, USP (metronidazole 1500 mg per 300 mL solution for injection bag) BAXTER CORPORATION",Active,9000360,metronidazole 1500 mg per 300 mL solution for injection bag,8000038,metronidazole,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
16852,Marketed,2021-08-18,02125226,NIDAGEL,1.0,G01AF01,Metronidazole,Gel,Vaginal,02125226,"NIDAGEL (metronidazole 0.75 % vaginal gel) BAUSCH HEALTH, CANADA INC.",Active,9000535,metronidazole 0.75 % vaginal gel,8000038,metronidazole,16857009,Vaginal,385100002,Gel,,,,,
17824,Marketed,1994-12-31,02092832,METROGEL 0.75%,1.0,D06BX01,Metronidazole,Gel,Topical,02092832,METROGEL 0.75% (metronidazole 0.75 % cutaneous gel) GALDERMA CANADA INC.,Active,9000534,metronidazole 0.75 % cutaneous gel,8000038,metronidazole,448598008,Cutaneous,385100002,Gel,,,,,
19257,Marketed,2019-05-07,02156091,NORITATE,1.0,D06BX01,Metronidazole,Cream,Topical,02156091,"NORITATE (metronidazole 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000616,metronidazole 1 % cutaneous cream,8000038,metronidazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
72917,Marketed,2018-04-26,02248562,APO-METRONIDAZOLE,1.0,P01AB01,Metronidazole,Capsule,Oral,02248562,APO-METRONIDAZOLE (metronidazole 500 mg oral capsule) APOTEX INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
78314,Marketed,2007-12-20,02297809,METROGEL 1%,1.0,D06BX01,Metronidazole,Gel,Topical,02297809,METROGEL 1% (metronidazole 1 % cutaneous gel) GALDERMA CANADA INC.,Active,9001230,metronidazole 1 % cutaneous gel,8000038,metronidazole,448598008,Cutaneous,385100002,Gel,,,,,
95926,Marketed,2018-04-03,02470284,AURO-METRONIDAZOLE,1.0,P01AB01,Metronidazole,Capsule,Oral,02470284,AURO-METRONIDAZOLE (metronidazole 500 mg oral capsule) AURO PHARMA INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100806,Marketed,2022-05-19,02518767,METRONIDAZOLE,1.0,P01AB01,Metronidazole,Capsule,Oral,02518767,METRONIDAZOLE (metronidazole 500 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100899,Marketed,2022-03-04,02519755,M-METRONIDAZOLE,1.0,P01AB01,Metronidazole,Capsule,Oral,02519755,M-METRONIDAZOLE (metronidazole 500 mg oral capsule) MANTRA PHARMA INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102350,Marketed,2023-12-21,02534592,METRONIDAZOLE,1.0,P01AB01,Metronidazole,Capsule,Oral,02534592,METRONIDAZOLE (metronidazole 500 mg oral capsule) SANIS HEALTH INC,Active,9000131,metronidazole 500 mg oral capsule,8000038,metronidazole,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102463,Marketed,2023-09-07,02535807,MINT-METRONIDAZOLE,1.0,P01AB01,Metronidazole,Tablet,Oral,02535807,MINT-METRONIDAZOLE (metronidazole 250 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000055,metronidazole 250 mg oral tablet,8000038,metronidazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49155,Marketed,2016-07-21,02230359,TEVA-MEXILETINE,1.0,C01BB02,Mexiletine,Capsule,Oral,02230359,TEVA-MEXILETINE (mexiletine hydrochloride 100 mg oral capsule) TEVA CANADA LIMITED,Active,9012842,mexiletine hydrochloride 100 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
49157,Marketed,2016-07-21,02230360,TEVA-MEXILETINE,1.0,C01BB02,Mexiletine,Capsule,Oral,02230360,TEVA-MEXILETINE (mexiletine hydrochloride 200 mg oral capsule) TEVA CANADA LIMITED,Active,9012843,mexiletine hydrochloride 200 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102557,Marketed,2024-04-08,02536846,MINT-MEXILETINE,1.0,C01BB02,Mexiletine,Capsule,Oral,02536846,MINT-MEXILETINE (mexiletine hydrochloride 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012842,mexiletine hydrochloride 100 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102558,Marketed,2024-01-18,02536854,MINT-MEXILETINE,1.0,C01BB02,Mexiletine,Capsule,Oral,02536854,MINT-MEXILETINE (mexiletine hydrochloride 200 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9012843,mexiletine hydrochloride 200 mg oral capsule,8001499,mexiletine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77957,Marketed,2025-03-20,02294222,MYCAMINE,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,02294222,MYCAMINE (micafungin sodium 50 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004329,micafungin sodium 50 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79665,Marketed,2025-03-25,02311054,MYCAMINE,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,02311054,MYCAMINE (micafungin sodium 100 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004610,micafungin sodium 100 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101398,Marketed,2023-07-17,02524953,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
101399,Marketed,2023-07-17,02524961,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
102138,Marketed,2023-05-29,02532344,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,02532344,MICAFUNGIN SODIUM FOR INJECTION (micafungin sodium 50 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004329,micafungin sodium 50 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102140,Marketed,2023-05-29,02532360,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,02532360,MICAFUNGIN SODIUM FOR INJECTION (micafungin sodium 100 mg per vial powder for solution for injection) HIKMA CANADA LIMITED,Active,9004610,micafungin sodium 100 mg per vial powder for solution for injection,8001216,micafungin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103585,Marketed,2024-12-12,02547228,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
103586,Marketed,2024-11-19,02547236,MICAFUNGIN SODIUM FOR INJECTION,1.0,J02AX05,Micafungin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
16608,Marketed,2012-10-10,02084309,MONISTAT 7 VAGINAL CREAM,1.0,G01AF04,Miconazole,Cream,Vaginal,02084309,"MONISTAT 7 VAGINAL CREAM (miconazole nitrate 2 % vaginal cream) INSIGHT PHARMACEUTICALS, LLC",Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
16609,Marketed,2021-09-10,02085852,MICATIN MICONAZOLE NITRATE CREAM 2% USP,1.0,D01AC02,Miconazole,Cream,Topical,02085852,MICATIN MICONAZOLE NITRATE CREAM 2% USP (miconazole nitrate 2 % cutaneous cream) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9001719,miconazole nitrate 2 % cutaneous cream,8001401,miconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
16611,Marketed,2012-12-11,02126257,MONISTAT 7 DUAL-PAK,2.0,G01AF04,Miconazole,"Cream,Suppository","Topical,Vaginal",02126257,"MONISTAT 7 DUAL-PAK (miconazole nitrate 100 mg pessary with miconazole nitrate 2 % cutaneous cream) INSIGHT PHARMACEUTICALS, LLC",Active,9012844,miconazole nitrate 100 mg pessary with miconazole nitrate 2 % cutaneous cream,8001401,miconazole,6064005,Topical,419179001,Kit,733007009,Pessary,,,
17832,Marketed,2012-08-30,02126567,MONISTAT DERM CREAM,1.0,D01AC02,Miconazole,Cream,Topical,02126567,"MONISTAT DERM CREAM (miconazole nitrate 2 % cutaneous cream) INSIGHT PHARMACEUTICALS, LLC",Active,9001719,miconazole nitrate 2 % cutaneous cream,8001401,miconazole,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
19677,Marketed,2002-02-28,02171775,MICONAZOLE 3 DAY OVULE TREATMENT 400MG,1.0,G01AF04,Miconazole,Suppository,Vaginal,02171775,MICONAZOLE 3 DAY OVULE TREATMENT 400MG (miconazole nitrate 400 mg pessary) VITA HEALTH PRODUCTS INC,Active,9001912,miconazole nitrate 400 mg pessary,8001401,miconazole,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,
49064,Marketed,2008-10-10,02230304,MICATIN POWDER SPRAY   - UNSCENTED 2%,1.0,D01AC02,Miconazole,Aerosol,Topical,02230304,MICATIN POWDER SPRAY   - UNSCENTED 2% (miconazole nitrate 2 % cutaneous spray) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9003106,miconazole nitrate 2 % cutaneous spray,8001401,miconazole,448598008,Cutaneous,421720008,Spray,,,,,
50876,Marketed,1997-08-12,02231533,"MICONAZOLE NITRATE VAGINAL CREAM USP, 2%",1.0,G01AF04,Miconazole,Cream,Vaginal,02231533,"MICONAZOLE NITRATE VAGINAL CREAM USP, 2% (miconazole nitrate 2 % vaginal cream) TARO PHARMACEUTICALS INC",Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
67948,Marketed,2012-11-02,02244005,MONISTAT 3 VAGINAL CREAM,1.0,G01AF04,Miconazole,Cream,Vaginal,02244005,"MONISTAT 3 VAGINAL CREAM (miconazole nitrate 4 % vaginal cream) INSIGHT PHARMACEUTICALS, LLC",Active,9003654,miconazole nitrate 4 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
69637,Marketed,2003-03-13,02245546,MICONAZOLE NITRATE VAGINAL CREAM 2%,1.0,G01AF04,Miconazole,Cream,Vaginal,02245546,MICONAZOLE NITRATE VAGINAL CREAM 2% (miconazole nitrate 2 % vaginal cream) VITA HEALTH PRODUCTS INC,Active,9001814,miconazole nitrate 2 % vaginal cream,8001401,miconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
67049,Marketed,2009-08-04,02243173,DEFINITY,1.0,V08DA04,Microspheres of phospholipids,Suspension,Intravenous,,,,,,,,,,,,,,,,
63823,Marketed,2005-10-06,02240285,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700595,MIDAZOLAM INJECTION (midazolam 5 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63823,Marketed,2005-10-06,02240285,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700596,MIDAZOLAM INJECTION (midazolam 2 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63823,Marketed,2005-10-06,02240285,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700597,MIDAZOLAM INJECTION (midazolam 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63824,Marketed,2005-10-06,02240286,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700598,MIDAZOLAM INJECTION (midazolam 10 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63824,Marketed,2005-10-06,02240286,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700599,MIDAZOLAM INJECTION (midazolam 5 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63824,Marketed,2005-10-06,02240286,MIDAZOLAM INJECTION,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700600,MIDAZOLAM INJECTION (midazolam 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66736,Marketed,2025-06-09,02242904,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700603,"MIDAZOLAM INJECTION, USP (midazolam 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66736,Marketed,2025-06-09,02242904,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700604,"MIDAZOLAM INJECTION, USP (midazolam 2 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66736,Marketed,2025-06-09,02242904,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700605,"MIDAZOLAM INJECTION, USP (midazolam 5 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66737,Marketed,2025-06-09,02242905,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700606,"MIDAZOLAM INJECTION, USP (midazolam 5 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66737,Marketed,2025-06-09,02242905,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700607,"MIDAZOLAM INJECTION, USP (midazolam 10 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66737,Marketed,2025-06-09,02242905,"MIDAZOLAM INJECTION, USP",1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700608,"MIDAZOLAM INJECTION, USP (midazolam 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86819,Marketed,2017-10-25,02382342,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700611,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9012740,midazolam 5 mg per 5 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86819,Marketed,2017-10-25,02382342,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",77700612,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 2 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012736,midazolam 2 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86821,Marketed,2017-10-25,02382350,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700613,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 5 mg per 1 mL solution for injection vial) PFIZER CANADA ULC,Active,9012738,midazolam 5 mg per 1 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86821,Marketed,2017-10-25,02382350,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",77700614,MIDAZOLAM INJECTION USP PRESERVATIVE-FREE (midazolam 10 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9012733,midazolam 10 mg per 2 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86822,Marketed,2017-10-25,02382377,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intravenous,Intramuscular",02382377,MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012731,midazolam 10 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86823,Marketed,2017-10-25,02382385,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,"Intramuscular,Intravenous",02382385,MIDAZOLAM INJECTION USP WITH PRESERVATIVE (midazolam 50 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012742,midazolam 50 mg per 10 mL solution for injection vial,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98782,Marketed,2020-10-26,02498022,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,Intravenous,02498022,MIDAZOLAM INJECTION USP (midazolam 100 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014405,midazolam 100 mg per 100 mL solution for injection bag,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
104206,Marketed,2025-12-04,02553104,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,Intravenous,77701195,MIDAZOLAM INJECTION USP (midazolam 50 mg per 50 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9015320,midazolam 50 mg per 50 mL solution for injection bag,8001107,midazolam,738984000,Injection,385219001,Solution for injection,732982009,Bag,,,
104206,Marketed,2025-12-04,02553104,MIDAZOLAM INJECTION USP,1.0,N05CD08,Midazolam,Solution,Intravenous,77701196,MIDAZOLAM INJECTION USP (midazolam 100 mg per 100 mL solution for injection bag) HIKMA CANADA LIMITED,Active,9014405,midazolam 100 mg per 100 mL solution for injection bag,8001107,midazolam,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
76425,Marketed,2018-12-10,02278677,APO-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02278677,APO-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) APOTEX INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76426,Marketed,2018-12-10,02278685,APO-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02278685,APO-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) APOTEX INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96400,Marketed,2018-08-03,02473984,MAR-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02473984,MAR-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96401,Marketed,2018-08-03,02473992,MAR-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02473992,MAR-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100707,Marketed,2022-02-21,02517701,JAMP MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02517701,JAMP MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100708,Marketed,2025-08-07,02517728,JAMP MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02517728,JAMP MIDODRINE (midodrine hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102221,Marketed,2023-05-31,02533200,MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02533200,MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) SANIS HEALTH INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102222,Marketed,2023-05-31,02533219,MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02533219,MIDODRINE (midodrine hydrochloride 5 mg oral tablet) SANIS HEALTH INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103576,Marketed,2024-10-23,02547112,M-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02547112,M-MIDODRINE (midodrine hydrochloride 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9004172,midodrine hydrochloride 2.5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103577,Marketed,2024-12-17,02547120,M-MIDODRINE,1.0,C01CA17,Midodrine,Tablet,Oral,02547120,M-MIDODRINE (midodrine hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9004173,midodrine hydrochloride 5 mg oral tablet,8001402,midodrine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95454,Marketed,2017-09-08,02466236,RYDAPT,1.0,L01EX10,Midostaurin,Capsule,Oral,02466236,RYDAPT (midostaurin 25 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014642,midostaurin 25 mg oral capsule,8002404,midostaurin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92881,Marketed,2017-01-10,02444038,MIFEGYMISO,2.0,G03XB51,"Mifepristone, combinations","Tablet,Kit","Buccal,Oral",02444038,MIFEGYMISO (mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet) LINEPHARMA INTERNATIONAL LIMITED,Active,9013785,mifepristone 200 mg oral tablet with misoprostol 200 mcg buccal tablet,8001020,mifepristone and misoprostol,54471007,Buccal,385085006,Buccal tablet,732936001,Tablet (unit of presentation),1.0,,
95640,Marketed,2023-08-03,02468042,GALAFOLD,1.0,A16AX14,Migalastat,Capsule,Oral,02468042,GALAFOLD (migalastat (migalastat hydrochloride) 123 mg oral capsule) AMICUS THERAPEUTICS CANADA INC.,Active,9012519,migalastat (migalastat hydrochloride) 123 mg oral capsule,8001151,migalastat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
73533,Marketed,2020-02-04,02250519,ZAVESCA,1.0,A16AX06,Miglustat,Capsule,Oral,02250519,ZAVESCA (miglustat 100 mg oral capsule) JANSSEN INC,Active,9003909,miglustat 100 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94314,Marketed,2020-04-20,02456257,SANDOZ MIGLUSTAT,1.0,A16AX06,Miglustat,Capsule,Oral,02456257,SANDOZ MIGLUSTAT (miglustat 100 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9003909,miglustat 100 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106020,Marketed,2025-12-05,02556812,OPFOLDA,1.0,A16AX06,Miglustat,Capsule,Oral,02556812,OPFOLDA (miglustat 65 mg oral capsule) AMICUS THERAPEUTICS CANADA INC.,Active,9015321,miglustat 65 mg oral capsule,8001858,miglustat,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
68609,Marketed,2022-11-02,02244622,"MILRINONE LACTATE INJECTION, USP",1.0,C01CE02,Milrinone,Solution,Intravenous,77700728,"MILRINONE LACTATE INJECTION, USP (milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013234,milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
68609,Marketed,2022-11-02,02244622,"MILRINONE LACTATE INJECTION, USP",1.0,C01CE02,Milrinone,Solution,Intravenous,77700729,"MILRINONE LACTATE INJECTION, USP (milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013235,milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101060,Marketed,2023-05-31,02521407,MILRINONE LACTATE INJECTION USP,1.0,C01CE02,Milrinone,Solution,Intravenous,77701125,MILRINONE LACTATE INJECTION USP (milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013234,milrinone (milrinone lactate) 10 mg per 10 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101060,Marketed,2023-05-31,02521407,MILRINONE LACTATE INJECTION USP,1.0,C01CE02,Milrinone,Solution,Intravenous,77701126,MILRINONE LACTATE INJECTION USP (milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013235,milrinone (milrinone lactate) 20 mg per 20 mL solution for injection vial,8001859,milrinone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
9351,Marketed,2013-05-22,00777838,PEGLYTE POWDER,5.0,A06AD10,Mineral salts in combination,Powder for solution,Oral,,,,,,,,,,,,,,,,
15925,Marketed,2020-01-03,02084104,MINOCYCLINE,1.0,J01AA08,Minocycline,Capsule,Oral,02084104,MINOCYCLINE (minocycline (minocycline hydrochloride) 100 mg oral capsule) AA PHARMA INC,Active,9000536,minocycline (minocycline hydrochloride) 100 mg oral capsule,8000205,minocycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
15927,Marketed,2019-12-20,02084090,MINOCYCLINE,1.0,J01AA08,Minocycline,Capsule,Oral,02084090,MINOCYCLINE (minocycline (minocycline hydrochloride) 50 mg oral capsule) AA PHARMA INC,Active,9000537,minocycline (minocycline hydrochloride) 50 mg oral capsule,8000205,minocycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
76380,Marketed,2011-01-20,02278219,ARESTIN MICROSPHERES,1.0,A01AB23,Minocycline,Powder (extended release),Subgingival,02278219,ARESTIN MICROSPHERES (minocycline (minocycline hydrochloride) 1 mg per 4 mg prolonged-release periodontal powder) ORA PHARMA INC.,Active,9001254,minocycline (minocycline hydrochloride) 1 mg per 4 mg prolonged-release periodontal powder,8000205,minocycline,447052000,Periodontal,739005008,Powder,,,,,
4010,Marketed,2006-03-09,00514500,LONITEN 10MG,1.0,C02DC01,Minoxidil,Tablet,Oral,00514500,LONITEN 10MG (minoxidil 10 mg oral tablet) PFIZER CANADA ULC,Active,9010663,minoxidil 10 mg oral tablet,8000824,minoxidil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4011,Marketed,2005-11-21,00514497,LONITEN 2.5MG,1.0,C02DC01,Minoxidil,Tablet,Oral,00514497,LONITEN 2.5MG (minoxidil 2.5 mg oral tablet) PFIZER CANADA ULC,Active,9010664,minoxidil 2.5 mg oral tablet,8000824,minoxidil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7084,Marketed,2025-12-24,00708925,MEN'S ROGAINE,1.0,D11AX01,"Minoxidil, topical",Solution,Topical,00708925,MEN'S ROGAINE (minoxidil 20 mg per mL cutaneous solution) KENVUE CANADA INC.,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
84173,Marketed,2011-04-15,02356597,HAIR REGROWTH FORMULA,1.0,D11AX01,"Minoxidil, topical",Solution,Topical,02356597,HAIR REGROWTH FORMULA (minoxidil 20 mg per mL cutaneous solution) VITA HEALTH PRODUCTS INC,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
85367,Marketed,2025-12-24,02368684,MEN'S ROGAINE FOAM 5%,1.0,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02368684,MEN'S ROGAINE FOAM 5% (minoxidil 5 % cutaneous foam) KENVUE CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,
90937,Marketed,2025-12-24,02424703,WOMEN'S ROGAINE FOAM 5%,1.0,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02424703,WOMEN'S ROGAINE FOAM 5% (minoxidil 5 % cutaneous foam) KENVUE CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,
101842,Marketed,2023-09-19,02529238,JAMP MINOXIDIL SOLUTION,1.0,D11AX01,"Minoxidil, topical",Solution,Topical,02529238,JAMP MINOXIDIL SOLUTION (minoxidil 20 mg per mL cutaneous solution) JAMP PHARMA CORPORATION,Active,9010665,minoxidil 20 mg per mL cutaneous solution,8000824,minoxidil,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
104015,Marketed,2025-03-04,02551446,MEN'S MINOXIDIL FOAM,1.0,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02551446,MEN'S MINOXIDIL FOAM (minoxidil 5 % cutaneous foam) TARO PHARMACEUTICALS INC,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,
104038,Marketed,2025-03-04,02551659,WOMEN'S MINOXIDIL FOAM,1.0,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02551659,WOMEN'S MINOXIDIL FOAM (minoxidil 5 % cutaneous foam) TARO PHARMACEUTICALS INC,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,
104240,Marketed,2025-07-04,02553465,MEN'S GLN-MINOXIDIL,1.0,D11AX01,"Minoxidil, topical","Aerosol, foam",Topical,02553465,MEN'S GLN-MINOXIDIL (minoxidil 5 % cutaneous foam) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9010666,minoxidil 5 % cutaneous foam,8000824,minoxidil,448598008,Cutaneous,421166008,Foam,,,,,
88771,Marketed,2013-03-28,02402882,MYRBETRIQ,1.0,G04BD12,Mirabegron,Tablet (extended-release),Oral,02402882,MYRBETRIQ (mirabegron 50 mg prolonged-release oral tablet) ASTELLAS PHARMA CANADA INC,Active,9005210,mirabegron 50 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102858,Marketed,2025-10-22,02539845,OMVOH,1.0,L04AC24,Mirikizumab,Solution,Subcutaneous,02539845,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen) ELI LILLY CANADA INC,Active,9014981,mirikizumab 100 mg per 1 mL solution for injection pen,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
102859,Marketed,2025-10-22,02539853,OMVOH,1.0,L04AC24,Mirikizumab,Solution,Subcutaneous,02539853,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9014982,mirikizumab 100 mg per 1 mL solution for injection syringe,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102860,Marketed,2023-10-03,02539861,OMVOH,1.0,L04AC24,Mirikizumab,Solution,Intravenous,02539861,OMVOH (mirikizumab 300 mg per 15 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014944,mirikizumab 300 mg per 15 mL solution for injection vial,8002483,mirikizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106238,Marketed,2025-10-22,02559218,OMVOH,1.0,L04AC24,Mirikizumab,Solution,Subcutaneous,02559218,OMVOH (mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015285,mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,
106239,Marketed,2025-10-22,02559226,OMVOH,1.0,L04AC24,Mirikizumab,Solution,Subcutaneous,02559226,OMVOH (mirikizumab 200 mL per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015286,mirikizumab 200 mL per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
106240,Marketed,2025-10-22,02559234,OMVOH,2.0,L04AC24,Mirikizumab,Kit,Subcutaneous,02559234,OMVOH (mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe) ELI LILLY CANADA INC,Active,9015284,mirikizumab 100 mg per 1 mL solution for injection syringe with mirikizumab 200 mg per 2 mL solution for injection syringe,8002483,mirikizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
106241,Marketed,2025-10-22,02559242,OMVOH,2.0,L04AC24,Mirikizumab,Kit,Subcutaneous,02559242,OMVOH (mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen) ELI LILLY CANADA INC,Active,9015283,mirikizumab 100 mg per 1 mL solution for injection pen with mirikizumab 200 mg per 2 mL solution for injection pen,8002483,mirikizumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,
67852,Marketed,2022-05-17,02243910,REMERON,1.0,N06AX11,Mirtazapine,Tablet,Oral,02243910,REMERON (mirtazapine 30 mg oral tablet) ORGANON CANADA INC.,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72897,Marketed,2022-05-24,02248542,REMERON RD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248542,REMERON RD (mirtazapine 15 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001061,mirtazapine 15 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
72898,Marketed,2022-08-04,02248543,REMERON RD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248543,REMERON RD (mirtazapine 30 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001062,mirtazapine 30 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
72899,Marketed,2022-11-04,02248544,REMERON RD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02248544,REMERON RD (mirtazapine 45 mg orodispersible tablet) ORGANON CANADA INC.,Active,9001063,mirtazapine 45 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
73540,Marketed,2006-01-27,02250594,SANDOZ MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02250594,SANDOZ MIRTAZAPINE (mirtazapine 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73541,Marketed,2006-01-27,02250608,SANDOZ MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02250608,SANDOZ MIRTAZAPINE (mirtazapine 30 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74133,Marketed,2009-10-21,02256096,MYLAN-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02256096,MYLAN-MIRTAZAPINE (mirtazapine 15 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74134,Marketed,2009-10-09,02256118,MYLAN-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02256118,MYLAN-MIRTAZAPINE (mirtazapine 30 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74135,Marketed,2010-10-20,02256126,MYLAN-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02256126,MYLAN-MIRTAZAPINE (mirtazapine 45 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74461,Marketed,2023-09-18,02259354,TEVA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02259354,TEVA-MIRTAZAPINE (mirtazapine 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77206,Marketed,2006-10-04,02286610,APO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02286610,APO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) APOTEX INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77207,Marketed,2006-10-04,02286629,APO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02286629,APO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) APOTEX INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77208,Marketed,2006-10-04,02286637,APO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02286637,APO-MIRTAZAPINE (mirtazapine 45 mg oral tablet) APOTEX INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78516,Marketed,2010-12-20,02299801,AURO-MIRTAZAPINE OD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299801,AURO-MIRTAZAPINE OD (mirtazapine 15 mg orodispersible tablet) AURO PHARMA INC,Active,9001061,mirtazapine 15 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
78517,Marketed,2010-12-20,02299828,AURO-MIRTAZAPINE OD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299828,AURO-MIRTAZAPINE OD (mirtazapine 30 mg orodispersible tablet) AURO PHARMA INC,Active,9001062,mirtazapine 30 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
78518,Marketed,2010-12-20,02299836,AURO-MIRTAZAPINE OD,1.0,N06AX11,Mirtazapine,Tablet (orally disintegrating),Oral,02299836,AURO-MIRTAZAPINE OD (mirtazapine 45 mg orodispersible tablet) AURO PHARMA INC,Active,9001063,mirtazapine 45 mg orodispersible tablet,8000298,mirtazapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
79829,Marketed,2024-03-11,02312778,PRO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02312778,PRO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) PRO DOC LIMITEE,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79830,Marketed,2024-03-11,02312786,PRO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02312786,PRO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) PRO DOC LIMITEE,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85581,Marketed,2025-10-28,02370689,MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02370689,MIRTAZAPINE (mirtazapine 30 mg oral tablet) SANIS HEALTH INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89629,Marketed,2013-10-16,02411695,AURO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02411695,AURO-MIRTAZAPINE (mirtazapine 15 mg oral tablet) AURO PHARMA INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89630,Marketed,2013-10-16,02411709,AURO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02411709,AURO-MIRTAZAPINE (mirtazapine 30 mg oral tablet) AURO PHARMA INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89632,Marketed,2013-10-16,02411717,AURO-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02411717,AURO-MIRTAZAPINE (mirtazapine 45 mg oral tablet) AURO PHARMA INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98652,Marketed,2020-10-22,02496666,MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02496666,MIRTAZAPINE (mirtazapine 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98653,Marketed,2020-10-22,02496674,MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02496674,MIRTAZAPINE (mirtazapine 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98654,Marketed,2020-10-22,02496682,MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02496682,MIRTAZAPINE (mirtazapine 45 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102170,Marketed,2023-10-12,02532689,MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02532689,MIRTAZAPINE (mirtazapine 15 mg oral tablet) SANIS HEALTH INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102381,Marketed,2023-07-27,02534924,NRA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02534924,NRA-MIRTAZAPINE (mirtazapine 15 mg oral tablet) NORA PHARMA INC,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102382,Marketed,2023-07-27,02534932,NRA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02534932,NRA-MIRTAZAPINE (mirtazapine 30 mg oral tablet) NORA PHARMA INC,Active,9000940,mirtazapine 30 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102383,Marketed,2023-07-27,02534940,NRA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02534940,NRA-MIRTAZAPINE (mirtazapine 45 mg oral tablet) NORA PHARMA INC,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103021,Marketed,2024-09-03,02541572,TEVA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02541572,TEVA-MIRTAZAPINE (mirtazapine 15 mg oral tablet) TEVA CANADA LIMITED,Active,9001075,mirtazapine 15 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103022,Marketed,2024-09-03,02541580,TEVA-MIRTAZAPINE,1.0,N06AX11,Mirtazapine,Tablet,Oral,02541580,TEVA-MIRTAZAPINE (mirtazapine 45 mg oral tablet) TEVA CANADA LIMITED,Active,9001088,mirtazapine 45 mg oral tablet,8000298,mirtazapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106381,Marketed,2026-01-09,02560771,ELAHERE,1.0,L01FX26,Mirvetuximab soravtansine,Solution,Intravenous,,,,,,,,,,,,,,1.0,,
67965,Marketed,2011-12-14,02244022,MISOPROSTOL,1.0,A02BB01,Misoprostol,Tablet,Oral,02244022,MISOPROSTOL (misoprostol 100 mcg oral tablet) AA PHARMA INC,Active,9003613,misoprostol 100 mcg oral tablet,8000921,misoprostol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
67966,Marketed,2011-08-06,02244023,MISOPROSTOL,1.0,A02BB01,Misoprostol,Tablet,Oral,02244023,MISOPROSTOL (misoprostol 200 mcg oral tablet) AA PHARMA INC,Active,9003614,misoprostol 200 mcg oral tablet,8000921,misoprostol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
49400,Marketed,2012-09-27,02230451,MITOMYCIN FOR INJECTION,1.0,L01DC03,Mitomycin,Powder for solution,"Intravesical,Intravenous",02230451,MITOMYCIN FOR INJECTION (mitomycin 20 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95282,Marketed,2018-04-30,02464691,MITOMYCIN FOR INJECTION USP,1.0,L01DC03,Mitomycin,Powder for solution,"Intravenous,Intravesical",02464691,MITOMYCIN FOR INJECTION USP (mitomycin 20 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
102103,Marketed,2023-02-27,02531941,"MITOMYCIN FOR INJECTION, USP",1.0,L01DC03,Mitomycin,Powder for solution,"Intravenous,Intravesical",02531941,"MITOMYCIN FOR INJECTION, USP (mitomycin 20 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9003172,mitomycin 20 mg per vial powder for solution for injection,8001860,mitomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
3348,Marketed,2025-06-26,00463221,LYSODREN,1.0,L01XX23,Mitotane,Tablet,Oral,00463221,LYSODREN (mitotane 500 mg oral tablet) ESTEVE PHARMACEUTICALS S.A.,Active,9001853,mitotane 500 mg oral tablet,8001861,mitotane,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77176,Marketed,2015-12-30,02286300,MITOXANTRONE INJECTION,1.0,L01DB07,Mitoxantrone,Solution,Intravenous,02286300,MITOXANTRONE INJECTION (mitoxantrone (mitoxantrone hydrochloride) 20 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013236,mitoxantrone (mitoxantrone hydrochloride) 20 mg per 10 mL solution for injection vial,8001862,mitoxantrone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
13256,Marketed,2021-06-24,00899356,MANERIX,1.0,N06AG02,Moclobemide,Tablet,Oral,00899356,"MANERIX (moclobemide 150 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002480,moclobemide 150 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18969,Marketed,2021-06-24,02166747,MANERIX,1.0,N06AG02,Moclobemide,Tablet,Oral,02166747,"MANERIX (moclobemide 300 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002850,moclobemide 300 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51594,Marketed,2018-03-27,02232148,MOCLOBEMIDE,1.0,N06AG02,Moclobemide,Tablet,Oral,02232148,MOCLOBEMIDE (moclobemide 100 mg oral tablet) AA PHARMA INC,Active,9003151,moclobemide 100 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
51595,Marketed,2018-05-24,02232150,MOCLOBEMIDE,1.0,N06AG02,Moclobemide,Tablet,Oral,02232150,MOCLOBEMIDE (moclobemide 150 mg oral tablet) AA PHARMA INC,Active,9002480,moclobemide 150 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64019,Marketed,2017-11-14,02240456,MOCLOBEMIDE,1.0,N06AG02,Moclobemide,Tablet,Oral,02240456,MOCLOBEMIDE (moclobemide 300 mg oral tablet) AA PHARMA INC,Active,9002850,moclobemide 300 mg oral tablet,8001668,moclobemide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63139,Marketed,2014-11-20,02239665,ALERTEC,1.0,N06BA07,Modafinil,Tablet,Oral,02239665,ALERTEC (modafinil 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77089,Marketed,2014-09-19,02285398,APO-MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02285398,APO-MODAFINIL (modafinil 100 mg oral tablet) APOTEX INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90485,Marketed,2014-07-02,02420260,TEVA-MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02420260,TEVA-MODAFINIL (modafinil 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91494,Marketed,2014-10-24,02430487,AURO-MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02430487,AURO-MODAFINIL (modafinil 100 mg oral tablet) AURO PHARMA INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91701,Marketed,2015-01-09,02432560,MAR-MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02432560,MAR-MODAFINIL (modafinil 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99317,Marketed,2021-03-11,02503727,JAMP MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02503727,JAMP MODAFINIL (modafinil 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101944,Marketed,2022-12-19,02530244,MODAFINIL,1.0,N06BA07,Modafinil,Tablet,Oral,02530244,MODAFINIL (modafinil 100 mg oral tablet) SANIS HEALTH INC,Active,9003367,modafinil 100 mg oral tablet,8001863,modafinil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101691,Marketed,2024-03-27,02527715,POTELIGEO,1.0,L01FX09,Mogamulizumab,Solution,Intravenous,02527715,"POTELIGEO (mogamulizumab 20 mg per 5 mL solution for injection vial) KYOWA KIRIN, INC.",Active,9015047,mogamulizumab 20 mg per 5 mL solution for injection vial,8002506,mogamulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104193,Marketed,2025-01-21,02552965,OJJAARA,1.0,L01EJ04,Momelotinib,Tablet,Oral,02552965,OJJAARA (momelotinib (momelotinib dihydrochloride) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015150,momelotinib (momelotinib dihydrochloride) 100 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
104194,Marketed,2025-01-21,02552973,OJJAARA,1.0,L01EJ04,Momelotinib,Tablet,Oral,02552973,OJJAARA (momelotinib (momelotinib dihydrochloride) 150 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015151,momelotinib (momelotinib dihydrochloride) 150 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
104195,Marketed,2025-01-21,02552981,OJJAARA,1.0,L01EJ04,Momelotinib,Tablet,Oral,02552981,OJJAARA (momelotinib (momelotinib dihydrochloride) 200 mg oral tablet) GLAXOSMITHKLINE INC,Active,9015152,momelotinib (momelotinib dihydrochloride) 200 mg oral tablet,8002528,momelotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
11196,Marketed,2023-05-23,00851744,ELOCOM,1.0,D07AC13,Mometasone,Cream,Topical,00851744,ELOCOM (mometasone furoate 0.1 % cutaneous cream) ORGANON CANADA INC.,Active,9000386,mometasone furoate 0.1 % cutaneous cream,8000148,mometasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
11443,Marketed,2022-06-21,00871095,ELOCOM,1.0,D07AC13,Mometasone,Lotion,Topical,00871095,ELOCOM (mometasone furoate 0.1 % lotion) ORGANON CANADA INC.,Active,9006222,mometasone furoate 0.1 % lotion,8000148,mometasone,448598008,Cutaneous,739000003,Lotion,,,,,
11444,Marketed,2022-08-18,00851736,ELOCOM,1.0,D07AC13,Mometasone,Ointment,Topical,00851736,ELOCOM (mometasone furoate 0.1 % cutaneous ointment) ORGANON CANADA INC.,Active,9000387,mometasone furoate 0.1 % cutaneous ointment,8000148,mometasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
61885,Marketed,2022-04-14,02238465,NASONEX,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02238465,NASONEX (mometasone furoate 50 mcg per actuation nasal spray) ORGANON CANADA INC.,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
67513,Marketed,2022-08-12,02243595,ASMANEX TWISTHALER,1.0,R03BA07,Mometasone,Powder,Inhalation,02243595,ASMANEX TWISTHALER (mometasone furoate 200 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001370,mometasone furoate 200 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
67514,Marketed,2022-01-04,02243596,ASMANEX TWISTHALER,1.0,R03BA07,Mometasone,Powder,Inhalation,02243596,ASMANEX TWISTHALER (mometasone furoate 400 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001371,mometasone furoate 400 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
72459,Marketed,2018-01-17,02248130,TEVA-MOMETASONE,1.0,D07AC13,Mometasone,Ointment,Topical,02248130,TEVA-MOMETASONE (mometasone furoate 0.1 % cutaneous ointment) TEVA CANADA LIMITED,Active,9000387,mometasone furoate 0.1 % cutaneous ointment,8000148,mometasone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
75180,Marketed,2009-12-01,02266385,TARO-MOMETASONE LOTION,1.0,D07AC13,Mometasone,Lotion,Topical,02266385,TARO-MOMETASONE LOTION (mometasone furoate 0.1 % lotion) TARO PHARMACEUTICALS INC,Active,9006222,mometasone furoate 0.1 % lotion,8000148,mometasone,448598008,Cutaneous,739000003,Lotion,,,,,
85196,Marketed,2011-06-08,02367157,TARO-MOMETASONE CREAM,1.0,D07AC13,Mometasone,Cream,Topical,02367157,TARO-MOMETASONE CREAM (mometasone furoate 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000386,mometasone furoate 0.1 % cutaneous cream,8000148,mometasone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
88837,Marketed,2013-03-25,02403587,APO-MOMETASONE,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02403587,APO-MOMETASONE (mometasone furoate 50 mcg per actuation nasal spray) APOTEX INC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
92309,Marketed,2022-08-04,02438690,ASMANEX TWISTHALER,1.0,R03BA07,Mometasone,Powder,Inhalation,02438690,ASMANEX TWISTHALER (mometasone furoate 100 mcg per actuation inhalation powder) ORGANON CANADA INC.,Active,9001441,mometasone furoate 100 mcg per actuation inhalation powder,8000148,mometasone,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
93568,Marketed,2016-07-27,02449811,SANDOZ MOMETASONE,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02449811,SANDOZ MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SANDOZ CANADA INCORPORATED,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
96662,Marketed,2018-10-02,02475863,TEVA-MOMETASONE,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02475863,TEVA-MOMETASONE (mometasone furoate 50 mcg per actuation nasal spray) TEVA CANADA LIMITED,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
100840,Marketed,2022-05-30,02519127,MOMETASONE,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02519127,MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SANIS HEALTH INC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
104047,Marketed,2025-06-06,02551756,MOMETASONE,1.0,R01AD09,Mometasone,"Spray, metered dose",Nasal,02551756,MOMETASONE (mometasone furoate (mometasone furoate monohydrate) 50 mcg per actuation nasal spray) SIVEM PHARMACEUTICALS ULC,Active,9006259,mometasone furoate 50 mcg per actuation nasal spray,8000148,mometasone,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
102033,Marketed,2023-03-17,02531186,RYALTRIS,2.0,R01AD59,"Mometasone, combinations","Spray, metered dose",Nasal,02531186,RYALTRIS (mometasone furoate (mometasone furoate monohydrate) 25 mcg per actuation and olopatadine hydrochloride 665 mcg per actuation nasal spray) GLENMARK SPECIALTY SA,Active,9014895,mometasone furoate 25 mcg per actuation and olopatadine hydrochloride 665 mcg per actuation nasal spray,8002470,mometasone and olopatadine,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
61609,Marketed,2022-06-23,02238216,SINGULAIR,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02238216,SINGULAIR (montelukast (montelukast sodium) 5 mg chewable tablet) ORGANON CANADA INC.,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
61610,Marketed,2022-09-23,02238217,SINGULAIR,1.0,R03DC03,Montelukast,Tablet,Oral,02238217,SINGULAIR (montelukast (montelukast sodium) 10 mg oral tablet) ORGANON CANADA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67521,Marketed,2022-03-28,02243602,SINGULAIR,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02243602,SINGULAIR (montelukast (montelukast sodium) 4 mg chewable tablet) ORGANON CANADA INC.,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
81411,Marketed,2011-10-11,02328593,SANDOZ MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02328593,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81612,Marketed,2011-10-11,02330385,SANDOZ MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02330385,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) SANDOZ CANADA INCORPORATED,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
81613,Marketed,2011-10-11,02330393,SANDOZ MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02330393,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SANDOZ CANADA INCORPORATED,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84016,Marketed,2011-10-11,02354977,PMS-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02354977,PMS-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) PHARMASCIENCE INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84017,Marketed,2011-10-11,02354985,PMS-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02354985,PMS-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) PHARMASCIENCE INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84073,Marketed,2011-10-11,02355507,TEVA-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02355507,TEVA-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) TEVA CANADA LIMITED,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84074,Marketed,2011-10-11,02355515,TEVA-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02355515,TEVA-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) TEVA CANADA LIMITED,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
84075,Marketed,2011-10-11,02355523,TEVA-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02355523,TEVA-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84365,Marketed,2011-10-11,02358611,SANDOZ MONTELUKAST,1.0,R03DC03,Montelukast,Granules,Oral,02358611,SANDOZ MONTELUKAST (montelukast (montelukast sodium) 4 mg per sachet oral granules) SANDOZ CANADA INCORPORATED,Active,9014703,montelukast (montelukast sodium) 4 mg per sachet oral granules,8000261,montelukast,26643006,Oral,420509004,Oral granules,733013000,Sachet (unit of presentation),,,
85916,Marketed,2011-10-11,02373947,PMS-MONTELUKAST FC,1.0,R03DC03,Montelukast,Tablet,Oral,02373947,PMS-MONTELUKAST FC (montelukast (montelukast sodium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85993,Marketed,2020-02-26,02374609,APO-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02374609,APO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) APOTEX INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86341,Marketed,2020-04-01,02377608,APO-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02377608,APO-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) APOTEX INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86342,Marketed,2020-04-01,02377616,APO-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02377616,APO-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) APOTEX INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86511,Marketed,2023-01-25,02379236,ACH-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02379236,ACH-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86520,Marketed,2022-09-28,02379325,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02379325,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SANIS HEALTH INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86521,Marketed,2022-09-20,02379333,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02379333,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SANIS HEALTH INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86569,Marketed,2012-03-29,02379821,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02379821,MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) PRO DOC LIMITEE,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86570,Marketed,2012-03-29,02379848,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02379848,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) PRO DOC LIMITEE,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86571,Marketed,2012-03-29,02379856,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02379856,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86829,Marketed,2018-03-26,02382458,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02382458,MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) SIVEM PHARMACEUTICALS ULC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86830,Marketed,2018-03-26,02382466,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02382466,MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) SIVEM PHARMACEUTICALS ULC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
86831,Marketed,2018-03-26,02382474,MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02382474,MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87502,Marketed,2025-04-15,02389517,SPC-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02389517,SPC-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87677,Marketed,2020-03-25,02391422,JAMP-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02391422,JAMP-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88374,Marketed,2026-01-21,02398826,RIVA-MONTELUKAST FC,1.0,R03DC03,Montelukast,Tablet,Oral,02398826,RIVA-MONTELUKAST FC (montelukast (montelukast sodium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88483,Marketed,2018-11-20,02399997,MAR-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02399997,MAR-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88618,Marketed,2013-03-04,02401274,AURO-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02401274,AURO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) AURO PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89336,Marketed,2013-10-17,02408627,MINT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02408627,MINT-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) MINT PHARMACEUTICALS INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
89337,Marketed,2013-10-17,02408635,MINT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02408635,MINT-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) MINT PHARMACEUTICALS INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
89338,Marketed,2013-10-17,02408643,MINT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02408643,MINT-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90752,Marketed,2022-05-10,02422867,AURO-MONTELUKAST CHEWABLE TABLET,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02422867,AURO-MONTELUKAST CHEWABLE TABLET (montelukast (montelukast sodium) 4 mg chewable tablet) AURO PHARMA INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
90753,Marketed,2022-05-10,02422875,AURO-MONTELUKAST CHEWABLE TABLET,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02422875,AURO-MONTELUKAST CHEWABLE TABLET (montelukast (montelukast sodium) 5 mg chewable tablet) AURO PHARMA INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
93101,Marketed,2024-12-05,02445735,BIO-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02445735,BIO-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) BIOMED PHARMA,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97324,Marketed,2022-12-29,02482835,AG-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02482835,AG-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97829,Marketed,2024-12-23,02488183,M-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02488183,M-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97990,Marketed,2024-06-10,02489821,NRA-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02489821,NRA-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) NORA PHARMA INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100428,Marketed,2022-08-26,02514877,JAMP MONTELUKAST CHEWABLE TABLETS,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02514877,JAMP MONTELUKAST CHEWABLE TABLETS (montelukast (montelukast sodium) 4 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
100429,Marketed,2022-08-26,02514885,JAMP MONTELUKAST CHEWABLE TABLETS,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02514885,JAMP MONTELUKAST CHEWABLE TABLETS (montelukast (montelukast sodium) 5 mg chewable tablet) JAMP PHARMA CORPORATION,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
101126,Marketed,2022-12-19,02522101,NAT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02522101,NAT-MONTELUKAST (montelukast (montelukast sodium) 4 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9000939,montelukast (montelukast sodium) 4 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
101127,Marketed,2022-12-19,02522128,NAT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet (chewable),Oral,02522128,NAT-MONTELUKAST (montelukast (montelukast sodium) 5 mg chewable tablet) NATCO PHARMA (CANADA) INC,Active,9000810,montelukast (montelukast sodium) 5 mg chewable tablet,8000261,montelukast,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
101128,Marketed,2022-12-19,02522136,NAT-MONTELUKAST,1.0,R03DC03,Montelukast,Tablet,Oral,02522136,NAT-MONTELUKAST (montelukast (montelukast sodium) 10 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9000809,montelukast (montelukast sodium) 10 mg oral tablet,8000261,montelukast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3042,Marketed,2005-08-09,00392561,MORPHINE SULFATE INJ 15MG/ML USP,1.0,N02AA01,Morphine,Liquid,"Intramuscular,Intravenous,Subcutaneous",00392561,MORPHINE SULFATE INJ 15MG/ML USP (morphine sulfate 15 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
3043,Marketed,2005-08-09,00392588,MORPHINE SULFATE INJ 10MG/ML USP,1.0,N02AA01,Morphine,Liquid,"Intramuscular,Intravenous,Subcutaneous",00392588,MORPHINE SULFATE INJ 10MG/ML USP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
6171,Marketed,2025-03-12,00614491,DOLORAL SIROP,1.0,N02AA01,Morphine,Syrup,Oral,00614491,DOLORAL SIROP (morphine hydrochloride 1 mg per mL syrup) LABORATOIRE ATLAS INC,Active,9000209,morphine hydrochloride 1 mg per mL syrup,8000071,morphine,26643006,Oral,739009002,Syrup,,,,1.0,
6754,Marketed,2025-05-07,00594644,STATEX,1.0,N02AA01,Morphine,Tablet,Oral,00594644,STATEX (morphine sulfate 10 mg oral tablet) ENDO OPERATIONS LTD.,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
6755,Marketed,2025-05-07,00594652,STATEX,1.0,N02AA01,Morphine,Tablet,Oral,00594652,STATEX (morphine sulfate 5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
7421,Marketed,2005-08-05,00617288,MORPHINE HP 50,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700347,MORPHINE HP 50 (morphine sulfate 250 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006211,morphine sulfate 250 mg per 5 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
7421,Marketed,2005-08-05,00617288,MORPHINE HP 50,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700348,MORPHINE HP 50 (morphine sulfate 500 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006212,morphine sulfate 500 mg per 10 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
7421,Marketed,2005-08-05,00617288,MORPHINE HP 50,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700349,MORPHINE HP 50 (morphine sulfate 50 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006213,morphine sulfate 50 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
7421,Marketed,2005-08-05,00617288,MORPHINE HP 50,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",77700350,MORPHINE HP 50 (morphine sulfate 50 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9006214,morphine sulfate 50 mg per mL solution for injection 50 mL vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
11597,Marketed,2025-03-12,00614505,DOLORAL SIROP,1.0,N02AA01,Morphine,Syrup,Oral,00614505,DOLORAL SIROP (morphine hydrochloride 5 mg per mL syrup) LABORATOIRE ATLAS INC,Active,9000228,morphine hydrochloride 5 mg per mL syrup,8000071,morphine,26643006,Oral,739009002,Syrup,,,,1.0,
13966,Marketed,2005-08-12,02021056,MORPHINE LP EPIDURAL,1.0,N02AA01,Morphine,Solution,"Epidural,Intravenous,Subcutaneous",02021056,MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000432,morphine sulfate 5 mg per 10 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
14020,Marketed,2005-08-12,02021048,MORPHINE LP EPIDURAL,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Epidural,Intravenous",02021048,MORPHINE LP EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000433,morphine sulfate 5 mg per 5 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
14142,Marketed,1993-12-31,02014327,MS CONTIN,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02014327,MS CONTIN (morphine sulfate 200 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
14144,Marketed,1993-12-31,02014211,MS.IR,1.0,N02AA01,Morphine,Tablet (immediate release),Oral,02014211,MS.IR (morphine sulfate 10 mg oral tablet) PURDUE PHARMA,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
14176,Marketed,1993-12-31,02014297,MS CONTIN,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02014297,MS CONTIN (morphine sulfate 30 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
14178,Marketed,1993-12-31,02014319,MS CONTIN,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02014319,MS CONTIN (morphine sulfate 100 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
14394,Marketed,1993-12-31,02014300,MS CONTIN,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02014300,MS CONTIN (morphine sulfate 60 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
14395,Marketed,1993-12-31,02015439,MS CONTIN,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02015439,MS CONTIN (morphine sulfate 15 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
14502,Marketed,2006-08-07,02019949,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02019949,M-ESLON (morphine sulfate 30 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000479,morphine sulfate 30 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
14541,Marketed,2006-08-17,02019965,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02019965,M-ESLON (morphine sulfate 100 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000474,morphine sulfate 100 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
14542,Marketed,2006-07-31,02019957,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02019957,M-ESLON (morphine sulfate 60 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000481,morphine sulfate 60 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
14543,Marketed,2006-08-22,02019930,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02019930,M-ESLON (morphine sulfate 10 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000476,morphine sulfate 10 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
16102,Marketed,1991-12-31,02014203,MS.IR,1.0,N02AA01,Morphine,Tablet (immediate release),Oral,02014203,MS.IR (morphine sulfate 5 mg oral tablet) PURDUE PHARMA,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
16480,Marketed,1991-12-31,02014238,MS.IR,1.0,N02AA01,Morphine,Tablet (immediate release),Oral,02014238,MS.IR (morphine sulfate 20 mg oral tablet) PURDUE PHARMA,Active,9000389,morphine sulfate 20 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
16481,Marketed,1991-12-31,02014254,MS.IR,1.0,N02AA01,Morphine,Tablet (immediate release),Oral,02014254,MS.IR (morphine sulfate 30 mg oral tablet) PURDUE PHARMA,Active,9000390,morphine sulfate 30 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
18877,Marketed,2006-09-05,02177757,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02177757,M-ESLON (morphine sulfate 200 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000618,morphine sulfate 200 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
18878,Marketed,2006-07-17,02177749,M-ESLON,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02177749,M-ESLON (morphine sulfate 15 mg prolonged-release oral capsule) ETHYPHARM INC,Active,9000617,morphine sulfate 15 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
42846,Marketed,2016-05-26,02184435,KADIAN,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02184435,KADIAN (morphine sulfate 20 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000665,morphine sulfate 20 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
42847,Marketed,2016-05-26,02184443,KADIAN,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02184443,KADIAN (morphine sulfate 50 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000664,morphine sulfate 50 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
42848,Marketed,2016-08-09,02184451,KADIAN,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02184451,KADIAN (morphine sulfate 100 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000474,morphine sulfate 100 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
65841,Marketed,2016-05-26,02242163,KADIAN,1.0,N02AA01,Morphine,Capsule (extended release),Oral,02242163,KADIAN (morphine sulfate 10 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000476,morphine sulfate 10 mg prolonged-release oral capsule,8000071,morphine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,1.0,
66221,Marketed,2005-08-09,02242484,MORPHINE SULFATE INJECTION USP,1.0,N02AA01,Morphine,Liquid,"Intramuscular,Subcutaneous,Intravenous",02242484,MORPHINE SULFATE INJECTION USP (morphine sulfate 2 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
68780,Marketed,2010-12-11,02244790,SANDOZ MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02244790,SANDOZ MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
68781,Marketed,2010-12-11,02244791,SANDOZ MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02244791,SANDOZ MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
68782,Marketed,2010-12-11,02244792,SANDOZ MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02244792,SANDOZ MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
78808,Marketed,2011-06-03,02302764,TEVA-MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02302764,TEVA-MORPHINE SR (morphine sulfate 15 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000477,morphine sulfate 15 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
78809,Marketed,2011-06-03,02302772,TEVA-MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02302772,TEVA-MORPHINE SR (morphine sulfate 30 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000480,morphine sulfate 30 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
78810,Marketed,2011-06-03,02302780,TEVA-MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02302780,TEVA-MORPHINE SR (morphine sulfate 60 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000482,morphine sulfate 60 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
78811,Marketed,2011-06-03,02302799,TEVA-MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02302799,TEVA-MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
78812,Marketed,2011-06-03,02302802,TEVA-MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02302802,TEVA-MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
80582,Marketed,2025-06-13,02320398,M-EDIAT,1.0,N02AA01,Morphine,Capsule (immediate release),Oral,02320398,M-EDIAT (morphine sulfate 5 mg oral capsule) ETHYPHARM INC,Active,9001466,morphine sulfate 5 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
80584,Marketed,2025-06-13,02320428,M-EDIAT,1.0,N02AA01,Morphine,Capsule (immediate release),Oral,02320428,M-EDIAT (morphine sulfate 10 mg oral capsule) ETHYPHARM INC,Active,9001463,morphine sulfate 10 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
80585,Marketed,2025-06-13,02320436,M-EDIAT,1.0,N02AA01,Morphine,Capsule (immediate release),Oral,02320436,M-EDIAT (morphine sulfate 20 mg oral capsule) ETHYPHARM INC,Active,9001464,morphine sulfate 20 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
80586,Marketed,2025-06-13,02320444,M-EDIAT,1.0,N02AA01,Morphine,Capsule (immediate release),Oral,02320444,M-EDIAT (morphine sulfate 30 mg oral capsule) ETHYPHARM INC,Active,9001465,morphine sulfate 30 mg oral capsule,8000071,morphine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,1.0,
86878,Marketed,2012-10-18,02382997,MORPHINE SULFATE INJECTION SDZ,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intravenous,Intramuscular",77700356,MORPHINE SULFATE INJECTION SDZ (morphine sulfate 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
86878,Marketed,2012-10-18,02382997,MORPHINE SULFATE INJECTION SDZ,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intravenous,Intramuscular",77700357,MORPHINE SULFATE INJECTION SDZ (morphine sulfate 50 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9001392,morphine sulfate 50 mg per 5 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
96526,Marketed,2018-09-21,02474980,MORPHINE SULFATE INJECTION BP,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",02474980,MORPHINE SULFATE INJECTION BP (morphine sulfate 10 mg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
96959,Marketed,2018-12-19,02478889,SANDOZ MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02478889,SANDOZ MORPHINE SR (morphine sulfate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000475,morphine sulfate 100 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
96961,Marketed,2018-12-19,02478897,SANDOZ MORPHINE SR,1.0,N02AA01,Morphine,Tablet (extended-release),Oral,02478897,SANDOZ MORPHINE SR (morphine sulfate 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9000478,morphine sulfate 200 mg prolonged-release oral tablet,8000071,morphine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
97311,Marketed,2019-12-17,02482681,"MORPHINE SULFATE INJECTION, USP",1.0,N02AA01,Morphine,Solution,"Intramuscular,Intravenous,Subcutaneous",02482681,"MORPHINE SULFATE INJECTION, USP (morphine sulfate 2 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
97315,Marketed,2019-12-17,02482746,"MORPHINE SULFATE INJECTION, USP",1.0,N02AA01,Morphine,Solution,"Intravenous,Intramuscular,Subcutaneous",02482746,"MORPHINE SULFATE INJECTION, USP (morphine sulfate 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014225,morphine sulfate 10 mg per 1 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98194,Marketed,2020-08-25,02491931,MORPHINE SULFATE INJECTION USP,1.0,N02AA01,Morphine,Solution,Intravenous,02491931,MORPHINE SULFATE INJECTION USP (morphine sulfate 100 mg per 100 mL solution for injection bag) STERINOVA INC.,Active,9014366,morphine sulfate 100 mg per 100 mL solution for injection bag,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,1.0,
98805,Marketed,2021-05-21,02498278,MORPHINE SULFATE INJECTION EPIDURAL,1.0,N02AA01,Morphine,Solution,Epidural,02498278,MORPHINE SULFATE INJECTION EPIDURAL (morphine sulfate 5 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014552,morphine sulfate 5 mg per 10 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
98806,Marketed,2021-06-02,02498286,MORPHINE SULFATE INJECTION EPIDURAL,1.0,N02AA01,Morphine,Solution,Epidural,02498286,MORPHINE SULFATE INJECTION EPIDURAL (morphine sulfate 5 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9006229,morphine sulfate 5 mg per 5 mL solution for injection vial,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
99036,Marketed,2021-04-29,02500701,MORPHINE SULFATE INJECTION,1.0,N02AA01,Morphine,Solution,"Intravenous,Subcutaneous,Intramuscular",02500701,MORPHINE SULFATE INJECTION (morphine sulfate 2 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000331,morphine sulfate 2 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
99037,Marketed,2021-04-29,02500728,MORPHINE SULFATE INJECTION,1.0,N02AA01,Morphine,Solution,"Intramuscular,Intravenous,Subcutaneous",02500728,MORPHINE SULFATE INJECTION (morphine sulfate 10 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
99038,Marketed,2021-04-29,02500736,MORPHINE SULFATE INJECTION,1.0,N02AA01,Morphine,Solution,"Subcutaneous,Intramuscular,Intravenous",02500736,MORPHINE SULFATE INJECTION (morphine sulfate 15 mg per 1 mL solution for injection ampoule) JAMP PHARMA CORPORATION,Active,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,8000071,morphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
103861,Marketed,2024-07-29,02549794,PMS-MORPHINE SULFATE,1.0,N02AA01,Morphine,Tablet,Oral,02549794,PMS-MORPHINE SULFATE (morphine sulfate 5 mg oral tablet) PHARMASCIENCE INC,Active,9000233,morphine sulfate 5 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
103862,Marketed,2024-07-29,02549808,PMS-MORPHINE SULFATE,1.0,N02AA01,Morphine,Tablet,Oral,02549808,PMS-MORPHINE SULFATE (morphine sulfate 10 mg oral tablet) PHARMASCIENCE INC,Active,9000229,morphine sulfate 10 mg oral tablet,8000071,morphine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
73714,Marketed,2018-03-15,02252260,VIGAMOX,1.0,S01AE07,Moxifloxacin,Solution,Ophthalmic,02252260,VIGAMOX (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
86112,Marketed,2015-11-04,02375702,TEVA-MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02375702,TEVA-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) TEVA CANADA LIMITED,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86914,Marketed,2017-11-30,02383381,SANDOZ MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02383381,SANDOZ MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88976,Marketed,2020-07-13,02404923,APO-MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02404923,APO-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) APOTEX INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89109,Marketed,2015-11-19,02406373,APO-MOXIFLOXACIN,1.0,S01AE07,Moxifloxacin,Solution,Ophthalmic,02406373,APO-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) APOTEX INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
89614,Marketed,2015-10-29,02411520,SANDOZ MOXIFLOXACIN,1.0,S01AE07,Moxifloxacin,Solution,Ophthalmic,02411520,SANDOZ MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91667,Marketed,2015-12-21,02432218,PMS-MOXIFLOXACIN,1.0,S01AE07,Moxifloxacin,Solution,Ophthalmic,02432218,PMS-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) PHARMASCIENCE INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
91672,Marketed,2015-11-04,02432242,AURO-MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02432242,AURO-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) AURO PHARMA INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91749,Marketed,2017-08-16,02433087,MOXIFLOXACIN INJECTION,1.0,J01MA14,Moxifloxacin,Solution,Intravenous,02433087,MOXIFLOXACIN INJECTION (moxifloxacin (moxifloxacin hydrochloride) 400 mg per 250 mL solution for injection 250 mL bag) FRESENIUS KABI CANADA LTD,Active,9001032,moxifloxacin (moxifloxacin hydrochloride) 400 mg per 250 mL solution for injection 250 mL bag,8000291,moxifloxacin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
92870,Marketed,2025-10-31,02443929,JAMP-MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02443929,JAMP-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95086,Marketed,2020-10-30,02462974,MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02462974,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) PRO DOC LIMITEE,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96210,Marketed,2024-01-10,02472791,M-MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02472791,M-MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) MANTRA PHARMA INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100991,Marketed,2022-04-04,02520710,MOXIFLOXACIN,1.0,J01MA14,Moxifloxacin,Tablet,Oral,02520710,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet) SANIS HEALTH INC,Active,9000923,moxifloxacin (moxifloxacin hydrochloride) 400 mg oral tablet,8000291,moxifloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101826,Marketed,2022-12-21,02529076,MOXIFLOXACIN,1.0,S01AE07,Moxifloxacin,Solution,Ophthalmic,02529076,MOXIFLOXACIN (moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops) SANIS HEALTH INC,Active,9001078,moxifloxacin (moxifloxacin hydrochloride) 0.5 % ophthalmic drops,8000291,moxifloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
1649,Marketed,2022-01-07,00263818,COTAZYM,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (immediate release),Oral,00263818,COTAZYM (amylase 40000 unit and lipase 10000 unit and protease 35000 unit oral capsule) ORGANON CANADA INC.,Active,9001695,amylase 40000 unit and lipase 10000 unit and protease 35000 unit oral capsule,8002151,pancrelipase,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
3891,Marketed,2021-11-01,00502790,COTAZYM ECS 8,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00502790,COTAZYM ECS 8 (amylase 42000 unit and lipase 10800 unit and protease 45000 unit gastro-resistant capsule) ORGANON CANADA INC.,Active,9001871,amylase 42000 unit and lipase 10800 unit and protease 45000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
9512,Marketed,2019-08-09,00789429,PANCREASE MT 16,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789429,PANCREASE MT 16 (amylase 70000 unit and lipase 16800 unit and protease 40000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002135,amylase 70000 unit and lipase 16800 unit and protease 40000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
9513,Marketed,2019-08-02,00789437,PANCREASE MT 10,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789437,PANCREASE MT 10 (amylase 43750 unit and lipase 10500 unit and protease 25000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002134,amylase 43750 unit and lipase 10500 unit and protease 25000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
9514,Marketed,2019-08-01,00789445,PANCREASE MT 4,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00789445,PANCREASE MT 4 (amylase 17500 unit and lipase 4200 unit and protease 10000 unit gastro-resistant capsule) VIVUS LLC.,Active,9002133,amylase 17500 unit and lipase 4200 unit and protease 10000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
9892,Marketed,2021-12-17,00821373,COTAZYM ECS 20,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,00821373,COTAZYM ECS 20 (amylase 100000 unit and lipase 25000 unit and protease 100000 unit gastro-resistant capsule) ORGANON CANADA INC.,Active,9002174,amylase 100000 unit and lipase 25000 unit and protease 100000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
13302,Marketed,2015-11-20,01985205,CREON MINIMICROSPHERES 25,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,01985205,CREON MINIMICROSPHERES 25 (amylase 25500 unit and lipase 25000 unit and protease 1600 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9013641,amylase 25500 unit and lipase 25000 unit and protease 1600 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
36179,Marketed,2015-11-20,02200104,CREON MINIMICROSPHERES 10,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02200104,CREON MINIMICROSPHERES 10 (amylase 11200 unit and lipase 10000 unit and protease 730 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9013640,amylase 11200 unit and lipase 10000 unit and protease 730 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
48551,Marketed,2020-07-02,02230019,VIOKACE,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Tablet,Oral,02230019,VIOKACE (amylase 56400 unit and lipase 10440 unit and protease 57100 unit oral tablet) NESTLE ENTERPRISES S.A.,Active,9003052,amylase 56400 unit and lipase 10440 unit and protease 57100 unit oral tablet,8002151,pancrelipase,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65603,Marketed,2020-07-02,02241933,VIOKACE,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Tablet,Oral,02241933,VIOKACE (amylase 113400 unit and lipase 20880 unit and protease 112500 unit oral tablet) NESTLE ENTERPRISES S.A.,Active,9003495,amylase 113400 unit and lipase 20880 unit and protease 112500 unit oral tablet,8002151,pancrelipase,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93037,Marketed,2015-11-18,02445158,CREON MINIMICROSPHERES MICRO,3.0,A09AA02,"Multienzymes (lipase, protease etc)","Granules for suspension, delayed release",Oral,02445158,CREON MINIMICROSPHERES MICRO (amylase 5100 unit per 100 mg and lipase 5000 unit per 100 mg and protease 320 unit per 100 mg gastro-resistant granules for oral suspension) BGP PHARMA ULC,Active,9013642,amylase 5100 unit per 100 mg and lipase 5000 unit per 100 mg and protease 320 unit per 100 mg gastro-resistant granules for oral suspension,8002151,pancrelipase,26643006,Oral,385029002,Granules for oral suspension,,,,,
98463,Marketed,2021-01-26,02494639,CREON MINIMICROSPHERES 35,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02494639,CREON MINIMICROSPHERES 35 (amylase 35700 unit and lipase 35000 unit and protease 2240 unit gastro-resistant capsule) BGP PHARMA ULC,Active,9014473,amylase 35700 unit and lipase 35000 unit and protease 2240 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99291,Marketed,2020-12-21,02503433,PANCREASE MT 2,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503433,PANCREASE MT 2 (amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule) VIVUS LLC.,Active,9014421,amylase 10850 unit and lipase 2600 unit and protease 6200 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
99292,Marketed,2020-12-21,02503441,PANCREASE MT 20,3.0,A09AA02,"Multienzymes (lipase, protease etc)",Capsule (delayed release),Oral,02503441,PANCREASE MT 20 (amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule) VIVUS LLC.,Active,9014422,amylase 61000 unit and lipase 21000 unit and protease 37000 unit gastro-resistant capsule,8002151,pancrelipase,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
76560,Marketed,2006-07-10,02279983,TARO-MUPIROCIN,1.0,D06AX09,Mupirocin,Ointment,Topical,02279983,TARO-MUPIROCIN (mupirocin 2 % cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9002481,mupirocin 2 % cutaneous ointment,8000866,mupirocin,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
97385,Marketed,2019-06-05,02483459,STRAMUCIN,1.0,D06AX09,Mupirocin,Cream,Topical,02483459,STRAMUCIN (mupirocin (mupirocin calcium) 2 % cutaneous cream) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9012520,mupirocin (mupirocin calcium) 2 % cutaneous cream,8000866,mupirocin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
19525,Marketed,1995-12-31,02192748,CELLCEPT,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02192748,CELLCEPT (mycophenolate mofetil 250 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
60818,Marketed,1998-11-11,02237484,CELLCEPT,1.0,L04AA06,Mycophenolic acid,Tablet,Oral,02237484,CELLCEPT (mycophenolate mofetil 500 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
63885,Marketed,1999-12-20,02240347,CELLCEPT I.V.,1.0,L04AA06,Mycophenolic acid,Powder for solution,Intravenous,02240347,CELLCEPT I.V. (mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9003442,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection,8001292,mycophenolic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
65823,Marketed,2002-08-27,02242145,CELLCEPT,1.0,L04AA06,Mycophenolic acid,Powder for suspension,Oral,02242145,CELLCEPT (mycophenolate mofetil 200 mg per mL oral suspension) HOFFMANN-LA ROCHE LIMITED,Active,9006375,mycophenolate mofetil 200 mg per mL oral suspension,8001292,mycophenolic acid,26643006,Oral,385024007,Oral suspension,,,1.0,,
75000,Marketed,2026-01-08,02264560,MYFORTIC,1.0,L04AA06,Mycophenolic acid,Tablet (delayed-release),Oral,02264560,MYFORTIC (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
75001,Marketed,2026-01-08,02264579,MYFORTIC,1.0,L04AA06,Mycophenolic acid,Tablet (delayed-release),Oral,02264579,MYFORTIC (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
79937,Marketed,2012-02-03,02313855,SANDOZ MYCOPHENOLATE MOFETIL,1.0,L04AA06,Mycophenolic acid,Tablet,Oral,02313855,SANDOZ MYCOPHENOLATE MOFETIL (mycophenolate mofetil 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80604,Marketed,2012-02-03,02320630,SANDOZ MYCOPHENOLATE MOFETIL,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02320630,SANDOZ MYCOPHENOLATE MOFETIL (mycophenolate mofetil 250 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
83402,Marketed,2017-08-08,02348675,TEVA-MYCOPHENOLATE,1.0,L04AA06,Mycophenolic acid,Tablet,Oral,02348675,TEVA-MYCOPHENOLATE (mycophenolate mofetil 500 mg oral tablet) TEVA CANADA LIMITED,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84976,Marketed,2017-08-08,02364883,TEVA-MYCOPHENOLATE,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02364883,TEVA-MYCOPHENOLATE (mycophenolate mofetil 250 mg oral capsule) TEVA CANADA LIMITED,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
85782,Marketed,2014-07-02,02372738,APO-MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02372738,APO-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) APOTEX INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
85783,Marketed,2014-07-02,02372746,APO-MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02372746,APO-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) APOTEX INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
86436,Marketed,2023-03-28,02378574,ACH-MYCOPHENOLATE,1.0,L04AA06,Mycophenolic acid,Tablet,Oral,02378574,ACH-MYCOPHENOLATE (mycophenolate mofetil 500 mg oral tablet) ACCORD HEALTHCARE INC,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86955,Marketed,2014-05-08,02383780,ACH-MYCOPHENOLATE,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02383780,ACH-MYCOPHENOLATE (mycophenolate mofetil 250 mg oral capsule) ACCORD HEALTHCARE INC,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87198,Marketed,2025-10-07,02386399,JAMP-MYCOPHENOLATE CAPSULES,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02386399,JAMP-MYCOPHENOLATE CAPSULES (mycophenolate mofetil 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93003,Marketed,2019-04-23,02444836,"MYCOPHENOLATE MOFETIL FOR INJECTION, USP",1.0,L04AA06,Mycophenolic acid,Powder for solution,Intravenous,02444836,"MYCOPHENOLATE MOFETIL FOR INJECTION, USP (mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC",Active,9003442,mycophenolate mofetil (mycophenolate mofetil hydrochloride) 500 mg per vial powder for solution for injection,8001292,mycophenolic acid,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94442,Marketed,2016-09-29,02457369,MYCOPHENOLATE MOFETIL,1.0,L04AA06,Mycophenolic acid,Capsule,Oral,02457369,MYCOPHENOLATE MOFETIL (mycophenolate mofetil 250 mg oral capsule) SANIS HEALTH INC,Active,9002851,mycophenolate mofetil 250 mg oral capsule,8001292,mycophenolic acid,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94443,Marketed,2016-09-29,02457377,MYCOPHENOLATE MOFETIL,1.0,L04AA06,Mycophenolic acid,Tablet,Oral,02457377,MYCOPHENOLATE MOFETIL (mycophenolate mofetil 500 mg oral tablet) SANIS HEALTH INC,Active,9003330,mycophenolate mofetil 500 mg oral tablet,8001292,mycophenolic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100086,Marketed,2021-04-07,02511673,MAR-MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02511673,MAR-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
100087,Marketed,2021-04-07,02511681,MAR-MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02511681,MAR-MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
100782,Marketed,2025-03-13,02518511,JAMP MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02518511,JAMP MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9004017,mycophenolic acid (mycophenolate sodium) 360 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
100783,Marketed,2025-03-13,02518538,JAMP MYCOPHENOLIC ACID,1.0,L04AA06,Mycophenolic acid,Tablet (enteric-coated),Oral,02518538,JAMP MYCOPHENOLIC ACID (mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9004016,mycophenolic acid (mycophenolate sodium) 180 mg gastro-resistant tablet,8001292,mycophenolic acid,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
101138,Marketed,2022-02-03,02522233,MAR-MYCOPHENOLATE MOFETIL,1.0,L04AA06,Mycophenolic acid,Powder for suspension,Oral,02522233,MAR-MYCOPHENOLATE MOFETIL (mycophenolate mofetil 200 mg per mL oral suspension) MARCAN PHARMACEUTICALS INC,Active,9006375,mycophenolate mofetil 200 mg per mL oral suspension,8001292,mycophenolic acid,26643006,Oral,385024007,Oral suspension,,,1.0,,
4941,Marketed,2019-05-27,00548375,CESAMET,1.0,A04AD11,Nabilone,Capsule,Oral,00548375,"CESAMET (nabilone 1 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74143,Marketed,2019-05-27,02256193,CESAMET,1.0,A04AD11,Nabilone,Capsule,Oral,02256193,"CESAMET (nabilone 0.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79778,Marketed,2019-05-27,02312263,CESAMET,1.0,A04AD11,Nabilone,Capsule,Oral,02312263,"CESAMET (nabilone 0.25 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86665,Marketed,2021-01-22,02380897,PMS-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02380897,PMS-NABILONE (nabilone 0.25 mg oral capsule) PHARMASCIENCE INC,Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86666,Marketed,2012-03-26,02380900,PMS-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02380900,PMS-NABILONE (nabilone 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86667,Marketed,2012-03-26,02380919,PMS-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02380919,PMS-NABILONE (nabilone 1 mg oral capsule) PHARMASCIENCE INC,Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87056,Marketed,2012-05-23,02384884,TEVA-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02384884,TEVA-NABILONE (nabilone 0.5 mg oral capsule) TEVA CANADA LIMITED,Active,9003937,nabilone 0.5 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87057,Marketed,2012-05-23,02384892,TEVA-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02384892,TEVA-NABILONE (nabilone 1 mg oral capsule) TEVA CANADA LIMITED,Active,9001947,nabilone 1 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87819,Marketed,2013-05-27,02392925,TEVA-NABILONE,1.0,A04AD11,Nabilone,Capsule,Oral,02392925,TEVA-NABILONE (nabilone 0.25 mg oral capsule) TEVA CANADA LIMITED,Active,9004457,nabilone 0.25 mg oral capsule,8001093,nabilone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
62067,Marketed,2021-11-08,02238639,NABUMETONE,1.0,M01AX01,Nabumetone,Tablet,Oral,02238639,NABUMETONE (nabumetone 500 mg oral tablet) AA PHARMA INC,Active,9003286,nabumetone 500 mg oral tablet,8001669,nabumetone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9176,Marketed,2021-02-26,00782467,APO-NADOLOL,1.0,C07AA12,Nadolol,Tablet,Oral,00782467,APO-NADOLOL (nadolol 80 mg oral tablet) APOTEX INC,Active,9010784,nadolol 80 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9177,Marketed,2021-02-26,00782475,APO-NADOLOL,1.0,C07AA12,Nadolol,Tablet,Oral,00782475,APO-NADOLOL (nadolol 160 mg oral tablet) APOTEX INC,Active,9010782,nadolol 160 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9178,Marketed,2020-11-05,00782505,APO-NADOLOL,1.0,C07AA12,Nadolol,Tablet,Oral,00782505,APO-NADOLOL (nadolol 40 mg oral tablet) APOTEX INC,Active,9010783,nadolol 40 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98626,Marketed,2020-07-21,02496380,MINT-NADOLOL,1.0,C07AA12,Nadolol,Tablet,Oral,02496380,MINT-NADOLOL (nadolol 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9010783,nadolol 40 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98627,Marketed,2020-08-19,02496399,MINT-NADOLOL,1.0,C07AA12,Nadolol,Tablet,Oral,02496399,MINT-NADOLOL (nadolol 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9010784,nadolol 80 mg oral tablet,8000842,nadolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
42902,Marketed,2003-10-09,02188783,SYNAREL,1.0,H01CA02,Nafarelin,Metered-dose aerosol,Nasal,02188783,SYNAREL (nafarelin (nafarelin acetate) 200 mcg per actuation nasal spray) PFIZER CANADA ULC,Active,9013586,nafarelin (nafarelin acetate) 200 mcg per actuation nasal spray,8001670,nafarelin,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),1.0,,
13803,Marketed,2006-11-17,01913980,NUBAIN INJECTION 10MG/ML,1.0,N02AF02,Nalbufine,Solution,"Intramuscular,Subcutaneous,Intravenous",01913980,NUBAIN INJECTION 10MG/ML (nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012743,nalbuphine hydrochloride 10 mg per 1 mL solution for injection ampoule,8001403,nalbuphine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92652,Marketed,2018-09-28,02442167,MOVANTIK,1.0,A06AH03,Naloxegol,Tablet,Oral,02442167,MOVANTIK (naloxegol (naloxegol oxalate) 12.5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005763,naloxegol (naloxegol oxalate) 12.5 mg oral tablet,8002148,naloxegol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92653,Marketed,2018-09-28,02442175,MOVANTIK,1.0,A06AH03,Naloxegol,Tablet,Oral,02442175,MOVANTIK (naloxegol (naloxegol oxalate) 25 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9005764,naloxegol (naloxegol oxalate) 25 mg oral tablet,8002148,naloxegol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18024,Marketed,2005-10-04,02148714,NALOXONE HCL INJECTION - 1MG/ML USP,1.0,V03AB15,Naloxone,Liquid,"Subcutaneous,Intramuscular,Intravenous",02148714,NALOXONE HCL INJECTION - 1MG/ML USP (naloxone hydrochloride 2 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012523,naloxone hydrochloride 2 mg per 2 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18025,Marketed,2005-10-04,02148706,NALOXONE HCL INJECTION - 0.4MG/ML USP,1.0,V03AB15,Naloxone,Liquid,"Subcutaneous,Intramuscular,Intravenous",77700524,NALOXONE HCL INJECTION - 0.4MG/ML USP (naloxone hydrochloride 4 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012524,naloxone hydrochloride 4 mg per 10 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18025,Marketed,2005-10-04,02148706,NALOXONE HCL INJECTION - 0.4MG/ML USP,1.0,V03AB15,Naloxone,Liquid,"Subcutaneous,Intramuscular,Intravenous",77700525,NALOXONE HCL INJECTION - 0.4MG/ML USP (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
86832,Marketed,2024-04-29,02382482,NALOXONE HYDROCHLORIDE INJECTION USP,1.0,V03AB15,Naloxone,Solution,"Intramuscular,Intravenous,Subcutaneous",02382482,NALOXONE HYDROCHLORIDE INJECTION USP (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
87828,Marketed,2024-10-16,02393034,NALOXONE HYDROCHLORIDE INJECTION,1.0,V03AB15,Naloxone,Solution,"Subcutaneous,Intravenous,Intramuscular",02393034,NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012522,naloxone hydrochloride 0.4 mg per 1 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87829,Marketed,2024-06-26,02393042,NALOXONE HYDROCHLORIDE INJECTION,1.0,V03AB15,Naloxone,Solution,"Subcutaneous,Intramuscular,Intravenous",02393042,NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride (naloxone hydrochloride dihydrate) 2 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012523,naloxone hydrochloride 2 mg per 2 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
93978,Marketed,2016-06-21,02453258,S.O.S. NALOXONE HYDROCHLORIDE INJECTION,1.0,V03AB15,Naloxone,Solution,"Intramuscular,Subcutaneous,Intravenous",02453258,S.O.S. NALOXONE HYDROCHLORIDE INJECTION (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94280,Marketed,2016-08-05,02455935,INJECTABLE NALOXONE HYDROCHLORIDE,1.0,V03AB15,Naloxone,Solution,"Intravenous,Intramuscular,Subcutaneous",02455935,INJECTABLE NALOXONE HYDROCHLORIDE (naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012522,naloxone hydrochloride 0.4 mg per 1 mL solution for injection vial,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94523,Marketed,2021-03-09,02458187,NARCAN NASAL SPRAY,1.0,V03AB15,Naloxone,"Spray, metered dose",Nasal,02458187,NARCAN NASAL SPRAY (naloxone hydrochloride 4 mg per 0.1 mL nasal spray) EMERGENT OPERATIONS IRELAND LIMITED,Active,9012409,naloxone hydrochloride 4 mg per 0.1 mL nasal spray,8000891,naloxone,46713006,Nasal,385157007,Nasal spray,,,,,
94572,Marketed,2022-05-19,02458578,NALOXONE INJECTABLE,1.0,V03AB15,Naloxone,Solution,"Intramuscular,Intravenous,Subcutaneous",02458578,NALOXONE INJECTABLE (naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED,Active,9012521,naloxone hydrochloride 0.4 mg per 1 mL solution for injection ampoule,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
100074,Marketed,2024-01-08,02511568,TEVA-NALOXONE NASAL SPRAY,1.0,V03AB15,Naloxone,"Spray, metered dose",Nasal,02511568,TEVA-NALOXONE NASAL SPRAY (naloxone hydrochloride 4 mg per 0.1 mL nasal spray) TEVA CANADA LIMITED,Active,9012409,naloxone hydrochloride 4 mg per 0.1 mL nasal spray,8000891,naloxone,46713006,Nasal,385157007,Nasal spray,,,,,
103708,Marketed,2024-09-26,02548194,NALOXONE HYDROCHLORIDE INJECTION USP,1.0,V03AB15,Naloxone,Solution,"Intramuscular,Subcutaneous",02548194,NALOXONE HYDROCHLORIDE INJECTION USP (naloxone hydrochloride 0.4 mg per 1 mL solution for injection syringe) STERINOVA INC.,Active,9015100,naloxone hydrochloride 0.4 mg per 1 mL solution for injection syringe,8000891,naloxone,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
43143,Marketed,2015-05-06,02213826,REVIA,1.0,N07BB04,Naltrexone,Tablet,Oral,02213826,REVIA (naltrexone hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92924,Marketed,2015-11-10,02444275,APO-NALTREXONE,1.0,N07BB04,Naltrexone,Tablet,Oral,02444275,APO-NALTREXONE (naltrexone hydrochloride 50 mg oral tablet) APOTEX INC,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93829,Marketed,2017-05-30,02451883,NALTREXONE HYDROCHLORIDE TABLETS USP,1.0,N07BB04,Naltrexone,Tablet,Oral,02451883,NALTREXONE HYDROCHLORIDE TABLETS USP (naltrexone hydrochloride 50 mg oral tablet) STERINOVA INC.,Active,9003173,naltrexone hydrochloride 50 mg oral tablet,8001404,naltrexone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
934,Marketed,2025-05-15,00001147,ALBALON,1.0,S01GA01,Naphazoline,Drops,Ophthalmic,00001147,ALBALON (naphazoline hydrochloride 0.1 % ophthalmic drops) ABBVIE CORPORATION,Active,9001665,naphazoline hydrochloride 0.1 % ophthalmic drops,8001864,naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
7203,Marketed,2022-07-01,00674354,COLLYRE BLEU LAITER,2.0,S01GA01,Naphazoline,Drops,Ophthalmic,00674354,COLLYRE BLEU LAITER (methylene blue 0.2 mg per mL and naphazoline nitrate 0.5 mg per mL ophthalmic drops) FRILAB SA,Active,9002073,methylene blue 0.2 mg per mL and naphazoline nitrate 0.5 mg per mL ophthalmic drops,8002141,methylene blue and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
72380,Marketed,2004-03-24,02248060,CLEAR EYES,1.0,S01GA01,Naphazoline,Liquid,Ophthalmic,02248060,CLEAR EYES (naphazoline hydrochloride 0.012 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9002148,naphazoline hydrochloride 0.012 % ophthalmic drops,8001864,naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
3743,Marketed,2019-10-17,00481408,NAPHCON A,2.0,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,00481408,NAPHCON A (naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops) ALCON CANADA INC,Active,9001891,naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
8155,Marketed,2016-05-01,00750794,SOOTHE ALLERGY,2.0,S01GA51,"Naphazoline, combinations",Drops,Ophthalmic,00750794,SOOTHE ALLERGY (naphazoline hydrochloride 0.02675 % and pheniramine maleate 0.315 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002111,naphazoline hydrochloride 0.02675 % and pheniramine maleate 0.315 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
66582,Marketed,2016-03-09,02242764,VISINE FOR ALLERGY WITH ANTIHISTAMINE,2.0,S01GA51,"Naphazoline, combinations",Drops,Ophthalmic,02242764,VISINE FOR ALLERGY WITH ANTIHISTAMINE (naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9001891,naphazoline hydrochloride 0.025 % and pheniramine maleate 0.3 % ophthalmic drops,8001912,naphazoline and pheniramine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
72379,Marketed,2004-03-24,02248059,CLEAR EYES ALLERGY,3.0,S01GA51,"Naphazoline, combinations",Liquid,Ophthalmic,02248059,CLEAR EYES ALLERGY (glycerin 0.26 % and naphazoline hydrochloride 0.012 % and zinc sulfate 0.25 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9013560,glycerin 0.26 % and naphazoline hydrochloride 0.012 % and zinc sulfate 0.25 % ophthalmic drops,8002124,glycerin and naphazoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
84583,Marketed,2011-04-27,02360837,CLEAR EYES EXTRA STRENGTH REDNESS RELIEF,2.0,S01GA51,"Naphazoline, combinations",Solution,Ophthalmic,02360837,CLEAR EYES EXTRA STRENGTH REDNESS RELIEF (glycerin 0.5 % and naphazoline hydrochloride 0.03 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9013562,glycerin 0.5 % and naphazoline hydrochloride 0.03 % ophthalmic drops,8002123,glycerin and naphazoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
4980,Marketed,1982-12-31,00522651,APO-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00522651,APO-NAPROXEN (naproxen 250 mg oral tablet) APOTEX INC,Active,9000179,naproxen 250 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5036,Marketed,2010-08-04,00565350,TEVA-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00565350,TEVA-NAPROXEN (naproxen 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000179,naproxen 250 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5183,Marketed,2010-08-04,00589861,TEVA-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00589861,TEVA-NAPROXEN (naproxen 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000193,naproxen 500 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5222,Marketed,1983-12-31,00592277,APO-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00592277,APO-NAPROXEN (naproxen 500 mg oral tablet) APOTEX INC,Active,9000193,naproxen 500 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5508,Marketed,1983-12-31,00600806,APO-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00600806,APO-NAPROXEN (naproxen 375 mg oral tablet) APOTEX INC,Active,9000192,naproxen 375 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5860,Marketed,2010-08-04,00627097,TEVA-NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,00627097,TEVA-NAPROXEN (naproxen 375 mg oral tablet) TEVA CANADA LIMITED,Active,9000192,naproxen 375 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9241,Marketed,2010-07-20,00778389,TEVA-NAPROXEN SODIUM,1.0,M01AE02,Naproxen,Tablet,Oral,00778389,TEVA-NAPROXEN SODIUM (naproxen sodium 275 mg oral tablet) TEVA CANADA LIMITED,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10035,Marketed,1989-12-31,00784354,APO-NAPRO-NA,1.0,M01AE02,Naproxen,Tablet,Oral,00784354,APO-NAPRO-NA (naproxen sodium 275 mg oral tablet) APOTEX INC,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13848,Marketed,2010-07-20,02026600,TEVA-NAPROXEN SODIUM DS,1.0,M01AE02,Naproxen,Tablet,Oral,02026600,TEVA-NAPROXEN SODIUM DS (naproxen sodium 550 mg oral tablet) TEVA CANADA LIMITED,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14048,Marketed,1993-12-31,01940309,APO-NAPRO-NA DS,1.0,M01AE02,Naproxen,Tablet,Oral,01940309,APO-NAPRO-NA DS (naproxen sodium 550 mg oral tablet) APOTEX INC,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17199,Marketed,2019-06-20,00887056,NAPROXEN-NA,1.0,M01AE02,Naproxen,Tablet,Oral,00887056,NAPROXEN-NA (naproxen sodium 275 mg oral tablet) PRO DOC LIMITEE,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19313,Marketed,2025-06-25,02162717,ANAPROX DS,1.0,M01AE02,Naproxen,Tablet,Oral,02162717,ANAPROX DS (naproxen sodium 550 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19314,Marketed,2025-04-24,02162466,NAPROSYN,1.0,M01AE02,Naproxen,Tablet (extended-release),Oral,02162466,NAPROSYN (naproxen 750 mg prolonged-release oral tablet) SEARCHLIGHT PHARMA INC,Active,9000621,naproxen 750 mg prolonged-release oral tablet,8000218,naproxen,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
19315,Marketed,2025-04-24,02162423,NAPROSYN,1.0,M01AE02,Naproxen,Tablet (delayed-release),Oral,02162423,NAPROSYN (naproxen 500 mg gastro-resistant tablet) SEARCHLIGHT PHARMA INC,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
19446,Marketed,2025-06-26,02162725,ANAPROX,1.0,M01AE02,Naproxen,Tablet,Oral,02162725,ANAPROX (naproxen sodium 275 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000300,naproxen sodium 275 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19661,Marketed,2022-12-20,02162431,PEDIAPHARM NAPROXEN SUSPENSION,1.0,M01AE02,Naproxen,Suspension,Oral,02162431,PEDIAPHARM NAPROXEN SUSPENSION (naproxen 25 mg per mL oral suspension) MEDEXUS PHARMACEUTICALS INC.,Active,9006252,naproxen 25 mg per mL oral suspension,8000218,naproxen,26643006,Oral,385024007,Oral suspension,,,,,
44029,Marketed,2019-06-20,02153386,NAPROXEN-NA DF,1.0,M01AE02,Naproxen,Tablet,Oral,02153386,NAPROXEN-NA DF (naproxen sodium 550 mg oral tablet) PRO DOC LIMITEE,Active,9000484,naproxen sodium 550 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67215,Marketed,2010-08-04,02243312,TEVA-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243312,TEVA-NAPROXEN EC (naproxen 250 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000936,naproxen 250 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
67216,Marketed,2010-08-04,02243313,TEVA-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243313,TEVA-NAPROXEN EC (naproxen 375 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000619,naproxen 375 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
67217,Marketed,2010-08-04,02243314,TEVA-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02243314,TEVA-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
70894,Marketed,2003-04-23,02246699,APO-NAPROXEN EC TABLETS,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246699,APO-NAPROXEN EC TABLETS (naproxen 250 mg gastro-resistant tablet) APOTEX INC,Active,9000936,naproxen 250 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
70895,Marketed,2003-04-23,02246700,APO-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246700,APO-NAPROXEN EC (naproxen 375 mg gastro-resistant tablet) APOTEX INC,Active,9000619,naproxen 375 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
70896,Marketed,2003-04-23,02246701,APO-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02246701,APO-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) APOTEX INC,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78704,Marketed,2021-09-09,02301733,ALEVE CAPLETS,1.0,M01AE02,Naproxen,Tablet,Oral,02301733,ALEVE CAPLETS (naproxen sodium 220 mg oral tablet) BAYER INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79657,Marketed,2019-10-25,02310953,PRO-NAPROXEN EC,1.0,M01AE02,Naproxen,Tablet (enteric-coated),Oral,02310953,PRO-NAPROXEN EC (naproxen 500 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000620,naproxen 500 mg gastro-resistant tablet,8000218,naproxen,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
84684,Marketed,2011-09-12,02361795,ALEVE LIQUID GELS,1.0,M01AE02,Naproxen,Capsule,Oral,02361795,ALEVE LIQUID GELS (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84744,Marketed,2013-09-13,02362430,NAPROXEN,1.0,M01AE02,Naproxen,Tablet,Oral,02362430,NAPROXEN (naproxen sodium 220 mg oral tablet) PHARMASCIENCE INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85812,Marketed,2012-05-17,02372991,MAXIDOL LIQUID GELS,1.0,M01AE02,Naproxen,Capsule,Oral,02372991,MAXIDOL LIQUID GELS (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88106,Marketed,2014-01-24,02396009,NAPROXEN MENSTRUAL PAIN RELIEF,1.0,M01AE02,Naproxen,Tablet,Oral,02396009,NAPROXEN MENSTRUAL PAIN RELIEF (naproxen sodium 220 mg oral tablet) PHARMASCIENCE INC,Active,9001275,naproxen sodium 220 mg oral tablet,8000218,naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92069,Marketed,2015-06-30,02436337,ALEVE BACK AND BODY PAIN,1.0,M01AE02,Naproxen,Capsule,Oral,02436337,ALEVE BACK AND BODY PAIN (naproxen sodium 220 mg oral capsule) BAYER INC,Active,9001354,naproxen sodium 220 mg oral capsule,8000218,naproxen,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92965,Marketed,2016-02-24,02444593,ALEVE NIGHTTIME,2.0,M01AE02,Naproxen,Tablet,Oral,02444593,ALEVE NIGHTTIME (diphenhydramine hydrochloride 25 mg and naproxen sodium 220 mg oral tablet) BAYER INC,Active,9005895,diphenhydramine hydrochloride 25 mg and naproxen sodium 220 mg oral tablet,8001189,diphenhydramine and naproxen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84676,Marketed,2022-02-28,02361701,VIMOVO,2.0,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02361701,VIMOVO (esomeprazole (esomeprazole magnesium trihydrate) 20 mg and naproxen 375 mg modified-release oral tablet) XEDITON PHARMACEUTICALS INC,Active,9001334,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
84677,Marketed,2022-02-28,02361728,VIMOVO,2.0,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02361728,VIMOVO (esomeprazole (esomeprazole magnesium trihydrate) 20 mg and naproxen 500 mg modified-release oral tablet) XEDITON PHARMACEUTICALS INC,Active,9001335,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
92813,Marketed,2017-02-10,02443449,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,2.0,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02443449,MYLAN-NAPROXEN/ESOMEPRAZOLE MR (esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001335,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 500 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
94575,Marketed,2017-02-27,02458608,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,2.0,M01AE52,Naproxen and esomeprazole,Tablet (immediate and delayed-release),Oral,02458608,MYLAN-NAPROXEN/ESOMEPRAZOLE MR (esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001334,esomeprazole (esomeprazole magnesium) 20 mg and naproxen 375 mg modified-release oral tablet,8000398,esomeprazole and naproxen,26643006,Oral,385061003,Modified-release oral tablet,732936001,Tablet (unit of presentation),,,
79985,Marketed,2018-02-28,02314290,TEVA-NARATRIPTAN,1.0,N02CC02,Naratriptan,Tablet,Oral,02314290,TEVA-NARATRIPTAN (naratriptan (naratriptan hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9003252,naratriptan (naratriptan hydrochloride) 1 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79986,Marketed,2012-01-14,02314304,TEVA-NARATRIPTAN,1.0,N02CC02,Naratriptan,Tablet,Oral,02314304,TEVA-NARATRIPTAN (naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003253,naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80778,Marketed,2018-01-19,02322323,SANDOZ NARATRIPTAN,1.0,N02CC02,Naratriptan,Tablet,Oral,02322323,SANDOZ NARATRIPTAN (naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003253,naratriptan (naratriptan hydrochloride) 2.5 mg oral tablet,8001104,naratriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77184,Marketed,2006-11-21,02286386,TYSABRI,1.0,L04AG03,Natalizumab,Solution,Intravenous,02286386,TYSABRI (natalizumab 300 mg per 15 mL solution for injection vial) BIOGEN CANADA INC,Active,9013458,natalizumab 300 mg per 15 mL solution for injection vial,8002032,natalizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
14318,Marketed,2014-06-30,02016109,SURVANTA,1.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700652,SURVANTA (beractant 100 mg per 4 mL endotracheopulmonary instillation vial) ABBVIE CORPORATION,Active,9012908,beractant 100 mg per 4 mL endotracheopulmonary instillation vial,8001583,beractant,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
14318,Marketed,2014-06-30,02016109,SURVANTA,1.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700653,SURVANTA (beractant 200 mg per 8 mL endotracheopulmonary instillation vial) ABBVIE CORPORATION,Active,9012909,beractant 200 mg per 8 mL endotracheopulmonary instillation vial,8001583,beractant,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
65204,Marketed,2016-12-19,02241551,CUROSURF,1.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700924,CUROSURF (poractant alfa 120 mg per 1.5 mL endotracheopulmonary instillation vial) CHIESI FARMACEUTICI S.P.A.,Active,9013512,poractant alfa 120 mg per 1.5 mL endotracheopulmonary instillation vial,8002078,poractant alfa,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
65204,Marketed,2016-12-19,02241551,CUROSURF,1.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700925,CUROSURF (poractant alfa 240 mg per 3 mL endotracheopulmonary instillation vial) CHIESI FARMACEUTICI S.P.A.,Active,9013513,poractant alfa 240 mg per 3 mL endotracheopulmonary instillation vial,8002078,poractant alfa,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
69524,Marketed,2002-02-05,02245464,BLES,2.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700971,BLES (phospholipid 81 mg per 3 mL and surfactant-associated proteins sp-b and sp-c 1500 mcg per 3 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013598,phospholipid 81 mg per 3 mL and surfactant-associated proteins sp-b and sp-c 1500 mcg per 3 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
69524,Marketed,2002-02-05,02245464,BLES,2.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700972,BLES (phospholipid 135 mg per 5 mL and surfactant-associated proteins sp-b and sp-c 2500 mcg per 5 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013597,phospholipid 135 mg per 5 mL and surfactant-associated proteins sp-b and sp-c 2500 mcg per 5 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
69524,Marketed,2002-02-05,02245464,BLES,2.0,R07AA02,Natural phospholipids,Suspension,Intratracheal,77700973,BLES (phospholipid 108 mg per 4 mL and surfactant-associated proteins sp-b and sp-c 2000 mcg per 4 mL endotracheopulmonary instillation vial) BLES BIOCHEMICALS INC,Active,9013596,phospholipid 108 mg per 4 mL and surfactant-associated proteins sp-b and sp-c 2000 mcg per 4 mL endotracheopulmonary instillation vial,8002224,phospholipid and surfactant-associated proteins sp-b and sp-c,372452007,Endotracheopulmonary,385250004,Suspension for endotrachealbronchial installation,733026001,Vial (unit of presentation),,,
88390,Marketed,2024-04-19,02398990,BYSTOLIC,1.0,C07AB12,Nebivolol,Tablet,Oral,02398990,BYSTOLIC (nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet) ABBVIE CORPORATION,Active,9010820,nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88391,Marketed,2023-11-22,02399008,BYSTOLIC,1.0,C07AB12,Nebivolol,Tablet,Oral,02399008,BYSTOLIC (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) ABBVIE CORPORATION,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88392,Marketed,2024-08-19,02399016,BYSTOLIC,1.0,C07AB12,Nebivolol,Tablet,Oral,02399016,BYSTOLIC (nebivolol (nebivolol hydrochloride) 10 mg oral tablet) ABBVIE CORPORATION,Active,9010819,nebivolol (nebivolol hydrochloride) 10 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88393,Marketed,2024-07-02,02399024,BYSTOLIC,1.0,C07AB12,Nebivolol,Tablet,Oral,02399024,BYSTOLIC (nebivolol (nebivolol hydrochloride) 20 mg oral tablet) ABBVIE CORPORATION,Active,9010821,nebivolol (nebivolol hydrochloride) 20 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103196,Marketed,2024-09-16,02543508,JAMP NEBIVOLOL,1.0,C07AB12,Nebivolol,Tablet,Oral,02543508,JAMP NEBIVOLOL (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103755,Marketed,2025-12-18,02548704,PRZ-NEBIVOLOL,1.0,C07AB12,Nebivolol,Tablet,Oral,02548704,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9010820,nebivolol (nebivolol hydrochloride) 2.5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103756,Marketed,2025-12-18,02548712,PRZ-NEBIVOLOL,1.0,C07AB12,Nebivolol,Tablet,Oral,02548712,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9010822,nebivolol (nebivolol hydrochloride) 5 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103757,Marketed,2025-12-18,02548720,PRZ-NEBIVOLOL,1.0,C07AB12,Nebivolol,Tablet,Oral,02548720,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9010819,nebivolol (nebivolol hydrochloride) 10 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103758,Marketed,2025-12-19,02548739,PRZ-NEBIVOLOL,1.0,C07AB12,Nebivolol,Tablet,Oral,02548739,PRZ-NEBIVOLOL (nebivolol (nebivolol hydrochloride) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9010821,nebivolol (nebivolol hydrochloride) 20 mg oral tablet,8000999,nebivolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78527,Marketed,2022-11-30,02299925,ATRIANCE,1.0,L01BB07,Nelarabine,Solution,Intravenous,02299925,ATRIANCE (nelarabine 250 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013014,nelarabine 250 mg per 50 mL solution for injection vial,8001672,nelarabine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
49701,Marketed,1999-07-23,02230592,NEOSTIGMINE OMEGA,1.0,N07AA01,Neostigmine,Liquid,"Intramuscular,Subcutaneous,Intravenous",02230592,NEOSTIGMINE OMEGA (neostigmine methylsulfate 10 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013460,neostigmine methylsulfate 10 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49702,Marketed,1999-07-23,02230593,NEOSTIGMINE OMEGA,1.0,N07AA01,Neostigmine,Liquid,"Intravenous,Intramuscular,Subcutaneous",77700920,NEOSTIGMINE OMEGA (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49702,Marketed,1999-07-23,02230593,NEOSTIGMINE OMEGA,1.0,N07AA01,Neostigmine,Liquid,"Intravenous,Intramuscular,Subcutaneous",77700921,NEOSTIGMINE OMEGA (neostigmine methylsulfate 0.5 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013459,neostigmine methylsulfate 0.5 mg per 1 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87274,Marketed,2013-04-17,02387166,NEOSTIGMINE OMEGA,1.0,N07AA01,Neostigmine,Solution,"Intravenous,Intramuscular,Subcutaneous",02387166,NEOSTIGMINE OMEGA (neostigmine methylsulfate 12.5 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013461,neostigmine methylsulfate 12.5 mg per 5 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96586,Marketed,2019-03-26,02475480,NEOSTIGMINE METHYLSULFATE INJECTION USP,1.0,N07AA01,Neostigmine,Solution,"Intravenous,Intramuscular,Subcutaneous",02475480,NEOSTIGMINE METHYLSULFATE INJECTION USP (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96587,Marketed,2019-03-26,02475499,NEOSTIGMINE METHYLSULFATE INJECTION USP,1.0,N07AA01,Neostigmine,Solution,"Subcutaneous,Intravenous,Intramuscular",02475499,NEOSTIGMINE METHYLSULFATE INJECTION USP (neostigmine methylsulfate 10 mg per 10 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013460,neostigmine methylsulfate 10 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102622,Marketed,2024-03-28,02537516,"NEOSTIGMINE METHYLSULFATE INJECTION, USP",1.0,N07AA01,Neostigmine,Solution,"Intravenous,Intramuscular,Subcutaneous",02537516,"NEOSTIGMINE METHYLSULFATE INJECTION, USP (neostigmine methylsulfate 5 mg per 10 mL solution for injection vial) JAMP PHARMA CORPORATION",Active,9013462,neostigmine methylsulfate 5 mg per 10 mL solution for injection vial,8002033,neostigmine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79459,Marketed,2018-09-17,02308983,NEVANAC,1.0,S01BC10,Nepafenac,Suspension,Ophthalmic,02308983,NEVANAC (nepafenac 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012647,nepafenac 0.1 % ophthalmic drops,8001294,nepafenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
89601,Marketed,2018-03-21,02411393,ILEVRO,1.0,S01BC10,Nepafenac,Suspension,Ophthalmic,02411393,ILEVRO (nepafenac 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012648,nepafenac 0.3 % ophthalmic drops,8001294,nepafenac,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
98057,Marketed,2019-12-20,02490536,NERLYNX,1.0,L01EH02,Neratinib,Tablet,Oral,02490536,NERLYNX (neratinib (neratinib maleate) 40 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014210,neratinib (neratinib maleate) 40 mg oral tablet,8002309,neratinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80408,Marketed,2020-11-20,02318601,AURO-NEVIRAPINE,1.0,J05AG01,Nevirapine,Tablet,Oral,02318601,AURO-NEVIRAPINE (nevirapine 200 mg oral tablet) AURO PHARMA INC,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87331,Marketed,2012-06-20,02387727,MYLAN-NEVIRAPINE,1.0,J05AG01,Nevirapine,Tablet,Oral,02387727,MYLAN-NEVIRAPINE (nevirapine 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89053,Marketed,2019-10-09,02405776,JAMP NEVIRAPINE,1.0,J05AG01,Nevirapine,Tablet,Oral,02405776,JAMP NEVIRAPINE (nevirapine 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003307,nevirapine 200 mg oral tablet,8001218,nevirapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
8376,Marketed,2011-01-13,00755907,NIFEDIPINE,1.0,C08CA05,Nifedipine,Capsule,Oral,00755907,NIFEDIPINE (nifedipine 10 mg oral capsule) AA PHARMA INC,Active,9000301,nifedipine 10 mg oral capsule,8000123,nifedipine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9938,Marketed,2010-11-25,00725110,NIFEDIPINE,1.0,C08CA05,Nifedipine,Capsule,Oral,00725110,NIFEDIPINE (nifedipine 5 mg oral capsule) AA PHARMA INC,Active,9000332,nifedipine 5 mg oral capsule,8000123,nifedipine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19099,Marketed,1995-02-28,02155907,ADALAT XL,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02155907,ADALAT XL (nifedipine 30 mg prolonged-release oral tablet) BAYER INC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80655,Marketed,2009-12-21,02321149,MYLAN-NIFEDIPINE EXTENDED RELEASE,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02321149,MYLAN-NIFEDIPINE EXTENDED RELEASE (nifedipine 60 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
83448,Marketed,2010-04-23,02349167,MYLAN-NIFEDIPINE EXTENDED RELEASE,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02349167,MYLAN-NIFEDIPINE EXTENDED RELEASE (nifedipine 30 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90087,Marketed,2015-03-17,02416301,PMS-NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02416301,PMS-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90628,Marketed,2015-01-13,02421631,NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02421631,NIFEDIPINE ER (nifedipine 30 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90629,Marketed,2015-01-13,02421658,NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02421658,NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100066,Marketed,2022-05-17,02511460,AG-NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511460,AG-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100083,Marketed,2022-04-27,02511649,M-NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511649,M-NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100090,Marketed,2022-05-12,02511711,JAMP NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02511711,JAMP NIFEDIPINE ER (nifedipine 60 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9000436,nifedipine 60 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102233,Marketed,2023-03-21,02533332,PMSC-NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02533332,PMSC-NIFEDIPINE ER (nifedipine 30 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102374,Marketed,2023-04-24,02534843,PRO-NIFEDIPINE ER,1.0,C08CA05,Nifedipine,Tablet (extended-release),Oral,02534843,PRO-NIFEDIPINE ER (nifedipine 30 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9000435,nifedipine 30 mg prolonged-release oral tablet,8000123,nifedipine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80138,Marketed,2008-09-30,02315874,TASIGNA,1.0,L01EA03,Nilotinib,Capsule,Oral,02315874,TASIGNA (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
85322,Marketed,2011-07-15,02368250,TASIGNA,1.0,L01EA03,Nilotinib,Capsule,Oral,02368250,TASIGNA (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103966,Marketed,2025-02-13,02550881,APO-NILOTINIB,1.0,L01EA03,Nilotinib,Capsule,Oral,02550881,APO-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) APOTEX INC,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103967,Marketed,2025-02-13,02550903,APO-NILOTINIB,1.0,L01EA03,Nilotinib,Capsule,Oral,02550903,APO-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) APOTEX INC,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
106003,Marketed,2025-04-24,02556634,REDDY-NILOTINIB,1.0,L01EA03,Nilotinib,Capsule,Oral,02556634,REDDY-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 150 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9013463,nilotinib (nilotinib hydrochloride) 150 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
106004,Marketed,2025-04-24,02556642,REDDY-NILOTINIB,1.0,L01EA03,Nilotinib,Capsule,Oral,02556642,REDDY-NILOTINIB (nilotinib (nilotinib hydrochloride monohydrate) 200 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9013464,nilotinib (nilotinib hydrochloride) 200 mg oral capsule,8002034,nilotinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
81127,Marketed,2025-08-18,02325926,NIMOTOP,1.0,C08CA06,Nimodipine,Tablet,Oral,02325926,NIMOTOP (nimodipine 30 mg oral tablet) LABORATOIRE X.0,Active,9004575,nimodipine 30 mg oral tablet,8001674,nimodipine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92756,Marketed,2015-06-29,02443066,OFEV,1.0,L01EX09,Nintedanib,Capsule,Oral,02443066,OFEV (nintedanib (nintedanib esilate) 100 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005736,nintedanib (nintedanib esilate) 100 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92761,Marketed,2015-06-29,02443074,OFEV,1.0,L01EX09,Nintedanib,Capsule,Oral,02443074,OFEV (nintedanib (nintedanib esilate) 150 mg oral capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005737,nintedanib (nintedanib esilate) 150 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101595,Marketed,2025-12-22,02526891,AURO-NINTEDANIB,1.0,L01EX09,Nintedanib,Capsule,Oral,,,,,,,,,,,,,,,,
101596,Marketed,2025-12-22,02526905,AURO-NINTEDANIB,1.0,L01EX09,Nintedanib,Capsule,Oral,,,,,,,,,,,,,,,,
102944,Marketed,2025-12-22,02540762,JAMP NINTEDANIB,1.0,L01EX09,Nintedanib,Capsule,Oral,02540762,JAMP NINTEDANIB (nintedanib (nintedanib esilate) 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005737,nintedanib (nintedanib esilate) 150 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103962,Marketed,2025-12-22,02550849,JAMP NINTEDANIB,1.0,L01EX09,Nintedanib,Capsule,Oral,02550849,JAMP NINTEDANIB (nintedanib (nintedanib esilate) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005736,nintedanib (nintedanib esilate) 100 mg oral capsule,8002035,nintedanib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101925,Marketed,2023-09-13,02530031,ZEJULA,1.0,L01XK02,Niraparib,Tablet,Oral,02530031,ZEJULA (niraparib (niraparib tosylate) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9014919,niraparib (niraparib tosylate) 100 mg oral tablet,8002312,niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102726,Marketed,2023-08-14,02538555,AKEEGA,2.0,L01XK52,Niraparib and abiraterone,Tablet,Oral,02538555,AKEEGA (abiraterone acetate 500 mg and niraparib (niraparib tosylate) 50 mg oral tablet) JANSSEN INC,Active,9014901,abiraterone acetate 500 mg and niraparib (niraparib tosylate) 50 mg oral tablet,8002474,abiraterone and niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102728,Marketed,2023-08-14,02538563,AKEEGA,2.0,L01XK52,Niraparib and abiraterone,Tablet,Oral,02538563,AKEEGA (abiraterone acetate 500 mg and niraparib (niraparib tosylate) 100 mg oral tablet) JANSSEN INC,Active,9014900,abiraterone acetate 500 mg and niraparib (niraparib tosylate) 100 mg oral tablet,8002474,abiraterone and niraparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101307,Marketed,2022-01-18,02524031,PAXLOVID,2.0,J05AE30,Nirmatrelvir and ritonavir,Tablet,Oral,02524031,PAXLOVID (nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet) PFIZER CANADA ULC,Active,9014643,nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet,8002405,nirmatrelvir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101698,Marketed,2022-08-01,02527804,PAXLOVID,2.0,J05AE30,Nirmatrelvir and ritonavir,Tablet,Oral,02527804,PAXLOVID FOR MODERATE RENAL IMPAIRMENT (nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet) PFIZER CANADA ULC,Active,9014643,nirmatrelvir 150 mg oral tablet with ritonavir 100 mg oral tablet,8002405,nirmatrelvir and ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102594,Marketed,2024-10-21,02537206,BEYFORTUS,1.0,J06BD08,Nirsevimab,Solution,Intramuscular,,,,,,,,,,,,,,,,
102595,Marketed,2024-11-04,02537214,BEYFORTUS,1.0,J06BD08,Nirsevimab,Solution,Intramuscular,,,,,,,,,,,,,,,,
94475,Marketed,2016-10-20,02457717,MDK-NITISINONE,1.0,A16AX04,Nitisinone,Capsule,Oral,02457717,MDK-NITISINONE (nitisinone 2 mg oral capsule) MENDELIKABS INC,Active,9006053,nitisinone 2 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94476,Marketed,2016-10-20,02457725,MDK-NITISINONE,1.0,A16AX04,Nitisinone,Capsule,Oral,02457725,MDK-NITISINONE (nitisinone 5 mg oral capsule) MENDELIKABS INC,Active,9006054,nitisinone 5 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94477,Marketed,2025-10-15,02457733,MDK-NITISINONE,1.0,A16AX04,Nitisinone,Capsule,Oral,02457733,MDK-NITISINONE (nitisinone 10 mg oral capsule) MENDELIKABS INC,Active,9006052,nitisinone 10 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94699,Marketed,2017-02-17,02459698,ORFADIN,1.0,A16AX04,Nitisinone,Capsule,Oral,02459698,ORFADIN (nitisinone 2 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006053,nitisinone 2 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94700,Marketed,2017-02-17,02459701,ORFADIN,1.0,A16AX04,Nitisinone,Capsule,Oral,02459701,ORFADIN (nitisinone 5 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006054,nitisinone 5 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94701,Marketed,2017-02-17,02459728,ORFADIN,1.0,A16AX04,Nitisinone,Capsule,Oral,02459728,ORFADIN (nitisinone 10 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006052,nitisinone 10 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94702,Marketed,2017-02-17,02459736,ORFADIN,1.0,A16AX04,Nitisinone,Capsule,Oral,02459736,ORFADIN (nitisinone 20 mg oral capsule) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9006131,nitisinone 20 mg oral capsule,8001675,nitisinone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95850,Marketed,2018-07-10,02469693,ORFADIN,1.0,A16AX04,Nitisinone,Suspension,Oral,02469693,ORFADIN (nitisinone 4 mg per mL oral suspension) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9013015,nitisinone 4 mg per mL oral suspension,8001675,nitisinone,26643006,Oral,385024007,Oral suspension,,,,,
3991,Marketed,2014-04-16,00511528,MOGADON,1.0,N05CD02,Nitrazepam,Tablet,Oral,00511528,MOGADON (nitrazepam 5 mg oral tablet) AA PHARMA INC,Active,9001893,nitrazepam 5 mg oral tablet,8001092,nitrazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3992,Marketed,2014-04-16,00511536,MOGADON,1.0,N05CD02,Nitrazepam,Tablet,Oral,00511536,MOGADON (nitrazepam 10 mg oral tablet) AA PHARMA INC,Active,9001892,nitrazepam 10 mg oral tablet,8001092,nitrazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75619,Marketed,2005-11-23,02270846,INOMAX,1.0,R07AX01,Nitric oxide,Gas,Inhalation,,,,,,,,,,,,,,,,
93757,Marketed,2022-04-30,02451328,KINOX,1.0,R07AX01,Nitric oxide,Gas,Inhalation,,,,,,,,,,,,,,,,
2093,Marketed,2011-10-25,00312738,NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Tablet,Oral,00312738,NITROFURANTOIN (nitrofurantoin 100 mg oral tablet) AA PHARMA INC,Active,9000079,nitrofurantoin 100 mg oral tablet,8000050,nitrofurantoin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2094,Marketed,2010-11-29,00319511,NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Tablet,Oral,00319511,NITROFURANTOIN (nitrofurantoin 50 mg oral tablet) AA PHARMA INC,Active,9000080,nitrofurantoin 50 mg oral tablet,8000050,nitrofurantoin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
50295,Marketed,2011-10-19,02231015,TEVA-NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02231015,TEVA-NITROFURANTOIN (nitrofurantoin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000725,nitrofurantoin 50 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
50297,Marketed,2011-10-19,02231016,TEVA-NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02231016,TEVA-NITROFURANTOIN (nitrofurantoin 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94248,Marketed,2021-08-11,02455676,PMS-NITROFURANTOIN BID,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02455676,PMS-NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) PHARMASCIENCE INC,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95474,Marketed,2020-09-09,02466392,AURO-NITROFURANTOIN BID,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02466392,AURO-NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) AURO PHARMA INC,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98541,Marketed,2025-04-02,02495503,JAMP NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02495503,JAMP NITROFURANTOIN (nitrofurantoin 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000725,nitrofurantoin 50 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98542,Marketed,2025-04-02,02495511,JAMP NITROFURANTOIN,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02495511,JAMP NITROFURANTOIN (nitrofurantoin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103357,Marketed,2025-02-18,02544954,JAMP NITROFURANTOIN BID,1.0,J01XE01,Nitrofurantoin,Capsule,Oral,02544954,JAMP NITROFURANTOIN BID (nitrofurantoin 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000485,nitrofurantoin 100 mg oral capsule,8000050,nitrofurantoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
5221,Marketed,1983-12-31,00591645,GASEOUS NITROGEN 99.0%,1.0,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,
5683,Marketed,1911-12-31,00572829,NITROGEN 100%,1.0,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,
13882,Marketed,2022-04-20,02014394,NITROGEN NF,1.0,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,
19292,Marketed,2020-08-04,02154803,NITROGEN N.F.,1.0,V03AN04,Nitrogen,Gas,Inhalation,,,,,,,,,,,,,,,,
78261,Marketed,2025-01-27,02297248,LIQUID NITROGEN NF,1.0,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,
85318,Marketed,2011-09-13,02368218,LIQUID NITROGEN,1.0,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,
92092,Marketed,2015-10-20,02436590,LIQUID NITROGEN NF,1.0,V03AN04,Nitrogen,Liquid,Topical,,,,,,,,,,,,,,,,
84678,Marketed,2017-08-02,02361736,NIPRIDE,1.0,C02DD01,Nitroprusside,Solution,Intravenous,02361736,NIPRIDE (sodium nitroprusside 50 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
93610,Marketed,2021-04-26,02450089,SODIUM NITROPRUSSIDE FOR INJECTION,1.0,C02DD01,Nitroprusside,Solution,Intravenous,02450089,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96981,Marketed,2019-04-15,02479109,SODIUM NITROPRUSSIDE FOR INJECTION,1.0,C02DD01,Nitroprusside,Solution,Intravenous,02479109,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99680,Marketed,2021-05-26,02507404,SODIUM NITROPRUSSIDE FOR INJECTION,1.0,C02DD01,Nitroprusside,Solution,Intravenous,02507404,SODIUM NITROPRUSSIDE FOR INJECTION (sodium nitroprusside 50 mg per 2 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9013343,sodium nitroprusside 50 mg per 2 mL solution for injection vial,8001913,nitroprusside,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103072,Marketed,2025-02-13,02542129,SODIUM NITROPRUSSIDE FOR INJECTION,1.0,C02DD01,Nitroprusside,Solution,Intravenous,,,,,,,,,,,,,,,,
5685,Marketed,1911-12-31,00572845,NITROUS OXIDE 100%,1.0,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,
13887,Marketed,2022-03-08,02014467,NITROUS OXIDE USP,1.0,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,
19262,Marketed,2020-08-04,02154811,NITROUS OXIDE U.S.P.,1.0,N01AX13,Nitrous oxide,Gas,Inhalation,,,,,,,,,,,,,,,,
6850,Marketed,1997-05-02,00693596,LIQUI-MED ANALGESIC GAS,2.0,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,
18513,Marketed,1995-12-31,02071010,ALNOX GAS,2.0,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,
19102,Marketed,2022-01-28,02154757,MEOPA,2.0,N01AX63,"Nitrous oxide,combinations",Gas,Inhalation,,,,,,,,,,,,,,,,
93204,Marketed,2015-10-23,02446626,OPDIVO,1.0,L01FF01,Nivolumab,Solution,Intravenous,02446626,OPDIVO (nivolumab 40 mg per 4 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013017,nivolumab 40 mg per 4 mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93205,Marketed,2015-10-23,02446634,OPDIVO,1.0,L01FF01,Nivolumab,Solution,Intravenous,02446634,OPDIVO (nivolumab 10 mg per mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9013016,nivolumab 10 mg per mL solution for injection vial,8001676,nivolumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
106066,Marketed,2025-12-30,02557320,OPDIVO SC,1.0,L01FF01,Nivolumab,Solution,Subcutaneous,02557320,OPDIVO SC (nivolumab 600 mg per 5 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015342,nivolumab 600 mg per 5 mL solution for injection vial,8001676,nivolumab,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
103005,Marketed,2024-02-12,02541416,OPDUALAG,2.0,L01FY02,Nivolumab and relatlimab,Solution,Intravenous,02541416,OPDUALAG (nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9015027,nivolumab 240 mg per 20 mL and relatlimab 80 mg per 20 mL solution for injection vial,8002502,nivolumab and relatlimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
8915,Marketed,2013-09-26,00778338,AXID,1.0,A02BA04,Nizatidine,Capsule,Oral,00778338,AXID (nizatidine 150 mg oral capsule) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002150,nizatidine 150 mg oral capsule,8001406,nizatidine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72637,Marketed,2022-10-25,02248297,EVRA,2.0,G03AA13,Norelgestromin and estrogen,Patch (extended release),Transdermal,02248297,EVRA (ethinyl estradiol 35 mcg per 24 hour and norelgestromin 200 mcg per 24 hour transdermal patch) SEARCHLIGHT PHARMA INC,Active,9013290,ethinyl estradiol 35 mcg per 24 hour and norelgestromin 200 mcg per 24 hour transdermal patch,8000334,ethinyl estradiol and norelgestromin,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
11641,Marketed,2023-12-12,00893285,NOREPINEPHRINE BITARTRATE INJECTION USP,1.0,C01CA03,Norepinephrine,Solution,Intravenous,00893285,NOREPINEPHRINE BITARTRATE INJECTION USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84377,Marketed,2024-09-20,02358743,"NOREPINEPHRINE BITARTRATE INJECTION, USP",1.0,C01CA03,Norepinephrine,Solution,Intravenous,02358743,"NOREPINEPHRINE BITARTRATE INJECTION, USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) STERIMAX INC",Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
97591,Marketed,2020-05-04,02485680,NOREPINEPHRINE BITARTRATE INJECTION USP,1.0,C01CA03,Norepinephrine,Solution,Intravenous,02485680,NOREPINEPHRINE BITARTRATE INJECTION USP (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection ampoule) GENERIC MEDICAL PARTNERS INC,Active,9013465,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection ampoule,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
99106,Marketed,2021-07-20,02501430,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION,1.0,C01CA03,Norepinephrine,Solution,Intravenous,02501430,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION (norepinephrine (norepinephrine bitartrate) 4 mg per 250 mL solution for injection bag) BAXTER CORPORATION,Active,9014585,norepinephrine (norepinephrine bitartrate) 4 mg per 250 mL solution for injection bag,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
99107,Marketed,2021-07-20,02501449,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION,1.0,C01CA03,Norepinephrine,Solution,Intravenous,02501449,NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION (norepinephrine (norepinephrine bitartrate) 8 mg per 250 mL solution for injection bag) BAXTER CORPORATION,Active,9014586,norepinephrine (norepinephrine bitartrate) 8 mg per 250 mL solution for injection bag,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
102932,Marketed,2024-04-30,02540630,NOREPINEPHRINE BITARTRATE INJECTION,1.0,C01CA03,Norepinephrine,Solution,Intravenous,02540630,NOREPINEPHRINE BITARTRATE INJECTION (norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013466,norepinephrine (norepinephrine bitartrate) 4 mg per 4 mL solution for injection vial,8002036,norepinephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1401,Marketed,2022-10-14,00023760,NORLUTATE,1.0,G03DC02,Norethisterone,Tablet,Oral,00023760,NORLUTATE (norethindrone acetate 5 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9000028,norethindrone acetate 5 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89495,Marketed,2016-05-18,02410303,MOVISSE,1.0,G03AC01,Norethisterone,Tablet,Oral,02410303,MOVISSE (norethindrone 0.35 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92570,Marketed,2018-08-14,02441306,JENCYCLA,1.0,G03AC01,Norethisterone,Tablet,Oral,02441306,JENCYCLA (norethindrone 0.35 mg oral tablet) LUPIN PHARMA CANADA LIMITED,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94584,Marketed,2022-12-16,02458683,MAEVE,1.0,G03AC01,Norethisterone,Tablet,Oral,02458683,MAEVE (norethindrone 0.35 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000062,norethindrone 0.35 mg oral tablet,8000020,norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
20162,Marketed,2009-02-03,02187086,BREVICON 0.5/35 TABLETS (21-DAY PACK),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02187086,BREVICON 0.5/35 TABLETS (21-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9009390,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42888,Marketed,2006-04-18,02187094,BREVICON 0.5/35 TABLETS (28-DAY PACK),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02187094,BREVICON 0.5/35 TABLETS (28-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009393,ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42889,Marketed,2009-02-03,02187108,SYNPHASIC 21 TABLETS,4.0,G03AB04,Norethisterone and estrogen,Tablet,Oral,02187108,SYNPHASIC 21 TABLETS (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet) PFIZER CANADA ULC,Active,9009395,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42890,Marketed,2006-07-20,02187116,SYNPHASIC 28 TABLETS,4.0,G03AB04,Norethisterone and estrogen,Tablet,Oral,02187116,SYNPHASIC 28 TABLETS (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009396,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with ethinyl estradiol 35 mcg and norethindrone 0.5 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42921,Marketed,2009-02-03,02189054,BREVICON 1/35 TABLETS (21-DAY PACK),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02189054,BREVICON 1/35 TABLETS (21-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) PFIZER CANADA ULC,Active,9009394,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42922,Marketed,2009-02-03,02189062,BREVICON 1/35 TABLETS (28-DAY PACK),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02189062,BREVICON 1/35 TABLETS (28-DAY PACK) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009397,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42952,Marketed,2006-02-22,02197502,SELECT 1/35 (21-DAY),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02197502,SELECT 1/35 (21-DAY) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet) PFIZER CANADA ULC,Active,9009394,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
42960,Marketed,2005-01-13,02199297,SELECT 1/35 (28-DAY),2.0,G03AA05,Norethisterone and estrogen,Tablet,Oral,02199297,SELECT 1/35 (28-DAY) (ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet) PFIZER CANADA ULC,Active,9009397,ethinyl estradiol 35 mcg and norethindrone 1 mg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65502,Marketed,2022-12-06,02241835,ESTALIS 140/50 MCG,2.0,G03FA01,Norethisterone and estrogen,Patch,Transdermal,02241835,ESTALIS 140/50 MCG (estradiol 50 mcg per 24 hour and norethindrone acetate 140 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9012362,estradiol 50 mcg per 24 hour and norethindrone acetate 140 mcg per 24 hour transdermal patch,8000917,estradiol and norethindrone,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
65503,Marketed,2022-12-06,02241837,ESTALIS 250/50 MCG,2.0,G03FA01,Norethisterone and estrogen,Patch,Transdermal,02241837,ESTALIS 250/50 MCG (estradiol 50 mcg per 24 hour and norethindrone acetate 250 mcg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9006577,estradiol 50 mcg per 24 hour and norethindrone acetate 250 mcg per 24 hour transdermal patch,8000917,estradiol and norethindrone,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),1.0,,
73420,Marketed,2008-05-16,02249405,ACTIVELLE,2.0,G03FA01,Norethisterone and estrogen,Tablet,Oral,02249405,ACTIVELLE (estradiol 1 mg and norethindrone acetate 0.5 mg oral tablet) NOVO NORDISK CANADA INC,Active,9004423,estradiol 1 mg and norethindrone acetate 0.5 mg oral tablet,8000917,estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79461,Marketed,2008-05-16,02309009,ACTIVELLE LD,2.0,G03FA01,Norethisterone and estrogen,Tablet,Oral,02309009,ACTIVELLE LD (estradiol 0.5 mg and norethindrone acetate 0.1 mg oral tablet) NOVO NORDISK CANADA INC,Active,9004422,estradiol 0.5 mg and norethindrone acetate 0.1 mg oral tablet,8000917,estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90215,Marketed,2024-05-06,02417456,LOLO,3.0,G03AB04,Norethisterone and estrogen,Tablet,Oral,02417456,LOLO (ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with ethinyl estradiol 10 mcg oral tablet with lactose oral tablet) ABBVIE CORPORATION,Active,9009374,ethinyl estradiol 10 mcg and norethindrone acetate 1 mg oral tablet with ethinyl estradiol 10 mcg oral tablet with lactose oral tablet,8000049,ethinyl estradiol and norethindrone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
47429,Marketed,2018-09-18,02229524,NORFLOXACIN,1.0,J01MA06,Norfloxacin,Tablet,Oral,02229524,NORFLOXACIN (norfloxacin 400 mg oral tablet) AA PHARMA INC,Active,9003268,norfloxacin 400 mg oral tablet,8001219,norfloxacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88684,Marketed,2021-03-23,02401967,TRI-CIRA LO 21,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02401967,TRI-CIRA LO 21 (ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet) APOTEX INC,Active,9009380,ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88685,Marketed,2021-03-23,02401975,TRI-CIRA LO 28,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02401975,TRI-CIRA LO 28 (ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009381,ethinyl estradiol 25 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 25 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97651,Marketed,2020-07-08,02486296,TRI-JORDYNA 21,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02486296,TRI-JORDYNA 21 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9009398,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97652,Marketed,2020-03-18,02486318,TRI-JORDYNA 28,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02486318,TRI-JORDYNA 28 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9009399,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99744,Marketed,2021-03-19,02508087,TRI-CIRA 21,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02508087,TRI-CIRA 21 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet) APOTEX INC,Active,9009398,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99745,Marketed,2021-03-08,02508095,TRI-CIRA 28,6.0,G03AB09,Norgestimate and ethinylestradiol,Tablet,Oral,02508095,TRI-CIRA 28 (ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet) APOTEX INC,Active,9009399,ethinyl estradiol 35 mcg and norgestimate 180 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 215 mcg oral tablet with ethinyl estradiol 35 mcg and norgestimate 250 mcg oral tablet with lactose oral tablet,8000164,ethinyl estradiol and norgestimate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
15,Marketed,2022-01-10,00015229,AVENTYL,1.0,N06AA10,Nortriptyline,Capsule,Oral,00015229,AVENTYL (nortriptyline (nortriptyline hydrochloride) 10 mg oral capsule) AA PHARMA INC,Active,9000034,nortriptyline (nortriptyline hydrochloride) 10 mg oral capsule,8000026,nortriptyline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
16,Marketed,2022-01-10,00015237,AVENTYL,1.0,N06AA10,Nortriptyline,Capsule,Oral,00015237,AVENTYL (nortriptyline (nortriptyline hydrochloride) 25 mg oral capsule) AA PHARMA INC,Active,9000035,nortriptyline (nortriptyline hydrochloride) 25 mg oral capsule,8000026,nortriptyline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95389,Marketed,2017-08-29,02465663,SPINRAZA,1.0,M09AX07,Nusinersen,Solution,Intrathecal,02465663,SPINRAZA (nusinersen (nusinersen sodium) 12 mg per 5 mL solution for injection vial) BIOGEN CANADA INC,Active,9012526,nusinersen (nusinersen sodium) 12 mg per 5 mL solution for injection vial,8001132,nusinersen,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
8977,Marketed,1979-12-31,00716871,NYADERM,1.0,D01AA01,Nystatin,Cream,Topical,00716871,NYADERM (nystatin 100000 unit per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000132,nystatin 100000 unit per g cutaneous cream,8000078,nystatin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
9277,Marketed,2022-07-22,00716901,NYADERM,1.0,G01AA01,Nystatin,Cream,Vaginal,00716901,"NYADERM (nystatin 25000 unit per g vaginal cream) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000134,nystatin 25000 unit per g vaginal cream,8000078,nystatin,16857009,Vaginal,385165005,Vaginal cream,,,,,
9973,Marketed,1989-12-31,00792667,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML,1.0,A07AA02,Nystatin,Suspension,Oral,00792667,PMS-NYSTATIN SUSPENSION 100000 UNIT/ML (nystatin 100000 unit per mL oral suspension) PHARMASCIENCE INC,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,
35795,Marketed,2018-05-02,02194163,TEVA-NYSTATIN,1.0,G01AA01,Nystatin,Cream,Vaginal,02194163,TEVA-NYSTATIN (nystatin 100000 unit per g vaginal cream) TEVA CANADA LIMITED,Active,9000820,nystatin 100000 unit per g vaginal cream,8000078,nystatin,16857009,Vaginal,385165005,Vaginal cream,,,,,
35798,Marketed,2018-05-02,02194201,TEVA-NYSTATIN,1.0,A07AA02,Nystatin,Suspension,Oral,02194201,TEVA-NYSTATIN (nystatin 100000 unit per mL oral suspension) TEVA CANADA LIMITED,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,
91783,Marketed,2015-01-09,02433443,JAMP-NYSTATIN ORAL SUSPENSION USP,1.0,A07AA02,Nystatin,Suspension,Oral,02433443,JAMP-NYSTATIN ORAL SUSPENSION USP (nystatin 100000 unit per mL oral suspension) JAMP PHARMA CORPORATION,Active,9000335,nystatin 100000 unit per mL oral suspension,8000078,nystatin,26643006,Oral,385024007,Oral suspension,,,,,
12654,Marketed,2007-12-11,01926829,FLAGYSTATIN,2.0,G01AA51,"Nystatin, combinations",Ovule,Vaginal,01926829,FLAGYSTATIN (metronidazole 500 mg and nystatin 100000 unit pessary) SANOFI-AVENTIS CANADA INC,Active,9001852,metronidazole 500 mg and nystatin 100000 unit pessary,8000814,metronidazole and nystatin,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,
95104,Marketed,2023-12-08,02463121,OCALIVA,1.0,A05AA04,Obeticholic acid,Tablet,Oral,02463121,OCALIVA (obeticholic acid 5 mg oral tablet) ADVANZ PHARMA CANADA INC.,Active,9006182,obeticholic acid 5 mg oral tablet,8002037,obeticholic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95105,Marketed,2023-12-07,02463148,OCALIVA,1.0,A05AA04,Obeticholic acid,Tablet,Oral,02463148,OCALIVA (obeticholic acid 10 mg oral tablet) ADVANZ PHARMA CANADA INC.,Active,9006181,obeticholic acid 10 mg oral tablet,8002037,obeticholic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91910,Marketed,2014-11-28,02434806,GAZYVA,1.0,L01FA03,Obinutuzumab,Solution,Intravenous,02434806,GAZYVA (obinutuzumab 1000 mg per 40 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013467,obinutuzumab 1000 mg per 40 mL solution for injection vial,8002038,obinutuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95561,Marketed,2017-09-21,02467224,OCREVUS,1.0,L04AG08,Ocrelizumab,Solution,Intravenous,02467224,OCREVUS (ocrelizumab 300 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9012527,ocrelizumab 300 mg per 10 mL solution for injection vial,8001135,ocrelizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
9915,Marketed,1998-04-15,00839191,SANDOSTATIN,1.0,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",00839191,SANDOSTATIN (octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection ampoule) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013476,octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection ampoule,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
62792,Marketed,1999-01-27,02239323,SANDOSTATIN LAR,1.0,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239323,SANDOSTATIN LAR (octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013470,octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
62793,Marketed,1999-01-27,02239324,SANDOSTATIN LAR,1.0,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239324,SANDOSTATIN LAR (octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013474,octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
62794,Marketed,1999-01-27,02239325,SANDOSTATIN LAR,1.0,H01CB02,Octreotide,"Powder for suspension, sustained-release",Intramuscular,02239325,SANDOSTATIN LAR (octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013475,octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
72996,Marketed,2004-02-26,02248639,OCTREOTIDE ACETATE OMEGA,1.0,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02248639,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013478,octreotide (octreotide acetate) 50 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72997,Marketed,2004-02-26,02248640,OCTREOTIDE ACETATE OMEGA,1.0,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02248640,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013472,octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72998,Marketed,2004-02-26,02248641,OCTREOTIDE ACETATE OMEGA,1.0,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02248641,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013479,octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72999,Marketed,2004-03-11,02248642,OCTREOTIDE ACETATE OMEGA,1.0,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02248642,OCTREOTIDE ACETATE OMEGA (octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013473,octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99320,Marketed,2021-08-09,02503751,OCTREOTIDE FOR INJECTABLE SUSPENSION,1.0,H01CB02,Octreotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02503751,OCTREOTIDE FOR INJECTABLE SUSPENSION (octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) TEVA CANADA LIMITED,Active,9013470,octreotide (octreotide acetate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
99321,Marketed,2021-08-09,02503778,OCTREOTIDE FOR INJECTABLE SUSPENSION,1.0,H01CB02,Octreotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02503778,OCTREOTIDE FOR INJECTABLE SUSPENSION (octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) TEVA CANADA LIMITED,Active,9013474,octreotide (octreotide acetate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
99322,Marketed,2021-08-09,02503786,OCTREOTIDE FOR INJECTABLE SUSPENSION,1.0,H01CB02,Octreotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02503786,OCTREOTIDE FOR INJECTABLE SUSPENSION (octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) TEVA CANADA LIMITED,Active,9013475,octreotide (octreotide acetate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002040,octreotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
106332,Marketed,2026-01-05,02560240,OCTREOTIDE INJECTION,1.0,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02560240,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial) STERIMAX INC,Active,9013472,octreotide (octreotide acetate) 100 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106336,Marketed,2026-01-07,02560283,OCTREOTIDE INJECTION,1.0,H01CB02,Octreotide,Solution,"Subcutaneous,Intravenous",02560283,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial) STERIMAX INC,Active,9013473,octreotide (octreotide acetate) 1000 mcg per 5 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
106337,Marketed,2026-01-05,02560291,OCTREOTIDE INJECTION,1.0,H01CB02,Octreotide,Solution,"Intravenous,Subcutaneous",02560291,OCTREOTIDE INJECTION (octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial) STERIMAX INC,Active,9013479,octreotide (octreotide acetate) 500 mcg per 1 mL solution for injection vial,8002040,octreotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87257,Marketed,2012-05-30,02387018,TRUE MATCH LUMI,1.0,D02BA02,Octyl methoxycinnamate,Lotion,Topical,,,,,,,,,,,,,,,,
94450,Marketed,2017-01-01,02457458,LISE WATIER CC CREME FPS 25 SPF,1.0,D02BA02,Octyl methoxycinnamate,Cream,Topical,,,,,,,,,,,,,,,,
98113,Marketed,2019-10-30,02491117,SULWHASOO PERFECTING CUSHION,3.0,D02BA02,Octyl methoxycinnamate,Lotion,Topical,,,,,,,,,,,,,,,,
103119,Marketed,2024-02-07,02542641,BYLVAY,1.0,A05AX05,Odevixibat,Capsule,Oral,02542641,BYLVAY (odevixibat 200 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015029,odevixibat 200 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103121,Marketed,2024-02-07,02542676,BYLVAY,1.0,A05AX05,Odevixibat,Capsule,Oral,02542676,BYLVAY (odevixibat 400 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015030,odevixibat 400 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103122,Marketed,2024-03-06,02542684,BYLVAY,1.0,A05AX05,Odevixibat,Capsule,Oral,02542684,BYLVAY (odevixibat 600 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015031,odevixibat 600 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103123,Marketed,2024-02-07,02542692,BYLVAY,1.0,A05AX05,Odevixibat,Capsule,Oral,02542692,BYLVAY (odevixibat 1200 mcg oral capsule) MEDISON PHARMA CANADA INC.,Active,9015028,odevixibat 1200 mcg oral capsule,8002503,odevixibat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100057,Marketed,2021-04-08,02511355,KESIMPTA,1.0,L04AG12,Ofatumumab,Solution,Subcutaneous,02511355,KESIMPTA (ofatumumab 20 mg per 0.4 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014489,ofatumumab 20 mg per 0.4 mL solution for injection pen,8001500,ofatumumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
18491,Marketed,2024-05-27,02143291,OCUFLOX,1.0,S01AE01,Ofloxacin,Solution,Ophthalmic,02143291,OCUFLOX (ofloxacin 0.3 % ophthalmic drops) ABBVIE CORPORATION,Active,9002857,ofloxacin 0.3 % ophthalmic drops,8001407,ofloxacin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
43530,Marketed,2025-01-30,02229250,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02229250,ZYPREXA (olanzapine 2.5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43531,Marketed,2025-01-30,02229269,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02229269,ZYPREXA (olanzapine 5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43532,Marketed,2025-01-30,02229277,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02229277,ZYPREXA (olanzapine 7.5 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43533,Marketed,2025-01-30,02229285,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02229285,ZYPREXA (olanzapine 10 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62290,Marketed,2025-01-30,02238850,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02238850,ZYPREXA (olanzapine 15 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62291,Marketed,2025-01-30,02238851,ZYPREXA,1.0,N05AH03,Olanzapine,Tablet,Oral,02238851,ZYPREXA (olanzapine 20 mg oral tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66953,Marketed,2025-01-30,02243086,ZYPREXA ZYDIS,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243086,ZYPREXA ZYDIS (olanzapine 5 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
66954,Marketed,2025-01-30,02243087,ZYPREXA ZYDIS,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243087,ZYPREXA ZYDIS (olanzapine 10 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
66955,Marketed,2025-01-30,02243088,ZYPREXA ZYDIS,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243088,ZYPREXA ZYDIS (olanzapine 15 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
66956,Marketed,2025-01-30,02243089,ZYPREXA ZYDIS,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02243089,ZYPREXA ZYDIS (olanzapine 20 mg orodispersible tablet) CHEPLAPHARM REGISTRATION GMBH,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
71336,Marketed,2025-12-15,02247099,ZYPREXA INTRAMUSCULAR,1.0,N05AH03,Olanzapine,Powder for solution,Intramuscular,02247099,ZYPREXA INTRAMUSCULAR (olanzapine (olanzapine tartrate) 10 mg per vial powder for solution for injection) CHEPLAPHARM REGISTRATION GMBH,Active,9001069,olanzapine (olanzapine tartrate) 10 mg per vial powder for solution for injection,8000226,olanzapine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
76239,Marketed,2010-04-30,02276712,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02276712,TEVA-OLANZAPINE (olanzapine 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76240,Marketed,2010-04-30,02276720,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02276720,TEVA-OLANZAPINE (olanzapine 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76241,Marketed,2010-04-30,02276739,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02276739,TEVA-OLANZAPINE (olanzapine 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76242,Marketed,2010-04-30,02276747,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02276747,TEVA-OLANZAPINE (olanzapine 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76243,Marketed,2010-04-30,02276755,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02276755,TEVA-OLANZAPINE (olanzapine 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76745,Marketed,2009-10-09,02281791,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02281791,APO-OLANZAPINE (olanzapine 2.5 mg oral tablet) APOTEX INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76746,Marketed,2009-10-09,02281805,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02281805,APO-OLANZAPINE (olanzapine 5 mg oral tablet) APOTEX INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76747,Marketed,2009-10-09,02281813,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02281813,APO-OLANZAPINE (olanzapine 7.5 mg oral tablet) APOTEX INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76748,Marketed,2009-10-09,02281821,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02281821,APO-OLANZAPINE (olanzapine 10 mg oral tablet) APOTEX INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76749,Marketed,2009-10-09,02281848,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02281848,APO-OLANZAPINE (olanzapine 15 mg oral tablet) APOTEX INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78844,Marketed,2008-04-02,02303116,PMS-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02303116,PMS-OLANZAPINE (olanzapine 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78848,Marketed,2008-04-02,02303159,PMS-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02303159,PMS-OLANZAPINE (olanzapine 5 mg oral tablet) PHARMASCIENCE INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78849,Marketed,2008-04-02,02303167,PMS-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02303167,PMS-OLANZAPINE (olanzapine 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78850,Marketed,2008-04-02,02303175,PMS-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02303175,PMS-OLANZAPINE (olanzapine 10 mg oral tablet) PHARMASCIENCE INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78851,Marketed,2008-04-02,02303183,PMS-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02303183,PMS-OLANZAPINE (olanzapine 15 mg oral tablet) PHARMASCIENCE INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78852,Marketed,2009-10-15,02303191,PMS-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303191,PMS-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
78853,Marketed,2009-10-15,02303205,PMS-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303205,PMS-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
78854,Marketed,2009-10-15,02303213,PMS-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02303213,PMS-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) PHARMASCIENCE INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
79599,Marketed,2009-12-06,02310341,SANDOZ OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02310341,SANDOZ OLANZAPINE (olanzapine 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79600,Marketed,2009-12-06,02310368,SANDOZ OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02310368,SANDOZ OLANZAPINE (olanzapine 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79601,Marketed,2009-12-06,02310376,SANDOZ OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02310376,SANDOZ OLANZAPINE (olanzapine 7.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79602,Marketed,2009-12-06,02310384,SANDOZ OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02310384,SANDOZ OLANZAPINE (olanzapine 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79603,Marketed,2009-12-06,02310392,SANDOZ OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02310392,SANDOZ OLANZAPINE (olanzapine 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79749,Marketed,2019-01-31,02311968,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02311968,OLANZAPINE (olanzapine 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79750,Marketed,2019-03-20,02311976,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02311976,OLANZAPINE (olanzapine 5 mg oral tablet) PRO DOC LIMITEE,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79751,Marketed,2019-01-31,02311984,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02311984,OLANZAPINE (olanzapine 7.5 mg oral tablet) PRO DOC LIMITEE,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79752,Marketed,2019-02-13,02311992,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02311992,OLANZAPINE (olanzapine 10 mg oral tablet) PRO DOC LIMITEE,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79753,Marketed,2018-12-11,02312018,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02312018,OLANZAPINE (olanzapine 15 mg oral tablet) PRO DOC LIMITEE,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81318,Marketed,2010-02-26,02327775,SANDOZ OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327775,SANDOZ OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
81319,Marketed,2010-02-26,02327783,SANDOZ OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327783,SANDOZ OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
81320,Marketed,2010-02-26,02327791,SANDOZ OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327791,SANDOZ OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
81321,Marketed,2010-02-26,02327805,SANDOZ OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02327805,SANDOZ OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
81866,Marketed,2009-10-09,02333015,APO-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02333015,APO-OLANZAPINE (olanzapine 20 mg oral tablet) APOTEX INC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82431,Marketed,2018-12-11,02338645,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338645,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82432,Marketed,2018-12-14,02338653,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338653,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82433,Marketed,2018-12-11,02338661,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02338661,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) PRO DOC LIMITEE,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82910,Marketed,2018-06-08,02343665,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343665,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82911,Marketed,2018-06-08,02343673,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343673,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82912,Marketed,2018-06-08,02343681,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343681,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
82913,Marketed,2018-06-08,02343703,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02343703,OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
83820,Marketed,2022-03-25,02352974,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352974,OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) SANIS HEALTH INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
83821,Marketed,2022-03-25,02352982,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352982,OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) SANIS HEALTH INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
83822,Marketed,2022-03-25,02352990,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02352990,OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) SANIS HEALTH INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
84470,Marketed,2011-04-28,02359707,TEVA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02359707,TEVA-OLANZAPINE (olanzapine 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84558,Marketed,2011-11-16,02360616,APO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360616,APO-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) APOTEX INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
84559,Marketed,2011-08-08,02360624,APO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360624,APO-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) APOTEX INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
84560,Marketed,2011-08-08,02360632,APO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360632,APO-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) APOTEX INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
84561,Marketed,2011-08-08,02360640,APO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02360640,APO-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) APOTEX INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
85790,Marketed,2015-10-28,02372819,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02372819,OLANZAPINE (olanzapine 2.5 mg oral tablet) SANIS HEALTH INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85791,Marketed,2015-10-28,02372827,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02372827,OLANZAPINE (olanzapine 5 mg oral tablet) SANIS HEALTH INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85792,Marketed,2015-10-28,02372835,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02372835,OLANZAPINE (olanzapine 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85793,Marketed,2015-10-28,02372843,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02372843,OLANZAPINE (olanzapine 10 mg oral tablet) SANIS HEALTH INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85794,Marketed,2015-10-28,02372851,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02372851,OLANZAPINE (olanzapine 15 mg oral tablet) SANIS HEALTH INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87147,Marketed,2012-06-12,02385864,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385864,OLANZAPINE (olanzapine 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87148,Marketed,2012-06-12,02385872,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385872,OLANZAPINE (olanzapine 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87149,Marketed,2012-06-12,02385880,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385880,OLANZAPINE (olanzapine 7.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87150,Marketed,2012-06-12,02385899,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385899,OLANZAPINE (olanzapine 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87151,Marketed,2012-06-12,02385902,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385902,OLANZAPINE (olanzapine 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87152,Marketed,2023-07-06,02385910,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02385910,OLANZAPINE (olanzapine 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89481,Marketed,2019-09-18,02410141,MINT-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02410141,MINT-OLANZAPINE (olanzapine 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89482,Marketed,2019-09-18,02410168,MINT-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02410168,MINT-OLANZAPINE (olanzapine 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89483,Marketed,2019-09-18,02410176,MINT-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02410176,MINT-OLANZAPINE (olanzapine 7.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89484,Marketed,2019-09-18,02410184,MINT-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02410184,MINT-OLANZAPINE (olanzapine 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89485,Marketed,2019-09-18,02410192,MINT-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02410192,MINT-OLANZAPINE (olanzapine 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90188,Marketed,2015-06-05,02417243,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417243,JAMP OLANZAPINE FC (olanzapine 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90189,Marketed,2015-06-05,02417251,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417251,JAMP OLANZAPINE FC (olanzapine 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90190,Marketed,2015-06-05,02417278,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417278,JAMP OLANZAPINE FC (olanzapine 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90191,Marketed,2015-06-05,02417286,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417286,JAMP OLANZAPINE FC (olanzapine 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90192,Marketed,2015-06-05,02417294,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417294,JAMP OLANZAPINE FC (olanzapine 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90193,Marketed,2015-06-05,02417308,JAMP OLANZAPINE FC,1.0,N05AH03,Olanzapine,Tablet,Oral,02417308,JAMP OLANZAPINE FC (olanzapine 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90636,Marketed,2019-06-28,02421704,OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02421704,OLANZAPINE (olanzapine 20 mg oral tablet) PRO DOC LIMITEE,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90977,Marketed,2017-08-09,02425114,OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02425114,OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) PRO DOC LIMITEE,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92128,Marketed,2015-03-18,02436965,MINT-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436965,MINT-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92129,Marketed,2015-03-18,02436973,MINT-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436973,MINT-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92130,Marketed,2015-03-18,02436981,MINT-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02436981,MINT-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93444,Marketed,2015-12-01,02448726,AURO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448726,AURO-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) AURO PHARMA INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93445,Marketed,2015-12-01,02448734,AURO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448734,AURO-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) AURO PHARMA INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93446,Marketed,2015-12-01,02448742,AURO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448742,AURO-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) AURO PHARMA INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93447,Marketed,2015-12-01,02448750,AURO-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02448750,AURO-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) AURO PHARMA INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102498,Marketed,2024-04-08,02536188,NRA-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536188,NRA-OLANZAPINE ODT (olanzapine 5 mg orodispersible tablet) NORA PHARMA INC,Active,9000934,olanzapine 5 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102499,Marketed,2024-04-08,02536196,NRA-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536196,NRA-OLANZAPINE ODT (olanzapine 10 mg orodispersible tablet) NORA PHARMA INC,Active,9000935,olanzapine 10 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102500,Marketed,2024-04-08,02536218,NRA-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536218,NRA-OLANZAPINE ODT (olanzapine 15 mg orodispersible tablet) NORA PHARMA INC,Active,9001068,olanzapine 15 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102501,Marketed,2024-04-08,02536226,NRA-OLANZAPINE ODT,1.0,N05AH03,Olanzapine,Tablet (orally disintegrating),Oral,02536226,NRA-OLANZAPINE ODT (olanzapine 20 mg orodispersible tablet) NORA PHARMA INC,Active,9001186,olanzapine 20 mg orodispersible tablet,8000226,olanzapine,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
103433,Marketed,2024-04-08,02545586,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545586,NRA-OLANZAPINE (olanzapine 2.5 mg oral tablet) NORA PHARMA INC,Active,9000766,olanzapine 2.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103434,Marketed,2024-04-08,02545594,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545594,NRA-OLANZAPINE (olanzapine 5 mg oral tablet) NORA PHARMA INC,Active,9000670,olanzapine 5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103435,Marketed,2024-04-08,02545608,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545608,NRA-OLANZAPINE (olanzapine 7.5 mg oral tablet) NORA PHARMA INC,Active,9000667,olanzapine 7.5 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103436,Marketed,2024-04-08,02545616,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545616,NRA-OLANZAPINE (olanzapine 10 mg oral tablet) NORA PHARMA INC,Active,9000669,olanzapine 10 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103437,Marketed,2024-04-08,02545624,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545624,NRA-OLANZAPINE (olanzapine 15 mg oral tablet) NORA PHARMA INC,Active,9000993,olanzapine 15 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103438,Marketed,2024-04-08,02545632,NRA-OLANZAPINE,1.0,N05AH03,Olanzapine,Tablet,Oral,02545632,NRA-OLANZAPINE (olanzapine 20 mg oral tablet) NORA PHARMA INC,Active,9001199,olanzapine 20 mg oral tablet,8000226,olanzapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96554,Marketed,2018-05-23,02475200,LYNPARZA,1.0,L01XK01,Olaparib,Tablet,Oral,02475200,LYNPARZA (olaparib 100 mg oral tablet) ASTRAZENECA CANADA INC,Active,9013480,olaparib 100 mg oral tablet,8002041,olaparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96555,Marketed,2018-05-23,02475219,LYNPARZA,1.0,L01XK01,Olaparib,Tablet,Oral,02475219,LYNPARZA (olaparib 150 mg oral tablet) ASTRAZENECA CANADA INC,Active,9013481,olaparib 150 mg oral tablet,8002041,olaparib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103447,Marketed,2024-10-18,02545721,XENPOZYME,1.0,A16AB25,Olipudase alfa,Powder for solution,Intravenous,02545721,XENPOZYME (olipudase alfa 20 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9015124,olipudase alfa 20 mg per vial powder for solution for injection,8002521,olipudase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
80414,Marketed,2023-08-03,02318660,OLMETEC,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02318660,OLMETEC (olmesartan medoxomil 20 mg oral tablet) ORGANON CANADA INC.,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80415,Marketed,2023-04-13,02318679,OLMETEC,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02318679,OLMETEC (olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92655,Marketed,2023-03-10,02442191,TEVA-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02442191,TEVA-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92656,Marketed,2023-03-10,02442205,TEVA-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02442205,TEVA-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92810,Marketed,2017-05-01,02443414,SANDOZ OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443414,SANDOZ OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92811,Marketed,2017-05-01,02443422,SANDOZ OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443422,SANDOZ OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92863,Marketed,2017-05-01,02443864,AURO-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443864,AURO-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) AURO PHARMA INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92864,Marketed,2017-05-01,02443872,AURO-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02443872,AURO-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94319,Marketed,2020-05-06,02456311,ACH-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02456311,ACH-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94320,Marketed,2020-05-06,02456338,ACH-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02456338,ACH-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94881,Marketed,2017-06-02,02461307,PMS-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461307,PMS-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) PHARMASCIENCE INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94882,Marketed,2017-06-02,02461315,PMS-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461315,PMS-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) PHARMASCIENCE INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94931,Marketed,2021-10-28,02461641,JAMP OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461641,JAMP OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94932,Marketed,2021-10-28,02461668,JAMP OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02461668,JAMP OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95870,Marketed,2019-03-05,02469812,GLN-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02469812,GLN-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95871,Marketed,2019-03-05,02469820,GLN-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02469820,GLN-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97140,Marketed,2020-02-21,02481057,OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02481057,OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) SANIS HEALTH INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97141,Marketed,2020-02-21,02481065,OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02481065,OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) SANIS HEALTH INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97883,Marketed,2019-07-09,02488744,OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02488744,OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) PRO DOC LIMITEE,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97884,Marketed,2019-07-09,02488752,OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02488752,OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) PRO DOC LIMITEE,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98899,Marketed,2020-11-04,02499258,NRA-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02499258,NRA-OLMESARTAN (olmesartan medoxomil 20 mg oral tablet) NORA PHARMA INC,Active,9001265,olmesartan medoxomil 20 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98900,Marketed,2020-11-04,02499266,NRA-OLMESARTAN,1.0,C09CA08,Olmesartan medoxomil,Tablet,Oral,02499266,NRA-OLMESARTAN (olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001266,olmesartan medoxomil 40 mg oral tablet,8000383,olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80508,Marketed,2022-10-31,02319616,OLMETEC PLUS,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319616,OLMETEC PLUS (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) ORGANON CANADA INC.,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80509,Marketed,2023-01-03,02319624,OLMETEC PLUS,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319624,OLMETEC PLUS (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80510,Marketed,2022-12-16,02319632,OLMETEC PLUS,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02319632,OLMETEC PLUS (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) ORGANON CANADA INC.,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92768,Marketed,2023-12-01,02443112,TEVA-OLMESARTAN / HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443112,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92771,Marketed,2023-12-01,02443120,TEVA-OLMESARTAN / HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443120,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92772,Marketed,2023-12-01,02443139,TEVA-OLMESARTAN / HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02443139,TEVA-OLMESARTAN / HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95759,Marketed,2019-06-27,02468948,ACH-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468948,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95760,Marketed,2019-06-27,02468956,ACH-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468956,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95761,Marketed,2019-06-27,02468964,ACH-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02468964,ACH-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96608,Marketed,2020-02-28,02475707,GLN-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475707,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96609,Marketed,2020-02-28,02475715,GLN-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475715,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96610,Marketed,2020-02-28,02475723,GLN-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02475723,GLN-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96741,Marketed,2019-01-29,02476487,AURO-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476487,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) AURO PHARMA INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96742,Marketed,2019-01-29,02476495,AURO-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476495,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96743,Marketed,2019-01-29,02476509,AURO-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02476509,AURO-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) AURO PHARMA INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99766,Marketed,2021-07-20,02508273,NRA-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508273,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) NORA PHARMA INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99767,Marketed,2021-07-20,02508281,NRA-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508281,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001263,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99768,Marketed,2021-07-20,02508303,NRA-OLMESARTAN HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02508303,NRA-OLMESARTAN HCTZ (hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet) NORA PHARMA INC,Active,9001264,hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99889,Marketed,2021-06-14,02509601,OLMESARTAN/HCTZ,2.0,C09DA08,Olmesartan medoxomil and diuretics,Tablet,Oral,02509601,OLMESARTAN/HCTZ (hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet) SANIS HEALTH INC,Active,9001262,hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet,8000382,hydrochlorothiazide and olmesartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92626,Marketed,2015-05-29,02441888,INSPIOLTO RESPIMAT,2.0,R03AL06,Olodaterol and tiotropium bromide,Solution,Inhalation,02441888,INSPIOLTO RESPIMAT (olodaterol (olodaterol hydrochloride) 2.5 mcg per actuation and tiotropium (tiotropium bromide monohydrate) 2.5 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005723,olodaterol (olodaterol hydrochloride) 2.5 mcg per actuation and tiotropium (tiotropium bromide) 2.5 mcg per actuation inhalation solution,8001085,olodaterol and tiotropium,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,
53275,Marketed,2018-06-13,02233143,PATANOL,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02233143,PATANOL (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
84395,Marketed,2013-02-04,02358913,SANDOZ OLOPATADINE,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02358913,SANDOZ OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
84721,Marketed,2018-05-09,02362171,PATADAY,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02362171,PATADAY (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90478,Marketed,2014-02-24,02420171,SANDOZ OLOPATADINE 0.2%,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02420171,SANDOZ OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
90739,Marketed,2014-07-29,02422727,MINT-OLOPATADINE,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02422727,MINT-OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) MINT PHARMACEUTICALS INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94571,Marketed,2018-03-12,02458551,PAZEO,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02458551,PAZEO (olopatadine (olopatadine hydrochloride) 0.7 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012587,olopatadine (olopatadine hydrochloride) 0.7 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
99796,Marketed,2021-12-17,02508605,MINT-OLOPATADINE 0.2%,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02508605,MINT-OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) MINT PHARMACEUTICALS INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101039,Marketed,2022-07-13,02521172,OLOPATADINE,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02521172,OLOPATADINE (olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops) SANIS HEALTH INC,Active,9000778,olopatadine (olopatadine hydrochloride) 0.1 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
103030,Marketed,2024-04-08,02541653,OLOPATADINE 0.2%,1.0,S01GX09,Olopatadine,Solution,Ophthalmic,02541653,OLOPATADINE 0.2% (olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops) SANIS HEALTH INC,Active,9001342,olopatadine (olopatadine hydrochloride) 0.2 % ophthalmic drops,8000251,olopatadine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
17893,Marketed,2025-04-08,02063808,DIPENTUM,1.0,A07EC03,Olsalazine,Capsule,Oral,02063808,DIPENTUM (olsalazine sodium 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002858,olsalazine sodium 250 mg oral capsule,8001408,olsalazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74602,Marketed,2005-02-03,02260565,XOLAIR,1.0,R03DX05,Omalizumab,Powder for solution,Subcutaneous,02260565,XOLAIR (omalizumab 150 mg per vial powder for solution for injection) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004010,omalizumab 150 mg per vial powder for solution for injection,8001060,omalizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94711,Marketed,2017-06-28,02459787,XOLAIR,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02459787,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94712,Marketed,2017-07-06,02459795,XOLAIR,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02459795,XOLAIR (omalizumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103392,Marketed,2024-09-25,02545136,XOLAIR,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02545136,XOLAIR (omalizumab 75 mg per 0.5 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015102,omalizumab 75 mg per 0.5 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103393,Marketed,2024-09-25,02545144,XOLAIR,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02545144,XOLAIR (omalizumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015101,omalizumab 150 mg per 1 mL solution for injection pen,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
103395,Marketed,2025-10-15,02545160,XOLAIR,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02545160,XOLAIR (omalizumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015268,omalizumab 300 mg per 2 mL solution for injection syringe,8001060,omalizumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
104271,Marketed,2025-03-04,02553805,OMLYCLO,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02553805,OMLYCLO (omalizumab 75 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9012530,omalizumab 75 mg per 0.5 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104272,Marketed,2025-03-04,02553813,OMLYCLO,1.0,R03DX05,Omalizumab,Solution,Subcutaneous,02553813,OMLYCLO (omalizumab 150 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9012588,omalizumab 150 mg per 1 mL solution for injection syringe,8001060,omalizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
98517,Marketed,2020-02-07,02495244,VASCEPA,1.0,C10AX06,Omega-3-triglycerides incl. other esters and acids,Capsule,Oral,02495244,VASCEPA (icosapent ethyl 1 g oral capsule) HLS THERAPEUTICS INC,Active,9014244,icosapent ethyl 1 g oral capsule,8002318,icosapent,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9823,Marketed,2020-11-03,00846503,LOSEC,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,00846503,LOSEC (omeprazole 20 mg gastro-resistant capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
66187,Marketed,2021-06-16,02242462,LOSEC MUPS,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02242462,LOSEC MUPS (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
69062,Marketed,2004-01-28,02245058,APO-OMEPRAZOLE,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02245058,APO-OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) APOTEX INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
78071,Marketed,2013-11-14,02295407,TEVA-OMEPRAZOLE,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02295407,TEVA-OMEPRAZOLE (omeprazole (omeprazole magnesium) 10 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000724,omeprazole (omeprazole magnesium) 10 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78072,Marketed,2013-07-04,02295415,TEVA-OMEPRAZOLE,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02295415,TEVA-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78176,Marketed,2007-09-14,02296446,SANDOZ OMEPRAZOLE,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02296446,SANDOZ OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) SANDOZ CANADA INCORPORATED,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
82550,Marketed,2010-02-05,02339927,OMEPRAZOLE,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02339927,OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) PRO DOC LIMITEE,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
83404,Marketed,2016-12-22,02348691,OMEPRAZOLE,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02348691,OMEPRAZOLE (omeprazole 20 mg gastro-resistant capsule) SANIS HEALTH INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
88725,Marketed,2015-08-12,02402416,RIVA-OMEPRAZOLE DR,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02402416,RIVA-OMEPRAZOLE DR (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
89644,Marketed,2013-10-23,02411857,OMEPRAZOLE-20,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02411857,OMEPRAZOLE-20 (omeprazole 20 mg gastro-resistant capsule) SIVEM PHARMACEUTICALS ULC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
90114,Marketed,2024-05-22,02416549,ACH-OMEPRAZOLE,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02416549,ACH-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) ACCORD HEALTHCARE INC,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90479,Marketed,2016-02-10,02420198,JAMP-OMEPRAZOLE DR,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02420198,JAMP-OMEPRAZOLE DR (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92002,Marketed,2015-03-12,02435683,HEARTBURN CONTROL,1.0,A02BC01,Omeprazole,Capsule (delayed release),Oral,02435683,HEARTBURN CONTROL (omeprazole 20 mg gastro-resistant capsule) APOTEX INC,Active,9000336,omeprazole 20 mg gastro-resistant capsule,8000131,omeprazole,26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),,,
93579,Marketed,2016-09-07,02449927,BIO-OMEPRAZOLE,1.0,A02BC01,Omeprazole,Tablet (delayed-release),Oral,02449927,BIO-OMEPRAZOLE (omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet) BIOMED PHARMA,Active,9000691,omeprazole (omeprazole magnesium) 20 mg gastro-resistant tablet,8000131,omeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701036,ZOLGENSMA (onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014511,onasemnogene abeparvovec 2.212e15 vg per 110.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701037,ZOLGENSMA (onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014518,onasemnogene abeparvovec 5.52e14 vg per 27.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701038,ZOLGENSMA (onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014514,onasemnogene abeparvovec 3.32e14 vg per 16.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701039,ZOLGENSMA (onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014510,onasemnogene abeparvovec 2.158e15 vg per 107.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701040,ZOLGENSMA (onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014500,onasemnogene abeparvovec 1.604e15 vg per 80.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701041,ZOLGENSMA (onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014502,onasemnogene abeparvovec 1.714e15 vg per 85.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701042,ZOLGENSMA (onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014508,onasemnogene abeparvovec 2.046e15 vg per 102.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701043,ZOLGENSMA (onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014517,onasemnogene abeparvovec 4.98e14 vg per 24.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701044,ZOLGENSMA (onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014513,onasemnogene abeparvovec 2.324e15 vg per 116.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701045,ZOLGENSMA (onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014504,onasemnogene abeparvovec 1.826e15 vg per 91.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701046,ZOLGENSMA (onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014496,onasemnogene abeparvovec 1.382e15 vg per 69.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701047,ZOLGENSMA (onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014512,onasemnogene abeparvovec 2.268e15 vg per 113.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701048,ZOLGENSMA (onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014499,onasemnogene abeparvovec 1.548e15 vg per 77.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701049,ZOLGENSMA (onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014523,onasemnogene abeparvovec 8.3e14 vg per 41.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701050,ZOLGENSMA (onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014509,onasemnogene abeparvovec 2.102e15 vg per 105.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701051,ZOLGENSMA (onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014521,onasemnogene abeparvovec 7.18e14 vg per 35.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701052,ZOLGENSMA (onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014519,onasemnogene abeparvovec 6.08e14 vg per 30.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701053,ZOLGENSMA (onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014505,onasemnogene abeparvovec 1.88e15 vg per 94 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701054,ZOLGENSMA (onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014507,onasemnogene abeparvovec 1.992e15 vg per 99.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701055,ZOLGENSMA (onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014497,onasemnogene abeparvovec 1.438e15 vg per 71.9 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701056,ZOLGENSMA (onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014526,onasemnogene abeparvovec 9.96e14 vg per 49.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701057,ZOLGENSMA (onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014525,onasemnogene abeparvovec 9.4e14 vg per 47 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701058,ZOLGENSMA (onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014501,onasemnogene abeparvovec 1.66e15 vg per 83 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701059,ZOLGENSMA (onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014506,onasemnogene abeparvovec 1.936e15 vg per 96.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701060,ZOLGENSMA (onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014520,onasemnogene abeparvovec 6.64e14 vg per 33.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701061,ZOLGENSMA (onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014503,onasemnogene abeparvovec 1.77e15 vg per 88.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701062,ZOLGENSMA (onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014516,onasemnogene abeparvovec 4.42e14 vg per 22.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701063,ZOLGENSMA (onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014492,onasemnogene abeparvovec 1.162e15 vg per 58.1 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701064,ZOLGENSMA (onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014494,onasemnogene abeparvovec 1.272e15 vg per 63.6 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701065,ZOLGENSMA (onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014515,onasemnogene abeparvovec 3.86e14 vg per 19.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701066,ZOLGENSMA (onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014490,onasemnogene abeparvovec 1.05e15 vg per 52.5 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701067,ZOLGENSMA (onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014493,onasemnogene abeparvovec 1.216e15 vg per 60.8 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701068,ZOLGENSMA (onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014522,onasemnogene abeparvovec 7.74e14 vg per 38.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701069,ZOLGENSMA (onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014498,onasemnogene abeparvovec 1.494e15 vg per 74.7 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701070,ZOLGENSMA (onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014491,onasemnogene abeparvovec 1.106e15 vg per 55.3 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701071,ZOLGENSMA (onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014495,onasemnogene abeparvovec 1.328e15 vg per 66.4 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99897,Marketed,2021-02-04,02509695,ZOLGENSMA,1.0,M09AX09,Onasemnogene abeparvovec,Solution,Intravenous,77701072,ZOLGENSMA (onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014524,onasemnogene abeparvovec 8.84e14 vg per 44.2 mL solution for injection vial,8002364,onasemnogene abeparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
74341,Marketed,2006-04-19,02258188,PMS-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02258188,PMS-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) PHARMASCIENCE INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74342,Marketed,2006-04-19,02258196,PMS-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02258196,PMS-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) PHARMASCIENCE INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75976,Marketed,2006-04-19,02274310,SANDOZ ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02274310,SANDOZ ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75977,Marketed,2006-04-19,02274329,SANDOZ ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02274329,SANDOZ ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75986,Marketed,2012-06-28,02274418,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,77700581,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012532,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
75986,Marketed,2012-06-28,02274418,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,77700582,ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9012535,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
76501,Marketed,2006-04-19,02279428,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE),1.0,A04AA01,Ondansetron,Solution,Intravenous,77700541,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE) (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
76501,Marketed,2006-04-19,02279428,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE),1.0,A04AA01,Ondansetron,Solution,Intravenous,77700542,ONDANSETRON INJECTION USP   -(PRESERVATIVE FREE) (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
76502,Marketed,2006-04-19,02279436,ONDANSETRON INJECTION USP   -(WITH PRESERVATIVE),1.0,A04AA01,Ondansetron,Solution,Intravenous,02279436,ONDANSETRON INJECTION USP   -(WITH PRESERVATIVE) (ondansetron (ondansetron hydrochloride dihydrate) 2 mg per mL solution for injection 20 mL vial) SANDOZ CANADA INCORPORATED,Active,9012531,ondansetron (ondansetron hydrochloride) 2 mg per mL solution for injection 20 mL vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
77362,Marketed,2006-11-16,02288184,APO-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02288184,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) APOTEX INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77363,Marketed,2006-11-16,02288192,APO-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02288192,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) APOTEX INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77733,Marketed,2020-12-17,02291967,APO-ONDANSETRON,1.0,A04AA01,Ondansetron,Solution,Oral,02291967,APO-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 5 mL oral solution) APOTEX INC,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,
78168,Marketed,2022-05-09,02296349,TEVA-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02296349,TEVA-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) TEVA CANADA LIMITED,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78169,Marketed,2022-05-09,02296357,TEVA-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02296357,TEVA-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) TEVA CANADA LIMITED,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78319,Marketed,2011-04-08,02297868,MYLAN-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02297868,MYLAN-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78320,Marketed,2010-05-21,02297876,MYLAN-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02297876,MYLAN-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79079,Marketed,2013-10-31,02305259,MINT-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02305259,MINT-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79080,Marketed,2013-10-31,02305267,MINT-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02305267,MINT-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79919,Marketed,2008-09-26,02313685,JAMP-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02313685,JAMP-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79920,Marketed,2008-09-26,02313693,JAMP-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02313693,JAMP-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81057,Marketed,2023-11-07,02325160,ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02325160,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) PRO DOC LIMITEE,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85687,Marketed,2012-12-21,02371731,MAR-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02371731,MAR-ONDANSETRON (ondansetron (ondansetron hydrochloride) 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85688,Marketed,2012-12-21,02371758,MAR-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02371758,MAR-ONDANSETRON (ondansetron (ondansetron hydrochloride) 8 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87545,Marketed,2013-02-08,02389983,ONDISSOLVE ODF,1.0,A04AA01,Ondansetron,"Film, soluble",Oral,02389983,ONDISSOLVE ODF (ondansetron 4 mg orodispersible film) TAKEDA CANADA INC,Active,9005179,ondansetron 4 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,
87546,Marketed,2013-02-08,02389991,ONDISSOLVE ODF,1.0,A04AA01,Ondansetron,"Film, soluble",Oral,02389991,ONDISSOLVE ODF (ondansetron 8 mg orodispersible film) TAKEDA CANADA INC,Active,9005180,ondansetron 8 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,
90245,Marketed,2015-03-18,02417839,NAT-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02417839,NAT-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90246,Marketed,2015-03-18,02417847,NAT-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02417847,NAT-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90603,Marketed,2017-09-27,02421402,ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02421402,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SANIS HEALTH INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90604,Marketed,2017-09-27,02421410,ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02421410,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SANIS HEALTH INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94903,Marketed,2021-10-07,02461420,ONDANSETRON INJECTION BP,1.0,A04AA01,Ondansetron,Solution,Intravenous,77701095,ONDANSETRON INJECTION BP (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection ampoule) AURO PHARMA INC,Active,9012535,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94903,Marketed,2021-10-07,02461420,ONDANSETRON INJECTION BP,1.0,A04AA01,Ondansetron,Solution,Intravenous,77701096,ONDANSETRON INJECTION BP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection ampoule) AURO PHARMA INC,Active,9012532,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection ampoule,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94995,Marketed,2021-04-28,02462257,ONDANSETRON INJECTION USP,1.0,A04AA01,Ondansetron,Solution,Intravenous,02462257,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 2 mg per mL solution for injection 20 mL vial) STERIMAX INC,Active,9012531,ondansetron (ondansetron hydrochloride) 2 mg per mL solution for injection 20 mL vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95270,Marketed,2018-05-22,02464578,ONDANSETRON INJECTION USP,1.0,A04AA01,Ondansetron,Solution,Intravenous,77700587,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95270,Marketed,2018-05-22,02464578,ONDANSETRON INJECTION USP,1.0,A04AA01,Ondansetron,Solution,Intravenous,77700588,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) STERIMAX INC,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96963,Marketed,2019-09-19,02478927,ACCEL-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02478927,ACCEL-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) ACCEL PHARMA INC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96964,Marketed,2019-09-19,02478935,ACCEL-ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02478935,ACCEL-ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) ACCEL PHARMA INC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97221,Marketed,2019-05-15,02481723,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02481723,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97222,Marketed,2019-05-15,02481731,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02481731,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97750,Marketed,2019-10-16,02487330,MINT-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02487330,MINT-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97751,Marketed,2019-10-16,02487349,MINT-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02487349,MINT-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) MINT PHARMACEUTICALS INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
98068,Marketed,2020-04-22,02490617,JAMP ONDANSETRON,1.0,A04AA01,Ondansetron,Solution,Oral,02490617,JAMP ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,
98138,Marketed,2021-10-07,02491524,AURO-ONDANSETRON INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,02491524,AURO-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) AURO PHARMA INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98152,Marketed,2021-07-29,02491532,AURO-ONDANSETRON INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,02491532,AURO-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) AURO PHARMA INC,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99334,Marketed,2021-05-10,02503905,ONDANSETRON INJECTION USP,1.0,A04AA01,Ondansetron,Solution,Intravenous,02503905,ONDANSETRON INJECTION USP (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100050,Marketed,2021-12-23,02511282,AURO-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02511282,AURO-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) AURO PHARMA INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100051,Marketed,2021-12-23,02511290,AURO-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02511290,AURO-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) AURO PHARMA INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100436,Marketed,2022-04-05,02514966,MAR-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02514966,MAR-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100437,Marketed,2022-04-05,02514974,MAR-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02514974,MAR-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100851,Marketed,2022-04-25,02519232,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519232,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100852,Marketed,2022-04-25,02519240,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519240,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100871,Marketed,2022-04-14,02519445,PMS-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519445,PMS-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) PHARMASCIENCE INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100872,Marketed,2022-04-14,02519453,PMS-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02519453,PMS-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) PHARMASCIENCE INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
101313,Marketed,2024-09-11,02524090,MINT-ONDANSETRON SOLUTION,1.0,A04AA01,Ondansetron,Solution,Oral,02524090,MINT-ONDANSETRON SOLUTION (ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution) MINT PHARMACEUTICALS INC,Active,9012534,ondansetron (ondansetron hydrochloride) 4 mg per 5 mL oral solution,8001106,ondansetron,26643006,Oral,385023001,Oral solution,,,,,
101331,Marketed,2025-07-08,02524279,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02524279,ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) SANIS HEALTH INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
101332,Marketed,2025-07-08,02524287,ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02524287,ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) SANIS HEALTH INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102417,Marketed,2023-12-19,02535319,ACCEL-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02535319,ACCEL-ONDANSETRON ODT (ondansetron 4 mg orodispersible tablet) ACCEL PHARMA INC,Active,9003372,ondansetron 4 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
102418,Marketed,2023-12-19,02535327,ACCEL-ONDANSETRON ODT,1.0,A04AA01,Ondansetron,Tablet (orally disintegrating),Oral,02535327,ACCEL-ONDANSETRON ODT (ondansetron 8 mg orodispersible tablet) ACCEL PHARMA INC,Active,9003373,ondansetron 8 mg orodispersible tablet,8001106,ondansetron,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
103000,Marketed,2024-05-10,02541351,JAMP ONDANSETRON ODF,1.0,A04AA01,Ondansetron,"Film, soluble",Oral,02541351,JAMP ONDANSETRON ODF (ondansetron 4 mg orodispersible film) JAMP PHARMA CORPORATION,Active,9005179,ondansetron 4 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,
103001,Marketed,2024-05-10,02541378,JAMP ONDANSETRON ODF,1.0,A04AA01,Ondansetron,"Film, soluble",Oral,02541378,JAMP ONDANSETRON ODF (ondansetron 8 mg orodispersible film) JAMP PHARMA CORPORATION,Active,9005180,ondansetron 8 mg orodispersible film,8001106,ondansetron,26643006,Oral,447050008,Orodispersible film,732995004,Film (unit of presentation),,,
103007,Marketed,2024-03-25,02541424,ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02541424,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004408,ondansetron (ondansetron hydrochloride) 4 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103008,Marketed,2024-03-25,02541432,ONDANSETRON,1.0,A04AA01,Ondansetron,Tablet,Oral,02541432,ONDANSETRON (ondansetron (ondansetron hydrochloride dihydrate) 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9004409,ondansetron (ondansetron hydrochloride) 8 mg oral tablet,8001106,ondansetron,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103346,Marketed,2024-10-08,02544822,EUGIA-ONDANSETRON INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,02544822,EUGIA-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 4 mg per 2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012533,ondansetron (ondansetron hydrochloride) 4 mg per 2 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103347,Marketed,2024-10-08,02544830,EUGIA-ONDANSETRON INJECTION,1.0,A04AA01,Ondansetron,Solution,Intravenous,02544830,EUGIA-ONDANSETRON INJECTION (ondansetron (ondansetron hydrochloride dihydrate) 8 mg per 4 mL solution for injection vial) EUGIA PHARMA INC.,Active,9012536,ondansetron (ondansetron hydrochloride) 8 mg per 4 mL solution for injection vial,8001106,ondansetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94350,Marketed,2017-03-23,02456532,BEPREVE,1.0,S01,Ophthalmologicals,Solution,Ophthalmic,02456532,BEPREVE (bepotastine besilate 1.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9006144,bepotastine besilate 1.5 % ophthalmic drops,8001582,bepotastine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
4469,Marketed,2013-04-24,00535230,CALMYLIN,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,00535230,CALMYLIN (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,
6844,Marketed,2013-04-11,00690074,COUGH SYRUP,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,00690074,COUGH SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,
12449,Marketed,2019-09-03,01944762,BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,01944762,BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
13296,Marketed,2024-06-12,01931024,ROBITUSSIN COUGH CONTROL,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,01931024,ROBITUSSIN COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
13440,Marketed,2019-09-03,02003317,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02003317,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
15618,Marketed,2018-03-05,02053403,TEVA-COTRIDIN EXPECTORANT,4.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02053403,TEVA-COTRIDIN EXPECTORANT (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002653,codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL and triprolidine hydrochloride 2 mg per 5 mL syrup,8002112,codeine and guaifenesin and pseudoephedrine and triprolidine,26643006,Oral,739009002,Syrup,,,,,
19026,Marketed,2024-05-31,02142775,ROBITUSSIN EXTRA STRENGTH COUGH CONTROL,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02142775,ROBITUSSIN EXTRA STRENGTH COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) HALEON CANADA ULC,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
19060,Marketed,2024-05-23,02172380,ROBITUSSIN EXTRA STRENGTH COUGH & COLD,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02172380,ROBITUSSIN EXTRA STRENGTH COUGH & COLD (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) HALEON CANADA ULC,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
19625,Marketed,2013-04-23,02099748,COUGH SYRUP WITH CODEINE,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02099748,COUGH SYRUP WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002768,codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001364,codeine and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
19690,Marketed,2013-04-16,02198630,CALMYLIN ACE,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02198630,CALMYLIN ACE (codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002543,codeine phosphate 10 mg per 5 mL and guaifenesin 100 mg per 5 mL and pheniramine maleate 7.5 mg per 5 mL syrup,8001900,codeine and guaifenesin and pheniramine,26643006,Oral,739009002,Syrup,,,,,
34650,Marketed,2013-05-03,02172917,CALMYLIN PSE WITH CODEINE,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02172917,CALMYLIN PSE WITH CODEINE (codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) TEVA CANADA LIMITED,Active,9002768,codeine phosphate 3.3 mg per 5 mL and guaifenesin 100 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001364,codeine and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
69689,Marketed,2002-09-13,02245592,DAMYLIN WITH CODEINE SYRUP,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02245592,DAMYLIN WITH CODEINE SYRUP (ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup) LABORATOIRE RIVA INC.,Active,9003752,ammonium chloride 125 mg per 5 mL and codeine phosphate 3.3 mg per 5 mL and diphenhydramine hydrochloride 12.5 mg per 5 mL syrup,8001692,ammonium chloride and codeine and diphenhydramine,26643006,Oral,739009002,Syrup,,,,,
72923,Marketed,2022-04-04,02248568,ROBITUSSIN SUGAR FREE COUGH CONTROL,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02248568,ROBITUSSIN SUGAR FREE COUGH CONTROL (dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,Active,9014268,dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
75087,Marketed,2020-04-30,02265400,BENYLIN EXTRA STRENGTH COUGH COMPLETE,4.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02265400,BENYLIN EXTRA STRENGTH COUGH COMPLETE (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004091,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001747,dextromethorphan and guaifenesin and menthol and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
75088,Marketed,2019-09-03,02265419,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02265419,BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
80637,Marketed,2011-10-07,02320959,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02320959,BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
91764,Marketed,2024-07-25,02433249,"MUCINEX MULTI-ACTION CONGESTION, STUFFY NOSE & COUGH LIQUID",3.0,R05FA02,Opium derivatives and expectorants,Solution,Oral,02433249,"MUCINEX MULTI-ACTION CONGESTION, STUFFY NOSE & COUGH LIQUID (dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution) RB HEALTH (CANADA) INC.",Active,9015070,dextromethorphan hydrobromide 20 mg per 20 mL and guaifenesin 400 mg per 20 mL and phenylephrine hydrochloride 10 mg per 20 mL oral solution,8002381,dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,385023001,Oral solution,,,,,
91765,Marketed,2026-01-12,02433257,MUCINEX CONGESTION & COUGH,2.0,R05FA02,Opium derivatives and expectorants,Solution,Oral,02433257,MUCINEX CONGESTION & COUGH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) RB HEALTH (CANADA) INC.,Active,9002350,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
92082,Marketed,2017-09-28,02436485,BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02436485,BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9004029,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup,8001746,dextromethorphan and guaifenesin and menthol,26643006,Oral,739009002,Syrup,,,,,
97576,Marketed,2024-05-17,02485524,ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02485524,ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION (dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014097,dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
99274,Marketed,2021-07-19,02503247,DAYQUIL COUGH DM + CONGESTION,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02503247,DAYQUIL COUGH DM + CONGESTION (dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup) PROCTER & GAMBLE INC,Active,9014566,dextromethorphan hydrobromide 20 mg per 30 mL and guaifenesin 400 mg per 30 mL and phenylephrine hydrochloride 10 mg per 30 mL syrup,8002381,dextromethorphan and guaifenesin and phenylephrine,26643006,Oral,739009002,Syrup,,,,,
101203,Marketed,2024-08-19,02522950,JACK & JILL HONEY COUGH & COLD,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02522950,JACK & JILL HONEY COUGH & COLD (dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 50 mg per 5 mL syrup) HALEON CANADA ULC,Active,9014904,dextromethorphan hydrobromide 5 mg per 5 mL and guaifenesin 50 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
102948,Marketed,2025-11-18,02540800,COUGH & COLD RELIEF EXTRA STRENGTH,3.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02540800,COUGH & COLD RELIEF EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup) CRLS,Active,9002452,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and pseudoephedrine hydrochloride 30 mg per 5 mL syrup,8001371,dextromethorphan and guaifenesin and pseudoephedrine,26643006,Oral,739009002,Syrup,,,,,
102957,Marketed,2024-12-30,02540908,MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH,2.0,R05FA02,Opium derivatives and expectorants,Syrup,Oral,02540908,MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup) CRLS,Active,9003243,dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL syrup,8001370,dextromethorphan and guaifenesin,26643006,Oral,739009002,Syrup,,,,,
10217,Marketed,2003-04-04,00623709,STOMAAX PLUS,3.0,A02AF02,Ordinary salt combinations and antiflatulents,Suspension,Oral,00623709,STOMAAX PLUS (aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension) LABORATOIRE ATLAS INC,Active,9002172,aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension,8002090,aluminum hydroxide and dimethicone and magnesium hydroxide,26643006,Oral,385024007,Oral suspension,,,,,
44552,Marketed,1997-04-09,00815527,ALMAGEL PLUS SUS,3.0,A02AF02,Ordinary salt combinations and antiflatulents,Suspension,Oral,00815527,ALMAGEL PLUS SUS (aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension) LABORATOIRE ATLAS INC,Active,9002172,aluminum hydroxide 200 mg per 5 mL and dimethicone 25 mg per 5 mL and magnesium hydroxide 200 mg per 5 mL oral suspension,8002090,aluminum hydroxide and dimethicone and magnesium hydroxide,26643006,Oral,385024007,Oral suspension,,,,,
89449,Marketed,2024-12-12,02409836,GELUSIL ANTACID AND ANTI-GAS,3.0,A02AF02,Ordinary salt combinations and antiflatulents,Tablet (chewable),Oral,02409836,GELUSIL ANTACID AND ANTI-GAS (aluminum hydroxide 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet) PHARMASCIENCE INC,Active,9013941,aluminum hydroxide 200 mg and magnesium hydroxide 200 mg and simethicone 25 mg chewable tablet,8002091,aluminum hydroxide and magnesium hydroxide and simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
102897,Marketed,2024-07-29,02540274,TUMS CHEWY BITES WITH GAS RELIEF,2.0,A02AF02,Ordinary salt combinations and antiflatulents,Tablet (chewable),Oral,02540274,TUMS CHEWY BITES WITH GAS RELIEF (calcium carbonate 750 mg and simethicone 80 mg chewable tablet) HALEON CANADA ULC,Active,9015058,calcium carbonate 750 mg and simethicone 80 mg chewable tablet,8002510,calcium carbonate and simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
63865,Marketed,2018-06-01,02240325,XENICAL,1.0,A08AB01,Orlistat,Capsule,Oral,02240325,XENICAL (orlistat 120 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003383,orlistat 120 mg oral capsule,8001677,orlistat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
67477,Marketed,2005-12-23,02243559,SANDOZ ORPHENADRINE,1.0,M03BC01,Orphenadrine (citrate),Tablet (extended-release),Oral,02243559,SANDOZ ORPHENADRINE (orphenadrine citrate 100 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9003564,orphenadrine citrate 100 mg prolonged-release oral tablet,8001409,orphenadrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
65111,Marketed,1999-12-23,02241472,TAMIFLU,1.0,J05AH02,Oseltamivir,Capsule,Oral,02241472,TAMIFLU (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79011,Marketed,2008-12-01,02304848,TAMIFLU,1.0,J05AH02,Oseltamivir,Capsule,Oral,02304848,TAMIFLU (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79012,Marketed,2008-12-08,02304856,TAMIFLU,1.0,J05AH02,Oseltamivir,Capsule,Oral,02304856,TAMIFLU (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86768,Marketed,2012-09-10,02381842,TAMIFLU,1.0,J05AH02,Oseltamivir,Powder for suspension,Oral,02381842,TAMIFLU (oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension) HOFFMANN-LA ROCHE LIMITED,Active,9006402,oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension,8001297,oseltamivir,26643006,Oral,385024007,Oral suspension,,,,,
94501,Marketed,2016-09-29,02457989,NAT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02457989,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96194,Marketed,2018-02-06,02472635,NAT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02472635,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96195,Marketed,2018-02-06,02472643,NAT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02472643,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98723,Marketed,2020-09-24,02497409,JAMP OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02497409,JAMP OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98725,Marketed,2020-09-24,02497425,JAMP OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02497425,JAMP OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98727,Marketed,2023-10-18,02497441,MINT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02497441,MINT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98729,Marketed,2023-10-18,02497476,MINT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02497476,MINT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98960,Marketed,2020-09-29,02499894,NAT-OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Powder for suspension,Oral,02499894,NAT-OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension) NATCO PHARMA (CANADA) INC,Active,9006402,oseltamivir (oseltamivir phosphate) 6 mg per mL oral suspension,8001297,oseltamivir,26643006,Oral,385024007,Oral suspension,,,,,
99346,Marketed,2025-04-15,02504006,SANDOZ OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02504006,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 30 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004473,oseltamivir (oseltamivir phosphate) 30 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99347,Marketed,2025-04-15,02504014,SANDOZ OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02504014,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 45 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9004476,oseltamivir (oseltamivir phosphate) 45 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99348,Marketed,2025-04-15,02504022,SANDOZ OSELTAMIVIR,1.0,J05AH02,Oseltamivir,Capsule,Oral,02504022,SANDOZ OSELTAMIVIR (oseltamivir (oseltamivir phosphate) 75 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9003445,oseltamivir (oseltamivir phosphate) 75 mg oral capsule,8001297,oseltamivir,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106212,Marketed,2025-12-17,02558912,ISTURISA,1.0,H02CA02,Osilodrostat,Tablet,Oral,02558912,ISTURISA (osilodrostat (osilodrostat phosphate) 1 mg oral tablet) RECORDATI RARE DISEASES CANADA INC,Active,9015343,osilodrostat (osilodrostat phosphate) 1 mg oral tablet,8002574,osilodrostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
106213,Marketed,2025-12-17,02558920,ISTURISA,1.0,H02CA02,Osilodrostat,Tablet,Oral,02558920,ISTURISA (osilodrostat (osilodrostat phosphate) 5 mg oral tablet) RECORDATI RARE DISEASES CANADA INC,Active,9015344,osilodrostat (osilodrostat phosphate) 5 mg oral tablet,8002574,osilodrostat,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
94310,Marketed,2016-07-19,02456214,TAGRISSO,1.0,L01EB04,Osimertinib,Tablet,Oral,02456214,TAGRISSO (osimertinib (osimertinib mesylate) 40 mg oral tablet) ASTRAZENECA CANADA INC,Active,9006001,osimertinib (osimertinib mesylate) 40 mg oral tablet,8002042,osimertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94311,Marketed,2016-07-19,02456222,TAGRISSO,1.0,L01EB04,Osimertinib,Tablet,Oral,02456222,TAGRISSO (osimertinib (osimertinib mesylate) 80 mg oral tablet) ASTRAZENECA CANADA INC,Active,9006002,osimertinib (osimertinib mesylate) 80 mg oral tablet,8002042,osimertinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100744,Marketed,2022-01-13,02518112,OSPHENA,1.0,G03XC05,Ospemifene,Tablet,Oral,02518112,OSPHENA (ospemifene 60 mg oral tablet) DUCHESNAY INC,Active,9014644,ospemifene 60 mg oral tablet,8002406,ospemifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84835,Marketed,2011-04-04,02363356,EMEND IV,1.0,A04AD,Other antiemetics,Powder for solution,Intravenous,02363356,EMEND IV (fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection) MERCK CANADA INC,Active,9004861,fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection,8001656,fosaprepitant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103822,Marketed,2025-08-07,02549379,FOSAPREPITANT FOR INJECTION,1.0,A04AD,Other antiemetics,Powder for solution,Intravenous,02549379,FOSAPREPITANT FOR INJECTION (fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection) JUNO PHARMACEUTICALS CORP.,Active,9004861,fosaprepitant (fosaprepitant dimeglumine) 150 mg per vial powder for solution for injection,8001656,fosaprepitant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103870,Marketed,2024-10-29,02549883,APO-BILASTINE TABLETS,1.0,R06AX,Other antihistamines for systemic use,Tablet,Oral,02549883,APO-BILASTINE TABLETS (bilastine 20 mg oral tablet) APOTEX INC,Active,9006072,bilastine 20 mg oral tablet,8001590,bilastine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95816,Marketed,2017-12-20,02469375,PREVYMIS,1.0,J05AX,Other antivirals,Tablet,Oral,02469375,PREVYMIS (letermovir 240 mg oral tablet) MERCK CANADA INC,Active,9012444,letermovir 240 mg oral tablet,8001140,letermovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95817,Marketed,2017-12-20,02469383,PREVYMIS,1.0,J05AX,Other antivirals,Tablet,Oral,02469383,PREVYMIS (letermovir 480 mg oral tablet) MERCK CANADA INC,Active,9012445,letermovir 480 mg oral tablet,8001140,letermovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71860,Marketed,2007-05-29,02247600,BOOSTRIX,5.0,J07AX,Other bacterial vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,
81349,Marketed,2018-09-04,02328003,CARDIOLITE,1.0,V09GX,Other cardiovascular system diagnostic radiopharm.,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
2175,Marketed,2012-01-03,00328693,PRE-PEN,1.0,V04CX,Other diagnostic agents,Solution,Intradermal,,,,,,,,,,,,,,,,
3486,Marketed,2014-03-18,00405396,PATENT BLUE SODIUM INJECTION,1.0,V04CX,Other diagnostic agents,Solution,"Subcutaneous,Intravenous",,,,,,,,,,,,,,,,
3781,Marketed,2019-05-30,00505005,FLUORESCITE,1.0,V04CX,Other diagnostic agents,Solution,Intravenous,00505005,FLUORESCITE (fluorescein (fluorescein sodium) 100 mg per mL solution for injection 5 mL vial) ALCON CANADA INC,Active,9013819,fluorescein (fluorescein sodium) 100 mg per mL solution for injection 5 mL vial,8001469,fluorescein,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63128,Marketed,1999-12-08,02239656,PROVOCHOLINE,1.0,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02239656,PROVOCHOLINE (methacholine chloride 100 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9003375,methacholine chloride 100 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
67775,Marketed,2001-09-24,02243834,PROVOCHOLINE,1.0,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02243834,PROVOCHOLINE (methacholine chloride 1280 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9003649,methacholine chloride 1280 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
74930,Marketed,2006-03-27,02263890,METHACHOLINE OMEGA,1.0,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02263890,METHACHOLINE OMEGA (methacholine chloride 100 mg per vial powder for nebulizer solution) OMEGA LABORATORIES LIMITED,Active,9003375,methacholine chloride 100 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
74932,Marketed,2006-07-03,02263912,METHACHOLINE OMEGA,1.0,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02263912,METHACHOLINE OMEGA (methacholine chloride 1600 mg per vial powder for nebulizer solution) OMEGA LABORATORIES LIMITED,Active,9004182,methacholine chloride 1600 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
77421,Marketed,2008-02-28,02288826,PROVOCHOLINE,1.0,V04CX,Other diagnostic agents,Powder for solution,Inhalation,02288826,PROVOCHOLINE (methacholine chloride 1600 mg per vial powder for nebulizer solution) METHAPHARM INC,Active,9004182,methacholine chloride 1600 mg per vial powder for nebulizer solution,8001852,methacholine,447694001,Respiratory tract,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),,,
92096,Marketed,2022-01-24,02436639,CYSVIEW,1.0,V04CX,Other diagnostic agents,"Powder for solution,Kit",Intravesical,,,,,,,,,,,,,,,,
97957,Marketed,2024-07-30,02489562,ARIDOL,4.0,V04CX,Other diagnostic agents,"Kit,Powder",Inhalation,02489562,ARIDOL (mannitol 5 mg inhalation powder capsule with mannitol 10 mg inhalation powder capsule with mannitol 20 mg inhalation powder capsule with mannitol 40 mg inhalation powder capsule) PHARMAXIS EUROPE LIMITED,Active,9014348,mannitol 5 mg inhalation powder capsule with mannitol 10 mg inhalation powder capsule with mannitol 20 mg inhalation powder capsule with mannitol 40 mg inhalation powder capsule,8002138,mannitol,447694001,Respiratory tract,385207009,Powder for inhalation,732937005,Capsule,,,
98280,Marketed,2020-07-29,02492806,GALLI EO,1.0,V09IX,Other diagnostic radiopharm. for tumor detection,Solution,0-unassigned,,,,,,,,,,,,,,,,
99306,Marketed,2023-07-10,02503603,GALLIAPHARM,1.0,V09X,Other diagnostic radiopharmaceuticals,Solution,0-unassigned,,,,,,,,,,,,,,,,
76520,Marketed,2019-05-09,02279592,RESULTZ,1.0,P03AX,"Other ectoparasiticides, incl scabicides",Solution,Topical,02279592,RESULTZ (isopropyl myristate 50 % cutaneous solution) ARALEZ PHARMACEUTICALS CANADA INC,Active,9004209,isopropyl myristate 50 % cutaneous solution,8002131,isopropyl myristate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
13486,Marketed,2006-07-29,00786942,MICRO MN,1.0,A12CX,Other mineral products,Solution,Intravenous,00786942,MICRO MN (manganese (manganese sulfate) 1 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013223,manganese (manganese sulfate) 1 mg per 10 mL solution for injection vial,8001846,manganese sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13523,Marketed,2006-07-15,00786985,MICRO CR,1.0,A12CX,Other mineral products,Solution,Intravenous,00786985,MICRO CR (chromium (chromic chloride) 40 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013050,chromium (chromic chloride) 40 mcg per 10 mL solution for injection vial,8001725,chromic chloride,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13559,Marketed,2006-06-17,01986007,MICRO SE,1.0,A12CX,Other mineral products,Solution,Intravenous,01986007,MICRO SE (selenium (selenious acid) 400 mcg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013342,selenium (selenious acid) 400 mcg per 10 mL solution for injection vial,8001933,selenium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13563,Marketed,2006-07-15,00786969,MICRO CU,1.0,A12CX,Other mineral products,Solution,Intravenous,,,,,,,,,,,,,,,,
13600,Marketed,2006-06-17,01974548,MICRO I,1.0,A12CX,Other mineral products,Liquid,Intravenous,,,,,,,,,,,,,,,,
104491,Marketed,2025-05-29,02556219,SKYCLARYS,1.0,N07XX,Other nervous system drugs,Capsule,Oral,02556219,SKYCLARYS (omaveloxolone 50 mg oral capsule) BIOGEN CANADA INC,Active,9015222,omaveloxolone 50 mg oral capsule,8002547,omaveloxolone,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
36788,Marketed,2024-08-06,02209594,PREPARATION H-PE GEL,2.0,C05AX03,"Other preparations, combinations",Gel,"Rectal,Topical",02209594,PREPARATION H-PE GEL (hamamelis virginiana 50 % and phenylephrine hydrochloride 0.25 % rectal gel) HALEON CANADA ULC,Active,9003095,hamamelis virginiana 50 % and phenylephrine hydrochloride 0.25 % rectal gel,8000900,hamamelis virginiana and phenylephrine,37161004,Rectal,385100002,Gel,,,,,
99088,Marketed,2022-03-07,02501252,HEMORRHOIDAL OINTMENT,3.0,C05AX03,"Other preparations, combinations",Ointment,Topical,02501252,HEMORRHOIDAL OINTMENT (mineral oil heavy 14.05 % and petrolatum 74.9 % and phenylephrine hydrochloride 0.25 % cutaneous ointment) PERRIGO INTERNATIONAL,Active,9014918,mineral oil heavy 14.05 % and petrolatum 74.9 % and phenylephrine hydrochloride 0.25 % cutaneous ointment,8002479,mineral oil heavy and petrolatum and phenylephrine,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
104427,Marketed,2025-04-10,02555476,ITOVEBI,1.0,L01EX,Other protein kinase inhibitors,Tablet,Oral,02555476,ITOVEBI (inavolisib 3 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015188,inavolisib 3 mg oral tablet,8002537,inavolisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
104428,Marketed,2025-04-10,02555484,ITOVEBI,1.0,L01EX,Other protein kinase inhibitors,Tablet,Oral,02555484,ITOVEBI (inavolisib 9 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015189,inavolisib 9 mg oral tablet,8002537,inavolisib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
106280,Marketed,2025-07-31,02559676,ALYFTREK,3.0,R07AX,Other respiratory system products,Tablet,Oral,,,,,,,,,,,,,,,,
106281,Marketed,2025-07-31,02559684,ALYFTREK,3.0,R07AX,Other respiratory system products,Tablet,Oral,,,,,,,,,,,,,,,,
91937,Marketed,2015-12-16,02435071,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700935,OXALIPLATIN INJECTION (oxaliplatin 50 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91937,Marketed,2015-12-16,02435071,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700936,OXALIPLATIN INJECTION (oxaliplatin 100 mg per 20 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91937,Marketed,2015-12-16,02435071,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700937,OXALIPLATIN INJECTION (oxaliplatin 200 mg per 40 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92127,Marketed,2015-12-17,02436957,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700941,OXALIPLATIN INJECTION (oxaliplatin 100 mg per 20 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92127,Marketed,2015-12-17,02436957,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700942,OXALIPLATIN INJECTION (oxaliplatin 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92127,Marketed,2015-12-17,02436957,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700943,OXALIPLATIN INJECTION (oxaliplatin 200 mg per 40 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92127,Marketed,2015-12-17,02436957,OXALIPLATIN INJECTION,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700944,OXALIPLATIN INJECTION (oxaliplatin 150 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013483,oxaliplatin 150 mg per 30 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92996,Marketed,2019-01-16,02444763,OXALIPLATIN,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700951,OXALIPLATIN (oxaliplatin 200 mg per 40 mL solution for injection vial) PFIZER CANADA ULC,Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92996,Marketed,2019-01-16,02444763,OXALIPLATIN,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700952,OXALIPLATIN (oxaliplatin 100 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92996,Marketed,2019-01-16,02444763,OXALIPLATIN,1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77700953,OXALIPLATIN (oxaliplatin 50 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94448,Marketed,2022-03-31,02457423,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701102,"OXALIPLATIN INJECTION, USP (oxaliplatin 200 mg per 40 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94448,Marketed,2022-03-31,02457423,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701103,"OXALIPLATIN INJECTION, USP (oxaliplatin 50 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94448,Marketed,2022-03-31,02457423,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701104,"OXALIPLATIN INJECTION, USP (oxaliplatin 100 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94551,Marketed,2022-07-13,02458403,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701113,"OXALIPLATIN INJECTION, USP (oxaliplatin 200 mg per 40 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013484,oxaliplatin 200 mg per 40 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94551,Marketed,2022-07-13,02458403,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701114,"OXALIPLATIN INJECTION, USP (oxaliplatin 50 mg per 10 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013485,oxaliplatin 50 mg per 10 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94551,Marketed,2022-07-13,02458403,"OXALIPLATIN INJECTION, USP",1.0,L01XA03,Oxaliplatin,Solution,Intravenous,77701115,"OXALIPLATIN INJECTION, USP (oxaliplatin 100 mg per 20 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013482,oxaliplatin 100 mg per 20 mL solution for injection vial,8002043,oxaliplatin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
3463,Marketed,1979-12-31,00402680,APO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00402680,APO-OXAZEPAM (oxazepam 10 mg oral tablet) APOTEX INC,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3464,Marketed,1979-12-31,00402737,APO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00402737,APO-OXAZEPAM (oxazepam 30 mg oral tablet) APOTEX INC,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3465,Marketed,1979-12-31,00402745,APO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00402745,APO-OXAZEPAM (oxazepam 15 mg oral tablet) APOTEX INC,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3806,Marketed,2023-07-18,00497754,PRO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00497754,PRO-OXAZEPAM (oxazepam 10 mg oral tablet) PRO DOC LIMITEE,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3807,Marketed,2023-07-19,00497762,PRO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00497762,PRO-OXAZEPAM (oxazepam 15 mg oral tablet) PRO DOC LIMITEE,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3808,Marketed,2023-07-19,00497770,PRO-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00497770,PRO-OXAZEPAM (oxazepam 30 mg oral tablet) PRO DOC LIMITEE,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5213,Marketed,2007-03-21,00568406,RIVA-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00568406,RIVA-OXAZEPAM (oxazepam 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000136,oxazepam 15 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5214,Marketed,2007-03-21,00568414,RIVA-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00568414,RIVA-OXAZEPAM (oxazepam 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000137,oxazepam 30 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5563,Marketed,2007-03-21,00568392,RIVA-OXAZEPAM,1.0,N05BA04,Oxazepam,Tablet,Oral,00568392,RIVA-OXAZEPAM (oxazepam 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000135,oxazepam 10 mg oral tablet,8000079,oxazepam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65741,Marketed,2002-04-01,02242068,TRILEPTAL 300 MG,1.0,N03AF02,Oxcarbazepine,Tablet,Oral,02242068,TRILEPTAL 300 MG (oxcarbazepine 300 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003707,oxcarbazepine 300 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
65742,Marketed,2002-04-01,02242069,TRILEPTAL 600 MG,1.0,N03AF02,Oxcarbazepine,Tablet,Oral,02242069,TRILEPTAL 600 MG (oxcarbazepine 600 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9003708,oxcarbazepine 600 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
68661,Marketed,2002-09-05,02244673,TRILEPTAL ORAL SUSPENSION,1.0,N03AF02,Oxcarbazepine,Suspension,Oral,02244673,TRILEPTAL ORAL SUSPENSION (oxcarbazepine 300 mg per 5 mL oral suspension) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013831,oxcarbazepine 300 mg per 5 mL oral suspension,8002044,oxcarbazepine,26643006,Oral,385024007,Oral suspension,,,1.0,,
76987,Marketed,2022-02-08,02284294,APO-OXCARBAZEPINE,1.0,N03AF02,Oxcarbazepine,Tablet,Oral,02284294,APO-OXCARBAZEPINE (oxcarbazepine 150 mg oral tablet) APOTEX INC,Active,9003706,oxcarbazepine 150 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76988,Marketed,2016-06-08,02284308,APO-OXCARBAZEPINE,1.0,N03AF02,Oxcarbazepine,Tablet,Oral,02284308,APO-OXCARBAZEPINE (oxcarbazepine 300 mg oral tablet) APOTEX INC,Active,9003707,oxcarbazepine 300 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76989,Marketed,2016-06-08,02284316,APO-OXCARBAZEPINE,1.0,N03AF02,Oxcarbazepine,Tablet,Oral,02284316,APO-OXCARBAZEPINE (oxcarbazepine 600 mg oral tablet) APOTEX INC,Active,9003708,oxcarbazepine 600 mg oral tablet,8002044,oxcarbazepine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18355,Marketed,2022-01-25,02163543,APO-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02163543,APO-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) APOTEX INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43358,Marketed,1996-09-04,02223376,PMS-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Syrup,Oral,02223376,PMS-OXYBUTYNIN (oxybutynin chloride 5 mg per 5 mL syrup) PHARMASCIENCE INC,Active,9006249,oxybutynin chloride 5 mg per 5 mL syrup,8000219,oxybutynin,26643006,Oral,739009002,Syrup,,,,,
49219,Marketed,2015-07-27,02230394,TEVA-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02230394,TEVA-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64119,Marketed,1999-11-22,02240549,PMS-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02240549,PMS-OXYBUTYNIN (oxybutynin chloride 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9000876,oxybutynin chloride 2.5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64120,Marketed,1999-11-22,02240550,PMS-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02240550,PMS-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78474,Marketed,2008-06-09,02299364,RIVA-OXYBUTYNIN,1.0,G04BD04,Oxybutynin,Tablet,Oral,02299364,RIVA-OXYBUTYNIN (oxybutynin chloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000627,oxybutynin chloride 5 mg oral tablet,8000219,oxybutynin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3996,Marketed,2005-08-05,00443948,SUPEUDOL 10,1.0,N02AA05,Oxycodone,Tablet,Oral,00443948,SUPEUDOL 10 (oxycodone hydrochloride 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
10433,Marketed,2005-08-05,00789739,SUPEUDOL 5,1.0,N02AA05,Oxycodone,Tablet,Oral,00789739,SUPEUDOL 5 (oxycodone hydrochloride 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
51386,Marketed,2000-03-31,02231934,OXY.IR,1.0,N02AA05,Oxycodone,Tablet,Oral,02231934,OXY.IR (oxycodone hydrochloride 5 mg oral tablet) PURDUE PHARMA,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
63645,Marketed,2000-03-31,02240131,OXY.IR,1.0,N02AA05,Oxycodone,Tablet,Oral,02240131,OXY.IR (oxycodone hydrochloride 10 mg oral tablet) PURDUE PHARMA,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
63646,Marketed,2000-03-31,02240132,OXY.IR,1.0,N02AA05,Oxycodone,Tablet (immediate release),Oral,02240132,OXY.IR (oxycodone hydrochloride 20 mg oral tablet) PURDUE PHARMA,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
74839,Marketed,2024-10-04,02262983,SUPEUDOL 20,1.0,N02AA05,Oxycodone,Tablet,Oral,02262983,SUPEUDOL 20 (oxycodone hydrochloride 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
79224,Marketed,2012-11-26,02306530,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02306530,APO-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) APOTEX INC,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
79557,Marketed,2012-11-27,02309882,PMS-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309882,PMS-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
79558,Marketed,2012-11-27,02309890,PMS-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309890,PMS-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
79559,Marketed,2012-11-27,02309904,PMS-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309904,PMS-OXYCODONE CR (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
79560,Marketed,2012-11-27,02309912,PMS-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02309912,PMS-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PHARMASCIENCE INC,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
80542,Marketed,2008-12-03,02319977,PMS-OXYCODONE,1.0,N02AA05,Oxycodone,Tablet,Oral,02319977,PMS-OXYCODONE (oxycodone hydrochloride 5 mg oral tablet) PHARMASCIENCE INC,Active,9000367,oxycodone hydrochloride 5 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
80543,Marketed,2008-12-03,02319985,PMS-OXYCODONE,1.0,N02AA05,Oxycodone,Tablet,Oral,02319985,PMS-OXYCODONE (oxycodone hydrochloride 10 mg oral tablet) PHARMASCIENCE INC,Active,9000153,oxycodone hydrochloride 10 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
80544,Marketed,2008-12-03,02319993,PMS-OXYCODONE,1.0,N02AA05,Oxycodone,Tablet,Oral,02319993,PMS-OXYCODONE (oxycodone hydrochloride 20 mg oral tablet) PHARMASCIENCE INC,Active,9000890,oxycodone hydrochloride 20 mg oral tablet,8000045,oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
85157,Marketed,2012-11-26,02366746,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366746,APO-OXYCODONE CR (oxycodone hydrochloride 5 mg prolonged-release oral tablet) APOTEX INC,Active,9001393,oxycodone hydrochloride 5 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85158,Marketed,2018-05-17,02366754,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366754,APO-OXYCODONE CR (oxycodone hydrochloride 10 mg prolonged-release oral tablet) APOTEX INC,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85159,Marketed,2012-11-26,02366762,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366762,APO-OXYCODONE CR (oxycodone hydrochloride 20 mg prolonged-release oral tablet) APOTEX INC,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85161,Marketed,2012-11-26,02366789,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02366789,APO-OXYCODONE CR (oxycodone hydrochloride 80 mg prolonged-release oral tablet) APOTEX INC,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85760,Marketed,2011-09-13,02372525,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372525,OXYNEO (oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85765,Marketed,2011-09-13,02372533,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372533,OXYNEO (oxycodone hydrochloride 15 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85766,Marketed,2011-09-13,02372541,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372541,OXYNEO (oxycodone hydrochloride 30 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85767,Marketed,2011-09-13,02372568,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372568,OXYNEO (oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85768,Marketed,2011-09-13,02372576,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372576,OXYNEO (oxycodone hydrochloride 60 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85769,Marketed,2011-09-13,02372584,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372584,OXYNEO (oxycodone hydrochloride 80 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
85788,Marketed,2011-09-13,02372797,OXYNEO,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02372797,OXYNEO (oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
87990,Marketed,2012-11-27,02394766,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394766,APO-OXYCODONE CR (oxycodone hydrochloride 15 mg prolonged-release oral tablet) APOTEX INC,Active,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
87991,Marketed,2018-06-13,02394774,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394774,APO-OXYCODONE CR (oxycodone hydrochloride 30 mg prolonged-release oral tablet) APOTEX INC,Active,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
87993,Marketed,2012-11-27,02394782,APO-OXYCODONE CR,1.0,N02AA05,Oxycodone,Tablet (extended-release),Oral,02394782,APO-OXYCODONE CR (oxycodone hydrochloride 60 mg prolonged-release oral tablet) APOTEX INC,Active,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,8000045,oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
5777,Marketed,2017-12-21,00608157,TEVA-OXYCODAN,2.0,N02AJ18,Oxycodone and acetylsalicylic acid,Tablet,Oral,00608157,TEVA-OXYCODAN (acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000195,acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000774,acetylsalicylic acid and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
82520,Marketed,2010-10-05,02339609,TARGIN,2.0,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339609,TARGIN (naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001324,naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
82521,Marketed,2010-10-05,02339617,TARGIN,2.0,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339617,TARGIN (naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001322,naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
82522,Marketed,2010-10-05,02339625,TARGIN,2.0,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02339625,TARGIN (naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001323,naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
87301,Marketed,2012-10-16,02387425,TARGIN,2.0,N02AA55,Oxycodone and naloxone,Tablet (extended-release),Oral,02387425,TARGIN (naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001391,naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet,8000783,naloxone and oxycodone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
5778,Marketed,2017-07-07,00608165,TEVA-OXYCOCET,2.0,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,00608165,TEVA-OXYCOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
66193,Marketed,2001-12-12,02242468,RIVACOCET,2.0,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,02242468,RIVACOCET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
81005,Marketed,2009-05-22,02324628,APO-OXYCODONE/ACET,2.0,N02AJ17,Oxycodone and paracetamol,Tablet,Oral,02324628,APO-OXYCODONE/ACET (acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet) APOTEX INC,Active,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,8000059,acetaminophen and oxycodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
5682,Marketed,1911-12-31,00572810,OXYGEN 100%,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
6826,Marketed,1986-12-31,00591629,OXYGEN 99.0%,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
13886,Marketed,2022-05-04,02014408,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
18663,Marketed,1995-12-31,02170175,OXYGENE - GAS INH,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
19299,Marketed,2020-04-08,02154838,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
20349,Marketed,1998-09-11,02219719,OXYGEN USP - GAS 100%,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
27306,Marketed,2004-03-23,02052881,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
50235,Marketed,1997-03-11,02230956,OXYGEN U.S.P.,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
64194,Marketed,2005-08-01,02240621,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
66284,Marketed,2000-07-13,02242542,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
72159,Marketed,2003-07-03,02247852,OXYGEN USP,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
96434,Marketed,2018-03-26,02474298,OXYGEN,1.0,V03AN01,Oxygen,Gas,Inhalation,,,,,,,,,,,,,,,,
41903,Marketed,2016-05-18,00740861,DRIXORAL DECONGESTANT NASAL SPRAY,1.0,R01AA05,Oxymetazoline,Solution,Nasal,00740861,DRIXORAL DECONGESTANT NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
41954,Marketed,2021-01-26,01929372,LONG LASTING DRISTAN NASAL MIST,1.0,R01AA05,Oxymetazoline,Spray,Nasal,01929372,"LONG LASTING DRISTAN NASAL MIST (oxymetazoline hydrochloride 0.05 % nasal spray) FOUNDATION CONSUMER BRANDS, LLC",Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
41970,Marketed,2021-01-26,01929380,LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY,1.0,R01AA05,Oxymetazoline,Spray,Nasal,01929380,"LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) FOUNDATION CONSUMER BRANDS, LLC",Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
67620,Marketed,2017-04-13,02243690,CLARITIN ALLERGY DECONGESTANT,1.0,R01AA05,Oxymetazoline,Solution,Nasal,02243690,CLARITIN ALLERGY DECONGESTANT (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
69670,Marketed,2016-12-21,02245575,DRIXORAL NO DRIP EXTRA MOISTURIZING,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02245575,DRIXORAL NO DRIP EXTRA MOISTURIZING (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
69673,Marketed,2016-07-28,02245578,DRIXORAL NO DRIP ORIGINAL UNSCENTED,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02245578,DRIXORAL NO DRIP ORIGINAL UNSCENTED (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
69676,Marketed,2018-08-02,02245580,DRIXORAL NO DRIP COOLING MENTHOL,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02245580,DRIXORAL NO DRIP COOLING MENTHOL (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
86596,Marketed,2016-03-03,02380129,DRIXORAL NASAL CONGESTION,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02380129,DRIXORAL NASAL CONGESTION (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
94094,Marketed,2017-05-28,02454351,LONG LASTING DECONGESTANT NASAL SPRAY,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02454351,LONG LASTING DECONGESTANT NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) CRLS,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
94800,Marketed,2018-06-27,02460572,EXTRA MOISTURIZING NASAL SPRAY,1.0,R01AA05,Oxymetazoline,"Spray, metered dose",Nasal,02460572,EXTRA MOISTURIZING NASAL SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) JUNO OTC INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
94802,Marketed,2018-06-28,02460599,NASAL CONGESTION SPRAY,1.0,R01AA05,Oxymetazoline,"Spray, metered dose",Nasal,02460599,NASAL CONGESTION SPRAY (oxymetazoline hydrochloride 0.05 % nasal spray) JUNO OTC INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
98807,Marketed,2021-03-08,02498294,DRIXORAL NO DRIP NASAL CONGESTION,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02498294,DRIXORAL NO DRIP NASAL CONGESTION (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
98808,Marketed,2021-03-08,02498308,DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL,1.0,R01AA05,Oxymetazoline,Spray,Nasal,02498308,DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL (oxymetazoline hydrochloride 0.05 % nasal spray) BAYER INC,Active,9002052,oxymetazoline hydrochloride 0.05 % nasal spray,8002150,oxymetazoline,46713006,Nasal,385157007,Nasal spray,,,,,
4293,Marketed,2017-10-16,00497398,OXYTOCIN INJECTION USP,1.0,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700912,OXYTOCIN INJECTION USP (oxytocin 10 unit per 1 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013486,oxytocin 10 unit per 1 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
4293,Marketed,2017-10-16,00497398,OXYTOCIN INJECTION USP,1.0,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700913,OXYTOCIN INJECTION USP (oxytocin 50 unit per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013489,oxytocin 50 unit per 5 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
31361,Marketed,2021-02-24,02139561,"OXYTOCIN INJECTION, USP",1.0,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700918,"OXYTOCIN INJECTION, USP (oxytocin 100 unit per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013488,oxytocin 100 unit per 10 mL solution for injection vial,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
31361,Marketed,2021-02-24,02139561,"OXYTOCIN INJECTION, USP",1.0,H01BB02,Oxytocin,Solution,"Intramuscular,Intravenous",77700919,"OXYTOCIN INJECTION, USP (oxytocin 10 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013487,oxytocin 10 unit per 1 mL solution for injection vial,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
103903,Marketed,2025-08-26,02550199,"OXYTOCIN INJECTION, USP",1.0,H01BB02,Oxytocin,Solution,"Intravenous,Intramuscular",02550199,"OXYTOCIN INJECTION, USP (oxytocin 10 unit per 1 mL solution for injection ampoule) HIKMA CANADA LIMITED",Active,9013486,oxytocin 10 unit per 1 mL solution for injection ampoule,8002046,oxytocin,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
99535,Marketed,2024-09-03,02505991,ZEPOSIA,1.0,L04AE02,Ozanimod,Capsule,Oral,02505991,ZEPOSIA (ozanimod (ozanimod hydrochloride) 0.92 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014464,ozanimod (ozanimod hydrochloride) 0.92 mg oral capsule,8002365,ozanimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99536,Marketed,2025-02-14,02506009,ZEPOSIA,2.0,L04AE02,Ozanimod,Capsule,Oral,02506009,ZEPOSIA (ozanimod (ozanimod hydrochloride) 0.23 mg oral capsule with ozanimod (ozanimod hydrochloride) 0.46 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9014480,ozanimod (ozanimod hydrochloride) 0.23 mg oral capsule with ozanimod (ozanimod hydrochloride) 0.46 mg oral capsule,8002365,ozanimod,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68340,Marketed,2003-06-16,02244372,PACLITAXEL FOR INJECTION,1.0,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,
76673,Marketed,2025-01-24,02281066,ABRAXANE FOR INJECTABLE SUSPENSION,1.0,L01CD01,Paclitaxel,Powder for suspension,Intravenous,,,,,,,,,,,,,,1.0,,
80560,Marketed,2015-03-31,02320150,PACLITAXEL INJECTION USP,1.0,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,
87681,Marketed,2014-07-02,02391465,PACLITAXEL INJECTION USP,1.0,L01CD01,Paclitaxel,Solution,Intravenous,,,,,,,,,,,,,,1.0,,
98597,Marketed,2023-10-27,02496097,"PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL",1.0,L01CD01,Paclitaxel,Powder for suspension,Intravenous,,,,,,,,,,,,,,1.0,,
98354,Marketed,2020-09-21,02493535,IBRANCE,1.0,L01EF01,Palbociclib,Tablet,Oral,02493535,IBRANCE (palbociclib 75 mg oral tablet) PFIZER CANADA ULC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98355,Marketed,2020-09-21,02493543,IBRANCE,1.0,L01EF01,Palbociclib,Tablet,Oral,02493543,IBRANCE (palbociclib 100 mg oral tablet) PFIZER CANADA ULC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98356,Marketed,2020-09-21,02493551,IBRANCE,1.0,L01EF01,Palbociclib,Tablet,Oral,02493551,IBRANCE (palbociclib 125 mg oral tablet) PFIZER CANADA ULC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103657,Marketed,2024-09-17,02547635,TARO-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02547635,TARO-PALBOCICLIB (palbociclib 75 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103658,Marketed,2024-09-17,02547643,TARO-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02547643,TARO-PALBOCICLIB (palbociclib 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103659,Marketed,2024-09-17,02547651,TARO-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02547651,TARO-PALBOCICLIB (palbociclib 125 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104081,Marketed,2024-09-27,02552124,PMS-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02552124,PMS-PALBOCICLIB (palbociclib 75 mg oral tablet) PHARMASCIENCE INC,Active,9014388,palbociclib 75 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104082,Marketed,2024-09-27,02552132,PMS-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02552132,PMS-PALBOCICLIB (palbociclib 100 mg oral tablet) PHARMASCIENCE INC,Active,9014386,palbociclib 100 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104083,Marketed,2024-09-27,02552140,PMS-PALBOCICLIB,1.0,L01EF01,Palbociclib,Tablet,Oral,02552140,PMS-PALBOCICLIB (palbociclib 125 mg oral tablet) PHARMASCIENCE INC,Active,9014387,palbociclib 125 mg oral tablet,8002048,palbociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78559,Marketed,2007-10-02,02300273,INVEGA,1.0,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300273,INVEGA (paliperidone 3 mg prolonged-release oral tablet) JANSSEN INC,Active,9004337,paliperidone 3 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78560,Marketed,2007-10-02,02300281,INVEGA,1.0,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300281,INVEGA (paliperidone 6 mg prolonged-release oral tablet) JANSSEN INC,Active,9004338,paliperidone 6 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78561,Marketed,2007-10-02,02300303,INVEGA,1.0,N05AX13,Paliperidone,Tablet (extended-release),Oral,02300303,INVEGA (paliperidone 9 mg prolonged-release oral tablet) JANSSEN INC,Active,9004339,paliperidone 9 mg prolonged-release oral tablet,8001298,paliperidone,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
83941,Marketed,2010-07-21,02354217,INVEGA SUSTENNA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354217,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 50 mg per 0.5 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012682,paliperidone (paliperidone palmitate) 50 mg per 0.5 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
83942,Marketed,2010-07-21,02354225,INVEGA SUSTENNA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354225,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 75 mg per 0.75 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012684,paliperidone (paliperidone palmitate) 75 mg per 0.75 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
83943,Marketed,2010-07-21,02354233,INVEGA SUSTENNA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354233,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 100 mg per 1 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012677,paliperidone (paliperidone palmitate) 100 mg per 1 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
83944,Marketed,2010-07-21,02354241,INVEGA SUSTENNA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02354241,INVEGA SUSTENNA (paliperidone (paliperidone palmitate) 150 mg per 1.5 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012678,paliperidone (paliperidone palmitate) 150 mg per 1.5 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
94281,Marketed,2016-07-25,02455943,INVEGA TRINZA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455943,INVEGA TRINZA (paliperidone (paliperidone palmitate) 175 mg per 0.875 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012679,paliperidone (paliperidone palmitate) 175 mg per 0.875 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
94284,Marketed,2016-07-25,02455986,INVEGA TRINZA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455986,INVEGA TRINZA (paliperidone (paliperidone palmitate) 263 mg per 1.315 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012680,paliperidone (paliperidone palmitate) 263 mg per 1.315 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
94285,Marketed,2016-07-25,02455994,INVEGA TRINZA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02455994,INVEGA TRINZA (paliperidone (paliperidone palmitate) 350 mg per 1.75 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012681,paliperidone (paliperidone palmitate) 350 mg per 1.75 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
94286,Marketed,2016-07-25,02456001,INVEGA TRINZA,1.0,N05AX13,Paliperidone,Suspension (extended-release),Intramuscular,02456001,INVEGA TRINZA (paliperidone (paliperidone palmitate) 525 mg per 2.625 mL prolonged-release suspension for injection syringe) JANSSEN INC,Active,9012683,paliperidone (paliperidone palmitate) 525 mg per 2.625 mL prolonged-release suspension for injection syringe,8001298,paliperidone,738984000,Parenteral,420873008,Prolonged-release suspension for injection,733020007,Syringe (unit of presentation),,,
92274,Marketed,2022-04-29,02438364,SYNAGIS,1.0,J06BD01,Palivizumab,Solution,Intramuscular,02438364,SYNAGIS (palivizumab 100 mg per 1 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9013490,palivizumab 100 mg per 1 mL solution for injection vial,8002049,palivizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92275,Marketed,2022-03-24,02438372,SYNAGIS,1.0,J06BD01,Palivizumab,Solution,Intramuscular,02438372,SYNAGIS (palivizumab 50 mg per 0.5 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9013491,palivizumab 50 mg per 0.5 mL solution for injection vial,8002049,palivizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
86757,Marketed,2022-12-02,02381710,ALOXI,1.0,A04AA05,Palonosetron,Solution,Intravenous,02381710,ALOXI (palonosetron (palonosetron hydrochloride) 0.25 mg per 5 mL solution for injection vial) KNIGHT THERAPEUTICS INC.,Active,9012589,palonosetron (palonosetron hydrochloride) 0.25 mg per 5 mL solution for injection vial,8001153,palonosetron,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95721,Marketed,2022-11-30,02468735,AKYNZEO,2.0,A04AA55,"Palonosetron, combinations",Capsule,Oral,02468735,AKYNZEO (netupitant 300 mg and palonosetron (palonosetron hydrochloride) 0.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9012525,netupitant 300 mg and palonosetron (palonosetron hydrochloride) 0.5 mg oral capsule,8001152,netupitant and palonosetron,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101365,Marketed,2022-06-20,02524627,SOHONOS,1.0,M09AX11,Palovarotene,Capsule,Oral,02524627,SOHONOS (palovarotene 1 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014723,palovarotene 1 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101366,Marketed,2022-06-20,02524635,SOHONOS,1.0,M09AX11,Palovarotene,Capsule,Oral,02524635,SOHONOS (palovarotene 1.5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014724,palovarotene 1.5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101367,Marketed,2022-06-20,02524643,SOHONOS,1.0,M09AX11,Palovarotene,Capsule,Oral,02524643,SOHONOS (palovarotene 2.5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014726,palovarotene 2.5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101368,Marketed,2022-06-20,02524651,SOHONOS,1.0,M09AX11,Palovarotene,Capsule,Oral,02524651,SOHONOS (palovarotene 5 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014727,palovarotene 5 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101369,Marketed,2022-06-20,02524678,SOHONOS,1.0,M09AX11,Palovarotene,Capsule,Oral,02524678,SOHONOS (palovarotene 10 mg oral capsule) IPSEN BIOPHARMACEUTICALS CANADA INC,Active,9014725,palovarotene 10 mg oral capsule,8002426,palovarotene,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
68533,Marketed,2018-02-21,02244550,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02244550,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 30 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012745,pamidronate disodium 30 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
68534,Marketed,2018-03-21,02244551,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02244551,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 60 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
68535,Marketed,2018-07-25,02244552,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02244552,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 90 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
70784,Marketed,2015-07-07,02246597,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02246597,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 30 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012745,pamidronate disodium 30 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
70785,Marketed,2015-07-07,02246598,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02246598,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 60 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
70786,Marketed,2015-07-09,02246599,PAMIDRONATE DISODIUM FOR INJECTION,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02246599,PAMIDRONATE DISODIUM FOR INJECTION (pamidronate disodium 90 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
73448,Marketed,2006-05-24,02249677,PAMIDRONATE DISODIUM OMEGA 6 MG/ML,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02249677,PAMIDRONATE DISODIUM OMEGA 6 MG/ML (pamidronate disodium 60 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012746,pamidronate disodium 60 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
73449,Marketed,2005-07-27,02249685,PAMIDRONATE DISODIUM OMEGA 9 MG/ML,1.0,M05BA03,Pamidronic acid,Solution,Intravenous,02249685,PAMIDRONATE DISODIUM OMEGA 9 MG/ML (pamidronate disodium 90 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012747,pamidronate disodium 90 mg per 10 mL solution for injection vial,8001410,pamidronate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
79412,Marketed,2008-05-27,02308487,VECTIBIX,1.0,L01FE02,Panitumumab,Solution,Intravenous,02308487,VECTIBIX (panitumumab 100 mg per 5 mL solution for injection vial) AMGEN CANADA INC,Active,9013492,panitumumab 100 mg per 5 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79414,Marketed,2017-01-03,02308509,VECTIBIX,1.0,L01FE02,Panitumumab,Solution,Intravenous,02308509,VECTIBIX (panitumumab 400 mg per 20 mL solution for injection vial) AMGEN CANADA INC,Active,9013493,panitumumab 400 mg per 20 mL solution for injection vial,8002051,panitumumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
47339,Marketed,2013-01-09,02229453,PANTOLOC,1.0,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02229453,PANTOLOC (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
65469,Marketed,2013-01-09,02241804,PANTOLOC,1.0,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02241804,PANTOLOC (pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
75263,Marketed,2013-06-21,02267233,TECTA,1.0,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02267233,TECTA (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) TAKEDA CANADA INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
77096,Marketed,2023-03-22,02285479,TEVA-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02285479,TEVA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
77097,Marketed,2023-03-22,02285487,TEVA-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02285487,TEVA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
77826,Marketed,2008-03-05,02292912,APO-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02292912,APO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet) APOTEX INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
77827,Marketed,2008-03-05,02292920,APO-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02292920,APO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) APOTEX INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78642,Marketed,2008-06-03,02301075,SANDOZ PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02301075,SANDOZ PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
78643,Marketed,2008-06-03,02301083,SANDOZ PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02301083,SANDOZ PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
79041,Marketed,2025-10-09,02305046,SPC-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02305046,SPC-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SUN PHARMA CANADA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
79242,Marketed,2008-03-11,02306727,PANTOPRAZOLE SODIUM FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02306727,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
79355,Marketed,2008-06-04,02307871,PMS-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02307871,PMS-PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
80417,Marketed,2009-01-29,02318695,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02318695,PANTOPRAZOLE (pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet) PRO DOC LIMITEE,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
83745,Marketed,2015-11-03,02352214,PANTOPRAZOLE FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02352214,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84215,Marketed,2020-06-15,02357054,JAMP-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02357054,JAMP-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
85592,Marketed,2023-10-30,02370808,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02370808,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87787,Marketed,2021-11-26,02392615,JAMP PANTOPRAZOLE SODIUM,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02392615,JAMP PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87788,Marketed,2021-03-18,02392623,JAMP PANTOPRAZOLE SODIUM,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02392623,JAMP PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) JAMP PHARMA CORPORATION,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
89331,Marketed,2015-08-31,02408570,MYLAN-PANTOPRAZOLE T,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02408570,MYLAN-PANTOPRAZOLE T (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
89982,Marketed,2016-02-06,02415208,AURO-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02415208,AURO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) AURO PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90116,Marketed,2014-07-18,02416565,MAR-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02416565,MAR-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MARCAN PHARMACEUTICALS INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
90206,Marketed,2014-01-16,02417448,MINT-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02417448,MINT-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MINT PHARMACEUTICALS INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91265,Marketed,2024-03-21,02428172,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02428172,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91266,Marketed,2025-10-01,02428180,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02428180,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
91574,Marketed,2014-10-16,02431327,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02431327,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) LABORATOIRE RIVA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92500,Marketed,2015-11-16,02440628,TEVA-PANTOPRAZOLE MAGNESIUM,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02440628,TEVA-PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) TEVA CANADA LIMITED,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
92591,Marketed,2017-11-20,02441527,PANTOPRAZOLE SODIUM FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02441527,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92624,Marketed,2017-09-25,02441853,PANTOPRAZOLE MAGNESIUM,1.0,A02BC02,Pantoprazole,Tablet (enteric-coated),Oral,02441853,PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet) ALTIUS HEALTHCARE INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
93114,Marketed,2024-03-13,02445867,BIO-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02445867,BIO-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) BIOMED PHARMA,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
94611,Marketed,2017-10-20,02458969,PANTOPRAZOLE FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02458969,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95445,Marketed,2017-10-25,02466147,PANTOPRAZOLE T,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02466147,PANTOPRAZOLE T (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
95575,Marketed,2024-08-21,02467372,M-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02467372,M-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) MANTRA PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
95779,Marketed,2025-11-11,02469138,ALTA-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02469138,ALTA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) ALTAMED PHARMA,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
96103,Marketed,2024-05-27,02471825,NRA-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02471825,NRA-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) NORA PHARMA INC,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
97204,Marketed,2018-12-27,02481588,AG-PANTOPRAZOLE SODIUM,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02481588,AG-PANTOPRAZOLE SODIUM (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) ANGITA PHARMA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
100525,Marketed,2022-03-25,02515857,PANTOPRAZOLE SODIUM FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02515857,PANTOPRAZOLE SODIUM FOR INJECTION (pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
100878,Marketed,2023-02-07,02519534,PANTOPRAZOLE MAGNESIUM,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02519534,PANTOPRAZOLE MAGNESIUM (pantoprazole (pantoprazole magnesium hemipentahydrate) 40 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9001139,pantoprazole (pantoprazole magnesium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
101802,Marketed,2024-10-29,02528835,PANTOPRAZOLE FOR INJECTION,1.0,A02BC02,Pantoprazole,Powder for solution,Intravenous,02528835,PANTOPRAZOLE FOR INJECTION (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9001196,pantoprazole (pantoprazole sodium) 40 mg per vial powder for solution for injection,8000236,pantoprazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102493,Marketed,2023-11-17,02536137,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02536137,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000895,pantoprazole (pantoprazole sodium) 20 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
103598,Marketed,2024-11-01,02547368,PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02547368,PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
106065,Marketed,2025-10-03,02557304,NB-PANTOPRAZOLE,1.0,A02BC02,Pantoprazole,Tablet (delayed-release),Oral,02557304,NB-PANTOPRAZOLE (pantoprazole (pantoprazole sodium sesquihydrate) 40 mg gastro-resistant tablet) NB PHARMA INC.,Active,9000706,pantoprazole (pantoprazole sodium) 40 mg gastro-resistant tablet,8000236,pantoprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
160,Marketed,2005-08-20,00009881,PAPAVERINE HYDROCHLORIDE INJECTION USP,1.0,A03AD01,Papaverine,Liquid,"Intramuscular,Subcutaneous,Intravenous",00009881,PAPAVERINE HYDROCHLORIDE INJECTION USP (papaverine hydrochloride 65 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013494,papaverine hydrochloride 65 mg per 2 mL solution for injection vial,8002052,papaverine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
82773,Marketed,2010-02-10,02342227,CERVARIX,2.0,J07BM02,"Papillomavirus (human types 16,18)",Suspension,Intramuscular,,,,,,,,,,,,,,,,
92136,Marketed,2015-03-18,02437058,GARDASIL 9,9.0,J07BM03,"Papillomavirus (human types 6,11,16,18,31,33,45,52,58)",Suspension,Intramuscular,,,,,,,,,,,,,,,,
16701,Marketed,2022-10-14,02078759,HUMATIN,1.0,A07AA06,Paromomycin,Capsule,Oral,02078759,HUMATIN (paromomycin (paromomycin sulfate) 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002704,paromomycin (paromomycin sulfate) 250 mg oral capsule,8002053,paromomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
14006,Marketed,2002-11-13,01940473,PAXIL TAB 30MG,1.0,N06AB05,Paroxetine,Tablet,Oral,01940473,PAXIL TAB 30MG (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
14007,Marketed,2002-09-13,01940481,PAXIL TAB 20MG,1.0,N06AB05,Paroxetine,Tablet,Oral,01940481,PAXIL TAB 20MG (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
64498,Marketed,2003-10-24,02240907,APO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02240907,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
64499,Marketed,2003-10-24,02240908,APO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02240908,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
64500,Marketed,2003-10-24,02240909,APO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02240909,APO-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) APOTEX INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72042,Marketed,2018-09-05,02247750,PMS-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02247750,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72043,Marketed,2003-10-29,02247751,PMS-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02247751,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72044,Marketed,2003-10-29,02247752,PMS-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02247752,PMS-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) PHARMASCIENCE INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72855,Marketed,2004-01-05,02248503,PAXIL CR,1.0,N06AB05,Paroxetine,Tablet (extended-release),Oral,02248503,PAXIL CR (paroxetine (paroxetine hydrochloride) 12.5 mg prolonged-release oral tablet) GLAXOSMITHKLINE INC,Active,9001066,paroxetine (paroxetine hydrochloride) 12.5 mg prolonged-release oral tablet,8000185,paroxetine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
72856,Marketed,2004-01-05,02248504,PAXIL CR,1.0,N06AB05,Paroxetine,Tablet (extended-release),Oral,02248504,PAXIL CR (paroxetine (paroxetine hydrochloride) 25 mg prolonged-release oral tablet) GLAXOSMITHKLINE INC,Active,9001067,paroxetine (paroxetine hydrochloride) 25 mg prolonged-release oral tablet,8000185,paroxetine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
72911,Marketed,2024-02-15,02248556,TEVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248556,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72912,Marketed,2024-02-15,02248557,TEVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248557,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72913,Marketed,2024-02-15,02248558,TEVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248558,TEVA-PAROXETINE (paroxetine (paroxetine hydrochloride acetone solvate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72914,Marketed,2016-04-22,02248559,RIVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248559,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72915,Marketed,2016-04-22,02248560,RIVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248560,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72916,Marketed,2016-04-22,02248561,RIVA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248561,RIVA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73287,Marketed,2025-10-16,02248913,PRO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248913,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) PRO DOC LIMITEE,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73288,Marketed,2025-10-16,02248914,PRO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248914,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) PRO DOC LIMITEE,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73289,Marketed,2025-10-16,02248915,PRO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02248915,PRO-PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) PRO DOC LIMITEE,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76846,Marketed,2021-09-27,02282844,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02282844,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76847,Marketed,2021-09-27,02282852,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02282852,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76848,Marketed,2021-09-27,02282860,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02282860,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) SANIS HEALTH INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85384,Marketed,2016-01-18,02368870,JAMP-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02368870,JAMP-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86903,Marketed,2012-07-24,02383276,AURO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02383276,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) AURO PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86904,Marketed,2012-07-24,02383284,AURO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02383284,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) AURO PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86905,Marketed,2012-07-24,02383292,AURO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02383292,AURO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) AURO PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87377,Marketed,2016-02-09,02388227,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02388227,PAROXETINE (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87378,Marketed,2016-02-09,02388235,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02388235,PAROXETINE (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87379,Marketed,2016-02-09,02388243,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02388243,PAROXETINE (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89652,Marketed,2014-06-24,02411954,MAR-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02411954,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89654,Marketed,2014-06-24,02411946,MAR-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02411946,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89655,Marketed,2014-06-24,02411962,MAR-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02411962,MAR-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90600,Marketed,2014-03-17,02421372,MINT-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02421372,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90601,Marketed,2014-03-17,02421380,MINT-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02421380,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90602,Marketed,2014-03-17,02421399,MINT-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02421399,MINT-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93013,Marketed,2016-12-21,02444909,BIO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02444909,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) BIOMED PHARMA,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93014,Marketed,2016-12-21,02444917,BIO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02444917,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) BIOMED PHARMA,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
93015,Marketed,2016-12-21,02444925,BIO-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02444925,BIO-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) BIOMED PHARMA,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95578,Marketed,2018-03-07,02467402,M-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02467402,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95579,Marketed,2018-03-07,02467410,M-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02467410,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) MANTRA PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95580,Marketed,2018-07-30,02467429,M-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02467429,M-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) MANTRA PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96844,Marketed,2023-03-22,02477823,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02477823,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) ALTAMED PHARMA,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96845,Marketed,2023-02-22,02477831,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02477831,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) ALTAMED PHARMA,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96846,Marketed,2023-03-29,02477858,PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02477858,PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) ALTAMED PHARMA,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97010,Marketed,2018-12-10,02479753,NRA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02479753,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 10 mg oral tablet) NORA PHARMA INC,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97011,Marketed,2018-12-10,02479761,NRA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02479761,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 20 mg oral tablet) NORA PHARMA INC,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97012,Marketed,2018-12-10,02479788,NRA-PAROXETINE,1.0,N06AB05,Paroxetine,Tablet,Oral,02479788,NRA-PAROXETINE (paroxetine (paroxetine hydrochloride hemihydrate) 30 mg oral tablet) NORA PHARMA INC,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99717,Marketed,2022-01-03,02507773,JAMP PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02507773,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99718,Marketed,2022-01-03,02507781,JAMP PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02507781,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99719,Marketed,2021-12-30,02507803,JAMP PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02507803,JAMP PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99970,Marketed,2022-03-18,02510480,AG-PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02510480,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000697,paroxetine (paroxetine hydrochloride) 10 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99971,Marketed,2022-03-18,02510499,AG-PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02510499,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000487,paroxetine (paroxetine hydrochloride) 20 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99973,Marketed,2022-03-18,02510510,AG-PAROXETINE TABLETS,1.0,N06AB05,Paroxetine,Tablet,Oral,02510510,AG-PAROXETINE TABLETS (paroxetine (paroxetine hydrochloride) 30 mg oral tablet) ANGITA PHARMA INC.,Active,9000488,paroxetine (paroxetine hydrochloride) 30 mg oral tablet,8000185,paroxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89797,Marketed,2020-05-21,02413299,SIGNIFOR,1.0,H01CB05,Pasireotide,Solution,Subcutaneous,02413299,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.3 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013495,pasireotide (pasireotide diaspartate) 0.3 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
89798,Marketed,2020-05-21,02413302,SIGNIFOR,1.0,H01CB05,Pasireotide,Solution,Subcutaneous,02413302,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.6 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013496,pasireotide (pasireotide diaspartate) 0.6 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
89799,Marketed,2020-05-21,02413310,SIGNIFOR,1.0,H01CB05,Pasireotide,Solution,Subcutaneous,02413310,SIGNIFOR (pasireotide (pasireotide diaspartate) 0.9 mg per 1 mL solution for injection ampoule) RECORDATI RARE DISEASES CANADA INC,Active,9013497,pasireotide (pasireotide diaspartate) 0.9 mg per 1 mL solution for injection ampoule,8002054,pasireotide,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
92155,Marketed,2020-05-21,02437252,SIGNIFOR LAR,1.0,H01CB05,Pasireotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02437252,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013498,pasireotide (pasireotide pamoate) 20 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
92156,Marketed,2020-05-21,02437279,SIGNIFOR LAR,1.0,H01CB05,Pasireotide,"Kit,Powder for suspension, sustained-release",Intramuscular,02437279,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 60 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013500,pasireotide (pasireotide pamoate) 60 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
92157,Marketed,2020-05-21,02437260,SIGNIFOR LAR,1.0,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02437260,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 40 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9013499,pasireotide (pasireotide pamoate) 40 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
97095,Marketed,2020-05-21,02480425,SIGNIFOR LAR,1.0,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02480425,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9014055,pasireotide (pasireotide pamoate) 10 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
97096,Marketed,2020-05-21,02480433,SIGNIFOR LAR,1.0,H01CB05,Pasireotide,"Powder for suspension, sustained-release,Kit",Intramuscular,02480433,SIGNIFOR LAR (pasireotide (pasireotide pamoate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe) RECORDATI RARE DISEASES CANADA INC,Active,9014057,pasireotide (pasireotide pamoate) 30 mg per vial powder for prolonged-release suspension for injection with diluent solution syringe,8002054,pasireotide,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
97184,Marketed,2020-03-09,02481359,VELTASSA,1.0,V03AE09,Patiromer calcium,Powder for suspension,Oral,02481359,VELTASSA (patiromer (patiromer sorbitex calcium) 8.4 g per sachet powder for oral suspension) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014272,patiromer (patiromer sorbitex calcium) 8.4 g per sachet powder for oral suspension,8002310,patiromer,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
97185,Marketed,2019-11-27,02481367,VELTASSA,1.0,V03AE09,Patiromer calcium,Powder for suspension,Oral,02481367,VELTASSA (patiromer (patiromer sorbitex calcium) 16.8 g per sachet powder for oral suspension) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014227,patiromer (patiromer sorbitex calcium) 16.8 g per sachet powder for oral suspension,8002310,patiromer,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
97933,Marketed,2019-07-25,02489252,ONPATTRO,1.0,N07XX12,Patisiran,Solution,Intravenous,02489252,ONPATTRO (patisiran (patisiran sodium lipid complex) 10 mg per 5 mL solution for injection vial) ALNYLAM NETHERLANDS B.V.,Active,9014156,patisiran (patisiran sodium lipid complex) 10 mg per 5 mL solution for injection vial,8002298,patisiran (lipid complex),738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
83758,Marketed,2016-09-07,02352303,VOTRIENT,1.0,L01EX03,Pazopanib,Tablet,Oral,02352303,VOTRIENT (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101466,Marketed,2022-08-31,02525666,PMS-PAZOPANIB,1.0,L01EX03,Pazopanib,Tablet,Oral,02525666,PMS-PAZOPANIB (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) PHARMASCIENCE INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104192,Marketed,2026-01-02,02552957,AURO-PAZOPANIB,1.0,L01EX03,Pazopanib,Tablet,Oral,02552957,AURO-PAZOPANIB (pazopanib (pazopanib hydrochloride) 200 mg oral tablet) AURO PHARMA INC,Active,9004763,pazopanib (pazopanib hydrochloride) 200 mg oral tablet,8002055,pazopanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94965,Marketed,2019-05-27,02461900,ONCASPAR,1.0,L01XX24,Pegaspargase,Solution,"Intramuscular,Intravenous",02461900,ONCASPAR (pegaspargase 3750 unit per 5 mL solution for injection vial) SERVIER CANADA INC,Active,9013501,pegaspargase 3750 unit per 5 mL solution for injection vial,8002056,pegaspargase,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102229,Marketed,2023-02-15,02533294,EMPAVELI,1.0,L04AJ03,Pegcetacoplan,Solution,Subcutaneous,02533294,EMPAVELI (pegcetacoplan 1080 mg per 20 mL solution for injection vial) SWEDISH ORPHAN BIOVITRUM AB (PUBL),Active,9014841,pegcetacoplan 1080 mg per 20 mL solution for injection vial,8002464,pegcetacoplan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
73463,Marketed,2004-03-12,02249790,NEULASTA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02249790,NEULASTA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) AMGEN CANADA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
96479,Marketed,2019-02-27,02474565,LAPELGA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02474565,LAPELGA SINGLE-USE PREFILLED SYRINGE (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
97449,Marketed,2024-04-04,02484153,FULPHILA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02484153,FULPHILA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
98722,Marketed,2020-05-15,02497395,ZIEXTENZO,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02497395,ZIEXTENZO (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) SANDOZ CANADA INCORPORATED,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
99556,Marketed,2021-01-18,02506238,NYVEPRIA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02506238,NYVEPRIA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) PFIZER CANADA ULC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
101856,Marketed,2022-11-28,02529343,LAPELGA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02529343,LAPELGA SINGLE-USE PRE-FILLED AUTOINJECTOR (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) APOTEX INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103564,Marketed,2025-02-12,02546973,NIOPEG,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02546973,NIOPEG (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) NORA PHARMA INC,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104284,Marketed,2025-09-09,02553945,PEXEGRA,1.0,L03AA13,Pegfilgrastim,Solution,Subcutaneous,02553945,PEXEGRA (filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013502,filgrastim (pegfilgrastim) 6 mg per 0.6 mL solution for injection syringe,8002057,filgrastim (pegfilgrastim),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
72399,Marketed,2024-06-03,02248077,PEGASYS,1.0,L03AB11,Peginterferon alfa-2a,Solution,Subcutaneous,02248077,PEGASYS (interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe) PHARMAAND GMBH,Active,9014152,interferon alfa-2a (peginterferon alfa-2a) 180 mcg per 0.5 mL solution for injection syringe,8002294,interferon alfa-2a (peginterferon alfa-2a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
92943,Marketed,2015-09-29,02444399,PLEGRIDY,1.0,L03AB13,Peginterferon beta-1a,Liquid,Subcutaneous,02444399,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014153,interferon beta-1a (peginterferon beta-1a) 125 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
92944,Marketed,2015-09-25,02444402,PLEGRIDY,2.0,L03AB13,Peginterferon beta-1a,"Kit,Liquid",Subcutaneous,02444402,PLEGRIDY (interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe) BIOGEN CANADA INC,Active,9014175,interferon beta-1a (peginterferon beta-1a) 63 mcg per 0.5 mL solution for injection syringe with interferon beta-1a (peginterferon beta-1a) 94 mcg per 0.5 mL solution for injection syringe,8002296,interferon beta-1a (peginterferon beta-1a),738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101536,Marketed,2022-08-26,02526247,PALYNZIQ,1.0,A16AB19,Pegvaliase,Solution,Subcutaneous,02526247,PALYNZIQ (pegvaliase 2.5 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014783,pegvaliase 2.5 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101537,Marketed,2022-08-26,02526255,PALYNZIQ,1.0,A16AB19,Pegvaliase,Solution,Subcutaneous,02526255,PALYNZIQ (pegvaliase 10 mg per 0.5 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014782,pegvaliase 10 mg per 0.5 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
101538,Marketed,2022-08-26,02526263,PALYNZIQ,1.0,A16AB19,Pegvaliase,Solution,Subcutaneous,02526263,PALYNZIQ (pegvaliase 20 mg per 1 mL solution for injection syringe) BIOMARIN INTERNATIONAL LIMITED,Active,9014784,pegvaliase 20 mg per 1 mL solution for injection syringe,8002437,pegvaliase,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
75772,Marketed,2006-01-24,02272199,SOMAVERT,1.0,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272199,SOMAVERT (pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013590,pegvisomant 10 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
75774,Marketed,2006-01-24,02272202,SOMAVERT,1.0,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272202,SOMAVERT (pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013591,pegvisomant 15 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
75775,Marketed,2006-01-24,02272210,SOMAVERT,1.0,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02272210,SOMAVERT (pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013592,pegvisomant 20 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93460,Marketed,2016-03-10,02448831,SOMAVERT,1.0,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02448831,SOMAVERT (pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013593,pegvisomant 25 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
93461,Marketed,2016-03-10,02448858,SOMAVERT,1.0,H01AX01,Pegvisomant,"Kit,Powder for solution",Subcutaneous,02448858,SOMAVERT (pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe) PFIZER CANADA ULC,Active,9013594,pegvisomant 30 mg per vial powder for solution for injection with diluent solution syringe,8002060,pegvisomant,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
94388,Marketed,2017-07-13,02456869,KEYTRUDA,1.0,L01FF02,Pembrolizumab,Solution,Intravenous,02456869,KEYTRUDA (pembrolizumab 100 mg per 4 mL solution for injection vial) MERCK CANADA INC,Active,9013503,pembrolizumab 100 mg per 4 mL solution for injection vial,8002061,pembrolizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
79204,Marketed,2009-01-09,02306433,ALIMTA,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02306433,ALIMTA (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) ELI LILLY CANADA INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
87938,Marketed,2017-03-31,02394227,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02394227,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
91363,Marketed,2018-10-18,02429195,TARO-PEMETREXED,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02429195,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
91364,Marketed,2017-02-15,02429209,TARO-PEMETREXED,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02429209,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
92306,Marketed,2017-05-24,02438674,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02438674,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
92307,Marketed,2017-05-29,02438682,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02438682,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg per vial powder for solution for injection) ACCORD HEALTHCARE INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
94667,Marketed,2017-03-31,02459434,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02459434,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95098,Marketed,2022-06-17,02463083,"PEMETREXED FOR INJECTION, USP",1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02463083,"PEMETREXED FOR INJECTION, USP (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD",Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95099,Marketed,2022-06-17,02463091,"PEMETREXED FOR INJECTION, USP",1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02463091,"PEMETREXED FOR INJECTION, USP (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) DR REDDY'S LABORATORIES LTD",Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
97105,Marketed,2021-05-07,02480492,TARO-PEMETREXED,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02480492,TARO-PEMETREXED (pemetrexed (pemetrexed disodium) 1000 mg per vial powder for solution for injection) TARO PHARMACEUTICALS INC,Active,9014538,pemetrexed (pemetrexed disodium) 1000 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100483,Marketed,2022-05-10,02515423,PEMETREXED FOR INJECTION,1.0,L01BA04,Pemetrexed,Solution,Intravenous,77701105,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 850 mg per 34 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014707,pemetrexed (pemetrexed disodium) 850 mg per 34 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100483,Marketed,2022-05-10,02515423,PEMETREXED FOR INJECTION,1.0,L01BA04,Pemetrexed,Solution,Intravenous,77701106,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 100 mg per 4 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014704,pemetrexed (pemetrexed disodium) 100 mg per 4 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100483,Marketed,2022-05-10,02515423,PEMETREXED FOR INJECTION,1.0,L01BA04,Pemetrexed,Solution,Intravenous,77701107,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 500 mg per 20 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014706,pemetrexed (pemetrexed disodium) 500 mg per 20 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100483,Marketed,2022-05-10,02515423,PEMETREXED FOR INJECTION,1.0,L01BA04,Pemetrexed,Solution,Intravenous,77701108,PEMETREXED FOR INJECTION (pemetrexed (pemetrexed disodium hemipentahydrate) 1000 mg per 40 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9014705,pemetrexed (pemetrexed disodium) 1000 mg per 40 mL solution for injection vial,8001501,pemetrexed,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100701,Marketed,2022-09-15,02517639,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02517639,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100702,Marketed,2022-09-15,02517647,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02517647,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) AURO PHARMA INC,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101793,Marketed,2024-10-08,02528746,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02528746,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004485,pemetrexed (pemetrexed disodium) 100 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101794,Marketed,2024-10-08,02528754,PEMETREXED DISODIUM FOR INJECTION,1.0,L01BA04,Pemetrexed,Powder for solution,Intravenous,02528754,PEMETREXED DISODIUM FOR INJECTION (pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9003927,pemetrexed (pemetrexed disodium) 500 mg per vial powder for solution for injection,8001501,pemetrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100917,Marketed,2022-01-06,02519933,PEMAZYRE,1.0,L01EN02,Pemigatinib,Tablet,Oral,02519933,PEMAZYRE (pemigatinib 4.5 mg oral tablet) INCYTE CORPORATION,Active,9014646,pemigatinib 4.5 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100918,Marketed,2021-11-30,02519941,PEMAZYRE,1.0,L01EN02,Pemigatinib,Tablet,Oral,02519941,PEMAZYRE (pemigatinib 9 mg oral tablet) INCYTE CORPORATION,Active,9014647,pemigatinib 9 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100919,Marketed,2021-11-26,02519968,PEMAZYRE,1.0,L01EN02,Pemigatinib,Tablet,Oral,02519968,PEMAZYRE (pemigatinib 13.5 mg oral tablet) INCYTE CORPORATION,Active,9014645,pemigatinib 13.5 mg oral tablet,8002407,pemigatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
287,Marketed,2019-12-13,00016055,CUPRIMINE,1.0,M01CC01,Penicillamine,Capsule,Oral,00016055,"CUPRIMINE (penicillamine 250 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9013018,penicillamine 250 mg oral capsule,8001678,penicillamine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
44273,Marketed,2018-06-27,02183080,PENTAMIDINE ISETIONATE FOR INJECTION BP,1.0,P01CX01,Pentamidine isethionate,Powder for solution,"Intramuscular,Intravenous",02183080,PENTAMIDINE ISETIONATE FOR INJECTION BP (pentamidine isetionate 300 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9012849,pentamidine isetionate 300 mg per vial powder for solution for injection,8001502,pentamidine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100704,Marketed,2021-10-14,02517663,PENTAMIDINE ISETIONATE FOR INJECTION BP,1.0,P01CX01,Pentamidine isethionate,Powder for solution,"Intravenous,Intramuscular",02517663,PENTAMIDINE ISETIONATE FOR INJECTION BP (pentamidine isetionate 300 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9012849,pentamidine isetionate 300 mg per vial powder for solution for injection,8001502,pentamidine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
14161,Marketed,2003-02-13,02029448,ELMIRON,1.0,C05BA04,Pentostan polysulfate sodium,Capsule,Oral,02029448,ELMIRON (pentosan polysulfate sodium 100 mg oral capsule) JANSSEN INC,Active,9002604,pentosan polysulfate sodium 100 mg oral capsule,8002062,pentosan polysulfate sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
48622,Marketed,2025-06-25,02230090,APO-PENTOXIFYLLINE SR,1.0,C04AD03,Pentoxifylline,Tablet (extended-release),Oral,02230090,APO-PENTOXIFYLLINE SR (pentoxifylline 400 mg prolonged-release oral tablet) APOTEX INC,Active,9003044,pentoxifylline 400 mg prolonged-release oral tablet,8001412,pentoxifylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103158,Marketed,2024-09-20,02543087,JAMP PENTOXIFYLLINE SR,1.0,C04AD03,Pentoxifylline,Tablet (extended-release),Oral,02543087,JAMP PENTOXIFYLLINE SR (pentoxifylline 400 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9003044,pentoxifylline 400 mg prolonged-release oral tablet,8001412,pentoxifylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
88927,Marketed,2013-06-19,02404516,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404516,FYCOMPA (perampanel 2 mg oral tablet) EISAI LIMITED,Active,9005269,perampanel 2 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88928,Marketed,2013-05-17,02404567,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404567,FYCOMPA (perampanel 12 mg oral tablet) EISAI LIMITED,Active,9005249,perampanel 12 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88929,Marketed,2013-06-19,02404524,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404524,FYCOMPA (perampanel 4 mg oral tablet) EISAI LIMITED,Active,9005270,perampanel 4 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88930,Marketed,2013-06-19,02404532,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404532,FYCOMPA (perampanel 6 mg oral tablet) EISAI LIMITED,Active,9005271,perampanel 6 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88931,Marketed,2013-06-19,02404540,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404540,FYCOMPA (perampanel 8 mg oral tablet) EISAI LIMITED,Active,9005272,perampanel 8 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88932,Marketed,2013-06-03,02404559,FYCOMPA,1.0,N03AX22,Perampanel,Tablet,Oral,02404559,FYCOMPA (perampanel 10 mg oral tablet) EISAI LIMITED,Active,9005260,perampanel 10 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101174,Marketed,2023-12-04,02522632,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522632,TARO-PERAMPANEL (perampanel 2 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005269,perampanel 2 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101175,Marketed,2023-12-04,02522640,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522640,TARO-PERAMPANEL (perampanel 4 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005270,perampanel 4 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101176,Marketed,2023-12-04,02522659,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522659,TARO-PERAMPANEL (perampanel 6 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005271,perampanel 6 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101177,Marketed,2023-12-04,02522667,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522667,TARO-PERAMPANEL (perampanel 8 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005272,perampanel 8 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101178,Marketed,2023-12-04,02522675,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522675,TARO-PERAMPANEL (perampanel 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005260,perampanel 10 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101179,Marketed,2023-12-04,02522683,TARO-PERAMPANEL,1.0,N03AX22,Perampanel,Tablet,Oral,02522683,TARO-PERAMPANEL (perampanel 12 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005249,perampanel 12 mg oral tablet,8002063,perampanel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12425,Marketed,2023-01-27,01926772,NEULEPTIL,1.0,N05AC01,Periciazine,Capsule,Oral,01926772,NEULEPTIL (periciazine 10 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001647,periciazine 10 mg oral capsule,8001503,periciazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
12653,Marketed,2023-01-27,01926780,NEULEPTIL,1.0,N05AC01,Periciazine,Capsule,Oral,01926780,NEULEPTIL (periciazine 5 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9001648,periciazine 5 mg oral capsule,8001503,periciazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13159,Marketed,2023-01-27,01926756,NEULEPTIL,1.0,N05AC01,Periciazine,Drops,Oral,01926756,NEULEPTIL (periciazine 10 mg per mL oral drops) SEARCHLIGHT PHARMA INC,Active,9001767,periciazine 10 mg per mL oral drops,8001503,periciazine,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
16879,Marketed,1994-12-31,02123282,COVERSYL,1.0,C09AA04,Perindopril,Tablet,Oral,02123282,COVERSYL (perindopril erbumine 4 mg oral tablet) SERVIER CANADA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16880,Marketed,1994-12-31,02123274,COVERSYL,1.0,C09AA04,Perindopril,Tablet,Oral,02123274,COVERSYL (perindopril erbumine 2 mg oral tablet) SERVIER CANADA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70814,Marketed,2003-09-11,02246624,COVERSYL,1.0,C09AA04,Perindopril,Tablet,Oral,02246624,COVERSYL (perindopril erbumine 8 mg oral tablet) SERVIER CANADA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77465,Marketed,2020-12-18,02289261,APO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02289261,APO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) APOTEX INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77466,Marketed,2020-12-18,02289288,APO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02289288,APO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) APOTEX INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77467,Marketed,2020-12-18,02289296,APO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02289296,APO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) APOTEX INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94713,Marketed,2018-03-07,02459817,AURO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02459817,AURO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) AURO PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94714,Marketed,2018-03-07,02459825,AURO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02459825,AURO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) AURO PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94715,Marketed,2018-03-07,02459833,AURO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02459833,AURO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) AURO PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95319,Marketed,2018-03-07,02464985,TEVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02464985,TEVA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95320,Marketed,2018-03-07,02464993,TEVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02464993,TEVA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95321,Marketed,2018-03-07,02465000,TEVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02465000,TEVA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95921,Marketed,2018-03-05,02470225,SANDOZ PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02470225,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95922,Marketed,2018-03-05,02470233,SANDOZ PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02470233,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95923,Marketed,2018-03-05,02470241,SANDOZ PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02470241,SANDOZ PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95968,Marketed,2018-03-07,02470675,PMS-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02470675,PMS-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) PHARMASCIENCE INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95969,Marketed,2018-03-07,02470683,PMS-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02470683,PMS-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) PHARMASCIENCE INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95970,Marketed,2018-03-07,02470691,PMS-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02470691,PMS-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) PHARMASCIENCE INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96126,Marketed,2018-03-07,02472015,RIVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02472015,RIVA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96127,Marketed,2018-03-07,02472023,RIVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02472023,RIVA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96128,Marketed,2018-03-07,02472031,RIVA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02472031,RIVA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96501,Marketed,2019-04-11,02474824,MAR-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02474824,MAR-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96502,Marketed,2019-04-11,02474832,MAR-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02474832,MAR-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96503,Marketed,2019-04-11,02474840,MAR-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02474840,MAR-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96760,Marketed,2019-03-22,02476762,MINT-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02476762,MINT-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96761,Marketed,2019-01-23,02476770,MINT-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02476770,MINT-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96762,Marketed,2019-01-23,02476789,MINT-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02476789,MINT-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97044,Marketed,2019-02-13,02479877,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02479877,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97045,Marketed,2019-02-13,02479885,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02479885,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97046,Marketed,2019-02-13,02479893,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02479893,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97209,Marketed,2022-08-04,02481634,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02481634,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) SANIS HEALTH INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97210,Marketed,2022-08-04,02481642,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02481642,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) SANIS HEALTH INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97211,Marketed,2022-08-04,02481650,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02481650,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) SANIS HEALTH INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97332,Marketed,2019-07-23,02482924,M-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02482924,M-PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) MANTRA PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97333,Marketed,2019-07-23,02482932,M-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02482932,M-PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) MANTRA PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97334,Marketed,2019-07-23,02482940,M-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02482940,M-PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) MANTRA PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97901,Marketed,2019-07-09,02488949,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02488949,PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) PRO DOC LIMITEE,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97902,Marketed,2019-07-09,02488957,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02488957,PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) PRO DOC LIMITEE,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97903,Marketed,2019-07-09,02488965,PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02488965,PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) PRO DOC LIMITEE,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97907,Marketed,2019-10-24,02489015,NRA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02489015,NRA-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) NORA PHARMA INC,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97908,Marketed,2019-10-24,02489023,NRA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02489023,NRA-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) NORA PHARMA INC,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97909,Marketed,2019-10-24,02489031,NRA-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02489031,NRA-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) NORA PHARMA INC,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99093,Marketed,2020-07-13,02501309,BIO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02501309,BIO-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) BIOMED PHARMA,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99094,Marketed,2020-07-13,02501317,BIO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02501317,BIO-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) BIOMED PHARMA,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99095,Marketed,2020-07-13,02501325,BIO-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02501325,BIO-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) BIOMED PHARMA,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101623,Marketed,2022-12-15,02527200,JAMP PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02527200,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101626,Marketed,2022-12-15,02527219,JAMP PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02527219,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101627,Marketed,2022-12-16,02527227,JAMP PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02527227,JAMP PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101869,Marketed,2022-12-16,02529491,AG-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02529491,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 2 mg oral tablet) ANGITA PHARMA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101874,Marketed,2022-12-16,02529505,AG-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02529505,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 4 mg oral tablet) ANGITA PHARMA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101875,Marketed,2022-12-16,02529513,AG-PERINDOPRIL ERBUMINE,1.0,C09AA04,Perindopril,Tablet,Oral,02529513,AG-PERINDOPRIL ERBUMINE (perindopril erbumine 8 mg oral tablet) ANGITA PHARMA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104444,Marketed,2025-07-16,02555697,NB-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02555697,NB-PERINDOPRIL (perindopril erbumine 2 mg oral tablet) NB PHARMA INC.,Active,9000539,perindopril erbumine 2 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104445,Marketed,2025-07-16,02555700,NB-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02555700,NB-PERINDOPRIL (perindopril erbumine 4 mg oral tablet) NB PHARMA INC.,Active,9000540,perindopril erbumine 4 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104446,Marketed,2025-07-16,02555719,NB-PERINDOPRIL,1.0,C09AA04,Perindopril,Tablet,Oral,02555719,NB-PERINDOPRIL (perindopril erbumine 8 mg oral tablet) NB PHARMA INC.,Active,9001051,perindopril erbumine 8 mg oral tablet,8000206,perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93782,Marketed,2016-04-05,02451530,VIACORAM,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451530,VIACORAM (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) SERVIER CANADA INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93783,Marketed,2016-04-05,02451549,VIACORAM,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451549,VIACORAM (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) SERVIER CANADA INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93784,Marketed,2016-04-05,02451557,VIACORAM,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02451557,VIACORAM (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) SERVIER CANADA INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95699,Marketed,2019-06-03,02468565,APO-PERINDOPRIL/AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468565,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) APOTEX INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95700,Marketed,2019-06-03,02468573,APO-PERINDOPRIL/AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468573,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) APOTEX INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95701,Marketed,2019-06-03,02468581,APO-PERINDOPRIL/AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02468581,APO-PERINDOPRIL/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) APOTEX INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103033,Marketed,2024-02-21,02541696,PMS-PERINDOPRIL-AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541696,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet) PHARMASCIENCE INC,Active,9005925,amlodipine (amlodipine besylate) 2.5 mg and perindopril arginine 3.5 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103034,Marketed,2024-02-21,02541718,PMS-PERINDOPRIL-AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541718,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet) PHARMASCIENCE INC,Active,9005926,amlodipine (amlodipine besylate) 5 mg and perindopril arginine 7 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103035,Marketed,2024-02-21,02541726,PMS-PERINDOPRIL-AMLODIPINE,2.0,C09BB04,Perindopril and amlodipine,Tablet,Oral,02541726,PMS-PERINDOPRIL-AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet) PHARMASCIENCE INC,Active,9005924,amlodipine (amlodipine besylate) 10 mg and perindopril arginine 14 mg oral tablet,8001014,amlodipine and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70751,Marketed,2007-10-02,02246568,COVERSYL PLUS LD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02246568,COVERSYL PLUS LD (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) SERVIER CANADA INC,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70752,Marketed,2003-10-10,02246569,COVERSYL PLUS,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02246569,COVERSYL PLUS (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SERVIER CANADA INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78291,Marketed,2021-02-02,02297574,APO-PERINDOPRIL-INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02297574,APO-PERINDOPRIL-INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) APOTEX INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80705,Marketed,2009-05-07,02321653,COVERSYL PLUS HD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02321653,COVERSYL PLUS HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SERVIER CANADA INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93369,Marketed,2025-12-16,02447991,AG-PERINDOPRIL / INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02447991,AG-PERINDOPRIL / INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) ANGITA PHARMA INC.,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93370,Marketed,2025-12-16,02448009,AG-PERINDOPRIL / INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02448009,AG-PERINDOPRIL / INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) ANGITA PHARMA INC.,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93371,Marketed,2025-12-16,02448017,AG-PERINDOPRIL / INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02448017,AG-PERINDOPRIL / INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) ANGITA PHARMA INC.,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93947,Marketed,2021-02-02,02453061,APO-PERINDOPRIL-INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02453061,APO-PERINDOPRIL-INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) APOTEX INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95215,Marketed,2018-03-07,02464039,TEVA-PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02464039,TEVA-PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) TEVA CANADA LIMITED,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95216,Marketed,2018-03-07,02464020,TEVA-PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02464020,TEVA-PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) TEVA CANADA LIMITED,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95939,Marketed,2018-03-05,02470411,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02470411,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95940,Marketed,2018-03-05,02470438,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02470438,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95941,Marketed,2018-03-05,02470446,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02470446,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97039,Marketed,2022-01-20,02479834,PERINDOPRIL ERBUMINE/ INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02479834,PERINDOPRIL ERBUMINE/ INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97042,Marketed,2022-01-20,02479842,PERINDOPRIL ERBUMINE/ INDAPAMIDE HD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02479842,PERINDOPRIL ERBUMINE/ INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100896,Marketed,2021-12-15,02519720,PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02519720,PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) SANIS HEALTH INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100897,Marketed,2021-12-15,02519739,PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02519739,PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) SANIS HEALTH INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101211,Marketed,2023-01-20,02523035,PERINDOPRIL ERBUMINE/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02523035,PERINDOPRIL ERBUMINE/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) PRO DOC LIMITEE,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101212,Marketed,2023-01-20,02523043,PERINDOPRIL ERBUMINE/INDAPAMIDE HD,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02523043,PERINDOPRIL ERBUMINE/INDAPAMIDE HD (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) PRO DOC LIMITEE,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102673,Marketed,2023-08-29,02537990,PMS-PERINDOPRIL-INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02537990,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) PHARMASCIENCE INC,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102674,Marketed,2023-08-29,02538008,PMS-PERINDOPRIL-INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02538008,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) PHARMASCIENCE INC,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102675,Marketed,2023-08-29,02537982,PMS-PERINDOPRIL-INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02537982,PMS-PERINDOPRIL-INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) PHARMASCIENCE INC,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104299,Marketed,2025-12-16,02554119,JAMP PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02554119,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001028,indapamide 0.625 mg and perindopril erbumine 2 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104300,Marketed,2025-12-16,02554127,JAMP PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02554127,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001009,indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104301,Marketed,2025-12-16,02554135,JAMP PERINDOPRIL/INDAPAMIDE,2.0,C09BA04,Perindopril and diuretics,Tablet,Oral,02554135,JAMP PERINDOPRIL/INDAPAMIDE (indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001274,indapamide 2.5 mg and perindopril erbumine 8 mg oral tablet,8000321,indapamide and perindopril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8964,Marketed,2003-05-01,00771368,NIX CREME RINSE,1.0,P03AC04,Permethrin,Cream,Topical,00771368,"NIX CREME RINSE (permethrin 1 % cutaneous solution) INSIGHT PHARMACEUTICALS, LLC",Active,9013832,permethrin 1 % cutaneous solution,8001299,permethrin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
37239,Marketed,2024-04-05,02219905,NIX DERMAL CREAM,1.0,P03AC04,Permethrin,Cream,Topical,02219905,NIX DERMAL CREAM (permethrin 5 % cutaneous cream) HALEON CANADA ULC,Active,9003393,permethrin 5 % cutaneous cream,8001299,permethrin,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
50657,Marketed,2013-02-15,02231348,KWELLADA-P LOTION,1.0,P03AC04,Permethrin,Lotion,Topical,02231348,KWELLADA-P LOTION (permethrin 5 % lotion) MEDTECH PRODUCTS INC,Active,9003168,permethrin 5 % lotion,8001299,permethrin,448598008,Cutaneous,739000003,Lotion,,,,,
50804,Marketed,2013-02-15,02231480,KWELLADA-P CRèME RINSE,1.0,P03AC04,Permethrin,Liquid,Topical,02231480,KWELLADA-P CRÈME RINSE (permethrin 1 % cutaneous solution) MEDTECH PRODUCTS INC,Active,9013832,permethrin 1 % cutaneous solution,8001299,permethrin,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
2365,Marketed,2010-11-25,00335096,PERPHENAZINE,1.0,N05AB03,Perphenazine,Tablet,Oral,00335096,PERPHENAZINE (perphenazine 16 mg oral tablet) AA PHARMA INC,Active,9001769,perphenazine 16 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2366,Marketed,2010-10-22,00335118,PERPHENAZINE,1.0,N05AB03,Perphenazine,Tablet,Oral,00335118,PERPHENAZINE (perphenazine 8 mg oral tablet) AA PHARMA INC,Active,9001772,perphenazine 8 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2367,Marketed,2010-10-19,00335126,PERPHENAZINE,1.0,N05AB03,Perphenazine,Tablet,Oral,00335126,PERPHENAZINE (perphenazine 4 mg oral tablet) AA PHARMA INC,Active,9001771,perphenazine 4 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2368,Marketed,2010-11-23,00335134,PERPHENAZINE,1.0,N05AB03,Perphenazine,Tablet,Oral,00335134,PERPHENAZINE (perphenazine 2 mg oral tablet) AA PHARMA INC,Active,9001770,perphenazine 2 mg oral tablet,8001504,perphenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63789,Marketed,2006-07-27,02240255,ADACEL,6.0,J07AJ52,"Pertussis, purified antigen, comb. with toxoids",Suspension,Intramuscular,,,,,,,,,,,,,,,,
88984,Marketed,2013-05-08,02405016,PERJETA,1.0,L01FD02,Pertuzumab,Solution,Intravenous,02405016,PERJETA (pertuzumab 420 mg per 14 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013504,pertuzumab 420 mg per 14 mL solution for injection vial,8002064,pertuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88985,Marketed,2013-05-09,02405024,PERJETA-HERCEPTIN,2.0,L01FY01,Pertuzumab and trastuzumab,"Powder for solution,Kit,Solution",Intravenous,02405024,PERJETA-HERCEPTIN (pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013505,pertuzumab 420 mg per 14 mL solution for injection vial with trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100216,Marketed,2021-04-08,02512912,PHESGO,2.0,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512912,PHESGO (pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014527,pertuzumab 1200 mg per 15 mL and trastuzumab 600 mg per 15 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100217,Marketed,2021-04-09,02512920,PHESGO,2.0,L01FY01,Pertuzumab and trastuzumab,Solution,Subcutaneous,02512920,PHESGO (pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9014528,pertuzumab 600 mg per 10 mL and trastuzumab 600 mg per 10 mL solution for injection vial,8002065,pertuzumab and trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
8121,Marketed,2005-10-05,00725765,MEPERIDINE HYDROCHLORIDE INJECTION USP,1.0,N02AB02,Pethidine,Solution,"Intramuscular,Intravenous,Subcutaneous",00725765,MEPERIDINE HYDROCHLORIDE INJECTION USP (meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9006548,meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule,8000782,meperidine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
4388,Marketed,2025-07-07,00476714,PYRIDIUM,1.0,G04BX06,Phenazopyridine,Tablet,Oral,00476714,PYRIDIUM (phenazopyridine hydrochloride 100 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001703,phenazopyridine hydrochloride 100 mg oral tablet,8002311,phenazopyridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4309,Marketed,2022-10-04,00476552,NARDIL,1.0,N06AF03,Phenelzine,Tablet,Oral,00476552,NARDIL (phenelzine (phenelzine sulfate) 15 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001914,phenelzine (phenelzine sulfate) 15 mg oral tablet,8001505,phenelzine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
405,Marketed,2012-03-19,00178799,PHENOBARB,1.0,N03AA02,Phenobarbital,Tablet,Oral,00178799,PHENOBARB (phenobarbital 15 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001557,phenobarbital 15 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
406,Marketed,2012-03-05,00178802,PHENOBARB,1.0,N03AA02,Phenobarbital,Tablet,Oral,00178802,PHENOBARB (phenobarbital 30 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001558,phenobarbital 30 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
407,Marketed,2012-03-05,00178810,PHENOBARB,1.0,N03AA02,Phenobarbital,Tablet,Oral,00178810,PHENOBARB (phenobarbital 60 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001559,phenobarbital 60 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
408,Marketed,2012-03-05,00178829,PHENOBARB,1.0,N03AA02,Phenobarbital,Tablet,Oral,00178829,PHENOBARB (phenobarbital 100 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001556,phenobarbital 100 mg oral tablet,8000799,phenobarbital,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6095,Marketed,2012-03-05,00645575,PHENOBARB ELIXIR,1.0,N03AA02,Phenobarbital,Solution,Oral,00645575,PHENOBARB ELIXIR (phenobarbital 5 mg per mL oral solution) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001616,phenobarbital 5 mg per mL oral solution,8000799,phenobarbital,26643006,Oral,385023001,Oral solution,,,,,
78939,Marketed,2008-02-29,02304082,"PHENOBARBITAL SODIUM INJECTION, USP",1.0,N03AA02,Phenobarbital,Solution,"Intramuscular,Intravenous",02304082,"PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 30 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED",Active,9013507,phenobarbital sodium 30 mg per 1 mL solution for injection ampoule,8000799,phenobarbital,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
78940,Marketed,2008-02-29,02304090,"PHENOBARBITAL SODIUM INJECTION, USP",1.0,N03AA02,Phenobarbital,Solution,"Intramuscular,Intravenous",02304090,"PHENOBARBITAL SODIUM INJECTION, USP (phenobarbital sodium 120 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED",Active,9013506,phenobarbital sodium 120 mg per 1 mL solution for injection ampoule,8000799,phenobarbital,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
6421,Marketed,2014-09-05,00642215,PEN-VK,1.0,J01CE02,Phenoxymethylpenicillin,Tablet,Oral,00642215,PEN-VK (penicillin V potassium 300 mg oral tablet) AA PHARMA INC,Active,9006206,penicillin V potassium 300 mg oral tablet,8000064,penicillin V,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67670,Marketed,2005-08-18,02243737,PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD,1.0,C04AB01,Phentolamine,Solution,"Intravenous,Intramuscular",02243737,PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD (phentolamine mesylate 5 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013508,phentolamine mesylate 5 mg per 1 mL solution for injection vial,8002066,phentolamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90632,Marketed,2014-09-17,02421666,ORAVERSE,1.0,V03AB36,Phentolamine,Solution,Submucosal,02421666,ORAVERSE (phentolamine mesylate 0.4 mg per 1.7 mL solution for injection cartridge) SEPTODONT,Active,9013833,phentolamine mesylate 0.4 mg per 1.7 mL solution for injection cartridge,8002066,phentolamine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
3319,Marketed,2019-04-30,00465763,MYDFRIN,1.0,S01FB01,Phenylephrine,Solution,Ophthalmic,00465763,MYDFRIN (phenylephrine hydrochloride 2.5 % ophthalmic drops) ALCON CANADA INC,Active,9001859,phenylephrine hydrochloride 2.5 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
12889,Marketed,2005-08-09,01953583,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Liquid,"Subcutaneous,Intramuscular,Intravenous",77700593,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine (phenylephrine hydrochloride) 10 mg per 1 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012748,phenylephrine (phenylephrine hydrochloride) 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
12889,Marketed,2005-08-09,01953583,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Liquid,"Subcutaneous,Intramuscular,Intravenous",77700594,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine (phenylephrine hydrochloride) 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012749,phenylephrine (phenylephrine hydrochloride) 50 mg per 5 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
18759,Marketed,2022-12-29,02148455,MINIMS PHENYLEPHRINE HYDROCHLORIDE,1.0,S01FB01,Phenylephrine,Solution,Ophthalmic,02148455,MINIMS PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride 10 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002861,phenylephrine hydrochloride 10 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18860,Marketed,2022-12-29,02148447,MINIMS PHENYLEPHRINE HYDROCHLORIDE,1.0,S01FB01,Phenylephrine,Solution,Ophthalmic,02148447,MINIMS PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride 2.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001859,phenylephrine hydrochloride 2.5 % ophthalmic drops,8000823,phenylephrine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
37384,Marketed,2023-02-10,02224860,SOFRAMYCIN NASAL SPRAY,3.0,R01AB01,Phenylephrine,Spray,Nasal,02224860,SOFRAMYCIN NASAL SPRAY (framycetin sulfate 12.5 mg per mL and gramicidin 0.05 mg per mL and phenylephrine hydrochloride 2.5 mg per mL nasal spray) SEARCHLIGHT PHARMA INC,Active,9003597,framycetin sulfate 12.5 mg per mL and gramicidin 0.05 mg per mL and phenylephrine hydrochloride 2.5 mg per mL nasal spray,8000920,framycetin and gramicidin and phenylephrine,46713006,Nasal,385157007,Nasal spray,,,,,
61817,Marketed,2001-07-30,02238400,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%,1.0,C01CA06,Phenylephrine,Solution,"Subcutaneous,Intravenous,Intramuscular",02238400,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94130,Marketed,2021-11-25,02454599,PHENYLEPHRINE HYDROCHLORIDE INJECTION,1.0,C01CA06,Phenylephrine,Solution,Intravenous,02454599,PHENYLEPHRINE HYDROCHLORIDE INJECTION (phenylephrine hydrochloride 500 mcg per 10 mL solution for injection syringe) LABORATOIRE AGUETTANT,Active,9012752,phenylephrine hydrochloride 500 mcg per 10 mL solution for injection syringe,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
96812,Marketed,2019-03-26,02477254,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Solution,"Intravenous,Subcutaneous,Intramuscular",02477254,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96967,Marketed,2022-07-06,02479281,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%,1.0,C01CA06,Phenylephrine,Solution,"Intramuscular,Intravenous,Subcutaneous",02479281,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) MONT-PHARMA INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99396,Marketed,2021-06-02,02504545,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Solution,"Intramuscular,Intravenous,Subcutaneous",77701079,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial) STERIMAX INC,Active,9012751,phenylephrine hydrochloride 10 mg per 1 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99396,Marketed,2021-06-02,02504545,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Solution,"Intramuscular,Intravenous,Subcutaneous",77701080,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 100 mg per 10 mL solution for injection vial) STERIMAX INC,Active,9014553,phenylephrine hydrochloride 100 mg per 10 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99396,Marketed,2021-06-02,02504545,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,1.0,C01CA06,Phenylephrine,Solution,"Intramuscular,Intravenous,Subcutaneous",77701081,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP (phenylephrine hydrochloride 50 mg per 5 mL solution for injection vial) STERIMAX INC,Active,9014554,phenylephrine hydrochloride 50 mg per 5 mL solution for injection vial,8000823,phenylephrine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
1036,Marketed,2023-06-07,00022772,DILANTIN,1.0,N03AB02,Phenytoin,Capsule,Oral,00022772,DILANTIN (phenytoin sodium 30 mg oral capsule) BGP PHARMA ULC,Active,9000007,phenytoin sodium 30 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
1037,Marketed,2023-06-07,00022780,DILANTIN,1.0,N03AB02,Phenytoin,Capsule,Oral,00022780,DILANTIN (phenytoin sodium 100 mg oral capsule) BGP PHARMA ULC,Active,9000006,phenytoin sodium 100 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
1086,Marketed,2023-08-02,00023698,DILANTIN INFATABS,1.0,N03AB02,Phenytoin,Tablet (chewable),Oral,00023698,DILANTIN INFATABS (phenytoin 50 mg chewable tablet) BGP PHARMA ULC,Active,9014908,phenytoin 50 mg chewable tablet,8000005,phenytoin (base),26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),1.0,,
9398,Marketed,2005-10-01,00780626,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Liquid,"Intramuscular,Intravenous",77700013,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000303,phenytoin sodium 100 mg per 2 mL solution for injection ampoule,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
9398,Marketed,2005-10-01,00780626,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Liquid,"Intramuscular,Intravenous",77700014,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000304,phenytoin sodium 250 mg per 5 mL solution for injection ampoule,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
13063,Marketed,2021-07-13,00498335,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700157,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000437,phenytoin sodium 100 mg per 2 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
13063,Marketed,2021-07-13,00498335,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700158,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9000438,phenytoin sodium 250 mg per 5 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
73583,Marketed,2005-05-03,02250896,TARO-PHENYTOIN,1.0,N03AB02,Phenytoin,Suspension,Oral,02250896,TARO-PHENYTOIN (phenytoin 125 mg per 5 mL oral suspension) TARO PHARMACEUTICALS INC,Active,9000009,phenytoin 125 mg per 5 mL oral suspension,8000005,phenytoin (base),26643006,Oral,385024007,Oral suspension,,,1.0,,
91579,Marketed,2024-02-16,02431378,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700131,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 100 mg per 2 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9000437,phenytoin sodium 100 mg per 2 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91579,Marketed,2024-02-16,02431378,PHENYTOIN SODIUM INJECTION USP,1.0,N03AB02,Phenytoin,Solution,"Intramuscular,Intravenous",77700132,PHENYTOIN SODIUM INJECTION USP (phenytoin sodium 250 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9000438,phenytoin sodium 250 mg per 5 mL solution for injection vial,8000004,phenytoin sodium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
94843,Marketed,2021-07-13,02460912,PHENYTOIN SODIUM,1.0,N03AB02,Phenytoin,Capsule,Oral,02460912,PHENYTOIN SODIUM (phenytoin sodium 100 mg oral capsule) AA PHARMA INC,Active,9000006,phenytoin sodium 100 mg oral capsule,8000004,phenytoin sodium,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
9993,Marketed,2024-02-16,00781878,VITAMIN K1,1.0,B02BA01,Phytomenadione,Emulsion,"Subcutaneous,Intramuscular,Intravenous",00781878,VITAMIN K1 (phytonadione 1 mg per 0.5 mL emulsion for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013719,phytonadione 1 mg per 0.5 mL emulsion for injection ampoule,8002209,phytonadione,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,
9994,Marketed,2024-02-16,00804312,VITAMIN K1,1.0,B02BA01,Phytomenadione,Emulsion,"Intravenous,Subcutaneous,Intramuscular",00804312,VITAMIN K1 (phytonadione 10 mg per 1 mL emulsion for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013720,phytonadione 10 mg per 1 mL emulsion for injection ampoule,8002209,phytonadione,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,
2375,Marketed,2017-12-08,00000868,ISOPTO CARPINE,1.0,S01EB01,Pilocarpine,Liquid,Ophthalmic,00000868,ISOPTO CARPINE (pilocarpine hydrochloride 2 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002708,pilocarpine hydrochloride 2 % ophthalmic drops,8001506,pilocarpine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18744,Marketed,2023-02-03,02148463,MINIMS PILOCARPINE NITRATE,1.0,S01EB01,Pilocarpine,Drops,Ophthalmic,02148463,MINIMS PILOCARPINE NITRATE (pilocarpine nitrate 2 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002862,pilocarpine nitrate 2 % ophthalmic drops,8001506,pilocarpine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
43182,Marketed,2020-07-21,02216345,SALAGEN,1.0,N07AX01,Pilocarpine,Tablet,Oral,02216345,SALAGEN (pilocarpine hydrochloride 5 mg oral tablet) AMDIPHARM LIMITED,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98599,Marketed,2021-06-14,02496119,M-PILOCARPINE,1.0,N07AX01,Pilocarpine,Tablet,Oral,02496119,M-PILOCARPINE (pilocarpine hydrochloride 5 mg oral tablet) MANTRA PHARMA INC,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99887,Marketed,2021-04-30,02509571,JAMP PILOCARPINE,1.0,N07AX01,Pilocarpine,Tablet,Oral,02509571,JAMP PILOCARPINE (pilocarpine hydrochloride 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003078,pilocarpine hydrochloride 5 mg oral tablet,8001506,pilocarpine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71480,Marketed,2020-01-20,02247238,ELIDEL,1.0,D11AH02,Pimecrolimus,Cream,Topical,02247238,"ELIDEL (pimecrolimus 1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003789,pimecrolimus 1 % cutaneous cream,8002067,pimecrolimus,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
69484,Marketed,2014-08-22,02245432,PIMOZIDE,1.0,N05AG02,Pimozide,Tablet,Oral,02245432,PIMOZIDE (pimozide 2 mg oral tablet) AA PHARMA INC,Active,9001741,pimozide 2 mg oral tablet,8001507,pimozide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69485,Marketed,2016-02-10,02245433,PIMOZIDE,1.0,N05AG02,Pimozide,Tablet,Oral,02245433,PIMOZIDE (pimozide 4 mg oral tablet) AA PHARMA INC,Active,9001742,pimozide 4 mg oral tablet,8001507,pimozide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15176,Marketed,2016-03-09,01950592,DICETEL,1.0,A03AX04,Pinaverium,Tablet,Oral,01950592,DICETEL (pinaverium bromide 50 mg oral tablet) BGP PHARMA ULC,Active,9002606,pinaverium bromide 50 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49943,Marketed,2016-03-09,02230684,DICETEL,1.0,A03AX04,Pinaverium,Tablet,Oral,02230684,DICETEL (pinaverium bromide 100 mg oral tablet) BGP PHARMA ULC,Active,9003401,pinaverium bromide 100 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95848,Marketed,2021-08-16,02469677,PINAVERIUM,1.0,A03AX04,Pinaverium,Tablet,Oral,02469677,PINAVERIUM (pinaverium bromide 50 mg oral tablet) AA PHARMA INC,Active,9002606,pinaverium bromide 50 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95849,Marketed,2021-08-16,02469685,PINAVERIUM,1.0,A03AX04,Pinaverium,Tablet,Oral,02469685,PINAVERIUM (pinaverium bromide 100 mg oral tablet) AA PHARMA INC,Active,9003401,pinaverium bromide 100 mg oral tablet,8001300,pinaverium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10949,Marketed,2011-10-20,00869007,TEVA-PINDOLOL,1.0,C07AA03,Pindolol,Tablet,Oral,00869007,TEVA-PINDOLOL (pindolol 5 mg oral tablet) TEVA CANADA LIMITED,Active,9011416,pindolol 5 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10950,Marketed,2011-10-20,00869015,TEVA-PINDOLOL,1.0,C07AA03,Pindolol,Tablet,Oral,00869015,TEVA-PINDOLOL (pindolol 10 mg oral tablet) TEVA CANADA LIMITED,Active,9011414,pindolol 10 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10951,Marketed,2011-10-20,00869023,TEVA-PINDOLOL,1.0,C07AA03,Pindolol,Tablet,Oral,00869023,TEVA-PINDOLOL (pindolol 15 mg oral tablet) TEVA CANADA LIMITED,Active,9011415,pindolol 15 mg oral tablet,8000819,pindolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78818,Marketed,2025-12-12,02302861,TEVA-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02302861,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) TEVA CANADA LIMITED,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78819,Marketed,2025-12-12,02302888,TEVA-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02302888,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78820,Marketed,2025-12-12,02302896,TEVA-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02302896,TEVA-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) TEVA CANADA LIMITED,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78827,Marketed,2007-12-05,02302977,APO-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02302977,APO-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) APOTEX INC,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81184,Marketed,2022-03-03,02326477,MINT-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02326477,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81185,Marketed,2022-03-03,02326485,MINT-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02326485,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81186,Marketed,2022-03-03,02326493,MINT-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02326493,MINT-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82518,Marketed,2014-10-31,02339587,ACH-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02339587,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82519,Marketed,2014-10-31,02339595,ACH-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02339595,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85042,Marketed,2025-03-04,02365529,JAMP PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02365529,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000917,pioglitazone (pioglitazone hydrochloride) 30 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85043,Marketed,2025-03-04,02365537,JAMP PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02365537,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000918,pioglitazone (pioglitazone hydrochloride) 45 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87693,Marketed,2014-10-31,02391600,ACH-PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02391600,ACH-PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88227,Marketed,2025-03-04,02397307,JAMP PIOGLITAZONE,1.0,A10BG03,Pioglitazone,Tablet,Oral,02397307,JAMP PIOGLITAZONE (pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000916,pioglitazone (pioglitazone hydrochloride) 15 mg oral tablet,8000289,pioglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78500,Marketed,2021-10-22,02299623,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299623,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
78501,Marketed,2021-10-22,02299631,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299631,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
78502,Marketed,2021-10-22,02299658,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02299658,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81627,Marketed,2021-10-22,02330547,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02330547,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9004666,piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84762,Marketed,2011-08-29,02362619,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362619,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) STERIMAX INC,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84763,Marketed,2011-08-29,02362627,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362627,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) STERIMAX INC,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84764,Marketed,2011-08-29,02362635,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02362635,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) STERIMAX INC,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
86356,Marketed,2012-03-13,02377748,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02377748,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection) STERIMAX INC,Active,9004666,piperacillin (piperacillin sodium) 12 g per vial and tazobactam (tazobactam sodium) 1.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88693,Marketed,2021-06-09,02402068,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402068,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88694,Marketed,2021-06-09,02402076,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402076,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
88695,Marketed,2021-06-09,02402084,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02402084,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) AURO PHARMA INC,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92352,Marketed,2015-09-11,02439131,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02439131,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection) STERIMAX INC,Active,9005772,piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101072,Marketed,2022-04-29,02521539,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02521539,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9005772,piperacillin (piperacillin sodium) 36 g per vial and tazobactam (tazobactam sodium) 4.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101789,Marketed,2024-11-06,02528673,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528673,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004347,piperacillin (piperacillin sodium) 2 g per vial and tazobactam (tazobactam sodium) 0.25 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101790,Marketed,2024-10-07,02528703,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528703,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004348,piperacillin (piperacillin sodium) 3 g per vial and tazobactam (tazobactam sodium) 0.375 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
101791,Marketed,2024-10-07,02528711,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,2.0,J01CR05,Piperacillin and beta-lactamase inhibitor,Powder for solution,Intravenous,02528711,PIPERACILLIN AND TAZOBACTAM FOR INJECTION (piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection) EUGIA PHARMA INC.,Active,9004349,piperacillin (piperacillin sodium) 4 g per vial and tazobactam (tazobactam sodium) 0.5 g per vial powder for solution for injection,8001413,piperacillin and tazobactam,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95262,Marketed,2017-07-26,02464489,ESBRIET,1.0,L04AX05,Pirfenidone,Tablet,Oral,02464489,ESBRIET (pirfenidone 267 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95264,Marketed,2017-07-26,02464500,ESBRIET,1.0,L04AX05,Pirfenidone,Tablet,Oral,02464500,ESBRIET (pirfenidone 801 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97860,Marketed,2021-05-04,02488507,SANDOZ PIRFENIDONE TABLETS,1.0,L04AX05,Pirfenidone,Tablet,Oral,02488507,SANDOZ PIRFENIDONE TABLETS (pirfenidone 267 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97861,Marketed,2021-05-04,02488515,SANDOZ PIRFENIDONE TABLETS,1.0,L04AX05,Pirfenidone,Tablet,Oral,02488515,SANDOZ PIRFENIDONE TABLETS (pirfenidone 801 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97891,Marketed,2021-10-25,02488833,SANDOZ PIRFENIDONE CAPSULES,1.0,L04AX05,Pirfenidone,Capsule,Oral,02488833,SANDOZ PIRFENIDONE CAPSULES (pirfenidone 267 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005153,pirfenidone 267 mg oral capsule,8002070,pirfenidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
99919,Marketed,2021-06-04,02509938,JAMP PIRFENIDONE,1.0,L04AX05,Pirfenidone,Capsule,Oral,02509938,JAMP PIRFENIDONE (pirfenidone 267 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005153,pirfenidone 267 mg oral capsule,8002070,pirfenidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100410,Marketed,2021-10-08,02514702,JAMP PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02514702,JAMP PIRFENIDONE (pirfenidone 267 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100411,Marketed,2021-10-07,02514710,JAMP PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02514710,JAMP PIRFENIDONE (pirfenidone 801 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102064,Marketed,2023-04-26,02531526,PMS-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02531526,PMS-PIRFENIDONE (pirfenidone 267 mg oral tablet) PHARMASCIENCE INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102065,Marketed,2023-04-26,02531534,PMS-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02531534,PMS-PIRFENIDONE (pirfenidone 801 mg oral tablet) PHARMASCIENCE INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102653,Marketed,2024-03-05,02537753,AURO-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02537753,AURO-PIRFENIDONE (pirfenidone 267 mg oral tablet) AURO PHARMA INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102654,Marketed,2024-03-05,02537761,AURO-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02537761,AURO-PIRFENIDONE (pirfenidone 801 mg oral tablet) AURO PHARMA INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103943,Marketed,2025-01-29,02550644,M-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02550644,M-PIRFENIDONE (pirfenidone 267 mg oral tablet) MANTRA PHARMA INC,Active,9013509,pirfenidone 267 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103944,Marketed,2025-01-29,02550652,M-PIRFENIDONE,1.0,L04AX05,Pirfenidone,Tablet,Oral,02550652,M-PIRFENIDONE (pirfenidone 801 mg oral tablet) MANTRA PHARMA INC,Active,9013510,pirfenidone 801 mg oral tablet,8002070,pirfenidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6714,Marketed,1986-12-31,00642886,APO PIROXICAM CAP 10MG,1.0,M01AC01,Piroxicam,Capsule,Oral,00642886,APO PIROXICAM CAP 10MG (piroxicam 10 mg oral capsule) APOTEX INC,Active,9002081,piroxicam 10 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
6715,Marketed,1986-12-31,00642894,APO PIROXICAM CAP 20MG,1.0,M01AC01,Piroxicam,Capsule,Oral,00642894,APO PIROXICAM CAP 20MG (piroxicam 20 mg oral capsule) APOTEX INC,Active,9002082,piroxicam 20 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
6812,Marketed,2015-07-15,00695696,TEVA-PIROXICAM,1.0,M01AC01,Piroxicam,Capsule,Oral,00695696,TEVA-PIROXICAM (piroxicam 20 mg oral capsule) TEVA CANADA LIMITED,Active,9002082,piroxicam 20 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
6813,Marketed,2015-07-15,00695718,TEVA-PIROXICAM,1.0,M01AC01,Piroxicam,Capsule,Oral,00695718,TEVA-PIROXICAM (piroxicam 10 mg oral capsule) TEVA CANADA LIMITED,Active,9002081,piroxicam 10 mg oral capsule,8001508,piroxicam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106492,Marketed,2025-11-28,02562006,JAYPIRCA,1.0,L01EL05,Pirtobrutinib,Tablet,Oral,02562006,JAYPIRCA (pirtobrutinib 50 mg oral tablet) ELI LILLY CANADA INC,Active,9015323,pirtobrutinib 50 mg oral tablet,8002567,pirtobrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
106493,Marketed,2025-11-28,02562014,JAYPIRCA,1.0,L01EL05,Pirtobrutinib,Tablet,Oral,02562014,JAYPIRCA (pirtobrutinib 100 mg oral tablet) ELI LILLY CANADA INC,Active,9015322,pirtobrutinib 100 mg oral tablet,8002567,pirtobrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
100561,Marketed,2021-12-31,02516241,WAKIX,1.0,N07XX11,Pitolisant,Tablet,Oral,02516241,WAKIX (pitolisant hydrochloride 5 mg oral tablet) ENDO OPERATIONS LTD.,Active,9014649,pitolisant hydrochloride 5 mg oral tablet,8002408,pitolisant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100562,Marketed,2021-12-31,02516268,WAKIX,1.0,N07XX11,Pitolisant,Tablet,Oral,02516268,WAKIX (pitolisant hydrochloride 20 mg oral tablet) ENDO OPERATIONS LTD.,Active,9014648,pitolisant hydrochloride 20 mg oral tablet,8002408,pitolisant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4222,Marketed,2025-11-28,00511552,SANDOMIGRAN DS,1.0,N02CX01,Pizotifen,Tablet,Oral,00511552,SANDOMIGRAN DS (pizotifen (pizotifen malate) 1 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9001895,pizotifen (pizotifen malate) 1 mg oral tablet,8001414,pizotifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66845,Marketed,2007-11-22,02243005,MIRENA,1.0,G02BA03,Plastic iud with progestogens,Insert (extended-release),Intrauterine,02243005,MIRENA (levonorgestrel 52 mg intrauterine delivery system) BAYER INC,Active,9003563,levonorgestrel 52 mg intrauterine delivery system,8000915,levonorgestrel,62226000,Intrauterine,784576003,Prolonged-release intrauterine drug delivery system,733021006,System (unit of presentation),1.0,,
94684,Marketed,2017-01-10,02459523,KYLEENA,1.0,G02BA03,Plastic iud with progestogens,Insert (extended-release),Intrauterine,02459523,KYLEENA (levonorgestrel 19.5 mg intrauterine delivery system) BAYER INC,Active,9006096,levonorgestrel 19.5 mg intrauterine delivery system,8000915,levonorgestrel,62226000,Intrauterine,784576003,Prolonged-release intrauterine drug delivery system,733021006,System (unit of presentation),1.0,,
98299,Marketed,2022-01-12,02493012,TRULANCE,1.0,A06AX07,Plecanatide,Tablet,Oral,02493012,"TRULANCE (plecanatide 3 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9014650,plecanatide 3 mg oral tablet,8002409,plecanatide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101905,Marketed,2023-08-31,02529815,PLERIXAFOR INJECTION,1.0,L03AX16,Plerixafor,Solution,Subcutaneous,02529815,PLERIXAFOR INJECTION (plerixafor 24 mg per 1.2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102820,Marketed,2024-01-05,02539454,PLERIXAFOR INJECTION,1.0,L03AX16,Plerixafor,Solution,Subcutaneous,02539454,PLERIXAFOR INJECTION (plerixafor 24 mg per 1.2 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013511,plerixafor 24 mg per 1.2 mL solution for injection vial,8002071,plerixafor,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
82074,Marketed,2012-10-25,02335204,PREVNAR 13,14.0,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,
101153,Marketed,2022-09-02,02522403,VAXNEUVANCE,16.0,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,
101610,Marketed,2022-07-08,02527049,PREVNAR 20,21.0,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Suspension,Intramuscular,,,,,,,,,,,,,,,,
103871,Marketed,2024-08-29,02549891,CAPVAXIVE,22.0,J07AL02,"Pneumococcus, purified polysacc.antigen conjugated",Solution,Intramuscular,,,,,,,,,,,,,,,,
98934,Marketed,2020-11-25,02499614,POLIVY,1.0,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02499614,POLIVY (polatuzumab vedotin 140 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014433,polatuzumab vedotin 140 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100484,Marketed,2021-10-26,02515431,POLIVY,1.0,L01FX14,Polatuzumab vedotin,Powder for solution,Intravenous,02515431,POLIVY (polatuzumab vedotin 30 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9014626,polatuzumab vedotin 30 mg per vial powder for solution for injection,8002358,polatuzumab vedotin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
44019,Marketed,2007-03-22,01959042,IMOVAX POLIO,3.0,J07BF03,"Poliomyelitis, trivalent, inactivated, whole virus",Solution,Subcutaneous,,,,,,,,,,,,,,,,
8918,Marketed,2014-01-28,00755338,SOLYSTAT,1.0,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",00755338,SOLYSTAT (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
9611,Marketed,2012-06-19,00769541,SOLYSTAT,1.0,V03AE01,Polystyrene sulphonate,Suspension,Oral,00769541,SOLYSTAT (sodium polystyrene sulfonate 250 mg per mL oral suspension) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9002224,sodium polystyrene sulfonate 250 mg per mL oral suspension,8001941,sodium polystyrene sulfonate,26643006,Oral,385024007,Oral suspension,,,,,
17205,Marketed,2008-07-18,02017741,RESONIUM CALCIUM,1.0,V03AE01,Polystyrene sulphonate,Powder for solution,"Oral,Rectal",02017741,RESONIUM CALCIUM (calcium polystyrene sulfonate 999 mg per g powder for oral/rectal suspension) SANOFI-AVENTIS CANADA INC,Active,9006313,calcium polystyrene sulfonate 999 mg per g powder for oral/rectal suspension,8001712,calcium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
17752,Marketed,2009-02-06,02026961,KAYEXALATE,1.0,V03AE01,Polystyrene sulphonate,Powder for suspension,"Oral,Rectal",02026961,KAYEXALATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) SANOFI-AVENTIS CANADA INC,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
96396,Marketed,2018-10-25,02473941,ODAN-SODIUM POLYSTYRENE SULFONATE,1.0,V03AE01,Polystyrene sulphonate,Powder for suspension,"Rectal,Oral",02473941,ODAN-SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) ODAN LABORATORIES LTD,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
96397,Marketed,2018-12-11,02473968,ODAN-SODIUM POLYSTYRENE SULFONATE,1.0,V03AE01,Polystyrene sulphonate,Suspension,"Rectal,Oral",02473968,ODAN-SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 250 mg per mL oral/rectal suspension) ODAN LABORATORIES LTD,Active,9013727,sodium polystyrene sulfonate 250 mg per mL oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
98738,Marketed,2021-02-04,02497557,JAMP SODIUM POLYSTYRENE SULFONATE,1.0,V03AE01,Polystyrene sulphonate,Powder for suspension,"Rectal,Oral",02497557,JAMP SODIUM POLYSTYRENE SULFONATE (sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension) JAMP PHARMA CORPORATION,Active,9013345,sodium polystyrene sulfonate 1 g per g powder for oral/rectal suspension,8001941,sodium polystyrene sulfonate,255204007,Multiple (oral or rectal),739008005,Suspension,,,,,
90423,Marketed,2024-11-11,02419580,POMALYST,1.0,L04AX06,Pomalidomide,Capsule,Oral,02419580,POMALYST (pomalidomide 1 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90424,Marketed,2025-01-31,02419599,POMALYST,1.0,L04AX06,Pomalidomide,Capsule,Oral,02419599,POMALYST (pomalidomide 2 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90425,Marketed,2025-02-03,02419602,POMALYST,1.0,L04AX06,Pomalidomide,Capsule,Oral,02419602,POMALYST (pomalidomide 3 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90426,Marketed,2025-01-31,02419610,POMALYST,1.0,L04AX06,Pomalidomide,Capsule,Oral,02419610,POMALYST (pomalidomide 4 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99353,Marketed,2023-03-15,02504073,REDDY-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02504073,REDDY-POMALIDOMIDE (pomalidomide 1 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99354,Marketed,2023-03-15,02504081,REDDY-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02504081,REDDY-POMALIDOMIDE (pomalidomide 2 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99355,Marketed,2023-03-15,02504103,REDDY-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02504103,REDDY-POMALIDOMIDE (pomalidomide 3 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99356,Marketed,2023-03-15,02504111,REDDY-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02504111,REDDY-POMALIDOMIDE (pomalidomide 4 mg oral capsule) DR REDDY'S LABORATORIES LTD,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99576,Marketed,2023-02-28,02506394,NAT-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02506394,NAT-POMALIDOMIDE (pomalidomide 1 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99577,Marketed,2023-02-28,02506408,NAT-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02506408,NAT-POMALIDOMIDE (pomalidomide 2 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99578,Marketed,2023-02-28,02506416,NAT-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02506416,NAT-POMALIDOMIDE (pomalidomide 3 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
99579,Marketed,2023-02-28,02506424,NAT-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02506424,NAT-POMALIDOMIDE (pomalidomide 4 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100962,Marketed,2023-02-28,02520427,APO-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02520427,APO-POMALIDOMIDE (pomalidomide 1 mg oral capsule) APOTEX INC,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100963,Marketed,2023-02-28,02520435,APO-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02520435,APO-POMALIDOMIDE (pomalidomide 2 mg oral capsule) APOTEX INC,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100964,Marketed,2023-02-28,02520443,APO-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02520443,APO-POMALIDOMIDE (pomalidomide 3 mg oral capsule) APOTEX INC,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100965,Marketed,2023-02-28,02520451,APO-POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02520451,APO-POMALIDOMIDE (pomalidomide 4 mg oral capsule) APOTEX INC,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101302,Marketed,2023-02-28,02523973,SANDOZ POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02523973,SANDOZ POMALIDOMIDE (pomalidomide 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101303,Marketed,2023-02-28,02523981,SANDOZ POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02523981,SANDOZ POMALIDOMIDE (pomalidomide 2 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101304,Marketed,2023-02-28,02524007,SANDOZ POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02524007,SANDOZ POMALIDOMIDE (pomalidomide 3 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101305,Marketed,2023-02-28,02524015,SANDOZ POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02524015,SANDOZ POMALIDOMIDE (pomalidomide 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102681,Marketed,2023-08-01,02538059,JAMP POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02538059,JAMP POMALIDOMIDE (pomalidomide 1 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005437,pomalidomide 1 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102682,Marketed,2023-08-01,02538075,JAMP POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02538075,JAMP POMALIDOMIDE (pomalidomide 2 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005438,pomalidomide 2 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102683,Marketed,2023-08-01,02538083,JAMP POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02538083,JAMP POMALIDOMIDE (pomalidomide 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005439,pomalidomide 3 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102684,Marketed,2023-08-01,02538091,JAMP POMALIDOMIDE,1.0,L04AX06,Pomalidomide,Capsule,Oral,02538091,JAMP POMALIDOMIDE (pomalidomide 4 mg oral capsule) JAMP PHARMA CORPORATION,Active,9005440,pomalidomide 4 mg oral capsule,8002076,pomalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92168,Marketed,2023-06-29,02437333,ICLUSIG,1.0,L01EA05,Ponatinib,Tablet,Oral,02437333,"ICLUSIG (ponatinib (ponatinib hydrochloride) 15 mg oral tablet) TAKEDA PHARMACEUTICALS U.S.A., INC.",Active,9005760,ponatinib (ponatinib hydrochloride) 15 mg oral tablet,8002077,ponatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100487,Marketed,2025-08-25,02515482,PONVORY,1.0,L04AE04,Ponesimod,Tablet,Oral,02515482,PONVORY (ponesimod 20 mg oral tablet) VANDA PHARMACEUTICALS INC.,Active,9014628,ponesimod 20 mg oral tablet,8002397,ponesimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77877,Marketed,2011-03-18,02293404,POSANOL,1.0,J02AC04,Posaconazole,Suspension,Oral,02293404,POSANOL (posaconazole 200 mg per 5 mL oral suspension) MERCK CANADA INC,Active,9013599,posaconazole 200 mg per 5 mL oral suspension,8001511,posaconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,
90930,Marketed,2014-05-21,02424622,POSANOL,1.0,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02424622,POSANOL (posaconazole 100 mg gastro-resistant tablet) MERCK CANADA INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
91710,Marketed,2014-11-24,02432676,POSANOL,1.0,J02AC04,Posaconazole,Solution,Intravenous,02432676,POSANOL (posaconazole 300 mg per 16.7 mL solution for injection vial) MERCK CANADA INC,Active,9013600,posaconazole 300 mg per 16.7 mL solution for injection vial,8001511,posaconazole,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98612,Marketed,2020-12-08,02496259,SANDOZ POSACONAZOLE,1.0,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02496259,SANDOZ POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
101953,Marketed,2023-05-24,02530333,JAMP POSACONAZOLE,1.0,J02AC04,Posaconazole,Suspension,Oral,02530333,JAMP POSACONAZOLE (posaconazole 200 mg per 5 mL oral suspension) JAMP PHARMA CORPORATION,Active,9013599,posaconazole 200 mg per 5 mL oral suspension,8001511,posaconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,
103062,Marketed,2023-10-04,02542021,GLN-POSACONAZOLE,1.0,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02542021,GLN-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
103180,Marketed,2024-03-25,02543311,TARO-POSACONAZOLE,1.0,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02543311,TARO-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) TARO PHARMACEUTICALS INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
103321,Marketed,2024-07-25,02544644,MINT-POSACONAZOLE,1.0,J02AC04,Posaconazole,Tablet (delayed-release),Oral,02544644,MINT-POSACONAZOLE (posaconazole 100 mg gastro-resistant tablet) MINT PHARMACEUTICALS INC,Active,9005523,posaconazole 100 mg gastro-resistant tablet,8001511,posaconazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
84760,Marketed,2025-10-10,02362597,POTASSIUM ACETATE INJECTION USP,1.0,B05XA17,Potassium acetate,Solution,Intravenous,02362597,POTASSIUM ACETATE INJECTION USP (potassium (potassium acetate) 4 mmol per mL solution for injection 50 mL vial) JUNO PHARMA CANADA INC.,Active,9013932,potassium (potassium acetate) 4 mmol per mL solution for injection 50 mL vial,8001869,potassium acetate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
2527,Marketed,2017-09-14,00037869,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
3394,Marketed,2019-08-02,00402206,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
65336,Marketed,2000-08-10,02241676,POTASSIUM CHLORIDE INJECTION,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
65337,Marketed,2000-08-10,02241677,POTASSIUM CHLORIDE INJECTION,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
65339,Marketed,2000-08-10,02241679,POTASSIUM CHLORIDE INJECTION,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
97058,Marketed,2019-08-03,02480034,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
97592,Marketed,2020-03-25,02485699,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,1.0,B05XA01,Potassium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
101903,Marketed,2022-10-03,02529793,POTASSIUM CHLORIDE FOR HEMODIALYSIS 7.55,1.0,A12BA01,Potassium chloride,Powder for solution,Haemodialysis,,,,,,,,,,,,,,,,
83921,Marketed,2011-02-11,02353997,UROCIT-K,1.0,A12BA02,Potassium citrate,Tablet (extended-release),Oral,02353997,UROCIT-K (potassium citrate 10 mEq prolonged-release oral tablet) MISSION PHARMACAL COMPANY,Active,9013987,potassium citrate 10 mEq prolonged-release oral tablet,8001871,potassium citrate,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
8119,Marketed,2006-05-31,00711306,POTASSIUM PHOSPHATE MONOBASIC INJECTION,1.0,B05XA06,Potassium phos incl comb w/0th pot. salts,Solution,Intravenous,00711306,POTASSIUM PHOSPHATE MONOBASIC INJECTION (phosphorus (potassium phosphate monobasic) 12.9 mmol per 10 mL and potassium (potassium phosphate monobasic) 12.9 mmol per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013928,phosphorus (potassium phosphate monobasic) 12.9 mmol per 10 mL and potassium (potassium phosphate monobasic) 12.9 mmol per 10 mL solution for injection vial,8002155,potassium phosphate monobasic,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10509,Marketed,2006-07-06,00804789,POTASSIUM PHOSPHATES,2.0,B05XA06,Potassium phos incl comb w/0th pot. salts,Liquid,Intravenous,,,,,,,,,,,,,,,,
19442,Marketed,2015-12-22,02139545,"POTASSIUM PHOSPHATES INJECTION, USP",2.0,B05XA06,Potassium phos incl comb w/0th pot. salts,Solution,Intravenous,,,,,,,,,,,,,,,,
97230,Marketed,2019-01-15,02481820,FOLOTYN,1.0,L01BA05,Pralatrexate%,Solution,Intravenous,02481820,FOLOTYN (pralatrexate 20 mg per 1 mL solution for injection vial) SERVIER CANADA INC,Active,9013989,pralatrexate 20 mg per 1 mL solution for injection vial,8002265,pralatrexate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
60463,Marketed,1998-02-26,02237145,MIRAPEX,1.0,N04BC05,Pramipexole,Tablet,Oral,02237145,MIRAPEX (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77772,Marketed,2007-02-26,02292378,APO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02292378,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) APOTEX INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77773,Marketed,2007-02-26,02292386,APO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02292386,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) APOTEX INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77774,Marketed,2007-02-26,02292394,APO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02292394,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) APOTEX INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77776,Marketed,2007-02-26,02292408,APO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02292408,APO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) APOTEX INC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78262,Marketed,2008-07-09,02297256,MIRAPEX,1.0,N04BC05,Pramipexole,Tablet,Oral,02297256,MIRAPEX (pramipexole dihydrochloride monohydrate 0.125 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001252,pramipexole dihydrochloride 0.125 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78267,Marketed,2020-04-27,02297302,ACT PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02297302,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78268,Marketed,2020-04-27,02297310,ACT PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02297310,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78269,Marketed,2020-04-27,02297329,ACT PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02297329,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78270,Marketed,2020-04-27,02297337,ACT PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02297337,ACT PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79472,Marketed,2018-09-13,02309122,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02309122,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79473,Marketed,2018-09-13,02309130,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02309130,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79474,Marketed,2018-11-23,02309149,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02309149,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79475,Marketed,2018-11-23,02309157,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02309157,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80080,Marketed,2008-08-14,02315262,SANDOZ PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02315262,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80081,Marketed,2008-08-14,02315270,SANDOZ PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02315270,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80082,Marketed,2008-08-14,02315289,SANDOZ PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02315289,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80083,Marketed,2008-08-14,02315297,SANDOZ PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02315297,SANDOZ PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81116,Marketed,2018-06-13,02325802,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02325802,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81117,Marketed,2018-05-15,02325810,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02325810,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81118,Marketed,2018-06-18,02325829,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02325829,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) PRO DOC LIMITEE,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81119,Marketed,2018-06-18,02325837,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02325837,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) PRO DOC LIMITEE,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85244,Marketed,2022-03-28,02367602,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02367602,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) SANIS HEALTH INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85245,Marketed,2022-03-28,02367610,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02367610,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) SANIS HEALTH INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85247,Marketed,2022-03-28,02367629,PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02367629,PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) SANIS HEALTH INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90879,Marketed,2014-04-29,02424061,AURO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02424061,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.25 mg oral tablet) AURO PHARMA INC,Active,9000783,pramipexole dihydrochloride 0.25 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90880,Marketed,2014-04-29,02424088,AURO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02424088,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 0.5 mg oral tablet) AURO PHARMA INC,Active,9000889,pramipexole dihydrochloride 0.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90881,Marketed,2014-04-29,02424096,AURO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02424096,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1 mg oral tablet) AURO PHARMA INC,Active,9000785,pramipexole dihydrochloride 1 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90882,Marketed,2014-04-29,02424118,AURO-PRAMIPEXOLE,1.0,N04BC05,Pramipexole,Tablet,Oral,02424118,AURO-PRAMIPEXOLE (pramipexole dihydrochloride monohydrate 1.5 mg oral tablet) AURO PHARMA INC,Active,9000784,pramipexole dihydrochloride 1.5 mg oral tablet,8000253,pramipexole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12763,Marketed,2017-03-03,01945904,ANUSOL PLUS SUPPOSITORIES,2.0,C05AD07,Pramocaine,Suppository,Rectal,01945904,ANUSOL PLUS SUPPOSITORIES (pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository) CHURCH & DWIGHT CANADA CORP,Active,9002492,pramoxine hydrochloride 20 mg and zinc sulfate 10 mg suppository,8001873,pramoxine and zinc sulfate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
12764,Marketed,2017-03-03,01945912,ANUSOL PLUS OINTMENT,2.0,C05AD07,Pramocaine,Ointment,"Rectal,Topical",01945912,ANUSOL PLUS OINTMENT (pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment) CHURCH & DWIGHT CANADA CORP,Active,9002491,pramoxine hydrochloride 1 % and zinc sulfate 0.5 % rectal ointment,8001873,pramoxine and zinc sulfate,37161004,Rectal,385184008,Rectal ointment,,,,,
60289,Marketed,2011-12-16,02236991,GOLD BOND MEDICATED ANTI-ITCH CREAM,2.0,D04AB07,Pramocaine,Cream,Topical,02236991,GOLD BOND MEDICATED ANTI-ITCH CREAM (menthol 1 % and pramoxine hydrochloride 1 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9003350,menthol 1 % and pramoxine hydrochloride 1 % cutaneous cream,8001848,menthol and pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
63620,Marketed,2000-05-01,02240105,AVEENO ANTI-ITCH LOTION,2.0,D04AB07,Pramocaine,Lotion,Topical,02240105,AVEENO ANTI-ITCH LOTION (calamine 3 % and pramoxine hydrochloride 1 % lotion) JOHNSON & JOHNSON INC,Active,9003490,calamine 3 % and pramoxine hydrochloride 1 % lotion,8001708,calamine and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,
70300,Marketed,2007-01-18,02246156,POLYSPORIN ITCH RELIEF,2.0,D04AB07,Pramocaine,Lotion,Topical,02246156,POLYSPORIN ITCH RELIEF (pramoxine hydrochloride 1 % and zinc acetate 0.1 % lotion) JOHNSON & JOHNSON INC,Active,9003791,pramoxine hydrochloride 1 % and zinc acetate 0.1 % lotion,8001872,pramoxine and zinc acetate,448598008,Cutaneous,739000003,Lotion,,,,,
80397,Marketed,2011-11-19,02318482,GOLD BOND ANTI-ITCH LOTION,3.0,D04AB07,Pramocaine,Lotion,Topical,02318482,GOLD BOND ANTI-ITCH LOTION (dimethicone 5 % and menthol 0.5 % and pramoxine hydrochloride 1 % lotion) SANOFI CONSUMER HEALTH INC,Active,9004520,dimethicone 5 % and menthol 0.5 % and pramoxine hydrochloride 1 % lotion,8001749,dimethicone and menthol and pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,
97516,Marketed,2021-02-01,02484889,ITCH RELIEF MOISTURIZING CREAM,1.0,D04AB07,Pramocaine,Cream,Topical,02484889,ITCH RELIEF MOISTURIZING CREAM (pramoxine hydrochloride 1 % cutaneous cream) CERAVE CANADA,Active,9014465,pramoxine hydrochloride 1 % cutaneous cream,8002336,pramoxine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
97705,Marketed,2021-02-01,02486881,ITCH RELIEF MOISTURIZING LOTION,1.0,D04AB07,Pramocaine,Lotion,Topical,02486881,ITCH RELIEF MOISTURIZING LOTION (pramoxine hydrochloride 1 % lotion) CERAVE CANADA,Active,9014466,pramoxine hydrochloride 1 % lotion,8002336,pramoxine,448598008,Cutaneous,739000003,Lotion,,,,,
103690,Marketed,2025-06-09,02547996,PRECISE COOLING PAIN RELIEF CREAM,2.0,D04AB07,Pramocaine,Cream,Topical,02547996,PRECISE COOLING PAIN RELIEF CREAM (lidocaine 4 % and menthol 1 % cutaneous cream) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9015221,lidocaine 4 % and menthol 1 % cutaneous cream,8001838,lidocaine and menthol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
98351,Marketed,2024-05-28,02493500,INTRAROSA,1.0,G03XX01,Prasterone,Ovule,Vaginal,02493500,"INTRAROSA (prasterone 6.5 mg pessary) COSETTE PHARMACEUTICALS, INC.",Active,9014766,prasterone 6.5 mg pessary,8002438,prasterone,16857009,Vaginal,385174007,Pessary,733007009,Pessary (unit of presentation),,,
99200,Marketed,2021-05-14,02502429,JAMP PRASUGREL,1.0,B01AC22,Prasugrel,Tablet,Oral,02502429,JAMP PRASUGREL (prasugrel (prasugrel hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004728,prasugrel (prasugrel hydrochloride) 10 mg oral tablet,8001681,prasugrel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67424,Marketed,2001-02-27,02243506,APO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243506,APO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) APOTEX INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67425,Marketed,2001-02-27,02243507,APO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243507,APO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) APOTEX INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67426,Marketed,2001-02-27,02243508,APO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243508,APO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) APOTEX INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67763,Marketed,2025-04-17,02243824,PRO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243824,PRO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) PRO DOC LIMITEE,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67764,Marketed,2025-04-17,02243825,PRO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243825,PRO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) PRO DOC LIMITEE,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67765,Marketed,2025-04-17,02243826,PRO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02243826,PRO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) PRO DOC LIMITEE,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71241,Marketed,2012-02-16,02247008,TEVA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247008,TEVA-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71242,Marketed,2012-02-16,02247009,TEVA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247009,TEVA-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71243,Marketed,2012-02-16,02247010,TEVA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247010,TEVA-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71918,Marketed,2003-07-21,02247655,PMS-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247655,PMS-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) PHARMASCIENCE INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71919,Marketed,2003-07-21,02247656,PMS-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247656,PMS-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) PHARMASCIENCE INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71920,Marketed,2003-07-21,02247657,PMS-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02247657,PMS-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) PHARMASCIENCE INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77000,Marketed,2022-12-09,02284421,TARO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02284421,TARO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77001,Marketed,2022-12-09,02284448,TARO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02284448,TARO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77002,Marketed,2022-12-09,02284456,TARO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02284456,TARO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80298,Marketed,2024-03-08,02317451,MINT-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02317451,MINT-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80299,Marketed,2024-03-08,02317478,MINT-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02317478,MINT-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80300,Marketed,2024-03-08,02317486,MINT-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02317486,MINT-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81669,Marketed,2015-06-19,02330954,JAMP-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02330954,JAMP-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81670,Marketed,2015-06-19,02330962,JAMP-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02330962,JAMP-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81671,Marketed,2015-06-19,02330970,JAMP-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02330970,JAMP-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84168,Marketed,2025-04-24,02356546,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02356546,PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SANIS HEALTH INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84169,Marketed,2025-04-24,02356554,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02356554,PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SANIS HEALTH INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84170,Marketed,2025-04-24,02356562,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02356562,PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SANIS HEALTH INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87519,Marketed,2024-05-01,02389703,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02389703,PRAVASTATIN (pravastatin sodium 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87521,Marketed,2024-05-01,02389738,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02389738,PRAVASTATIN (pravastatin sodium 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87522,Marketed,2024-05-01,02389746,PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02389746,PRAVASTATIN (pravastatin sodium 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91649,Marketed,2023-08-21,02432048,MAR-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02432048,MAR-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91650,Marketed,2023-08-21,02432056,MAR-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02432056,MAR-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91651,Marketed,2023-08-21,02432064,MAR-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02432064,MAR-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92501,Marketed,2019-12-11,02440644,ACH-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02440644,ACH-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92502,Marketed,2020-02-24,02440652,ACH-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02440652,ACH-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92503,Marketed,2020-02-24,02440660,ACH-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02440660,ACH-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93068,Marketed,2016-08-17,02446251,BIO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02446251,BIO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) BIOMED PHARMA,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93069,Marketed,2016-08-17,02446278,BIO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02446278,BIO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) BIOMED PHARMA,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93070,Marketed,2016-08-17,02446286,BIO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02446286,BIO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) BIOMED PHARMA,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94613,Marketed,2018-05-22,02458977,AURO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02458977,AURO-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) AURO PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94614,Marketed,2018-05-22,02458985,AURO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02458985,AURO-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) AURO PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94615,Marketed,2018-05-22,02458993,AURO-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02458993,AURO-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) AURO PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95718,Marketed,2018-06-29,02468700,SANDOZ PRAVASTATIN TABLETS,1.0,C10AA03,Pravastatin,Tablet,Oral,02468700,SANDOZ PRAVASTATIN TABLETS (pravastatin sodium 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95719,Marketed,2018-06-29,02468719,SANDOZ PRAVASTATIN TABLETS,1.0,C10AA03,Pravastatin,Tablet,Oral,02468719,SANDOZ PRAVASTATIN TABLETS (pravastatin sodium 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95720,Marketed,2018-06-29,02468727,SANDOZ PRAVASTATIN TABLETS,1.0,C10AA03,Pravastatin,Tablet,Oral,02468727,SANDOZ PRAVASTATIN TABLETS (pravastatin sodium 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96641,Marketed,2020-01-13,02476142,AG-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476142,AG-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) ANGITA PHARMA INC.,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96642,Marketed,2019-12-04,02476150,AG-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476150,AG-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) ANGITA PHARMA INC.,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96643,Marketed,2019-12-04,02476169,AG-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476169,AG-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96728,Marketed,2025-04-17,02476274,M-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476274,M-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) MANTRA PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96729,Marketed,2025-04-16,02476282,M-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476282,M-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) MANTRA PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96730,Marketed,2025-04-28,02476290,M-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02476290,M-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) MANTRA PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102450,Marketed,2025-09-10,02535653,NRA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02535653,NRA-PRAVASTATIN (pravastatin sodium 10 mg oral tablet) NORA PHARMA INC,Active,9000932,pravastatin sodium 10 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102451,Marketed,2025-09-10,02535661,NRA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02535661,NRA-PRAVASTATIN (pravastatin sodium 20 mg oral tablet) NORA PHARMA INC,Active,9000368,pravastatin sodium 20 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102452,Marketed,2025-09-03,02535688,NRA-PRAVASTATIN,1.0,C10AA03,Pravastatin,Tablet,Oral,02535688,NRA-PRAVASTATIN (pravastatin sodium 40 mg oral tablet) NORA PHARMA INC,Active,9000647,pravastatin sodium 40 mg oral tablet,8000141,pravastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10828,Marketed,2025-01-23,00882801,APO-PRAZO,1.0,C02CA01,Prazosin,Tablet,Oral,00882801,APO-PRAZO (prazosin (prazosin hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9011504,prazosin (prazosin hydrochloride) 1 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10829,Marketed,2025-01-23,00882828,APO-PRAZO,1.0,C02CA01,Prazosin,Tablet,Oral,00882828,APO-PRAZO (prazosin (prazosin hydrochloride) 2 mg oral tablet) APOTEX INC,Active,9011505,prazosin (prazosin hydrochloride) 2 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10830,Marketed,2025-01-23,00882836,APO-PRAZO,1.0,C02CA01,Prazosin,Tablet,Oral,00882836,APO-PRAZO (prazosin (prazosin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9011506,prazosin (prazosin hydrochloride) 5 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12451,Marketed,2011-10-20,01934198,TEVA-PRAZOSIN,1.0,C02CA01,Prazosin,Tablet,Oral,01934198,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9011504,prazosin (prazosin hydrochloride) 1 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12452,Marketed,2011-10-20,01934201,TEVA-PRAZOSIN,1.0,C02CA01,Prazosin,Tablet,Oral,01934201,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9011505,prazosin (prazosin hydrochloride) 2 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12453,Marketed,2011-10-20,01934228,TEVA-PRAZOSIN,1.0,C02CA01,Prazosin,Tablet,Oral,01934228,TEVA-PRAZOSIN (prazosin (prazosin hydrochloride) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9011506,prazosin (prazosin hydrochloride) 5 mg oral tablet,8000836,prazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49818,Marketed,2020-12-03,02230642,DERMATOP EMOLLIENT CREAM,1.0,D07AC18,Prednicarbate,Cream,Topical,02230642,"DERMATOP EMOLLIENT CREAM (prednicarbate 0.1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9003577,prednicarbate 0.1 % cutaneous cream,8001874,prednicarbate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
1937,Marketed,2024-09-25,00301175,PRED FORTE,1.0,S01BA04,Prednisolone,Suspension,Ophthalmic,00301175,PRED FORTE (prednisolone acetate 1 % ophthalmic drops) ABBVIE CORPORATION,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
7042,Marketed,2018-04-20,00700401,TEVA-PREDNISOLONE,1.0,S01BA04,Prednisolone,Suspension,Ophthalmic,00700401,TEVA-PREDNISOLONE (prednisolone acetate 1 % ophthalmic drops) TEVA CANADA LIMITED,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
13946,Marketed,2005-08-06,01916203,SANDOZ PREDNISOLONE,1.0,S01BA04,Prednisolone,Suspension,Ophthalmic,01916203,SANDOZ PREDNISOLONE (prednisolone acetate 1 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000082,prednisolone acetate 1 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18750,Marketed,2023-01-26,02148498,MINIMS PREDNISOLONE SODIUM PHOSPHATE,1.0,S01BA04,Prednisolone,Drops,Ophthalmic,02148498,MINIMS PREDNISOLONE SODIUM PHOSPHATE (prednisolone sodium phosphate 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9000629,prednisolone sodium phosphate 0.5 % ophthalmic drops,8000051,prednisolone,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
69619,Marketed,2002-03-19,02245532,PMS-PREDNISOLONE,1.0,H02AB06,Prednisolone,Solution,Oral,02245532,PMS-PREDNISOLONE (prednisolone (prednisolone sodium phosphate) 5 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9000975,prednisolone (prednisolone sodium phosphate) 5 mg per 5 mL oral solution,8000051,prednisolone,26643006,Oral,385023001,Oral solution,,,,,
507,Marketed,2015-06-12,00021695,TEVA-PREDNISONE,1.0,H02AB07,Prednisone,Tablet,Oral,00021695,TEVA-PREDNISONE (prednisone 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000024,prednisone 5 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1286,Marketed,2015-06-12,00232378,TEVA-PREDNISONE,1.0,H02AB07,Prednisone,Tablet,Oral,00232378,TEVA-PREDNISONE (prednisone 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000063,prednisone 50 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3076,Marketed,2013-12-11,00271373,WINPRED,1.0,H02AB07,Prednisone,Tablet,Oral,00271373,WINPRED (prednisone 1 mg oral tablet) AA PHARMA INC,Active,9000112,prednisone 1 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4732,Marketed,1982-12-31,00312770,APO PREDNISONE TAB 5MG,1.0,H02AB07,Prednisone,Tablet,Oral,00312770,APO PREDNISONE TAB 5MG (prednisone 5 mg oral tablet) APOTEX INC,Active,9000024,prednisone 5 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4736,Marketed,1982-12-31,00550957,APO PREDNISONE TAB 50MG,1.0,H02AB07,Prednisone,Tablet,Oral,00550957,APO PREDNISONE TAB 50MG (prednisone 50 mg oral tablet) APOTEX INC,Active,9000063,prednisone 50 mg oral tablet,8000014,prednisone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75379,Marketed,2023-05-11,02268418,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268418,LYRICA (pregabalin 25 mg oral capsule) BGP PHARMA ULC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75380,Marketed,2023-05-11,02268426,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268426,LYRICA (pregabalin 50 mg oral capsule) BGP PHARMA ULC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75381,Marketed,2023-05-11,02268434,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268434,LYRICA (pregabalin 75 mg oral capsule) BGP PHARMA ULC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75383,Marketed,2023-05-11,02268450,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268450,LYRICA (pregabalin 150 mg oral capsule) BGP PHARMA ULC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75385,Marketed,2023-05-11,02268477,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268477,LYRICA (pregabalin 225 mg oral capsule) BGP PHARMA ULC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
75386,Marketed,2023-05-11,02268485,LYRICA,1.0,N02BF02,Pregabalin,Capsule,Oral,02268485,LYRICA (pregabalin 300 mg oral capsule) BGP PHARMA ULC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84460,Marketed,2013-02-14,02359596,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02359596,PMS-PREGABALIN (pregabalin 25 mg oral capsule) PHARMASCIENCE INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84461,Marketed,2013-02-14,02359618,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02359618,PMS-PREGABALIN (pregabalin 50 mg oral capsule) PHARMASCIENCE INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84462,Marketed,2013-02-14,02359626,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02359626,PMS-PREGABALIN (pregabalin 75 mg oral capsule) PHARMASCIENCE INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84463,Marketed,2013-02-14,02359634,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02359634,PMS-PREGABALIN (pregabalin 150 mg oral capsule) PHARMASCIENCE INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84464,Marketed,2013-02-14,02359642,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02359642,PMS-PREGABALIN (pregabalin 300 mg oral capsule) PHARMASCIENCE INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84620,Marketed,2013-03-06,02361159,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361159,TEVA-PREGABALIN (pregabalin 25 mg oral capsule) TEVA CANADA LIMITED,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84623,Marketed,2013-03-06,02361175,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361175,TEVA-PREGABALIN (pregabalin 50 mg oral capsule) TEVA CANADA LIMITED,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84624,Marketed,2013-03-06,02361183,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361183,TEVA-PREGABALIN (pregabalin 75 mg oral capsule) TEVA CANADA LIMITED,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84626,Marketed,2013-03-06,02361205,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361205,TEVA-PREGABALIN (pregabalin 150 mg oral capsule) TEVA CANADA LIMITED,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84628,Marketed,2013-03-06,02361221,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361221,TEVA-PREGABALIN (pregabalin 225 mg oral capsule) TEVA CANADA LIMITED,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84629,Marketed,2013-03-06,02361248,TEVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02361248,TEVA-PREGABALIN (pregabalin 300 mg oral capsule) TEVA CANADA LIMITED,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86261,Marketed,2013-02-15,02377039,RIVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02377039,RIVA-PREGABALIN (pregabalin 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86262,Marketed,2013-02-15,02377047,RIVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02377047,RIVA-PREGABALIN (pregabalin 50 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86263,Marketed,2013-02-15,02377055,RIVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02377055,RIVA-PREGABALIN (pregabalin 75 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86264,Marketed,2013-02-15,02377063,RIVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02377063,RIVA-PREGABALIN (pregabalin 150 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86265,Marketed,2013-02-15,02377071,RIVA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02377071,RIVA-PREGABALIN (pregabalin 300 mg oral capsule) LABORATOIRE RIVA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87621,Marketed,2013-02-15,02390817,SANDOZ PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02390817,SANDOZ PREGABALIN (pregabalin 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87622,Marketed,2013-02-15,02390825,SANDOZ PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02390825,SANDOZ PREGABALIN (pregabalin 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87623,Marketed,2013-02-15,02390833,SANDOZ PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02390833,SANDOZ PREGABALIN (pregabalin 75 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87624,Marketed,2013-02-15,02390841,SANDOZ PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02390841,SANDOZ PREGABALIN (pregabalin 150 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87625,Marketed,2013-02-15,02390868,SANDOZ PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02390868,SANDOZ PREGABALIN (pregabalin 300 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87804,Marketed,2020-06-02,02392801,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392801,TARO-PREGABALIN (pregabalin 25 mg oral capsule) SUN PHARMA CANADA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87805,Marketed,2020-06-02,02392828,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392828,TARO-PREGABALIN (pregabalin 50 mg oral capsule) SUN PHARMA CANADA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87806,Marketed,2020-06-02,02392836,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392836,TARO-PREGABALIN (pregabalin 75 mg oral capsule) SUN PHARMA CANADA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87807,Marketed,2020-06-02,02392844,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392844,TARO-PREGABALIN (pregabalin 150 mg oral capsule) SUN PHARMA CANADA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87808,Marketed,2020-06-02,02392852,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392852,TARO-PREGABALIN (pregabalin 225 mg oral capsule) SUN PHARMA CANADA INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87809,Marketed,2020-06-02,02392860,TARO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02392860,TARO-PREGABALIN (pregabalin 300 mg oral capsule) SUN PHARMA CANADA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88153,Marketed,2013-02-15,02396483,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02396483,PREGABALIN (pregabalin 25 mg oral capsule) PRO DOC LIMITEE,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88156,Marketed,2013-02-15,02396505,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02396505,PREGABALIN (pregabalin 50 mg oral capsule) PRO DOC LIMITEE,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88157,Marketed,2013-02-15,02396513,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02396513,PREGABALIN (pregabalin 75 mg oral capsule) PRO DOC LIMITEE,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88158,Marketed,2013-02-15,02396521,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02396521,PREGABALIN (pregabalin 150 mg oral capsule) PRO DOC LIMITEE,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88159,Marketed,2013-02-15,02396548,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02396548,PREGABALIN (pregabalin 300 mg oral capsule) PRO DOC LIMITEE,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88302,Marketed,2013-02-19,02398079,PMS-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02398079,PMS-PREGABALIN (pregabalin 225 mg oral capsule) PHARMASCIENCE INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88848,Marketed,2021-08-20,02403692,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02403692,PREGABALIN (pregabalin 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88849,Marketed,2021-08-20,02403706,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02403706,PREGABALIN (pregabalin 50 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88850,Marketed,2021-08-20,02403714,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02403714,PREGABALIN (pregabalin 75 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88851,Marketed,2021-08-20,02403722,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02403722,PREGABALIN (pregabalin 150 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88852,Marketed,2021-08-20,02403730,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02403730,PREGABALIN (pregabalin 300 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89032,Marketed,2016-01-27,02405539,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02405539,PREGABALIN (pregabalin 25 mg oral capsule) SANIS HEALTH INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89033,Marketed,2016-01-27,02405547,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02405547,PREGABALIN (pregabalin 50 mg oral capsule) SANIS HEALTH INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89034,Marketed,2016-01-27,02405555,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02405555,PREGABALIN (pregabalin 75 mg oral capsule) SANIS HEALTH INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89035,Marketed,2016-01-27,02405563,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02405563,PREGABALIN (pregabalin 150 mg oral capsule) SANIS HEALTH INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89037,Marketed,2016-01-27,02405598,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02405598,PREGABALIN (pregabalin 300 mg oral capsule) SANIS HEALTH INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90207,Marketed,2022-04-28,02417529,MAR-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02417529,MAR-PREGABALIN (pregabalin 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90208,Marketed,2022-04-28,02417537,MAR-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02417537,MAR-PREGABALIN (pregabalin 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90209,Marketed,2022-04-28,02417545,MAR-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02417545,MAR-PREGABALIN (pregabalin 75 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90211,Marketed,2022-04-28,02417561,MAR-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02417561,MAR-PREGABALIN (pregabalin 150 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90851,Marketed,2014-06-12,02423804,MINT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02423804,MINT-PREGABALIN (pregabalin 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90852,Marketed,2014-06-12,02423812,MINT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02423812,MINT-PREGABALIN (pregabalin 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90890,Marketed,2014-06-12,02424185,MINT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02424185,MINT-PREGABALIN (pregabalin 75 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90892,Marketed,2014-06-12,02424207,MINT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02424207,MINT-PREGABALIN (pregabalin 150 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91825,Marketed,2015-03-02,02433869,AURO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02433869,AURO-PREGABALIN (pregabalin 25 mg oral capsule) AURO PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91826,Marketed,2015-03-02,02433877,AURO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02433877,AURO-PREGABALIN (pregabalin 50 mg oral capsule) AURO PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91827,Marketed,2015-03-02,02433885,AURO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02433885,AURO-PREGABALIN (pregabalin 75 mg oral capsule) AURO PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91829,Marketed,2015-03-02,02433907,AURO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02433907,AURO-PREGABALIN (pregabalin 150 mg oral capsule) AURO PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92031,Marketed,2019-10-01,02435977,JAMP-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02435977,JAMP-PREGABALIN (pregabalin 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92032,Marketed,2018-07-25,02435985,JAMP-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02435985,JAMP-PREGABALIN (pregabalin 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92033,Marketed,2018-07-25,02435993,JAMP-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02435993,JAMP-PREGABALIN (pregabalin 75 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92034,Marketed,2018-07-25,02436000,JAMP-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02436000,JAMP-PREGABALIN (pregabalin 150 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92035,Marketed,2019-09-27,02436019,JAMP-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02436019,JAMP-PREGABALIN (pregabalin 300 mg oral capsule) JAMP PHARMA CORPORATION,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93569,Marketed,2021-05-27,02449838,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449838,ACH-PREGABALIN (pregabalin 25 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93570,Marketed,2021-05-27,02449846,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449846,ACH-PREGABALIN (pregabalin 50 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93571,Marketed,2021-05-27,02449854,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449854,ACH-PREGABALIN (pregabalin 75 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93573,Marketed,2021-05-31,02449870,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449870,ACH-PREGABALIN (pregabalin 150 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93575,Marketed,2021-05-27,02449897,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449897,ACH-PREGABALIN (pregabalin 225 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93576,Marketed,2021-05-27,02449900,ACH-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02449900,ACH-PREGABALIN (pregabalin 300 mg oral capsule) ACCORD HEALTHCARE INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95568,Marketed,2023-10-06,02467291,M-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02467291,M-PREGABALIN (pregabalin 25 mg oral capsule) MANTRA PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95569,Marketed,2023-10-06,02467305,M-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02467305,M-PREGABALIN (pregabalin 50 mg oral capsule) MANTRA PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95570,Marketed,2023-10-06,02467313,M-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02467313,M-PREGABALIN (pregabalin 75 mg oral capsule) MANTRA PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95571,Marketed,2023-10-06,02467321,M-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02467321,M-PREGABALIN (pregabalin 150 mg oral capsule) MANTRA PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96443,Marketed,2018-08-22,02474352,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02474352,PREGABALIN (pregabalin 25 mg oral capsule) ALTAMED PHARMA,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96444,Marketed,2018-08-22,02474360,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02474360,PREGABALIN (pregabalin 50 mg oral capsule) ALTAMED PHARMA,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96445,Marketed,2018-08-22,02474379,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02474379,PREGABALIN (pregabalin 75 mg oral capsule) ALTAMED PHARMA,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96446,Marketed,2018-08-22,02474387,PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02474387,PREGABALIN (pregabalin 150 mg oral capsule) ALTAMED PHARMA,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96708,Marketed,2018-10-22,02479117,NRA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02479117,NRA-PREGABALIN (pregabalin 25 mg oral capsule) NORA PHARMA INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96709,Marketed,2018-10-22,02479125,NRA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02479125,NRA-PREGABALIN (pregabalin 50 mg oral capsule) NORA PHARMA INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96710,Marketed,2018-10-22,02479133,NRA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02479133,NRA-PREGABALIN (pregabalin 75 mg oral capsule) NORA PHARMA INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96712,Marketed,2018-10-22,02479168,NRA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02479168,NRA-PREGABALIN (pregabalin 150 mg oral capsule) NORA PHARMA INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96715,Marketed,2021-12-23,02479192,NRA-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02479192,NRA-PREGABALIN (pregabalin 300 mg oral capsule) NORA PHARMA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97125,Marketed,2018-09-28,02480727,AG-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02480727,AG-PREGABALIN (pregabalin 25 mg oral capsule) ANGITA PHARMA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97126,Marketed,2018-09-28,02480735,AG-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02480735,AG-PREGABALIN (pregabalin 50 mg oral capsule) ANGITA PHARMA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97127,Marketed,2018-09-28,02480743,AG-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02480743,AG-PREGABALIN (pregabalin 75 mg oral capsule) ANGITA PHARMA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97128,Marketed,2018-09-28,02480751,AG-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02480751,AG-PREGABALIN (pregabalin 150 mg oral capsule) ANGITA PHARMA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97129,Marketed,2018-09-28,02480778,AG-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02480778,AG-PREGABALIN (pregabalin 300 mg oral capsule) ANGITA PHARMA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98482,Marketed,2020-05-07,02494841,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494841,NAT-PREGABALIN (pregabalin 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98483,Marketed,2020-05-07,02494868,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494868,NAT-PREGABALIN (pregabalin 50 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98484,Marketed,2020-05-07,02494876,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494876,NAT-PREGABALIN (pregabalin 75 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98485,Marketed,2020-05-07,02494884,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494884,NAT-PREGABALIN (pregabalin 150 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98486,Marketed,2020-05-07,02494892,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494892,NAT-PREGABALIN (pregabalin 225 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001297,pregabalin 225 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98487,Marketed,2020-05-07,02494906,NAT-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02494906,NAT-PREGABALIN (pregabalin 300 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102979,Marketed,2024-02-29,02541122,BIO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541122,BIO-PREGABALIN (pregabalin 25 mg oral capsule) BIOMED PHARMA,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102980,Marketed,2024-03-11,02541130,BIO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541130,BIO-PREGABALIN (pregabalin 50 mg oral capsule) BIOMED PHARMA,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102981,Marketed,2024-02-29,02541149,BIO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541149,BIO-PREGABALIN (pregabalin 75 mg oral capsule) BIOMED PHARMA,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102983,Marketed,2024-02-29,02541165,BIO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541165,BIO-PREGABALIN (pregabalin 150 mg oral capsule) BIOMED PHARMA,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102986,Marketed,2024-04-08,02541203,BIO-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541203,BIO-PREGABALIN (pregabalin 300 mg oral capsule) BIOMED PHARMA,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103057,Marketed,2024-04-04,02541963,M-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02541963,M-PREGABALIN (pregabalin 300 mg oral capsule) MANTRA PHARMA INC,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104365,Marketed,2025-06-05,02554836,NB-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02554836,NB-PREGABALIN (pregabalin 25 mg oral capsule) NB PHARMA INC.,Active,9001116,pregabalin 25 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104366,Marketed,2025-06-05,02554844,NB-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02554844,NB-PREGABALIN (pregabalin 50 mg oral capsule) NB PHARMA INC.,Active,9001118,pregabalin 50 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104367,Marketed,2025-06-05,02554852,NB-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02554852,NB-PREGABALIN (pregabalin 75 mg oral capsule) NB PHARMA INC.,Active,9001119,pregabalin 75 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104368,Marketed,2025-06-05,02554860,NB-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02554860,NB-PREGABALIN (pregabalin 150 mg oral capsule) NB PHARMA INC.,Active,9001115,pregabalin 150 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104370,Marketed,2025-06-05,02554887,NB-PREGABALIN,1.0,N02BF02,Pregabalin,Capsule,Oral,02554887,NB-PREGABALIN (pregabalin 300 mg oral capsule) NB PHARMA INC.,Active,9001117,pregabalin 300 mg oral capsule,8000348,pregabalin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
33476,Marketed,2018-10-10,02226022,MYOFLEX EXTRA STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02226022,MYOFLEX EXTRA STRENGTH (trolamine salicylate 15 % cutaneous cream) EXZELL PHARMA INC,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
42373,Marketed,2011-11-19,02074702,EXTRA STRENGTH ASPERCREME CREME RUB 15%,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02074702,EXTRA STRENGTH ASPERCREME CREME RUB 15% (trolamine salicylate 15 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
42699,Marketed,2019-02-15,02152827,MYOFLEX REGULAR STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02152827,MYOFLEX REGULAR STRENGTH (trolamine salicylate 10 % cutaneous cream) EXZELL PHARMA INC,Active,9003038,trolamine salicylate 10 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
68558,Marketed,2019-02-14,02244573,MYOFLEX MAXIMUM STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02244573,MYOFLEX MAXIMUM STRENGTH (trolamine salicylate 20 % cutaneous cream) EXZELL PHARMA INC,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
84320,Marketed,2024-07-03,02358131,PAIN RELIEF CREAM REGULAR STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02358131,PAIN RELIEF CREAM REGULAR STRENGTH (trolamine salicylate 13.3 % cutaneous cream) CRLS,Active,9002617,trolamine salicylate 13.3 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
89554,Marketed,2018-03-21,02410907,PAIN RELIEF RUB TRIETHANOLAMINE SALICYLATE CREAM,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02410907,PAIN RELIEF RUB TRIETHANOLAMINE SALICYLATE CREAM (trolamine salicylate 15 % cutaneous cream) CRLS,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
89811,Marketed,2024-06-24,02413442,PAIN RELIEF CREAM EXTRA STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02413442,PAIN RELIEF CREAM EXTRA STRENGTH (trolamine salicylate 20 % cutaneous cream) CRLS,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
96248,Marketed,2018-09-24,02473135,MUSCLE & JOINT NO ODOUR EXTRA STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02473135,MUSCLE & JOINT NO ODOUR EXTRA STRENGTH (trolamine salicylate 20 % cutaneous cream) CHURCH & DWIGHT CANADA CORP,Active,9003700,trolamine salicylate 20 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
96250,Marketed,2018-08-31,02473143,MUSCLE & JOINT NO ODOUR REGULAR STRENGTH,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02473143,MUSCLE & JOINT NO ODOUR REGULAR STRENGTH (trolamine salicylate 13.3 % cutaneous cream) CHURCH & DWIGHT CANADA CORP,Active,9002617,trolamine salicylate 13.3 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
97690,Marketed,2019-10-28,02486725,ARTHRITIS PAIN RELIEF,3.0,M02AC,Preparations with salicylic acid derivatives,Lotion,Topical,02486725,ARTHRITIS PAIN RELIEF (capsaicin 0.035 % and menthol 1.25 % and trolamine salicylate 10 % lotion) CHURCH & DWIGHT CANADA CORP,Active,9013276,capsaicin 0.035 % and menthol 1.25 % and trolamine salicylate 10 % lotion,8001894,capsaicin and menthol and trolamine salicylate,448598008,Cutaneous,739000003,Lotion,,,,,
100605,Marketed,2022-02-22,02516713,FLEXACRèME PAIN RELIEF RUB,1.0,M02AC,Preparations with salicylic acid derivatives,Cream,Topical,02516713,FLEXACRÈME PAIN RELIEF RUB (trolamine salicylate 15 % cutaneous cream) CRLS,Active,9002037,trolamine salicylate 15 % cutaneous cream,8001980,trolamine salicylate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
91954,Marketed,2015-12-23,02435276,4% CITANEST PLAIN DENTAL,1.0,N01BB04,Prilocaine,Solution,Block/infiltration,02435276,4% CITANEST PLAIN DENTAL (prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED,Active,9013240,prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001875,prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
2828,Marketed,1977-12-31,00393746,PRILOCAINE HCL 4% EPINEPH 1:200000INJ,2.0,N01BB54,"Prilocaine, combinations",Solution,Block/infiltration,00393746,PRILOCAINE HCL 4% EPINEPH 1:200000INJ (epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) NOVOCOL PHARMACEUTICAL OF CANADA INC,Active,9014024,epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001763,epinephrine and prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
11440,Marketed,2018-06-01,00886858,EMLA CREAM,2.0,N01BB54,"Prilocaine, combinations",Cream,Topical,00886858,EMLA CREAM (lidocaine 2.5 % and prilocaine 2.5 % cutaneous cream) ASPEN PHARMACARE CANADA INC.,Active,9006325,lidocaine 2.5 % and prilocaine 2.5 % cutaneous cream,8001841,lidocaine and prilocaine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
16733,Marketed,2018-05-08,02057794,EMLA PATCH,2.0,N01BB54,"Prilocaine, combinations",Patch,Topical,02057794,EMLA PATCH (lidocaine 2.5 % and prilocaine 2.5 % cutaneous patch) ASPEN PHARMACARE CANADA INC.,Active,9002690,lidocaine 2.5 % and prilocaine 2.5 % cutaneous patch,8001841,lidocaine and prilocaine,448598008,Cutaneous,739003001,Patch,733005001,Patch (unit of presentation),,,
83307,Marketed,2011-01-18,02347695,"4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000",2.0,N01BB54,"Prilocaine, combinations",Solution,Block/infiltration,02347695,"4% CITANEST FORTE DENTAL WITH EPINEPHRINE 1:200,000 (epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge) DENTSPLY CANADA LIMITED",Active,9014024,epinephrine 0.005 mg per mL and prilocaine hydrochloride 40 mg per mL solution for injection 1.8 mL cartridge,8001763,epinephrine and prilocaine,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
18330,Marketed,2009-03-26,02017776,PRIMAQUINE,1.0,P01BA03,Primaquine,Tablet,Oral,02017776,PRIMAQUINE (primaquine phosphate 26.3 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9001494,primaquine phosphate 26.3 mg oral tablet,8002079,primaquine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2750,Marketed,2011-07-21,00396761,PRIMIDONE,1.0,N03AA03,Primidone,Tablet,Oral,00396761,PRIMIDONE (primidone 250 mg oral tablet) AA PHARMA INC,Active,9001794,primidone 250 mg oral tablet,8001301,primidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2751,Marketed,2011-07-21,00399310,PRIMIDONE,1.0,N03AA03,Primidone,Tablet,Oral,00399310,PRIMIDONE (primidone 125 mg oral tablet) AA PHARMA INC,Active,9001793,primidone 125 mg oral tablet,8001301,primidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19357,Marketed,2005-09-27,02184486,PROCAINAMIDE HYDROCHLORIDE INJECTION USP,1.0,C01BA02,Procainamide,Solution,"Intramuscular,Intravenous",02184486,PROCAINAMIDE HYDROCHLORIDE INJECTION USP (procainamide hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013020,procainamide hydrochloride 1000 mg per 10 mL solution for injection vial,8001416,procainamide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
938,Marketed,2018-05-09,00012750,MATULANE,1.0,L01XB01,Procarbazine,Capsule,Oral,00012750,"MATULANE (procarbazine (procarbazine hydrochloride) 50 mg oral capsule) LEADIANT BIOSCIENCES, INC",Active,9001667,procarbazine (procarbazine hydrochloride) 50 mg oral capsule,8002080,procarbazine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
9919,Marketed,2024-11-18,00789720,ODAN-PROCHLORPERAZINE,1.0,N05AB04,Prochlorperazine,Suppository,Rectal,00789720,ODAN-PROCHLORPERAZINE (prochlorperazine 10 mg suppository) ODAN LABORATORIES LTD,Active,9002217,prochlorperazine 10 mg suppository,8001302,prochlorperazine,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
45324,Marketed,2013-04-30,00886432,PROCHLORAZINE,1.0,N05AB04,Prochlorperazine,Tablet,Oral,00886432,PROCHLORAZINE (prochlorperazine (prochlorperazine maleate) 10 mg oral tablet) AA PHARMA INC,Active,9002218,prochlorperazine (prochlorperazine maleate) 10 mg oral tablet,8001302,prochlorperazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
45325,Marketed,2013-04-30,00886440,PROCHLORAZINE,1.0,N05AB04,Prochlorperazine,Tablet,Oral,00886440,PROCHLORAZINE (prochlorperazine (prochlorperazine maleate) 5 mg oral tablet) AA PHARMA INC,Active,9002219,prochlorperazine (prochlorperazine maleate) 5 mg oral tablet,8001302,prochlorperazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
12549,Marketed,2022-10-14,01927744,PARSITAN 50,1.0,N04AA05,Profenamine,Tablet,Oral,01927744,PARSITAN 50 (ethopropazine (ethopropazine hydrochloride) 50 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001537,ethopropazine (ethopropazine hydrochloride) 50 mg oral tablet,8001649,ethopropazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18500,Marketed,2022-02-18,02166704,PROMETRIUM,1.0,G03DA04,Progesterone,Capsule,Oral,02166704,PROMETRIUM (progesterone 100 mg oral capsule) ORGANON CANADA INC.,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
64606,Marketed,2000-06-12,02241013,CRINONE,1.0,G03DA04,Progesterone,Gel,Vaginal,02241013,"CRINONE (progesterone 8 % vaginal gel) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9000904,progesterone 8 % vaginal gel,8000220,progesterone,16857009,Vaginal,385100002,Gel,,,1.0,,
92431,Marketed,2015-04-16,02439913,TEVA-PROGESTERONE,1.0,G03DA04,Progesterone,Capsule,Oral,02439913,TEVA-PROGESTERONE (progesterone 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93234,Marketed,2020-05-12,02446820,ACT PROGESTERONE INJECTION,1.0,G03DA04,Progesterone,Solution,Intramuscular,02446820,ACT PROGESTERONE INJECTION (progesterone 500 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9001457,progesterone 500 mg per 10 mL solution for injection vial,8000220,progesterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
95102,Marketed,2018-08-09,02463113,REDDY-PROGESTERONE,1.0,G03DA04,Progesterone,Capsule,Oral,02463113,REDDY-PROGESTERONE (progesterone 100 mg oral capsule) DR. REDDY'S LABORATORIES INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
96745,Marketed,2018-08-08,02476576,PMS-PROGESTERONE,1.0,G03DA04,Progesterone,Capsule,Oral,02476576,PMS-PROGESTERONE (progesterone 100 mg oral capsule) PHARMASCIENCE INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
98357,Marketed,2020-03-16,02493578,AURO-PROGESTERONE,1.0,G03DA04,Progesterone,Capsule,Oral,02493578,AURO-PROGESTERONE (progesterone 100 mg oral capsule) AURO PHARMA INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100552,Marketed,2022-08-19,02516187,PROGESTERONE,1.0,G03DA04,Progesterone,Capsule,Oral,02516187,PROGESTERONE (progesterone 100 mg oral capsule) SANIS HEALTH INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102091,Marketed,2023-04-28,02531828,"PROGESTERONE INJECTION, USP",1.0,G03DA04,Progesterone,Solution,Intramuscular,02531828,"PROGESTERONE INJECTION, USP (progesterone 500 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED",Active,9001457,progesterone 500 mg per 10 mL solution for injection vial,8000220,progesterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
99458,Marketed,2024-01-31,02505223,BIJUVA,2.0,G03FA04,Progesterone and estrogen,Capsule,Oral,02505223,BIJUVA (estradiol (estradiol hemihydrate) 1 mg and progesterone 100 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9015017,estradiol 1 mg and progesterone 100 mg oral capsule,8002500,estradiol and progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
103999,Marketed,2025-07-18,02551268,M-PROGESTERONE,1.0,G03FA04,Progesterone and estrogen,Capsule,Oral,02551268,M-PROGESTERONE (progesterone 100 mg oral capsule) MANTRA PHARMA INC,Active,9000630,progesterone 100 mg oral capsule,8000220,progesterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
61542,Marketed,2002-08-20,02238151,MALARONE,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02238151,MALARONE (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75044,Marketed,2005-05-17,02264935,MALARONE PEDIATRIC,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02264935,MALARONE PEDIATRIC (atovaquone 62.5 mg and proguanil hydrochloride 25 mg oral tablet) GLAXOSMITHKLINE INC,Active,9004047,atovaquone 62.5 mg and proguanil hydrochloride 25 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86668,Marketed,2012-03-01,02380927,TEVA-ATOVAQUONE PROGUANIL,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02380927,TEVA-ATOVAQUONE PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) TEVA CANADA LIMITED,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88703,Marketed,2013-10-16,02402165,MYLAN-ATOVAQUONE/PROGUANIL,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02402165,MYLAN-ATOVAQUONE/PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90605,Marketed,2014-05-22,02421429,ATOVAQUONE PROGUANIL,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02421429,ATOVAQUONE PROGUANIL (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) SANIS HEALTH INC,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95514,Marketed,2017-10-30,02466783,ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS,2.0,P01BB51,Proguanil and atovaquone,Tablet,Oral,02466783,ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS (atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003275,atovaquone 250 mg and proguanil hydrochloride 100 mg oral tablet,8001437,atovaquone and proguanil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5369,Marketed,1983-12-31,00575186,HISTANTIL TAB 50MG,1.0,R06AD02,Promethazine,Tablet,Oral,00575186,HISTANTIL TAB 50MG (promethazine hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9001995,promethazine hydrochloride 50 mg oral tablet,8001512,promethazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8464,Marketed,2016-08-12,00603708,RYTHMOL,1.0,C01BC03,Propafenone,Tablet,Oral,00603708,RYTHMOL (propafenone hydrochloride 150 mg oral tablet) BGP PHARMA ULC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8465,Marketed,2016-06-17,00603716,RYTHMOL,1.0,C01BC03,Propafenone,Tablet,Oral,00603716,RYTHMOL (propafenone hydrochloride 300 mg oral tablet) BGP PHARMA ULC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67227,Marketed,2001-02-22,02243324,APO-PROPAFENONE,1.0,C01BC03,Propafenone,Tablet,Oral,02243324,APO-PROPAFENONE (propafenone hydrochloride 150 mg oral tablet) APOTEX INC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67228,Marketed,2018-08-31,02243325,APO-PROPAFENONE,1.0,C01BC03,Propafenone,Tablet,Oral,02243325,APO-PROPAFENONE (propafenone hydrochloride 300 mg oral tablet) APOTEX INC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94424,Marketed,2017-10-31,02457164,MYLAN-PROPAFENONE,1.0,C01BC03,Propafenone,Tablet,Oral,02457164,MYLAN-PROPAFENONE (propafenone hydrochloride 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002155,propafenone hydrochloride 300 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94425,Marketed,2017-10-31,02457172,MYLAN-PROPAFENONE,1.0,C01BC03,Propafenone,Tablet,Oral,02457172,MYLAN-PROPAFENONE (propafenone hydrochloride 150 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9002154,propafenone hydrochloride 150 mg oral tablet,8001417,propafenone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94755,Marketed,2017-05-08,02460262,MICTORYL,1.0,G04BD06,Propiverine,Capsule (extended release),Oral,02460262,MICTORYL (propiverine hydrochloride 30 mg prolonged-release oral capsule) DUCHESNAY INC,Active,9015287,propiverine hydrochloride 30 mg prolonged-release oral capsule,8001513,propiverine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
94756,Marketed,2017-05-08,02460270,MICTORYL,1.0,G04BD06,Propiverine,Capsule (extended release),Oral,02460270,MICTORYL (propiverine hydrochloride 45 mg prolonged-release oral capsule) DUCHESNAY INC,Active,9015288,propiverine hydrochloride 45 mg prolonged-release oral capsule,8001513,propiverine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,,,
94757,Marketed,2017-04-13,02460289,MICTORYL PEDIATRIC,1.0,G04BD06,Propiverine,Tablet,Oral,02460289,MICTORYL PEDIATRIC (propiverine hydrochloride 5 mg oral tablet) DUCHESNAY INC,Active,9006148,propiverine hydrochloride 5 mg oral tablet,8001513,propiverine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14476,Marketed,2018-07-16,02018950,DIPRIVAN 1%,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700966,DIPRIVAN 1% (propofol 1000 mg per 100 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
14476,Marketed,2018-07-16,02018950,DIPRIVAN 1%,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700967,DIPRIVAN 1% (propofol 500 mg per 50 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
14476,Marketed,2018-07-16,02018950,DIPRIVAN 1%,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700968,DIPRIVAN 1% (propofol 200 mg per 20 mL emulsion for injection vial) ASPEN PHARMACARE CANADA INC.,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
68347,Marketed,2022-09-21,02244379,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700926,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection ampoule) BAXTER CORPORATION,Active,9013515,propofol 200 mg per 20 mL emulsion for injection ampoule,8002081,propofol,738984000,Parenteral,385221006,Emulsion for injection,732978007,Ampule (unit of presentation),,,
68347,Marketed,2022-09-21,02244379,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700927,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) BAXTER CORPORATION,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
68347,Marketed,2022-09-21,02244379,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700928,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) BAXTER CORPORATION,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
92203,Marketed,2015-06-01,02437643,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700945,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
92203,Marketed,2015-06-01,02437643,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700946,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
92203,Marketed,2015-06-01,02437643,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77700947,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) FRESENIUS KABI CANADA LTD,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
101486,Marketed,2023-04-18,02525879,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77701122,PROPOFOL INJECTION (propofol 200 mg per 20 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013516,propofol 200 mg per 20 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
101486,Marketed,2023-04-18,02525879,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77701123,PROPOFOL INJECTION (propofol 500 mg per 50 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013517,propofol 500 mg per 50 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
101486,Marketed,2023-04-18,02525879,PROPOFOL INJECTION,1.0,N01AX10,Propofol,Emulsion,Intravenous,77701124,PROPOFOL INJECTION (propofol 1000 mg per 100 mL emulsion for injection vial) MARCAN PHARMACEUTICALS INC,Active,9013514,propofol 1000 mg per 100 mL emulsion for injection vial,8002081,propofol,738984000,Parenteral,738998008,Emulsion,733026001,Vial (unit of presentation),,,
4254,Marketed,2011-10-25,00496480,TEVA-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,00496480,TEVA-PROPRANOLOL (propranolol hydrochloride 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000154,propranolol hydrochloride 10 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4255,Marketed,2011-10-25,00496499,TEVA-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,00496499,TEVA-PROPRANOLOL (propranolol hydrochloride 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000155,propranolol hydrochloride 40 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4256,Marketed,2011-10-25,00496502,TEVA-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,00496502,TEVA-PROPRANOLOL (propranolol hydrochloride 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000156,propranolol hydrochloride 80 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
7349,Marketed,2011-10-25,00740675,TEVA-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,00740675,TEVA-PROPRANOLOL (propranolol hydrochloride 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000265,propranolol hydrochloride 20 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43431,Marketed,2005-09-27,02225883,PROPRANOLOL HYDROCHLORIDE INJECTION USP,1.0,C07AA05,Propranolol,Solution,Intravenous,02225883,PROPRANOLOL HYDROCHLORIDE INJECTION USP (propranolol hydrochloride 1 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9000659,propranolol hydrochloride 1 mg per 1 mL solution for injection ampoule,8000086,propranolol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
94488,Marketed,2017-03-23,02457857,HEMANGIOL,1.0,C07AA05,Propranolol,Solution,Oral,02457857,HEMANGIOL (propranolol (propranolol hydrochloride) 3.75 mg per mL oral solution) PIERRE FABRE DERMO-COSMETIQUE CANADA INC,Active,9006576,propranolol (propranolol hydrochloride) 3.75 mg per mL oral solution,8000086,propranolol,26643006,Oral,385023001,Oral solution,,,,,
98190,Marketed,2023-06-30,02491893,LUPIN-PROPRANOLOL LA,1.0,C07AA05,Propranolol,Capsule (extended release),Oral,02491893,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 60 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000631,propranolol hydrochloride 60 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98191,Marketed,2023-06-30,02491907,LUPIN-PROPRANOLOL LA,1.0,C07AA05,Propranolol,Capsule (extended release),Oral,02491907,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 80 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000543,propranolol hydrochloride 80 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98192,Marketed,2023-06-30,02491915,LUPIN-PROPRANOLOL LA,1.0,C07AA05,Propranolol,Capsule (extended release),Oral,02491915,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 120 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000541,propranolol hydrochloride 120 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
98193,Marketed,2023-06-30,02491923,LUPIN-PROPRANOLOL LA,1.0,C07AA05,Propranolol,Capsule (extended release),Oral,02491923,LUPIN-PROPRANOLOL LA (propranolol hydrochloride 160 mg prolonged-release oral capsule) LUPIN PHARMA CANADA LIMITED,Active,9000542,propranolol hydrochloride 160 mg prolonged-release oral capsule,8000086,propranolol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
103959,Marketed,2025-04-30,02550814,PRZ-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,02550814,PRZ-PROPRANOLOL (propranolol hydrochloride 20 mg oral tablet) PHARMARIS CANADA INC,Active,9000265,propranolol hydrochloride 20 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103960,Marketed,2025-04-30,02550822,PRZ-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,02550822,PRZ-PROPRANOLOL (propranolol hydrochloride 40 mg oral tablet) PHARMARIS CANADA INC,Active,9000155,propranolol hydrochloride 40 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103961,Marketed,2025-04-30,02550830,PRZ-PROPRANOLOL,1.0,C07AA05,Propranolol,Tablet,Oral,02550830,PRZ-PROPRANOLOL (propranolol hydrochloride 80 mg oral tablet) PHARMARIS CANADA INC,Active,9000156,propranolol hydrochloride 80 mg oral tablet,8000086,propranolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101028,Marketed,2022-03-23,02521059,HALYCIL,1.0,H03BA02,Propylthiouracil,Tablet,Oral,02521059,HALYCIL (propylthiouracil 50 mg oral tablet) HALEWOOD CHEMICALS LIMITED,Active,9001524,propylthiouracil 50 mg oral tablet,8001514,propylthiouracil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101209,Marketed,2022-07-21,02523019,PROPYLTHIOURACIL TABLETS,1.0,H03BA02,Propylthiouracil,Tablet,Oral,02523019,PROPYLTHIOURACIL TABLETS (propylthiouracil 50 mg oral tablet) PHEBRA CANADA INC,Active,9001524,propylthiouracil 50 mg oral tablet,8001514,propylthiouracil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
19443,Marketed,2016-05-19,02139537,"PROTAMINE SULFATE INJECTION, USP",1.0,V03AB14,Protamine,Solution,Intravenous,77700914,"PROTAMINE SULFATE INJECTION, USP (protamine sulfate 250 mg per 25 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013518,protamine sulfate 250 mg per 25 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
19443,Marketed,2016-05-19,02139537,"PROTAMINE SULFATE INJECTION, USP",1.0,V03AB14,Protamine,Solution,Intravenous,77700915,"PROTAMINE SULFATE INJECTION, USP (protamine sulfate 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013519,protamine sulfate 50 mg per 5 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
51049,Marketed,2005-08-18,02231674,PROTAMINE SULFATE INJECTION USP,1.0,V03AB14,Protamine,Solution,Intravenous,77700922,PROTAMINE SULFATE INJECTION USP (protamine sulfate 250 mg per 25 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013518,protamine sulfate 250 mg per 25 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
51049,Marketed,2005-08-18,02231674,PROTAMINE SULFATE INJECTION USP,1.0,V03AB14,Protamine,Solution,Intravenous,77700923,PROTAMINE SULFATE INJECTION USP (protamine sulfate 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013519,protamine sulfate 50 mg per 5 mL solution for injection vial,8002082,protamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99639,Marketed,2021-06-01,02506971,WATER DRENCH,4.0,D02BA,Protectives against uv-radiation for topical use,Lotion,Topical,,,,,,,,,,,,,,,,
1172,Marketed,2019-08-21,00035076,ALCAINE,1.0,S01HA04,Proxymetacaine,Drops,Ophthalmic,00035076,ALCAINE (proparacaine hydrochloride 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9014228,proparacaine hydrochloride 0.5 % ophthalmic drops,8002313,proparacaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
86259,Marketed,2024-10-30,02377012,RESOTRAN,1.0,A06AX05,Prucalopride,Tablet,Oral,02377012,RESOTRAN (prucalopride (prucalopride succinate) 1 mg oral tablet) AMDIPHARM LIMITED,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86260,Marketed,2025-01-02,02377020,RESOTRAN,1.0,A06AX05,Prucalopride,Tablet,Oral,02377020,RESOTRAN (prucalopride (prucalopride succinate) 2 mg oral tablet) AMDIPHARM LIMITED,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98158,Marketed,2020-01-27,02491591,APO-PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02491591,APO-PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) APOTEX INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98159,Marketed,2020-01-27,02491605,APO-PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02491605,APO-PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) APOTEX INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98349,Marketed,2021-02-26,02493489,JAMP PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02493489,JAMP PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98350,Marketed,2021-02-26,02493497,JAMP PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02493497,JAMP PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103919,Marketed,2024-10-28,02550377,NRA-PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02550377,NRA-PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) NORA PHARMA INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103920,Marketed,2024-10-28,02550385,NRA-PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02550385,NRA-PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) NORA PHARMA INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106220,Marketed,2025-11-19,02559005,PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02559005,PRUCALOPRIDE (prucalopride (prucalopride succinate) 1 mg oral tablet) SANIS HEALTH INC,Active,9004970,prucalopride (prucalopride succinate) 1 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106221,Marketed,2025-11-19,02559013,PRUCALOPRIDE,1.0,A06AX05,Prucalopride,Tablet,Oral,02559013,PRUCALOPRIDE (prucalopride (prucalopride succinate) 2 mg oral tablet) SANIS HEALTH INC,Active,9004971,prucalopride (prucalopride succinate) 2 mg oral tablet,8002083,prucalopride,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11974,Marketed,2017-03-20,01945157,CLARITIN ALLERGY + SINUS,2.0,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,01945157,CLARITIN ALLERGY + SINUS (loratadine 5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet) BAYER INC,Active,9015307,loratadine 5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet,8001493,loratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
63341,Marketed,2020-01-31,02239853,ALLEGRA-D,2.0,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,02239853,ALLEGRA-D (fexofenadine hydrochloride 60 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet) SANOFI CONSUMER HEALTH INC,Active,9015301,fexofenadine hydrochloride 60 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet,8001467,fexofenadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
70312,Marketed,2013-10-23,02246162,REACTINE COMPLETE,2.0,R01BA52,"Pseudoephedrine, combinations",Tablet (extended-release),Oral,02246162,REACTINE COMPLETE (cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9003783,cetirizine hydrochloride 5 mg and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet,8001348,cetirizine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
74601,Marketed,2015-09-11,02260557,CLARITIN ALLERGY + SINUS EXTRA STRENGTH,2.0,R01BA52,"Pseudoephedrine, combinations",Tablet (immediate and extended release),Oral,02260557,CLARITIN ALLERGY + SINUS EXTRA STRENGTH (loratadine 10 mg and pseudoephedrine sulfate 240 mg prolonged-release oral tablet) BAYER INC,Active,9015306,loratadine 10 mg and pseudoephedrine sulfate 240 mg prolonged-release oral tablet,8001493,loratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet,,,
79491,Marketed,2024-02-29,02309300,AERIUS SINUS + ALLERGY,2.0,R01BA52,"Pseudoephedrine, combinations",Tablet (extended-release),Oral,02309300,AERIUS SINUS + ALLERGY (desloratadine 2.5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet) BAYER INC,Active,9004639,desloratadine 2.5 mg and pseudoephedrine sulfate 120 mg prolonged-release oral tablet,8001367,desloratadine and pseudoephedrine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
12926,Marketed,2007-01-13,01944363,COMBANTRIN TAB 125MG,1.0,P02CC01,Pyrantel,Tablet,Oral,01944363,COMBANTRIN TAB 125MG (pyrantel (pyrantel pamoate) 125 mg oral tablet) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86640,Marketed,2018-08-22,02380617,JAMP-PYRANTEL PAMOATE,1.0,P02CC01,Pyrantel,Tablet,Oral,02380617,JAMP-PYRANTEL PAMOATE (pyrantel (pyrantel pamoate) 125 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89708,Marketed,2017-12-08,02412470,JAMP-PYRANTEL PAMOATE SUSPENSION,1.0,P02CC01,Pyrantel,Suspension,Oral,02412470,JAMP-PYRANTEL PAMOATE SUSPENSION (pyrantel (pyrantel pamoate) 50 mg per mL oral suspension) JAMP PHARMA CORPORATION,Active,9001705,pyrantel (pyrantel pamoate) 50 mg per mL oral suspension,8002084,pyrantel,26643006,Oral,385024007,Oral suspension,,,,,
102431,Marketed,2025-02-17,02535467,RIVA-PYRANTEL PAMOATE,1.0,P02CC01,Pyrantel,Tablet,Oral,02535467,RIVA-PYRANTEL PAMOATE (pyrantel (pyrantel pamoate) 125 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001704,pyrantel (pyrantel pamoate) 125 mg oral tablet,8002084,pyrantel,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
6130,Marketed,2014-03-05,00618810,PDP-PYRAZINAMIDE,1.0,J04AK01,Pyrazinamide,Tablet,Oral,00618810,PDP-PYRAZINAMIDE (pyrazinamide 500 mg oral tablet) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9001706,pyrazinamide 500 mg oral tablet,8001223,pyrazinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18634,Marketed,2013-03-01,02125447,R & C SHAMPOO WITH CONDITIONER,2.0,P03AC51,"Pyrethrum, combinations",Shampoo,Topical,02125447,R & C SHAMPOO WITH CONDITIONER (piperonyl butoxide 3 % and pyrethrins 0.33 % shampoo) MEDTECH PRODUCTS INC,Active,9002863,piperonyl butoxide 3 % and pyrethrins 0.33 % shampoo,8002069,piperonyl butoxide and pyrethrins,41695006,Scalp structure,785908001,Shampoo,,,,,
10567,Marketed,2019-07-04,00869961,MESTINON,1.0,N07AA02,Pyridostigmine,Tablet,Oral,00869961,"MESTINON (pyridostigmine bromide 60 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11135,Marketed,2019-07-04,00869953,MESTINON-SR,1.0,N07AA02,Pyridostigmine,Tablet (extended-release),Oral,00869953,"MESTINON-SR (pyridostigmine bromide 180 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002384,pyridostigmine bromide 180 mg prolonged-release oral tablet,8001516,pyridostigmine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
98554,Marketed,2020-08-24,02495643,RIVA-PYRIDOSTIGMINE,1.0,N07AA02,Pyridostigmine,Tablet,Oral,02495643,RIVA-PYRIDOSTIGMINE (pyridostigmine bromide 60 mg oral tablet) LABORATOIRE RIVA INC.,Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99773,Marketed,2023-03-07,02508362,JAMP PYRIDOSTIGMINE BROMIDE,1.0,N07AA02,Pyridostigmine,Tablet,Oral,02508362,JAMP PYRIDOSTIGMINE BROMIDE (pyridostigmine bromide 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002322,pyridostigmine bromide 60 mg oral tablet,8001516,pyridostigmine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69230,Marketed,2018-08-03,02245215,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",1.0,A11HA02,Pyridoxine (vit b6),Solution,"Intravenous,Intramuscular",02245215,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP (pyridoxine hydrochloride 3000 mg per 30 mL solution for injection vial) MYLAN PHARMACEUTICALS ULC",Active,9013601,pyridoxine hydrochloride 3000 mg per 30 mL solution for injection vial,8001916,pyridoxine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
10999,Marketed,1990-12-31,00800686,Z-PLUS SHAMPOO,2.0,D11AX12,Pyrithione zinc,Shampoo,Topical,00800686,Z-PLUS SHAMPOO (menthol 0.3 % and pyrithione zinc 2 % shampoo) DORMER LABORATORIES INC.,Active,9002318,menthol 0.3 % and pyrithione zinc 2 % shampoo,8002031,menthol and pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
80576,Marketed,2011-11-19,02320320,SELSUN BLUE ANTI-DANDRUFF SHAMPOO,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02320320,SELSUN BLUE ANTI-DANDRUFF SHAMPOO (pyrithione zinc 1 % shampoo) SANOFI CONSUMER HEALTH INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
84283,Marketed,2016-07-29,02357739,DOVE MEN+CARE FORTIFYING SHAMPOO + CONDITIONER ANTI-DANDRUFF 2 IN 1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02357739,DOVE MEN+CARE FORTIFYING SHAMPOO + CONDITIONER ANTI-DANDRUFF 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88440,Marketed,2023-03-15,02399520,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399520,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88442,Marketed,2022-09-09,02399547,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399547,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88443,Marketed,2023-03-15,02399555,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399555,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88444,Marketed,2023-03-15,02399563,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399563,PYRITHIONE ZINC DANDRUFF SHAMPOO GREEN APPLE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88449,Marketed,2023-03-15,02399636,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399636,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88450,Marketed,2023-03-15,02399644,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399644,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88452,Marketed,2023-03-15,02399660,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS BREEZE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399660,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS BREEZE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88453,Marketed,2023-03-15,02399679,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399679,PYRITHIONE ZINC DANDRUFF SHAMPOO DRY SCALP CARE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88454,Marketed,2023-03-15,02399687,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399687,PYRITHIONE ZINC DANDRUFF SHAMPOO ITCHY SCALP CARE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88455,Marketed,2023-03-15,02399695,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399695,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
88456,Marketed,2023-03-15,02399709,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02399709,PYRITHIONE ZINC DANDRUFF SHAMPOO SMOOTH & SILKY 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
91022,Marketed,2014-07-02,02425580,SCALPSYNC ANTI-DANDRUFF,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02425580,SCALPSYNC ANTI-DANDRUFF (pyrithione zinc 1 % shampoo) MATRIX CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
93449,Marketed,2016-04-13,02448769,PYRITHIONE ZINC DANDRUFF SHAMPOO AND CONDITIONER CLASSIC CLEAN 2 IN 1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02448769,PYRITHIONE ZINC DANDRUFF SHAMPOO AND CONDITIONER CLASSIC CLEAN 2 IN 1 (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
93469,Marketed,2016-04-13,02448912,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02448912,PYRITHIONE ZINC DANDRUFF SHAMPOO CLASSIC CLEAN (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
93592,Marketed,2016-05-17,02449986,PYRITHIONE ZINC DANDRUFF SHAMPOO REFRESH,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02449986,PYRITHIONE ZINC DANDRUFF SHAMPOO REFRESH (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
93593,Marketed,2016-06-13,02449994,PYRITHIONE ZINC DANDRUFF SHAMPOO SCALP CARE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02449994,PYRITHIONE ZINC DANDRUFF SHAMPOO SCALP CARE (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
93597,Marketed,2016-04-27,02450011,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02450011,PYRITHIONE ZINC DANDRUFF SHAMPOO CITRUS (pyrithione zinc 1 % shampoo) CANADIAN CUSTOM PACKAGING COMPANY,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94483,Marketed,2023-06-15,02457806,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER GREEN APPLE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02457806,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER GREEN APPLE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94485,Marketed,2023-06-15,02457822,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER SMOOTH & SILKY,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02457822,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER SMOOTH & SILKY (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94486,Marketed,2023-06-15,02457830,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER DRY SCALP CARE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02457830,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER DRY SCALP CARE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94487,Marketed,2023-06-15,02457849,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER CLASSIC CLEAN,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02457849,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF CONDITIONER CLASSIC CLEAN (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94885,Marketed,2023-06-15,02461358,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02461358,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
94999,Marketed,2023-06-15,02462249,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02462249,HEAD & SHOULDERS PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP MOISTURE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
95440,Marketed,2018-02-01,02466090,DOVE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02466090,DOVE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
95558,Marketed,2018-02-01,02467194,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF 2 IN 1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02467194,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF DRYNESS & ITCH RELIEF 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
95560,Marketed,2018-02-01,02467216,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF GENTLE CLEAN 2 IN 1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02467216,DOVE MEN+CARE DERMA+CARE SCALP ANTI-DANDRUFF GENTLE CLEAN 2 IN 1 (pyrithione zinc 1 % shampoo) UNILEVER CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96721,Marketed,2024-02-07,02476193,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 SWAGGER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02476193,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 SWAGGER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96727,Marketed,2023-03-15,02476266,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN SWAGGER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02476266,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN SWAGGER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96806,Marketed,2024-02-07,02477211,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 PURE SPORT,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02477211,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 PURE SPORT (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96807,Marketed,2023-03-15,02477238,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN PURE SPORT,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02477238,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN PURE SPORT (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96824,Marketed,2024-02-07,02477289,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 FIJI,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02477289,PYRITHIONE ZINC DANDRUFF SHAMPOO MEN 2IN1 FIJI (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96975,Marketed,2023-06-26,02479044,ORIGINAL / ORIGINALE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02479044,ORIGINAL / ORIGINALE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96976,Marketed,2024-06-15,02479052,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02479052,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96978,Marketed,2019-11-09,02479079,CLEANSING NETTOYANT DANDRUFF PYRITHIONE ZINC SHAMPOO,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02479079,CLEANSING NETTOYANT DANDRUFF PYRITHIONE ZINC SHAMPOO (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
96980,Marketed,2024-06-15,02479095,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02479095,GREEN APPLE POMME VERTE DANDRUFF PYRITHIONE ZINC SHAMPOO & CONDITIONER (pyrithione zinc 1 % shampoo) APOLLO HEALTH AND BEAUTY CARE,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
97824,Marketed,2020-05-26,02488132,SCALP RELIEF,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02488132,SCALP RELIEF (pyrithione zinc 1 % shampoo) REDKEN 5TH AVENUE NYC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98145,Marketed,2020-01-31,02491443,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRêME NOURISH,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02491443,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME NOURISH (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98147,Marketed,2020-01-31,02491478,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRêME PURIFY & HYDRATE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02491478,PYRITHIONE ZINC DANDRUFF SHAMPOO SUPRÊME PURIFY & HYDRATE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98150,Marketed,2020-01-31,02491508,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRêME NOURISH,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02491508,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME NOURISH (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98151,Marketed,2020-01-31,02491516,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRêME PURIFY & HYDRATE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02491516,PYRITHIONE ZINC DANDRUFF CONDITIONER SUPRÊME PURIFY & HYDRATE (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98326,Marketed,2019-11-11,02493284,TEA TREE OIL 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02493284,TEA TREE OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
98327,Marketed,2023-03-15,02493292,PYRITHIONE ZINC DANDRUFF SHAMPOO TEA TREE OIL,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02493292,PYRITHIONE ZINC DANDRUFF SHAMPOO TEA TREE OIL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
99696,Marketed,2023-06-15,02507595,PYRITHIONE ZINC DANDRUFF SHAMPOO APPLE CIDER VINEGAR,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02507595,PYRITHIONE ZINC DANDRUFF SHAMPOO APPLE CIDER VINEGAR (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
101112,Marketed,2025-04-23,02521954,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02521954,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
101113,Marketed,2025-04-22,02521962,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT ,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02521962,PYRITHIONE ZINC DANDRUFF SHAMPOO HYDRATING COCONUT  (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
101166,Marketed,2021-12-30,02522543,PYRITHIONE ZINC DANDRUFF SHAMPOO LEMON OIL 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02522543,PYRITHIONE ZINC DANDRUFF SHAMPOO LEMON OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
101904,Marketed,2023-03-15,02529807,PYRITHIONE ZINC DANDRUFF SHAMPOO GINGER 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02529807,PYRITHIONE ZINC DANDRUFF SHAMPOO GINGER 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
101926,Marketed,2023-03-15,02530058,PYRITHIONE ZINC DANDRUFF SHAMPOO 2IN1 MEN EUCALYPTUS & NEEM,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02530058,PYRITHIONE ZINC DANDRUFF SHAMPOO 2IN1 MEN EUCALYPTUS & NEEM (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102048,Marketed,2025-04-24,02531348,PYRITHIONE ZINC DANDRUFF CONDITIONER SULFATE FREE SHEA BUTTER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531348,PYRITHIONE ZINC DANDRUFF CONDITIONER SULFATE FREE SHEA BUTTER (pyrithione zinc 0.5 % shampoo) PROCTER & GAMBLE INC,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102049,Marketed,2025-04-10,02531356,PYRITHIONE ZINC DANDRUFF SHAMPOO SULFATE FREE SHEA BUTTER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531356,PYRITHIONE ZINC DANDRUFF SHAMPOO SULFATE FREE SHEA BUTTER (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102102,Marketed,2023-03-15,02531933,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531933,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102104,Marketed,2023-03-15,02531968,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531968,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102106,Marketed,2024-07-01,02531984,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531984,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102107,Marketed,2024-07-01,02531992,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02531992,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP CLEANSE 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102109,Marketed,2023-03-15,02532026,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02532026,PYRITHIONE ZINC DANDRUFF SHAMPOO DEEP SCALP HYDRATION 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102553,Marketed,2024-02-01,02536781,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL 2IN1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02536781,PYRITHIONE ZINC DANDRUFF SHAMPOO AVOCADO OIL 2IN1 (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102662,Marketed,2024-02-01,02537869,BARE MINIMAL INGREDIENTS SHAMPOO SOOTHING HYDRATION,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02537869,BARE MINIMAL INGREDIENTS SHAMPOO SOOTHING HYDRATION (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
102664,Marketed,2024-02-01,02537885,BARE MINIMAL INGREDIENTS SHAMPOO PURE CLEAN,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02537885,BARE MINIMAL INGREDIENTS SHAMPOO PURE CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
103358,Marketed,2025-07-01,02544962,BARE MINIMAL INGREDIENTS SHAMPOO ITCH CONTROL,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02544962,BARE MINIMAL INGREDIENTS SHAMPOO ITCH CONTROL (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
103517,Marketed,2025-07-01,02546485,BARE MINIMAL INGREDIENTS 2IN1 SHAMPOO PURE CLEAN,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02546485,BARE MINIMAL INGREDIENTS 2IN1 SHAMPOO PURE CLEAN (pyrithione zinc 1 % shampoo) PROCTER & GAMBLE INC,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
103913,Marketed,2025-03-01,02550318,ANTI-DANDRUFF HYDRATING CONDITIONER,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02550318,ANTI-DANDRUFF HYDRATING CONDITIONER (pyrithione zinc 0.5 % shampoo) CERAVE CANADA,Active,9005596,pyrithione zinc 0.5 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
103939,Marketed,2025-03-01,02550598,ANTI-DANDRUFF 2 IN 1,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02550598,ANTI-DANDRUFF 2 IN 1 (pyrithione zinc 1 % shampoo) CERAVE CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
103970,Marketed,2025-03-01,02550946,ANTI-DANDRUFF HYDRATING SHAMPOO,1.0,D11AX12,Pyrithione zinc,Shampoo,Topical,02550946,ANTI-DANDRUFF HYDRATING SHAMPOO (pyrithione zinc 1 % shampoo) CERAVE CANADA,Active,9002610,pyrithione zinc 1 % shampoo,8002085,pyrithione zinc,41695006,Scalp structure,785908001,Shampoo,,,,,
60245,Marketed,2025-11-28,02236951,SEROQUEL,1.0,N05AH04,Quetiapine,Tablet,Oral,02236951,SEROQUEL (quetiapine (quetiapine fumarate) 25 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60246,Marketed,2025-03-18,02236952,SEROQUEL,1.0,N05AH04,Quetiapine,Tablet,Oral,02236952,SEROQUEL (quetiapine (quetiapine fumarate) 100 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60247,Marketed,2025-10-24,02236953,SEROQUEL,1.0,N05AH04,Quetiapine,Tablet,Oral,02236953,SEROQUEL (quetiapine (quetiapine fumarate) 200 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68066,Marketed,2025-11-21,02244107,SEROQUEL,1.0,N05AH04,Quetiapine,Tablet,Oral,02244107,SEROQUEL (quetiapine (quetiapine fumarate) 300 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78188,Marketed,2008-09-04,02296551,PMS-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02296551,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78189,Marketed,2008-09-04,02296578,PMS-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02296578,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78191,Marketed,2008-09-04,02296594,PMS-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02296594,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) PHARMASCIENCE INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78192,Marketed,2008-09-04,02296608,PMS-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02296608,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) PHARMASCIENCE INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78550,Marketed,2025-11-05,02300184,SEROQUEL XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300184,SEROQUEL XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78551,Marketed,2025-12-12,02300192,SEROQUEL XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300192,SEROQUEL XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78552,Marketed,2025-11-05,02300206,SEROQUEL XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300206,SEROQUEL XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78553,Marketed,2025-03-18,02300214,SEROQUEL XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02300214,SEROQUEL XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
80161,Marketed,2019-12-06,02316080,ACT QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316080,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80162,Marketed,2019-12-06,02316099,ACT QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316099,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80164,Marketed,2019-12-06,02316110,ACT QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316110,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80165,Marketed,2019-12-06,02316129,ACT QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316129,ACT QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) TEVA CANADA LIMITED,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80220,Marketed,2013-06-25,02316692,RIVA-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316692,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80221,Marketed,2013-06-25,02316706,RIVA-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316706,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80223,Marketed,2013-06-25,02316722,RIVA-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316722,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80224,Marketed,2013-06-25,02316730,RIVA-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02316730,RIVA-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80287,Marketed,2025-07-17,02317346,PRO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317346,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) PRO DOC LIMITEE,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80288,Marketed,2025-07-17,02317354,PRO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317354,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80289,Marketed,2025-07-17,02317362,PRO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317362,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) PRO DOC LIMITEE,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80290,Marketed,2025-07-17,02317370,PRO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317370,PRO-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) PRO DOC LIMITEE,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80341,Marketed,2016-08-12,02317893,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317893,QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80342,Marketed,2016-08-12,02317907,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317907,QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80344,Marketed,2016-07-12,02317923,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317923,QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80345,Marketed,2016-08-12,02317931,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02317931,QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80692,Marketed,2025-03-18,02321513,SEROQUEL XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02321513,SEROQUEL XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
83838,Marketed,2010-07-26,02353164,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02353164,QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) SANIS HEALTH INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83839,Marketed,2010-07-26,02353172,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02353172,QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83841,Marketed,2010-07-26,02353199,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02353199,QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) SANIS HEALTH INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83842,Marketed,2010-07-26,02353202,QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02353202,QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) SANIS HEALTH INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84693,Marketed,2011-01-21,02361892,PMS-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02361892,PMS-QUETIAPINE (quetiapine (quetiapine fumarate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9001333,quetiapine (quetiapine fumarate) 50 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87337,Marketed,2024-04-03,02387794,ACH-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387794,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87338,Marketed,2024-04-03,02387808,ACH-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387808,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87339,Marketed,2024-04-03,02387816,ACH-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387816,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 150 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001256,quetiapine (quetiapine fumarate) 150 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87340,Marketed,2024-04-03,02387824,ACH-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387824,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87341,Marketed,2024-04-03,02387832,ACH-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02387832,ACH-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87560,Marketed,2021-11-03,02390140,JAMP QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390140,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87561,Marketed,2021-11-03,02390159,JAMP QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390159,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87562,Marketed,2021-11-03,02390167,JAMP QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390167,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87563,Marketed,2021-11-03,02390175,JAMP QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02390175,JAMP QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87566,Marketed,2012-10-18,02390205,AURO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02390205,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) AURO PHARMA INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87567,Marketed,2012-10-18,02390213,AURO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02390213,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) AURO PHARMA INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87569,Marketed,2012-10-18,02390248,AURO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02390248,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) AURO PHARMA INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87570,Marketed,2012-10-18,02390256,AURO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02390256,AURO-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) AURO PHARMA INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88053,Marketed,2013-03-08,02395444,TEVA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395444,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
88054,Marketed,2013-03-08,02395452,TEVA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395452,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
88055,Marketed,2013-03-08,02395460,TEVA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395460,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
88056,Marketed,2013-03-08,02395479,TEVA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395479,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
88057,Marketed,2013-03-08,02395487,TEVA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02395487,TEVA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89240,Marketed,2017-11-07,02407671,SANDOZ QUETIAPINE XRT,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407671,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89241,Marketed,2017-11-07,02407701,SANDOZ QUETIAPINE XRT,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407701,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89242,Marketed,2017-11-07,02407728,SANDOZ QUETIAPINE XRT,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407728,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89243,Marketed,2017-11-07,02407736,SANDOZ QUETIAPINE XRT,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407736,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89244,Marketed,2017-11-07,02407698,SANDOZ QUETIAPINE XRT,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02407698,SANDOZ QUETIAPINE XRT (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90198,Marketed,2025-06-11,02417359,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417359,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90199,Marketed,2025-06-11,02417367,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417367,QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90200,Marketed,2025-06-11,02417375,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417375,QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90201,Marketed,2025-06-11,02417383,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417383,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90202,Marketed,2025-06-11,02417391,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417391,QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90240,Marketed,2022-09-23,02417782,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417782,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90241,Marketed,2022-09-23,02417790,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417790,QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90242,Marketed,2022-09-23,02417804,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417804,QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90243,Marketed,2022-09-23,02417812,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417812,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
90244,Marketed,2022-09-23,02417820,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02417820,QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
92237,Marketed,2015-03-19,02438003,MINT-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02438003,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92238,Marketed,2015-03-19,02438011,MINT-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02438011,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92240,Marketed,2015-03-19,02438046,MINT-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02438046,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92241,Marketed,2015-03-19,02438054,MINT-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet,Oral,02438054,MINT-QUETIAPINE (quetiapine (quetiapine fumarate) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93276,Marketed,2016-09-07,02447193,BIO-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02447193,BIO-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) BIOMED PHARMA,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93699,Marketed,2020-10-21,02450860,ACH-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450860,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93700,Marketed,2020-10-21,02450879,ACH-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450879,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93701,Marketed,2020-10-21,02450887,ACH-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450887,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93702,Marketed,2021-01-21,02450895,ACH-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450895,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93703,Marketed,2020-10-29,02450909,ACH-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02450909,ACH-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) ACCORD HEALTHCARE INC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
94433,Marketed,2020-10-23,02457253,APO-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02457253,APO-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) APOTEX INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97646,Marketed,2022-11-09,02486237,NRA-QUETIAPINE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02486237,NRA-QUETIAPINE (quetiapine (quetiapine fumarate) 25 mg oral tablet) NORA PHARMA INC,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99126,Marketed,2021-07-28,02501643,APO-QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02501643,APO-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) APOTEX INC,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99987,Marketed,2021-07-20,02510677,NRA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510677,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99988,Marketed,2021-07-20,02510685,NRA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510685,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99989,Marketed,2021-07-20,02510693,NRA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510693,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99990,Marketed,2021-07-20,02510707,NRA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510707,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99991,Marketed,2021-07-20,02510715,NRA-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02510715,NRA-QUETIAPINE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) NORA PHARMA INC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100627,Marketed,2022-07-14,02516934,AG-QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516934,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000769,quetiapine (quetiapine fumarate) 25 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100628,Marketed,2023-01-31,02516942,AG-QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516942,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000767,quetiapine (quetiapine fumarate) 100 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100629,Marketed,2023-02-01,02516950,AG-QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516950,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 200 mg oral tablet) ANGITA PHARMA INC.,Active,9000768,quetiapine (quetiapine fumarate) 200 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100630,Marketed,2023-02-01,02516969,AG-QUETIAPINE FUMARATE,1.0,N05AH04,Quetiapine,Tablet (immediate release),Oral,02516969,AG-QUETIAPINE FUMARATE (quetiapine (quetiapine fumarate) 300 mg oral tablet) ANGITA PHARMA INC.,Active,9000954,quetiapine (quetiapine fumarate) 300 mg oral tablet,8000248,quetiapine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100885,Marketed,2022-04-27,02519607,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02519607,QUETIAPINE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100898,Marketed,2022-04-27,02519747,QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02519747,QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) JAMP PHARMA CORPORATION,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
100976,Marketed,2022-04-27,02520567,AG-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02520567,AG-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) ANGITA PHARMA INC.,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101136,Marketed,2022-04-07,02522217,MINT-QUETIAPINE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02522217,MINT-QUETIAPINE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) MINT PHARMACEUTICALS INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101719,Marketed,2023-03-17,02527928,M-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02527928,M-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001214,quetiapine (quetiapine fumarate) 50 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101720,Marketed,2023-03-17,02527936,M-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02527936,M-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001273,quetiapine (quetiapine fumarate) 150 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101721,Marketed,2023-03-17,02527944,M-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02527944,M-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001211,quetiapine (quetiapine fumarate) 200 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101722,Marketed,2023-03-17,02527952,M-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02527952,M-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001212,quetiapine (quetiapine fumarate) 300 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
101723,Marketed,2023-03-17,02527960,M-QUETIAPINE FUMARATE XR,1.0,N05AH04,Quetiapine,Tablet (extended-release),Oral,02527960,M-QUETIAPINE FUMARATE XR (quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet) MANTRA PHARMA INC,Active,9001213,quetiapine (quetiapine fumarate) 400 mg prolonged-release oral tablet,8000248,quetiapine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
82614,Marketed,2013-11-18,02340569,PMS-QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02340569,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000440,quinapril (quinapril hydrochloride) 10 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82615,Marketed,2013-11-18,02340577,PMS-QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02340577,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 20 mg oral tablet) PHARMASCIENCE INC,Active,9000441,quinapril (quinapril hydrochloride) 20 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82616,Marketed,2013-11-18,02340585,PMS-QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02340585,PMS-QUINAPRIL (quinapril (quinapril hydrochloride) 40 mg oral tablet) PHARMASCIENCE INC,Active,9000442,quinapril (quinapril hydrochloride) 40 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100684,Marketed,2023-12-19,02517450,JAMP QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02517450,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000440,quinapril (quinapril hydrochloride) 10 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100685,Marketed,2023-12-19,02517469,JAMP QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02517469,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000441,quinapril (quinapril hydrochloride) 20 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100686,Marketed,2023-12-19,02517477,JAMP QUINAPRIL,1.0,C09AA06,Quinapril,Tablet,Oral,02517477,JAMP QUINAPRIL (quinapril (quinapril hydrochloride) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000442,quinapril (quinapril hydrochloride) 40 mg oral tablet,8000170,quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89352,Marketed,2025-06-16,02408767,APO-QUINAPRIL/HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02408767,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89353,Marketed,2025-06-16,02408775,APO-QUINAPRIL/HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02408775,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9000815,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89354,Marketed,2025-06-16,02408783,APO-QUINAPRIL/HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02408783,APO-QUINAPRIL/HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96270,Marketed,2019-02-01,02473291,AURO-QUINAPRIL HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02473291,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) AURO PHARMA INC,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96271,Marketed,2019-02-01,02473305,AURO-QUINAPRIL HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02473305,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) AURO PHARMA INC,Active,9000815,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96273,Marketed,2019-02-01,02473321,AURO-QUINAPRIL HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02473321,AURO-QUINAPRIL HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) AURO PHARMA INC,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103639,Marketed,2025-03-18,02547430,JAMP QUINAPRIL / HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02547430,JAMP QUINAPRIL / HCTZ (hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000814,hydrochlorothiazide 12.5 mg and quinapril (quinapril hydrochloride) 10 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103640,Marketed,2025-03-18,02547449,JAMP QUINAPRIL / HCTZ,2.0,C09BA06,Quinapril and diuretics,Tablet,Oral,02547449,JAMP QUINAPRIL / HCTZ (hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001030,hydrochlorothiazide 25 mg and quinapril (quinapril hydrochloride) 20 mg oral tablet,8000262,hydrochlorothiazide and quinapril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
290,Marketed,2011-11-26,00021016,TEVA-QUININE,1.0,P01BC01,Quinine,Capsule,Oral,00021016,TEVA-QUININE (quinine sulfate 300 mg oral capsule) TEVA CANADA LIMITED,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
651,Marketed,2011-11-26,00021008,TEVA-QUININE,1.0,P01BC01,Quinine,Capsule,Oral,00021008,TEVA-QUININE (quinine sulfate 200 mg oral capsule) TEVA CANADA LIMITED,Active,9000039,quinine sulfate 200 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
38056,Marketed,2005-02-10,00695459,QUININE - ODAN,1.0,P01BC01,Quinine,Capsule,Oral,00695459,QUININE - ODAN (quinine sulfate 300 mg oral capsule) ODAN LABORATORIES LTD,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79680,Marketed,2020-06-22,02311216,PRO-QUININE - 200,1.0,P01BC01,Quinine,Capsule,Oral,02311216,PRO-QUININE - 200 (quinine sulfate 200 mg oral capsule) PRO DOC LIMITEE,Active,9000039,quinine sulfate 200 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79681,Marketed,2020-05-21,02311224,PRO-QUININE - 300,1.0,P01BC01,Quinine,Capsule,Oral,02311224,PRO-QUININE - 300 (quinine sulfate 300 mg oral capsule) PRO DOC LIMITEE,Active,9000040,quinine sulfate 300 mg oral capsule,8000029,quinine sulfate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
106161,Marketed,2025-10-30,02558351,VANFLYTA,1.0,L01EX11,Quizartinib,Tablet,Oral,02558351,VANFLYTA (quizartinib (quizartinib hydrochloride) 17.7 mg oral tablet) DAIICHI SANKYO PHARMA CANADA LIMITED,Active,9015289,quizartinib (quizartinib hydrochloride) 17.7 mg oral tablet,8002560,quizartinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,,,
67734,Marketed,2002-04-02,02243796,"PARIET, ENTERIC-COATED TABLET 10MG",1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02243796,"PARIET, ENTERIC-COATED TABLET 10MG (rabeprazole sodium 10 mg gastro-resistant tablet) JANSSEN INC",Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
67735,Marketed,2002-04-02,02243797,"PARIET, ENTERIC-COATED TABLET 20MG",1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02243797,"PARIET, ENTERIC-COATED TABLET 20MG (rabeprazole sodium 20 mg gastro-resistant tablet) JANSSEN INC",Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
79974,Marketed,2008-07-29,02314177,SANDOZ RABEPRAZOLE,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02314177,SANDOZ RABEPRAZOLE (rabeprazole sodium 10 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
79975,Marketed,2008-07-29,02314185,SANDOZ RABEPRAZOLE,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02314185,SANDOZ RABEPRAZOLE (rabeprazole sodium 20 mg gastro-resistant tablet) SANDOZ CANADA INCORPORATED,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
84166,Marketed,2019-05-30,02356511,RABEPRAZOLE EC,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02356511,RABEPRAZOLE EC (rabeprazole sodium 10 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
84167,Marketed,2019-05-30,02356538,RABEPRAZOLE EC,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02356538,RABEPRAZOLE EC (rabeprazole sodium 20 mg gastro-resistant tablet) SANIS HEALTH INC,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87107,Marketed,2012-06-10,02385449,RABEPRAZOLE,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02385449,RABEPRAZOLE (rabeprazole sodium 10 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000980,rabeprazole sodium 10 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
87108,Marketed,2012-06-10,02385457,RABEPRAZOLE,1.0,A02BC04,Rabeprazole,Tablet (enteric-coated),Oral,02385457,RABEPRAZOLE (rabeprazole sodium 20 mg gastro-resistant tablet) SIVEM PHARMACEUTICALS ULC,Active,9000981,rabeprazole sodium 20 mg gastro-resistant tablet,8000314,rabeprazole,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
97288,Marketed,2020-04-06,02482436,KAMRAB,1.0,J06BB05,Rabies immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,
97677,Marketed,2019-07-02,02486571,HYPERRAB,1.0,J06BB05,Rabies immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,
46832,Marketed,2006-04-12,01908286,IMOVAX RABIES,1.0,J07BG01,"Rabies, inactivated, whole virus",Powder for suspension,Intramuscular,,,,,,,,,,,,,,,,
75308,Marketed,2021-01-14,02267667,RABAVERT,1.0,J07BG01,"Rabies, inactivated, whole virus",Powder for solution,Intramuscular,,,,,,,,,,,,,,,,
90297,Marketed,2018-07-26,02418398,XOFIGO,1.0,V10XX03,Radium (223ra) dichloride,Solution,Intravenous,,,,,,,,,,,,,,,,
62480,Marketed,1998-11-20,02239028,EVISTA,1.0,G03XC01,Raloxifene,Tablet,Oral,02239028,EVISTA (raloxifene hydrochloride 60 mg oral tablet) ELI LILLY CANADA INC,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76475,Marketed,2009-03-31,02279215,APO-RALOXIFENE,1.0,G03XC01,Raloxifene,Tablet,Oral,02279215,APO-RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) APOTEX INC,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84388,Marketed,2020-04-16,02358840,ACT RALOXIFENE,1.0,G03XC01,Raloxifene,Tablet,Oral,02358840,ACT RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) TEVA CANADA LIMITED,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102937,Marketed,2024-06-28,02540681,JAMP RALOXIFENE,1.0,G03XC01,Raloxifene,Tablet,Oral,02540681,JAMP RALOXIFENE (raloxifene hydrochloride 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003333,raloxifene hydrochloride 60 mg oral tablet,8001682,raloxifene,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78722,Marketed,2009-03-05,02301881,ISENTRESS,1.0,J05AJ01,Raltegravir,Tablet,Oral,02301881,ISENTRESS (raltegravir (raltegravir potassium) 400 mg oral tablet) MERCK CANADA INC,Active,9004356,raltegravir (raltegravir potassium) 400 mg oral tablet,8001224,raltegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95353,Marketed,2017-09-11,02465337,ISENTRESS HD,1.0,J05AJ01,Raltegravir,Tablet,Oral,02465337,ISENTRESS HD (raltegravir (raltegravir potassium) 600 mg oral tablet) MERCK CANADA INC,Active,9012590,raltegravir (raltegravir potassium) 600 mg oral tablet,8001224,raltegravir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
47482,Marketed,2021-12-08,02229566,TOMUDEX,1.0,L01BA03,Raltitrexed,Powder for solution,Intravenous,02229566,TOMUDEX (raltitrexed 2 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014637,raltitrexed 2 mg per vial powder for solution for injection,8001225,raltitrexed,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
43308,Marketed,2021-01-11,02221829,ALTACE,1.0,C09AA05,Ramipril,Capsule,Oral,02221829,"ALTACE (ramipril 1.25 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
43309,Marketed,2021-01-11,02221837,ALTACE,1.0,C09AA05,Ramipril,Capsule,Oral,02221837,"ALTACE (ramipril 2.5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
43310,Marketed,2021-01-11,02221845,ALTACE,1.0,C09AA05,Ramipril,Capsule,Oral,02221845,"ALTACE (ramipril 5 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
43311,Marketed,2021-01-11,02221853,ALTACE,1.0,C09AA05,Ramipril,Capsule,Oral,02221853,"ALTACE (ramipril 10 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72255,Marketed,2010-05-27,02247945,TEVA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02247945,TEVA-RAMIPRIL (ramipril 2.5 mg oral capsule) TEVA CANADA LIMITED,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72256,Marketed,2010-05-27,02247946,TEVA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02247946,TEVA-RAMIPRIL (ramipril 5 mg oral capsule) TEVA CANADA LIMITED,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72257,Marketed,2010-05-27,02247947,TEVA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02247947,TEVA-RAMIPRIL (ramipril 10 mg oral capsule) TEVA CANADA LIMITED,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73644,Marketed,2006-12-12,02251515,APO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02251515,APO-RAMIPRIL (ramipril 1.25 mg oral capsule) APOTEX INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73646,Marketed,2006-12-12,02251531,APO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02251531,APO-RAMIPRIL (ramipril 2.5 mg oral capsule) APOTEX INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73648,Marketed,2006-12-12,02251574,APO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02251574,APO-RAMIPRIL (ramipril 5 mg oral capsule) APOTEX INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
73650,Marketed,2006-12-12,02251582,APO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02251582,APO-RAMIPRIL (ramipril 10 mg oral capsule) APOTEX INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74047,Marketed,2017-11-13,02255316,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02255316,RAMIPRIL (ramipril 2.5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74048,Marketed,2017-11-03,02255324,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02255324,RAMIPRIL (ramipril 5 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
74051,Marketed,2017-11-03,02255332,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02255332,RAMIPRIL (ramipril 10 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77332,Marketed,2018-04-26,02287927,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02287927,RAMIPRIL (ramipril 2.5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77334,Marketed,2018-04-26,02287935,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02287935,RAMIPRIL (ramipril 5 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
77335,Marketed,2018-04-26,02287943,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02287943,RAMIPRIL (ramipril 10 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79402,Marketed,2018-04-26,02308363,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02308363,RAMIPRIL (ramipril 1.25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79569,Marketed,2011-11-25,02310023,PRO-RAMIPRIL - 1.25,1.0,C09AA05,Ramipril,Capsule,Oral,02310023,PRO-RAMIPRIL - 1.25 (ramipril 1.25 mg oral capsule) PRO DOC LIMITEE,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79571,Marketed,2011-11-25,02310066,PRO-RAMIPRIL - 2.5,1.0,C09AA05,Ramipril,Capsule,Oral,02310066,PRO-RAMIPRIL - 2.5 (ramipril 2.5 mg oral capsule) PRO DOC LIMITEE,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79574,Marketed,2011-11-25,02310074,PRO-RAMIPRIL - 5,1.0,C09AA05,Ramipril,Capsule,Oral,02310074,PRO-RAMIPRIL - 5 (ramipril 5 mg oral capsule) PRO DOC LIMITEE,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79575,Marketed,2011-11-25,02310104,PRO-RAMIPRIL - 10,1.0,C09AA05,Ramipril,Capsule,Oral,02310104,PRO-RAMIPRIL - 10 (ramipril 10 mg oral capsule) PRO DOC LIMITEE,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79613,Marketed,2020-02-10,02310503,TARO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02310503,TARO-RAMIPRIL (ramipril 1.25 mg oral capsule) SUN PHARMA CANADA INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79614,Marketed,2020-02-10,02310511,TARO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02310511,TARO-RAMIPRIL (ramipril 2.5 mg oral capsule) SUN PHARMA CANADA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79615,Marketed,2020-02-04,02310538,TARO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02310538,TARO-RAMIPRIL (ramipril 5 mg oral capsule) SUN PHARMA CANADA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
79616,Marketed,2020-02-04,02310546,TARO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02310546,TARO-RAMIPRIL (ramipril 10 mg oral capsule) SUN PHARMA CANADA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81078,Marketed,2009-05-01,02325381,APO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02325381,APO-RAMIPRIL (ramipril 15 mg oral capsule) APOTEX INC,Active,9001172,ramipril 15 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81684,Marketed,2015-09-01,02331128,JAMP-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02331128,JAMP-RAMIPRIL (ramipril 2.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81685,Marketed,2015-09-01,02331136,JAMP-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02331136,JAMP-RAMIPRIL (ramipril 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81686,Marketed,2015-09-01,02331144,JAMP-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02331144,JAMP-RAMIPRIL (ramipril 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86019,Marketed,2016-01-06,02374846,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02374846,RAMIPRIL (ramipril 2.5 mg oral capsule) SANIS HEALTH INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86020,Marketed,2016-01-06,02374854,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02374854,RAMIPRIL (ramipril 5 mg oral capsule) SANIS HEALTH INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
86021,Marketed,2016-01-06,02374862,RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02374862,RAMIPRIL (ramipril 10 mg oral capsule) SANIS HEALTH INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87297,Marketed,2012-09-13,02387387,AURO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02387387,AURO-RAMIPRIL (ramipril 1.25 mg oral capsule) AURO PHARMA INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87298,Marketed,2012-09-13,02387395,AURO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02387395,AURO-RAMIPRIL (ramipril 2.5 mg oral capsule) AURO PHARMA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87299,Marketed,2012-09-13,02387409,AURO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02387409,AURO-RAMIPRIL (ramipril 5 mg oral capsule) AURO PHARMA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87300,Marketed,2012-09-13,02387417,AURO-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02387417,AURO-RAMIPRIL (ramipril 10 mg oral capsule) AURO PHARMA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90505,Marketed,2015-01-09,02420465,MAR-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02420465,MAR-RAMIPRIL (ramipril 2.5 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90506,Marketed,2015-01-09,02420473,MAR-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02420473,MAR-RAMIPRIL (ramipril 5 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90507,Marketed,2015-01-09,02420481,MAR-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02420481,MAR-RAMIPRIL (ramipril 10 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90508,Marketed,2014-09-10,02420503,MAR-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02420503,MAR-RAMIPRIL (ramipril 15 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9001172,ramipril 15 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90594,Marketed,2014-03-17,02421305,MINT-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02421305,MINT-RAMIPRIL (ramipril 2.5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90595,Marketed,2014-03-17,02421313,MINT-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02421313,MINT-RAMIPRIL (ramipril 5 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90596,Marketed,2014-03-17,02421321,MINT-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02421321,MINT-RAMIPRIL (ramipril 10 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95770,Marketed,2018-04-16,02469057,PHARMA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02469057,PHARMA-RAMIPRIL (ramipril 1.25 mg oral capsule) PHARMASCIENCE INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95771,Marketed,2018-04-16,02469065,PHARMA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02469065,PHARMA-RAMIPRIL (ramipril 2.5 mg oral capsule) PHARMASCIENCE INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95772,Marketed,2018-04-16,02469073,PHARMA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02469073,PHARMA-RAMIPRIL (ramipril 5 mg oral capsule) PHARMASCIENCE INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95773,Marketed,2018-04-16,02469081,PHARMA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02469081,PHARMA-RAMIPRIL (ramipril 10 mg oral capsule) PHARMASCIENCE INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96784,Marketed,2018-09-06,02477572,AG-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02477572,AG-RAMIPRIL (ramipril 2.5 mg oral capsule) ANGITA PHARMA INC.,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96785,Marketed,2018-09-06,02477580,AG-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02477580,AG-RAMIPRIL (ramipril 5 mg oral capsule) ANGITA PHARMA INC.,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96786,Marketed,2018-09-06,02477599,AG-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02477599,AG-RAMIPRIL (ramipril 10 mg oral capsule) ANGITA PHARMA INC.,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97640,Marketed,2019-09-20,02486172,NRA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02486172,NRA-RAMIPRIL (ramipril 2.5 mg oral capsule) NORA PHARMA INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97641,Marketed,2019-09-20,02486180,NRA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02486180,NRA-RAMIPRIL (ramipril 5 mg oral capsule) NORA PHARMA INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97642,Marketed,2019-09-20,02486199,NRA-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02486199,NRA-RAMIPRIL (ramipril 10 mg oral capsule) NORA PHARMA INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103904,Marketed,2025-10-03,02550202,PMSC-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02550202,PMSC-RAMIPRIL (ramipril 1.25 mg oral capsule) PHARMASCIENCE INC,Active,9000727,ramipril 1.25 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103905,Marketed,2025-10-03,02550210,PMSC-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02550210,PMSC-RAMIPRIL (ramipril 2.5 mg oral capsule) PHARMASCIENCE INC,Active,9000722,ramipril 2.5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103906,Marketed,2025-10-03,02550229,PMSC-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02550229,PMSC-RAMIPRIL (ramipril 5 mg oral capsule) PHARMASCIENCE INC,Active,9000723,ramipril 5 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
103907,Marketed,2025-10-03,02550237,PMSC-RAMIPRIL,1.0,C09AA05,Ramipril,Capsule,Oral,02550237,PMSC-RAMIPRIL (ramipril 10 mg oral capsule) PHARMASCIENCE INC,Active,9000712,ramipril 10 mg oral capsule,8000239,ramipril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
76877,Marketed,2025-08-01,02283158,ALTACE HCT,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02283158,"ALTACE HCT (hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001178,hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76878,Marketed,2021-03-03,02283166,ALTACE HCT,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02283166,"ALTACE HCT (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82765,Marketed,2010-02-03,02342154,PMS-RAMIPRIL-HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02342154,PMS-RAMIPRIL-HCTZ (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) PHARMASCIENCE INC,Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82767,Marketed,2010-02-03,02342170,PMS-RAMIPRIL-HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02342170,PMS-RAMIPRIL-HCTZ (hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet) PHARMASCIENCE INC,Active,9001179,hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93527,Marketed,2023-11-04,02449439,TARO-RAMIPRIL HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02449439,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 2.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001177,hydrochlorothiazide 12.5 mg and ramipril 2.5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93528,Marketed,2023-12-12,02449447,TARO-RAMIPRIL HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02449447,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001178,hydrochlorothiazide 12.5 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93529,Marketed,2023-12-12,02449455,TARO-RAMIPRIL HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02449455,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001176,hydrochlorothiazide 12.5 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93530,Marketed,2023-12-12,02449463,TARO-RAMIPRIL HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02449463,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 25 mg and ramipril 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001180,hydrochlorothiazide 25 mg and ramipril 5 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93531,Marketed,2023-11-04,02449471,TARO-RAMIPRIL HCTZ,2.0,C09BA05,Ramipril and diuretics,Tablet,Oral,02449471,TARO-RAMIPRIL HCTZ (hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001179,hydrochlorothiazide 25 mg and ramipril 10 mg oral tablet,8000368,hydrochlorothiazide and ramipril,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92855,Marketed,2015-09-10,02443805,CYRAMZA,1.0,L01FG02,Ramucirumab,Solution,Intravenous,77700903,CYRAMZA (ramucirumab 100 mg per 10 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013316,ramucirumab 100 mg per 10 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92855,Marketed,2015-09-10,02443805,CYRAMZA,1.0,L01FG02,Ramucirumab,Solution,Intravenous,77700904,CYRAMZA (ramucirumab 500 mg per 50 mL solution for injection vial) ELI LILLY CANADA INC,Active,9013317,ramucirumab 500 mg per 50 mL solution for injection vial,8001917,ramucirumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
78217,Marketed,2014-05-29,02296810,LUCENTIS,1.0,S01LA04,Ranibizumab,Solution,Intravitreal,02296810,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
91026,Marketed,2014-09-18,02425629,LUCENTIS,1.0,S01LA04,Ranibizumab,Solution,Intravitreal,02425629,LUCENTIS (ranibizumab 10 mg per mL solution for injection 0.165 mL syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012753,ranibizumab 10 mg per mL solution for injection 0.165 mL syringe,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101483,Marketed,2025-11-07,02525852,MELVIZO,1.0,S01LA04,Ranibizumab,Solution,Intravitreal,02525852,"MELVIZO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) SAMSUNG BIOEPIS CO., LTD",Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
103083,Marketed,2024-02-26,02542250,RANOPTO,1.0,S01LA04,Ranibizumab,Solution,Intravitreal,02542250,RANOPTO (ranibizumab 10 mg per mL solution for injection 0.23 mL vial) TEVA CANADA LIMITED,Active,9012754,ranibizumab 10 mg per mL solution for injection 0.23 mL vial,8001303,ranibizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
77884,Marketed,2024-08-01,02293471,MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION,1.0,A02BA02,Ranitidine,Tablet,Oral,02293471,MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) PHARMASCIENCE INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92844,Marketed,2018-11-09,02443708,MAR-RANITIDINE,1.0,A02BA02,Ranitidine,Tablet,Oral,02443708,MAR-RANITIDINE (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92845,Marketed,2018-11-09,02443716,MAR-RANITIDINE,1.0,A02BA02,Ranitidine,Tablet,Oral,02443716,MAR-RANITIDINE (ranitidine (ranitidine hydrochloride) 300 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000283,ranitidine (ranitidine hydrochloride) 300 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101547,Marketed,2022-10-07,02526379,MINT-RANITIDINE,1.0,A02BA02,Ranitidine,Tablet,Oral,02526379,MINT-RANITIDINE (ranitidine (ranitidine hydrochloride) 150 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000282,ranitidine (ranitidine hydrochloride) 150 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101548,Marketed,2022-10-07,02526387,MINT-RANITIDINE,1.0,A02BA02,Ranitidine,Tablet,Oral,02526387,MINT-RANITIDINE (ranitidine (ranitidine hydrochloride) 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000283,ranitidine (ranitidine hydrochloride) 300 mg oral tablet,8000120,ranitidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99945,Marketed,2021-05-03,02510219,CORZYNA,1.0,C01EB18,Ranolazine,Tablet (extended-release),Oral,02510219,CORZYNA (ranolazine 500 mg prolonged-release oral tablet) KYE PHARMACEUTICALS INC.,Active,9014539,ranolazine 500 mg prolonged-release oral tablet,8002371,ranolazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
99946,Marketed,2023-05-24,02510227,CORZYNA,1.0,C01EB18,Ranolazine,Tablet (extended-release),Oral,02510227,CORZYNA (ranolazine 1000 mg prolonged-release oral tablet) KYE PHARMACEUTICALS INC.,Active,9014855,ranolazine 1000 mg prolonged-release oral tablet,8002371,ranolazine,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77019,Marketed,2021-06-03,02284642,AZILECT,1.0,N04BD02,Rasagiline,Tablet,Oral,02284642,AZILECT (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77020,Marketed,2021-06-03,02284650,AZILECT,1.0,N04BD02,Rasagiline,Tablet,Oral,02284650,AZILECT (rasagiline (rasagiline mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88948,Marketed,2016-01-12,02404680,APO-RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02404680,APO-RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) APOTEX INC,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88949,Marketed,2016-01-12,02404699,APO-RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02404699,APO-RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) APOTEX INC,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90300,Marketed,2016-05-30,02418436,TEVA-RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02418436,TEVA-RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) TEVA CANADA LIMITED,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
90301,Marketed,2016-05-30,02418444,TEVA-RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02418444,TEVA-RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98198,Marketed,2020-09-04,02491974,JAMP RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02491974,JAMP RASAGILINE (rasagiline (rasagiline mesylate) 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004213,rasagiline (rasagiline mesylate) 0.5 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98199,Marketed,2020-09-04,02491982,JAMP RASAGILINE,1.0,N04BD02,Rasagiline,Tablet,Oral,02491982,JAMP RASAGILINE (rasagiline (rasagiline mesylate) 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004214,rasagiline (rasagiline mesylate) 1 mg oral tablet,8001683,rasagiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
72766,Marketed,2006-11-03,02248416,FASTURTEC,1.0,V03AF07,Rasburicase,Powder for solution,Intravenous,02248416,FASTURTEC (rasburicase 1.5 mg per vial powder for solution for injection with diluent solution) SANOFI-AVENTIS CANADA INC,Active,9013318,rasburicase 1.5 mg per vial powder for solution for injection with diluent solution,8001918,rasburicase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102243,Marketed,2023-04-19,02533448,ULTOMIRIS,1.0,L04AJ02,Ravulizumab,Solution,Intravenous,02533448,ULTOMIRIS (ravulizumab 300 mg per 3 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014857,ravulizumab 300 mg per 3 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102244,Marketed,2023-04-19,02533456,ULTOMIRIS,1.0,L04AJ02,Ravulizumab,Solution,Intravenous,02533456,ULTOMIRIS (ravulizumab 1100 mg per 11 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9014856,ravulizumab 1100 mg per 11 mL solution for injection vial,8002392,ravulizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88820,Marketed,2013-04-02,02403390,STIVARGA,1.0,L01EX05,Regorafenib,Tablet,Oral,02403390,STIVARGA (regorafenib 40 mg oral tablet) BAYER INC,Active,9005215,regorafenib 40 mg oral tablet,8001919,regorafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103073,Marketed,2025-11-05,02542137,ORGOVYX,1.0,L02BX04,Relugolix,Tablet,Oral,02542137,ORGOVYX (relugolix 120 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015006,relugolix 120 mg oral tablet,8002495,relugolix,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
103029,Marketed,2025-10-28,02541742,MYFEMBREE,3.0,H01CC54,"Relugolix, estradiol and norethisterone",Tablet,Oral,02541742,MYFEMBREE (estradiol 1 mg and norethindrone acetate 0.5 mg and relugolix 40 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9015016,estradiol 1 mg and norethindrone acetate 0.5 mg and relugolix 40 mg oral tablet,8002499,estradiol and norethindrone and relugolix,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99173,Marketed,2020-10-16,02502143,VEKLURY,1.0,J05AB16,Remdesivir,Powder for solution,Intravenous,02502143,VEKLURY (remdesivir 100 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9014406,remdesivir 100 mg per vial powder for solution for injection,8002350,remdesivir,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
85131,Marketed,2011-09-27,02366460,REMIFENTANIL HYDROCHLORIDE FOR INJECTION,1.0,N01AH06,Remifentanil,Powder for solution,Intravenous,02366460,REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection) STERIMAX INC,Active,9004933,remifentanil (remifentanil hydrochloride) 1 mg per vial powder for solution for injection,8001920,remifentanil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
85132,Marketed,2011-09-29,02366479,REMIFENTANIL HYDROCHLORIDE FOR INJECTION,1.0,N01AH06,Remifentanil,Powder for solution,Intravenous,02366479,REMIFENTANIL HYDROCHLORIDE FOR INJECTION (remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection) STERIMAX INC,Active,9004935,remifentanil (remifentanil hydrochloride) 2 mg per vial powder for solution for injection,8001920,remifentanil,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
84011,Marketed,2023-03-07,02354926,JAMP REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02354926,JAMP REPAGLINIDE (repaglinide 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84012,Marketed,2023-03-07,02354934,JAMP REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02354934,JAMP REPAGLINIDE (repaglinide 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84013,Marketed,2023-03-07,02354942,JAMP REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02354942,JAMP REPAGLINIDE (repaglinide 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84259,Marketed,2011-02-17,02357453,SANDOZ REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02357453,SANDOZ REPAGLINIDE (repaglinide 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84260,Marketed,2011-02-17,02357461,SANDOZ REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02357461,SANDOZ REPAGLINIDE (repaglinide 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84261,Marketed,2011-02-17,02357488,SANDOZ REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02357488,SANDOZ REPAGLINIDE (repaglinide 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90056,Marketed,2016-12-16,02415968,REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02415968,REPAGLINIDE (repaglinide 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90057,Marketed,2016-12-16,02415976,REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02415976,REPAGLINIDE (repaglinide 1 mg oral tablet) PRO DOC LIMITEE,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90058,Marketed,2016-12-16,02415984,REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02415984,REPAGLINIDE (repaglinide 2 mg oral tablet) PRO DOC LIMITEE,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90896,Marketed,2014-04-30,02424258,AURO-REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02424258,AURO-REPAGLINIDE (repaglinide 0.5 mg oral tablet) AURO PHARMA INC,Active,9000856,repaglinide 0.5 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90897,Marketed,2014-04-30,02424266,AURO-REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02424266,AURO-REPAGLINIDE (repaglinide 1 mg oral tablet) AURO PHARMA INC,Active,9000857,repaglinide 1 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90898,Marketed,2014-04-30,02424274,AURO-REPAGLINIDE,1.0,A10BX02,Repaglinide,Tablet,Oral,02424274,AURO-REPAGLINIDE (repaglinide 2 mg oral tablet) AURO PHARMA INC,Active,9000858,repaglinide 2 mg oral tablet,8000273,repaglinide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94330,Marketed,2016-12-19,02456419,CINQAIR,1.0,R03DX08,Reslizumab,Solution,Intravenous,02456419,CINQAIR (reslizumab 100 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9012406,reslizumab 100 mg per 10 mL solution for injection vial,8001067,reslizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102891,Marketed,2023-09-06,02540207,AREXVY,1.0,J07BX05,Respiratory syncytial virus vaccine,Powder for suspension,Intramuscular,,,,,,,,,,,,,,,,
103244,Marketed,2024-05-22,02544040,ABRYSVO,2.0,J07BX05,Respiratory syncytial virus vaccine,"Kit,Powder for solution",Intramuscular,,,,,,,,,,,,,,,,
104399,Marketed,2025-08-14,02555239,ZYNYZ,1.0,L01FF10,Retifanlimab,Solution,Intravenous,02555239,ZYNYZ (retifanlimab 500 mg per 20 mL solution for injection vial) INCYTE CORPORATION,Active,9015324,retifanlimab 500 mg per 20 mL solution for injection vial,8002561,retifanlimab,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
34574,Marketed,2020-09-30,02170140,VIRAZOLE,1.0,J05AP01,Ribavirin,"Aerosol,Powder for solution",Inhalation,02170140,"VIRAZOLE (ribavirin 6 g per vial powder for nebulizer solution) BAUSCH HEALTH, CANADA INC.",Active,9002980,ribavirin 6 g per vial powder for nebulizer solution,8001517,ribavirin,447694001,Inhalation,385201005,Powder for nebulizer solution,733026001,Vial (unit of presentation),1.0,,
96295,Marketed,2018-04-27,02473569,KISQALI,1.0,L01EF02,Ribociclib,Tablet,Oral,02473569,KISQALI (ribociclib (ribociclib succinate) 200 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012857,ribociclib (ribociclib succinate) 200 mg oral tablet,8001518,ribociclib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18081,Marketed,2005-02-16,02063786,MYCOBUTIN,1.0,J04AB04,Rifabutin,Capsule,Oral,02063786,MYCOBUTIN (rifabutin 150 mg oral capsule) PFIZER CANADA ULC,Active,9002866,rifabutin 150 mg oral capsule,8001226,rifabutin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2863,Marketed,2019-07-02,00343617,ROFACT,1.0,J04AB02,Rifampicin,Capsule,Oral,00343617,"ROFACT (rifampin 300 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001796,rifampin 300 mg oral capsule,8001227,rifampin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
2866,Marketed,2019-07-02,00393444,ROFACT,1.0,J04AB02,Rifampicin,Capsule,Oral,00393444,"ROFACT (rifampin 150 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9001795,rifampin 150 mg oral capsule,8001227,rifampin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89537,Marketed,2013-11-07,02410702,ZAXINE,1.0,A07AA11,Rifaximin,Tablet,Oral,02410702,ZAXINE (rifaximin 550 mg oral tablet) SALIX PHARMACEUTICALS INC,Active,9005360,rifaximin 550 mg oral tablet,8001921,rifaximin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85574,Marketed,2014-09-09,02370603,EDURANT,1.0,J05AG05,Rilpivirine,Tablet,Oral,02370603,EDURANT (rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet) JANSSEN INC,Active,9004920,rilpivirine (rilpivirine hydrochloride) 25 mg oral tablet,8001228,rilpivirine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66576,Marketed,2007-01-08,02242763,RILUTEK,1.0,N07XX02,Riluzole,Tablet,Oral,02242763,RILUTEK (riluzole 50 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83784,Marketed,2022-09-23,02352583,APO-RILUZOLE,1.0,N07XX02,Riluzole,Tablet,Oral,02352583,APO-RILUZOLE (riluzole 50 mg oral tablet) APOTEX INC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87574,Marketed,2012-10-23,02390299,MYLAN-RILUZOLE,1.0,N07XX02,Riluzole,Tablet,Oral,02390299,MYLAN-RILUZOLE (riluzole 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003531,riluzole 50 mg oral tablet,8001419,riluzole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103205,Marketed,2024-03-25,02543605,NURTEC ODT,1.0,N02CD06,Rimegepant,Tablet (orally disintegrating),Oral,02543605,NURTEC ODT (rimegepant (rimegepant sulfate) 75 mg orodispersible tablet) PFIZER CANADA ULC,Active,9015038,rimegepant (rimegepant sulfate) 75 mg orodispersible tablet,8002507,rimegepant,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),1.0,,
89742,Marketed,2013-09-25,02412764,ADEMPAS,1.0,C02KX05,Riociguat,Tablet,Oral,02412764,ADEMPAS (riociguat 0.5 mg oral tablet) BAYER INC,Active,9005338,riociguat 0.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89743,Marketed,2013-09-25,02412772,ADEMPAS,1.0,C02KX05,Riociguat,Tablet,Oral,02412772,ADEMPAS (riociguat 1 mg oral tablet) BAYER INC,Active,9005340,riociguat 1 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89745,Marketed,2013-09-25,02412799,ADEMPAS,1.0,C02KX05,Riociguat,Tablet,Oral,02412799,ADEMPAS (riociguat 1.5 mg oral tablet) BAYER INC,Active,9005339,riociguat 1.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89746,Marketed,2013-09-25,02412802,ADEMPAS,1.0,C02KX05,Riociguat,Tablet,Oral,02412802,ADEMPAS (riociguat 2 mg oral tablet) BAYER INC,Active,9005342,riociguat 2 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89747,Marketed,2013-09-25,02412810,ADEMPAS,1.0,C02KX05,Riociguat,Tablet,Oral,02412810,ADEMPAS (riociguat 2.5 mg oral tablet) BAYER INC,Active,9005341,riociguat 2.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102253,Marketed,2024-04-29,02533545,SANDOZ RIOCIGUAT,1.0,C02KX05,Riociguat,Tablet,Oral,02533545,SANDOZ RIOCIGUAT (riociguat 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005338,riociguat 0.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102255,Marketed,2024-04-29,02533561,SANDOZ RIOCIGUAT,1.0,C02KX05,Riociguat,Tablet,Oral,02533561,SANDOZ RIOCIGUAT (riociguat 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005340,riociguat 1 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102256,Marketed,2024-04-29,02533588,SANDOZ RIOCIGUAT,1.0,C02KX05,Riociguat,Tablet,Oral,02533588,SANDOZ RIOCIGUAT (riociguat 1.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005339,riociguat 1.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102257,Marketed,2024-04-29,02533618,SANDOZ RIOCIGUAT,1.0,C02KX05,Riociguat,Tablet,Oral,02533618,SANDOZ RIOCIGUAT (riociguat 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005341,riociguat 2.5 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102258,Marketed,2024-04-29,02533596,SANDOZ RIOCIGUAT,1.0,C02KX05,Riociguat,Tablet,Oral,02533596,SANDOZ RIOCIGUAT (riociguat 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005342,riociguat 2 mg oral tablet,8001922,riociguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99049,Marketed,2020-12-10,02500833,QINLOCK,1.0,L01EX19,Ripretinib,Tablet,Oral,02500833,QINLOCK (ripretinib 50 mg oral tablet) DECIPHERA PHARMACEUTICALS. LLC,Active,9014434,ripretinib 50 mg oral tablet,8002359,ripretinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100434,Marketed,2021-05-19,02514931,EVRYSDI,1.0,M09AX10,Risdiplam,Powder for solution,Oral,02514931,EVRYSDI (risdiplam 0.75 mg per mL oral solution) HOFFMANN-LA ROCHE LIMITED,Active,9014555,risdiplam 0.75 mg per mL oral solution,8002377,risdiplam,26643006,Oral,385023001,Oral solution,,,1.0,,
106378,Marketed,2025-11-27,02560747,EVRYSDI,1.0,M09AX10,Risdiplam,Tablet,Oral,02560747,EVRYSDI (risdiplam 5 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9015325,risdiplam 5 mg oral tablet,8002377,risdiplam,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
71123,Marketed,2025-03-05,02246896,ACTONEL,1.0,M05BA07,Risedronic acid,Tablet,Oral,02246896,ACTONEL (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) ABBVIE CORPORATION,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78367,Marketed,2011-06-03,02298376,TEVA-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02298376,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000912,risedronate sodium 5 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78368,Marketed,2011-06-03,02298384,TEVA-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02298384,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 30 mg oral tablet) TEVA CANADA LIMITED,Active,9000868,risedronate sodium 30 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78369,Marketed,2011-06-03,02298392,TEVA-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02298392,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 35 mg oral tablet) TEVA CANADA LIMITED,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78754,Marketed,2010-07-27,02302209,PMS-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02302209,PMS-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) PHARMASCIENCE INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80233,Marketed,2025-05-05,02316838,ACTONEL,1.0,M05BA07,Risedronic acid,Tablet,Oral,02316838,ACTONEL (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) ABBVIE CORPORATION,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81259,Marketed,2010-07-28,02327295,SANDOZ RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02327295,SANDOZ RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82662,Marketed,2010-07-28,02341077,RIVA-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02341077,RIVA-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83286,Marketed,2020-09-15,02347474,RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02347474,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) PRO DOC LIMITEE,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83888,Marketed,2012-06-20,02353687,APO-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02353687,APO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) APOTEX INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85541,Marketed,2025-02-13,02370255,RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02370255,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) SANIS HEALTH INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85557,Marketed,2025-05-22,02370417,ACTONEL DR,1.0,M05BA07,Risedronic acid,Tablet (delayed-release),Oral,02370417,ACTONEL DR (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg gastro-resistant tablet) ABBVIE CORPORATION,Active,9001353,risedronate sodium 35 mg gastro-resistant tablet,8000278,risedronate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
86354,Marketed,2012-05-17,02377721,APO-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02377721,APO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) APOTEX INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89102,Marketed,2013-07-08,02406306,AURO-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02406306,AURO-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg oral tablet) AURO PHARMA INC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89602,Marketed,2024-02-01,02411407,RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02411407,RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 35 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001008,risedronate sodium 35 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89845,Marketed,2013-10-10,02413809,TEVA-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02413809,TEVA-RISEDRONATE (risedronate sodium (risedronate sodium monohydrate) 150 mg oral tablet) TEVA CANADA LIMITED,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90889,Marketed,2014-05-28,02424177,PMS-RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02424177,PMS-RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) PHARMASCIENCE INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98324,Marketed,2023-09-08,02493268,AA-RISEDRONATE DR,1.0,M05BA07,Risedronic acid,Tablet (delayed-release),Oral,02493268,AA-RISEDRONATE DR (risedronate sodium (risedronate sodium hemipentahydrate) 35 mg gastro-resistant tablet) AA PHARMA INC,Active,9001353,risedronate sodium 35 mg gastro-resistant tablet,8000278,risedronate,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
101771,Marketed,2022-10-05,02528460,RISEDRONATE,1.0,M05BA07,Risedronic acid,Tablet,Oral,02528460,RISEDRONATE (risedronate sodium (risedronate sodium hemipentahydrate) 150 mg oral tablet) SANIS HEALTH INC,Active,9001260,risedronate sodium 150 mg oral tablet,8000278,risedronate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73690,Marketed,2006-07-05,02252007,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252007,PMS-RISPERIDONE (risperidone 0.25 mg oral tablet) PHARMASCIENCE INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73691,Marketed,2006-07-05,02252015,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252015,PMS-RISPERIDONE (risperidone 0.5 mg oral tablet) PHARMASCIENCE INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73692,Marketed,2006-07-05,02252023,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252023,PMS-RISPERIDONE (risperidone 1 mg oral tablet) PHARMASCIENCE INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73693,Marketed,2006-07-05,02252031,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252031,PMS-RISPERIDONE (risperidone 2 mg oral tablet) PHARMASCIENCE INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73694,Marketed,2006-07-05,02252058,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252058,PMS-RISPERIDONE (risperidone 3 mg oral tablet) PHARMASCIENCE INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73695,Marketed,2006-07-05,02252066,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02252066,PMS-RISPERIDONE (risperidone 4 mg oral tablet) PHARMASCIENCE INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74089,Marketed,2004-09-08,02255707,RISPERDAL CONSTA,1.0,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02255707,RISPERDAL CONSTA (risperidone 25 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006473,risperidone 25 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
74091,Marketed,2004-09-08,02255723,RISPERDAL CONSTA,1.0,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02255723,RISPERDAL CONSTA (risperidone 37.5 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006472,risperidone 37.5 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
74093,Marketed,2004-09-08,02255758,RISPERDAL CONSTA,1.0,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02255758,RISPERDAL CONSTA (risperidone 50 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006474,risperidone 50 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
74963,Marketed,2022-10-26,02264196,TEVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02264196,TEVA-RISPERIDONE (risperidone 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74964,Marketed,2022-10-26,02264218,TEVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02264218,TEVA-RISPERIDONE (risperidone 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74965,Marketed,2022-10-26,02264226,TEVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02264226,TEVA-RISPERIDONE (risperidone 3 mg oral tablet) TEVA CANADA LIMITED,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74966,Marketed,2022-10-26,02264234,TEVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02264234,TEVA-RISPERIDONE (risperidone 4 mg oral tablet) TEVA CANADA LIMITED,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76481,Marketed,2006-07-05,02279266,PMS-RISPERIDONE,1.0,N05AX08,Risperidone,Solution,Oral,02279266,PMS-RISPERIDONE (risperidone (risperidone tartrate) 1 mg per mL oral solution) PHARMASCIENCE INC,Active,9000788,risperidone (risperidone tartrate) 1 mg per mL oral solution,8000187,risperidone,26643006,Oral,385023001,Oral solution,,,,,
76539,Marketed,2006-07-05,02279800,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02279800,SANDOZ RISPERIDONE (risperidone 1 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76540,Marketed,2006-07-05,02279819,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02279819,SANDOZ RISPERIDONE (risperidone 2 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76541,Marketed,2006-07-05,02279827,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02279827,SANDOZ RISPERIDONE (risperidone 3 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76542,Marketed,2006-07-05,02279835,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02279835,SANDOZ RISPERIDONE (risperidone 4 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76778,Marketed,2006-07-05,02282119,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282119,APO-RISPERIDONE (risperidone 0.25 mg oral tablet) APOTEX INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76779,Marketed,2006-07-05,02282127,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282127,APO-RISPERIDONE (risperidone 0.5 mg oral tablet) APOTEX INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76780,Marketed,2006-07-05,02282135,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282135,APO-RISPERIDONE (risperidone 1 mg oral tablet) APOTEX INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76781,Marketed,2006-07-05,02282143,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282143,APO-RISPERIDONE (risperidone 2 mg oral tablet) APOTEX INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76782,Marketed,2006-07-05,02282151,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282151,APO-RISPERIDONE (risperidone 3 mg oral tablet) APOTEX INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76783,Marketed,2006-07-05,02282178,APO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282178,APO-RISPERIDONE (risperidone 4 mg oral tablet) APOTEX INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76833,Marketed,2022-10-26,02282690,TEVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02282690,TEVA-RISPERIDONE (risperidone 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76916,Marketed,2017-07-11,02283565,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283565,RIVA-RISPERIDONE (risperidone 0.25 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76917,Marketed,2017-07-11,02283573,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283573,RIVA-RISPERIDONE (risperidone 0.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76918,Marketed,2017-07-11,02283581,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283581,RIVA-RISPERIDONE (risperidone 1 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76919,Marketed,2017-07-11,02283603,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283603,RIVA-RISPERIDONE (risperidone 2 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76920,Marketed,2017-07-11,02283611,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283611,RIVA-RISPERIDONE (risperidone 3 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76921,Marketed,2017-07-11,02283638,RIVA-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02283638,RIVA-RISPERIDONE (risperidone 4 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78377,Marketed,2007-10-24,02298465,RISPERDAL CONSTA,1.0,N05AX08,Risperidone,"Powder for suspension, sustained-release,Kit",Intramuscular,02298465,RISPERDAL CONSTA (risperidone 12.5 mg per vial powder for prolonged-release suspension for injection with diluent solution) JANSSEN INC,Active,9006486,risperidone 12.5 mg per vial powder for prolonged-release suspension for injection with diluent solution,8000187,risperidone,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),,,
78897,Marketed,2007-12-21,02303655,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02303655,SANDOZ RISPERIDONE (risperidone 0.25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78898,Marketed,2007-12-21,02303663,SANDOZ RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02303663,SANDOZ RISPERIDONE (risperidone 0.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79823,Marketed,2008-07-09,02312700,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312700,PRO-RISPERIDONE (risperidone 0.25 mg oral tablet) PRO DOC LIMITEE,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79824,Marketed,2008-07-09,02312719,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312719,PRO-RISPERIDONE (risperidone 0.5 mg oral tablet) PRO DOC LIMITEE,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79825,Marketed,2008-07-09,02312727,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312727,PRO-RISPERIDONE (risperidone 1 mg oral tablet) PRO DOC LIMITEE,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79826,Marketed,2008-07-09,02312735,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312735,PRO-RISPERIDONE (risperidone 2 mg oral tablet) PRO DOC LIMITEE,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79827,Marketed,2008-07-09,02312743,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312743,PRO-RISPERIDONE (risperidone 3 mg oral tablet) PRO DOC LIMITEE,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79828,Marketed,2008-07-09,02312751,PRO-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02312751,PRO-RISPERIDONE (risperidone 4 mg oral tablet) PRO DOC LIMITEE,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84200,Marketed,2016-08-19,02356880,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356880,RISPERIDONE (risperidone 0.25 mg oral tablet) SANIS HEALTH INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84201,Marketed,2016-08-19,02356899,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356899,RISPERIDONE (risperidone 0.5 mg oral tablet) SANIS HEALTH INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84202,Marketed,2016-08-19,02356902,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356902,RISPERIDONE (risperidone 1 mg oral tablet) SANIS HEALTH INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84203,Marketed,2016-08-19,02356910,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356910,RISPERIDONE (risperidone 2 mg oral tablet) SANIS HEALTH INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84204,Marketed,2016-08-19,02356929,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356929,RISPERIDONE (risperidone 3 mg oral tablet) SANIS HEALTH INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84205,Marketed,2016-08-19,02356937,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02356937,RISPERIDONE (risperidone 4 mg oral tablet) SANIS HEALTH INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84454,Marketed,2010-12-23,02359529,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359529,JAMP-RISPERIDONE (risperidone 0.25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84455,Marketed,2010-12-23,02359537,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359537,JAMP-RISPERIDONE (risperidone 0.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84456,Marketed,2010-12-23,02359545,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359545,JAMP-RISPERIDONE (risperidone 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84457,Marketed,2010-12-23,02359553,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359553,JAMP-RISPERIDONE (risperidone 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84458,Marketed,2010-12-23,02359561,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359561,JAMP-RISPERIDONE (risperidone 3 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84459,Marketed,2010-12-23,02359588,JAMP-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02359588,JAMP-RISPERIDONE (risperidone 4 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84478,Marketed,2011-01-05,02359790,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359790,MINT-RISPERIDON (risperidone 0.25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84479,Marketed,2011-01-05,02359804,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359804,MINT-RISPERIDON (risperidone 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84480,Marketed,2011-01-05,02359812,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359812,MINT-RISPERIDON (risperidone 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84481,Marketed,2011-01-05,02359820,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359820,MINT-RISPERIDON (risperidone 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84482,Marketed,2011-01-05,02359839,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359839,MINT-RISPERIDON (risperidone 3 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84483,Marketed,2011-01-05,02359847,MINT-RISPERIDON,1.0,N05AX08,Risperidone,Tablet,Oral,02359847,MINT-RISPERIDON (risperidone 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85689,Marketed,2013-04-17,02371766,MAR-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02371766,MAR-RISPERIDONE (risperidone 0.25 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85690,Marketed,2013-04-17,02371774,MAR-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02371774,MAR-RISPERIDONE (risperidone 0.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85691,Marketed,2013-04-17,02371782,MAR-RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02371782,MAR-RISPERIDONE (risperidone 1 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102277,Marketed,2023-11-09,02533804,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533804,RISPERIDONE (risperidone 0.25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000871,risperidone 0.25 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102288,Marketed,2023-11-09,02533928,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533928,RISPERIDONE (risperidone 0.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000872,risperidone 0.5 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102289,Marketed,2023-11-09,02533936,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533936,RISPERIDONE (risperidone 1 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000489,risperidone 1 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102290,Marketed,2023-11-09,02533944,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533944,RISPERIDONE (risperidone 2 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000490,risperidone 2 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102291,Marketed,2023-11-09,02533952,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533952,RISPERIDONE (risperidone 3 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000491,risperidone 3 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102292,Marketed,2023-11-09,02533960,RISPERIDONE,1.0,N05AX08,Risperidone,Tablet,Oral,02533960,RISPERIDONE (risperidone 4 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000492,risperidone 4 mg oral tablet,8000187,risperidone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103318,Marketed,2025-05-27,02544601,OKEDI,1.0,N05AX08,Risperidone,"Kit,Powder for suspension, sustained-release",Intramuscular,02544601,"OKEDI (risperidone 75 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) LABORATORIOS FARMACEUTICOS ROVI, S.A.",Active,9015224,risperidone 75 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8000187,risperidone,738984000,Injection,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe,,,
103319,Marketed,2025-05-27,02544628,OKEDI,1.0,N05AX08,Risperidone,"Kit,Powder for suspension, sustained-release",Intramuscular,02544628,"OKEDI (risperidone 100 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe) LABORATORIOS FARMACEUTICOS ROVI, S.A.",Active,9015223,risperidone 100 mg per syringe powder for prolonged-release suspension for injection with diluent solution syringe,8000187,risperidone,738984000,Injection,422264003,Powder for prolonged-release suspension for injection,733020007,Syringe,,,
103199,Marketed,2024-02-13,02543532,LITFULO,1.0,L04AF08,Ritlecitinib,Capsule,Oral,02543532,LITFULO (ritlecitinib (ritlecitinib tosylate) 50 mg oral capsule) PFIZER CANADA ULC,Active,9015021,ritlecitinib (ritlecitinib tosylate) 50 mg oral capsule,8002501,ritlecitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
84270,Marketed,2014-04-30,02357593,NORVIR,1.0,J05AE03,Ritonavir,Tablet,Oral,02357593,NORVIR (ritonavir 100 mg oral tablet) ABBVIE CORPORATION,Active,9004799,ritonavir 100 mg oral tablet,8001229,ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101271,Marketed,2022-09-08,02523620,AURO-RITONAVIR,1.0,J05AE03,Ritonavir,Tablet,Oral,02523620,AURO-RITONAVIR (ritonavir 100 mg oral tablet) AURO PHARMA INC,Active,9004799,ritonavir 100 mg oral tablet,8001229,ritonavir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65597,Marketed,2000-03-20,02241927,RITUXAN,1.0,L01FA01,Rituximab,Solution,Intravenous,77700854,RITUXAN (rituximab 100 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65597,Marketed,2000-03-20,02241927,RITUXAN,1.0,L01FA01,Rituximab,Solution,Intravenous,77700855,RITUXAN (rituximab 500 mg per 50 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
94441,Marketed,2016-11-22,02457350,RITUXAN SC,1.0,L01FA01,Rituximab,Solution,Subcutaneous,02457350,RITUXAN SC (rituximab 1400 mg per 11.7 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013320,rituximab 1400 mg per 11.7 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96398,Marketed,2018-04-24,02473976,RITUXAN SC,1.0,L01FA01,Rituximab,Solution,Subcutaneous,02473976,RITUXAN SC (rituximab 1600 mg per 13.4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013321,rituximab 1600 mg per 13.4 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
96914,Marketed,2025-11-24,02478382,TRUXIMA,1.0,L01FA01,Rituximab,Solution,Intravenous,02478382,TRUXIMA (rituximab 100 mg per 10 mL solution for injection vial) CELLTRION INC.,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
96915,Marketed,2025-11-24,02478390,TRUXIMA,1.0,L01FA01,Rituximab,Solution,Intravenous,02478390,TRUXIMA (rituximab 500 mg per 50 mL solution for injection vial) CELLTRION INC.,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
98562,Marketed,2020-05-26,02495724,RUXIENCE,1.0,L01FA01,Rituximab,Solution,Intravenous,77701017,RUXIENCE (rituximab 500 mg per 50 mL solution for injection vial) PFIZER CANADA ULC,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
98562,Marketed,2020-05-26,02495724,RUXIENCE,1.0,L01FA01,Rituximab,Solution,Intravenous,77701018,RUXIENCE (rituximab 100 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
98809,Marketed,2020-05-22,02498316,RIXIMYO,1.0,L01FA01,Rituximab,Solution,Intravenous,77701019,RIXIMYO (rituximab 100 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013319,rituximab 100 mg per 10 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
98809,Marketed,2020-05-22,02498316,RIXIMYO,1.0,L01FA01,Rituximab,Solution,Intravenous,77701020,RIXIMYO (rituximab 500 mg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013322,rituximab 500 mg per 50 mL solution for injection vial,8001923,rituximab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
80247,Marketed,2008-09-16,02316986,XARELTO,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02316986,XARELTO (rivaroxaban 10 mg oral tablet) BAYER INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86439,Marketed,2012-01-17,02378604,XARELTO,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02378604,XARELTO (rivaroxaban 15 mg oral tablet) BAYER INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86440,Marketed,2012-01-17,02378612,XARELTO,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02378612,XARELTO (rivaroxaban 20 mg oral tablet) BAYER INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95947,Marketed,2023-11-01,02470497,APO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02470497,APO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) APOTEX INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95948,Marketed,2023-11-01,02470500,APO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02470500,APO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) APOTEX INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95949,Marketed,2023-11-01,02470519,APO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02470519,APO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) APOTEX INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96172,Marketed,2023-11-01,02472414,REDDY-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02472414,REDDY-RIVAROXABAN (rivaroxaban 10 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96173,Marketed,2023-11-01,02472430,REDDY-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02472430,REDDY-RIVAROXABAN (rivaroxaban 15 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96174,Marketed,2023-11-01,02472422,REDDY-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02472422,REDDY-RIVAROXABAN (rivaroxaban 20 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97146,Marketed,2018-09-28,02480808,XARELTO,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02480808,XARELTO (rivaroxaban 2.5 mg oral tablet) BAYER INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97270,Marketed,2023-11-01,02482223,SANDOZ RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02482223,SANDOZ RIVAROXABAN (rivaroxaban 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97271,Marketed,2023-11-01,02482231,SANDOZ RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02482231,SANDOZ RIVAROXABAN (rivaroxaban 15 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97272,Marketed,2023-11-01,02482258,SANDOZ RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02482258,SANDOZ RIVAROXABAN (rivaroxaban 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97416,Marketed,2023-11-01,02483807,TARO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02483807,TARO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97417,Marketed,2023-11-01,02483815,TARO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02483815,TARO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97418,Marketed,2023-11-01,02483823,TARO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02483823,TARO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99659,Marketed,2023-11-01,02507196,TEVA-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02507196,TEVA-RIVAROXABAN (rivaroxaban 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99660,Marketed,2023-11-01,02507218,TEVA-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02507218,TEVA-RIVAROXABAN (rivaroxaban 15 mg oral tablet) TEVA CANADA LIMITED,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99661,Marketed,2023-11-01,02507226,TEVA-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02507226,TEVA-RIVAROXABAN (rivaroxaban 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99940,Marketed,2021-06-11,02510162,XARELTO,1.0,B01AF01,Rivaroxaban,Granules for suspension,Oral,02510162,XARELTO FOR LESS THAN 4 KG (rivaroxaban 1 mg per mL oral suspension) BAYER INC,Active,9014572,rivaroxaban 1 mg per mL oral suspension,8000379,rivaroxaban,26643006,Oral,385024007,Oral suspension,,,,,
99941,Marketed,2021-06-11,02510170,XARELTO,1.0,B01AF01,Rivaroxaban,Granules for suspension,Oral,02510170,XARELTO FOR 4 KG OR MORE (rivaroxaban 1 mg per mL oral suspension) BAYER INC,Active,9014572,rivaroxaban 1 mg per mL oral suspension,8000379,rivaroxaban,26643006,Oral,385024007,Oral suspension,,,,,
100127,Marketed,2023-11-01,02512041,PMS-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02512041,PMS-RIVAROXABAN (rivaroxaban 10 mg oral tablet) PHARMASCIENCE INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100128,Marketed,2023-11-01,02512068,PMS-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02512068,PMS-RIVAROXABAN (rivaroxaban 15 mg oral tablet) PHARMASCIENCE INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100129,Marketed,2023-11-01,02512076,PMS-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02512076,PMS-RIVAROXABAN (rivaroxaban 20 mg oral tablet) PHARMASCIENCE INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100565,Marketed,2024-02-05,02516292,JAMP RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02516292,JAMP RIVAROXABAN (rivaroxaban 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100566,Marketed,2024-02-05,02516306,JAMP RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02516306,JAMP RIVAROXABAN (rivaroxaban 15 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100567,Marketed,2024-02-05,02516314,JAMP RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02516314,JAMP RIVAROXABAN (rivaroxaban 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101353,Marketed,2023-11-01,02524503,REDDY-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02524503,REDDY-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) DR REDDY'S LABORATORIES LTD,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101584,Marketed,2023-11-01,02526786,TARO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02526786,TARO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101660,Marketed,2023-11-01,02527537,PMS-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02527537,PMS-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101726,Marketed,2024-08-22,02527995,AG-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02527995,AG-RIVAROXABAN (rivaroxaban 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101727,Marketed,2024-08-22,02528002,AG-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02528002,AG-RIVAROXABAN (rivaroxaban 15 mg oral tablet) ANGITA PHARMA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101728,Marketed,2024-08-22,02528010,AG-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02528010,AG-RIVAROXABAN (rivaroxaban 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102663,Marketed,2023-11-01,02537877,SANDOZ RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02537877,SANDOZ RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102951,Marketed,2023-11-06,02540835,RIVA RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540835,RIVA RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102952,Marketed,2023-11-06,02540843,RIVA RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540843,RIVA RIVAROXABAN (rivaroxaban 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102953,Marketed,2023-11-06,02540851,RIVA RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540851,RIVA RIVAROXABAN (rivaroxaban 15 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102954,Marketed,2023-11-06,02540878,RIVA RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540878,RIVA RIVAROXABAN (rivaroxaban 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102959,Marketed,2023-11-02,02540967,PRO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540967,PRO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) PRO DOC LIMITEE,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102960,Marketed,2023-11-02,02540975,PRO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540975,PRO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) PRO DOC LIMITEE,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102961,Marketed,2023-11-02,02540983,PRO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540983,PRO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) PRO DOC LIMITEE,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102962,Marketed,2023-11-02,02540991,PRO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02540991,PRO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) PRO DOC LIMITEE,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103011,Marketed,2023-11-08,02541467,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02541467,RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103012,Marketed,2023-11-08,02541475,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02541475,RIVAROXABAN (rivaroxaban 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103013,Marketed,2023-11-08,02541483,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02541483,RIVAROXABAN (rivaroxaban 15 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103014,Marketed,2023-11-08,02541491,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02541491,RIVAROXABAN (rivaroxaban 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103036,Marketed,2023-11-01,02541734,APO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02541734,APO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) APOTEX INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103592,Marketed,2024-11-26,02547295,TEVA-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02547295,TEVA-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103681,Marketed,2024-12-13,02547899,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02547899,RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) SANIS HEALTH INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103682,Marketed,2024-12-13,02547902,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02547902,RIVAROXABAN (rivaroxaban 10 mg oral tablet) SANIS HEALTH INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103683,Marketed,2024-12-13,02547910,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02547910,RIVAROXABAN (rivaroxaban 15 mg oral tablet) SANIS HEALTH INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103684,Marketed,2024-12-13,02547929,RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02547929,RIVAROXABAN (rivaroxaban 20 mg oral tablet) SANIS HEALTH INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103818,Marketed,2025-01-14,02549328,BIO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02549328,BIO-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) BIOMED PHARMA,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103819,Marketed,2025-01-14,02549336,BIO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02549336,BIO-RIVAROXABAN (rivaroxaban 10 mg oral tablet) BIOMED PHARMA,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103820,Marketed,2025-01-14,02549344,BIO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02549344,BIO-RIVAROXABAN (rivaroxaban 15 mg oral tablet) BIOMED PHARMA,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103821,Marketed,2025-01-14,02549352,BIO-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02549352,BIO-RIVAROXABAN (rivaroxaban 20 mg oral tablet) BIOMED PHARMA,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104033,Marketed,2024-12-19,02551608,M-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02551608,M-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) MANTRA PHARMA INC,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104034,Marketed,2024-12-19,02551616,M-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02551616,M-RIVAROXABAN (rivaroxaban 10 mg oral tablet) MANTRA PHARMA INC,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104035,Marketed,2024-12-19,02551624,M-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02551624,M-RIVAROXABAN (rivaroxaban 15 mg oral tablet) MANTRA PHARMA INC,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104036,Marketed,2024-12-19,02551632,M-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02551632,M-RIVAROXABAN (rivaroxaban 20 mg oral tablet) MANTRA PHARMA INC,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104230,Marketed,2025-06-10,02553368,JAMP RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02553368,JAMP RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104390,Marketed,2025-06-05,02555107,NB-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02555107,NB-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) NB PHARMA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104391,Marketed,2025-06-05,02555115,NB-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02555115,NB-RIVAROXABAN (rivaroxaban 10 mg oral tablet) NB PHARMA INC.,Active,9001257,rivaroxaban 10 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104392,Marketed,2025-06-05,02555123,NB-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02555123,NB-RIVAROXABAN (rivaroxaban 15 mg oral tablet) NB PHARMA INC.,Active,9001374,rivaroxaban 15 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104393,Marketed,2025-06-05,02555131,NB-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02555131,NB-RIVAROXABAN (rivaroxaban 20 mg oral tablet) NB PHARMA INC.,Active,9001375,rivaroxaban 20 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104404,Marketed,2025-07-21,02555255,AG-RIVAROXABAN,1.0,B01AF01,Rivaroxaban,Tablet,Oral,02555255,AG-RIVAROXABAN (rivaroxaban 2.5 mg oral tablet) ANGITA PHARMA INC.,Active,9013323,rivaroxaban 2.5 mg oral tablet,8000379,rivaroxaban,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65791,Marketed,2022-11-24,02242115,EXELON,1.0,N06DA03,Rivastigmine,Capsule,Oral,02242115,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65792,Marketed,2022-12-09,02242116,EXELON,1.0,N06DA03,Rivastigmine,Capsule,Oral,02242116,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65793,Marketed,2022-11-17,02242117,EXELON,1.0,N06DA03,Rivastigmine,Capsule,Oral,02242117,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
65794,Marketed,2022-11-28,02242118,EXELON,1.0,N06DA03,Rivastigmine,Capsule,Oral,02242118,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) KNIGHT THERAPEUTICS INC.,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
69257,Marketed,2022-11-18,02245240,EXELON,1.0,N06DA03,Rivastigmine,Solution,Oral,02245240,EXELON (rivastigmine (rivastigmine hydrogen tartrate) 2 mg per mL oral solution) KNIGHT THERAPEUTICS INC.,Active,9011705,rivastigmine (rivastigmine hydrogen tartrate) 2 mg per mL oral solution,8000287,rivastigmine,26643006,Oral,385023001,Oral solution,,,,,
78816,Marketed,2022-10-26,02302845,EXELON PATCH 5,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02302845,EXELON PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
78817,Marketed,2022-11-10,02302853,EXELON PATCH 10,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02302853,EXELON PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
81001,Marketed,2009-07-21,02324563,SANDOZ RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02324563,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81002,Marketed,2009-07-21,02324571,SANDOZ RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02324571,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81003,Marketed,2009-07-21,02324598,SANDOZ RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02324598,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81004,Marketed,2009-07-21,02324601,SANDOZ RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02324601,SANDOZ RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82234,Marketed,2010-04-07,02336715,APO-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02336715,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) APOTEX INC,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82235,Marketed,2010-04-07,02336723,APO-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02336723,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) APOTEX INC,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82236,Marketed,2010-04-07,02336731,APO-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02336731,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) APOTEX INC,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
82237,Marketed,2010-04-07,02336758,APO-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02336758,APO-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) APOTEX INC,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88650,Marketed,2013-11-27,02401614,MED-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02401614,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88651,Marketed,2013-11-27,02401622,MED-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02401622,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88652,Marketed,2014-11-12,02401630,MED-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02401630,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88653,Marketed,2013-11-27,02401649,MED-RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02401649,MED-RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) GENERIC MEDICAL PARTNERS INC,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
90814,Marketed,2016-12-05,02423413,MYLAN-RIVASTIGMINE PATCH 5,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02423413,MYLAN-RIVASTIGMINE PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
90815,Marketed,2016-12-05,02423421,MYLAN-RIVASTIGMINE PATCH 10,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02423421,MYLAN-RIVASTIGMINE PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) MYLAN PHARMACEUTICALS ULC,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
91089,Marketed,2016-11-30,02426293,SANDOZ RIVASTIGMINE PATCH 5,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02426293,SANDOZ RIVASTIGMINE PATCH 5 (rivastigmine 4.6 mg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9011710,rivastigmine 4.6 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
91090,Marketed,2016-11-30,02426307,SANDOZ RIVASTIGMINE PATCH 10,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02426307,SANDOZ RIVASTIGMINE PATCH 10 (rivastigmine 9.5 mg per 24 hour transdermal patch) SANDOZ CANADA INCORPORATED,Active,9011711,rivastigmine 9.5 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
91722,Marketed,2022-10-26,02432803,EXELON PATCH 15,1.0,N06DA03,Rivastigmine,Patch,Transdermal,02432803,EXELON PATCH 15 (rivastigmine 13.3 mg per 24 hour transdermal patch) KNIGHT THERAPEUTICS INC.,Active,9011709,rivastigmine 13.3 mg per 24 hour transdermal patch,8000287,rivastigmine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
97561,Marketed,2020-02-10,02485362,JAMP RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02485362,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97562,Marketed,2020-02-10,02485370,JAMP RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02485370,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97563,Marketed,2020-02-10,02485389,JAMP RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02485389,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97564,Marketed,2020-02-10,02485397,JAMP RIVASTIGMINE,1.0,N06DA03,Rivastigmine,Capsule,Oral,02485397,JAMP RIVASTIGMINE (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104093,Marketed,2025-07-11,02552256,JAMP RIVASTIGMINE CAPSULES,1.0,N06DA03,Rivastigmine,Capsule,Oral,02552256,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011704,rivastigmine (rivastigmine hydrogen tartrate) 1.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104094,Marketed,2025-07-11,02552264,JAMP RIVASTIGMINE CAPSULES,1.0,N06DA03,Rivastigmine,Capsule,Oral,02552264,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011706,rivastigmine (rivastigmine hydrogen tartrate) 3 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104095,Marketed,2025-07-11,02552272,JAMP RIVASTIGMINE CAPSULES,1.0,N06DA03,Rivastigmine,Capsule,Oral,02552272,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011707,rivastigmine (rivastigmine hydrogen tartrate) 4.5 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104096,Marketed,2025-07-11,02552280,JAMP RIVASTIGMINE CAPSULES,1.0,N06DA03,Rivastigmine,Capsule,Oral,02552280,JAMP RIVASTIGMINE CAPSULES (rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule) JAMP PHARMA CORPORATION,Active,9011708,rivastigmine (rivastigmine hydrogen tartrate) 6 mg oral capsule,8000287,rivastigmine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100855,Marketed,2022-06-01,02519283,SKYRIZI,1.0,L04AC18,Rizankizumab,Solution,Subcutaneous,02519283,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection syringe) ABBVIE CORPORATION,Active,9014729,risankizumab 150 mg per 1 mL solution for injection syringe,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
100857,Marketed,2022-06-01,02519291,SKYRIZI,1.0,L04AC18,Rizankizumab,Solution,Subcutaneous,02519291,SKYRIZI (risankizumab 150 mg per 1 mL solution for injection pen) ABBVIE CORPORATION,Active,9014728,risankizumab 150 mg per 1 mL solution for injection pen,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
102116,Marketed,2023-03-14,02532093,SKYRIZI,1.0,L04AC18,Rizankizumab,Solution,Subcutaneous,02532093,SKYRIZI (risankizumab 360 mg per 2.4 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9014843,risankizumab 360 mg per 2.4 mL solution for injection cartridge,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),1.0,,
102117,Marketed,2022-12-01,02532107,SKYRIZI,1.0,L04AC18,Rizankizumab,Solution,Intravenous,02532107,SKYRIZI (risankizumab 600 mg per 10 mL solution for injection vial) ABBVIE CORPORATION,Active,9014812,risankizumab 600 mg per 10 mL solution for injection vial,8002266,risankizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104147,Marketed,2025-02-14,02552507,SKYRIZI,1.0,L04AC18,Rizankizumab,Solution,Subcutaneous,02552507,SKYRIZI (risankizumab 180 mg per 1.2 mL solution for injection cartridge) ABBVIE CORPORATION,Active,9015206,risankizumab 180 mg per 1.2 mL solution for injection cartridge,8002266,risankizumab,738984000,Injection,385219001,Solution for injection,732988008,Cartridge,1.0,,
64089,Marketed,2023-05-29,02240518,MAXALT RPD,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02240518,MAXALT RPD (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ORGANON CANADA INC.,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
64090,Marketed,2023-03-06,02240519,MAXALT RPD,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02240519,MAXALT RPD (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ORGANON CANADA INC.,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
64092,Marketed,2022-09-20,02240521,MAXALT,1.0,N02CC04,Rizatriptan,Tablet,Oral,02240521,MAXALT (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) ORGANON CANADA INC.,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83711,Marketed,2012-01-30,02351870,SANDOZ RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02351870,SANDOZ RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
83712,Marketed,2012-01-30,02351889,SANDOZ RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02351889,SANDOZ RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
86508,Marketed,2012-01-31,02379198,MYLAN-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02379198,MYLAN-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
86509,Marketed,2012-01-31,02379201,MYLAN-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02379201,MYLAN-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MYLAN PHARMACEUTICALS ULC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
86554,Marketed,2018-11-05,02379678,MAR-RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02379678,MAR-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86627,Marketed,2021-05-06,02380463,JAMP RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02380463,JAMP RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86756,Marketed,2020-05-06,02381702,ACT RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02381702,ACT RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87859,Marketed,2012-10-30,02393360,PMS-RIZATRIPTAN RDT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02393360,PMS-RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
87860,Marketed,2012-10-30,02393379,PMS-RIZATRIPTAN RDT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02393379,PMS-RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) PHARMASCIENCE INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
87868,Marketed,2013-03-06,02393468,APO-RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02393468,APO-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 5 mg oral tablet) APOTEX INC,Active,9001382,rizatriptan (rizatriptan benzoate) 5 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87869,Marketed,2013-03-06,02393476,APO-RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02393476,APO-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) APOTEX INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88170,Marketed,2014-11-04,02396661,TEVA-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02396661,TEVA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
88171,Marketed,2014-11-04,02396688,TEVA-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02396688,TEVA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
90039,Marketed,2013-11-28,02415798,RIZATRIPTAN RDT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02415798,RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
90040,Marketed,2013-11-28,02415801,RIZATRIPTAN RDT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02415801,RIZATRIPTAN RDT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) PRO DOC LIMITEE,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92093,Marketed,2015-02-17,02436604,NAT-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02436604,NAT-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) NATCO PHARMA (CANADA) INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92094,Marketed,2015-02-17,02436612,NAT-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02436612,NAT-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) NATCO PHARMA (CANADA) INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92741,Marketed,2015-07-23,02442906,RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02442906,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SANIS HEALTH INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
92742,Marketed,2015-07-23,02442914,RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02442914,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SANIS HEALTH INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93138,Marketed,2018-02-13,02446111,RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02446111,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
93139,Marketed,2018-02-13,02446138,RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02446138,RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) SIVEM PHARMACEUTICALS ULC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
95062,Marketed,2018-02-15,02462788,MAR-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02462788,MAR-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
95063,Marketed,2018-02-15,02462796,MAR-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02462796,MAR-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MARCAN PHARMACEUTICALS INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
95327,Marketed,2018-02-12,02465086,JAMP-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02465086,JAMP-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
95328,Marketed,2018-02-12,02465094,JAMP-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02465094,JAMP-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97371,Marketed,2019-10-07,02483270,ACCEL-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02483270,ACCEL-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ACCEL PHARMA INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97372,Marketed,2019-10-07,02483289,ACCEL-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02483289,ACCEL-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ACCEL PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
97947,Marketed,2022-04-06,02489384,NRA-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02489384,NRA-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) NORA PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
98249,Marketed,2021-08-06,02492482,AG-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02492482,AG-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) ANGITA PHARMA INC.,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
98250,Marketed,2020-11-25,02492490,AG-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02492490,AG-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) ANGITA PHARMA INC.,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100607,Marketed,2022-01-07,02516756,RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02516756,RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) SANIS HEALTH INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103664,Marketed,2025-01-29,02547716,M-RIZATRIPTAN,1.0,N02CC04,Rizatriptan,Tablet,Oral,02547716,M-RIZATRIPTAN (rizatriptan (rizatriptan benzoate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9000864,rizatriptan (rizatriptan benzoate) 10 mg oral tablet,8000276,rizatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103764,Marketed,2025-06-10,02548801,M-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02548801,M-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet) MANTRA PHARMA INC,Active,9000897,rizatriptan (rizatriptan benzoate) 5 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
103765,Marketed,2025-06-10,02548828,M-RIZATRIPTAN ODT,1.0,N02CC04,Rizatriptan,Tablet (orally disintegrating),Oral,02548828,M-RIZATRIPTAN ODT (rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet) MANTRA PHARMA INC,Active,9000865,rizatriptan (rizatriptan benzoate) 10 mg orodispersible tablet,8000276,rizatriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
80390,Marketed,2008-10-24,02318415,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,02318415,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95863,Marketed,2021-11-15,02469774,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,02469774,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98856,Marketed,2020-11-24,02498820,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,77701028,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 100 mg per 10 mL solution for injection vial) AURO PHARMA INC,Active,9013324,rocuronium bromide 100 mg per 10 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98856,Marketed,2020-11-24,02498820,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,77701029,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) AURO PHARMA INC,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100710,Marketed,2023-09-29,02517744,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,02517744,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101786,Marketed,2024-10-08,02528657,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,77701164,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101786,Marketed,2024-10-08,02528657,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,77701165,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 100 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013324,rocuronium bromide 100 mg per 10 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101907,Marketed,2024-02-26,02529831,ROCURONIUM BROMIDE INJECTION,1.0,M03AC09,Rocuronium bromide,Solution,Intravenous,02529831,ROCURONIUM BROMIDE INJECTION (rocuronium bromide 50 mg per 5 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013325,rocuronium bromide 50 mg per 5 mL solution for injection vial,8001924,rocuronium,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
84447,Marketed,2017-07-20,02359456,DAXAS,1.0,R03DX07,Roflumilast,Tablet,Oral,02359456,DAXAS (roflumilast 500 mcg oral tablet) ASTRAZENECA CANADA INC,Active,9012538,roflumilast 500 mcg oral tablet,8001155,roflumilast,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102624,Marketed,2025-04-29,02537532,ZORYVE,1.0,D05AX06,Roflumilast,Cream,Topical,02537532,"ZORYVE (roflumilast 0.3 % cutaneous cream) ARCUTIS CANADA, INC.",Active,9014875,roflumilast 0.3 % cutaneous cream,8001155,roflumilast,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
104152,Marketed,2024-10-22,02552566,ZORYVE,1.0,D05AX06,Roflumilast,Foam,Topical,02552566,"ZORYVE (roflumilast 0.3 % cutaneous foam) ARCUTIS CANADA, INC.",Active,9015125,roflumilast 0.3 % cutaneous foam,8001155,roflumilast,448598008,Cutaneous,385103000,Conventional release cutaneous foam,,,,,
104484,Marketed,2025-03-18,02556146,ZORYVE,1.0,D05AX06,Roflumilast,Cream,Topical,02556146,"ZORYVE (roflumilast 0.15 % cutaneous cream) ARCUTIS CANADA, INC.",Active,9015178,roflumilast 0.15 % cutaneous cream,8001155,roflumilast,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
89895,Marketed,2025-11-04,02414295,ISTODAX,1.0,L01XH02,Romidepsin,"Powder for solution,Kit",Intravenous,02414295,ISTODAX (romidepsin 10 mg per vial powder for solution for injection with diluent solution) BRISTOL-MYERS SQUIBB CANADA,Active,9013326,romidepsin 10 mg per vial powder for solution for injection with diluent solution,8001925,romidepsin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
80832,Marketed,2009-04-15,02322854,NPLATE,1.0,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322854,NPLATE (romiplostim 375 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015225,romiplostim 375 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
80833,Marketed,2009-04-15,02322862,NPLATE,1.0,B02BX04,Romiplostim,Powder for solution,Subcutaneous,02322862,NPLATE (romiplostim 625 mcg per vial powder for solution for injection) AMGEN CANADA INC,Active,9015226,romiplostim 625 mcg per vial powder for solution for injection,8001926,romiplostim,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
97967,Marketed,2019-08-12,02489597,EVENITY,1.0,M05BX06,Romosozumab,Solution,Subcutaneous,02489597,EVENITY (romosozumab 105 mg per 1.17 mL solution for injection syringe) AMGEN CANADA INC,Active,9014157,romosozumab 105 mg per 1.17 mL solution for injection syringe,8002287,romosozumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
79955,Marketed,2025-06-26,02314037,SPC-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02314037,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet) SUN PHARMA CANADA INC,Active,9003165,ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79957,Marketed,2025-06-26,02314053,SPC-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02314053,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 1 mg oral tablet) SUN PHARMA CANADA INC,Active,9003161,ropinirole (ropinirole hydrochloride) 1 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79958,Marketed,2025-06-26,02314061,SPC-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02314061,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 2 mg oral tablet) SUN PHARMA CANADA INC,Active,9003162,ropinirole (ropinirole hydrochloride) 2 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79959,Marketed,2025-06-26,02314088,SPC-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02314088,SPC-ROPINIROLE (ropinirole (ropinirole hydrochloride) 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9003163,ropinirole (ropinirole hydrochloride) 5 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80234,Marketed,2020-05-22,02316846,TEVA-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02316846,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet) TEVA CANADA LIMITED,Active,9003165,ropinirole (ropinirole hydrochloride) 0.25 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80235,Marketed,2020-05-22,02316854,TEVA-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02316854,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 1 mg oral tablet) TEVA CANADA LIMITED,Active,9003161,ropinirole (ropinirole hydrochloride) 1 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80236,Marketed,2020-05-22,02316862,TEVA-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02316862,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 2 mg oral tablet) TEVA CANADA LIMITED,Active,9003162,ropinirole (ropinirole hydrochloride) 2 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80237,Marketed,2020-05-22,02316870,TEVA-ROPINIROLE,1.0,N04BC04,Ropinirole,Tablet,Oral,02316870,TEVA-ROPINIROLE (ropinirole (ropinirole hydrochloride) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9003163,ropinirole (ropinirole hydrochloride) 5 mg oral tablet,8001519,ropinirole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
47216,Marketed,2017-07-28,02229411,NAROPIN,1.0,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",77700848,NAROPIN (ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag) ASPEN PHARMACARE CANADA INC.,Active,9013331,ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
47216,Marketed,2017-07-28,02229411,NAROPIN,1.0,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",77700849,NAROPIN (ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag) ASPEN PHARMACARE CANADA INC.,Active,9013334,ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
47220,Marketed,2018-09-20,02229415,NAROPIN,1.0,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",02229415,NAROPIN (ropivacaine hydrochloride 100 mg per 20 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013329,ropivacaine hydrochloride 100 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
47225,Marketed,2019-01-11,02229418,NAROPIN,1.0,N01BB09,Ropivacaine,Solution,Epidural,77700850,NAROPIN (ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013332,ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
47225,Marketed,2019-01-11,02229418,NAROPIN,1.0,N01BB09,Ropivacaine,Solution,Epidural,77700851,NAROPIN (ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9013327,ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92374,Marketed,2018-09-28,02439379,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700978,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag) FRESENIUS KABI CANADA LTD",Active,9013334,ropivacaine hydrochloride 400 mg per 200 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
92374,Marketed,2018-09-28,02439379,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700979,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 40 mg per 20 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013604,ropivacaine hydrochloride 40 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92374,Marketed,2018-09-28,02439379,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700980,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag) FRESENIUS KABI CANADA LTD",Active,9013331,ropivacaine hydrochloride 200 mg per 100 mL solution for injection bag,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
92374,Marketed,2018-09-28,02439379,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,"Infiltration,Epidural",77700981,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 20 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013603,ropivacaine hydrochloride 20 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92375,Marketed,2019-09-13,02439387,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,"Block/infiltration,Epidural",02439387,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9014247,ropivacaine hydrochloride 50 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92377,Marketed,2019-02-26,02439409,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,Epidural,77701002,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013332,ropivacaine hydrochloride 200 mg per 20 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
92377,Marketed,2019-02-26,02439409,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",1.0,N01BB09,Ropivacaine,Solution,Epidural,77701003,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP (ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule) FRESENIUS KABI CANADA LTD",Active,9013327,ropivacaine hydrochloride 100 mg per 10 mL solution for injection ampoule,8001927,ropivacaine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
88817,Marketed,2019-09-17,02403366,ROSIGLITAZONE,1.0,A10BG02,Rosiglitazone,Tablet,Oral,02403366,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 2 mg oral tablet) AA PHARMA INC,Active,9003473,rosiglitazone (rosiglitazone maleate) 2 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88818,Marketed,2019-09-17,02403374,ROSIGLITAZONE,1.0,A10BG02,Rosiglitazone,Tablet,Oral,02403374,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 4 mg oral tablet) AA PHARMA INC,Active,9003474,rosiglitazone (rosiglitazone maleate) 4 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88819,Marketed,2019-09-17,02403382,ROSIGLITAZONE,1.0,A10BG02,Rosiglitazone,Tablet,Oral,02403382,ROSIGLITAZONE (rosiglitazone (rosiglitazone maleate) 8 mg oral tablet) AA PHARMA INC,Active,9003475,rosiglitazone (rosiglitazone maleate) 8 mg oral tablet,8001087,rosiglitazone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71404,Marketed,2003-02-19,02247162,CRESTOR - 10MG,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02247162,CRESTOR - 10MG (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71405,Marketed,2003-02-19,02247163,CRESTOR - 20MG,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02247163,CRESTOR - 20MG (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71406,Marketed,2003-02-19,02247164,CRESTOR - 40MG,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02247164,CRESTOR - 40MG (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75100,Marketed,2005-03-18,02265540,CRESTOR - 5MG,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02265540,CRESTOR - 5MG (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82362,Marketed,2012-04-02,02337975,APO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02337975,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) APOTEX INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82363,Marketed,2012-04-02,02337983,APO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02337983,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) APOTEX INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82364,Marketed,2012-04-02,02337991,APO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02337991,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) APOTEX INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82365,Marketed,2012-04-02,02338009,APO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02338009,APO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) APOTEX INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82437,Marketed,2012-03-15,02338726,SANDOZ ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02338726,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82438,Marketed,2012-03-15,02338734,SANDOZ ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02338734,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82439,Marketed,2012-03-15,02338742,SANDOZ ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02338742,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82440,Marketed,2012-03-15,02338750,SANDOZ ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02338750,SANDOZ ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83977,Marketed,2012-03-15,02354608,TEVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02354608,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83978,Marketed,2012-03-15,02354616,TEVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02354616,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83979,Marketed,2012-03-15,02354624,TEVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02354624,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83980,Marketed,2012-03-15,02354632,TEVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02354632,TEVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86432,Marketed,2012-03-15,02378523,PMS-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02378523,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PHARMASCIENCE INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86433,Marketed,2012-03-15,02378531,PMS-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02378531,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PHARMASCIENCE INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86434,Marketed,2012-03-15,02378558,PMS-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02378558,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PHARMASCIENCE INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86435,Marketed,2012-03-15,02378566,PMS-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02378566,PMS-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PHARMASCIENCE INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86586,Marketed,2025-11-25,02380013,RIVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02380013,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86589,Marketed,2025-11-25,02380056,RIVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02380056,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86590,Marketed,2025-11-25,02380064,RIVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02380064,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86594,Marketed,2025-11-25,02380102,RIVA-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02380102,RIVA-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86695,Marketed,2025-09-03,02381176,PRO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02381176,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PRO DOC LIMITEE,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86696,Marketed,2025-09-03,02381184,PRO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02381184,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PRO DOC LIMITEE,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86697,Marketed,2025-09-03,02381192,PRO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02381192,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PRO DOC LIMITEE,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86698,Marketed,2025-09-03,02381206,PRO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02381206,PRO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PRO DOC LIMITEE,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86846,Marketed,2020-03-01,02382644,TARO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02382644,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86847,Marketed,2020-03-01,02382652,TARO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02382652,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86848,Marketed,2020-03-01,02382660,TARO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02382660,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86849,Marketed,2020-03-01,02382679,TARO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02382679,TARO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88271,Marketed,2025-11-04,02397781,MINT-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02397781,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88272,Marketed,2025-11-04,02397803,MINT-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02397803,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88273,Marketed,2025-11-04,02397811,MINT-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02397811,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88274,Marketed,2025-11-04,02397838,MINT-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02397838,MINT-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89039,Marketed,2022-09-01,02405628,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02405628,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SANIS HEALTH INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89040,Marketed,2022-09-01,02405636,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02405636,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SANIS HEALTH INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89041,Marketed,2022-09-01,02405644,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02405644,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SANIS HEALTH INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89042,Marketed,2022-09-01,02405652,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02405652,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SANIS HEALTH INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89622,Marketed,2024-01-12,02411628,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02411628,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89623,Marketed,2024-02-02,02411636,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02411636,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89624,Marketed,2024-02-02,02411644,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02411644,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89625,Marketed,2024-02-13,02411652,ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02411652,ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89772,Marketed,2023-06-09,02413051,MAR-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02413051,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89773,Marketed,2023-06-09,02413078,MAR-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02413078,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89774,Marketed,2023-06-09,02413086,MAR-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02413086,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89775,Marketed,2023-06-09,02413108,MAR-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02413108,MAR-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92329,Marketed,2019-05-23,02438917,ACH-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02438917,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92330,Marketed,2019-05-23,02438925,ACH-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02438925,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92331,Marketed,2019-05-23,02438933,ACH-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02438933,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92332,Marketed,2019-05-23,02438941,ACH-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02438941,ACH-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92691,Marketed,2015-11-30,02442574,AURO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02442574,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) AURO PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92692,Marketed,2015-11-30,02442582,AURO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02442582,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) AURO PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92693,Marketed,2015-11-30,02442590,AURO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02442590,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) AURO PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92694,Marketed,2015-11-30,02442604,AURO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02442604,AURO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) AURO PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93018,Marketed,2021-08-11,02444968,BIO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02444968,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) BIOMED PHARMA,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93019,Marketed,2021-08-11,02444976,BIO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02444976,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) BIOMED PHARMA,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93020,Marketed,2021-08-11,02444984,BIO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02444984,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) BIOMED PHARMA,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93021,Marketed,2021-08-11,02444992,BIO-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02444992,BIO-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) BIOMED PHARMA,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98639,Marketed,2023-12-21,02496534,M-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02496534,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) MANTRA PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98640,Marketed,2024-02-28,02496542,M-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02496542,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) MANTRA PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98641,Marketed,2024-02-19,02496550,M-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02496550,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) MANTRA PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98642,Marketed,2024-04-29,02496569,M-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02496569,M-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) MANTRA PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98811,Marketed,2025-07-15,02498332,JAMP ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02498332,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98812,Marketed,2025-07-16,02498340,JAMP ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02498340,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98813,Marketed,2025-07-15,02498359,JAMP ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02498359,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98814,Marketed,2025-07-15,02498367,JAMP ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02498367,JAMP ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98984,Marketed,2025-08-29,02500132,AG-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02500132,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98985,Marketed,2025-08-29,02500140,AG-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02500140,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) ANGITA PHARMA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98986,Marketed,2025-08-29,02500159,AG-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02500159,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98987,Marketed,2025-08-29,02500167,AG-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02500167,AG-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) ANGITA PHARMA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99494,Marketed,2021-10-12,02505576,PRZ-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02505576,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99495,Marketed,2021-10-12,02505584,PRZ-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02505584,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99496,Marketed,2021-10-12,02505592,PRZ-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02505592,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) PHARMARIS CANADA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99497,Marketed,2021-10-12,02505606,PRZ-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02505606,PRZ-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) PHARMARIS CANADA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102535,Marketed,2023-09-14,02536595,NRA-ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02536595,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) NORA PHARMA INC,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102537,Marketed,2023-09-12,02536609,NRA-ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02536609,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) NORA PHARMA INC,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102538,Marketed,2023-09-12,02536625,NRA-ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02536625,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) NORA PHARMA INC,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102539,Marketed,2023-09-12,02536633,NRA-ROSUVASTATIN TABLETS,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02536633,NRA-ROSUVASTATIN TABLETS (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) NORA PHARMA INC,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104423,Marketed,2025-06-05,02555492,NB-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02555492,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 5 mg oral tablet) NB PHARMA INC.,Active,9001109,rosuvastatin (rosuvastatin calcium) 5 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104424,Marketed,2025-06-05,02555506,NB-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02555506,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 10 mg oral tablet) NB PHARMA INC.,Active,9001015,rosuvastatin (rosuvastatin calcium) 10 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104425,Marketed,2025-06-05,02555514,NB-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02555514,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 20 mg oral tablet) NB PHARMA INC.,Active,9001016,rosuvastatin (rosuvastatin calcium) 20 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104426,Marketed,2025-06-05,02555522,NB-ROSUVASTATIN,1.0,C10AA07,Rosuvastatin,Tablet,Oral,02555522,NB-ROSUVASTATIN (rosuvastatin (rosuvastatin calcium) 40 mg oral tablet) NB PHARMA INC.,Active,9001017,rosuvastatin (rosuvastatin calcium) 40 mg oral tablet,8000322,rosuvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78588,Marketed,2021-04-06,02300591,ROTARIX,1.0,J07BH01,"Rota virus, live attenuated",Suspension,Oral,,,,,,,,,,,,,,,,
76999,Marketed,2006-10-16,02284413,ROTATEQ,5.0,J07BH02,"Rota virus, pentavalent, live, reassorted",Solution,Oral,,,,,,,,,,,,,,,,
88866,Marketed,2013-12-19,02403897,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403897,NEUPRO (rotigotine 1 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005382,rotigotine 1 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
88867,Marketed,2013-06-27,02403900,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403900,NEUPRO (rotigotine 2 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005275,rotigotine 2 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
88868,Marketed,2013-12-19,02403919,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403919,NEUPRO (rotigotine 3 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005383,rotigotine 3 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
88869,Marketed,2013-06-27,02403927,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403927,NEUPRO (rotigotine 4 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005276,rotigotine 4 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
88870,Marketed,2013-06-27,02403935,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403935,NEUPRO (rotigotine 6 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005277,rotigotine 6 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
88871,Marketed,2013-06-27,02403943,NEUPRO,1.0,N04BC09,Rotigotine,Patch,Transdermal,02403943,NEUPRO (rotigotine 8 mg per 24 hour transdermal patch) UCB CANADA INC,Active,9005278,rotigotine 8 mg per 24 hour transdermal patch,8001520,rotigotine,45890007,Transdermal,739003001,Patch,733005001,Patch (unit of presentation),,,
104480,Marketed,2025-09-05,02556081,RYSTIGGO,1.0,L04AG16,Rozanolixizumab,Solution,Subcutaneous,02556081,RYSTIGGO (rozanolixizumab 280 mg per 2 mL solution for injection vial) UCB CANADA INC,Active,9015269,rozanolixizumab 280 mg per 2 mL solution for injection vial,8002556,rozanolixizumab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
85454,Marketed,2011-10-20,02369613,BANZEL,1.0,N03AF03,Rufinamide,Tablet,Oral,02369613,BANZEL (rufinamide 100 mg oral tablet) EISAI LIMITED,Active,9004943,rufinamide 100 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85455,Marketed,2011-08-29,02369621,BANZEL,1.0,N03AF03,Rufinamide,Tablet,Oral,02369621,BANZEL (rufinamide 200 mg oral tablet) EISAI LIMITED,Active,9004918,rufinamide 200 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85456,Marketed,2011-09-01,02369648,BANZEL,1.0,N03AF03,Rufinamide,Tablet,Oral,02369648,BANZEL (rufinamide 400 mg oral tablet) EISAI LIMITED,Active,9004921,rufinamide 400 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103472,Marketed,2024-07-04,02545985,AURO-RUFINAMIDE,1.0,N03AF03,Rufinamide,Tablet,Oral,02545985,AURO-RUFINAMIDE (rufinamide 200 mg oral tablet) AURO PHARMA INC,Active,9004918,rufinamide 200 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103473,Marketed,2024-07-04,02545993,AURO-RUFINAMIDE,1.0,N03AF03,Rufinamide,Tablet,Oral,02545993,AURO-RUFINAMIDE (rufinamide 400 mg oral tablet) AURO PHARMA INC,Active,9004921,rufinamide 400 mg oral tablet,8001521,rufinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94335,Marketed,2023-02-02,02456451,RUPALL,1.0,R06AX28,Rupatadine,Tablet,Oral,02456451,RUPALL (rupatadine (rupatadine fumarate) 10 mg oral tablet) MEDEXUS PHARMACEUTICALS INC.,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94336,Marketed,2023-02-02,02456478,RUPALL,1.0,R06AX28,Rupatadine,Solution,Oral,02456478,RUPALL (rupatadine (rupatadine fumarate) 1 mg per mL oral solution) MEDEXUS PHARMACEUTICALS INC.,Active,9006112,rupatadine (rupatadine fumarate) 1 mg per mL oral solution,8001522,rupatadine,26643006,Oral,385023001,Oral solution,,,,,
104156,Marketed,2025-01-21,02552604,PMS-RUPATADINE,1.0,R06AX28,Rupatadine,Tablet,Oral,02552604,PMS-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) PHARMASCIENCE INC,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104211,Marketed,2025-01-21,02553155,APO-RUPATADINE,1.0,R06AX28,Rupatadine,Tablet,Oral,02553155,APO-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) APOTEX INC,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106320,Marketed,2025-11-05,02560119,RIVA-RUPATADINE,1.0,R06AX28,Rupatadine,Tablet,Oral,02560119,RIVA-RUPATADINE (rupatadine (rupatadine fumarate) 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9006104,rupatadine (rupatadine fumarate) 10 mg oral tablet,8001522,rupatadine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87357,Marketed,2012-07-19,02388006,JAKAVI,1.0,L01EJ01,Ruxolitinib,Tablet,Oral,02388006,JAKAVI (ruxolitinib (ruxolitinib phosphate) 5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005068,ruxolitinib (ruxolitinib phosphate) 5 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87358,Marketed,2012-07-19,02388014,JAKAVI,1.0,L01EJ01,Ruxolitinib,Tablet,Oral,02388014,JAKAVI (ruxolitinib (ruxolitinib phosphate) 15 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005066,ruxolitinib (ruxolitinib phosphate) 15 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87359,Marketed,2012-07-19,02388022,JAKAVI,1.0,L01EJ01,Ruxolitinib,Tablet,Oral,02388022,JAKAVI (ruxolitinib (ruxolitinib phosphate) 20 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005067,ruxolitinib (ruxolitinib phosphate) 20 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91911,Marketed,2015-04-15,02434814,JAKAVI,1.0,L01EJ01,Ruxolitinib,Tablet,Oral,02434814,JAKAVI (ruxolitinib (ruxolitinib phosphate) 10 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005700,ruxolitinib (ruxolitinib phosphate) 10 mg oral tablet,8001928,ruxolitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104109,Marketed,2024-11-28,02552434,OPZELURA,1.0,D11AH09,Ruxolitinib,Cream,Topical,02552434,OPZELURA (ruxolitinib (ruxolitinib phosphate) 1.5 % cutaneous cream) INCYTE CORPORATION,Active,9015141,ruxolitinib (ruxolitinib phosphate) 1.5 % cutaneous cream,8001928,ruxolitinib,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
100997,Marketed,2021-11-22,02520788,TRODELVY,1.0,L01FX17,Sacituzumab govitecan,Powder for solution,Intravenous,02520788,TRODELVY (sacituzumab govitecan 180 mg per vial powder for solution for injection) GILEAD SCIENCES CANADA INC,Active,9014630,sacituzumab govitecan 180 mg per vial powder for solution for injection,8002399,sacituzumab govitecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
97492,Marketed,2019-07-08,02484641,ONSTRYV,1.0,N04BD03,Safinamide,Tablet,Oral,02484641,ONSTRYV (safinamide (safinamide mesylate) 50 mg oral tablet) VALEO PHARMA INC,Active,9014064,safinamide (safinamide mesylate) 50 mg oral tablet,8002272,safinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97495,Marketed,2019-07-08,02484668,ONSTRYV,1.0,N04BD03,Safinamide,Tablet,Oral,02484668,ONSTRYV (safinamide (safinamide mesylate) 100 mg oral tablet) VALEO PHARMA INC,Active,9014063,safinamide (safinamide mesylate) 100 mg oral tablet,8002272,safinamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13550,Marketed,2012-07-06,01926934,TEVA-SALBUTAMOL STERINEBS P.F.,1.0,R03AC02,Salbutamol,Solution,Inhalation,01926934,TEVA-SALBUTAMOL STERINEBS P.F. (salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000444,salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,420641004,Solution for inhalation,733026001,Vial (unit of presentation),,,
19058,Marketed,2012-07-05,02173360,TEVA-SALBUTAMOL STERINEBS P.F.,1.0,R03AC02,Salbutamol,Solution,Inhalation,02173360,TEVA-SALBUTAMOL STERINEBS P.F. (salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9000634,salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
19761,Marketed,2010-05-07,02208245,PMS-SALBUTAMOL,1.0,R03AC02,Salbutamol,Solution,Inhalation,02208245,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 1.25 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000692,salbutamol (salbutamol sulfate) 1.25 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
19762,Marketed,2010-05-07,02208237,PMS-SALBUTAMOL,1.0,R03AC02,Salbutamol,Solution,Inhalation,02208237,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000634,salbutamol (salbutamol sulfate) 5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
19763,Marketed,2010-05-07,02208229,PMS-SALBUTAMOL,1.0,R03AC02,Salbutamol,Solution,Inhalation,02208229,PMS-SALBUTAMOL (salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) PHARMASCIENCE INC,Active,9000444,salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000132,salbutamol,738984000,Parenteral,420641004,Solution for inhalation,733026001,Vial (unit of presentation),,,
43104,Marketed,2002-11-19,02213451,VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML),1.0,R03CC02,Salbutamol,Solution,Intravenous,02213451,VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML) (salbutamol (salbutamol sulfate) 5 mg per 5 mL solution for injection ampoule) GLAXOSMITHKLINE INC,Active,9000849,salbutamol (salbutamol sulfate) 5 mg per 5 mL solution for injection ampoule,8000132,salbutamol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
43108,Marketed,2002-08-26,02213486,VENTOLIN RESPIRATOR SOLUTION,1.0,R03AC02,Salbutamol,Solution,Inhalation,02213486,VENTOLIN RESPIRATOR SOLUTION (salbutamol (salbutamol sulfate) 5 mg per mL nebulizer solution 10 mL bottle) GLAXOSMITHKLINE INC,Active,9000338,salbutamol (salbutamol sulfate) 5 mg per mL nebulizer solution 10 mL bottle,8000132,salbutamol,738984000,Parenteral,385198000,Solution for nebuliser,,,,,
65137,Marketed,2001-11-22,02241497,VENTOLIN HFA,1.0,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02241497,VENTOLIN HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
66984,Marketed,2002-03-08,02243115,VENTOLIN DISKUS,1.0,R03AC02,Salbutamol,Powder,Inhalation,02243115,VENTOLIN DISKUS (salbutamol (salbutamol sulfate) 200 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012387,salbutamol (salbutamol sulfate) 200 mcg per actuation inhalation powder,8000132,salbutamol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
69769,Marketed,2019-12-16,02245669,APO-SALBUTAMOL HFA,1.0,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02245669,APO-SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) APOTEX INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
81180,Marketed,2018-03-21,02326450,TEVA-SALBUTAMOL HFA,1.0,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02326450,TEVA-SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) TEVA CANADA LIMITED,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
90447,Marketed,2014-02-13,02419858,SALBUTAMOL HFA,1.0,R03AC02,Salbutamol,Metered-dose aerosol,Inhalation,02419858,SALBUTAMOL HFA (salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation) SANIS HEALTH INC,Active,9000996,salbutamol (salbutamol sulfate) 100 mcg per actuation pressurized inhalation,8000132,salbutamol,447694001,447694001,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
75820,Marketed,2012-07-17,02272695,TEVA-COMBO STERINEBS,2.0,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02272695,TEVA-COMBO STERINEBS (ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9012555,ipratropium bromide 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000903,ipratropium and salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
90364,Marketed,2014-09-16,02419106,COMBIVENT RESPIMAT,2.0,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02419106,COMBIVENT RESPIMAT (ipratropium bromide (ipratropium bromide monohydrate) 20 mcg per actuation and salbutamol (salbutamol sulfate) 100 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9005585,ipratropium bromide 20 mcg per actuation and salbutamol (salbutamol sulfate) 100 mcg per actuation inhalation solution,8000903,ipratropium and salbutamol,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,
97384,Marketed,2022-10-17,02483394,IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION,2.0,R03AL02,Salbutamol and ipratropium bromide,Solution,Inhalation,02483394,IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION (ipratropium bromide (ipratropium bromide monohydrate) 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial) JUNO PHARMACEUTICALS CORP.,Active,9012555,ipratropium bromide 0.5 mg per 2.5 mL and salbutamol (salbutamol sulfate) 2.5 mg per 2.5 mL nebulizer solution unit dose vial,8000903,ipratropium and salbutamol,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
50436,Marketed,2003-01-16,02231129,SEREVENT DISKUS (50MCG/DOSE),1.0,R03AC12,Salmeterol,Powder,Inhalation,02231129,SEREVENT DISKUS (50MCG/DOSE) (salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012458,salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000905,salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
64426,Marketed,2002-03-12,02240835,ADVAIR 100 DISKUS,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240835,ADVAIR 100 DISKUS (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
64427,Marketed,2002-04-03,02240836,ADVAIR 250 DISKUS,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240836,ADVAIR 250 DISKUS (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
64428,Marketed,2002-03-08,02240837,ADVAIR 500 DISKUS,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02240837,ADVAIR 500 DISKUS (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
69136,Marketed,2001-12-21,02245126,ADVAIR,2.0,R03AK06,Salmeterol and fluticasone,"Aerosol, metered dose",Inhalation,02245126,ADVAIR (fluticasone propionate 125 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9006275,fluticasone propionate 125 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation,8000279,fluticasone and salmeterol,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
69137,Marketed,2001-12-21,02245127,ADVAIR,2.0,R03AK06,Salmeterol and fluticasone,"Aerosol, metered dose",Inhalation,02245127,ADVAIR (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation) GLAXOSMITHKLINE INC,Active,9006276,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 25 mcg per actuation pressurized inhalation,8000279,fluticasone and salmeterol,447694001,Inhalation,420847003,Metered dose aerosol,732981002,Actuation (unit of presentation),,,
98451,Marketed,2020-03-05,02494507,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494507,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98452,Marketed,2020-03-05,02494515,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494515,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98453,Marketed,2020-03-05,02494523,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02494523,PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) PHARMASCIENCE INC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98549,Marketed,2020-02-13,02495597,WIXELA INHUB,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495597,WIXELA INHUB (fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006268,fluticasone propionate 100 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98550,Marketed,2020-02-13,02495600,WIXELA INHUB,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495600,WIXELA INHUB (fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006269,fluticasone propionate 250 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98551,Marketed,2020-02-13,02495619,WIXELA INHUB,2.0,R03AK06,Salmeterol and fluticasone,Powder,Inhalation,02495619,WIXELA INHUB (fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder) MYLAN PHARMACEUTICALS ULC,Active,9006270,fluticasone propionate 500 mcg per actuation and salmeterol (salmeterol xinafoate) 50 mcg per actuation inhalation powder,8000279,fluticasone and salmeterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
83577,Marketed,2019-04-11,02350580,KUVAN,1.0,A16AX07,Sapropterin,Tablet,Oral,02350580,KUVAN (sapropterin dihydrochloride 100 mg oral tablet) BIOMARIN INTERNATIONAL LIMITED,Active,9004745,sapropterin dihydrochloride 100 mg oral tablet,8001929,sapropterin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97268,Marketed,2019-12-05,02482207,KUVAN,1.0,A16AX07,Sapropterin,Powder,Oral,02482207,KUVAN (sapropterin dihydrochloride 100 mg per sachet powder for oral solution) BIOMARIN INTERNATIONAL LIMITED,Active,9014273,sapropterin dihydrochloride 100 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
102345,Marketed,2023-12-11,02534533,REDDY-SAPROPTERIN,1.0,A16AX07,Sapropterin,Powder for solution,Oral,02534533,REDDY-SAPROPTERIN (sapropterin dihydrochloride 100 mg per sachet powder for oral solution) DR REDDY'S LABORATORIES LTD,Active,9014273,sapropterin dihydrochloride 100 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
102445,Marketed,2023-12-19,02535610,REDDY-SAPROPTERIN,1.0,A16AX07,Sapropterin,Powder for solution,Oral,02535610,REDDY-SAPROPTERIN (sapropterin dihydrochloride 500 mg per sachet powder for oral solution) DR REDDY'S LABORATORIES LTD,Active,9014274,sapropterin dihydrochloride 500 mg per sachet powder for oral solution,8001929,sapropterin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
94797,Marketed,2017-02-08,02460548,KEVZARA,1.0,L04AC14,Sarilumab,Solution,Subcutaneous,02460548,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection syringe) SANOFI-AVENTIS CANADA INC,Active,9013338,sarilumab 200 mg per 1.14 mL solution for injection syringe,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
96232,Marketed,2018-06-21,02472961,KEVZARA,1.0,L04AC14,Sarilumab,Solution,Subcutaneous,02472961,KEVZARA (sarilumab 150 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013335,sarilumab 150 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
96233,Marketed,2018-06-21,02472988,KEVZARA,1.0,L04AC14,Sarilumab,Solution,Subcutaneous,02472988,KEVZARA (sarilumab 200 mg per 1.14 mL solution for injection pen) SANOFI-AVENTIS CANADA INC,Active,9013337,sarilumab 200 mg per 1.14 mL solution for injection pen,8001930,sarilumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
98941,Marketed,2020-08-26,02499681,ENSPRYNG,1.0,L04AC19,Satralizumab,Solution,Subcutaneous,02499681,ENSPRYNG (satralizumab 120 mg per 1 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9014390,satralizumab 120 mg per 1 mL solution for injection syringe,8002346,satralizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
81917,Marketed,2014-12-03,02333554,ONGLYZA,1.0,A10BH03,Saxagliptin,Tablet,Oral,02333554,ONGLYZA (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86124,Marketed,2015-02-18,02375842,ONGLYZA,1.0,A10BH03,Saxagliptin,Tablet,Oral,02375842,ONGLYZA (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) ASTRAZENECA CANADA INC,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95702,Marketed,2021-03-08,02468603,SANDOZ SAXAGLIPTIN,1.0,A10BH03,Saxagliptin,Tablet,Oral,02468603,SANDOZ SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95703,Marketed,2021-03-08,02468611,SANDOZ SAXAGLIPTIN,1.0,A10BH03,Saxagliptin,Tablet,Oral,02468611,SANDOZ SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99686,Marketed,2021-03-29,02507471,APO-SAXAGLIPTIN,1.0,A10BH03,Saxagliptin,Tablet,Oral,02507471,APO-SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet) APOTEX INC,Active,9001372,saxagliptin (saxagliptin hydrochloride) 2.5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99687,Marketed,2021-03-29,02507498,APO-SAXAGLIPTIN,1.0,A10BH03,Saxagliptin,Tablet,Oral,02507498,APO-SAXAGLIPTIN (saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9001296,saxagliptin (saxagliptin hydrochloride) 5 mg oral tablet,8000391,saxagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66635,Marketed,2008-05-31,02242810,SCOPOLAMINE HYDROBROMIDE INJECTION,1.0,N05CM05,Scopolamine,Liquid,"Subcutaneous,Intramuscular,Intravenous",02242810,SCOPOLAMINE HYDROBROMIDE INJECTION (scopolamine hydrobromide 0.4 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013242,scopolamine hydrobromide 0.4 mg per 1 mL solution for injection vial,8002211,scopolamine hydrobromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66636,Marketed,2008-07-08,02242811,SCOPOLAMINE HYDROBROMIDE INJECTION,1.0,N05CM05,Scopolamine,Liquid,"Intramuscular,Intravenous,Subcutaneous",02242811,SCOPOLAMINE HYDROBROMIDE INJECTION (scopolamine hydrobromide 0.6 mg per 1 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013244,scopolamine hydrobromide 0.6 mg per 1 mL solution for injection vial,8002211,scopolamine hydrobromide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95840,Marketed,2018-04-05,02469596,KANUMA,1.0,A16AB14,Sebelipase alfa,Solution,Intravenous,02469596,KANUMA (sebelipase alfa 20 mg per 10 mL solution for injection vial) ALEXION PHARMA GMBH,Active,9013339,sebelipase alfa 20 mg per 10 mL solution for injection vial,8001931,sebelipase alfa,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92243,Marketed,2015-04-10,02438070,COSENTYX,1.0,L04AC10,Secukinumab,Solution,Subcutaneous,77700900,COSENTYX (secukinumab 150 mg per 1 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013340,secukinumab 150 mg per 1 mL solution for injection pen,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101457,Marketed,2022-06-02,02525569,COSENTYX,1.0,L04AC10,Secukinumab,Solution,Subcutaneous,02525569,COSENTYX (secukinumab 75 mg per 0.5 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014730,secukinumab 75 mg per 0.5 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101890,Marketed,2025-09-17,02529653,COSENTYX,1.0,L04AC10,Secukinumab,Solution,Subcutaneous,02529653,COSENTYX (secukinumab 300 mg per 2 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015271,secukinumab 300 mg per 2 mL solution for injection syringe,8001932,secukinumab,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
101891,Marketed,2025-08-21,02529661,COSENTYX,1.0,L04AC10,Secukinumab,Solution,Subcutaneous,02529661,COSENTYX (secukinumab 300 mg per 2 mL solution for injection pen) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9015250,secukinumab 300 mg per 2 mL solution for injection pen,8001932,secukinumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,
103665,Marketed,2025-04-17,02547724,COSENTYX,1.0,L04AC10,Secukinumab,Solution,Subcutaneous,02547724,COSENTYX (secukinumab 150 mg per 1 mL solution for injection syringe) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9013341,secukinumab 150 mg per 1 mL solution for injection syringe,8001932,secukinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
106445,Marketed,2025-11-25,02561492,LYVDELZI,1.0,A05AX07,Seladelpar,Capsule,Oral,02561492,LYVDELZI (seladelpar (seladelpar lysine) 10 mg oral capsule) GILEAD SCIENCES CANADA INC,Active,9015326,seladelpar (seladelpar lysine) 10 mg oral capsule,8002568,seladelpar,26643006,Oral,420692007,Oral capsule,732937005,Capsule,,,
49813,Marketed,2021-08-23,02230641,SELEGILINE,1.0,N04BD01,Selegiline,Tablet,Oral,02230641,SELEGILINE (selegiline hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9002715,selegiline hydrochloride 5 mg oral tablet,8001524,selegiline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81473,Marketed,2019-02-26,02329050,SEHCAT,1.0,V09DX01,Selenium 75 se tauroselcholic acid,Capsule,Oral,,,,,,,,,,,,,,,,
93741,Marketed,2020-03-17,02451158,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451158,UPTRAVI (selexipag 200 mcg oral tablet) JANSSEN INC,Active,9005942,selexipag 200 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93742,Marketed,2019-12-16,02451166,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451166,UPTRAVI (selexipag 400 mcg oral tablet) JANSSEN INC,Active,9005943,selexipag 400 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93743,Marketed,2020-03-17,02451174,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451174,UPTRAVI (selexipag 600 mcg oral tablet) JANSSEN INC,Active,9005944,selexipag 600 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93744,Marketed,2020-03-23,02451182,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451182,UPTRAVI (selexipag 800 mcg oral tablet) JANSSEN INC,Active,9005945,selexipag 800 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93745,Marketed,2020-03-17,02451190,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451190,UPTRAVI (selexipag 1000 mcg oral tablet) JANSSEN INC,Active,9005938,selexipag 1000 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93746,Marketed,2020-01-08,02451204,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451204,UPTRAVI (selexipag 1200 mcg oral tablet) JANSSEN INC,Active,9005939,selexipag 1200 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93747,Marketed,2020-01-06,02451212,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451212,UPTRAVI (selexipag 1400 mcg oral tablet) JANSSEN INC,Active,9005940,selexipag 1400 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93748,Marketed,2019-11-08,02451220,UPTRAVI,1.0,B01AC27,Selexipag,Tablet,Oral,02451220,UPTRAVI (selexipag 1600 mcg oral tablet) JANSSEN INC,Active,9005941,selexipag 1600 mcg oral tablet,8001934,selexipag,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101672,Marketed,2022-07-07,02527677,XPOVIO,1.0,L01XX66,Selinexor,Tablet,Oral,02527677,XPOVIO (selinexor 20 mg oral tablet) FORUS THERAPEUTICS INC.,Active,9014742,selinexor 20 mg oral tablet,8002428,selinexor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100625,Marketed,2025-11-06,02516918,RETEVMO,1.0,L01EX22,Selpercatinib,Capsule,Oral,02516918,RETEVMO (selpercatinib 40 mg oral capsule) ELI LILLY CANADA INC,Active,9014743,selpercatinib 40 mg oral capsule,8002429,selpercatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100626,Marketed,2025-11-06,02516926,RETEVMO,1.0,L01EX22,Selpercatinib,Capsule,Oral,02516926,RETEVMO (selpercatinib 80 mg oral capsule) ELI LILLY CANADA INC,Active,9014744,selpercatinib 80 mg oral capsule,8002429,selpercatinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101934,Marketed,2024-04-26,02530139,KOSELUGO,1.0,L01EE04,Selumetinib,Capsule,Oral,02530139,KOSELUGO (selumetinib (selumetinib sulfate) 10 mg oral capsule) ALEXION PHARMA GMBH,Active,9014823,selumetinib (selumetinib sulfate) 10 mg oral capsule,8002459,selumetinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101935,Marketed,2024-10-02,02530147,KOSELUGO,1.0,L01EE04,Selumetinib,Capsule,Oral,02530147,KOSELUGO (selumetinib (selumetinib sulfate) 25 mg oral capsule) ALEXION PHARMA GMBH,Active,9014824,selumetinib (selumetinib sulfate) 25 mg oral capsule,8002459,selumetinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
96058,Marketed,2018-02-22,02471469,OZEMPIC,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02471469,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 1 MG DOSES (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,
96059,Marketed,2018-02-22,02471477,OZEMPIC,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02471477,OZEMPIC MULTIDOSE PREFILLED PEN DISPENSES 0.25MG OR 0.5MG DOSE (semaglutide 1.34 mg per mL solution for injection 1.5 mL pen) NOVO NORDISK CANADA INC,Active,9013021,semaglutide 1.34 mg per mL solution for injection 1.5 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
98740,Marketed,2020-04-19,02497581,RYBELSUS,1.0,A10BJ06,Semaglutide,Tablet,Oral,02497581,RYBELSUS (semaglutide 3 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014276,semaglutide 3 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98741,Marketed,2020-04-19,02497603,RYBELSUS,1.0,A10BJ06,Semaglutide,Tablet,Oral,02497603,RYBELSUS (semaglutide 7 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014277,semaglutide 7 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98742,Marketed,2020-04-19,02497611,RYBELSUS,1.0,A10BJ06,Semaglutide,Tablet,Oral,02497611,RYBELSUS (semaglutide 14 mg oral tablet) NOVO NORDISK CANADA INC,Active,9014275,semaglutide 14 mg oral tablet,8001525,semaglutide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101765,Marketed,2024-03-28,02528509,WEGOVY,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02528509,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.25 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015039,semaglutide 0.25 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,
101773,Marketed,2024-04-02,02528517,WEGOVY,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02528517,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 0.5 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015040,semaglutide 0.5 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,
101774,Marketed,2024-03-28,02528525,WEGOVY,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02528525,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9013605,semaglutide 1 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),1.0,,
101775,Marketed,2024-04-02,02528533,WEGOVY,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02528533,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 1.7 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015041,semaglutide 1.7 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,
101776,Marketed,2024-04-22,02528541,WEGOVY,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02528541,WEGOVY MULTI-DOSE PRE-FILLED PEN (semaglutide 2.4 mg per actuation solution for injection pre-filled pen) NOVO NORDISK CANADA INC,Active,9015042,semaglutide 2.4 mg per actuation solution for injection pre-filled pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation,1.0,,
102895,Marketed,2023-12-22,02540258,OZEMPIC,1.0,A10BJ06,Semaglutide,Solution,Subcutaneous,02540258,OZEMPIC MULTI-DOSE PRE-FILLED PEN DISPENSES 0.25 MG OR 0.5 MG DOSES (semaglutide 0.68 mg per mL solution for injection 3 mL pen) NOVO NORDISK CANADA INC,Active,9015008,semaglutide 0.68 mg per mL solution for injection 3 mL pen,8001525,semaglutide,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),1.0,,
2133,Marketed,2025-09-17,00026123,SENOKOT S,2.0,A06AB56,"Senna glycosides, combinations",Tablet,Oral,00026123,SENOKOT S (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) INOVA PHARMACEUTICALS (AUSTRALIA) PTY LIMITED,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71178,Marketed,2024-12-31,02246951,SENNA S. TABLETS,2.0,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02246951,SENNA S. TABLETS (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) SIGMA LIFE SCIENCES INC.,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71374,Marketed,2003-03-07,02247134,SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS,2.0,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02247134,SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) VITA HEALTH PRODUCTS INC,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71635,Marketed,2017-12-27,02247390,SANDOZ SENNA S,2.0,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02247390,SANDOZ SENNA S (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100558,Marketed,2025-05-23,02516209,COLACE PLUS STIMULANT LAXATIVE,2.0,A06AB56,"Senna glycosides, combinations",Tablet,Oral,02516209,COLACE PLUS STIMULANT LAXATIVE (docusate sodium 50 mg and sennosides 8.6 mg oral tablet) PHARMASCIENCE INC,Active,9003784,docusate sodium 50 mg and sennosides 8.6 mg oral tablet,8000811,docusate and sennosides,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106475,Marketed,2025-12-01,02561824,SEPHIENCE,1.0,A16AX28,Sepiapterin,Powder,Oral,02561824,SEPHIENCE (sepiapterin 250 mg per sachet powder for oral suspension) PTC THERAPEUTICS INTERNATIONAL LIMITED,Active,9015328,sepiapterin 250 mg per sachet powder for oral suspension,8002569,sepiapterin,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet,,,
106476,Marketed,2025-12-01,02561832,SEPHIENCE,2.0,A16AX28,Sepiapterin,Powder,Oral,02561832,SEPHIENCE (sepiapterin 1000 mg per sachet powder for oral suspension) PTC THERAPEUTICS INTERNATIONAL LIMITED,Active,9015327,sepiapterin 1000 mg per sachet powder for oral suspension,8002569,sepiapterin,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet,,,
12662,Marketed,2023-08-22,01962817,ZOLOFT,1.0,N06AB06,Sertraline,Capsule,Oral,01962817,ZOLOFT (sertraline (sertraline hydrochloride) 50 mg oral capsule) BGP PHARMA ULC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
13392,Marketed,2023-08-22,01962779,ZOLOFT,1.0,N06AB06,Sertraline,Capsule,Oral,01962779,ZOLOFT (sertraline (sertraline hydrochloride) 100 mg oral capsule) BGP PHARMA ULC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
18005,Marketed,2023-08-22,02132702,ZOLOFT,1.0,N06AB06,Sertraline,Capsule,Oral,02132702,ZOLOFT (sertraline (sertraline hydrochloride) 25 mg oral capsule) BGP PHARMA ULC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
61676,Marketed,1999-09-01,02238280,APO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02238280,APO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) APOTEX INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
61677,Marketed,1999-09-01,02238281,APO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02238281,APO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) APOTEX INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
61678,Marketed,1999-09-01,02238282,APO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02238282,APO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) APOTEX INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64051,Marketed,2010-11-13,02240481,TEVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02240481,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) TEVA CANADA LIMITED,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64054,Marketed,2010-11-13,02240484,TEVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02240484,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) TEVA CANADA LIMITED,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64055,Marketed,2010-11-13,02240485,TEVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02240485,TEVA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64918,Marketed,2001-02-15,02241302,SERTRALINE-25,1.0,N06AB06,Sertraline,Capsule,Oral,02241302,SERTRALINE-25 (sertraline (sertraline hydrochloride) 25 mg oral capsule) PRO DOC LIMITEE,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64919,Marketed,2001-02-15,02241303,SERTRALINE-50,1.0,N06AB06,Sertraline,Capsule,Oral,02241303,SERTRALINE-50 (sertraline (sertraline hydrochloride) 50 mg oral capsule) PRO DOC LIMITEE,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
64920,Marketed,2001-02-15,02241304,SERTRALINE-100,1.0,N06AB06,Sertraline,Capsule,Oral,02241304,SERTRALINE-100 (sertraline (sertraline hydrochloride) 100 mg oral capsule) PRO DOC LIMITEE,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68828,Marketed,2002-01-30,02244838,PMS-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02244838,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) PHARMASCIENCE INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68829,Marketed,2002-01-30,02244839,PMS-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02244839,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) PHARMASCIENCE INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68830,Marketed,2002-01-30,02244840,PMS-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02244840,PMS-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) PHARMASCIENCE INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72848,Marketed,2024-06-27,02248496,RIVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02248496,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72849,Marketed,2024-06-27,02248497,RIVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02248497,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72850,Marketed,2024-06-27,02248498,RIVA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02248498,RIVA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) LABORATOIRE RIVA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83874,Marketed,2022-06-21,02353520,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02353520,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) SANIS HEALTH INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83875,Marketed,2022-06-21,02353539,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02353539,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) SANIS HEALTH INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
83876,Marketed,2022-06-21,02353547,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02353547,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) SANIS HEALTH INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87166,Marketed,2019-04-05,02386070,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02386070,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87167,Marketed,2019-04-05,02386089,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02386089,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87168,Marketed,2019-04-05,02386097,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02386097,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87629,Marketed,2012-10-18,02390906,AURO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02390906,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) AURO PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87630,Marketed,2012-10-18,02390914,AURO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02390914,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) AURO PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
87631,Marketed,2012-10-18,02390922,AURO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02390922,AURO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) AURO PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88430,Marketed,2014-01-16,02399415,MAR-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02399415,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88431,Marketed,2014-01-06,02399423,MAR-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02399423,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88432,Marketed,2014-01-16,02399431,MAR-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02399431,MAR-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88721,Marketed,2013-04-29,02402378,MINT-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02402378,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88722,Marketed,2013-04-29,02402394,MINT-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02402394,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
88723,Marketed,2013-04-29,02402408,MINT-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02402408,MINT-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MINT PHARMACEUTICALS INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93025,Marketed,2016-11-23,02445042,BIO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02445042,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) BIOMED PHARMA,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93026,Marketed,2016-11-23,02445050,BIO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02445050,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) BIOMED PHARMA,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
93027,Marketed,2016-12-08,02445069,BIO-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02445069,BIO-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) BIOMED PHARMA,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95842,Marketed,2018-01-17,02469626,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02469626,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95843,Marketed,2018-01-17,02469634,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02469634,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
95844,Marketed,2018-01-17,02469642,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02469642,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96809,Marketed,2018-09-06,02477882,AG-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02477882,AG-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) ANGITA PHARMA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96810,Marketed,2018-09-06,02477890,AG-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02477890,AG-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) ANGITA PHARMA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96811,Marketed,2018-09-06,02477904,AG-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02477904,AG-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) ANGITA PHARMA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97852,Marketed,2019-09-04,02488434,NRA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02488434,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) NORA PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97853,Marketed,2019-09-04,02488442,NRA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02488442,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) NORA PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97854,Marketed,2019-09-04,02488450,NRA-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02488450,NRA-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) NORA PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102010,Marketed,2023-03-20,02530937,M-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02530937,M-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) MANTRA PHARMA INC,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102011,Marketed,2023-03-20,02530945,M-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02530945,M-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) MANTRA PHARMA INC,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102012,Marketed,2023-03-20,02530953,M-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02530953,M-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) MANTRA PHARMA INC,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102599,Marketed,2024-04-09,02537249,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02537249,SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) ALTAMED PHARMA,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102600,Marketed,2023-12-21,02537265,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02537265,SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) ALTAMED PHARMA,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102602,Marketed,2023-12-13,02537281,SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02537281,SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) ALTAMED PHARMA,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104494,Marketed,2025-07-16,02556235,NB-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02556235,NB-SERTRALINE (sertraline (sertraline hydrochloride) 25 mg oral capsule) NB PHARMA INC.,Active,9000635,sertraline (sertraline hydrochloride) 25 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104495,Marketed,2025-07-16,02556243,NB-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02556243,NB-SERTRALINE (sertraline (sertraline hydrochloride) 50 mg oral capsule) NB PHARMA INC.,Active,9000446,sertraline (sertraline hydrochloride) 50 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
104496,Marketed,2025-07-16,02556251,NB-SERTRALINE,1.0,N06AB06,Sertraline,Capsule,Oral,02556251,NB-SERTRALINE (sertraline (sertraline hydrochloride) 100 mg oral capsule) NB PHARMA INC.,Active,9000445,sertraline (sertraline hydrochloride) 100 mg oral capsule,8000171,sertraline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102647,Marketed,2023-07-12,02537745,IMCIVREE,1.0,A08AA12,Setmelanotide,Solution,Subcutaneous,02537745,"IMCIVREE (setmelanotide (setmelanotide acetate) 10 mg per 1 mL solution for injection vial) RHYTHM PHARMACEUTICALS, INC.",Active,9014896,setmelanotide (setmelanotide acetate) 10 mg per 1 mL solution for injection vial,8002473,setmelanotide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
68278,Marketed,2015-02-13,02244310,RENAGEL,1.0,V03AE02,Sevelamer,Tablet,Oral,02244310,RENAGEL (sevelamer hydrochloride 800 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9003668,sevelamer hydrochloride 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83974,Marketed,2014-07-24,02354586,RENVELA,1.0,V03AE02,Sevelamer,Tablet,Oral,02354586,RENVELA (sevelamer carbonate 800 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9004792,sevelamer carbonate 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94913,Marketed,2017-11-08,02461501,ACCEL-SEVELAMER,1.0,V03AE02,Sevelamer,Tablet,Oral,02461501,ACCEL-SEVELAMER (sevelamer carbonate 800 mg oral tablet) ACCEL PHARMA INC,Active,9004792,sevelamer carbonate 800 mg oral tablet,8001877,sevelamer,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19497,Marketed,2014-06-19,02172763,SEVORANE AF,1.0,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
75141,Marketed,2007-04-11,02265974,SEVOFLURANE,1.0,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
79344,Marketed,2022-06-27,02307766,SEVOFLURANE,1.0,N01AB08,Sevoflurane,Liquid,Inhalation,,,,,,,,,,,,,,,,
63248,Marketed,2023-07-28,02239766,VIAGRA,1.0,G04BE03,Sildenafil,Tablet,Oral,02239766,VIAGRA (sildenafil (sildenafil citrate) 25 mg oral tablet) BGP PHARMA ULC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63249,Marketed,2023-07-28,02239767,VIAGRA,1.0,G04BE03,Sildenafil,Tablet,Oral,02239767,VIAGRA (sildenafil (sildenafil citrate) 50 mg oral tablet) BGP PHARMA ULC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63250,Marketed,2023-07-28,02239768,VIAGRA,1.0,G04BE03,Sildenafil,Tablet,Oral,02239768,VIAGRA (sildenafil (sildenafil citrate) 100 mg oral tablet) BGP PHARMA ULC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72537,Marketed,2012-11-14,02248201,APO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02248201,APO-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) APOTEX INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72538,Marketed,2012-11-14,02248202,APO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02248202,APO-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) APOTEX INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72539,Marketed,2012-11-09,02248203,APO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02248203,APO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) APOTEX INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79435,Marketed,2012-12-19,02308738,TEVA-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02308738,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79436,Marketed,2012-12-19,02308746,TEVA-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02308746,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79437,Marketed,2012-12-19,02308754,TEVA-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02308754,TEVA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80308,Marketed,2013-08-05,02317559,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02317559,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80310,Marketed,2013-08-05,02317575,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02317575,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80311,Marketed,2013-08-05,02317583,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02317583,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87831,Marketed,2025-11-07,02393069,MINT-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02393069,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87832,Marketed,2013-02-15,02393077,MINT-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02393077,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87833,Marketed,2013-02-15,02393085,MINT-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02393085,MINT-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88547,Marketed,2024-04-29,02400693,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02400693,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88548,Marketed,2024-04-29,02400707,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02400707,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88549,Marketed,2024-04-29,02400715,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02400715,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88737,Marketed,2017-01-11,02402548,MAR-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02402548,MAR-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89088,Marketed,2024-04-01,02406152,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02406152,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89089,Marketed,2024-06-25,02406160,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02406160,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89902,Marketed,2019-05-17,02414368,AURO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02414368,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) AURO PHARMA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89903,Marketed,2019-05-17,02414376,AURO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02414376,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) AURO PHARMA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89904,Marketed,2019-05-17,02414384,AURO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02414384,AURO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) AURO PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90902,Marketed,2014-10-07,02424312,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02424312,SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90903,Marketed,2014-10-07,02424320,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02424320,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91445,Marketed,2015-06-04,02430037,M-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02430037,M-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) MANTRA PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93880,Marketed,2023-07-20,02452413,RIVA-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02452413,RIVA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95698,Marketed,2021-08-20,02468557,PRZ-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02468557,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) PHARMARIS CANADA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96718,Marketed,2018-12-04,02476819,NRA-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02476819,NRA-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) NORA PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97038,Marketed,2019-08-15,02479796,ACCEL-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02479796,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) ACCEL PHARMA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97040,Marketed,2019-08-15,02479818,ACCEL-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02479818,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) ACCEL PHARMA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97041,Marketed,2019-08-15,02479826,ACCEL-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02479826,ACCEL-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) ACCEL PHARMA INC,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97103,Marketed,2019-07-02,02480980,BIO-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02480980,BIO-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) BIOMED PHARMA,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99282,Marketed,2021-07-30,02503344,AG-SILDENAFIL TABLETS,1.0,G04BE03,Sildenafil,Tablet,Oral,02503344,AG-SILDENAFIL TABLETS (sildenafil (sildenafil citrate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99297,Marketed,2021-01-27,02503506,JAMP SILDENAFIL TABLETS,1.0,G04BE03,Sildenafil,Tablet,Oral,02503506,JAMP SILDENAFIL TABLETS (sildenafil (sildenafil citrate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99450,Marketed,2021-08-20,02505150,PRZ-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02505150,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) PHARMARIS CANADA INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99451,Marketed,2021-08-20,02505169,PRZ-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02505169,PRZ-SILDENAFIL (sildenafil (sildenafil citrate) 50 mg oral tablet) PHARMARIS CANADA INC,Active,9000838,sildenafil (sildenafil citrate) 50 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102652,Marketed,2024-03-12,02537737,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02537737,SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) ALTAMED PHARMA,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102945,Marketed,2024-07-11,02540770,SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02540770,SILDENAFIL (sildenafil (sildenafil citrate) 25 mg oral tablet) SANIS HEALTH INC,Active,9000837,sildenafil (sildenafil citrate) 25 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103103,Marketed,2025-04-03,02542463,UPH-SILDENAFIL,1.0,G04BE03,Sildenafil,Tablet,Oral,02542463,UPH-SILDENAFIL (sildenafil (sildenafil citrate) 100 mg oral tablet) UPHEALTH PHARMA INC.,Active,9000836,sildenafil (sildenafil citrate) 100 mg oral tablet,8000268,sildenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103270,Marketed,2024-09-26,02544172,VIAGRA,1.0,G04BE03,Sildenafil,"Film, soluble",Oral,02544172,VIAGRA (sildenafil (sildenafil citrate) 50 mg orodispersible film) BGP PHARMA ULC,Active,9015105,sildenafil (sildenafil citrate) 50 mg orodispersible film,8000268,sildenafil,26643006,Oral,447050008,Orodispersible film,732995004,Film,,,
27514,Marketed,2002-10-02,02060841,BARRIERE CREAM 20%,1.0,D02AA,Silicone products,Cream,Topical,02060841,BARRIERE CREAM 20% (silicone 20 % cutaneous cream) WELLSPRING PHARMACEUTICAL CANADA CORP,Active,9003079,silicone 20 % cutaneous cream,8002157,silicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
67909,Marketed,2009-06-18,02243966,BAZA CLEANSE & PROTECT,1.0,D02AA,Silicone products,Lotion,Topical,02243966,BAZA CLEANSE & PROTECT (dimethicone 2 % lotion) COLOPLAST A/S,Active,9003726,dimethicone 2 % lotion,8001633,dimethicone,448598008,Cutaneous,739000003,Lotion,,,,,
69988,Marketed,2004-12-10,02245871,COMFORT SHIELD,1.0,D02AA,Silicone products,Wipe,Topical,02245871,COMFORT SHIELD (dimethicone 3 % wipe) SAGE PRODUCTS LLC,Active,9003988,dimethicone 3 % wipe,8001633,dimethicone,448598008,Cutaneous,465925000,Wipe,465925000,Skin-cleaning wipe (physical object),,,
73513,Marketed,2009-06-18,02250322,SWEEN 24,1.0,D02AA,Silicone products,Cream,Topical,02250322,SWEEN 24 (dimethicone 6 % cutaneous cream) COLOPLAST A/S,Active,9003979,dimethicone 6 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
74220,Marketed,2015-11-26,02256975,PROSHIELD PLUS,1.0,D02AA,Silicone products,Ointment,Topical,02256975,PROSHIELD PLUS (dimethicone 1 % cutaneous ointment) SMITH & NEPHEW INC,Active,9004015,dimethicone 1 % cutaneous ointment,8001633,dimethicone,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
78703,Marketed,2008-05-30,02301725,DIMETHICONE PROTECTANT,1.0,D02AA,Silicone products,Cream,Topical,02301725,DIMETHICONE PROTECTANT (dimethicone 5 % cutaneous cream) SMITH & NEPHEW INC,Active,9004425,dimethicone 5 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
94265,Marketed,2024-07-12,02455838,CAVILON DURABLE BARRIER CREAM,1.0,D02AA,Silicone products,Cream,Topical,02455838,CAVILON DURABLE BARRIER CREAM (dimethicone 1.3 % cutaneous cream) 3M HEALTHCARE CANADA COMPANY LIMITED,Active,9006166,dimethicone 1.3 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
101693,Marketed,2023-02-14,02527731,CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE,1.0,D02AA,Silicone products,Cream,Topical,02527731,CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE (dimethicone 9 % cutaneous cream) LABORATOIRES LA ROCHE-POSAY CANADA,Active,9014829,dimethicone 9 % cutaneous cream,8001633,dimethicone,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
198,Marketed,2021-01-11,00013617,OVOL DROPS,1.0,A03AX13,Silicones,Drops,Oral,00013617,OVOL DROPS (simethicone 40 mg per mL oral drops) CHURCH & DWIGHT CANADA CORP,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
1889,Marketed,2016-11-29,00292990,OVOL FOR GAS 80 MG TABLET,1.0,A03AX13,Silicones,Tablet,Oral,00292990,OVOL FOR GAS 80 MG TABLET (simethicone 80 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9001724,simethicone 80 mg oral tablet,8002158,simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13362,Marketed,2024-04-10,00896675,GAS-X EXTRA STRENGTH,1.0,A03AX13,Silicones,Tablet (chewable),Oral,00896675,GAS-X EXTRA STRENGTH (simethicone 125 mg chewable tablet) HALEON CANADA ULC,Active,9002385,simethicone 125 mg chewable tablet,8002158,simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
61044,Marketed,2013-12-06,02237698,ULTRA STRENGTH PHAZYME 180MG SOFTGELS,1.0,A03AX13,Silicones,Capsule,Oral,02237698,ULTRA STRENGTH PHAZYME 180MG SOFTGELS (simethicone 180 mg oral capsule) C B FLEET COMPANY INC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
62764,Marketed,2016-12-02,02239298,OVOL FOR GAS 180 MG CAPSULE,1.0,A03AX13,Silicones,Capsule,Oral,02239298,OVOL FOR GAS 180 MG CAPSULE (simethicone 180 mg oral capsule) CHURCH & DWIGHT CANADA CORP,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
68167,Marketed,2010-07-01,02244204,ULTRA STRENGTH GAS RELIEF,1.0,A03AX13,Silicones,Capsule,Oral,02244204,ULTRA STRENGTH GAS RELIEF (simethicone 180 mg oral capsule) VITA HEALTH PRODUCTS INC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
69597,Marketed,2004-05-21,02245510,PEDIACOL,1.0,A03AX13,Silicones,Drops,Oral,02245510,PEDIACOL (simethicone 40 mg per mL oral drops) EURO-PHARM INTERNATIONAL CANADA INC,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
71367,Marketed,2016-12-02,02247127,OVOL FOR GAS 180 MG TABLET,1.0,A03AX13,Silicones,Tablet,Oral,02247127,OVOL FOR GAS 180 MG TABLET (simethicone 180 mg oral tablet) CHURCH & DWIGHT CANADA CORP,Active,9003803,simethicone 180 mg oral tablet,8002158,simethicone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72943,Marketed,2025-07-04,02248588,INFACOL,1.0,A03AX13,Silicones,Suspension,Oral,02248588,INFACOL (simethicone 40 mg per mL oral drops) PHOENIX LABS UNLIMITED COMPANY,Active,9001600,simethicone 40 mg per mL oral drops,8002158,simethicone,26643006,Oral,385018001,Oral drops,732994000,Drop (unit of presentation),,,
78612,Marketed,2024-05-23,02300761,GAS X ULTRA STRENGTH,1.0,A03AX13,Silicones,Capsule,Oral,02300761,GAS X ULTRA STRENGTH (simethicone 180 mg oral capsule) HALEON CANADA ULC,Active,9003321,simethicone 180 mg oral capsule,8002158,simethicone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81363,Marketed,2010-03-25,02328127,GAS RELIEF TABLETS,1.0,A03AX13,Silicones,Tablet (chewable),Oral,02328127,GAS RELIEF TABLETS (simethicone 125 mg chewable tablet) GUARDIAN DRUG COMPANY INC,Active,9002385,simethicone 125 mg chewable tablet,8002158,simethicone,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
96581,Marketed,2021-01-08,02475421,SANDOZ SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02475421,SANDOZ SILODOSIN (silodosin 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96582,Marketed,2021-01-08,02475448,SANDOZ SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02475448,SANDOZ SILODOSIN (silodosin 8 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96929,Marketed,2022-02-16,02478501,AURO-SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02478501,AURO-SILODOSIN (silodosin 4 mg oral capsule) AURO PHARMA INC,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96930,Marketed,2022-02-16,02478528,AURO-SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02478528,AURO-SILODOSIN (silodosin 8 mg oral capsule) AURO PHARMA INC,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100713,Marketed,2021-10-21,02517779,PMS-SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02517779,PMS-SILODOSIN (silodosin 4 mg oral capsule) PHARMASCIENCE INC,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100714,Marketed,2021-10-21,02517787,PMS-SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02517787,PMS-SILODOSIN (silodosin 8 mg oral capsule) PHARMASCIENCE INC,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102827,Marketed,2024-05-22,02539519,JAMP SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02539519,JAMP SILODOSIN (silodosin 4 mg oral capsule) JAMP PHARMA CORPORATION,Active,9012394,silodosin 4 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
102828,Marketed,2024-05-22,02539527,JAMP SILODOSIN,1.0,G04CA04,Silodosin,Capsule,Oral,02539527,JAMP SILODOSIN (silodosin 8 mg oral capsule) JAMP PHARMA CORPORATION,Active,9012395,silodosin 8 mg oral capsule,8001120,silodosin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
91940,Marketed,2024-07-30,02435128,SYLVANT,1.0,L04AC11,Siltuximab,Powder for solution,Intravenous,02435128,SYLVANT (siltuximab 100 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005671,siltuximab 100 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
91941,Marketed,2024-07-30,02435136,SYLVANT,1.0,L04AC11,Siltuximab,Powder for solution,Intravenous,02435136,SYLVANT (siltuximab 400 mg per vial powder for solution for injection) RECORDATI RARE DISEASES CANADA INC,Active,9005672,siltuximab 400 mg per vial powder for solution for injection,8001935,siltuximab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
2146,Marketed,2001-01-01,00323098,FLAMAZINE,1.0,D06BA01,Silver sulfadiazine,Cream,Topical,00323098,FLAMAZINE (silver sulfadiazine 1 % cutaneous cream) SMITH & NEPHEW INC,Active,9001723,silver sulfadiazine 1 % cutaneous cream,8001526,silver sulfadiazine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
10947,Marketed,2022-03-11,00884332,ZOCOR,1.0,C10AA01,Simvastatin,Tablet,Oral,00884332,ZOCOR (simvastatin 10 mg oral tablet) ORGANON CANADA INC.,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16473,Marketed,2022-04-01,00884340,ZOCOR,1.0,C10AA01,Simvastatin,Tablet,Oral,00884340,ZOCOR (simvastatin 20 mg oral tablet) ORGANON CANADA INC.,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
46718,Marketed,2022-02-11,00884359,ZOCOR,1.0,C10AA01,Simvastatin,Tablet,Oral,00884359,ZOCOR (simvastatin 40 mg oral tablet) ORGANON CANADA INC.,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71245,Marketed,2002-12-20,02247011,APO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247011,APO-SIMVASTATIN (simvastatin 5 mg oral tablet) APOTEX INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71246,Marketed,2002-12-20,02247012,APO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247012,APO-SIMVASTATIN (simvastatin 10 mg oral tablet) APOTEX INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71247,Marketed,2002-12-20,02247013,APO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247013,APO-SIMVASTATIN (simvastatin 20 mg oral tablet) APOTEX INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71248,Marketed,2002-12-20,02247014,APO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247014,APO-SIMVASTATIN (simvastatin 40 mg oral tablet) APOTEX INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71249,Marketed,2002-12-20,02247015,APO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247015,APO-SIMVASTATIN (simvastatin 80 mg oral tablet) APOTEX INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71463,Marketed,2025-06-03,02247221,PRO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247221,PRO-SIMVASTATIN (simvastatin 10 mg oral tablet) PRO DOC LIMITEE,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71464,Marketed,2025-06-03,02247222,PRO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247222,PRO-SIMVASTATIN (simvastatin 20 mg oral tablet) PRO DOC LIMITEE,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71465,Marketed,2025-06-03,02247223,PRO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247223,PRO-SIMVASTATIN (simvastatin 40 mg oral tablet) PRO DOC LIMITEE,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71466,Marketed,2025-06-03,02247224,PRO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02247224,PRO-SIMVASTATIN (simvastatin 80 mg oral tablet) PRO DOC LIMITEE,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73495,Marketed,2010-05-01,02250144,TEVA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02250144,TEVA-SIMVASTATIN (simvastatin 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73496,Marketed,2010-05-01,02250152,TEVA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02250152,TEVA-SIMVASTATIN (simvastatin 10 mg oral tablet) TEVA CANADA LIMITED,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73497,Marketed,2010-05-01,02250160,TEVA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02250160,TEVA-SIMVASTATIN (simvastatin 20 mg oral tablet) TEVA CANADA LIMITED,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73498,Marketed,2010-05-01,02250179,TEVA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02250179,TEVA-SIMVASTATIN (simvastatin 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73499,Marketed,2010-05-01,02250187,TEVA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02250187,TEVA-SIMVASTATIN (simvastatin 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77028,Marketed,2021-03-03,02284723,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02284723,SIMVASTATIN (simvastatin 5 mg oral tablet) SANIS HEALTH INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77029,Marketed,2021-03-03,02284731,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02284731,SIMVASTATIN (simvastatin 10 mg oral tablet) SANIS HEALTH INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77030,Marketed,2021-03-03,02284758,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02284758,SIMVASTATIN (simvastatin 20 mg oral tablet) SANIS HEALTH INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77031,Marketed,2021-03-03,02284766,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02284766,SIMVASTATIN (simvastatin 40 mg oral tablet) SANIS HEALTH INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77032,Marketed,2021-03-03,02284774,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02284774,SIMVASTATIN (simvastatin 80 mg oral tablet) SANIS HEALTH INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81483,Marketed,2020-01-20,02329131,TARO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02329131,TARO-SIMVASTATIN (simvastatin 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81484,Marketed,2020-01-20,02329158,TARO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02329158,TARO-SIMVASTATIN (simvastatin 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81485,Marketed,2020-01-20,02329166,TARO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02329166,TARO-SIMVASTATIN (simvastatin 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81486,Marketed,2020-01-20,02329174,TARO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02329174,TARO-SIMVASTATIN (simvastatin 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81487,Marketed,2020-01-20,02329182,TARO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02329182,TARO-SIMVASTATIN (simvastatin 80 mg oral tablet) SUN PHARMA CANADA INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85804,Marketed,2011-09-07,02372932,MINT-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02372932,MINT-SIMVASTATIN (simvastatin 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85805,Marketed,2011-09-07,02372940,MINT-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02372940,MINT-SIMVASTATIN (simvastatin 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85806,Marketed,2011-09-07,02372959,MINT-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02372959,MINT-SIMVASTATIN (simvastatin 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85807,Marketed,2011-09-07,02372967,MINT-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02372967,MINT-SIMVASTATIN (simvastatin 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85808,Marketed,2011-09-07,02372975,MINT-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02372975,MINT-SIMVASTATIN (simvastatin 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86044,Marketed,2012-12-20,02375044,MAR-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375044,MAR-SIMVASTATIN (simvastatin 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86045,Marketed,2023-04-18,02375052,MAR-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375052,MAR-SIMVASTATIN (simvastatin 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86046,Marketed,2023-05-25,02375060,MAR-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375060,MAR-SIMVASTATIN (simvastatin 40 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86101,Marketed,2018-10-16,02375591,JAMP-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375591,JAMP-SIMVASTATIN (simvastatin 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86102,Marketed,2018-10-17,02375605,JAMP-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375605,JAMP-SIMVASTATIN (simvastatin 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86103,Marketed,2018-10-17,02375613,JAMP-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375613,JAMP-SIMVASTATIN (simvastatin 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86104,Marketed,2018-10-17,02375621,JAMP-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375621,JAMP-SIMVASTATIN (simvastatin 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86105,Marketed,2018-10-16,02375648,JAMP-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02375648,JAMP-SIMVASTATIN (simvastatin 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87187,Marketed,2022-05-31,02386291,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02386291,SIMVASTATIN (simvastatin 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87188,Marketed,2022-05-31,02386305,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02386305,SIMVASTATIN (simvastatin 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87189,Marketed,2022-05-31,02386313,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02386313,SIMVASTATIN (simvastatin 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87190,Marketed,2022-05-31,02386321,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02386321,SIMVASTATIN (simvastatin 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87191,Marketed,2022-05-31,02386348,SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02386348,SIMVASTATIN (simvastatin 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88996,Marketed,2013-07-08,02405148,AURO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02405148,AURO-SIMVASTATIN (simvastatin 5 mg oral tablet) AURO PHARMA INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88997,Marketed,2013-07-08,02405172,AURO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02405172,AURO-SIMVASTATIN (simvastatin 40 mg oral tablet) AURO PHARMA INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88998,Marketed,2013-07-08,02405156,AURO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02405156,AURO-SIMVASTATIN (simvastatin 10 mg oral tablet) AURO PHARMA INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88999,Marketed,2013-07-08,02405164,AURO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02405164,AURO-SIMVASTATIN (simvastatin 20 mg oral tablet) AURO PHARMA INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89000,Marketed,2013-07-08,02405180,AURO-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02405180,AURO-SIMVASTATIN (simvastatin 80 mg oral tablet) AURO PHARMA INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95892,Marketed,2017-11-29,02469979,PHARMA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02469979,PHARMA-SIMVASTATIN (simvastatin 5 mg oral tablet) PHARMASCIENCE INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95893,Marketed,2017-11-29,02469987,PHARMA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02469987,PHARMA-SIMVASTATIN (simvastatin 10 mg oral tablet) PHARMASCIENCE INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95894,Marketed,2017-11-29,02469995,PHARMA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02469995,PHARMA-SIMVASTATIN (simvastatin 20 mg oral tablet) PHARMASCIENCE INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95895,Marketed,2017-11-29,02470004,PHARMA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02470004,PHARMA-SIMVASTATIN (simvastatin 40 mg oral tablet) PHARMASCIENCE INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95896,Marketed,2017-11-29,02470012,PHARMA-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02470012,PHARMA-SIMVASTATIN (simvastatin 80 mg oral tablet) PHARMASCIENCE INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103845,Marketed,2025-05-30,02549638,PMSC-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02549638,PMSC-SIMVASTATIN (simvastatin 5 mg oral tablet) PHARMASCIENCE INC,Active,9001010,simvastatin 5 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103846,Marketed,2025-05-30,02549646,PMSC-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02549646,PMSC-SIMVASTATIN (simvastatin 10 mg oral tablet) PHARMASCIENCE INC,Active,9000369,simvastatin 10 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103847,Marketed,2025-05-30,02549654,PMSC-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02549654,PMSC-SIMVASTATIN (simvastatin 20 mg oral tablet) PHARMASCIENCE INC,Active,9000545,simvastatin 20 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103848,Marketed,2025-05-30,02549662,PMSC-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02549662,PMSC-SIMVASTATIN (simvastatin 40 mg oral tablet) PHARMASCIENCE INC,Active,9000643,simvastatin 40 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103849,Marketed,2025-05-30,02549670,PMSC-SIMVASTATIN,1.0,C10AA01,Simvastatin,Tablet,Oral,02549670,PMSC-SIMVASTATIN (simvastatin 80 mg oral tablet) PHARMASCIENCE INC,Active,9001011,simvastatin 80 mg oral tablet,8000142,simvastatin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
37574,Marketed,1998-07-08,02228602,KINEVAC,1.0,V04CC03,Sincalide,Powder for solution,Intravenous,02228602,KINEVAC (sincalide 5 mcg per vial powder for solution for injection) BRACCO IMAGING CANADA,Active,9003264,sincalide 5 mcg per vial powder for solution for injection,8001936,sincalide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98439,Marketed,2023-08-03,02494361,SINCALIDE FOR INJECTION,1.0,V04CC03,Sincalide,Powder for solution,Intravenous,02494361,SINCALIDE FOR INJECTION (sincalide 5 mcg per vial powder for solution for injection) AVIR PHARMA INC.,Active,9003264,sincalide 5 mcg per vial powder for solution for injection,8001936,sincalide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89643,Marketed,2024-07-19,02411849,VEREGEN,1.0,D06BB12,Sinecatechins,Ointment,Topical,02411849,VEREGEN (sinecatechins 10 % cutaneous ointment) ENDO OPERATIONS LTD.,Active,9005548,sinecatechins 10 % cutaneous ointment,8001937,sinecatechins,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
98630,Marketed,2020-04-24,02496429,MAYZENT,1.0,L04AE03,Siponimod,Tablet,Oral,02496429,MAYZENT (siponimod 0.25 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014299,siponimod 0.25 mg oral tablet,8002327,siponimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98631,Marketed,2020-04-24,02496437,MAYZENT,1.0,L04AE03,Siponimod,Tablet,Oral,02496437,MAYZENT (siponimod 2 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014300,siponimod 2 mg oral tablet,8002327,siponimod,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
67127,Marketed,2013-06-10,02243237,RAPAMUNE,1.0,L04AH01,Sirolimus,Solution,Oral,02243237,RAPAMUNE (sirolimus 1 mg per mL oral solution) PFIZER CANADA ULC,Active,9003600,sirolimus 1 mg per mL oral solution,8001938,sirolimus,26643006,Oral,385023001,Oral solution,,,1.0,,
71350,Marketed,2012-02-28,02247111,RAPAMUNE,1.0,L04AH01,Sirolimus,Tablet,Oral,02247111,RAPAMUNE (sirolimus 1 mg oral tablet) PFIZER CANADA ULC,Active,9003790,sirolimus 1 mg oral tablet,8001938,sirolimus,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78924,Marketed,2008-01-02,02303922,JANUVIA,1.0,A10BH01,Sitagliptin,Tablet,Oral,02303922,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) MERCK CANADA INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87438,Marketed,2012-09-17,02388839,JANUVIA,1.0,A10BH01,Sitagliptin,Tablet,Oral,02388839,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) MERCK CANADA INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87439,Marketed,2012-09-17,02388847,JANUVIA,1.0,A10BH01,Sitagliptin,Tablet,Oral,02388847,JANUVIA (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) MERCK CANADA INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91274,Marketed,2025-12-22,02428261,APO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02428261,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) APOTEX INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91275,Marketed,2025-12-22,02428288,APO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02428288,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) APOTEX INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91276,Marketed,2025-12-22,02428296,APO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02428296,APO-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) APOTEX INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99328,Marketed,2024-11-26,02503840,PMS-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02503840,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99329,Marketed,2024-11-26,02503859,PMS-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02503859,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99330,Marketed,2024-11-26,02503867,PMS-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02503867,PMS-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99350,Marketed,2023-01-05,02504049,SANDOZ SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02504049,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99351,Marketed,2023-01-05,02504057,SANDOZ SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02504057,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99352,Marketed,2023-01-05,02504065,SANDOZ SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02504065,SANDOZ SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99800,Marketed,2022-11-07,02508656,APO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02508656,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) APOTEX INC,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99801,Marketed,2022-11-07,02508664,APO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02508664,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) APOTEX INC,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99802,Marketed,2022-11-07,02508672,APO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02508672,APO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) APOTEX INC,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100176,Marketed,2023-05-12,02512475,ACH-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02512475,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 25 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100177,Marketed,2023-05-12,02512483,ACH-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02512483,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 50 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100178,Marketed,2023-05-12,02512491,ACH-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02512491,ACH-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 100 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101181,Marketed,2023-08-31,02522705,TEVA-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02522705,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101182,Marketed,2023-08-31,02522713,TEVA-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02522713,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101183,Marketed,2023-08-31,02522721,TEVA-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02522721,TEVA-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101823,Marketed,2023-01-26,02529033,SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529033,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101824,Marketed,2023-01-26,02529041,SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529041,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101825,Marketed,2023-01-26,02529068,SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529068,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101909,Marketed,2023-01-05,02529866,AURO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529866,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) AURO PHARMA INC,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101910,Marketed,2023-01-05,02529874,AURO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529874,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) AURO PHARMA INC,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101911,Marketed,2023-01-05,02529882,AURO-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02529882,AURO-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) AURO PHARMA INC,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102075,Marketed,2023-01-05,02531631,TARO-SITAGLIPTIN FUMARATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02531631,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 25 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014877,sitagliptin (sitagliptin fumarate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102076,Marketed,2023-01-05,02531658,TARO-SITAGLIPTIN FUMARATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02531658,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 50 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014878,sitagliptin (sitagliptin fumarate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102078,Marketed,2023-01-05,02531666,TARO-SITAGLIPTIN FUMARATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02531666,TARO-SITAGLIPTIN FUMARATE (sitagliptin (sitagliptin fumarate) 100 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9014876,sitagliptin (sitagliptin fumarate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102308,Marketed,2023-02-02,02534134,JAMP SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534134,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102309,Marketed,2023-02-02,02534142,JAMP SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534142,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102310,Marketed,2023-02-02,02534150,JAMP SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534150,JAMP SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102323,Marketed,2023-02-01,02534290,PRO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534290,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 25 mg oral tablet) PRO DOC LIMITEE,Active,9014883,sitagliptin (sitagliptin malate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102324,Marketed,2023-02-01,02534304,PRO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534304,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9014884,sitagliptin (sitagliptin malate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102325,Marketed,2023-02-03,02534312,PRO-SITAGLIPTIN MALATE,1.0,A10BH01,Sitagliptin,Tablet,Oral,02534312,PRO-SITAGLIPTIN MALATE (sitagliptin (sitagliptin malate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9014882,sitagliptin (sitagliptin malate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102436,Marketed,2023-12-01,02535513,AG-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02535513,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 25 mg oral tablet) ANGITA PHARMA INC.,Active,9014880,sitagliptin (sitagliptin hydrochloride) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102437,Marketed,2023-12-01,02535521,AG-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02535521,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 50 mg oral tablet) ANGITA PHARMA INC.,Active,9014881,sitagliptin (sitagliptin hydrochloride) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102438,Marketed,2023-12-01,02535548,AG-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02535548,AG-SITAGLIPTIN (sitagliptin (sitagliptin hydrochloride monohydrate) 100 mg oral tablet) ANGITA PHARMA INC.,Active,9014879,sitagliptin (sitagliptin hydrochloride) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103187,Marketed,2026-01-06,02543400,NAT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02543400,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103742,Marketed,2024-12-17,02548569,SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02548569,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) SANIS HEALTH INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103743,Marketed,2024-12-17,02548577,SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02548577,SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 100 mg oral tablet) SANIS HEALTH INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104281,Marketed,2025-12-10,02553910,MINT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02553910,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104282,Marketed,2025-12-10,02553929,MINT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02553929,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 50 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104283,Marketed,2025-12-10,02553937,MINT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02553937,MINT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate) 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001232,sitagliptin (sitagliptin phosphate) 100 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106144,Marketed,2026-01-06,02558157,NAT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02558157,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 25 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001387,sitagliptin (sitagliptin phosphate) 25 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106145,Marketed,2026-01-06,02558165,NAT-SITAGLIPTIN,1.0,A10BH01,Sitagliptin,Tablet,Oral,02558165,NAT-SITAGLIPTIN (sitagliptin (sitagliptin phosphate monohydrate) 50 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9001388,sitagliptin (sitagliptin phosphate) 50 mg oral tablet,8000374,sitagliptin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
31360,Marketed,2016-04-26,02139529,"SODIUM ACETATE INJECTION, USP",1.0,B05XA08,Sodium acetate,Solution,Intravenous,,,,,,,,,,,,,,,,
35083,Marketed,2024-01-11,02181746,SODIUM ACETATE INJECTION USP,1.0,B05XA08,Sodium acetate,Solution,Intravenous,,,,,,,,,,,,,,,,
1905,Marketed,2017-07-24,00261998,SODIUM BICARBONATE INJECTION USP,1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
8350,Marketed,2017-07-24,00261971,SODIUM BICARBONATE INJECTION USP,1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
95595,Marketed,2017-10-20,02467585,SODIUM BICARBONATE INJECTION USP,1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
97681,Marketed,2019-09-17,02486636,"SODIUM BICARBONATE INJECTION, USP",1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
100560,Marketed,2022-03-24,02516225,SODIUM BICARBONATE INJECTION USP,1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
103051,Marketed,2024-05-08,02541904,SODIUM BICARBONATE INJECTION USP,1.0,B05XA02,Sodium bicarbonate,Solution,Intravenous,,,,,,,,,,,,,,,,
228,Marketed,2020-02-20,00037834,SODIUM CHLORIDE IRRIGATION USP,1.0,B05CB01,Sodium chloride,Solution,"Intraperitoneal,Irrigation,Topical",,,,,,,,,,,,,,,,
817,Marketed,2017-08-30,00037796,SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,"Subcutaneous,Intravenous,Intramuscular,Intraperitoneal",,,,,,,,,,,,,,,,
1239,Marketed,2019-10-22,00037826,SODIUM CHLORIDE IRRIGATION USP,1.0,B05CB01,Sodium chloride,Solution,"Intraperitoneal,Irrigation",,,,,,,,,,,,,,,,
1736,Marketed,2020-08-12,00037788,SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
3395,Marketed,1977-12-31,00402230,SODIUM CHLORIDE INJ 23.4%,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
4092,Marketed,2020-02-05,00037842,SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
9825,Marketed,2021-01-15,00786160,"0.9% SODIUM CHLORIDE IRRIGATION, USP",1.0,B05CB01,Sodium chloride,Solution,Irrigation,,,,,,,,,,,,,,,,
10040,Marketed,2019-02-11,00060208,"0.9% SODIUM CHLORIDE INJECTION, USP",1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
10442,Marketed,1990-12-31,00060186,SODIUM CHLORIDE 0.45% INJ,1.0,B05XA03,Sodium chloride,Liquid,Intravenous,,,,,,,,,,,,,,,,
11039,Marketed,1990-12-31,00060232,SODIUM CHLORIDE 3% INJ,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
12185,Marketed,1998-04-25,01924303,0.9% SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
14579,Marketed,1998-04-30,01927949,0.45% SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
15492,Marketed,1998-04-30,01928007,5% SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
18136,Marketed,2020-07-09,02150204,0.9% SODIUM CHLORIDE INJECTION USP,1.0,B05XA03,Sodium chloride,Solution,"Subcutaneous,Intravenous,Intramuscular",,,,,,,,,,,,,,,,
18937,Marketed,2015-11-13,02139510,"SODIUM CHLORIDE INJECTION, USP",1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
88027,Marketed,2023-02-24,02395150,0.9% SODIUM CHLORIDE INJECTION,1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
100335,Marketed,2022-07-06,02514184,"20% SODIUM CHLORIDE INJECTION, BP",1.0,B05XA03,Sodium chloride,Solution,Intravenous,,,,,,,,,,,,,,,,
81546,Marketed,2018-11-14,02329743,"DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC",1.0,V10XA01,Sodium iodide 131 i,Capsule,Oral,,,,,,,,,,,,,,,,
81548,Marketed,2018-11-14,02329778,"DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC",1.0,V10XA01,Sodium iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,
92430,Marketed,2018-08-03,02439905,SODIUM IODIDE (131I) SOLUTION,1.0,V10XA01,Sodium iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,
92099,Marketed,2015-01-27,02436663,PHEBURANE,1.0,A16AX03,Sodium phenylbutyrate,Granules,Oral,02436663,PHEBURANE (sodium phenylbutyrate 483 mg per g oral granules) MEDUNIK CANADA,Active,9014708,sodium phenylbutyrate 483 mg per g oral granules,8001915,phenylbutyric acid,26643006,Oral,420509004,Oral granules,1141902006,Medicine spoon (physical object),1.0,,
11258,Marketed,2006-07-22,00896187,SODIUM PHOSPHATES INJECTION USP,2.0,B05XA09,Sodium phosphate,Solution,Intravenous,00896187,SODIUM PHOSPHATES INJECTION USP (phosphorus (sodium phosphate dibasic and sodium phosphate monobasic) 30 mmol per 10 mL and sodium (sodium phosphate dibasic and sodium phosphate monobasic) 40 mmol per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013929,phosphorus (sodium phosphate dibasic and sodium phosphate monobasic) 30 mmol per 10 mL and sodium (sodium phosphate dibasic and sodium phosphate monobasic) 40 mmol per 10 mL solution for injection vial,8002162,sodium phosphate dibasic and sodium phosphate monobasic,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
73995,Marketed,2004-11-25,02254794,PICO-SALAX,3.0,A06AB58,"Sodium picosulfate, combinations",Powder for solution,Oral,02254794,PICO-SALAX (citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution) FERRING INC,Active,9013538,citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution,8002108,citric acid and magnesium oxide and sodium picosulfate,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
80347,Marketed,2009-02-16,02317966,PURG-ODAN,3.0,A06AB58,"Sodium picosulfate, combinations",Powder for solution,Oral,02317966,PURG-ODAN (citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution) ODAN LABORATORIES LTD,Active,9013538,citric acid 12 g per sachet and magnesium oxide 3.5 g per sachet and sodium picosulfate 10 mg per sachet powder for oral solution,8002108,citric acid and magnesium oxide and sodium picosulfate,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),,,
8274,Marketed,1987-12-31,00511226,TROMBOJECT 3%,1.0,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,77700821,TROMBOJECT 3% (sodium tetradecyl sulfate 150 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013346,sodium tetradecyl sulfate 150 mg per 5 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
8274,Marketed,1987-12-31,00511226,TROMBOJECT 3%,1.0,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,77700822,TROMBOJECT 3% (sodium tetradecyl sulfate 60 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013348,sodium tetradecyl sulfate 60 mg per 2 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
8275,Marketed,1987-12-31,00511234,TROMBOJECT 1%,1.0,C05BB04,Sodium tetradecyl sulphate,Solution,Intravenous,00511234,TROMBOJECT 1% (sodium tetradecyl sulfate 20 mg per 2 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013347,sodium tetradecyl sulfate 20 mg per 2 mL solution for injection vial,8001942,sodium tetradecyl sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
98077,Marketed,2019-10-17,02490714,LOKELMA,1.0,V03AE10,Sodium zirconium cyclosilicate,Powder for suspension,Oral,02490714,LOKELMA (sodium zirconium cyclosilicate 5 g per sachet powder for oral suspension) ASTRAZENECA CANADA INC,Active,9014200,sodium zirconium cyclosilicate 5 g per sachet powder for oral suspension,8002303,sodium zirconium cyclosilicate,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
98078,Marketed,2019-10-17,02490722,LOKELMA,1.0,V03AE10,Sodium zirconium cyclosilicate,Powder for suspension,Oral,02490722,LOKELMA (sodium zirconium cyclosilicate 10 g per sachet powder for oral suspension) ASTRAZENECA CANADA INC,Active,9014199,sodium zirconium cyclosilicate 10 g per sachet powder for oral suspension,8002303,sodium zirconium cyclosilicate,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),,,
96912,Marketed,2019-12-17,02478366,SODIUM IODIDE I-123 ORAL SOLUTION,1.0,V09FX02,Sodiunm iodide 123 i,Solution,Oral,,,,,,,,,,,,,,,,
81547,Marketed,2018-11-14,02329751,"DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTIC",1.0,V09FX03,Sodiunm iodide 131 i,Capsule,Oral,,,,,,,,,,,,,,,,
81549,Marketed,2018-11-14,02329786,"DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC",1.0,V09FX03,Sodiunm iodide 131 i,Solution,Oral,,,,,,,,,,,,,,,,
90293,Marketed,2014-01-06,02418355,SOVALDI,1.0,J05AP08,Sofosbuvir,Tablet,Oral,02418355,SOVALDI (sofosbuvir 400 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005390,sofosbuvir 400 mg oral tablet,8001156,sofosbuvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91668,Marketed,2014-10-16,02432226,HARVONI,2.0,J05AP51,Sofosbuvir and ledipasvir,Tablet,Oral,02432226,HARVONI (ledipasvir 90 mg and sofosbuvir 400 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9005599,ledipasvir 90 mg and sofosbuvir 400 mg oral tablet,8001212,ledipasvir and sofosbuvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94324,Marketed,2016-08-02,02456370,EPCLUSA,2.0,J05AP55,Sofosbuvir and velpatasvir,Tablet,Oral,02456370,EPCLUSA (sofosbuvir 400 mg and velpatasvir 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006017,sofosbuvir 400 mg and velpatasvir 100 mg oral tablet,8001157,sofosbuvir and velpatasvir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95590,Marketed,2017-09-18,02467542,VOSEVI,3.0,J05AP56,"Sofosbuvir, velpatasvir and voxilaprevir",Tablet,Oral,02467542,VOSEVI (sofosbuvir 400 mg and velpatasvir 100 mg and voxilaprevir 100 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9012539,sofosbuvir 400 mg and velpatasvir 100 mg and voxilaprevir 100 mg oral tablet,8001158,sofosbuvir and velpatasvir and voxilaprevir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
57,Marketed,1951-12-31,00050520,MINERALE LEGERE HUILE,1.0,D02AC,Soft paraffin and fat products,Liquid,Topical,00050520,MINERALE LEGERE HUILE (mineral oil light 100 % cutaneous liquid) LABORATOIRE ATLAS INC,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,
9587,Marketed,2022-02-18,00741515,WHITE PETROLATUM OINTMENT,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,00741515,WHITE PETROLATUM OINTMENT (white petrolatum 100 % cutaneous ointment) CANADIAN CUSTOM PACKAGING COMPANY,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
12947,Marketed,1992-12-31,01939068,HUILE DE BAIN THERAPEUTIQUE,2.0,D02AC,Soft paraffin and fat products,Solution,Topical,01939068,HUILE DE BAIN THERAPEUTIQUE (lanolin 3 % and mineral oil heavy 91.7 % cutaneous solution) LABORATOIRE ATLAS INC,Active,9013824,lanolin 3 % and mineral oil heavy 91.7 % cutaneous solution,8002201,lanolin and mineral oil heavy,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
14042,Marketed,1993-12-31,01935321,LIGHT MINERAL OIL 100% NF,1.0,D02AC,Soft paraffin and fat products,Liquid,Topical,01935321,LIGHT MINERAL OIL 100% NF (mineral oil light 100 % cutaneous liquid) RW CONSUMER PRODUCTS LTD,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,
36404,Marketed,2019-12-05,02203375,STERILE LIGHT MINERAL OIL 100%,1.0,D02AC,Soft paraffin and fat products,Oil,Topical,02203375,STERILE LIGHT MINERAL OIL 100% (mineral oil light 100 % cutaneous liquid) OMEGA LABORATORIES LIMITED,Active,9003625,mineral oil light 100 % cutaneous liquid,8002146,mineral oil light,448598008,Cutaneous,420699003,Liquid,,,,,
41756,Marketed,1998-04-08,00790516,PETROLATUM BLANC ONT USP,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,00790516,PETROLATUM BLANC ONT USP (white petrolatum 100 % cutaneous ointment) LABORATOIRE ATLAS INC,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
76338,Marketed,2026-01-22,02277778,MEDLINE REMEDY SIMPLIFIED PREVENT CRITIC-AID CLEAR,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02277778,"MEDLINE REMEDY SIMPLIFIED PREVENT CRITIC-AID CLEAR (white petrolatum 71.5 % cutaneous ointment) MEDLINE INDUSTRIES, LP",Active,9004221,white petrolatum 71.5 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
79066,Marketed,2015-02-10,02305178,COMPLIMENTS WHITE PETROLEUM JELLY,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02305178,COMPLIMENTS WHITE PETROLEUM JELLY (white petrolatum 100 % cutaneous ointment) GEMINI PACKAGING LTD,Active,9001536,white petrolatum 100 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
88479,Marketed,2020-02-10,02399954,OINTMENT WITH MOISTURIZING VITAMIN E,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02399954,OINTMENT WITH MOISTURIZING VITAMIN E (petrolatum 95.7 % cutaneous ointment) CRLS,Active,9005462,petrolatum 95.7 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
90292,Marketed,2015-02-23,02418347,DIABETICS' DRY SKIN RELIEF FOOT CREAM,1.0,D02AC,Soft paraffin and fat products,Cream,Topical,02418347,DIABETICS' DRY SKIN RELIEF FOOT CREAM (white petrolatum 30 % cutaneous cream) SANOFI CONSUMER HEALTH INC,Active,9004048,white petrolatum 30 % cutaneous cream,8001880,white petrolatum,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
93145,Marketed,2023-10-30,02446189,AQUAPHOR HEALING OINTMENT,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02446189,AQUAPHOR HEALING OINTMENT (mineral oil heavy 52.74 % cutaneous ointment) BEIERSDORF CANADA INC,Active,9014365,mineral oil heavy 52.74 % cutaneous ointment,8002204,mineral oil heavy,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
95080,Marketed,2024-01-01,02462915,HEALING OINTMENT,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02462915,HEALING OINTMENT (white petrolatum 46.5 % cutaneous ointment) CERAVE CANADA,Active,9015010,white petrolatum 46.5 % cutaneous ointment,8001880,white petrolatum,448598008,Cutaneous,385101003,Ointment,,,,,
100126,Marketed,2022-02-01,02512033,BABY HEALING OINTMENT,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02512033,BABY HEALING OINTMENT (petrolatum 46.5 % cutaneous ointment) CERAVE CANADA,Active,9013239,petrolatum 46.5 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
100695,Marketed,2022-11-22,02517574,BAG BALM SKIN MOISTURIZER,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02517574,BAG BALM SKIN MOISTURIZER (petrolatum 84.3 % cutaneous ointment) VERMONT'S ORIGINAL LLC,Active,9014907,petrolatum 84.3 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
102494,Marketed,2024-01-22,02536129,PROTECTIVE OINTMENT,1.0,D02AC,Soft paraffin and fat products,Ointment,Topical,02536129,PROTECTIVE OINTMENT (petrolatum 98.85 % cutaneous ointment) SMITH & NEPHEW INC,Active,9015019,petrolatum 98.85 % cutaneous ointment,8001866,petrolatum,448598008,Cutaneous,385101003,Ointment,,,,,
103143,Marketed,2024-01-19,02542900,REPAIR & PROTECT,1.0,D02AC,Soft paraffin and fat products,Stick,Topical,02542900,REPAIR & PROTECT (petrolatum 45 % cutaneous stick) BLISTEX CORPORATION,Active,9015005,petrolatum 45 % cutaneous stick,8001866,petrolatum,448598008,Cutaneous,739007000,Stick,733016008,Stick (unit of presentation),,,
76292,Marketed,2006-06-23,02277263,VESICARE,1.0,G04BD08,Solifenacin,Tablet,Oral,02277263,VESICARE (solifenacin succinate 5 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76293,Marketed,2006-06-23,02277271,VESICARE,1.0,G04BD08,Solifenacin,Tablet,Oral,02277271,VESICARE (solifenacin succinate 10 mg oral tablet) ASTELLAS PHARMA CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88283,Marketed,2015-07-30,02397900,TEVA-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02397900,TEVA-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88284,Marketed,2015-07-30,02397919,TEVA-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02397919,TEVA-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88394,Marketed,2015-09-30,02399032,SANDOZ SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02399032,SANDOZ SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88395,Marketed,2015-09-30,02399040,SANDOZ SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02399040,SANDOZ SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90235,Marketed,2015-10-28,02417723,PMS-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02417723,PMS-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PHARMASCIENCE INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90236,Marketed,2015-10-28,02417731,PMS-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02417731,PMS-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PHARMASCIENCE INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91336,Marketed,2024-01-25,02428911,JAMP SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02428911,JAMP SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91337,Marketed,2024-01-25,02428938,JAMP SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02428938,JAMP SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92234,Marketed,2019-12-11,02437988,TARO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02437988,TARO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92235,Marketed,2019-12-11,02437996,TARO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02437996,TARO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SUN PHARMA CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92372,Marketed,2023-03-20,02439344,ACH-SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02439344,ACH-SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92373,Marketed,2023-03-20,02439352,ACH-SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02439352,ACH-SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93171,Marketed,2016-01-04,02446375,AURO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02446375,AURO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) AURO PHARMA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93172,Marketed,2016-01-04,02446383,AURO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02446383,AURO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) AURO PHARMA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94519,Marketed,2016-10-27,02458144,SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02458144,SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PRO DOC LIMITEE,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94520,Marketed,2016-10-27,02458152,SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02458152,SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PRO DOC LIMITEE,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94535,Marketed,2016-11-03,02458241,SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02458241,SOLIFENACIN (solifenacin succinate 5 mg oral tablet) SANIS HEALTH INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94536,Marketed,2016-11-03,02458268,SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02458268,SOLIFENACIN (solifenacin succinate 10 mg oral tablet) SANIS HEALTH INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98302,Marketed,2020-11-13,02493039,PRZ-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02493039,PRZ-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98303,Marketed,2020-11-13,02493047,PRZ-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02493047,PRZ-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100586,Marketed,2026-01-13,02516519,BIO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02516519,BIO-SOLIFENACIN (solifenacin succinate 5 mg oral tablet) BIOMED PHARMA,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100587,Marketed,2026-01-13,02516527,BIO-SOLIFENACIN,1.0,G04BD08,Solifenacin,Tablet,Oral,02516527,BIO-SOLIFENACIN (solifenacin succinate 10 mg oral tablet) BIOMED PHARMA,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101893,Marketed,2023-08-18,02529696,M-SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02529696,M-SOLIFENACIN SUCCINATE (solifenacin succinate 5 mg oral tablet) MANTRA PHARMA INC,Active,9001160,solifenacin succinate 5 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101894,Marketed,2023-08-18,02529718,M-SOLIFENACIN SUCCINATE,1.0,G04BD08,Solifenacin,Tablet,Oral,02529718,M-SOLIFENACIN SUCCINATE (solifenacin succinate 10 mg oral tablet) MANTRA PHARMA INC,Active,9001159,solifenacin succinate 10 mg oral tablet,8000360,solifenacin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100521,Marketed,2022-11-17,02515814,SUNOSI,1.0,N06BA14,Solriamfetol,Tablet,Oral,02515814,SUNOSI (solriamfetol (solriamfetol hydrochloride) 75 mg oral tablet) AXSOME MALTA LTD.,Active,9014589,solriamfetol (solriamfetol hydrochloride) 75 mg oral tablet,8002385,solriamfetol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100522,Marketed,2022-11-17,02515822,SUNOSI,1.0,N06BA14,Solriamfetol,Tablet,Oral,02515822,SUNOSI (solriamfetol (solriamfetol hydrochloride) 150 mg oral tablet) AXSOME MALTA LTD.,Active,9014588,solriamfetol (solriamfetol hydrochloride) 150 mg oral tablet,8002385,solriamfetol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
115,Marketed,2017-08-30,00037818,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intramuscular,Subcutaneous,Intravenous",,,,,,,,,,,,,,,,
117,Marketed,2018-05-09,00038202,BACTERIOSTATIC WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intramuscular,Intravenous,Subcutaneous",,,,,,,,,,,,,,,,
1911,Marketed,2005-01-17,00298409,PHENOL SALINE INJ,2.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
1912,Marketed,2005-01-17,00298417,GLYCERINATED PHENOL SALINE,3.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
3383,Marketed,2020-06-05,00402257,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Subcutaneous,Intravenous,Intramuscular",,,,,,,,,,,,,,,,
3396,Marketed,1977-12-31,00402249,SODIUM CHLORIDE BACTERIOSTATIC INJ,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Subcutaneous,Intravenous,Intramuscular",,,,,,,,,,,,,,,,
3822,Marketed,2019-11-28,00498785,STERILE WATER FOR IRRIGATION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,"Irrigation,Intraperitoneal",,,,,,,,,,,,,,,,
4913,Marketed,1982-12-31,00568082,BSS PLUS,8.0,V07AB,"Solvents and diluting agents, incl irrigat solut","Solution,Kit",Intraocular,,,,,,,,,,,,,,,,
6366,Marketed,2008-11-28,00512990,BSS STERILE IRRIGATING SOLUTION,6.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,Irrigation,,,,,,,,,,,,,,,,
9831,Marketed,2020-12-08,00799998,"STERILE WATER FOR IRRIGATION, USP",1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Irrigation,,,,,,,,,,,,,,,,
13509,Marketed,1998-06-17,01927930,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,
15867,Marketed,2015-01-01,02014882,"STERILE WATER FOR INJECTION, USP",1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,
19812,Marketed,2003-03-10,02214733,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,
20354,Marketed,2005-11-09,02215721,BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intracavernosal,,,,,,,,,,,,,,,,
31491,Marketed,2017-08-29,02142546,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intraperitoneal,Intramuscular,Subcutaneous,Intravenous",,,,,,,,,,,,,,,,
76932,Marketed,2007-03-02,02283735,STERILE DILUENT FOR ALLERGENIC EXTRACT - ALBUMIN SALINE WITH PHENOL,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,Subcutaneous,,,,,,,,,,,,,,,,
78457,Marketed,2024-01-08,02299186,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Subcutaneous,Intramuscular,Intravenous",,,,,,,,,,,,,,,,
78963,Marketed,2024-05-09,02304341,0.9% SODIUM CHLORIDE INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Solution,"Intravenous,Subcutaneous,Intramuscular",,,,,,,,,,,,,,,,
86658,Marketed,2023-10-12,02380811,"STERILE DILUENT FOR MERCK SHARP & DOHME LLC LIVE, ATTENUATED, VIRUS VACCINES",1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Parenteral (unspecified),,,,,,,,,,,,,,,,
92834,Marketed,2016-08-04,02443651,PH 12 STERILE DILUENT FOR FLOLAN,3.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,
99333,Marketed,2024-02-02,02503891,STERILE WATER FOR INJECTION USP,1.0,V07AB,"Solvents and diluting agents, incl irrigat solut",Liquid,Intravenous,,,,,,,,,,,,,,,,
102866,Marketed,2023-11-27,02539934,SOGROYA,1.0,H01AC07,Somapacitan,Solution,Subcutaneous,02539934,SOGROYA (somapacitan 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014991,somapacitan 5 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
102867,Marketed,2023-11-27,02539942,SOGROYA,1.0,H01AC07,Somapacitan,Solution,Subcutaneous,02539942,SOGROYA (somapacitan 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014989,somapacitan 10 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
102868,Marketed,2023-11-27,02539950,SOGROYA,1.0,H01AC07,Somapacitan,Solution,Subcutaneous,02539950,SOGROYA (somapacitan 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9014990,somapacitan 15 mg per 1.5 mL solution for injection pen,8002493,somapacitan,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101087,Marketed,2022-02-22,02521679,NGENLA,1.0,H01AC08,Somatrogon,Solution,Subcutaneous,02521679,NGENLA (somatrogon 24 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014682,somatrogon 24 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101089,Marketed,2022-02-22,02521687,NGENLA,1.0,H01AC08,Somatrogon,Solution,Subcutaneous,02521687,NGENLA (somatrogon 60 mg per 1.2 mL solution for injection pen) PFIZER CANADA ULC,Active,9014683,somatrogon 60 mg per 1.2 mL solution for injection pen,8002414,somatrogon,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
61332,Marketed,1999-10-26,02237971,SAIZEN,1.0,H01AC01,Somatropin,Powder for solution,"Subcutaneous,Intramuscular",02237971,"SAIZEN (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
62499,Marketed,1999-07-28,02239046,SEROSTIM,2.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02239046,"SEROSTIM (somatropin 5 mg per vial powder for solution for injection with diluent solution) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013750,somatropin 5 mg per vial powder for solution for injection with diluent solution,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
81048,Marketed,2009-04-20,02325063,OMNITROPE,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02325063,OMNITROPE (somatropin 5 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013747,somatropin 5 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
81049,Marketed,2009-04-20,02325071,OMNITROPE,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02325071,OMNITROPE (somatropin 10 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013735,somatropin 10 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
83536,Marketed,2010-12-02,02350122,SAIZEN,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02350122,"SAIZEN (somatropin 6 mg per 1.03 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013939,somatropin 6 mg per 1.03 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
83537,Marketed,2010-12-02,02350130,SAIZEN,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02350130,"SAIZEN (somatropin 12 mg per 1.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013738,somatropin 12 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
83538,Marketed,2010-12-02,02350149,SAIZEN,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02350149,"SAIZEN (somatropin 20 mg per 2.5 mL solution for injection cartridge) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9013745,somatropin 20 mg per 2.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,
88659,Marketed,2013-09-18,02401703,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401703,GENOTROPIN (somatropin 5.3 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013751,somatropin 5.3 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,
88660,Marketed,2013-09-18,02401711,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401711,GENOTROPIN (somatropin 12 mg powder for solution for injection with diluent solution per pen) PFIZER CANADA ULC,Active,9013740,somatropin 12 mg powder for solution for injection with diluent solution per pen,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733006000,Pen (unit of presentation),,,
88662,Marketed,2020-09-17,02401746,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401746,GENOTROPIN (somatropin 0.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014391,somatropin 0.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88663,Marketed,2020-09-17,02401754,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401754,GENOTROPIN (somatropin 0.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9014392,somatropin 0.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88664,Marketed,2013-09-18,02401762,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401762,GENOTROPIN (somatropin 0.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013728,somatropin 0.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88665,Marketed,2013-09-18,02401770,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401770,GENOTROPIN (somatropin 0.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013729,somatropin 0.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88666,Marketed,2013-09-18,02401789,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401789,GENOTROPIN (somatropin 1 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013730,somatropin 1 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88667,Marketed,2013-09-18,02401797,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401797,GENOTROPIN (somatropin 1.2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013731,somatropin 1.2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88668,Marketed,2013-09-18,02401800,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401800,GENOTROPIN (somatropin 1.4 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013732,somatropin 1.4 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88669,Marketed,2013-09-18,02401819,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401819,GENOTROPIN (somatropin 1.6 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013733,somatropin 1.6 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88670,Marketed,2013-09-18,02401827,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401827,GENOTROPIN (somatropin 1.8 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013734,somatropin 1.8 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
88671,Marketed,2013-09-18,02401835,GENOTROPIN,1.0,H01AC01,Somatropin,Powder for solution,Subcutaneous,02401835,GENOTROPIN (somatropin 2 mg powder for solution for injection with diluent solution per syringe) PFIZER CANADA ULC,Active,9013743,somatropin 2 mg powder for solution for injection with diluent solution per syringe,8001943,somatropin,738984000,Parenteral,385223009,Powder for solution for injection,733020007,Syringe (unit of presentation),,,
94695,Marketed,2017-08-14,02459647,OMNITROPE,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02459647,OMNITROPE (somatropin 15 mg per 1.5 mL solution for injection cartridge) SANDOZ CANADA INCORPORATED,Active,9013741,somatropin 15 mg per 1.5 mL solution for injection cartridge,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
101843,Marketed,2022-12-07,02529181,NORDITROPIN FLEXPRO,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02529181,NORDITROPIN FLEXPRO (somatropin 5 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013748,somatropin 5 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101844,Marketed,2022-12-07,02529203,NORDITROPIN FLEXPRO,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02529203,NORDITROPIN FLEXPRO (somatropin 10 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013736,somatropin 10 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
101845,Marketed,2022-12-07,02529211,NORDITROPIN FLEXPRO,1.0,H01AC01,Somatropin,Solution,Subcutaneous,02529211,NORDITROPIN FLEXPRO (somatropin 15 mg per 1.5 mL solution for injection pen) NOVO NORDISK CANADA INC,Active,9013742,somatropin 15 mg per 1.5 mL solution for injection pen,8001943,somatropin,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
99003,Marketed,2022-01-04,02500337,ODOMZO,1.0,L01XJ02,Sonidegib,Capsule,Oral,02500337,ODOMZO (sonidegib (sonidegib phosphate) 200 mg oral capsule) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014435,sonidegib (sonidegib phosphate) 200 mg oral capsule,8002360,sonidegib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
76977,Marketed,2006-07-31,02284227,NEXAVAR,1.0,L01EX02,Sorafenib,Tablet,Oral,02284227,NEXAVAR (sorafenib (sorafenib tosylate) 200 mg oral tablet) BAYER INC,Active,9004194,sorafenib (sorafenib tosylate) 200 mg oral tablet,8001945,sorafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
18779,Marketed,2022-07-26,02167794,APO-SOTALOL,1.0,C07AA07,Sotalol,Tablet,Oral,02167794,APO-SOTALOL (sotalol hydrochloride 160 mg oral tablet) APOTEX INC,Active,9011919,sotalol hydrochloride 160 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
20002,Marketed,2022-07-26,02210428,APO-SOTALOL,1.0,C07AA07,Sotalol,Tablet,Oral,02210428,APO-SOTALOL (sotalol hydrochloride 80 mg oral tablet) APOTEX INC,Active,9011920,sotalol hydrochloride 80 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61729,Marketed,1998-07-22,02238326,PMS-SOTALOL - 80 MG,1.0,C07AA07,Sotalol,Tablet,Oral,02238326,PMS-SOTALOL - 80 MG (sotalol hydrochloride 80 mg oral tablet) PHARMASCIENCE INC,Active,9011920,sotalol hydrochloride 80 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
61730,Marketed,1998-07-22,02238327,PMS-SOTALOL - 160 MG,1.0,C07AA07,Sotalol,Tablet,Oral,02238327,PMS-SOTALOL - 160 MG (sotalol hydrochloride 160 mg oral tablet) PHARMASCIENCE INC,Active,9011919,sotalol hydrochloride 160 mg oral tablet,8000893,sotalol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104003,Marketed,2025-02-12,02551306,WINREVAIR,1.0,C02KX06,Sotatercept,"Powder for solution,Kit",Subcutaneous,02551306,WINREVAIR (sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015179,sotatercept 45 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
104004,Marketed,2025-02-12,02551314,WINREVAIR,1.0,C02KX06,Sotatercept,"Kit,Powder for solution",Subcutaneous,02551314,WINREVAIR (sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe) MERCK CANADA INC,Active,9015180,sotatercept 60 mg per vial powder for solution for injection with diluent solution syringe,8002531,sotatercept,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
100931,Marketed,2021-10-22,02520095,LUMAKRAS,1.0,L01XX73,Sotorasib,Tablet,Oral,02520095,LUMAKRAS (sotorasib 120 mg oral tablet) AMGEN CANADA INC,Active,9014613,sotorasib 120 mg oral tablet,8002393,sotorasib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104162,Marketed,2025-10-14,02552655,LUMAKRAS,1.0,L01XX73,Sotorasib,Tablet,Oral,02552655,LUMAKRAS (sotorasib 240 mg oral tablet) AMGEN CANADA INC,Active,9015272,sotorasib 240 mg oral tablet,8002393,sotorasib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
102523,Marketed,2023-05-11,02536455,SPEVIGO,1.0,L04AC22,Spesolimab,Solution,Intravenous,02536455,SPEVIGO (spesolimab 450 mg per 7.5 mL solution for injection vial) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9014858,spesolimab 450 mg per 7.5 mL solution for injection vial,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103912,Marketed,2024-10-28,02550296,SPEVIGO,1.0,L04AC22,Spesolimab,Solution,Subcutaneous,02550296,SPEVIGO (spesolimab 150 mg per 1 mL solution for injection syringe) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9015126,spesolimab 150 mg per 1 mL solution for injection syringe,8002468,spesolimab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
1403,Marketed,2006-02-13,00028606,ALDACTONE 25 MG,1.0,C03DA01,Spironolactone,Tablet,Oral,00028606,ALDACTONE 25 MG (spironolactone 25 mg oral tablet) PFIZER CANADA ULC,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
2145,Marketed,2009-02-03,00285455,ALDACTONE 100 MG,1.0,C03DA01,Spironolactone,Tablet,Oral,00285455,ALDACTONE 100 MG (spironolactone 100 mg oral tablet) PFIZER CANADA ULC,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
5646,Marketed,2011-06-29,00613215,TEVA-SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,00613215,TEVA-SPIRONOLACTONE (spironolactone 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
5647,Marketed,2011-06-29,00613223,TEVA-SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,00613223,TEVA-SPIRONOLACTONE (spironolactone 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97825,Marketed,2020-02-06,02488140,MINT-SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,02488140,MINT-SPIRONOLACTONE (spironolactone 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97826,Marketed,2020-02-06,02488159,MINT-SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,02488159,MINT-SPIRONOLACTONE (spironolactone 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100812,Marketed,2022-07-14,02518821,JAMP SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,02518821,JAMP SPIRONOLACTONE (spironolactone 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000025,spironolactone 25 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100813,Marketed,2022-07-14,02518848,JAMP SPIRONOLACTONE,1.0,C03DA01,Spironolactone,Tablet,Oral,02518848,JAMP SPIRONOLACTONE (spironolactone 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000090,spironolactone 100 mg oral tablet,8000015,spironolactone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88386,Marketed,2013-05-01,02398958,DIACOMIT,1.0,N03AX17,Stiripentol,Capsule,Oral,02398958,DIACOMIT (stiripentol 250 mg oral capsule) BIOCODEX SAS,Active,9005235,stiripentol 250 mg oral capsule,8002087,stiripentol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88387,Marketed,2013-05-01,02398966,DIACOMIT,1.0,N03AX17,Stiripentol,Capsule,Oral,02398966,DIACOMIT (stiripentol 500 mg oral capsule) BIOCODEX SAS,Active,9005237,stiripentol 500 mg oral capsule,8002087,stiripentol,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88388,Marketed,2013-05-01,02398974,DIACOMIT,1.0,N03AX17,Stiripentol,Powder for suspension,Oral,02398974,DIACOMIT (stiripentol 250 mg per sachet powder for oral suspension) BIOCODEX SAS,Active,9013789,stiripentol 250 mg per sachet powder for oral suspension,8002087,stiripentol,26643006,Oral,385027000,Powder for oral suspension,733013000,Sachet (unit of presentation),1.0,,
67590,Marketed,2001-10-15,02243660,STREPTOMYCIN FOR INJECTION USP,1.0,J01GA01,Streptomycin,Powder for solution,Intramuscular,02243660,STREPTOMYCIN FOR INJECTION USP (streptomycin (streptomycin sulfate) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9003655,streptomycin (streptomycin sulfate) 1 g per vial powder for solution for injection,8001234,streptomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
14504,Marketed,2011-06-18,02045702,TEVA-SUCRALFATE,1.0,A02BX02,Sucralfate,Tablet,Oral,02045702,TEVA-SUCRALFATE (sucralfate 1 g oral tablet) TEVA CANADA LIMITED,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
16656,Marketed,1994-12-31,02125250,APO-SUCRALFATE - TAB 1G,1.0,A02BX02,Sucralfate,Tablet,Oral,02125250,APO-SUCRALFATE - TAB 1G (sucralfate 1 g oral tablet) APOTEX INC,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17250,Marketed,2025-10-31,02100622,SULCRATE,1.0,A02BX02,Sucralfate,Tablet,Oral,02100622,SULCRATE (sucralfate 1 g oral tablet) ABBVIE CORPORATION,Active,9002613,sucralfate 1 g oral tablet,8001304,sucralfate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17852,Marketed,2025-04-23,02103567,SULCRATE SUSPENSION PLUS,1.0,A02BX02,Sucralfate,Suspension,Oral,02103567,SULCRATE SUSPENSION PLUS (sucralfate 1 g per 5 mL oral suspension) ABBVIE CORPORATION,Active,9002876,sucralfate 1 g per 5 mL oral suspension,8001304,sucralfate,26643006,Oral,385024007,Oral suspension,,,,,
96073,Marketed,2019-11-20,02471574,VELPHORO,1.0,V03AE05,Sucroferric oxyhydroxide,Tablet (chewable),Oral,02471574,VELPHORO (iron (sucroferric oxyhydroxide) 500 mg chewable tablet) VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD,Active,9014261,iron (sucroferric oxyhydroxide) 500 mg chewable tablet,8002322,sucroferric oxyhydroxide,26643006,Oral,66076007,Chewable tablet,732936001,Tablet (unit of presentation),,,
68108,Marketed,2005-09-27,02244147,SUFENTANIL CITRATE INJECTION USP,1.0,N01AH03,Sufentanil,Solution,"Intravenous,Epidural",77700856,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
68108,Marketed,2005-09-27,02244147,SUFENTANIL CITRATE INJECTION USP,1.0,N01AH03,Sufentanil,Solution,"Intravenous,Epidural",77700857,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013353,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,1.0,
92657,Marketed,2019-05-27,02442213,SUFENTANIL CITRATE INJECTION USP,1.0,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700901,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule) STERIMAX INC,Active,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
92657,Marketed,2019-05-27,02442213,SUFENTANIL CITRATE INJECTION USP,1.0,N01AH03,Sufentanil,Solution,"Epidural,Intravenous",77700902,SUFENTANIL CITRATE INJECTION USP (sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule) STERIMAX INC,Active,9013352,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule,8001947,sufentanil,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,1.0,
93817,Marketed,2016-02-19,02451816,BRIDION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77700905,BRIDION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) MERCK CANADA INC,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
93817,Marketed,2016-02-19,02451816,BRIDION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77700906,BRIDION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) MERCK CANADA INC,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102779,Marketed,2025-05-12,02539144,SUGAMMADEX INJECTION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701182,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102779,Marketed,2025-05-12,02539144,SUGAMMADEX INJECTION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701183,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) JUNO PHARMACEUTICALS CORP.,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103751,Marketed,2025-06-16,02548666,SUGAMMADEX INJECTION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701180,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103751,Marketed,2025-06-16,02548666,SUGAMMADEX INJECTION,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701181,SUGAMMADEX INJECTION (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103887,Marketed,2025-02-13,02550067,PMS-SUGAMMADEX,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701173,PMS-SUGAMMADEX (sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial) PHARMASCIENCE INC,Active,9013355,sugammadex (sugammadex sodium) 200 mg per 2 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103887,Marketed,2025-02-13,02550067,PMS-SUGAMMADEX,1.0,V03AB35,Sugammadex,Solution,Intravenous,77701174,PMS-SUGAMMADEX (sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial) PHARMASCIENCE INC,Active,9013356,sugammadex (sugammadex sodium) 500 mg per 5 mL solution for injection vial,8001948,sugammadex,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
3677,Marketed,2021-09-01,00445266,SULFATRIM PEDIATRIC,2.0,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445266,SULFATRIM PEDIATRIC (sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet) AA PHARMA INC,Active,9000138,sulfamethoxazole 100 mg and trimethoprim 20 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3678,Marketed,2019-06-07,00445274,SULFATRIM,2.0,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445274,SULFATRIM (sulfamethoxazole 400 mg and trimethoprim 80 mg oral tablet) AA PHARMA INC,Active,9000139,sulfamethoxazole 400 mg and trimethoprim 80 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
3679,Marketed,2019-04-10,00445282,SULFATRIM DS,2.0,J01EE01,Sulfamethoxazole and trimethoprim,Tablet,Oral,00445282,SULFATRIM DS (sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet) AA PHARMA INC,Active,9000140,sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet,8000080,sulfamethoxazole and trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4703,Marketed,2018-01-18,00550086,SEPTRA INJECTION,2.0,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,00550086,SEPTRA INJECTION (sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection ampoule) ASPEN PHARMACARE CANADA INC.,Active,9000180,sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection ampoule,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
101490,Marketed,2023-06-26,02525917,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP",2.0,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701127,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 800 mg per 10 mL and trimethoprim 160 mg per 10 mL solution for injection vial) AURO PHARMA INC",Active,9014899,sulfamethoxazole 800 mg per 10 mL and trimethoprim 160 mg per 10 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101490,Marketed,2023-06-26,02525917,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP",2.0,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701128,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection vial) AURO PHARMA INC",Active,9014898,sulfamethoxazole 400 mg per 5 mL and trimethoprim 80 mg per 5 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
101490,Marketed,2023-06-26,02525917,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP",2.0,J01EE01,Sulfamethoxazole and trimethoprim,Solution,Intravenous,77701129,"SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP (sulfamethoxazole 2400 mg per 30 mL and trimethoprim 480 mg per 30 mL solution for injection vial) AURO PHARMA INC",Active,9014897,sulfamethoxazole 2400 mg per 30 mL and trimethoprim 480 mg per 30 mL solution for injection vial,8000080,sulfamethoxazole and trimethoprim,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
5728,Marketed,1984-12-31,00598461,PMS-SULFASALAZINE 500MG/TAB USP,1.0,A07EC01,Sulfasalazine,Tablet,Oral,00598461,PMS-SULFASALAZINE 500MG/TAB USP (sulfasalazine 500 mg oral tablet) PHARMASCIENCE INC,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5864,Marketed,1984-12-31,00598488,PMS-SULFASALAZINE-E.C. TAB 500MG,1.0,A07EC01,Sulfasalazine,Tablet (enteric-coated),Oral,00598488,PMS-SULFASALAZINE-E.C. TAB 500MG (sulfasalazine 500 mg gastro-resistant tablet) PHARMASCIENCE INC,Active,9002033,sulfasalazine 500 mg gastro-resistant tablet,8001528,sulfasalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
17416,Marketed,2006-01-11,02064480,SALAZOPYRIN TAB 500MG,1.0,A07EC01,Sulfasalazine,Tablet,Oral,02064480,SALAZOPYRIN TAB 500MG (sulfasalazine 500 mg oral tablet) PFIZER CANADA ULC,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
17417,Marketed,2009-02-03,02064472,SALAZOPYRIN EN-TABS 500 MG,1.0,A07EC01,Sulfasalazine,Tablet (enteric-coated),Oral,02064472,SALAZOPYRIN EN-TABS 500 MG (sulfasalazine 500 mg gastro-resistant tablet) PFIZER CANADA ULC,Active,9002033,sulfasalazine 500 mg gastro-resistant tablet,8001528,sulfasalazine,26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),,,
103322,Marketed,2025-12-10,02544652,JAMP SULFASALAZINE,1.0,A07EC01,Sulfasalazine,Tablet,Oral,02544652,JAMP SULFASALAZINE (sulfasalazine 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001821,sulfasalazine 500 mg oral tablet,8001528,sulfasalazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77308,Marketed,2022-05-18,02287684,SONOVUE,1.0,V08DA05,Sulfur hexafluoride,Powder for suspension,"Intravesical,Intravenous",,,,,,,,,,,,,,,,
9238,Marketed,2011-06-18,00745588,TEVA-SULINDAC,1.0,M01AB02,Sulindac,Tablet,Oral,00745588,TEVA-SULINDAC (sulindac 150 mg oral tablet) TEVA CANADA LIMITED,Active,9002161,sulindac 150 mg oral tablet,8001529,sulindac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
9239,Marketed,2011-06-18,00745596,TEVA-SULINDAC,1.0,M01AB02,Sulindac,Tablet,Oral,00745596,TEVA-SULINDAC (sulindac 200 mg oral tablet) TEVA CANADA LIMITED,Active,9002162,sulindac 200 mg oral tablet,8001529,sulindac,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43077,Marketed,2004-08-30,02212161,IMITREX DF - TAB 100MG,1.0,N02CC01,Sumatriptan,Tablet,Oral,02212161,IMITREX DF - TAB 100MG (sumatriptan (sumatriptan succinate) 100 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43078,Marketed,2003-08-11,02212188,IMITREX,1.0,N02CC01,Sumatriptan,Solution,Subcutaneous,77700585,IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection vial) GLAXOSMITHKLINE INC,Active,9012652,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection vial,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
43078,Marketed,2003-08-11,02212188,IMITREX,1.0,N02CC01,Sumatriptan,Solution,Subcutaneous,77700586,IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) GLAXOSMITHKLINE INC,Active,9006267,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
49288,Marketed,2002-04-25,02230418,IMITREX,1.0,N02CC01,Sumatriptan,Spray,Nasal,02230418,IMITREX (sumatriptan (sumatriptan hemisulfate) 5 mg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9006255,sumatriptan (sumatriptan hemisulfate) 5 mg per actuation nasal spray,8000234,sumatriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
49290,Marketed,2002-03-22,02230420,IMITREX,1.0,N02CC01,Sumatriptan,Spray,Nasal,02230420,IMITREX (sumatriptan (sumatriptan hemisulfate) 20 mg per actuation nasal spray) GLAXOSMITHKLINE INC,Active,9006254,sumatriptan (sumatriptan hemisulfate) 20 mg per actuation nasal spray,8000234,sumatriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
62836,Marketed,2011-06-29,02239367,TEVA-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02239367,TEVA-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74163,Marketed,2005-08-24,02256428,PMS-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02256428,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) PHARMASCIENCE INC,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74164,Marketed,2005-08-24,02256436,PMS-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02256436,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) PHARMASCIENCE INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
74165,Marketed,2005-08-24,02256444,PMS-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02256444,PMS-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) PHARMASCIENCE INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75377,Marketed,2005-08-24,02268388,APO-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02268388,APO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) APOTEX INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75378,Marketed,2005-08-24,02268396,APO-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02268396,APO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) APOTEX INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75430,Marketed,2010-06-30,02268906,MYLAN-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02268906,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75431,Marketed,2010-02-08,02268914,MYLAN-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02268914,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75432,Marketed,2010-01-12,02268922,MYLAN-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02268922,MYLAN-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77198,Marketed,2010-04-05,02286521,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02286521,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SANIS HEALTH INC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77199,Marketed,2010-04-05,02286548,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02286548,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SANIS HEALTH INC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77227,Marketed,2011-06-29,02286815,TEVA-SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02286815,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 25 mg oral tablet) TEVA CANADA LIMITED,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77228,Marketed,2011-06-29,02286823,TEVA-SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02286823,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77229,Marketed,2011-06-29,02286831,TEVA-SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02286831,TEVA-SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81009,Marketed,2009-06-15,02324652,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02324652,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) PRO DOC LIMITEE,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81010,Marketed,2009-06-15,02324660,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02324660,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) PRO DOC LIMITEE,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84675,Marketed,2013-09-20,02361698,TARO-SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Solution,Subcutaneous,02361698,TARO-SUMATRIPTAN (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) TARO PHARMACEUTICALS INC,Active,9006267,sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe,8000234,sumatriptan,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
87118,Marketed,2023-06-01,02385570,SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02385570,SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87119,Marketed,2023-06-01,02385589,SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02385589,SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103407,Marketed,2024-09-30,02545292,JAMP SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545292,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103408,Marketed,2024-09-30,02545306,JAMP SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545306,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103409,Marketed,2024-09-30,02545314,JAMP SUMATRIPTAN DF,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545314,JAMP SUMATRIPTAN DF (sumatriptan (sumatriptan succinate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103412,Marketed,2024-11-01,02545349,JAMP SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545349,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001125,sumatriptan (sumatriptan succinate) 25 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103413,Marketed,2024-11-01,02545357,JAMP SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545357,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103414,Marketed,2024-11-01,02545365,JAMP SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02545365,JAMP SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103476,Marketed,2024-04-29,02546035,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02546035,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 50 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000780,sumatriptan (sumatriptan succinate) 50 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103477,Marketed,2024-04-29,02546043,SUMATRIPTAN,1.0,N02CC01,Sumatriptan,Tablet,Oral,02546043,SUMATRIPTAN (sumatriptan (sumatriptan succinate) 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000698,sumatriptan (sumatriptan succinate) 100 mg oral tablet,8000234,sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98619,Marketed,2020-07-24,02496305,SUVEXX,2.0,N02CC51,Sumatriptan and naproxen,Tablet,Oral,02496305,SUVEXX (naproxen sodium 500 mg and sumatriptan (sumatriptan succinate) 85 mg oral tablet) ARALEZ PHARMACEUTICALS CANADA INC,Active,9014331,naproxen sodium 500 mg and sumatriptan (sumatriptan succinate) 85 mg oral tablet,8002335,naproxen and sumatriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76647,Marketed,2006-06-22,02280795,SUTENT,1.0,L01EX01,Sunitinib,Capsule,Oral,02280795,SUTENT (sunitinib (sunitinib malate) 12.5 mg oral capsule) PFIZER CANADA ULC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
76648,Marketed,2006-06-22,02280809,SUTENT,1.0,L01EX01,Sunitinib,Capsule,Oral,02280809,SUTENT (sunitinib (sunitinib malate) 25 mg oral capsule) PFIZER CANADA ULC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
76649,Marketed,2006-06-22,02280817,SUTENT,1.0,L01EX01,Sunitinib,Capsule,Oral,02280817,SUTENT (sunitinib (sunitinib malate) 50 mg oral capsule) PFIZER CANADA ULC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101308,Marketed,2023-01-17,02524058,TARO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02524058,TARO-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101310,Marketed,2022-09-20,02524066,TARO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02524066,TARO-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101312,Marketed,2022-09-20,02524082,TARO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02524082,TARO-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101531,Marketed,2023-09-11,02526204,TEVA-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02526204,TEVA-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) TEVA CANADA LIMITED,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101532,Marketed,2023-09-11,02526212,TEVA-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02526212,TEVA-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) TEVA CANADA LIMITED,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
101533,Marketed,2023-09-11,02526220,TEVA-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02526220,TEVA-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) TEVA CANADA LIMITED,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102126,Marketed,2023-09-18,02532190,AURO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532190,AURO-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) AURO PHARMA INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102127,Marketed,2023-07-21,02532204,AURO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532204,AURO-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) AURO PHARMA INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102129,Marketed,2023-07-21,02532220,AURO-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532220,AURO-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) AURO PHARMA INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102186,Marketed,2023-05-24,02532840,SANDOZ SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532840,SANDOZ SUNITINIB (sunitinib 12.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014885,sunitinib 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102187,Marketed,2023-05-24,02532867,SANDOZ SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532867,SANDOZ SUNITINIB (sunitinib 25 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014886,sunitinib 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102189,Marketed,2023-05-24,02532883,SANDOZ SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02532883,SANDOZ SUNITINIB (sunitinib 50 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9014887,sunitinib 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
102792,Marketed,2025-09-30,02539284,NAT-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02539284,NAT-SUNITINIB (sunitinib (sunitinib malate) 50 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004178,sunitinib (sunitinib malate) 50 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
104182,Marketed,2025-09-30,02552906,NAT-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02552906,NAT-SUNITINIB (sunitinib (sunitinib malate) 25 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004177,sunitinib (sunitinib malate) 25 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
104183,Marketed,2025-09-30,02552892,NAT-SUNITINIB,1.0,L01EX01,Sunitinib,Capsule,Oral,02552892,NAT-SUNITINIB (sunitinib (sunitinib malate) 12.5 mg oral capsule) NATCO PHARMA (CANADA) INC,Active,9004176,sunitinib (sunitinib malate) 12.5 mg oral capsule,8001950,sunitinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100024,Marketed,2021-09-30,02510995,TISSUEBLUE,1.0,S01K,Surgical aids,Solution,Intravitreal,,,,,,,,,,,,,,,,
227,Marketed,2017-06-23,00038172,QUELICIN,1.0,M03AB01,Suxamethonium,Solution,Intravenous,77700819,QUELICIN (succinylcholine chloride 400 mg per 20 mL solution for injection vial) PFIZER CANADA ULC,Active,9013351,succinylcholine chloride 400 mg per 20 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
227,Marketed,2017-06-23,00038172,QUELICIN,1.0,M03AB01,Suxamethonium,Solution,Intravenous,77700820,QUELICIN (succinylcholine chloride 200 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90702,Marketed,2022-04-22,02422336,SUCCINYLCHOLINE CHLORIDE INJECTION USP,1.0,M03AB01,Suxamethonium,Solution,Intravenous,77700895,SUCCINYLCHOLINE CHLORIDE INJECTION USP (succinylcholine chloride 400 mg per 20 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013351,succinylcholine chloride 400 mg per 20 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90702,Marketed,2022-04-22,02422336,SUCCINYLCHOLINE CHLORIDE INJECTION USP,1.0,M03AB01,Suxamethonium,Solution,Intravenous,77700896,SUCCINYLCHOLINE CHLORIDE INJECTION USP (succinylcholine chloride 200 mg per 10 mL solution for injection vial) HIKMA CANADA LIMITED,Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
99139,Marketed,2020-09-29,02501783,"SUCCINYLCHOLINE CHLORIDE INJECTION, USP",1.0,M03AB01,Suxamethonium,Solution,Intravenous,02501783,"SUCCINYLCHOLINE CHLORIDE INJECTION, USP (succinylcholine chloride 200 mg per 10 mL solution for injection vial) DR REDDY'S LABORATORIES LTD",Active,9013350,succinylcholine chloride 200 mg per 10 mL solution for injection vial,8001946,succinylcholine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
44210,Marketed,2006-04-03,02175983,PROGRAF,1.0,L04AD02,Tacrolimus,Capsule,Oral,02175983,PROGRAF (tacrolimus 5 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
44211,Marketed,2006-04-03,02175991,PROGRAF,1.0,L04AD02,Tacrolimus,Capsule,Oral,02175991,PROGRAF (tacrolimus 1 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
44212,Marketed,2005-09-15,02176009,PROGRAF,1.0,L04AD02,Tacrolimus,Solution,Intravenous,02176009,PROGRAF (tacrolimus 5 mg per 1 mL solution for injection ampoule) ASTELLAS PHARMA CANADA INC,Active,9000646,tacrolimus 5 mg per 1 mL solution for injection ampoule,8000222,tacrolimus,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),1.0,,
67015,Marketed,2005-11-07,02243144,PROGRAF,1.0,L04AD02,Tacrolimus,Capsule,Oral,02243144,PROGRAF (tacrolimus 0.5 mg oral capsule) ASTELLAS PHARMA CANADA INC,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
68109,Marketed,2017-05-25,02244148,PROTOPIC,1.0,D11AH01,Tacrolimus,Ointment,Topical,02244148,PROTOPIC (tacrolimus 0.1 % cutaneous ointment) LEO PHARMA INC,Active,9000960,tacrolimus 0.1 % cutaneous ointment,8000222,tacrolimus,448598008,Cutaneous,425753008,Cutaneous ointment,,,1.0,,
68110,Marketed,2017-05-25,02244149,PROTOPIC,1.0,D11AH01,Tacrolimus,Ointment,Topical,02244149,PROTOPIC (tacrolimus 0.03 % cutaneous ointment) LEO PHARMA INC,Active,9000959,tacrolimus 0.03 % cutaneous ointment,8000222,tacrolimus,448598008,Cutaneous,425753008,Cutaneous ointment,,,1.0,,
78179,Marketed,2008-04-09,02296462,ADVAGRAF,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296462,ADVAGRAF (tacrolimus 0.5 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001241,tacrolimus 0.5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
78180,Marketed,2008-04-09,02296470,ADVAGRAF,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296470,ADVAGRAF (tacrolimus 1 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001242,tacrolimus 1 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
78181,Marketed,2008-04-09,02296489,ADVAGRAF,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02296489,ADVAGRAF (tacrolimus 5 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001243,tacrolimus 5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
81736,Marketed,2010-04-05,02331667,ADVAGRAF,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02331667,ADVAGRAF (tacrolimus 3 mg prolonged-release oral capsule) ASTELLAS PHARMA CANADA INC,Active,9001308,tacrolimus 3 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
90142,Marketed,2014-06-11,02416816,SANDOZ TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416816,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90143,Marketed,2013-11-25,02416824,SANDOZ TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416824,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
90144,Marketed,2013-11-25,02416832,SANDOZ TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02416832,SANDOZ TACROLIMUS (tacrolimus (tacrolimus monohydrate) 5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94058,Marketed,2023-09-21,02454068,ACH-TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02454068,ACH-TACROLIMUS (tacrolimus 0.5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000937,tacrolimus 0.5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94294,Marketed,2023-09-15,02456095,ACH-TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02456095,ACH-TACROLIMUS (tacrolimus (tacrolimus monohydrate) 1 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000644,tacrolimus 1 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
94295,Marketed,2023-09-15,02456109,ACH-TACROLIMUS,1.0,L04AD02,Tacrolimus,Capsule (immediate release),Oral,02456109,ACH-TACROLIMUS (tacrolimus (tacrolimus monohydrate) 5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9000645,tacrolimus 5 mg oral capsule,8000222,tacrolimus,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
97609,Marketed,2019-04-17,02485877,ENVARSUS PA,1.0,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485877,ENVARSUS PA (tacrolimus 0.75 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9013895,tacrolimus 0.75 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
97610,Marketed,2019-04-17,02485885,ENVARSUS PA,1.0,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485885,ENVARSUS PA (tacrolimus 1 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9013896,tacrolimus 1 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
97611,Marketed,2019-04-17,02485893,ENVARSUS PA,1.0,L04AD02,Tacrolimus,Tablet (extended-release),Oral,02485893,ENVARSUS PA (tacrolimus 4 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9013897,tacrolimus 4 mg prolonged-release oral tablet,8000222,tacrolimus,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
101781,Marketed,2025-11-25,02528606,SANDOZ TACROLIMUS XR,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528606,SANDOZ TACROLIMUS XR (tacrolimus 1 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001242,tacrolimus 1 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
101783,Marketed,2025-11-25,02528622,SANDOZ TACROLIMUS XR,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528622,SANDOZ TACROLIMUS XR (tacrolimus 3 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001308,tacrolimus 3 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
101784,Marketed,2025-11-25,02528630,SANDOZ TACROLIMUS XR,1.0,L04AD02,Tacrolimus,Capsule (extended release),Oral,02528630,SANDOZ TACROLIMUS XR (tacrolimus 5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001243,tacrolimus 5 mg prolonged-release oral capsule,8000222,tacrolimus,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),1.0,,
72410,Marketed,2007-09-12,02248088,CIALIS,1.0,G04BE08,Tadalafil,Tablet,Oral,02248088,CIALIS (tadalafil 10 mg oral tablet) ELI LILLY CANADA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72411,Marketed,2007-09-12,02248089,CIALIS,1.0,G04BE08,Tadalafil,Tablet,Oral,02248089,CIALIS (tadalafil 20 mg oral tablet) ELI LILLY CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78223,Marketed,2008-01-18,02296888,CIALIS,1.0,G04BE08,Tadalafil,Tablet,Oral,02296888,CIALIS (tadalafil 2.5 mg oral tablet) ELI LILLY CANADA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78224,Marketed,2008-01-18,02296896,CIALIS,1.0,G04BE08,Tadalafil,Tablet,Oral,02296896,CIALIS (tadalafil 5 mg oral tablet) ELI LILLY CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82395,Marketed,2010-01-19,02338327,ADCIRCA,1.0,G04BE08,Tadalafil,Tablet,Oral,02338327,ADCIRCA (tadalafil 20 mg oral tablet) ELI LILLY CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89412,Marketed,2020-05-22,02409410,PMS-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02409410,PMS-TADALAFIL (tadalafil 2.5 mg oral tablet) PHARMASCIENCE INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89413,Marketed,2020-05-21,02409429,PMS-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02409429,PMS-TADALAFIL (tadalafil 5 mg oral tablet) PHARMASCIENCE INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89414,Marketed,2020-05-21,02409437,PMS-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02409437,PMS-TADALAFIL (tadalafil 10 mg oral tablet) PHARMASCIENCE INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89415,Marketed,2020-05-21,02409445,PMS-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02409445,PMS-TADALAFIL (tadalafil 20 mg oral tablet) PHARMASCIENCE INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89530,Marketed,2016-07-12,02410621,MYLAN-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02410621,MYLAN-TADALAFIL (tadalafil 2.5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89531,Marketed,2016-07-12,02410648,MYLAN-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02410648,MYLAN-TADALAFIL (tadalafil 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89532,Marketed,2016-07-12,02410656,MYLAN-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02410656,MYLAN-TADALAFIL (tadalafil 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89533,Marketed,2016-07-12,02410664,MYLAN-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02410664,MYLAN-TADALAFIL (tadalafil 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90663,Marketed,2015-10-15,02421933,APO-TADALAFIL PAH,1.0,G04BE08,Tadalafil,Tablet,Oral,02421933,APO-TADALAFIL PAH (tadalafil 20 mg oral tablet) APOTEX INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90680,Marketed,2016-07-12,02422085,APO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02422085,APO-TADALAFIL (tadalafil 2.5 mg oral tablet) APOTEX INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90681,Marketed,2016-07-12,02422093,APO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02422093,APO-TADALAFIL (tadalafil 5 mg oral tablet) APOTEX INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90682,Marketed,2016-07-12,02422107,APO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02422107,APO-TADALAFIL (tadalafil 10 mg oral tablet) APOTEX INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90683,Marketed,2016-07-12,02422115,APO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02422115,APO-TADALAFIL (tadalafil 20 mg oral tablet) APOTEX INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92025,Marketed,2016-07-14,02435896,AURO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02435896,AURO-TADALAFIL (tadalafil 2.5 mg oral tablet) AURO PHARMA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92026,Marketed,2016-07-14,02435926,AURO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02435926,AURO-TADALAFIL (tadalafil 5 mg oral tablet) AURO PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92027,Marketed,2016-07-14,02435934,AURO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02435934,AURO-TADALAFIL (tadalafil 10 mg oral tablet) AURO PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92028,Marketed,2016-07-14,02435942,AURO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02435942,AURO-TADALAFIL (tadalafil 20 mg oral tablet) AURO PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92452,Marketed,2016-07-12,02440148,TEVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02440148,TEVA-TADALAFIL (tadalafil 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92453,Marketed,2016-07-12,02440156,TEVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02440156,TEVA-TADALAFIL (tadalafil 5 mg oral tablet) TEVA CANADA LIMITED,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92454,Marketed,2016-07-12,02440164,TEVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02440164,TEVA-TADALAFIL (tadalafil 10 mg oral tablet) TEVA CANADA LIMITED,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92455,Marketed,2016-07-12,02440172,TEVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02440172,TEVA-TADALAFIL (tadalafil 20 mg oral tablet) TEVA CANADA LIMITED,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93791,Marketed,2016-07-14,02451670,MINT-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451670,MINT-TADALAFIL (tadalafil 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93792,Marketed,2023-04-06,02451689,MINT-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451689,MINT-TADALAFIL (tadalafil 10 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93793,Marketed,2016-07-14,02451697,MINT-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451697,MINT-TADALAFIL (tadalafil 20 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93819,Marketed,2016-07-13,02451832,JAMP-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451832,JAMP-TADALAFIL (tadalafil 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93820,Marketed,2016-07-13,02451840,JAMP-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451840,JAMP-TADALAFIL (tadalafil 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93821,Marketed,2016-07-13,02451859,JAMP-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02451859,JAMP-TADALAFIL (tadalafil 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93848,Marketed,2016-07-13,02452278,MAR-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02452278,MAR-TADALAFIL (tadalafil 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93849,Marketed,2016-07-13,02452251,MAR-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02452251,MAR-TADALAFIL (tadalafil 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93850,Marketed,2016-07-13,02452243,MAR-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02452243,MAR-TADALAFIL (tadalafil 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93851,Marketed,2024-03-08,02452073,TARO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02452073,TARO-TADALAFIL (tadalafil 5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93854,Marketed,2024-03-08,02452111,TARO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02452111,TARO-TADALAFIL (tadalafil 20 mg oral tablet) SUN PHARMA CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93886,Marketed,2025-12-04,02452480,NRA-TADALAFIL TABLETS,1.0,G04BE08,Tadalafil,Tablet,Oral,02452480,NRA-TADALAFIL TABLETS (tadalafil 5 mg oral tablet) NORA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93887,Marketed,2024-02-20,02452499,NRA-TADALAFIL TABLETS,1.0,G04BE08,Tadalafil,Tablet,Oral,02452499,NRA-TADALAFIL TABLETS (tadalafil 10 mg oral tablet) NORA PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93888,Marketed,2024-02-20,02452502,NRA-TADALAFIL TABLETS,1.0,G04BE08,Tadalafil,Tablet,Oral,02452502,NRA-TADALAFIL TABLETS (tadalafil 20 mg oral tablet) NORA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94141,Marketed,2022-11-25,02454726,RIVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02454726,RIVA-TADALAFIL (tadalafil 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94142,Marketed,2025-03-31,02454734,RIVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02454734,RIVA-TADALAFIL (tadalafil 10 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94143,Marketed,2022-11-25,02454742,RIVA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02454742,RIVA-TADALAFIL (tadalafil 20 mg oral tablet) LABORATOIRE RIVA INC.,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94216,Marketed,2016-08-11,02455358,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02455358,TADALAFIL (tadalafil 5 mg oral tablet) PRO DOC LIMITEE,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94217,Marketed,2016-09-09,02455366,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02455366,TADALAFIL (tadalafil 10 mg oral tablet) PRO DOC LIMITEE,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94218,Marketed,2016-08-11,02455374,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02455374,TADALAFIL (tadalafil 20 mg oral tablet) PRO DOC LIMITEE,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94401,Marketed,2021-07-08,02457016,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02457016,TADALAFIL (tadalafil 5 mg oral tablet) SANIS HEALTH INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94402,Marketed,2021-07-08,02457024,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02457024,TADALAFIL (tadalafil 10 mg oral tablet) SANIS HEALTH INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94403,Marketed,2021-07-13,02457032,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02457032,TADALAFIL (tadalafil 20 mg oral tablet) SANIS HEALTH INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97173,Marketed,2022-03-16,02481405,AG-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02481405,AG-TADALAFIL (tadalafil 5 mg oral tablet) ANGITA PHARMA INC.,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97175,Marketed,2019-11-21,02481421,AG-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02481421,AG-TADALAFIL (tadalafil 20 mg oral tablet) ANGITA PHARMA INC.,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99807,Marketed,2021-07-28,02508729,BIO-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02508729,BIO-TADALAFIL (tadalafil 20 mg oral tablet) BIOMED PHARMA,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100133,Marketed,2021-09-27,02512114,M-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512114,M-TADALAFIL (tadalafil 5 mg oral tablet) MANTRA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100134,Marketed,2021-09-27,02512122,M-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512122,M-TADALAFIL (tadalafil 10 mg oral tablet) MANTRA PHARMA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100135,Marketed,2021-09-27,02512130,M-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512130,M-TADALAFIL (tadalafil 20 mg oral tablet) MANTRA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100156,Marketed,2021-09-27,02512262,PRZ-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512262,PRZ-TADALAFIL (tadalafil 2.5 mg oral tablet) PHARMARIS CANADA INC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100157,Marketed,2021-09-27,02512270,PRZ-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512270,PRZ-TADALAFIL (tadalafil 5 mg oral tablet) PHARMARIS CANADA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100158,Marketed,2021-09-27,02512289,PRZ-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512289,PRZ-TADALAFIL (tadalafil 10 mg oral tablet) PHARMARIS CANADA INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100159,Marketed,2021-09-27,02512297,PRZ-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02512297,PRZ-TADALAFIL (tadalafil 20 mg oral tablet) PHARMARIS CANADA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100534,Marketed,2023-03-30,02515989,ACH-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02515989,ACH-TADALAFIL (tadalafil 5 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100535,Marketed,2023-03-30,02515997,ACH-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02515997,ACH-TADALAFIL (tadalafil 10 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100536,Marketed,2023-03-30,02516004,ACH-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02516004,ACH-TADALAFIL (tadalafil 20 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101018,Marketed,2022-10-13,02520931,NRA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02520931,NRA-TADALAFIL (tadalafil 5 mg oral tablet) NORA PHARMA INC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101020,Marketed,2022-10-13,02520966,NRA-TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02520966,NRA-TADALAFIL (tadalafil 20 mg oral tablet) NORA PHARMA INC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102542,Marketed,2024-08-29,02536676,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02536676,TADALAFIL (tadalafil 2.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001236,tadalafil 2.5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102543,Marketed,2024-08-29,02536684,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02536684,TADALAFIL (tadalafil 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001237,tadalafil 5 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102544,Marketed,2024-08-29,02536692,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02536692,TADALAFIL (tadalafil 10 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001060,tadalafil 10 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102545,Marketed,2024-08-29,02536706,TADALAFIL,1.0,G04BE08,Tadalafil,Tablet,Oral,02536706,TADALAFIL (tadalafil 20 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001056,tadalafil 20 mg oral tablet,8000331,tadalafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98563,Marketed,2020-04-07,02495732,VYNDAQEL,1.0,N07XX08,Tafamidis,Capsule,Oral,02495732,VYNDAQEL (tafamidis meglumine 20 mg oral capsule) PFIZER CANADA ULC,Active,9014301,tafamidis meglumine 20 mg oral capsule,8002328,tafamidis,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100720,Marketed,2021-09-15,02517841,VYNDAMAX,1.0,N07XX08,Tafamidis,Capsule,Oral,02517841,VYNDAMAX (tafamidis 61 mg oral capsule) PFIZER CANADA ULC,Active,9014813,tafamidis 61 mg oral capsule,8002328,tafamidis,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100793,Marketed,2021-12-06,02518627,MINJUVI,1.0,L01FX12,Tafasitamab,Powder for solution,Intravenous,02518627,MINJUVI (tafasitamab 200 mg per vial powder for solution for injection) INCYTE CORPORATION,Active,9014653,tafasitamab 200 mg per vial powder for solution for injection,8002410,tafasitamab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98204,Marketed,2025-05-16,02492032,TALZENNA,1.0,L01XK04,Talazoparib,Capsule,Oral,02492032,TALZENNA (talazoparib (talazoparib tosylate) 0.25 mg oral capsule) PFIZER CANADA ULC,Active,9015208,talazoparib (talazoparib tosylate) 0.25 mg oral capsule,8002545,talazoparib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,
104385,Marketed,2025-05-16,02555050,TALZENNA,1.0,L01XK04,Talazoparib,Capsule,Oral,02555050,TALZENNA (talazoparib (talazoparib tosylate) 0.1 mg oral capsule) PFIZER CANADA ULC,Active,9015207,talazoparib (talazoparib tosylate) 0.1 mg oral capsule,8002545,talazoparib,26643006,Oral,420692007,Oral capsule,732937005,Capsule,1.0,,
103601,Marketed,2025-03-04,02547392,TALVEY,1.0,L01FX29,Talquetamab,Solution,Subcutaneous,02547392,TALVEY (talquetamab 3 mg per 1.5 mL solution for injection vial) JANSSEN INC,Active,9015193,talquetamab 3 mg per 1.5 mL solution for injection vial,8002539,talquetamab,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
103602,Marketed,2025-03-04,02547406,TALVEY,1.0,L01FX29,Talquetamab,Solution,Subcutaneous,02547406,TALVEY (talquetamab 40 mg per 1 mL solution for injection vial) JANSSEN INC,Active,9015194,talquetamab 40 mg per 1 mL solution for injection vial,8002539,talquetamab,738984000,Injection,385219001,Solution for injection,733026001,Vial,1.0,,
10664,Marketed,1989-12-31,00812404,APO-TAMOX TAB 10MG,1.0,L02BA01,Tamoxifen,Tablet,Oral,00812404,APO-TAMOX TAB 10MG (tamoxifen (tamoxifen citrate) 10 mg oral tablet) APOTEX INC,Active,9002226,tamoxifen (tamoxifen citrate) 10 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10762,Marketed,1989-12-31,00812390,APO-TAMOX TAB 20MG,1.0,L02BA01,Tamoxifen,Tablet,Oral,00812390,APO-TAMOX TAB 20MG (tamoxifen (tamoxifen citrate) 20 mg oral tablet) APOTEX INC,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10790,Marketed,2011-06-01,00851965,TEVA-TAMOXIFEN,1.0,L02BA01,Tamoxifen,Tablet,Oral,00851965,TEVA-TAMOXIFEN (tamoxifen (tamoxifen citrate) 10 mg oral tablet) TEVA CANADA LIMITED,Active,9002226,tamoxifen (tamoxifen citrate) 10 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10791,Marketed,2011-06-01,00851973,TEVA-TAMOXIFEN,1.0,L02BA01,Tamoxifen,Tablet,Oral,00851973,TEVA-TAMOXIFEN (tamoxifen (tamoxifen citrate) 20 mg oral tablet) TEVA CANADA LIMITED,Active,9002227,tamoxifen (tamoxifen citrate) 20 mg oral tablet,8001096,tamoxifen,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80468,Marketed,2014-03-19,02319217,SANDOZ TAMSULOSIN,1.0,G04CA02,Tamsulosin,Capsule (sustained-release),Oral,02319217,SANDOZ TAMSULOSIN (tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9001188,tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000352,tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82577,Marketed,2011-01-04,02340208,SANDOZ TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02340208,SANDOZ TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SANDOZ CANADA INCORPORATED,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
83768,Marketed,2023-12-19,02352419,JAMP TAMSULOSIN,1.0,G04CA02,Tamsulosin,Capsule (sustained-release),Oral,02352419,JAMP TAMSULOSIN (tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9001188,tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000352,tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
84741,Marketed,2012-02-09,02362406,APO-TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02362406,APO-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) APOTEX INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
85321,Marketed,2013-09-04,02368242,TEVA-TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02368242,TEVA-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) TEVA CANADA LIMITED,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
89826,Marketed,2013-11-21,02413612,TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02413612,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) PRO DOC LIMITEE,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91164,Marketed,2014-07-24,02427117,TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02427117,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SANIS HEALTH INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
91411,Marketed,2014-10-08,02429667,TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02429667,TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
103396,Marketed,2024-08-27,02545179,AURO-TAMSULOSIN CR,1.0,G04CA02,Tamsulosin,Tablet (extended-release),Oral,02545179,AURO-TAMSULOSIN CR (tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet) AURO PHARMA INC,Active,9001127,tamsulosin hydrochloride 0.4 mg prolonged-release oral tablet,8000352,tamsulosin,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
85714,Marketed,2011-11-17,02372010,JALYN,2.0,G04CA52,Tamsulosin and dutasteride,Capsule (immediate and extended release),Oral,02372010,JALYN (dutasteride 0.5 mg and tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule) GLAXOSMITHKLINE INC,Active,9015296,dutasteride 0.5 mg and tamsulosin hydrochloride 0.4 mg prolonged-release oral capsule,8000988,dutasteride and tamsulosin,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule,1.0,,
86409,Marketed,2017-09-12,02378272,NUCYNTA IR,1.0,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378272,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 50 mg oral tablet) ENDO OPERATIONS LTD.,Active,9005008,tapentadol (tapentadol hydrochloride) 50 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
86410,Marketed,2017-08-30,02378280,NUCYNTA IR,1.0,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378280,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 75 mg oral tablet) ENDO OPERATIONS LTD.,Active,9005009,tapentadol (tapentadol hydrochloride) 75 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
86411,Marketed,2017-08-30,02378299,NUCYNTA IR,1.0,N02AX06,Tapentadol,Tablet (immediate release),Oral,02378299,NUCYNTA IR (tapentadol (tapentadol hydrochloride) 100 mg oral tablet) ENDO OPERATIONS LTD.,Active,9005007,tapentadol (tapentadol hydrochloride) 100 mg oral tablet,8000789,tapentadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,1.0,
90016,Marketed,2017-09-20,02415577,NUCYNTA EXTENDED-RELEASE,1.0,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415577,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9005496,tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
90017,Marketed,2017-10-03,02415585,NUCYNTA EXTENDED-RELEASE,1.0,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415585,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9005492,tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
90018,Marketed,2017-10-17,02415593,NUCYNTA EXTENDED-RELEASE,1.0,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415593,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9005493,tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
90019,Marketed,2017-11-28,02415607,NUCYNTA EXTENDED-RELEASE,1.0,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415607,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9005494,tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
90020,Marketed,2017-10-24,02415615,NUCYNTA EXTENDED-RELEASE,1.0,N02AX06,Tapentadol,Tablet (extended-release),Oral,02415615,NUCYNTA EXTENDED-RELEASE (tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9005495,tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet,8000789,tapentadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,1.0,
93392,Marketed,2025-09-25,02448254,NDUVRA,2.0,D05AX07,Tapinarof,Cream,Topical,02448254,NDUVRA (tapinarof 1 % cutaneous cream) ORGANON CANADA INC.,Active,9015273,tapinarof 1 % cutaneous cream,8002558,tapinarof,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
104029,Marketed,2024-11-28,02551551,IMDELLTRA,1.0,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551551,IMDELLTRA (tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015155,tarlatamab 1 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
104030,Marketed,2024-11-28,02551578,IMDELLTRA,1.0,L01FX33,Tarlatamab,Powder for solution,Intravenous,02551578,IMDELLTRA (tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer) AMGEN CANADA INC,Active,9015154,tarlatamab 10 mg per vial powder for solution for injection with solution stabilizer,8002526,tarlatamab,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,1.0,,
1667,Marketed,1973-12-31,00266493,TARDAN SHP,3.0,D05AA,Tars,Shampoo,Topical,00266493,TARDAN SHP (coal tar 5 % and salicylic acid 2 % and triclosan 0.3 % shampoo) ODAN LABORATORIES LTD,Active,9001699,coal tar 5 % and salicylic acid 2 % and triclosan 0.3 % shampoo,8002111,coal tar and salicylic acid and triclosan,41695006,Scalp structure,785908001,Shampoo,,,,,
6848,Marketed,1986-12-31,00666114,SEBCUR-T,2.0,D05AA,Tars,Shampoo,Topical,00666114,SEBCUR-T (coal tar 10 % and salicylic acid 4 % shampoo) DERMTEK PHARMA INC,Active,9002064,coal tar 10 % and salicylic acid 4 % shampoo,8002110,coal tar and salicylic acid,41695006,Scalp structure,785908001,Shampoo,,,,,
93479,Marketed,2016-08-01,02448963,DERM OIL,1.0,D05AA,Tars,Solution,Topical,02448963,DERM OIL (coal tar 10 % cutaneous solution) DERMTEK PHARMA INC,Active,9006016,coal tar 10 % cutaneous solution,8002109,coal tar,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
102761,Marketed,2024-09-15,02538954,COAL-TAR SHAMPOO,1.0,D05AA,Tars,Shampoo,Topical,02538954,COAL-TAR SHAMPOO (coal tar 0.5 % shampoo) SEAFORD PHARMACEUTICALS INC,Active,9003517,coal tar 0.5 % shampoo,8002109,coal tar,41695006,Scalp structure,785908001,Shampoo,,,,,
98967,Marketed,2020-08-04,02499967,DUOBRII,2.0,D05AX05,Tazarotene,Lotion,Topical,02499967,"DUOBRII (halobetasol propionate 0.01 % and tazarotene 0.045 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014344,halobetasol propionate 0.01 % and tazarotene 0.045 % lotion,8002338,halobetasol and tazarotene,448598008,Cutaneous,739000003,Lotion,,,,,
100721,Marketed,2021-09-16,02517868,ARAZLO,1.0,D05AX05,Tazarotene,Lotion,Topical,02517868,"ARAZLO (tazarotene 0.045 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014604,tazarotene 0.045 % lotion,8001952,tazarotene,448598008,Cutaneous,739000003,Lotion,,,,,
101664,Marketed,2022-08-23,02527588,KIMMTRAK,1.0,L01XX75,Tebentafusp,Solution,Intravenous,02527588,KIMMTRAK (tebentafusp 100 mcg per 0.5 mL solution for injection vial) IMMUNOCORE IRELAND LIMITED,Active,9014786,tebentafusp 100 mcg per 0.5 mL solution for injection vial,8002439,tebentafusp,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97623,Marketed,2019-03-24,02486008,STANNOUS DISIDA KIT,1.0,V09DA01,Technetium (99m tc) disofenin,"Solution,Kit",Intravenous,,,,,,,,,,,,,,,,
81468,Marketed,2019-01-17,02329034,CERETEC,1.0,V09HA02,Technetium (99m tc) exametazime labelled cells,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
97437,Marketed,2019-04-15,02484048,CERETEC,1.0,V09HA02,Technetium (99m tc) exametazime labelled cells,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
82750,Marketed,2018-08-28,02342006,DRAXIMAGE GLUCEPTATE,2.0,V09CA04,Technetium (99m tc) gluceptate,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
81495,Marketed,2022-05-10,02329263,CHOLETEC,1.0,V09DA04,Technetium (99m tc) mebrofenin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
81492,Marketed,2018-08-23,02329239,DRAXIMAGE MDP-25,1.0,V09BA02,Technetium (99m tc) medronic acid,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
81515,Marketed,2018-08-23,02329409,DRAXIMAGE MDP,1.0,V09BA02,Technetium (99m tc) medronic acid,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
97605,Marketed,2019-03-23,02485834,STANNOUS MDP KIT,1.0,V09BA02,Technetium (99m tc) medronic acid,"Solution,Kit",Intravenous,,,,,,,,,,,,,,,,
81499,Marketed,2019-10-01,02329298,TECHNESCAN MAG3,1.0,V09CA03,Technetium (99m tc) mertiatide,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
92599,Marketed,2019-10-23,02441608,ULTRA-TECHNEKOW V4,1.0,V09FX01,Technetium (99m tc) pertechnetate,Solution,Intravenous,,,,,,,,,,,,,,,,
97624,Marketed,2019-03-24,02486016,STANNOUS PYP KIT,1.0,V09BA03,Technetium (99m tc) pyrophosphate,"Solution,Kit",Intravenous,,,,,,,,,,,,,,,,
100307,Marketed,2022-08-09,02513870,KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION,1.0,V09BA03,Technetium (99m tc) pyrophosphate,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
81314,Marketed,2018-08-23,02327732,DRAXIMAGE SESTAMIBI,1.0,V09GA01,Technetium (99m tc) sestamibi,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
81550,Marketed,2019-12-02,02329794,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION,1.0,V09GA01,Technetium (99m tc) sestamibi,"Kit,Powder for solution",Intravenous,,,,,,,,,,,,,,,,
81508,Marketed,2019-10-29,02329336,ULTRATAG RBC,1.0,V09GA06,Technetium (99m tc) stannous agent labelled cells,"Kit,Solution",Intravenous,,,,,,,,,,,,,,,,
81439,Marketed,2018-11-27,02328755,MYOVIEW,1.0,V09GA02,Technetium (99m tc) tetrofosmin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
90686,Marketed,2018-11-27,02422158,MYOVIEW 30ML,1.0,V09GA02,Technetium (99m tc) tetrofosmin,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
102408,Marketed,2024-05-26,02535211,KIDS 50 CLEAR SUNSCREEN SPRAY,4.0,V07AV,Technical disinfectants,Spray,Topical,,,,,,,,,,,,,,,,
102849,Marketed,2023-10-20,02539756,TECVAYLI,1.0,L01FX24,Teclistamab,Solution,Subcutaneous,02539756,TECVAYLI (teclistamab 30 mg per 3 mL solution for injection vial) JANSSEN INC,Active,9014949,teclistamab 30 mg per 3 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102850,Marketed,2023-10-20,02539764,TECVAYLI,1.0,L01FX24,Teclistamab,Solution,Subcutaneous,02539764,TECVAYLI (teclistamab 153 mg per 1.7 mL solution for injection vial) JANSSEN INC,Active,9014948,teclistamab 153 mg per 1.7 mL solution for injection vial,8002484,teclistamab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
93100,Marketed,2021-10-13,02445727,REVESTIVE,1.0,A16AX08,Teduglutide,"Kit,Powder for solution",Subcutaneous,02445727,REVESTIVE (teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe) TAKEDA CANADA INC,Active,9013023,teduglutide 5 mg per vial powder for solution for injection with diluent solution syringe,8001530,teduglutide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
64358,Marketed,1999-09-01,02240769,MICARDIS 40MG TAB,1.0,C09CA07,Telmisartan,Tablet,Oral,02240769,MICARDIS 40MG TAB (telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64359,Marketed,1999-09-01,02240770,MICARDIS 80MG TAB,1.0,C09CA07,Telmisartan,Tablet,Oral,02240770,MICARDIS 80MG TAB (telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80562,Marketed,2012-01-09,02320177,TEVA-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02320177,TEVA-TELMISARTAN (telmisartan 40 mg oral tablet) TEVA CANADA LIMITED,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80563,Marketed,2012-01-09,02320185,TEVA-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02320185,TEVA-TELMISARTAN (telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86141,Marketed,2012-01-04,02375958,SANDOZ TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02375958,SANDOZ TELMISARTAN (telmisartan 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86142,Marketed,2012-01-04,02375966,SANDOZ TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02375966,SANDOZ TELMISARTAN (telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87235,Marketed,2020-12-29,02386755,JAMP TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02386755,JAMP TELMISARTAN (telmisartan 40 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87236,Marketed,2020-12-29,02386763,JAMP TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02386763,JAMP TELMISARTAN (telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87447,Marketed,2023-08-29,02388944,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02388944,TELMISARTAN (telmisartan 40 mg oral tablet) SANIS HEALTH INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87448,Marketed,2023-08-29,02388952,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02388952,TELMISARTAN (telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87579,Marketed,2025-07-23,02390345,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02390345,TELMISARTAN (telmisartan 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87580,Marketed,2025-07-23,02390353,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02390353,TELMISARTAN (telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88034,Marketed,2012-11-22,02395223,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02395223,TELMISARTAN (telmisartan 40 mg oral tablet) PRO DOC LIMITEE,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88035,Marketed,2012-11-22,02395231,TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02395231,TELMISARTAN (telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89217,Marketed,2023-04-14,02407485,ACH-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02407485,ACH-TELMISARTAN (telmisartan 40 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89218,Marketed,2022-08-03,02407493,ACH-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02407493,ACH-TELMISARTAN (telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94012,Marketed,2016-04-08,02453568,AURO-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02453568,AURO-TELMISARTAN (telmisartan 40 mg oral tablet) AURO PHARMA INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94013,Marketed,2016-04-08,02453576,AURO-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02453576,AURO-TELMISARTAN (telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97483,Marketed,2021-10-12,02484536,AG-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02484536,AG-TELMISARTAN (telmisartan 40 mg oral tablet) ANGITA PHARMA INC.,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97484,Marketed,2021-10-12,02484544,AG-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02484544,AG-TELMISARTAN (telmisartan 80 mg oral tablet) ANGITA PHARMA INC.,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97657,Marketed,2020-04-16,02486369,MINT-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02486369,MINT-TELMISARTAN (telmisartan 40 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97658,Marketed,2020-03-18,02486377,MINT-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02486377,MINT-TELMISARTAN (telmisartan 80 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98935,Marketed,2021-03-25,02499622,PMS-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02499622,PMS-TELMISARTAN (telmisartan 40 mg oral tablet) PHARMASCIENCE INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98936,Marketed,2021-03-25,02499630,PMS-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02499630,PMS-TELMISARTAN (telmisartan 80 mg oral tablet) PHARMASCIENCE INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99323,Marketed,2024-10-16,02503794,NRA-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02503794,NRA-TELMISARTAN (telmisartan 40 mg oral tablet) NORA PHARMA INC,Active,9000866,telmisartan 40 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99324,Marketed,2024-10-16,02503808,NRA-TELMISARTAN,1.0,C09CA07,Telmisartan,Tablet,Oral,02503808,NRA-TELMISARTAN (telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9000867,telmisartan 80 mg oral tablet,8000277,telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85622,Marketed,2011-08-11,02371022,TWYNSTA,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371022,TWYNSTA (amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004910,amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85623,Marketed,2011-08-11,02371030,TWYNSTA,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371030,TWYNSTA (amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004908,amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85624,Marketed,2011-08-11,02371049,TWYNSTA,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371049,TWYNSTA (amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004911,amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85625,Marketed,2011-08-11,02371057,TWYNSTA,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02371057,TWYNSTA (amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9004909,amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106296,Marketed,2025-11-13,02559854,RIVA-TELMISARTAN/AMLODIPINE,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559854,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004910,amlodipine (amlodipine besylate) 5 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106297,Marketed,2025-10-21,02559862,RIVA-TELMISARTAN/AMLODIPINE,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559862,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004908,amlodipine (amlodipine besylate) 10 mg and telmisartan 40 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106298,Marketed,2025-10-21,02559870,RIVA-TELMISARTAN/AMLODIPINE,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559870,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004911,amlodipine (amlodipine besylate) 5 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106299,Marketed,2025-10-21,02559889,RIVA-TELMISARTAN/AMLODIPINE,2.0,C09DB04,Telmisartan and amlodipine,Tablet,Oral,02559889,RIVA-TELMISARTAN/AMLODIPINE (amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet) LABORATOIRE RIVA INC.,Active,9004909,amlodipine (amlodipine besylate) 10 mg and telmisartan 80 mg oral tablet,8000985,amlodipine and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68312,Marketed,2001-08-16,02244344,MICARDIS PLUS,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02244344,MICARDIS PLUS (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80418,Marketed,2008-12-02,02318709,MICARDIS PLUS,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02318709,MICARDIS PLUS (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
81603,Marketed,2012-02-16,02330288,TEVA-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02330288,TEVA-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86513,Marketed,2012-02-06,02379252,TEVA-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02379252,TEVA-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87541,Marketed,2020-12-29,02389940,JAMP TELMISARTAN-HCT,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02389940,JAMP TELMISARTAN-HCT (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87542,Marketed,2020-12-29,02389959,JAMP TELMISARTAN-HCT,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02389959,JAMP TELMISARTAN-HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87575,Marketed,2025-08-14,02390302,TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02390302,TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87576,Marketed,2025-08-14,02390310,TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02390310,TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87877,Marketed,2012-09-28,02393557,SANDOZ TELMISARTAN HCT,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02393557,SANDOZ TELMISARTAN HCT (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87878,Marketed,2012-09-28,02393565,SANDOZ TELMISARTAN HCT,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02393565,SANDOZ TELMISARTAN HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88046,Marketed,2012-11-12,02395355,TELMISARTAN/HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395355,TELMISARTAN/HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88047,Marketed,2012-11-12,02395363,TELMISARTAN/HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395363,TELMISARTAN/HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) SANIS HEALTH INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88061,Marketed,2025-05-29,02395525,PRO-TELMISARTAN-HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395525,PRO-TELMISARTAN-HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88062,Marketed,2025-05-29,02395533,PRO-TELMISARTAN-HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02395533,PRO-TELMISARTAN-HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90365,Marketed,2014-11-24,02419114,ACH-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02419114,ACH-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90366,Marketed,2014-11-24,02419122,ACH-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02419122,ACH-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) ACCORD HEALTHCARE INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94325,Marketed,2016-08-23,02456389,AURO-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02456389,AURO-TELMISARTAN HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94326,Marketed,2016-08-23,02456397,AURO-TELMISARTAN HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02456397,AURO-TELMISARTAN HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) AURO PHARMA INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97487,Marketed,2022-09-07,02484579,AG TELMISARTAN-HCT,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02484579,AG TELMISARTAN-HCT (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) ANGITA PHARMA INC.,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99357,Marketed,2024-10-16,02504138,NRA-TELMISARTAN/HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02504138,NRA-TELMISARTAN/HCTZ (hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9001261,hydrochlorothiazide 25 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99358,Marketed,2024-10-16,02504146,NRA-TELMISARTAN/HCTZ,2.0,C09DA07,Telmisartan and diuretics,Tablet,Oral,02504146,NRA-TELMISARTAN/HCTZ (hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet) NORA PHARMA INC,Active,9000950,hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet,8000301,hydrochlorothiazide and telmisartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97200,Marketed,2024-07-02,02481553,XERMELO,1.0,A16AX15,Telotristat,Tablet,Oral,02481553,XERMELO (telotristat ethyl (telotristat etiprate) 250 mg oral tablet) SERB SAS,Active,9013754,telotristat ethyl (telotristat etiprate) 250 mg oral tablet,8002213,telotristat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
5616,Marketed,2018-01-31,00604453,RESTORIL,1.0,N05CD07,Temazepam,Capsule,Oral,00604453,RESTORIL (temazepam 15 mg oral capsule) AA PHARMA INC,Active,9000157,temazepam 15 mg oral capsule,8000087,temazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
5618,Marketed,2018-03-06,00604461,RESTORIL,1.0,N05CD07,Temazepam,Capsule,Oral,00604461,RESTORIL (temazepam 30 mg oral capsule) AA PHARMA INC,Active,9000158,temazepam 30 mg oral capsule,8000087,temazepam,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
64696,Marketed,2012-03-15,02241093,TEMODAL,1.0,L01AX03,Temozolomide,Capsule,Oral,02241093,TEMODAL (temozolomide 5 mg oral capsule) MERCK CANADA INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
64697,Marketed,2012-03-13,02241094,TEMODAL,1.0,L01AX03,Temozolomide,Capsule,Oral,02241094,TEMODAL (temozolomide 20 mg oral capsule) MERCK CANADA INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
64698,Marketed,2012-03-28,02241095,TEMODAL,1.0,L01AX03,Temozolomide,Capsule,Oral,02241095,TEMODAL (temozolomide 100 mg oral capsule) MERCK CANADA INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
64699,Marketed,2012-03-21,02241096,TEMODAL,1.0,L01AX03,Temozolomide,Capsule,Oral,02241096,TEMODAL (temozolomide 250 mg oral capsule) MERCK CANADA INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
79831,Marketed,2012-03-23,02312794,TEMODAL,1.0,L01AX03,Temozolomide,Capsule,Oral,02312794,TEMODAL (temozolomide 140 mg oral capsule) MERCK CANADA INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87529,Marketed,2014-07-24,02389819,ACH-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02389819,ACH-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87530,Marketed,2014-07-24,02389827,ACH-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02389827,ACH-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87531,Marketed,2014-07-24,02389835,ACH-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02389835,ACH-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) ACCORD HEALTHCARE INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
87533,Marketed,2014-07-24,02389851,ACH-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02389851,ACH-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88038,Marketed,2021-10-19,02395274,TEVA-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02395274,TEVA-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) TEVA CANADA LIMITED,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88039,Marketed,2021-10-19,02395282,TEVA-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02395282,TEVA-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) TEVA CANADA LIMITED,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88040,Marketed,2021-10-19,02395290,TEVA-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02395290,TEVA-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) TEVA CANADA LIMITED,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
88042,Marketed,2021-10-19,02395312,TEVA-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02395312,TEVA-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) TEVA CANADA LIMITED,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92249,Marketed,2016-01-13,02438119,ACH-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02438119,ACH-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) ACCORD HEALTHCARE INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92553,Marketed,2021-10-19,02441160,TEVA-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02441160,TEVA-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) TEVA CANADA LIMITED,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92817,Marketed,2015-07-23,02443473,TARO-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02443473,TARO-TEMOZOLOMIDE (temozolomide 5 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92818,Marketed,2015-07-23,02443481,TARO-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02443481,TARO-TEMOZOLOMIDE (temozolomide 20 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92820,Marketed,2015-07-23,02443511,TARO-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02443511,TARO-TEMOZOLOMIDE (temozolomide 100 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92821,Marketed,2015-07-23,02443538,TARO-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02443538,TARO-TEMOZOLOMIDE (temozolomide 140 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
92823,Marketed,2015-07-23,02443554,TARO-TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02443554,TARO-TEMOZOLOMIDE (temozolomide 250 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100615,Marketed,2022-07-27,02516799,JAMP TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02516799,JAMP TEMOZOLOMIDE (temozolomide 5 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003435,temozolomide 5 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100616,Marketed,2022-08-05,02516802,JAMP TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02516802,JAMP TEMOZOLOMIDE (temozolomide 20 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003433,temozolomide 20 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100617,Marketed,2022-07-25,02516810,JAMP TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02516810,JAMP TEMOZOLOMIDE (temozolomide 100 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003432,temozolomide 100 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100618,Marketed,2022-07-26,02516829,JAMP TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02516829,JAMP TEMOZOLOMIDE (temozolomide 140 mg oral capsule) JAMP PHARMA CORPORATION,Active,9004517,temozolomide 140 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
100620,Marketed,2022-07-26,02516845,JAMP TEMOZOLOMIDE,1.0,L01AX03,Temozolomide,Capsule,Oral,02516845,JAMP TEMOZOLOMIDE (temozolomide 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9003434,temozolomide 250 mg oral capsule,8001953,temozolomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
78941,Marketed,2011-07-11,02304104,TORISEL,1.0,L01EG01,Temsirolimus,Solution,Intravenous,02304104,TORISEL (temsirolimus 30 mg per 1.2 mL solution for injection vial with diluent solution) PFIZER CANADA ULC,Active,9013024,temsirolimus 30 mg per 1.2 mL solution for injection vial with diluent solution,8001686,temsirolimus,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
98784,Marketed,2020-11-23,02498049,IBSRELA,1.0,A06AX08,Tenapanor,Tablet,Oral,02498049,IBSRELA (tenapanor (tenapanor hydrochloride) 50 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014407,tenapanor (tenapanor hydrochloride) 50 mg oral tablet,8002351,tenapanor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68816,Marketed,2001-10-18,02244826,TNKASE,1.0,B01AD11,Tenecteplase,Powder for solution,Intravenous,02244826,TNKASE (tenecteplase 50 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013357,tenecteplase 50 mg per vial powder for solution for injection with diluent solution,8001954,tenecteplase,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
95241,Marketed,2017-06-20,02464241,VEMLIDY,1.0,J05AF13,Tenofovir alafenamide,Tablet,Oral,02464241,VEMLIDY (tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9006196,tenofovir alafenamide (tenofovir alafenamide hemifumarate) 25 mg oral tablet,8001236,tenofovir alafenamide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71368,Marketed,2009-05-21,02247128,VIREAD,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02247128,VIREAD (tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88865,Marketed,2017-07-26,02403889,TEVA-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02403889,TEVA-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93838,Marketed,2017-07-26,02451980,APO-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02451980,APO-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93899,Marketed,2017-07-31,02452634,MYLAN-TENOFOVIR DISOPROXIL,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02452634,MYLAN-TENOFOVIR DISOPROXIL (tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94047,Marketed,2018-04-25,02453940,PMS-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02453940,PMS-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) PHARMASCIENCE INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94747,Marketed,2017-07-26,02460173,AURO-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02460173,AURO-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96182,Marketed,2018-03-15,02472511,NAT-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02472511,NAT-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96979,Marketed,2018-10-24,02479087,JAMP-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02479087,JAMP-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100162,Marketed,2021-08-20,02512327,TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02512327,TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) SANIS HEALTH INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100218,Marketed,2021-09-07,02512939,MINT-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02512939,MINT-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100454,Marketed,2021-06-14,02515156,RIVA-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02515156,RIVA-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) LABORATOIRE RIVA INC.,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100563,Marketed,2022-06-09,02516276,AG-TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02516276,AG-TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) ANGITA PHARMA INC.,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101297,Marketed,2022-05-12,02523922,TENOFOVIR,1.0,J05AF07,Tenofovir disoproxil,Tablet,Oral,02523922,TENOFOVIR (tenofovir disoproxil fumarate 300 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9003883,tenofovir disoproxil fumarate 300 mg oral tablet,8001237,tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76043,Marketed,2009-05-21,02274906,TRUVADA,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02274906,TRUVADA (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) GILEAD SCIENCES CANADA INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88396,Marketed,2017-07-26,02399059,TEVA-EMTRICITABINE/TENOFOVIR,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02399059,TEVA-EMTRICITABINE/TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) TEVA CANADA LIMITED,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92868,Marketed,2017-07-31,02443902,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02443902,MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93840,Marketed,2017-07-26,02452006,APO-EMTRICITABINE-TENOFOVIR,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02452006,APO-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) APOTEX INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94861,Marketed,2019-09-12,02461110,PMS-EMTRICITABINE-TENOFOVIR,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02461110,PMS-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) PHARMASCIENCE INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97716,Marketed,2019-07-23,02487012,JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02487012,JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98074,Marketed,2023-03-01,02490684,AURO-EMTRICITABINE-TENOFOVIR,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02490684,AURO-EMTRICITABINE-TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) AURO PHARMA INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98623,Marketed,2020-11-09,02496356,AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02496356,AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) ANGITA PHARMA INC.,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101073,Marketed,2022-08-11,02521547,MINT-EMTRICITABINE/TENOFOVIR,2.0,J05AR03,Tenofovir disoproxil and emtricitabine,Tablet,Oral,02521547,MINT-EMTRICITABINE/TENOFOVIR (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9004149,emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet,8001198,emtricitabine and tenofovir disoproxil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106068,Marketed,2025-08-20,02557347,TZIELD,1.0,A10XX01,Teplizumab,Solution,Intravenous,02557347,TZIELD (teplizumab 2 mg per 2 mL solution for injection vial) SANOFI-AVENTIS CANADA INC,Active,9015260,teplizumab 2 mg per 2 mL solution for injection vial,8002553,teplizumab,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
100568,Marketed,2021-10-07,02516322,TEPMETKO,1.0,L01EX21,Tepotinib,Tablet,Oral,02516322,"TEPMETKO (tepotinib (tepotinib hydrochloride) 225 mg oral tablet) EMD SERONO, A DIVISION OF EMD INC., CANADA",Active,9014615,tepotinib (tepotinib hydrochloride) 225 mg oral tablet,8002395,tepotinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
55839,Marketed,2021-09-23,02234502,APO-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02234502,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 1 mg oral tablet) APOTEX INC,Active,9000749,terazosin (terazosin hydrochloride) 1 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
55840,Marketed,2021-09-23,02234503,APO-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02234503,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 2 mg oral tablet) APOTEX INC,Active,9000750,terazosin (terazosin hydrochloride) 2 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
55841,Marketed,2021-09-23,02234504,APO-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02234504,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9000751,terazosin (terazosin hydrochloride) 5 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
55842,Marketed,2021-09-23,02234505,APO-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02234505,APO-TERAZOSIN (terazosin (terazosin hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9000748,terazosin (terazosin hydrochloride) 10 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67437,Marketed,2001-02-23,02243518,PMS-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02243518,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 1 mg oral tablet) PHARMASCIENCE INC,Active,9000749,terazosin (terazosin hydrochloride) 1 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67438,Marketed,2001-02-23,02243519,PMS-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02243519,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 2 mg oral tablet) PHARMASCIENCE INC,Active,9000750,terazosin (terazosin hydrochloride) 2 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67439,Marketed,2001-02-23,02243520,PMS-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02243520,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 5 mg oral tablet) PHARMASCIENCE INC,Active,9000751,terazosin (terazosin hydrochloride) 5 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67440,Marketed,2001-02-23,02243521,PMS-TERAZOSIN,1.0,G04CA03,Terazosin,Tablet,Oral,02243521,PMS-TERAZOSIN (terazosin (terazosin hydrochloride) 10 mg oral tablet) PHARMASCIENCE INC,Active,9000748,terazosin (terazosin hydrochloride) 10 mg oral tablet,8000247,terazosin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
14532,Marketed,1999-02-23,02031094,LAMISIL,1.0,D01AE15,Terbinafine,Cream,Topical,02031094,LAMISIL (terbinafine hydrochloride 1 % cutaneous cream) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000494,terbinafine hydrochloride 1 % cutaneous cream,8000188,terbinafine,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
62135,Marketed,1999-01-05,02238703,LAMISIL,1.0,D01AE15,Terbinafine,Spray,Topical,02238703,LAMISIL (terbinafine hydrochloride 1 % cutaneous spray) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000832,terbinafine hydrochloride 1 % cutaneous spray,8000188,terbinafine,448598008,Cutaneous,421720008,Spray,,,,,
63385,Marketed,2020-08-04,02239893,APO-TERBINAFINE,1.0,D01BA02,Terbinafine,Tablet,Oral,02239893,APO-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) APOTEX INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66543,Marketed,2008-03-07,02242735,TERBINAFINE-250,1.0,D01BA02,Terbinafine,Tablet,Oral,02242735,TERBINAFINE-250 (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) PRO DOC LIMITEE,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
73989,Marketed,2024-12-20,02254727,TEVA-TERBINAFINE,1.0,D01BA02,Terbinafine,Tablet,Oral,02254727,TEVA-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) TEVA CANADA LIMITED,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77963,Marketed,2009-06-19,02294273,PMS-TERBINAFINE,1.0,D01BA02,Terbinafine,Tablet,Oral,02294273,PMS-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) PHARMASCIENCE INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80558,Marketed,2011-05-30,02320134,AURO-TERBINAFINE,1.0,D01BA02,Terbinafine,Tablet,Oral,02320134,AURO-TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) AURO PHARMA INC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87091,Marketed,2020-08-04,02385279,TERBINAFINE,1.0,D01BA02,Terbinafine,Tablet,Oral,02385279,TERBINAFINE (terbinafine (terbinafine hydrochloride) 250 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000495,terbinafine (terbinafine hydrochloride) 250 mg oral tablet,8000188,terbinafine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10665,Marketed,2024-08-09,00786616,BRICANYL TURBUHALER,1.0,R03AC03,Terbutaline,Powder,Inhalation,00786616,BRICANYL TURBUHALER (terbutaline sulfate 0.5 mg per actuation inhalation powder) ASTRAZENECA CANADA INC,Active,9002327,terbutaline sulfate 0.5 mg per actuation inhalation powder,8001088,terbutaline,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
71914,Marketed,2004-09-21,02247651,TARO-TERCONAZOLE,1.0,G01AG02,Terconazole,Cream,Vaginal,02247651,TARO-TERCONAZOLE (terconazole 0.4 % vaginal cream) TARO PHARMACEUTICALS INC,Active,9003956,terconazole 0.4 % vaginal cream,8001420,terconazole,16857009,Vaginal,385165005,Vaginal cream,,,,,
99001,Marketed,2022-05-16,02500310,NAT-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02500310,NAT-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99011,Marketed,2022-05-16,02500434,PMS-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02500434,PMS-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) PHARMASCIENCE INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99014,Marketed,2022-05-18,02500469,MAR-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02500469,MAR-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99030,Marketed,2022-05-16,02500639,APO-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02500639,APO-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) APOTEX INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99074,Marketed,2022-05-16,02501090,TEVA-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02501090,TEVA-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) TEVA CANADA LIMITED,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99361,Marketed,2022-05-16,02504170,JAMP TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02504170,JAMP TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99522,Marketed,2022-05-16,02505843,SANDOZ TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02505843,SANDOZ TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101289,Marketed,2022-05-16,02523833,M-TERIFLUNOMIDE,1.0,L04AK02,Teriflunomide,Tablet,Oral,02523833,M-TERIFLUNOMIDE (teriflunomide 14 mg oral tablet) MANTRA PHARMA INC,Active,9005367,teriflunomide 14 mg oral tablet,8001687,teriflunomide,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73983,Marketed,2004-07-15,02254689,FORTEO,1.0,H05AA02,Teriparatide,Solution,Subcutaneous,02254689,FORTEO (teriparatide 20 mcg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9014070,teriparatide 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,
97663,Marketed,2020-07-08,02486423,TEVA-TERIPARATIDE INJECTION,1.0,H05AA02,Teriparatide,Solution,Subcutaneous,02486423,TEVA-TERIPARATIDE INJECTION (teriparatide (teriparatide acetate) 20 mcg per actuation solution for injection pre-filled pen) TEVA CANADA LIMITED,Active,9014371,teriparatide (teriparatide acetate) 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,
98548,Marketed,2020-10-27,02495589,OSNUVO,1.0,H05AA02,Teriparatide,Solution,Subcutaneous,02495589,OSNUVO (teriparatide 600 mcg per 2.4 mL solution for injection cartridge) AVIR PHARMA INC.,Active,9014408,teriparatide 600 mcg per 2.4 mL solution for injection cartridge,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732988008,Cartridge (unit of presentation),,,1.0
98854,Marketed,2024-12-04,02498804,APO-TERIPARATIDE INJECTION,1.0,H05AA02,Teriparatide,Solution,Subcutaneous,02498804,APO-TERIPARATIDE INJECTION (teriparatide 20 mcg per actuation solution for injection pre-filled pen) APOTEX INC,Active,9014070,teriparatide 20 mcg per actuation solution for injection pre-filled pen,8001688,teriparatide,738984000,Parenteral,385219001,Solution for injection,732981002,Actuation (unit of presentation),,,
69384,Marketed,2016-04-07,02245345,ANDROGEL,1.0,G03BA03,Testosterone,Gel,Transdermal,02245345,ANDROGEL (testosterone 1 % transdermal gel 2.5 g sachet) BGP PHARMA ULC,Active,9012541,testosterone 1 % transdermal gel 2.5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
69385,Marketed,2016-04-07,02245346,ANDROGEL,1.0,G03BA03,Testosterone,Gel,Transdermal,02245346,ANDROGEL (testosterone 1 % transdermal gel 5 g sachet) BGP PHARMA ULC,Active,9012542,testosterone 1 % transdermal gel 5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
73432,Marketed,2016-04-07,02249499,ANDROGEL,1.0,G03BA03,Testosterone,Gel,Transdermal,02249499,ANDROGEL (testosterone 12.5 mg per actuation transdermal gel) BGP PHARMA ULC,Active,9012592,testosterone 12.5 mg per actuation transdermal gel,8000006,testosterone,45890007,Transdermal,385100002,Gel,732981002,Actuation (unit of presentation),1.0,,
76591,Marketed,2026-01-16,02280248,TESTIM 1%,1.0,G03BA03,Testosterone,Gel,Transdermal,02280248,TESTIM 1% (testosterone 1 % transdermal gel 5 g tube) KNIGHT THERAPEUTICS INC.,Active,9012543,testosterone 1 % transdermal gel 5 g tube,8000006,testosterone,45890007,Transdermal,385100002,Gel,,,1.0,,
90578,Marketed,2014-09-02,02421186,TARO-TESTOSTERONE,1.0,G03BA03,Testosterone,Capsule,Oral,02421186,TARO-TESTOSTERONE (testosterone undecanoate 40 mg oral capsule) TARO PHARMACEUTICALS INC,Active,9001294,testosterone undecanoate 40 mg oral capsule,8000006,testosterone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93671,Marketed,2022-09-15,02450550,NATESTO,1.0,G03BA03,Testosterone,Gel,Nasal,02450550,NATESTO (testosterone 4.5 % nasal gel) ACERUS BIOPHARMA INC,Active,9001458,testosterone 4.5 % nasal gel,8000006,testosterone,46713006,Nasal,385100002,Gel,,,1.0,,
95189,Marketed,2017-10-31,02463792,TARO-TESTOSTERONE GEL,1.0,G03BA03,Testosterone,Gel,Transdermal,02463792,TARO-TESTOSTERONE GEL 2.5G/PACKET (testosterone 1 % transdermal gel 2.5 g sachet) TARO PHARMACEUTICALS INC,Active,9012541,testosterone 1 % transdermal gel 2.5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
95190,Marketed,2017-10-31,02463806,TARO-TESTOSTERONE GEL,1.0,G03BA03,Testosterone,Gel,Transdermal,02463806,TARO-TESTOSTERONE GEL 5G/PACKET (testosterone 1 % transdermal gel 5 g sachet) TARO PHARMACEUTICALS INC,Active,9012542,testosterone 1 % transdermal gel 5 g sachet,8000006,testosterone,45890007,Transdermal,385100002,Gel,733013000,Sachet (unit of presentation),1.0,,
98589,Marketed,2020-10-20,02496003,TARO-TESTOSTERONE CYPIONATE INJECTION,1.0,G03BA03,Testosterone,Solution,Intramuscular,02496003,TARO-TESTOSTERONE CYPIONATE INJECTION (testosterone cypionate 1000 mg per 10 mL solution for injection vial) TARO PHARMACEUTICALS INC,Active,9000010,testosterone cypionate 1000 mg per 10 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102510,Marketed,2024-01-30,02536315,"TESTOSTERONE ENANTHATE INJECTION, USP",1.0,G03BA03,Testosterone,Solution,Intramuscular,02536315,"TESTOSTERONE ENANTHATE INJECTION, USP (testosterone enanthate 1000 mg per 5 mL solution for injection vial) HIKMA CANADA LIMITED",Active,9015022,testosterone enanthate 1000 mg per 5 mL solution for injection vial,8000006,testosterone,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
5537,Marketed,2004-10-22,00609692,HISTATROL,1.0,V04CL,Tests for allergic diseases,Solution,Percutaneous,,,,,,,,,,,,,,,,
5538,Marketed,2004-10-22,00609706,HISTATROL,1.0,V04CL,Tests for allergic diseases,Solution,Intradermal,,,,,,,,,,,,,,,,
92393,Marketed,2024-12-18,02439514,POSITIVE SKIN TEST CONTROL-HISTAMINE,1.0,V04CL,Tests for allergic diseases,Solution,Percutaneous,,,,,,,,,,,,,,,,
95465,Marketed,2017-09-13,02466325,TOPICAL HAPTEN GEL,1.0,V04CL,Tests for allergic diseases,Gel,Topical,,,,,,,,,,,,,,,,
95467,Marketed,2017-09-13,02466333,TOPICAL HAPTEN GEL,1.0,V04CL,Tests for allergic diseases,Gel,Topical,,,,,,,,,,,,,,,,
95469,Marketed,2017-09-13,02466341,TOPICAL HAPTEN LIQUID,1.0,V04CL,Tests for allergic diseases,Liquid,Topical,,,,,,,,,,,,,,,,
95470,Marketed,2017-09-13,02466368,TOPICAL HAPTEN LIQUID,1.0,V04CL,Tests for allergic diseases,Liquid,Topical,,,,,,,,,,,,,,,,
3378,Marketed,2006-06-15,00399736,L-ARGININE HYDROCHLORIDE INJECTION,1.0,V04CD,Tests for pituitary function,Liquid,Intravenous,00399736,L-ARGININE HYDROCHLORIDE INJECTION (arginine hydrochloride 7500 mg per 30 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9014000,arginine hydrochloride 7500 mg per 30 mL solution for injection vial,8002275,arginine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100930,Marketed,2021-12-13,02520087,HYPERTET,1.0,J06BB02,Tetanus immunoglobulin,Solution,Intramuscular,,,,,,,,,,,,,,,,
101763,Marketed,2024-04-09,02528401,TD ADSORBED,2.0,J07AM51,"Tetanus toxoid, comb. with diphtheria toxoid",Suspension,Intramuscular,,,,,,,,,,,,,,,,
42959,Marketed,2020-10-02,02199270,NITOMAN,1.0,N07XX06,Tetrabenazine,Tablet,Oral,02199270,"NITOMAN (tetrabenazine 25 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88726,Marketed,2013-02-26,02402424,PMS-TETRABENAZINE,1.0,N07XX06,Tetrabenazine,Tablet,Oral,02402424,PMS-TETRABENAZINE (tetrabenazine 25 mg oral tablet) PHARMASCIENCE INC,Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89232,Marketed,2013-11-01,02407590,APO-TETRABENAZINE,1.0,N07XX06,Tetrabenazine,Tablet,Oral,02407590,APO-TETRABENAZINE (tetrabenazine 25 mg oral tablet) APOTEX INC,Active,9002981,tetrabenazine 25 mg oral tablet,8001533,tetrabenazine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18749,Marketed,2023-02-07,02148544,MINIMS TETRACAINE HYDROCHLORIDE,1.0,S01HA03,Tetracaine,Drops,Ophthalmic,02148544,MINIMS TETRACAINE HYDROCHLORIDE (tetracaine hydrochloride 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002878,tetracaine hydrochloride 1 % ophthalmic drops,8001956,tetracaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18751,Marketed,2023-02-07,02148528,MINIMS TETRACAINE HYDROCHLORIDE,1.0,S01HA03,Tetracaine,Drops,Ophthalmic,02148528,MINIMS TETRACAINE HYDROCHLORIDE (tetracaine hydrochloride 0.5 % ophthalmic drops) BAUSCH & LOMB INC,Active,9002877,tetracaine hydrochloride 0.5 % ophthalmic drops,8001956,tetracaine,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
49664,Marketed,2020-07-09,02230575,AMETOP GEL 4%,1.0,D04AB06,Tetracaine,Gel,Topical,02230575,AMETOP GEL 4% (tetracaine (tetracaine hydrochloride) 40 mg per g cutaneous gel) VALEO PHARMA INC,Active,9003236,tetracaine (tetracaine hydrochloride) 40 mg per g cutaneous gel,8001956,tetracaine,448598008,Cutaneous,385100002,Gel,,,,,
1954,Marketed,2004-05-19,00022381,CORTROSYN INJ 0.25MG,1.0,H01AA02,Tetracosactide,Powder for solution,"Intravenous,Intramuscular",00022381,"CORTROSYN INJ 0.25MG (tetracosactide 0.25 mg per vial powder for solution for injection) AMPHASTAR PHARMACEUTICALS, INC.",Active,9001726,tetracosactide 0.25 mg per vial powder for solution for injection,8001957,tetracosactide,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
5293,Marketed,2011-07-12,00580929,TETRACYCLINE,1.0,J01AA07,Tetracycline,Capsule,Oral,00580929,TETRACYCLINE (tetracycline hydrochloride 250 mg oral capsule) AA PHARMA INC,Active,9001996,tetracycline hydrochloride 250 mg oral capsule,8001421,tetracycline,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
42015,Marketed,2007-01-20,01942425,VISINE ORIGINAL,1.0,S01GA02,Tetryzoline,Drops,Ophthalmic,01942425,VISINE ORIGINAL (tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9001581,tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8001958,tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
75893,Marketed,2025-01-22,02273446,ORIGINAL EYE DROPS,1.0,S01GA02,Tetryzoline,Solution,Ophthalmic,02273446,ORIGINAL EYE DROPS (tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JUNO OTC INC,Active,9001581,tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8001958,tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
42685,Marketed,2015-09-01,02144093,VISINE FOR ALLERGY 3 SYMPTOM RELIEF,2.0,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02144093,VISINE FOR ALLERGY 3 SYMPTOM RELIEF (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
77592,Marketed,2025-02-03,02290596,ALLERGY EYE DROPS,2.0,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02290596,ALLERGY EYE DROPS (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JUNO OTC INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78699,Marketed,2008-03-26,02301687,CLEAR EYES TRIPLE ACTION RELIEF,3.0,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02301687,CLEAR EYES TRIPLE ACTION RELIEF (polyvinyl alcohol 0.5 % and povidone 0.6 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) PRESTIGE BRANDS INC,Active,9004385,polyvinyl alcohol 0.5 % and povidone 0.6 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002075,polyvinyl alcohol and povidone and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
82425,Marketed,2012-03-21,02338602,VISINE MULTI-SYMPTOM,2.0,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02338602,VISINE MULTI-SYMPTOM (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JOHNSON & JOHNSON INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
82979,Marketed,2025-02-04,02344319,ADVANCED RELIEF EYE DROPS,4.0,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02344319,ADVANCED RELIEF EYE DROPS (dextran 70 0.1 % and polyethylene glycol 400 1 % and povidone 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) JUNO OTC INC,Active,9004025,dextran 70 0.1 % and polyethylene glycol 400 1 % and povidone 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002117,dextran 70 and polyethylene glycol 400 and povidone and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
93478,Marketed,2025-02-03,02448955,8-SYMPTOM RELIEF,2.0,S01GA52,"Tetryzoline, combinations",Solution,Ophthalmic,02448955,8-SYMPTOM RELIEF (tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops) JUNO OTC INC,Active,9003035,tetrahydrozoline hydrochloride 0.05 % and zinc sulfate 0.25 % ophthalmic drops,8001959,tetrahydrozoline and zinc sulfate,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100752,Marketed,2025-09-12,02518201,RED EYE TRIPLE ACTION,2.0,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02518201,RED EYE TRIPLE ACTION (polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) KENVUE CANADA INC.,Active,9014681,polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002420,polyethylene glycol 400 and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100753,Marketed,2025-09-12,02518228,RED EYE WORKPLACE,2.0,S01GA52,"Tetryzoline, combinations",Drops,Ophthalmic,02518228,RED EYE WORKPLACE (polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops) KENVUE CANADA INC.,Active,9014681,polyethylene glycol 400 1 % and tetrahydrozoline hydrochloride 0.05 % ophthalmic drops,8002420,polyethylene glycol 400 and tetrahydrozoline,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101878,Marketed,2022-10-19,02529548,TEZSPIRE,1.0,R03DX11,Tezepelumab,Solution,Subcutaneous,02529548,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection syringe) ASTRAZENECA CANADA INC,Active,9014788,tezepelumab 210 mg per 1.91 mL solution for injection syringe,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
101879,Marketed,2022-10-19,02529556,TEZSPIRE,1.0,R03DX11,Tezepelumab,Solution,Subcutaneous,02529556,TEZSPIRE (tezepelumab 210 mg per 1.91 mL solution for injection pen) ASTRAZENECA CANADA INC,Active,9014787,tezepelumab 210 mg per 1.91 mL solution for injection pen,8002445,tezepelumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
84045,Marketed,2024-06-12,02355191,THALOMID,1.0,L04AX02,Thalidomide,Capsule,Oral,02355191,THALOMID (thalidomide 50 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004789,thalidomide 50 mg oral capsule,8001960,thalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
84046,Marketed,2024-08-26,02355205,THALOMID,1.0,L04AX02,Thalidomide,Capsule,Oral,02355205,THALOMID (thalidomide 100 mg oral capsule) BRISTOL-MYERS SQUIBB CANADA,Active,9004828,thalidomide 100 mg oral capsule,8001960,thalidomide,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
6170,Marketed,1985-12-31,00627410,ELIXIR DE THEOPHYLLINE,1.0,R03DA04,Theophylline,Elixir,Oral,00627410,ELIXIR DE THEOPHYLLINE (theophylline 80 mg per 15 mL oral solution) LABORATOIRE ATLAS INC,Active,9001863,theophylline 80 mg per 15 mL oral solution,8001094,theophylline,26643006,Oral,385023001,Oral solution,,,,,
14031,Marketed,2019-08-13,00692700,AA-THEO LA,1.0,R03DA04,Theophylline,Tablet (extended-release),Oral,00692700,AA-THEO LA (theophylline 300 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002616,theophylline 300 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
14032,Marketed,2020-05-28,00692697,AA-THEO LA,1.0,R03DA04,Theophylline,Tablet (extended-release),Oral,00692697,AA-THEO LA (theophylline 200 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002615,theophylline 200 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
14033,Marketed,2019-07-22,00692689,AA-THEO LA,1.0,R03DA04,Theophylline,Tablet (extended-release),Oral,00692689,AA-THEO LA (theophylline 100 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002614,theophylline 100 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
84507,Marketed,2011-06-23,02360101,THEO ER,1.0,R03DA04,Theophylline,Tablet (extended-release),Oral,02360101,THEO ER (theophylline 400 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002117,theophylline 400 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
84508,Marketed,2011-06-23,02360128,THEO ER,1.0,R03DA04,Theophylline,Tablet (extended-release),Oral,02360128,THEO ER (theophylline 600 mg prolonged-release oral tablet) AA PHARMA INC,Active,9002118,theophylline 600 mg prolonged-release oral tablet,8001094,theophylline,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
4258,Marketed,2022-10-20,00476374,CHOLEDYL EXPECTORANT,2.0,R03DA54,"Theophylline, combinations excl. psycholeptics",Solution,Oral,00476374,CHOLEDYL EXPECTORANT (guaifenesin 50 mg per 5 mL and oxtriphylline 100 mg per 5 mL oral solution) SEARCHLIGHT PHARMA INC,Active,9001909,guaifenesin 50 mg per 5 mL and oxtriphylline 100 mg per 5 mL oral solution,8000826,guaifenesin and oxtriphylline,26643006,Oral,385023001,Oral solution,,,,,
9,Marketed,2025-12-19,00015741,TAPAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,00015741,TAPAZOLE (methimazole 5 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
78139,Marketed,2025-12-19,02296039,TAPAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,02296039,TAPAZOLE (methimazole 10 mg oral tablet) KNIGHT THERAPEUTICS INC.,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97066,Marketed,2018-10-19,02480107,MAR-METHIMAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,02480107,MAR-METHIMAZOLE (methimazole 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
97067,Marketed,2018-10-19,02480115,MAR-METHIMAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,02480115,MAR-METHIMAZOLE (methimazole 10 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98069,Marketed,2020-08-21,02490625,JAMP METHIMAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,02490625,JAMP METHIMAZOLE (methimazole 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014049,methimazole 5 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98070,Marketed,2021-08-21,02490633,JAMP METHIMAZOLE,1.0,H03BB02,Thiamazole,Tablet,Oral,02490633,JAMP METHIMAZOLE (methimazole 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9014048,methimazole 10 mg oral tablet,8002271,methimazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
10063,Marketed,2006-10-25,00816078,VITAMIN B1,1.0,A11DA01,Thiamine (vit b1),Solution,"Intravenous,Intramuscular",77700823,VITAMIN B1 (thiamine hydrochloride 100 mg per 1 mL solution for injection ampoule) SANDOZ CANADA INCORPORATED,Active,9013360,thiamine hydrochloride 100 mg per 1 mL solution for injection ampoule,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
10063,Marketed,2006-10-25,00816078,VITAMIN B1,1.0,A11DA01,Thiamine (vit b1),Solution,"Intravenous,Intramuscular",77700824,VITAMIN B1 (thiamine hydrochloride 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013361,thiamine hydrochloride 1000 mg per 10 mL solution for injection vial,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
35700,Marketed,1998-07-16,02193221,THIAMIJECT INJECTION - LIQ IM IV 100MG/ML,1.0,A11DA01,Thiamine (vit b1),Liquid,"Intramuscular,Intravenous",02193221,THIAMIJECT INJECTION - LIQ IM IV 100MG/ML (thiamine hydrochloride 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013361,thiamine hydrochloride 1000 mg per 10 mL solution for injection vial,8001961,thiamine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
31283,Marketed,2018-11-14,02137186,SODIUM THIOSULFATE INJECTION USP,1.0,V03AB06,Thiosulphate,Solution,Intravenous,02137186,SODIUM THIOSULFATE INJECTION USP (sodium thiosulfate 2500 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013839,sodium thiosulfate 2500 mg per 10 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87223,Marketed,2013-01-08,02386666,SEACALPHYX,1.0,V03AB06,Thiosulphate,Solution,Intravenous,02386666,SEACALPHYX (sodium thiosulfate 25000 mg per 100 mL solution for injection vial) SEAFORD PHARMACEUTICALS INC,Active,9013618,sodium thiosulfate 25000 mg per 100 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
91283,Marketed,2015-11-23,02428393,SODIUM THIOSULFATE INJECTION USP,1.0,V03AB06,Thiosulphate,Solution,Intravenous,02428393,SODIUM THIOSULFATE INJECTION USP (sodium thiosulfate 12500 mg per 50 mL solution for injection vial) HOPE PHARMACEUTICALS LTD,Active,9013617,sodium thiosulfate 12500 mg per 50 mL solution for injection vial,8002163,sodium thiosulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
95050,Marketed,2017-11-06,02462680,TEPADINA,1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02462680,TEPADINA (thiotepa 15 mg per vial powder for solution for injection) ADIENNE SA,Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
95051,Marketed,2017-10-31,02462702,TEPADINA,1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02462702,TEPADINA (thiotepa 100 mg per vial powder for solution for injection) ADIENNE SA,Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101295,Marketed,2025-06-25,02523906,TEPADINA,1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02523906,TEPADINA (thiotepa 400 mg powder for solution for injection with diluent solution per bag) ADIENNE SA,Active,9015240,thiotepa 400 mg powder for solution for injection with diluent solution per bag,8001128,thiotepa,738984000,Injection,385223009,Powder for solution for injection,732982009,Bag,1.0,,
101551,Marketed,2023-02-15,02526417,THIOTEPA FOR INJECTION USP,1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02526417,THIOTEPA FOR INJECTION USP (thiotepa 15 mg per vial powder for solution for injection) STERIMAX INC,Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101552,Marketed,2023-02-15,02526425,THIOTEPA FOR INJECTION USP,1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02526425,THIOTEPA FOR INJECTION USP (thiotepa 100 mg per vial powder for solution for injection) STERIMAX INC,Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
102559,Marketed,2023-06-27,02536862,"THIOTEPA FOR INJECTION, BP",1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02536862,"THIOTEPA FOR INJECTION, BP (thiotepa 15 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012432,thiotepa 15 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
102560,Marketed,2023-06-27,02536870,"THIOTEPA FOR INJECTION, BP",1.0,L01AC01,Thiotepa,Powder for solution,Intravenous,02536870,"THIOTEPA FOR INJECTION, BP (thiotepa 100 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9012431,thiotepa 100 mg per vial powder for solution for injection,8001128,thiotepa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
100340,Marketed,2022-01-19,02514230,VISTASEAL,2.0,B02BD30,Thrombin,Solution,Topical,,,,,,,,,,,,,,,,
772,Marketed,2022-10-04,00023949,THYROID,1.0,H03AA05,Thyroid gland preparations,Tablet,Oral,00023949,THYROID (thyroid 30 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001532,thyroid 30 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
773,Marketed,2022-10-04,00023957,THYROID,1.0,H03AA05,Thyroid gland preparations,Tablet,Oral,00023957,THYROID (thyroid 60 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001533,thyroid 60 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
774,Marketed,2022-10-04,00023965,THYROID,1.0,H03AA05,Thyroid gland preparations,Tablet,Oral,00023965,THYROID (thyroid 125 mg oral tablet) SEARCHLIGHT PHARMA INC,Active,9001531,thyroid 125 mg oral tablet,8001962,thyroid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70142,Marketed,2025-09-16,02246016,THYROGEN,1.0,H01AB01,Thyrotrophin alfa,Powder for solution,Intramuscular,02246016,THYROGEN (thyrotropin alfa 0.9 mg per vial powder for solution for injection) SANOFI-AVENTIS CANADA INC,Active,9013619,thyrotropin alfa 0.9 mg per vial powder for solution for injection,8001963,thyrotropin alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19720,Marketed,2011-06-01,02179679,TEVA-TIAPROFENIC ACID,1.0,M01AE11,Tiaprofenic acid,Tablet,Oral,02179679,TEVA-TIAPROFENIC ACID (tiaprofenic acid 200 mg oral tablet) TEVA CANADA LIMITED,Active,9002718,tiaprofenic acid 200 mg oral tablet,8001535,tiaprofenic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19722,Marketed,2011-06-01,02179687,TEVA-TIAPROFENIC ACID,1.0,M01AE11,Tiaprofenic acid,Tablet,Oral,02179687,TEVA-TIAPROFENIC ACID (tiaprofenic acid 300 mg oral tablet) TEVA CANADA LIMITED,Active,9002719,tiaprofenic acid 300 mg oral tablet,8001535,tiaprofenic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97847,Marketed,2020-07-29,02488361,TIBELLA,1.0,G03CX01,Tibolone,Tablet,Oral,02488361,TIBELLA (tibolone 2.5 mg oral tablet) BIOSYENT PHARMA INC,Active,9014349,tibolone 2.5 mg oral tablet,8002340,tibolone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
85352,Marketed,2011-06-01,02368544,BRILINTA,1.0,B01AC24,Ticagrelor,Tablet,Oral,02368544,BRILINTA (ticagrelor 90 mg oral tablet) ASTRAZENECA CANADA INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94181,Marketed,2016-06-13,02455005,BRILINTA,1.0,B01AC24,Ticagrelor,Tablet,Oral,02455005,BRILINTA (ticagrelor 60 mg oral tablet) ASTRAZENECA CANADA INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97305,Marketed,2022-12-22,02482622,APO-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02482622,APO-TICAGRELOR (ticagrelor 60 mg oral tablet) APOTEX INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97306,Marketed,2022-12-14,02482630,APO-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02482630,APO-TICAGRELOR (ticagrelor 90 mg oral tablet) APOTEX INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98258,Marketed,2022-05-31,02492571,TARO-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02492571,TARO-TICAGRELOR (ticagrelor 60 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98259,Marketed,2022-04-29,02492598,TARO-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02492598,TARO-TICAGRELOR (ticagrelor 90 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101899,Marketed,2022-12-20,02529750,M-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02529750,M-TICAGRELOR (ticagrelor 60 mg oral tablet) MANTRA PHARMA INC,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
101900,Marketed,2022-11-11,02529769,M-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02529769,M-TICAGRELOR (ticagrelor 90 mg oral tablet) MANTRA PHARMA INC,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102089,Marketed,2024-03-28,02531798,JAMP TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02531798,JAMP TICAGRELOR (ticagrelor 60 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102090,Marketed,2024-03-28,02531801,JAMP TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02531801,JAMP TICAGRELOR (ticagrelor 90 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102592,Marketed,2024-03-28,02537184,AG-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02537184,AG-TICAGRELOR (ticagrelor 60 mg oral tablet) ANGITA PHARMA INC.,Active,9005982,ticagrelor 60 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102593,Marketed,2024-03-28,02537192,AG-TICAGRELOR,1.0,B01AC24,Ticagrelor,Tablet,Oral,02537192,AG-TICAGRELOR (ticagrelor 90 mg oral tablet) ANGITA PHARMA INC.,Active,9004879,ticagrelor 90 mg oral tablet,8001306,ticagrelor,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77090,Marketed,2012-04-17,02285401,TYGACIL,1.0,J01AA12,Tigecycline,Powder for solution,Intravenous,02285401,TYGACIL (tigecycline 50 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9004233,tigecycline 50 mg per vial powder for solution for injection,8001238,tigecycline,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89406,Marketed,2014-10-23,02409356,TIGECYCLINE,1.0,J01AA12,Tigecycline,Powder for solution,Intravenous,02409356,TIGECYCLINE (tigecycline 50 mg per vial powder for solution for injection) APOTEX INC,Active,9004233,tigecycline 50 mg per vial powder for solution for injection,8001238,tigecycline,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
100544,Marketed,2022-10-24,02516098,ILUMYA,1.0,L04AC17,Tildrakizumab,Solution,Subcutaneous,02516098,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection syringe) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9014605,tildrakizumab 100 mg per 1 mL solution for injection syringe,8002386,tildrakizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
106211,Marketed,2026-01-06,02558904,ILUMYA,1.0,L04AC17,Tildrakizumab,Solution,Subcutaneous,02558904,ILUMYA (tildrakizumab 100 mg per 1 mL solution for injection pen) SUN PHARMACEUTICAL INDUSTRIES LIMITED,Active,9015345,tildrakizumab 100 mg per 1 mL solution for injection pen,8002386,tildrakizumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,
3186,Marketed,2020-09-02,00451207,TIMOPTIC,1.0,S01ED01,Timolol,Solution,Ophthalmic,00451207,TIMOPTIC (timolol (timolol maleate) 0.5 % ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
8589,Marketed,2018-12-12,00755842,TIMOLOL,1.0,C07AA06,Timolol,Tablet,Oral,00755842,TIMOLOL (timolol maleate 5 mg oral tablet) AA PHARMA INC,Active,9000307,timolol maleate 5 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8590,Marketed,2018-02-27,00755850,TIMOLOL,1.0,C07AA06,Timolol,Tablet,Oral,00755850,TIMOLOL (timolol maleate 10 mg oral tablet) AA PHARMA INC,Active,9000305,timolol maleate 10 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8591,Marketed,2018-11-01,00755869,TIMOLOL,1.0,C07AA06,Timolol,Tablet,Oral,00755869,TIMOLOL (timolol maleate 20 mg oral tablet) AA PHARMA INC,Active,9000306,timolol maleate 20 mg oral tablet,8000081,timolol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8959,Marketed,1988-12-31,00755834,APO-TIMOP,1.0,S01ED01,Timolol,Solution,Ophthalmic,00755834,APO-TIMOP (timolol (timolol maleate) 0.5 % ophthalmic drops) APOTEX INC,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18778,Marketed,2020-09-02,02171899,TIMOPTIC-XE,1.0,S01ED01,Timolol,Solution (extended release),Ophthalmic,02171899,TIMOPTIC-XE (timolol (timolol maleate) 0.5 % prolonged-release eye drops) ELVIUM LIFE SCIENCES,Active,9000637,timolol (timolol maleate) 0.5 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,
19242,Marketed,2011-06-15,02166720,SANDOZ TIMOLOL,1.0,S01ED01,Timolol,Solution,Ophthalmic,02166720,SANDOZ TIMOLOL (timolol (timolol maleate) 0.5 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
19252,Marketed,2011-06-15,02166712,SANDOZ TIMOLOL,1.0,S01ED01,Timolol,Solution,Ophthalmic,02166712,SANDOZ TIMOLOL (timolol (timolol maleate) 0.25 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000308,timolol (timolol maleate) 0.25 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
65975,Marketed,2017-05-19,02242275,TIMOLOL MALEATE-EX,1.0,S01ED01,Timolol,Solution (extended release),Ophthalmic,02242275,TIMOLOL MALEATE-EX (timolol (timolol maleate) 0.25 % prolonged-release eye drops) SANDOZ CANADA INCORPORATED,Active,9000636,timolol (timolol maleate) 0.25 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,
65976,Marketed,2017-05-19,02242276,TIMOLOL MALEATE-EX,1.0,S01ED01,Timolol,Solution (extended release),Ophthalmic,02242276,TIMOLOL MALEATE-EX (timolol (timolol maleate) 0.5 % prolonged-release eye drops) SANDOZ CANADA INCORPORATED,Active,9000637,timolol (timolol maleate) 0.5 % prolonged-release eye drops,8000081,timolol,54485002,Ophthalmic,385128008,Prolonged-release eye drops,732994000,Drop (unit of presentation),,,
93340,Marketed,2020-08-20,02447800,JAMP-TIMOLOL,1.0,S01ED01,Timolol,Solution,Ophthalmic,02447800,JAMP-TIMOLOL (timolol (timolol maleate) 0.5 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000141,timolol (timolol maleate) 0.5 % ophthalmic drops,8000081,timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
63627,Marketed,2020-08-31,02240113,COSOPT,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02240113,COSOPT (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
70807,Marketed,2023-07-24,02246619,XALACOM,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02246619,XALACOM (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) BGP PHARMA ULC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
72692,Marketed,2023-12-13,02248347,COMBIGAN,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02248347,COMBIGAN (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) ABBVIE CORPORATION,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
74388,Marketed,2022-05-24,02258692,COSOPT PRESERVATIVE-FREE,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02258692,COSOPT PRESERVATIVE-FREE (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) ELVIUM LIFE SCIENCES,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
76384,Marketed,2018-01-19,02278251,DUOTRAV PQ,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02278251,DUOTRAV PQ (timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9004152,timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops,8000955,timolol and travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
78499,Marketed,2018-06-15,02299615,APO-DORZO-TIMOP,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02299615,APO-DORZO-TIMOP (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) APOTEX INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
81730,Marketed,2018-03-09,02331624,AZARGA,2.0,S01ED51,"Timolol, combinations",Suspension,Ophthalmic,02331624,AZARGA (brinzolamide 1 % and timolol (timolol maleate) 0.5 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012375,brinzolamide 1 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001099,brinzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
82984,Marketed,2010-10-25,02344351,SANDOZ DORZOLAMIDE/TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02344351,SANDOZ DORZOLAMIDE/TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
85818,Marketed,2023-11-16,02373068,MYLAN-LATANOPROST/TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02373068,MYLAN-LATANOPROST/TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MYLAN PHARMACEUTICALS ULC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
86073,Marketed,2022-11-09,02375311,APO-BRIMONIDINE-TIMOP,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02375311,APO-BRIMONIDINE-TIMOP (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) APOTEX INC,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
89992,Marketed,2020-03-03,02415305,APO-TRAVOPROST-TIMOP PQ,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02415305,APO-TRAVOPROST-TIMOP PQ (timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops) APOTEX INC,Active,9004152,timolol (timolol maleate) 0.5 % and travoprost 0.004 % ophthalmic drops,8000955,timolol and travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
92058,Marketed,2025-01-10,02436256,TEVA-LATANOPROST-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02436256,TEVA-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) TEVA CANADA LIMITED,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
92207,Marketed,2016-05-17,02437686,MED-DORZOLAMIDE-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02437686,MED-DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
92604,Marketed,2015-07-22,02441659,RIVA-DORZOLAMIDE/TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02441659,RIVA-DORZOLAMIDE/TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) LABORATOIRE RIVA INC.,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94031,Marketed,2020-02-07,02453770,JAMP-LATANOPROST/TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02453770,JAMP-LATANOPROST/TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94108,Marketed,2019-08-22,02454505,MED-LATANOPROST-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02454505,MED-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) GENERIC MEDICAL PARTNERS INC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
100369,Marketed,2021-11-10,02514516,M-LATANOPROST-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02514516,M-LATANOPROST-TIMOLOL (latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9003762,latanoprost 50 mcg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000933,latanoprost and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
101119,Marketed,2023-06-12,02522020,DORZOLAMIDE-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02522020,DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) JAMP PHARMA CORPORATION,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102081,Marketed,2023-07-21,02531704,JAMP BRIMONIDINE/TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02531704,JAMP BRIMONIDINE/TIMOLOL (brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9003850,brimonidine tartrate 0.2 % and timolol (timolol maleate) 0.5 % ophthalmic drops,8001111,brimonidine and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
102656,Marketed,2023-11-13,02537796,M-DORZOLAMIDE-TIMOLOL,2.0,S01ED51,"Timolol, combinations",Solution,Ophthalmic,02537796,M-DORZOLAMIDE-TIMOLOL (dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops) MANTRA PHARMA INC,Active,9000850,dorzolamide (dorzolamide hydrochloride) 20 mg per mL and timolol (timolol maleate) 5 mg per mL ophthalmic drops,8000272,dorzolamide and timolol,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
19202,Marketed,1995-12-31,02167840,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02167840,INNOHEP (tinzaparin sodium 10000 unit per mL solution for injection 2 mL vial) LEO PHARMA INC,Active,9012756,tinzaparin sodium 10000 unit per mL solution for injection 2 mL vial,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
47420,Marketed,1997-02-28,02229515,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02229515,INNOHEP (tinzaparin sodium 20000 unit per mL solution for injection 2 mL vial) LEO PHARMA INC,Active,9012761,tinzaparin sodium 20000 unit per mL solution for injection 2 mL vial,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
47983,Marketed,2011-09-28,02229755,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02229755,INNOHEP (tinzaparin sodium 2500 unit per 0.25 mL solution for injection syringe) LEO PHARMA INC,Active,9012762,tinzaparin sodium 2500 unit per 0.25 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
50802,Marketed,2011-09-08,02231478,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02231478,INNOHEP (tinzaparin sodium 10000 unit per 0.5 mL solution for injection syringe) LEO PHARMA INC,Active,9012755,tinzaparin sodium 10000 unit per 0.5 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
84321,Marketed,2011-09-09,02358158,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02358158,INNOHEP (tinzaparin sodium 3500 unit per 0.35 mL solution for injection syringe) LEO PHARMA INC,Active,9012763,tinzaparin sodium 3500 unit per 0.35 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
84322,Marketed,2011-12-10,02358166,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02358166,INNOHEP (tinzaparin sodium 4500 unit per 0.45 mL solution for injection syringe) LEO PHARMA INC,Active,9012764,tinzaparin sodium 4500 unit per 0.45 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
84323,Marketed,2011-09-16,02358174,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02358174,INNOHEP (tinzaparin sodium 14000 unit per 0.7 mL solution for injection syringe) LEO PHARMA INC,Active,9012758,tinzaparin sodium 14000 unit per 0.7 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
84324,Marketed,2011-09-13,02358182,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02358182,INNOHEP (tinzaparin sodium 18000 unit per 0.9 mL solution for injection syringe) LEO PHARMA INC,Active,9012760,tinzaparin sodium 18000 unit per 0.9 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91392,Marketed,2014-09-30,02429462,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02429462,INNOHEP (tinzaparin sodium 8000 unit per 0.4 mL solution for injection syringe) LEO PHARMA INC,Active,9012765,tinzaparin sodium 8000 unit per 0.4 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91393,Marketed,2014-09-30,02429470,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02429470,INNOHEP (tinzaparin sodium 12000 unit per 0.6 mL solution for injection syringe) LEO PHARMA INC,Active,9012757,tinzaparin sodium 12000 unit per 0.6 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
91394,Marketed,2014-09-30,02429489,INNOHEP,1.0,B01AB10,Tinzaparin,Solution,Subcutaneous,02429489,INNOHEP (tinzaparin sodium 16000 unit per 0.8 mL solution for injection syringe) LEO PHARMA INC,Active,9012759,tinzaparin sodium 16000 unit per 0.8 mL solution for injection syringe,8001422,tinzaparin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
1812,Marketed,2020-07-10,00282081,LANVIS,1.0,L01BB03,Tioguanine,Tablet,Oral,00282081,LANVIS (thioguanine 40 mg oral tablet) ASPEN PHARMACARE CANADA INC.,Active,9012865,thioguanine 40 mg oral tablet,8001534,thioguanine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
70993,Marketed,2002-11-21,02246793,SPIRIVA,1.0,R03BB04,Tiotropium bromide,Capsule,Inhalation,02246793,SPIRIVA (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,
91971,Marketed,2014-12-19,02435381,SPIRIVA RESPIMAT,1.0,R03BB04,Tiotropium bromide,Solution,Inhalation,02435381,SPIRIVA RESPIMAT (tiotropium (tiotropium bromide monohydrate) 2.5 mcg per actuation inhalation solution) BOEHRINGER INGELHEIM (CANADA) LTD LTEE,Active,9001436,tiotropium (tiotropium bromide) 2.5 mcg per actuation inhalation solution,8000320,tiotropium,447694001,Inhalation,420641004,Solution for inhalation,732981002,Actuation (unit of presentation),,,
102661,Marketed,2023-12-18,02537850,LUPIN-TIOTROPIUM,1.0,R03BB04,Tiotropium bromide,Capsule,Inhalation,02537850,LUPIN-TIOTROPIUM (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) LUPIN PHARMA CANADA LIMITED,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,
103964,Marketed,2025-01-23,02550865,APO-TIOTROPIUM,1.0,R03BB04,Tiotropium bromide,Capsule,Inhalation,02550865,APO-TIOTROPIUM (tiotropium (tiotropium bromide monohydrate) 18 mcg inhalation powder capsule) APOTEX INC,Active,9001003,tiotropium (tiotropium bromide) 18 mcg inhalation powder capsule,8000320,tiotropium,447694001,447694001,385207009,Powder for inhalation,732937005,Capsule,,,
64293,Marketed,2021-07-29,02240706,AGGRASTAT,1.0,B01AC17,Tirofiban,Solution,Intravenous,02240706,AGGRASTAT (tirofiban (tirofiban hydrochloride) 12.5 mg per 250 mL solution for injection bag) CIPHER PHARMACEUTICALS INC,Active,9013362,tirofiban (tirofiban hydrochloride) 12.5 mg per 250 mL solution for injection bag,8001964,tirofiban,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
102972,Marketed,2023-10-23,02541041,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541041,MOUNJARO (tirzepatide 2.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014995,tirzepatide 2.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102973,Marketed,2023-10-23,02541068,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541068,MOUNJARO (tirzepatide 5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014996,tirzepatide 5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102974,Marketed,2023-10-23,02541076,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541076,MOUNJARO (tirzepatide 7.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014997,tirzepatide 7.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102975,Marketed,2023-10-23,02541084,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541084,MOUNJARO (tirzepatide 10 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014992,tirzepatide 10 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102976,Marketed,2023-10-23,02541092,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541092,MOUNJARO (tirzepatide 12.5 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014993,tirzepatide 12.5 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102977,Marketed,2023-10-23,02541106,MOUNJARO,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02541106,MOUNJARO (tirzepatide 15 mg per 0.5 mL solution for injection vial) ELI LILLY CANADA INC,Active,9014994,tirzepatide 15 mg per 0.5 mL solution for injection vial,8002488,tirzepatide,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
104065,Marketed,2024-12-10,02551950,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02551950,MOUNJARO KWIKPEN (tirzepatide 2.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015159,tirzepatide 2.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
104066,Marketed,2024-12-10,02551969,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02551969,MOUNJARO KWIKPEN (tirzepatide 5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015160,tirzepatide 5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
104067,Marketed,2024-12-10,02551977,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02551977,MOUNJARO KWIKPEN (tirzepatide 7.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015161,tirzepatide 7.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
104068,Marketed,2024-12-10,02551985,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02551985,MOUNJARO KWIKPEN (tirzepatide 10 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015156,tirzepatide 10 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
104069,Marketed,2024-12-10,02551993,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02551993,MOUNJARO KWIKPEN (tirzepatide 12.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015157,tirzepatide 12.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
104070,Marketed,2024-12-10,02552000,MOUNJARO KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02552000,MOUNJARO KWIKPEN (tirzepatide 15 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015158,tirzepatide 15 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106082,Marketed,2025-07-09,02557509,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557509,ZEPBOUND KWIKPEN (tirzepatide 2.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015159,tirzepatide 2.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106083,Marketed,2025-07-09,02557517,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557517,ZEPBOUND KWIKPEN (tirzepatide 5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015160,tirzepatide 5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106084,Marketed,2025-07-09,02557525,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557525,ZEPBOUND KWIKPEN (tirzepatide 7.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015161,tirzepatide 7.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106085,Marketed,2025-07-09,02557533,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557533,ZEPBOUND KWIKPEN (tirzepatide 10 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015156,tirzepatide 10 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106086,Marketed,2025-07-09,02557541,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557541,ZEPBOUND KWIKPEN (tirzepatide 12.5 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015157,tirzepatide 12.5 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
106087,Marketed,2025-07-09,02557568,ZEPBOUND KWIKPEN,1.0,A10BX16,Tirzepatide,Solution,Subcutaneous,02557568,ZEPBOUND KWIKPEN (tirzepatide 15 mg per actuation solution for injection pre-filled pen) ELI LILLY CANADA INC,Active,9015158,tirzepatide 15 mg per actuation solution for injection pre-filled pen,8002488,tirzepatide,738984000,Injection,385219001,Solution for injection,732981002,Actuation,1.0,,
97104,Marketed,2019-05-24,02480514,KYMRIAH,1.0,L01XL04,Tisagenlecleucel,Suspension,Intravenous,,,,,,,,,,,,,,,,
74515,Marketed,2024-05-06,02259893,APO-TIZANIDINE,1.0,M03BX02,Tizanidine,Tablet,Oral,02259893,APO-TIZANIDINE (tizanidine (tizanidine hydrochloride) 4 mg oral tablet) APOTEX INC,Active,9003427,tizanidine (tizanidine hydrochloride) 4 mg oral tablet,8001965,tizanidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102551,Marketed,2023-09-07,02536765,MINT-TIZANIDINE,1.0,M03BX02,Tizanidine,Tablet,Oral,02536765,MINT-TIZANIDINE (tizanidine (tizanidine hydrochloride) 4 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003427,tizanidine (tizanidine hydrochloride) 4 mg oral tablet,8001965,tizanidine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4571,Marketed,2018-09-10,00513962,TOBREX,1.0,S01AA12,Tobramycin,Solution,Ophthalmic,00513962,TOBREX (tobramycin 0.3 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001920,tobramycin 0.3 % ophthalmic drops,8000827,tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
5402,Marketed,2016-03-03,00533688,TOBRAMYCIN FOR INJECTION,1.0,J01GB01,Tobramycin,Powder for solution,Intravenous,00533688,TOBRAMYCIN FOR INJECTION (tobramycin (tobramycin sulfate) 1.2 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9001997,tobramycin (tobramycin sulfate) 1.2 g per vial powder for solution for injection,8000827,tobramycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
5707,Marketed,2018-08-02,00614254,TOBREX,1.0,S01AA12,Tobramycin,Ointment,Ophthalmic,00614254,TOBREX (tobramycin 0.3 % ophthalmic ointment) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9002035,tobramycin 0.3 % ophthalmic ointment,8000827,tobramycin,54485002,Ophthalmic,385123004,Ophthalmic ointment,,,,,
49817,Marketed,2016-03-03,02230640,TOBRAMYCIN INJECTION,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700640,TOBRAMYCIN INJECTION (tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial) FRESENIUS KABI CANADA LTD,Active,9012870,tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49817,Marketed,2016-03-03,02230640,TOBRAMYCIN INJECTION,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700641,TOBRAMYCIN INJECTION (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
63101,Marketed,2021-10-06,02239630,TOBI,1.0,J01GB01,Tobramycin,Solution,Inhalation,02239630,TOBI (tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial) BGP PHARMA ULC,Active,9012869,tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial,8000827,tobramycin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
64815,Marketed,2005-08-26,02241209,TOBRAMYCIN INJECTION USP,1.0,J01GB01,Tobramycin,Solution,"Intramuscular,Intravenous",02241209,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 20 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012868,tobramycin (tobramycin sulfate) 20 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
64816,Marketed,2005-08-26,02241210,TOBRAMYCIN INJECTION USP,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700644,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial) SANDOZ CANADA INCORPORATED,Active,9012870,tobramycin (tobramycin sulfate) 40 mg per mL solution for injection 30 mL vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
64816,Marketed,2005-08-26,02241210,TOBRAMYCIN INJECTION USP,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",77700645,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
65418,Marketed,2005-10-08,02241755,SANDOZ TOBRAMYCIN,1.0,S01AA12,Tobramycin,Solution,Ophthalmic,02241755,SANDOZ TOBRAMYCIN (tobramycin 0.3 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001920,tobramycin 0.3 % ophthalmic drops,8000827,tobramycin,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
85000,Marketed,2020-03-11,02365154,TOBI PODHALER,1.0,J01GB01,Tobramycin,Capsule,Inhalation,02365154,TOBI PODHALER (tobramycin 28 mg inhalation powder capsule) BGP PHARMA ULC,Active,9004870,tobramycin 28 mg inhalation powder capsule,8000827,tobramycin,447694001,Inhalation,385207009,Powder for inhalation,732937005,Capsule,,,
87512,Marketed,2016-02-03,02389622,TEVA-TOBRAMYCIN,1.0,J01GB01,Tobramycin,Solution,Inhalation,02389622,TEVA-TOBRAMYCIN (tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial) TEVA CANADA LIMITED,Active,9012869,tobramycin (tobramycin sulfate) 300 mg per 5 mL nebulizer solution unit dose vial,8000827,tobramycin,447694001,Inhalation,385198000,Solution for nebuliser,733026001,Vial (unit of presentation),,,
99195,Marketed,2021-02-17,02502372,TOBRAMYCIN INJECTION USP,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",02502372,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) STERIMAX INC,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102212,Marketed,2024-05-16,02533103,TOBRAMYCIN INJECTION USP,1.0,J01GB01,Tobramycin,Solution,"Intravenous,Intramuscular",02533103,TOBRAMYCIN INJECTION USP (tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012871,tobramycin (tobramycin sulfate) 80 mg per 2 mL solution for injection vial,8000827,tobramycin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
83533,Marketed,2010-05-26,02350092,ACTEMRA,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02350092,ACTEMRA (tocilizumab 80 mg per 4 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
83534,Marketed,2010-05-26,02350106,ACTEMRA,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02350106,ACTEMRA (tocilizumab 200 mg per 10 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
83535,Marketed,2010-05-26,02350114,ACTEMRA,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02350114,ACTEMRA (tocilizumab 400 mg per 20 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
90943,Marketed,2014-05-30,02424770,ACTEMRA,1.0,L04AC07,Tocilizumab,Solution,Subcutaneous,02424770,ACTEMRA PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
97376,Marketed,2019-01-15,02483327,ACTEMRA,1.0,L04AC07,Tocilizumab,Solution,Subcutaneous,02483327,ACTEMRA PREFILLED AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) HOFFMANN-LA ROCHE LIMITED,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
104142,Marketed,2025-04-14,02552450,TYENNE,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02552450,TYENNE (tocilizumab 80 mg per 4 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013366,tocilizumab 80 mg per 4 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
104143,Marketed,2025-04-14,02552469,TYENNE,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02552469,TYENNE (tocilizumab 200 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013364,tocilizumab 200 mg per 10 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
104144,Marketed,2025-04-14,02552477,TYENNE,1.0,L04AC07,Tocilizumab,Solution,Intravenous,02552477,TYENNE (tocilizumab 400 mg per 20 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013365,tocilizumab 400 mg per 20 mL solution for injection vial,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
104145,Marketed,2025-04-14,02552485,TYENNE,1.0,L04AC07,Tocilizumab,Solution,Subcutaneous,02552485,TYENNE SINGLE USE AUTOINJECTOR (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104146,Marketed,2025-04-14,02552493,TYENNE,1.0,L04AC07,Tocilizumab,Solution,Subcutaneous,02552493,TYENNE SINGLE USE PREFILLED SYRINGE (tocilizumab 162 mg per 0.9 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013363,tocilizumab 162 mg per 0.9 mL solution for injection syringe,8001966,tocilizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
90863,Marketed,2014-06-03,02423898,XELJANZ,1.0,L04AF01,Tofacitinib,Tablet,Oral,02423898,XELJANZ (tofacitinib (tofacitinib citrate) 5 mg oral tablet) PFIZER CANADA ULC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95960,Marketed,2018-03-29,02470608,XELJANZ XR,1.0,L04AF01,Tofacitinib,Tablet (extended-release),Oral,02470608,XELJANZ XR (tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet) PFIZER CANADA ULC,Active,9013367,tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet,8001967,tofacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
97137,Marketed,2019-01-30,02480786,XELJANZ,1.0,L04AF01,Tofacitinib,Tablet,Oral,02480786,XELJANZ (tofacitinib (tofacitinib citrate) 10 mg oral tablet) PFIZER CANADA ULC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100052,Marketed,2022-11-28,02511304,TARO-TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02511304,TARO-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100053,Marketed,2022-11-28,02511312,TARO-TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02511312,TARO-TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101191,Marketed,2022-11-25,02522799,PMS-TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02522799,PMS-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) PHARMASCIENCE INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101198,Marketed,2023-10-20,02522896,JAMP TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02522896,JAMP TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101923,Marketed,2022-11-28,02530007,AURO-TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02530007,AURO-TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) AURO PHARMA INC,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101924,Marketed,2022-11-28,02530015,AURO-TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02530015,AURO-TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) AURO PHARMA INC,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104042,Marketed,2025-08-27,02551691,SANDOZ TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02551691,SANDOZ TOFACITINIB (tofacitinib (tofacitinib citrate) 5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9005537,tofacitinib (tofacitinib citrate) 5 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104044,Marketed,2025-08-27,02551705,SANDOZ TOFACITINIB,1.0,L04AF01,Tofacitinib,Tablet,Oral,02551705,SANDOZ TOFACITINIB (tofacitinib (tofacitinib citrate) 10 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9013790,tofacitinib (tofacitinib citrate) 10 mg oral tablet,8001967,tofacitinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104287,Marketed,2025-03-03,02553988,TARO-TOFACITINIB XR,1.0,L04AF01,Tofacitinib,Tablet (extended-release),Oral,02553988,TARO-TOFACITINIB XR (tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9013367,tofacitinib (tofacitinib citrate) 11 mg prolonged-release oral tablet,8001967,tofacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
104447,Marketed,2025-05-14,02555735,QALSODY,1.0,N07XX22,Tofersen,Solution,Intrathecal,02555735,QALSODY (tofersen 100 mg per 15 mL solution for injection vial) BIOGEN CANADA INC,Active,9015209,tofersen 100 mg per 15 mL solution for injection vial,8002546,tofersen,738984000,Injection,385219001,Solution for injection,733026001,Vial,,,
37941,Marketed,2010-03-10,02226707,"TOLNAFTATE CREAM USP, 1%",1.0,D01AE18,Tolnaftate,Cream,Topical,02226707,"TOLNAFTATE CREAM USP, 1% (tolnaftate 1 % cutaneous cream) TARO PHARMACEUTICALS INC",Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
41608,Marketed,2016-07-25,00576034,TINACTIN,1.0,D01AE18,Tolnaftate,Cream,Topical,00576034,TINACTIN (tolnaftate 1 % cutaneous cream) BAYER INC,Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
41611,Marketed,2018-05-22,00576042,TINACTIN POWDER,1.0,D01AE18,Tolnaftate,Powder,Topical,00576042,TINACTIN POWDER (tolnaftate 1 % cutaneous powder) BAYER INC,Active,9001618,tolnaftate 1 % cutaneous powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,,,,,
41612,Marketed,2017-07-17,00576050,TINACTIN AEROSOL POWDER,1.0,D01AE18,Tolnaftate,"Powder,Aerosol",Topical,00576050,TINACTIN AEROSOL POWDER (tolnaftate 1 % cutaneous spray powder) BAYER INC,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,
41933,Marketed,2023-02-10,01919245,DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER,1.0,D01AE18,Tolnaftate,"Powder,Aerosol",Topical,01919245,DR. SCHOLL'S ATHLETE'S FOOT SPRAY POWDER (tolnaftate 1 % cutaneous spray powder) SCHOLL'S WELLNESS COMPANY,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,
68767,Marketed,2014-10-27,02244777,ODOR-EATERS,1.0,D01AE18,Tolnaftate,Aerosol,Topical,02244777,ODOR-EATERS (tolnaftate 1 % cutaneous spray) BLISTEX CORPORATION,Active,9001998,tolnaftate 1 % cutaneous spray,8001968,tolnaftate,448598008,Cutaneous,421720008,Spray,,,,,
78123,Marketed,2015-09-25,02295873,FLEXITOL MEDICATED ANTI-FUNGAL CREAM,1.0,D01AE18,Tolnaftate,Cream,Topical,02295873,FLEXITOL MEDICATED ANTI-FUNGAL CREAM (tolnaftate 1 % cutaneous cream) LACORIUM HEALTH INTERNATIONAL PTY LTD.,Active,9001617,tolnaftate 1 % cutaneous cream,8001968,tolnaftate,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
80475,Marketed,2017-06-09,02319276,TINACTIN CHILL DEODORANT POWDER SPRAY,1.0,D01AE18,Tolnaftate,"Aerosol,Powder",Topical,02319276,TINACTIN CHILL DEODORANT POWDER SPRAY (tolnaftate 1 % cutaneous spray powder) BAYER INC,Active,9013368,tolnaftate 1 % cutaneous spray powder,8001968,tolnaftate,448598008,Cutaneous,385112003,Cutaneous powder,30784000,Aerosol sprayer (physical object),,,
80479,Marketed,2017-08-23,02319314,TINACTIN CHILL LIQUID SPRAY,1.0,D01AE18,Tolnaftate,Aerosol,Topical,02319314,TINACTIN CHILL LIQUID SPRAY (tolnaftate 1 % cutaneous spray) BAYER INC,Active,9001998,tolnaftate 1 % cutaneous spray,8001968,tolnaftate,448598008,Cutaneous,421720008,Spray,,,,,
89839,Marketed,2024-06-04,02413760,FORMULA 3,1.0,D01AE18,Tolnaftate,Solution,Topical,02413760,FORMULA 3 (tolnaftate 1 % cutaneous solution) THE TETRA CORPORATION,Active,9005400,tolnaftate 1 % cutaneous solution,8001968,tolnaftate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
91618,Marketed,2020-04-07,02431718,FOOT CARE FOAM,1.0,D01AE18,Tolnaftate,"Aerosol, foam",Topical,02431718,FOOT CARE FOAM (tolnaftate 1 % cutaneous foam) NSC PHARMA GMBH & CO.KG,Active,9005788,tolnaftate 1 % cutaneous foam,8001968,tolnaftate,448598008,Cutaneous,421166008,Foam,,,,,
101690,Marketed,2023-06-01,02527723,FOOTRENEW,1.0,D01AE18,Tolnaftate,Solution,Topical,02527723,FOOTRENEW (tolnaftate 1 % cutaneous solution) NAILRENEW CORP.,Active,9005400,tolnaftate 1 % cutaneous solution,8001968,tolnaftate,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
62518,Marketed,2023-08-30,02239064,DETROL,1.0,G04BD07,Tolterodine,Tablet,Oral,02239064,DETROL (tolterodine tartrate 1 mg oral tablet) BGP PHARMA ULC,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62519,Marketed,2023-08-30,02239065,DETROL,1.0,G04BD07,Tolterodine,Tablet,Oral,02239065,DETROL (tolterodine tartrate 2 mg oral tablet) BGP PHARMA ULC,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68599,Marketed,2023-05-29,02244612,DETROL LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02244612,DETROL LA (tolterodine tartrate 2 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
68600,Marketed,2023-05-29,02244613,DETROL LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02244613,DETROL LA (tolterodine tartrate 4 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
78497,Marketed,2015-12-16,02299593,TEVA-TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02299593,TEVA-TOLTERODINE (tolterodine tartrate 1 mg oral tablet) TEVA CANADA LIMITED,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78498,Marketed,2021-08-16,02299607,TEVA-TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02299607,TEVA-TOLTERODINE (tolterodine tartrate 2 mg oral tablet) TEVA CANADA LIMITED,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89676,Marketed,2015-12-16,02412195,TEVA-TOLTERODINE LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02412195,TEVA-TOLTERODINE LA (tolterodine tartrate 2 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
89677,Marketed,2015-12-16,02412209,TEVA-TOLTERODINE LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02412209,TEVA-TOLTERODINE LA (tolterodine tartrate 4 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
89782,Marketed,2015-12-16,02413140,SANDOZ TOLTERODINE LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02413140,SANDOZ TOLTERODINE LA (tolterodine tartrate 2 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000978,tolterodine tartrate 2 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
89783,Marketed,2015-12-16,02413159,SANDOZ TOLTERODINE LA,1.0,G04BD07,Tolterodine,Capsule (extended release),Oral,02413159,SANDOZ TOLTERODINE LA (tolterodine tartrate 4 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000979,tolterodine tartrate 4 mg prolonged-release oral capsule,8000265,tolterodine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
90805,Marketed,2015-12-16,02423308,MINT-TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02423308,MINT-TOLTERODINE (tolterodine tartrate 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90806,Marketed,2015-12-16,02423316,MINT-TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02423316,MINT-TOLTERODINE (tolterodine tartrate 2 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98668,Marketed,2022-07-21,02496836,JAMP TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02496836,JAMP TOLTERODINE (tolterodine tartrate 1 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000826,tolterodine tartrate 1 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98669,Marketed,2022-07-21,02496844,JAMP TOLTERODINE,1.0,G04BD07,Tolterodine,Tablet,Oral,02496844,JAMP TOLTERODINE (tolterodine tartrate 2 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000825,tolterodine tartrate 2 mg oral tablet,8000265,tolterodine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85561,Marketed,2011-09-22,02370468,SAMSCA,1.0,C03XA01,Tolvaptan,Tablet,Oral,02370468,SAMSCA (tolvaptan 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012159,tolvaptan 15 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85562,Marketed,2011-09-22,02370476,SAMSCA,1.0,C03XA01,Tolvaptan,Tablet,Oral,02370476,SAMSCA (tolvaptan 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012161,tolvaptan 30 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92184,Marketed,2015-06-01,02437503,JINARC,2.0,C03XA01,Tolvaptan,Tablet,Oral,02437503,JINARC (tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012160,tolvaptan 15 mg oral tablet with tolvaptan 45 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92185,Marketed,2015-06-01,02437511,JINARC,2.0,C03XA01,Tolvaptan,Tablet,Oral,02437511,JINARC (tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012162,tolvaptan 30 mg oral tablet with tolvaptan 60 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92186,Marketed,2015-06-01,02437538,JINARC,2.0,C03XA01,Tolvaptan,Tablet,Oral,02437538,JINARC (tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012163,tolvaptan 30 mg oral tablet with tolvaptan 90 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98156,Marketed,2020-03-26,02491575,JINARC,2.0,C03XA01,Tolvaptan,Tablet,Oral,02491575,JINARC (tolvaptan 15 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9012159,tolvaptan 15 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98157,Marketed,2020-03-26,02491583,JINARC,2.0,C03XA01,Tolvaptan,Tablet,Oral,02491583,JINARC (tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet) OTSUKA PHARMACEUTICAL CO LTD,Active,9014278,tolvaptan 15 mg oral tablet with tolvaptan 30 mg oral tablet,8000986,tolvaptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106052,Marketed,2026-01-21,02557177,LUPIN-TOLVAPTAN,2.0,C03XA01,Tolvaptan,Tablet,Oral,,,,,,,,,,,,,,,,
106053,Marketed,2026-01-21,02557185,LUPIN-TOLVAPTAN,2.0,C03XA01,Tolvaptan,Tablet,Oral,,,,,,,,,,,,,,,,
106056,Marketed,2026-01-21,02557215,LUPIN-TOLVAPTAN,2.0,C03XA01,Tolvaptan,Tablet,Oral,,,,,,,,,,,,,,,,
13347,Marketed,1992-12-31,01930699,ZAP TOPICAL ANESTHETIC GEL,2.0,D04AB30,"Topical anesthetics, combinations",Gel,Topical,01930699,ZAP TOPICAL ANESTHETIC GEL (benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel) GERMIPHENE CORPORATION,Active,9003248,benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel,8001891,benzocaine and tetracaine,372473007,Oromucosal,385100002,Gel,,,,,
50238,Marketed,2024-01-03,02230958,ONE TOUCH TOPICAL ANESTHETIC GEL,2.0,D04AB30,"Topical anesthetics, combinations",Gel,Buccal,02230958,ONE TOUCH TOPICAL ANESTHETIC GEL (benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel) ABJ CUSTOM PACKAGING,Active,9003248,benzocaine 18 % and tetracaine hydrochloride 2 % oromucosal gel,8001891,benzocaine and tetracaine,372473007,Oromucosal,385100002,Gel,,,,,
50171,Marketed,1997-03-25,02230893,TOPAMAX 25MG,1.0,N03AX11,Topiramate,Tablet,Oral,02230893,TOPAMAX 25MG (topiramate 25 mg oral tablet) JANSSEN INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
50172,Marketed,1997-03-25,02230894,TOPAMAX 100MG,1.0,N03AX11,Topiramate,Tablet,Oral,02230894,TOPAMAX 100MG (topiramate 100 mg oral tablet) JANSSEN INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
50174,Marketed,1997-03-25,02230896,TOPAMAX 200MG,1.0,N03AX11,Topiramate,Tablet,Oral,02230896,TOPAMAX 200MG (topiramate 200 mg oral tablet) JANSSEN INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
63399,Marketed,1999-06-11,02239907,TOPAMAX,1.0,N03AX11,Topiramate,Capsule,Oral,02239907,TOPAMAX (topiramate 15 mg oral capsule) JANSSEN INC,Active,9000854,topiramate 15 mg oral capsule,8000240,topiramate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
63400,Marketed,1999-06-11,02239908,TOPAMAX,1.0,N03AX11,Topiramate,Capsule,Oral,02239908,TOPAMAX (topiramate 25 mg oral capsule) JANSSEN INC,Active,9000855,topiramate 25 mg oral capsule,8000240,topiramate,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
73232,Marketed,2011-05-07,02248860,TEVA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02248860,TEVA-TOPIRAMATE (topiramate 25 mg oral tablet) TEVA CANADA LIMITED,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73233,Marketed,2011-05-07,02248861,TEVA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02248861,TEVA-TOPIRAMATE (topiramate 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
73234,Marketed,2011-05-07,02248862,TEVA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02248862,TEVA-TOPIRAMATE (topiramate 200 mg oral tablet) TEVA CANADA LIMITED,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74840,Marketed,2005-09-14,02262991,PMS-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02262991,PMS-TOPIRAMATE (topiramate 25 mg oral tablet) PHARMASCIENCE INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74841,Marketed,2005-09-14,02263009,PMS-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02263009,PMS-TOPIRAMATE (topiramate 100 mg oral tablet) PHARMASCIENCE INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74842,Marketed,2005-09-14,02263017,PMS-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02263017,PMS-TOPIRAMATE (topiramate 200 mg oral tablet) PHARMASCIENCE INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74874,Marketed,2009-10-21,02263351,MYLAN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02263351,MYLAN-TOPIRAMATE (topiramate 25 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74875,Marketed,2010-02-04,02263378,MYLAN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02263378,MYLAN-TOPIRAMATE (topiramate 100 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74876,Marketed,2009-11-06,02263386,MYLAN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02263386,MYLAN-TOPIRAMATE (topiramate 200 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76522,Marketed,2006-04-21,02279614,APO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02279614,APO-TOPIRAMATE (topiramate 25 mg oral tablet) APOTEX INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76524,Marketed,2006-04-21,02279630,APO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02279630,APO-TOPIRAMATE (topiramate 100 mg oral tablet) APOTEX INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
76525,Marketed,2006-04-21,02279649,APO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02279649,APO-TOPIRAMATE (topiramate 200 mg oral tablet) APOTEX INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77316,Marketed,2021-09-28,02287765,GLN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02287765,GLN-TOPIRAMATE (topiramate 25 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77317,Marketed,2021-09-28,02287773,GLN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02287773,GLN-TOPIRAMATE (topiramate 100 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
77318,Marketed,2021-09-28,02287781,GLN-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02287781,GLN-TOPIRAMATE (topiramate 200 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79760,Marketed,2008-06-17,02312085,PMS-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02312085,PMS-TOPIRAMATE (topiramate 50 mg oral tablet) PHARMASCIENCE INC,Active,9001248,topiramate 50 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79915,Marketed,2008-10-27,02313650,PRO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02313650,PRO-TOPIRAMATE (topiramate 25 mg oral tablet) PRO DOC LIMITEE,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79916,Marketed,2008-10-27,02313669,PRO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02313669,PRO-TOPIRAMATE (topiramate 100 mg oral tablet) PRO DOC LIMITEE,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79917,Marketed,2008-10-27,02313677,PRO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02313677,PRO-TOPIRAMATE (topiramate 200 mg oral tablet) PRO DOC LIMITEE,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80117,Marketed,2024-06-26,02315645,MINT-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02315645,MINT-TOPIRAMATE (topiramate 25 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80118,Marketed,2024-06-26,02315653,MINT-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02315653,MINT-TOPIRAMATE (topiramate 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
80119,Marketed,2024-06-26,02315661,MINT-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02315661,MINT-TOPIRAMATE (topiramate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83068,Marketed,2023-03-01,02345250,JAMP TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02345250,JAMP TOPIRAMATE TABLETS (topiramate 25 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83069,Marketed,2024-02-28,02345269,JAMP TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02345269,JAMP TOPIRAMATE TABLETS (topiramate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83070,Marketed,2023-12-14,02345277,JAMP TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02345277,JAMP TOPIRAMATE TABLETS (topiramate 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83123,Marketed,2020-03-31,02345803,AURO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02345803,AURO-TOPIRAMATE (topiramate 25 mg oral tablet) AURO PHARMA INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83125,Marketed,2020-03-31,02345838,AURO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02345838,AURO-TOPIRAMATE (topiramate 100 mg oral tablet) AURO PHARMA INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
83126,Marketed,2020-03-31,02345846,AURO-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02345846,AURO-TOPIRAMATE (topiramate 200 mg oral tablet) AURO PHARMA INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84197,Marketed,2010-10-06,02356856,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02356856,TOPIRAMATE (topiramate 25 mg oral tablet) SANIS HEALTH INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84198,Marketed,2010-10-06,02356864,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02356864,TOPIRAMATE (topiramate 100 mg oral tablet) SANIS HEALTH INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
84199,Marketed,2010-10-06,02356872,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02356872,TOPIRAMATE (topiramate 200 mg oral tablet) SANIS HEALTH INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87497,Marketed,2018-07-06,02389460,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02389460,TOPIRAMATE (topiramate 25 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
87499,Marketed,2018-05-04,02389487,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02389487,TOPIRAMATE (topiramate 100 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91995,Marketed,2015-02-06,02435616,JAMP-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02435616,JAMP-TOPIRAMATE (topiramate 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102548,Marketed,2023-07-19,02536722,AG-TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02536722,AG-TOPIRAMATE TABLETS (topiramate 25 mg oral tablet) ANGITA PHARMA INC.,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102549,Marketed,2024-02-28,02536730,AG-TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02536730,AG-TOPIRAMATE TABLETS (topiramate 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102717,Marketed,2024-01-11,02538458,NRA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02538458,NRA-TOPIRAMATE (topiramate 100 mg oral tablet) NORA PHARMA INC,Active,9000713,topiramate 100 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102718,Marketed,2024-01-11,02538466,NRA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02538466,NRA-TOPIRAMATE (topiramate 25 mg oral tablet) NORA PHARMA INC,Active,9000715,topiramate 25 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102719,Marketed,2024-01-11,02538474,NRA-TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02538474,NRA-TOPIRAMATE (topiramate 200 mg oral tablet) NORA PHARMA INC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103293,Marketed,2024-08-28,02544377,JAMP TOPIRAMATE TABLETS,1.0,N03AX11,Topiramate,Tablet,Oral,02544377,JAMP TOPIRAMATE TABLETS (topiramate 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001248,topiramate 50 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
104278,Marketed,2025-12-29,02553880,TOPIRAMATE,1.0,N03AX11,Topiramate,Tablet,Oral,02553880,TOPIRAMATE (topiramate 200 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000714,topiramate 200 mg oral tablet,8000240,topiramate,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86529,Marketed,2017-05-18,02379422,TOPOTECAN HYDROCHLORIDE FOR INJECTION,1.0,L01CE01,Topotecan,Solution,Intravenous,02379422,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) PFIZER CANADA ULC,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
87637,Marketed,2014-02-05,02390981,TOPOTECAN INJECTION,1.0,L01CE01,Topotecan,Solution,Intravenous,02390981,TOPOTECAN INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88140,Marketed,2013-11-21,02396378,TOPOTECAN HYDROCHLORIDE FOR INJECTION,1.0,L01CE01,Topotecan,Solution,Intravenous,77700890,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9013370,topotecan (topotecan hydrochloride) 4 mg per 4 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88140,Marketed,2013-11-21,02396378,TOPOTECAN HYDROCHLORIDE FOR INJECTION,1.0,L01CE01,Topotecan,Solution,Intravenous,77700891,TOPOTECAN HYDROCHLORIDE FOR INJECTION (topotecan (topotecan hydrochloride) 1 mg per 1 mL solution for injection vial) ACCORD HEALTHCARE INC,Active,9013369,topotecan (topotecan hydrochloride) 1 mg per 1 mL solution for injection vial,8001969,topotecan,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
92544,Marketed,2020-10-09,02441071,TEVA-TOPOTECAN,1.0,L01CE01,Topotecan,Powder for solution,Intravenous,02441071,TEVA-TOPOTECAN (topotecan (topotecan hydrochloride) 4 mg per vial powder for solution for injection) TEVA CANADA LIMITED,Active,9003109,topotecan (topotecan hydrochloride) 4 mg per vial powder for solution for injection,8001969,topotecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
83679,Marketed,2020-08-24,02351528,YONDELIS,1.0,L01CX01,Trabectedin,Powder for solution,Intravenous,02351528,YONDELIS (trabectedin 1 mg per vial powder for solution for injection) VALEO PHARMA INC,Active,9004760,trabectedin 1 mg per vial powder for solution for injection,8001970,trabectedin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101050,Marketed,2022-03-17,02521288,ADTRALZA,1.0,D11AH07,Tralokinumab,Solution,Subcutaneous,02521288,ADTRALZA (tralokinumab 150 mg per 1 mL solution for injection syringe) LEO PHARMA INC,Active,9014709,tralokinumab 150 mg per 1 mL solution for injection syringe,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102890,Marketed,2024-06-03,02540193,ADTRALZA,1.0,D11AH07,Tralokinumab,Solution,Subcutaneous,02540193,ADTRALZA (tralokinumab 300 mg per 2 mL solution for injection pen) LEO PHARMA INC,Active,9015057,tralokinumab 300 mg per 2 mL solution for injection pen,8002421,tralokinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
77188,Marketed,2006-12-07,02286424,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02286424,ZYTRAM XL (tramadol hydrochloride 150 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001182,tramadol hydrochloride 150 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77189,Marketed,2006-12-07,02286432,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02286432,ZYTRAM XL (tramadol hydrochloride 200 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77190,Marketed,2006-12-07,02286440,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02286440,ZYTRAM XL (tramadol hydrochloride 300 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
77191,Marketed,2006-12-07,02286459,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02286459,ZYTRAM XL (tramadol hydrochloride 400 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001185,tramadol hydrochloride 400 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78172,Marketed,2025-02-19,02296381,TRIDURAL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02296381,TRIDURAL (tramadol hydrochloride 100 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78173,Marketed,2025-02-19,02296403,TRIDURAL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02296403,TRIDURAL (tramadol hydrochloride 200 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78174,Marketed,2025-02-19,02296411,TRIDURAL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02296411,TRIDURAL (tramadol hydrochloride 300 mg prolonged-release oral tablet) ENDO OPERATIONS LTD.,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78458,Marketed,2021-06-25,02299194,RALIVIA,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02299194,"RALIVIA (tramadol hydrochloride 100 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78459,Marketed,2021-06-25,02299208,RALIVIA,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02299208,"RALIVIA (tramadol hydrochloride 200 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
78460,Marketed,2021-06-25,02299216,RALIVIA,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02299216,"RALIVIA (tramadol hydrochloride 300 mg prolonged-release oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
84529,Marketed,2011-03-02,02360322,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02360322,ZYTRAM XL (tramadol hydrochloride 75 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001336,tramadol hydrochloride 75 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
84531,Marketed,2011-03-02,02360349,ZYTRAM XL,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02360349,ZYTRAM XL (tramadol hydrochloride 100 mg prolonged-release oral tablet) PURDUE PHARMA,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
85814,Marketed,2012-03-19,02373017,DURELA,1.0,N02AX02,Tramadol,Capsule (extended release),Oral,02373017,DURELA (tramadol hydrochloride 100 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001379,tramadol hydrochloride 100 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85815,Marketed,2012-03-19,02373025,DURELA,1.0,N02AX02,Tramadol,Capsule (extended release),Oral,02373025,DURELA (tramadol hydrochloride 200 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001380,tramadol hydrochloride 200 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
85816,Marketed,2012-03-19,02373033,DURELA,1.0,N02AX02,Tramadol,Capsule (extended release),Oral,02373033,DURELA (tramadol hydrochloride 300 mg prolonged-release oral capsule) CIPHER PHARMACEUTICALS INC,Active,9001381,tramadol hydrochloride 300 mg prolonged-release oral capsule,8000369,tramadol,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
91076,Marketed,2020-03-16,02426153,APO-TRAMADOL,1.0,N02AX02,Tramadol,Tablet,Oral,02426153,APO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) APOTEX INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93657,Marketed,2016-03-07,02450429,TARO-TRAMADOL ER,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02450429,TARO-TRAMADOL ER (tramadol hydrochloride 100 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001207,tramadol hydrochloride 100 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93658,Marketed,2016-05-27,02450437,TARO-TRAMADOL ER,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02450437,TARO-TRAMADOL ER (tramadol hydrochloride 200 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001183,tramadol hydrochloride 200 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
93659,Marketed,2016-05-27,02450445,TARO-TRAMADOL ER,1.0,N02AX02,Tramadol,Tablet (extended-release),Oral,02450445,TARO-TRAMADOL ER (tramadol hydrochloride 300 mg prolonged-release oral tablet) TARO PHARMACEUTICALS INC,Active,9001184,tramadol hydrochloride 300 mg prolonged-release oral tablet,8000369,tramadol,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
97034,Marketed,2019-04-11,02479672,AURO-TRAMADOL,1.0,N02AX02,Tramadol,Tablet,Oral,02479672,AURO-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) AURO PHARMA INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97151,Marketed,2019-07-18,02480859,MAR-TRAMADOL,1.0,N02AX02,Tramadol,Tablet,Oral,02480859,MAR-TRAMADOL (tramadol hydrochloride 50 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100805,Marketed,2023-02-08,02518759,JAMP TRAMADOL HCL,1.0,N02AX02,Tramadol,Tablet,Oral,02518759,JAMP TRAMADOL HCL (tramadol hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001318,tramadol hydrochloride 50 mg oral tablet,8000369,tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82241,Marketed,2009-11-09,02336790,APO-TRAMADOL/ACET,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02336790,APO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) APOTEX INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83257,Marketed,2012-09-04,02347180,TEVA-TRAMADOL/ACETAMINOPHEN,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02347180,TEVA-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) TEVA CANADA LIMITED,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87374,Marketed,2021-10-21,02388197,TARO-TRAMADOL/ACET,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388197,TARO-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) SUN PHARMA CANADA INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87385,Marketed,2012-09-05,02388308,JAMP-ACET-TRAMADOL,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388308,JAMP-ACET-TRAMADOL (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87386,Marketed,2012-09-04,02388324,MAR-TRAMADOL/ACET,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02388324,MAR-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87528,Marketed,2012-09-18,02389800,MINT-TRAMADOL/ACET,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02389800,MINT-TRAMADOL/ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88654,Marketed,2023-07-28,02401657,PMS-TRAMADOL-ACET,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02401657,PMS-TRAMADOL-ACET (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) PHARMASCIENCE INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92342,Marketed,2015-04-08,02439050,AURO-TRAMADOL/ACETAMINOPHEN,2.0,N02AJ13,Tramadol and paracetamol,Tablet,Oral,02439050,AURO-TRAMADOL/ACETAMINOPHEN (acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet) AURO PHARMA INC,Active,9001121,acetaminophen 325 mg and tramadol hydrochloride 37.5 mg oral tablet,8000349,acetaminophen and tramadol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89431,Marketed,2016-07-04,02409623,MEKINIST,1.0,L01EE01,Trametinib,Tablet,Oral,02409623,MEKINIST (trametinib 0.5 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005316,trametinib 0.5 mg oral tablet,8001971,trametinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89433,Marketed,2015-07-31,02409658,MEKINIST,1.0,L01EE01,Trametinib,Tablet,Oral,02409658,MEKINIST (trametinib 2 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9005317,trametinib 2 mg oral tablet,8001971,trametinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102872,Marketed,2023-11-30,02539993,MEKINIST,1.0,L01EE01,Trametinib,Powder for solution,Oral,02539993,MEKINIST (trametinib 0.05 mg/mL oral solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014998,trametinib 0.05 mg/mL oral solution,8001971,trametinib,26643006,Oral,739006009,Solution,733026001,Vial (unit of presentation),1.0,,
50773,Marketed,2015-05-05,02231457,MAVIK,1.0,C09AA10,Trandolapril,Capsule,Oral,02231457,MAVIK (trandolapril 0.5 mg oral capsule) BGP PHARMA ULC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
50775,Marketed,2016-04-22,02231459,MAVIK,1.0,C09AA10,Trandolapril,Capsule,Oral,02231459,MAVIK (trandolapril 1 mg oral capsule) BGP PHARMA ULC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
50776,Marketed,2016-04-14,02231460,MAVIK,1.0,C09AA10,Trandolapril,Capsule,Oral,02231460,MAVIK (trandolapril 2 mg oral capsule) BGP PHARMA ULC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
62731,Marketed,2015-01-01,02239267,MAVIK,1.0,C09AA10,Trandolapril,Capsule,Oral,02239267,MAVIK (trandolapril 4 mg oral capsule) BGP PHARMA ULC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81109,Marketed,2018-07-12,02325721,SANDOZ TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02325721,SANDOZ TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81110,Marketed,2018-07-12,02325748,SANDOZ TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02325748,SANDOZ TRANDOLAPRIL (trandolapril 1 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81111,Marketed,2018-07-12,02325756,SANDOZ TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02325756,SANDOZ TRANDOLAPRIL (trandolapril 2 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
81112,Marketed,2018-07-12,02325764,SANDOZ TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02325764,SANDOZ TRANDOLAPRIL (trandolapril 4 mg oral capsule) SANDOZ CANADA INCORPORATED,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84285,Marketed,2018-05-18,02357755,PMS-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02357755,PMS-TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) PHARMASCIENCE INC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84286,Marketed,2018-05-18,02357763,PMS-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02357763,PMS-TRANDOLAPRIL (trandolapril 1 mg oral capsule) PHARMASCIENCE INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84287,Marketed,2018-05-18,02357771,PMS-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02357771,PMS-TRANDOLAPRIL (trandolapril 2 mg oral capsule) PHARMASCIENCE INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
84288,Marketed,2018-05-20,02357798,PMS-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02357798,PMS-TRANDOLAPRIL (trandolapril 4 mg oral capsule) PHARMASCIENCE INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96106,Marketed,2018-09-27,02471868,AURO-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02471868,AURO-TRANDOLAPRIL (trandolapril 0.5 mg oral capsule) AURO PHARMA INC,Active,9000776,trandolapril 0.5 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96109,Marketed,2018-09-27,02471876,AURO-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02471876,AURO-TRANDOLAPRIL (trandolapril 1 mg oral capsule) AURO PHARMA INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96110,Marketed,2018-09-27,02471884,AURO-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02471884,AURO-TRANDOLAPRIL (trandolapril 2 mg oral capsule) AURO PHARMA INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
96111,Marketed,2018-09-27,02471892,AURO-TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02471892,AURO-TRANDOLAPRIL (trandolapril 4 mg oral capsule) AURO PHARMA INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97878,Marketed,2019-07-09,02488698,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02488698,TRANDOLAPRIL (trandolapril 1 mg oral capsule) PRO DOC LIMITEE,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97879,Marketed,2019-07-09,02488701,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02488701,TRANDOLAPRIL (trandolapril 2 mg oral capsule) PRO DOC LIMITEE,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
97880,Marketed,2019-07-09,02488728,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02488728,TRANDOLAPRIL (trandolapril 4 mg oral capsule) PRO DOC LIMITEE,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101407,Marketed,2022-11-10,02525046,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02525046,TRANDOLAPRIL (trandolapril 1 mg oral capsule) SANIS HEALTH INC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101408,Marketed,2022-11-10,02525054,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02525054,TRANDOLAPRIL (trandolapril 2 mg oral capsule) SANIS HEALTH INC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101409,Marketed,2022-11-19,02525070,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02525070,TRANDOLAPRIL (trandolapril 4 mg oral capsule) SANIS HEALTH INC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101565,Marketed,2022-11-23,02526565,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02526565,TRANDOLAPRIL (trandolapril 1 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000773,trandolapril 1 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101566,Marketed,2022-11-23,02526573,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02526573,TRANDOLAPRIL (trandolapril 2 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000774,trandolapril 2 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
101567,Marketed,2022-11-23,02526581,TRANDOLAPRIL,1.0,C09AA10,Trandolapril,Capsule,Oral,02526581,TRANDOLAPRIL (trandolapril 4 mg oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9001053,trandolapril 4 mg oral capsule,8000250,trandolapril,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
18072,Marketed,2005-07-08,02064405,CYKLOKAPRON 500 MG,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02064405,CYKLOKAPRON 500 MG (tranexamic acid 500 mg oral tablet) PFIZER CANADA ULC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18371,Marketed,2006-02-15,02064413,CYKLOKAPRON 100 MG/ML,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700836,CYKLOKAPRON 100 MG/ML (tranexamic acid 1000 mg per 10 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013372,tranexamic acid 1000 mg per 10 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
18371,Marketed,2006-02-15,02064413,CYKLOKAPRON 100 MG/ML,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700837,CYKLOKAPRON 100 MG/ML (tranexamic acid 500 mg per 5 mL solution for injection ampoule) PFIZER CANADA ULC,Active,9013374,tranexamic acid 500 mg per 5 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
70531,Marketed,2005-11-15,02246365,TRANEXAMIC ACID INJECTION BP,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700858,TRANEXAMIC ACID INJECTION BP (tranexamic acid 500 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70531,Marketed,2005-11-15,02246365,TRANEXAMIC ACID INJECTION BP,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700859,TRANEXAMIC ACID INJECTION BP (tranexamic acid 1000 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70531,Marketed,2005-11-15,02246365,TRANEXAMIC ACID INJECTION BP,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700860,TRANEXAMIC ACID INJECTION BP (tranexamic acid 100 mg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED,Active,9013371,tranexamic acid 100 mg per mL solution for injection 50 mL vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87801,Marketed,2013-03-27,02392763,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700887,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87801,Marketed,2013-03-27,02392763,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700888,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) OMEGA LABORATORIES LIMITED,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
87801,Marketed,2013-03-27,02392763,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77700889,TRANEXAMIC ACID INJECTION (tranexamic acid 100 mg per mL solution for injection 50 mL vial) OMEGA LABORATORIES LIMITED,Active,9013371,tranexamic acid 100 mg per mL solution for injection 50 mL vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
88596,Marketed,2013-02-13,02401231,TRANEXAMIC ACID TABLETS,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02401231,TRANEXAMIC ACID TABLETS (tranexamic acid 500 mg oral tablet) STERIMAX INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89382,Marketed,2014-03-07,02409097,GD-TRANEXAMIC ACID,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02409097,GD-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) GENMED A DIVISION OF PFIZER CANADA ULC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95428,Marketed,2021-06-09,02466015,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77701077,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection ampoule) AURO PHARMA INC,Active,9013374,tranexamic acid 500 mg per 5 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
95428,Marketed,2021-06-09,02466015,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77701078,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection ampoule) AURO PHARMA INC,Active,9013372,tranexamic acid 1000 mg per 10 mL solution for injection ampoule,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
98610,Marketed,2020-06-04,02496232,MAR-TRANEXAMIC ACID,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02496232,MAR-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98715,Marketed,2021-04-30,02497328,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,02497328,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
100846,Marketed,2022-02-23,02519194,TRANEXAMIC ACID,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02519194,TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102035,Marketed,2024-11-06,02531208,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77701166,TRANEXAMIC ACID INJECTION (tranexamic acid 1000 mg per 10 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013373,tranexamic acid 1000 mg per 10 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102035,Marketed,2024-11-06,02531208,TRANEXAMIC ACID INJECTION,1.0,B02AA02,Tranexamic acid,Solution,Intravenous,77701167,TRANEXAMIC ACID INJECTION (tranexamic acid 500 mg per 5 mL solution for injection vial) EUGIA PHARMA INC.,Active,9013375,tranexamic acid 500 mg per 5 mL solution for injection vial,8001972,tranexamic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103824,Marketed,2024-12-03,02549395,M-TRANEXAMIC ACID,1.0,B02AA02,Tranexamic acid,Tablet,Oral,02549395,M-TRANEXAMIC ACID (tranexamic acid 500 mg oral tablet) MANTRA PHARMA INC,Active,9002881,tranexamic acid 500 mg oral tablet,8001972,tranexamic acid,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15231,Marketed,2002-07-16,01919598,PARNATE,1.0,N06AF04,Tranylcypromine,Tablet,Oral,01919598,PARNATE (tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet) GLAXOSMITHKLINE INC,Active,9002496,tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet,8001538,tranylcypromine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103077,Marketed,2025-03-07,02542188,M-TRANYLCYPROMINE,1.0,N06AF04,Tranylcypromine,Tablet,Oral,02542188,M-TRANYLCYPROMINE (tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet) MANTRA PHARMA INC,Active,9002496,tranylcypromine (tranylcypromine sulfate) 10 mg oral tablet,8001538,tranylcypromine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64277,Marketed,1999-08-23,02240692,HERCEPTIN,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02240692,HERCEPTIN (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) HOFFMANN-LA ROCHE LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
96453,Marketed,2023-12-18,02474425,OGIVRI,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474425,OGIVRI (trastuzumab 150 mg per vial powder for solution for injection) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
96454,Marketed,2024-02-15,02474433,OGIVRI,2.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02474433,OGIVRI (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
97124,Marketed,2018-10-12,02480697,HERCEPTIN SC,1.0,L01FD01,Trastuzumab,Solution,Subcutaneous,02480697,HERCEPTIN SC (trastuzumab 600 mg per 5 mL solution for injection vial) HOFFMANN-LA ROCHE LIMITED,Active,9013526,trastuzumab 600 mg per 5 mL solution for injection vial,8001973,trastuzumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97138,Marketed,2025-11-28,02480794,HERZUMA,1.0,L01FD01,Trastuzumab,"Kit,Powder for solution",Intravenous,02480794,HERZUMA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) CELLTRION INC.,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
97382,Marketed,2019-10-22,02483467,TRAZIMERA,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483467,TRAZIMERA (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) PFIZER CANADA ULC,Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
97383,Marketed,2019-10-22,02483475,TRAZIMERA,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02483475,TRAZIMERA (trastuzumab 150 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
98651,Marketed,2020-04-16,02496690,KANJINTI,1.0,L01FD01,Trastuzumab,"Kit,Powder for solution",Intravenous,02496690,KANJINTI (trastuzumab 420 mg per vial powder for solution for injection with diluent solution) AMGEN CANADA INC,Active,9014279,trastuzumab 420 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
99555,Marketed,2024-10-03,02506211,HERZUMA,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02506211,HERZUMA (trastuzumab 150 mg per vial powder for solution for injection) CELLTRION INC.,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
100755,Marketed,2021-10-07,02518244,KANJINTI,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02518244,KANJINTI (trastuzumab 150 mg per vial powder for solution for injection) AMGEN CANADA INC,Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
101335,Marketed,2022-07-20,02524317,ONTRUZANT,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524317,"ONTRUZANT (trastuzumab 150 mg per vial powder for solution for injection) SAMSUNG BIOEPIS CO., LTD",Active,9014072,trastuzumab 150 mg per vial powder for solution for injection,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
101336,Marketed,2022-07-20,02524325,ONTRUZANT,1.0,L01FD01,Trastuzumab,Powder for solution,Intravenous,02524325,"ONTRUZANT (trastuzumab 440 mg per vial powder for solution for injection with diluent solution) SAMSUNG BIOEPIS CO., LTD",Active,9013525,trastuzumab 440 mg per vial powder for solution for injection with diluent solution,8001973,trastuzumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,1.0
100355,Marketed,2021-07-09,02514400,ENHERTU,1.0,L01FD04,Trastuzumab deruxtecan,Powder for solution,Intravenous,02514400,ENHERTU (trastuzumab deruxtecan 100 mg per vial powder for solution for injection) ASTRAZENECA CANADA INC,Active,9014573,trastuzumab deruxtecan 100 mg per vial powder for solution for injection,8002382,trastuzumab deruxtecan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
89698,Marketed,2013-10-09,02412365,KADCYLA,1.0,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02412365,KADCYLA (trastuzumab emtansine 100 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013377,trastuzumab emtansine 100 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
96263,Marketed,2018-10-24,02473224,KADCYLA,1.0,L01FD03,Trastuzumab emtansine,Powder for solution,Intravenous,02473224,KADCYLA (trastuzumab emtansine 160 mg per vial powder for solution for injection) HOFFMANN-LA ROCHE LIMITED,Active,9013527,trastuzumab emtansine 160 mg per vial powder for solution for injection,8001974,trastuzumab emtansine,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
80351,Marketed,2018-02-01,02318008,TRAVATAN Z,1.0,S01EE04,Travoprost,Solution,Ophthalmic,02318008,TRAVATAN Z (travoprost 0.004 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
89784,Marketed,2014-08-15,02413167,SANDOZ TRAVOPROST,1.0,S01EE04,Travoprost,Solution,Ophthalmic,02413167,SANDOZ TRAVOPROST (travoprost 0.004 % ophthalmic drops) SANDOZ CANADA INCORPORATED,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
94502,Marketed,2018-04-03,02457997,IZBA,1.0,S01EE04,Travoprost,Solution,Ophthalmic,02457997,IZBA (travoprost 0.003 % ophthalmic drops) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001475,travoprost 0.003 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
103698,Marketed,2025-05-20,02548089,JAMP TRAVOPROST Z,1.0,S01EE04,Travoprost,Solution,Ophthalmic,02548089,JAMP TRAVOPROST Z (travoprost 0.004 % ophthalmic drops) JAMP PHARMA CORPORATION,Active,9001259,travoprost 0.004 % ophthalmic drops,8000381,travoprost,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
4241,Marketed,1993-12-31,01937227,PMS TRAZODONE HCL TAB 50MG,1.0,N06AX05,Trazodone,Tablet,Oral,01937227,PMS TRAZODONE HCL TAB 50MG (trazodone hydrochloride 50 mg oral tablet) PHARMASCIENCE INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
13780,Marketed,1993-12-31,01937235,PMS TRAZODONE HCL TAB 100MG,1.0,N06AX05,Trazodone,Tablet,Oral,01937235,PMS TRAZODONE HCL TAB 100MG (trazodone hydrochloride 100 mg oral tablet) PHARMASCIENCE INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18040,Marketed,1995-12-31,02147653,APO-TRAZODONE D TABLETS 150MG,1.0,N06AX05,Trazodone,Tablet,Oral,02147653,APO-TRAZODONE D TABLETS 150MG (trazodone hydrochloride 150 mg oral tablet) APOTEX INC,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18045,Marketed,1995-12-31,02147645,APO-TRAZODONE TABLETS 100MG,1.0,N06AX05,Trazodone,Tablet,Oral,02147645,APO-TRAZODONE TABLETS 100MG (trazodone hydrochloride 100 mg oral tablet) APOTEX INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18046,Marketed,1995-12-31,02147637,APO-TRAZODONE TABLETS 50MG,1.0,N06AX05,Trazodone,Tablet,Oral,02147637,APO-TRAZODONE TABLETS 50MG (trazodone hydrochloride 50 mg oral tablet) APOTEX INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18189,Marketed,2011-06-15,02144298,TEVA-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02144298,TEVA-TRAZODONE (trazodone hydrochloride 150 mg oral tablet) TEVA CANADA LIMITED,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18190,Marketed,2011-06-15,02144271,TEVA-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02144271,TEVA-TRAZODONE (trazodone hydrochloride 100 mg oral tablet) TEVA CANADA LIMITED,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
18191,Marketed,2011-06-15,02144263,TEVA-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02144263,TEVA-TRAZODONE (trazodone hydrochloride 50 mg oral tablet) TEVA CANADA LIMITED,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19936,Marketed,1996-12-31,02164353,TRAZODONE-50,1.0,N06AX05,Trazodone,Tablet,Oral,02164353,TRAZODONE-50 (trazodone hydrochloride 50 mg oral tablet) PRO DOC LIMITEE,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19937,Marketed,1996-12-31,02164361,TRAZODONE-100,1.0,N06AX05,Trazodone,Tablet,Oral,02164361,TRAZODONE-100 (trazodone hydrochloride 100 mg oral tablet) PRO DOC LIMITEE,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
19938,Marketed,1996-12-31,02164388,TRAZODONE-150 D,1.0,N06AX05,Trazodone,Tablet,Oral,02164388,TRAZODONE-150 D (trazodone hydrochloride 150 mg oral tablet) PRO DOC LIMITEE,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60663,Marketed,1998-02-17,02237339,PMS-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02237339,PMS-TRAZODONE (trazodone hydrochloride 75 mg oral tablet) PHARMASCIENCE INC,Active,9000782,trazodone hydrochloride 75 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83411,Marketed,2014-07-31,02348772,TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02348772,TRAZODONE (trazodone hydrochloride 50 mg oral tablet) SANIS HEALTH INC,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83412,Marketed,2014-07-31,02348780,TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02348780,TRAZODONE (trazodone hydrochloride 100 mg oral tablet) SANIS HEALTH INC,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83413,Marketed,2014-07-31,02348799,TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02348799,TRAZODONE (trazodone hydrochloride 150 mg oral tablet) SANIS HEALTH INC,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92726,Marketed,2021-12-07,02442809,JAMP TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02442809,JAMP TRAZODONE (trazodone hydrochloride 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92727,Marketed,2021-11-19,02442817,JAMP TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02442817,JAMP TRAZODONE (trazodone hydrochloride 100 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92729,Marketed,2021-11-19,02442825,JAMP TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02442825,JAMP TRAZODONE (trazodone hydrochloride 150 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102666,Marketed,2024-04-23,02537907,AG-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02537907,AG-TRAZODONE (trazodone hydrochloride 50 mg oral tablet) ANGITA PHARMA INC.,Active,9000497,trazodone hydrochloride 50 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102667,Marketed,2024-04-23,02537915,AG-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02537915,AG-TRAZODONE (trazodone hydrochloride 100 mg oral tablet) ANGITA PHARMA INC.,Active,9000496,trazodone hydrochloride 100 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102668,Marketed,2024-04-23,02537923,AG-TRAZODONE,1.0,N06AX05,Trazodone,Tablet,Oral,02537923,AG-TRAZODONE (trazodone hydrochloride 150 mg oral tablet) ANGITA PHARMA INC.,Active,9000638,trazodone hydrochloride 150 mg oral tablet,8000189,trazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
98787,Marketed,2020-09-28,02498073,ITULATEK,1.0,V01AA05,Tree pollen,Tablet,Sublingual,,,,,,,,,,,,,,,,
102967,Marketed,2023-10-23,02541009,IMJUDO,1.0,L01FX20,Tremelimumab,Solution,Intravenous,77701137,IMJUDO (tremelimumab 25 mg per 1.25 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014956,tremelimumab 25 mg per 1.25 mL solution for injection vial,8002485,tremelimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
102967,Marketed,2023-10-23,02541009,IMJUDO,1.0,L01FX20,Tremelimumab,Solution,Intravenous,77701138,IMJUDO (tremelimumab 300 mg per 15 mL solution for injection vial) ASTRAZENECA CANADA INC,Active,9014957,tremelimumab 300 mg per 15 mL solution for injection vial,8002485,tremelimumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100679,Marketed,2021-08-31,02517388,TRECONDYV,1.0,L01AB02,Treosulfan,Powder,Intravenous,02517388,TRECONDYV (treosulfan 5 g per vial powder for solution for injection) MEDEXUS PHARMACEUTICALS INC.,Active,9014815,treosulfan 5 g per vial powder for solution for injection,8002457,treosulfan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
106363,Marketed,2025-11-26,02560585,TREOSULFAN FOR INJECTION,1.0,L01AB02,Treosulfan,Powder,Intravenous,02560585,TREOSULFAN FOR INJECTION (treosulfan 5 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC,Active,9014815,treosulfan 5 g per vial powder for solution for injection,8002457,treosulfan,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
70735,Marketed,2005-10-07,02246552,REMODULIN,1.0,B01AC21,Treprostinil,Solution,"Intravenous,Subcutaneous",02246552,REMODULIN (treprostinil (treprostinil sodium) 20 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013379,treprostinil (treprostinil sodium) 20 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70736,Marketed,2005-10-07,02246553,REMODULIN,1.0,B01AC21,Treprostinil,Solution,"Intravenous,Subcutaneous",02246553,REMODULIN (treprostinil (treprostinil sodium) 50 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013381,treprostinil (treprostinil sodium) 50 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70737,Marketed,2005-10-07,02246554,REMODULIN,1.0,B01AC21,Treprostinil,Solution,"Subcutaneous,Intravenous",02246554,REMODULIN (treprostinil (treprostinil sodium) 100 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013378,treprostinil (treprostinil sodium) 100 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
70738,Marketed,2005-10-07,02246555,REMODULIN,1.0,B01AC21,Treprostinil,Solution,"Intravenous,Subcutaneous",02246555,REMODULIN (treprostinil (treprostinil sodium) 200 mg per 20 mL solution for injection vial) UNITED THERAPEUTICS CORPORATION,Active,9013380,treprostinil (treprostinil sodium) 200 mg per 20 mL solution for injection vial,8001975,treprostinil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
11152,Marketed,2019-12-13,00443794,RETIN-A,1.0,D10AD01,Tretinoin,Cream,Topical,00443794,"RETIN-A (tretinoin 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9001921,tretinoin 0.05 % cutaneous cream,8001307,tretinoin,448598008,Cutaneous,421628006,Cutaneous cream,,,1.0,,
11153,Marketed,2019-12-13,00443816,RETIN-A,1.0,D10AD01,Tretinoin,Gel,Topical,00443816,"RETIN-A (tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002092,tretinoin 0.025 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
12544,Marketed,2020-09-30,01926489,VITAMIN A ACID,1.0,D10AD01,Tretinoin,Gel,Topical,01926489,"VITAMIN A ACID (tretinoin 0.05 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9001823,tretinoin 0.05 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
12753,Marketed,2020-09-30,01926462,VITAMIN A ACID,1.0,D10AD01,Tretinoin,Gel,Topical,01926462,"VITAMIN A ACID (tretinoin 0.01 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9001999,tretinoin 0.01 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
12754,Marketed,2020-09-30,01926470,VITAMIN A ACID,1.0,D10AD01,Tretinoin,Gel,Topical,01926470,"VITAMIN A ACID (tretinoin 0.025 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9002092,tretinoin 0.025 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
18080,Marketed,2013-10-21,02145839,VESANOID,1.0,L01XF01,Tretinoin,Capsule,Oral,02145839,VESANOID (tretinoin 10 mg oral capsule) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9002882,tretinoin 10 mg oral capsule,8001307,tretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
67856,Marketed,2020-09-30,02243914,RETIN-A MICRO,1.0,D10AD01,Tretinoin,Gel,Topical,02243914,"RETIN-A MICRO (tretinoin 0.1 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9003629,tretinoin 0.1 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
75010,Marketed,2020-09-30,02264633,RETIN-A MICRO,1.0,D10AD01,Tretinoin,Gel,Topical,02264633,"RETIN-A MICRO (tretinoin 0.04 % cutaneous gel) BAUSCH HEALTH, CANADA INC.",Active,9004082,tretinoin 0.04 % cutaneous gel,8001307,tretinoin,448598008,Cutaneous,385100002,Gel,,,1.0,,
100925,Marketed,2022-08-29,02520036,JAMP TRETINOIN,1.0,L01XF01,Tretinoin,Capsule,Oral,02520036,JAMP TRETINOIN (tretinoin 10 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002882,tretinoin 10 mg oral capsule,8001307,tretinoin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
8573,Marketed,1979-12-31,00716960,TRIADERM CRM 0.1%,1.0,D07AB09,Triamcinolone,Cream,Topical,00716960,TRIADERM CRM 0.1% (triamcinolone acetonide 0.1 % cutaneous cream) TARO PHARMACEUTICALS INC,Active,9000143,triamcinolone acetonide 0.1 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
13360,Marketed,2021-10-12,01964054,ORACORT,1.0,A01AC01,Triamcinolone,Paste,Dental,01964054,"ORACORT (triamcinolone acetonide 0.1 % oromucosal paste) TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",Active,9000449,triamcinolone acetonide 0.1 % oromucosal paste,8000030,triamcinolone acetonide,372473007,Oromucosal,739002006,Paste,,,,,
13998,Marketed,2020-11-24,01977563,TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP,1.0,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intramuscular",01977563,TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP (triamcinolone acetonide 200 mg per 5 mL suspension for injection vial) STERIMAX INC,Active,9000071,triamcinolone acetonide 200 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
15481,Marketed,2010-11-23,01999869,KENALOG-40 INJECTION,1.0,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intramuscular",77700022,KENALOG-40 INJECTION (triamcinolone acetonide 40 mg per 1 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000072,triamcinolone acetonide 40 mg per 1 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
15481,Marketed,2010-11-23,01999869,KENALOG-40 INJECTION,1.0,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intramuscular",77700023,KENALOG-40 INJECTION (triamcinolone acetonide 200 mg per 5 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000071,triamcinolone acetonide 200 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
15482,Marketed,2009-12-02,01999761,KENALOG-10 INJECTION,1.0,H02AB08,Triamcinolone,Suspension,"Intra-articular,Intrasynovial,Intradermal,Intrabursal",01999761,KENALOG-10 INJECTION (triamcinolone acetonide 50 mg per 5 mL suspension for injection vial) BRISTOL-MYERS SQUIBB CANADA,Active,9000041,triamcinolone acetonide 50 mg per 5 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
19807,Marketed,2022-07-16,02213834,NASACORT AQ,1.0,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02213834,NASACORT AQ (triamcinolone acetonide 55 mcg per actuation nasal spray) SANOFI CONSUMER HEALTH INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
35783,Marketed,2020-11-24,02194031,ARISTOCORT R,1.0,D07AB09,Triamcinolone,Ointment,Topical,02194031,"ARISTOCORT R (triamcinolone acetonide 0.1 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9000309,triamcinolone acetonide 0.1 % cutaneous ointment,8000030,triamcinolone acetonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
35784,Marketed,2020-11-24,02194058,ARISTOCORT R,1.0,D07AB09,Triamcinolone,Cream,Topical,02194058,"ARISTOCORT R (triamcinolone acetonide 0.1 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000143,triamcinolone acetonide 0.1 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
35785,Marketed,2020-11-24,02194066,ARISTOCORT C,1.0,D07AB09,Triamcinolone,Cream,Topical,02194066,"ARISTOCORT C (triamcinolone acetonide 0.5 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9000752,triamcinolone acetonide 0.5 % cutaneous cream,8000030,triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
85366,Marketed,2018-11-12,02368676,TRIESENCE,1.0,S01BA05,Triamcinolone,Suspension,Intravitreal,02368676,TRIESENCE (triamcinolone acetonide 40 mg per 1 mL suspension for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000072,triamcinolone acetonide 40 mg per 1 mL suspension for injection vial,8000030,triamcinolone acetonide,738984000,Parenteral,385220007,Suspension for injection,733026001,Vial (unit of presentation),,,
90220,Marketed,2020-03-25,02417510,NASACORT ALLERGY 24HR,1.0,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02417510,NASACORT ALLERGY 24HR (triamcinolone acetonide 55 mcg per actuation nasal spray) SANOFI CONSUMER HEALTH INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
92202,Marketed,2016-06-15,02437635,APO-TRIAMCINOLONE AQ,1.0,R01AD11,Triamcinolone,"Spray, metered dose",Nasal,02437635,APO-TRIAMCINOLONE AQ (triamcinolone acetonide 55 mcg per actuation nasal spray) APOTEX INC,Active,9000693,triamcinolone acetonide 55 mcg per actuation nasal spray,8000030,triamcinolone acetonide,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
9448,Marketed,1983-12-31,00717002,VIADERM KC CRM,4.0,D07CB01,Triamcinolone and antibiotics,Cream,Topical,00717002,VIADERM KC CRM (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) TARO PHARMACEUTICALS INC,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
9449,Marketed,1983-12-31,00717029,VIADERM KC ONT,4.0,D07CB01,Triamcinolone and antibiotics,Ointment,Topical,00717029,VIADERM KC ONT (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous ointment) TARO PHARMACEUTICALS INC,Active,9001979,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous ointment,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
12862,Marketed,2018-01-10,00550507,TEVA-TRIACOMB,4.0,D07CB01,Triamcinolone and antibiotics,Cream,Topical,00550507,TEVA-TRIACOMB (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) TEVA CANADA LIMITED,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
15598,Marketed,2000-05-01,02022818,THERADERM CREAM,4.0,D07CB01,Triamcinolone and antibiotics,Cream,Topical,02022818,THERADERM CREAM (gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream) BIMEDA-MTC ANIMAL HEALTH INC,Active,9001978,gramicidin 0.25 mg per g and neomycin (neomycin sulfate) 2.5 mg per g and nystatin 100000 unit per g and triamcinolone acetonide 1 mg per g cutaneous cream,8001909,gramicidin and neomycin and nystatin and triamcinolone acetonide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
9575,Marketed,2014-06-27,00808571,TRIAZOLAM,1.0,N05CD05,Triazolam,Tablet,Oral,00808571,TRIAZOLAM (triazolam 0.25 mg oral tablet) AA PHARMA INC,Active,9002228,triazolam 0.25 mg oral tablet,8001095,triazolam,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
1668,Marketed,1973-12-31,00266507,ADASEPT LIQ 0.5%,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
11537,Marketed,2000-07-01,00779237,BACTI-STAT 0.3%,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
62780,Marketed,1999-04-30,02239311,ECOCARE 250,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
66676,Marketed,2000-11-15,02242846,DIGICLEAN ANTIBACTERIAL FOAM HAND SOAP,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
67995,Marketed,2003-04-01,02244052,KEYSTONE ANTIBACTERIAL FOAM HAND SOAP,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
75280,Marketed,2008-06-07,02267373,INO-F ANTIBAC ANTIBACTERIAL HAND SOAP,1.0,D08AE04,Triclosan,Liquid,Topical,,,,,,,,,,,,,,,,
76939,Marketed,2006-12-01,02283816,ANTIBACTERIAL CLEAN & SMOOTH,1.0,D08AE04,Triclosan,Solution,Topical,,,,,,,,,,,,,,,,
103443,Marketed,2024-08-01,02545683,FOAMING ANTIBACTERIAL HAND CLEANSER,1.0,D08AE04,Triclosan,Solution,Topical (commercial),,,,,,,,,,,,,,,,
99424,Marketed,2020-11-10,02504855,MAR-TRIENTINE,1.0,A16AX12,Trientine,Capsule,Oral,02504855,MAR-TRIENTINE (trientine hydrochloride 250 mg oral capsule) MARCAN PHARMACEUTICALS INC,Active,9014468,trientine hydrochloride 250 mg oral capsule,8002366,trientine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
100446,Marketed,2021-07-05,02515067,WAYMADE-TRIENTINE,1.0,A16AX12,Trientine,Capsule,Oral,02515067,WAYMADE-TRIENTINE (trientine hydrochloride 250 mg oral capsule) WAYMADE PLC,Active,9014468,trientine hydrochloride 250 mg oral capsule,8002366,trientine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
98421,Marketed,2019-11-28,02494175,AKLIEF,1.0,D10AD06,Trifarotene,Cream,Topical,02494175,AKLIEF (trifarotene 50 mcg per g cutaneous cream) GALDERMA CANADA INC.,Active,9014302,trifarotene 50 mcg per g cutaneous cream,8002329,trifarotene,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
96138,Marketed,2018-03-22,02472104,LONSURF,2.0,L01BC59,"Trifluridine, combinations",Tablet,Oral,02472104,"LONSURF (tipiracil (tipiracil hydrochloride) 6.14 mg and trifluridine 15 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9012866,tipiracil (tipiracil hydrochloride) 6.14 mg and trifluridine 15 mg oral tablet,8001537,tipiracil and trifluridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96139,Marketed,2018-03-22,02472112,LONSURF,2.0,L01BC59,"Trifluridine, combinations",Tablet,Oral,02472112,"LONSURF (tipiracil (tipiracil hydrochloride) 8.19 mg and trifluridine 20 mg oral tablet) TAIHO PHARMA CANADA, INC.",Active,9012867,tipiracil (tipiracil hydrochloride) 8.19 mg and trifluridine 20 mg oral tablet,8001537,tipiracil and trifluridine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
100183,Marketed,2021-04-01,02512556,DOJOLVI,1.0,A16AX17,Triheptanoin,Liquid,Oral,02512556,DOJOLVI (triheptanoin 100 % oral liquid) ULTRAGENYX PHARMACEUTICAL INC,Active,9014561,triheptanoin 100 % oral liquid,8002378,triheptanoin,26643006,Oral,420699003,Liquid,,,,,
4901,Marketed,2012-03-01,00545058,TRIHEXYPHENIDYL,1.0,N04AA01,Trihexyphenidyl,Tablet,Oral,00545058,TRIHEXYPHENIDYL (trihexyphenidyl hydrochloride 2 mg oral tablet) AA PHARMA INC,Active,9001956,trihexyphenidyl hydrochloride 2 mg oral tablet,8001540,trihexyphenidyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
4903,Marketed,2014-06-12,00545074,TRIHEXYPHENIDYL,1.0,N04AA01,Trihexyphenidyl,Tablet,Oral,00545074,TRIHEXYPHENIDYL (trihexyphenidyl hydrochloride 5 mg oral tablet) AA PHARMA INC,Active,9001957,trihexyphenidyl hydrochloride 5 mg oral tablet,8001540,trihexyphenidyl,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69763,Marketed,2024-05-09,02245663,APO-TRIMEBUTINE,1.0,A03AA05,Trimebutine,Tablet,Oral,02245663,APO-TRIMEBUTINE (trimebutine maleate 100 mg oral tablet) APOTEX INC,Active,9003760,trimebutine maleate 100 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69764,Marketed,2024-09-13,02245664,APO-TRIMEBUTINE,1.0,A03AA05,Trimebutine,Tablet,Oral,02245664,APO-TRIMEBUTINE (trimebutine maleate 200 mg oral tablet) APOTEX INC,Active,9002393,trimebutine maleate 200 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102695,Marketed,2024-01-17,02538202,MINT-TRIMEBUTINE,1.0,A03AA05,Trimebutine,Tablet,Oral,02538202,MINT-TRIMEBUTINE (trimebutine maleate 100 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003760,trimebutine maleate 100 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
102696,Marketed,2024-01-17,02538210,MINT-TRIMEBUTINE,1.0,A03AA05,Trimebutine,Tablet,Oral,02538210,MINT-TRIMEBUTINE (trimebutine maleate 200 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9002393,trimebutine maleate 200 mg oral tablet,8001978,trimebutine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66985,Marketed,2011-05-07,02243116,TRIMETHOPRIM TABLETS,1.0,J01EA01,Trimethoprim,Tablet,Oral,02243116,TRIMETHOPRIM TABLETS (trimethoprim 100 mg oral tablet) AA PHARMA INC,Active,9003551,trimethoprim 100 mg oral tablet,8000919,trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66986,Marketed,2011-04-07,02243117,TRIMETHOPRIM TABLETS,1.0,J01EA01,Trimethoprim,Tablet,Oral,02243117,TRIMETHOPRIM TABLETS (trimethoprim 200 mg oral tablet) AA PHARMA INC,Active,9003627,trimethoprim 200 mg oral tablet,8000919,trimethoprim,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8065,Marketed,2014-06-12,00740799,TRIMIPRAMINE,1.0,N06AA06,Trimipramine,Tablet,Oral,00740799,TRIMIPRAMINE (trimipramine (trimipramine maleate) 12.5 mg oral tablet) AA PHARMA INC,Active,9002121,trimipramine (trimipramine maleate) 12.5 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8066,Marketed,2011-01-17,00740802,TRIMIPRAMINE,1.0,N06AA06,Trimipramine,Tablet,Oral,00740802,TRIMIPRAMINE (trimipramine (trimipramine maleate) 25 mg oral tablet) AA PHARMA INC,Active,9002122,trimipramine (trimipramine maleate) 25 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8067,Marketed,2011-05-09,00740810,TRIMIPRAMINE,1.0,N06AA06,Trimipramine,Tablet,Oral,00740810,TRIMIPRAMINE (trimipramine (trimipramine maleate) 50 mg oral tablet) AA PHARMA INC,Active,9002123,trimipramine (trimipramine maleate) 50 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
8106,Marketed,2012-01-06,00740829,TRIMIPRAMINE,1.0,N06AA06,Trimipramine,Tablet,Oral,00740829,TRIMIPRAMINE (trimipramine (trimipramine maleate) 100 mg oral tablet) AA PHARMA INC,Active,9002120,trimipramine (trimipramine maleate) 100 mg oral tablet,8001423,trimipramine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15592,Marketed,2013-04-08,02070987,TRIMIPRAMINE,1.0,N06AA06,Trimipramine,Capsule,Oral,02070987,TRIMIPRAMINE (trimipramine (trimipramine maleate) 75 mg oral capsule) AA PHARMA INC,Active,9002720,trimipramine (trimipramine maleate) 75 mg oral capsule,8001423,trimipramine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
63507,Marketed,2020-09-08,02240000,TRELSTAR,1.0,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02240000,TRELSTAR (triptorelin (triptorelin pamoate) 3.75 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9004105,triptorelin (triptorelin pamoate) 3.75 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
67797,Marketed,2020-09-14,02243856,TRELSTAR,1.0,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02243856,TRELSTAR (triptorelin (triptorelin pamoate) 11.25 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9004104,triptorelin (triptorelin pamoate) 11.25 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
87478,Marketed,2012-08-09,02389282,DECAPEPTYL,1.0,L02AE04,Triptorelin,Solution,Subcutaneous,02389282,DECAPEPTYL (triptorelin acetate 0.1 mg per 1 mL solution for injection syringe) FERRING INC,Active,9013383,triptorelin acetate 0.1 mg per 1 mL solution for injection syringe,8001979,triptorelin,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),1.0,,
89690,Marketed,2020-10-14,02412322,TRELSTAR,1.0,L02AE04,Triptorelin,"Powder for suspension, sustained-release",Intramuscular,02412322,TRELSTAR (triptorelin (triptorelin pamoate) 22.5 mg per vial powder for prolonged-release suspension for injection) KNIGHT THERAPEUTICS INC.,Active,9005355,triptorelin (triptorelin pamoate) 22.5 mg per vial powder for prolonged-release suspension for injection,8001979,triptorelin,738984000,Parenteral,422264003,Powder for prolonged-release suspension for injection,733026001,Vial (unit of presentation),1.0,,
104149,Marketed,2025-02-12,02552523,DAYBUE,1.0,N07XX24,Trofinetide,Solution,"Oral,Gastric",02552523,DAYBUE (trofinetide 200 mg per mL oral solution) ACADIA PHARMACEUTICALS INC.,Active,9015181,trofinetide 200 mg per mL oral solution,8002532,trofinetide,26643006,Oral,385023001,Oral solution,,,,,
260,Marketed,2019-04-24,00000981,MYDRIACYL,1.0,S01FA06,Tropicamide,Solution,Ophthalmic,00000981,MYDRIACYL (tropicamide 0.5 % ophthalmic drops) ALCON CANADA INC,Active,9001534,tropicamide 0.5 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
780,Marketed,2019-03-14,00001007,MYDRIACYL,1.0,S01FA06,Tropicamide,Solution,Ophthalmic,00001007,MYDRIACYL (tropicamide 1 % ophthalmic drops) ALCON CANADA INC,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
6054,Marketed,2021-08-05,00622885,ODAN-TROPICAMIDE,1.0,S01FA06,Tropicamide,Solution,Ophthalmic,00622885,ODAN-TROPICAMIDE (tropicamide 1 % ophthalmic drops) ODAN LABORATORIES LTD,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
18758,Marketed,2023-01-26,02148536,MINIMS TROPICAMIDE,1.0,S01FA06,Tropicamide,Drops,Ophthalmic,02148536,MINIMS TROPICAMIDE (tropicamide 1 % ophthalmic drops) BAUSCH & LOMB INC,Active,9001650,tropicamide 1 % ophthalmic drops,8001542,tropicamide,54485002,Ophthalmic,385124005,Eye drops,732994000,Drop (unit of presentation),,,
97846,Marketed,2019-06-21,02488353,MAR-TROSPIUM,1.0,G04BD09,Trospium,Tablet,Oral,02488353,MAR-TROSPIUM (trospium chloride 20 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99603,Marketed,2023-11-21,02506661,JAMP TROSPIUM,1.0,G04BD09,Trospium,Tablet,Oral,02506661,JAMP TROSPIUM (trospium chloride 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9004146,trospium chloride 20 mg oral tablet,8001115,trospium,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76514,Marketed,2023-08-08,02279525,VISIONBLUE,1.0,S01KX02,Trypan blue,Solution,Intraocular,02279525,VISIONBLUE (trypan blue 0.06 % solution for injection 0.5 mL syringe) DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV,Active,9013384,trypan blue 0.06 % solution for injection 0.5 mL syringe,8001981,trypan blue,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
7263,Marketed,2021-06-11,00718149,TRYPTAN,1.0,N06AX02,Tryptophan,Capsule,Oral,00718149,"TRYPTAN (tryptophan 500 mg oral capsule) BAUSCH HEALTH, CANADA INC.",Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
7264,Marketed,2021-06-11,00654531,TRYPTAN,1.0,N06AX02,Tryptophan,Tablet,Oral,00654531,"TRYPTAN (tryptophan 1 g oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
15485,Marketed,2021-06-11,02029456,TRYPTAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02029456,"TRYPTAN (tryptophan 500 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
60571,Marketed,2013-01-03,02237250,TEVA-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02237250,TEVA-TRYPTOPHAN (tryptophan 1 g oral tablet) TEVA CANADA LIMITED,Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62795,Marketed,2021-06-11,02239326,TRYPTAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02239326,"TRYPTAN (tryptophan 250 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9003348,tryptophan 250 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
62796,Marketed,2021-06-11,02239327,TRYPTAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02239327,"TRYPTAN (tryptophan 750 mg oral tablet) BAUSCH HEALTH, CANADA INC.",Active,9003349,tryptophan 750 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63872,Marketed,2013-01-03,02240333,TEVA-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02240333,TEVA-TRYPTOPHAN (tryptophan 500 mg oral tablet) TEVA CANADA LIMITED,Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
63873,Marketed,2013-01-03,02240334,TEVA-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Capsule,Oral,02240334,TEVA-TRYPTOPHAN (tryptophan 500 mg oral capsule) TEVA CANADA LIMITED,Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
72892,Marketed,2003-12-09,02248538,APO-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02248538,APO-TRYPTOPHAN (tryptophan 500 mg oral tablet) APOTEX INC,Active,9002721,tryptophan 500 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72893,Marketed,2003-12-09,02248539,APO-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02248539,APO-TRYPTOPHAN (tryptophan 1 g oral tablet) APOTEX INC,Active,9002094,tryptophan 1 g oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
72895,Marketed,2003-12-09,02248540,APO-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Capsule,Oral,02248540,APO-TRYPTOPHAN (tryptophan 500 mg oral capsule) APOTEX INC,Active,9002095,tryptophan 500 mg oral capsule,8002164,tryptophan,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
94588,Marketed,2017-02-06,02458721,APO-TRYPTOPHAN,1.0,N06AX02,Tryptophan,Tablet,Oral,02458721,APO-TRYPTOPHAN (tryptophan 750 mg oral tablet) APOTEX INC,Active,9003349,tryptophan 750 mg oral tablet,8002164,tryptophan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
2087,Marketed,2006-11-10,00317268,TUBERSOL,1.0,V04CF01,Tuberculin,Solution,Intradermal,,,,,,,,,,,,,,,,
98955,Marketed,2025-11-24,02499827,TUKYSA,1.0,L01EH03,Tucatinib,Tablet,Oral,02499827,TUKYSA (tucatinib 50 mg oral tablet) PFIZER CANADA ULC,Active,9014437,tucatinib 50 mg oral tablet,8002361,tucatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98956,Marketed,2025-11-24,02499835,TUKYSA,1.0,L01EH03,Tucatinib,Tablet,Oral,02499835,TUKYSA (tucatinib 150 mg oral tablet) PFIZER CANADA ULC,Active,9014436,tucatinib 150 mg oral tablet,8002361,tucatinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98007,Marketed,2024-02-28,02490005,NETSPOT,1.0,V09I,Tumour detection,"Powder for solution,Kit",Intravenous,,,,,,,,,,,,,,,,
13630,Marketed,2024-11-14,00885975,VIVOTIF,1.0,J07AP01,"Typhoid, oral, live attenuated",Capsule (enteric-coated),Oral,,,,,,,,,,,,,,,,
20287,Marketed,2006-09-06,02130955,TYPHIM VI,1.0,J07AP03,"Typhoid, purified polysaccharide antigen",Solution,Intramuscular,,,,,,,,,,,,,,,,
102156,Marketed,2023-05-11,02532530,UBRELVY,1.0,N02CD04,Ubrogepant,Tablet,Oral,02532530,UBRELVY (ubrogepant 50 mg oral tablet) ABBVIE CORPORATION,Active,9014859,ubrogepant 50 mg oral tablet,8002466,ubrogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102161,Marketed,2023-04-04,02532581,UBRELVY,1.0,N02CD04,Ubrogepant,Tablet,Oral,02532581,UBRELVY (ubrogepant 100 mg oral tablet) ABBVIE CORPORATION,Active,9014851,ubrogepant 100 mg oral tablet,8002466,ubrogepant,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
92065,Marketed,2015-09-01,02436329,ELLA,1.0,G03AD02,Ulipristal,Tablet,Oral,02436329,ELLA (ulipristal acetate 30 mg oral tablet) LABORATOIRE HRA PHARMA,Active,9005765,ulipristal acetate 30 mg oral tablet,8001982,ulipristal,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
13909,Marketed,2019-10-15,01962728,ULTRAVATE,1.0,D07AC21,Ulobetasol,Ointment,Topical,01962728,"ULTRAVATE (halobetasol propionate 0.05 % cutaneous ointment) BAUSCH HEALTH, CANADA INC.",Active,9002577,halobetasol propionate 0.05 % cutaneous ointment,8001660,halobetasol,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
13917,Marketed,2019-10-15,01962701,ULTRAVATE,1.0,D07AC21,Ulobetasol,Cream,Topical,01962701,"ULTRAVATE (halobetasol propionate 0.05 % cutaneous cream) BAUSCH HEALTH, CANADA INC.",Active,9002576,halobetasol propionate 0.05 % cutaneous cream,8001660,halobetasol,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
99560,Marketed,2021-08-06,02506262,BRYHALI,1.0,D07AC21,Ulobetasol,Lotion,Topical,02506262,"BRYHALI (halobetasol propionate 0.01 % lotion) BAUSCH HEALTH, CANADA INC.",Active,9014584,halobetasol propionate 0.01 % lotion,8001660,halobetasol,448598008,Cutaneous,739000003,Lotion,,,,,
90830,Marketed,2015-04-27,02423596,INCRUSE ELLIPTA,1.0,R03BB07,Umeclidinium bromide,Powder,Inhalation,02423596,INCRUSE ELLIPTA (umeclidinium (umeclidinium bromide) 62.5 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012402,umeclidinium (umeclidinium bromide) 62.5 mcg per actuation inhalation powder,8001089,umeclidinium,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
98509,Marketed,2020-01-16,02495155,RINVOQ,1.0,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02495155,RINVOQ (upadacitinib 15 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014233,upadacitinib 15 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
101013,Marketed,2021-10-28,02520893,RINVOQ,1.0,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02520893,RINVOQ (upadacitinib 30 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014632,upadacitinib 30 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
102847,Marketed,2023-09-07,02539721,RINVOQ,1.0,L04AF03,Upadacitinib,Tablet (extended-release),Oral,02539721,RINVOQ (upadacitinib 45 mg prolonged-release oral tablet) ABBVIE CORPORATION,Active,9014920,upadacitinib 45 mg prolonged-release oral tablet,8002315,upadacitinib,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),1.0,,
88770,Marketed,2013-03-28,02402874,MYRBETRIQ,1.0,G04BD,Urinary antispasmodics,Tablet (extended-release),Oral,02402874,MYRBETRIQ (mirabegron 25 mg prolonged-release oral tablet) ASTELLAS PHARMA CANADA INC,Active,9005209,mirabegron 25 mg prolonged-release oral tablet,8001124,mirabegron,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
75898,Marketed,2006-05-01,02273497,PMS-URSODIOL C,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02273497,PMS-URSODIOL C (ursodiol 250 mg oral tablet) PHARMASCIENCE INC,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75899,Marketed,2006-05-01,02273500,PMS-URSODIOL C,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02273500,PMS-URSODIOL C (ursodiol 500 mg oral tablet) PHARMASCIENCE INC,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91144,Marketed,2021-07-23,02426900,GLN-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02426900,GLN-URSODIOL (ursodiol 250 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91146,Marketed,2021-07-23,02426919,GLN-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02426919,GLN-URSODIOL (ursodiol 500 mg oral tablet) GLENMARK PHARMACEUTICALS CANADA INC.,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96170,Marketed,2018-09-28,02472392,JAMP-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02472392,JAMP-URSODIOL (ursodiol 250 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96171,Marketed,2024-11-14,02472406,JAMP-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02472406,JAMP-URSODIOL (ursodiol 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103245,Marketed,2024-07-17,02544024,NRA-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02544024,NRA-URSODIOL (ursodiol 500 mg oral tablet) NORA PHARMA INC,Active,9003780,ursodiol 500 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103246,Marketed,2024-07-17,02544032,NRA-URSODIOL,1.0,A05AA02,Ursodeoxycholic acid,Tablet,Oral,02544032,NRA-URSODIOL (ursodiol 250 mg oral tablet) NORA PHARMA INC,Active,9003327,ursodiol 250 mg oral tablet,8001308,ursodiol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80608,Marketed,2009-01-05,02320673,STELARA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77700875,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
80608,Marketed,2009-01-05,02320673,STELARA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77700876,STELARA (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
80609,Marketed,2013-01-07,02320681,STELARA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02320681,STELARA (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
94698,Marketed,2018-01-02,02459671,STELARA I.V.,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02459671,STELARA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102598,Marketed,2024-07-02,02537257,FINLIUS,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02537257,FINLIUS (ustekinumab 90 mg per 1 mL solution for injection syringe) JANSSEN INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102603,Marketed,2024-07-02,02537303,FINLIUS,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77701158,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection vial) JANSSEN INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102603,Marketed,2024-07-02,02537303,FINLIUS,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77701159,FINLIUS (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JANSSEN INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
102604,Marketed,2024-07-02,02537311,FINLIUS I.V.,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02537311,FINLIUS I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) JANSSEN INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103153,Marketed,2024-03-01,02543036,JAMTEKI,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02543036,JAMTEKI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103154,Marketed,2024-03-01,02543044,JAMTEKI,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02543044,JAMTEKI (ustekinumab 90 mg per 1 mL solution for injection syringe) JAMP PHARMA CORPORATION,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103271,Marketed,2024-03-01,02544180,WEZLANA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02544180,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) AMGEN CANADA INC,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103272,Marketed,2024-03-01,02544199,WEZLANA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02544199,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection syringe) AMGEN CANADA INC,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
103273,Marketed,2024-03-01,02544202,WEZLANA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02544202,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection vial) AMGEN CANADA INC,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103274,Marketed,2024-03-01,02544210,WEZLANA I.V.,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02544210,WEZLANA I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) AMGEN CANADA INC,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
103908,Marketed,2024-08-29,02550245,STEQEYMA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02550245,STEQEYMA (ustekinumab 45 mg per 0.5 mL solution for injection syringe) CELLTRION INC.,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103909,Marketed,2024-08-29,02550253,STEQEYMA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02550253,STEQEYMA (ustekinumab 90 mg per 1 mL solution for injection syringe) CELLTRION INC.,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
103910,Marketed,2024-08-29,02550261,STEQEYMA IV,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02550261,STEQEYMA IV (ustekinumab 130 mg per 26 mL solution for injection vial) CELLTRION INC.,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
104225,Marketed,2025-02-05,02553309,WEZLANA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02553309,WEZLANA (ustekinumab 90 mg per 1 mL solution for injection pen) AMGEN CANADA INC,Active,9015174,ustekinumab 90 mg per 1 mL solution for injection pen,8001983,ustekinumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,1.0
104226,Marketed,2025-02-05,02553317,WEZLANA,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02553317,WEZLANA (ustekinumab 45 mg per 0.5 mL solution for injection pen) AMGEN CANADA INC,Active,9015173,ustekinumab 45 mg per 0.5 mL solution for injection pen,8001983,ustekinumab,738984000,Injection,385219001,Solution for injection,733006000,Pen(s),,,1.0
104315,Marketed,2025-04-15,02554283,OTULFI,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02554283,OTULFI (ustekinumab 45 mg per 0.5 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104316,Marketed,2025-04-15,02554291,OTULFI,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02554291,OTULFI (ustekinumab 90 mg per 1 mL solution for injection syringe) FRESENIUS KABI CANADA LTD,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
104317,Marketed,2025-04-16,02554305,OTULFI I.V.,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02554305,OTULFI I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
106500,Marketed,2025-10-24,02562081,YESINTEK,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77701199,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013386,ustekinumab 45 mg per 0.5 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
106500,Marketed,2025-10-24,02562081,YESINTEK,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,77701200,YESINTEK (ustekinumab 45 mg per 0.5 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013387,ustekinumab 45 mg per 0.5 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
106501,Marketed,2025-10-24,02562103,YESINTEK,1.0,L04AC05,Ustekinumab,Solution,Subcutaneous,02562103,YESINTEK (ustekinumab 90 mg per 1 mL solution for injection syringe) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013388,ustekinumab 90 mg per 1 mL solution for injection syringe,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,1.0
106502,Marketed,2025-10-24,02562111,YESINTEK I.V.,1.0,L04AC05,Ustekinumab,Solution,Intravenous,02562111,YESINTEK I.V. (ustekinumab 130 mg per 26 mL solution for injection vial) BIOSIMILAR COLLABORATIONS IRELAND LIMITED,Active,9013385,ustekinumab 130 mg per 26 mL solution for injection vial,8001983,ustekinumab,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,1.0
73815,Marketed,2022-02-01,02253186,NUVARING,2.0,G02BB01,Vaginal ring with progestogen and estrogen,Ring (slow-release),Vaginal,02253186,NUVARING (ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system) ORGANON CANADA INC.,Active,9006475,ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system,8000343,ethinyl estradiol and etonogestrel,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,
100924,Marketed,2021-09-29,02520028,HALOETTE,2.0,G02BB01,Vaginal ring with progestogen and estrogen,Ring (slow-release),Vaginal,02520028,HALOETTE (ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system) SEARCHLIGHT PHARMA INC,Active,9006475,ethinyl estradiol 15 mcg per 24 hour and etonogestrel 120 mcg per 24 hour vaginal delivery system,8000343,ethinyl estradiol and etonogestrel,16857009,Vaginal,764772008,Prolonged-release vaginal ring,733021006,System (unit of presentation),1.0,,
20218,Marketed,2002-09-27,02219492,VALTREX,1.0,J05AB11,Valaciclovir,Tablet,Oral,02219492,VALTREX (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) GLAXOSMITHKLINE INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70742,Marketed,2005-05-09,02246559,VALTREX,1.0,J05AB11,Valaciclovir,Tablet,Oral,02246559,VALTREX (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) GLAXOSMITHKLINE INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78118,Marketed,2008-05-23,02295822,APO-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02295822,APO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) APOTEX INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
78376,Marketed,2008-05-16,02298457,PMS-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02298457,PMS-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) PHARMASCIENCE INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80073,Marketed,2009-02-10,02315173,PRO-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02315173,PRO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) PRO DOC LIMITEE,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
80195,Marketed,2008-10-27,02316447,RIVA-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02316447,RIVA-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83249,Marketed,2015-07-21,02347091,SANDOZ VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02347091,SANDOZ VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride monohydrate) 500 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83683,Marketed,2010-05-25,02351579,MYLAN-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02351579,MYLAN-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83684,Marketed,2010-05-25,02351560,MYLAN-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02351560,MYLAN-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
83987,Marketed,2011-10-21,02354705,APO-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02354705,APO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) APOTEX INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84264,Marketed,2012-11-01,02357534,TEVA-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02357534,TEVA-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) TEVA CANADA LIMITED,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
86701,Marketed,2012-03-13,02381230,PMS-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02381230,PMS-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) PHARMASCIENCE INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88988,Marketed,2015-07-24,02405040,AURO-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02405040,AURO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) AURO PHARMA INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
88989,Marketed,2021-01-09,02405059,AURO-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02405059,AURO-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) AURO PHARMA INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92496,Marketed,2021-04-13,02440598,JAMP VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02440598,JAMP VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92637,Marketed,2018-05-04,02442000,VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02442000,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94135,Marketed,2016-06-10,02454645,VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02454645,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) SANIS HEALTH INC,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
99025,Marketed,2022-03-25,02500582,AG-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02500582,AG-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) ANGITA PHARMA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100883,Marketed,2022-05-23,02519585,VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02519585,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) SANIS HEALTH INC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104244,Marketed,2025-11-27,02553511,VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02553511,VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106142,Marketed,2025-08-26,02558130,NB-VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02558130,NB-VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet) NB PHARMA INC.,Active,9000694,valacyclovir (valacyclovir hydrochloride) 500 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106206,Marketed,2025-12-10,02558858,JAMP VALACYCLOVIR,1.0,J05AB11,Valaciclovir,Tablet,Oral,02558858,JAMP VALACYCLOVIR (valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet) JAMP PHARMA CORPORATION,Active,9001314,valacyclovir (valacyclovir hydrochloride) 1000 mg oral tablet,8000233,valacyclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69890,Marketed,2022-07-19,02245777,VALCYTE,1.0,J05AB14,Valganciclovir,Tablet,Oral,02245777,VALCYTE (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
79164,Marketed,2022-07-19,02306085,VALCYTE,1.0,J05AB14,Valganciclovir,Powder for solution,Oral,02306085,VALCYTE (valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9013791,valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution,8001309,valganciclovir,26643006,Oral,385023001,Oral solution,,,1.0,,
89847,Marketed,2014-11-27,02413825,TEVA-VALGANCICLOVIR,1.0,J05AB14,Valganciclovir,Tablet,Oral,02413825,TEVA-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) TEVA CANADA LIMITED,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
91945,Marketed,2015-04-10,02435179,AURO-VALGANCICLOVIR,1.0,J05AB14,Valganciclovir,Tablet,Oral,02435179,AURO-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) AURO PHARMA INC,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
98537,Marketed,2020-05-27,02495457,MINT-VALGANCICLOVIR,1.0,J05AB14,Valganciclovir,Tablet,Oral,02495457,MINT-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003735,valganciclovir (valganciclovir hydrochloride) 450 mg oral tablet,8001309,valganciclovir,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102433,Marketed,2023-09-13,02535483,AURO-VALGANCICLOVIR,1.0,J05AB14,Valganciclovir,Powder for solution,Oral,02535483,AURO-VALGANCICLOVIR (valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution) AURO PHARMA INC,Active,9013791,valganciclovir (valganciclovir hydrochloride) 50 mg per mL oral solution,8001309,valganciclovir,26643006,Oral,385023001,Oral solution,,,1.0,,
3156,Marketed,2016-09-15,00443832,DEPAKENE,1.0,N03AG01,Valproic acid,Solution,Oral,00443832,DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) BGP PHARMA ULC,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,
5676,Marketed,2016-11-29,00596418,EPIVAL,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596418,EPIVAL (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
5677,Marketed,2016-07-22,00596426,EPIVAL,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596426,EPIVAL (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
5678,Marketed,2016-05-25,00596434,EPIVAL,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,00596434,EPIVAL (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) BGP PHARMA ULC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
47553,Marketed,1996-12-13,02229628,PMS-VALPROIC ACID E.C.,1.0,N03AG01,Valproic acid,Capsule (enteric-coated),Oral,02229628,PMS-VALPROIC ACID E.C. (valproic acid 500 mg gastro-resistant capsule) PHARMASCIENCE INC,Active,9000677,valproic acid 500 mg gastro-resistant capsule,8000221,valproic acid (base),26643006,Oral,385052003,Gastro-resistant oral capsule,732937005,Capsule (unit of presentation),1.0,,
50031,Marketed,1997-02-27,02230768,PMS-VALPROIC ACID,1.0,N03AG01,Valproic acid,Capsule,Oral,02230768,PMS-VALPROIC ACID (valproic acid 250 mg oral capsule) PHARMASCIENCE INC,Active,9000639,valproic acid 250 mg oral capsule,8000221,valproic acid (base),26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
60096,Marketed,1997-11-20,02236807,PMS-VALPROIC ACID,1.0,N03AG01,Valproic acid,Solution,Oral,02236807,PMS-VALPROIC ACID (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) PHARMASCIENCE INC,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,
61432,Marketed,2021-08-13,02238048,APO-VALPROIC ACID,1.0,N03AG01,Valproic acid,Capsule,Oral,02238048,APO-VALPROIC ACID (valproic acid 250 mg oral capsule) APOTEX INC,Active,9000639,valproic acid 250 mg oral capsule,8000221,valproic acid (base),26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
63179,Marketed,2021-12-21,02239698,APO-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239698,APO-DIVALPROEX (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) APOTEX INC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
63180,Marketed,2021-12-21,02239699,APO-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239699,APO-DIVALPROEX (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) APOTEX INC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
63181,Marketed,2021-12-21,02239700,APO-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02239700,APO-DIVALPROEX (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) APOTEX INC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
94597,Marketed,2017-04-21,02458926,MYLAN-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02458926,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 125 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000214,valproic acid (divalproex sodium) 125 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
94598,Marketed,2017-05-21,02458934,MYLAN-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02458934,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 250 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000215,valproic acid (divalproex sodium) 250 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
94599,Marketed,2017-04-11,02459019,MYLAN-DIVALPROEX,1.0,N03AG01,Valproic acid,Tablet (delayed-release),Oral,02459019,MYLAN-DIVALPROEX (valproic acid (divalproex sodium) 500 mg gastro-resistant tablet) MYLAN PHARMACEUTICALS ULC,Active,9000216,valproic acid (divalproex sodium) 500 mg gastro-resistant tablet,8000108,valproic acid (divalproex),26643006,Oral,385059007,Gastro-resistant oral tablet,732936001,Tablet (unit of presentation),1.0,,
102148,Marketed,2023-10-05,02532441,JAMP VALPROIC ACID ORAL SOLUTION,1.0,N03AG01,Valproic acid,Solution,Oral,02532441,JAMP VALPROIC ACID ORAL SOLUTION (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) JAMP PHARMA CORPORATION,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,
103806,Marketed,2024-11-06,02549190,ODAN-VALPROIC ACID,1.0,N03AG01,Valproic acid,Solution,Oral,02549190,ODAN-VALPROIC ACID (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) ODAN LABORATORIES LTD,Active,9006541,valproic acid (sodium valproate) 250 mg per 5 mL oral solution,8000072,valproic acid (valproate),26643006,Oral,385023001,Oral solution,,,1.0,,
68771,Marketed,2003-01-24,02244781,DIOVAN 80MG TABLETS,1.0,C09CA03,Valsartan,Tablet,Oral,02244781,DIOVAN 80MG TABLETS (valsartan 80 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
68772,Marketed,2003-01-24,02244782,DIOVAN 160MG TABLETS,1.0,C09CA03,Valsartan,Tablet,Oral,02244782,DIOVAN 160MG TABLETS (valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
75588,Marketed,2005-11-01,02270528,DIOVAN,1.0,C09CA03,Valsartan,Tablet,Oral,02270528,DIOVAN (valsartan 40 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
77486,Marketed,2007-02-14,02289504,DIOVAN,1.0,C09CA03,Valsartan,Tablet,Oral,02289504,DIOVAN (valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84178,Marketed,2011-02-16,02356643,TEVA-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356643,TEVA-VALSARTAN (valsartan 40 mg oral tablet) TEVA CANADA LIMITED,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84179,Marketed,2011-02-16,02356651,TEVA-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356651,TEVA-VALSARTAN (valsartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84180,Marketed,2011-02-16,02356678,TEVA-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356678,TEVA-VALSARTAN (valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84181,Marketed,2011-02-16,02356686,TEVA-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356686,TEVA-VALSARTAN (valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84187,Marketed,2014-09-16,02356740,SANDOZ VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356740,SANDOZ VALSARTAN (valsartan 40 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84188,Marketed,2014-09-16,02356759,SANDOZ VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356759,SANDOZ VALSARTAN (valsartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84189,Marketed,2014-09-16,02356767,SANDOZ VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356767,SANDOZ VALSARTAN (valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84190,Marketed,2014-09-16,02356775,SANDOZ VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02356775,SANDOZ VALSARTAN (valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84808,Marketed,2021-08-18,02363062,TARO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02363062,TARO-VALSARTAN (valsartan 40 mg oral tablet) SUN PHARMA CANADA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84812,Marketed,2021-08-18,02363100,TARO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02363100,TARO-VALSARTAN (valsartan 80 mg oral tablet) SUN PHARMA CANADA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84813,Marketed,2021-08-18,02363119,TARO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02363119,TARO-VALSARTAN (valsartan 160 mg oral tablet) SUN PHARMA CANADA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85176,Marketed,2021-12-10,02366940,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02366940,VALSARTAN (valsartan 40 mg oral tablet) SANIS HEALTH INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85177,Marketed,2021-12-10,02366959,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02366959,VALSARTAN (valsartan 80 mg oral tablet) SANIS HEALTH INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85178,Marketed,2021-12-10,02366967,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02366967,VALSARTAN (valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85179,Marketed,2021-12-10,02366975,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02366975,VALSARTAN (valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85256,Marketed,2021-12-21,02367726,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02367726,VALSARTAN (valsartan 40 mg oral tablet) PRO DOC LIMITEE,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85257,Marketed,2021-12-21,02367734,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02367734,VALSARTAN (valsartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85258,Marketed,2021-12-21,02367742,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02367742,VALSARTAN (valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85259,Marketed,2021-12-21,02367750,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02367750,VALSARTAN (valsartan 320 mg oral tablet) PRO DOC LIMITEE,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87024,Marketed,2022-05-03,02384523,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02384523,VALSARTAN (valsartan 40 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87025,Marketed,2022-05-03,02384531,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02384531,VALSARTAN (valsartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87026,Marketed,2022-05-03,02384558,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02384558,VALSARTAN (valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87027,Marketed,2022-05-03,02384566,VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02384566,VALSARTAN (valsartan 320 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89887,Marketed,2014-02-06,02414201,AURO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02414201,AURO-VALSARTAN (valsartan 40 mg oral tablet) AURO PHARMA INC,Active,9001128,valsartan 40 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89888,Marketed,2014-02-06,02414228,AURO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02414228,AURO-VALSARTAN (valsartan 80 mg oral tablet) AURO PHARMA INC,Active,9001014,valsartan 80 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89889,Marketed,2014-02-06,02414236,AURO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02414236,AURO-VALSARTAN (valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9001013,valsartan 160 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89890,Marketed,2014-02-06,02414244,AURO-VALSARTAN,1.0,C09CA03,Valsartan,Tablet,Oral,02414244,AURO-VALSARTAN (valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001187,valsartan 320 mg oral tablet,8000249,valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65570,Marketed,2000-05-10,02241900,DIOVAN-HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02241900,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
65571,Marketed,2000-05-10,02241901,DIOVAN-HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02241901,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
71182,Marketed,2003-01-24,02246955,DIOVAN-HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02246955,DIOVAN-HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79451,Marketed,2008-05-12,02308908,DIOVAN-HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02308908,DIOVAN-HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79452,Marketed,2008-05-12,02308916,DIOVAN-HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02308916,DIOVAN-HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84182,Marketed,2016-05-27,02356694,SANDOZ VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356694,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84183,Marketed,2016-05-27,02356708,SANDOZ VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356708,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84184,Marketed,2016-05-27,02356716,SANDOZ VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356716,SANDOZ VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84185,Marketed,2016-05-27,02356724,SANDOZ VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356724,SANDOZ VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84186,Marketed,2016-05-27,02356732,SANDOZ VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356732,SANDOZ VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84210,Marketed,2011-02-16,02356996,TEVA-VALSARTAN/HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02356996,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) TEVA CANADA LIMITED,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84211,Marketed,2011-02-16,02357003,TEVA-VALSARTAN/HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02357003,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84212,Marketed,2011-02-16,02357011,TEVA-VALSARTAN/HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02357011,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) TEVA CANADA LIMITED,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84213,Marketed,2011-02-16,02357038,TEVA-VALSARTAN/HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02357038,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84214,Marketed,2011-02-16,02357046,TEVA-VALSARTAN/HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02357046,TEVA-VALSARTAN/HCTZ (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) TEVA CANADA LIMITED,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85182,Marketed,2022-02-18,02367009,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367009,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SANIS HEALTH INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85183,Marketed,2022-02-18,02367017,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367017,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85184,Marketed,2022-02-18,02367025,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367025,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SANIS HEALTH INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85185,Marketed,2022-02-18,02367033,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367033,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85186,Marketed,2022-02-18,02367041,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367041,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) SANIS HEALTH INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85260,Marketed,2022-01-13,02367769,VALSARTAN-HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367769,VALSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) PRO DOC LIMITEE,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85261,Marketed,2022-01-13,02367777,VALSARTAN-HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367777,VALSARTAN-HCTZ (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85262,Marketed,2022-01-13,02367785,VALSARTAN-HCTZ,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02367785,VALSARTAN-HCTZ (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) PRO DOC LIMITEE,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87042,Marketed,2012-06-10,02384736,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02384736,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87043,Marketed,2012-06-10,02384744,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02384744,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87044,Marketed,2012-06-10,02384752,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02384752,VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87045,Marketed,2012-06-10,02384760,VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02384760,VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89280,Marketed,2013-06-19,02408112,AURO-VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02408112,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet) AURO PHARMA INC,Active,9000899,hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89287,Marketed,2013-06-19,02408120,AURO-VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02408120,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9000898,hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89288,Marketed,2013-06-19,02408139,AURO-VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02408139,AURO-VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet) AURO PHARMA INC,Active,9001012,hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89289,Marketed,2013-06-19,02408147,AURO-VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02408147,AURO-VALSARTAN HCT (hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001245,hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89290,Marketed,2013-06-19,02408155,AURO-VALSARTAN HCT,2.0,C09DA03,Valsartan and diuretics,Tablet,Oral,02408155,AURO-VALSARTAN HCT (hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet) AURO PHARMA INC,Active,9001246,hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet,8000286,hydrochlorothiazide and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93249,Marketed,2016-08-04,02446928,ENTRESTO,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446928,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012858,sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93250,Marketed,2016-08-04,02446936,ENTRESTO,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446936,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012859,sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
93251,Marketed,2016-08-04,02446944,ENTRESTO,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02446944,ENTRESTO (sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012860,sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103789,Marketed,2025-10-01,02549018,SANDOZ SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549018,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012858,sacubitril (sacubitril valsartan sodium hydrate complex) 24 mg and valsartan (sacubitril valsartan sodium hydrate complex) 26 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103790,Marketed,2025-10-01,02549026,SANDOZ SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549026,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012859,sacubitril (sacubitril valsartan sodium hydrate complex) 49 mg and valsartan (sacubitril valsartan sodium hydrate complex) 51 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103791,Marketed,2025-10-01,02549034,SANDOZ SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,02549034,SANDOZ SACUBITRIL-VALSARTAN (sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9012860,sacubitril (sacubitril valsartan sodium hydrate complex) 97 mg and valsartan (sacubitril valsartan sodium hydrate complex) 103 mg oral tablet,8001523,sacubitril and valsartan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
106713,Marketed,2026-01-22,02564432,PMS-SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,
106714,Marketed,2026-01-22,02564440,PMS-SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,
106715,Marketed,2026-01-22,02564459,PMS-SACUBITRIL-VALSARTAN,2.0,C09DX04,Valsartan and sacubitril,Tablet,Oral,,,,,,,,,,,,,,,,
9593,Marketed,2019-04-02,00788716,VANCOCIN,1.0,A07AA09,Vancomycin,Capsule,Oral,00788716,VANCOCIN (vancomycin (vancomycin hydrochloride) 250 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002230,vancomycin (vancomycin hydrochloride) 250 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
9594,Marketed,2019-04-02,00800430,VANCOCIN,1.0,A07AA09,Vancomycin,Capsule,Oral,00800430,VANCOCIN (vancomycin (vancomycin hydrochloride) 125 mg oral capsule) SEARCHLIGHT PHARMA INC,Active,9002229,vancomycin (vancomycin hydrochloride) 125 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
19703,Marketed,2015-08-14,02139375,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02139375,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
19705,Marketed,2015-08-14,02139383,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02139383,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
43933,Marketed,2015-08-20,02139243,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02139243,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
65472,Marketed,2015-08-12,02241807,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02241807,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection) FRESENIUS KABI CANADA LTD",Active,9003500,vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
82835,Marketed,2018-01-11,02342855,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02342855,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) STERIMAX INC,Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
82836,Marketed,2018-01-12,02342863,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02342863,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) STERIMAX INC,Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87976,Marketed,2014-03-18,02394626,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02394626,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87977,Marketed,2014-03-18,02394634,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02394634,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
87978,Marketed,2013-02-14,02394642,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02394642,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) SANDOZ CANADA INCORPORATED",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89059,Marketed,2020-10-19,02405822,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02405822,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) STERIMAX INC,Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89060,Marketed,2018-01-12,02405830,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02405830,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection) STERIMAX INC,Active,9003500,vancomycin (vancomycin hydrochloride) 10 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89123,Marketed,2024-06-10,02406535,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02406535,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89124,Marketed,2024-06-10,02406543,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02406543,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89125,Marketed,2024-08-07,02406551,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02406551,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection) MARCAN PHARMACEUTICALS INC",Active,9002903,vancomycin (vancomycin hydrochloride) 5 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
89245,Marketed,2021-06-17,02407744,JAMP VANCOMYCIN,1.0,A07AA09,Vancomycin,Capsule,Oral,02407744,JAMP VANCOMYCIN (vancomycin (vancomycin hydrochloride) 125 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002229,vancomycin (vancomycin hydrochloride) 125 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
89246,Marketed,2021-06-17,02407752,JAMP VANCOMYCIN,1.0,A07AA09,Vancomycin,Capsule,Oral,02407752,JAMP VANCOMYCIN (vancomycin (vancomycin hydrochloride) 250 mg oral capsule) JAMP PHARMA CORPORATION,Active,9002230,vancomycin (vancomycin hydrochloride) 250 mg oral capsule,8001424,vancomycin,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),,,
92006,Marketed,2017-07-27,02435713,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02435713,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
92007,Marketed,2019-10-17,02435721,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP,1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02435721,VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) GENERIC MEDICAL PARTNERS INC,Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
97722,Marketed,2021-01-11,02487071,VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE,1.0,J01XA01,Vancomycin,Solution,Intravenous,02487071,VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE (vancomycin (vancomycin hydrochloride) 1000 mg per 200 mL solution for injection bag) BAXTER CORPORATION,Active,9014469,vancomycin (vancomycin hydrochloride) 1000 mg per 200 mL solution for injection bag,8001424,vancomycin,738984000,Parenteral,385219001,Solution for injection,732982009,Bag (unit of presentation),,,
99216,Marketed,2021-01-14,02502593,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02502593,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
99217,Marketed,2021-01-14,02502607,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02502607,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) JAMP PHARMA CORPORATION",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102199,Marketed,2024-10-02,02532999,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02532999,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
102202,Marketed,2024-10-02,02533006,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02533006,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) EUGIA PHARMA INC.",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103239,Marketed,2024-08-02,02543974,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02543974,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9002498,vancomycin (vancomycin hydrochloride) 500 mg per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
103241,Marketed,2024-08-02,02543982,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",1.0,J01XA01,Vancomycin,Powder for solution,Intravenous,02543982,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP (vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection) HIKMA CANADA LIMITED",Active,9002497,vancomycin (vancomycin hydrochloride) 1 g per vial powder for solution for injection,8001424,vancomycin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
86437,Marketed,2025-11-27,02378582,CAPRELSA,1.0,L01EX04,Vandetanib,Tablet,Oral,02378582,CAPRELSA (vandetanib 100 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9012396,vandetanib 100 mg oral tablet,8001122,vandetanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
86438,Marketed,2024-04-05,02378590,CAPRELSA,1.0,L01EX04,Vandetanib,Tablet,Oral,02378590,CAPRELSA (vandetanib 300 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9012397,vandetanib 300 mg oral tablet,8001122,vandetanib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95236,Marketed,2018-11-01,02464209,MYLAN-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02464209,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 5 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95239,Marketed,2018-11-01,02464225,MYLAN-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02464225,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 10 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95240,Marketed,2018-11-01,02464233,MYLAN-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02464233,MYLAN-VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 20 mg oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96086,Marketed,2018-12-21,02471647,APO-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02471647,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 5 mg oral tablet) APOTEX INC,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96087,Marketed,2018-12-21,02471655,APO-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02471655,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 10 mg oral tablet) APOTEX INC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96088,Marketed,2018-12-21,02471663,APO-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02471663,APO-VARDENAFIL (vardenafil (vardenafil hydrochloride) 20 mg oral tablet) APOTEX INC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96605,Marketed,2018-11-01,02475677,JAMP-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02475677,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003886,vardenafil (vardenafil hydrochloride) 5 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96606,Marketed,2018-11-01,02475685,JAMP-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02475685,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 10 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96607,Marketed,2018-11-01,02475693,JAMP-VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02475693,JAMP-VARDENAFIL (vardenafil (vardenafil hydrochloride) 20 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96702,Marketed,2019-06-06,02476088,JAMP-VARDENAFIL ODT,1.0,G04BE09,Vardenafil,Tablet (orally disintegrating),Oral,02476088,JAMP-VARDENAFIL ODT (vardenafil (vardenafil hydrochloride trihydrate) 10 mg orodispersible tablet) JAMP PHARMA CORPORATION,Active,9004917,vardenafil (vardenafil hydrochloride) 10 mg orodispersible tablet,8001543,vardenafil,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
100959,Marketed,2022-03-25,02520397,VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02520397,VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 10 mg oral tablet) SANIS HEALTH INC,Active,9003884,vardenafil (vardenafil hydrochloride) 10 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100960,Marketed,2022-03-25,02520400,VARDENAFIL,1.0,G04BE09,Vardenafil,Tablet,Oral,02520400,VARDENAFIL (vardenafil (vardenafil hydrochloride trihydrate) 20 mg oral tablet) SANIS HEALTH INC,Active,9003885,vardenafil (vardenafil hydrochloride) 20 mg oral tablet,8001543,vardenafil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90450,Marketed,2018-05-02,02419882,APO-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02419882,APO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) APOTEX INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90451,Marketed,2018-05-02,02419890,APO-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02419890,APO-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) APOTEX INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92001,Marketed,2024-12-23,02435675,APO-VARENICLINE,2.0,N07BA03,Varenicline,"Tablet,Kit",Oral,02435675,APO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) APOTEX INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103147,Marketed,2024-06-19,02542951,NRA-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02542951,NRA-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) NORA PHARMA INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103148,Marketed,2024-06-19,02542978,NRA-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02542978,NRA-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) NORA PHARMA INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103149,Marketed,2024-06-19,02542986,NRA-VARENICLINE,2.0,N07BA03,Varenicline,"Kit,Tablet",Oral,02542986,NRA-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) NORA PHARMA INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103561,Marketed,2024-10-28,02546949,MINT-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02546949,MINT-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103562,Marketed,2024-10-28,02546957,MINT-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02546957,MINT-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103563,Marketed,2025-05-15,02546965,MINT-VARENICLINE,2.0,N07BA03,Varenicline,"Kit,Tablet",Oral,02546965,MINT-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9001216,varenicline (varenicline tartrate) 0.5 mg oral tablet with varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104330,Marketed,2026-01-26,02554445,AURO-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02554445,AURO-VARENICLINE (varenicline (varenicline tartrate) 0.5 mg oral tablet) AURO PHARMA INC,Active,9001197,varenicline (varenicline tartrate) 0.5 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104331,Marketed,2026-01-26,02554453,AURO-VARENICLINE,1.0,N07BA03,Varenicline,Tablet,Oral,02554453,AURO-VARENICLINE (varenicline (varenicline tartrate) 1 mg oral tablet) AURO PHARMA INC,Active,9001198,varenicline (varenicline tartrate) 1 mg oral tablet,8000371,varenicline,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95685,Marketed,2018-01-02,02468425,SHINGRIX,1.0,J07BK,Varicella zoster vaccines,Suspension,Intramuscular,,,,,,,,,,,,,,,,
64641,Marketed,2003-04-09,02241047,VARILRIX,2.0,J07BK01,"Varicella, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
70216,Marketed,2024-10-11,02246081,VARIVAX III,1.0,J07BK01,"Varicella, live attenuated",Powder for solution,"Intramuscular,Subcutaneous",,,,,,,,,,,,,,,,
92654,Marketed,2022-07-11,02442183,VARIZIG,1.0,J06BB03,Varicella/zoster immunoglobulin,Solution,"Intravenous,Intramuscular",,,,,,,,,,,,,,,,
1090,Marketed,2013-04-20,00065927,NEO-LARYNGOBIS,1.0,R02AA20,Various,Suppository,Rectal,00065927,NEO-LARYNGOBIS (bismuth dipropylacetate 135 mg suppository) TEVA CANADA LIMITED,Active,9001497,bismuth dipropylacetate 135 mg suppository,8001703,bismuth dipropylacetate,37161004,Rectal,385194003,Suppository,733019001,Suppository (unit of presentation),,,
1913,Marketed,2005-02-22,00299979,ALLERGENIC EXTRACT NON POLLENS,1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
1914,Marketed,2005-02-22,00299987,ALLERGENIC EXTRACT POLLENS,1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
4410,Marketed,1981-12-31,00479896,XYLONOR GEL,2.0,A01AD11,Various,Gel,Topical,00479896,XYLONOR GEL (cetrimide 0.15 % and lidocaine 5 % oromucosal gel) SEPTODONT,Active,9014016,cetrimide 0.15 % and lidocaine 5 % oromucosal gel,8002103,cetrimide and lidocaine,372473007,Oromucosal,385100002,Gel,,,,,
4885,Marketed,2012-01-21,00551805,SECARIS,2.0,R01AX10,Various,Gel,Nasal,00551805,SECARIS (polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013930,polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385100002,Gel,,,,,
37484,Marketed,2023-03-24,02226928,ALLERGENIC EXTRACT - POLLENS,1.0,V01AA20,Various,Solution,"Intradermal,Subcutaneous,Percutaneous",,,,,,,,,,,,,,,,
37486,Marketed,2022-09-12,02226944,ALLERGENIC EXTRACT - NON-POLLENS,1.0,V01AA20,Various,Solution,"Percutaneous,Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
41939,Marketed,2021-08-18,01942271,ABSORBINE JR EXTRA STRENGTH LINIMENT,2.0,M02AX10,Various,Liquid,Topical,01942271,ABSORBINE JR EXTRA STRENGTH LINIMENT (chloroxylenol 0.5 % and menthol 4 % cutaneous solution) BRIDGES CONSUMER HEALTHCARE LLC,Active,9013809,chloroxylenol 0.5 % and menthol 4 % cutaneous solution,8001721,chloroxylenol and menthol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
42113,Marketed,2021-10-08,01942301,ABSORBINE JR LINIMENT,2.0,M02AX10,Various,Solution,Topical,01942301,ABSORBINE JR LINIMENT (chloroxylenol 0.5 % and menthol 1.25 % cutaneous solution) BRIDGES CONSUMER HEALTHCARE LLC,Active,9013808,chloroxylenol 0.5 % and menthol 1.25 % cutaneous solution,8001721,chloroxylenol and menthol,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
42486,Marketed,2010-02-03,02035286,ORABASE PASTE,3.0,A01AD11,Various,Paste,"Topical,Oral",02035286,ORABASE PASTE (carboxymethylcellulose sodium 13.3 % and gelatin 13.3 % and pectin 13.3 % oral paste) CONVATEC CANADA LTD.,Active,9013778,carboxymethylcellulose sodium 13.3 % and gelatin 13.3 % and pectin 13.3 % oral paste,8002221,carboxymethylcellulose and gelatin and pectin,26643006,Oral,739002006,Paste,,,,,
72045,Marketed,2003-06-30,02247753,OMEGA ALLERGENIC EXTRACTS - POLLENS (AQUEOUS),1.0,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
72046,Marketed,2003-07-02,02247754,OMEGA ALLERGENIC EXTRACTS - POLLENS (GLYCERINATED),1.0,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
72047,Marketed,2003-07-02,02247755,OMEGA ALLERGENIC EXTRACTS - POLLENS (SUSPAL),1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
72048,Marketed,2003-06-30,02247756,OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (AQUEOUS),1.0,V01AA20,Various,Solution,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
72049,Marketed,2003-07-02,02247757,OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (GLYCERINATED),1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
72050,Marketed,2003-07-02,02247758,OMEGA ALLERGENIC EXTRACTS - NON-POLLENS (SUSPAL),1.0,V01AA20,Various,Liquid,"Subcutaneous,Intradermal",,,,,,,,,,,,,,,,
83795,Marketed,2012-01-21,02352699,RHINARIS NASAL GEL,2.0,R01AX10,Various,Gel,Nasal,02352699,RHINARIS NASAL GEL (polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013930,polyethylene glycol 3350 15 % and propylene glycol 20 % nasal gel,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385100002,Gel,,,,,
83972,Marketed,2012-01-21,02354551,RHINARIS NASAL MIST,2.0,R01AX10,Various,"Spray, metered dose",Nasal,02354551,RHINARIS NASAL MIST (polyethylene glycol 3350 15 % and propylene glycol 5 % nasal spray) PENDOPHARM DIVISION OF PHARMASCIENCE INC,Active,9013931,polyethylene glycol 3350 15 % and propylene glycol 5 % nasal spray,8002250,polyethylene glycol 3350 and propylene glycol,46713006,Nasal,385157007,Nasal spray,,,,,
85754,Marketed,2012-08-29,02372428,NON STANDARDIZED ALLERGENIC EXTRACTS - NON POLLENS,1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
85756,Marketed,2012-02-10,02372444,NON STANDARDIZED ALLERGENIC EXTRACTS - POLLENS,1.0,V01AA20,Various,Liquid,"Intradermal,Subcutaneous",,,,,,,,,,,,,,,,
81460,Marketed,2019-03-12,02328933,TECHNETIUM TC 99M TSC,1.0,V09XX,Various diagnostic radiopharmaceuticals,"Solution,Powder for solution,Kit","Oral,Intravenous,Intraperitoneal",,,,,,,,,,,,,,,,
84585,Marketed,2019-03-28,02360853,ANTIMONY SULFIDE COLLOID KIT,1.0,V09XX,Various diagnostic radiopharmaceuticals,"Kit,Solution",Intradermal,,,,,,,,,,,,,,,,
97628,Marketed,2019-03-24,02486067,SULFUR COLLOID KIT,1.0,V09XX,Various diagnostic radiopharmaceuticals,"Kit,Solution","Intradermal,Intravenous,Oral,Inhalation",,,,,,,,,,,,,,,,
31359,Marketed,2023-11-02,02139502,"VASOPRESSIN INJECTION, USP",1.0,H01BA01,Vasopressin (argipressin),Solution,"Subcutaneous,Intramuscular",02139502,"VASOPRESSIN INJECTION, USP (vasopressin 20 unit per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013390,vasopressin 20 unit per 1 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72248,Marketed,2005-08-20,02247938,VASOPRESSIN INJECTION USP,1.0,H01BA01,Vasopressin (argipressin),Solution,"Subcutaneous,Intramuscular",77700861,VASOPRESSIN INJECTION USP (vasopressin 100 unit per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013389,vasopressin 100 unit per 5 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
72248,Marketed,2005-08-20,02247938,VASOPRESSIN INJECTION USP,1.0,H01BA01,Vasopressin (argipressin),Solution,"Subcutaneous,Intramuscular",77700862,VASOPRESSIN INJECTION USP (vasopressin 40 unit per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013391,vasopressin 40 unit per 2 mL solution for injection vial,8001984,vasopressin,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
92117,Marketed,2015-04-21,02436841,ENTYVIO,1.0,L04AG05,Vedolizumab,Powder for solution,Intravenous,02436841,ENTYVIO (vedolizumab 300 mg per vial powder for solution for injection) TAKEDA CANADA INC,Active,9005703,vedolizumab 300 mg per vial powder for solution for injection,8001985,vedolizumab,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
98766,Marketed,2020-11-20,02497875,ENTYVIO,1.0,L04AG05,Vedolizumab,Solution,Subcutaneous,02497875,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection syringe) TAKEDA CANADA INC,Active,9014415,vedolizumab 108 mg per 0.68 mL solution for injection syringe,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
98767,Marketed,2020-07-08,02497867,ENTYVIO,1.0,L04AG05,Vedolizumab,Solution,Subcutaneous,02497867,ENTYVIO (vedolizumab 108 mg per 0.68 mL solution for injection pen) TAKEDA CANADA INC,Active,9014350,vedolizumab 108 mg per 0.68 mL solution for injection pen,8001985,vedolizumab,738984000,Parenteral,385219001,Solution for injection,733006000,Pen (unit of presentation),,,
84221,Marketed,2021-10-15,02357119,VPRIV,1.0,A16AB10,Velaglucerase alfa,Powder for solution,Intravenous,02357119,VPRIV (velaglucerase alfa 400 unit per vial powder for solution for injection) TAKEDA CANADA INC,Active,9004791,velaglucerase alfa 400 unit per vial powder for solution for injection,8001986,velaglucerase alfa,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
86606,Marketed,2012-03-05,02380242,ZELBORAF,1.0,L01EC01,Vemurafenib,Tablet,Oral,02380242,ZELBORAF (vemurafenib 240 mg oral tablet) HOFFMANN-LA ROCHE LIMITED,Active,9004996,vemurafenib 240 mg oral tablet,8001987,vemurafenib,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94509,Marketed,2016-10-31,02458039,VENCLEXTA,1.0,L01XX52,Venetoclax,Tablet,Oral,02458039,VENCLEXTA (venetoclax 10 mg oral tablet) ABBVIE CORPORATION,Active,9006059,venetoclax 10 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94510,Marketed,2016-10-31,02458047,VENCLEXTA,1.0,L01XX52,Venetoclax,Tablet,Oral,02458047,VENCLEXTA (venetoclax 50 mg oral tablet) ABBVIE CORPORATION,Active,9006060,venetoclax 50 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94511,Marketed,2016-10-31,02458055,VENCLEXTA,1.0,L01XX52,Venetoclax,Tablet,Oral,02458055,VENCLEXTA (venetoclax 100 mg oral tablet) ABBVIE CORPORATION,Active,9006056,venetoclax 100 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
94512,Marketed,2016-10-31,02458063,VENCLEXTA,3.0,L01XX52,Venetoclax,"Kit,Tablet",Oral,02458063,VENCLEXTA (venetoclax 10 mg oral tablet with venetoclax 50 mg oral tablet with venetoclax 100 mg oral tablet) ABBVIE CORPORATION,Active,9013392,venetoclax 10 mg oral tablet with venetoclax 50 mg oral tablet with venetoclax 100 mg oral tablet,8001988,venetoclax,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
60600,Marketed,2023-08-09,02237279,EFFEXOR XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237279,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
60601,Marketed,2023-08-09,02237280,EFFEXOR XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237280,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
60603,Marketed,2023-08-09,02237282,EFFEXOR XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02237282,EFFEXOR XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) BGP PHARMA ULC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
76056,Marketed,2010-04-30,02275058,TEVA-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02275058,TEVA-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
78960,Marketed,2019-03-01,02304317,ACT VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304317,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
78961,Marketed,2019-03-01,02304325,ACT VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304325,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
78962,Marketed,2019-03-01,02304333,ACT VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02304333,ACT VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) TEVA CANADA LIMITED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
79596,Marketed,2020-03-20,02310317,SANDOZ VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310317,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
79597,Marketed,2020-03-20,02310325,SANDOZ VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310325,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
79598,Marketed,2020-03-20,02310333,SANDOZ VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02310333,SANDOZ VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SANDOZ CANADA INCORPORATED,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82485,Marketed,2020-04-09,02339242,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339242,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82486,Marketed,2020-04-09,02339250,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339250,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
82487,Marketed,2020-04-09,02339269,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02339269,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) PRO DOC LIMITEE,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
83988,Marketed,2023-01-25,02354713,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354713,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
83989,Marketed,2023-05-23,02354721,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354721,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
83990,Marketed,2023-02-15,02354748,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02354748,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SANIS HEALTH INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
86591,Marketed,2020-10-16,02380072,TARO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380072,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
86592,Marketed,2020-10-16,02380080,TARO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380080,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
86593,Marketed,2020-10-16,02380099,TARO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02380099,TARO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SUN PHARMA CANADA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
87153,Marketed,2018-06-08,02385929,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385929,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
87154,Marketed,2018-06-08,02385937,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385937,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
87155,Marketed,2018-06-08,02385945,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02385945,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) SIVEM PHARMACEUTICALS ULC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93924,Marketed,2016-03-14,02452839,AURO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452839,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93925,Marketed,2016-03-14,02452847,AURO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452847,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
93926,Marketed,2016-03-14,02452855,AURO-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02452855,AURO-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) AURO PHARMA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
96039,Marketed,2018-03-07,02471280,M-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471280,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
96040,Marketed,2018-03-07,02471299,M-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471299,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
96041,Marketed,2018-03-07,02471302,M-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02471302,M-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) MANTRA PHARMA INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97974,Marketed,2019-08-07,02489678,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489678,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97975,Marketed,2019-08-07,02489686,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489686,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
97976,Marketed,2019-08-07,02489694,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02489694,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) LABORATOIRE RIVA INC.,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100588,Marketed,2021-12-29,02516535,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516535,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100589,Marketed,2022-01-13,02516543,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516543,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
100590,Marketed,2021-12-30,02516551,VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02516551,VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) JAMP PHARMA CORPORATION,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101065,Marketed,2022-09-23,02521466,PMSC-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521466,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101066,Marketed,2022-08-30,02521474,PMSC-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521474,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101067,Marketed,2022-08-30,02521482,PMSC-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02521482,PMSC-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) PHARMASCIENCE INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101205,Marketed,2025-03-06,02522977,MINT-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522977,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000790,venlafaxine (venlafaxine hydrochloride) 37.5 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101206,Marketed,2025-03-06,02522985,MINT-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522985,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000791,venlafaxine (venlafaxine hydrochloride) 75 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
101207,Marketed,2025-03-06,02522993,MINT-VENLAFAXINE XR,1.0,N06AX16,Venlafaxine,Capsule (extended release),Oral,02522993,MINT-VENLAFAXINE XR (venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule) MINT PHARMACEUTICALS INC,Active,9000789,venlafaxine (venlafaxine hydrochloride) 150 mg prolonged-release oral capsule,8000254,venlafaxine,26643006,Oral,385053008,Prolonged-release oral capsule,732937005,Capsule (unit of presentation),,,
9940,Marketed,2025-10-14,00782491,AA-VERAP,1.0,C08DA01,Verapamil,Tablet,Oral,00782491,AA-VERAP (verapamil hydrochloride 120 mg oral tablet) AA PHARMA INC,Active,9012352,verapamil hydrochloride 120 mg oral tablet,8000124,verapamil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
10034,Marketed,2025-10-14,00782483,AA-VERAP,1.0,C08DA01,Verapamil,Tablet,Oral,00782483,AA-VERAP (verapamil hydrochloride 80 mg oral tablet) AA PHARMA INC,Active,9012360,verapamil hydrochloride 80 mg oral tablet,8000124,verapamil,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
11534,Marketed,2017-12-18,01907123,ISOPTIN SR,1.0,C08DA01,Verapamil,Tablet (extended-release),Oral,01907123,ISOPTIN SR (verapamil hydrochloride 120 mg prolonged-release oral tablet) BGP PHARMA ULC,Active,9012354,verapamil hydrochloride 120 mg prolonged-release oral tablet,8000124,verapamil,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
18614,Marketed,2005-09-03,02166739,VERAPAMIL HYDROCHLORIDE INJECTION USP,1.0,C08DA01,Verapamil,Liquid,Intravenous,02166739,VERAPAMIL HYDROCHLORIDE INJECTION USP (verapamil hydrochloride 5 mg per 2 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012359,verapamil hydrochloride 5 mg per 2 mL solution for injection vial,8000124,verapamil,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
20018,Marketed,2022-06-13,02210347,MYLAN-VERAPAMIL SR,1.0,C08DA01,Verapamil,Tablet (extended-release),Oral,02210347,MYLAN-VERAPAMIL SR (verapamil hydrochloride 120 mg prolonged-release oral tablet) MYLAN PHARMACEUTICALS ULC,Active,9012354,verapamil hydrochloride 120 mg prolonged-release oral tablet,8000124,verapamil,26643006,Oral,385060002,Prolonged-release oral tablet,732936001,Tablet (unit of presentation),,,
102575,Marketed,2023-09-19,02537044,VERQUVO,1.0,C01DX22,Vericiguat,Tablet,Oral,02537044,VERQUVO (vericiguat 2.5 mg oral tablet) BAYER INC,Active,9014923,vericiguat 2.5 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102576,Marketed,2023-09-19,02537052,VERQUVO,1.0,C01DX22,Vericiguat,Tablet,Oral,02537052,VERQUVO (vericiguat 5 mg oral tablet) BAYER INC,Active,9014924,vericiguat 5 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
102577,Marketed,2023-09-19,02537060,VERQUVO,1.0,C01DX22,Vericiguat,Tablet,Oral,02537060,VERQUVO (vericiguat 10 mg oral tablet) BAYER INC,Active,9014922,vericiguat 10 mg oral tablet,8002481,vericiguat,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
95016,Marketed,2020-07-15,02462400,BRINAVESS,1.0,C01BG11,Vernakalant,Solution,Intravenous,02462400,BRINAVESS (vernakalant hydrochloride 500 mg per 25 mL solution for injection vial) CIPHER PHARMACEUTICALS INC,Active,9012548,vernakalant hydrochloride 500 mg per 25 mL solution for injection vial,8001160,vernakalant,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
66078,Marketed,2020-05-22,02242367,VISUDYNE,1.0,S01LA01,Verteporfin,Powder for solution,Intravenous,02242367,VISUDYNE (verteporfin 15 mg per vial powder for solution for injection) CHEPLAPHARM ARZNEIMITTEL GMBH,Active,9003498,verteporfin 15 mg per vial powder for solution for injection,8001989,verteporfin,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
15532,Marketed,2009-10-07,02065819,SABRIL,1.0,N03AG04,Vigabatrin,Tablet,Oral,02065819,SABRIL (vigabatrin 500 mg oral tablet) LUNDBECK PHARMACEUTICALS LLC,Active,9002722,vigabatrin 500 mg oral tablet,8001544,vigabatrin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
43682,Marketed,2009-10-07,02068036,SABRIL,1.0,N03AG04,Vigabatrin,Powder for solution,Oral,02068036,SABRIL (vigabatrin 500 mg per sachet powder for oral solution) LUNDBECK PHARMACEUTICALS LLC,Active,9013626,vigabatrin 500 mg per sachet powder for oral solution,8001544,vigabatrin,26643006,Oral,385026009,Powder for oral solution,733013000,Sachet (unit of presentation),1.0,,
89362,Marketed,2013-11-29,02408872,BREO ELLIPTA,2.0,R03AK10,Vilanterol and fluticasone furoate,Powder,Inhalation,02408872,BREO ELLIPTA (fluticasone furoate 100 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012398,fluticasone furoate 100 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001081,fluticasone and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
92906,Marketed,2015-10-02,02444186,BREO ELLIPTA,2.0,R03AK10,Vilanterol and fluticasone furoate,Powder,Inhalation,02444186,BREO ELLIPTA (fluticasone furoate 200 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012403,fluticasone furoate 200 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001081,fluticasone and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
90298,Marketed,2014-03-14,02418401,ANORO ELLIPTA,2.0,R03AL03,Vilanterol and umeclidinium bromide,Powder,Inhalation,02418401,ANORO ELLIPTA (umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012546,umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001090,umeclidinium and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
96469,Marketed,2018-05-30,02474522,TRELEGY ELLIPTA,3.0,R03AL08,"Vilanterol, umeclidinium bromide and fluticasone furoate",Powder,Inhalation,02474522,TRELEGY ELLIPTA (fluticasone furoate 100 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012710,fluticasone furoate 100 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001383,fluticasone and umeclidinium and vilanterol,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
100515,Marketed,2021-09-13,02515776,TRELEGY ELLIPTA,3.0,R03AL08,"Vilanterol, umeclidinium bromide and fluticasone furoate",Powder,Inhalation,02515776,TRELEGY ELLIPTA (fluticasone furoate 200 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9014608,fluticasone furoate 200 mcg per actuation and umeclidinium (umeclidinium bromide) 62.5 mcg per actuation and vilanterol (vilanterol trifenatate) 25 mcg per actuation inhalation powder,8001383,fluticasone and umeclidinium and vilanterol,447694001,Respiratory tract,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
92846,Marketed,2024-01-17,02443724,VIIBRYD,1.0,N06AX24,Vilazodone,Tablet,Oral,02443724,VIIBRYD (vilazodone hydrochloride 10 mg oral tablet) ABBVIE CORPORATION,Active,9012549,vilazodone hydrochloride 10 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92847,Marketed,2024-01-15,02443732,VIIBRYD,1.0,N06AX24,Vilazodone,Tablet,Oral,02443732,VIIBRYD (vilazodone hydrochloride 20 mg oral tablet) ABBVIE CORPORATION,Active,9012550,vilazodone hydrochloride 20 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92848,Marketed,2024-01-24,02443740,VIIBRYD,1.0,N06AX24,Vilazodone,Tablet,Oral,02443740,VIIBRYD (vilazodone hydrochloride 40 mg oral tablet) ABBVIE CORPORATION,Active,9012551,vilazodone hydrochloride 40 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104053,Marketed,2025-02-21,02551810,APO-VILAZODONE,1.0,N06AX24,Vilazodone,Tablet,Oral,02551810,APO-VILAZODONE (vilazodone hydrochloride 10 mg oral tablet) APOTEX INC,Active,9012549,vilazodone hydrochloride 10 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104054,Marketed,2025-02-21,02551829,APO-VILAZODONE,1.0,N06AX24,Vilazodone,Tablet,Oral,02551829,APO-VILAZODONE (vilazodone hydrochloride 20 mg oral tablet) APOTEX INC,Active,9012550,vilazodone hydrochloride 20 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104055,Marketed,2025-02-21,02551837,APO-VILAZODONE,1.0,N06AX24,Vilazodone,Tablet,Oral,02551837,APO-VILAZODONE (vilazodone hydrochloride 40 mg oral tablet) APOTEX INC,Active,9012551,vilazodone hydrochloride 40 mg oral tablet,8001161,vilazodone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
44270,Marketed,2018-07-31,02183056,VINBLASTINE SULFATE INJECTION,1.0,L01CA01,Vinblastine,Solution,Intravenous,02183056,VINBLASTINE SULFATE INJECTION (vinblastine sulfate 10 mg per 10 mL solution for injection vial) PFIZER CANADA ULC,Active,9013394,vinblastine sulfate 10 mg per 10 mL solution for injection vial,8001990,vinblastine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88636,Marketed,2013-02-08,02401460,VINBLASTINE SULPHATE INJECTION,1.0,L01CA01,Vinblastine,Solution,Intravenous,02401460,VINBLASTINE SULPHATE INJECTION (vinblastine sulfate 10 mg per 10 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013394,vinblastine sulfate 10 mg per 10 mL solution for injection vial,8001990,vinblastine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
19756,Marketed,2014-04-12,02143305,VINCRISTINE SULFATE INJECTION,1.0,L01CA02,Vincristine,Solution,Intravenous,77700843,VINCRISTINE SULFATE INJECTION (vincristine sulfate 5 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013397,vincristine sulfate 5 mg per 5 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
19756,Marketed,2014-04-12,02143305,VINCRISTINE SULFATE INJECTION,1.0,L01CA02,Vincristine,Solution,Intravenous,77700844,VINCRISTINE SULFATE INJECTION (vincristine sulfate 2 mg per 2 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013396,vincristine sulfate 2 mg per 2 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
19756,Marketed,2014-04-12,02143305,VINCRISTINE SULFATE INJECTION,1.0,L01CA02,Vincristine,Solution,Intravenous,77700845,VINCRISTINE SULFATE INJECTION (vincristine sulfate 1 mg per 1 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013395,vincristine sulfate 1 mg per 1 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44267,Marketed,2018-04-17,02183013,VINCRISTINE SULFATE INJECTION USP,1.0,L01CA02,Vincristine,Solution,Intravenous,77700846,VINCRISTINE SULFATE INJECTION USP (vincristine sulfate 2 mg per 2 mL solution for injection vial) PFIZER CANADA ULC,Active,9013396,vincristine sulfate 2 mg per 2 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
44267,Marketed,2018-04-17,02183013,VINCRISTINE SULFATE INJECTION USP,1.0,L01CA02,Vincristine,Solution,Intravenous,77700847,VINCRISTINE SULFATE INJECTION USP (vincristine sulfate 5 mg per 5 mL solution for injection vial) PFIZER CANADA ULC,Active,9013397,vincristine sulfate 5 mg per 5 mL solution for injection vial,8001991,vincristine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
75669,Marketed,2014-04-02,02271214,VINORELBINE TARTRATE FOR INJECTION,1.0,L01CA04,Vinorelbine,Solution,Intravenous,77700870,VINORELBINE TARTRATE FOR INJECTION (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
75669,Marketed,2014-04-02,02271214,VINORELBINE TARTRATE FOR INJECTION,1.0,L01CA04,Vinorelbine,Solution,Intravenous,77700871,VINORELBINE TARTRATE FOR INJECTION (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) TEVA CANADA LIMITED,Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91557,Marketed,2017-08-01,02431130,"VINORELBINE INJECTION, USP",1.0,L01CA04,Vinorelbine,Solution,Intravenous,77700897,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91557,Marketed,2017-08-01,02431130,"VINORELBINE INJECTION, USP",1.0,L01CA04,Vinorelbine,Solution,Intravenous,77700898,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) GENERIC MEDICAL PARTNERS INC",Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100056,Marketed,2021-06-25,02511347,"VINORELBINE INJECTION, USP",1.0,L01CA04,Vinorelbine,Solution,Intravenous,77701087,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013398,vinorelbine (vinorelbine tartrate) 10 mg per 1 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
100056,Marketed,2021-06-25,02511347,"VINORELBINE INJECTION, USP",1.0,L01CA04,Vinorelbine,Solution,Intravenous,77701088,"VINORELBINE INJECTION, USP (vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013399,vinorelbine (vinorelbine tartrate) 50 mg per 5 mL solution for injection vial,8001992,vinorelbine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89398,Marketed,2013-08-09,02409267,ERIVEDGE,1.0,L01XJ01,Vismodegib,Capsule,Oral,02409267,ERIVEDGE (vismodegib 150 mg oral capsule) HOFFMANN-LA ROCHE LIMITED,Active,9005304,vismodegib 150 mg oral capsule,8001993,vismodegib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
5613,Marketed,2005-10-07,00586315,MULTI 1000,9.0,B05XC,Vitamins,Solution,Intravenous,,,,,,,,,,,,,,,,
16462,Marketed,2025-10-23,02100606,MULTI 12,12.0,B05XC,Vitamins,Solution,Intravenous,,,,,,,,,,,,,,,,
66277,Marketed,2006-07-06,02242529,MULTI-12/K1 PEDIATRIC,13.0,B05XC,Vitamins,Liquid,Intravenous,,,,,,,,,,,,,,,,
74661,Marketed,2007-09-27,02261219,HUMATE-P,2.0,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261219,HUMATE-P (coagulation factor VIII human 250 unit per vial and von Willebrand factor human 600 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014160,coagulation factor VIII human 250 unit per vial and von Willebrand factor human 600 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
74662,Marketed,2007-10-09,02261227,HUMATE-P,2.0,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261227,HUMATE-P (coagulation factor VIII human 500 unit per vial and von Willebrand factor human 1200 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014161,coagulation factor VIII human 500 unit per vial and von Willebrand factor human 1200 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
74663,Marketed,2007-10-09,02261235,HUMATE-P,2.0,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,02261235,HUMATE-P (coagulation factor VIII human 1000 unit per vial and von Willebrand factor human 2400 unit per vial powder for solution for injection with diluent solution) CSL BEHRING CANADA INC,Active,9014162,coagulation factor VIII human 1000 unit per vial and von Willebrand factor human 2400 unit per vial powder for solution for injection with diluent solution,8002290,coagulation factor VIII human and von Willebrand factor human,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),,,
77219,Marketed,2008-04-29,02286750,WILATE,3.0,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
77222,Marketed,2008-04-29,02286769,WILATE,3.0,B02BD06,Von willebrand factor and coag. fact. viii in comb,Powder for solution,Intravenous,,,,,,,,,,,,,,,,
103996,Marketed,2024-10-21,02551225,VORANIGO,1.0,L01XM04,Vorasidenib,Tablet,Oral,02551225,VORANIGO (vorasidenib 10 mg oral tablet) SERVIER CANADA INC,Active,9015127,vorasidenib 10 mg oral tablet,8002522,vorasidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
103997,Marketed,2024-10-21,02551233,VORANIGO,1.0,L01XM04,Vorasidenib,Tablet,Oral,02551233,VORANIGO (vorasidenib 40 mg oral tablet) SERVIER CANADA INC,Active,9015128,vorasidenib 40 mg oral tablet,8002522,vorasidenib,26643006,Oral,385055001,Tablet,732936001,Tablet (unit of presentation),1.0,,
99512,Marketed,2022-03-14,02505851,LUXTURNA,1.0,S01XA27,Voretigene neparvovec,Solution,Subretinal,02505851,LUXTURNA (voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9014688,voretigene neparvovec 2.5e12 vg per 0.5 mL solution for injection vial with diluent solution,8002416,voretigene neparvovec,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
74170,Marketed,2004-11-12,02256460,VFEND,1.0,J02AC03,Voriconazole,Tablet,Oral,02256460,VFEND (voriconazole 50 mg oral tablet) PFIZER CANADA ULC,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74171,Marketed,2004-11-12,02256479,VFEND,1.0,J02AC03,Voriconazole,Tablet,Oral,02256479,VFEND (voriconazole 200 mg oral tablet) PFIZER CANADA ULC,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
74172,Marketed,2004-11-12,02256487,VFEND,1.0,J02AC03,Voriconazole,Powder for solution,Intravenous,02256487,VFEND (voriconazole 200 mg per vial powder for solution for injection) PFIZER CANADA ULC,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
76561,Marketed,2008-07-17,02279991,VFEND,1.0,J02AC03,Voriconazole,Powder for suspension,Oral,02279991,VFEND (voriconazole 200 mg per 5 mL oral suspension) PFIZER CANADA ULC,Active,9012873,voriconazole 200 mg per 5 mL oral suspension,8001545,voriconazole,26643006,Oral,385024007,Oral suspension,,,1.0,,
86783,Marketed,2014-04-30,02381966,VORICONAZOLE FOR INJECTION,1.0,J02AC03,Voriconazole,Powder for solution,Intravenous,02381966,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) SANDOZ CANADA INCORPORATED,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
88187,Marketed,2014-03-31,02396866,TEVA-VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02396866,TEVA-VORICONAZOLE (voriconazole 50 mg oral tablet) TEVA CANADA LIMITED,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88189,Marketed,2014-03-31,02396874,TEVA-VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02396874,TEVA-VORICONAZOLE (voriconazole 200 mg oral tablet) TEVA CANADA LIMITED,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88415,Marketed,2014-04-02,02399245,SANDOZ VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02399245,SANDOZ VORICONAZOLE (voriconazole 50 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
88416,Marketed,2014-04-02,02399253,SANDOZ VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02399253,SANDOZ VORICONAZOLE (voriconazole 200 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
96863,Marketed,2019-07-23,02477696,VORICONAZOLE FOR INJECTION,1.0,J02AC03,Voriconazole,Powder for solution,Intravenous,02477696,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) JAMP PHARMA CORPORATION,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
98382,Marketed,2021-09-01,02493829,VORICONAZOLE FOR INJECTION,1.0,J02AC03,Voriconazole,Powder for solution,Intravenous,02493829,VORICONAZOLE FOR INJECTION (voriconazole 200 mg per vial powder for solution for injection) FRESENIUS KABI CANADA LTD,Active,9003973,voriconazole 200 mg per vial powder for solution for injection,8001545,voriconazole,738984000,Parenteral,385223009,Powder for solution for injection,733026001,Vial (unit of presentation),1.0,,
101478,Marketed,2022-09-12,02525771,JAMP VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02525771,JAMP VORICONAZOLE (voriconazole 50 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003974,voriconazole 50 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
101479,Marketed,2022-09-12,02525798,JAMP VORICONAZOLE,1.0,J02AC03,Voriconazole,Tablet,Oral,02525798,JAMP VORICONAZOLE (voriconazole 200 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003972,voriconazole 200 mg oral tablet,8001545,voriconazole,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
81300,Marketed,2009-06-29,02327619,ZOLINZA,1.0,L01XH01,Vorinostat,Capsule,Oral,02327619,ZOLINZA (vorinostat 100 mg oral capsule) MERCK CANADA INC,Active,9004563,vorinostat 100 mg oral capsule,8002001,vorinostat,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
91732,Marketed,2014-10-28,02432919,TRINTELLIX,1.0,N06AX26,Vortioxetine,Tablet,Oral,02432919,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet) LUNDBECK CANADA INC,Active,9005606,vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91733,Marketed,2014-10-28,02432927,TRINTELLIX,1.0,N06AX26,Vortioxetine,Tablet,Oral,02432927,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9005604,vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
91735,Marketed,2014-10-28,02432943,TRINTELLIX,1.0,N06AX26,Vortioxetine,Tablet,Oral,02432943,TRINTELLIX (vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet) LUNDBECK CANADA INC,Active,9005605,vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104171,Marketed,2025-04-15,02552744,APO-VORTIOXETINE,1.0,N06AX26,Vortioxetine,Tablet,Oral,02552744,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet) APOTEX INC,Active,9005606,vortioxetine (vortioxetine hydrobromide) 5 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104172,Marketed,2025-04-15,02552752,APO-VORTIOXETINE,1.0,N06AX26,Vortioxetine,Tablet,Oral,02552752,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet) APOTEX INC,Active,9005604,vortioxetine (vortioxetine hydrobromide) 10 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
104174,Marketed,2025-04-15,02552779,APO-VORTIOXETINE,1.0,N06AX26,Vortioxetine,Tablet,Oral,02552779,APO-VORTIOXETINE (vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet) APOTEX INC,Active,9005605,vortioxetine (vortioxetine hydrobromide) 20 mg oral tablet,8002002,vortioxetine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103100,Marketed,2023-12-15,02542420,AMVUTTRA,1.0,N07XX18,Vutrisiran,Solution,Subcutaneous,02542420,AMVUTTRA (vutrisiran (vutrisiran sodium) 25 mg per 0.5 mL solution for injection syringe) ALNYLAM NETHERLANDS B.V.,Active,9015009,vutrisiran (vutrisiran sodium) 25 mg per 0.5 mL solution for injection syringe,8002497,vutrisiran,738984000,Parenteral,385219001,Solution for injection,733020007,Syringe (unit of presentation),,,
66470,Marketed,2000-08-09,02242680,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242680,TARO-WARFARIN (warfarin sodium 1 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000020,warfarin sodium 1 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66471,Marketed,2000-08-09,02242681,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242681,TARO-WARFARIN (warfarin sodium 2 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000498,warfarin sodium 2 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66472,Marketed,2000-08-09,02242682,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242682,TARO-WARFARIN (warfarin sodium 2.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000450,warfarin sodium 2.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66473,Marketed,2000-08-09,02242683,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242683,TARO-WARFARIN (warfarin sodium 3 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000861,warfarin sodium 3 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66474,Marketed,2000-08-09,02242684,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242684,TARO-WARFARIN (warfarin sodium 4 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000451,warfarin sodium 4 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66475,Marketed,2000-08-09,02242685,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242685,TARO-WARFARIN (warfarin sodium 5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000021,warfarin sodium 5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66476,Marketed,2000-08-09,02242686,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242686,TARO-WARFARIN (warfarin sodium 6 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000914,warfarin sodium 6 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66477,Marketed,2000-08-09,02242687,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242687,TARO-WARFARIN (warfarin sodium 10 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000019,warfarin sodium 10 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66492,Marketed,2000-08-09,02242697,TARO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242697,TARO-WARFARIN (warfarin sodium 7.5 mg oral tablet) TARO PHARMACEUTICALS INC,Active,9000915,warfarin sodium 7.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66762,Marketed,2000-10-16,02242924,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242924,APO-WARFARIN (warfarin sodium 1 mg oral tablet) APOTEX INC,Active,9000020,warfarin sodium 1 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66763,Marketed,2000-10-16,02242925,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242925,APO-WARFARIN (warfarin sodium 2 mg oral tablet) APOTEX INC,Active,9000498,warfarin sodium 2 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66764,Marketed,2000-10-16,02242926,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242926,APO-WARFARIN (warfarin sodium 2.5 mg oral tablet) APOTEX INC,Active,9000450,warfarin sodium 2.5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66765,Marketed,2000-10-16,02242927,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242927,APO-WARFARIN (warfarin sodium 4 mg oral tablet) APOTEX INC,Active,9000451,warfarin sodium 4 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66766,Marketed,2000-10-16,02242928,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242928,APO-WARFARIN (warfarin sodium 5 mg oral tablet) APOTEX INC,Active,9000021,warfarin sodium 5 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
66767,Marketed,2000-10-16,02242929,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02242929,APO-WARFARIN (warfarin sodium 10 mg oral tablet) APOTEX INC,Active,9000019,warfarin sodium 10 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
69718,Marketed,2002-04-23,02245618,APO-WARFARIN,1.0,B01AA03,Warfarin,Tablet,Oral,02245618,APO-WARFARIN (warfarin sodium 3 mg oral tablet) APOTEX INC,Active,9000861,warfarin sodium 3 mg oral tablet,8000013,warfarin,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
9361,Marketed,1984-12-31,00772011,CANTHARONE PLUS,3.0,D11AF,Wart and anti-corn preparations,Liquid,Topical,00772011,CANTHARONE PLUS (cantharidin 1 % and podophyllin 2 % and salicylic acid 30 % cutaneous solution) DORMER LABORATORIES INC.,Active,9013805,cantharidin 1 % and podophyllin 2 % and salicylic acid 30 % cutaneous solution,8001715,cantharidin and podophyllin and salicylic acid,448598008,Cutaneous,385108009,Cutaneous solution,,,,,
36767,Marketed,2024-06-18,02208903,OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS,1.0,R01AA07,Xylometazoline,Spray,Nasal,02208903,OTRIVIN MEDICATED COLD & ALLERGY RELIEF WITH MOISTURIZERS (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,
41684,Marketed,2024-06-18,00653330,OTRIVIN MEDICATED COLD & ALLERGY RELIEF,1.0,R01AA07,Xylometazoline,Spray,Nasal,00653330,OTRIVIN MEDICATED COLD & ALLERGY RELIEF (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,
81710,Marketed,2024-05-03,02331403,OTRIVIN MEDICATED COMPLETE NASAL CARE,1.0,R01AA07,Xylometazoline,Spray,Nasal,02331403,OTRIVIN MEDICATED COMPLETE NASAL CARE (xylometazoline hydrochloride 0.1 % nasal spray) HALEON CANADA ULC,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,
93922,Marketed,2017-03-07,02452812,DECONGESTANT NASAL SPRAY,1.0,R01AA07,Xylometazoline,Spray,Nasal,02452812,DECONGESTANT NASAL SPRAY (xylometazoline hydrochloride 0.1 % nasal spray) CRLS,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,
93927,Marketed,2017-02-27,02452863,NASAL DECONGESTANT SPRAY WITH MOISTURIZERS,1.0,R01AA07,Xylometazoline,Spray,Nasal,02452863,NASAL DECONGESTANT SPRAY WITH MOISTURIZERS (xylometazoline hydrochloride 0.1 % nasal spray) CRLS,Active,9001582,xylometazoline hydrochloride 0.1 % nasal spray,8002003,xylometazoline,46713006,Nasal,385157007,Nasal spray,,,,,
2964,Marketed,2006-05-26,00428833,YF-VAX,1.0,J07BL01,"Yellow fever, live attenuated",Powder for solution,Subcutaneous,,,,,,,,,,,,,,,,
64454,Marketed,2003-11-13,02240863,RELENZA,1.0,J05AH01,Zanamivir,Powder,"Oral,Inhalation",02240863,RELENZA (zanamivir 5 mg per actuation inhalation powder) GLAXOSMITHKLINE INC,Active,9012874,zanamivir 5 mg per actuation inhalation powder,8001546,zanamivir,447694001,Inhalation,385207009,Powder for inhalation,732981002,Actuation (unit of presentation),,,
100221,Marketed,2025-11-24,02512963,BRUKINSA,1.0,L01EL03,Zanubrutinib,Capsule,Oral,02512963,BRUKINSA (zanubrutinib 80 mg oral capsule) BEONE MEDICINES I GMBH,Active,9014562,zanubrutinib 80 mg oral capsule,8002379,zanubrutinib,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
104313,Marketed,2025-11-24,02554267,BRUKINSA,1.0,L01EL03,Zanubrutinib,Tablet,Oral,02554267,BRUKINSA (zanubrutinib 160 mg oral tablet) BEONE MEDICINES I GMBH,Active,9015210,zanubrutinib 160 mg oral tablet,8002379,zanubrutinib,26643006,Oral,421026006,Oral tablet,732936001,Tablet,1.0,,
11342,Marketed,2011-02-11,01902644,RETROVIR (AZT),1.0,J05AF01,Zidovudine,Solution,Intravenous,01902644,RETROVIR (AZT) (zidovudine 200 mg per 20 mL solution for injection vial) VIIV HEALTHCARE ULC,Active,9012594,zidovudine 200 mg per 20 mL solution for injection vial,8001240,zidovudine,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
11942,Marketed,2010-05-10,01902652,RETROVIR (AZT),1.0,J05AF01,Zidovudine,Syrup,Oral,01902652,RETROVIR (AZT) (zidovudine 50 mg per 5 mL syrup) VIIV HEALTHCARE ULC,Active,9002397,zidovudine 50 mg per 5 mL syrup,8001240,zidovudine,26643006,Oral,739009002,Syrup,,,1.0,,
12839,Marketed,1992-12-31,01946323,APO-ZIDOVUDINE,1.0,J05AF01,Zidovudine,Capsule,Oral,01946323,APO-ZIDOVUDINE (zidovudine 100 mg oral capsule) APOTEX INC,Active,9002329,zidovudine 100 mg oral capsule,8001240,zidovudine,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
86096,Marketed,2016-01-22,02375540,APO-LAMIVUDINE-ZIDOVUDINE,2.0,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02375540,APO-LAMIVUDINE-ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) APOTEX INC,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
89907,Marketed,2014-03-03,02414414,AURO-LAMIVUDINE/ZIDOVUDINE,2.0,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02414414,AURO-LAMIVUDINE/ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) AURO PHARMA INC,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
99234,Marketed,2022-03-14,02502801,JAMP LAMIVUDINE / ZIDOVUDINE,2.0,J05AR01,Zidovudine and lamivudine,Tablet,Oral,02502801,JAMP LAMIVUDINE / ZIDOVUDINE (lamivudine 150 mg and zidovudine 300 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003343,lamivudine 150 mg and zidovudine 300 mg oral tablet,8001211,lamivudine and zidovudine,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),1.0,,
103809,Marketed,2025-03-17,02549220,ZILBRYSQ,1.0,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549220,ZILBRYSQ (zilucoplan (zilucoplan sodium) 16.6 mg per 0.416 mL solution for injection syringe) UCB CANADA INC,Active,9015195,zilucoplan (zilucoplan sodium) 16.6 mg per 0.416 mL solution for injection syringe,8002540,zilucoplan,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
103810,Marketed,2025-03-17,02549239,ZILBRYSQ,1.0,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549239,ZILBRYSQ (zilucoplan (zilucoplan sodium) 23 mg per 0.574 mL solution for injection syringe) UCB CANADA INC,Active,9015196,zilucoplan (zilucoplan sodium) 23 mg per 0.574 mL solution for injection syringe,8002540,zilucoplan,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
103811,Marketed,2025-03-17,02549247,ZILBRYSQ,1.0,L04AJ06,Zilucoplan,Solution,Subcutaneous,02549247,ZILBRYSQ (zilucoplan (zilucoplan sodium) 32.4 mg per 0.81 mL solution for injection syringe) UCB CANADA INC,Active,9015197,zilucoplan (zilucoplan sodium) 32.4 mg per 0.81 mL solution for injection syringe,8002540,zilucoplan,738984000,Injection,385219001,Solution for injection,733020007,Syringe,,,
62616,Marketed,2025-08-20,02239160,ZINCOFAX EXTRA STRENGTH,2.0,D02AB,Zinc products,Ointment,Topical,02239160,ZINCOFAX EXTRA STRENGTH (white petrolatum 47 % and zinc oxide 40 % cutaneous ointment) KNIGHT THERAPEUTICS INC.,Active,9003430,white petrolatum 47 % and zinc oxide 40 % cutaneous ointment,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
62617,Marketed,2025-08-21,02239162,ZINCOFAX,2.0,D02AB,Zinc products,Ointment,Topical,02239162,ZINCOFAX (white petrolatum 69 % and zinc oxide 15 % cutaneous ointment) KNIGHT THERAPEUTICS INC.,Active,9003441,white petrolatum 69 % and zinc oxide 15 % cutaneous ointment,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,425753008,Cutaneous ointment,,,,,
80131,Marketed,2009-05-20,02315793,BAZA PROTECT II,2.0,D02AB,Zinc products,Cream,Topical,02315793,BAZA PROTECT II (dimethicone 1 % and zinc oxide 12 % cutaneous cream) COLOPLAST A/S,Active,9004550,dimethicone 1 % and zinc oxide 12 % cutaneous cream,8001752,dimethicone and zinc oxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
82304,Marketed,2010-04-19,02337452,DIAPER RASH CREAM,2.0,D02AB,Zinc products,Cream,Topical,02337452,DIAPER RASH CREAM (white petrolatum 80.3 % and zinc oxide 15 % cutaneous cream) H.J. SUTTON INDUSTRIES LTD.,Active,9004679,white petrolatum 80.3 % and zinc oxide 15 % cutaneous cream,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,421628006,Cutaneous cream,,,,,
94227,Marketed,2019-07-22,02455463,MEDLINE REMEDY ESSENTIALS PROTECTANT PASTE,2.0,D02AB,Zinc products,Paste,Topical,02455463,"MEDLINE REMEDY ESSENTIALS PROTECTANT PASTE (white petrolatum 75 % and zinc oxide 20 % cutaneous paste) MEDLINE INDUSTRIES, LP",Active,9014142,white petrolatum 75 % and zinc oxide 20 % cutaneous paste,8001881,white petrolatum and zinc oxide,448598008,Cutaneous,739002006,Paste,,,,,
96358,Marketed,2018-09-07,02473852,SKIN RENEWING DAY CREAM,2.0,D02AB,Zinc products,Cream,Topical,,,,,,,,,,,,,,,,
13416,Marketed,2006-07-20,00787000,MICRO ZN,1.0,B05XA18,Zinc sulfate,Solution,Intravenous,00787000,MICRO ZN (zinc (zinc sulfate) 50 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013249,zinc (zinc sulfate) 50 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
13451,Marketed,2006-07-20,00787019,MICRO ZN,1.0,B05XA18,Zinc sulfate,Solution,Intravenous,00787019,MICRO ZN (zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9013248,zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102196,Marketed,2024-07-05,02532972,"ZINC SULFATE INJECTION, USP",1.0,B05XA18,Zinc sulfate,Solution,Intravenous,02532972,"ZINC SULFATE INJECTION, USP (zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9013248,zinc (zinc sulfate) 10 mg per 10 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
102198,Marketed,2023-09-08,02532980,"ZINC SULFATE INJECTION, USP",1.0,B05XA18,Zinc sulfate,Solution,Intravenous,02532980,"ZINC SULFATE INJECTION, USP (zinc (zinc sulfate) 25 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD",Active,9014925,zinc (zinc sulfate) 25 mg per 5 mL solution for injection vial,8001882,zinc sulfate,738984000,Parenteral,385219001,Solution for injection,733026001,Vial,,,
78389,Marketed,2023-09-15,02298597,ZELDOX,1.0,N05AE04,Ziprasidone,Capsule,Oral,02298597,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule) BGP PHARMA ULC,Active,9012766,ziprasidone (ziprasidone hydrochloride) 20 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
78392,Marketed,2023-09-15,02298600,ZELDOX,1.0,N05AE04,Ziprasidone,Capsule,Oral,02298600,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule) BGP PHARMA ULC,Active,9012767,ziprasidone (ziprasidone hydrochloride) 40 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
78393,Marketed,2023-09-15,02298619,ZELDOX,1.0,N05AE04,Ziprasidone,Capsule,Oral,02298619,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule) BGP PHARMA ULC,Active,9012768,ziprasidone (ziprasidone hydrochloride) 60 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
78394,Marketed,2023-09-15,02298627,ZELDOX,1.0,N05AE04,Ziprasidone,Capsule,Oral,02298627,ZELDOX (ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule) BGP PHARMA ULC,Active,9012769,ziprasidone (ziprasidone hydrochloride) 80 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93537,Marketed,2018-03-19,02449544,AURO-ZIPRASIDONE,1.0,N05AE04,Ziprasidone,Capsule,Oral,02449544,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 20 mg oral capsule) AURO PHARMA INC,Active,9012766,ziprasidone (ziprasidone hydrochloride) 20 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93538,Marketed,2018-03-19,02449552,AURO-ZIPRASIDONE,1.0,N05AE04,Ziprasidone,Capsule,Oral,02449552,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 40 mg oral capsule) AURO PHARMA INC,Active,9012767,ziprasidone (ziprasidone hydrochloride) 40 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93539,Marketed,2018-03-19,02449560,AURO-ZIPRASIDONE,1.0,N05AE04,Ziprasidone,Capsule,Oral,02449560,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 60 mg oral capsule) AURO PHARMA INC,Active,9012768,ziprasidone (ziprasidone hydrochloride) 60 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
93540,Marketed,2018-03-19,02449579,AURO-ZIPRASIDONE,1.0,N05AE04,Ziprasidone,Capsule,Oral,02449579,AURO-ZIPRASIDONE (ziprasidone (ziprasidone hydrochloride monohydrate) 80 mg oral capsule) AURO PHARMA INC,Active,9012769,ziprasidone (ziprasidone hydrochloride) 80 mg oral capsule,8001425,ziprasidone,26643006,Oral,420692007,Oral capsule,732937005,Capsule (unit of presentation),1.0,,
104288,Marketed,2025-04-01,02553996,VYLOY,1.0,L01FX31,Zolbetuximab,Powder for solution,Intravenous,02553996,VYLOY (zolbetuximab 100 mg per vial powder for solution for injection) ASTELLAS PHARMA CANADA INC,Active,9015198,zolbetuximab 100 mg per vial powder for solution for injection,8002541,zolbetuximab,738984000,Injection,385223009,Powder for solution for injection,733026001,Vial,,,
72636,Marketed,2004-10-14,02248296,ZOMETA CONCENTRATE,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02248296,ZOMETA CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) NOVARTIS PHARMACEUTICALS CANADA INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
75458,Marketed,2022-12-13,02269198,ACLASTA,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02269198,ACLASTA (zoledronic acid (zoledronic acid monohydrate) 5 mg per 100 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012771,zoledronic acid 5 mg per 100 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
88649,Marketed,2014-01-15,02401606,ZOLEDRONIC ACID - Z,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02401606,ZOLEDRONIC ACID - Z (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) SANDOZ CANADA INCORPORATED,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
89980,Marketed,2014-02-26,02415186,TARO-ZOLEDRONIC ACID CONCENTRATE,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02415186,TARO-ZOLEDRONIC ACID CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) TARO PHARMACEUTICALS INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
90711,Marketed,2014-05-28,02422425,ZOLEDRONIC ACID FOR INJECTION CONCENTRATE,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02422425,ZOLEDRONIC ACID FOR INJECTION CONCENTRATE (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
90712,Marketed,2014-05-28,02422433,ZOLEDRONIC ACID INJECTION,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02422433,ZOLEDRONIC ACID INJECTION (zoledronic acid (zoledronic acid monohydrate) 5 mg per 100 mL solution for injection vial) DR REDDY'S LABORATORIES LTD,Active,9012771,zoledronic acid 5 mg per 100 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
91878,Marketed,2016-02-10,02434458,ZOLEDRONIC ACID FOR INJECTION,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02434458,ZOLEDRONIC ACID FOR INJECTION (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) FRESENIUS KABI CANADA LTD,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
96212,Marketed,2019-01-29,02472805,ZOLEDRONIC ACID FOR INJECTION,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02472805,ZOLEDRONIC ACID FOR INJECTION (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) MARCAN PHARMACEUTICALS INC,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
97282,Marketed,2020-01-20,02482525,JAMP-ZOLEDRONIC ACID,1.0,M05BA08,Zoledronic acid,Solution,Intravenous,02482525,JAMP-ZOLEDRONIC ACID (zoledronic acid (zoledronic acid monohydrate) 4 mg per 5 mL solution for injection vial) JAMP PHARMA CORPORATION,Active,9012770,zoledronic acid 4 mg per 5 mL solution for injection vial,8001426,zoledronic acid,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),1.0,,
62089,Marketed,2023-01-12,02238660,ZOMIG,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02238660,ZOMIG (zolmitriptan 2.5 mg oral tablet) XEDITON PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66907,Marketed,2023-01-12,02243045,ZOMIG RAPIMELT,1.0,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02243045,ZOMIG RAPIMELT (zolmitriptan 2.5 mg orodispersible tablet) XEDITON PHARMACEUTICALS INC,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
73377,Marketed,2023-01-12,02248992,ZOMIG NASAL SPRAY,1.0,N02CC03,Zolmitriptan,Spray,"Oral,Nasal",02248992,ZOMIG NASAL SPRAY (zolmitriptan 2.5 mg per actuation nasal spray) XEDITON PHARMACEUTICALS INC,Active,9012552,zolmitriptan 2.5 mg per actuation nasal spray,8001105,zolmitriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
73378,Marketed,2023-01-12,02248993,ZOMIG NASAL SPRAY,1.0,N02CC03,Zolmitriptan,Spray,"Nasal,Oral",02248993,ZOMIG NASAL SPRAY (zolmitriptan 5 mg per actuation nasal spray) XEDITON PHARMACEUTICALS INC,Active,9012553,zolmitriptan 5 mg per actuation nasal spray,8001105,zolmitriptan,46713006,Nasal,385157007,Nasal spray,732981002,Actuation (unit of presentation),,,
79948,Marketed,2011-06-07,02313960,TEVA-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02313960,TEVA-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) TEVA CANADA LIMITED,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82803,Marketed,2011-06-07,02342545,TEVA-ZOLMITRIPTAN OD,1.0,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02342545,TEVA-ZOLMITRIPTAN OD (zolmitriptan 2.5 mg orodispersible tablet) TEVA CANADA LIMITED,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
84796,Marketed,2011-06-07,02362988,SANDOZ ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02362988,SANDOZ ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) SANDOZ CANADA INCORPORATED,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
84797,Marketed,2011-06-07,02362996,SANDOZ ZOLMITRIPTAN ODT,1.0,N02CC03,Zolmitriptan,Tablet (orally disintegrating),Oral,02362996,SANDOZ ZOLMITRIPTAN ODT (zolmitriptan 2.5 mg orodispersible tablet) SANDOZ CANADA INCORPORATED,Active,9003566,zolmitriptan 2.5 mg orodispersible tablet,8001105,zolmitriptan,26643006,Oral,447079001,Orodispersible tablet,732936001,Tablet (unit of presentation),,,
88433,Marketed,2025-10-27,02399458,MAR-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02399458,MAR-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90415,Marketed,2021-12-02,02419521,MINT-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02419521,MINT-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90614,Marketed,2015-07-13,02421534,NAT-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02421534,NAT-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) NATCO PHARMA (CANADA) INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
90627,Marketed,2022-04-13,02421623,JAMP-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02421623,JAMP-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
92700,Marketed,2015-10-14,02442655,ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02442655,ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) SANIS HEALTH INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97162,Marketed,2020-03-18,02481030,AURO-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02481030,AURO-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) AURO PHARMA INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97948,Marketed,2026-01-30,02489392,NRA-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02489392,NRA-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) NORA PHARMA INC,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
100209,Marketed,2023-01-11,02512831,BIO-ZOLMITRIPTAN,1.0,N02CC03,Zolmitriptan,Tablet,Oral,02512831,BIO-ZOLMITRIPTAN (zolmitriptan 2.5 mg oral tablet) BIOMED PHARMA,Active,9003315,zolmitriptan 2.5 mg oral tablet,8001105,zolmitriptan,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
85559,Marketed,2019-07-05,02370433,SUBLINOX,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02370433,"SUBLINOX (zolpidem tartrate 10 mg sublingual tablet) BAUSCH HEALTH, CANADA INC.",Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
87699,Marketed,2019-07-05,02391678,SUBLINOX,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02391678,"SUBLINOX (zolpidem tartrate 5 mg sublingual tablet) BAUSCH HEALTH, CANADA INC.",Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
91923,Marketed,2015-02-13,02434946,APO-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02434946,APO-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) APOTEX INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
92048,Marketed,2015-02-13,02436159,APO-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436159,APO-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) APOTEX INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
92051,Marketed,2016-12-13,02436175,PMS-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436175,PMS-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) PHARMASCIENCE INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
92052,Marketed,2016-12-13,02436183,PMS-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02436183,PMS-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) PHARMASCIENCE INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
96216,Marketed,2021-03-19,02472821,MINT-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02472821,MINT-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) MINT PHARMACEUTICALS INC,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
96217,Marketed,2021-03-19,02472848,MINT-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02472848,MINT-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) MINT PHARMACEUTICALS INC,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
102606,Marketed,2023-10-30,02537346,PRO-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02537346,PRO-ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) PRO DOC LIMITEE,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
102607,Marketed,2023-10-30,02537354,PRO-ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02537354,PRO-ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) PRO DOC LIMITEE,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
102928,Marketed,2024-07-09,02540592,JAMP ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02540592,JAMP ZOLPIDEM ODT (zolpidem tartrate 5 mg sublingual tablet) JAMP PHARMA CORPORATION,Active,9014746,zolpidem tartrate 5 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
102929,Marketed,2024-07-09,02540606,JAMP ZOLPIDEM ODT,1.0,N05CF02,Zolpidem,Tablet (orally disintegrating),Sublingual,02540606,JAMP ZOLPIDEM ODT (zolpidem tartrate 10 mg sublingual tablet) JAMP PHARMA CORPORATION,Active,9014745,zolpidem tartrate 10 mg sublingual tablet,8001121,zolpidem,37839007,Sublingual,385055001,Tablet,732936001,Tablet (unit of presentation),,,
12426,Marketed,2006-06-13,01926799,IMOVANE,1.0,N05CF01,Zopiclone,Tablet,Oral,01926799,IMOVANE (zopiclone 7.5 mg oral tablet) SANOFI-AVENTIS CANADA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
43233,Marketed,1996-09-19,02218313,APO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02218313,APO-ZOPICLONE (zopiclone 7.5 mg oral tablet) APOTEX INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
64177,Marketed,1999-08-04,02240606,PMS-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02240606,PMS-ZOPICLONE (zopiclone 7.5 mg oral tablet) PHARMASCIENCE INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
66208,Marketed,2020-08-13,02242481,TEVA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02242481,TEVA-ZOPICLONE (zopiclone 7.5 mg oral tablet) TEVA CANADA LIMITED,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
67334,Marketed,2001-02-15,02243426,PMS-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02243426,PMS-ZOPICLONE (zopiclone 5 mg oral tablet) PHARMASCIENCE INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
69081,Marketed,2002-06-04,02245077,APO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02245077,APO-ZOPICLONE (zopiclone 5 mg oral tablet) APOTEX INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
70717,Marketed,2020-08-13,02246534,TEVA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02246534,TEVA-ZOPICLONE (zopiclone 5 mg oral tablet) TEVA CANADA LIMITED,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76362,Marketed,2006-10-10,02278030,RIVA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02278030,RIVA-ZOPICLONE (zopiclone 5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76363,Marketed,2008-11-14,02278049,RIVA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02278049,RIVA-ZOPICLONE (zopiclone 7.5 mg oral tablet) LABORATOIRE RIVA INC.,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
76809,Marketed,2013-10-18,02282445,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02282445,ZOPICLONE (zopiclone 7.5 mg oral tablet) SANIS HEALTH INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79861,Marketed,2008-07-09,02313065,PRO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02313065,PRO-ZOPICLONE (zopiclone 5 mg oral tablet) PRO DOC LIMITEE,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
79862,Marketed,2008-07-09,02313073,PRO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02313073,PRO-ZOPICLONE (zopiclone 7.5 mg oral tablet) PRO DOC LIMITEE,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
82952,Marketed,2013-10-18,02344122,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02344122,ZOPICLONE (zopiclone 5 mg oral tablet) SANIS HEALTH INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87144,Marketed,2018-07-26,02385821,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02385821,ZOPICLONE (zopiclone 5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87145,Marketed,2018-07-26,02385848,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02385848,ZOPICLONE (zopiclone 7.5 mg oral tablet) SIVEM PHARMACEUTICALS ULC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87237,Marketed,2013-04-17,02386771,MAR-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02386771,MAR-ZOPICLONE (zopiclone 5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87238,Marketed,2013-04-17,02386798,MAR-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02386798,MAR-ZOPICLONE (zopiclone 7.5 mg oral tablet) MARCAN PHARMACEUTICALS INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87703,Marketed,2012-10-10,02391716,MINT-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02391716,MINT-ZOPICLONE (zopiclone 5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
87704,Marketed,2012-10-10,02391724,MINT-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02391724,MINT-ZOPICLONE (zopiclone 7.5 mg oral tablet) MINT PHARMACEUTICALS INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89162,Marketed,2014-01-08,02406969,JAMP-ZOPICLONE TABLETS,1.0,N05CF01,Zopiclone,Tablet,Oral,02406969,JAMP-ZOPICLONE TABLETS (zopiclone 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
89163,Marketed,2014-11-19,02406977,JAMP-ZOPICLONE TABLETS,1.0,N05CF01,Zopiclone,Tablet,Oral,02406977,JAMP-ZOPICLONE TABLETS (zopiclone 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
94567,Marketed,2017-01-01,02458543,PMS-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02458543,PMS-ZOPICLONE (zopiclone 3.75 mg oral tablet) PHARMASCIENCE INC,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95631,Marketed,2018-04-16,02467941,M-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02467941,M-ZOPICLONE (zopiclone 5 mg oral tablet) MANTRA PHARMA INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95632,Marketed,2018-04-16,02467968,M-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02467968,M-ZOPICLONE (zopiclone 7.5 mg oral tablet) MANTRA PHARMA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95682,Marketed,2021-04-23,02468395,JAMP-ZOPICLONE TABLETS,1.0,N05CF01,Zopiclone,Tablet,Oral,02468395,JAMP-ZOPICLONE TABLETS (zopiclone 3.75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95692,Marketed,2018-08-07,02468492,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02468492,ZOPICLONE (zopiclone 5 mg oral tablet) ALTAMED PHARMA,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
95781,Marketed,2018-08-07,02469154,ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02469154,ZOPICLONE (zopiclone 7.5 mg oral tablet) ALTAMED PHARMA,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96656,Marketed,2018-07-25,02475839,AG-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02475839,AG-ZOPICLONE (zopiclone 5 mg oral tablet) ANGITA PHARMA INC.,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96657,Marketed,2018-07-25,02475847,AG-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02475847,AG-ZOPICLONE (zopiclone 7.5 mg oral tablet) ANGITA PHARMA INC.,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96835,Marketed,2018-08-30,02477378,NRA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02477378,NRA-ZOPICLONE (zopiclone 5 mg oral tablet) NORA PHARMA INC,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
96836,Marketed,2018-08-30,02477386,NRA-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02477386,NRA-ZOPICLONE (zopiclone 7.5 mg oral tablet) NORA PHARMA INC,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97135,Marketed,2019-06-10,02481006,BIO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02481006,BIO-ZOPICLONE (zopiclone 5 mg oral tablet) BIOMED PHARMA,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
97136,Marketed,2019-06-10,02481014,BIO-ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02481014,BIO-ZOPICLONE (zopiclone 7.5 mg oral tablet) BIOMED PHARMA,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103814,Marketed,2025-03-26,02549271,JAMP ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02549271,JAMP ZOPICLONE (zopiclone 3.75 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000995,zopiclone 3.75 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103816,Marketed,2025-08-08,02549298,JAMP ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02549298,JAMP ZOPICLONE (zopiclone 5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000779,zopiclone 5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
103817,Marketed,2025-08-28,02549301,JAMP ZOPICLONE,1.0,N05CF01,Zopiclone,Tablet,Oral,02549301,JAMP ZOPICLONE (zopiclone 7.5 mg oral tablet) JAMP PHARMA CORPORATION,Active,9000370,zopiclone 7.5 mg oral tablet,8000143,zopiclone,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49241,Marketed,1997-05-02,02230402,CLOPIXOL,1.0,N05AF05,Zuclopenthixol,Tablet,Oral,02230402,CLOPIXOL (zuclopenthixol (zuclopenthixol hydrochloride) 10 mg oral tablet) LUNDBECK CANADA INC,Active,9003092,zuclopenthixol (zuclopenthixol hydrochloride) 10 mg oral tablet,8001547,zuclopenthixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49242,Marketed,1997-05-02,02230403,CLOPIXOL,1.0,N05AF05,Zuclopenthixol,Tablet,Oral,02230403,CLOPIXOL (zuclopenthixol (zuclopenthixol hydrochloride) 25 mg oral tablet) LUNDBECK CANADA INC,Active,9003093,zuclopenthixol (zuclopenthixol hydrochloride) 25 mg oral tablet,8001547,zuclopenthixol,26643006,Oral,421026006,Oral tablet,732936001,Tablet (unit of presentation),,,
49244,Marketed,1997-05-02,02230405,CLOPIXOL ACUPHASE ,1.0,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700636,CLOPIXOL ACUPHASE  (zuclopenthixol acetate 50 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012876,zuclopenthixol acetate 50 mg per 1 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
49244,Marketed,1997-05-02,02230405,CLOPIXOL ACUPHASE ,1.0,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700637,CLOPIXOL ACUPHASE  (zuclopenthixol acetate 100 mg per 2 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012875,zuclopenthixol acetate 100 mg per 2 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
49245,Marketed,1997-05-02,02230406,CLOPIXOL DEPOT,1.0,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700638,CLOPIXOL DEPOT (zuclopenthixol decanoate 200 mg per mL solution for injection 10 mL vial) LUNDBECK CANADA INC,Active,9012878,zuclopenthixol decanoate 200 mg per mL solution for injection 10 mL vial,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,733026001,Vial (unit of presentation),,,
49245,Marketed,1997-05-02,02230406,CLOPIXOL DEPOT,1.0,N05AF05,Zuclopenthixol,Solution,Intramuscular,77700639,CLOPIXOL DEPOT (zuclopenthixol decanoate 200 mg per 1 mL solution for injection ampoule) LUNDBECK CANADA INC,Active,9012877,zuclopenthixol decanoate 200 mg per 1 mL solution for injection ampoule,8001547,zuclopenthixol,738984000,Parenteral,385219001,Solution for injection,732978007,Ampule (unit of presentation),,,
